PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Long, MY; Thornton, K				Long, MY; Thornton, K			Gene duplication and evolution	SCIENCE			English	Editorial Material							PRESERVATION; DROSOPHILA		Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Univ Chicago, Comm Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Long, MY (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.		Vision, Todd J/B-4867-2010	Vision, Todd J/0000-0002-6133-2581; Thornton, Kevin/0000-0003-0743-4445				Force A, 1999, GENETICS, V151, P1531; Li W.H., 1997, MOL EVOLUTION; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2000, GENETICS, V154, P459; Petrov DA, 1996, NATURE, V384, P346, DOI 10.1038/384346a0; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Wang W, 2000, MOL BIOL EVOL, V17, P1294, DOI 10.1093/oxfordjournals.molbev.a026413; Weichenhan D, 1998, CYTOGENET CELL GENET, V80, P226, DOI 10.1159/000014985; Zeng LW, 1998, GENETICA, V102-3, P369, DOI 10.1023/A:1017035109224	9	62	65	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1551	1551						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533445				2022-12-01	WOS:000170802900001
J	Hochhaus, A; Kreil, S; Corbin, A; La Rosee, P; Lahaye, T; Berger, U; Cross, NCP; Linkesch, W; Druker, BJ; Hehlmann, R				Hochhaus, A; Kreil, S; Corbin, A; La Rosee, P; Lahaye, T; Berger, U; Cross, NCP; Linkesch, W; Druker, BJ; Hehlmann, R			Roots of clinical resistance to STI-571 cancer therapy	SCIENCE			English	Editorial Material									Univ Heidelberg, Fak Klin Med Mannheim, Med Klin 3, D-6800 Mannheim, Germany; Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97207 USA; Hammersmith Hosp, Imperial Coll Sch med, Dept Haematol, London, England; Karl Franzens Univ Graz, Med Klin, Hamatol Abt, Graz, Austria	Ruprecht Karls University Heidelberg; Oregon Health & Science University; Imperial College London; University of Graz	Hochhaus, A (corresponding author), Univ Heidelberg, Fak Klin Med Mannheim, Med Klin 3, D-6800 Mannheim, Germany.	hochhaus@uni-hd.de	D'Incalci, Maurizio/AAA-9021-2020; Cross, Nicholas/B-4817-2009	D'Incalci, Maurizio/0000-0001-8784-1360; Cross, Nicholas/0000-0001-5481-2555; GAMBACORTI PASSERINI, CARLO/0000-0001-6058-515X; Hochhaus, Andreas/0000-0003-0626-0834; La Rosee, Paul/0000-0002-6758-7809; Druker, Brian/0000-0001-8331-8206				Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; *GENB, U07563 GENB; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Senechal K, 1998, MOL CELL BIOL, V18, P5082, DOI 10.1128/MCB.18.9.5082	4	233	243	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2001	293	5538					2163	2163						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11567109				2022-12-01	WOS:000171139400002
J	Matsumoto, K; Yoshitomi, H; Rossant, J; Zaret, KS				Matsumoto, K; Yoshitomi, H; Rossant, J; Zaret, KS			Liver organogenesis promoted by endothelial cells prior to vascular function	SCIENCE			English	Article							HEPATOCYTE GROWTH-FACTOR; TYROSINE KINASE; ANGIOGENESIS INHIBITOR; TIE2 RECEPTOR; ANGIOPOIETIN-1; VASCULOGENESIS; ANTAGONIST; HGF/NK4; LIGAND; FLK-1	The embryonic role of endothelial cells and nascent vessels in promoting organogenesis, prior to vascular function, is unclear. We find that early endothelial cells in mouse embryos surround newly specified hepatic endoderm and delimit the mesenchymal domain into which the Liver bud grows. In flk-1 mutant embryos, which lack endothelial cells, hepatic specification occurs, but liver morphogenesis fails prior to mesenchyme invasion. We developed an embryo tissue explant system that permits liver bud vasculogenesis and show that in the absence of endothelial cells, or when the latter are inhibited, there is a selective defect in hepatic outgrowth. We conclude that vasculogenic endothelial cells and nascent vessels are critical for the earliest stages of organogenesis, prior to blood vessel function.	Fox Chase Canc Ctr, Program Cell & Dev Biol, Philadelphia, PA 19111 USA; Osaka Univ, Grad Sch Med, Course Adv Med, Div Mol Regenerat Med, Osaka 5650871, Japan; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5T 1K5, Canada	Fox Chase Cancer Center; Osaka University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Zaret, KS (corresponding author), Fox Chase Canc Ctr, Program Cell & Dev Biol, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	zaret@fccc.edu	Matsumoto, Kunio/D-8441-2015; Yoshitomi, Hideyuki/AAN-8812-2020	Matsumoto, Kunio/0000-0002-6532-4482; Yoshitomi, Hideyuki/0000-0003-2911-8056	NCI NIH HHS [CA06297] Funding Source: Medline; NIGMS NIH HHS [GM36477] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036477, R01GM036477] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barbera JPM, 2000, DEVELOPMENT, V127, P2433; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Date K, 1997, FEBS LETT, V420, P1, DOI 10.1016/S0014-5793(97)01475-0; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; Gale NW, 1999, GENE DEV, V13, P1055, DOI 10.1101/gad.13.9.1055; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; KINGSBURY JW, 1956, ANAT RECORD, V124, P165, DOI 10.1002/ar.1091240204; Kuba K, 2000, CANCER RES, V60, P6737; LEDOUARIN NM, 1975, MED BIOL, V53, P427; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; OELRICHS RB, 1993, ONCOGENE, V8, P11; Ohmichi H, 1998, DEVELOPMENT, V125, P1315; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; PAUL J, 1969, CELL TISSUE KINET, V2, P283, DOI 10.1111/j.1365-2184.1969.tb00238.x; QUINN TP, 1993, P NATL ACAD SCI USA, V90, P7533, DOI 10.1073/pnas.90.16.7533; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; ROSS MA, IN PRESS HEPATOLOGY; Rossi JM, 2001, GENE DEV, V15, P1998, DOI 10.1101/gad.904601; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SHERER GK, 1975, DEV BIOL, V46, P281, DOI 10.1016/0012-1606(75)90105-0; SHERER GK, 1991, DEV VASCULAR SYSTEM, V14, P37; Sosa-Pineda B, 2000, NAT GENET, V25, P254, DOI 10.1038/76996; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Takebayashi-Suzuki K, 2000, DEVELOPMENT, V127, P3523; VECCHI A, 1994, EUR J CELL BIOL, V63, P247; WIDMANN JJ, 1975, AM J PATHOL, V80, P349; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; YAMANE A, 1994, ONCOGENE, V9, P2683	31	610	645	3	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					559	563		10.1126/science.1063889	http://dx.doi.org/10.1126/science.1063889			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11577199				2022-12-01	WOS:000171695600037
J	Sanchez, AM; Schreiber, GB; Bethel, J; McCurdy, PR; Glynn, SA; Williams, AE; Gilcher, R				Sanchez, AM; Schreiber, GB; Bethel, J; McCurdy, PR; Glynn, SA; Williams, AE; Gilcher, R		Retrovirus Epidemiology Donor Stud	Prevalence, donation practices, and risk assessment of blood donors with hemochromatosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-B ANTIGEN; HEREDITARY HEMOCHROMATOSIS; UNITED-STATES; TRANSFUSION; EXCLUSION; ANTIBODY; IMPACT	Context Despite changes in eligibility policies, practical barriers limit blood donations from individuals with hemochromatosis. Increased knowledge of hemochromatosis donor characteristics may help foster further changes that will promote more donations. Objectives To estimate the prevalence of donors diagnosed as having hemochromatosis and to compare rates of unreported deferrable risks for transfusion-transmissible viral infections (TTVIs), positive screening test results for TTVIs, and donation patterns between hemochromatosis patient donors and donors reporting no medical conditions necessitating phlebotomy (non-health-related donors). Design An anonymous mail survey conducted in 1998 as part of the ongoing Retrovirus Epidemiology Donor Study. Setting and Participants Among a stratified probability sample of 92581 blood donors from 8 geographically diverse US blood centers, 52650 (57%) responded. Main Outcome Measures Prevalence of hemochromatosis among blood donors; prevalence of unreported deferrable risks and positive screening test results for TTVIs among hemochromatosis patient donors vs non-health-related donors. Results One hundred ninety-seven respondents (0.4%) identified themselves as hemochromatosis patients and 50079 (95.1%) as non-health-related donors. An estimated 0.8% of all donations were from hemochromatosis patients, 45.8% of whom reported that they had donated blood to treat their illness. The proportion of repeat donors was higher in hemochromatosis patients than in non-health-related donors (83.5% vs 76.5%; P = .03). Among repeat donors, 68.7% of hemochromatosis patients reported donating at least 3 times in the past year compared with 49.1% of non-health-related donors (P<.001). The prevalence of unreported deferrable risks for TTVIs was similar in hemochromatosis patients (2.0%) and non-health-related donors (3.1%) as was the overall prevalence of positive screening test results (1.3% of hemochromatosis patients vs 1.6% of non-health-related donors). Conclusions Although significant numbers of hemochromatosis patients reported donating blood for therapeutic reasons, our findings suggest that this population does not present a greater risk to blood safety than other donors.	WESTAT Corp, Rockville, MD 20850 USA; Amer Red Cross, Jerome H Holland Lab, Rockville, MD USA; NHLBI, Bethesda, MD 20892 USA; Oklahoma Blood Inst, Sylvan N Goldman Ctr, Oklahoma City, OK USA	Westat; American Red Cross; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Sanchez, AM (corresponding author), WESTAT Corp, WB 266,1650 Res Blvd, Rockville, MD 20850 USA.				NHLBI NIH HHS [N01-HB-97079, N01-HB-97081, N01-HB-97082, N01-HB-97078, N01-HB-97077, N01-HB-47114, N01-HB-97080] Funding Source: Medline; DIVISION OF BLOOD DISEASES AND RESOURCES [N01HB097078, N01HB097082, N01HB097081, N01HB097080, N01HB097077, N01HB047114, N01HB097079] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF BLOOD DISEASES AND RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AACH RD, 1980, ANN INTERN MED, V92, P539, DOI 10.7326/0003-4819-92-4-539; ALTER HJ, 1972, ANN INTERN MED, V77, P691, DOI 10.7326/0003-4819-77-5-691; Bartolotta A, 1999, POLYM ENG SCI, V39, P549, DOI 10.1002/pen.11445; Barton JC, 1998, ANN INTERN MED, V129, P932, DOI 10.7326/0003-4819-129-11_Part_2-199812011-00003; Bothwell TH, 1998, SEMIN HEMATOL, V35, P55; CHERUBIN CE, 1971, TRANSFUSION, V11, P25, DOI 10.1111/j.1537-2995.1971.tb04370.x; Conry-Cantilena C, 2000, HEMOCHROMATOSIS: GENETICS, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT, P564; *CTR BIOL EV RES, 2001, GUID IND VAR BLOOD C; CUMMING PD, 1989, NEW ENGL J MED, V321, P941, DOI 10.1056/NEJM198910053211405; *CYT SOFTW CO, 1999, STATXACT 4 SOFTW PRO; DOMEN RE, 1995, TRANSFUS MED REV, V9, P53, DOI 10.1016/S0887-7963(05)80030-6; Eastlund T, 1998, TRANSFUSION, V38, P874, DOI 10.1046/j.1537-2995.1998.38998409009.x; EDWARDS CQ, 1993, NEW ENGL J MED, V328, P1616; EDWARDS CQ, 1988, NEW ENGL J MED, V318, P1355, DOI 10.1056/NEJM198805263182103; Glynn SA, 2000, JAMA-J AM MED ASSOC, V284, P229, DOI 10.1001/jama.284.2.229; GRINDON AJ, 1993, JAMA-J AM MED ASSOC, V270, P880; Jeffrey G, 1999, TRANSFUSION, V39, P549, DOI 10.1046/j.1537-2995.1999.39060549.x; JOHNSON ES, 1994, TRANSFUSION, V34, P769, DOI 10.1046/j.1537-2995.1994.34994378277.x; LEGGETT BA, 1990, BRIT J HAEMATOL, V74, P525, DOI 10.1111/j.1365-2141.1990.tb06345.x; Levstik M, 1998, CAN J GASTROENTEROL, V12, P61, DOI 10.1155/1998/590428; McCullough J, 2000, TRANSFUSION, V40, P143; McDonnell SM, 1999, TRANSFUSION, V39, P651, DOI 10.1046/j.1537-2995.1999.39060651.x; MCLAREN CE, 1995, BLOOD, V86, P2021, DOI 10.1182/blood.V86.5.2021.bloodjournal8652021; Mitka M, 2001, JAMA-J AM MED ASSOC, V285, P1694, DOI 10.1001/jama.285.13.1694; Munsterman KA, 1998, TRANSFUSION, V38, P45, DOI 10.1046/j.1537-2995.1998.38198141497.x; Niederau C, 1996, GASTROENTEROLOGY, V110, P1107, DOI 10.1053/gast.1996.v110.pm8613000; PILIAVIN JA, 1990, TRANSFUSION, V30, P444, DOI 10.1046/j.1537-2995.1990.30590296381.x; Powell LW, 1996, GASTROENTEROLOGY, V110, P1304, DOI 10.1053/gast.1996.v110.agast961304; Sacher RA, 1999, TRANSFUSION, V39, P551, DOI 10.1046/j.1537-2995.1999.39060551.x; Seeff L B, 1988, Transfus Med Rev, V2, P204, DOI 10.1016/S0887-7963(88)70046-2; SZMUNESS W, 1973, J INFECT DIS, V127, P17, DOI 10.1093/infdis/127.1.17; Tan L, 1999, TRANSFUSION, V39, P1018, DOI 10.1046/j.1537-2995.1999.39091018.x; THOMAS DG, 1971, APPLIED STATISTICS, V20, P105, DOI DOI 10.2307/2346643; Walker EM, 1998, ANN CLIN LAB SCI, V28, P300; *WEST INC, 1994, WESVAR SAS PROC; Williams AE, 1997, JAMA-J AM MED ASSOC, V277, P967, DOI 10.1001/jama.277.12.967; Witte DL, 1996, CLIN CHIM ACTA, V245, P139, DOI 10.1016/0009-8981(95)06212-2; Zuck TF, 1995, TRANSFUSION, V35, P944, DOI 10.1046/j.1537-2995.1995.351196110900.x; 1997, P 146 ANN M HOUS DEL	39	22	22	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2001	286	12					1475	1481		10.1001/jama.286.12.1475	http://dx.doi.org/10.1001/jama.286.12.1475			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	475UX	11572740	Bronze			2022-12-01	WOS:000171188600025
J	Nielsen, EE; Hansen, MM; Schmidt, C; Meldrup, D; Gronkjaer, P				Nielsen, EE; Hansen, MM; Schmidt, C; Meldrup, D; Gronkjaer, P			Fisheries - Population of origin of Atlantic cod	NATURE			English	Article									Danish Inst Fisheries Res, Dept Inland Fisheries, DK-8600 Silkeborg, Denmark; Univ Aarhus, Dept Marine Ecol, DK-8200 Aarhus, Denmark	Aarhus University	Nielsen, EE (corresponding author), Danish Inst Fisheries Res, Dept Inland Fisheries, DK-8600 Silkeborg, Denmark.		Nielsen, Einar/AAT-1737-2021; Hansen, Michael/I-5979-2013; Hansen, Michael M./Z-5047-2019; Grønkjær, Peter/A-3697-2008; Hansen, Michael/C-3336-2008	Nielsen, Einar/0000-0002-7009-9814; Hansen, Michael/0000-0001-5372-4828; Hansen, Michael M./0000-0001-5372-4828; Grønkjær, Peter/0000-0003-1337-4661; 				BAKER CS, 1994, SCIENCE, V265, P1538, DOI 10.1126/science.265.5178.1538; *INT COUNC EXPL SE, 200 AFCM INT COUNC E; Pritchard JK, 2000, GENETICS, V155, P945; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; Ward RD, 2000, HYDROBIOLOGIA, V420, P191, DOI 10.1023/A:1003928327503	5	108	112	0	30	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					272	272		10.1038/35095112	http://dx.doi.org/10.1038/35095112			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565021				2022-12-01	WOS:000171040500028
J	Freiman, RN; Albright, SR; Zheng, S; Sha, WC; Hammer, RE; Tjian, R				Freiman, RN; Albright, SR; Zheng, S; Sha, WC; Hammer, RE; Tjian, R			Requirement of tissue-selective TBP-associated factor TAF(II)105 in ovarian development	SCIENCE			English	Article							POLYMERASE-II TRANSCRIPTION; MOLECULAR-CLONING; TFIID COMPLEX; C-ELEGANS; ACTIVATION; SUBUNITS; DNA	Transcription factor TFIID, composed of TBP and TAF(11) subunits, is a central component of the RNA polymerase II machinery. Here, we report that the tissue-selective TAF(11)105 subunit of TFIID is essential for proper development and function of the mouse ovary. Female mice lacking TAF(11)105 are viable but infertile because of a defect in folliculogenesis correlating with restricted expression of TAF(11)105 in the granulosa cells of the ovarian follicle. Gene expression profiling has uncovered a defective inhibin-activin signaling pathway in TAF(11)105-deficient ovaries. Together, these studies suggest that TAF(11)105 mediates the transcription of a subset of genes required for proper folliculogenesis in the ovary and establishes TAF(11)105 as a cell type-specific component of the mammalian transcriptional machinery.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Tjian, R (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.							BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; Dantonel JC, 2000, MOL CELL, V6, P715, DOI 10.1016/S1097-2765(00)00069-1; Dikstein R, 1996, CELL, V87, P137, DOI 10.1016/S0092-8674(00)81330-6; Elvin JA, 1998, REV REPROD, V3, P183, DOI 10.1530/ror.0.0030183; FREIMAN RN, UNPUB; GOODRICH JA, 1993, CELL, V75, P519, DOI 10.1016/0092-8674(93)90386-5; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Hiller MA, 2001, GENE DEV, V15, P1021, DOI 10.1101/gad.869101; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; Kaltenbach L, 2000, MOL CELL, V6, P705, DOI 10.1016/S1097-2765(00)00068-X; Martianov I, 2001, MOL CELL, V7, P509, DOI 10.1016/S1097-2765(01)00198-8; Mengus G, 1997, GENE DEV, V11, P1381, DOI 10.1101/gad.11.11.1381; Sanders SL, 2000, J BIOL CHEM, V275, P13895, DOI 10.1074/jbc.275.18.13895; Tanese N, 1996, P NATL ACAD SCI USA, V93, P13611, DOI 10.1073/pnas.93.24.13611; Veenstra GJC, 2000, SCIENCE, V290, P2312, DOI 10.1126/science.290.5500.2312; VERRIJZER CP, 1994, SCIENCE, V264, P933, DOI 10.1126/science.8178153; Wolstein O, 2000, J BIOL CHEM, V275, P16459, DOI 10.1074/jbc.275.22.16459; Yamit-Hezi A, 1998, EMBO J, V17, P5161, DOI 10.1093/emboj/17.17.5161; Zhang D, 2001, SCIENCE, V292, P1153, DOI 10.1126/science.1059188	19	158	162	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					2084	2087		10.1126/science.1061935	http://dx.doi.org/10.1126/science.1061935			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557891				2022-12-01	WOS:000171028700073
J	Gifford, DK				Gifford, DK			Blazing pathways through genetic mountains	SCIENCE			English	Editorial Material								It is now widely accepted that high-throughput data sources will shed essential understanding on the inner workings of cellular and organism function. One key challenge is to distill the results of such experiments into an interpretable computational form that will be the basis of a predictive model. A predictive model represents the gold standard in understanding a biological system and will permit us to investigate the underlying cause of diseases and help us to develop therapeutics. Here I explore how discoveries can be based on high-throughput data sources and discuss how independent discoveries can be assembled into a comprehensive picture of cellular function.	MIT, Dept Comp Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Gifford, DK (corresponding author), MIT, Dept Comp Sci, 200 Technol Sq, Cambridge, MA 02139 USA.		Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647				HARTEMINK A, 2000, PAC S BIOC 2000 OAH; Hartemink A.J., 2001, THESIS MIT CAMBRIDGE; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; PEER D, 2001, 9 C INT SYST MOL BIO	5	18	21	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					2049	2051		10.1126/science.1065113	http://dx.doi.org/10.1126/science.1065113			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557882				2022-12-01	WOS:000171028700063
J	Krimpenfort, P; Quon, KC; Mooi, WJ; Loonstra, A; Berns, A				Krimpenfort, P; Quon, KC; Mooi, WJ; Loonstra, A; Berns, A			Loss of p16(Ink4a) confers susceptibility to metastatic melanoma in mice	NATURE			English	Article							TUMOR SUPPRESSION; G(1) CONTROL; INK4A LOCUS; IN-VITRO; SENESCENCE; MUTATIONS; GROWTH; DISRUPTION; P14(ARF); DELETION	CDKN2A (INK4a/ARF) is frequently disrupted in various types of human cancer, and germline mutations of this locus can confer susceptibility to melanoma and other tumours(1). However, because CDKN2A encodes two distinct cell cycle inhibitory proteins, p16(INK4a) and p14(ARF) (p19(Arf) in mice)(2), the mechanism of tumour suppression by CDKN2A has remained controversial. Genetic disruption of Cdkn2a(p19(Arf)) (hereafter Arf) alone predisposes mice to tumorigenesis(3), demonstrating that Arf is a tumour-suppressor gene in mice. We mutated mice specifically in Cdkn2a(p16(Ink4a)) (hereafter Ink4a). Here we demonstrate that these mice, designated Ink4a*/*, do not show a significant predisposition to spontaneous tumour formation within 17 months. Embryo fibroblasts derived from them proliferate normally, are mortal, and are not transformed by oncogenic HRAS. The very mild phenotype of the Ink4a*/* mice implies that the very strong phenotypes of the original Ink4a/Arf(Delta2,3) mice were primarily or solely due to loss of Arf. However, Ink4a*(/2 Delta ,3) mice that are deficient for Ink4a and heterozygous for Arf spontaneously develop a wide spectrum of tumours, including melanoma. Treatment of these mice with the carcinogen 7,12-dimethylbenzanthracene (DMBA) results in an increased incidence of melanoma, with frequent metastases. Our results show that, in the mouse, Ink4a is a tumour-suppressor gene that, when lost, can recapitulate the tumour predisposition seen in humans.	Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute	Berns, A (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	tberns@nki.nl						Arap W, 1997, ONCOGENE, V14, P603, DOI 10.1038/sj.onc.1200870; Burri N, 2001, LAB INVEST, V81, P217, DOI 10.1038/labinvest.3780230; Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; HARVEY M, 1993, ONCOGENE, V8, P2457; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Kamijo T, 1999, CANCER RES, V59, P2217; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Peeper DS, 2001, NAT CELL BIOL, V3, P198, DOI 10.1038/35055110; Randerson-Moor JA, 2001, HUM MOL GENET, V10, P55, DOI 10.1093/hmg/10.1.55; Rizos H, 1997, ONCOGENE, V15, P515, DOI 10.1038/sj.onc.1201217; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Wright WE, 2001, CURR OPIN GENET DEV, V11, P98, DOI 10.1016/S0959-437X(00)00163-5; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	27	427	436	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2001	413	6851					83	86		10.1038/35092584	http://dx.doi.org/10.1038/35092584			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544530				2022-12-01	WOS:000170801200043
J	Blanck, HM; Khan, LK; Serdula, MK				Blanck, HM; Khan, LK; Serdula, MK			Use of nonprescription weight loss products - Results from a multistate survey	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIETARY-SUPPLEMENTS; UNITED-STATES; DOUBLE-BLIND; PHENYLPROPANOLAMINE; PLACEBO; OBESITY	Context Lifestyle changes to lose weight can be difficult; hence, both prescription and nonprescription diet products are appealing. Usage patterns of the nonprescription products phenylpropanolamine (PPA) and ephedra are of particular interest because of recent safety concerns. Objective To estimate the prevalence of overall and specific nonprescription weight loss product use by demographic characteristics, prescription diet pill use, diabetic status, and lifestyle choices. Design and Setting The Behavioral Risk Factor Surveillance System, a random-digit telephone survey conducted in 1998 in 5 states. Florida, Iowa, Michigan, West Virginia, and Wisconsin. Participants Population-based sample of 14679 non institutionalized adults IS years or older. Main Outcome Measures Prevalence of nonprescription weight loss product use in 1996-1998. Results Seven percent reported overall nonprescription weight loss product use, 2% reported PPA use, and 1% reported ephedra product use. Overall use was especially common among young obese women (28.4%). Moreover, 7.9% of normal-weight women reported use. There was no difference in nonprescription weight loss product use by daily consumption of fruits and vegetables; however, more users than nonusers reported being physically active (for those who exercised greater than or equal to 30 minutes 5 times per week, odds ratio, 1.5, 95% confidence interval, 1.2-2.0). Among prescription weight loss product users, 33.8% also took nonprescription product. Conclusions With increasing rates of obesity, nonprescription product use is likely to increase. Clinicians should know about their patients' use of both prescription and nonprescription weight loss products.	Ctr Dis Control & Prevent, Div Nutr & Phys Act, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Blanck, HM (corresponding author), Ctr Dis Control & Prevent, Div Nutr & Phys Act, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy NE,MS K-26, Atlanta, GA 30341 USA.							Allison DB, 2001, CRIT REV FOOD SCI, V41, P1, DOI 10.1080/20014091091661; ASTRUP A, 1991, METABOLISM, V40, P323, DOI 10.1016/0026-0495(91)90117-F; ASTRUP A, 1992, INT J OBESITY, V16, P269; BRADLEY JG, 1991, POSTGRAD MED, V90, P43; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; *FDA, 2000, PUBL HLTH ADV SUBJ S; *FDA, 2000, DIET SUPPL CONT SPH; Greenway F, 1999, OBES RES, V7, P370, DOI 10.1002/j.1550-8528.1999.tb00420.x; Gurley BJ, 2000, AM J HEALTH-SYST PH, V57, P963, DOI 10.1093/ajhp/57.10.963; Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502; Hankin J, 2000, J AM DIET ASSOC, V100, P419, DOI 10.1016/S0002-8223(00)00129-2; INSEL PA, 1991, BETA ADRENERGIC RECE, P295; Kernan WN, 2000, NEW ENGL J MED, V343, P1826, DOI 10.1056/NEJM200012213432501; LAKE CR, 1990, AM J MED, V89, P195, DOI 10.1016/0002-9343(90)90299-S; LEAVY AS, 1993, ANN INTERN MED 2, V119, P661; Lewis CJ, 2001, CRIT REV FOOD SCI, V41, P43, DOI 10.1080/20014091091724; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; NELSON DE, 1998, P SECT SURV METH AM; PENTEL P, 1984, JAMA-J AM MED ASSOC, V252, P1898, DOI 10.1001/jama.252.14.1898; Radimer KL, 2000, J AM DIET ASSOC, V100, P447, DOI 10.1016/S0002-8223(00)00137-1; SHAH BV, 1997, SUDAAN USERS MANUAL; U.S. Department of Health and Human Services, 1996, 76200 US DEP HLTH HU; WILLARD HF, 1990, CHROMOSOMES TODAY, V10, P47; 2000, FED REG, V65, P17477; 1997, FED REG, V62, P30677; [No title captured]	26	97	103	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2001	286	8					930	935		10.1001/jama.286.8.930	http://dx.doi.org/10.1001/jama.286.8.930			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465EU	11509057	Bronze			2022-12-01	WOS:000170577300027
J	Cliffe, S; Tookey, PA; Nicoll, A				Cliffe, S; Tookey, PA; Nicoll, A			Antenatal detection of HIV: national surveillance and unlinked anonymous survey	BRITISH MEDICAL JOURNAL			English	Article							TRANSMISSION		Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England; Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, HIV & STI Div, London NW9 5EQ, England	University of London; University College London; Public Health England	Cliffe, S (corresponding author), Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, 30 Guilford St, London WC1N 1EH, England.		Tookey, Pat A/G-2732-2010	Tookey, Pat A/0000-0001-6258-0387				*COMM DIS SURV CTR, 2001, COMMUNICAB DIS REP, P11; Duong T, 1999, BRIT MED J, V319, P1227, DOI 10.1136/bmj.319.7219.1227; *INT WORK PART, 1998, RED MOTH CHILD TRANS; Ratcliffe J, 1998, AIDS, V12, P1381, DOI 10.1097/00002030-199811000-00021; *UK HLTH DEP, 1999, TARG AIM RED NUMB CH	5	20	20	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2001	323	7309					376	377		10.1136/bmj.323.7309.376	http://dx.doi.org/10.1136/bmj.323.7309.376			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11509430	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000170581400021
J	Snaith, ML				Snaith, ML			Gout: diet and uric acid revisited	LANCET			English	Editorial Material							WEIGHT-LOSS; PLASMA; URATE		Univ Sheffield, Sch Med, Dept Rheumatol, Sheffield S10 2RX, S Yorkshire, England	University of Sheffield	Snaith, ML (corresponding author), Univ Sheffield, Sch Med, Dept Rheumatol, Sheffield S10 2RX, S Yorkshire, England.							Dessein PH, 2000, ANN RHEUM DIS, V59, P539, DOI 10.1136/ard.59.7.539; FACCHINI F, 1991, JAMA-J AM MED ASSOC, V266, P3008, DOI 10.1001/jama.266.21.3008; GERTLER MN, ANN INTERN MED, V34, P1421; GUTMAN AB, 1957, AM J MED, P23600; HAVELOCK E, 1904, STUDY BRIT GENIUS; MYERS AR, 1968, AM J MED, V45, P520, DOI 10.1016/0002-9343(68)90168-X; NICHOLLS A, 1972, LANCET, V2, P1223; Phillips M, 2000, ARTHRITIS RHEUM, V43, pS401; Porter R, 1998, GOUT PATRICIAN MALAD; RUNDLES RW, 1966, ANN INTERN MED, V64, P229, DOI 10.7326/0003-4819-64-2-229; SIMKIN PA, 1977, ANN INTERN MED, V86, P230, DOI 10.7326/0003-4819-86-2-230; TALBOTT JH, 1981, SEMIN ARTHRITIS RHEU, V11, P288, DOI 10.1016/0049-0172(81)90094-9; WROTMANN RL, 1997, ARTHRITIS ALLIED CON, P2078; WYNGAARDEN JB, 1974, AM J MED, V56, P651, DOI 10.1016/0002-9343(74)90632-9; YAMASHITA S, 1986, INT J OBESITY, V10, P255; YU TF, 1974, AM J MED, V56, P676, DOI 10.1016/0002-9343(74)90634-2	16	22	23	1	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 18	2001	358	9281					525	525		10.1016/S0140-6736(01)05745-2	http://dx.doi.org/10.1016/S0140-6736(01)05745-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464NB	11520519				2022-12-01	WOS:000170537700006
J	Rescigno, M; Borrow, P				Rescigno, M; Borrow, P			The host-pathogen interaction: New themes from dendritic cell biology	CELL			English	Review							MATURATION; VIRUS; INFECTION		Univ Milano Bicocca, Dept Biosci & Biotechnol U3, I-20126 Milan, Italy; Edward Jenner Inst Vaccine Res, Newbury RG20 7NN, Berks, England	University of Milano-Bicocca	Rescigno, M (corresponding author), Univ Milano Bicocca, Dept Biosci & Biotechnol U3, Piazza Sci 2, I-20126 Milan, Italy.		Rescigno, Maria/J-9704-2012	Rescigno, Maria/0000-0002-6464-509X; Borrow, Persephone/0000-0002-3877-9780				Cella M, 1999, J EXP MED, V189, P821, DOI 10.1084/jem.189.5.821; Engelmayer J, 1999, J IMMUNOL, V163, P6762; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gewirtz AT, 2001, J CLIN INVEST, V107, P99, DOI 10.1172/JCI10501; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Kaisho T, 2001, TRENDS IMMUNOL, V22, P78, DOI 10.1016/S1471-4906(00)01811-1; Larsson M, 2001, TRENDS IMMUNOL, V22, P141, DOI 10.1016/S1471-4906(01)01860-9; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; MacDonald GH, 2000, J VIROL, V74, P914, DOI 10.1128/JVI.74.2.914-922.2000; Neutra MR, 1999, CURR TOP MICROBIOL, V236, P17; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Salio M, 1999, EUR J IMMUNOL, V29, P3245, DOI 10.1002/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.0.CO;2-X; Stahl-Hennig C, 1999, SCIENCE, V285, P1261, DOI 10.1126/science.285.5431.1261; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900	15	113	119	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 10	2001	106	3					267	270		10.1016/S0092-8674(01)00454-8	http://dx.doi.org/10.1016/S0092-8674(01)00454-8			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509175	Bronze			2022-12-01	WOS:000170433300004
J	Leman, P; Strachan, D				Leman, P; Strachan, D			A case-control study of food poisoning seen at an accident and emergency department	LANCET			English	Article							CONSUMER	We investigated the hypothesis that sporadic food poisoning is a result of the consumption of food cooked or prepared outside the home. We did a case-control study, set in an urban emergency department, to find out the odds ratios for the risk of food poisoning associated with various patterns of consumption. We found that recent eating out (exposure on the day of or day before presentation) was associated with an odds ratio of 2.41 (95% Cl 1.29-4.50) for presenting with food poisoning.	St Thomas Hosp, Dept Accid & Emergency, London SE1 7EH, England; Univ London St Georges Hosp, Sch Med, Dept Publ Hlth Sci, London, England	Guy's & St Thomas' NHS Foundation Trust; St Georges University London	Leman, P (corresponding author), St Thomas Hosp, Dept Accid & Emergency, London SE1 7EH, England.							Bruhn CM, 1997, EMERG INFECT DIS, V3, P511, DOI 10.3201/eid0304.970415; Collins JE, 1997, EMERG INFECT DIS, V3, P471, DOI 10.3201/eid0304.970409; *DEP HLTH, 1992, PLCMO9214 DEP HLTH; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046	4	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2001	358	9279					387	388		10.1016/S0140-6736(01)05582-9	http://dx.doi.org/10.1016/S0140-6736(01)05582-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502323				2022-12-01	WOS:000170235100018
J	Wahlqvist, ML; Wattanapenpaiboon, N				Wahlqvist, ML; Wattanapenpaiboon, N			Hot foods - unexpected help with energy balance?	LANCET			English	Editorial Material									Monash Univ, Fac Med Nursing & Hlth Sci, Int Hlth & Dev Unit, Melbourne, Vic 3800, Australia	Monash University	Wahlqvist, ML (corresponding author), Monash Univ, Fac Med Nursing & Hlth Sci, Int Hlth & Dev Unit, Melbourne, Vic 3800, Australia.		Wahlqvist, Mark Lawrence/E-8800-2010					Cannon ME, 2001, MED J AUSTRALIA, V174, P520, DOI 10.5694/j.1326-5377.2001.tb143404.x; COLQUHOUN EQ, 1995, LIFE SCI, V57, P91, DOI 10.1016/0024-3205(95)00250-A; HENRY CJK, 1986, HUM NUTR-CLIN NUTR, V40C, P165; Kannar D, 2001, J AM COLL NUTR, V20, P225, DOI 10.1080/07315724.2001.10719036; McCrory MA, 1999, AM J CLIN NUTR, V69, P440; Organization WH, 1998, WELLB MEAS PRIM HLTH; Wahlqvist M.L., 1994, FUNCTIONAL FOODS DES, P71; Yoshioka M, 2001, BRIT J NUTR, V85, P203, DOI 10.1079/BJN2000224	8	32	32	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2001	358	9279					348	349		10.1016/S0140-6736(01)05586-6	http://dx.doi.org/10.1016/S0140-6736(01)05586-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502310				2022-12-01	WOS:000170235100005
J	Owen-Davies, J				Owen-Davies, J			North Korea's public health tragedy	LANCET			English	Article											Owen-Davies, J (corresponding author), 9 Cleveland Rd, London SW13 0AA, England.								0	6	6	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2001	357	9256					628	630		10.1016/S0140-6736(00)04062-9	http://dx.doi.org/10.1016/S0140-6736(00)04062-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558502				2022-12-01	WOS:000167119100036
J	CALDEIRA, K; KASTING, JF				CALDEIRA, K; KASTING, JF			THE LIFE-SPAN OF THE BIOSPHERE REVISITED	NATURE			English	Article							EARTHS EARLY ATMOSPHERE; DISSOLUTION; EVOLUTION; CO2; TEMPERATURES; FEEDBACK; GROWTH; CLOUD; VENUS	A DECADE ago, Lovelock and Whitfield1 raised the question of how much longer the biosphere can survive on Earth. They pointed out that, despite the current fossil-fuel induced increase in the atmospheric CO2 concentration, the long-term trend should be in the opposite direction: as increased solar luminosity warms the Earth, silicate rocks should weather more readily, causing atmospheric CO2 to decrease. In their model1, atmospheric CO2 falls below the critical level for C3 photosynthesis, 150 parts per million (p.p.m.), in only 100 Myr, and this is assumed to mark the demise of the biosphere as a whole. Here, we re-examine this problem using a more elaborate model that includes a more accurate treatment of the greenhouse effect of CO2 (refs 2-4), a biologically mediated weathering parameterization, and the realization that C4 photosynthesis can persist to much lower concentrations of atmospheric CO2(<10 p.p.m.)5,6. We find that a C4-plant-based biosphere could survive for at least another 0.9 Gyr to 1.5 Gyr after the present time, depending respectively on whether CO2 or temperature is the limiting factor. Within an additional 1 Gyr, Earth may lose its water to space, thereby following the path of its sister planet, Venus.	PENN STATE UNIV,DEPT GEOSCI,UNIV PK,PA 16802	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	CALDEIRA, K (corresponding author), PENN STATE UNIV,CTR EARTH SYST SCI,UNIV PK,PA 16802, USA.		Caldeira, Ken/E-7914-2011; Kasting, James/AAF-6851-2020	Caldeira, Ken/0000-0002-4591-643X; 				BAROSS JA, 1983, NATURE, V303, P423, DOI 10.1038/303423a0; BLUM A, 1988, NATURE, V331, P431, DOI 10.1038/331431a0; BROCK TD, 1985, SCIENCE, V230, P132, DOI 10.1126/science.230.4722.132; CALDEIRA K, 1991, GEOLOGY, V19, P204, DOI 10.1130/0091-7613(1991)019<0204:CPCPAT>2.3.CO;2; CHAMEIDES WL, 1984, J GEOPHYS RES-ATMOS, V89, P4739, DOI 10.1029/JD089iD03p04739; GOUGH DO, 1981, SOL PHYS, V74, P21, DOI 10.1007/BF00151270; Heath O. V. S., 1969, PHYSL ASPECTS PHOTOS; KASTING JF, 1988, ICARUS, V74, P472, DOI 10.1016/0019-1035(88)90116-9; KASTING JF, 1986, SCIENCE, V234, P1383, DOI 10.1126/science.11539665; KASTING JF, IN PRESS ICARUS; KASTING JF, 1989, PALAEOGEOGR PALAEOCL, V75, P83; LAGACHE M, 1976, GEOCHIM COSMOCHIM AC, V40, P157, DOI 10.1016/0016-7037(76)90173-3; LAGACHE M, 1965, B SOC FR MINERAL CR, V88, P223, DOI 10.3406/bulmi.1965.5840; LOVELOCK JE, 1982, NATURE, V296, P561, DOI 10.1038/296561a0; MANABE S, 1967, J ATMOS SCI, V24, P241, DOI 10.1175/1520-0469(1967)024<0241:TEOTAW>2.0.CO;2; MILLER AG, 1984, PLANT PHYSIOL, V75, P1064, DOI 10.1104/pp.75.4.1064; NEWMAN MJ, 1977, SCIENCE, V198, P1035, DOI 10.1126/science.198.4321.1035; PEARCY RW, 1984, PLANT CELL ENVIRON, V7, P1, DOI 10.1111/j.1365-3040.1984.tb01194.x; ROSSOW WB, 1982, SCIENCE, V217, P1245, DOI 10.1126/science.217.4566.1245; SACKMANN IJ, 1990, ASTROPHYS J, V360, P727, DOI 10.1086/169158; SILLEN LG, 1961, OCEANOGRAPHY, P549; SLEEP NH, 1989, NATURE, V342, P139, DOI 10.1038/342139a0; STETTER KO, 1986, THERMOPHILES GENERAL, P39; Stumm W., 1981, AQUAT CHEM; VOLK T, 1987, AM J SCI, V287, P763, DOI 10.2475/ajs.287.8.763; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; WATSON AJ, 1981, ICARUS, V48, P150, DOI 10.1016/0019-1035(81)90101-9; WOGELIUS RA, 1991, GEOCHIM COSMOCHIM AC, V55, P943, DOI 10.1016/0016-7037(91)90153-V	28	165	168	1	28	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	DEC 24	1992	360	6406					721	723		10.1038/360721a0	http://dx.doi.org/10.1038/360721a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KE472	11536510				2022-12-01	WOS:A1992KE47200027
J	STUART, JJ; BROWN, SJ; BEEMAN, RW; DENELL, RE				STUART, JJ; BROWN, SJ; BEEMAN, RW; DENELL, RE			A DEFICIENCY OF THE HOMEOTIC COMPLEX OF THE BEETLE TRIBOLIUM	NATURE			English	Article							GENE FUSHI-TARAZU; DROSOPHILA-MELANOGASTER; BITHORAX COMPLEX; MOLECULAR ANALYSIS; ANTENNAPEDIA GENE; SEGMENTATION; EMBRYO; ACTIVATION; HEAD	IN Drosophila, the establishment of regional commitments along most of the anterior/posterior axis of the developing embryo depends on two clusters of homeotic genes: the Antennapedia complex (ANT-C) and the bithorax complex (BX-C). The red flour beetle has a single complex (HOM-C) representing the homologues of the ANT-C and BX-C in juxtaposition 1. Beetles trans-heterozygous for two particular HOM-C mutations spontaneously generate a large deficiency, presumably by an exchange within the common region of two overlapping inversions. Genetic and molecular results indicate that this deficiency spans at least the interval between the Deformed and abdominal-A homologues. In deficiency homozygous embryos, all gnathal, thoracic and abdominal segments develop antennal appendages, suggesting that a gene(s) has been deleted that acts to distinguish trunk from head. There is no evidence that beetles have a homologue of the segmentation gene fushi tarazu of similar genomic location and function. On the basis of the genetic tractability 2, convenient genome size and organization of Tribolium 3, and its relatively long phylogenetic divergence from Drosophila (> 300 million years), we have integrated developmental genetic and molecular analyses of the HOM-C. We isolated about 70 mutations in the complex representing at least six complementation groups. The homeotic phenotypes of adults 2 and lethal embryos lead us to believe that these beetle genes are homologous with the Drosophila genes indicated in Fig. 1.	KANSAS STATE UNIV AGR & APPL SCI,DIV BIOL,ACKERT HALL,MANHATTAN,KS 66506; USDA ARS,N CENT REG,US GRAIN MKT RES LAB,MANHATTAN,KS 66502	Kansas State University; United States Department of Agriculture (USDA)				Brown, Susan/0000-0002-7984-0445				AKAM M, 1988, DEVELOPMENT, V104, P123; BEEMAN RW, 1987, NATURE, V327, P247, DOI 10.1038/327247a0; BEEMAN RW, 1989, DEV BIOL, V133, P196, DOI 10.1016/0012-1606(89)90311-4; BROWN SJ, 1990, INSECT BIOCHEM, V20, P185, DOI 10.1016/0020-1790(90)90011-I; CARROLL SB, 1990, CELL, V60, P9, DOI 10.1016/0092-8674(90)90711-M; CHADWICK R, 1987, EMBO J, V6, P779, DOI 10.1002/j.1460-2075.1987.tb04820.x; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; DUNCAN I, 1987, ANNU REV GENET, V21, P285, DOI 10.1146/annurev.genet.21.1.285; DUNCAN I, 1986, CELL, V47, P297, DOI 10.1016/0092-8674(86)90452-6; INGHAM PW, 1986, NATURE, V324, P592, DOI 10.1038/324592a0; LEWIS E, 1978, NATURE, V276, P141; MAHAFFEY JW, 1989, DEVELOPMENT, V105, P167; MAHAFFEY JW, 1989, DEV GENETICS HIGHER, P329; MARTINEZARIAS A, 1986, EMBO J, V5, P135, DOI 10.1002/j.1460-2075.1986.tb04187.x; MERRILL VKL, 1987, DEV BIOL, V122, P379, DOI 10.1016/0012-1606(87)90303-4; NUSSLEINVOLHARD C, 1985, COLD SPRING HARB SYM, V50, P145, DOI 10.1101/SQB.1985.050.01.020; REGULSKI M, 1987, EMBO J, V6, P767, DOI 10.1002/j.1460-2075.1987.tb04819.x; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; STRUHL G, 1981, NATURE, V292, P635, DOI 10.1038/292635a0; Sturtevant AH, 1936, GENETICS, V21, P554; WAKIMOTO BT, 1981, DEV BIOL, V81, P51, DOI 10.1016/0012-1606(81)90347-X; WALLDORF U, 1989, P NATL ACAD SCI USA, V86, P9971, DOI 10.1073/pnas.86.24.9971; WEINER AJ, 1984, CELL, V37, P843, DOI 10.1016/0092-8674(84)90419-7; WINSLOW GM, 1989, CELL, V57, P1017, DOI 10.1016/0092-8674(89)90340-1	24	146	148	0	11	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 7	1991	350	6313					72	74		10.1038/350072a0	http://dx.doi.org/10.1038/350072a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA693	11536480				2022-12-01	WOS:A1991FA69300068
J	GEHRING, CA; WILLIAMS, DA; CODY, SH; PARISH, RW				GEHRING, CA; WILLIAMS, DA; CODY, SH; PARISH, RW			PHOTOTROPISM AND GEOTROPISM IN MAIZE COLEOPTILES ARE SPATIALLY CORRELATED WITH INCREASES IN CYTOSOLIC FREE CALCIUM	NATURE			English	Article									LA TROBE UNIV, CTR PROT & ENZYME TECHNOL, BUNDOORA, VIC 3083, AUSTRALIA; UNIV MELBOURNE, DEPT PHYSIOL, PARKVILLE, VIC 3052, AUSTRALIA	La Trobe University; University of Melbourne	GEHRING, CA (corresponding author), LA TROBE UNIV, DEPT BOT, BUNDOORA, VIC 3083, AUSTRALIA.			Gehring, Christoph/0000-0003-4355-4591				BASKIN TI, 1986, PLANT PHYSIOL, V81, P306, DOI 10.1104/pp.81.1.306; BLOWERS DP, 1988, 2ND MESSENGERS PLANT, P1; BRIGGS WR, 1963, ANNU REV PLANT PHYS, V14, P311, DOI 10.1146/annurev.pp.14.060163.001523; BRUMMER B, 1985, FEBS LETT, V189, P109, DOI 10.1016/0014-5793(85)80852-8; Darwin, 1880, POWER MOVEMENT PLANT, DOI 10.5962/bhl.title.102319; ETTLINGER C, 1988, NATURE, V331, P176, DOI 10.1038/331176a0; FELLE H, 1988, PLANTA, V174, P495, DOI 10.1007/BF00634478; FELLE H, 1986, P NATL ACAD SCI USA, V83, P8992, DOI 10.1073/pnas.83.23.8992; FILNER B, 1970, PLANTA, V94, P333, DOI 10.1007/BF00385765; GILLESPIE B, 1963, PLANT PHYSIOL, V38, P214, DOI 10.1104/pp.38.2.214; HEPLER PK, 1985, ANNU REV PLANT PHYS, V36, P397, DOI 10.1146/annurev.pp.36.060185.002145; HILD V, 1972, PLANTA, V108, P245, DOI 10.1007/BF00384112; IINO M, 1984, PLANT CELL ENVIRON, V7, P97, DOI 10.1111/j.1365-3040.1984.tb01562.x; MARME D, 1988, 2ND MESSENGERS PLANT, P57; MCCLURE BA, 1989, SCIENCE, V243, P91, DOI 10.1126/science.11540631; RINK TJ, 1982, J CELL BIOL, V95, P189, DOI 10.1083/jcb.95.1.189; SCANLON M, 1987, J BIOL CHEM, V262, P6308; TREWAVAS A, 1981, PLANT CELL ENVIRON, V4, P203, DOI 10.1111/j.1365-3040.1981.tb01048.x; WENT F. W., 1937, PHYTOHORMONES; WILLIAMS DA, IN PRESS CELL CALCIU	20	129	137	1	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 7	1990	345	6275					528	530		10.1038/345528a0	http://dx.doi.org/10.1038/345528a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH143	11540625				2022-12-01	WOS:A1990DH14300061
J	Levy, GG; Nichols, WC; Lian, EC; Foroud, T; McClintick, JN; McGee, BM; Yang, AY; Siemieniak, DR; Stark, KR; Gruppo, R; Sarode, R; Shurin, SB; Chandrasekaran, V; Stabler, SP; Sabio, H; Bouhassira, EE; Upshaw, JD; Ginsburg, D; Tsai, HM				Levy, GG; Nichols, WC; Lian, EC; Foroud, T; McClintick, JN; McGee, BM; Yang, AY; Siemieniak, DR; Stark, KR; Gruppo, R; Sarode, R; Shurin, SB; Chandrasekaran, V; Stabler, SP; Sabio, H; Bouhassira, EE; Upshaw, JD; Ginsburg, D; Tsai, HM			Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura	NATURE			English	Article							VON-WILLEBRAND-FACTOR; HEMOLYTIC-UREMIC SYNDROME; FACTOR-CLEAVING PROTEASE; PLASMA VONWILLEBRAND-FACTOR; ENDOTHELIAL-CELLS; LINKAGE ANALYSIS; METALLOPROTEINASE; CLEAVAGE; PURIFICATION; DERMATOSPARAXIS	Thrombotic thrombocytopenic purpura (TTP) is a life-threatening systemic illness of abrupt onset and unknown cause. Proteolysis of the blood-clotting protein von Willebrand factor (VWF) observed in normal plasma is decreased in TTP patients. However, the identity of the responsible protease and its role in the pathophysiology of TTP remain unknown. We performed genome-wide linkage analysis in four pedigrees of humans with congenital TTP and mapped the responsible genetic locus to chromosome 9q34. A predicted gene in the identifed interval corresponds to a segment of a much larger transcript, identifying a new member of the ADAMTS family of zinc metalloproteinase genes (ADAMTS13). Analysis of patients' genomic DNA identified 12 mutations in the ADAMTS13 gene, accounting for 14 of the 15 disease alleles studied. We show that deficiency of ADAMTS13 is the molecular mechanism responsible for TTP, and suggest that physiologic proteolysis of VWF and/or other ADAMTS13 substrates is required for normal vascular homeostasis.	Univ Michigan, Med Ctr, Howard Hughes Med Inst, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Med Ctr, Howard Hughes Med Inst, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Med Ctr, Mol & Cellular Biol Program, Ann Arbor, MI 48109 USA; Childrens Hosp, Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; Univ Miami, Hemophilia & Thrombosis Ctr, Miami, FL 33136 USA; Univ Miami, Sylvester Canc Ctr, Miami, FL 33136 USA; Vet Affairs Med Ctr, Miami, FL 33136 USA; Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; Childrens Hosp, Med Ctr, Div Hematol Oncol, Cincinnati, OH 45229 USA; Univ Texas, SW Med Sch, Blood Bank, Dallas, TX 75390 USA; Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA; Long Isl Jewish Med Ctr, Blood Bank, New Hyde Pk, NY 11040 USA; Albert Einstein Coll Med, New Hyde Pk, NY 11040 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA; Med Coll Georgia, Augusta, GA 30912 USA; Albert Einstein Coll Med, Dept Med Hematol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Memphis Canc Ctr, Memphis, TN 38119 USA; Montefiore Med Ctr, Div Hematol, Bronx, NY 10467 USA; Albert Einstein Coll Med, Bronx, NY 10467 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cincinnati Children's Hospital Medical Center; University of Miami; University of Miami; US Department of Veterans Affairs; Veterans Health Administration (VHA); Indiana University System; Indiana University-Purdue University Indianapolis; Cincinnati Children's Hospital Medical Center; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University; Northwell Health; Yeshiva University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University System of Georgia; Augusta University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Ginsburg, D (corresponding author), Univ Michigan, Med Ctr, Howard Hughes Med Inst, Dept Internal Med, Ann Arbor, MI 48109 USA.	ginsburg@umich.edu	Bouhassira, Eric/AAZ-4184-2021		NHLBI NIH HHS [R01 HL062136, R37 HL039693] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062136, R37HL039693] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bennett CL, 2000, NEW ENGL J MED, V342, P1773, DOI 10.1056/NEJM200006153422402; Blobel CP, 1997, CELL, V90, P589, DOI 10.1016/S0092-8674(00)80519-X; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; BURNS ER, 1982, BLOOD, V60, P1030; Cines DB, 2000, THROMB HAEMOSTASIS, V84, P528; Colige A, 1999, AM J HUM GENET, V65, P308, DOI 10.1086/302504; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Fernandes RJ, 2001, J BIOL CHEM, V276, P31502, DOI 10.1074/jbc.M103466200; Fujikawa K, 2001, BLOOD, V98, P1662, DOI 10.1182/blood.V98.6.1662; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; George JN, 2000, BLOOD, V96, P1223, DOI 10.1182/blood.V96.4.1223.h8001223_1223_1229; Gerritsen HE, 2001, BLOOD, V98, P1654, DOI 10.1182/blood.V98.6.1654; GINSBURG D, 1985, SCIENCE, V228, P1401, DOI 10.1126/science.3874428; Hurskainen TL, 1999, J BIOL CHEM, V274, P25555, DOI 10.1074/jbc.274.36.25555; Kaushal GP, 2000, J CLIN INVEST, V105, P1335, DOI 10.1172/JCI10078; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LYONS SE, 1992, J BIOL CHEM, V267, P4424; MANNUCCI PM, 1989, BLOOD, V74, P978; Matsushita M, 2001, IMMUNOL REV, V180, P78, DOI 10.1034/j.1600-065X.2001.1800107.x; Mitra D, 1997, BLOOD, V89, P1224, DOI 10.1182/blood.V89.4.1224; MOAKE JL, 1982, NEW ENGL J MED, V307, P1432, DOI 10.1056/NEJM198212023072306; Nagase T, 1998, DNA Res, V5, P31, DOI 10.1093/dnares/5.1.31; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; ROCK GA, 1991, NEW ENGL J MED, V325, P393, DOI 10.1056/NEJM199108083250604; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Shindo T, 2000, J CLIN INVEST, V105, P1345, DOI 10.1172/JCI8635; SIDDIQUI FA, 1985, J CLIN INVEST, V76, P1330, DOI 10.1172/JCI112107; Tang BL, 2001, INT J BIOCHEM CELL B, V33, P33, DOI 10.1016/S1357-2725(00)00061-3; Tang BL, 1999, FEBS LETT, V445, P223, DOI 10.1016/S0014-5793(99)00119-2; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; Tsai H M, 2001, Clin Lab, V47, P387; Tsai HM, 1997, BLOOD, V89, P1954, DOI 10.1182/blood.V89.6.1954; Tsai HM, 2000, ANN INTERN MED, V132, P794, DOI 10.7326/0003-4819-132-10-200005160-00005; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; UPSHAW JD, 1978, NEW ENGL J MED, V298, P1350, DOI 10.1056/NEJM197806152982407; ZIMMERMAN TS, 1986, J CLIN INVEST, V77, P947, DOI 10.1172/JCI112394	40	1256	1347	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2001	413	6855					488	494		10.1038/35097008	http://dx.doi.org/10.1038/35097008			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586351	Green Published			2022-12-01	WOS:000171340500038
J	Riipi, M; Alatalo, RV; Lindstrom, L; Mappes, J				Riipi, M; Alatalo, RV; Lindstrom, L; Mappes, J			Multiple benefits of gregariousness cover detectability costs in aposematic aggregations	NATURE			English	Article							KIN SELECTION; EVOLUTION; PREDATION; COLORATION; PROTECTION; LARVAE	Understanding the early evolution of aposematic (warning) coloration has been a challenge for scientists, as a new conspicuous morph in a population of cryptic insects would have a high predation risk and would probably die out before local predators learnt to avoid it(1-4). Fisher(5) presented the idea of aggregation benefit through the survival of related individuals; however, his theory has been strongly debated(6-8) as the mechanisms that favour grouping have never been explored experimentally with the incorporation of detectability costs. Here we create a comprehensive 'novel world' experiment with the great tit (Parus major) as a predator to explore simultaneously the predation-related benefits and costs for aposematic aggregated prey, manipulating both group size and signal strength. Our results show that grouping would have been highly beneficial for the first aposematic prey individuals surrounded by naive predators, because (1) detectability risk increased only asymptotically with group size; (2) additional detectability costs due to conspicuous signals were marginal in groups; (3) even naive predators deserted the group after detecting unpalatability (dilution effect); and (4) avoidance learning of signal was faster in groups. None of these mechanisms require kin selection.	Univ Jyvaskyla, Dept Biol & Environm Sci, Konnevesi Res Stn, FIN-40351 Jyvaskyla, Finland	University of Jyvaskyla	Riipi, M (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Konnevesi Res Stn, POB 35, FIN-40351 Jyvaskyla, Finland.	marianna.riipi@utu.fi; mappes@cc.jyu.fi	Lindstrom, Leena/B-2326-2012; Mappes, Johanna/AAZ-3627-2021	Lindstrom, Leena/0000-0002-6452-4538; Mappes, Johanna/0000-0002-1117-5629				Alatalo RV, 1996, NATURE, V382, P708, DOI 10.1038/382708a0; ENDLER JA, 1988, PHILOS T R SOC B, V319, P505, DOI 10.1098/rstb.1988.0062; Fisher R.A., 1930, GENETICAL THEORY NAT; GAGLIARDO A, 1993, P ROY SOC B-BIOL SCI, V251, P69, DOI 10.1098/rspb.1993.0010; GUILFORD T, 1985, OIKOS, V45, P31, DOI 10.2307/3565219; Guilford T., 1990, P23; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; JARVI T, 1981, OIKOS, V36, P267, DOI 10.2307/3544623; Lindstrom L, 1999, NATURE, V397, P249, DOI 10.1038/16692; LINDSTROM L, P R SOC LOND B, V268, P357; MALLET J, 1987, BIOL J LINN SOC, V32, P337, DOI 10.1111/j.1095-8312.1987.tb00435.x; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; MARPLES NM, 1994, ANIM BEHAV, V48, P967, DOI 10.1006/anbe.1994.1322; Rivero A, 2000, ANIM BEHAV, V60, P187, DOI 10.1006/anbe.2000.1452; SCHULER W, 1992, ADV STUD BEHAV, V21, P111, DOI 10.1016/S0065-3454(08)60143-6; SILLENTULLBERG B, 1982, OIKOS, V39, P131, DOI 10.2307/3544476; SILLENTULLBERG B, 1988, AM NAT, V132, P723, DOI 10.1086/284884; TREISMAN M, 1975, ANIM BEHAV, V23, P779, DOI 10.1016/0003-3472(75)90106-2; Tullberg BS, 2000, ANIM BEHAV, V59, P281, DOI 10.1006/anbe.1999.1302; TURNER GF, 1986, AM NAT, V128, P228, DOI 10.1086/284556; Weismann A, 1882, STUDIES THEORY DESCE	21	155	156	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2001	413	6855					512	514		10.1038/35097061	http://dx.doi.org/10.1038/35097061			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586357				2022-12-01	WOS:000171340500044
J	Geldner, N; Friml, J; Stierhof, YD; Jurgens, G; Palme, K				Geldner, N; Friml, J; Stierhof, YD; Jurgens, G; Palme, K			Auxin transport inhibitors block PIN1 cycling and vesicle traficking	NATURE			English	Article							BREFELDIN-A; ARABIDOPSIS-THALIANA; PLASMA-MEMBRANE; ACID-BINDING; CYTOSKELETON; PROTEIN; EFFLUX; CELLS; PLANT; ROOT	Polar transport of the phytohormone auxin mediates various processes in plant growth and development, such as apical dominance, tropisms, vascular patterning and axis formation(1,2). This view is based largely on the effects of polar auxin transport inhibitors. These compounds disrupt auxin efflux from the cell but their mode of action is unknown(3). It is thought that polar auxin flux is caused by the asymmetric distribution of efflux carriers acting at the plasma membrane(4). The polar localization of efflux carrier candidate PIN1 supports this model(4). Here we show that the seemingly static localization of PIN1 results from rapid actin-dependent cycling between the plasma membrane and endosomal compartments. Auxin transport inhibitors block PIN1 cycling and inhibit trafficking of membrane proteins that are unrelated to auxin transport. Our data suggest that PIN1 cycling is of central importance for auxin transport and that auxin transport inhibitors affect efflux by generally interfering with membrane-trafficking processes. In support of our conclusion, the vesicle-trafficking inhibitor brefeldin A mimics physiological effects of auxin transport inhibitors.	Univ Tubingen, Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany; Max Planck Gesell, Max Delbruck Lab, D-50829 Cologne, Germany; Masaryk Univ, Fac Sci, Dept Biochem, CS-61137 Brno, Czech Republic	Eberhard Karls University of Tubingen; Max Planck Society; Masaryk University Brno	Jurgens, G (corresponding author), Univ Tubingen, Zentrum Mol Biol Pflanzen, Morgenstelle 3, D-72076 Tubingen, Germany.		Geldner, Niko/Y-2481-2019; Palme, Klaus/A-9524-2013; Friml, Jiri/D-9511-2012	Palme, Klaus/0000-0002-2728-3835; Friml, Jiri/0000-0002-8302-7596; Geldner, Niko/0000-0002-2300-9644				Berleth T, 2001, CURR OPIN PLANT BIOL, V4, P57, DOI 10.1016/S1369-5266(00)00136-9; Bernasconi P, 1996, PLANT PHYSIOL, V111, P427, DOI 10.1104/pp.111.2.427; COX DN, 1994, PLANT CELL, V6, P1941, DOI 10.1105/tpc.6.12.1941; Delbarre A, 1998, PLANT PHYSIOL, V116, P833, DOI 10.1104/pp.116.2.833; Estelle M, 1998, PLANT CELL, V10, P1775, DOI 10.1105/tpc.10.11.1775; Fujita H, 1996, PLANT CELL PHYSIOL, V37, P1094, DOI 10.1093/oxfordjournals.pcp.a029059; Fujita H, 1997, PLANT J, V12, P583, DOI 10.1046/j.1365-313X.1997.00583.x; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Garbers C, 1996, EMBO J, V15, P2115, DOI 10.1002/j.1460-2075.1996.tb00565.x; Hadfi K, 1998, DEVELOPMENT, V125, P879; HAGER A, 1991, PLANTA, V185, P527, DOI 10.1007/BF00202963; KATEKAR GF, 1977, PLANT PHYSIOL, V60, P826, DOI 10.1104/pp.60.6.826; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Lauber MH, 1997, J CELL BIOL, V139, P1485, DOI 10.1083/jcb.139.6.1485; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; Mathur J, 1999, DEVELOPMENT, V126, P5559; Mattsson J, 1999, DEVELOPMENT, V126, P2979; MICHALKE W, 1992, PLANTA, V187, P254, DOI 10.1007/BF00201948; Morris DA, 1998, PLANTA, V205, P606, DOI 10.1007/s004250050363; Morris DA, 2000, PLANT GROWTH REGUL, V32, P161, DOI 10.1023/A:1010701527848; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Palme K, 1999, CURR OPIN PLANT BIOL, V2, P375, DOI 10.1016/S1369-5266(99)00008-4; Ruegger M, 1997, PLANT CELL, V9, P745, DOI 10.1105/tpc.9.5.745; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; SatiatJeunemaitre B, 1996, J MICROSC-OXFORD, V181, P162, DOI 10.1046/j.1365-2818.1996.112393.x; SatiatJeunemaitre B, 1996, PROTOPLASMA, V191, P21, DOI 10.1007/BF01280822; SATIATJEUNEMAITRE B, 1992, J CELL SCI, V103, P1153; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; VOLKER A, IN PRESS J CELL SCI; WOOD SA, 1991, CELL, V67, P591, DOI 10.1016/0092-8674(91)90533-5	30	919	976	8	167	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2001	413	6854					425	428		10.1038/35096571	http://dx.doi.org/10.1038/35096571			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475UY	11574889				2022-12-01	WOS:000171188700055
J	Israel, E; Banerjee, TR; Fitzmaurice, GM; Kotlov, TV; LaHive, K; LeBoff, MS				Israel, E; Banerjee, TR; Fitzmaurice, GM; Kotlov, TV; LaHive, K; LeBoff, MS			Effects of inhaled glucocorticoids on bone density in premenopausal women.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MINERAL DENSITY; ASTHMATIC-PATIENTS; BECLOMETHASONE DIPROPIONATE; INDUCED OSTEOPOROSIS; CORTICOSTEROIDS; THERAPY; FLUTICASONE; BUDESONIDE; METABOLISM; STEROIDS	Background: Inhaled glucocorticoids are the most commonly used medications for the long-term treatment of patients with asthma. Whether long-term therapy with inhaled glucocorticoids reduces bone mass, as oral glucocorticoid therapy does, is controversial. In a three-year prospective study, we examined the relation between the dose of inhaled glucocorticoids and the rate of bone loss in premenopausal women with asthma. Methods: We studied 109 premenopausal women, 18 to 45 years of age, who had asthma and no known conditions that cause bone loss and who were treated with inhaled triamcinolone acetonide (100 mu-g per puff). We measured bone density by dual-photon absorptiometry at base line, at six months, and at one, two, and three years. Serum osteocalcin and parathyroid hormone and urinary N-telopeptide, cortisol, and calcium excretion were measured serially. We measured inhaled glucocorticoid use by means of monthly diaries, supported by the use of an automated actuator-monitoring device. Results: Inhaled glucocorticoid therapy was associated with a dose-related decline in bone density at both the total hip and the trochanter of 0.00044 g per square centimeter per puff per year of treatment (P=0.01 and P=0.005, respectively). No dose-related effect was noted at the femoral neck or the spine. Even after the exclusion of all women who received oral or parenteral glucocorticoids at any time during the study, there was still an association between the decline in bone density and the number of puffs per year of use. Serum and urinary markers of bone turnover or adrenal function did not predict the degree of bone loss. Conclusions: Inhaled glucocorticoids lead to a dose-related loss of bone at the hip in premenopausal women. (N Engl J Med 2001;345:941-7.) Copyright (C) 2001 Massachusetts Medical Society.	Brigham & Womens Hosp, Div Pulm & Crit Care Med, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Endocrine Hypertens, Skeletal Hlth & Osteoporosis Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; Harvard Pilgrim Hlth Care, Dept Internal Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard Pilgrim Health Care	Israel, E (corresponding author), Brigham & Womens Hosp, Div Pulm & Crit Care Med, Dept Med, 75 Francis St, Boston, MA 02115 USA.	eisrael@partners.org			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002635] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR-02635] Funding Source: Medline; NHLBI NIH HHS [HL0843] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAYLINK DJ, 1983, NEW ENGL J MED, V309, P306, DOI 10.1056/NEJM198308043090509; Boulet LP, 1999, AM J RESP CRIT CARE, V159, P838, DOI 10.1164/ajrccm.159.3.9802096; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; Ebeling PR, 1998, J BONE MINER RES, V13, P1283, DOI 10.1359/jbmr.1998.13.8.1283; Egan JJ, 1999, EUR RESPIR J, V13, P1267, DOI 10.1183/09031936.99.13612769; EL-HAJJ FULEIHAN G, 1995, J BONE MINER RES, V10, P1004; Hughes JA, 1999, THORAX, V54, P223, DOI 10.1136/thx.54.3.223; IP M, 1994, CHEST, V105, P1722, DOI 10.1378/chest.105.6.1722; Kamada AK, 1996, AM J RESP CRIT CARE, V153, P1739, DOI 10.1164/ajrccm.153.6.8665030; KRISKA AM, 1992, DIABETES METAB REV, V8, P355, DOI 10.1002/dmr.5610080404; Lipworth BJ, 1999, ARCH INTERN MED, V159, P941, DOI 10.1001/archinte.159.9.941; Luengo M, 1997, EUR RESPIR J, V10, P2110, DOI 10.1183/09031936.97.10092110; LUENGO M, 1990, AM REV RESPIR DIS, V142, P104, DOI 10.1164/ajrccm/142.1.104; LUKERT BP, 1992, J BONE MINER RES, V7, P1063; MELTON LJ, 1983, OSTEOPOROTIC SYNDROM, P45; *NAT ASTHM ED PREV, 1997, NIH PUBL; *NHLBI, 1995, NIH PUBL; Packe GE, 1996, J ROY COLL PHYS LOND, V30, P128; PACKE GE, 1992, THORAX, V47, P414, DOI 10.1136/thx.47.6.414; RICH GM, 1992, J HEART LUNG TRANSPL, V11, P950; Saag KG, 1998, NEW ENGL J MED, V339, P292, DOI 10.1056/NEJM199807303390502; TOOGOOD JH, 1995, J ALLERGY CLIN IMMUN, V96, P157, DOI 10.1016/S0091-6749(95)70003-X; Wisniewski AF, 1997, THORAX, V52, P853, DOI 10.1136/thx.52.10.853; Wong CA, 2000, LANCET, V355, P1399, DOI 10.1016/S0140-6736(00)02138-3	25	218	227	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2001	345	13					941	947		10.1056/NEJMoa002304	http://dx.doi.org/10.1056/NEJMoa002304			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	475NF	11575285	Green Published			2022-12-01	WOS:000171170000002
J	Emanuel, EJ; Miller, FG				Emanuel, EJ; Miller, FG			The ethics of placebo-controlled trials - A middle ground.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CISPLATIN-INDUCED NAUSEA; HIGH-DOSE METOCLOPRAMIDE; MAMMARY-ARTERY LIGATION; ACTIVE-CONTROL TRIALS; CLINICAL-RESEARCH; ONDANSETRON GR-38032F; SEROTONIN ANTAGONIST; DOUBLE-BLIND; EFFICACY; PREVENTION		NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Emanuel, EJ (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.							[Anonymous], 1989, NEW ENGL J MED, V321, P406; BECK TM, 1993, ANN INTERN MED, V118, P407, DOI 10.7326/0003-4819-118-6-199303150-00002; Bienenfeld L, 1996, AM HEART J, V132, P1207, DOI 10.1016/S0002-8703(96)90465-2; Brody BA, 1997, CONTROL CLIN TRIALS, V18, P602, DOI 10.1016/S0197-2456(97)00006-8; COBB LA, 1959, NEW ENGL J MED, V260, P1115, DOI 10.1056/NEJM195905282602204; CUBEDDU LX, 1990, NEW ENGL J MED, V322, P810, DOI 10.1056/NEJM199003223221204; DIMOND EG, 1958, CIRCULATION, V18, P712; Ellenberg SS, 2000, ANN INTERN MED, V133, P464, DOI 10.7326/0003-4819-133-6-200009190-00015; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Enserink M, 2000, SCIENCE, V290, P418, DOI 10.1126/science.290.5491.418; FEINSTEIN AR, 1980, EUR J CLIN PHARMACOL, V17, P1, DOI 10.1007/BF00561669; Freedman B, 1996, J LAW MED ETHICS, V24, P243, DOI 10.1111/j.1748-720X.1996.tb01859.x; Freedman B, 1996, J LAW MED ETHICS, V24, P252, DOI 10.1111/j.1748-720X.1996.tb01860.x; Freedman Benjamin, 1990, IRB, V12, P1, DOI 10.2307/3564541; GANDARA DR, 1992, SEMIN ONCOL, V19, P67; GLASSER SP, 1991, JAMA-J AM MED ASSOC, V265, P1550, DOI 10.1001/jama.265.12.1550; GRALLA RJ, 1981, NEW ENGL J MED, V305, P905, DOI 10.1056/NEJM198110153051601; HAINSWORTH J, 1991, J CLIN ONCOL, V9, P721, DOI 10.1200/JCO.1991.9.5.721; HAIT WN, 1990, NEW ENGL J MED, V323, P1485; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Khan A, 2000, ARCH GEN PSYCHIAT, V57, P311, DOI 10.1001/archpsyc.57.4.311; Koski G, 2001, NEW ENGL J MED, V345, P136, DOI 10.1056/NEJM200107123450211; LASAGNA L, 1979, EUR J CLIN PHARMACOL, V15, P373, DOI 10.1007/BF00561733; LASAGNA L, 1954, AM J MED, V16, P770, DOI 10.1016/0002-9343(54)90441-6; Leon AC, 2000, ARCH GEN PSYCHIAT, V57, P329, DOI 10.1001/archpsyc.57.4.329; LILIENFELD AM, 1982, B HIST MED, V56, P1; MARTY M, 1990, NEW ENGL J MED, V322, P816, DOI 10.1056/NEJM199003223221205; Miller FG, 2000, BIOL PSYCHIAT, V47, P707, DOI 10.1016/S0006-3223(00)00833-7; Rothman KJ, 2000, BMJ-BRIT MED J, V321, P442, DOI 10.1136/bmj.321.7258.442; ROTHMAN KJ, 1994, NEW ENGL J MED, V331, P394, DOI 10.1056/NEJM199408113310611; RUTSTEIN DD, 1970, EXPT HUMAN SUBJECTS, P383; SENN S, IN PRESS APPL CLIN T; SENN S, 1997, STAT ISSUES DRUG DEV, P207; Shapiro HT, 2001, NEW ENGL J MED, V345, P139, DOI 10.1056/NEJM200107123450212; Temple R, 2000, ANN INTERN MED, V133, P455, DOI 10.7326/0003-4819-133-6-200009190-00014; Temple R, 1982, DRUG INF J, V10-17, DOI DOI 10.1177/009286158201600102; Temple Robert, 1996, Account Res, V4, P267, DOI 10.1080/08989629608573887; VANRIJ AM, 1994, CIRCULATION, V90, P1194, DOI 10.1161/01.CIR.90.3.1194; Vastag B, 2000, JAMA-J AM MED ASSOC, V284, P2983, DOI 10.1001/jama.284.23.2983; WAY WL, 1984, NEW ENGL J MED, V311, P413; WINSLOW R, 2000, WALL STREET J   1019, pB14; *WORLD MED ASS DEC, 2001, ETH PRINC MED RES IN	42	231	240	2	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2001	345	12					915	919		10.1056/NEJM200109203451211	http://dx.doi.org/10.1056/NEJM200109203451211			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	473JW	11565527				2022-12-01	WOS:000171039600011
J	Moll, J; Barzaghi, P; Lin, S; Bezakova, G; Lochmuller, H; Engvall, E; Muller, U; Ruegg, MA				Moll, J; Barzaghi, P; Lin, S; Bezakova, G; Lochmuller, H; Engvall, E; Muller, U; Ruegg, MA			An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy	NATURE			English	Article							CREATINE-KINASE GENE; NEUROMUSCULAR-JUNCTION; EXTRACELLULAR-MATRIX; BASEMENT-MEMBRANE; SKELETAL-MUSCLE; LAMININ; MICE; EXPRESSION; DIFFERENTIATION; DYSTROGLYCAN	Congenital muscular dystrophy is a heterogeneous and severe, progressive muscle-wasting disease that frequently leads to death in early childhood(1,2). Most cases of congenital muscular dystrophy are caused by mutations in LAMA2, the gene encoding the alpha2 chain of the main laminin isoforms expressed by muscle fibres. Muscle fibre deterioration in this disease is thought to be caused by the failure to form the primary laminin scaffold, which is necessary for basement membrane structure(3), and the missing interaction between muscle basement membrane and the dystrophin-glycoprotein complex (DGC)(4) or the integrins(5). With the aim to restore muscle function in a mouse model for this disease, we have designed a minigene of agrin, a protein known for its role in the formation of the neuromuscular junction(6). Here we show that this mini-agrin-which binds to basement membrane(7) and to alpha -dystroglycan(8), a member of the DGC-amends muscle pathology by a mechanism that includes agrin-mediated stabilization of alpha -dystroglycan and the laminin alpha5 chain. Our data provides in vivo evidence that a non-homologous protein in combination with rational protein design can be used to devise therapeutic tools that may restore muscle function in human muscular dystrophies.	Univ Basel, Biozentrum, Dept Pharmacol Neurobiol, CH-4056 Basel, Switzerland; Univ Munich, Genzentrum Munich, D-81377 Munich, Germany; Burnham Inst, La Jolla, CA 92037 USA; Friedrich Miescher Inst, CH-4058 Basel, Switzerland	University of Basel; University of Munich; Sanford Burnham Prebys Medical Discovery Institute; Friedrich Miescher Institute for Biomedical Research	Ruegg, MA (corresponding author), Univ Basel, Biozentrum, Dept Pharmacol Neurobiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.		Ruegg, Markus/X-7256-2019	Ruegg, Markus/0000-0002-4974-9384; Lochmuller, Hanns/0000-0003-2324-8001; Lin, Shuo/0000-0003-2317-0339				Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Colognato H, 1999, CURR BIOL, V9, P1327, DOI 10.1016/S0960-9822(00)80056-1; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Cote PD, 1999, NAT GENET, V23, P338, DOI 10.1038/15519; Denzer AJ, 1997, J CELL BIOL, V137, P671, DOI 10.1083/jcb.137.3.671; Denzer AJ, 1998, EMBO J, V17, P335, DOI 10.1093/emboj/17.2.335; ERVASTI JM, 1991, J BIOL CHEM, V266, P9161; Gesemann M, 1998, J BIOL CHEM, V273, P600, DOI 10.1074/jbc.273.1.600; Henry MD, 1998, CELL, V95, P859, DOI 10.1016/S0092-8674(00)81708-0; Herrmann R, 2000, HUM MOL GENET, V9, P2335, DOI 10.1093/oxfordjournals.hmg.a018926; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; JAYNES JB, 1986, MOL CELL BIOL, V6, P2855, DOI 10.1128/MCB.6.8.2855; Kuang W, 1998, J CLIN INVEST, V102, P844, DOI 10.1172/JCI3705; MACPIKE AD, 1976, P SOC EXP BIOL MED, V151, P670, DOI 10.3181/00379727-151-39283; Mayer U, 1997, NAT GENET, V17, P318, DOI 10.1038/ng1197-318; Meier T, 1998, EUR J NEUROSCI, V10, P3141, DOI 10.1046/j.1460-9568.1998.00320.x; Miyagoe-Suzuki Y, 2000, MICROSC RES TECHNIQ, V48, P181, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<181::AID-JEMT6>3.0.CO;2-Q; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; Ringelmann B, 1999, EXP CELL RES, V246, P165, DOI 10.1006/excr.1998.4244; Ruegg MA, 1998, TRENDS NEUROSCI, V21, P22, DOI 10.1016/S0166-2236(97)01154-5; SCHULZE B, 1995, EUR J BIOCHEM, V231, P551, DOI 10.1111/j.1432-1033.1995.tb20731.x; Sorokin LM, 1997, DEV DYNAM, V210, P446, DOI 10.1002/(SICI)1097-0177(199712)210:4<446::AID-AJA8>3.0.CO;2-G; STERNBERG EA, 1988, MOL CELL BIOL, V8, P2896, DOI 10.1128/MCB.8.7.2896; SUNADA Y, 1994, J BIOL CHEM, V269, P13729; Talts JF, 2000, J BIOL CHEM, V275, P35192, DOI 10.1074/jbc.M003261200; TOME FMS, 1998, NEUROMUSCULAR DISORD, P21; Turney SG, 1996, J NEUROSCI METH, V64, P199, DOI 10.1016/0165-0270(95)00135-2; XU H, 1994, NAT GENET, V8, P297, DOI 10.1038/ng1194-297; XU H, 1994, P NATL ACAD SCI USA, V91, P5572, DOI 10.1073/pnas.91.12.5572	30	175	180	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					302	307		10.1038/35095054	http://dx.doi.org/10.1038/35095054			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565031				2022-12-01	WOS:000171040500038
J	LeCouter, J; Kowalski, J; Foster, J; Hass, P; Zhang, ZM; Dillard-Telm, L; Frantz, G; Rangell, L; DeGuzman, L; Keller, GA; Peale, F; Gurney, A; Hillan, KJ; Ferrara, N				LeCouter, J; Kowalski, J; Foster, J; Hass, P; Zhang, ZM; Dillard-Telm, L; Frantz, G; Rangell, L; DeGuzman, L; Keller, GA; Peale, F; Gurney, A; Hillan, KJ; Ferrara, N			Identification of an angiogenic mitogen selective for endocrine gland endothelium	NATURE			English	Article							GROWTH-FACTOR; VASCULAR-PERMEABILITY; CORPUS-LUTEUM; EXPRESSION; CELLS; GENE; VEGF; MICROENVIRONMENT; DIFFERENTIATION; PROLIFERATION	The known endothelial mitogens stimulate growth of vascular endothelial cells without regard to their tissue of origin. Here we report a growth factor that is expressed largely in one type of tissue and acts selectively on one type of endothelium. This molecule, called endocrine-gland-derived vascular endothelial growth factor (EG-VEGF), induced proliferation, migration and fenestration (the formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. However, EG-VEGF had little or no effect on a variety of other endothelial and non-endothelial cell types tested. Similar to VEGF, EG-VEGF possesses a HIF-1 binding site, and its expression is induced by hypoxia. Both EG-VEGF and VEGF resulted in extensive angiogenesis and cyst formation when delivered in the ovary. However, unlike VEGF, EG-VEGF failed to promote angiogenesis in the cornea or skeletal muscle. Expression of human EG-VEGF messenger RNA is restricted to the steroidogenic glands, ovary, testis, adrenal and placenta and is often complementary to the expression of VEGF, suggesting that these molecules function in a coordinated manner. EG-VEGF is an example of a class of highly specific mitogens that act to regulate proliferation and differentiation of the vascular endothelium in a tissue-specific manner.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; Genentech Inc, Dept Toxicol Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Ferrara, N (corresponding author), Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA.	nf@gene.com						AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Aird WC, 1997, J CELL BIOL, V138, P1117, DOI 10.1083/jcb.138.5.1117; Aravind L, 1998, CURR BIOL, V8, pR477, DOI 10.1016/S0960-9822(98)70309-4; Arbiser JL, 1997, P NATL ACAD SCI USA, V94, P861, DOI 10.1073/pnas.94.3.861; Basset DL, 1943, AM J ANAT, V73, P251, DOI 10.1002/aja.1000730206; Boisbouvier J, 1998, J MOL BIOL, V283, P205, DOI 10.1006/jmbi.1998.2057; BREIER G, 1992, DEVELOPMENT, V114, P521; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Collin O, 1996, INT J ANDROL, V19, P221, DOI 10.1111/j.1365-2605.1996.tb00466.x; Dellian M, 1996, AM J PATHOL, V149, P59; Dor Y, 2001, AM J PHYSIOL-CELL PH, V280, pC1367, DOI 10.1152/ajpcell.2001.280.6.C1367; Esser S, 1998, J CELL BIOL, V140, P947, DOI 10.1083/jcb.140.4.947; Farrara N, 2000, CURR OPIN BIOTECH, V11, P617, DOI 10.1016/S0958-1669(00)00153-1; Ferrara N, 1998, NAT MED, V4, P336, DOI 10.1038/nm0398-336; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Gille H, 2001, J BIOL CHEM, V276, P3222, DOI 10.1074/jbc.M002016200; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; GOLDZIEHER JW, 1962, J CLIN ENDOCR METAB, V22, P325, DOI 10.1210/jcem-22-3-325; GOSPODAROWICZ D, 1984, J CELL BIOL, V99, P947, DOI 10.1083/jcb.99.3.947; JOUBERT FJ, 1980, H-S Z PHYSIOL CHEM, V361, P1787, DOI 10.1515/bchm2.1980.361.2.1787; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Klagsbrun M, 1992, Semin Cancer Biol, V3, P81; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; Miao HQ, 1999, J CELL BIOL, V146, P233, DOI 10.1083/jcb.146.1.233; MONACCI WT, 1993, AM J PHYSIOL, V264, pC995, DOI 10.1152/ajpcell.1993.264.4.C995; PALADE GE, 1979, ACTA PHYSIOL SCAND, P11; Pettersson A, 2000, LAB INVEST, V80, P99, DOI 10.1038/labinvest.3780013; PHILLIPS HS, 1990, ENDOCRINOLOGY, V127, P965, DOI 10.1210/endo-127-2-965; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; RAVINDRANATH N, 1992, ENDOCRINOLOGY, V131, P254, DOI 10.1210/en.131.1.254; Roberts WG, 1997, CANCER RES, V57, P765; Ryan AM, 1999, TOXICOL PATHOL, V27, P78, DOI 10.1177/019262339902700115; Schweitz H, 1999, FEBS LETT, V461, P183, DOI 10.1016/S0014-5793(99)01459-3; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Simionescu N., 1988, CELL TISSUE BIOL, P355; STEWART PA, 1981, DEV BIOL, V84, P183, DOI 10.1016/0012-1606(81)90382-1; VANTILBEURGH H, 1992, NATURE, V359, P159, DOI 10.1038/359159a0; Wechselberger C, 1999, FEBS LETT, V462, P177, DOI 10.1016/S0014-5793(99)01473-8; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; ZETTER BR, 1980, NATURE, V285, P41, DOI 10.1038/285041a0	46	425	485	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2001	412	6850					877	884		10.1038/35091000	http://dx.doi.org/10.1038/35091000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528470				2022-12-01	WOS:000170689000036
J	Beaglehole, R				Beaglehole, R			Global cardiovascular disease prevention: time to get serious	LANCET			English	Editorial Material							CORONARY-HEART-DISEASE; RISK-FACTORS; MORTALITY; TRENDS		Univ Auckland, Auckland 1, New Zealand	University of Auckland	Beaglehole, R (corresponding author), 206 Rue Chateau, F-01170 Vesancy, France.	beaglehole@compuserve.com						*ADV BOARD, 2001, 4 INT HEART HLTH C O; Beaglehole R, 1999, J CARDIOVASC RISK, V6, P63; BONITA R, IN PRESS GLOBAL BEHA; Bonita R, 2001, STROKE PREVENTION; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Ebrahim S, 2001, INT J EPIDEMIOL, V30, P201, DOI 10.1093/ije/30.2.201; Egger G, 1997, BRIT MED J, V315, P477, DOI 10.1136/bmj.315.7106.477; Holtzman NA, 2001, INT J HEALTH SERV, V31, P445, DOI 10.2190/JPFC-A4NW-KWT6-Y2H7; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Law M, 1999, BRIT MED J, V318, P1471, DOI 10.1136/bmj.318.7196.1471; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; MacGregor G., 1998, SALT DIET HLTH NEPTU; MAGNUS P, IN PRESS ARCH INTERN; McKinlay JB, 1999, AM J PUBLIC HEALTH, V89, P295, DOI 10.2105/AJPH.89.3.295; McMichael AJ, 2000, LANCET, V356, P495, DOI 10.1016/S0140-6736(00)02564-2; Nieto FJ, 1999, AM J PUBLIC HEALTH, V89, P292, DOI 10.2105/AJPH.89.3.292; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Puska P, 1998, B WORLD HEALTH ORGAN, V76, P419; Rose G., 1992, STRATEGY PREVENTIVE; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; STARNLER J, 1999, JAMA-J AM MED ASSOC, V282, P2012; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Willett W., 2013, NUTR EPIDEMIOLOGY, V3rd; World Health Organization, 2000, WORLD HLTH REP 2000; *WORLD HEART FED, 2001, BROCH WORLD HEART; Zhang X, 2000, J HYPERTENS, V18, pS25	27	67	72	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 25	2001	358	9282					661	663		10.1016/S0140-6736(01)05784-1	http://dx.doi.org/10.1016/S0140-6736(01)05784-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530175				2022-12-01	WOS:000170615500032
J	Mukhopadhyay, J; Kapanidis, AN; Mekler, V; Kortkhonjia, E; Ebright, YW; Ebright, RH				Mukhopadhyay, J; Kapanidis, AN; Mekler, V; Kortkhonjia, E; Ebright, YW; Ebright, RH			Translocation of sigma(70) with RNA polymerase during transcription: Fluorescence resonance energy transfer assay for movement relative to DNA	CELL			English	Article							LAC UV5 PROMOTER; ESCHERICHIA-COLI; TERNARY COMPLEXES; NUCLEIC-ACIDS; INITIATION; SUBUNIT; PROTEIN; ELONGATION; ORGANIZATION; PURIFICATION	Using fluorescence resonance energy transfer, we show that, in the majority of transcription complexes, sigma (70) is not released from RNA polymerase upon transition from initiation to elongation, but, instead, remains associated with RNA polymerase and translocates with RNA polymerase. The results argue against the presumption that there are necessary subunit-composition differences, and corresponding necessary mechanistic differences, in initiation and elongation. The methods of this report should be generalizable to monitor movement of any molecule relative to any nucleic acid.	Rutgers State Univ, Dept Chem, Waksman Inst, Howard Hughes Med Inst, Piscataway, NJ 08854 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick	Ebright, RH (corresponding author), Rutgers State Univ, Dept Chem, Waksman Inst, Howard Hughes Med Inst, POB 939, Piscataway, NJ 08854 USA.		Ebright, Richard/O-3321-2019	Ebright, Richard/0000-0001-8915-7140	NIGMS NIH HHS [GM41376] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041376] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bar-Nahum G, 2001, CELL, V106, P443, DOI 10.1016/S0092-8674(01)00461-5; Bown JA, 1999, J BIOL CHEM, V274, P2263, DOI 10.1074/jbc.274.4.2263; BURGESS RR, 1975, BIOCHEMISTRY-US, V14, P4634, DOI 10.1021/bi00692a011; Callaci S, 1998, J BIOL CHEM, V273, P32995, DOI 10.1074/jbc.273.49.32995; CARPOUSIS AJ, 1985, J MOL BIOL, V183, P165, DOI 10.1016/0022-2836(85)90210-4; CECH CL, 1980, BIOCHEMISTRY-US, V19, P2440, DOI 10.1021/bi00552a023; Chong SR, 1996, J BIOL CHEM, V271, P22159, DOI 10.1074/jbc.271.36.22159; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; Christie GE, 1996, J BACTERIOL, V178, P6991, DOI 10.1128/jb.178.23.6991-6993.1996; CHUI MM, 1995, J COLLOID INTERF SCI, V174, P336, DOI 10.1006/jcis.1995.1399; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Daube SS, 1999, P NATL ACAD SCI USA, V96, P8390, DOI 10.1073/pnas.96.15.8390; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; GILL SC, 1991, J MOL BIOL, V220, P307, DOI 10.1016/0022-2836(91)90015-X; GREENBLATT J, 1981, CELL, V24, P421, DOI 10.1016/0092-8674(81)90332-9; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; HANSEN UM, 1980, J BIOL CHEM, V255, P9564; HSU TP, 1984, POLYMER, V25, P1419, DOI 10.1016/0032-3861(84)90103-4; Kashlev M, 1996, METHOD ENZYMOL, V274, P326; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; KRUMMEL B, 1989, BIOCHEMISTRY-US, V28, P7829, DOI 10.1021/bi00445a045; Kubori T, 1996, J MOL BIOL, V256, P449, DOI 10.1006/jmbi.1996.0100; LEVIN JR, 1987, J MOL BIOL, V196, P85, DOI 10.1016/0022-2836(87)90512-2; Lilley DMJ, 2000, CURR OPIN CHEM BIOL, V4, P507, DOI 10.1016/S1367-5931(00)00124-1; Minakhin L, 2001, P NATL ACAD SCI USA, V98, P892, DOI 10.1073/pnas.98.3.892; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; Niu W, 1996, CELL, V87, P1123, DOI 10.1016/S0092-8674(00)81806-1; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; OSUMIDAVIS PA, 1987, BIOCHIM BIOPHYS ACTA, V910, P130, DOI 10.1016/0167-4781(87)90065-0; Owens JT, 1998, P NATL ACAD SCI USA, V95, P6021, DOI 10.1073/pnas.95.11.6021; Pluen A, 1998, ELECTROPHORESIS, V19, P1548, DOI 10.1002/elps.1150191005; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; Sambrook J, 2001, MOL CLONING LAB MANU, V3rd; SHIMAMOTO N, 1986, J BIOL CHEM, V261, P1859; STRANEY DC, 1985, CELL, V43, P449, DOI 10.1016/0092-8674(85)90175-8; STRANEY DC, 1987, J MOL BIOL, V193, P267, DOI 10.1016/0022-2836(87)90218-X; SUH WC, 1992, BIOCHEMISTRY-US, V31, P7815, DOI 10.1021/bi00149a011; TRAVERS AA, 1969, NATURE, V222, P537, DOI 10.1038/222537a0; WANG DG, 1995, CELL, V81, P341, DOI 10.1016/0092-8674(95)90387-9	41	144	153	1	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 24	2001	106	4					453	463		10.1016/S0092-8674(01)00464-0	http://dx.doi.org/10.1016/S0092-8674(01)00464-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525731	Bronze			2022-12-01	WOS:000170665200009
J	Wu, YT; Marsh, JW				Wu, YT; Marsh, JW			Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; QUIESCENT CD4 LYMPHOCYTES; NEF GENE; MESSENGER-RNA; IN-VITRO; REPLICATION; ACTIVATION; INFECTION; EXPRESSION; PROTEIN	The quiescent nature of most peripheral T cells poses an effective limitation to human immunodeficiency virus (HIV) replication and, in particular, to viral integration into the host chromatin. Two HIV proteins, Nef and Tat, increase T cell activity, but a requirement of integration for viral gene expression would preclude a rote for these proteins in resting cells. Here, we report that HIV infection leads to selective transcription of the nef and tat genes before integration. This preintegration transcription in quiescent cells leads to increased T cell activation and viral replication.	NIMH, Mol Biol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Marsh, JW (corresponding author), NIMH, Mol Biol Lab, Bethesda, MD 20892 USA.	jon@codon.nih.gov			NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002629, Z01MH002629] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; [Anonymous], UNPUB; CARA A, 1995, VIROLOGY, V208, P242, DOI 10.1006/viro.1995.1148; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Davis CB, 1997, J EXP MED, V186, P1793, DOI 10.1084/jem.186.10.1793; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; ENGLUND G, 1995, J VIROL, V69, P3216, DOI 10.1128/JVI.69.5.3216-3219.1995; FOLKS TM, 1986, J EXP MED, V164, P280, DOI 10.1084/jem.164.1.280; JONES KA, 1994, ANNU REV BIOCHEM, V63, P717, DOI 10.1146/annurev.bi.63.070194.003441; Kinoshita S, 1998, CELL, V95, P595, DOI 10.1016/S0092-8674(00)81630-X; Korin YD, 1998, J VIROL, V72, P3161, DOI 10.1128/JVI.72.4.3161-3168.1998; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MILLER MD, 1995, J VIROL, V69, P579, DOI 10.1128/JVI.69.1.579-584.1995; MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Pandori MW, 1996, J VIROL, V70, P4283, DOI 10.1128/JVI.70.7.4283-4290.1996; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; RHEE SS, 1994, J IMMUNOL, V152, P5128; Schrager JA, 1999, P NATL ACAD SCI USA, V96, P8167, DOI 10.1073/pnas.96.14.8167; SIEKEVITZ M, 1987, SCIENCE, V238, P1575, DOI 10.1126/science.2825351; SIEKEVITZ M, 1987, P NATL ACAD SCI USA, V84, P5389, DOI 10.1073/pnas.84.15.5389; SPINA CA, 1995, J VIROL, V69, P2977, DOI 10.1128/JVI.69.5.2977-2988.1995; SPINA CA, 1994, J EXP MED, V179, P115, DOI 10.1084/jem.179.1.115; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; TONGSTARKSEN SE, 1987, P NATL ACAD SCI USA, V84, P6845, DOI 10.1073/pnas.84.19.6845; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Wang JK, 2000, P NATL ACAD SCI USA, V97, P394, DOI 10.1073/pnas.97.1.394; WISKERCHEN M, 1995, J VIROL, V69, P376, DOI 10.1128/JVI.69.1.376-386.1995; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	31	283	293	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1503	1506		10.1126/science.1061548	http://dx.doi.org/10.1126/science.1061548			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520990				2022-12-01	WOS:000170616000048
J	Scuteri, A; Bos, AJG; Brant, LJ; Talbot, L; Lakatta, EG; Fleg, JL				Scuteri, A; Bos, AJG; Brant, LJ; Talbot, L; Lakatta, EG; Fleg, JL			Hormone replacement therapy and longitudinal changes in blood pressure in postmenopausal women	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; ESTROGEN REPLACEMENT; NITRIC-OXIDE; HYPERTENSION; MENOPAUSE; ESTRADIOL; AGE; PREVENTION; HEALTH; GENDER	Background: The incidence of hypertension in postmenopausal women exceeds that in age-matched men. Longitudinal studies relating hormone replacement therapy (HRT) to blood pressure changes are sparse. Objective: To investigate the association between HRT and longitudinal changes In blood pressure In postmenopausal women. Design: Longitudinal observational study. Setting: Community-dwelling volunteers. Patients: 226 healthy, normotensive postmenopausal women from the Baltimore Longitudinal Study of Aging with a mean (+/- SD) age of 64 +/- 10 years were followed for 5.7 +/- 5.3 years. Seventy-seven women used both estrogen and progestin, and 149 used neither. Measurements: Lifestyle variables, blood pressure, and traditional cardiovascular risk factors were measured at baseline and approximately every 2 years thereafter. Results: Systolic blood pressure at baseline was similar in HRT users and nonusers (133.9 +/- 16.0 mm Hg vs. 132.4 +/- 14.8 mm Hg). Over time, average systolic blood pressure increased less in HRT users than nonusers, independent of other cardiovascular risk factors, physical activity, and alcohol use. For example, HRT users who were 55 years of age at their first Baltimore Longitudinal Study of Aging visit experienced a 7.6-mm Hg average increase in systolic blood pressure over 10 years; in contrast, the average increase in nonusers was 18.7 mm Hg. The lesser increase in systolic blood pressure in HRT users was more evident at older age. Diastolic blood pressure, which did not change statistically over time in either group, was not associated with HRT. Conclusion: Postmenopausal women taking HRT have a smaller increase in systolic blood pressure over time than those not taking HRT. This difference is intensified at older ages.	NIA, Gerontol Res Ctr, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA; Johns Hopkins Univ, Sch Nursing, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University	Fleg, JL (corresponding author), NIA, Gerontol Res Ctr, Cardiovasc Sci Lab, NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.		Lakatta, Edward G/AAL-1447-2020; Bos, Angelo Jose/A-5227-2017	SCUTERI, ANGELO/0000-0003-4784-5441; Lakatta, Edward/0000-0002-4772-0035; Talbot, Laura/0000-0002-0381-4486; Bos, Angelo Jose/0000-0003-4901-3155	NATIONAL INSTITUTE ON AGING [Z01AG000270] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; ANASTOS K, 1991, ANN INTERN MED, V115, P287, DOI 10.7326/0003-4819-115-4-287; BARRETTCONNOR E, 1991, ANN INTERN MED, V115, P455, DOI 10.7326/0003-4819-115-6-455; Best PJM, 1998, ANN INTERN MED, V128, P285, DOI 10.7326/0003-4819-128-4-199802150-00006; Brant Larry J., 1994, P373; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Cagnacci A, 1999, AM J PHYSIOL-HEART C, V276, pH1355, DOI 10.1152/ajpheart.1999.276.4.H1355; COLDITZ GA, 1987, NEW ENGL J MED, V316, P1105, DOI 10.1056/NEJM198704303161801; CRANE MG, 1971, ANN INTERN MED, V74, P13, DOI 10.7326/0003-4819-74-1-13; FISCHER GM, 1977, AM J PHYSIOL, V232, pH617, DOI 10.1152/ajpheart.1977.232.6.H617; GANGAR KF, 1991, LANCET, V338, P839; GORDON T, 1979, NATL HEART I FRAMING, P74; Grady D, 2000, ANN INTERN MED, V133, P999, DOI 10.7326/0003-4819-133-12-200012190-00016; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; HIMMELMANN A, 1994, J HUM HYPERTENS, V8, P485; HJORTLAND MC, 1976, AM J EPIDEMIOL, V103, P304, DOI 10.1093/oxfordjournals.aje.a112228; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; JETTE M, 1990, CLIN CARDIOL, V13, P555, DOI 10.1002/clc.4960130809; Kawano H, 1997, J AM COLL CARDIOL, V30, P914, DOI 10.1016/S0735-1097(97)00234-9; Lakatta EG, 1999, J AM GERIATR SOC, V47, P613, DOI 10.1111/j.1532-5415.1999.tb02579.x; Lesaffre E, 1998, BIOMETRICS, V54, P570, DOI 10.2307/3109764; Lind T, 1979, Br J Obstet Gynaecol, V86 Suppl 3, P1, DOI 10.1111/j.1471-0528.1979.tb16232.x; LIP GYH, 1994, J HUM HYPERTENS, V8, P491; MAGNESS RR, 1989, AM J PHYSIOL, V256, pE536, DOI 10.1152/ajpendo.1989.256.4.E536; Majmudar NG, 2000, J CLIN ENDOCR METAB, V85, P1577, DOI 10.1210/jc.85.4.1577; MARIGLIANO V, 1997, SENILEHYPERTENSION 9, P1; Matthews KA, 1996, AM J EPIDEMIOL, V143, P971; MATTHEWS KA, 1989, NEW ENGL J MED, V321, P641, DOI 10.1056/NEJM198909073211004; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; Miyagawa K, 1997, NAT MED, V3, P324, DOI 10.1038/nm0397-324; Morrell CH, 1997, AM STAT, V51, P338, DOI 10.2307/2685902; Pearson JD, 1997, J GERONTOL A-BIOL, V52, pM177, DOI 10.1093/gerona/52A.3.M177; PFEFFER RI, 1978, J CHRON DIS, V31, P389, DOI 10.1016/0021-9681(78)90003-6; Schunkert H, 1997, CIRCULATION, V95, P39, DOI 10.1161/01.CIR.95.1.39; Scuteri A, 1999, CIRCULATION, V100, P105; Seely EW, 1999, HYPERTENSION, V33, P1190, DOI 10.1161/01.HYP.33.5.1190; SHOCK NW, 1984, NORMAL HUMAN AGING B, V84, P2450; STAESSEN J, 1989, J HUM HYPERTENS, V3, P427; STAMLER J, 1976, JAMA-J AM MED ASSOC, V235, P2299, DOI 10.1001/jama.235.21.2299; UTIAN WH, 1978, MATURITAS, V1, P3, DOI 10.1016/0378-5122(78)90003-8; VANBERESTEYN ECH, 1989, AM J EPIDEMIOL, V129, P947, DOI 10.1093/oxfordjournals.aje.a115227; VARGAS R, 1993, BRIT J PHARMACOL, V109, P612, DOI 10.1111/j.1476-5381.1993.tb13616.x; VERBEKE G, 1998, LINEAR MIXED MODELS, P63; Verbrugge LM, 1996, J GERONTOL B-PSYCHOL, V51, pS30, DOI 10.1093/geronb/51B.1.S30; WEISS NS, 1972, AM J EPIDEMIOL, V96, P237, DOI 10.1093/oxfordjournals.aje.a121454; YONG LC, 1993, AM J EPIDEMIOL, V138, P973, DOI 10.1093/oxfordjournals.aje.a116817	47	72	77	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2001	135	4					229	238		10.7326/0003-4819-135-4-200108210-00007	http://dx.doi.org/10.7326/0003-4819-135-4-200108210-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465KE	11511137				2022-12-01	WOS:000170587500001
J	Liu, R; Liu, H; Chen, X; Kirby, M; Brown, PO; Zhao, KJ				Liu, R; Liu, H; Chen, X; Kirby, M; Brown, PO; Zhao, KJ			Regulation of CSF1 promoter by the SWI/SNF-like BAF complex	CELL			English	Article							RNA ADENOSINE-DEAMINASE; HANDED Z-DNA; FORMING SEQUENCES; NUCLEAR FACTOR-1; HUMAN GENOME; ZAB DOMAIN; CHROMATIN; TRANSCRIPTION; NUCLEOSOME; BINDING	The mammalian BAF complex regulates gene expression by modifying chromatin structure. In this report, we identify 80 genes activated and 2 genes repressed by the BAF complex in SW-13 cells. We find that prior binding of NFI/CTF to the NFI/CTF binding site in CSF1 promoter is required for the recruitment of the BAF complex and the BAF-dependent activation of the promoter. Furthermore, the activation of the CSF1 promoter requires Z-DNA-forming sequences that are converted to Z-DNA structure upon activation by the BAF complex. The BAF complex facilitates Z-DNA formation in a nucleosomal template in vitro. We propose a model in which the BAF complex promotes Z-DNA formation which, in turn, stabilizes the open chromatin structure at the CSF1 promoter.	NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Howard Hughes Medical Institute; Stanford University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Zhao, KJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA.							Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; DEVRIES E, 1987, EMBO J, V6, P161, DOI 10.1002/j.1460-2075.1987.tb04734.x; Di Croce L, 1999, MOL CELL, V4, P45, DOI 10.1016/S1097-2765(00)80186-0; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Gao B, 1996, MOL CELL BIOL, V16, P5997; GARNER MM, 1987, J MOL BIOL, V196, P581, DOI 10.1016/0022-2836(87)90034-9; Gavin I, 2001, MOL CELL, V7, P97, DOI 10.1016/S1097-2765(01)00158-7; HAMADA H, 1982, NATURE, V298, P396, DOI 10.1038/298396a0; Havas K, 2000, CELL, V103, P1133, DOI 10.1016/S0092-8674(00)00215-4; Herbert A, 1999, GENETICA, V106, P37, DOI 10.1023/A:1003768526018; HERBERT A, 1995, P NATL ACAD SCI USA, V92, P7550, DOI 10.1073/pnas.92.16.7550; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Imbalzano AN, 1996, J BIOL CHEM, V271, P20726, DOI 10.1074/jbc.271.34.20726; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Kim YG, 1999, J BIOL CHEM, V274, P19081, DOI 10.1074/jbc.274.27.19081; Kim YG, 2000, J BIOL CHEM, V275, P26828; Kingston RE, 1996, GENE DEV, V10, P905, DOI 10.1101/gad.10.8.905; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Lorch Y, 1998, CELL, V94, P29, DOI 10.1016/S0092-8674(00)81218-0; Maas S, 2000, BIOESSAYS, V22, P790, DOI 10.1002/1521-1878(200009)22:9<790::AID-BIES4>3.0.CO;2-0; Muchardt C, 1999, J MOL BIOL, V293, P187, DOI 10.1006/jmbi.1999.2999; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; RAHMOUNI AR, 1989, SCIENCE, V246, P358, DOI 10.1126/science.2678475; RICH A, 1984, ANNU REV BIOCHEM, V53, P791, DOI 10.1146/annurev.bi.53.070184.004043; RUNKEL L, 1986, J MOL BIOL, V189, P487, DOI 10.1016/0022-2836(86)90319-0; Sawa H, 2000, MOL CELL, V6, P617, DOI 10.1016/S1097-2765(00)00060-5; Schnitzler G, 1998, CELL, V94, P17, DOI 10.1016/S0092-8674(00)81217-9; SCHROTH GP, 1992, J BIOL CHEM, V267, P11846; STANLEY ER, 1983, J CELL BIOCHEM, V21, P151, DOI 10.1002/jcb.240210206; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; te J, 1995, METH MOL GENET, V6, P108, DOI [10.1016/S1067-2389(06)80009-9, DOI 10.1016/S1067-2389(06)80009-9]; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; WANG AHJ, 1979, NATURE, V282, P680, DOI 10.1038/282680a0; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; WITTIG B, 1992, EMBO J, V11, P4653, DOI 10.1002/j.1460-2075.1992.tb05567.x; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	45	279	288	1	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 10	2001	106	3					309	318		10.1016/S0092-8674(01)00446-9	http://dx.doi.org/10.1016/S0092-8674(01)00446-9			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509180	Bronze			2022-12-01	WOS:000170433300009
J	Volkmann, N; Amann, KJ; Stoilova-McPhie, S; Egile, C; Winter, DC; Hazelwood, L; Heuser, JE; Li, R; Pollard, TD; Hanein, D				Volkmann, N; Amann, KJ; Stoilova-McPhie, S; Egile, C; Winter, DC; Hazelwood, L; Heuser, JE; Li, R; Pollard, TD; Hanein, D			Structure of Arp2/3 complex in its activated state and in actin filament branch junctions	SCIENCE			English	Article							ALDRICH-SYNDROME PROTEIN; WASP/SCAR PROTEINS; N-WASP; ACANTHAMOEBA; NUCLEATION; MOTILITY; CYTOSKELETON; DISSECTION; NETWORKS; PROFILIN	The seven-subunit Arp2/3 complex choreographs the formation of branched actin networks at the leading edge of migrating cells. When activated by Wiskott-Aldrich Syndrome protein (WASp), the Arp2/3 complex initiates actin filament branches from the sides of existing filaments. Electron cryomicroscopy and three-dimensional reconstruction of Acanthamoeba castellanil and Saccharomyces cerevisiae Arp2/3 complexes bound to the WASp carboxy-terminal domain reveal asymmetric, oblate ellipsoids. Image analysis of actin branches indicates that the complex binds the side of the mother filament, and Arp2 and Arp3 (for actin-related protein) are the first two subunits of the daughter filament. Comparison to the actin-free, WASp-activated complexes suggests that branch initiation involves large-scale structural rearrangements within Arp2/3.	Burnham Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63110 USA	Sanford Burnham Prebys Medical Discovery Institute; Salk Institute; Harvard University; Harvard Medical School; Washington University (WUSTL)	Hanein, D (corresponding author), Burnham Inst, La Jolla, CA 92037 USA.		Heuser, John/H-5940-2012					Amann KJ, 2001, NAT CELL BIOL, V3, P306, DOI 10.1038/35060104; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Higgs HN, 1999, J BIOL CHEM, V274, P32531, DOI 10.1074/jbc.274.46.32531; KELLEHER JF, 1995, J CELL BIOL, V131, P385, DOI 10.1083/jcb.131.2.385; Li R, 1997, J CELL BIOL, V136, P649, DOI 10.1083/jcb.136.3.649; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; MACHESKY LM, 1994, J CELL BIOL, V127, P107, DOI 10.1083/jcb.127.1.107; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Mullins RD, 1998, MOL BIOL CELL, V9, P841, DOI 10.1091/mbc.9.4.841; Mullins RD, 1997, J CELL BIOL, V136, P331, DOI 10.1083/jcb.136.2.331; Mullins RD, 1999, CURR OPIN STRUC BIOL, V9, P244; Pantaloni D, 2000, NAT CELL BIOL, V2, P385, DOI 10.1038/35017011; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; TRYBUS KM, 1994, J BIOL CHEM, V269, P20819; Volkmann N, 1999, J STRUCT BIOL, V125, P176, DOI 10.1006/jsbi.1998.4074; WAY M, 1989, J CELL BIOL, V109, P593, DOI 10.1083/jcb.109.2.593; Winter D, 1999, CURR BIOL, V9, P501, DOI 10.1016/S0960-9822(99)80218-8; Winter D, 1997, CURR BIOL, V7, P519, DOI 10.1016/S0960-9822(06)00223-5; Winter DC, 1999, P NATL ACAD SCI USA, V96, P7288, DOI 10.1073/pnas.96.13.7288; Yarar D, 1999, CURR BIOL, V9, P555, DOI 10.1016/S0960-9822(99)80243-7	28	194	201	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2001	293	5539					2456	2459		10.1126/science.1063025	http://dx.doi.org/10.1126/science.1063025			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11533442				2022-12-01	WOS:000171237200048
J	Steinmetz, EJ; Conrad, NK; Brow, DA; Corden, JL				Steinmetz, EJ; Conrad, NK; Brow, DA; Corden, JL			RNA-binding protein Nrd1 directs poly(A)-independent 3 '-end formation of RNA polymerase II transcripts	NATURE			English	Article							C-TERMINAL DOMAIN; SACCHAROMYCES-CEREVISIAE; SPLICING ENDONUCLEASE; YEAST; GENE; SNRNA; SEN1; ACCUMULATION; EXPRESSION; DELETION	A eukaryotic chromosome contains many genes, each transcribed separately by RNA polymerase (pol) I, II or III. Transcription termination between genes prevents the formation of polycistronic RNAs and anti-sense RNAs, which are generally detrimental to the correct expression of genes. Terminating the transcription of protein-coding genes by pol II requires a group of proteins that also direct cleavage and polyadenylation of the messenger RNA in response to a specific sequence element, and are associated with the carboxyl-terminal domain of the largest subunit of pol II (refs 1-6). By contrast, the cis-acting elements and trans-acting factors that direct termination of non-polyadenylated transcripts made by pol II, including small nucleolar and small nuclear RNAs, are not known. Here we show that read-through transcription from yeast small nucleolar RNA and small nuclear RNA genes into adjacent genes is prevented by a cis-acting element that is recognized, in part, by the essential RNA-binding protein Nrd1. The RNA-binding protein Nab3, the putative RNA helicase Sen1, and the intact C-terminal domain of pol II are also required for efficient response to the element. The same proteins are required for maintaining normal levels of Nrd1 mRNA, indicating that these proteins may control elongation of a subset of mRNA transcripts.	Univ Wisconsin, Sch Med, Dept Biomol Chem, Madison, WI 53706 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	University of Wisconsin System; University of Wisconsin Madison; Johns Hopkins University	Brow, DA (corresponding author), Univ Wisconsin, Sch Med, Dept Biomol Chem, Madison, WI 53706 USA.	dabrow@facstaff.wisc.edu; jcorden@jhmi.edu						Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Barilla D, 2001, P NATL ACAD SCI USA, V98, P445, DOI 10.1073/pnas.021545298; Birse CE, 1998, SCIENCE, V280, P298, DOI 10.1126/science.280.5361.298; Brachmann CB, 1998, YEAST, V14, P115; Chanfreau G, 1997, GENE DEV, V11, P2741, DOI 10.1101/gad.11.20.2741; Conrad NK, 2000, GENETICS, V154, P557; DEMARINI DJ, 1992, MOL CELL BIOL, V12, P2154, DOI 10.1128/MCB.12.5.2154; Elela SA, 1998, EMBO J, V17, P3738, DOI 10.1093/emboj/17.13.3738; Fatica A, 2000, EMBO J, V19, P6218, DOI 10.1093/emboj/19.22.6218; Greger IH, 2000, P NATL ACAD SCI USA, V97, P8415, DOI 10.1073/pnas.140217697; Hirose Y, 1998, NATURE, V395, P93, DOI 10.1038/25786; LEE JM, 1991, GENE EXPRESSION, V1, P149; LESSER CF, 1993, GENETICS, V133, P851; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Osheim YN, 1999, MOL CELL, V3, P379, DOI 10.1016/S1097-2765(00)80465-7; Rasmussen TP, 1999, MOL CELL BIOL, V19, P5235; Rodriguez CR, 2000, MOL CELL BIOL, V20, P104, DOI 10.1128/MCB.20.1.104-112.2000; Sacher M, 2000, EUR J CELL BIOL, V79, P71, DOI 10.1078/S0171-9335(04)70009-6; Seipelt RL, 1999, NUCLEIC ACIDS RES, V27, P587, DOI 10.1093/nar/27.2.587; Steinmetz EJ, 1998, P NATL ACAD SCI USA, V95, P6699, DOI 10.1073/pnas.95.12.6699; Steinmetz EJ, 1996, MOL CELL BIOL, V16, P6993, DOI 10.1128/mcb.16.12.6993; Trotta CR, 1997, CELL, V89, P849, DOI 10.1016/S0092-8674(00)80270-6; Ursic D, 1997, NUCLEIC ACIDS RES, V25, P4778, DOI 10.1093/nar/25.23.4778; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; WEST ML, 1995, GENETICS, V140, P1223; Yuryev A, 1996, P NATL ACAD SCI USA, V93, P6975, DOI 10.1073/pnas.93.14.6975	27	277	283	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2001	413	6853					327	331		10.1038/35095090	http://dx.doi.org/10.1038/35095090			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565036				2022-12-01	WOS:000171040500043
J	Dockray, GJ				Dockray, GJ			Gastrin-releasing peptide: an Identity crisis at 30?	LANCET			English	Editorial Material							BOMBESIN; SECRETION		Univ Liverpool, Physiol Lab, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Dockray, GJ (corresponding author), Univ Liverpool, Physiol Lab, POB 147, Liverpool L69 3BX, Merseyside, England.							ANASTASI A, 1971, EXPERIENTIA, V27, P166, DOI 10.1007/BF02145873; Degen LP, 2001, GASTROENTEROLOGY, V120, P361, DOI 10.1053/gast.2001.21174; DOCKRAY GJ, 1979, NEUROSCIENCE, V4, P561; ELOMAR E, 1995, GUT, V36, P534, DOI 10.1136/gut.36.4.534; Gibbons AH, 1997, GASTROENTEROLOGY, V112, P1940, DOI 10.1053/gast.1997.v112.pm9178686; Hildebrand P, 2001, GUT, V49, P23, DOI 10.1136/gut.49.1.23; HOLST JJ, 1990, SCAND J GASTROENTERO, V25, P89, DOI 10.3109/00365529008999214; MCDONALD TJ, 1979, BIOCHEM BIOPH RES CO, V90, P227, DOI 10.1016/0006-291X(79)91614-0; Moore EDW, 1999, J BIOL CHEM, V274, P22493, DOI 10.1074/jbc.274.32.22493; Rozengurt E, 1998, AM J PHYSIOL-GASTR L, V275, pG177, DOI 10.1152/ajpgi.1998.275.2.G177; SCHUBERT ML, 1992, AM J PHYSIOL, V262, pG685, DOI 10.1152/ajpgi.1992.262.4.G685; Wada E, 1997, BIOCHEM BIOPH RES CO, V239, P28, DOI 10.1006/bbrc.1997.7418; WALSH JH, 1979, FED PROC, V38, P2315	13	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 8	2001	358	9284					778	779		10.1016/S0140-6736(01)06008-1	http://dx.doi.org/10.1016/S0140-6736(01)06008-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NA	11564479				2022-12-01	WOS:000170989300005
J	Freeman, C; Evans, CD; Monteith, DT; Reynolds, B; Fenner, N				Freeman, C; Evans, CD; Monteith, DT; Reynolds, B; Fenner, N			Export of organic carbon from peat soils	NATURE			English	Article							MATTER; PEATLANDS; RIVERS		Univ Wales, Sch Biol Sci, Bangor LL57 2UW, Gwynedd, Wales; Ctr Ecol & Hydrol, Wallingford OX10 3BB, Oxon, England; UCL, Environm Change Res Ctr, London WC1H 0AP, England; Ctr Ecol & Hydrol, Bangor LL57 2UP, Gwynedd, Wales	Bangor University; UK Centre for Ecology & Hydrology (UKCEH); University of London; University College London; UK Centre for Ecology & Hydrology (UKCEH)	Freeman, C (corresponding author), Univ Wales, Sch Biol Sci, Bangor LL57 2UW, Gwynedd, Wales.	c.freeman@bangor.ac.uk	Evans, Christopher D/F-2087-2010; Monteith, Donald T/C-1534-2008; Reynolds, Brian/G-6292-2011	Evans, Christopher D/0000-0002-7052-354X; Monteith, Donald T/0000-0003-3219-1772; 				FREEMAN C, 1990, FRESHWATER BIOL, V24, P159, DOI 10.1111/j.1365-2427.1990.tb00315.x; Freeman C, 2001, NATURE, V409, P149, DOI 10.1038/35051650; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; Hope D, 1997, HYDROL PROCESS, V11, P325, DOI 10.1002/(SICI)1099-1085(19970315)11:3&lt;325::AID-HYP476&gt;3.0.CO;2-I; KRUG EC, 1983, SCIENCE, V221, P520, DOI 10.1126/science.221.4610.520; LUGO AE, 1989, ECOSYSTEMS WORLD, V15, P53; MONTEITH DT, 2000, UK ACID WATERS MONIT; PARKER DE, 1992, INT J CLIMATOL, V12, P317, DOI 10.1002/joc.3370120402; Raymond PA, 2001, NATURE, V409, P497, DOI 10.1038/35054034; WETZEL RG, 1992, HYDROBIOLOGIA, V229, P181, DOI 10.1007/BF00007000	10	745	783	13	399	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					785	785		10.1038/35090628	http://dx.doi.org/10.1038/35090628			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518954				2022-12-01	WOS:000170577200025
J	Rietze, RL; Valcanis, H; Brooker, GF; Thomas, T; Voss, AK; Bartlett, PF				Rietze, RL; Valcanis, H; Brooker, GF; Thomas, T; Voss, AK; Bartlett, PF			Purification of a pluripotent neural stem cell from the adult mouse brain	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; MAMMALIAN FOREBRAIN; IN-VIVO; NEURONS; EXPRESSION; ASTROCYTES; GENERATION; MARROW; BLOOD; MCD24	The adult mammalian central nervous system (CNS) contains a population of neural stem cells (NSCs)(1-4) with properties said to include the generation of non-neural progeny(5-7). However, the precise identity, location and potential of the NSC in situ remain unclear. We purified NSCs from the adult mouse brain by flow cytometry, and directly examined the cells' properties. Here we show that one type of NSC, which expresses the protein nestin but only low levels of PNA-binding and HSA proteins, is found in both ependymal and subventricular zones and accounts for about 63% of the total NSC activity. Furthermore, the selective depletion of the population of this stem cell in querkopf(8) mutant mice (which are deficient in production of olfactory neurons) suggests that it acts as a major functional stem cell in vivo. Most freshly isolated NSCs, when co-cultured with a muscle cell line, rapidly differentiated in vitro into myocytes that contain myosin heavy chain (MyHC). This demonstrates that a predominant, functional type of stem cell exists in the periventricular region of the adult brain with the intrinsic ability to generate neural and non-neural cells.	Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Univ Melbourne, Howard Florey Inst Expt Physiol & Med, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Bartlett, PF (corresponding author), Walter & Eliza Hall Inst Med Res, Royal Parade, Parkville, Vic 3050, Australia.	bartlett@wehi.edu.au	Bartlett, Perry/F-3813-2012; Voss, Anne K/F-5110-2013	Voss, Anne K/0000-0002-3853-9381; Thomas, Tim/0000-0002-7623-8344				BARTLETT PF, 1982, P NATL ACAD SCI-BIOL, V79, P2722, DOI 10.1073/pnas.79.8.2722; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Calaora V, 1996, NEUROSCIENCE, V73, P581, DOI 10.1016/0306-4522(96)00042-5; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Galli R, 2000, NAT NEUROSCI, V3, P986, DOI 10.1038/79924; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Gritti A, 1999, J NEUROSCI, V19, P3287; Gritti A, 1996, J NEUROSCI, V16, P1091; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; North KN, 1996, NEUROMUSCULAR DISORD, V6, P229, DOI 10.1016/0960-8966(96)00361-6; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RICHARDS LJ, 1992, P NATL ACAD SCI USA, V89, P8591, DOI 10.1073/pnas.89.18.8591; SALNER AL, 1982, J NATL CANCER I, V68, P639; Shewan D, 1996, J NEUROSCI, V16, P2624; TAM PPL, 1992, DEVELOPMENT, V115, P703; Thomas T, 2000, DEVELOPMENT, V127, P2537	25	525	572	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2001	412	6848					736	739		10.1038/35089085	http://dx.doi.org/10.1038/35089085			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507641				2022-12-01	WOS:000170450200045
J	Bellaiche, Y; Radovic, A; Woods, DF; Hough, CD; Parmentier, ML; O'Kane, CJ; Bryant, PJ; Schweisguth, F				Bellaiche, Y; Radovic, A; Woods, DF; Hough, CD; Parmentier, ML; O'Kane, CJ; Bryant, PJ; Schweisguth, F			The partner of inscuteable/discs-large complex is required to establish planar polarity during asymmetric cell division in Drosophila	CELL			English	Article							TUMOR-SUPPRESSOR GENE; PROTEIN-KINASE-C; SIGNALING POLARIZES; ELEGANS; LOCALIZATION; BAZOOKA; NUMB; DETERMINANTS; COLOCALIZES; ORIENTATION	Frizzled (Fz) signaling regulates cell polarity in both vertebrates and invertebrates. In Drosophila, Fz orients the asymmetric division of the sensory organ precursor cell (pl) along the antero-posterior axis of the notum. Planar polarization involves a remodeling of the apical-basal polarity of the pi cell. The Discs-large (Dlg) and Partner of Inscuteable (Pins) proteins accumulate at the anterior cortex, while Bazooka (Baz) relocalizes to the posterior cortex. Dig interacts directly with Pins and regulates the localization of Pins and Baz. Pins acts with Fz to localize Baz posteriorly, but Baz is not required to localize Pins anteriorly. Finally, Baz and the Dig/Pins complex are required for the asymmetric localization of Numb. Thus, the Dig/Pins complex responds to Fz signaling to establish planar asymmetry in the pl cell.	Ecole Normale Super, UMR 8544, F-75230 Paris 05, France; Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92697 USA; CCIPE, UPR 9023, F-34094 Montpellier 05, France; Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of California System; University of California Irvine; University of Cambridge	Bellaiche, Y (corresponding author), Ecole Normale Super, UMR 8544, 46 Rue Ulm, F-75230 Paris 05, France.	bellaich@wotan.ens.fr	O'Kane, Cahir J/C-4413-2011; O'Kane, Cahir/Q-6681-2019; Parmentier, Marie-Laure/N-9915-2017	O'Kane, Cahir/0000-0002-3488-2078; Parmentier, Marie-Laure/0000-0001-6133-3413; bellaiche, yohanns/0000-0003-1686-2943	NCI NIH HHS [CA 23928] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Boyd L, 1996, DEVELOPMENT, V122, P3075; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; DRUBIN DG, 2000, CELL POLARITY; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Fanto M, 2000, CURR BIOL, V10, P979, DOI 10.1016/S0960-9822(00)00645-X; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Gho M, 1999, DEVELOPMENT, V126, P3573; Goode S, 1997, GENE DEV, V11, P2532, DOI 10.1101/gad.11.19.2532; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hung TJ, 1999, DEVELOPMENT, V126, P127; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Jones KH, 1996, GENETICS, V142, P205; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; Knoblich JA, 1999, CURR BIOL, V9, P155, DOI 10.1016/S0960-9822(99)80070-0; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; Lu BW, 1999, MOL CELL, V4, P883, DOI 10.1016/S1097-2765(00)80218-X; Mlodzik M, 1999, EMBO J, V18, P6873, DOI 10.1093/emboj/18.24.6873; Muller HAJ, 2000, DEV DYNAM, V218, P52; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Pai LM, 1997, DEVELOPMENT, V124, P2255; Parmentier ML, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-14-j0003.2000; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; QUI RC, 2000, CURR BIOL, V10, P697; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Roegiers F, 2001, NAT CELL BIOL, V3, P58, DOI 10.1038/35050568; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; Shulman JM, 1998, TRENDS GENET, V14, P452, DOI 10.1016/S0168-9525(98)01584-4; STERNBERG PW, 1988, DEV BIOL, V130, P67, DOI 10.1016/0012-1606(88)90414-9; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Tada M, 2000, DEVELOPMENT, V127, P2227; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Wallenfang MR, 2000, NATURE, V408, P89, DOI 10.1038/35040562; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Watts JL, 1996, DEVELOPMENT, V122, P3133; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5	52	177	180	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2001	106	3					355	366		10.1016/S0092-8674(01)00444-5	http://dx.doi.org/10.1016/S0092-8674(01)00444-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509184	Bronze			2022-12-01	WOS:000170433300013
J	Martinez, E; Mocroft, A; Garcia-Viejo, MA; Perez-Cuevas, JB; Blanco, JL; Mallolas, J; Bianchi, L; Conget, I; Blanch, J; Phillips, A; Gatell, JM				Martinez, E; Mocroft, A; Garcia-Viejo, MA; Perez-Cuevas, JB; Blanco, JL; Mallolas, J; Bianchi, L; Conget, I; Blanch, J; Phillips, A; Gatell, JM			Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study	LANCET			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; NUCLEOSIDE ANALOG THERAPY; ANTIRETROVIRAL-THERAPY; BODY-COMPOSITION; METABOLIC ABNORMALITIES; FAT DISTRIBUTION; HIV-INFECTION; PERIPHERAL LIPODYSTROPHY; INSULIN-RESISTANCE; HYPERLIPIDEMIA	Background Risk factors for lipodystrophy in patients infected with HIV-1 treated with highly active antiretroviral therapy (HAART) containing HIV-1 protease inhibitors are poorly understood. We aimed to identify the risk factors for lipodystrophy in antiretroviral-naive HIV-1-infected adults on HAART. Methods Moderate or severe body-fat changes were clinically assessed and categorised as subcutaneous lipoatrophy, central obesity, or both, in all consecutive antiretroviral-naive HIV-1-infected adults who began HAART with two nucleoside reverse transcriptase inhibitors plus at least one protease inhibitor from October, 1996, to September, 1999. A person-years analysis was used to calculate the incidence of types of lipodystrophy, and Cox proportional hazards models were used to describe the univariate and multivariate factors associated with progression to any lipodystrophy. Findings After a median follow-up of 18 months, 85 (17%) of the 494 patients developed some type of lipodystrophy. The incidences of any lipodystrophy, lipodystrophy with subcutaneous lipoatrophy, and lipodystrophy with central obesity were 11.7 (95% CI 9.2-14.2), 9.2 (7.0-11.4), and 7.7 (5.7-9.7) per 100 patient-years. An increased risk for any lipodystrophy was found among women as compared with men (relative hazard 1.87 [1.07-3.28]), heterosexuals (2.86 [1.50-5.48]), and homosexuals (2.17 [1.07-4.42]) as compared with intravenous drug users, with increasing age (1.33 per 10 years older [1.08-1.62]), and with the duration of exposure to antiretroviral therapy (1.57 per 6 months extra [1.30-1.88]) but not with any individual antiretroviral agent. The factors associated with an increased risk for lipodystrophy with subcutaneous lipoatrophy or lipodystrophy with central obesity were very similar to those associated with any lipodystrophy. The duration of indinavir use may represent an additional contribution for the development of lipodystrophy with central obesity (1.26 per 6 months extra [0.99-1.60]); p=0.064). Interpretation Risk factors associated with development of any lipodystrophy, lipodystrophy with subcutaneous lipoatrophy, and tipodystrophy with central obesity in patients infected with HIV-1 who were receiving HAART containing protease inhibitors are multifactorial and overlapping, and cannot be exclusively ascribed to the duration of exposure to an particular antiretroviral agent.	August Pl I Sunyer Hosp Clin Barcelona, Inst Invest Biomed, Dept Infect Dis, Barcelona 08036, Spain; August Pl I Sunyer Hosp Clin Barcelona, Inst Invest Biomed, Dept Radiol, Barcelona 08036, Spain; August Pl I Sunyer Hosp Clin Barcelona, Inst Invest Biomed, Dept Endocrinol, Barcelona 08036, Spain; UCL, Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London NW3 2PF, England; UCL, Royal Free & Univ Coll Med Sch, Royal Free Ctr HIV Med, London NW3 2PF, England	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of London; University College London; University of London; University College London	Martinez, E (corresponding author), Hosp Clin Barcelona, Infect Dis Unit, C Villarroel 170, E-08036 Barcelona, Spain.	esteban@intercom.es	Gatell, Jose M/ABC-3607-2020; Blanch, Jordi/I-9022-2012; Mocroft, Amanda/G-8748-2011; Phillips, Andrew N/B-4427-2008; Mocroft, Amanda/C-1527-2008	Blanch, Jordi/0000-0003-2597-8454; Mocroft, Amanda/0000-0001-8316-1122; Phillips, Andrew N/0000-0003-2384-4807; Mallolas Masferrer, Josep/0000-0002-8365-141X				Brinkman K, 1999, LANCET, V354, P1112, DOI 10.1016/S0140-6736(99)06102-4; Carbonnel F, 1998, AIDS, V12, P1777, DOI 10.1097/00002030-199814000-00009; Carpenter CCJ, 1997, JAMA-J AM MED ASSOC, V277, P1962, DOI 10.1001/jama.277.24.1962; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Carr A, 2000, AIDS, V14, pF25, DOI 10.1097/00002030-200002180-00001; Carr A, 1998, LANCET, V351, P1881, DOI 10.1016/S0140-6736(98)03391-1; CARR A, 1997, 9 ANN C AUSTR SOC HI; DAUCOURT V, 1999, 1 INT WORKSH ADV DRU; Dong KL, 1999, J ACQ IMMUN DEF SYND, V21, P107; FALUTZ J, 1999, 1 INT WORKSH ADV DRU; FLYNN MA, 1989, AM J CLIN NUTR, V50, P713, DOI 10.1093/ajcn/50.4.713; GALLI M, 1990, 1 INT WORKSH ADV DRU; Gervasoni C, 1999, AIDS, V13, P465, DOI 10.1097/00002030-199903110-00004; Hadigan C, 1999, J CLIN ENDOCR METAB, V84, P1932, DOI 10.1210/jc.84.6.1932; Kirk O, 1998, AIDS, V12, P2031, DOI 10.1097/00002030-199815000-00015; Kotler DP, 1999, J ACQ IMMUN DEF SYND, V20, P228, DOI 10.1097/00042560-199903010-00003; Mallal SA, 2000, AIDS, V14, P1309, DOI 10.1097/00002030-200007070-00002; Martinez E, 2000, CLIN INFECT DIS, V31, P1266, DOI 10.1086/317426; Martinez E, 2000, LANCET, V356, P1412, DOI 10.1016/S0140-6736(00)02850-6; Martinez E, 1999, AIDS, V13, P805, DOI 10.1097/00002030-199905070-00009; Martinez E, 1999, CURR OPIN INFECT DIS, V12, P13, DOI 10.1097/00001432-199902000-00003; Miller KD, 1998, LANCET, V351, P871, DOI 10.1016/S0140-6736(97)11518-5; MUURAHAINEN N, 1999, 1 INT WORKSH ADV DRU; Pernerstorfer-Schoen H, 1999, AIDS, V13, P2389, DOI 10.1097/00002030-199912030-00010; Safrin S, 1999, AIDS, V13, P2493, DOI 10.1097/00002030-199912240-00002; Saint-Marc T, 1999, AIDS, V13, P1659, DOI 10.1097/00002030-199909100-00009; Saint-Marc T, 2000, AIDS, V14, P37, DOI 10.1097/00002030-200001070-00005; SCHWARTZ RS, 1990, J GERONTOL, V45, P181; SHIMOKATA H, 1989, J GERONTOL, V44, P66; Silva M, 1998, AIDS, V12, P1645, DOI 10.1097/00002030-199813000-00012; VIARD JP, 1999, 1 INT WORKSH ADV DRU; WARD DJ, 1999, 1 INT WORKSH ADV DRU	33	329	337	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	2001	357	9256					592	598		10.1016/S0140-6736(00)04056-3	http://dx.doi.org/10.1016/S0140-6736(00)04056-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558485				2022-12-01	WOS:000167119100011
J	BOWYER, S				BOWYER, S			ASTRONOMY AND THE EXTREME-ULTRAVIOLET EXPLORER SATELLITE	SCIENCE			English	Article							INTERSTELLAR	The extreme ultraviolet wave band (100 to 912 angstroms) was thought until recently to be useless to astronomy, primarily because the opacity of the interstellar medium would prevent observations at these wavelengths. However, the interstellar medium has been found to be markedly inhomogeneous in both density and ionization state and the sun is fortunately located in a region of low extreme ultraviolet opacity. The Extreme Ultraviolet Explorer, launched in June 1992, has surveyed the sky in this wave band and has detected a wide variety of astronomical sources at considerable distances, including some extragalactic objects. Studies in the extreme ultraviolet band have already begun to increase our understanding of the contents of the universe.			BOWYER, S (corresponding author), UNIV CALIF BERKELEY,CTR EUV ASTROPHYS,2150 KITTREDGE ST,BERKELEY,CA 94720, USA.							ALLER LH, 1959, PUBL ASTRON SOC PAC, V71, P324, DOI 10.1086/127390; BOWYER S, 1988, APPL OPTICS, V27, P1414, DOI 10.1364/AO.27.001414; Bowyer S., 1991, EXTREME ULTRAVIOLET, P397; BOWYER S, UNPUB; CASH W, 1978, ASTROPHYS J, V221, pL87, DOI 10.1086/182670; CASSINELLI JP, UNPUB; CULLY SL, 1993, ASTROPHYS J, V414, pL49, DOI 10.1086/186993; DUPREE AK, IN PRESS ASTROPHYS J; DUPUIS J, UNPUB; DUPUIS J, IN PRESS BR ASS ADV; FLEMING TA, 1986, ASTROPHYS J, V308, P176, DOI 10.1086/164488; FRUSCIONE A, IN PRESS ASTROPHYS J; GLADSTONE GR, UNPUB; GLADSTONE GR, IN PRESS GEOPHYS RES; GREEN J, 1990, ASTROPHYS J, V359, P499, DOI 10.1086/169081; GURSKY H, 1963, PHYS REV LETT, V11, P530, DOI 10.1103/PhysRevLett.11.530; HEILES C, 1991, EUV ASTRONOMY, P313; HENRY P, 1975, ASTROPHYS J, V195, P107, DOI 10.1086/153309; HETTRICK MC, 1983, APPL OPTICS, V22, P3921, DOI 10.1364/AO.22.003921; KIMBLE RA, 1993, ASTROPHYS J, V404, P663, DOI 10.1086/172319; KRASNOPOLSKY VA, UNPUB; LAMPTON M, 1976, ASTROPHYS J, V203, pL71, DOI 10.1086/182022; LIVINGSTON PM, 1968, J GEOPHYS RES, V73, P1107; MARTIN C, 1981, REV SCI INSTRUM, V52, P1967; PARESCE F, 1974, ASTROPHYS J, V187, P633, DOI 10.1086/152673; POUNDS K, 1993, MON NOT R ASTRON SOC, V206, P77; SIEGMUND OHW, 1986, J OPT SOC AM A, V3, P2139, DOI 10.1364/JOSAA.3.002139; SNOWDEN SL, 1993, ASTROPHYS J, V409, pL21, DOI 10.1086/186850; SPITZER L, 1990, ANNU REV ASTRON ASTR, V28, P71; VALLERGA JV, 1993, ASTROPHYS J, V414, pL65, DOI 10.1086/186997; VEDDER PW, 1993, IN PRESS ASTROPHYS J, V414, pL61; VENNES S, 1993, ASTROPHYS J, V410, pL119, DOI 10.1086/186894; [No title captured]	33	8	8	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 7	1994	263	5143					55	59		10.1126/science.11536659	http://dx.doi.org/10.1126/science.11536659			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MQ301	11536659				2022-12-01	WOS:A1994MQ30100025
J	OWEN, T; BARNUN, A; KLEINFELD, I				OWEN, T; BARNUN, A; KLEINFELD, I			POSSIBLE COMETARY ORIGIN OF HEAVY NOBLE-GASES IN THE ATMOSPHERES OF VENUS, EARTH AND MARS	NATURE			English	Article							AMORPHOUS WATER ICE; TERRESTRIAL PLANETS; METEORITES; SHERGOTTITES; BASALTS; IMPACT; GLASS	MODELS that trace the origin of noble gases in the atmospheres of the terrestrial planets (Venus, Earth and Mars) to the 'planetary component' in chondritic meteorites confront several problems. The 'missing' xenon in the atmospheres of Mars and Earth (Fig. 1) is one of the most obvious; this gas is not hidden or trapped in surface materials 1. On Venus, the absolute abundances of neon and argon per gram of rock are higher even than those in carbonaceous chondrites, whereas the relative abundances of argon and krypton are closer to solar than to chondritic values (there is only an upper limit on xenon) 2 (Fig. 1). Pepin 3 has developed a model that emphasizes hydrodynamic escape of early, massive hydrogen atmospheres to explain the abundances and isotope ratios of noble gases on all three planets. We have previously suggested that the unusual abundances of heavy noble gases on Venus might be explained by the impact of a low-temperature comet 4-6. Further consideration of the probable history of the martian atmosphere 7, the noble-gas data from the (Mars-derived) SNC meteorites 8-10 and laboratory experiments on the trapping of noble gases in ice 6,11,12 lead us to propose here that the noble gases in the atmospheres of all of the terrestrial planets are dominated by a mixture of an internal component and a contribution from impacting icy planetesimals (comets). If true, this hypothesis illustrates the importance of impacts in determining the volatile inventories of these planets.	TEL AVIV UNIV, DEPT GEOPHYS & PLANETARY SCI, IL-69978 TEL AVIV, ISRAEL	Tel Aviv University	OWEN, T (corresponding author), UNIV HAWAII, INST ASTRON, 2680 WOODLAWN DR, HONOLULU, HI 96822 USA.							BARNUN A, 1989, ICARUS, V80, P243, DOI 10.1016/0019-1035(89)90136-X; BARNUN A, 1988, PHYS REV B, V38, P7749, DOI 10.1103/PhysRevB.38.7749; BIEMANN K, 1976, SCIENCE, V194, P76, DOI 10.1126/science.194.4260.76; BOGARD DD, 1983, SCIENCE, V221, P651, DOI 10.1126/science.221.4611.651; BOSS AP, 1989, ORIGIN EVOLUTION PLA, P35; BUS SJ, 1991, SCIENCE, V251, P774, DOI 10.1126/science.251.4995.774; CAMERON AGW, 1983, ICARUS, V56, P195, DOI 10.1016/0019-1035(83)90032-5; CHYBA CF, 1987, NATURE, V330, P632, DOI 10.1038/330632a0; CLAYTON RN, 1983, EARTH PLANET SC LETT, V62, P1, DOI 10.1016/0012-821X(83)90066-3; CRAIG H, 1976, EARTH PLANET SC LETT, V31, P369, DOI 10.1016/0012-821X(76)90118-7; HART R, 1983, NATURE, V305, P403, DOI 10.1038/305403a0; Hoffman JH, 1980, J GEOPHYS RES-SPACE, V85, P7871, DOI 10.1029/JA085iA13p07871; HONDA M, 1991, NATURE, V349, P149, DOI 10.1038/349149a0; HUNTEN DM, 1988, METEORITES EARLY SOL, P565; IP WH, 1988, ICARUS, V74, P47, DOI 10.1016/0019-1035(88)90030-9; KANEOKA I, 1983, EARTH PLANET SC LETT, V66, P427, DOI 10.1016/0012-821X(83)90156-5; LAUFER D, 1987, PHYS REV B, V36, P9219, DOI 10.1103/PhysRevB.36.9219; LUNINE JI, 1991, ICARUS, V94, P333, DOI 10.1016/0019-1035(91)90232-I; LUU JX, 1990, ASTRON J, V100, P913, DOI 10.1086/115571; MCELROY MB, 1972, SCIENCE, V175, P443, DOI 10.1126/science.175.4020.443; MEECH KJ, 1989, IAU4470 CIRC; MELOSH HJ, 1989, NATURE, V338, P487, DOI 10.1038/338487a0; MUSSELWHITE DS, 1991, NATURE, V352, P697, DOI 10.1038/352697a0; ORO J, 1961, NATURE, V190, P389, DOI 10.1038/190389a0; OTT U, 1988, GEOCHIM COSMOCHIM AC, V52, P1937, DOI 10.1016/0016-7037(88)90017-8; OTT U, 1988, METEORITICS, V23, P295; OTT U, 1985, NATURE, V317, P509, DOI 10.1038/317509a0; OWEN T, 1991, ASTROPHYS SPACE SC L, V167, P429; Owen T., 1977, J GEOPHYS RES, V82, P4635, DOI DOI 10.1029/JS082I028P04635; OWEN T, 1986, WORKSHOP EVOLUTION M, P31; OWEN T, IN PRESS MARS; PEPIN RO, 1991, ICARUS, V92, P2, DOI 10.1016/0019-1035(91)90036-S; SILL GT, 1978, ICARUS, V33, P13, DOI 10.1016/0019-1035(78)90020-9; STERN SA, 1992, ICARUS, V95, P157, DOI 10.1016/0019-1035(92)90198-G; STOLPER E, 1979, GEOCHIM COSMOCHIM AC, V43, P1475, DOI 10.1016/0016-7037(79)90142-X; STOLPER EM, 1978, GEOCHIM COSMOCHIM AC, V42, P589; STUDACHER T, 1986, CHEM GEOL, V56, P193; WACKER JF, 1984, GEOCHIM COSMOCHIM AC, V48, P2373, DOI 10.1016/0016-7037(84)90232-1; WATSON LL, IN PRESS P LUNAR PLA; WETHERILL GW, 1990, ANNU REV EARTH PL SC, V18, P205, DOI 10.1146/annurev.ea.18.050190.001225; WETHERILL GW, 1981, ICARUS, V46, P70, DOI 10.1016/0019-1035(81)90076-2; WIENS RC, 1986, EARTH PLANET SC LETT, V77, P149, DOI 10.1016/0012-821X(86)90156-1; ZAHNLE K, 1990, ICARUS, V84, P502, DOI 10.1016/0019-1035(90)90050-J; [No title captured]	44	111	111	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 2	1992	358	6381					43	46		10.1038/358043a0	http://dx.doi.org/10.1038/358043a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB341	11536499				2022-12-01	WOS:A1992JB34100046
J	ENGEL, MH; MACKO, SA; SILFER, JA				ENGEL, MH; MACKO, SA; SILFER, JA			CARBON ISOTOPE COMPOSITION OF INDIVIDUAL AMINO-ACIDS IN THE MURCHISON METEORITE	NATURE			English	Article									UNIV VIRGINIA,DEPT ENVIRONM SCI,CHARLOTTESVILLE,VA 22903	University of Virginia	ENGEL, MH (corresponding author), UNIV OKLAHOMA,SCH GEOL & GEOPHYS,100 E BOYD ST,NORMAN,OK 73019, USA.		Macko, Stephen/K-4588-2015					CHANG S, 1978, LUNAR PLANET SCI, V9, P157; CHYBA CF, 1990, SCIENCE, V249, P366, DOI 10.1126/science.11538074; Cronin J. R., 1988, METEORITES EARLY SOL; CRONIN JR, 1971, SCIENCE, V172, P1327, DOI 10.1126/science.172.3990.1327; CRONIN JR, 1976, ORIGINS LIFE EVOL B, V7, P337, DOI 10.1007/BF00927928; Engel M.H., 1985, CHEM BIOCHEM AMINO, P462; ENGEL MH, 1982, NATURE, V296, P837, DOI 10.1038/296837a0; ENGEL MH, 1984, ANAL CHEM, V56, P2598, DOI 10.1021/ac00277a075; ENGEL MH, 1986, NATURE, V323, P531, DOI 10.1038/323531a0; ENGEL MH, 1983, NATURE, V301, P496, DOI 10.1038/301496a0; EPSTEIN S, 1987, NATURE, V326, P477, DOI 10.1038/326477a0; FREEDMAN PA, 1988, J AM LAB, P114; FREEMAN KH, 1990, NATURE, V343, P254, DOI 10.1038/343254a0; GRADY MM, 1988, GEOCHIM COSMOCHIM AC, V52, P2855, DOI 10.1016/0016-7037(88)90152-4; HARE PE, 1985, CHEM BIOCH AMINO ACI, P415; JULL AJT, 1989, GEOCHIM COSMOCHIM AC, V53, P2095, DOI 10.1016/0016-7037(89)90327-X; KENNICUTT MC, 1990, ORG GEOCHEM, V15, P193, DOI 10.1016/0146-6380(90)90083-C; KERRIDGE JF, 1985, GEOCHIM COSMOCHIM AC, V49, P1707, DOI 10.1016/0016-7037(85)90141-3; KHARE BN, 1986, ICARUS, V68, P176, DOI 10.1016/0019-1035(86)90080-1; MACKO SA, 1981, THESIS U TEXAS AUSTI; NOYES HP, 1977, ORIGINS LIFE EVOL B, V8, P21, DOI 10.1007/BF00930935; PILLINGER CT, 1982, NATURE, V296, P802, DOI 10.1038/296802a0; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; SERBAN A, 1988, ORG GEOCHEM, V13, P1123, DOI 10.1016/0146-6380(88)90298-7; SHOCK EL, IN PRESS GEOCHIM COS; SILFER JA, UNPUB ANAL CHEM; YUEN G, 1984, NATURE, V307, P252, DOI 10.1038/307252a0; 1990, SEARCH LIFES ORIGINS	28	219	222	2	40	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 1	1990	348	6296					47	49		10.1038/348047a0	http://dx.doi.org/10.1038/348047a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF994	11536470				2022-12-01	WOS:A1990EF99400056
J	ANDERS, E				ANDERS, E			PRE-BIOTIC ORGANIC-MATTER FROM COMETS AND ASTEROIDS	NATURE			English	Article									UNIV CHICAGO, DEPT CHEM, CHICAGO, IL 60637 USA	University of Chicago	ANDERS, E (corresponding author), UNIV CHICAGO, ENRICO FERMI INST, CHICAGO, IL 60637 USA.		Anders, Edward/B-7980-2009					ANDERS E, 1977, SCIENCE, V198, P453, DOI 10.1126/science.198.4316.453; ANDERS E, 1968, ACCOUNTS CHEM RES, V1, P289, DOI 10.1021/ar50010a001; ANDERS E, 1973, SCIENCE, V182, P781, DOI 10.1126/science.182.4114.781; Anders E., 1973, Moon, V8, P3, DOI 10.1007/BF00562747; [Anonymous], 2019, INT SOIL WATER CONSE, DOI DOI 10.1016/j.iswcr.2018.09.001; BALDWIN B, 1971, J GEOPHYS RES, V76, P4653, DOI 10.1029/JA076i019p04653; BARKER JL, 1968, GEOCHIM COSMOCHIM AC, V32, P627, DOI 10.1016/0016-7037(68)90053-7; BROWNLEE DE, 1985, REV EARTH PLANET SCI, V13, P189; CHAPMAN CR, 1975, SCIENCE, V190, P553, DOI 10.1126/science.190.4214.553; CHYBA CF, 1987, NATURE, V330, P632, DOI 10.1038/330632a0; Cronin J.R., 1988, METEORITES EARLY SOL, P819; DEAMER DW, 1985, NATURE, V317, P792, DOI 10.1038/317792a0; DEAMER DW, IN PRESS ORIGINS LIF; DELSEMME AH, 1984, ORIGINS LIFE EVOL B, V14, P51, DOI 10.1007/BF00933639; DOHNANYI JS, 1971, SCIENCE, V173, P558, DOI 10.1126/science.173.3996.558; EMILIANI C, 1981, EARTH PLANET SC LETT, V55, P317, DOI 10.1016/0012-821X(81)90161-8; GRADIE J, 1982, SCIENCE, V216, P1405, DOI 10.1126/science.216.4553.1405; GROS J, 1976, P LUNAR PLANET SCI C, V7, P2403; HAYATSU R, 1981, TOP CURR CHEM, V99, P1; HERTOGEN J, 1977, P LUNAR PLANET SCI C, V8, P17; HUDSON B, 1981, SCIENCE, V211, P383, DOI 10.1126/science.211.4480.383; Hughes D. W., 1978, Cosmic dust, P123; IP WH, 1988, ICARUS, V74, P47, DOI 10.1016/0019-1035(88)90030-9; JESSBERGER EK, 1988, NATURE, V332, P691, DOI 10.1038/332691a0; KIMURA K, 1974, GEOCHIM COSMOCHIM AC, V38, P683, DOI 10.1016/0016-7037(74)90144-6; KYTE FT, 1986, SCIENCE, V232, P1225, DOI 10.1126/science.232.4755.1225; LEWIS RS, 1986, METEORITICS, V21, P434; MATSUI T, 1986, NATURE, V322, P526, DOI 10.1038/322526a0; MORGAN JW, 1981, TECTONOPHYSICS, V75, P47, DOI 10.1016/0040-1951(81)90209-2; MORGAN JW, 1986, J GEOPHYS RES-SOLID, V91, P2375, DOI 10.1029/JB091iB12p12375; MULLIE F, 1987, TOP CURR CHEM, V139, P83; OPIK EJ, 1961, P GEOPHYS LAB LAWREN, P1; ORO J, 1961, NATURE, V190, P389, DOI 10.1038/190389a0; PALME H, 1981, GEOCHIM COSMOCHIM AC, V45, P2417, DOI 10.1016/0016-7037(81)90095-8; REVELLE DO, 1979, J ATMOS TERR PHYS, V41, P453, DOI 10.1016/0021-9169(79)90071-0; SCHRAMM LS, 1989, METEORITICS, V24, P99, DOI 10.1111/j.1945-5100.1989.tb00950.x; Sears D. W., 1975, Modern Geology, V5, P155; SHOEMAKER EM, 1983, ANNU REV EARTH PL SC, V11, P461, DOI 10.1146/annurev.ea.11.050183.002333; STRIBLING R, 1987, ORIGINS LIFE EVOL B, V17, P261, DOI 10.1007/BF02386466; THOMAS PJ, 1989, LUNAR PLANET SCI, V20, P1117; TURCO RP, 1982, ICARUS, V50, P1, DOI 10.1016/0019-1035(82)90096-3; TUREKIAN KK, 1969, EARTH PLANET SC LETT, V6, P346, DOI 10.1016/0012-821X(69)90183-6; Weissman P. R., 1982, GEOL SOC AM SPEC PAP, V190, P15; WETHERILL GW, 1981, ICARUS, V48, P308, DOI 10.1016/0019-1035(81)90112-3; WETHERILL GW, 1987, PHILOS T R SOC A, V323, P323, DOI 10.1098/rsta.1987.0089; WOLBACH WS, 1985, SCIENCE, V230, P167, DOI 10.1126/science.230.4722.167; ZAHNLE KJ, 1988, ICARUS, V74, P62, DOI 10.1016/0019-1035(88)90031-0; ZHAO MX, 1989, NATURE, V339, P463, DOI 10.1038/339463a0; [No title captured]	49	292	294	11	249	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	1989	342	6247					255	257		10.1038/342255a0	http://dx.doi.org/10.1038/342255a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ874	11536617				2022-12-01	WOS:A1989AZ87400046
J	Baker, D; Sali, A				Baker, D; Sali, A			Protein structure prediction and structural genomics	SCIENCE			English	Editorial Material							PROTEASES; DATABASE; BINDING; TOOL	Genome sequencing projects are producing linear amino acid sequences, but full understanding of the biological role of these proteins will require knowledge of their structure and function. Although experimental structure determination methods are providing high-resolution structure information about a subset of the proteins, computational structure prediction methods will provide valuable information for the large fraction of sequences whose structures will not be determined experimentally. The first class of protein structure prediction methods, including threading and comparative modeling, rely on detectable similarity spanning most of the modeled sequence and at least one known structure. The second class of methods, de novo or ab initio methods, predict the structure from sequence alone, without relying on similarity at the fold level between the modeled sequence and any of the known structures. In this Viewpoint, we begin by describing the essential features of the methods, the accuracy of the models, and their application to the prediction and understanding of protein function, both for single proteins and on the scale of whole genomes. We then discuss the important role that protein structure prediction methods play in the growing worldwide effort in structural genomics.	Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Rockefeller Univ, Pels Family Ctr Biochem & Struct Biol, Lab Mol Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Rockefeller University	Baker, D (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	dabaker@u.washington.edu; sail@rockefeller.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217	NIGMS NIH HHS [GM 54762] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM054762, R01GM054762] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aloy P, 2001, J MOL BIOL, V311, P395, DOI 10.1006/jmbi.2001.4870; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BLUNDELL TL, 1987, NATURE, V326, P347, DOI 10.1038/326347a0; Bonneau R, 2001, ANNU REV BIOPH BIOM, V30, P173, DOI 10.1146/annurev.biophys.30.1.173; Bonneau R, 2001, J STRUCT BIOL, V134, P186, DOI 10.1006/jsbi.2000.4370; BONNEAU R, IN PRESS PROTEINS ST; Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; Brenner SE, 2000, NAT STRUCT BIOL, V7, P967, DOI 10.1038/80747; BROWNE WJ, 1969, J MOL BIOL, V42, P65, DOI 10.1016/0022-2836(69)90487-2; Burley SK, 1999, NAT GENET, V23, P151, DOI 10.1038/13783; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Fischer D, 1997, P NATL ACAD SCI USA, V94, P11929, DOI 10.1073/pnas.94.22.11929; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gonzalez C, 2000, P NATL ACAD SCI USA, V97, P11221, DOI 10.1073/pnas.210301097; GREER J, 1981, J MOL BIOL, V153, P1027, DOI 10.1016/0022-2836(81)90465-4; Guex N, 1999, TRENDS BIOCHEM SCI, V24, P364, DOI 10.1016/S0968-0004(99)01427-9; HAVEL TF, 1991, J MOL BIOL, V217, P1, DOI 10.1016/0022-2836(91)90603-4; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jones DT, 1997, PROTEINS, P185; Koehl Patrice, 1999, Nature Structural Biology, V6, P108, DOI 10.1038/5794; Kolinski A, 2001, PROTEINS, V44, P133, DOI 10.1002/prot.1080; LEVITT M, 1992, J MOL BIOL, V226, P507, DOI 10.1016/0022-2836(92)90964-L; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MARTIRENOM MA, IN PRESS STRUCTURE; MATSUMOTO R, 1995, J BIOL CHEM, V270, P19524, DOI 10.1074/jbc.270.33.19524; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Ortiz AR, 1999, PROTEINS, P177; Pillardy A, 2001, P NATL ACAD SCI USA, V98, P2329, DOI 10.1073/pnas.041609598; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sali Andrej, 1998, Nature Structural Biology, V5, P1029, DOI 10.1038/4136; SAMUDRALA R, 1999, PROTEINS, V3, P197; Sanchez R, 2000, NUCLEIC ACIDS RES, V28, P250, DOI 10.1093/nar/28.1.250; Sanchez R, 1998, P NATL ACAD SCI USA, V95, P13597, DOI 10.1073/pnas.95.23.13597; Sanchez R, 2000, NAT STRUCT BIOL, V7, P986, DOI 10.1038/80776; Simons KT, 2001, J MOL BIOL, V306, P1191, DOI 10.1006/jmbi.2000.4459; SPAHN CMT, IN PRESS CELL; Torda AE, 1997, CURR OPIN STRUC BIOL, V7, P200, DOI 10.1016/S0959-440X(97)80026-7; Vitkup D, 2001, NAT STRUCT BIOL, V8, P559, DOI 10.1038/88640; Wallace AC, 1997, PROTEIN SCI, V6, P2308; Xu LZ, 1996, J BIOL CHEM, V271, P24711; Zhang BH, 1999, PROTEIN SCI, V8, P1104, DOI 10.1110/ps.8.5.1104	41	1161	1303	8	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2001	294	5540					93	96		10.1126/science.1065659	http://dx.doi.org/10.1126/science.1065659			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11588250				2022-12-01	WOS:000171448800038
J	Hilleren, P; McCarthy, T; Rosbash, M; Parker, R; Jensen, TH				Hilleren, P; McCarthy, T; Rosbash, M; Parker, R; Jensen, TH			Quality control of mRNA 3 '-end processing is linked to the nuclear exosome	NATURE			English	Article							MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; POLY(A) POLYMERASE; RIBOSOMAL-RNA; EXPORT; YEAST; POLYADENYLATION; MUTATIONS; TURNOVER; PATHWAY	An emerging theme in messenger RNA metabolism is the coupling of nuclear pre-mRNA processing events, which contributes to mRNA quality control(1). Most eukaryotic mRNAs acquire a poly(A) tail during 3'-end processing within the nucleus, and this is coupled to efficient export of mRNAs to the cytoplasm(2,3). In the yeast Saccharomyces cerevisiae, a common consequence of defective nuclear export of mRNA is the hyperadenylation of nascent transcripts(4,5), which are sequestered at or near their sites of transcription(5). This implies that polyadenylation and nuclear export are coupled in a step that involves the release of mRNA from transcription site foci. Here we demonstrate that transcripts which fail to acquire a poly(A) tail are also retained at or near transcription sites. Surprisingly, this retention mechanism requires the protein Rrp6p and the nuclear exosome, a large complex of exonucleolytic enzymes(6,7). In exosome mutants, hypo- as well as hyperadenylated mRNAs are released and translated. These observations suggest that the exosome contributes to a checkpoint that monitors proper 3'-end formation of mRNA.	Univ Arizona, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Brandeis Univ, Howard Hughes Med Inst, Dept Biol, Waltham, MA 02454 USA	Howard Hughes Medical Institute; University of Arizona; Brandeis University; Howard Hughes Medical Institute	Hilleren, P (corresponding author), Univ Arizona, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.		Jensen, Torben H/G-2954-2017					Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Amrani N, 1996, MOL GEN GENET, V252, P552, DOI 10.1007/BF02172401; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; ECKNER R, 1991, EMBO J, V10, P3513, DOI 10.1002/j.1460-2075.1991.tb04915.x; GORSCH LC, 1995, J CELL BIOL, V129, P939, DOI 10.1083/jcb.129.4.939; Hilleren P, 2001, RNA, V7, P753, DOI 10.1017/S1355838201010147; Huang YQ, 1996, MOL CELL BIOL, V16, P1534; Jensen TH, 2001, MOL CELL, V7, P887, DOI 10.1016/S1097-2765(01)00232-5; Lee MS, 1996, GENE DEV, V10, P1233, DOI 10.1101/gad.10.10.1233; MANDART E, 1995, MOL CELL BIOL, V15, P6979; Maquat LE, 2001, CELL, V104, P173, DOI 10.1016/S0092-8674(01)00202-1; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; PATEL D, 1992, MOL CELL BIOL, V12, P3297, DOI 10.1128/MCB.12.7.3297; Vainberg IE, 2000, MOL CELL BIOL, V20, P3996, DOI 10.1128/MCB.20.11.3996-4005.2000; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000	18	284	288	0	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2001	413	6855					538	542		10.1038/35097110	http://dx.doi.org/10.1038/35097110			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586364				2022-12-01	WOS:000171340500051
J	Goldie, SJ; Levin, AR				Goldie, SJ; Levin, AR			Genomics in medicine and public health: Role of cost-effectiveness analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review									Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Brown Univ, Providence, RI 02912 USA	Harvard University; Harvard T.H. Chan School of Public Health; Brown University	Goldie, SJ (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.			Levin, April/0000-0003-4192-4720				BROWN ML, 1995, J NATL CANCER I, V87, P1131, DOI 10.1093/jnci/87.15.1131; Collins FS, 1999, NEW ENGL J MED, V341, P28, DOI 10.1056/NEJM199907013410106; Emery J, 2001, LANCET, V358, P56, DOI 10.1016/S0140-6736(00)05257-0; Gold MR., 1996, COST EFFECTIVENESS H; Holtzman NA, 2000, NEW ENGL J MED, V343, P141, DOI 10.1056/NEJM200007133430213; Motulsky AG, 1999, LANCET, V354, pSI35; Veenstra DL, 2000, AAPS PHARMSCI, V2, part. no.; Weinstein MC, 2001, ANN INTERN MED, V134, P440, DOI 10.7326/0003-4819-134-6-200103200-00008	8	4	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2001	286	13					1637	1638		10.1001/jama.286.13.1637	http://dx.doi.org/10.1001/jama.286.13.1637			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478HH	11585493	hybrid			2022-12-01	WOS:000171340600036
J	Clutton-Brock, TH; Russell, AF; Sharpe, LL; Brotherton, PNM; McIlrath, GM; White, S; Cameron, EZ				Clutton-Brock, TH; Russell, AF; Sharpe, LL; Brotherton, PNM; McIlrath, GM; White, S; Cameron, EZ			Effects of helpers on juvenile development and survival in meerkats	SCIENCE			English	Article							COOPERATIVE MONGOOSE; FOOD ALLOCATION; GROUP-SIZE; BEHAVIOR; DYNAMICS	Although breeding success is known to increase with group size in several cooperative mammals, the mechanisms underlying these relationships are uncertain. We show that in wild groups of cooperative meerkats, Suricata suricatta, reductions in the ratio of helpers to pups depress the daily weight gain and growth of pups and the daily weight gain of helpers. Increases in the daily weight gain of pups are associated with heavier weights at independence and at 1 year of age, as well as with improved foraging success as juveniles and higher survival rates through the first year of life. These results suggest that the effects of helpers on the fitness of pups extend beyond weaning and that helpers may gain direct as well as indirect benefits by feeding pups.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Stellenbosch, Dept Zool, ZA-7602 Matieland, South Africa; Univ Pretoria, Mammal Res Inst, ZA-0002 Pretoria, South Africa	University of Cambridge; Stellenbosch University; University of Pretoria	Clutton-Brock, TH (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	thcb@hermes.cam.ac.uk	Cameron, Elissa/B-8053-2014; Cameron, Elissa Z/E-4280-2010	Cameron, Elissa/0000-0002-9243-0547; 				Brotherton PNM, 2001, BEHAV ECOL, V12, P590, DOI 10.1093/beheco/12.5.590; Brown J. L., 1987, HELPING COMMUNAL BRE; Clutton-Brock TH, 1998, P ROY SOC B-BIOL SCI, V265, P185, DOI 10.1098/rspb.1998.0281; Clutton-Brock TH, 2000, P ROY SOC B-BIOL SCI, V267, P301, DOI 10.1098/rspb.2000.1000; Clutton-Brock TH, 2001, SCIENCE, V291, P478, DOI 10.1126/science.291.5503.478; Clutton-Brock TH, 2001, ANIM BEHAV, V61, P705, DOI 10.1006/anbe.2000.1631; Clutton-Brock TH, 1999, J ANIM ECOL, V68, P672, DOI 10.1046/j.1365-2656.1999.00317.x; Clutton-Brock TH, 1999, SCIENCE, V284, P1640, DOI 10.1126/science.284.5420.1640; CLUTTONBROCK TH, 1982, NATURE, V300, P178, DOI 10.1038/300178a0; Cockburn A, 1998, ANNU REV ECOL SYST, V29, P141, DOI 10.1146/annurev.ecolsys.29.1.141; Courchamp F, 1999, P ROY SOC B-BIOL SCI, V266, P557, DOI 10.1098/rspb.1999.0672; Courchamp F, 2000, ANIM CONSERV, V3, P277, DOI 10.1017/S1367943000001001; CREEL S, IN PRESS AFRICAN WIL; GRIFFIN AS, 1999, THESIS U EDINBURGH; JENNIONS MD, 1994, TRENDS ECOL EVOL, V9, P89, DOI 10.1016/0169-5347(94)90202-X; *LAW AGR TRUST ROT, 1998, GENSTAT 5 4 1; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; MALCOLM JR, 1982, BEHAV ECOL SOCIOBIOL, V10, P1, DOI 10.1007/BF00296390; Manser MB, 2000, BEHAV ECOL SOCIOBIOL, V48, P429, DOI 10.1007/s002650000248; Moehlman P.D., 1989, P143; ROOD JP, 1990, ANIM BEHAV, V39, P566, DOI 10.1016/S0003-3472(05)80423-3; Solomon N.G., 1997, COOPERATIVE BREEDING; VANSCHAIK CP, 1983, BEHAVIOUR, V87, P120, DOI 10.1163/156853983X00147; Woodroffe R, 2000, J ZOOL, V250, P113, DOI 10.1017/S0952836900001102	24	168	169	1	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2001	293	5539					2446	2449		10.1126/science.1061274	http://dx.doi.org/10.1126/science.1061274			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11577235				2022-12-01	WOS:000171237200045
J	Lawrence, JM; Bennett, P; Young, A; Robinson, AM				Lawrence, JM; Bennett, P; Young, A; Robinson, AM			Screening for diabetes in general practice: cross sectional population study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR-DISEASE; OLDER-ADULTS; MELLITUS; GLUCOSE; PREVENTION; CRITERIA	Objective To assess the policy proposed by the American Diabetes Association of universal screening in general practice of all patients aged over 45 years for diabetes. Design Cross sectional Population study. Setting Local general practice in die United Kingdom. Participants All patients aged over 45 not known to have diabetes. Main outcome measures Prevalence of diabetes in the screened population, cardiovascular risk profile of patients diagnosed as having diabetes after screening. Results Of 2481 patients aged over 45 and not known to have diabetes, 876 attended for screening. There were no significant demographic differences between the screened and unscreened patients. Prevalence of diabetes in patients with age as a sole risk factor was 0.2% (95% confidence interval 0% to 1.4%). Prevalence of diabetes in patients with age and one or more other risk factors (hypertension, obesity, or a family history of diabetes) was 2.8% (1.6% to 4.7%). Four hours a week for a year would be needed to screen all people over 45 in the practice's population, about half this time would be needed to screen patients with risk factors other than age. More than 80% of patients newly diagnosed as having diabetes had a 10 year risk of coronary heart disease >15%. 73%) (45% to 92% were hypertensive, and 73% (45% to 92%) had a cholesterol concentration >5 mmol/l. Conclusions Screening for diabetes in general practice by measuring fasting blood glucose is feasible but has a very low yield in patients whose sole risk factor For diabetes is age over 45. Screening in a low risk population would best be targeted at patients with multiple risk factors.	Royal United Hosp, Dept Endocrinol & Diabet, Bath BA1 3NG, Avon, England; Batheaston Med Ctr, Bath BA1 7NP, Avon, England		Lawrence, JM (corresponding author), Royal United Hosp, Dept Endocrinol & Diabet, Bath BA1 3NG, Avon, England.	mpsjml@bath.ac.uk						Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; [Anonymous], 1999, Diabetologia, V42, P647; Balkau B, 1998, DIABETES CARE, V21, P360, DOI 10.2337/diacare.21.3.360; Barzilay JI, 1999, LANCET, V354, P622, DOI 10.1016/S0140-6736(98)12030-5; BLUNT BA, 1991, DIABETES CARE, V14, P989, DOI 10.2337/diacare.14.11.989; Borch-Johnsen K, 1999, LANCET, V354, P617; *DIAB UK, 2001, NEW DIAGN CRIT DIAB; GATLING W, 1985, J ROY COLL PHYS LOND, V19, P248; Gavin JR, 1997, DIABETES CARE, V20, P1183; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Majumdar SR, 1999, J GEN INTERN MED, V14, P711, DOI 10.1046/j.1525-1497.1999.02229.x; Resnick HE, 2000, DIABETES CARE, V23, P176, DOI 10.2337/diacare.23.2.176; Wareham NJ, 2001, BMJ-BRIT MED J, V322, P986, DOI 10.1136/bmj.322.7292.986; Wood D, 1998, HEART, V80, pS1	14	77	81	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 8	2001	323	7312					548	551		10.1136/bmj.323.7312.548	http://dx.doi.org/10.1136/bmj.323.7312.548			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471NC	11546702	Green Published, Bronze			2022-12-01	WOS:000170934600023
J	Eisenberg, DM; Kessler, RC; Van Rompay, MI; Kaptchuk, TJ; Wilkey, SA; Appel, S; Davis, RB				Eisenberg, DM; Kessler, RC; Van Rompay, MI; Kaptchuk, TJ; Wilkey, SA; Appel, S; Davis, RB			Perceptions about complementary therapies relative to conventional therapies among adults who use both: Results from a national survey	ANNALS OF INTERNAL MEDICINE			English	Article							ALTERNATIVE MEDICINE; HEALTH-CARE; UNCONVENTIONAL MEDICINE; UNITED-STATES; RHEUMATOLOGISTS; PREVALENCE; PHYSICIANS; CHOICE	Background: Little is known about perceptions of complementary and alternative medical (CAM) therapy relative to conventional therapy among patients who use both. Objective: To document perceptions about CAM therapies among persons who use CAM and conventional therapies. Design: Nationally representative, random-household telephone survey. Setting: The 48 contiguous U.S. states. Participants: 831 adults who saw a medical doctor and used CAM therapies in 1997. Measurements: Perceptions about helpfulness and patterns of CAM therapy use relative to conventional therapy use and reasons for nondisclosure of CAM therapies. Results: Of 831 respondents who saw a medical doctor and used CAM therapies in the previous 12 months, 79% perceived the combination to be superior to either one alone. Of 411 respondents who reported seeing both a medical doctor and a CAM provider, 70% typically saw a medical doctor before or concurrent with their visits to a CAM provider; 15% typically saw a CAM provider before seeing a medical doctor. Perceived confidence in CAM providers was not substantially different from confidence in medical doctors. Among the 831 respondents who in the past year had used a CAM therapy and seen a medical doctor, 63% to 72% did not disclose at least one type of CAM therapy to the medical doctor. Among 507 respondents who reported their reasons for nondisclosure of use of 726 alternative therapies, common reasons for nondisclosure were "It wasn't important for the doctor to know" (61%), "The doctor never asked" (60%), "It was none of the doctor's business" (31%), and "The doctor would not understand" (20%). Fewer respondents (14%) thought their doctor would disapprove of or discourage CAM use, and 2% thought their doctor might not continue as their provider. Respondents judged CAM therapies to be more helpful than conventional care for the treatment of headache and neck and back conditions but considered conventional care to be more helpful than CAM therapy for treatment of hypertension. Conclusions: National survey data do not support the view that use of CAM therapy in the United States primarily reflects dissatisfaction with conventional care. Adults who use both appear to value both and tend to be less concerned about their medical doctor's disapproval than about their doctor's inability to understand or incorporate CAM therapy use within the context of their medical management.	Beth Israel Deaconess Med Ctr, Ctr Alternat Med Res & Educ, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Eisenberg, DM (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Alternat Med Res & Educ, 330 Brookline Ave, Boston, MA 02215 USA.	deisenbe@caregroup.harvard.edu	Van Rompay, Maria/G-9452-2012		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U24AR043441] Funding Source: NIH RePORTER; NIAMS NIH HHS [U24 AR43441-02S1A1] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Angell M, 1998, NEW ENGL J MED, V339, P839, DOI 10.1056/NEJM199809173391210; Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; Beyerstein B, 1997, CAN J PUBLIC HEALTH, V88, P149, DOI 10.1007/BF03403878; CAMPION EW, 1993, NEW ENGL J MED, V328, P282, DOI 10.1056/NEJM199301283280413; CHERKIN DC, 1989, WESTERN J MED, V150, P351; Davidoff F, 1998, ANN INTERN MED, V129, P1068, DOI 10.7326/0003-4819-129-12-199812150-00014; Druss BG, 1999, JAMA-J AM MED ASSOC, V282, P651, DOI 10.1001/jama.282.7.651; EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; FISHER P, 1994, BRIT MED J, V309, P107, DOI 10.1136/bmj.309.6947.107; GoldbeckWood S, 1996, BRIT MED J, V313, P131, DOI 10.1136/bmj.313.7050.131a; HENTSCHEL C, 1996, EUR J PHYS MED REHAB, V6, P144; Hilsden RJ, 1998, AM J GASTROENTEROL, V93, P697; Kelner M, 1997, SOC SCI MED, V45, P203, DOI 10.1016/S0277-9536(96)00334-6; Lazar JS, 1997, PRIMARY CARE, V24, P699, DOI 10.1016/S0095-4543(05)70305-5; MacLennan AH, 1996, LANCET, V347, P569, DOI 10.1016/S0140-6736(96)91271-4; McGregor KJ, 1996, SOC SCI MED, V43, P1317, DOI 10.1016/0277-9536(95)00405-X; MOORE J, 1985, BRIT MED J, V290, P28, DOI 10.1136/bmj.290.6461.28; MURRAY J, 1993, SOC SCI MED, V37, P983, DOI 10.1016/0277-9536(93)90432-4; MURRAY RH, 1992, NEW ENGL J MED, V326, P61, DOI 10.1056/NEJM199201023260113; Rao JK, 1999, ANN INTERN MED, V131, P409, DOI 10.7326/0003-4819-131-6-199909210-00003; RASMUSSEN NK, 1990, COMPLEMENT MED RES, V4, P16; *RES TRIANGL I, 1997, SUDAAN PROF SOFTW SU; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; VASKILAMPI T, 1993, CLIN RES METHODOLOGY; Vincent C, 1996, BRIT J CLIN PSYCHOL, V35, P37, DOI 10.1111/j.2044-8260.1996.tb01160.x; VISSER GJ, 1992, BRIT J RHEUMATOL, V31, P485	27	428	436	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2001	135	5					344	351		10.7326/0003-4819-135-5-200109040-00011	http://dx.doi.org/10.7326/0003-4819-135-5-200109040-00011			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	468WF	11529698				2022-12-01	WOS:000170780600005
J	Lavery, JV; Boyle, J; Dickens, BM; Maclean, H; Singer, PA				Lavery, JV; Boyle, J; Dickens, BM; Maclean, H; Singer, PA			Origins of the desire for euthanasia and assisted suicide in people with HIV-1 or AIDS: a qualitative study	LANCET			English	Article							TERMINALLY ILL; NETHERLANDS; ATTITUDES; DEATH; CARE; CAREGIVERS	Background Euthanasia and assisted suicide, and policies to address them are the subjects of contentious debate in many countries. However, the question of why people desire euthanasia or assisted suicide has not been coherently answered. We aimed to answer this question in a specific group of patients. Methods We did a qualitative study of 32 people with HIV-1 or AIDS, who were enrolled in the HIV-1 Ontario Observational Database at Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, Canada. We elicited participants' experiences of deliberation about euthanasia or assisted suicide, and the meaning of these experiences with in-depth, face-to-face interviews. We analysed our data with grounded theory methods. Findings Participants' desire for euthanasia and assisted suicide were affected by two main factors: disintegration, which resulted from symptoms and loss of function; and loss of community, which we defined as progressive diminishment of opportunities to initiate and maintain close personal relationships. These factors resulted in perceived loss of self. Euthanasia and assisted suicide were seen by participants as means of limiting loss of self. Interpretation These determinants of desire for euthanasia or assisted suicide in people with HIV-1 or AIDS have implications for the debate on these practices, and development of policies to regulate them.	Univ Toronto, Joint Ctr Bioeth, Toronto, ON, Canada; Queens Univ, Queens Hlth Policy Res Unit, Kingston, ON, Canada; Univ Toronto, Fac Law, Dept Philosophy, Toronto, ON M5S 1A1, Canada; Univ Toronto, Fac Publ Hlth Sci, Toronto, ON M5S 1A1, Canada; Univ Toronto, Ctr Res Womens Hlth, Toronto, ON M5S 1A1, Canada; Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada; Univ Hlth Network, Toronto, ON, Canada	University of Toronto; Queens University - Canada; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Lavery, JV (corresponding author), NIH, Fogarty Int Ctr, Div Adv Studies & Policy Anal, Bldg 16, Bethesda, MD 20892 USA.		Lavery, James/E-5254-2012					Angell M, 1996, NEW ENGL J MED, V335, P1676, DOI 10.1056/NEJM199611283352209; Antonovsky A, 1987, UNRAVELING MYSTERY H, P15; ATKINSON JH, 1988, ARCH GEN PSYCHIAT, V45, P859; BARRETT RK, 1995, AIDS PATIENT CARE, V9, P240, DOI 10.1089/apc.1995.9.240; Breitbart W, 1996, AM J PSYCHIAT, V153, P238; CALLAHAN D, 1993, HASTINGS CENT REP, V23, P33, DOI 10.2307/3562588; Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; Chochinov HM, 1998, PSYCHOSOMATICS, V39, P366, DOI 10.1016/S0033-3182(98)71325-8; Chochinov HM, 1999, LANCET, V354, P816, DOI 10.1016/S0140-6736(99)80011-7; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; DWORKIN R, 1993, LIFES DOMINION ARGUM, P210; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V284, P2460, DOI 10.1001/jama.284.19.2460; Ganzini L, 1998, NEW ENGL J MED, V339, P967, DOI 10.1056/NEJM199810013391406; Giacomini MK, 2000, JAMA-J AM MED ASSOC, V284, P357, DOI 10.1001/jama.284.3.357; Glaser BG., 1992, EMERGENCE VS FORCING; GREEN G, 1995, AIDS CARE, V7, P169; Haverkate I, 2000, BRIT MED J, V321, P865, DOI 10.1136/bmj.321.7265.865; JECKER NS, 1993, J CLIN ETHIC, V4, P16; Kissane DW, 1998, LANCET, V352, P1097, DOI 10.1016/S0140-6736(98)05406-3; LAANE HM, 1995, AIDS CARE, V7, P163; Roscoe LA, 2000, NEW ENGL J MED, V343, P1735, DOI 10.1056/NEJM200012073432315; SCHNEIDER SG, 1991, J PERS SOC PSYCHOL, V61, P776, DOI 10.1037/0022-3514.61.5.776; Shortt S, 1999, J Health Serv Res Policy, V4, P230; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Strauss A., 1998, BASICS QUALITATIVE R; VANDENBOOM F, 1995, AIDS CARE, V7, P175; vanderWal G, 1996, NEW ENGL J MED, V335, P1706; Walker RJ, 1996, HEALTH SOC WORK, V21, P49, DOI 10.1093/hsw/21.1.49; Yalom I.D., 1980, EXISTENTIAL PSYCHOTH	30	72	72	0	18	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2001	358	9279					362	367		10.1016/S0140-6736(01)05555-6	http://dx.doi.org/10.1016/S0140-6736(01)05555-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	459DE	11502315				2022-12-01	WOS:000170235100010
J	Katzmann, DJ; Babst, M; Emr, SD				Katzmann, DJ; Babst, M; Emr, SD			Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I	CELL			English	Article							GROWTH-FACTOR-RECEPTOR; DOA4 DEUBIQUITINATING ENZYME; SACCHAROMYCES-CEREVISIAE; PREVACUOLAR COMPARTMENT; MULTIUBIQUITIN CHAIN; SYNTAXIN HOMOLOG; YEAST VACUOLE; C-CBL; TRANSPORT; MEMBRANE	The multivesicular body (MVB) pathway is responsible for both the biosynthetic delivery of lysosomal hydrolases and the downregulation of numerous activated cell surface receptors which are degraded in the lysosome. We demonstrate that ubiquitination serves as a signal for sorting into the MVB pathway. In addition, we characterize a 350 kDa complex, ESCRT-I (composed of Vps23, Vps28, and Vps37), that recognizes ubiquitinated MVB cargo and whose function is required for sorting into MVB vesicles. This recognition event depends on a conserved UBC-like domain in Vps23. We propose that ESCRT-I represents a conserved component of the endosomal sorting machinery that functions in both yeast and mammalian cells to couple ubiquitin modification to protein sorting and receptor downregulation in the MVB pathway.	Univ Calif San Diego, Sch Med, Div Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Emr, SD (corresponding author), Univ Calif San Diego, Sch Med, Div Cellular & Mol Med, La Jolla, CA 92093 USA.				NATIONAL CANCER INSTITUTE [P01CA058689] Funding Source: NIH RePORTER; NCI NIH HHS [CA 58689] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Becherer KA, 1996, MOL BIOL CELL, V7, P579, DOI 10.1091/mbc.7.4.579; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Bishop N, 2001, J BIOL CHEM, V276, P11735, DOI 10.1074/jbc.M009863200; Burd CG, 1997, MOL BIOL CELL, V8, P1089, DOI 10.1091/mbc.8.6.1089; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Costaguta G, 2001, MOL BIOL CELL, V12, P1885, DOI 10.1091/mbc.12.6.1885; Cowles CR, 1997, EMBO J, V16, P2769, DOI 10.1093/emboj/16.10.2769; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; Darsow T, 1997, J CELL BIOL, V138, P517, DOI 10.1083/jcb.138.3.517; Darsow T, 2001, MOL BIOL CELL, V12, P37, DOI 10.1091/mbc.12.1.37; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; Fernandez-Borja M, 1999, CURR BIOL, V9, P55, DOI 10.1016/S0960-9822(99)80048-7; FRANZUSOFF A, 1989, EMBO J, V8, P2695, DOI 10.1002/j.1460-2075.1989.tb08410.x; FRENCH AR, 1994, J BIOL CHEM, V269, P15749; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hong SJ, 1998, MOL GEN GENET, V259, P404, DOI 10.1007/s004380050830; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kornilova E, 1996, J BIOL CHEM, V271, P30340, DOI 10.1074/jbc.271.48.30340; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Li Y, 1999, MOL CELL BIOL, V19, P3588; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Losko S, 2001, MOL BIOL CELL, V12, P1047, DOI 10.1091/mbc.12.4.1047; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; ROBERTS CJ, 1989, J CELL BIOL, V108, P1363, DOI 10.1083/jcb.108.4.1363; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Sato TK, 2000, MOL CELL, V6, P661, DOI 10.1016/S1097-2765(00)00064-2; Sorkin Alexander, 1998, Frontiers in Bioscience, V3, pD729; SPORMANN DO, 1992, J BIOL CHEM, V267, P8021; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; TRAGLIA HM, 1989, MOL CELL BIOL, V9, P2989, DOI 10.1128/MCB.9.7.2989; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wurmser AE, 1998, EMBO J, V17, P4930, DOI 10.1093/emboj/17.17.4930; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707	46	1053	1082	5	55	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2001	106	2					145	155		10.1016/S0092-8674(01)00434-2	http://dx.doi.org/10.1016/S0092-8674(01)00434-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511343	Bronze			2022-12-01	WOS:000170193100005
J	Clark, I; Whitten, R; Molyneux, M; Taylor, L				Clark, I; Whitten, R; Molyneux, M; Taylor, L			Salicylates, nitric oxide, malaria, and Reye's syndrome	LANCET			English	Article							TUMOR-NECROSIS-FACTOR; SMOOTH-MUSCLE CELLS; PLASMODIUM-FALCIPARUM MALARIA; ACTIVATED PROTEIN-KINASE; SYNTHASE EXPRESSION; CEREBRAL MALARIA; CHILDREN; ASPIRIN; INTOXICATION; INDUCTION	Reye's syndrome virtually disappeared from much of the world after the use of salicylate in febrile children was successfully discouraged. This severe sepsis-like disease was thought tot be caused by a hypersensitivity to salicylates in children with mild viral infections, although mo mechanism consistent with this proposal was ever established. Salicylate toxicity in African children has been noted to have many clinical features in common with severe falciparum malaria, including acidosis, altered consciousness, convulsions, and hypoglycaemia. Salicylates are widely available in various formulations in many African countries, and are commonly used for initial treatment of the symptoms that malaria shares with other diseases. There is now experimental evidence that salicylate increases and prolongs the activity of key elements along the signalling pathway through which interferon gamma generates inducible nitric oxide synthase (iNOS), and we have shown that INOS is strongly expressed in fatal malaria and other acute fevers in African children. We further propose that, in areas where salicyaltes are still used to treat the symptoms of febrile illnesses in children, this mechanism could exacerbate potentially serious infectious diseases, including falciparum malaria. In contrast, the absence of salicylate use in children in some Pacific islands could contribute to the milder outcome of falciparum malaria than is observed in Africa. Widespread expression of iNOS has also been seen in the tissues of a patient with fatal clinically defined Reye's syndrome. This finding suggests that Reye's syndrome can be mediated through salicylate enhancement of iNOS expression, the initial trigger in this instance usually being a viral infection.	Australian Natl Univ, Sch Life Sci, Div Biochem & Mol Biol, Canberra, ACT 0200, Australia; Black Hills Pathol, Olympia, WA USA; Univ Malawi, Coll Med, Wellcome Trust Res Labs, Zomba, Malawi; Univ Liverpool, Sch Trop Med, Liverpool L69 3BX, Merseyside, England; Univ Malawi, Coll Med, Malaria Project, Zomba, Malawi; Michigan State Univ, E Lansing, MI 48824 USA	Australian National University; University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; Michigan State University	Clark, I (corresponding author), Australian Natl Univ, Sch Life Sci, Div Biochem & Mol Biol, Canberra, ACT 0200, Australia.							Chalasani N, 1996, SOUTHERN MED J, V89, P479, DOI 10.1097/00007611-199605000-00005; CHENLC, 1999, BIOCH J, V432, P503; CLARK IA, 1994, PARASITOL TODAY, V10, P410, DOI 10.1016/0169-4758(94)90237-2; CLARK IA, 1992, LANCET, V340, P894, DOI 10.1016/0140-6736(92)93295-X; CLARK IA, 1981, INFECT IMMUN, V32, P1058, DOI 10.1128/IAI.32.3.1058-1066.1981; Crocker JFS, 1998, CLIN INVEST MED, V21, P192; de Miguel LS, 1999, EUR J CLIN INVEST, V29, P93, DOI 10.1046/j.1365-2362.1999.00425.x; Durak I, 1999, CLIN CHIM ACTA, V288, P169, DOI 10.1016/S0009-8981(99)00134-5; English M, 1996, LANCET, V347, P1736, DOI 10.1016/S0140-6736(96)90809-0; Faure V, 1999, J BIOL CHEM, V274, P4794, DOI 10.1074/jbc.274.8.4794; GILES HM, 1965, LANCET, V1, P1075; Guan ZH, 1999, J BIOL CHEM, V274, P36200, DOI 10.1074/jbc.274.51.36200; HEMMER CJ, 1991, AM J TROP MED HYG, V45, P608, DOI 10.4269/ajtmh.1991.45.608; HURWITZ ES, 1987, JAMA-J AM MED ASSOC, V257, P1905, DOI 10.1001/jama.257.14.1905; KWIATKOWSKI D, 1990, LANCET, V336, P1201, DOI 10.1016/0140-6736(90)92827-5; LARRICK JW, 1986, LANCET, V2, P132; Maitland K, 1996, T ROY SOC TROP MED H, V90, P614, DOI 10.1016/S0035-9203(96)90406-X; Marsh K, 1996, ANN TROP MED PARASIT, V90, P395, DOI 10.1080/00034983.1996.11813068; Melillo G, 1996, J IMMUNOL, V157, P2638; Nishio E, 1998, LIFE SCI, V63, P429, DOI 10.1016/S0024-3205(98)00292-6; PARTIN JS, 1984, HEPATOLOGY, V4, P687, DOI 10.1002/hep.1840040421; PARTIN JS, 1982, LANCET, V1, P191; REYE RDK, 1963, LANCET, V2, P749; Roczniak A, 1996, AM J PHYSIOL-RENAL, V270, pF106, DOI 10.1152/ajprenal.1996.270.1.F106; ROWE PC, 1988, JAMA-J AM MED ASSOC, V260, P3167, DOI 10.1001/jama.260.21.3167; Ruetten H, 1996, BRIT J PHARMACOL, V118, P261, DOI 10.1111/j.1476-5381.1996.tb15397.x; Schwenger P, 1997, P NATL ACAD SCI USA, V94, P2869, DOI 10.1073/pnas.94.7.2869; STARKO KM, 1980, PEDIATRICS, V66, P859; Yan ZQ, 1999, ARTERIOSCL THROM VAS, V19, P2854, DOI 10.1161/01.ATV.19.12.2854; Ye ZC, 1996, NEUROREPORT, V7, P2181, DOI 10.1097/00001756-199609020-00025; 1965, LANCET, V1, P941	32	25	26	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2001	357	9256					625	627		10.1016/S0140-6736(00)04061-7	http://dx.doi.org/10.1016/S0140-6736(00)04061-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558501				2022-12-01	WOS:000167119100035
J	Tiwari, RK; Rao, KNN				Tiwari, RK; Rao, KNN			Periodicity in marine phosphorus burial rate	NATURE			English	Letter							CYCLE		Natl Geophys Res Inst, Theoret Geophys Grp, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Geophysical Research Institute (NGRI)	Tiwari, RK (corresponding author), Natl Geophys Res Inst, Theoret Geophys Grp, Hyderabad 500007, Andhra Pradesh, India.		Rajesh, Rekapalli/AAP-8508-2021					FILIPPELLI GM, 1994, PALEOCEANOGRAPHY, V9, P643, DOI 10.1029/94PA01453; FISCHER AG, 1977, DEEP WATER CARBONATE, P19, DOI DOI 10.2110/PEC.77.25; Follmi KB, 1996, EARTH-SCI REV, V40, P55, DOI 10.1016/0012-8252(95)00049-6; HARLAND WB, 1989, GEOLOGICAL TIME SCAL; Mann ME, 1996, CLIMATIC CHANGE, V33, P409, DOI 10.1007/BF00142586; Negi JG, 1996, MAR GEOL, V133, P113, DOI 10.1016/0025-3227(96)00003-5; RAMPINO MR, 1993, EARTH PLANET SC LETT, V114, P215, DOI 10.1016/0012-821X(93)90026-6; RAUP DM, 1988, SCIENCE, V241, P94, DOI 10.1126/science.241.4861.94; RAUP DM, 1986, SCIENCE, V231, P833, DOI 10.1126/science.11542060; STIGLER SM, 1987, SCIENCE, V238, P940, DOI 10.1126/science.238.4829.940; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; VANCAPPELLEN P, 1994, PALEOCEANOGRAPHY, V9, P677, DOI 10.1029/94PA01455	12	11	12	0	5	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 1	1999	400	6739					31	32		10.1038/21807	http://dx.doi.org/10.1038/21807			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	213DA	11536905				2022-12-01	WOS:000081255700035
J	BLAKE, D; ALLAMANDOLA, L; SANDFORD, S; HUDGINS, D; FREUND, F				BLAKE, D; ALLAMANDOLA, L; SANDFORD, S; HUDGINS, D; FREUND, F			CLATHRATE HYDRATE FORMATION IN AMORPHOUS COMETARY ICE ANALOGS INVACUO	SCIENCE			English	Article							PHYSICO-CHEMICAL PHENOMENA; INFRARED-SPECTRA; SOLAR-SYSTEM; WATER; EROSION; OXIRANE; GRAINS; SNOWS	The presence of clathrate hydrates in cometary ice has been suggested to account for anomalous gas release at large radial distances from the sun as well as the retention of volatiles in comets to elevated temperatures. However, how clathrate hydrates can form in low-pressure environments, such as in cold interstellar molecular clouds, in the outer reaches of the early solar nebula, or in cometary ices, has been poorly understood. Experiments performed with the use of a modified electron microscope demonstrate that during the warming of vapor-deposited amorphous ices in vacuo, clathrate hydrates can form by rearrangements in the solid state. Phase separations and microporous textures that are the result of these rearrangements may account for a variety of anomalous cometary phenomena.	NASA,AMES RES CTR,ASTROPHYS BRANCH,MOFFETT FIELD,CA 94035; SAN JOSE STATE UNIV,DEPT PHYS,SAN JOSE,CA 95192	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; California State University System; San Jose State University	BLAKE, D (corresponding author), NASA,AMES RES CTR,PLANETARY BIOL BRANCH,MAIL STOP 239-4,MOFFETT FIELD,CA 94035, USA.							ALLAMANDOLA LJ, 1988, ICARUS, V76, P225, DOI 10.1016/0019-1035(88)90070-X; ALLAMANDOLA LJ, 1988, DUST UNIVERSE, P229; BARNUN A, 1987, PHYS REV B, V35, P2427, DOI 10.1103/PhysRevB.35.2427; BERTIE JE, 1978, J CHEM PHYS, V69, P4105, DOI 10.1063/1.437089; BERTIE JE, 1983, J CHEM PHYS, V78, P6340, DOI 10.1063/1.444563; BLAKE DF, 1990, 12 P INT C EL MICR S, V1, P594; BOCKELEEMORVAN D, 1991, NATURE, V350, P318, DOI 10.1038/350318a0; BOUTRON P, 1978, J CHEM PHYS, V68, P5032, DOI 10.1063/1.435619; CHYBA CF, 1990, NATURE, V343, P129, DOI 10.1038/343129a0; Delsemme A., 1952, ANN ASTROPHYS, V15, P1; DELSEMME AH, 1970, PLANET SPACE SCI, V18, P717, DOI 10.1016/0032-0633(70)90053-X; DELSEMME AH, 1970, PLANET SPACE SCI, V18, P709, DOI 10.1016/0032-0633(70)90052-8; DHENDECOURT LB, 1986, ASTRON ASTROPHYS, V158, P119; ENGLE S, 1990, ICARUS, V85, P380; FLEYFEL F, 1991, J PHYS CHEM-US, V95, P3811, DOI 10.1021/j100162a068; Greenberg J., 1982, COMETS, P131; GUTZOW I, 1980, CONTEMP PHYS, V21, P121, DOI 10.1080/00107518008210949; HAGEN W, 1981, CHEM PHYS, V56, P367, DOI 10.1016/0301-0104(81)80158-9; HALLBRUCKER A, 1991, ICARUS, V90, P176, DOI 10.1016/0019-1035(91)90078-8; HSUING P, 1990, LUNAR PLANET SCI, V21, P538; JOHNSON RE, 1983, ASTRON ASTROPHYS, V123, P343; JOHNSON RE, 1987, ASTRON ASTROPHYS, V187, P889; KOCHAN H, 1989, LUNAR PLANET SCI, V20, P524; KOUCHI A, 1990, J CRYST GROWTH, V99, P1220, DOI 10.1016/S0022-0248(08)80112-1; KOUCHI A, 1990, NATURE, V344, P134, DOI 10.1038/344134a0; LUNINE JI, 1985, ASTROPHYS J SUPPL S, V58, P493, DOI 10.1086/191050; MAK TCW, 1965, J CHEM PHYS, V42, P2732, DOI 10.1063/1.1703229; MILLER SL, 1973, PHYSICS CHEM ICE, P42; MOORE MH, 1983, ICARUS, V54, P388, DOI 10.1016/0019-1035(83)90236-1; RICHARDSON HH, 1985, J CHEM PHYS, V83, P4387, DOI 10.1063/1.449055; SANDFORD SA, 1988, ICARUS, V76, P201, DOI 10.1016/0019-1035(88)90069-3; SANDFORD SA, 1990, ASTROPHYS J, V355, P357, DOI 10.1086/168770; STRAZZULLA G, 1983, ASTRON ASTROPHYS, V123, P93; Tielens A., 1989, IAU S, P239; Tielens A. G., 1987, PHYSICAL PROCESSES I, V333	35	151	151	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 25	1991	254	5031					548	551		10.1126/science.11538372	http://dx.doi.org/10.1126/science.11538372			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL799	11538372				2022-12-01	WOS:A1991GL79900042
J	OTT, U; BEGEMANN, F; YANG, JM; EPSTEIN, S				OTT, U; BEGEMANN, F; YANG, JM; EPSTEIN, S			S-PROCESS KRYPTON OF VARIABLE ISOTOPIC COMPOSITION IN THE MURCHISON METEORITE	NATURE			English	Article									CALTECH,DIV GEOL & PLANETARY SCI,PASADENA,CA 91125	California Institute of Technology	OTT, U (corresponding author), MAX PLANCK INST CHEM,SAARSTR 23,D-6500 MAINZ 1,FED REP GER.		Ott, Ulrich/ABH-2337-2020	Ulrich, Ott/0000-0003-3574-9591				ALAERTS L, 1980, GEOCHIM COSMOCHIM AC, V44, P189, DOI 10.1016/0016-7037(80)90131-3; BAO ZY, 1987, ATOM DATA NUCL DATA, V36, P411, DOI 10.1016/0092-640X(87)90011-8; BEER H, 1986, NUCLEOSYNTHESIS ITS, P263; BURBIDGE EM, 1957, REV MOD PHYS, V29, P547, DOI 10.1103/RevModPhys.29.547; CLAYTON DD, 1978, ASTROPHYS J, V244, P1000; FOWLER WA, 1984, SCIENCE, V226, P922, DOI 10.1126/science.226.4677.922; KAPPELER F, 1982, ASTROPHYS J, V257, P821, DOI 10.1086/160033; MARTI K, 1967, EARTH PLANET SC LETT, V3, P243, DOI 10.1016/0012-821X(67)90044-1; MATHEWS GJ, 1985, REP PROG PHYS, V48, P1371, DOI 10.1088/0034-4885/48/10/002; MATSUDA J, 1980, ASTROPHYS J, V237, pL21, DOI 10.1086/183226; OTT U, 1985, METEORITICS, V20, P722; SRINIVASAN B, 1978, SCIENCE, V201, P51, DOI 10.1126/science.201.4350.51; TANG M, 1987, METEORITICS, V22, P462; WALTER G, 1986, ASTRON ASTROPHYS, V155, P247; WALTER G, 1986, ASTRON ASTROPHYS, V167, P186; WARD RA, 1976, ASTROPHYS J SUPPL S, V31, P33, DOI 10.1086/190373; YANG JM, 1984, NATURE, V311, P544, DOI 10.1038/311544a0	17	53	54	0	2	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 21	1988	332	6166					700	702		10.1038/332700a0	http://dx.doi.org/10.1038/332700a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	N0293	11542152				2022-12-01	WOS:A1988N029300046
J	Dishy, V; Sofowora, GG; Xie, HG; Kim, RB; Byrne, DW; Stein, CM; Wood, AJJ				Dishy, V; Sofowora, GG; Xie, HG; Kim, RB; Byrne, DW; Stein, CM; Wood, AJJ			The effect of common polymorphisms of the beta(2)-adrenergic receptor on agonist-mediated vascular desensitization	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BETA-2-ADRENERGIC RECEPTOR; BLOOD-PRESSURE; HYPERTENSION; VASODILATION; GENOTYPES; ASTHMA	Background: With continuous exposure to beta (2)-adrenergic agonists, vascular tissue becomes desensitized to agonist-mediated vasodilatation. We studied the effects of two common polymorphisms of the beta (2)-adrenergic receptor, one at codon 16 and one at codon 27, on agonist-mediated vasodilatation and desensitization in the vascular bed. Methods: We studied 26 healthy subjects who were selected to represent three genotypes: 7 were homozygous for the alleles encoding Arg16 and GIn27, 8 were homozygous for the alleles encoding Gly16 and Gln27, and 11 were homozygous for the alleles encoding Gly16 and Glu27. Vascular responses were assessed by measuring changes in the diameter of a dorsal hand vein. A dose-response curve of the effect of the beta (2)-adrenergic-receptor agonist isoproterenol was constructed (dose range, 4 to 480 ng per minute). Desensitization was then induced by a 2-hour continuous infusion of isoproterenol, and venodilatation was measured 30, 60, 90, and 120 minutes after the start of the infusion. Results: Subjects who were homozygous for Arg16 had almost complete desensitization; venodilatation in response to isoproterenol in this group decreased from a mean (+/-SE) of 44+/-11 percent to 8+/-4 percent (P=0.006). In contrast, subjects who were homozygous for Gly16 did not have significant desensitization, irrespective of the amino acid encoded by codon 27. Subjects who were homozygous for Glu27 had higher maximal venodilatation in response to isoproterenol than those who were homozygous for Gln27 (86+/-13 percent vs. 54+/-8 percent, P=0.03). Conclusions: The Arg16 polymorphism of the beta (2)-adrenergic receptor is associated with enhanced agonist-mediated desensitization in the vasculature, and the Glu27 polymorphism is associated with increased agonist-mediated responsiveness. Therefore, polymorphisms of the beta (2)-adrenergic receptor are potentially important determinants of the vascular response to stress. (N Engl J Med 2001;345:1030-5.) Copyright (C) 2001 Massachusetts Medical Society.	Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Gen Clin Res Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Wood, AJJ (corresponding author), Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Rm 550,Med Res Bldg 1, Nashville, TN 37232 USA.		Byrne, Daniel/GRE-6302-2022; Sofowora, Gbemiga/E-4118-2011; Kim, Richard/D-6971-2011	Kim, Richard/0000-0001-8148-1632	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056251] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-04012, HL-56251] Funding Source: Medline; NIGMS NIH HHS [GM-RR0095] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AELLIG WH, 1981, BRIT J CLIN PHARMACO, V11, P237, DOI 10.1111/j.1365-2125.1981.tb00527.x; [Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.157.21.2413; BRISTOW MR, 1989, MOL PHARMACOL, V35, P295; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Chong LK, 2000, PHARMACOGENETICS, V10, P153, DOI 10.1097/00008571-200003000-00007; Cockcroft JR, 2000, HYPERTENSION, V36, P371, DOI 10.1161/01.HYP.36.3.371; Dewar JC, 1998, CLIN EXP ALLERGY, V28, P442; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; FELDMAN RD, 1990, J CLIN INVEST, V85, P647, DOI 10.1172/JCI114487; Flier J, 1996, NEW ENGL J MED, V334, P580, DOI 10.1056/NEJM199602293340907; GOLDSTEIN DS, 1983, HYPERTENSION, V5, P86, DOI 10.1161/01.HYP.5.1.86; Gratze G, 1999, HYPERTENSION, V33, P1425, DOI 10.1161/01.HYP.33.6.1425; GREEN SA, 1993, J BIOL CHEM, V268, P23116; GREEN SA, 1995, AM J RESP CELL MOL, V13, P25, DOI 10.1165/ajrcmb.13.1.7598936; Hoit BD, 2000, AM HEART J, V139, P537, DOI 10.1016/S0002-8703(00)90099-1; Israel E, 2000, AM J RESP CRIT CARE, V162, P75, DOI 10.1164/ajrccm.162.1.9907092; Landau R, 2000, ANESTHESIOLOGY, V93, pU212; LANG CC, 1995, NEW ENGL J MED, V333, P155, DOI 10.1056/NEJM199507203330304; NASLUND T, 1990, CLIN PHARMACOL THER, V48, P87, DOI 10.1038/clpt.1990.121; REIHSAUS E, 1993, AM J RESP CELL MOL, V8, P334, DOI 10.1165/ajrcmb/8.3.334; Schobel HP, 1996, NEW ENGL J MED, V335, P1480, DOI 10.1056/NEJM199611143352002; STEIN CM, 1995, J CLIN INVEST, V96, P579, DOI 10.1172/JCI118070; Stein CM, 2001, PHARMACOGENETICS, V11, P95, DOI 10.1097/00008571-200103000-00001; STEIN M, 1993, CLIN PHARMACOL THER, V54, P187, DOI 10.1038/clpt.1993.130; Tan S, 1997, LANCET, V350, P995, DOI 10.1016/S0140-6736(97)03211-X; Taylor DR, 2000, THORAX, V55, P762, DOI 10.1136/thorax.55.9.762; VINCENT J, 1992, J CARDIOVASC PHARM, V19, P447, DOI 10.1097/00005344-199203000-00023; Xie HG, 1999, PHARMACOGENETICS, V9, P511	28	283	301	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2001	345	14					1030	1035		10.1056/NEJMoa010819	http://dx.doi.org/10.1056/NEJMoa010819			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478HF	11586955				2022-12-01	WOS:000171340400004
J	Bailey, SM; Cornforth, MN; Kurimasa, A; Chen, DJ; Goodwin, EH				Bailey, SM; Cornforth, MN; Kurimasa, A; Chen, DJ; Goodwin, EH			Strand-specific postreplicative processing of mammalian telomeres	SCIENCE			English	Article							HUMAN-CHROMOSOMES; DNA; END; TRF2; FUSIONS; LENGTH	Telomeres are specialized nucleoprotein structures that stabilize the ends of linear eukaryotic chromosomes. In mammalian cells, abrogation of telomeric repeat binding factor TRF2 or DNA-dependent protein kinase (DNA-PK) activity causes end-to-end chromosomal fusion, thus establishing an essential role for these proteins in telomere function. Here we show that TRF2-mediated endcapping occurs after telomere replication. The postreplicative requirement for TRF2 and DNA-PKcs, the catalytic subunit of DNA-PK, is confined to only half of the telomeres, namely, those that were produced by leading-strand DNA synthesis. These results demonstrate a crucial difference in postrepticative processing of telomeres that is linked to their mode of replication.	Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87544 USA; Univ Texas, Med Branch, Dept Radiat Oncol, Galveston, TX 77550 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Cell & Mol Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; University of Texas System; University of Texas Medical Branch Galveston; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Goodwin, EH (corresponding author), Los Alamos Natl Lab, Biosci Div, POB 1663, Los Alamos, NM 87544 USA.				NATIONAL CANCER INSTITUTE [R01CA050519, R01CA076260, R37CA050519] Funding Source: NIH RePORTER; NCI NIH HHS [CA76260, CA50519] Funding Source: Medline; NIA NIH HHS [AG-917709] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bailey SM, 1999, P NATL ACAD SCI USA, V96, P14899, DOI 10.1073/pnas.96.26.14899; BAILEY SM, 2001, DNA DAMAGE REPAIR, V3, pCH14; BLACKBURN EH, 1984, ANNU REV BIOCHEM, V53, P163, DOI 10.1146/annurev.bi.53.070184.001115; Cech TR, 2000, ANGEW CHEM INT EDIT, V39, P34, DOI 10.1002/(SICI)1521-3773(20000103)39:1<34::AID-ANIE34>3.0.CO;2-N; Cornforth MN, 2001, MUTAGENESIS, V16, P85, DOI 10.1093/mutage/16.1.85; GOODWIN EH, 1993, CYTOGENET CELL GENET, V63, P253; Goodwin EH, 1996, CHROMOSOMA, V104, P345, DOI 10.1007/BF00337223; Goytisolo FA, 2001, MOL CELL BIOL, V21, P3642, DOI 10.1128/MCB.21.11.3642-3651.2001; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P12454, DOI 10.1073/pnas.96.22.12454; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kurimasa A, 1999, P NATL ACAD SCI USA, V96, P1403, DOI 10.1073/pnas.96.4.1403; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; MEYNE J, 1995, CHROMOSOME RES, V3, P375, DOI 10.1007/BF00710019; Samper E, 2000, EMBO REP, V1, P244, DOI 10.1093/embo-reports/kvd051; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Wellinger RJ, 1996, CELL, V85, P423, DOI 10.1016/S0092-8674(00)81120-4; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801; ZAKIAN VA, 1989, ANNU REV GENET, V23, P579, DOI 10.1146/annurev.genet.23.1.579	20	217	224	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2001	293	5539					2462	2465		10.1126/science.1062560	http://dx.doi.org/10.1126/science.1062560			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11577237	Green Published			2022-12-01	WOS:000171237200050
J	Katsanis, N; Ansley, SJ; Badano, JL; Eichers, ER; Lewis, RA; Hoskins, BE; Scambler, PJ; Davidson, WS; Beales, PL; Lupski, JR				Katsanis, N; Ansley, SJ; Badano, JL; Eichers, ER; Lewis, RA; Hoskins, BE; Scambler, PJ; Davidson, WS; Beales, PL; Lupski, JR			Triallelic inheritance in Bardet-Biedl syndrome, a Mendelian recessive disorder	SCIENCE			English	Article							MICE LACKING GDNF; RETINITIS-PIGMENTOSA; HIRSCHSPRUNG DISEASE; GERMLINE MUTATIONS; CHROMOSOME 16Q; SYNDROME LOCUS; LINKAGE; FORM; RET; FAMILIES	Bardet-Biedl syndrome (BBS) is a genetically heterogeneous disorder characterized by multiple clinical features that include pigmentary retinal dystrophy, polydactyly, obesity, developmental delay, and renal defects. BBS is considered an autosomal recessive disorder, and recent positional cloning efforts have identified two BBS genes (BBS2 and BBS6). We screened our cohort of 163 BBS families for, mutations in both BBS2 and BBS6 and report the presence of three mutant alleles in affected individuals in four pedigrees. In addition, we detected unaffected individuals in two pedigrees who carry two BBS2 mutations but not a BBS6 mutation. We therefore propose that BBS may not be a single-gene recessive disease but a complex trait requiring three mutant alleles to manifest the phenotype. This triallelic model of disease transmission may be important in the study of both Mendelian and multifactorial disorders.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA; UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of London; University College London; Simon Fraser University	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu	Katsanis, Nicholas/E-1837-2012; Scambler, Peter J/C-4998-2008; Beales, Philip L/C-7367-2009; Scambler, Peter/AAZ-6026-2020	Scambler, Peter J/0000-0002-1487-4628; Scambler, Peter/0000-0002-1487-4628; Badano, Jose/0000-0002-0706-8652; Katsanis, Nicholas/0000-0002-2480-0171	NATIONAL EYE INSTITUTE [R01EY012666] Funding Source: NIH RePORTER; NEI NIH HHS [EY12666] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; Beales PL, 1997, J MED GENET, V34, P92, DOI 10.1136/jmg.34.2.92; Beales PL, 2001, AM J HUM GENET, V68, P606, DOI 10.1086/318794; Bruford EA, 1997, GENOMICS, V41, P93, DOI 10.1006/geno.1997.4613; CARMI R, 1995, HUM MOL GENET, V4, P9, DOI 10.1093/hmg/4.1.9; Floeth M, 1999, AM J HUM GENET, V65, P1530, DOI 10.1086/302672; Goldberg AFX, 1996, P NATL ACAD SCI USA, V93, P13726, DOI 10.1073/pnas.93.24.13726; GREEN JS, 1989, NEW ENGL J MED, V321, P1002, DOI 10.1056/NEJM198910123211503; HELWIG U, 1995, NAT GENET, V11, P60, DOI 10.1038/ng0995-60; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Katsanis N, 1999, AM J HUM GENET, V65, P1672, DOI 10.1086/302684; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; KWITEKBLACK AE, 1993, NAT GENET, V5, P392, DOI 10.1038/ng1293-392; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Morell R, 1997, HUM MOL GENET, V6, P659, DOI 10.1093/hmg/6.5.659; Nishimura DY, 2001, HUM MOL GENET, V10, P865, DOI 10.1093/hmg/10.8.865; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Salomon R, 1996, NAT GENET, V14, P345, DOI 10.1038/ng1196-345; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P1331, DOI 10.1093/hmg/3.8.1331; Slavotinek AM, 2000, NAT GENET, V26, P15, DOI 10.1038/79116; Stone DL, 2000, NAT GENET, V25, P79, DOI 10.1038/75637; Todd JA, 1999, BIOESSAYS, V21, P164, DOI 10.1002/(SICI)1521-1878(199902)21:2<164::AID-BIES10>3.3.CO;2-W; Young TL, 1999, AM J HUM GENET, V64, P900, DOI 10.1086/302301	26	443	459	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2001	293	5538					2256	2259		10.1126/science.1063525	http://dx.doi.org/10.1126/science.1063525			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11567139				2022-12-01	WOS:000171139400044
J	Flick, K; Scholander, C; Chen, QJ; Fernandez, V; Pouvelle, B; Gysin, J; Wahlgren, M				Flick, K; Scholander, C; Chen, QJ; Fernandez, V; Pouvelle, B; Gysin, J; Wahlgren, M			Rote of nonimmune IgG bound to PfEMP1 in placental malaria	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM; PREGNANCY	Infections with Plasmodium falciparum during pregnancy lead to the accumulation of parasitized red blood cells (infected erythrocytes, IEs) in the placenta. IEs of A falciparum isolates that infect the human placenta were found to bind immunoglobulin G (IgG). A strain of P. falciparum cloned for IgG binding adhered massively to placental syncytiotrophoblasts in a pattern similar to that of natural infections. Adherence was inhibited by IgG-binding proteins, but not by glycosaminoglycans or enzymatic digestion of chondroitin sulfate A or hyaluronic acid. Normal, nonimmune IgG that is bound to a duffy binding-like domain beta of the P. falciparum erythrocyte membrane protein 1 (PfEMP1) might at the IE surface act as a bridge to neonatal Fc receptors of the placenta.	Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden; Swedish Inst Infect Dis Control, S-17177 Stockholm, Sweden; Univ Aix Marseille 2, Fac Med, Unite Parasitol Expt, F-13385 Marseille 5, France	Karolinska Institutet; Swedish Institute for Infectious Disease Control; UDICE-French Research Universities; Aix-Marseille Universite; Universite de Franche-Comte	Wahlgren, M (corresponding author), Karolinska Inst, Ctr Microbiol & Tumor Biol, Box 280, S-17177 Stockholm, Sweden.	Mats.wahlgren@smi.ki.se	Pouvelle, Bruno/AAA-3968-2022					BEESON JG, 2000, NAT MED, V6, P1; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; Buffet PA, 1999, P NATL ACAD SCI USA, V96, P12743, DOI 10.1073/pnas.96.22.12743; BULMER JN, 1993, HISTOPATHOLOGY, V22, P3; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; GITLIN D, 1969, J CLIN INVEST, V48, P1433, DOI 10.1172/JCI106109; Gysin J, 1999, INFECT IMMUN, V67, P6596; McGregor I A, 1987, Parassitologia, V29, P153; MCGREGOR IA, 1984, AM J TROP MED HYG, V33, P517, DOI 10.4269/ajtmh.1984.33.517; MENENDEZ C, 1995, PARASITOL TODAY, V11, P178, DOI 10.1016/0169-4758(95)80151-0; Reeder JC, 1999, P NATL ACAD SCI USA, V96, P5198, DOI 10.1073/pnas.96.9.5198; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Robert C, 1995, RES IMMUNOL, V146, P383, DOI 10.1016/0923-2494(96)81042-X; ROGERSON SJ, 1995, J EXP MED, V182, P15, DOI 10.1084/jem.182.1.15; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; SCHOLANDER C, 1996, NAT MED, V2, P2	17	121	121	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2098	2100		10.1126/science.1062891	http://dx.doi.org/10.1126/science.1062891			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557894				2022-12-01	WOS:000171028700076
J	Herzig, S; Long, FX; Jhala, US; Hedrick, S; Quinn, R; Bauer, A; Rudolph, D; Schutz, G; Yoon, C; Puigserver, P; Spiegelman, B; Montminy, M				Herzig, S; Long, FX; Jhala, US; Hedrick, S; Quinn, R; Bauer, A; Rudolph, D; Schutz, G; Yoon, C; Puigserver, P; Spiegelman, B; Montminy, M			CREB regulates hepatic gluconeogenesis through the coactivator PGC-1	NATURE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; CAMP RESPONSE ELEMENT; GTP GENE; LEPTIN RECEPTOR; BINDING PROTEIN; TRANSCRIPTION; GLUCOCORTICOIDS; PROMOTER; MICE; IDENTIFICATION	When mammals fast, glucose homeostasis is achieved by triggering expression of gluconeogenic genes in response to glucagon and glucocorticoids. The pathways act synergistically to induce gluconeogenesis (glucose synthesis), although the underlying mechanism has not been determined(1-4). Here we show that mice carrying a targeted disruption of the cyclic AMP (cAMP) response element binding (CREB) protein gene, or overexpressing a dominant-negative CREB inhibitor, exhibit fasting hyperglycaemia and reduced expression of gluconeogenic enzymes. CREB was found to induce expression of the gluconeogenic programme through the nuclear receptor coactivator PGC-1, which is shown here to be a direct target for CREB regulation in vivo. Overexpression of PGC-1 in CREB-dercient mice restored glucose homeostasis and rescued expression of gluconeogenic genes. In transient assays, PGC-1 potentiated glucocorticoid induction of the gene for phosphoenolpyruvate carboxykinase (PEPCK), the rate-limiting enzyme in gluconeogenesis. PGC-1 promotes cooperativity between cyclic AMP and glucocorticoid signalling pathways during hepatic gluconeogenesis. Fasting hyperglycaemia is strongly correlated with type II diabetes, so our results suggest that the activation of PGC-1 by CREB in liver contributes importantly to the pathogenesis of this disease.	Salk Inst Biol Studies, Peptide Biol Labs, La Jolla, CA 92037 USA; Joslin Diabet Ctr, Boston, MA 02215 USA; Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Cell Biol, Boston, MA 02115 USA	Salk Institute; Harvard University; Joslin Diabetes Center, Inc.; Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Montminy, M (corresponding author), Salk Inst Biol Studies, Peptide Biol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Herzig, Stephan/0000-0003-3950-3652				Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; ANGRAND PO, 1994, CELL GROWTH DIFFER, V5, P957; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; CONSOLI A, 1992, DIABETES CARE, V15, P430, DOI 10.2337/diacare.15.3.430; Friedman JE, 1997, J BIOL CHEM, V272, P31475, DOI 10.1074/jbc.272.50.31475; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; IMAI E, 1993, J BIOL CHEM, V268, P5353; IMAI E, 1990, MOL CELL BIOL, V10, P4712, DOI 10.1128/MCB.10.9.4712; Jitrapakdee S, 1997, J BIOL CHEM, V272, P20522, DOI 10.1074/jbc.272.33.20522; Knutti D, 2000, MOL CELL BIOL, V20, P2411, DOI 10.1128/MCB.20.7.2411-2422.2000; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Lei KJ, 1996, NAT GENET, V13, P203, DOI 10.1038/ng0696-203; LEMAIGRE FP, 1994, BIOCHEM J, V303, P1; LIU JK, 1988, GENE DEV, V2, P528, DOI 10.1101/gad.2.5.528; LIU JS, 1991, J BIOL CHEM, V266, P19095; Long FX, 2001, DEVELOPMENT, V128, P541; Michael LF, 2000, MOL CELL BIOL, V20, P1596, DOI 10.1128/MCB.20.5.1596-1603.2000; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; QUINN PG, 1990, MOL CELL BIOL, V10, P3357, DOI 10.1128/MCB.10.7.3357; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; Schmoll D, 1999, BIOCHEM J, V338, P457, DOI 10.1042/0264-6021:3380457; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; SHORT JM, 1986, J BIOL CHEM, V261, P9721; Wexler ID, 1998, PEDIATR RES, V43, P579, DOI 10.1203/00006450-199805000-00004; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	29	1095	1134	6	103	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					179	183		10.1038/35093131	http://dx.doi.org/10.1038/35093131			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557984				2022-12-01	WOS:000170918800050
J	Dong, XZ; Han, SK; Zylka, MJ; Simon, MI; Anderson, DJ				Dong, XZ; Han, SK; Zylka, MJ; Simon, MI; Anderson, DJ			A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons	CELL			English	Article							PROTEIN-COUPLED RECEPTORS; PUTATIVE PHEROMONE RECEPTORS; NEUROPEPTIDE FF RECEPTORS; LECTIN-BINDING ANALYSIS; DORSAL-ROOT; SPINAL-CORD; CAPSAICIN RECEPTOR; ODORANT RECEPTORS; TASTE RECEPTORS; COMPREHENSIVE IMMUNOFLUORESCENCE	In vertebrates, peripheral chemosensory neurons express large families of G protein-coupled receptors (GPCRs), reflecting the diversity and specificity of stimuli they detect. However, somatosensory neurons, which respond to chemical, thermal, or mechanical stimuli, are more broadly tuned. Here we describe a family of approximately 50 GPCRs related to Mas1, called mrgs, a subset of which is expressed in specific subpopulations of sensory neurons that detect painful stimuli. The expression patterns of mrgs thus reveal an unexpected degree of molecular diversity among nociceptive neurons. Some of these receptors can be specifically activated in heterologous cells by RFamide neuropeptides such as NPFF and NPAF, which are analgesic in vivo. Thus, mrgs may regulate nociceptor function and/or development, including the sensation or modulation of pain.	CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA; CALTECH, Div Biol 147 75, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Anderson, DJ (corresponding author), CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA.	wuwei@caltech.edu			NIGMS NIH HHS [GM-34236] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034236, R37GM034236] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Akopian AN, 1996, TRENDS NEUROSCI, V19, P240, DOI 10.1016/0166-2236(96)10030-8; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSON L, 1995, BIOCHEM J, V311, P385, DOI 10.1042/bj3110385; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Bennett DLH, 1998, J NEUROSCI, V18, P3059; Bonini JA, 2000, J BIOL CHEM, V275, P39324, DOI 10.1074/jbc.M004385200; Bradbury EJ, 1998, MOL CELL NEUROSCI, V12, P256, DOI 10.1006/mcne.1998.0719; Brosius J, 1999, TRENDS GENET, V15, P304, DOI 10.1016/S0168-9525(99)01783-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, CURR OPIN NEUROBIOL, V9, P525, DOI 10.1016/S0959-4388(99)00009-4; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; DADO RJ, 1993, NEUROREPORT, V5, P341, DOI 10.1097/00001756-199312000-00041; Donaldson LF, 2001, PROSTAG OTH LIPID M, V63, P109, DOI 10.1016/S0090-6980(00)00101-5; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Elshourbagy NA, 2000, J BIOL CHEM, V275, P25965, DOI 10.1074/jbc.M004515200; Friedel RH, 2001, MOL CELL NEUROSCI, V17, P31, DOI 10.1006/mcne.2000.0912; Fundin BT, 1997, J COMP NEUROL, V385, P185, DOI 10.1002/(SICI)1096-9861(19970825)385:2<185::AID-CNE2>3.0.CO;2-Y; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Goodier JL, 2000, HUM MOL GENET, V9, P653, DOI 10.1093/hmg/9.4.653; Gouarderes C, 2000, SYNAPSE, V35, P45, DOI 10.1002/(SICI)1098-2396(200001)35:1<45::AID-SYN6>3.0.CO;2-0; Gouarderes C, 1996, NEUROSCIENCE, V74, P21, DOI 10.1016/0306-4522(96)00122-4; Hinuma S, 1998, NATURE, V393, P272, DOI 10.1038/30515; Hinuma S, 2000, NAT CELL BIOL, V2, P703, DOI 10.1038/35036326; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Jackman A, 2000, J COMP NEUROL, V418, P281; JACKSON TR, 1988, NATURE, V335, P437, DOI 10.1038/335437a0; KOBILKA B, 1992, ANNU REV NEUROSCI, V15, P87, DOI 10.1146/annurev.ne.15.030192.000511; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li C, 1999, BRAIN RES, V848, P26, DOI 10.1016/S0006-8993(99)01972-1; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; MCMAHON SB, 1994, NEURON, V12, P1161, DOI 10.1016/0896-6273(94)90323-9; Michael GJ, 1999, J NEUROSCI, V19, P1844; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; MONNOT C, 1991, MOL ENDOCRINOL, V5, P1477, DOI 10.1210/mend-5-10-1477; Nelson LS, 1998, SCIENCE, V281, P1686, DOI 10.1126/science.281.5383.1686; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Pantages E, 2000, NEURON, V28, P835, DOI 10.1016/S0896-6273(00)00157-4; Panula P, 1999, BRAIN RES, V848, P191, DOI 10.1016/S0006-8993(99)02044-2; Perez SE, 1999, DEVELOPMENT, V126, P1715; Perry SJ, 1997, FEBS LETT, V409, P426, DOI 10.1016/S0014-5793(97)00557-7; PRICE DA, 1977, SCIENCE, V197, P670, DOI 10.1126/science.877582; Rebeyrolles S, 1996, NEUROREPORT, V7, P2979, DOI 10.1097/00001756-199611250-00036; Rice FL, 1997, J COMP NEUROL, V385, P149; ROSS PC, 1990, P NATL ACAD SCI USA, V87, P3052, DOI 10.1073/pnas.87.8.3052; Scott SA, 1992, SENSORY NEURONS DIVE; Snider WD, 1996, PHILOS T ROY SOC B, V351, P395, DOI 10.1098/rstb.1996.0034; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Stucky CL, 1999, J NEUROSCI, V19, P6497; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; TSIEN RY, 1985, CELL CALCIUM, V6, P145, DOI 10.1016/0143-4160(85)90041-7; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vilim FS, 1999, MOL PHARMACOL, V55, P804; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Willis WD., 1991, SENSORY MECH SPINAL, V2 edn; Xie SY, 2000, MAMM GENOME, V11, P1070, DOI 10.1007/s003350010217; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237	72	474	540	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2001	106	5					619	632		10.1016/S0092-8674(01)00483-4	http://dx.doi.org/10.1016/S0092-8674(01)00483-4			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551509	Bronze			2022-12-01	WOS:000170973200012
J	Birch, JM; Dickinson, MH				Birch, JM; Dickinson, MH			Spanwise flow and the attachment of the leading-edge vortex on insect wings	NATURE			English	Article							UNSTEADY AERODYNAMIC PERFORMANCE; LOW REYNOLDS-NUMBERS; MANDUCA-SEXTA; FLIGHT; HAWKMOTH; MODEL; MECHANISM; ROTATION	The flow structure that is largely responsible for the good performance of insect wings has recently been identified as a leading-edge vortex(1,2). But because such vortices become detached from a wing in two-dimensional flow(1), an unknown mechanism must keep them attached to (three-dimensional) flapping wings. The current explanation, analogous to a mechanism operating on delta-wing aircraft, is that spanwise flow through a spiral vortex drains energy from the vortex core(3). We have tested this hypothesis by systematically mapping the flow generated by a dynamically scaled model insect while simultaneously measuring the resulting aerodynamic forces. Here we report that, at the Reynolds numbers matching the flows relevant for most insects, flapping wings do not generate a spiral vortex akin to that produced by delta-wing aircraft. We also rnd that limiting spanwise flow with fences and edge baffles does not cause detachment of the leading-edge vortex. The data support an alternative hypothesis-that downward flow induced by tip vortices limits the growth of the leading-edge vortex.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Dickinson, MH (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	flymanmd@socrates.berkeley.edu						Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; DICKINSON MH, 1994, J EXP BIOL, V192, P179; DICKINSON MH, 1993, J EXP BIOL, V174, P45; Dudley R., 2000, BIOMECHANICS INSECT; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P79, DOI 10.1098/rstb.1984.0052; Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0; KYIA M, 1977, J FLUID MECH, V82, P223; Liu H, 1998, J EXP BIOL, V201, P461; MAXWORTHY T, 1979, J FLUID MECH, V93, P47, DOI 10.1017/S0022112079001774; May RM, 1978, DIVERSITY INSECT FAU, P188; Milne-Thomson L. M., 2012, THEORETICAL AERODYNA; SARPKAYA T, 1975, J FLUID MECH, V68, P109, DOI 10.1017/S0022112075000717; Sunada S, 1997, J FLUID ENG-T ASME, V119, P129, DOI 10.1115/1.2819098; VandenBerg C, 1997, PHILOS T ROY SOC B, V352, P329, DOI 10.1098/rstb.1997.0024; Wang ZJ, 2000, PHYS REV LETT, V85, P2216, DOI 10.1103/PhysRevLett.85.2216; Willmott AP, 1997, PHILOS T ROY SOC B, V352, P303, DOI 10.1098/rstb.1997.0022; Willmott AP, 1997, J EXP BIOL, V200, P2723	17	415	433	5	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2001	412	6848					729	733		10.1038/35089071	http://dx.doi.org/10.1038/35089071			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507639				2022-12-01	WOS:000170450200043
J	Hyman, DJ; Pavlik, VN				Hyman, DJ; Pavlik, VN			Characteristics of patients with uncontrolled hypertension in the United States.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYSTOLIC BLOOD-PRESSURE; CARE; AWARENESS	Background: Treatment of hypertension is one of the most common clinical responsibilities of U.S. physicians, yet only one fourth of patients with hypertension have their blood pressure adequately controlled. Methods: We analyzed data from the third National Health and Nutrition Examination Survey to assess the role of access to and use of health care in the control of hypertension. Hypertension was defined as a blood pressure of at least 140/90 mm Hg or the use of antihypertensive medication. Results: The study sample consisted of 16,095 adults who were at least 25 years old and for whom blood-pressure values were known. We estimated that 27 percent of the population had hypertension, but only 23 percent of those with hypertension were taking medications that controlled their condition. Among subjects with untreated or uncontrolled hypertension, the pattern was an elevation in the systolic blood pressure with a diastolic pressure of less than 90 mm Hg. The great majority had health insurance. Independent predictors of a lack of awareness of hypertension were an age of at least 65 years, male sex, non-Hispanic black race, and not having visited a physician within the preceding 12 months. The same variables, except for non-Hispanic black race, were independently associated with poor control of hypertension among those who were aware of their condition. An age of at least 65 years accounted for the greatest proportion of the attributable risk of the lack of awareness of hypertension and the lack of control of hypertension among those who were aware of their condition. Conclusions: Most cases of uncontrolled hypertension in the United States consist of isolated, mild systolic hypertension in older adults, most of whom have access to health care and relatively frequent contact with physicians. (N Engl J Med 2001;345:479-86.) Copyright (C) 2001 Massachusetts Medical Society.	Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Baylor Coll Med, Dept Family & Community Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Hyman, DJ (corresponding author), Ben Taub Gen Hosp, Dept Med, 1504 Taub Loop, Houston, TX 77030 USA.	dhyman@bcm.tmc.edu						Aday L A, 1974, Health Serv Res, V9, P208; Alexander M, 1999, ARCH INTERN MED, V159, P2673, DOI 10.1001/archinte.159.22.2673; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.157.21.2413; Berlowitz DR, 1998, NEW ENGL J MED, V339, P1957, DOI 10.1056/NEJM199812313392701; Black HR, 1998, ARCH INTERN MED, V158, P573; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Coca A, 1998, J HYPERTENS, V16, pS45; Fagard RH, 1999, CLIN EXP HYPERTENS, V21, P491, DOI 10.3109/10641969909060982; GOLDMAN L, 1984, ANN INTERN MED, V101, P825, DOI 10.7326/0003-4819-101-6-825; HYMAN D, 2000, CLIN HYPERTENS, V2, P324; Hyman DJ, 2000, ARCH INTERN MED, V160, P2281, DOI 10.1001/archinte.160.15.2281; Izzo JL, 2000, HYPERTENSION, V35, P1021, DOI 10.1161/01.HYP.35.5.1021; Joffres MR, 1997, AM J HYPERTENS, V10, P1097; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES PR, P160; Meissner I, 1999, HYPERTENSION, V34, P466, DOI 10.1161/01.HYP.34.3.466; MOY E, 1995, ARCH INTERN MED, V155, P1497, DOI 10.1001/archinte.155.14.1497; *NAT COMM QUAL ASS, 1999, HEDIS 2000, V2; *NAT CTR HLTH STAT, 1994, VIT HLTH STAT, V1; Nelson C, 1999, VITAL HLTH STAT, V13; Port S, 2000, LANCET, V355, P175, DOI 10.1016/S0140-6736(99)07051-8; SHAH BV, 1997, SUDAAN USERS MANUAL, V1	22	564	587	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2001	345	7					479	486		10.1056/NEJMoa010273	http://dx.doi.org/10.1056/NEJMoa010273			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	462QM	11519501				2022-12-01	WOS:000170431300001
J	Collins, S				Collins, S			Changing the way we address severe malnutrition during famine	LANCET			English	Editorial Material							CHILDREN	This year, yet again, saw widespread food Insecurity and famine across the horn of Africa. Again, humanitarian agencies set up operations to implement various relief programmes. Nutritional interventions included general ration distribution to the whole of an affected population; blanket supplementary feeding to all members of an identified risk group; and targeted dry supplementary feeding centres for moderately malnourished and therapeutic feeding centres for the severely malnourished. As is usual in emergencies, many of the therapeutic feeding centres were hard to set up and did not achieve an adequate coverage of all the severely malnourished. This combination of delays and low coverage meant that many therapeutic feeding centres achieved little overall impact on mortality. I believe that the present focus on therapeutic feeding centres as the sole mode of treating severely malnourished people during famine is inappropriate and often counter-productive. A new concept of community-based therapeutic care is necessary to complement therapeutic feeding centres' interventions if famine relief programmes are to address the plight of the severely malnourished in an efficient and effective manner. During an emergency, the community-based therapeutic care approach could quickly provide good coverage and appropriate treatment for large numbers of severely malnourished people. The principles behind community-based therapeutic care are, however, developmental, empowering communities to cope more effectively with crisis and with transition back to normality. This is very different to the therapeutic feeding centres' approach that disempowers communities, requires very large amounts of external staff and resources, and undermines the Infrastructure. Although emergency community-based therapeutic care programmes could be large-scale and implemented quickly, they could also evolve into developmental Hearth model nutritional programmes without changing their conceptual basis. Conversely, Hearth programmes, although largely sustainable, could in times of crisis quickly scale-up into rapid effective emergency interventions. Creating such a continuum between emergency and developmental approaches has long been a holy grall of humanitarianism.	Valld Int, Llanidloes SY18 6PJ, Powys, Wales; Inst Child Hlth, Ctr Int Child Hlth, London WC1N 1EH, England	University of London; University College London	Collins, S (corresponding author), 37 Squires Court,Binfield Rd, London SW4 6TD, England.							Ashworth A, 1997, HEALTH POLICY PLANN, V12, P115, DOI 10.1093/heapol/12.2.115; Briend A, 1999, LANCET, V353, P1767, DOI 10.1016/S0140-6736(99)01078-8; Collins S, 1996, JAMA-J AM MED ASSOC, V276, P391, DOI 10.1001/jama.276.5.391; de Waal A., 1989, FAMINE KILLS DARFUR; Khanum S, 1998, AM J CLIN NUTR, V67, P940, DOI 10.1093/ajcn/67.5.940; KHANUM S, 1994, LANCET, V344, P1728; PHELPS L, 2001, UNPUB REPORT OXFAMS; *SPHER PROJ, 1999, PROJ TEAM SPHERE PRO; WOLLINKA O, 1997, HLTH NUTR MODEL APPL	9	78	79	0	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 11	2001	358	9280					498	501		10.1016/S0140-6736(01)05630-6	http://dx.doi.org/10.1016/S0140-6736(01)05630-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463TB	11513936				2022-12-01	WOS:000170492400036
J	Weiss, NS; Rossing, MA				Weiss, NS; Rossing, MA			Oestrogen-replacement therapy and risk of ovarian cancer	LANCET			English	Editorial Material									Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Weiss, NS (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.							AEDO AR, 1989, MATURITAS, V11, P147, DOI 10.1016/0378-5122(89)90007-8; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; COOK LS, 2000, WOMEN HLTH; Garg PP, 1998, OBSTET GYNECOL, V92, P472, DOI 10.1016/S0029-7844(98)00139-2; HELZLSOUER KJ, 1995, JAMA-J AM MED ASSOC, V274, P1926, DOI 10.1001/jama.274.24.1926; Rodriguez C, 2001, JAMA-J AM MED ASSOC, V285, P1460, DOI 10.1001/jama.285.11.1460; RODRIGUEZ G, 1999, H HARR OV CANC C STO; Rodriguez GC, 1998, J SOC GYNECOL INVEST, V5, P271, DOI 10.1016/S1071-5576(98)00017-3; WEISS NS, 1996, CANC EPIDEMIOLOGY PR	9	6	6	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 11	2001	358	9280					438	438		10.1016/S0140-6736(01)05669-0	http://dx.doi.org/10.1016/S0140-6736(01)05669-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463TB	11513905				2022-12-01	WOS:000170492400007
J	Hackett, JA; Feldser, DM; Greider, CW				Hackett, JA; Feldser, DM; Greider, CW			Telomere dysfunction increases mutation rate and genomic instability	CELL			English	Article							SINGLE-STRANDED-DNA; SACCHAROMYCES-CEREVISIAE; NONRECIPROCAL TRANSLOCATIONS; CHROMOSOMAL REARRANGEMENTS; FISSION YEAST; CAN1 LOCUS; REPLICATION; IDENTIFICATION; RECOMBINATION; MUTANTS	The increased tumor incidence in telomerase null mice suggests that telomere dysfunction induces genetic instability. To test this directly, we examined mutation rate in the absence of telomerase in S. cerevisiae. The mutation rate in the CAN1 gene increased 10- to 100-fold in est1 Delta strains as telomeres became dysfunctional. This increased mutation rate resulted from an increased frequency of terminal deletions. Chromosome fusions were recovered from est1 Delta strains, suggesting that the terminal deletions may occur by a breakage-fusion-bridge type mechanism. At one locus, chromosomes with terminal deletions gained a new telomere through a Rad52p-dependent, Rad51p-independent process consistent with break-induced replication. At a second locus, more complicated rearrangements involving multiple chromosomes were seen. These data suggest that telomerase can inhibit chromosomal instability.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Predoctoral Training Program Human Genet & Mol Bi, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Greider, CW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	cgreider@jhmi.edu		Greider, Carol/0000-0002-5494-8126	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043080] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM43080] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bosco G, 1998, GENETICS, V150, P1037; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; Brachmann CB, 1998, YEAST, V14, P115; Cahill DP, 1999, TRENDS CELL BIOL, V9, pM57, DOI 10.1016/S0962-8924(99)01661-X; Chen C, 1998, MOL CELL, V2, P9, DOI 10.1016/S1097-2765(00)80109-4; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Gasser SM, 2000, SCIENCE, V288, P1377, DOI 10.1126/science.288.5470.1377; GERRING SL, 1991, METHOD ENZYMOL, V194, P57; GOCKE E, 1979, GENETICS, V91, P53; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; HABER JE, 1984, GENETICS, V106, P185; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; KRAMER KM, 1993, GENE DEV, V7, P2345, DOI 10.1101/gad.7.12a.2345; KRAMER KM, 1994, MOL CELL BIOL, V14, P1293, DOI 10.1128/MCB.14.2.1293; Le S, 1999, GENETICS, V152, P143; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Lendvay TS, 1996, GENETICS, V144, P1399; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lewis LK, 2000, MUTAT RES-FUND MOL M, V451, P71, DOI 10.1016/S0027-5107(00)00041-5; Ling MF, 1995, NUCLEIC ACIDS RES, V23, P4924, DOI 10.1093/nar/23.23.4924; LOEB LA, 1991, CANCER RES, V51, P3075; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; Malkova A, 2001, GENE DEV, V15, P1055, DOI 10.1101/gad.875901; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; McClintock B, 1941, GENETICS, V26, P234; McEachern MJ, 2000, P NATL ACAD SCI USA, V97, P11409, DOI 10.1073/pnas.210388397; Morrow DM, 1997, GENETICS, V147, P371; Muller HJ., 1938, COLLECT NET, V13, P181; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Nadas A, 1996, ENVIRON MOL MUTAGEN, V28, P90; Naito T, 1998, NAT GENET, V20, P203, DOI 10.1038/2517; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; NIGRO JM, 1992, MOL CELL BIOL, V12, P1357, DOI 10.1128/MCB.12.3.1357; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Shih IM, 2001, CANCER RES, V61, P818; SINGH D, 1994, INDIAN J CHEM TECHN, V1, P266; SUGAWARA N, 1992, MOL CELL BIOL, V12, P563, DOI 10.1128/MCB.12.2.563; Teo SH, 1997, EMBO J, V16, P4788, DOI 10.1093/emboj/16.15.4788; Thiagalingam S, 2001, P NATL ACAD SCI USA, V98, P2698, DOI 10.1073/pnas.051625398; WHELAN WL, 1979, GENETICS, V91, P35; ZAKIAN VA, 1989, ANNU REV GENET, V23, P579, DOI 10.1146/annurev.genet.23.1.579	48	290	299	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2001	106	3					275	286		10.1016/S0092-8674(01)00457-3	http://dx.doi.org/10.1016/S0092-8674(01)00457-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509177	Bronze			2022-12-01	WOS:000170433300006
J	Kirkwood, TBL				Kirkwood, TBL			Where will it all end?	LANCET			English	Editorial Material									Univ Newcastle Upon Tyne, Newcastle Gen Hosp, Inst Hlth Elderly, Dept Gerontol, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England	Newcastle General Hospital; Newcastle University - UK	Kirkwood, TBL (corresponding author), Univ Newcastle Upon Tyne, Newcastle Gen Hosp, Inst Hlth Elderly, Dept Gerontol, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.							Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Tuljapurkar S, 2000, NATURE, V405, P789, DOI 10.1038/35015561; Vaupel JW, 1997, PHILOS T ROY SOC B, V352, P1799, DOI 10.1098/rstb.1997.0164; Wilmoth JR, 2000, SCIENCE, V289, P2366, DOI 10.1126/science.289.5488.2366	4	4	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2001	357	9256					576	576		10.1016/S0140-6736(00)04077-0	http://dx.doi.org/10.1016/S0140-6736(00)04077-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558481				2022-12-01	WOS:000167119100007
J	Nieman, K; Oudkerk, M; Rensing, BJ; van Ooijen, P; Munne, A; van Geuns, RJ; de Feyter, PJ				Nieman, K; Oudkerk, M; Rensing, BJ; van Ooijen, P; Munne, A; van Geuns, RJ; de Feyter, PJ			Coronary angiography with multi-slice computed tomography	LANCET			English	Article							ARTERY STENOSES	Background A new generation of subsecond multi-slice computed tomography (MSCT) scanners, which allow complete coronary coverage, are becoming widely available. We investigated the potential value of MSCT angiography in a range of coronary disorders. Methods We studied 35 patients, including 11 who had undergone percutaneous transluminal coronary angioplasty and four who had had coronary-artery bypass grafts, by both MSCT and conventional coronary angiography. After intravenous injection of a non-ionic contrast medium with high iodine content, the entire heart was scanned within a single breath-hold. The total examination time was no more than 20 min. The retrospective electrocardiographically gated reconstruction source images and three-dimensional reconstructed volumes were analysed by two investigators, unaware of the results of conventional angiography. Findings In the 31 patients without previous coronary surgery, 173 (73%) of the 237 proximal and middle coronary segments were assessable. In the assessable segments, 17 of 21 significant stenoses (>50% reduction of vessel diameter) were correctly diagnosed. The non-assessable segments included four lesions. Misinterpretations were mainly the result of severe calcification of the vessel wall. Segments with implanted stents were poorly visualised, but stent patency could be assessed in all cases. Of the 17 segments of bypass grafts, 15 were assessable and four of five graft lesions were detected. Two cases of anomalous coronary anatomy could be visualised well. Interpretation These preliminary data suggest that MSCT allows non-invasive imaging of coronary-artery stenoses and has potential to develop into a reliable clinical technique.	Univ Rotterdam Hosp, Thoraxctr BD 406, Dept Cardiol, Catheterizat Lab, NL-3000 CA Rotterdam, Netherlands; Univ Rotterdam Hosp, Daniel Den Hoed Klin, Dept Radiol, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	de Feyter, PJ (corresponding author), Univ Rotterdam Hosp, Thoraxctr BD 406, Dept Cardiol, Catheterizat Lab, POB 2040, NL-3000 CA Rotterdam, Netherlands.		van Geuns, Robert/AAR-6386-2021; van Ooijen, Peter/B-9150-2008; van Geuns, Robert-Jan M/N-7976-2017	van Ooijen, Peter/0000-0002-8995-1210; van Geuns, Robert-Jan M/0000-0003-2943-5932; Oudkerk, Matthijs/0000-0003-2800-4110				Achenbach S, 1998, NEW ENGL J MED, V339, P1964, DOI 10.1056/NEJM199812313392702; Austen W G, 1975, Circulation, V51, P5; Becker CR, 2000, RADIOLOGE, V40, P118, DOI 10.1007/s001170050019; Bielak LF, 2000, CIRCULATION, V102, P380; de Feyter PJ, 2000, HEART, V84, P442, DOI 10.1136/heart.84.4.442; Hu H, 2000, RADIOLOGY, V215, P55, DOI 10.1148/radiology.215.1.r00ap3755; Huber A, 1999, AM J ROENTGENOL, V173, P95, DOI 10.2214/ajr.173.1.10397107; Kachelriess M, 1998, MED PHYS, V25, P2417, DOI 10.1118/1.598453; Kessler W, 1997, AM J CARDIOL, V80, P989, DOI 10.1016/S0002-9149(97)00590-0; Klingenbeck-Regn K, 1999, EUR J RADIOL, V31, P110, DOI 10.1016/S0720-048X(99)00086-8; Leclerc X, 2000, AM J ROENTGENOL, V174, P820, DOI 10.2214/ajr.174.3.1740820; Ohnesorge B, 2000, RADIOLOGY, V217, P564, DOI 10.1148/radiology.217.2.r00nv30564; PATTYNAMA PMT, 1994, AM HEART J, V128, P595, DOI 10.1016/0002-8703(94)90636-X; Pennell DJ, 1996, HEART, V75, P127, DOI 10.1136/hrt.75.2.127; Post JC, 1996, AM J ROENTGENOL, V166, P1399, DOI 10.2214/ajr.166.6.8633453; Rensing BJ, 1998, CIRCULATION, V98, P2509, DOI 10.1161/01.CIR.98.23.2509; Sandstede JJW, 1999, AM J ROENTGENOL, V172, P135, DOI 10.2214/ajr.172.1.9888755; van Geuns RJM, 1999, HEART, V82, P515, DOI 10.1136/hrt.82.4.515; van Geuns RJM, 2000, RADIOLOGY, V217, P270, DOI 10.1148/radiology.217.1.r00oc01270; Wielopolski PA, 2000, EUR RADIOL, V10, P12, DOI 10.1007/s003300050004	20	521	575	0	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2001	357	9256					599	603		10.1016/S0140-6736(00)04058-7	http://dx.doi.org/10.1016/S0140-6736(00)04058-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558487				2022-12-01	WOS:000167119100013
J	LOGAN, GA; HAYES, JM; HIESHIMA, GB; SUMMONS, RE				LOGAN, GA; HAYES, JM; HIESHIMA, GB; SUMMONS, RE			TERMINAL PROTEROZOIC REORGANIZATION OF BIOGEOCHEMICAL CYCLES	NATURE			English	Article							CARBON ISOTOPE RATIOS; FOSSIL RECORD; ORGANIC-COMPOUNDS; WATER COLUMN	THE Proterozoic aeon (2,500-540 million years ago) saw episodic increases in atmospheric oxygen content(1), the evolution of multicellular life(2,3) and, at its close, an enormous radiation of animal diversity(3). These profound biological and environmental changes must have been linked, but the underlying mechanisms have been obscure, Here we show that hydrocarbons extracted from Proterozoic sediments in several locations worldwide are derived mainly from bacteria or other heterotrophs rather than from photosynthetic organisms, Biodegradation of algal products in sedimenting matter was therefore unusually complete, indicating that organic material was extensively reworked as it sank slowly through the water column, We propose that a significant proportion of this reworking will have been mediated by sulphate-reducing bacteria, forming sulphide, The production of sulphide and consumption of oxygen near the ocean surface will have inhibited transport of O-2 to the deep ocean, We find that preservation of algal-lipid skeletons improves at the beginning of the Cambrian, reflecting the increase in transport by rapidly sinking faecal pellets, We suggest that this rapid removal of organic matter will have increased oxygenation of surface waters, leading to a descent of the O-2-sulphide interface to the sea Boor and to marked changes in the marine environment, ultimately contributing to the Cambrian radiation.	INDIANA UNIV, DEPT CHEM, BLOOMINGTON, IN 47405 USA; GEOL SURVEY AUSTRALIA ORG, CANBERRA, ACT 2601, AUSTRALIA	Indiana University System; Indiana University Bloomington	LOGAN, GA (corresponding author), INDIANA UNIV, DEPT GEOL SCI, BIOGEOCHEM LABS, BLOOMINGTON, IN 47405 USA.		Summons, Roger Everett/AAL-3789-2020					ALT JC, 1993, EARTH PLANET SC LETT, V119, P477, DOI 10.1016/0012-821X(93)90057-G; [Anonymous], [No title captured]; BENDER ML, 1990, J GEOPHYS RES-OCEANS, V95, P22243, DOI 10.1029/JC095iC12p22243; BJOROY M, 1992, ORG GEOCHEM, V19, P89, DOI 10.1016/0146-6380(92)90029-W; BRASIER MD, 1992, J GEOL SOC LONDON, V149, P621, DOI 10.1144/gsjgs.149.4.0621; CHAMBERS LA, 1979, GEOMICROBIOL J, V1, P249, DOI 10.1080/01490457909377735; COLLISTER JW, 1992, THESIS INDIANA U; CRIMES TP, 1992, ANNU REV ECOL SYST, V23, P339, DOI 10.1146/annurev.es.23.110192.002011; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DERRY LA, 1992, GEOCHIM COSMOCHIM AC, V56, P1317, DOI 10.1016/0016-7037(92)90064-P; FOWLER SW, 1986, PROG OCEANOGR, V16, P147, DOI 10.1016/0079-6611(86)90032-7; GUTHRIE JM, 1994, THESIS INDIANA U; Hayes J.M., 1992, PROTEROZOIC BIOSPHER, P129; HAYES JM, 1993, MAR GEOL, V113, P111, DOI 10.1016/0025-3227(93)90153-M; HIESHIMA GB, 1992, THESIS INDIANA U; HOERING TC, 1965, YB CARNEGIE I WASH, V64, P215; HOERING TC, 1966, YB CARNEGIE I WASH, V65, P365; HOLLANDER DJ, 1993, ORG GEOCHEM, V20, P1253, DOI 10.1016/0146-6380(93)90013-2; Holser W. T., 1988, CHEM CYCLES EVOLUTIO, P105; INGALL ED, 1993, GEOCHIM COSMOCHIM AC, V57, P303, DOI 10.1016/0016-7037(93)90433-W; Klein C, 1992, PROTEROZOIC BIOSPHER, P147; Knoll A. H, 1992, ORIGIN EARLY EVOLUTI, P53; KNOLL AH, 1986, NATURE, V321, P832, DOI 10.1038/321832a0; KNOLL AH, 1993, PALAIOS, V8, P512, DOI 10.2307/3515029; KNOLL AH, 1992, NATURE, V356, P673, DOI 10.1038/356673a0; LAMBERT IB, 1990, STABLE ISOTOPE COMPO, P260; Largeau C, 1993, ORGANIC GEOCHEMISTRY, P23, DOI [10.1007/978-1-4615-2890-6_2, DOI 10.1007/978-1-4615-2890-6]; LIEN AY, 1983, GLOBAL BIOGEOCHEMICA, P95; LIPPS TH, 1992, ORIGIN EARLY EVOLUTI; MARAIS DJD, 1992, NATURE, V359, P605, DOI 10.1038/359605a0; MOORE TB, 1992, PROTEROZOIC BIOSPHER, P605; MORRIS SC, 1993, NATURE, V361, P219, DOI 10.1038/361219a0; NOTHOLT AJG, 1990, SPEC PUBL GEOL SOC L, V52; RAFF RA, 1970, NATURE, V228, P1003, DOI 10.1038/2281003a0; ROSS GM, IN PRESS PRECAMBR RE; Runnegar B, 1991, PALAEOGEOGR PALAEOCL, V97, P97, DOI 10.1016/0031-0182(91)90186-U; SCHOELL M, 1994, ORG GEOCHEM, V21, P713, DOI 10.1016/0146-6380(94)90014-0; TEGELAAR EW, 1989, GEOCHIM COSMOCHIM AC, V53, P3103, DOI 10.1016/0016-7037(89)90191-9	38	345	368	3	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	1995	376	6535					53	56		10.1038/376053a0	http://dx.doi.org/10.1038/376053a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH111	11536694				2022-12-01	WOS:A1995RH11100059
J	JENNISKENS, P; BLAKE, DF				JENNISKENS, P; BLAKE, DF			STRUCTURAL TRANSITIONS IN AMORPHOUS WATER ICE AND ASTROPHYSICAL IMPLICATIONS	SCIENCE			English	Article							SOLID WATER; INTERSTELLAR GRAINS; LIQUID WATER; VAPOR; PRESSURE; AMORPHIZATION; DIFFRACTION; BEHAVIOR; REGION; IH	Selected area electron diffraction is used to monitor structural changes of vapor-deposited water ice in vacuum during warm-up from 15 to 188 K. A progression of three amorphous forms of water ice is found with well-defined transitions. The formation of a high-density amorphous form (I(a)h) at 15 K is confirmed, and the transition to the more familiar low-density form (I(a)l) occurs gradually over the range 38 to 68 K. At 131 K, the ice transforms into a third amorphous form (I(a)r), which precedes the crystallization of cubic ice (I-c) and coexists metastably with I-c from 148 K until at least 188 K. These structural transformations of amorphous water ice can be used to explain hitherto anomalous properties of astrophysical ices. The structural transition from I(a)h to I(a)l is responsible for the diffusion and recombination of radicals in ultraviolet-photolyzed interstellar ices at low temperatures. The occurrence and persistence of I(a)r explains anomalous gas retention and gas release from water-rich ices at temperatures above 150 K.			JENNISKENS, P (corresponding author), NASA,AMES RES CTR,SPACE SCI MICROSCOPY LAB,MAIL STOP 239-4,MOFFETT FIELD,CA 94035, USA.							ALLEN LC, 1974, PHYSICS CHEM ICE, P13; BARATTA GA, 1990, ASTRON ASTROPHYS, V240, P429; BARNUN A, 1985, ICARUS, V63, P317, DOI 10.1016/0019-1035(85)90048-X; BIZID A, 1987, J CHEM PHYS, V87, P2225, DOI 10.1063/1.453149; BLAKE DF, 1991, MICROBEAM ANAL 1991, P293; DOWELL LG, 1960, NATURE, V188, P1144, DOI 10.1038/1881144a0; DUBOCHET J, 1982, ULTRAMICROSCOPY, V10, P55, DOI 10.1016/0304-3991(82)90187-5; DUNCAN M, 1987, ASTRON J, V94, P1330, DOI 10.1086/114571; FESTOU MC, 1993, ASTRON ASTROPHYS REV, V5, P37, DOI 10.1007/BF00872923; GHORMLEY JA, 1968, J CHEM PHYS, V48, P503, DOI 10.1063/1.1667954; GHORMLEY JA, 1967, J CHEM PHYS, V46, P1321, DOI 10.1063/1.1840851; GREENBERG JM, 1972, MEM SOC ROY SCI LI 6, V3, P425; GREENBERG JM, 1991, CHEM SPACE, P227; HAGEN W, 1979, ASTROPHYS SPACE SCI, V65, P215, DOI 10.1007/BF00643502; HAGEN W, 1981, CHEM PHYS, V56, P367, DOI 10.1016/0301-0104(81)80158-9; HALLBRUCKER A, 1989, J PHYS CHEM-US, V93, P7751, DOI 10.1021/j100360a003; HALLBRUCKER A, 1991, ICARUS, V90, P176, DOI 10.1016/0019-1035(91)90078-8; HANDA YP, 1986, J CHEM PHYS, V84, P2766, DOI 10.1063/1.450301; HEIDE HG, 1985, ULTRAMICROSCOPY, V16, P151, DOI 10.1016/0304-3991(85)90070-1; HEIDE HG, 1984, ULTRAMICROSCOPY, V14, P271, DOI 10.1016/0304-3991(84)90095-0; JENNISKENS P, 1993, ASTRON ASTROPHYS, V273, P583; Jichen Li, 1993, Nature, V365, P327, DOI 10.1038/365327a0; KAMB B, 1973, WATER AQUEOUS SOLUTI, P9; KOUCHI A, 1990, J CRYST GROWTH, V99, P1220, DOI 10.1016/S0022-0248(08)80112-1; KOUCHI A, 1990, NATURE, V344, P134, DOI 10.1038/344134a0; KOUCHI A, 1987, NATURE, V330, P550, DOI 10.1038/330550a0; KOUCHI A, 1990, SP315 EUR SPAC AG, P193; MISHIMA O, 1984, NATURE, V310, P393, DOI 10.1038/310393a0; MUMMA MJ, 1993, PROTOSTARS PLANETS, V3, P1177; NARTEN AH, 1976, J CHEM PHYS, V64, P1106, DOI 10.1063/1.432298; Pauling L., 1960, NATURE CHEM BOND, P449; POHORILLE A, 1987, J CHEM PHYS, V87, P6070, DOI 10.1063/1.453481; ROWLAND B, 1991, J CHEM PHYS, V95, P1378, DOI 10.1063/1.461119; SACK NJ, 1993, PHYS REV B, V48, P9973, DOI 10.1103/PhysRevB.48.9973; SANDFORD SA, 1988, ICARUS, V76, P201, DOI 10.1016/0019-1035(88)90069-3; Sceats M.G., 1982, WATER COMPREHENSIVE, V7, P83; SCHMITT B, 1989, ESASP302, P65; SCHUTTE WA, 1988, THESIS U LEIDEN LEID; SCIORTINO F, 1992, J CHEM PHYS, V96, P3857, DOI 10.1063/1.461890; SCIORTINO F, 1991, NATURE, V354, P218, DOI 10.1038/354218a0; SIVAKUMAR TC, 1978, J CHEM PHYS, V69, P3468, DOI 10.1063/1.437079; SPEEDY RJ, 1992, J PHYS CHEM-US, V96, P2322, DOI 10.1021/j100184a056; TIELENS AGG, 1988, INTERSTELLAR DUST, V135, P239; TIELENS AGGM, 1983, J PHYS CHEM-US, V87, P4220, DOI 10.1021/j100244a049; TSE JS, 1992, J CHEM PHYS, V96, P5482, DOI 10.1063/1.462732	45	389	388	1	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 5	1994	265	5173					753	756		10.1126/science.11539186	http://dx.doi.org/10.1126/science.11539186			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PA372	11539186	Green Submitted			2022-12-01	WOS:A1994PA37200024
J	DIBROZOLO, FR; BUNCH, TE; FLEMING, RH; MACKLIN, J				DIBROZOLO, FR; BUNCH, TE; FLEMING, RH; MACKLIN, J			FULLERENES IN AN IMPACT CRATER ON THE LDEF SPACECRAFT	NATURE			English	Article							ENVIRONMENT; C-60	THE fullerenes C-60 (ref. 1) and C-70 have been found to occur naturally on Earth(2,3), and have also been invoked to explain features in the absorption spectra of interstellar clouds(1,4). But no definitive spectroscopic evidence exists for fullerenes in space and attempts to find fullerenes in carbonaceous chondrites have been unsuccessful(5,6), Here we report the observation of fullerenes associated with carbonaceous impact residue in a crater on the Long Duration Exposure Facility (LDEF) spacecraft. Laser ionization mass spectrometry and Raman spectroscopy indicate the presence of fullerenes in the crater and in adjacent ejecta. Man-made fullerenes survive experimental hypervelocity (similar to 6.1 km s(-1)) impacts into aluminium targets, suggesting that space fullerenes contained in a carbonaceous micrometeorite could have survived the LDEF impact at velocities towards the lower end of the natural particle encounter range (<13 km s(-1)). We also demonstrate that the fullerenes were unlikely to have formed as instrumental artefacts, nor are they present as contaminants. Although we cannot specify the origin of the fullerenes with certainty, the most plausible source is the chondritic impactor. If, alternatively, the impact produced the fullerenes in situ on LDEF, then this suggests a viable mechanism for fullerene production in space.	NASA, AMES RES CTR, PLANETARY BIOL BRANCH, MOFFETT FIELD, CA 94035 USA; UNIV WASHINGTON, DEPT CHEM, SEATTLE, WA 98195 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Washington; University of Washington Seattle	DIBROZOLO, FR (corresponding author), CHARLES EVANS & ASSOCIATES, REDWOOD CITY, CA 94063 USA.							BETHUNE DS, 1990, CHEM PHYS LETT, V174, P219, DOI 10.1016/0009-2614(90)85335-A; BROWNLEE DE, 1993, NASA CP3194 C P, P577; BUNCH TE, 1993, NASA CP3194 C P, P453; BUNCH TE, 1992, NASA CP3134 C P; BUSECK PR, 1992, SCIENCE, V257, P215, DOI 10.1126/science.257.5067.215; COOMBS CR, 1993, NASA CP3194 C P, P595; DALY CF, 1993, SCIENCE, V259, P1599; DEVRIES MS, 1993, GEOCHIM COSMOCHIM AC, V57, P933, DOI 10.1016/0016-7037(93)90179-Z; GILMOUR L, 1991, LUNAR PLANET SCI, V22, P445; HCELVANY SH, 1992, J AM SOC MASS SPECTR, V3, P268; HORZ F, 1992, NASA CP3134 C P, P487; KESSLER DJ, 1991, J SPACECRAFT ROCKETS, V28, P347, DOI 10.2514/3.26250; KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0; KROTO HW, 1985, NATURE, V318, P33; ONEAL RL, 1992, NASA CP3134 C P, P3; WEEKS S, 1990, LASERS MASS SPECTROM, P510; [No title captured]	17	39	39	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	1994	369	6475					37	40		10.1038/369037a0	http://dx.doi.org/10.1038/369037a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NJ860	11541208				2022-12-01	WOS:A1994NJ86000044
J	Polyak, VJ; Asmerom, Y				Polyak, VJ; Asmerom, Y			Late Holocene climate and cultural changes in the southwestern United States	SCIENCE			English	Article							NEW-MEXICO; ARIZONA; SPELEOTHEM; HISTORY; RECORD; CAVE; PALEOCLIMATE; ENVIRONMENTS; STALAGMITES; VEGETATION	Columnar stalagmites in caves of the Guadalupe Mountains during the late Holocene record a 4000-year annually resolved climate history for the southwestern United States. Annual banding, hiatuses, and high-precision uranium-series dating show a present day-like climate from 4000 to 3000 years ago, following a drier middle Holocene. A distinctly wetter and cooler period from 3000 to 800 years ago was followed by a period of present day-like conditions, with the exception of a slightly wetter interval from 440 to 290 years before the present. The stalagmite record correlates well with the archaeological record of changes in cultural activities of indigenous people. Such climate change may help to explain evidence of dwelling abandonment and population redistribution.	Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA	University of New Mexico	Polyak, VJ (corresponding author), Univ New Mexico, Dept Earth & Planetary Sci, 200 Yale Blvd, Albuquerque, NM 87131 USA.							ANDERSON RS, 1993, QUATERNARY RES, V40, P351, DOI 10.1006/qres.1993.1088; Antevs E, 1955, AM ANTIQUITY, V20, P317, DOI 10.2307/277066; APPLEGARTH JS, 1979, US NATL PARK SERVICE, V4, P159; BAKER A, 1993, NATURE, V364, P518, DOI 10.1038/364518a0; Betancourt JL, 2001, PALAEOGEOGR PALAEOCL, V165, P71, DOI 10.1016/S0031-0182(00)00154-1; Brook GA, 1999, HOLOCENE, V9, P695, DOI 10.1191/095968399677907790; Buck BJ, 1999, J ARID ENVIRON, V43, P357, DOI 10.1006/jare.1999.0584; Cheng H, 2000, CHEM GEOL, V169, P17, DOI 10.1016/S0009-2541(99)00157-6; Cordell L. S., 1997, ARCHAEOLOGY SW; DAVIS OK, 1992, PALAEOGEOGR PALAEOCL, V92, P107, DOI 10.1016/0031-0182(92)90137-T; Denniston RF, 2000, QUATERNARY RES, V53, P196, DOI 10.1006/qres.1999.2111; DORALE JA, 1992, SCIENCE, V258, P1626, DOI 10.1126/science.258.5088.1626; EULER RC, 1979, SCIENCE, V205, P1089, DOI 10.1126/science.205.4411.1089; Genty D, 1996, J SEDIMENT RES, V66, P275; HALL SA, 1977, GEOL SOC AM BULL, V88, P1593, DOI 10.1130/0016-7606(1977)88<1593:LQSAPH>2.0.CO;2; HENDY CH, 1971, GEOCHIM COSMOCHIM AC, V35, P801, DOI 10.1016/0016-7037(71)90127-X; HILL CA, 1987, NEW MEXICO BUREAU MI, V117; HOLLIDAY VT, 1989, QUATERNARY RES, V31, P74, DOI 10.1016/0033-5894(89)90086-0; Krider PR, 1998, QUATERNARY RES, V50, P283, DOI 10.1006/qres.1998.1997; Lamb H.H., 1977, CLIMATIC HIST FUTURE; LUNDELIUS EL, 1979, US NATL PARK SERVICE, V4, P239; McFadden LD, 1997, GEOMORPHOLOGY, V19, P303, DOI 10.1016/S0169-555X(97)00017-2; MURRAY JW, 1954, J GEOL, V62, P481, DOI 10.1086/626192; Polyak VJ, 2001, GEOLOGY, V29, P643, DOI 10.1130/0091-7613(2001)029<0643:WACLHC>2.0.CO;2; RAILSBACK LB, 1994, J SEDIMENT RES A, V64, P147; SHOPOV YY, 1994, GEOLOGY, V22, P407, DOI 10.1130/0091-7613(1994)022<0407:LMISHR>2.3.CO;2; SMITH GI, 1983, LATE QUATERNARY ENV, V1, P190; STUART DE, 1996, PREHISTORIC NEW MEXI; Tagg MD, 1996, AM ANTIQUITY, V61, P311, DOI 10.2307/282428; Van Geel B, 1998, RADIOCARBON, V40, P535, DOI 10.1017/S0033822200018403; VANDEVENDER TR, 1994, QUATERNARY RES, V41, P99, DOI 10.1006/qres.1994.1011; Weng CY, 1999, PALAEOGEOGR PALAEOCL, V153, P179, DOI 10.1016/S0031-0182(99)00070-X; Wilkins DE, 1999, HOLOCENE, V9, P363, DOI 10.1191/095968399677728249	33	181	213	2	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2001	294	5540					148	151		10.1126/science.1062771	http://dx.doi.org/10.1126/science.1062771			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11588259				2022-12-01	WOS:000171448800048
J	Stevens, RC; Yokoyama, S; Wilson, IA				Stevens, RC; Yokoyama, S; Wilson, IA			Global efforts in structural genomics	SCIENCE			English	Editorial Material							PROJECT	A worldwide initiative in structural genomics aims to capitalize on the recent successes of the genome projects. Substantial new investments in structural genomics in the past 2 years indicate the high level of support for these international efforts. Already, enormous progress has been made on high-throughput methodologies and technologies that will speed up macromolecular structure determinations. Recent international meetings have resulted in the formation of an International Structural Genomics Organization to formulate policy and foster cooperation between the public and private efforts.	Scripps Res Inst, Joint Ctr Struct Genom, La Jolla, CA 92037 USA; RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan	Scripps Research Institute; RIKEN	Stevens, RC (corresponding author), Scripps Res Inst, Joint Ctr Struct Genom, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Yokoyama, Shigeyuki/N-6911-2015; Stevens, Raymond/K-7272-2015	Yokoyama, Shigeyuki/0000-0003-3133-7338; Stevens, Raymond/0000-0002-4522-8725	NIGMS NIH HHS [P50 GM62411] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM062411] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Burley SK, 1999, NAT GENET, V23, P151, DOI 10.1038/13783; Kim SH, 1998, NAT STRUCT BIOL, V5, P643, DOI 10.1038/1334; Marshall E, 2001, SCIENCE, V292, P188; Montelione GT, 1999, NAT STRUCT BIOL, V6, P11, DOI 10.1038/4878; Stevens RC, 2001, SCIENCE, V293, P519, DOI 10.1126/science.293.5529.519; Terwilliger TC, 2000, NAT STRUCT BIOL, V7, P935, DOI 10.1038/80700; Vitkup D, 2001, NAT STRUCT BIOL, V8, P559, DOI 10.1038/88640	9	152	161	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2001	294	5540					89	92		10.1126/science.1066011	http://dx.doi.org/10.1126/science.1066011			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11588249				2022-12-01	WOS:000171448800037
J	Quill, TE; Arnold, RM; Platt, F				Quill, TE; Arnold, RM; Platt, F			"I wish things were different": Expressing wishes in response to loss, futility, and unrealistic hopes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							EMPATHIC COMMUNICATION; PHYSICIANS; CARE		Univ Rochester, Sch Med & Dent, Rochester, NY 14642 USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA 15213 USA; Univ Colorado, Sch Med, Denver, CO 80205 USA	University of Rochester; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Quill, TE (corresponding author), Univ Rochester, Med Ctr, 601 Elmwood Ave,Box 601, Rochester, NY 14642 USA.							ACKERMAN F, 1991, HASTINGS CENT REP, V21, P27, DOI 10.2307/3562998; BARRETTLENNARD GT, 1993, BRIT J MED PSYCHOL, V66, P3, DOI 10.1111/j.2044-8341.1993.tb01722.x; BRANCH WT, 1993, JAMA-J AM MED ASSOC, V269, P1667, DOI 10.1001/jama.269.13.1667; Byock I., 1997, DYING WELL PEACE POS; Coulehan JL, 2001, ANN INTERN MED, V135, P221, DOI 10.7326/0003-4819-135-3-200108070-00022; FOX RC, 1959, EXPT PERILOUS PHYSIC; GOOD MJD, 1990, CULT MED PSYCHIAT, V14, P59; Kohn L.T., 2000, TO ERR IS HUMAN BUIL; LAZARE A, 1989, OUTPATIENT PSYCHIAT, P157; Levinson W, 2000, JAMA-J AM MED ASSOC, V284, P1021, DOI 10.1001/jama.284.8.1021; Lo B, 1999, ANN INTERN MED, V130, P744, DOI 10.7326/0003-4819-130-9-199905040-00015; MATTHEWS DA, 1993, ANN INTERN MED, V118, P973, DOI 10.7326/0003-4819-118-12-199306150-00010; NIGHTINGALE SD, 1991, J GEN INTERN MED, V6, P420, DOI 10.1007/BF02598163; PLATT FW, 1994, J GEN INTERN MED, V9, P222, DOI 10.1007/BF02600129; Quill T, 1996, MIDWIFE DYING PROCES; QUILL TE, 1995, ANN INTERN MED, V122, P368, DOI 10.7326/0003-4819-122-5-199503010-00008; Quill TE, 2000, JAMA-J AM MED ASSOC, V284, P2502, DOI 10.1001/jama.284.19.2502; RIE MA, 1991, HASTINGS CENT REP, V21, P24, DOI 10.2307/3562997; ROTER DL, 1995, ARCH INTERN MED, V155, P1877, DOI 10.1001/archinte.155.17.1877; Suchman AL, 1997, JAMA-J AM MED ASSOC, V277, P678, DOI 10.1001/jama.277.8.678; [No title captured]; 1993, CONCISE OXFORD ENGLI	22	91	93	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 2	2001	135	7					551	555		10.7326/0003-4819-135-7-200110020-00022	http://dx.doi.org/10.7326/0003-4819-135-7-200110020-00022			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	477EF	11578166				2022-12-01	WOS:000171269600017
J	Waugh, J; Johnson, A; Farkas, A				Waugh, J; Johnson, A; Farkas, A			Analysis of cord blood gas at delivery: questionnaire study of practice in the United Kingdom	BRITISH MEDICAL JOURNAL			English	Article									Royal Hallamshire Hosp, Dept Obstet & Gynaecol, Sheffield S10 2SF, S Yorkshire, England	University of Sheffield	Farkas, A (corresponding author), Royal Hallamshire Hosp, Dept Obstet & Gynaecol, Sheffield S10 2SF, S Yorkshire, England.							GELDABER GK, 1991, OBSTET GYNECOL, V78, P1103; MacLennan A, 1999, BMJ-BRIT MED J, V319, P1054, DOI 10.1136/bmj.319.7216.1054; *ROYAL COLL OBST G, 1999, SAF CHILDB MIN STAND, P22; WESTGATE J, 1994, BRIT J OBSTET GYNAEC, V101, P1054, DOI 10.1111/j.1471-0528.1994.tb13581.x	4	7	8	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 29	2001	323	7315					727	727		10.1136/bmj.323.7315.727	http://dx.doi.org/10.1136/bmj.323.7315.727			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478HJ	11576980	Bronze, Green Published			2022-12-01	WOS:000171340700020
J	Downing, PE; Jiang, YH; Shuman, M; Kanwisher, N				Downing, PE; Jiang, YH; Shuman, M; Kanwisher, N			A cortical area selective for visual processing of the human body	SCIENCE			English	Article							TEMPORAL CORTEX; PERCEPTION; REPRESENTATION; ACTIVATION; MOTION; PARTS	Despite extensive evidence for regions of human visual cortex that respond selectively to faces, few studies have considered the cortical representation of the appearance of the rest of the human body. We present a series of functional magnetic resonance imaging (fMRI) studies revealing substantial evidence for a distinct cortical region in humans that responds selectively to images of the human body, as compared with a wide range of control stimuli. This region was found in the lateral occipitotemporal cortex in all subjects tested and apparently reflects a specialized neural system for the visual perception of the human body.	Univ Wales, Ctr Cognit Neurosci, Sch Psychol, Bangor LL57 2AS, Gwynedd, Wales; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Nucl Magnet Resonance Imaging Ctr, Charlestown, MA 02129 USA	Bangor University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital	Downing, PE (corresponding author), Univ Wales, Ctr Cognit Neurosci, Sch Psychol, Bangor LL57 2AS, Gwynedd, Wales.	p.downing@bangor.ac.uk		Downing, Paul/0000-0002-5046-2858				Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Howard RJ, 1996, CURR BIOL, V6, P1015, DOI 10.1016/S0960-9822(02)00646-2; Jellema T, 2000, BRAIN COGNITION, V44, P280, DOI 10.1006/brcg.2000.1231; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; Le Clec'H G, 2000, NEUROIMAGE, V12, P381, DOI 10.1006/nimg.2000.0627; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Puce A, 1996, J NEUROSCI, V16, P5205; Puce A, 1998, J NEUROSCI, V18, P2188; Rizzolatti G, 1997, CURR OPIN NEUROBIOL, V7, P562, DOI 10.1016/S0959-4388(97)80037-2; Shelton JR, 1998, NEUROCASE, V4, P339, DOI 10.1080/13554799808410631; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; WACHSMUTH E, 1994, CEREB CORTEX, V4, P509, DOI 10.1093/cercor/4.5.509	21	1363	1377	12	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2001	293	5539					2470	2473		10.1126/science.1063414	http://dx.doi.org/10.1126/science.1063414			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11577239				2022-12-01	WOS:000171237200052
J	Groom, AV; Wolsey, DH; Naimi, TS; Smith, K; Johnson, S; Boxrud, D; Moore, KA; Cheek, JE				Groom, AV; Wolsey, DH; Naimi, TS; Smith, K; Johnson, S; Boxrud, D; Moore, KA; Cheek, JE			Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FIELD GEL-ELECTROPHORESIS; CHILDREN; OUTBREAK; CLONE; RISK; EPIDEMIOLOGY; STRAINS; MRSA; MEC	Context Until recently, methicillin-resistant Staphylococcus aureus (MRSA) infections have been acquired primarily in nosocomial settings. Four recent deaths due to MRSA infection in previously healthy children in the Midwest suggest that serious MRSA infections can be acquired in the community in rural as well as urban locations. Objectives To document the occurrence of community-acquired MRSA infections and evaluate risk factors for community-acquired MRSA infection compared with methicillin-susceptible S aureus (MSSA) infection. Design Retrospective cohort study with medical record review. Setting Indian Health Service facility in a rural midwestern American Indian community. Patients Patients whose medical records indicated laboratory-confirmed S aureus infection diagnosed during 1997. Main Outcome Measures Proportion of MRSA infections classified as community acquired based on standardized criteria; risk factors for community-acquired MRSA infection compared with those for community-acquired MSSA infection; and relatedness of MRSA strains, determined by pulsed-field gel electrophoresis (PFGE). Results Of 112 S aureus isolates, 62 (55%) were MRSA and 50 (45%) were MSSA. Forty-six (74%) of the 62 MRSA infections were classified as community acquired. Risk factors for community-acquired MRSA infections were not significantly different from those for community-acquired MSSA. Pulsed-field gel electrophoresis subtyping indicated that 34 (89%) of 38 community-acquired MRSA isolates were clonally related and distinct from nosocomial MRSA isolates found in the region. Conclusions Community-acquired MRSA may have replaced community-acquired MSSA as the dominant strain in this community. Antimicrobial susceptibility patterns and PFGE subtyping support the finding that MRSA is circulating beyond nosocomial settings in this and possibly other rural US communities.	Indian Hlth Serv, Natl Epidemiol Program, Albuquerque, NM 87110 USA; Ctr Dis Control & Prevent, Epidemiol Program Off, Atlanta, GA USA; Minnesota Dept Hlth, Acute Dis Epidemiol Sect, Minneapolis, MN USA; Minnesota Dept Hlth, Div Publ Hlth Labs, Minneapolis, MN USA; ICAN Inc, Eden Prairie, MN USA	Centers for Disease Control & Prevention - USA; Minnesota Department of Health (MHD); Minnesota Department of Health (MHD)	Cheek, JE (corresponding author), Indian Hlth Serv, Natl Epidemiol Program, 5300 Homestead Rd NE,Headquarters, Albuquerque, NM 87110 USA.			Naimi, Timothy/0000-0001-9849-4413	PHS HHS [U50/CCU511190] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abi-Hanna P, 2000, CLIN INFECT DIS, V30, P630, DOI 10.1086/313706; ANTHONY BF, 1967, PEDIATRICS, V39, P263; Ayliffe GAJ, 1997, CLIN INFECT DIS, V24, pS74, DOI 10.1093/clinids/24.Supplement_1.S74; BANNERMAN TL, 1995, J CLIN MICROBIOL, V33, P551, DOI 10.1128/JCM.33.3.551-555.1995; Boyce JM, 1998, JAMA-J AM MED ASSOC, V279, P623, DOI 10.1001/jama.279.8.623; *CDCP, 1998, NAT NOS INF SURV SYS; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P707; *CDCP, 1997, EP INF VERS 6 04C; Cockerill FR, 1997, JAMA-J AM MED ASSOC, V277, P38, DOI 10.1001/jama.277.1.38; Cookson BD, 2000, INFECT CONT HOSP EP, V21, P398, DOI 10.1086/501781; *CYT SOFTW CORP, 1997, STATX 3; DAJANI AS, 1973, ARCH DERMATOL, V108, P517, DOI 10.1001/archderm.108.4.517; de Sousa MA, 1998, J CLIN MICROBIOL, V36, P2590, DOI 10.1128/JCM.36.9.2590-2596.1998; EMBIL J, 1994, INFECT CONT HOSP EP, V15, P646; Frank AL, 1999, PEDIATR INFECT DIS J, V18, P993, DOI 10.1097/00006454-199911000-00012; Gorak EJ, 1999, CLIN INFECT DIS, V29, P797, DOI 10.1086/520437; HARTMAN BJ, 1984, J BACTERIOL, V158, P513, DOI 10.1128/JB.158.2.513-516.1984; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Joe J R, 1996, J Am Med Womens Assoc (1972), V51, P141; JORGENSEN JH, 1986, EUR J CLIN MICROBIOL, V5, P693, DOI 10.1007/BF02013307; Kallen AJ, 2000, INFECT CONT HOSP EP, V21, P223, DOI 10.1086/501750; KREISWIRTH B, 1993, SCIENCE, V259, P227, DOI 10.1126/science.8093647; Macfarlane L, 1999, J HOSP INFECT, V41, P29, DOI 10.1016/S0195-6701(99)90034-8; Maguire GP, 1996, MED J AUSTRALIA, V164, P721, DOI 10.5694/j.1326-5377.1996.tb122270.x; Monnet DL, 1998, INFECT CONT HOSP EP, V19, P552; MORENO F, 1995, CLIN INFECT DIS, V21, P1308, DOI 10.1093/clinids/21.5.1308; MUSSER JM, 1992, J CLIN MICROBIOL, V30, P2058, DOI 10.1128/JCM.30.8.2058-2063.1992; National Committee for Clinical Laboratory Standards, 1997, M2A6 NCCLS CLIN LAB, V6th; National Committee for Clinical Laboratory Standars, 1999, M100S9 NAT COMM CLIN; NISHI JI, 1995, J LAB CLIN MED, V126, P29; O'Brien FG, 1999, J CLIN MICROBIOL, V37, P2858; RHOADES ER, 1987, PUBLIC HEALTH REP, V102, P361; Roberts RB, 1998, MICROB DRUG RESIST, V4, P175, DOI 10.1089/mdr.1998.4.175; Roberts RB, 1998, J INFECT DIS, V178, P164, DOI 10.1086/515610; Shopsin B, 2000, J INFECT DIS, V182, P359, DOI 10.1086/315695; Tenover F, 1998, BACTERIAL INFECT HUM, P83; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Warshawsky B, 2000, INFECT CONT HOSP EP, V21, P724, DOI 10.1086/501718; Wayne P.A, 1997, PERF VOL ANT SUSC FL, Vsixth; Wu SW, 1996, MICROB DRUG RESIST, V2, P435, DOI 10.1089/mdr.1996.2.435	40	282	296	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1201	1205		10.1001/jama.286.10.1201	http://dx.doi.org/10.1001/jama.286.10.1201			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471CR	11559265	Bronze			2022-12-01	WOS:000170910400030
J	Bedford, H; de Louvois, J; Halket, S; Peckham, C; Hurley, R; Harvey, D				Bedford, H; de Louvois, J; Halket, S; Peckham, C; Hurley, R; Harvey, D			Meningitis in infancy in England and Wales: follow up at age 5 years	BRITISH MEDICAL JOURNAL			English	Article							BACTERIAL-MENINGITIS; INFLUENZAE MENINGITIS; HEARING-LOSS; CHILDREN; OUTCOMES; SEQUELA	Objective To describe important sequelae occurring among a cohort of children aged 5 years who had had meningitis during the first year of life and who had been identified by a prospective national study of meningitis in infancy in England and Wales between 1985 and 1987. Design Follow up questionnaires asking about the children's health and development were sent to general practitioners and parents of the children and to parents of matched controls. The organism that caused the infection and age at infection were also recorded. Setting England and Wales. Participants General practitioners and parents of children who had had meningitis before the age of 1 year and of matched controls. Main outcome measures The prevalence of health and developmental problems and overall disability among children who had had meningitis compared with controls. Results Altogether, 1584 of 1717 (92.2%) children who had had meningitis mid 1391 of 1485 (93.6'%) controls were successfully followed up, Among children who survived to age 5 years 247 of 1584 (15.6%) had a disability; there was a 10-fold increase in the risk of severe or moderate disability at 5 years of age among children who had had meningitis (relative risk 10.3, 95% confidence interval 6.7 to 16.0, P<0.001). There was considerable variation in the rates of severe or moderate disability in children infected with different organisms. Conclusion The long term consequences of having meningitis during the first year of life are significant: 32 of 1717 (1.8%) children died within five years. Not only did almost a fifth of children with meningitis have a permanent, severe or moderately severe disability, but subtle deficits were also more prevalent.	Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England; Publ Hlth Lab Serv, Environm Surveillance Unit, London NW9 5EQ, England; Queen Charlottes & Chelsea Hosp, Dept Paediat & Neonatal Med, Imperial Coll Sch Med, Karim Ctr Meningitis Res, London W6 0XG, England	University of London; University College London; Public Health England; Imperial College London	Bedford, H (corresponding author), Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, 30 Guilford St, London WC1N 1EH, England.		peckham, catherine s/I-6300-2013					BARAFF LJ, 1993, PEDIATR INFECT DIS J, V12, P389, DOI 10.1097/00006454-199305000-00008; BERLOW SJ, 1980, LARYNGOSCOPE, V90, P1445, DOI 10.1288/00005537-198009000-00004; CRIMWOOD K, 1995, PEDIATRICS, V95, P646; DAVIES PA, 1994, NEONATAL MENINGITIS, P140; DELOUVOIS J, 1991, ARCH DIS CHILD, V66, P603, DOI 10.1136/adc.66.5.603; DODGE PR, 1984, NEW ENGL J MED, V311, P869, DOI 10.1056/NEJM198410043111401; FELDMAN HM, 1988, PEDIATRICS, V81, P339; FORTNUM HM, 1992, ARCH DIS CHILD, V67, P1111, DOI 10.1136/adc.67.9.1111; GRIMWOOD K, 1995, PEDIATRICS, V95, P646; Holt DE, 2001, ARCH DIS CHILD-FETAL, V84, pF85, DOI 10.1136/fn.84.2.F85; KAPLAN SL, 1981, PEDIATRICS, V68, P8; MCINTYRE P, 1993, MED J AUSTRALIA, V159, P766, DOI 10.5694/j.1326-5377.1993.tb141344.x; NADOL JB, 1978, LARYNGOSCOPE, V88, P739; RIORDAN A, 1993, BRIT J AUDIOL, V27, P375, DOI 10.3109/03005369309076713; Shields M D, 1995, Qual Health Care, V4, P269, DOI 10.1136/qshc.4.4.269; UNHANAND M, 1993, J PEDIATR-US, V122, P15, DOI 10.1016/S0022-3476(05)83480-8	16	178	186	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 8	2001	323	7312					533	536		10.1136/bmj.323.7312.533	http://dx.doi.org/10.1136/bmj.323.7312.533			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471NC	11546697	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000170934600017
J	Puthalakath, H; Villunger, A; O'Reilly, LA; Beaumont, JG; Coultas, L; Cheney, RE; Huang, DCS; Strasser, A				Puthalakath, H; Villunger, A; O'Reilly, LA; Beaumont, JG; Coultas, L; Cheney, RE; Huang, DCS; Strasser, A			Bmf: A proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis	SCIENCE			English	Article							BCL-2 FAMILY; LIGHT-CHAIN; CELL-DEATH; APOPTOSIS; DYNEIN; MEMBER; BIM; PURIFICATION; INTEGRINS	Bcl-2 family members bearing only the BH3 domain are essential inducers of apoptosis. We identified a BH3-only protein, Bmf, and show that its BH3 domain is required both for binding to prosurvival Bcl-2 proteins and for triggering apoptosis. In healthy cells, Bmf is sequestered to myosin V motors by association with dynein light chain 2. Certain damage signals, such as loss of cell attachment (anoikis), unleash Bmf, allowing it to translocate and bind prosurvival. Bcl-2 proteins. Thus, at least two mammalian BH3-only proteins, Bmf and Bim, function to sense intracellular damage by their localization to distinct cytoskeletal structures.	Walter & Eliza Hall Inst Med Res, PO Royal Melbourne Hosp, Melbourne, Vic 3050, Australia; Univ N Carolina, Chapel Hill, NC 27599 USA	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of North Carolina; University of North Carolina Chapel Hill	Strasser, A (corresponding author), Walter & Eliza Hall Inst Med Res, PO Royal Melbourne Hosp, Melbourne, Vic 3050, Australia.	strasser@wehi.edu.au	Strasser, Andreas/C-7581-2013; Puthalakath, Hamsa/B-8541-2011; Huang, David C. S./C-7586-2013	Strasser, Andreas/0000-0002-5020-4891; Huang, David C. S./0000-0002-3101-4873; Cheney, Richard/0000-0001-6565-7888	NATIONAL CANCER INSTITUTE [R01CA080188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC003299] Funding Source: NIH RePORTER; NCI NIH HHS [CA 80188] Funding Source: Medline; NIDCD NIH HHS [R29 DC003299] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Benashski SE, 1997, J BIOL CHEM, V272, P20929, DOI 10.1074/jbc.272.33.20929; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Cheney RE, 1998, METHOD ENZYMOL, V298, P3, DOI 10.1016/S0076-6879(98)98003-X; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Lo KWH, 2001, J BIOL CHEM, V276, P14059, DOI 10.1074/jbc.M010320200; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; O'Reilly LA, 1998, BIOTECHNIQUES, V25, P824, DOI 10.2144/98255st03; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; PUTHALAKATH H, UNPUB; RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Wick W, 1996, ONCOGENE, V12, P973; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; [No title captured]	23	469	502	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1829	1832		10.1126/science.1062257	http://dx.doi.org/10.1126/science.1062257			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546872				2022-12-01	WOS:000170894400047
J	Astagneau, P; Desplaces, N; Vincent, V; Chicheportiche, V; Botherel, AH; Maugat, S; Lebascle, K; Leonard, P; Desenclos, JC; Grosset, J; Ziza, JM; Brucker, G				Astagneau, P; Desplaces, N; Vincent, V; Chicheportiche, V; Botherel, AH; Maugat, S; Lebascle, K; Leonard, P; Desenclos, JC; Grosset, J; Ziza, JM; Brucker, G			Mycobacterium xenopi spinal infections after discovertebral surgery: investigation and screening of a large outbreak	LANCET			English	Article							IMMUNOCOMPETENT PATIENT; DISEASE; PREVENTION; ARTHRITIS; GUIDELINE; FRANCE	Background Mycobacterium xenopi spinal infections were diagnosed in 1993 in patients who had undergone surgical microdiscectomy for disc hernia, by nucleotomy or microsurgery, in a private hospital. Contaminated tap water, used for rinsing surgical devices after disinfection, was identified as the source of the outbreak. Several cases were recorded in the 4 years after implementation of effective control measures because of the long time between discectomy and case detection. The national health authorities decided to launch a retrospective investigation in patients who were exposed to M xenopi contamination in that hospital. Methods Mailing and media campaigns were undertaken concurrently to trace exposed patients for spinal infections. Patients we re screened by magnetic resonance imaging (MRI), and the scans were reviewed by a radiologist who was unaware of the diagnosis. Suspected cases had discovertebral biopsy for histopathological and bacteriological examination. Findings Of 3244 exposed patients, 2971 (92%) were informed about the risk of infection and 2454 (76%) had MRI, Overall, 58 cases of M xenopi spinal infection were identified (overall cumulative frequency 1.8%), including 26 by the campaign (mean delay in detection 5.2 years, SD 2.4, range 1-10 years). Multivariate analysis showed that the risk of M xenopi spinal infection was related to nucleotomy and high number of patients per operating session. Interpretation Failures in hygiene practices could result in an uncontrolled outbreak of nosocomial infection. Patients who have been exposed to an iatrogenic infectious hazard should be screened promptly and receive effective information.	CCLIN Paris Nord, Inst Cordeliers, F-75006 Paris, France; Hop Croix St Simon, Paris, France; Inst Pasteur, Paris, France; Hop Lariboisiere, F-75475 Paris, France; Hop La Pitie Salpetriere, Paris, France; Inst Veille Sanitaire, St Maurice, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris 13; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institute of Public Health Surveillance	Astagneau, P (corresponding author), CCLIN Paris Nord, Inst Cordeliers, 15 Rue Ecole Med, F-75006 Paris, France.		Astagneau, Pascal/AAF-3473-2020					Astagneau P, 2001, J HOSP INFECT, V47, P84, DOI 10.1053/jhin.2000.0874; BANKS J, 1984, THORAX, V39, P376, DOI 10.1136/thx.39.5.376; BENNETT SN, 1994, AM J RESP CRIT CARE, V150, P245, DOI 10.1164/ajrccm.150.1.8025757; BULLIN CH, 1970, J HYG-CAMB, V68, P97, DOI 10.1017/S0022172400028540; Coombes GM, 1996, BRIT J RHEUMATOL, V35, P1008; Danesh-Clough R, 2000, SPINE, V25, P626, DOI 10.1097/00007632-200003010-00015; DECLUDT B, 2000, B EPIDEMIOL HEBD, V17, P71; ElHelou P, 1997, CLIN INFECT DIS, V25, P206, DOI 10.1086/514525; Falkinham JO, 1996, CLIN MICROBIOL REV, V9, P177, DOI 10.1128/CMR.9.2.177; FEYEN J, 1983, CLIN ORTHOP RELAT R, P189; Froideveaux D, 1996, CLIN INFECT DIS, V22, P723, DOI 10.1093/clinids/22.4.723; GHOSEZ JP, 1994, RACHIS, V6, P147; GOUJARD J, 1988, INT J EPIDEMIOL, V17, P423, DOI 10.1093/ije/17.2.423; GROSS W M, 1976, Bulletin of the International Union Against Tuberculosis, V51, P267; Jiva TM, 1997, CLIN INFECT DIS, V24, P226, DOI 10.1093/clinids/24.2.226; JONES PG, 1995, CLIN INFECT DIS, V21, P1352, DOI 10.1093/clinids/21.5.1352-a; Kelly M, 1999, CLIN INFECT DIS, V29, P1342, DOI 10.1086/313447; Lot F, 1999, ANN INTERN MED, V130, P1, DOI 10.7326/0003-4819-130-1-199901050-00002; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; MARKS J, 1975, TUBERCLE, V56, P157, DOI 10.1016/0041-3879(75)90026-4; MILLER WC, 1994, CLIN INFECT DIS, V19, P1024, DOI 10.1093/clinids/19.6.1024; PICARDEAU M, 1995, RES MICROBIOL, V146, P237, DOI 10.1016/0923-2508(96)80279-8; PROSSER AJ, 1986, TUBERCLE, V67, P229, DOI 10.1016/S0041-3879(86)80030-7; RAHMAN MAA, 1992, TUBERCLE LUNG DIS, V73, P392, DOI 10.1016/0962-8479(92)90047-N; Rutala WA, 1996, AM J INFECT CONTROL, V24, P313, DOI 10.1016/S0196-6553(96)90066-8; SCHWABACHER HERTA, 1959, JOUR HYG, V57, P57; SMITH MJ, 1983, THORAX, V38, P373, DOI 10.1136/thx.38.5.373; SNIADACK DH, 1993, INFECT CONT HOSP EP, V14, P636; Telgt DSC, 1997, BRIT J RHEUMATOL, V36, P1025; VESTAL ASM, 1975, PROCEDURES ISOLATION	30	72	75	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 1	2001	358	9283					747	751		10.1016/S0140-6736(01)05843-3	http://dx.doi.org/10.1016/S0140-6736(01)05843-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467XR	11551599				2022-12-01	WOS:000170729500031
J	MacWilliams, B				MacWilliams, B			It's a dog's life for Siberian foxes	NATURE			English	News Item																			0	0	0	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2001	412	6850					845	845		10.1038/35091208	http://dx.doi.org/10.1038/35091208			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528439	Bronze			2022-12-01	WOS:000170689000009
J	Senftleben, U; Cao, YX; Xiao, GT; Greten, FR; Krahn, G; Bonizzi, G; Chen, Y; Hu, YL; Fong, A; Sun, SC; Karin, M				Senftleben, U; Cao, YX; Xiao, GT; Greten, FR; Krahn, G; Bonizzi, G; Chen, Y; Hu, YL; Fong, A; Sun, SC; Karin, M			Activation by IKK alpha of a second, evolutionary conserved, NF-kappa B signaling pathway	SCIENCE			English	Article							MICE LACKING; BETA; PROTEINS; PHOSPHORYLATION; ALYMPHOPLASIA; DEFICIENT; INDUCTION; RESPONSES; SUBUNIT; CELLS	In mammals, the canonical nuclear factor kappaB (NF-kappaB) signaling pathway activated in response to infections is based on degradation Of I kappaB inhibitors. This pathway depends on the I kappaB kinase (IKK), which contains two catalytic subunits, IKK alpha and IKK beta. IKK beta is essential for inducible I kappaB phosphorylation and degradation, whereas IKK alpha is not. Here we show that IKK alpha is required for B cell maturation, formation of secondary lymphoid organs, increased expression of certain NF-kappaB target genes, and processing of the NF-kappa B2 (p100) precursor. IKK alpha preferentially phosphorylates NF-kappa B2, and this activity requires its phosphorylation by upstream kinases, one of which may be NF-kappaB-inducing kinase (NIK). IKK alpha is therefore a pivotal component of a second NF-kappaB activation pathway based on regulated NF-kappa B2 processing rather than I kappaB degradation.	Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Ulm, Anesthesiol Clin, D-89075 Ulm, Germany; Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA; Univ Ulm, Dept Dermatol, D-89081 Ulm, Germany	University of California System; University of California San Diego; Ulm University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Ulm University	Karin, M (corresponding author), Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Hu, Yinling/G-5682-2015; Greten, Florian R/AAF-5196-2020; Bonizzi, Giuseppina/AAD-9042-2022	Hu, Yinling/0000-0002-4795-8537; Greten, Florian R/0000-0002-3928-6080; 	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004151, R37ES004151] Funding Source: NIH RePORTER; NIAID NIH HHS [AI434477, AI45045] Funding Source: Medline; NIEHS NIH HHS [ESO4151] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Cao Y., UNPUB; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Ishikawa H, 1997, J EXP MED, V186, P999, DOI 10.1084/jem.186.7.999; Kaisho T, 2001, J EXP MED, V193, P417, DOI 10.1084/jem.193.4.417; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; LIOU HC, 1994, MOL CELL BIOL, V14, P5349, DOI 10.1128/MCB.14.8.5349; Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; MERCURIO F, 1993, GENE DEV, V7, P705, DOI 10.1101/gad.7.4.705; RICE NR, 1992, CELL, V78, P773; Rothwarf D.M., 1999, SCI STKE, V1999, pRE1; Senftleben U, 2001, IMMUNITY, V14, P217, DOI 10.1016/S1074-7613(01)00104-2; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yamada T, 2000, J IMMUNOL, V165, P804, DOI 10.4049/jimmunol.165.2.804; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360	29	1080	1138	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1495	1499		10.1126/science.1062677	http://dx.doi.org/10.1126/science.1062677			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520989				2022-12-01	WOS:000170616000046
J	Barnes, DKA				Barnes, DKA			Resource availability Ancient homes for hard-up hermit crabs	NATURE			English	Article							SHELL UTILIZATION		Natl Univ Ireland Univ Coll Cork, Dept Zool & Anim Ecol, Cork, Ireland; Frontier, London EC2A 4QS, England	University College Cork	Barnes, DKA (corresponding author), British Antarctic Survey, High Cross,Maddingley Rd, Cambridge CB3 0ET, England.							Barnes DKA, 1998, J SHELLFISH RES, V17, P51; BARNES DKA, IN PRESS ECOLOGY BIO; BERTNESS MD, 1982, J EXP MAR BIOL ECOL, V64, P159, DOI 10.1016/0022-0981(82)90151-4; Burggren W.W., 1988, BIOL LAND CRABS; FOTHERINGHAM N, 1976, ECOLOGY, V57, P570, DOI 10.2307/1936441; HAZLETT BA, 1980, BEHAV ECOL SOCIOBIOL, V6, P177, DOI 10.1007/BF00569198; KELLOGG CW, 1976, J EXP MAR BIOL ECOL, V22, P101, DOI 10.1016/0022-0981(76)90112-X; REESE ERNST S., 1962, ANIMAL BEHAVIOUR, V10, P347, DOI 10.1016/0003-3472(62)90058-1; RUTHERFORD JC, 1977, VELIGER, V19, P438	9	14	17	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					785	786		10.1038/35090632	http://dx.doi.org/10.1038/35090632			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518955				2022-12-01	WOS:000170577200026
J	Fukui, Y; Hashimoto, O; Sanui, T; Oono, T; Koga, H; Abe, M; Inayoshi, A; Noda, M; Oike, M; Shirai, T; Sasazuki, T				Fukui, Y; Hashimoto, O; Sanui, T; Oono, T; Koga, H; Abe, M; Inayoshi, A; Noda, M; Oike, M; Shirai, T; Sasazuki, T			Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration	NATURE			English	Article							CHEMOKINE RECEPTOR; MYOBLAST CITY; T-CELLS; ACTIVATION; ORGANS; CDC42; PHAGOCYTOSIS; POLARIZATION; CHEMOTAXIS; EXPRESSION	Cell migration is a fundamental biological process involving membrane polarization and cytoskeletal dynamics(1), both of which are regulated by Rho family GTPases(2-5). Among these molecules, Rac is crucial for generating the actin-rich lamellipodial protrusion, a principal part of the driving force for movement(3,6). The CDM family proteins, Caenorhabditis elegans CED-5, human DOCK180 and Drosophila melanogaster Myoblast City (MBC), are implicated to mediate membrane extension by functioning upstream of Rac(7-12). Although genetic analysis has shown that CED-5 and Myoblast City are crucial for migration of particular types of cells(8,9,12), physiological relevance of the CDM family proteins in mammals remains unknown. Here we show that DOCK2, a haematopoietic cell-specific CDM family protein(13), is indispensable for lymphocyte chemotaxis. DOCK2-dercient mice (DOCK2(-/-)) exhibited migration defects of T and B lymphocytes, but not of monocytes, in response to chemokines, resulting in several abnormalities including T lymphocytopenia, atrophy of lymphoid follicles and loss of marginal-zone B cells. In DOCK2(-/-) lymphocytes, chemokine-induced Rac activation and actin polymerization were almost totally abolished. Thus, in lymphocyte migration DOCK2 functions as a central regulator that mediates cytoskeletal reorganization through Rac activation.	Kyushu Univ, Med Inst Bioregulat, Dept Immunobiol & Neurosci, Div Immunogenet,Higashi Ku, Fukuoka 8128582, Japan; Japan Sci & Technol Corp, CREST, Higashi Ku, Fukuoka 8128582, Japan; Kurume Univ, Sch Med, Res Ctr Innovat Canc Therapy, Kurume, Fukuoka 8300011, Japan; Juntendo Univ, Sch Med, Dept Pathol 2, Bunkyo Ku, Tokyo 1130033, Japan; Kyushu Univ, Grad Sch Med Sci, Dept Pharmacol, Higashi Ku, Fukuoka 8128582, Japan; Int Med Ctr Japan, Shinjuku Ku, Tokyo 1628655, Japan	Kyushu University; Japan Science & Technology Agency (JST); Kurume University; Juntendo University; Kyushu University; National Center for Global Health & Medicine - Japan	Sasazuki, T (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Immunobiol & Neurosci, Div Immunogenet,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.			Fukui, Yoshinori/0000-0003-2335-8745				Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Kim CH, 1998, BLOOD, V91, P4434, DOI 10.1182/blood.V91.12.4434.412k45_4434_4443; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Nagase T, 1996, DNA Res, V3, P321, DOI 10.1093/dnares/3.5.321; Nakano H, 1998, BLOOD, V91, P2886, DOI 10.1182/blood.V91.8.2886.2886_2886_2895; Nishihara H, 1999, BBA-MOL CELL RES, V1452, P179, DOI 10.1016/S0167-4889(99)00133-0; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; OBERLEY LW, 1982, SUPEROXIDE DISMUTASE, V1, P1; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Onai N, 2000, BLOOD, V96, P2074; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Sotsios Y, 2000, IMMUNOL REV, V177, P217, DOI 10.1034/j.1600-065X.2000.17712.x; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Yoshida R, 1998, J BIOL CHEM, V273, P7118, DOI 10.1074/jbc.273.12.7118	30	348	358	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					826	831		10.1038/35090591	http://dx.doi.org/10.1038/35090591			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518968				2022-12-01	WOS:000170577200039
J	Shah, RR; Abbott, NL				Shah, RR; Abbott, NL			Principles for measurement of chemical exposure based on recognition-driven anchoring transitions in liquid crystals	SCIENCE			English	Article							SURFACE-CONFINED MONOLAYERS; PHASE PROBE MOLECULES; ACID; AMPLIFICATION; SENSORS; GOLD	The competitive binding of a molecule forming a liquid crystal and a targeted anatyte to a common molecular receptor presented at a solid surface possessing nanometer-scate topography is used to trigger an easily visualized surface-driven change in the orientation of a micrometer-thick film of liquid crystal. Diffusion of the targeted analyte from atmosphere to surface-immobilized receptor across the micrometer-thick film of liquid crystal is fast (on the order of seconds), and the competitive interaction of the targeted analyte and liquid crystal with the receptor provides a high level of tolerance to nontargeted species (water, ethanol, acetone, and hexanes). Systems that provide parts-per-billion (by volume) sensitivity to either organoamine or organophosphorus compounds are demonstrated, and their use for imaging of spatial gradients in concentration is reported. This approach does not require complex instrumentation and could provide the basis of wearable personalized sensors for measurement of real-time and cumulative exposure to environmental agents.	Univ Wisconsin, Dept Chem Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Abbott, NL (corresponding author), Univ Wisconsin, Dept Chem Engn, 1415 Johnson Dr, Madison, WI 53706 USA.							Berger R, 1997, SCIENCE, V276, P2021, DOI 10.1126/science.276.5321.2021; Cisper ME, 1997, RAPID COMMUN MASS SP, V11, P1449; Coetzee JF, 1972, J SOLUTION CHEM, V1, P77, DOI 10.1007/BF00648418; Crooks RM, 1997, FARADAY DISCUSS, V107, P285, DOI 10.1039/a704586g; DAWOOD MR, 1992, J CLIN MICROBIOL, V30, P2279, DOI 10.1128/JCM.30.9.2279-2283.1992; DICKERT FL, 1992, SENSOR ACTUAT B-CHEM, V6, P25, DOI 10.1016/0925-4005(92)80025-S; Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316; GUILBAUL.GG, 1969, J PHYS CHEM-US, V73, P2243, DOI 10.1021/j100727a024; Gupta VK, 1998, SCIENCE, V279, P2077, DOI 10.1126/science.279.5359.2077; ISRAELACHVILI JN, 2000, INTERMOLECULAR SURFA; JEROME B, 1993, PHYS REV E, V48, P4556, DOI 10.1103/PhysRevE.48.4556; Jung LS, 1998, LANGMUIR, V14, P5636, DOI 10.1021/la971228b; KEPLEY LJ, 1992, ANAL CHEM, V64, P3191, DOI 10.1021/ac00048a018; MARCUS Y, 1991, J CHEM SOC DALTON, P2265, DOI 10.1039/dt9910002265; MARTELL AE, 1952, CHEM METAL CHELATE C; McQuade DT, 2000, CHEM REV, V100, P2537, DOI 10.1021/cr9801014; Niculescu M, 2000, ANAL CHEM, V72, P1591, DOI 10.1021/ac990848+; NUZZO RG, 1990, J AM CHEM SOC, V112, P558, DOI 10.1021/ja00158a012; PIERANSKI P, 1990, MOL CRYST LIQ CRYST, V179, P285, DOI 10.1080/00268949008055377; POZIOMEK EJ, 1974, MOL CRYST LIQ CRYST, V27, P175, DOI 10.1080/15421407408083128; Rittmann B., 2000, ENV BIOTECHNOLOGY PR; Shah RR, 2001, J PHYS CHEM B, V105, P4936, DOI 10.1021/jp004073g; Shah RR, 1999, J AM CHEM SOC, V121, P11300, DOI 10.1021/ja9844837; Skaife JJ, 1999, CHEM MATER, V11, P612, DOI 10.1021/cm9804822; THOMAS RC, 1995, J AM CHEM SOC, V117, P3830, DOI 10.1021/ja00118a019; Vo-Dinh T, 1999, FIELD ANAL CHEM TECH, V3, P346, DOI 10.1002/(SICI)1520-6521(1999)3:6<346::AID-FACT4>3.0.CO;2-Q; Wells M, 1996, LANGMUIR, V12, P1989, DOI 10.1021/la9507951; Yang HC, 1996, LANGMUIR, V12, P726, DOI 10.1021/la9505226	28	246	270	3	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1296	1299		10.1126/science.1062293	http://dx.doi.org/10.1126/science.1062293			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509724				2022-12-01	WOS:000170492600033
J	DEPATER, I; HEILES, C; WONG, M; MADDALENA, RJ; BIRD, MK; FUNKE, O; NEIDHOEFER, J; PRICE, RM; KESTEVEN, M; CALABRETTA, M; KLEIN, MJ; GULKIS, S; BOLTON, SJ; FOSTER, RS; SUKUMAR, S; STROM, RG; LEPOOLE, RS; SPOELSTRA, T; ROBISON, M; HUNSTEAD, RW; CAMPBELLWILSON, D; YE, T; DULK, G; LEBLANC, Y; GALOPEAU, P; GERARD, E; LECACHEUX, A				DEPATER, I; HEILES, C; WONG, M; MADDALENA, RJ; BIRD, MK; FUNKE, O; NEIDHOEFER, J; PRICE, RM; KESTEVEN, M; CALABRETTA, M; KLEIN, MJ; GULKIS, S; BOLTON, SJ; FOSTER, RS; SUKUMAR, S; STROM, RG; LEPOOLE, RS; SPOELSTRA, T; ROBISON, M; HUNSTEAD, RW; CAMPBELLWILSON, D; YE, T; DULK, G; LEBLANC, Y; GALOPEAU, P; GERARD, E; LECACHEUX, A			OUTBURST OF JUPITER SYNCHROTRON-RADIATION AFTER THE IMPACT OF COMET SHOEMAKER-LEVY-9	SCIENCE			English	Article							RADIO IMAGES	Jupiter's nonthermal microwave emission, as measured by a global network of 11 radio telescopes, increased dramatically during the Shoemaker-Levy 9 impacts. The increase was wavelength-dependent, varying from similar to 10 percent at 70 to 90 centimeters to similar to 45 percent at 6 and 36 centimeters. The radio spectrum hardened (flattened toward shorter wavelengths) considerably during the week of impacts and continued to harden afterward. After the week of cometary impacts, the flux density began to subside at all wavelengths and was still declining 3 months later. Very Large Array and Australia Telescope images of the brightness distribution showed the enhancement to be localized in longitude and concentrated near the magnetic equator. The evidence therefore suggests that the increase in flux density was caused by a change in the resident particle population, for example, through an energization or spatial redistribution of the emitting particles.	NATL RADIO ASTRON OBSERV,GREEN BANK,WV 24944; UNIV BONN,D-53121 BONN,GERMANY; MAX PLANCK INST RADIOASTRON,D-53121 BONN,GERMANY; CSIRO,EPPING,NSW 2121,AUSTRALIA; CALTECH,JET PROP LAB,PASADENA,CA 91109; USN,RES LAB,WASHINGTON,DC 20375; NATL RES COUNCIL CANADA,DOMIN RADIO ASTROPHYS OBSERV,PENTICTON,BC V2A 6K3,CANADA; NETHERLANDS FDN RES ASTRON,7990 AA DWINGELOO,NETHERLANDS; LEIDEN UNIV,2300 RA LEIDEN,NETHERLANDS; NEW MEXICO INST MIN & TECHNOL,SOCORRO,NM 87801; UNIV SYDNEY,SCH PHYS,SYDNEY,NSW 2006,AUSTRALIA; DEPT ASTROPHYS PLANETARY & ATMOSPHER SCI,BOULDER,CO 80309; OBSERV PARIS,F-92195 MEUDON,FRANCE	National Radio Astronomy Observatory (NRAO); University of Bonn; Max Planck Society; Commonwealth Scientific & Industrial Research Organisation (CSIRO); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of Defense; United States Navy; Naval Research Laboratory; National Research Council Canada; Leiden University; Leiden University - Excl LUMC; New Mexico Institute of Mining Technology; University of Sydney; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris	DEPATER, I (corresponding author), UNIV CALIF BERKELEY,DEPT ASTRON,BERKELEY,CA 94720, USA.		Bolton, Scott/M-4392-2019	bolton, scott/0000-0002-9115-0789				BAARS JWM, 1977, ASTRON ASTROPHYS, V61, P99; BIRD MK, 1994, 6069 INT ASTR UN CIR; BOLTON SJ, 1991, THESIS U CALIFORNIA; BOLTON SJ, 1994, EOS                S, V75, P405; BRECHT SH, IN PRESS GEOPHYS RES; BRICE N, 1973, ICARUS, V18, P206, DOI 10.1016/0019-1035(73)90204-2; CLARKE JT, 1995, SCIENCE, V267, P1302, DOI 10.1126/science.7871427; DEPATER I, 1991, ASTRON J, V102, P795, DOI 10.1086/115911; DEPATER I, 1990, J GEOPHYS RES-SPACE, V95, P39, DOI 10.1029/JA095iA01p00039; DEPATER I, 1990, ANNU REV ASTRON ASTR, V28, P347, DOI 10.1146/annurev.astro.28.1.347; DEPATER I, 1994, J GEOPHYS RES-SPACE, V99, P2271, DOI 10.1029/93JA02097; DEPATER I, 1994, GEOPHYS RES LETT, V21, P1071, DOI 10.1029/94GL01058; DEPATER I, UNPUB; DEPATER I, 1994, 6074 INT ASTR UN CIR; DEPATER I, NASA P, V494, P139; DESSLER AJ, 1994, GEOPHYS RES LETT, V21, P1043, DOI 10.1029/94GL01294; DESSLER AJ, 1994, B AM ASTRON SOC, V26, P1593; DULK GA, IN PRESS GEOPHYS RES; GROSSMAN AW, 1994, B AM ASTRON SOC, V26, P1587; HILL T, 1994, EOS                S, V75, P402; HORANYI M, 1994, GEOPHYS RES LETT, V21, P1039, DOI 10.1029/94GL01326; IP WH, 1994, PLANET SPACE SCI, V42, P527, DOI 10.1016/0032-0633(94)90073-6; IP WH, 1994, EOS                S, V75, P404; IP WH, IN PRESS PLANET SPAC; KLEIN MJ, NASA P, V494, P151; LEBLANC Y, IN PRESS GEOPHYS RES; OTT M, 1994, ASTRON ASTROPHYS, V284, P331; ULICH BL, 1976, ASTROPHYS J SUPPL S, V30, P247, DOI 10.1086/190361; WAITE JH, IN PRESS SCIENCE; Willis A. G., 1977, IAU S, V74, P39; Wong M, UNPUB	31	40	40	0	2	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 30	1995	268	5219					1879	1883		10.1126/science.11536723	http://dx.doi.org/10.1126/science.11536723			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF990	11536723				2022-12-01	WOS:A1995RF99000032
J	DAMSTE, JSS; WAKEHAM, SG; KOHNEN, MEL; HAYES, JM; DELEEUW, JW				DAMSTE, JSS; WAKEHAM, SG; KOHNEN, MEL; HAYES, JM; DELEEUW, JW			A 6,000-YEAR SEDIMENTARY MOLECULAR RECORD OF CHEMOCLINE EXCURSIONS IN THE BLACK-SEA	NATURE			English	Article							PHOTOSYNTHESIS; DIAGENESIS	THE Black Sea is the world's largest anoxic basin; it is also a contemporary analogue of the environment in which carbonaceous shales and petroleum source beds formed1. Recently, Repeta et al.2,3 reported that anoxygenic photosynthesis may be an important component of carbon cycling in the present Black Sea, owing to a shoaling of the chemocline and consequent penetration of the photic zone by anaerobic waters in the past few decades4,5. It has been suggested4 that this was due to an anthropogenic decrease in freshwater input to the Black Sea, although natural causes were not ruled out. Here we report the distributions of sequestered photosynthetic pigments in eight core samples of sediments from the Black Sea ranging in age from zero to 6,200 years before the present. Our results show that photosynthetic green sulphur bacteria (Clorobiaceae) have been active in the Black Sea for substantial periods of time in the past. This finding indicates that the penetration of the photic zone by anaerobic waters is not a recent phenomenon, and suggests that natural causes for shoaling of the chemocline are more likely than anthropogenic ones4.	DELFT UNIV TECHNOL,ORGAN GEOCHEM UNIT,2628 RZ DELFT,NETHERLANDS; SKIDAWAY INST OCEANOG,SAVANNAH,GA 31416; INDIANA UNIV,DEPT GEOL SCI,BIOGEOCHEM LABS,BLOOMINGTON,IN 47405; INDIANA UNIV,DEPT CHEM,BLOOMINGTON,IN 47405	Delft University of Technology; University System of Georgia; University of Georgia; Skidaway Institute of Oceanography; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	DAMSTE, JSS (corresponding author), NETHERLANDS INST SEA RES,DIV MARINE BIOGEOCHEM,POB 59,1790 AB DEN BURG,NETHERLANDS.		Damste, Jaap S Sinninghe/F-6128-2011; de Leeuw, Jan W/F-6471-2011	Damste, Jaap S Sinninghe/0000-0002-8683-1854; 				BRASSELL SC, 1986, NATURE, V320, P160, DOI 10.1038/320160a0; BRYANTSEV VA, 1988, OCEANOLOGY, V28, P180; BUKRY D, 1974, MEM AM ASS PETROL GE, V20, P253; DEMAISON GJ, 1980, AAPG BULL, V64, P1179; DEUSER WG, 1974, AAPG BULL, V20, P133; HAY BJ, 1991, DEEP-SEA RES, V38, pS1211; JORGENSEN BB, 1991, DEEP-SEA RES, V38, pS1083; KEMPE S, 1990, NATURE, V346, P419, DOI 10.1038/346419a0; KOHNEN MEL, 1990, GEOCHIM COSMOCHIM AC, V54, P3053, DOI 10.1016/0016-7037(90)90121-Z; KOHNEN MEL, 1992, SCIENCE, V256, P358, DOI 10.1126/science.256.5055.358; KOHNEN MEL, 1991, NATURE, V349, P775, DOI 10.1038/349775a0; MURRAY JW, 1989, NATURE, V338, P411, DOI 10.1038/338411a0; OVERMANN J, 1992, LIMNOL OCEANOGR, V37, P150, DOI 10.4319/lo.1992.37.1.0150; QUANDT L, 1977, FEMS MICROBIOL LETT, V1, P125, DOI 10.1016/0378-1097(77)90140-9; REPETA DJ, 1991, DEEP-SEA RES, V38, pS969, DOI 10.1016/S0198-0149(10)80019-6; REPETA DJ, 1989, NATURE, V342, P69, DOI 10.1038/342069a0; Ross D., 1974, BLACK SEA GEOLOGY CH, P183; ROSS DA, 1970, SCIENCE, V170, P163, DOI 10.1126/science.170.3954.163; SIREVAG R, 1977, ARCH MICROBIOL, V112, P35, DOI 10.1007/BF00446651; SUMMONS RE, 1986, NATURE, V319, P763, DOI 10.1038/319763a0; TUGRUL S, 1992, NATURE, V359, P137, DOI 10.1038/359137a0	21	199	203	0	18	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 29	1993	362	6423					827	829		10.1038/362827a0	http://dx.doi.org/10.1038/362827a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KZ563	11536532				2022-12-01	WOS:A1993KZ56300051
J	ALLAMANDOLA, LJ; SANDFORD, SA; TIELENS, AGGM; HERBST, TM				ALLAMANDOLA, LJ; SANDFORD, SA; TIELENS, AGGM; HERBST, TM			DIAMONDS IN DENSE MOLECULAR CLOUDS - A CHALLENGE TO THE STANDARD INTERSTELLAR-MEDIUM PARADIGM	SCIENCE			English	Article							METEORITES; EVOLUTION; ORIGIN; DUST	Observations of a newly discovered infrared C-H stretching band indicate that interstellar diamond-like material appears to be characteristic of dense clouds. In sharp contrast. the spectral signature of dust in the diffuse interstellar medium is dominated by -CH2- and -CH3 groups. This dichotomy in the aliphatic organic component between the dense and diffuse media challenges standard assumptions about the processes occurring in, and interactions between, these two media. The ubiquity of this interstellar diamond-like material rules out models for meteoritic diamond formation in unusual circumstellar environments and implies that the formation of the diamond-like material is associated with common interstellar processes or stellar types.	UNIV HAWAII,INST ASTRON,HONOLULU,HI 96822	University of Hawaii System	ALLAMANDOLA, LJ (corresponding author), NASA,AMES RES CTR,MAIL STOP 245-6,MT VIEW,CA 94035, USA.							ALLAMANDOLA LJ, 1988, ICARUS, V76, P225, DOI 10.1016/0019-1035(88)90070-X; ALLAMANDOLA LJ, 1992, ASTROPHYS J, V399, P134, DOI 10.1086/171909; Bellamy L.J, 1958, INFRA RED SPECTRA CO; BERNATOWICZ TJ, 1990, ASTROPHYS J, V359, P246, DOI 10.1086/169056; BLAKE DF, 1988, NATURE, V332, P611, DOI 10.1038/332611a0; Clayton D. D., 1981, P LUNAR PLANET SCI, V12B, P1781; DULEY WW, 1989, MON NOT R ASTRON SOC, V236, P709, DOI 10.1093/mnras/236.4.709; EHRENFREUND P, 1992, ASTRON ASTROPHYS, V252, P612; Greenberg J. M., 1982, Submillimetre Wave Astronomy, P261; JONES AP, 1990, Q J ROY ASTRON SOC, V31, P567; JORGENSON UG, 1989, NATURE, V322, P702; KOBASHI K, 1988, SPIE, V969, P159; LEWIS RS, 1987, NATURE, V326, P160, DOI 10.1038/326160a0; LEWIS RS, 1989, NATURE, V339, P117, DOI 10.1038/339117a0; MCKEE CF, 1989, INTERSTELLAR DUST, P431; MING T, 1988, GEOCHIM COSMOCHIM AC, V52, P1235, DOI 10.1016/0016-7037(88)90277-3; MORRISON RT, 1966, ORGANIC CHEM; NUTH JA, 1987, NATURE, V329, P589, DOI 10.1038/329589b0; NUTH JA, 1985, NATURE, V318, P166, DOI 10.1038/318166a0; PENDLETON Y, UNPUB; SANDFORD SA, 1991, ASTROPHYS J, V371, P607, DOI 10.1086/169925; SANDHU GS, 1988, SPIE DIAMOND OPTICS, V969, P37; SILVERSTEIN RM, 1967, SPECTROMETRIC IDENTI, pCH3; Tielens A. G., 1987, PHYSICAL PROCESSES I, V333; TIELENS AGG, 1989, INTERSTELLAR DUST, P239; TIELENS AGG, 1990, NASA CP3061, P59; TIELENS AGGM, 1987, ASTROPHYS J, V319, pL109, DOI 10.1086/184964; Wexler AS., 1967, APPL SPECTROSC REV, V1, P29, DOI [DOI 10.1080/05704926708547581, 10.1080/05704926708547581]; WILLNER SP, 1982, ASTROPHYS J, V253, P174, DOI 10.1086/159622	29	89	89	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	APR 2	1993	260	5104					64	66		10.1126/science.11538059	http://dx.doi.org/10.1126/science.11538059			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV423	11538059				2022-12-01	WOS:A1993KV42300025
J	BARON, R; JOSEPH, RD; OWEN, T; TENNYSON, J; MILLER, S; BALLESTER, GE				BARON, R; JOSEPH, RD; OWEN, T; TENNYSON, J; MILLER, S; BALLESTER, GE			IMAGING JUPITER AURORAE FROM H-3+ EMISSIONS IN THE 3-4 MU-M BAND	NATURE			English	Article							SOUTH POLAR AURORAE; FUNDAMENTAL-BAND; IUE DATA; NORTH; SPECTROMETRY; VOYAGER	SINCE H-3+ was first spectroscopically detected on Jupiter 1,2, there has been considerable interest in using this simple molecular ion to probe conditions existing in the planet's auroral regions. Here we present a series of images of Jupiter recorded at wavelengths sensitive to emission by H-3+, which reveal the spatial distribution of excited H-3+ molecular ions in the jovian ionosphere, as seen from Earth. We believe that they provide high-spatial-resolution images of polar aurorae on Jupiter. They suggest that the intensity of the auroral emission can vary on a timescale of an hour, a shorter period than had previously been noted. We also find that the spatial distribution of H-3+ emissions correlates only partially with the loci of auroral activity inferred from ultraviolet and longer-wavelength infrared observations. The H-3+ emission may therefore be controlled by auroral processes that are different from those responsible for the ultraviolet and infrared emissions.	UNIV LONDON UNIV COLL,DEPT PHYS & ASTRON,LONDON WC1E 6BT,ENGLAND; UNIV OXFORD,DEPT EARTH SCI,OXFORD OX1 3PR,ENGLAND	University of London; University College London; University of Oxford	BARON, R (corresponding author), UNIV HAWAII,INST ASTRON,2680 WOODLAWN DR,HONOLULU,HI 96822, USA.		Tennyson, Jonathan/I-2222-2012	Tennyson, Jonathan/0000-0002-4994-5238; Miller, Steven/0000-0002-7159-6871				BARON R, 1991, IAU5132 CIRC; BARON R, 1991, IAU5211 CIRC; BROADFOOT AL, 1981, J GEOPHYS RES-SPACE, V86, P8259, DOI 10.1029/JA086iA10p08259; CALDWELL J, 1980, ICARUS, V44, P667, DOI 10.1016/0019-1035(80)90135-9; CALDWELL J, 1988, ICARUS, V74, P331, DOI 10.1016/0019-1035(88)90045-0; CONNERNEY JEP, 1981, J GEOPHYS RES-SPACE, V86, P8370, DOI 10.1029/JA086iA10p08370; DROSSART P, 1986, ICARUS, V66, P610, DOI 10.1016/0019-1035(86)90094-1; DROSSART P, 1989, NATURE, V340, P539, DOI 10.1038/340539a0; HERBERT F, 1987, J GEOPHYS RES, V92, P3141, DOI 10.1029/JA092iA04p03141; KIM SJ, 1985, ICARUS, V64, P233, DOI 10.1016/0019-1035(85)90088-0; KOSTIUK T, 1987, ICARUS, V72, P394, DOI 10.1016/0019-1035(87)90182-5; LIVENGOOD TA, 1990, GEOPHYS RES LETT, V17, P2265, DOI 10.1029/GL017i012p02265; LIVENGOOD TA, 1991, EOS, V72, P186; LIVENGOOD TA, 1990, J GEOPHYS RES, V95, P10365; MAILLARD JP, 1990, ASTROPHYS J, V363, pL37, DOI 10.1086/185859; MAJEWSKI WA, 1989, ASTROPHYS J, V347, pL51, DOI 10.1086/185605; MILLER S, 1990, ASTROPHYS J, V360, pL55, DOI 10.1086/185811; OKA T, 1990, ASTROPHYS J, V351, pL53, DOI 10.1086/185678; PRANGE R, IN PRESS ADV SPACE R; SKINNER TE, 1984, THESIS J HOPKINS U; STROBEL DF, 1983, INT REV PHYS CHEM, V3, P145; TRAFTON L, 1989, ASTROPHYS J, V343, pL73, DOI 10.1086/185514	22	92	92	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 10	1991	353	6344					539	542		10.1038/353539a0	http://dx.doi.org/10.1038/353539a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ643	11538254				2022-12-01	WOS:A1991GJ64300059
J	FREEMAN, KH; HAYES, JM; TRENDEL, JM; ALBRECHT, P				FREEMAN, KH; HAYES, JM; TRENDEL, JM; ALBRECHT, P			EVIDENCE FROM CARBON ISOTOPE MEASUREMENTS FOR DIVERSE ORIGINS OF SEDIMENTARY HYDROCARBONS	NATURE			English	Article									INDIANA UNIV,DEPT GEOL,BLOOMINGTON,IN 47405; UNIV STRASBOURG 1,DEPT CHIM,CHIM ORGAN SUBST NAT LAB,F-67008 STRASBOURG,FRANCE	Indiana University System; Indiana University Bloomington; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	FREEMAN, KH (corresponding author), INDIANA UNIV,DEPT CHEM,BIOGEOCHEM LABS,GEOL BLDG,BLOOMINGTON,IN 47405, USA.		Freeman, Katherine H/H-5140-2011	Freeman, Katherine H/0000-0002-3350-7671				COLEMAN DD, 1981, GEOCHIM COSMOCHIM AC, V45, P1033, DOI 10.1016/0016-7037(81)90129-0; COLLISTER JW, IN PRESS B US GEOL S; CORBET B, 1980, J AM CHEM SOC, V192, P1171; Deines P., 1980, HDB ENV ISOTOPE GEOC, V1, P329, DOI DOI 10.1016/B978-0-444-41780-0.50015-8; DIDYK BM, 1978, NATURE, V272, P216, DOI 10.1038/272216a0; Ensminger A., 1973, ADV ORG GEOCHEM, P245; FRY B, 1986, LIMNOL OCEANOGR, V31, P79, DOI 10.4319/lo.1986.31.1.0079; GOTH K, 1988, NATURE, V336, P759, DOI 10.1038/336759a0; HAYES JM, 1987, NATURE, V329, P48, DOI 10.1038/329048a0; KEPKAY PE, 1979, SCIENCE, V204, P68, DOI 10.1126/science.204.4388.68; KIMBLE BJ, 1974, GEOCHIM COSMOCHIM AC, V38, P1165, DOI 10.1016/0016-7037(74)90011-8; KNOLL AH, 1986, NATURE, V321, P832, DOI 10.1038/321832a0; MATTHEWS DE, 1978, ANAL CHEM, V50, P1465, DOI 10.1021/ac50033a022; MICHAELIS W, 1989, SCI TOTAL ENVIRON, V81-2, P41, DOI 10.1016/0048-9697(89)90109-5; NEUNLIST S, 1985, BIOCHEM J, V231, P635, DOI 10.1042/bj2310635; OSMOND CB, 1981, OECOLOGIA, V50, P117, DOI 10.1007/BF00378804; OURISSON G, 1987, ANNU REV MICROBIOL, V41, P301, DOI 10.1146/annurev.mi.41.100187.001505; OURISSON G, 1979, PURE APPL CHEM, V51, P709, DOI 10.1351/pac197951040709; OURISSON G, 1982, TRENDS BIOCHEM SCI, V7, P236, DOI 10.1016/0968-0004(82)90028-7; POPP BN, 1989, AM J SCI, V289, P436, DOI 10.2475/ajs.289.4.436; QUIRK MM, 1984, CHEM GEOL, V42, P25, DOI 10.1016/0009-2541(84)90003-2; RIESKAUTT M, 1989, CHEM GEOL, V76, P143, DOI 10.1016/0009-2541(89)90133-2; Risatti J.B., 1984, ORG GEOCHEM, V6, P93, DOI DOI 10.1016/0146-6380(84)90030-5; ROBINSON N, 1989, CHEM GEOL, V76, P153, DOI 10.1016/0009-2541(89)90134-4; SEIFERT WK, 1980, ADV ORG GEOCHEM, P229; SIREVAG R, 1977, ARCH MICROBIOL, V112, P35, DOI 10.1007/BF00446651; TENHAVEN HL, 1987, NATURE, V330, P641, DOI 10.1038/330641a0; TRENDEL JM, 1989, TETRAHEDRON, V45, P4457, DOI 10.1016/S0040-4020(01)89081-5; VANDORSSELAER A, 1977, B SOC CHIM FR II-CH, P165; WHITICAR MJ, 1986, GEOCHIM COSMOCHIM AC, V50, P693, DOI 10.1016/0016-7037(86)90346-7; ZUNDEL M, 1985, FEMS MICROBIOL LETT, V28, P61, DOI 10.1111/j.1574-6968.1985.tb00764.x	31	448	489	1	78	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 18	1990	343	6255					254	256		10.1038/343254a0	http://dx.doi.org/10.1038/343254a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ682	11536462				2022-12-01	WOS:A1990CJ68200068
J	MAHER, KA; STEVENSON, DJ				MAHER, KA; STEVENSON, DJ			IMPACT FRUSTRATION OF THE ORIGIN OF LIFE	NATURE			English	Article											MAHER, KA (corresponding author), CALTECH,DIV GEOL & PLANETARY SCI,PASADENA,CA 91125, USA.							ABBOTT DH, 1984, TECTONICS, V3, P429, DOI 10.1029/TC003i004p00429; ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; Alvarez W., 1986, EOS, V67, P649, DOI [10.1029/EO067I035P00649, DOI 10.1029/EO067I035P00649]; AWRAMIK SM, 1982, MINERAL DEPOSITS EVO, P309; BAROSS JA, 1985, ORIGINS LIFE EVOL B, V15, P327, DOI 10.1007/BF01808177; CAIRNSMITH AG, 1985, SCI AM, V256, P90; CARR MH, 1984, NASA SP469; CHANG S, 1982, PHYS EARTH PLANET IN, V29, P261, DOI 10.1016/0031-9201(82)90017-6; FROUDE DO, 1983, NATURE, V304, P616, DOI 10.1038/304616a0; Gault D.E., 1982, GEOL SOC AM SPEC PAP, V190, P69; GRIEVE RAF, 1987, ANNU REV EARTH PL SC, V15, P245, DOI 10.1146/annurev.ea.15.050187.001333; GRIEVE RAF, 1979, ICARUS, V38, P230, DOI 10.1016/0019-1035(79)90180-5; GRIEVE RAF, 1984, 27TH INT GEOL C MOSC, V19, P99; HARTMAN WK, 1977, COMETS ASTEROIDS MET, P277; KARHU J, 1986, GEOCHIM COSMOCHIM AC, V50, P1745, DOI 10.1016/0016-7037(86)90136-5; KASTING JF, 1984, ORIGINS LIFE EVOL B, V14, P75, DOI 10.1007/BF00933642; LAZCANO A, 1983, PRECAMBRIAN RES, V20, P259, DOI 10.1016/0301-9268(83)90076-1; LEVINE JS, 1985, ORIGINS LIFE EVOL B, V15, P299, DOI 10.1007/BF01808175; MCGETCHIN TR, 1973, EARTH PLANET SC LETT, V20, P226, DOI 10.1016/0012-821X(74)90115-0; Melosh H. J., 1982, GEOL SOC AM SPEC PAP, V190, P121; MILLER SL, 1982, MINERAL DEPOSITS EVO, P155; MOORBATH S, 1984, ORIGINS LIFE, V15, P251; OKEEFE JD, 1982, NATURE, V298, P123, DOI 10.1038/298123a0; PRINN RG, 1985, EOS, V46, P813; SCHMIDT RM, 1982, GEOL SOC AM SPEC PAP, V190, P93, DOI DOI 10.1130/SPE190-P93; SEEBAUGH WR, 1977, IMPACT EXPLOSION CRA, P1043; Shoemaker E. M., 1979, ASTEROIDS, P253; SHOEMAKER EM, 1970, ICARUS, V12, P188, DOI 10.1016/0019-1035(70)90072-2; SHOEMAKER EM, 1983, ANNU REV EARTH PL SC, V11, P461, DOI 10.1146/annurev.ea.11.050183.002333; SHOEMAKER EM, 1982, NEW SOLAR SYSTEM, P33; Toon OB., 1982, GEOL SOC AM SPEC PAP, V190, P187	31	269	275	0	83	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	FEB 18	1988	331	6157					612	614		10.1038/331612a0	http://dx.doi.org/10.1038/331612a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	M1180	11536595				2022-12-01	WOS:A1988M118000053
J	Stevenson, DJ				Stevenson, DJ			Planetary science - Jupiter and its moons	SCIENCE			English	Editorial Material									CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology	Stevenson, DJ (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.							Anderson JD, 1998, SCIENCE, V280, P1573, DOI 10.1126/science.280.5369.1573; CANUP RM, 2000, ORIGIN EARTH MOON; Showman AP, 1999, SCIENCE, V286, P77, DOI 10.1126/science.286.5437.77; Wuchterl G., 2000, Protostars and planets 4, P1081	4	15	15	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2001	294	5540					71	72		10.1126/science.1065306	http://dx.doi.org/10.1126/science.1065306			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11588243				2022-12-01	WOS:000171448800031
J	Panikashvili, D; Simeonidou, C; Ben-Shabat, S; Hanus, L; Breuer, A; Mechoulam, R; Shohami, E				Panikashvili, D; Simeonidou, C; Ben-Shabat, S; Hanus, L; Breuer, A; Mechoulam, R; Shohami, E			An endogenous cannabinoid (2-AG) is neuroprotective after brain injury	NATURE			English	Article							CLOSED-HEAD-INJURY; NECROSIS-FACTOR-ALPHA; RECEPTOR-LIGAND; RAT-BRAIN; ANANDAMIDE; MICE; SYSTEM; 2-ARACHIDONOYLGLYCEROL; ENDOCANNABINOIDS; AMIDOHYDROLASE	Traumatic brain injury triggers the accumulation of harmful mediators that may lead to secondary damage(1,2). Protective mechanisms to attenuate damage are also set in motion(2). 2-Arachidonoyl glycerol (2-AG) is an endogenous cannabinoid, identified both in the periphery(3) and in the brain(4), but its physiological roles have been only partially clarified(5-7). Here we show that, after injury to the mouse brain, 2-AG may have a neuroprotective role in which the cannabinoid system is involved. After closed head injury (CHI) in mice, the level of endogenous 2-AG was significantly elevated. We administered synthetic 2-AG to mice after CHI and found significant reduction of brain oedema, better clinical recovery, reduced infarct volume and reduced hippocampal cell death compared with controls. When 2-AG was administered together with additional inactive 2-acyl-glycerols that are normally present in the brain, functional recovery was significantly enhanced. The beneficial effect of 2-AG was dose-dependently attenuated by SR-141761A, an antagonist of the CB1 cannabinoid receptor.	Hebrew Univ Jerusalem, Fac Med, Dept Pharmacol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Fac Med, Dept Med Chem & Nat Prod, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Shohami, E (corresponding author), Hebrew Univ Jerusalem, Fac Med, Dept Pharmacol, IL-91120 Jerusalem, Israel.							Adams IB, 1998, J PHARMACOL EXP THER, V284, P1209; Axelrod J, 1998, NEUROCHEM RES, V23, P575, DOI 10.1023/A:1022418217479; Ben-Shabat S, 1998, EUR J PHARMACOL, V353, P23, DOI 10.1016/S0014-2999(98)00392-6; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; CHEN DS, 1987, J GASTROEN HEPATOL, V2, P1, DOI 10.1111/j.1440-1746.1987.tb00142.x; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Gallily R, 2000, EUR J PHARMACOL, V406, pR5, DOI 10.1016/S0014-2999(00)00653-1; Goparaju SK, 1998, FEBS LETT, V422, P69, DOI 10.1016/S0014-5793(97)01603-7; Hansen HS, 2000, CHEM PHYS LIPIDS, V108, P135, DOI 10.1016/S0009-3084(00)00192-4; Klein TW, 2000, P SOC EXP BIOL MED, V225, P1, DOI 10.1046/j.1525-1373.2000.22501.x; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Mathews KS, 2000, J NEUROSCI METH, V102, P43, DOI 10.1016/S0165-0270(00)00277-6; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Mechoulam R, 1998, EUR J PHARMACOL, V359, P1, DOI 10.1016/S0014-2999(98)00649-9; NADLER V, 1995, BRAIN RES, V685, P1, DOI 10.1016/0006-8993(95)00367-Y; Nagayama T, 1999, J NEUROSCI, V19, P2987; OVADIA H, 1995, NEUROPHARMACOLOGY, V34, P175, DOI 10.1016/0028-3908(94)00133-D; Piomelli D, 2000, TRENDS PHARMACOL SCI, V21, P218, DOI 10.1016/S0165-6147(00)01482-6; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Reggio PH, 2000, CHEM PHYS LIPIDS, V108, P15, DOI 10.1016/S0009-3084(00)00185-7; Shen MX, 1998, MOL PHARMACOL, V54, P459, DOI 10.1124/mol.54.3.459; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Shohami E, 2000, DRUG DEVELOP RES, V50, P211, DOI 10.1002/1098-2299(200007/08)50:3/4<211::AID-DDR3>3.0.CO;2-G; SHOHAMI E, 1989, J NEUROCHEM, V53, P1541, DOI 10.1111/j.1471-4159.1989.tb08550.x; Sinor AD, 2000, NEUROSCI LETT, V278, P157, DOI 10.1016/S0304-3940(99)00922-2; Smith SR, 2000, J PHARMACOL EXP THER, V293, P136; Sugiura T, 2000, BIOCHEM BIOPH RES CO, V271, P654, DOI 10.1006/bbrc.2000.2686; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; van der Stelt M, 2001, J NEUROSCI, V21, P6475, DOI 10.1523/JNEUROSCI.21-17-06475.2001	31	573	602	2	30	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2001	413	6855					527	531		10.1038/35097089	http://dx.doi.org/10.1038/35097089			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586361				2022-12-01	WOS:000171340500048
J	Takayama, S; Shimosato, H; Shiba, H; Funato, M; Che, FS; Watanabe, M; Iwano, M; Isogai, A				Takayama, S; Shimosato, H; Shiba, H; Funato, M; Che, FS; Watanabe, M; Iwano, M; Isogai, A			Direct ligand-receptor complex interaction controls Brassica self-incompatibility	NATURE			English	Article							S-LOCUS GLYCOPROTEIN; CAMPESTRIS SYN. RAPA; TRANSGENIC TOBACCO; MALE DETERMINANT; KINASE; GENE; OLERACEA; STIGMA; EXPRESSION; HAPLOTYPES	Many higher plants have evolved self-incompatibility mechanisms to prevent self-fertilization(1). In Brassica self-incompatibility, recognition between pollen and the stigma is controlled by the S locus, which contains three highly polymorphic genes: S-receptor kinase (SRK)(2), S-locus protein 11 (SP11)(3) (also called S-locus cysteine-rich protein; SCR)(4) and S-locus glycoprotein (SLG)(5). SRK encodes a membrane-spanning serine/threonine kinase that determines the S-haplotype specificity of the stigma(6), and SP11 encodes a small cysteine-rich protein that determines the S-haplotype specificity of pollen(4,7,8). SP11 is localized in the pollen coat(8). It is thought that, during self-pollination, SP11 is secreted from the pollen coat and interacts with its cognate SRK in the papilla cell of the stigma to elicit the self-incompatibility response. SLG is a secreted stigma protein(9) that is highly homologous to the SRK extracellular domain. Although it is not required for S-haplotype specificity of the stigma, SLG enhances the self-incompatibility response(6); however, how this is accomplished remains controversial(10-12). Here we show that a single form of SP11 of the S-8 haplotype (S-8-SP11) stabilized with four intramolecular disulphide bonds specifically binds the stigma membrane of the S-8 haplotype to induce autophosphorylation of SRK8, and that SRK8 and SLG(8) together form a high-affinity receptor complex for S-8-SP11 on the stigma membrane.	Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma 6300101, Japan; Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan	Nara Institute of Science & Technology; Iwate University	Isogai, A (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Ikoma 6300101, Japan.	isogai@bs.aist-nara.ac.jp	Isogai, Akira/O-8897-2017; Watanabe, Masao/N-1465-2019; Watanabe, Masao/E-6300-2011	Isogai, Akira/0000-0001-8095-0441; Watanabe, Masao/0000-0002-9419-5149; Watanabe, Masao/0000-0002-9419-5149				BROEKAERT WF, 1995, PLANT PHYSIOL, V108, P1353, DOI 10.1016/j.chiabu.2021.105188; Brugiere N, 2000, TRENDS PLANT SCI, V5, P432, DOI 10.1016/S1360-1385(00)01759-3; BRUIX M, 1993, BIOCHEMISTRY-US, V32, P715, DOI 10.1021/bi00053a041; Cabrillac D, 2001, NATURE, V410, P220, DOI 10.1038/35065626; Dickinson HG, 2000, TRENDS GENET, V16, P373, DOI 10.1016/S0168-9525(00)02083-7; Dixit R, 2000, PLANT PHYSIOL, V124, P297, DOI 10.1104/pp.124.1.297; Doughty J, 1998, PLANT CELL, V10, P1333, DOI 10.1105/tpc.10.8.1333; Giranton JL, 1995, PLANT J, V8, P827, DOI 10.1046/j.1365-313X.1995.8060827.x; Giranton JL, 2000, P NATL ACAD SCI USA, V97, P3759, DOI 10.1073/pnas.070025097; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; LARSSON C, 1987, METHOD ENZYMOL, V148, P558; McCubbin AG, 2000, ANNU REV CELL DEV BI, V16, P333, DOI 10.1146/annurev.cellbio.16.1.333; NASRALLAH JB, 1987, NATURE, V326, P617, DOI 10.1038/326617a0; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Shiba H, 2000, BIOSCI BIOTECH BIOCH, V64, P1016, DOI 10.1271/bbb.64.1016; Shiba H, 2001, PLANT PHYSIOL, V125, P2095, DOI 10.1104/pp.125.4.2095; STEIN JC, 1991, P NATL ACAD SCI USA, V88, P8816, DOI 10.1073/pnas.88.19.8816; Stephenson AG, 1997, PLANT J, V12, P1351, DOI 10.1046/j.1365-313x.1997.12061351.x; Suzuki G, 1996, PLANT CELL PHYSIOL, V37, P866, DOI 10.1093/oxfordjournals.pcp.a029024; Suzuki G, 1999, GENETICS, V153, P391; Suzuki T, 2000, FEBS LETT, V482, P102, DOI 10.1016/S0014-5793(00)02048-2; Takasaki T, 2000, NATURE, V403, P913, DOI 10.1038/35002628; Takayama S, 2000, P NATL ACAD SCI USA, V97, P3765, DOI 10.1073/pnas.040580797; TAKAYAMA S, 1987, NATURE, V326, P102, DOI 10.1038/326102a0; Takayama S, 2000, P NATL ACAD SCI USA, V97, P1920, DOI 10.1073/pnas.040556397; Torii KU, 2000, CURR OPIN PLANT BIOL, V3, P361, DOI 10.1016/S1369-5266(00)00097-2; Trotochaud AE, 2000, SCIENCE, V289, P613, DOI 10.1126/science.289.5479.613; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Watanabe M, 2000, FEBS LETT, V473, P139, DOI 10.1016/S0014-5793(00)01514-3	30	319	361	2	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2001	413	6855					534	538		10.1038/35097104	http://dx.doi.org/10.1038/35097104			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586363				2022-12-01	WOS:000171340500050
J	Schwetz, BA				Schwetz, BA			Reprocessing of single-use devices	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	4	4	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2001	286	13					1569	1569		10.1001/jama.286.13.1569-b	http://dx.doi.org/10.1001/jama.286.13.1569-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478HH	11585463				2022-12-01	WOS:000171340600007
J	Mondal, N; Parvin, JD				Mondal, N; Parvin, JD			DNA topoisomerase IIa is required for RNA polymerase II transcription on chromatin templates	NATURE			English	Article							IN-VITRO; RIBOSOMAL-RNA; HOLOENZYME; PURIFICATION; ACTIVATION; YEAST; BRCA1; INVITRO; ELUTION; COMPLEX	In the nucleus of the cell, core RNA polymerase II (pol II) is associated with a large complex called the pol II holoenzyme (holo-pol)(1,2). Transcription by core pol II in vitro on nucleosomal templates is repressed compared with that on templates of histone-free naked DNA(3-5). We found that the transcriptional activity of holo-pol, in contrast to that of core pol II, is not markedly repressed on chromatin templates. We refer to this property of holo-pol as chromatin-dependent coactivation (CDC). Here we show that DNA topoisomerase II alpha is associated with the holo-pol and is a required component of CDC. Etoposide and ICRF-193, specific inhibitors of topoisomerase II, blocked transcription on chromatin templates, but did not affect transcription on naked templates. Addition of purified topoisomerase IIa reconstituted CDC activity in reactions with core pol II. These findings suggest that transcription on chromatin templates results in the accumulation of superhelical tension, making the relaxation activity of topoisomerase II essential for productive RNA synthesis on nucleosomal DNA.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Parvin, JD (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA.	jparvin@rics.bwh.harvard.edu	Parvin, Jeffrey D/C-8955-2009					BRILL SJ, 1987, NATURE, V326, P414, DOI 10.1038/326414a0; Chao DM, 1996, NATURE, V380, P82, DOI 10.1038/380082a0; CHASMAN DI, 1989, MOL CELL BIOL, V9, P4746, DOI 10.1128/MCB.9.11.4746; CHIANG CM, 1993, PEPTIDE RES, V6, P62; Cho H, 1998, MOL CELL BIOL, V18, P5355, DOI 10.1128/MCB.18.9.5355; Cho H, 1997, J BIOL CHEM, V272, P11495; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; GARTENBERG MR, 1992, P NATL ACAD SCI USA, V89, P11461, DOI 10.1073/pnas.89.23.11461; Haile DT, 1999, J BIOL CHEM, V274, P2113, DOI 10.1074/jbc.274.4.2113; ISHIDA R, 1995, CANCER RES, V55, P2299; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; KOLESKE AJ, 1994, NATURE, V368, P466, DOI 10.1038/368466a0; LAYBOURN PJ, 1991, SCIENCE, V254, P238, DOI 10.1126/science.1718039; LeRoy G, 1998, SCIENCE, V282, P1900, DOI 10.1126/science.282.5395.1900; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; MANLEY JL, 1983, METHOD ENZYMOL, V101, P568; Neish AS, 1998, NUCLEIC ACIDS RES, V26, P847, DOI 10.1093/nar/26.3.847; Parvin JD, 1998, CURR OPIN GENET DEV, V8, P565, DOI 10.1016/S0959-437X(98)80012-9; Sandbrink R, 1994, Neurobiol Dis, V1, P13, DOI 10.1006/nbdi.1994.0003; Schlegel BP, 2000, P NATL ACAD SCI USA, V97, P3148, DOI 10.1073/pnas.070452397; SCHULTZ MC, 1992, GENE DEV, V6, P1332, DOI 10.1101/gad.6.7.1332; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; THOMPSON NE, 1990, J BIOL CHEM, V265, P7069; WANG JC, 1993, CURR OPIN GENET DEV, V3, P764, DOI 10.1016/S0959-437X(05)80096-6; WORKMAN JL, 1991, METHOD CELL BIOL, V35, P419	25	100	100	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2001	413	6854					435	438		10.1038/35096590	http://dx.doi.org/10.1038/35096590			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475UY	11574892				2022-12-01	WOS:000171188700058
J	Groeneveld, PW; Kwong, JL; Liu, YY; Rodriguez, AJ; Jones, MP; Sanders, GD; Garber, AM				Groeneveld, PW; Kwong, JL; Liu, YY; Rodriguez, AJ; Jones, MP; Sanders, GD; Garber, AM			Cost-effectiveness of automated external defibrillators on airlines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EMERGENCY MEDICAL-SERVICES; HOSPITAL CARDIAC-ARREST; RAPID DEFIBRILLATION; SURVIVORS; QUALITY; LIFE; ANTIARRHYTHMICS; OUTCOMES; VICTIMS; STATES	Context Installation of automated external defibrillators (AEDs) on passenger aircraft has been shown to improve survival of cardiac arrest in that setting, but the cost-effectiveness of such measures has not been proven. Objective To examine the costs and effectiveness of several different options for AED deployment in the US commercial air transportation system. Design, Setting, and Subjects Decision and cost-effectiveness analysis of a strategy of full deployment on all aircraft as well as several strategies of partial deployment only on larger aircraft, compared with a baseline strategy of no AEDs on aircraft (but training flight attendants in basic life support) for a hypothetical cohort of persons experiencing cardiac arrest aboard US commercial aircraft. Estimates for costs and outcomes were obtained from the medical literature, the Federal Aviation Administration, the Air Transport Association of America, a population-based cohort of Medicare patients, AED manufacturers, and the Bureau of Labor Statistics. Main Outcome Measures Quality-adjusted survival after cardiac arrest; costs of AED deployment on aircraft and of medical care for cardiac arrest survivors. Results Adding AEDs on passenger aircraft with more than 200 passengers would cost $35300 per quality-adjusted life-year (QALY) gained. Additional AEDs on aircraft with capacities between 100 and 200 persons would cost an additional $40800 per added QALY compared with deployment on large-capacity aircraft only, and full deployment on all passenger aircraft would cost an additional $94700 per QALY gained compared with limited deployment on aircraft with capacity greater than 100. Sensitivity analyses indicated that the quality of life, annual mortality rate, and the effectiveness of AEDs in improving survival were the most influential factors in the model. In 85% of Monte Carlo simulations, AED placement on large-capacity aircraft produced cost-effectiveness ratios of less than $50000 per QALY. Conclusion The cost-effectiveness of placing AEDs on commercial aircraft compares favorably with the cost-effectiveness of widely accepted medical interventions and health policy regulations, but is critically dependent on the passenger capacity of the aircraft. Placing AEDs on most US commercial aircraft would meet conventional standards of cost-effectiveness.	Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA; Stanford Univ, Stanford Biomed Informat, Stanford, CA 94305 USA; Front Line Strateg Management Consulting, Foster City, CA USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Groeneveld, PW (corresponding author), Stanford Univ, Ctr Primary Care & Outcomes Res, 179 Encina Commons,MC 6019, Stanford, CA 94305 USA.	petegro@healthpolicy.stanford.edu	Garber, Alan M/F-1476-2010	Groeneveld, Peter/0000-0002-7374-4292	AHRQ HHS [HS00028-15] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [F32HS000028, T32HS000028] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*AIR TRANSP ASS AM, 2000, IND ANN REP 2000; AUBLE TE, 1995, ANN EMERG MED, V25, P642, DOI 10.1016/S0196-0644(95)70178-8; BANTA HD, 1990, JAMA-J AM MED ASSOC, V264, P235, DOI 10.1001/jama.264.2.235; Berek K, 1997, J NEUROL, V244, P556, DOI 10.1007/s004150050143; *BUR LAB STAT, 2000, OCC OUTL HDB; CREWDSON J, 1996, CHICAGO TRIBUNE 0630, P1; de Vos R, 1999, ARCH INTERN MED, V159, P249, DOI 10.1001/archinte.159.3.249; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; EISENBERG MS, 1984, JAMA-J AM MED ASSOC, V251, P1723, DOI 10.1001/jama.251.13.1723; EISENBERG MS, 1980, NEW ENGL J MED, V302, P1379, DOI 10.1056/NEJM198006193022502; EISENBERG MS, 1984, AM J EMERG MED, V2, P189, DOI 10.1016/0735-6757(84)90001-9; EVERY N, 1994, DEFIBRILLATION HEART, P182; Ewy GA, 2000, J AM COLL CARDIOL, V35, P830; Federal Aviation Administration, 2001, FED REGISTER, V66, P19028; FLINT P, 1998, INT AIR TRANSP ASS A; Foutz R A, 2000, Prehosp Emerg Care, V4, P314, DOI 10.1080/10903120090941010; FREEMAN KD, 2001, ACAD EMERG MED, V8, P431; Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829; GILLUM RF, 1989, CIRCULATION, V79, P756, DOI 10.1161/01.CIR.79.4.756; Gold MR., 1996, COST EFFECTIVENESS H; Graham JD, 1997, JAMA-J AM MED ASSOC, V278, P1418, DOI 10.1001/jama.278.17.1418; Gratton M, 1999, Prehosp Emerg Care, V3, P303, DOI 10.1080/10903129908958958; Graves JR, 1997, RESUSCITATION, V35, P117; HOFER S, 1998, PUBLICATION FEDERAL; *INT AIR TRANSP AS, 2000, CORP AIR TRAV SURV 1; Jermyn B D, 2000, Prehosp Emerg Care, V4, P43, DOI 10.1080/10903120090941632; KELLERMANN AL, 1993, JAMA-J AM MED ASSOC, V270, P1708, DOI 10.1001/jama.270.14.1708; Kim SG, 1997, AM J CARDIOL, V80, P454, DOI 10.1016/S0002-9149(97)00394-9; Marenco JP, 2001, JAMA-J AM MED ASSOC, V285, P1193, DOI 10.1001/jama.285.9.1193; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; *NAT CTR HLTH STAT, 2000, HLTH US 2000; *NAT HEART LUNG BL, 2001, STUD LAUNCH TEST PUB; Nichol G, 1999, ANN EMERG MED, V34, P517, DOI 10.1016/S0196-0644(99)80054-7; Nichol G, 1999, ACAD EMERG MED, V6, P95, DOI 10.1111/j.1553-2712.1999.tb01044.x; Nichol G, 1998, CIRCULATION, V97, P1315, DOI 10.1161/01.CIR.97.13.1315; Nichol G, 1996, ANN EMERG MED, V27, P711, DOI 10.1016/S0196-0644(96)70188-9; ORourke MF, 1997, CIRCULATION, V96, P2849, DOI 10.1161/01.CIR.96.9.2849; Owens DK, 1997, ANN INTERN MED, V126, P1, DOI 10.7326/0003-4819-126-1-199701010-00001; Page RL, 1998, CIRCULATION, V97, P1429; Page RL, 2000, NEW ENGL J MED, V343, P1210, DOI 10.1056/NEJM200010263431702; Pasta DJ, 1999, MED DECIS MAKING, V19, P353, DOI 10.1177/0272989X9901900314; Pinski SL, 2000, AM HEART J, V139, P804, DOI 10.1016/S0002-8703(00)90011-5; RAYMAN RB, 1994, JAMA-J AM MED ASSOC, V271, P1657, DOI 10.1001/jama.271.21.1657; Riegel B, 1998, Am J Crit Care, V7, P402; ROINE RO, 1993, JAMA-J AM MED ASSOC, V269, P237, DOI 10.1001/jama.269.2.237; SAPP F, 2001, PUBLICATION FEDERAL; SEDGWICK ML, 1993, RESUSCITATION, V26, P75, DOI 10.1016/0300-9572(93)90166-N; Skogvoll E, 1999, ANN EMERG MED, V33, P409, DOI 10.1016/S0196-0644(99)70305-7; SoRelle R, 1999, CIRCULATION, V99, P2606, DOI 10.1161/01.CIR.99.20.2606; STULTS KR, 1984, NEW ENGL J MED, V310, P219, DOI 10.1056/NEJM198401263100403; Thompson RJ, 1998, AM J CARDIOL, V81, P17, DOI 10.1016/S0002-9149(97)00798-4; TORRANCE GW, 1995, PHARMACOECONOMICS, V7, P503, DOI 10.2165/00019053-199507060-00005; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701; Valenzuela TD, 1997, CIRCULATION, V96, P3308; Varon J, 1999, RESUSCITATION, V41, P219, DOI 10.1016/S0300-9572(99)00064-7; VUKOV LF, 1988, ANN EMERG MED, V17, P318, DOI 10.1016/S0196-0644(88)80771-6; WEAVER WD, 1988, NEW ENGL J MED, V319, P661, DOI 10.1056/NEJM198809153191101; Weiss JP, 2000, CIRCULATION, V102, P395; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	59	71	72	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2001	286	12					1482	1489		10.1001/jama.286.12.1482	http://dx.doi.org/10.1001/jama.286.12.1482			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	475UX	11572741	Bronze			2022-12-01	WOS:000171188600026
J	Nakajima, K; Sena, G; Nawy, T; Benfey, PN				Nakajima, K; Sena, G; Nawy, T; Benfey, PN			Intercellular movement of the putative transcription factor SHR in root patterning	NATURE			English	Article							ARABIDOPSIS ROOT; CELL-DIFFERENTIATION; THALIANA; ORGANIZATION; MERISTEM; MORPHOGENESIS; TRAFFICKING; EXPRESSION; POSITION; PROTEINS	Positional information is pivotal for establishing developmental patterning in plants(1-3), but little is known about the underlying signalling mechanisms. The Arabidopsis root radial pattern is generated through stereotyped division of initial cells and the subsequent acquisition of cell fate(4). short-root (shr) mutants do not undergo the longitudinal cell division of the cortex/endodermis initial daughter cell, resulting in a single cell layer with only cortex attributes(5,6). Thus, SHR is necessary for both cell division and endodermis specification(5,6). SHR messenger RNA is found exclusively in the stele cells internal to the endodermis and cortex, indicating that it has a non-cell-autonomous mode of action(6). Here we show that the SHR protein, a putative transcription factor, moves from the stele to a single layer of adjacent cells, where it enters the nucleus. Ectopic expression of SHR driven by the promoter of the downstream gene SCARECROW(SCR) results in autocatalytic reinforcement of SHR signalling, producing altered cell fates and multiplication of cell layers. These results support a model in which SHR protein acts both as a signal from the stele and as an activator of endodermal cell fate and SCR-mediated cell division.	NYU, Dept Biol, New York, NY 10003 USA	New York University	Benfey, PN (corresponding author), NYU, Dept Biol, 1009 Main Bldg,100 Washington Sq E, New York, NY 10003 USA.		Sena, Giovanni/C-3297-2012	Sena, Giovanni/0000-0003-3626-5038; Nakajima, Keiji/0000-0002-1580-3354; Nawy, Tal/0000-0003-3720-3699				BENFEY PN, 1993, DEVELOPMENT, V119, P57; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; DOLAN L, 1993, DEVELOPMENT, V119, P71; Esau K, 1977, ANATOMY SEED PLANTS, P215; Freshour G, 1996, PLANT PHYSIOL, V110, P1413, DOI 10.1104/pp.110.4.1413; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; JACKSON D, 1994, DEVELOPMENT, V120, P405; Kidner C, 2000, PLANTA, V211, P191, DOI 10.1007/s004250000284; KNOX JP, 1990, PLANTA, V181, P512, DOI 10.1007/BF00193004; LUCAS WJ, 1995, SCIENCE, V270, P1980, DOI 10.1126/science.270.5244.1980; Malamy JE, 1997, DEVELOPMENT, V124, P33; Masucci JD, 1996, DEVELOPMENT, V122, P1253; Perbal MC, 1996, DEVELOPMENT, V122, P3433; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; SESSIONS A, 2000, SCIENCE, V287, P419; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; VANDENBERG C, 1995, NATURE, V378, P62, DOI 10.1038/378062a0; von Arnim AG, 1998, GENE, V221, P35, DOI 10.1016/S0378-1119(98)00433-8; Wysocka-Diller JW, 2000, DEVELOPMENT, V127, P595	20	587	626	2	103	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					307	311		10.1038/35095061	http://dx.doi.org/10.1038/35095061			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565032	Green Submitted			2022-12-01	WOS:000171040500039
J	Radman, M				Radman, M			Fidelity and infidelity	NATURE			English	Editorial Material									Univ Paris 05, Lab Evolut & Med Mol Genet, INSERM, E9916, F-75730 Paris 15, France; Univ Paris 05, Dept Cell Biol, F-75730 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Radman, M (corresponding author), Univ Paris 05, Lab Evolut & Med Mol Genet, INSERM, E9916, F-75730 Paris 15, France.		; Radman, Miroslav/HDM-5955-2022	Radman, Miroslav/0000-0002-7034-4365; Radman, Miroslav/0000-0003-0216-3148				CAPORALE LH, 1999, MOL STRATEGIES BIOL; Fox Keller E., 2000, CENTURY GENE; Freidberg E. C., 1997, CORRECTING BLUEPRINT	3	24	26	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					115	115		10.1038/35093178	http://dx.doi.org/10.1038/35093178			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557959	Bronze			2022-12-01	WOS:000170918800027
J	Gindler, J; Li, Z; Berry, RJ; Zheng, JC; Correa, A; Sun, XM; Wong, LY; Cheng, LC; Erickson, JD; Wang, Y; Tong, QL				Gindler, J; Li, Z; Berry, RJ; Zheng, JC; Correa, A; Sun, XM; Wong, LY; Cheng, LC; Erickson, JD; Wang, Y; Tong, QL		Jiaxing City Collaborative Project	Folic acid supplements during pregnancy and risk of miscarriage	LANCET			English	Article							NEURAL-TUBE DEFECTS; METHYLENETETRAHYDROFOLATE REDUCTASE; PREVENTION	Background Although taking supplements that contain 400 mug of folic acid before and during early pregnancy reduces a woman's risk for having a baby with a neural-tube defect (NTD), the effects of such supplements on other pregnancy outcomes remain unclear. We examined whether the use of such supplements affects the occurrence of miscarriage. Methods Participants were women in China who had taken part in a recent folic acid campaign to prevent NTDs and who had registered in this campaign before they became pregnant for the first time. We examined the risk for miscarriage among women who had confirmed pregnancies and who had or had not taken pills containing only 400 mug of folic acid before and during early pregnancy. Results The overall rate of miscarriage was 9.1% (2155/23 806). The rates of miscarriage among women who had and had not taken folic acid pills before and during the first trimester were 9.0% and 9.3%, respectively (risk ratio 0.97 [95% Cl 0.84-1.12]). The distributions of gestational age at pregnancy diagnosis and at miscarriage were similar for both groups of women. Interpretation In this population-based study of a cohort of women whose use of folic acid supplements while pregnant had been previously documented and who had been pregnant for the first time, we found no evidence that daily consumption of 400 pg of folic acid before and during early pregnancy influenced their risk for miscarriage.	Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30341 USA; Beijing Univ, Hlth Sci Ctr, Natl Ctr Maternal Hlth & Infant Hlth, Beijing 100871, Peoples R China; Jiaxing City Collaborat Project Neural Tube Defec, Jiaxing, Zhejiang Provin, Peoples R China	Centers for Disease Control & Prevention - USA; Peking University	Berry, RJ (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, 4770 Buford Highway,MS F-45, Atlanta, GA 30341 USA.	rjb1@cdc.gov		Berry, Robert/0000-0002-7162-5046				[Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A; BENDICH A, 1991, MICRONUTRIENTS HLTH, P251; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Berry RJ, 2000, NEW ENGL J MED, V342, P1136; Botto LD, 1998, CLIN GENET, V53, P456; Christensen B, 1999, AM J MED GENET, V84, P151, DOI 10.1002/(SICI)1096-8628(19990521)84:2<151::AID-AJMG12>3.0.CO;2-T; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; FRENCH FE, 1962, PUBLIC HEALTH REP, V77, P835, DOI 10.2307/4591645; Hook EB, 2000, NEW ENGL J MED, V342, P1136; Hook EB, 1997, LANCET, V350, P513, DOI 10.1016/S0140-6736(97)01342-1; Ou CY, 1996, AM J MED GENET, V63, P610, DOI 10.1002/(SICI)1096-8628(19960628)63:4<610::AID-AJMG15>3.3.CO;2-Y; Ray JG, 1999, PLACENTA, V20, P519, DOI 10.1053/plac.1999.0417; THIERSCH JB, 1952, AM J OBSTET GYNECOL, V63, P1298; VANDERPUT NMJ, 1995, LANCET, V346, P1070, DOI 10.1016/S0140-6736(95)91743-8; Wald N, 1997, LANCET, V350, P665, DOI 10.1016/S0140-6736(05)63358-2; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; Windham GC, 2000, AM J MED GENET, V90, P261, DOI 10.1002/(SICI)1096-8628(20000131)90:3<261::AID-AJMG18>3.0.CO;2-L; Xu Z., 1992, CHUNG HUA HSUEH TSA, V72, P216	18	73	79	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 8	2001	358	9284					796	800		10.1016/S0140-6736(01)05969-4	http://dx.doi.org/10.1016/S0140-6736(01)05969-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NA	11564486				2022-12-01	WOS:000170989300012
J	Winther, JF; Sankila, R; Boice, JD; Tulinius, H; Bautz, A; Barlow, L; Glattre, E; Langmark, F; Moller, TR; Mulvihill, JJ; Olafsdottir, GH; Ritvanen, A; Olsen, JH				Winther, JF; Sankila, R; Boice, JD; Tulinius, H; Bautz, A; Barlow, L; Glattre, E; Langmark, F; Moller, TR; Mulvihill, JJ; Olafsdottir, GH; Ritvanen, A; Olsen, JH			Cancer in siblings of children with cancer in the Nordic countries: a population-based cohort study	LANCET			English	Article							CHILDHOOD-CANCER; HEREDITARY RETINOBLASTOMA; RELATIVES; FAMILIES; RISK; TUMORS; SIBS; EPIDEMIOLOGY; SURVIVORS; NEOPLASMS	Background In some rare inherited disorders such as Li-Fraumeni syndrome, relatives of children with cancer are at increased risk of cancer. We aimed to assess relations between childhood cancer and sibling risk, and evaluate the influence of recessive conditions in cancer causation. Methods We did a population-based cohort study in the Nordic countries of 42 277 siblings of 25 605 children with cancer. Children with cancer were identified from records in the five Nordic cancer registries, and their siblings from nationwide population registries. Cancers in siblings were documented through record linkage with cancer registries and compared with national incidence rates. We also assessed cancer incidence in parents to identify familial cancer syndromes. Findings 284.2 cancers were expected in siblings, whereas 353 were diagnosed (standardised incidence ratio 1.24 95% CI 1.12-1.38). Risk ratios for siblings were highest in the first decade of life (2.59, 1.89-3.46). We excluded 56 families with genetic syndromes linked to cancer, which reduced this ratio from 1.7 to 1.0 (0.7-1.3) for siblings younger than 20 years, and from 1.3 to 1.0 (0.8-1.3) for those aged 20-29 years. We found no new patterns of familial cancer that indicated inherited susceptibility, or evidence that recessive conditions might contribute to cancers not explained by syndromes. 40% of cancers in siblings that occurred before age 20 years could be attributed to known genetic factors, whereas 60% remained unexplained. Interpretation Apart from rare cancer syndromes, paediatric cancer is not an indicator of increased cancer risk in siblings.	Finnish Canc Registry, FIN-00170 Helsinki, Finland; Natl Res & Dev Ctr Welf & Hlth, Finnish Register Congenital Malformat, Helsinki, Finland; Int Epidemiol Inst, Rockville, MD USA; Vanderbilt Univ, Dept Med, Nashville, TN USA; Vanderbilt Ingram Canc Ctr, Nashville, TN USA; Univ Oklahoma, Oklahoma City, OK USA; Iceland Canc Registry, Reykjavik, Iceland; Natl Board Hlth & Welf, Ctr Epidemiol, Stockholm, Sweden; So Swedish Reg Registry, Lund, Sweden; Canc Registry Norway, Oslo, Norway	Finnish Cancer Registry; Vanderbilt University; Vanderbilt University; University of Oklahoma System; University of Oklahoma Health Sciences Center; National Board of Health & Welfare; University of Oslo	Winther, JF (corresponding author), Danish Canc Soc, Inst Canc Epidemiol, Strandblvd 49,Box 839, DK-2100 Copenhagen, Denmark.		Winther, Jeanette Falck/AAS-2754-2020	Winther, Jeanette Falck/0000-0002-3440-5108; Olsen, Jorgen Helge/0000-0001-9633-5662				BIRCH JM, 1987, INT J CANCER, V40, P620, DOI 10.1002/ijc.2910400508; BIRCH JM, 1990, CANCER-AM CANCER SOC, V66, P2239, DOI 10.1002/1097-0142(19901115)66:10<2239::AID-CNCR2820661034>3.0.CO;2-Q; BONDY ML, 1991, GENET EPIDEMIOL, V8, P253, DOI 10.1002/gepi.1370080406; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; BURKE E, 1991, CANCER-AM CANCER SOC, V67, P1467, DOI 10.1002/1097-0142(19910301)67:5<1467::AID-CNCR2820670535>3.0.CO;2-4; *DAN NAT BOARD HLT, 1999, CANC INC DENM 1996; DERKINDEREN DJ, 1988, INT J CANCER, V41, P499, DOI 10.1002/ijc.2910410405; DRAPER GJ, 1992, BRIT J CANCER, V66, P211, DOI 10.1038/bjc.1992.244; Draper GJ, 1996, BRIT J CANCER, V74, P152, DOI 10.1038/bjc.1996.331; DRAPER GJ, 1977, J MED GENET, V14, P81, DOI 10.1136/jmg.14.2.81; FARWELL J, 1984, NEW ENGL J MED, V311, P749, DOI 10.1056/NEJM198409203111201; HARTLEY AL, 1991, J NATL CANCER I, V83, P955, DOI 10.1093/jnci/83.13.955; Hoover RN, 2000, NEW ENGL J MED, V343, P135, DOI 10.1056/NEJM200007133430210; JONES SM, 1995, J MED GENET, V32, P627, DOI 10.1136/jmg.32.8.627; LI FP, 1995, CANCER EPIDEM BIOMAR, V4, P579; LI FP, 1976, J PEDIATR-US, V88, P419, DOI 10.1016/S0022-3476(76)80256-9; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lindor NM, 1998, JNCI-J NATL CANCER I, V90, P1039, DOI 10.1093/jnci/90.14.1039; MILLER RW, 1971, J NATL CANCER I, V46, P203; MOUTOU C, 1994, J MED GENET, V31, P429, DOI 10.1136/jmg.31.6.429; MULVIHILL JJ, 1999, CATALOG HUMAN CANC G, P1; *NORD MED STAT COM, 1991, NOMESCO PUBL, V36; OLSEN JH, 1990, HUM GENET, V85, P283; OLSEN JH, 1995, NEW ENGL J MED, V333, P1594, DOI 10.1056/NEJM199512143332403; OLSEN JH, 1993, BRIT MED J, V307, P1030, DOI 10.1136/bmj.307.6911.1030; PASTORE G, 1985, FAM CANCER, P146; PERKKIO M, 1990, PEDIATR HEMAT ONCOL, V7, P159, DOI 10.3109/08880019009033386; Sankila R, 1998, NEW ENGL J MED, V338, P1339, DOI 10.1056/NEJM199805073381902; SCHULL WJ, 1977, GENETICS HUMAN CANC, P15; STEINBERG AG, 1960, CANCER, V13, P985, DOI 10.1002/1097-0142(196009/10)13:5<985::AID-CNCR2820130520>3.0.CO;2-J; STROM SS, 1991, AM J EPIDEMIOL, V134, P766; STRONG LC, 1984, J NATL CANCER I, V73, P303, DOI 10.1093/jnci/73.2.303; Tulinius H, 1992, APMIS Suppl, V31, P1	33	54	56	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 1	2001	358	9283					711	717		10.1016/S0140-6736(01)05838-X	http://dx.doi.org/10.1016/S0140-6736(01)05838-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467XR	11551577				2022-12-01	WOS:000170729500010
J	Etienne-Manneville, S; Hall, A				Etienne-Manneville, S; Hall, A			Integrin-mediated activation of Cdc42 controls cell polarity in migrating astrocytes through PKC zeta	CELL			English	Article							SACCHAROMYCES-CEREVISIAE GENE; PROTEIN-KINASE-C; RHO GTPASES; T-CELLS; BINDING; RAC; ADHESION; PHOSPHORYLATION; MEMBRANE; DYNACTIN	We describe here a signal transduction pathway controlling the establishment of mammalian cell polarity. Scratching a confluent monolayer of primary rat astrocytes leads to polarization of cells at the leading edge. The microtubule organizing center, the microtubule cytoskeleton, and the Golgi reorganize to face the new free space, and directed cell protrusion and migration specifically occur perpendicularly to the scratch. We show here that the interaction of integrins with extracellular matrix at the newly formed cell front leads to the activation and polarized recruitment of Cdc42, which in turn recruits and activates a cytoplasmic mPar6/PKC zeta complex. Localized PKC zeta activity, acting through the microtubule motor protein dynein, is required for all aspects of induced polarity in these cells.	UCL, MRC, Lab Mol Cell Biol, London WC1E 6BT, England; UCL, CRC, Oncogene & Signal Transduct Grp, Cell Biol Unit, London WC1E 6BT, England; UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	Hall, A (corresponding author), UCL, MRC, Lab Mol Cell Biol, Gower St, London WC1E 6BT, England.	alan.hall@ucl.ac.uk	Etienne-Manneville, Sandrine/C-5879-2015	Etienne-Manneville, Sandrine/0000-0001-6651-3675				Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bloom K, 2001, CURR BIOL, V11, pR326, DOI 10.1016/S0960-9822(01)00176-2; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; Cook TA, 1998, J CELL BIOL, V141, P175, DOI 10.1083/jcb.141.1.175; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; DIAZMECO MT, 1994, EMBO J, V13, P2842, DOI 10.1002/j.1460-2075.1994.tb06578.x; Doe CQ, 2001, NAT CELL BIOL, V3, pE7, DOI 10.1038/35050684; Etienne-Manneville S, 1999, J IMMUNOL, V163, P668; Guo S, 1996, CURR OPIN GENET DEV, V6, P408, DOI 10.1016/S0959-437X(96)80061-X; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hung TJ, 1999, DEVELOPMENT, V126, P127; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Johansson AS, 2000, J CELL SCI, V113, P3267; JOHNSON DI, 1990, J CELL BIOL, V111, P143, DOI 10.1083/jcb.111.1.143; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kjoller L, 2001, J CELL BIOL, V152, P1145, DOI 10.1083/jcb.152.6.1145; Koonce MP, 1999, EMBO J, V18, P6786, DOI 10.1093/emboj/18.23.6786; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Leng LJ, 1998, BLOOD, V91, P4206, DOI 10.1182/blood.V91.11.4206.411k30_4206_4215; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; TANAKA E, 1995, J CELL BIOL, V128, P139, DOI 10.1083/jcb.128.1.139; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; ZIMAN M, 1991, MOL CELL BIOL, V11, P3537, DOI 10.1128/MCB.11.7.3537	41	808	829	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2001	106	4					489	498		10.1016/S0092-8674(01)00471-8	http://dx.doi.org/10.1016/S0092-8674(01)00471-8			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525734	Bronze			2022-12-01	WOS:000170665200012
J	Kim, T; Tao-Cheng, JH; Eiden, LE; Loh, YP				Kim, T; Tao-Cheng, JH; Eiden, LE; Loh, YP			Chromogranin A, an "on/off" switch controlling dense-core secretory granule biogenesis	CELL			English	Article							TERMINAL DOMAINS; CELLS; EXPRESSION; AGGREGATION; PROTEIN; GENE; PH; VESICLES; PEPTIDES; PATHWAY	We present evidence that regulation of dense-core secretory granule biogenesis and hormone secretion in endocrine cells is dependent on chromogranin A (CGA). Downregulation of CGA expression in a neuroendocrine cell line, PC12, by antisense RNAs led to profound loss of dense-core secretory granules, impairment of regulated secretion of a transfected prohormone, and reduction of secretory granule proteins. Transfection of bovine CGA into a CGA-deficient PC12 clone rescued the regulated secretory phenotype. Stable transfection of CGA into a CGA-deficient pituitary cell line, 6T3, lacking a regulated secretory pathway, restored regulated secretion. Overexpression of CGA induced dense-core granules, immunoreactive for CGA, in nonendocrine fibroblast CV-1 cells. We conclude that CGA is an "on/off" switch that alone is sufficient to drive dense-core secretory granule biogenesis and hormone sequestration in endocrine cells.	NICHHD, Dev Neurobiol Lab, Cellular Neurobiol Sect, NIH, Bethesda, MD 20892 USA; NINDS, EM Facil, Bethesda, MD 20892 USA; NIMH, Lab Cellular & Mol Regulat, Mol Neurosci Sect, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Loh, YP (corresponding author), NICHHD, Dev Neurobiol Lab, Cellular Neurobiol Sect, NIH, Bethesda, MD 20892 USA.	ypl@codon.nih.gov		Eiden, Lee/0000-0001-7524-944X	NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002386, Z01MH002386] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BENEDUM UM, 1987, EMBO J, V6, P1203, DOI 10.1002/j.1460-2075.1987.tb02355.x; CASTRO MG, 1989, MOL CELL ENDOCRINOL, V65, P165, DOI 10.1016/0303-7207(89)90177-9; Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; Corradi N, 1996, J BIOL CHEM, V271, P27116, DOI 10.1074/jbc.271.43.27116; Cowley DJ, 2000, J BIOL CHEM, V275, P7743, DOI 10.1074/jbc.275.11.7743; ERICKSON JD, 1993, J NEUROCHEM, V61, P2314, DOI 10.1111/j.1471-4159.1993.tb07476.x; FISCHERCOLBRIE R, 1987, ANN NY ACAD SCI, V493, P120, DOI 10.1111/j.1749-6632.1987.tb27189.x; FISCHERCOLBRIE R, 1987, J NEUROCHEM, V48, P262, DOI 10.1111/j.1471-4159.1987.tb13157.x; Galas MC, 1997, J BIOL CHEM, V272, P2788, DOI 10.1074/jbc.272.5.2788; GERDES HH, 1989, J BIOL CHEM, V264, P12009; Glombik MM, 2000, BIOCHIMIE, V82, P315, DOI 10.1016/S0300-9084(00)00195-4; GORR SU, 1989, AM J PHYSIOL, V257, pE247, DOI 10.1152/ajpendo.1989.257.2.E247; HEISLER S, 1984, J NEUROCHEM, V42, P1659, DOI 10.1111/j.1471-4159.1984.tb12757.x; HENDY GN, 1995, CLIN INVEST MED, V18, P47; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; HUTTNER WB, 1991, TRENDS BIOCHEM SCI, V16, P27, DOI 10.1016/0968-0004(91)90012-K; IACANGELO AL, 1991, MOL ENDOCRINOL, V5, P1651, DOI 10.1210/mend-5-11-1651; IACANGELO AL, 1995, REGUL PEPTIDES, V58, P65, DOI 10.1016/0167-0115(95)00069-N; Jain RK, 2000, J BIOL CHEM, V275, P27032; LOH YP, 1985, J BIOL CHEM, V260, P7194; MATSUUCHI L, 1991, J CELL BIOL, V112, P843, DOI 10.1083/jcb.112.5.843; Ozawa H, 1995, CELL STRUCT FUNCT, V20, P415, DOI 10.1247/csf.20.415; Pance A, 1999, J NEUROCHEM, V73, P21, DOI 10.1046/j.1471-4159.1999.0730021.x; SCHAFER MKH, 1994, PEPTIDES, V15, P263, DOI 10.1016/0196-9781(94)90012-4; Tanner VA, 1996, J HISTOCHEM CYTOCHEM, V44, P1481, DOI 10.1177/44.12.8985140; Watanabe T, 1998, ENDOCRINOLOGY, V139, P2765, DOI 10.1210/en.139.6.2765; WINKLER H, 1992, NEUROSCIENCE, V49, P497, DOI 10.1016/0306-4522(92)90222-N; WU HJ, 1991, J BIOL CHEM, V266, P13130; Yoo SH, 1996, J BIOL CHEM, V271, P17041, DOI 10.1074/jbc.271.29.17041; YOO SH, 1995, J BIOL CHEM, V270, P12578, DOI 10.1074/jbc.270.21.12578	30	336	351	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2001	106	4					499	509		10.1016/S0092-8674(01)00459-7	http://dx.doi.org/10.1016/S0092-8674(01)00459-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525735	Bronze			2022-12-01	WOS:000170665200013
J	Nelson, G; Hoon, MA; Chandrashekar, J; Zhang, YF; Ryba, NJP; Zuker, CS				Nelson, G; Hoon, MA; Chandrashekar, J; Zhang, YF; Ryba, NJP; Zuker, CS			Mammalian sweet taste receptors	CELL			English	Article							PUTATIVE PHEROMONE RECEPTORS; PROTEIN-COUPLED RECEPTORS; GLUTAMATE RECEPTORS; MULTIGENE FAMILY; MICE; EXPRESSION; RESPONSES; G-ALPHA(16); PREFERENCE; HAMSTER	The sense of taste provides animals with valuable information about the quality and nutritional value of food. Previously, we identified a large family of mammalian taste receptors involved in bitter taste perception (the T2Rs). We now report the characterization of mammalian sweet taste receptors. First, transgenic rescue experiments prove that the Sac locus encodes T1R3, a member of the T1R family of candidate taste receptors. Second, using a heterologous expression system, we demonstrate that T1R2 and T1R3 combine to function as a sweet receptor, recognizing sweet-tasting molecules as diverse as sucrose, saccharin, dulcin, and acesulfame-K. Finally, we present a detailed analysis of the patterns of expression of T1Rs and T2Rs, thus providing a view of the representation of sweet and bitter taste at the periphery.	Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Zuker, CS (corresponding author), Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA.	czuker@flyeye.ucsd.edu		Chandrashekar, jayaram/0000-0001-6412-0114; Ryba, Nicholas/0000-0002-2060-8393	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000561] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Bachmanov AA, 1997, MAMM GENOME, V8, P545, DOI 10.1007/s003359900500; BAKER EK, 1994, EMBO J, V13, P4886, DOI 10.1002/j.1460-2075.1994.tb06816.x; Boughter JD, 1997, J NEUROSCI, V17, P2852; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; CAPELESS CG, 1995, CHEM SENSES, V20, P291, DOI 10.1093/chemse/20.3.291; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Danilova V, 1998, J NEUROPHYSIOL, V80, P2102, DOI 10.1152/jn.1998.80.4.2102; Dwyer ND, 1998, CELL, V93, P455, DOI 10.1016/S0092-8674(00)81173-3; FULLER JL, 1974, J HERED, V65, P33, DOI 10.1093/oxfordjournals.jhered.a108452; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; LEFKOWITZ RJ, 1992, COLD SPRING HARB SYM, V57, P127, DOI 10.1101/SQB.1992.057.01.016; Li X, 2001, MAMM GENOME, V12, P13, DOI 10.1007/s003350010236; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; MCBURNEY DH, 1979, PSYCHOL BULL, V86, P151, DOI 10.1037/0033-2909.86.1.151; MISTRETTA CM, 1995, NEUROL DIS, V32, P635; Mody SM, 2000, MOL PHARMACOL, V57, P13; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Nagarajan S, 1996, J MED CHEM, V39, P4167, DOI 10.1021/jm960349q; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NINOMIYA Y, 1984, BRAIN RES, V302, P305, DOI 10.1016/0006-8993(84)90244-0; Ninomiya Y, 1997, AM J PHYSIOL-REG I, V272, pR1002, DOI 10.1152/ajpregu.1997.272.3.R1002; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Sainz E, 2001, J NEUROCHEM, V77, P896, DOI 10.1046/j.1471-4159.2001.00292.x; Salahpour A, 2000, TRENDS ENDOCRIN MET, V11, P163, DOI 10.1016/S1043-2760(00)00260-5; SCHIFFMAN SS, 1981, PHARMACOL BIOCHEM BE, V15, P377, DOI 10.1016/0091-3057(81)90266-5; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; SMITH DV, 1993, MECH TASTE TRANSDUCT, P295; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; TSIEN RY, 1985, CELL CALCIUM, V6, P145, DOI 10.1016/0143-4160(85)90041-7	38	1254	1340	8	253	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2001	106	3					381	390		10.1016/S0092-8674(01)00451-2	http://dx.doi.org/10.1016/S0092-8674(01)00451-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509186	Bronze			2022-12-01	WOS:000170433300015
J	KARLSSON, KR; CLAYTON, RN; GIBSON, EK; MAYEDA, TK				KARLSSON, KR; CLAYTON, RN; GIBSON, EK; MAYEDA, TK			WATER IN SNC METEORITES - EVIDENCE FOR A MARTIAN HYDROSPHERE	SCIENCE			English	Article							ANTARCTIC SHERGOTTITE; NOBLE-GASES; MARS; EETA-79001; AMPHIBOLE; OXYGEN	The Shergotty-Nakhla-Chassigny (SNC) meteorites, purportedly of martian origin, contain 0.04 to 0.4 percent water by weight. Oxygen isotopic analysis can bc used to determine whether this water is extraterrestrial or terrestrial. Such analysis reveals that a portion of the water is extraterrestrial and furthermore was not in oxygen isotopic equilibrium with the host rock. Lack of equilibrium between water and host rock implies that the lithosphere and hydrosphere of the SNC parent body formed two distinct oxygen isotopic reservoirs. If Mars was the parent body, the maintenance of two distinct reservoirs may result from the absence of plate tectonics on the planet.	NASA,LYNDON B JOHNSON SPACE CTR,PLANETARY SCI BRANCH,HOUSTON,TX 77058; UNIV CHICAGO,DEPT GEOPHYS SCI,CHICAGO,IL 60637; UNIV CHICAGO,ENRICO FERMI INST,DEPT CHEM,CHICAGO,IL 60637	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Chicago; University of Chicago								ASHWORTH JR, 1975, NATURE, V256, P714, DOI 10.1038/256714a0; BECKER RH, 1984, EARTH PLANET SC LETT, V69, P225, DOI 10.1016/0012-821X(84)90183-3; BOGARD DD, 1983, SCIENCE, V221, P651, DOI 10.1126/science.221.4611.651; CARR MH, 1987, NATURE, V326, P30, DOI 10.1038/326030a0; CLAYTON RN, 1983, EARTH PLANET SC LETT, V62, P1, DOI 10.1016/0012-821X(83)90066-3; CRAIG H, 1957, GEOCHIM COSMOCHIM AC, V12, P133, DOI 10.1016/0016-7037(57)90024-8; FALLICK AE, 1983, LUNAR PLANET SCI, V14, P183; FIREMAN EL, 1982, EARTH PLANET SC LETT, V60, P339, DOI 10.1016/0012-821X(82)90072-3; FLORAN RJ, 1978, GEOCHIM COSMOCHIM AC, V42, P1213, DOI 10.1016/0016-7037(78)90115-1; GOODING JL, 1990, METEORITICS, V25, P281, DOI 10.1111/j.1945-5100.1990.tb00712.x; GOODING JL, 1991, GEOCHIM COSMOCHIM AC, V26, P135; HARVEY HP, 1991, METEORITICS, V26, P343; JAKOSKY BM, 1991, ICARUS, V94, P14, DOI 10.1016/0019-1035(91)90138-J; JULL AJT, 1988, GEOCHIM COSMOCHIM AC, V52, P1309, DOI 10.1016/0016-7037(88)90285-2; KERRIDGE JF, 1988, LUNAR PLANET SCI, V19, P599; MUEHLENBACHS K, 1976, J GEOPHYS RES, V81, P4365, DOI 10.1029/JB081i023p04365; NORMAN DI, 1982, NATURE, V296, P551, DOI 10.1038/296551a0; ONEIL JR, 1966, J GEOPHYS RES, V71, P4956; OWEN T, 1988, SCIENCE, V240, P1767, DOI 10.1126/science.240.4860.1767; SARAFIN R, 1985, EARTH PLANET SC LETT, V75, P72, DOI 10.1016/0012-821X(85)90051-2; SCHUELER B, 1990, GEOPHYS RES LETT, V17, P1295, DOI 10.1029/GL017i009p01295; Smykatz-Kloss W., 1974, DIFFERENTIAL THERMAL, DOI DOI 10.1007/978-3-642-65951-5; SQUYRES SW, 1989, ICARUS, V79, P229, DOI 10.1016/0019-1035(89)90078-X; THIEMENS MH, 1983, SCIENCE, V219, P1073, DOI 10.1126/science.219.4588.1073; TREIMAN AH, 1985, METEORITICS, V20, P229, DOI 10.1111/j.1945-5100.1985.tb00862.x; TREIMAN AH, 1991, METEORITICS, V26, P402; WATSON LL, 1991, LUNAR PLANET SCI, V22, P1473; Wood C.A., 1981, P LUNAR PLANET SCI C, V12B, P1359; YANG J, 1985, LUNAR PLANET SCI, V16, P25	29	150	151	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 13	1992	255	5050					1409	1411		10.1126/science.11537889	http://dx.doi.org/10.1126/science.11537889			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH744	11537889				2022-12-01	WOS:A1992HH74400046
J	MELOSH, HJ; SCHNEIDER, NM; ZAHNLE, KJ; LATHAM, D				MELOSH, HJ; SCHNEIDER, NM; ZAHNLE, KJ; LATHAM, D			IGNITION OF GLOBAL WILDFIRES AT THE CRETACEOUS TERTIARY BOUNDARY	NATURE			English	Article									NASA,AMES RES CTR,MOFFETT FIELD,CA 94035; US FOREST SERV,INTERMT FIRE SCI LAB,MISSOULA,MT 59807	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; United States Department of Agriculture (USDA); United States Forest Service	MELOSH, HJ (corresponding author), UNIV ARIZONA,LUNAR & PLANETARY LAB,TUCSON,AZ 85721, USA.		Baykaykom, supit/B-5173-2009					ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; ALVAREZ W, 1986, EOS, V67, P653; ARGYLE E, 1986, SCIENCE, V234, P261, DOI 10.1126/science.234.4774.261-d; ARGYLE E, 1989, ICARUS, V77, P220, DOI 10.1016/0019-1035(89)90018-3; Bate R. R., 1971, FUNDAMENTALS ASTRODY; BOHOR BF, 1987, GEOLOGY, V15, P896, DOI 10.1130/0091-7613(1987)15<896:DSATML>2.0.CO;2; BOHOR BF, 1987, SCIENCE, V236, P705, DOI 10.1126/science.236.4802.705; BROWNLEE DE, 1985, ANNU REV EARTH PL SC, V13, P147, DOI 10.1146/annurev.ea.13.050185.001051; Chamberlain J. W., 1987, THEORY PLANETARY ATM, p[1, 89]; EMILIANI C, 1981, EARTH PLANET SC LETT, V55, P317, DOI 10.1016/0012-821X(81)90161-8; GLASSTONE S, 1977, EFFECTS NUCLEAR WEAP; HILDEBRAND AR, 1989, LUNAR PLANET SCI, V20, P414; HOLTON JR, 1979, INTRO DYNAMIC METEOR, P1; JONES EM, 1982, GEOL SOC AM SPEC PAP, V190, P175; KYTE FT, 1985, EARTH PLANET SC LETT, V73, P183, DOI 10.1016/0012-821X(85)90067-6; LAROCCA AJ, 1978, INFRARED HDB; Martin S., 1965, 10 S INT COMB, P877, DOI 10.1016/S0082-0784(65)80232-6; Melosh H. J., 1982, GEOL SOC AM SPEC PAP, V190, P121; MELOSH HJ, 1989, NATURE, V338, P487, DOI 10.1038/338487a0; MELOSH HJ, 1989, IMPACT CRATERING GEO, P1; MONTANARI A, 1983, GEOLOGY, V11, P668, DOI 10.1130/0091-7613(1983)11<668:SATCBA>2.0.CO;2; OKEEFE JD, 1988, GLOBAL CATASTROPHES, P133; SIMMS DL, 1967, COMBUST FLAME, V11, P377, DOI 10.1016/0010-2180(67)90058-2; SIMMS DL, 1963, COMBUST FLAME, V7, P253; SMIT J, 1981, NATURE, V292, P47, DOI 10.1038/292047a0; VICKERY AM, IN PRESS GEOL SOC AM; WHIPPLE FL, 1950, P NATL ACAD SCI USA, V36, P687, DOI 10.1073/pnas.36.12.687; WOLBACH WS, 1985, SCIENCE, V230, P167, DOI 10.1126/science.230.4722.167; WOLBACH WS, 1988, NATURE, V334, P665, DOI 10.1038/334665a0; ZAHNLE KJ, IN PRESS GEOL SOC AM; [No title captured], DOI DOI 10.1130/SPE190-P103	31	139	143	1	20	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 18	1990	343	6255					251	254		10.1038/343251a0	http://dx.doi.org/10.1038/343251a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ682	11536461				2022-12-01	WOS:A1990CJ68200067
J	Etterson, JR; Shaw, RG				Etterson, JR; Shaw, RG			Constraint to adaptive evolution in response to global warming	SCIENCE			English	Article							CHAMAECRISTA-FASCICULATA; QUANTITATIVE GENETICS; NATURAL-SELECTION; SIZE	We characterized the genetic architecture of three populations of a native North American prairie plant in field conditions that simulate the warmer and more and climates predicted by global climate models. Despite genetic variance for traits under selection, among-trait genetic correlations that are antagonistic to the direction of selection limit adaptive evolution within these populations. Predicted rates of evolutionary response are much slower than the predicted rate of climate change.	Univ Minnesota, Dept Ecol Evolut & Behav, Minnesota Ctr Community Genet, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Etterson, JR (corresponding author), Univ Virginia, Dept Biol, Gilmer Hall, Charlottesville, VA 22903 USA.			Etterson, Julie/0000-0001-6657-0610				ANTONOVICS J, 1976, ANN MO BOT GARD, V63, P224, DOI 10.2307/2395303; BARTON NH, 1989, ANNU REV GENET, V23, P337, DOI 10.1146/annurev.ge.23.120189.002005; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; ETTERSON JR, 2000, THESIS U MINNESOTA S; FENSTER CB, 1991, EVOLUTION, V45, P398, DOI 10.1111/j.1558-5646.1991.tb04413.x; GROOM MJ, 1993, BIOTIC INTERACTIONS; HUNTLY B, 1997, PAST FUTURE RAPID EN; KALISZ S, 1986, EVOLUTION, V40, P470; KELLY CA, 1992, EVOLUTION, V46, P1658, DOI 10.2307/2410022; LANDE R, 1979, EVOLUTION, V33, P402, DOI [10.2307/2407630, 10.1111/j.1558-5646.1979.tb04694.x]; LANDE R, 1983, EVOLUTION, V37, P1210, DOI [10.2307/2408842, 10.1111/j.1558-5646.1983.tb00236.x]; MITCHELLOLDS T, 1987, EVOLUTION, V41, P1149, DOI [10.2307/2409084, 10.1111/j.1558-5646.1987.tb02457.x]; PRICE GR, 1970, NATURE, V227, P520, DOI 10.1038/227520a0; ROBERTSON A, 1966, ANIM PROD, V8, P95, DOI 10.1017/S0003356100037752; SHAW RG, 1987, EVOLUTION, V41, P812, DOI 10.1111/j.1558-5646.1987.tb05855.x; SHAW RG, 1994, QUERCUS PROGRAMS; Shigesada N., 1997, BIOL INVASIONS THEOR; THOMPSON RS, 2000, 1650 AB US GEOL SURV; WALKER KV, COMMUNICATION	19	610	621	8	332	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2001	294	5540					151	154		10.1126/science.1063656	http://dx.doi.org/10.1126/science.1063656			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11588260				2022-12-01	WOS:000171448800049
J	Koepp, DM; Schaefer, LK; Ye, X; Keyomarsi, K; Chu, C; Harper, JW; Elledge, SJ				Koepp, DM; Schaefer, LK; Ye, X; Keyomarsi, K; Chu, C; Harper, JW; Elledge, SJ			Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase	SCIENCE			English	Article							F-BOX PROTEINS; CELL-CYCLE; FAMILY; PROTEOLYSIS; DEGRADATION; REGULATORS; SKP2; G(1)	Cyclin E binds and activates the cyclin-dependent kinase Cdk2 and catalyzes the transition from the G(1) phase to the S phase of the cell cycle. The amount of cyclin E protein present in the cell is tightly controlled by ubiquitin-mediated proteolysis. Here we identify the ubiquitin ligase responsible for cyclin E ubiquitination as SCFFbw7 and demonstrate that it is functionally conserved in yeast, flies, and mammals. Fbw7 associates specifically with phosphorylated cyclin E, and SCF Fbw7 catalyzes cyclin E ubiquitination in vitro. Depletion of Fbw7 leads to accumulation and stabilization of cyclin E in vivo in human and Drosophila melanogaster cells. Multiple F-box proteins contribute to cyclin E stability in yeast, suggesting an overlap in SCF E3 ligase specificity that allows combinatorial control of cyclin E degradation.	Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Texas System; UTMD Anderson Cancer Center	Elledge, SJ (corresponding author), Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA.		Keyomarsi, Khandan/H-2716-2016	Keyomarsi, Khandan/0000-0002-5440-0849; Harper, Jeffrey/0000-0002-6944-7236	NIA NIH HHS [R01 AG011085] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Dealy MJ, 1999, NAT GENET, V23, P245, DOI 10.1038/13886; Ekholm SV, 2000, CURR OPIN CELL BIOL, V12, P676, DOI 10.1016/S0955-0674(00)00151-4; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hsiung YG, 2001, MOL CELL BIOL, V21, P2506, DOI 10.1128/MCB.21.7.2506-2520.2001; Hubbard EJA, 1997, GENE DEV, V11, P3182, DOI 10.1101/gad.11.23.3182; KEYOMARSI K, 1995, ONCOGENE, V11, P941; Knuutila S, 1999, AM J PATHOL, V155, P683, DOI 10.1016/S0002-9440(10)65166-8; KOEPP D, UNPUB; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Spruck C, 2001, MOL CELL, V7, P639, DOI 10.1016/S1097-2765(01)00210-6; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Wang YS, 1999, CURR BIOL, V9, P1191, DOI 10.1016/S0960-9822(00)80024-X; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Wu GY, 1998, P NATL ACAD SCI USA, V95, P15787, DOI 10.1073/pnas.95.26.15787	26	640	656	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2001	294	5540					173	177		10.1126/science.1065203	http://dx.doi.org/10.1126/science.1065203			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11533444				2022-12-01	WOS:000171448800055
J	Schwetz, BA				Schwetz, BA			Congestive heart failure treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drug, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner Food & Drug, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	4	4	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2001	286	13					1569	1569		10.1001/jama.286.13.1569-b	http://dx.doi.org/10.1001/jama.286.13.1569-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478HH	11585463				2022-12-01	WOS:000171340600006
J	Rahman, M; DaVanzo, J; Razzaque, A				Rahman, M; DaVanzo, J; Razzaque, A			Do better family planning services reduce abortion in Bangladesh?	LANCET			English	Article							MATERNAL MORTALITY; RURAL BANGLADESH; PROGRAMS; MATLAB; DECLINE; TRENDS; AREA	Background Fertility decline is often associated with an increase in contraception and abortion, but the causal relations are difficult to examine with non-experimental data. We aimed to assess the effects of family planning services on abortion rates in two similar areas. Methods We examined trends in overall abortion rates and rates for intended and unintended pregnancies in two similar areas typical of rural Bangladesh. We analysed Matlab Demographic Surveillance System (DSS) data on pregnancy outcomes between 1979 and 1998 in these areas, matching them to survey data on fertility preferences, which enabled us to identify pregnancies as intended or unintended. Findings Abortion rates were significantly lower in the area with better family planning services compared with the comparison area (1984-86, 2.2 vs 5.2; 1996-98, 2.3 vs 6.8). Abortion of unintended pregnancies is similar in both areas, but the higher levels of contraceptive use in the treatment area have led to lower levels of unintended pregnancy and abortion. The likelihood that an unintended pregnancy will be aborted has increased in both areas but the decrease in unintended pregnancies was sufficiently large in the treatment area to offset this increase. Interpretations Abortion may increase during the fertility transition in less-developed countries as the desire to limit family size increases unless there is widespread availability of quality family planning services.	Pathfinder Int, Watertown, MA 02472 USA; RAND Corp, Santa Monica, CA 90401 USA; Int Ctr Diarrhoeal Dis Res, Ctr Hlth & Populat Res B, Dhaka 1000, Bangladesh	RAND Corporation; International Centre for Diarrhoeal Disease Research (ICDDR)	Rahman, M (corresponding author), Pathfinder Int, 9 Galen St,Ste 217, Watertown, MA 02472 USA.	MRahman@pathfind.org						Ahmed K., 1996, DEMOGRAPHY INDIA, V25, P105; Ahmed MK, 1998, INT FAM PLAN PERSPEC, V24, P128, DOI 10.2307/3038209; ALAUDDIN M, 1986, STUD FAMILY PLANN, V17, P13, DOI 10.2307/1966951; BAIRAGI R, 2000, MCH FP PROGRAM BRING; BHATIA S, 1980, J BIOSOC SCI, V12, P31, DOI 10.1017/S0021932000012669; Bulatao R., 1998, VALUE FAMILY PLANNIN; Caldwell B, 2000, STUD FAMILY PLANN, V31, P239, DOI 10.1111/j.1728-4465.2000.00239.x; CHEN LC, 1974, STUD FAMILY PLANN, V5, P334, DOI 10.2307/1965185; DIXONMUELLER R, 1988, STUD FAMILY PLANN, V19, P129, DOI 10.2307/1966749; FAUVEAU V, 1989, SOC SCI MED, V29, P1121, DOI 10.1016/0277-9536(89)90025-7; Henshaw SK, 1999, INT FAM PLAN PERSPEC, V25, pS30, DOI 10.2307/2991869; *ICDDR B CTR HLTH, 2000, 87 ICDDR B CTR HLTH; KHAN AR, 1986, STUD FAMILY PLANN, V17, P95, DOI 10.2307/1967069; KOENIG MA, 1992, STUD FAMILY PLANN, V23, P352, DOI 10.2307/1966893; KOENIG MA, 1988, STUD FAMILY PLANN, V19, P69, DOI 10.2307/1966492; Maine D, 1996, STUD FAMILY PLANN, V27, P179, DOI 10.2307/2137952; MITRA S, 1997, BANGLADESH DEMOGRAPH; MITRA SNA, 1994, BANGLADESH DEMOGRAPH; *NAT I POP RES TRA, 2000, BANGL DEM HLTH SURV; POTTS M, 1977, ABORTION; REQUENA MB, 1968, MILBANK FUND Q, V46, P191; ROSS J, 1999, PROFILES FAMILY PLAN; SIMMONS GB, 1991, STUD FAMILY PLANN, V22, P83, DOI 10.2307/1966779; VANDERTAK J, 1974, ABORTION FERTILITY C; *WHO DIV REPR HLTH, 1998, UNS AB GLOB REG EST	25	40	40	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	2001	358	9287					1051	1056		10.1016/S0140-6736(01)06182-7	http://dx.doi.org/10.1016/S0140-6736(01)06182-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	479EY	11589936				2022-12-01	WOS:000171393100011
J	Jackson, JBC; Johnson, KG				Jackson, JBC; Johnson, KG			Paleoecology - Measuring past biodiversity	SCIENCE			English	Editorial Material							EXTINCTION; PATTERNS; DIVERSITY		Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Smithsonian Trop Res Inst, Balboa, Panama; Nat Hist Museum Los Agneles Cty, Los Angeles, CA 90007 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Smithsonian Institution; Smithsonian Tropical Research Institute	Jackson, JBC (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.							Adrain JM, 2000, PALEOBIOLOGY, V26, P625, DOI 10.1666/0094-8373(2000)026<0625:STADAT>2.0.CO;2; ALLISON PA, 1993, GEOLOGY, V21, P65, DOI 10.1130/0091-7613(1993)021<0065:PSBPSD>2.3.CO;2; Alroy J, 2001, P NATL ACAD SCI USA, V98, P6261, DOI 10.1073/pnas.111144698; Behrensmeyer AK, 2000, PALEOBIOLOGY, V26, P103, DOI 10.1666/0094-8373(2000)26[103:TAP]2.0.CO;2; BUDD AF, 1994, J PALEONTOL, V68, P951, DOI 10.1017/S0022336000026585; Cheetham Alan H., 1999, Bulletins of American Paleontology, V357, P159; Collins Laurel S., 1999, Bulletins of American Paleontology, V357, P1; Conway Morris, 1998, CRUCIBLE CREATION BU; Foote M, 1996, EVOLUTION, V50, P1, DOI 10.1111/j.1558-5646.1996.tb04467.x; FOOTE M, COMMUNICATION; JACKSON JBC, 1994, PALEOBIOLOGY, V20, P407, DOI 10.1017/S0094837300012902; Jackson JBC, 2000, PALEOBIOLOGY, V26, P221, DOI 10.1666/0094-8373(2000)26[221:LITLFM]2.0.CO;2; Jackson JCB., 1996, EVOLUTION ENV TROPIC; Jackson Jeremy B.C., 1999, Bulletins of American Paleontology, V357, P193; Jin YG, 2000, SCIENCE, V289, P432, DOI 10.1126/science.289.5478.432; Kestenbaum D, 1998, SCIENCE, V279, P798, DOI 10.1126/science.279.5352.798; Khain V.Y., 1981, INT GEOL REV, V23, P426, DOI [DOI 10.1080/00206818109455078, 10.1080/00206818109455078]; MAY RM, 1994, PHILOS T R SOC B, V343, P105, DOI 10.1098/rstb.1994.0014; MAY RM, 1990, PHILOS T R SOC B, V330, P171; Newman M, 2001, P NATL ACAD SCI USA, V98, P5955, DOI 10.1073/pnas.121190498; Pennisi E, 2000, SCIENCE, V289, P2306, DOI 10.1126/science.289.5488.2306; RAUP D M, 1976, Paleobiology, V2, P289; RAUP DM, 1994, P NATL ACAD SCI USA, V91, P6758, DOI 10.1073/pnas.91.15.6758; RAUP DM, 1991, PALEOBIOLOGY, V17, P37, DOI 10.1017/S0094837300010332; Roy K, 1996, PHILOS T R SOC B, V351, P1605, DOI 10.1098/rstb.1996.0144; SEPKOSKI JJ, 1993, PALEOBIOLOGY, V19, P43, DOI 10.1017/S0094837300012306; Smith AB, 2001, PHILOS T R SOC B, V356, P351, DOI 10.1098/rstb.2000.0768; Stokstad E, 2001, SCIENCE, V291, P232, DOI 10.1126/science.291.5502.232; VALENTINE J W, 1970, Journal of Paleontology, V44, P410; VALENTINE JW, 1973, SCIENCE, V180, P1078, DOI 10.1126/science.180.4090.1078; Vermeij G.J, 1987, EVOLUTION ESCALATION; Wilson Moyra E. J., 1998, P165	32	92	98	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2001	293	5539					2401	+		10.1126/science.1063789	http://dx.doi.org/10.1126/science.1063789			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11577222				2022-12-01	WOS:000171237200031
J	Ludwig, DS; Ebbeling, CB				Ludwig, DS; Ebbeling, CB			Type 2 diabetes mellitus in children - Primary care and public health considerations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POSTPRANDIAL STATE; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; GLYCEMIC INDEX; BIRTH-WEIGHT; RISK-FACTOR; SYNDROME-X; CHILDHOOD; ADOLESCENTS; OBESITY		Childrens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	Ludwig, DS (corresponding author), Childrens Hosp, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@tch.harvard.edu		Ludwig, David/0000-0003-3307-8544	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002440, T32DK007699] Funding Source: NIH RePORTER; NIDDK NIH HHS [5T32DK07699-18, 1K08DK02440] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2000, Pediatrics, V105, P671; Arslanian S, 1996, J CLIN ENDOCR METAB, V81, P1058, DOI 10.1210/jc.81.3.1058; Bar-Or O, 1998, MED SCI SPORT EXER, V30, P2, DOI 10.1097/00005768-199801000-00002; BECKNIELSEN H, 1994, J CLIN INVEST, V94, P1714, DOI 10.1172/JCI117518; Blair SN, 1999, MED SCI SPORT EXER, V31, pS646, DOI 10.1097/00005768-199911001-00025; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Ceriello A, 2000, DIABETES-METAB RES, V16, P125, DOI 10.1002/(SICI)1520-7560(200003/04)16:2<125::AID-DMRR90>3.0.CO;2-4; Dabelea D, 1999, DIABETES CARE, V22, P944, DOI 10.2337/diacare.22.6.944; Dabelea D, 2000, J Matern Fetal Med, V9, P83, DOI 10.1002/(SICI)1520-6661(200001/02)9:1<83::AID-MFM17>3.0.CO;2-O; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; Eckel RH, 1998, CIRCULATION, V97, P2099, DOI 10.1161/01.CIR.97.21.2099; Epstein LH, 2000, ARCH PEDIAT ADOL MED, V154, P220, DOI 10.1001/archpedi.154.3.220; Fagot-Campagna A, 2000, J PEDIATR-US, V136, P664, DOI 10.1067/mpd.2000.105141; FLETCHER SW, 1993, ANN INTERN MED, V119, P764, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00026; Forsen T, 2000, ANN INTERN MED, V133, P176, DOI 10.7326/0003-4819-133-3-200008010-00008; Freemark M, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.4.e55; Glaser NS, 1998, WESTERN J MED, V168, P11; Glaser NS, 1997, PEDIATR CLIN N AM, V44, P307, DOI 10.1016/S0031-3955(05)70479-X; Gortmaker SL, 1996, ARCH PEDIAT ADOL MED, V150, P356, DOI 10.1001/archpedi.1996.02170290022003; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; Lefebvre P, 1998, DIABETIC MED, V15, pS63, DOI 10.1002/(SICI)1096-9136(1998120)15:4+<S63::AID-DIA737>3.3.CO;2-Z; Ludwig DS, 2000, J NUTR, V130, p280S, DOI 10.1093/jn/130.2.280S; MILLER JCB, 1994, AM J CLIN NUTR, V59, p747S, DOI 10.1093/ajcn/59.3.747S; Phillips DIW, 1998, DIABETES CARE, V21, pB150; PinhasHamiel O, 1996, J PEDIATR-US, V128, P608, DOI 10.1016/S0022-3476(96)80124-7; PiSunyer FX, 1996, CLIN THER, V18, P1006, DOI 10.1016/S0149-2918(96)80057-9; REAVEN GM, 1995, PHYSIOL REV, V75, P473, DOI 10.1152/physrev.1995.75.3.473; Reaven GM, 1997, CURR OPIN LIPIDOL, V8, P23, DOI 10.1097/00041433-199702000-00006; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; Salmeron J, 2001, AM J CLIN NUTR, V73, P1019; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Trent Maria E., 1999, Current Opinion in Pediatrics, V11, P297, DOI 10.1097/00008480-199908000-00005; Troiano RP, 1998, PEDIATRICS, V101, P497; Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005; Whitaker RC, 1998, J PEDIATR-US, V132, P768, DOI 10.1016/S0022-3476(98)70302-6; Willi SM, 1998, DIABETES, V47, pA306; WING RR, 1995, J AM DIET ASSOC, V95, P569, DOI 10.1016/S0002-8223(95)00155-7	37	121	125	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2001	286	12					1427	1430		10.1001/jama.286.12.1427	http://dx.doi.org/10.1001/jama.286.12.1427			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	475UX	11572718				2022-12-01	WOS:000171188600002
J	Vaughan, DG; Marshall, GJ; Connolley, WM; King, JC; Mulvaney, R				Vaughan, DG; Marshall, GJ; Connolley, WM; King, JC; Mulvaney, R			Climate change - Devil in the detail	SCIENCE			English	Editorial Material							SEA-ICE-EXTENT; ANTARCTIC PENINSULA; TEMPERATURE; INCREASES; SHELF; OCEAN		British Antarctic Survey, NERC, Cambridge CB3 0ET, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Vaughan, DG (corresponding author), British Antarctic Survey, NERC, Madingley Rd, Cambridge CB3 0ET, England.	d.vaughan@bas.ac.uk	Vaughan, David/C-8348-2011; Mulvaney, Robert/K-3929-2012	Mulvaney, Robert/0000-0002-5372-8148; Vaughan, David/0000-0002-9065-0570				Cai WJ, 1999, J CLIMATE, V12, P132, DOI 10.1175/1520-0442(1999)012<3087:SMTHLV>2.0.CO;2; Connolley WM, 1998, ANN GLACIOL, V27, P565; delaMare WK, 1997, NATURE, V389, P57, DOI 10.1038/37956; Domack E. A., 2001, EOS, V82, P13, DOI [DOI 10.1029/01EO00009, DOI 10.1029/01E000009]; DOMACK EW, 1995, ANTARCT SCI, V7, P159, DOI 10.1017/S0954102095000228; FOWBERT JA, 1994, ARCTIC ALPINE RES, V26, P290, DOI 10.2307/1551941; Fox AJ, 1998, ANN GLACIOL, V27, P636; FRASER WR, 1992, POLAR BIOL, V11, P525; Hansen J, 1999, J GEOPHYS RES-ATMOS, V104, P30997, DOI 10.1029/1999JD900835; Hofmann EE., 1996, FDN ECOLOGICAL RES W, V70, P61, DOI 10.1029/AR070p0061; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; Jacka TH, 1998, ANN GLACIOL, V27, P553; KING JC, 1994, INT J CLIMATOL, V14, P357, DOI 10.1002/joc.3370140402; King JC, 1998, ANN GLACIOL, V27, P571; MERCER JH, 1978, NATURE, V271, P321, DOI 10.1038/271321a0; PARKINSON C, IN PRESS ANN GLACIOL; Pudsey CJ, 2001, GEOLOGY, V29, P787, DOI 10.1130/0091-7613(2001)029<0787:FSOASI>2.0.CO;2; SHUMAN CA, 1993, GEOPHYS RES LETT, V20, P2643, DOI 10.1029/93GL02810; Smith AM, 1998, ANN GLACIOL, V27, P113; THOMPSON LG, 1994, ANN GLACIOL, V20, P420, DOI 10.3189/172756494794587438; Vaughan DG, 1996, NATURE, V379, P328, DOI 10.1038/379328a0; WEATHERLY JW, 1991, J GEOPHYS RES-OCEANS, V96, P15119, DOI 10.1029/91JC01432	22	224	232	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1777	1779		10.1126/science.1065116	http://dx.doi.org/10.1126/science.1065116			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546858				2022-12-01	WOS:000170894400031
J	Bessereau, JL; Wright, A; Williams, DC; Schuske, K; Davis, MW; Jorgensen, EM				Bessereau, JL; Wright, A; Williams, DC; Schuske, K; Davis, MW; Jorgensen, EM			Mobilization of a Drosophila transposon in the Caenorhabditis elegans germ line	NATURE			English	Article							C-ELEGANS; MARINER; EXPRESSION; ELEMENT; GENE; SEQUENCE; ENCODES; MOS1; TC3	Transposons have been enormously useful for genetic analysis in both Drosophila and bacteria. Mutagenic insertions constitute molecular tags that are used to rapidly clone the mutated gene. Such techniques would be especially advantageous in the nematode Caenorhabditis elegans, as the entire sequence of the genome has been determined. Several different types of endogenous transposons are present in C. elegans, and these can be mobilized in mutator strains (reviewed in ref. 1). Unfortunately, use of these native transposons for regulated transposition in C. elegans is limited. First, all strains contain multiple copies of these transposons and thus new insertions do not provide unique tags. Second, mutator strains tend to activate the transposition of several classes of transposons, so that the type of transposon associated with a particular mutation is not known. Here we demonstrate that the Drosophila mariner element Mos1 can be mobilized in C. elegans. First, efficient mobilization of Mos1 is possible in somatic cells. Second, heritable insertions of the transposon can be generated in the germ line. Third, genes that have been mutated by insertion can be rapidly identified using inverse polymerase chain reaction. Fourth, these insertions can subsequently be remobilized to generate deletion and frameshift mutations by imperfect excision.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Jorgensen, EM (corresponding author), Univ Utah, Dept Biol, 257 S 1400 E, Salt Lake City, UT 84112 USA.	jorgensen@biology.utah.edu	Bessereau, Jean-Louis/M-2988-2017	Bessereau, Jean-Louis/0000-0002-3088-7621; Davis, Mikel/0000-0003-1867-1593				BRYAN G, 1990, GENETICS, V125, P103; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CANDIDO EPM, 1989, GENOME, V31, P690, DOI 10.1139/g89-126; CLARK SG, 1994, GENETICS, V137, P987; Coates CJ, 1998, P NATL ACAD SCI USA, V95, P3748, DOI 10.1073/pnas.95.7.3748; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Gruidl ME, 1996, P NATL ACAD SCI USA, V93, P13837, DOI 10.1073/pnas.93.24.13837; Gueiros FJ, 1997, SCIENCE, V276, P1716, DOI 10.1126/science.276.5319.1716; Hart DL, 1997, ANNU REV GENET, V31, P337, DOI 10.1146/annurev.genet.31.1.337; JACOBSON JW, 1986, P NATL ACAD SCI USA, V83, P8684, DOI 10.1073/pnas.83.22.8684; Kelly WG, 1997, GENETICS, V146, P227; KRAMER JM, 1990, MOL CELL BIOL, V10, P2081, DOI 10.1128/MCB.10.5.2081; Lohe AR, 2000, GENETICS, V154, P647; MEDHORA M, 1991, GENETICS, V128, P311; Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1; Plasterk Ronald H.A., 1997, Cold Spring Harbor Monograph Series, V33, P97; ROBERTSON HM, 1995, MOL BIOL EVOL, V12, P850; SEDENSKY MM, 1994, NUCLEIC ACIDS RES, V22, P1719, DOI 10.1093/nar/22.9.1719; SULSTON JE, 1974, GENETICS, V77, P95; Tosi LRO, 2000, NUCLEIC ACIDS RES, V28, P784, DOI 10.1093/nar/28.3.784; VANLUENEN HGAM, 1994, CELL, V79, P293, DOI 10.1016/0092-8674(94)90198-8; VANLUENEN HGAM, 1993, EMBO J, V12, P2513, DOI 10.1002/j.1460-2075.1993.tb05906.x; Waterston Robert H., 1997, Cold Spring Harbor Monograph Series, V33, P23; WILLIAMS BD, 1992, GENETICS, V131, P609	24	106	114	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2001	413	6851					70	74		10.1038/35092567	http://dx.doi.org/10.1038/35092567			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544527				2022-12-01	WOS:000170801200040
J	Shin, JS; Abraham, SN				Shin, JS; Abraham, SN			Cell biology - Caveolae - Not just craters in the cellular landscape	SCIENCE			English	Editorial Material							TRANSCYTOSIS; CHOLESTEROL; TOXIN; ENTRY		Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Microbiol, Durham, NC 27710 USA	Duke University; Duke University	Shin, JS (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	Abrah006@mc.duke.edu	Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051				Abrami L, 2000, TRENDS MICROBIOL, V8, P168, DOI 10.1016/S0966-842X(00)01722-4; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Baorto DM, 1997, NATURE, V389, P636, DOI 10.1038/39376; Bomsel M, 2000, MOL BIOL CELL, V11, p497A; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Hansen GH, 1999, GASTROENTEROLOGY, V116, P610, DOI 10.1016/S0016-5085(99)70183-6; Lauer S, 2000, EMBO J, V19, P3556, DOI 10.1093/emboj/19.14.3556; Lencer WI, 1999, BBA-MOL CELL RES, V1450, P177, DOI 10.1016/S0167-4889(99)00070-1; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Mordue DG, 1999, J EXP MED, V190, P1783, DOI 10.1084/jem.190.12.1783; Ricci V, 2000, MOL BIOL CELL, V11, P3897, DOI 10.1091/mbc.11.11.3897; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Shin JS, 2000, SCIENCE, V289, P785, DOI 10.1126/science.289.5480.785; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408	14	59	63	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1447	1448		10.1126/science.1061079	http://dx.doi.org/10.1126/science.1061079			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520975				2022-12-01	WOS:000170616000032
J	Tice, JA; Ross, E; Coxson, PG; Rosenberg, I; Weinstein, MC; Hunink, MGM; Goldman, PA; Williams, L; Goldman, L				Tice, JA; Ross, E; Coxson, PG; Rosenberg, I; Weinstein, MC; Hunink, MGM; Goldman, PA; Williams, L; Goldman, L			Cost-effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease - Effect of grain fortification and beyond	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOLIC-ACID SUPPLEMENTATION; CARDIOVASCULAR RISK FACTOR; SERUM TOTAL HOMOCYSTEINE; VASCULAR-DISEASE; ARTERY DISEASE; MYOCARDIAL-INFARCTION; CONTROLLED TRIAL; CLINICAL-TRIALS; HOMOCYST(E)INE LEVELS; SECONDARY PREVENTION	Context A high homocysteine level has been identified as an independent modifiable risk factor for coronary heart disease (CHD) events and death. Since January 1998, the US Food and Drug Administration has required that all enriched grain products contain 140 mug of folic acid per 100 g, a level considered to decrease homocysteine levels. Objectives To examine the potential effect of grain fortification with folic acid on CHID events and to estimate the cost-effectiveness of additional vitamin supplementation (folic acid and cyanocobalamin) for CHID prevention. Design and Setting Cost-effectiveness analysis using the Coronary Heart Disease Policy Model, a validated, state-transition model of CHD events in adults aged 35 through 84 years. Data from the third National Health and Nutrition Examination Survey (NHANES III) were used to estimate age- and sex-specific differences in homocysteine levels. Intervention Hypothetical comparison between a diet that includes enriched grain products projected to increase folic acid intake by 100 mug/d with the same diet without folic acid fortification; and a comparison between vitamin therapy that consists of 1 mg of folic acid and 0.5 mg of cyanocobalamin and the diet that includes grains fortified with folic acid. Main Outcome Measures Incidence of myocardial infarction and death from CHID, quality-adjusted life-years (QALYs) saved, and medical costs. Results Grain fortification with folic acid was predicted to decrease CHID events by 8% in women and 13% in men, with comparable reductions in CHID mortality. The model projected that, compared with grain fortification alone, treating all patients with known CHID with folic acid and cyanocobalamin over a 10-year period would result in 310000 fewer deaths and lower costs. Over the same 10-year period, providing vitamin supplementation in addition to grain fortification to all men aged 45 years or older without known CHID was projected to save more than 300000 QALYs, to save more than US $2 billion, and to be the preferred strategy. For women without CHD, the preferred vitamin supplementation strategy would be to treat all women older than 55 years, a strategy projected to save more than 140000 QALYs over 10 years. Conclusions Folic acid and cyanocobalamin supplementation may be cost-effective among many population subgroups and could have a major epidemiologic benefit for primary and secondary prevention of CHID if ongoing clinical trials confirm that homocysteine-lowering therapy decreases CHID event rates.	Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA 94143 USA; Tufts Univ, Div Clin Nutr, Boston, MA 02111 USA; Tufts Univ, Div Gen Internal Med, Boston, MA 02111 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Erasmus Med Ctr, Dept Radiol, Rotterdam, Netherlands; Erasmus Med Ctr, Dept Epidemiol & Biostat, Rotterdam, Netherlands	University of California System; University of California San Francisco; Tufts University; Tufts University; Harvard University; Harvard T.H. Chan School of Public Health; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Tice, JA (corresponding author), Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA 94143 USA.			Tice, Jeffrey/0000-0002-9857-2028				ALFTHAN G, 1994, ATHEROSCLEROSIS, V106, P9, DOI 10.1016/0021-9150(94)90078-7; [Anonymous], 1996, FED REGISTER, V61, P8781; ARNESEN E, 1995, INT J EPIDEMIOL, V24, P704, DOI 10.1093/ije/24.4.704; Avins AL, 1998, JAMA-J AM MED ASSOC, V279, P445, DOI 10.1001/jama.279.6.445; BERGMARK C, 1993, EUR J VASCULAR SURG, V7, P391, DOI 10.1016/S0950-821X(05)80255-5; Bostom AG, 1997, ARTERIOSCL THROM VAS, V17, P2554, DOI 10.1161/01.ATV.17.11.2554; Bostom AG, 1997, ANN INTERN MED, V127, P1089, DOI 10.7326/0003-4819-127-12-199712150-00006; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; BRATTSTROM L, 1990, ATHEROSCLEROSIS, V81, P51, DOI 10.1016/0021-9150(90)90058-Q; Brattstrom L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894; BRATTSTROM LE, 1988, SCAND J CLIN LAB INV, V48, P215, DOI 10.3109/00365518809167487; Bronstrup A, 1998, AM J CLIN NUTR, V68, P1104; Caro J, 1997, BRIT MED J, V315, P1577, DOI 10.1136/bmj.315.7122.1577; Chauveau P, 1996, MINER ELECTROL METAB, V22, P106; Cheng SWK, 1997, ANN VASC SURG, V11, P217, DOI 10.1007/s100169900037; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; Cuskelly G. J., 1995, IRISH J MED SCI, V164; DALERY K, 1995, AM J CARDIOL, V75, P1107, DOI 10.1016/S0002-9149(99)80739-5; den Heijer M, 1998, ARTERIOSCL THROM VAS, V18, P356, DOI 10.1161/01.ATV.18.3.356; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DICKINSON CJ, 1995, QJM-INT J MED, V88, P357; ELVEBACK LR, 1981, MAYO CLIN PROC, V56, P665; Evans RW, 1997, ARTERIOSCL THROM VAS, V17, P1947, DOI 10.1161/01.ATV.17.10.1947; Fenech M, 1998, CARCINOGENESIS, V19, P1163, DOI 10.1093/carcin/19.7.1163; Folsom AR, 1998, CIRCULATION, V98, P204, DOI 10.1161/01.CIR.98.3.204; FRANKEN DG, 1994, J INHERIT METAB DIS, V17, P159, DOI 10.1007/BF00735426; FRANKEN DG, 1994, ARTERIOSCLER THROMB, V14, P465, DOI 10.1161/01.ATV.14.3.465; FRISON L, 1992, STAT MED, V11, P1685, DOI 10.1002/sim.4780111304; GENEST JJ, 1990, J AM COLL CARDIOL, V16, P1114, DOI 10.1016/0735-1097(90)90542-W; GOLDMAN L, 1991, JAMA-J AM MED ASSOC, V265, P1145, DOI 10.1001/jama.265.9.1145; Graham IM, 1997, JAMA-J AM MED ASSOC, V277, P1775, DOI 10.1001/jama.277.22.1775; Guttormsen AB, 1996, J CLIN INVEST, V98, P2174, DOI 10.1172/JCI119024; Hankey GJ, 1999, LANCET, V354, P407, DOI 10.1016/S0140-6736(98)11058-9; HEINONEN OP, 1994, NEW ENGL J MED, V330, P1029; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; ISRAELSSON B, 1988, ATHEROSCLEROSIS, V71, P227, DOI 10.1016/0021-9150(88)90147-5; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Janssen MJFM, 1996, MINER ELECTROL METAB, V22, P110; Johannesson M, 1997, NEW ENGL J MED, V336, P332, DOI 10.1056/NEJM199701303360503; Koehler KM, 1997, J AM DIET ASSOC, V97, P167, DOI 10.1016/S0002-8223(97)00044-8; Kuzminski AM, 1998, BLOOD, V92, P1191, DOI 10.1182/blood.V92.4.1191.416k15_1191_1198; LANDGREN F, 1995, J INTERN MED, V237, P381, DOI 10.1111/j.1365-2796.1995.tb01190.x; Malinow MR, 1998, NEW ENGL J MED, V338, P1009, DOI 10.1056/NEJM199804093381501; MALINOW MR, 1990, CIRCULATION, V81, P2004, DOI 10.1161/01.CIR.81.6.2004; MALINOW MR, 1989, CIRCULATION, V79, P1180, DOI 10.1161/01.CIR.79.6.1180; Malinow MR, 1997, ARTERIOSCL THROM VAS, V17, P1157, DOI 10.1161/01.ATV.17.6.1157; MCCULLY KS, 1969, AM J PATHOL, V56, P111; *MED EC CO INC, 1997, DRUG TOP RED BOOK; MOLGAARD J, 1992, J INTERN MED, V231, P273; Morris S, 1997, HEALTH ECON, V6, P589, DOI 10.1002/(SICI)1099-1050(199711)6:6<589::AID-HEC286>3.0.CO;2-D; Moustapha A, 1998, CIRCULATION, V97, P138, DOI 10.1161/01.CIR.97.2.138; *NAT CTR HLTH STAT, 1989, VIT STAT US 1986, V2; *NAT CTR HLTH STAT, 1981, VIT STA US A, V2; *NAT HLTH NUTR EX, 1990, NAT HLTH NUTR EX SUR; National Health and Nutrition Examination Survey III, 1998, NAT HLTH NUTR EX SUR; NAURATH HJ, 1995, LANCET, V346, P85, DOI 10.1016/S0140-6736(95)92113-3; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; OKEEFE CA, 1995, J NUTR, V125, P2717; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; PANCHARUNITI N, 1994, AM J CLIN NUTR, V59, P940, DOI 10.1093/ajcn/59.4.940; PERRY IJ, 1995, LANCET, V346, P1395, DOI 10.1016/S0140-6736(95)92407-8; Rasmussen K, 1996, CLIN CHEM, V42, P630; ROBINSON K, 1995, CIRCULATION, V92, P2825, DOI 10.1161/01.CIR.92.10.2825; Russell LB, 1998, NEW ENGL J MED, V339, P1158, DOI 10.1056/NEJM199810153391612; SALTZMAN E, 1994, CLIN RES, V42, pA172; SanthoshKumar CR, 1997, EUR J CLIN NUTR, V51, P188, DOI 10.1038/sj.ejcn.1600385; Schorah CJ, 1998, EUR J CLIN NUTR, V52, P407, DOI 10.1038/sj.ejcn.1600576; Schwartz SM, 1997, CIRCULATION, V96, P412; STAMPFER MJ, 1992, JAMA-J AM MED ASSOC, V268, P877, DOI 10.1001/jama.268.7.877; Stehouwer CDA, 1998, ARTERIOSCL THROM VAS, V18, P1895, DOI 10.1161/01.ATV.18.12.1895; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; STINNETT A, 1996, COST EFFECTIVENESS H, P348; TAYLOR LM, 1991, J VASC SURG, V13, P128, DOI 10.1016/0741-5214(91)90020-U; Torrance GW, 1996, COST EFFECTIVENESS H, P276; Tsevat J, 2001, AM HEART J, V141, P727, DOI 10.1067/mhj.2001.114805; Tucker KL, 1996, JAMA-J AM MED ASSOC, V276, P1879, DOI 10.1001/jama.276.23.1879; U.S. Department of Health and Human Services, 1990, NIH PUBL; UBBINK JB, 1991, KLIN WOCHENSCHR, V69, P527, DOI 10.1007/BF01649290; UBBINK JB, 1994, J NUTR, V124, P1927, DOI 10.1093/jn/124.10.1927; UBBINK JB, 1995, CLIN CHEM, V41, P1033; UBBINK JB, 1993, CLIN INVESTIGATOR, V71, P993, DOI 10.1007/BF00180030; *US BUR CENS, 1990, US POP EST AG SE S P, V25; VANDENBERG M, 1994, J VASC SURG, V20, P933, DOI 10.1016/0741-5214(94)90230-5; VERHOEF P, 1994, STROKE, V25, P1924, DOI 10.1161/01.STR.25.10.1924; Verhoef P, 1996, AM J EPIDEMIOL, V143, P845, DOI 10.1093/oxfordjournals.aje.a008828; VONECKARDSTEIN A, 1994, ARTERIOSCLER THROMB, V14, P460, DOI 10.1161/01.ATV.14.3.460; Wald NJ, 1998, ARCH INTERN MED, V158, P862, DOI 10.1001/archinte.158.8.862; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; WEINSTEIN MC, 1987, AM J PUBLIC HEALTH, V77, P1417, DOI 10.2105/AJPH.77.11.1417; Wilcken DEL, 1997, J INHERIT METAB DIS, V20, P295, DOI 10.1023/A:1005373209964; WILCKEN DEL, 1988, METABOLISM, V37, P697, DOI 10.1016/0026-0495(88)90093-5; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Woodside JV, 1998, AM J CLIN NUTR, V67, P858, DOI 10.1093/ajcn/67.5.858; Woodside JV, 1997, P NUTR SOC, V56, P479, DOI 10.1079/PNS19970048; WU LL, 1994, CLIN CHEM, V40, P552; 1996, FED REG, V61, P59489; 1993, FED REG, V58, P53305	99	71	76	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2001	286	8					936	943		10.1001/jama.286.8.936	http://dx.doi.org/10.1001/jama.286.8.936			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465EU	11509058	Bronze			2022-12-01	WOS:000170577300028
J	Greig-Midlane, H				Greig-Midlane, H			The parents' perspective on withdrawing treatment	BRITISH MEDICAL JOURNAL			English	Article											Greig-Midlane, H (corresponding author), 32 Littleheath, London SE7 8HU, England.								0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2001	323	7309					390	390						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11548687				2022-12-01	WOS:000170581400029
J	Dobbek, H; Svetlitchnyi, V; Gremer, L; Huber, R; Meyer, O				Dobbek, H; Svetlitchnyi, V; Gremer, L; Huber, R; Meyer, O			Crystal structure of a carbon monoxide dehydrogenase reveals a [Ni-4Fe-5S] cluster	SCIENCE			English	Article							IRON-SULFUR PROTEINS; RUBRUM CO-DEHYDROGENASE; RHODOSPIRILLUM-RUBRUM; ANGSTROM; NICKEL; FE; RESOLUTION; REDUCTION; OXIDATION	The homodimeric nickel-containing CO dehydrogenase from the anaerobic bacterium Carboxydothermus hydrogenoformans catalyzes the oxidation of CO to CO2. A crystal structure of the reduced enzyme has been solved at 1.6 angstrom resolution. This structure represents the prototype for Ni-containing CO dehydrogenases from anaerobic bacteria and archaea. It contains five metal clusters of which clusters B, B', and a subunit-bridging, surface-exposed cluster D are cubane-type [4Fe-4S] clusters. The active-site clusters C and C' are novel, asymmetric [Ni-4Fe-5S] clusters. Their integral Ni ion, which is the likely site of CO oxidation, is coordinated by four sulfur ligands with square planar geometry.	Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany; Univ Bayreuth, Bayreuther Zentrum Mol Biowissensch, D-95440 Bayreuth, Germany; Univ Bayreuth, Lehrstuhl Mikrobiol, D-95440 Bayreuth, Germany	Max Planck Society; University of Bayreuth; University of Bayreuth	Dobbek, H (corresponding author), Max Planck Inst Biochem, Abt Strukturforsch, Klopferspitz 18A, D-82152 Martinsried, Germany.		Gremer, Lothar/H-9128-2013	Gremer, Lothar/0000-0001-7065-5027				Arendsen AF, 1998, J BIOL INORG CHEM, V3, P81, DOI 10.1007/s007750050210; Arendsen AF, 1999, ADV INORG CHEM, V47, P219, DOI 10.1016/S0898-8838(08)60079-3; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; BONAM D, 1987, J BIOL CHEM, V262, P2980; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Coyle C.L, 1988, BIOINORGANIC CHEM NI, P1; CRANE BR, 1995, SCIENCE, V270, P59, DOI 10.1126/science.270.5233.59; DELATTRE O, 1997, EUR J ORTHOP SURG TR, V7, P1; DeRose VJ, 1998, J AM CHEM SOC, V120, P8767, DOI 10.1021/ja9731480; Dobbek H, 1999, P NATL ACAD SCI USA, V96, P8884, DOI 10.1073/pnas.96.16.8884; Ermler U, 1998, CURR OPIN STRUC BIOL, V8, P749, DOI 10.1016/S0959-440X(98)80095-X; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FERRY JG, 1995, ANNU REV MICROBIOL, V49, P305, DOI 10.1146/annurev.mi.49.100195.001513; Gonzalez JM, 2000, FEMS MICROBIOL LETT, V191, P243, DOI 10.1016/S0378-1097(00)00397-9; Hanzelmann P, 2000, J MOL BIOL, V301, P1221, DOI 10.1006/jmbi.2000.4023; Heo J, 1999, J AM CHEM SOC, V121, P11045, DOI 10.1021/ja990397a; Heo JY, 2000, BIOCHEMISTRY-US, V39, P7956, DOI 10.1021/bi992958g; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu ZG, 1996, J AM CHEM SOC, V118, P830, DOI 10.1021/ja9528386; Johnson MK, 1998, CURR OPIN CHEM BIOL, V2, P173, DOI 10.1016/S1367-5931(98)80058-6; KUMAR M, 1993, J AM CHEM SOC, V115, P11646, DOI 10.1021/ja00077a093; Meyer O, 2000, BIOL CHEM, V381, P865, DOI 10.1515/BC.2000.108; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Ragsdale SW, 1996, CHEM REV, V96, P2515, DOI 10.1021/cr950058+; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Spangler NJ, 1998, J BIOL CHEM, V273, P4059, DOI 10.1074/jbc.273.7.4059; Staples CR, 1999, J AM CHEM SOC, V121, P11034, DOI 10.1021/ja990396i; Sticht H, 1998, PROG BIOPHYS MOL BIO, V70, P95, DOI 10.1016/S0079-6107(98)00027-3; SVETLICHNY VA, 1991, SYST APPL MICROBIOL, V14, P254, DOI 10.1016/S0723-2020(11)80377-2; SVETLITCHNYI V, IN PRESS J BACTERIOL; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; TURK D, 1992, THESIS TU MUNCHEN MU	36	389	428	3	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1281	1285		10.1126/science.1061500	http://dx.doi.org/10.1126/science.1061500			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509720				2022-12-01	WOS:000170492600029
J	Boekema, EJ; Hifney, A; Yakushevska, AE; Piotrowski, M; Keegstra, W; Berry, S; Michel, KP; Pistorius, EK; Kruip, J				Boekema, EJ; Hifney, A; Yakushevska, AE; Piotrowski, M; Keegstra, W; Berry, S; Michel, KP; Pistorius, EK; Kruip, J			A giant chlorophyll-protein complex induced by iron defciency in cyanobacteria	NATURE			English	Article							LIGHT-HARVESTING COMPLEX; PHOTOSYSTEM-II COMPLEX; SYNECHOCOCCUS SP; ISIA GENE; STRESS; PURIFICATION; ORGANIZATION; LIMITATION; SUBUNITS	Cyanobacteria are abundant throughout most of the world's water bodies and contribute significantly to global primary productivity through oxygenic photosynthesis. This reaction is catalysed by two membrane-bound protein complexes, photosystem I (PSI) and photosystem II (PSII), which both contain chlorophyll-binding subunits functioning as an internal antenna(1). In addition, phycobilisomes act as peripheral antenna systems, but no additional light-harvesting systems have been found under normal growth conditions. Iron deficiency, which is often the limiting factor for cyanobacterial growth in aquatic ecosystems(2), leads to the induction of additional proteins such as IsiA (ref. 3). Although IsiA has been implicated in chlorophyll storage, energy absorption and protection against excessive light, its precise molecular function and association to other proteins is unknown. Here we report the purification of a specific PSI-IsiA supercomplex, which is abundant under conditions of iron limitation. Electron microscopy shows that this supercomplex consists of trimeric PSI surrounded by a closed ring of 18 IsiA proteins binding around 180 chlorophyll molecules. We provide a structural characterization of an additional chlorophyll-containing, membrane-integral antenna in a cyanobacterial photosystem.	Univ Bielefeld, D-33501 Bielefeld, Germany; Univ Groningen, Groningen Biomol Sci, NL-9747 AG Groningen, Netherlands; Univ Groningen, Inst Biotechnol, NL-9747 AG Groningen, Netherlands; Ruhr Univ Bochum, D-44780 Bochum, Germany	University of Bielefeld; University of Groningen; University of Groningen; Ruhr University Bochum	Pistorius, EK (corresponding author), Univ Bielefeld, D-33501 Bielefeld, Germany.	e.pistorius@biologie.uni-bielefeld.de; jochen.kruip@ruhr-uni-bochum.de	Piotrowski, Markus/F-5419-2010	Piotrowski, Markus/0000-0002-6347-3337; hifney, Awatief/0000-0002-1247-1876				Behrenfeld MJ, 1996, NATURE, V383, P508, DOI 10.1038/383508a0; BOEKEMA EJ, 1995, P NATL ACAD SCI USA, V92, P175, DOI 10.1073/pnas.92.1.175; Boekema EJ, 2001, BIOCHEMISTRY-US, V40, P1029, DOI 10.1021/bi0015358; BURNAP RL, 1993, PLANT PHYSIOL, V103, P893, DOI 10.1104/pp.103.3.893; DEKKER JP, 1988, BIOCHIM BIOPHYS ACTA, V936, P307, DOI 10.1016/0005-2728(88)90006-0; Exss-Sonne P, 2000, PHOTOSYNTH RES, V63, P145, DOI 10.1023/A:1006322925324; Garczarek L, 2000, P NATL ACAD SCI USA, V97, P4098, DOI 10.1073/pnas.070040897; GUIKEMA JA, 1983, PLANT PHYSIOL, V73, P250, DOI 10.1104/pp.73.2.250; HARAUZ G, 1988, METHOD ENZYMOL, V164, P35; HIYAMA T, 1972, BIOCHIM BIOPHYS ACTA, V267, P160, DOI 10.1016/0005-2728(72)90147-8; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; KARRASCH S, 1995, EMBO J, V14, P631, DOI 10.1002/j.1460-2075.1995.tb07041.x; LaRoche J, 1996, P NATL ACAD SCI USA, V93, P15244; LAUDENBACH DE, 1988, J BACTERIOL, V170, P5018, DOI 10.1128/jb.170.11.5018-5026.1988; Lelong C, 1996, EMBO J, V15, P2160, DOI 10.1002/j.1460-2075.1996.tb00569.x; LEONHARDT K, 1992, J GEN MICROBIOL, V138, P1613, DOI 10.1099/00221287-138-8-1613; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; NITSCHKE W, 1991, TRENDS BIOCHEM SCI, V16, P241, DOI 10.1016/0968-0004(91)90095-D; PAKRASI HB, 1985, P NATL ACAD SCI USA, V82, P6903, DOI 10.1073/pnas.82.20.6903; Park YI, 1999, MOL MICROBIOL, V32, P123, DOI 10.1046/j.1365-2958.1999.01332.x; STRAUS NA, 1994, ADV PHOTOSYNTHESIS, V1, P731; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/S0304-3991(81)80197-0; Wenk SO, 2000, J CHROMATOGR B, V737, P131, DOI 10.1016/S0378-4347(99)00525-3; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	24	270	289	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2001	412	6848					745	748		10.1038/35089104	http://dx.doi.org/10.1038/35089104			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507644	Green Published			2022-12-01	WOS:000170450200048
J	Ohl, FW; Scheich, H; Freeman, WJ				Ohl, FW; Scheich, H; Freeman, WJ			Change in pattern of ongoing cortical activity with auditory category learning	NATURE			English	Article							FREQUENCY-MODULATED TONES; OLFACTORY EEG; CORTEX; DISCRIMINATION; REPRESENTATION; SYSTEMS	Humans are able to classify novel items correctly by category(1,2); some other animals have also been shown to do this(3-7). During category learning, humans group perceptual stimuli by abstracting qualities from similarity relationships of their physical properties(1,2,8). Forming categories is fundamental to cognition(9) and can be independent of a 'memory store' of information about the items or a prototype(10). The neurophysiological mechanisms underlying the formation of categories are unknown. Using an animal model of category learning(6), in which frequency-modulated tones are distinguished into the categories of 'rising' and 'falling' modulation, we demonstrate here that the sorting of stimuli into these categories emerges as a sudden change in an animal's learning strategy. Electro-corticographical recording from the auditory cortex(11) shows that the transition is accompanied by a change in the dynamics of cortical stimulus representation. We suggest that this dynamic change represents a mechanism underlying the recognition of the abstract quality (or qualities) that defines the categories.	Leibniz Inst Neurobiol, D-39118 Magdeburg, Germany; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Leibniz Institut fur Neurobiologie (LIN); University of California System; University of California Berkeley	Ohl, FW (corresponding author), Leibniz Inst Neurobiol, Brenneckstr 6, D-39118 Magdeburg, Germany.	frank.ohl@ifn-magdeburg.de						Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Barrie JM, 1996, J NEUROPHYSIOL, V76, P520, DOI 10.1152/jn.1996.76.1.520; CREUTZFELDT O, 1989, EXP BRAIN RES, V77, P451, DOI 10.1007/BF00249600; Feldman J, 2000, NATURE, V407, P630, DOI 10.1038/35036586; Freeman W.J., 2000, NEURODYNAMICS EXPLOR, DOI 10.1007/978-1-4471-0371-4; FREEMAN WJ, 1987, BEHAV NEUROSCI, V101, P766, DOI 10.1037/0735-7044.101.6.766; FREEMAN WJ, 1982, PSYCHOPHYSIOLOGY, V19, P44, DOI 10.1111/j.1469-8986.1982.tb02598.x; FREEMAN WJ, 1994, PHYSICA D, V75, P151, DOI 10.1016/0167-2789(94)90280-1; HART J, 1985, NATURE, V316, P439, DOI 10.1038/316439a0; HEIL P, 1992, J COMP NEUROL, V322, P548, DOI 10.1002/cne.903220409; HERRNSTEIN RJ, 1990, COGNITION, V37, P133, DOI 10.1016/0010-0277(90)90021-B; HUOTILAINEN M, 1995, NEUROREPORT, V6, P841, DOI 10.1097/00001756-199504190-00004; KNOWLTON BJ, 1993, SCIENCE, V262, P1747, DOI 10.1126/science.8259522; KOMATSU LK, 1992, PSYCHOL BULL, V112, P500, DOI 10.1037/0033-2909.112.3.500; KUHL PK, 1975, SCIENCE, V190, P69, DOI 10.1126/science.1166301; LEA SEG, 1984, ANIMAL COGNITION, P263; Marshuetz C, 2000, J COGNITIVE NEUROSCI, P146; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; MCCARTHY RA, 1988, NATURE, V334, P428, DOI 10.1038/334428a0; Medin D.L., 1998, PERCEPTION COGNITION, P403, DOI DOI 10.1016/B978-012301160-2/50015-0; MOODY DB, 1995, METHODS COMP PSYCHOA, P293; Ohl FW, 1999, LEARN MEMORY, V6, P347; Ohl FW, 1997, P NATL ACAD SCI USA, V94, P9440, DOI 10.1073/pnas.94.17.9440; Ohl FW, 2000, J NEUROPHYSIOL, V83, P3123, DOI 10.1152/jn.2000.83.5.3123; Orlov T, 2000, NATURE, V404, P77, DOI 10.1038/35003571; PEARCE JM, 1991, CURRENT TOPICS IN ANIMAL LEARNING : BRAIN, EMOTION, AND COGNITION, P141; SAMMON JW, 1969, IEEE T COMPUT, VC 18, P401, DOI 10.1109/T-C.1969.222678; Schreiner CE, 2000, ANNU REV NEUROSCI, V23, P501, DOI 10.1146/annurev.neuro.23.1.501; Wetzel W, 1998, BEHAV BRAIN RES, V91, P29, DOI 10.1016/S0166-4328(97)00099-5; WOODRUFF G, 1981, NATURE, V293, P568, DOI 10.1038/293568a0	30	246	249	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2001	412	6848					733	736		10.1038/35089076	http://dx.doi.org/10.1038/35089076			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	462ZB	11507640				2022-12-01	WOS:000170450200044
J	Robert, KA; Thompson, MB				Robert, KA; Thompson, MB			Sex determination - Viviparous lizard selects sex of embryos	NATURE			English	Article							REPTILES; TEMPERATURES		Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; Univ Sydney, Inst Wildlife Res, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Robert, KA (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	krobert@bio.usyd.edu.au	Thompson, Mike/ABA-8716-2020; Robert, Kylie/C-5181-2009	Robert, Kylie/0000-0002-8554-8440; Thompson, Michael/0000-0002-2496-992X				BULL JJ, 1980, Q REV BIOL, V55, P3, DOI 10.1086/411613; Ciofi C, 1997, APPL ANIM BEHAV SCI, V51, P251, DOI 10.1016/S0168-1591(96)01108-2; Cogger HG, 1986, REPTILES AMPHIBIANS; CREE A, 1995, NATURE, V375, P543, DOI 10.1038/375543a0; Harlow Peter S., 1996, Herpetological Review, V27, P71; JANZEN FJ, 1994, P NATL ACAD SCI USA, V91, P7487, DOI 10.1073/pnas.91.16.7487; JANZEN FJ, 1991, Q REV BIOL, V66, P149, DOI 10.1086/417143; Olsson M, 2001, J EVOLUTION BIOL, V14, P120, DOI 10.1046/j.1420-9101.2001.00255.x; SCHWARZKOPF L, 1991, OECOLOGIA, V88, P562, DOI 10.1007/BF00317720; Whetton PH, 2001, CLIMATE RES, V16, P181, DOI 10.3354/cr016181; YNTEMA CL, 1980, HERPETOLOGICA, V36, P33; YNTEMA CL, 1981, J MORPHOL, V167, P297, DOI 10.1002/jmor.1051670304	12	79	87	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2001	412	6848					698	699		10.1038/35089135	http://dx.doi.org/10.1038/35089135			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507628				2022-12-01	WOS:000170450200032
J	Yung, YL; Lee, T; Wang, CH; Shieh, YT				Yung, YL; Lee, T; Wang, CH; Shieh, YT			Dust: A diagnostic of the hydrologic cycle during the last glacial maximum	SCIENCE			English	Article							GENERAL-CIRCULATION MODEL; DESERT DUST; ICE; ATMOSPHERE; AEROSOLS; CLIMATE; SIMULATIONS; TRANSPORT; IMPACT	Dust concentrations in ice of the last glacial maximum (LGM) are high in ice cores from Greenland and Antarctica. The magnitude of the enhancements can be explained if the strength of the hydrologic cycle during the LGM was about half of that at present. This notion is consistent with a large decrease (5 degrees C) in ocean temperature during the LGM, as recently deduced from measurements of strontium and calcium in corals.	ACAD SINICA, INST EARTH SCI, TAIPEI 115, TAIWAN	Academia Sinica - Taiwan	Yung, YL (corresponding author), CALTECH, DIV GEOL & PLANETARY SCI, PASADENA, CA 91125 USA.		Yung, Yuk/AAM-4850-2021; Lee, Typhoon/N-8347-2013	Yung, Yuk/0000-0002-4263-2562; Wang, Chung-Ho/0000-0003-2014-6747	NINDS NIH HHS [NSC 84-2111-M-001-027GP] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALKANSKI YJ, 1993, J GEOPHYS RES-ATMOS, V98, P20573, DOI 10.1029/93JD02456; BROECKER WS, 1989, GEOCHIM COSMOCHIM AC, V53, P2465, DOI 10.1016/0016-7037(89)90123-3; Bryant V.M., 1985, POLLEN RECORDS LATE, P39; CESS RD, 1990, J GEOPHYS RES-ATMOS, V95, P16601, DOI 10.1029/JD095iD10p16601; CHAPPELLAZ JA, 1993, TELLUS B, V45, P228, DOI 10.1034/j.1600-0889.1993.t01-2-00002.x; Crowley T. J., 1991, PALEOCLIMATOLOGY; Fairbridge R.W., 1961, PHYS CHEM EARTH, V4, P99, DOI [10.1016/0079-1946(61)90004-0, DOI 10.1016/0079-1946(61)90004-0]; FRIEDLINGSTEIN P, 1995, J GEOPHYS RES-ATMOS, V100, P7203, DOI 10.1029/94JD02948; GENTHON C, 1992, TELLUS B, V44, P371, DOI 10.1034/j.1600-0889.1992.00014.x; GROUSSET FE, 1992, EARTH PLANET SC LETT, V111, P175, DOI 10.1016/0012-821X(92)90177-W; GUILDERSON TP, 1994, SCIENCE, V263, P663, DOI 10.1126/science.263.5147.663; Hammer C. U., 1985, GEOPHYS MONOGR SER, V33, P90, DOI DOI 10.1029/GM033P0090/SUMMARY); Hansen J., 1984, GEOPHYS MONOGR SER, P130, DOI [10.1029/gm029p0130, 10.1029/GM029p0130, DOI 10.1029/GM029P0130]; HARVEY LDD, 1988, NATURE, V334, P333, DOI 10.1038/334333a0; JOUSSAUME S, 1993, J GEOPHYS RES-ATMOS, V98, P2767, DOI 10.1029/92JD01921; JOUZEL J, 1989, QUATERNARY RES, V31, P135, DOI 10.1016/0033-5894(89)90003-3; KUKLA G, 1988, GEOLOGY, V16, P811, DOI 10.1130/0091-7613(1988)016<0811:PCICDB>2.3.CO;2; LINDZEN RS, 1990, B AM METEOROL SOC, V71, P288, DOI 10.1175/1520-0477(1990)071<0288:SCCGW>2.0.CO;2; LINDZEN RS, 1990, B AM METEOROL SOC, V71, P1465; MURPHY JR, 1993, J GEOPHYS RES-PLANET, V98, P3197, DOI 10.1029/92JE02945; PETIT JR, 1981, NATURE, V293, P391, DOI 10.1038/293391a0; RIND D, 1985, QUATERNARY RES, V24, P1, DOI 10.1016/0033-5894(85)90080-8; SANTEE M, 1993, J GEOPHYS RES-PLANET, V98, P3261, DOI 10.1029/92JE01896; SENIOR CA, 1993, J CLIMATE, V6, P393, DOI 10.1175/1520-0442(1993)006<0393:CDACTI>2.0.CO;2; SHIA RL, 1989, J GEOPHYS RES-ATMOS, V94, P18467, DOI 10.1029/JD094iD15p18467; STUTE M, 1992, SCIENCE, V256, P1000, DOI 10.1126/science.256.5059.1000; STUTE M, 1995, SCIENCE, V269, P379, DOI 10.1126/science.269.5222.379; THOMPSON LG, 1989, SCIENCE, V246, P474, DOI 10.1126/science.246.4929.474; THOMPSON LG, 1995, SCIENCE, V269, P46, DOI 10.1126/science.269.5220.46; WEARE BC, 1994, J CLIMATE, V7, P248, DOI 10.1175/1520-0442(1994)007<0248:IBCPAS>2.0.CO;2; YANG H, 1991, J ATMOS SCI, V48, P442, DOI 10.1175/1520-0469(1991)048<0442:SOTPDA>2.0.CO;2; 1992, CLIMATE CHANGE 199 S; 1990, CLIMATE CHANGE IPCC	33	103	114	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	1996	271	5251					962	963		10.1126/science.271.5251.962	http://dx.doi.org/10.1126/science.271.5251.962			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TV704	11536732				2022-12-01	WOS:A1996TV70400040
J	HEATH, JR; SHEEKS, RA; COOKSY, AL; SAYKALLY, RJ				HEATH, JR; SHEEKS, RA; COOKSY, AL; SAYKALLY, RJ			THE C7 CLUSTER - STRUCTURE AND INFRARED FREQUENCIES	SCIENCE			English	Article											HEATH, JR (corresponding author), UNIV CALIF BERKELEY,DEPT CHEM,BERKELEY,CA 94720, USA.			SAYKALLY, RICHARD/0000-0001-8942-3656; Cooksy, Andrew/0000-0002-2794-4269				BERNATH PF, 1989, SCIENCE, V244, P562, DOI 10.1126/science.244.4904.562; BUSAROW KL, 1988, J CHEM PHYS, V89, P1968; DROWART J, 1959, J CHEM PHYS, V31, P1131, DOI 10.1063/1.1730519; FREED KF, 1982, ASTROPHYS J, V263, P718, DOI 10.1086/160543; FUSINA L, 1980, J MOL SPECTROSC, V79, P101, DOI 10.1016/0022-2852(80)90296-9; GERHARDT P, 1987, CHEM PHYS LETT, V137, P306, DOI 10.1016/0009-2614(87)80889-8; GEUSIC ME, 1986, J CHEM PHYS, V84, P2421, DOI 10.1063/1.450354; HEATH JR, 1989, SCIENCE, V244, P564, DOI 10.1126/science.11539817; Herzberg G., 1945, INFRARED RAMAN SPECT, V2; HINKLE KW, 1988, SCIENCE, V241, P1319, DOI 10.1126/science.241.4871.1319; KARU D, 1990, APPL OPTICS, V29, P119; KAWAGUCHI K, 1989, J CHEM PHYS, V91, P1953, DOI 10.1063/1.457054; MATSUMURA K, 1988, J CHEM PHYS, V89, P3491, DOI 10.1063/1.454919; MOAZZENAHMADI N, 1989, CHEM PHYS LETT, V157, P1, DOI 10.1016/0009-2614(89)87196-9; MOAZZENAHMADI N, 1989, J CHEM PHYS, V91, P2140, DOI 10.1063/1.457073; PITZER KS, 1959, J AM CHEM SOC, V81, P4477, DOI 10.1021/ja01526a010; RAGHAVACHARI K, 1987, J CHEM PHYS, V87, P2191, DOI 10.1063/1.453145; ROHLFING EA, 1988, J CHEM PHYS, V89, P6103, DOI 10.1063/1.455426; SCHMUTTENMAER CA, 1990, SCIENCE, V249, P897, DOI 10.1126/science.11538082; SUZUKI H, 1981, 13TH OK C TRANS IONS; WELTNER W, 1989, CHEM REV, V89, P1713, DOI 10.1021/cr00098a005; YANG SH, 1987, CHEM PHYS LETT, V139, P233, DOI 10.1016/0009-2614(87)80548-1	22	67	67	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 24	1990	249	4971					895	897						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV751	11538081	Green Accepted			2022-12-01	WOS:A1990DV75100037
J	Grigg, ME; Bonnefoy, S; Hehl, AB; Suzuki, Y; Boothroyd, JC				Grigg, ME; Bonnefoy, S; Hehl, AB; Suzuki, Y; Boothroyd, JC			Success and virulence in toxoplasma as the result of sexual recombination between two distinct ancestries	SCIENCE			English	Article							GONDII STRAINS; INTRAGENIC RECOMBINATION; GENE; PLASMODIUM; ANTIGEN; POLYMORPHISM; MICE; PATHOGENICITY; TRYPANOSOMA; ALLELES	Toxoplasma gondii is a common human pathogen causing serious, even fatal, disease in the developing fetus and in immunocompromised patients. Despite its ability to reproduce sexually and its broad geographic and host range, Toxoplasma has a clonal population structure comprised principally of three lines. We have analyzed 15 polymorphic loci in the archetypal type I, II, and III strains and found that polymorphism was limited to, at most, two rather than three allelic classes and no polymorphism was detected between alleles in strains of a given type. Multilocus analysis of 10 nonarchetypal isolates likewise clustered the vast majority of alleles into the same two distinct ancestries. These data strongly suggest that the currently predominant genotypes exist as a pandemic outbreak from a genetic mixing of two discrete ancestral lines. To determine if such mixing could lead to the extreme virulence observed for some strains, we examined the F-1 progeny of a cross between a type II and III strain, both of which are relatively avirulent in mice. Among the progeny were recombinants that were at least 3 logs more virulent than either parent. Thus, sexual recombination, by combining polymorphisms in two distinct and competing clonal lines, can be a powerful force driving the natural evolution of virulence in this highly successful pathogen.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Palo Alto Med Fdn, Res Inst, Dept Immunol & Infect Dis, Palo Alto, CA 94301 USA; Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA	Stanford University; Palo Alto Medical Foundation Research Institute; Stanford University	Suzuki, Y (corresponding author), Virginia Polytech Inst & State Univ, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.	ysuzuki@vt.edu; John.Boothroyd@stanford.edu	Bonnefoy, Serge/B-2466-2014	Bonnefoy, Serge/0000-0001-9148-0123; Boothroyd, John C./0000-0001-9719-745X; Hehl, Adrian/0000-0002-2110-4445	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041014, R37AI021423, R01AI021423, R37AI004717, R01AI004717] Funding Source: NIH RePORTER; NIAID NIH HHS [AI41014, AI04717, AI21423] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ayala FJ, 1998, P NATL ACAD SCI USA, V95, P3346, DOI 10.1073/pnas.95.7.3346; Binas M, 1998, INT J PARASITOL, V28, P1033, DOI 10.1016/S0020-7519(98)00052-6; BOOTHROYD JC, 1993, INFECT AGENT DIS, V2, P100; BOOTHROYD JC, 1993, TOXIPLASMOSIS, P63; BULOW R, 1991, J IMMUNOL, V147, P3496; CONWAY DJ, 1991, EXP PARASITOL, V73, P469, DOI 10.1016/0014-4894(91)90071-4; COUVREUR G, 1988, PARASITOLOGY, V97, P1, DOI 10.1017/S0031182000066695; Darde ML, 1998, J CLIN MICROBIOL, V36, P324; Darde ML, 1996, CURR TOP MICROBIOL, V219, P27; Fazaeli A, 2000, J PARASITOL, V86, P716, DOI 10.1645/0022-3395(2000)086[0716:ISIPAN]2.0.CO;2; Fazaeli A, 2000, INT J PARASITOL, V30, P637, DOI 10.1016/S0020-7519(00)00036-9; Grigg ME, 2001, J INFECT DIS, V184, P633, DOI 10.1086/322800; Homan WL, 1997, PARASITOL RES, V83, P285, DOI 10.1007/s004360050248; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Howe DK, 1997, J CLIN MICROBIOL, V35, P1411, DOI 10.1128/JCM.35.6.1411-1414.1997; HOWE DK, 1994, EXP PARASITOL, V78, P242, DOI 10.1006/expr.1994.1024; Howe DK, 1996, INFECT IMMUN, V64, P5193, DOI 10.1128/IAI.64.12.5193-5198.1996; KERR PJ, 1994, MOL BIOCHEM PARASIT, V66, P241, DOI 10.1016/0166-6851(94)90151-1; Lehmann T, 2000, J PARASITOL, V86, P960, DOI 10.1645/0022-3395(2000)086[0960:STOTGC]2.0.CO;2; LUTON K, 1995, PARASITOL RES, V81, P310, DOI 10.1007/BF00931536; MacLeod A, 2000, P NATL ACAD SCI USA, V97, P13442, DOI 10.1073/pnas.230434097; Meisel R, 1996, MOL BIOCHEM PARASIT, V81, P259, DOI 10.1016/0166-6851(96)02719-3; PARMLEY SF, 1994, J PARASITOL, V80, P293, DOI 10.2307/3283761; PFEFFERKORN LC, 1980, EXP PARASITOL, V50, P305, DOI 10.1016/0014-4894(80)90034-X; RINDER H, 1995, MOL BIOCHEM PARASIT, V69, P123, DOI 10.1016/0166-6851(94)00211-5; SCHOLTISSEK C, 1979, VIROLOGY, V95, P492, DOI 10.1016/0042-6822(79)90503-8; SIBLEY LD, 1992, GENETICS, V132, P1003; SIBLEY LD, 1992, NATURE, V359, P82, DOI 10.1038/359082a0; Sibley LD, 1996, CURR TOP MICROBIOL, V219, P3; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; TANABE K, 1987, J MOL BIOL, V195, P273, DOI 10.1016/0022-2836(87)90649-8; TIBAYRENC M, 1990, P NATL ACAD SCI USA, V87, P2414, DOI 10.1073/pnas.87.7.2414; TIBAYRENC M, 1991, P NATL ACAD SCI USA, V88, P5129, DOI 10.1073/pnas.88.12.5129; TOMAVO S, 1991, INFECT IMMUN, V59, P3750, DOI 10.1128/IAI.59.10.3750-3753.1991	34	231	243	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2001	294	5540					161	165		10.1126/science.1061888	http://dx.doi.org/10.1126/science.1061888			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11588262				2022-12-01	WOS:000171448800052
J	Lohse, D; Schmitz, B; Versluis, M				Lohse, D; Schmitz, B; Versluis, M			Snapping shrimp make flashing bubbles	NATURE			English	Article							SONOLUMINESCENCE		Univ Twente, Res Ctr Fluid Dynam, NL-7500 AE Enschede, Netherlands; Tech Univ Munich, Lehrstuhl Zool, D-85747 Garching, Germany	University of Twente; Technical University of Munich	Lohse, D (corresponding author), Univ Twente, Res Ctr Fluid Dynam, POB 217, NL-7500 AE Enschede, Netherlands.		Lohse, Detlef/B-4915-2013; Versluis, Michel/F-3541-2011	Lohse, Detlef/0000-0003-4138-2255; Versluis, Michel/0000-0002-2296-1860				Baghdassarian O, 1999, PHYS REV LETT, V83, P2437, DOI 10.1103/PhysRevLett.83.2437; Brennen C.E., 1995, CAVITATION BUBBLE DY, DOI [10.1017/S0022112096230599, DOI 10.1017/S0022112096230599]; CRUM LA, 1994, PHYS TODAY, V47, P22, DOI 10.1063/1.881402; EVEREST FA, 1948, J ACOUST SOC AM, V20, P137, DOI 10.1121/1.1906355; McNamara WB, 1999, NATURE, V401, P772, DOI 10.1038/44536; OHL CD, 1999, THESIS G AUGUST U GO; SCHMITZ B, 2001, PHYSL CRUSTACEAN NER, P521; Versluis M, 2000, SCIENCE, V289, P2114, DOI 10.1126/science.289.5487.2114	8	67	72	5	110	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2001	413	6855					477	478		10.1038/35097152	http://dx.doi.org/10.1038/35097152			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586346				2022-12-01	WOS:000171340500033
J	Dalton, R				Dalton, R			Transgenic corn found growing in Mexico	NATURE			English	News Item																			0	17	26	1	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2001	413	6854					337	337		10.1038/35096714	http://dx.doi.org/10.1038/35096714			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475UY	11574839	Bronze			2022-12-01	WOS:000171188700007
J	van Walraven, C; Mamdani, MM; Wells, PS; Williams, JI				van Walraven, C; Mamdani, MM; Wells, PS; Williams, JI			Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FLUOXETINE; HEMORRHAGE; RISK; ASSOCIATION; DRUGS; TIME	Objectives To determine the association between inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding. Design Retrospective cohort study from population based databases. Setting Ontario, Canada. Participants 317 824 elderly people observed for more than 130 000 person years. The patients started taking an antidepressant between 1992 and 1998 and were grouped by how much the drug inhibited serotonin reuptake. Patients were observed until they stopped the drug, had an upper gastrointestinal bleed, or died or the study ended. Main outcome measure Admission to hospital for acute upper gastrointestinal bleeding. Results Overall, 974 bleeds were observed, with an overall bleeding rate of 7.3 per 1000 person years. After controlling for age or previous gastrointestinal bleeding, the risk of bleeding significantly increased by 10.7% and 9.8%, respectively, with increasing inhibition of serotonin reuptake. Absolute differences in bleeding between antidepressant groups were greatest for octogenarians (low inhibition of serotonin reuptake, 10.6 bleeds/1000 person years v high inhibition of serotonin reuptake, 14.7 bleeds/1000 person years; number needed to harm 244) and those with previous upper gastrointestinal bleeding (low, 28.6 bleeds/1000 person years v high, 40.3 bleeds/1000 person years; number needed to harm 85). Conclusions After age or previous upper gastrointestinal bleeding were controlled for, antidepressants with high inhibition of serotonin reuptake increased the risk of upper gastrointestinal bleeding. These increases are clinically important for elderly patients and those with previous gastrointestinal bleeding.	Ottawa Hosp, Ottawa Hlth Res Inst, Clin Epidemiol Unit, Ottawa, ON K1Y 4E9, Canada; Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Toronto Rehabil Inst, Toronto, ON M5G 2A2, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute	van Walraven, C (corresponding author), Ottawa Hosp, Ottawa Hlth Res Inst, Clin Epidemiol Unit, Civ Campus, Ottawa, ON K1Y 4E9, Canada.	carlv@ohri.ca						ALDERMAN CP, 1992, ANN PHARMACOTHER, V26, P1517, DOI 10.1177/106002809202601205; ARANTH J, 1992, AM J PSYCHIAT, V149, P412; Blatchford O, 1997, BMJ-BRIT MED J, V315, P510, DOI 10.1136/bmj.315.7107.510; Calhoun JW, 1996, AM J PSYCHIAT, V153, P443; de Abajo FJ, 1999, BRIT MED J, V319, P1106, DOI 10.1136/bmj.319.7217.1106; Dickinson T, 2000, BRIT MED J, V320, P1406; Dunn NR, 2000, BRIT MED J, V320, P1405; Grymonpre RE, 1998, ANN PHARMACOTHER, V32, P749, DOI 10.1345/aph.17423; GUNZBERGER DW, 1992, AM J PSYCHIAT, V149, P1751; HENNEKENS CH, 1987, EPIDEMIOLOGY MED, P153; HUMPHRIES JE, 1990, ARCH PATHOL LAB MED, V114, P727; Leung M, 1996, CAN J PSYCHIAT, V41, P604, DOI 10.1177/070674379604100919; Li N, 1997, BLOOD COAGUL FIBRIN, V8, P517, DOI 10.1097/00001721-199711000-00006; OTTERVANGER JD, 1994, AM J PSYCHIAT, V151, P781; Pahor M, 1996, LANCET, V347, P1061, DOI 10.1016/S0140-6736(96)90276-7; PAHOR M, 1994, JAMA-J AM MED ASSOC, V272, P595, DOI 10.1001/jama.272.8.595; Po ALW, 1999, BMJ-BRIT MED J, V319, P1081, DOI 10.1136/bmj.319.7217.1081; Raiford DS, 1996, EPIDEMIOLOGY, V7, P101, DOI 10.1097/00001648-199601000-00018; RODRIGUEZ LAG, 1994, LANCET, V343, P769, DOI 10.1016/S0140-6736(94)91843-0; ROSS SB, 1980, PSYCHOPHARMACOLOGY, V67, P1, DOI 10.1007/BF00427588; Tatsumi M, 1997, EUR J PHARMACOL, V340, P249, DOI 10.1016/S0014-2999(97)01393-9; Weil J, 2000, GUT, V46, P27, DOI 10.1136/gut.46.1.27; Williams D, 2000, BRIT MED J, V320, P1405, DOI 10.1136/bmj.320.7246.1405; Wilmshurst PT, 1996, EYE, V10, P141, DOI 10.1038/eye.1996.26	24	167	167	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 22	2001	323	7314					655	658		10.1136/bmj.323.7314.655	http://dx.doi.org/10.1136/bmj.323.7314.655			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	476LP	11566827	Green Published, Bronze			2022-12-01	WOS:000171228800014
J	Parle, JV; Maisonneuve, P; Sheppard, MC; Boyle, P; Franklyn, JA				Parle, JV; Maisonneuve, P; Sheppard, MC; Boyle, P; Franklyn, JA			Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study	LANCET			English	Article							SUPPRESSIVE THERAPY; FOLLOW-UP; THYROTOXICOSIS; LEVOTHYROXINE; ASSAY; TSH; HYPERTHYROIDISM; THYROXINE; HEART	Background Low serum thyrotropin, in combination with normal concentrations of circulating thyroid hormones, is common, especially in elderly people and in individuals with a history of thyroid disease. We aimed to assess the long-term effects of subclinical hyperthyroidism on mortality. Methods We did a population-based study of mortality in a cohort of 1191 individuals not on thyroxine or antithyroid medication. All participants were aged 60 years or older. We measured concentration of thyrotropin in serum at baseline in 1988-89. We recorded vital status on June 1, 1999, and ascertained causes of death for those who had died. We compared data for causes of death with age-specific, sex-specific, and year-specific data for England and Wales. We also compared mortality within the cohort according to initial thyrotropin measurement. Results During 9733 person-years of follow-up, 509 of 1191 people died, the expected number of deaths being 496 (standardised mortality ratio [SMR] 1.0, 95% CI 0.9-1.1). Mortality from all causes was significantly increased at 2 (SMR 2.1), 3 (2.1), 4 (1.7), and 5 (1.8) years after first measurement in those with low serum thyrotropin (n=71). These increases were largely accounted for by significant increases in mortality due to circulatory diseases (SMR 2.1, 2.2, 1.9, 2.0, at years 2, 3, 4, and 5 respectively). Increases in mortality from all causes in years 2-5 were higher in patients with low serum thyrotropin than in the rest of the cohort (hazard ratios for years 2, 3, 4, and 5 were 2.1, 2.2, 1.8, and 1.8, respectively). This result reflects an increase in mortality from circulatory diseases (hazard ratios at years 2, 3, 4, and 5 were 2.3, 2.6, 2.3, 2.3), and specifically from cardiovascular diseases (hazard ratios at years 2, 3, 4, and 5 were 3.3, 3.0, 2.3, 2.2). Interpretation A single measurement of low serum thyrotropin in individuals aged 60 years or older is associated with increased mortality from all causes, and in particular mortality due to circulatory and cardiovascular diseases.	Univ Birmingham, Div Primary Care Publ & Occupat Hlth, Birmingham, W Midlands, England; Univ Birmingham, Div Med Sci, Birmingham, W Midlands, England; European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy	University of Birmingham; University of Birmingham; IRCCS European Institute of Oncology (IEO)	Franklyn, JA (corresponding author), Univ Birmingham, Queen Elizabeth Hosp, Dept Med, Birmingham B15 2TH, W Midlands, England.		Boyle, Peter/A-4380-2014; Maisonneuve, Patrick/U-9789-2018	Boyle, Peter/0000-0001-6251-0610; Maisonneuve, Patrick/0000-0002-5309-4704				Biondi B, 1996, J CLIN ENDOCR METAB, V81, P4224, DOI 10.1210/jc.81.12.4224; BIONDI B, 1994, J CLIN ENDOCR METAB, V78, P1028, DOI 10.1210/jc.78.5.1028; BIONDI B, 1993, J CLIN ENDOCR METAB, V77, P334, DOI 10.1210/jc.77.2.334; Ching GW, 1996, HEART, V75, P363, DOI 10.1136/hrt.75.4.363; DAVIES PH, 1992, J CLIN ENDOCR METAB, V74, P1189, DOI 10.1210/jc.74.5.1189; EGGERTSEN R, 1988, BRIT MED J, V297, P1586, DOI 10.1136/bmj.297.6663.1586; Franklyn JA, 1998, NEW ENGL J MED, V338, P712, DOI 10.1056/NEJM199803123381103; LADENSON PW, 1993, J CLIN ENDOCR METAB, V77, P332, DOI 10.1210/jc.77.2.332; LEESE GP, 1992, CLIN ENDOCRINOL, V37, P500, DOI 10.1111/j.1365-2265.1992.tb01480.x; PARLE JV, 1991, CLIN ENDOCRINOL, V34, P77; PRESTI CF, 1989, AM HEART J, V117, P967; SANDLER G, 1958, Q J MED, V111, P347; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; SPENCER CA, 1990, J CLIN ENDOCR METAB, V70, P453, DOI 10.1210/jcem-70-2-453; UTIGER RD, 1994, NEW ENGL J MED, V331, P1302, DOI 10.1056/NEJM199411103311909; Uzzan B, 1996, J CLIN ENDOCR METAB, V81, P4278, DOI 10.1210/jc.81.12.4278; WOEBER KA, 1992, NEW ENGL J MED, V327, P94	17	498	521	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 15	2001	358	9285					861	865		10.1016/S0140-6736(01)06067-6	http://dx.doi.org/10.1016/S0140-6736(01)06067-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474CP	11567699				2022-12-01	WOS:000171087000006
J	Deitsch, KW; Calderwood, MS; Wellems, TE				Deitsch, KW; Calderwood, MS; Wellems, TE			Malaria - Cooperative silencing elements in var genes	NATURE			English	Article							PLASMODIUM-FALCIPARUM; ANTIGENIC VARIATION; ERYTHROCYTES; TRANSCRIPTION; EXPRESSION; SWITCHES		NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Deitsch, KW (corresponding author), NIAID, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000483, Z01AI000483] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Deitsch KW, 1999, MOL BIOCHEM PARASIT, V101, P107, DOI 10.1016/S0166-6851(99)00062-6; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Firestein R, 2000, MOL CELL BIOL, V20, P4900, DOI 10.1128/MCB.20.13.4900-4909.2000; Newbold CI, 1999, CURR OPIN MICROBIOL, V2, P420, DOI 10.1016/S1369-5274(99)80074-5; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Scherf A, 2001, CELL MICROBIOL, V3, P125, DOI 10.1046/j.1462-5822.2001.00109.x; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1	10	172	174	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2001	412	6850					875	876		10.1038/35091146	http://dx.doi.org/10.1038/35091146			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528468				2022-12-01	WOS:000170689000034
J	Mollereau, B; Dominguez, M; Webel, R; Colley, NJ; Keung, B; de Celis, JF; Desplan, C				Mollereau, B; Dominguez, M; Webel, R; Colley, NJ; Keung, B; de Celis, JF; Desplan, C			Two-step process for photoreceptor formation in Drosophila	NATURE			English	Article							CELL-FATE; RHODOPSIN; EYE; R7; EXPRESSION; PROTEIN; GENE; IDENTIFICATION; RECEPTOR; COMPLEX	The formation of photoreceptor cells (PRCs) in Drosophila serves as a paradigm for understanding neuronal determination and differentiation. During larval stages, a precise series of sequential inductive processes leads to the recruitment of eight distinct PRCs (R1-R8)(1). But, final photoreceptor differentiation, including rhabdomere morphogenesis and opsin expression, is completed four days later, during pupal development(2,3). It is thought that photoreceptor cell fate is irreversibly established during larval development, when each photoreceptor expresses a particular set of transcriptional regulators and sends its projection to different layers of the optic lobes. Here, we show that the spalt (sal) gene complex(4-7) encodes two transcription factors that are required late in pupation for photoreceptor differentiation. In the absence of the sal complex, rhabdomere morphology and expression of opsin genes in the inner PRCs R7 and R8 are changed to become identical to those of outer R1-R6 PRCs. However, these cells maintain their normal projections to the medulla part of the optic lobe, and not to the lamina where outer PRCs project. These data indicate that photoreceptor differentiation occurs as a two-step process. First, during larval development, the photoreceptor neurons become committed and send their axonal projections to their targets in the brain. Second, terminal differentiation is executed during pupal development and the photoreceptors adopt their final cellular properties.	NYU, Dept Biol, New York, NY 10003 USA; UMH, CSIC, Inst Neurociencias, San Juan Alicante 03550, Spain; Univ Wisconsin, Dept Ophthalmol, Madison, WI 53792 USA; Univ Wisconsin, Dept Visual Sci & Genet, Madison, WI 53792 USA; Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	New York University; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	de Celis, JF (corresponding author), NYU, Dept Biol, New York, NY 10003 USA.		Dominguez, Maria/G-2171-2014; Mollereau, Bertrand/S-4447-2017; de+Celis, Jose/AAE-8142-2019	Dominguez, Maria/0000-0002-3329-7862; Mollereau, Bertrand/0000-0003-4710-8185; de Celis, Jose F./0000-0003-4808-9844; Desplan, Claude/0000-0002-6914-1413	NEI NIH HHS [R01 EY008768] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008768] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Barrio R, 1999, DEV BIOL, V215, P33, DOI 10.1006/dbio.1999.9434; BEGEMANN G, 1995, DEVELOPMENT, V121, P225; Cadavid ALM, 2000, DEVELOPMENT, V127, P1727; CAGAN RL, 1989, DEV BIOL, V136, P346, DOI 10.1016/0012-1606(89)90261-3; Chang HY, 2000, SCIENCE, V290, P1978, DOI 10.1126/science.290.5498.1978; Chou WH, 1996, NEURON, V17, P1101, DOI 10.1016/S0896-6273(00)80243-3; Chou WH, 1999, DEVELOPMENT, V126, P607; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; COLLEY NJ, 1995, P NATL ACAD SCI USA, V92, P3070, DOI 10.1073/pnas.92.7.3070; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; Dominguez M, 1998, CURR BIOL, V8, P1039, DOI 10.1016/S0960-9822(98)70441-5; Elstob PR, 2001, DEVELOPMENT, V128, P723; FORTINI ME, 1991, CELL TISSUE RES, V265, P185, DOI 10.1007/BF00318153; Freeman M, 1997, DEVELOPMENT, V124, P261; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Hardie R.C., 1985, Progress in Sensory Physiology, V5, P1; Kauffmann RC, 1996, GENE DEV, V10, P2167, DOI 10.1101/gad.10.17.2167; KIMMEL BE, 1990, GENE DEV, V4, P712, DOI 10.1101/gad.4.5.712; KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x; Kumar JP, 1997, DEV BIOL, V188, P43, DOI 10.1006/dbio.1997.8636; Kumar JP, 1995, DEVELOPMENT, V121, P4359; Mollereau B, 2000, MECH DEVELOP, V93, P151, DOI 10.1016/S0925-4773(00)00287-2; Papatsenko D, 1997, DEVELOPMENT, V124, P1665; PERRY MM, 1968, J MORPHOL, V124, P227, DOI 10.1002/jmor.1051240208; PORTER JA, 1993, J CELL BIOL, V122, P601, DOI 10.1083/jcb.122.3.601; Rusten TE, 2001, DEVELOPMENT, V128, P711; Sheng GJ, 1997, GENE DEV, V11, P1122, DOI 10.1101/gad.11.9.1122; Stowers RS, 1999, GENETICS, V152, P1631; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; VENKATESH TR, 1985, TRENDS NEUROSCI, V8, P251, DOI 10.1016/0166-2236(85)90098-0	30	101	101	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2001	412	6850					911	913		10.1038/35091076	http://dx.doi.org/10.1038/35091076			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528479				2022-12-01	WOS:000170689000045
J	Chiosis, G; Boneca, IG				Chiosis, G; Boneca, IG			Selective cleavage of D-Ala-D-Lac by small molecules: Re-sensitizing resistant bacteria to vancomycin	SCIENCE			English	Article							BIOSYNTHESIS; MECHANISM; PLASMID	Pathogenic enterococci are becoming resistant to currently available antibiotics, including vancomycin, the drug of last resort for Gram-positive infections. Enterococci pose a significant public health threat, not least because of the risk of transferring vancomycin resistance to the ubiquitous Staphylococcus aureus. Vancomycin resistance is manifested by cell wall peptidoglycan precursors with altered termini that cannot bind the antibiotic. Small molecules with well-oriented nucleophile-electrophile assembly and complementary chirality to the peptidoglycan termini were identified as catalytic and selective cleavers of the peptidoglycan precursor depsipeptide. These molecules were tested in combination with vancomycin and were found to re-sensitize vancomycin-resistant bacteria to the antibiotic.	Columbia Univ, Dept Chem, New York, NY 10027 USA; Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA	Columbia University; Rockefeller University	Chiosis, G (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.	chiosisg@mskmail.mskcc.org; bonecai@pasteur.fr	Boneca, Ivo G/H-1677-2014	Boneca, Ivo G/0000-0001-8122-509X				Abraham EP, 1940, NATURE, V146, P837, DOI 10.1038/146837a0; Arthur M, 1996, MOL MICROBIOL, V21, P33, DOI 10.1046/j.1365-2958.1996.00617.x; BUGG TDH, 1991, BIOCHEMISTRY-US, V30, P10408, DOI 10.1021/bi00107a007; deJonge BLM, 1996, MICROB DRUG RESIST, V2, P225, DOI 10.1089/mdr.1996.2.225; French GL, 1998, CLIN INFECT DIS, V27, pS75, DOI 10.1086/514910; Ge M, 1999, SCIENCE, V284, P507, DOI 10.1126/science.284.5413.507; HANDWERGER S, 1990, ANTIMICROB AGENTS CH, V34, P358, DOI 10.1128/AAC.34.2.358; JACOB AE, 1974, J BACTERIOL, V117, P360, DOI 10.1128/JB.117.2.360-372.1974; NESTLER HP, 1994, J ORG CHEM, V59, P4723, DOI 10.1021/jo00096a008; OHLMEYER MHJ, 1993, P NATL ACAD SCI USA, V90, P10922, DOI 10.1073/pnas.90.23.10922; Perl Trish M., 1999, American Journal of Medicine, V106, p26S, DOI 10.1016/S0002-9343(98)00354-4; REYNOLDS PE, 1989, EUR J CLIN MICROBIOL, V8, P943, DOI 10.1007/BF01967563; Sundram UN, 1996, J AM CHEM SOC, V118, P13107, DOI 10.1021/ja9621298; Tenover FC, 2001, EMERG INFECT DIS, V7, P327, DOI 10.3201/eid0702.010237; WALSH CT, 1993, SCIENCE, V261, P308, DOI 10.1126/science.8392747; Woodford N, 1998, J MED MICROBIOL, V47, P849, DOI 10.1099/00222615-47-10-849; WRIGHT GD, 1992, ACCOUNTS CHEM RES, V25, P468, DOI 10.1021/ar00022a006; Xu R, 1999, J AM CHEM SOC, V121, P4898, DOI 10.1021/ja990240i	18	52	54	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1484	1487		10.1126/science.1060324	http://dx.doi.org/10.1126/science.1060324			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520986				2022-12-01	WOS:000170616000043
J	Dhanasekaran, SM; Barrette, TR; Ghosh, D; Shah, R; Varambally, S; Kurachi, K; Pienta, KJ; Rubin, MA; Chinnaiyan, AM				Dhanasekaran, SM; Barrette, TR; Ghosh, D; Shah, R; Varambally, S; Kurachi, K; Pienta, KJ; Rubin, MA; Chinnaiyan, AM			Delineation of prognostic biomarkers in prostate cancer	NATURE			English	Article							MOLECULAR CLASSIFICATION; EXPRESSION; PROGRESSION; GENETICS	Prostate cancer is the most frequently diagnosed cancer in American men(1,2). Screening for prostate-specific antigen (PSA) has led to earlier detection of prostate cancer(3), but elevated serum PSA levels may be present in non-malignant conditions such as benign prostatic hyperlasia (BPH). Characterization of gene-expression profiles that molecularly distinguish prostatic neoplasms may identify genes involved in prostate carcinogenesis, elucidate clinical biomarkers, and lead to an improved classification of prostate cancer(4-6). Using microarrays of complementary DNA, we examined gene-expression profiles of more than 50 normal and neoplastic prostate specimens and three common prostate-cancer cell lines. Signature expression profiles of normal adjacent prostate (NAP), BPH, localized prostate cancer, and metastatic, hormone-refractory prostate cancer were determined. Here we establish many associations between genes and prostate cancer. We assessed two of these genes-hepsin, a transmembrane serine protease, and pim-1, a serine/threonine kinase-at the protein level using tissue microarrays consisting of over 700 clinically stratified prostate-cancer specimens. Expression of hepsin and pim-1 proteins was significantly correlated with measures of clinical outcome. Thus, the integration of cDNA microarray, high-density tissue microarray, and linked clinical and pathology data is a powerful approach to molecular profiling of human cancer.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	; Pienta, Kenneth/E-7679-2015	Dhanasekaran, saravana mohan/0000-0002-0489-2224; Ghosh, Debashis/0000-0001-6618-1316; Rubin, Mark/0000-0002-8321-9950; Varambally, Sooryanarayana/0000-0002-2277-1127; Pienta, Kenneth/0000-0002-4138-2186				Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Barry MJ, 2001, NEW ENGL J MED, V344, P1373, DOI 10.1056/NEJM200105033441806; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; BUTTYAN R, 1987, PROSTATE, V11, P327, DOI 10.1002/pros.2990110405; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elek J, 2000, IN VIVO, V14, P173; Emmert-Buck MR, 2000, AM J PATHOL, V156, P1109, DOI 10.1016/S0002-9440(10)64979-6; GLEASON DF, 1992, HUM PATHOL, V23, P273, DOI 10.1016/0046-8177(92)90108-F; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Liotta L, 2000, NAT REV GENET, V1, P48, DOI 10.1038/35049567; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Perrone EE, 2000, JNCI-J NATL CANCER I, V92, P937, DOI 10.1093/jnci/92.11.937; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Rubin MA, 2000, CLIN CANCER RES, V6, P1038; Ruijter E, 1999, ENDOCR REV, V20, P22, DOI 10.1210/er.20.1.22; Shurbaji MS, 1996, HUM PATHOL, V27, P917, DOI 10.1016/S0046-8177(96)90218-X; Tomita K, 2000, CANCER RES, V60, P3650; TSUJI A, 1991, J BIOL CHEM, V266, P16948	20	1328	1471	3	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 23	2001	412	6849					822	826		10.1038/35090585	http://dx.doi.org/10.1038/35090585			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518967	Green Published			2022-12-01	WOS:000170577200038
J	Peretz, D; Williamson, RA; Kaneko, K; Vergara, J; Leclerc, E; Schmitt-Ulms, G; Mehlhorn, IR; Legname, G; Wormald, MR; Rudd, PM; Dwek, RA; Burton, DR; Prusiner, SB				Peretz, D; Williamson, RA; Kaneko, K; Vergara, J; Leclerc, E; Schmitt-Ulms, G; Mehlhorn, IR; Legname, G; Wormald, MR; Rudd, PM; Dwek, RA; Burton, DR; Prusiner, SB			Antibodies inhibit prion propagation and clear cell cultures of prion infectivity	NATURE			English	Article							DOMINANT-NEGATIVE INHIBITION; MONOCLONAL-ANTIBODIES; HAMSTER PRP; PROTEIN PRP; SCRAPIE; CONVERSION; REPLICATION; PATHOLOGY; MODEL	Prions are the transmissible pathogenic agents responsible for diseases such as scrapie and bovine spongiform encephalopathy. In the favoured model of prion replication, direct interaction between the pathogenic prion protein (PrPSc) template and endogenous cellular prion protein (PrPC) is proposed to drive the formation of nascent infectious prions(1,2). Reagents specifically binding either prion-protein conformer may interrupt prion production by inhibiting this interaction. We examined the ability of several recombinant antibody antigen-binding fragments (Fabs) to inhibit prion propagation in cultured mouse neuroblastoma cells (ScN2a) infected with PrPSc. Here we show that antibodies binding cell-surface PrPC inhibit PrPSc formation in a dose-dependent manner. In cells treated with the most potent antibody, Fab D18, prion replication is abolished and pre-existing PrPSc is rapidly cleared, suggesting that this antibody may cure established infection. The potent activity of Fab D18 is associated with its ability to better recognize the total population of PrPC molecules on the cell surface, and with the location of its epitope on PrPC. Our observations support the use of antibodies in the prevention and treatment of prion diseases and identify a region of PrPC for drug targeting.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Oxford, Dept Biochem, Glycobiol Inst, Oxford OX1 3QU, England	Scripps Research Institute; Scripps Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Oxford	Williamson, RA (corresponding author), Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA.	anthony@scripps.edu; burton@scripps.edu	Wormald, Mark R/G-2785-2011; Legname, Giuseppe/C-1723-2012	Wormald, Mark R/0000-0002-4853-2773; Legname, Giuseppe/0000-0003-0716-4393				Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Caughey WS, 1998, P NATL ACAD SCI USA, V95, P12117, DOI 10.1073/pnas.95.21.12117; Chabry J, 1999, J VIROL, V73, P6245, DOI 10.1128/JVI.73.8.6245-6250.1999; CHUONG CM, 1982, P NATL ACAD SCI-BIOL, V79, P4234, DOI 10.1073/pnas.79.13.4234; Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178; James TL, 1997, P NATL ACAD SCI USA, V94, P10086, DOI 10.1073/pnas.94.19.10086; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; Leclerc E, 2001, EMBO J, V20, P1547, DOI 10.1093/emboj/20.7.1547; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Perrier V, 2000, P NATL ACAD SCI USA, V97, P6073, DOI 10.1073/pnas.97.11.6073; Petrescu AJ, 1999, GLYCOBIOLOGY, V9, P343, DOI 10.1093/glycob/9.4.343; PRIOLA SA, 1995, J VIROL, V69, P7754, DOI 10.1128/JVI.69.12.7754-7758.1995; Priola SA, 2001, J VIROL, V75, P4673, DOI 10.1128/JVI.75.10.4673-4680.2001; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RACE RE, 1987, J GEN VIROL, V68, P1391, DOI 10.1099/0022-1317-68-5-1391; Rudd PM, 2001, BIOCHEMISTRY-US, V40, P3759, DOI 10.1021/bi002625f; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SCOTT M, 1993, CELL, V73, P979, DOI 10.1016/0092-8674(93)90275-U; Supattapone S, 1999, P NATL ACAD SCI USA, V96, P14529, DOI 10.1073/pnas.96.25.14529; Supattapone S, 1999, CELL, V96, P869, DOI 10.1016/S0092-8674(00)80596-6; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Williamson RA, 1996, P NATL ACAD SCI USA, V93, P7279, DOI 10.1073/pnas.93.14.7279; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Xu DL, 2000, CELL IMMUNOL, V200, P16, DOI 10.1006/cimm.2000.1617; Zulianello L, 2000, J VIROL, V74, P4351, DOI 10.1128/JVI.74.9.4351-4360.2000	29	431	467	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2001	412	6848					739	743		10.1038/35089090	http://dx.doi.org/10.1038/35089090			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507642				2022-12-01	WOS:000170450200046
J	SQUYRES, SW; KASTING, JF				SQUYRES, SW; KASTING, JF			EARLY MARS - HOW WARM AND HOW WET	SCIENCE			English	Article							SMALL MARTIAN VALLEYS; TERRESTRIAL PLANETS; CHAOTIC OBLIQUITY; CLIMATIC CHANGE; MASS-LOSS; EVOLUTION; EARTH; ORIGIN; ATMOSPHERE; SURFACE	Early in its history, Mars underwent fluvial erosion that has been interpreted as evidence for a warmer, wetter climate. However, no atmosphere composed of only CO2 and H2O appears capable of producing mean planetary temperatures even close to 0 degrees C. Rather than by precipitation, aquifer recharge and ground water seepage may have been enabled by hydrothermal convection driven by geothermal heat and heat associated with impacts. Some climatic warming was probably necessary to allow water to flow for long distances across the surface. Modest warming could be provided by even a low-pressure CO2 atmosphere if it was supplemented with small amounts of CH4, NH3, or SO2. Episodic excursions to high obliquities may also have raised temperatures over some portions of the planet's surface.	PENN STATE UNIV,DEPT GEOSCI,STATE COLL,PA 16802	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	SQUYRES, SW (corresponding author), CORNELL UNIV,CTR RADIOPHYS & SPACE RES,ITHACA,NY 14853, USA.		Kasting, James/AAF-6851-2020					ANDERS E, 1977, SCIENCE, V198, P453, DOI 10.1126/science.198.4316.453; Baker V.R., 1992, CHANNELS VALLEY NETW, P493; BAROSS JA, 1985, ORIGINS LIFE EVOL B, V15, P327, DOI 10.1007/BF01808177; Biemann K., 1977, Journal of Geophysical Research, V82, P4641, DOI 10.1029/JS082i028p04641; BOGARD DD, 1983, SCIENCE, V221, P651, DOI 10.1126/science.221.4611.651; BOOTHROYD AI, 1991, ASTROPHYS J, V377, P318, DOI 10.1086/170361; BRAKENRIDGE GR, 1985, GEOLOGY, V13, P859, DOI 10.1130/0091-7613(1985)13<859:AHSOMO>2.0.CO;2; Brown L.L., 1993, WORKSHOP EARLY MARS, P3; Brutsaert W, 2013, EVAPORATION ATMOSPHE; CARR MH, 1983, ICARUS, V56, P476, DOI 10.1016/0019-1035(83)90168-9; CARR MH, 1981, ICARUS, V48, P91, DOI 10.1016/0019-1035(81)90156-1; CARR MH, 1979, J GEOPHYS RES, V84, P2995, DOI 10.1029/JB084iB06p02995; CHAPMAN CR, 1977, ANNU REV EARTH PL SC, V5, P515, DOI 10.1146/annurev.ea.05.050177.002503; CHEN JH, 1986, GEOCHIM COSMOCHIM AC, V50, P955, DOI 10.1016/0016-7037(86)90376-5; CLIFFORD SM, 1981, CONTRIBUTION LUNAR P, V441, P46; CLIFFORD SM, 1985, J GEOPHYS RES S, V90, pD144; CORADINI A, 1983, PHYS EARTH PLANET IN, V31, P145, DOI 10.1016/0031-9201(83)90106-1; CRADDOCK RA, 1990, J GEOPHYS RES-SOLID, V95, P14265, DOI 10.1029/JB095iB09p14265; GIERASCH PJ, 1973, J ATMOS SCI, V30, P1502, DOI 10.1175/1520-0469(1973)030<1502:APVATC>2.0.CO;2; GOLDREICH P, 1969, J GEOPHYS RES, V74, P2555, DOI 10.1029/JB074i010p02555; GOLDSPIEL JM, 1993, ICARUS, V105, P479, DOI 10.1006/icar.1993.1143; GOLDSPIEL JM, 1991, ICARUS, V89, P392, DOI 10.1016/0019-1035(91)90186-W; GOLDSPIEL JM, 1993, ICARUS, V106, P346, DOI 10.1006/icar.1993.1177; GOLDSPIEL JM, 1994, THESIS CORNELL U ITH; GOUGH DO, 1981, SOL PHYS, V74, P21, DOI 10.1007/BF00151270; GRAEDEL TE, 1991, GEOPHYS RES LETT, V18, P1881, DOI 10.1029/91GL02314; GULICK VC, 1990, J GEOPHYS RES-SOLID, V95, P14325, DOI 10.1029/JB095iB09p14325; GULICK VC, 1993, WORKSHOP EARLY MARS, P12; GULICK VC, 1992, LUNAR PLANET SCI, V22, P509; HARTMANN WK, 1970, ICARUS, V12, P131, DOI 10.1016/0019-1035(70)90039-4; HIGGINS CG, 1982, GEOLOGY, V10, P147, DOI 10.1130/0091-7613(1982)10<147:DSDBSO>2.0.CO;2; HUNTEN DM, 1987, ICARUS, V69, P532, DOI 10.1016/0019-1035(87)90022-4; HUNTEN DM, 1993, SCIENCE, V259, P915, DOI 10.1126/science.259.5097.915; KASTING JF, 1991, ICARUS, V94, P1, DOI 10.1016/0019-1035(91)90137-I; KOCHEL RC, 1985, J GEOPHYS RES S, V91, pE175; LAITY JE, 1985, GEOL SOC AM BULL, V96, P203, DOI 10.1130/0016-7606(1985)96<203:SPATDO>2.0.CO;2; LASKAR J, 1993, NATURE, V361, P608, DOI 10.1038/361608a0; LEWIS JS, 1972, ICARUS, V16, P241, DOI 10.1016/0019-1035(72)90071-1; MATSUI T, 1986, NATURE, V319, P303, DOI 10.1038/319303a0; MCKAY CP, 1991, NATURE, V352, P489, DOI 10.1038/352489a0; MCSWEEN HY, 1985, REV GEOPHYS, V23, P391, DOI 10.1029/RG023i004p00391; MELOSH HJ, 1989, NATURE, V338, P487, DOI 10.1038/338487a0; NEWMAN MJ, 1977, SCIENCE, V198, P1035, DOI 10.1126/science.198.4321.1035; NEWSOM HE, 1980, ICARUS, V44, P207, DOI 10.1016/0019-1035(80)90066-4; OWEN T, 1979, NATURE, V277, P640, DOI 10.1038/277640a0; PIERI D, 1976, ICARUS, V27, P25, DOI 10.1016/0019-1035(76)90182-2; PIERI DC, 1980, SCIENCE, V210, P895, DOI 10.1126/science.210.4472.895; PLAUT JJ, 1988, ICARUS, V75, P357; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; POLLACK JB, 1979, ICARUS, V37, P479, DOI 10.1016/0019-1035(79)90012-5; POSTAWKO SE, 1986, J GEOPHYS RES-SOLID, V91, pD431, DOI 10.1029/JB091iB04p0D431; SAGAN C, 1973, SCIENCE, V181, P1045, DOI 10.1126/science.181.4104.1045; SAGAN C, 1972, SCIENCE, V177, P52, DOI 10.1126/science.177.4043.52; SAGAN C, 1991, B AM ASTRON SOC, V23, P1211; Schubert G., 1992, MARS, P147, DOI [10.2307/j.ctt207g59v.9, DOI 10.2307/J.CTT207G59V.9]; SHIH CY, 1982, GEOCHIM COSMOCHIM AC, V46, P2323, DOI 10.1016/0016-7037(82)90205-8; SLOAN CE, 1976, 979 US GEOL SURV PRO; TOUMA J, 1993, SCIENCE, V259, P1294, DOI 10.1126/science.259.5099.1294; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; WALLACE D, 1979, ICARUS, V39, P385, DOI 10.1016/0019-1035(79)90148-9; WARD WR, 1974, J GEOPHYS RES, V79, P3375, DOI 10.1029/JC079i024p03375; Wasson J.T., 1979, ASTEROIDS, P926; WETHERILL GW, 1985, SCIENCE, V228, P877, DOI 10.1126/science.228.4701.877; Wetherill GW, 1986, ORIGIN MOON, P519; Wood C.A., 1981, P LUNAR PLANET SCI C, V12B, P1359	65	207	208	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 5	1994	265	5173					744	749		10.1126/science.265.5173.744	http://dx.doi.org/10.1126/science.265.5173.744			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PA372	11539185				2022-12-01	WOS:A1994PA37200022
J	OHMOTO, H; KAKEGAWA, T; LOWE, DR				OHMOTO, H; KAKEGAWA, T; LOWE, DR			3.4-BILLION-YEAR-OLD BIOGENIC PYRITES FROM BARBERTON, SOUTH-AFRICA - SULFUR ISOTOPE EVIDENCE	SCIENCE			English	Article							BEARING	Laser ablation mass spectroscopy analyses of sulfur isotopic compositions of microscopic-sized grains of pyrite that formed about 3.4 billion years ago in the Barberton Greenstone Belt, South Africa, show that the pyrite formed by bacterial reduction of seawater sulfate. These data imply that by about 3.4 billion years ago sulfate-reducing bacteria had become active, the oceans were rich in sulfate, and the atmosphere contained appreciable amounts (>>10(-13) of the present atmospheric level) of free oxygen.	STANFORD UNIV,DEPT GEOL,STANFORD,CA 94305; TOHOKU UNIV,INST MINERAL PETROL & ECON GEOL,SENDAI,MIYAGI 980,JAPAN	Stanford University; Tohoku University	OHMOTO, H (corresponding author), PENN STATE UNIV,DEPT GEOSCI,UNIV PK,PA 16802, USA.				NCI NIH HHS [NCA2-332] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AULT WV, 1963, BIOGEOCHEMISTRY SULF, P16; CROWE DE, 1990, GEOCHIM COSMOCHIM AC, V54, P2075, DOI 10.1016/0016-7037(90)90272-M; Jones L. M., 1986, TERRA COGNITA, V6, P263; JORGENSEN BB, 1977, LIMNOL OCEANOGR, V22, P657, DOI 10.4319/lo.1977.22.4.0657; KELLEY SP, 1990, GEOCHIM COSMOCHIM AC, V54, P883, DOI 10.1016/0016-7037(90)90381-T; LOWE DR, 1977, J GEOL, V85, P699, DOI 10.1086/628358; OHMOTO H, 1987, NATURE, V328, P244, DOI 10.1038/328244a0; Ohmoto H., 1979, GEOCHEMISTRY HYDROTH, P509; OHMOTO H, 1990, STABLE ISOTOPES FLUI, P70; Ohmoto H, 1992, EARLY ORGANIC EVOLUT, P378, DOI DOI 10.1007/978-3-642-76884-2_29; WALKER JCG, 1985, PRECAMBRIAN RES, V28, P205, DOI 10.1016/0301-9268(85)90031-2	11	126	132	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 22	1993	262	5133					555	557		10.1126/science.11539502	http://dx.doi.org/10.1126/science.11539502			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC935	11539502				2022-12-01	WOS:A1993MC93500036
J	GRUN, E; ZOOK, HA; BAGUHL, M; FECHTIG, H; HANNER, MS; KISSEL, J; LINDBLAD, BA; LINKERT, D; LINKERT, G; MANN, IB; MCDONNELL, JAM; MORFILL, GE; POLANSKEY, C; RIEMANN, R; SCHWEHM, G; SIDDIQUE, N				GRUN, E; ZOOK, HA; BAGUHL, M; FECHTIG, H; HANNER, MS; KISSEL, J; LINDBLAD, BA; LINKERT, D; LINKERT, G; MANN, IB; MCDONNELL, JAM; MORFILL, GE; POLANSKEY, C; RIEMANN, R; SCHWEHM, G; SIDDIQUE, N			ULYSSES DUST MEASUREMENTS NEAR JUPITER	SCIENCE			English	Article							GOSSAMER RING	Submicrometer- to micrometer-sized particles were recorded by the Ulysses dust detector within 40 days of the Jupiter flyby. Nine impacts were recorded within 50 Jupiter radii with most of them recorded after closest approach. Three of these impacts are consistent with particles on prograde orbits around Jupiter and the rest are believed to have resulted from gravitationally focused interplanetary dust. From the ratio of the impact rate before the Jupiter flyby to the impact rate after the Jupiter flyby it is concluded that interplanetary dust particles at the distance of Jupiter move on mostly retrograde orbits. On 10 March 1992, Ulysses passed through an intense dust stream. The dust detector recorded 126 impacts within 26 hours. The stream particles were moving on highly inclined and apparently hyperbolic orbits with perihelion distances of >5 astronomical units. Interplanetary dust is lost rather quickly from the solar system through collisions and other mechanisms and must be almost continuously replenished to maintain observed abundances. Dust flux measurements, therefore, give evidence of the recent rates of production from sources such as comets, asteroids, and moons, as well as the possible presence of interstellar grains.	NASA, LYNDON B JOHNSON SPACE CTR, HOUSTON, TX 77058 USA; JET PROP LAB, PASADENA, CA 91109 USA; MAX PLANCK INST AERON, W-3411 KATLENBURG DUHM, GERMANY; UNIV KENT, CANTERBURY CT2 7NR, ENGLAND; MAX PLANCK INST EXTRATERRESTR PHYS, W-8046 GARCHING, GERMANY; EUROPEAN SPACE AGCY, EUROPEAN SPACE TECHNOL CTR, 2200 AG NOORDWIJK, NETHERLANDS	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Max Planck Society; University of Kent; Max Planck Society; European Space Agency	GRUN, E (corresponding author), MAX PLANCK INST NUCL PHYS, W-6900 HEIDELBERG 1, GERMANY.							BAGUHL M, IN PRESS P HYPERVELO; DIVINE N, 1992, 52179214 JET PROP LA; GOLLER JR, 1989, PLANET SPACE SCI, V37, P1197, DOI 10.1016/0032-0633(89)90014-7; GRUN E, 1992, ASTRON ASTROPHYS SUP, V92, P411; GRUN E, 1992, GEOPHYS RES LETT, V19, P1311, DOI 10.1029/92GL00629; Grun E., 1984, PLANETARY RINGS, P275; GURNETT DA, 1983, ICARUS, V53, P236, DOI 10.1016/0019-1035(83)90145-8; HOLZER TE, 1989, ANNU REV ASTRON ASTR, V27, P199; HUMES DH, 1974, J GEOPHYS RES, V79, P3677, DOI 10.1029/JA079i025p03677; HUMES DH, 1980, J GEOPHYS RES-SPACE, V85, P5841, DOI 10.1029/JA085iA11p05841; KAISER ML, COMMUNICATION; MARSDEN BG, 1989, CATALOGUE COMETARY O; NORTHROP TG, 1989, ICARUS, V79, P101, DOI 10.1016/0019-1035(89)90110-3; SHOWALTER MR, 1985, NATURE, V316, P526, DOI 10.1038/316526a0; SMITH BA, 1979, SCIENCE, V204, P951, DOI 10.1126/science.204.4396.951; SMITH EJ, 1992, SCIENCE, V257, P1503, DOI 10.1126/science.257.5076.1503; STONE RG, 1992, ASTRON ASTROPHYS SUP, V92, P291	17	40	40	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	1992	257	5076					1550	1552		10.1126/science.11538054	http://dx.doi.org/10.1126/science.11538054			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JM570	11538054				2022-12-01	WOS:A1992JM57000033
J	DEBERGH, C; BEZARD, B; OWEN, T; CRISP, D; MAILLARD, JP; LUTZ, BL				DEBERGH, C; BEZARD, B; OWEN, T; CRISP, D; MAILLARD, JP; LUTZ, BL			DEUTERIUM ON VENUS - OBSERVATIONS FROM EARTH	SCIENCE			English	Article							ATMOSPHERE; HYDROGEN; ABUNDANCE; ESCAPE; MODEL; MARS; WET	Absorption lines of HDO and H2O have been detected in a 0.23-wave number resolution spectrum of the dark side of Venus in the interval 2.34 to 2.43 micrometers, where the atmosphere is sounded in the altitude range from 32 to 42 kilometers (8 to 3 bars). The resulting value of the deuterium-to-hydrogen ratio (D/H) is 120 +/- 40 times the telluric ratio, providing unequivocal confirmation of in situ Pioneer Venus mass spectrometer measurements that were in apparent conflict with an upper limit set from International Ultraviolet Explorer spectra. The 100-fold enrichment of the D/H ratio on Venus compared to Earth is thus a fundamental constraint on models for its atmospheric evolution.	LOWELL OBSERV,FLAGSTAFF,AZ 86001; UNIV HAWAII,INST ASTRON,HONOLULU,HI 96822; CALTECH,JET PROP LAB,PASADENA,CA 91109; INST ASTROPHYS,F-75014 PARIS,FRANCE	University of Hawaii System; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); UDICE-French Research Universities; Sorbonne Universite	DEBERGH, C (corresponding author), OBSERV PARIS,DEPT RECH SPATIALE,SECT MEUDON,F-92195 MEUDON,FRANCE.		Crisp, David/F-6642-2017	Crisp, David/0000-0002-4573-9998; Bezard, Bruno/0000-0002-5433-5661				ALLEN D, 1990, 4962 INT ASTR UN CIR; ALLEN DA, 1984, NATURE, V307, P222, DOI 10.1038/307222a0; ANDERS E, 1977, SCIENCE, V198, P453, DOI 10.1126/science.198.4316.453; BERTAUX JL, 1989, NATURE, V338, P567, DOI 10.1038/338567a0; BEZARD B, 1990, NATURE, V345, P508, DOI 10.1038/345508a0; CHYBA CF, 1987, NATURE, V330, P632, DOI 10.1038/330632a0; CHYBA CF, 1990, NATURE, V343, P129, DOI 10.1038/343129a0; CRAIG H, 1961, SCIENCE, V133, P1833, DOI 10.1126/science.133.3467.1833; CRISP D, 1986, ICARUS, V67, P484, DOI 10.1016/0019-1035(86)90126-0; desBergh C., 1989, B AM ASTRON SOC, V21, P926; DONAHUE T, 1989, NATURE, V340, P514; DONAHUE TM, 1989, NATURE, V340, P513, DOI 10.1038/340513b0; DONAHUE TM, 1982, SCIENCE, V216, P630, DOI 10.1126/science.216.4546.630; Esposito L. W., 1983, Venus, P484; GRINSPOON DH, 1988, ICARUS, V74, P21, DOI 10.1016/0019-1035(88)90028-0; GRINSPOON DH, 1987, SCIENCE, V238, P1702, DOI 10.1126/science.238.4834.1702; HARTLE RE, 1983, J GEOPHYS RES LETT, V10, P1965; HUNTEN DM, 1989, ORIGIN EVOLUTION PLA, P00386; IP WH, 1988, ICARUS, V74, P47, DOI 10.1016/0019-1035(88)90030-9; KAULA WM, 1990, SCIENCE, V247, P1191, DOI 10.1126/science.247.4947.1191; KUMAR S, 1985, ICARUS, V62, P494, DOI 10.1016/0019-1035(85)90189-7; Lewis J. S., 1970, Earth and Planetary Science Letters, V10, P73, DOI 10.1016/0012-821X(70)90066-X; MCELROY MB, 1982, SCIENCE, V215, P1614, DOI 10.1126/science.215.4540.1614; OWEN T, 1988, SCIENCE, V240, P1767, DOI 10.1126/science.240.4860.1767; REVERCOMB HE, 1985, ICARUS, V61, P521, DOI 10.1016/0019-1035(85)90140-X; RODRIGUEZ JM, 1984, PLANET SPACE SCI, V32, P1235, DOI 10.1016/0032-0633(84)90067-9; Taylor HA, 1980, J GEOPHYS RES-SPACE, V85, P7765, DOI 10.1029/JA085iA13p07765; TUREKIAN KK, 1975, J ATMOS SCI, V32, P1257, DOI 10.1175/1520-0469(1975)032<1257:TNHAMF>2.0.CO;2; von Zahn U., 1983, Venus, P299; WALKER JCG, 1970, J GEOPHYS RES, V75, P3558, DOI 10.1029/JC075i018p03558	30	125	126	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 1	1991	251	4993					547	549		10.1126/science.251.4993.547	http://dx.doi.org/10.1126/science.251.4993.547			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV459	11538265	Green Submitted			2022-12-01	WOS:A1991EV45900046
J	Fukuchi-Shimogori, T; Grove, EA				Fukuchi-Shimogori, T; Grove, EA			Neocortex patterning by the secreted signaling molecule FGF8	SCIENCE			English	Article							CEREBRAL-CORTEX; SOMATOSENSORY CORTEX; REGIONAL DIFFERENCES; AREA IDENTITY; SPECIFICATION; EXPRESSION; MIDBRAIN; DIFFERENTIATION; HIPPOCAMPUS; FOREBRAIN	A classic model proposes that the mammalian neocortex is divided into areas early in neurogenesis, but the molecular mechanisms that generate the area map have been elusive. Here we provide evidence that FGF8 regulates development of the map from a source in the anterior telencephalon. Using electroporation-mediated gene transfer in mouse embryos, we show that augmenting the endogenous anterior FGF8 signal shifts area boundaries posteriorly, reducing the signal shifts them anteriorly, and introducing a posterior source of FGF8 elicits partial area duplications, revealed by ectopic somatosensory barrel fields. These findings support a rote for FGF signaling in specifying positional identity in the neocortex.	Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	University of Chicago	Grove, EA (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA.		Shimogori, Tomomi/L-2893-2013	Shimogori, Tomomi/0000-0002-6931-5401				Agarwala S, 2001, SCIENCE, V291, P2147, DOI 10.1126/science.1058624; BARBE MF, 1991, J NEUROSCI, V11, P519; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Chellaiah A, 1999, J BIOL CHEM, V274, P34785, DOI 10.1074/jbc.274.49.34785; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; FERRI RT, 1995, DEVELOPMENT, V121, P1151; FUKUCHISHIMOGOR.T, UNPUB; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Galceran J, 2000, DEVELOPMENT, V127, P469; Gitton Y, 1999, J NEUROSCI, V19, P4889; Grove EA, 1998, DEVELOPMENT, V125, P2315; HEIKINHEIMO M, 1994, MECH DEVELOP, V48, P129, DOI 10.1016/0925-4773(94)90022-1; Huffman KJ, 1999, J NEUROSCI, V19, P9939; JENSEN KF, 1987, J NEUROSCI, V7, P3529; Lee SMK, 2000, DEVELOPMENT, V127, P457; Lee SMK, 1997, DEVELOPMENT, V124, P959; Levitt P, 1997, ANNU REV NEUROSCI, V20, P1, DOI 10.1146/annurev.neuro.20.1.1; MACARTHUR CA, 1995, DEVELOPMENT, V121, P3603; MACARTHUR CA, 1995, CELL GROWTH DIFFER, V6, P817; Mackarehtschian K, 1999, CEREB CORTEX, V9, P601, DOI 10.1093/cercor/9.6.601; Minowada G, 1999, DEVELOPMENT, V126, P4465; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; Nauta W., 1986, FUNDAMENTAL NEUROANA; Neubuser A, 1997, CELL, V90, P247, DOI 10.1016/S0092-8674(00)80333-5; Ragsdale CW, 2001, CURR OPIN NEUROBIOL, V11, P50, DOI 10.1016/S0959-4388(00)00173-2; RAGSDALE CW, UNPUB; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rubenstein JLR, 1999, CEREB CORTEX, V9, P524, DOI 10.1093/cercor/9.6.524; Shamim H, 1999, DEVELOPMENT, V126, P945; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; Tucker AS, 1999, DEVELOPMENT, V126, P51; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Xu JS, 2000, DEVELOPMENT, V127, P1833; Yasuda K, 2000, DEV GROWTH DIFFER, V42, P203; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3	39	506	520	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2001	294	5544					1071	1074		10.1126/science.1064252	http://dx.doi.org/10.1126/science.1064252			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11567107				2022-12-01	WOS:000172013800041
J	Brundtland, GH				Brundtland, GH			Health professionals must confront HIV/AIDS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									WHO, CH-1211 Geneva, Switzerland	World Health Organization	Brundtland, GH (corresponding author), WHO, CH-1211 Geneva, Switzerland.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2001	286	12					1444	1444		10.1001/jama.286.12.1444	http://dx.doi.org/10.1001/jama.286.12.1444			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	475UX	11572726				2022-12-01	WOS:000171188600010
J	Malek, NP; Sundberg, H; McGrew, S; Nakayama, K; Kyriakidis, TR; Roberts, JM				Malek, NP; Sundberg, H; McGrew, S; Nakayama, K; Kyriakidis, TR; Roberts, JM			A mouse knock-in model exposes sequential proteolytic pathways that regulate p27(Kip1) in G1 and S phase	NATURE			English	Article							KINASE INHIBITOR P27(KIP1); CELL-CYCLE; F-BOX; P27; MYC; ACCUMULATION; DEGRADATION; COMPLEX; UBIQUITINATION; PROGRESSION	The protein p27(Kip1) is an inhibitor of cell division(1). An increase in p27 causes proliferating cells to exit from the cell cycle, and a decrease in p27 is necessary for quiescent cells to resume division(2,3). Abnormally low amounts of p27 are associated with pathological states of excessive cell proliferation, especially cancers(4-8). In normal and tumour cells, p27 is regulated primarily at the level of translation(9-11) and protein turnover. Phosphorylation of p27 on threonine 187 (T187) by cyclin-dependent kinase 2 (Cdk2) is thought to initiate the major pathway for p27 proteolysis(12-15). To critically test the importance of this pathway in vivo, we replaced the murine p27 gene with one that encoded alanine instead of threonine at position 187 (p27(T187A)). Here we show that cells expressing p27(T187A) were unable to downregulate p27 during the S and G2 phases of the cell cycle, but that this had a surprisingly modest effect on cell proliferation both in vitro and in vivo. Our efforts to explain this unexpected result led to the discovery of a second proteolytic pathway for controlling p27, one that is activated by mitogens and degrades p27 exclusively during G1.	Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98104 USA; Fred Hutchinson Canc Res Ctr, Dept Basic Sci, Seattle, WA 98104 USA; Kyushu Univ, Med Inst Bioregulat, Lab Embryon & Genet Engn, Fukuoka 8128582, Japan; Univ Washington, Dept Biochem, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; Fred Hutchinson Cancer Center; Kyushu University; University of Washington; University of Washington Seattle	Roberts, JM (corresponding author), Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98104 USA.							Agrawal D, 1996, MOL CELL BIOL, V16, P4327; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Catzavelos C, 1997, NAT MED, V3, P227, DOI 10.1038/nm0297-227; Coats S, 1999, CURR BIOL, V9, P163, DOI 10.1016/S0960-9822(99)80086-4; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; HATAKEYAMA M, 1994, COLD SPRING HARB SYM, V59, P1; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Kyriakides TR, 1999, J INVEST DERMATOL, V113, P782, DOI 10.1046/j.1523-1747.1999.00755.x; Leone G, 1997, NATURE, V387, P422, DOI 10.1038/387422a0; Millard SS, 2000, MOL CELL BIOL, V20, P5947, DOI 10.1128/MCB.20.16.5947-5959.2000; Muller D, 1997, ONCOGENE, V15, P2561, DOI 10.1038/sj.onc.1201440; Nagy A, 1998, CURR BIOL, V8, P661, DOI 10.1016/S0960-9822(98)70254-4; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; O'Hagan RC, 2000, GENE DEV, V14, P2185, DOI 10.1101/gad.827200; Ophascharoensuk V, 1998, NAT MED, V4, P575, DOI 10.1038/nm0598-575; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; PORTENOY RK, 1997, T PALLIAT CARE, V1, P3; Rolfe M, 1997, J MOL MED-JMM, V75, P5, DOI 10.1007/s001090050081; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Tan P, 1997, CANCER RES, V57, P1259; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Vlach J, 1996, EMBO J, V15, P6595, DOI 10.1002/j.1460-2075.1996.tb01050.x	30	222	232	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					323	327		10.1038/35095083	http://dx.doi.org/10.1038/35095083			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565035				2022-12-01	WOS:000171040500042
J	Poliakoff, M; Anastas, P				Poliakoff, M; Anastas, P			A principled stance	NATURE			English	Article									Univ Nottingham, Sch Chem, Nottingham NG7 2RD, England	University of Nottingham	Poliakoff, M (corresponding author), Univ Nottingham, Sch Chem, Univ Pk, Nottingham NG7 2RD, England.		Anastas, Paul/L-3258-2013	Anastas, Paul/0000-0003-4777-5172				Anastas P, 2001, CHEM BRIT, V37, P26; Anastas P.T., 1998, GREEN CHEM THEORY PR, P29; HAMLEY PA, 2001, CHEM ENG, V72, P24; Ritter SK, 2001, CHEM ENG NEWS, V79, P24, DOI 10.1021/cen-v079n027.p024	4	135	136	0	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					257	257		10.1038/35095133	http://dx.doi.org/10.1038/35095133			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565009	Bronze			2022-12-01	WOS:000171040500018
J	Schiemann, B; Gommerman, JL; Vora, K; Cachero, TG; Shulga-Morskaya, S; Dobles, M; Frew, E; Scott, ML				Schiemann, B; Gommerman, JL; Vora, K; Cachero, TG; Shulga-Morskaya, S; Dobles, M; Frew, E; Scott, ML			An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway	SCIENCE			English	Article							NECROSIS-FACTOR FAMILY; FACTOR RECEPTOR SUPERFAMILY; MOUSE BONE-MARROW; AUTOIMMUNE-DISEASE; MEMBER; MICE; GROWTH; APRIL; IDENTIFICATION; LYMPHOCYTES	The B cell activating factor BAFF (BtyS/TALL-1/zTNF4) is a tumor necrosis factor (TNF)-related ligand that promotes B cell survival and binds to three receptors (BCMA, TACI, and the recently described BAFF-R). Here we report an absolute requirement for BAFF in normal B cell development. Examination of secondary lymphoid organs from BAFF-deficient mice revealed an almost complete loss of follicular and marginal zone B lymphocytes. In contrast, mice lacking BCMA had normal-appearing B lymphocyte compartments. BAFF therefore plays a crucial role in B cell development and can function through receptors other than BCMA.	Biogen Inc, Cambridge, MA 02142 USA	Biogen	Scott, ML (corresponding author), Biogen Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA.	martin_scott@biogen.com		Gommerman, Jennifer/0000-0003-4576-6168				Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S; Clarke SH, 1998, J EXP MED, V187, P1325, DOI 10.1084/jem.187.8.1325; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; GRAS MP, 1995, INT IMMUNOL, V7, P1093, DOI 10.1093/intimm/7.7.1093; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; HARDY RR, 1994, IMMUNOL REV, V137, P91, DOI 10.1111/j.1600-065X.1994.tb00660.x; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; KALLED S, UNPUB; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Lentz VM, 1996, J IMMUNOL, V157, P598; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Madry C, 1998, INT IMMUNOL, V10, P1693, DOI 10.1093/intimm/10.11.1693; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; Meffre E, 2000, NAT IMMUNOL, V1, P379, DOI 10.1038/80816; MILLER DJ, 1991, EUR J IMMUNOL, V21, P1123, DOI 10.1002/eji.1830210506; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Mukhopadhyay A, 1999, J BIOL CHEM, V274, P15978, DOI 10.1074/jbc.274.23.15978; Nemazee D, 2000, Adv Immunol, V74, P89; Rennert P, 2000, J EXP MED, V192, P1677, DOI 10.1084/jem.192.11.1677; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Shu HB, 1999, J LEUKOCYTE BIOL, V65, P680, DOI 10.1002/jlb.65.5.680; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; vonBulow GU, 1997, SCIENCE, V278, P138, DOI 10.1126/science.278.5335.138; Vora KA, 1999, J EXP MED, V189, P471, DOI 10.1084/jem.189.3.471; Xu SL, 2001, MOL CELL BIOL, V21, P4067, DOI 10.1128/MCB.21.12.4067-4074.2001; Yu G, 2000, NAT IMMUNOL, V1, P252, DOI 10.1038/79802; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6	33	861	940	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2111	2114		10.1126/science.1061964	http://dx.doi.org/10.1126/science.1061964			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11509691				2022-12-01	WOS:000171028700080
J	Petitto, LA; Holowka, S; Sergio, LE; Ostry, D				Petitto, LA; Holowka, S; Sergio, LE; Ostry, D			Language rhythms in baby hand movements	NATURE			English	Article									York Univ, Dept Kinesiol & Hlth Sci, N York, ON M3J 1P3, Canada; Haskins Labs Inc, New Haven, CT 06511 USA; McGill Univ, Dept Psychol, Montreal, PQ H3A 1B1, Canada	York University - Canada; Yale University; Haskins Laboratories; McGill University	Petitto, LA (corresponding author), Dartmouth Coll, Dept Psychol, 302 Silsby Hall, Hanover, NH 03755 USA.		Galantucci, Bruno/E-5770-2010; Sergio, Lauren/AAK-3274-2020					Bloom P., 1992, ADAPTED MIND EVOLUTI, P451; Jusczyk P.W., 1997, DISCOVERY SPOKEN LAN; Lieberman Philip, 2000, HUMAN LANGUAGE OUR R; Locke J, 1993, CHILDS PATH SPOKEN L; Locke JL, 2000, SCIENCE, V288, P449, DOI 10.1126/science.288.5465.449; MacNeilage PF, 2000, SCIENCE, V288, P527, DOI 10.1126/science.288.5465.527; MEIER RP, 1995, LANGUAGE, GESTURE, AND SPACE, P391; Petitto LA, 2000, P NATL ACAD SCI USA, V97, P13961, DOI 10.1073/pnas.97.25.13961; PETITTO LA, 1991, SCIENCE, V251, P1493, DOI 10.1126/science.2006424; STUDDERTKENNEDY MG, 1991, COGNITION SYMBOLIC P, P38; van der Stelt J. M., 1986, WENNER GREN CTR IN B, P163; Vihman M.M., 2019, PHONOLOGICAL TEMPLAT	12	69	71	0	16	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					35	36		10.1038/35092613	http://dx.doi.org/10.1038/35092613			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544514				2022-12-01	WOS:000170801200027
J	Dhoot, GK; Gustafsson, MK; Ai, XB; Sun, WT; Standiford, DM; Emerson, CP				Dhoot, GK; Gustafsson, MK; Ai, XB; Sun, WT; Standiford, DM; Emerson, CP			Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase	SCIENCE			English	Article							SONIC HEDGEHOG; HEPARAN-SULFATE; ARYLSULFATASE-A; ACTIVATION; MYOD; GLYCOSAMINOGLYCANS; PROTEOGLYCANS; DOWNSTREAM; INDUCTION; MUSCLE	The developmental signaling functions of cell surface heparan sulfate proteoglycans (HSPGs) are dependent on their sulfation states. Here, we report the identification of QSulf1, the avian ortholog of an evolutionarily conserved protein family related to heparan-specific N-acetyl glucosamine sulfatases. QSulf1 expression is induced by Sonic hedgehog in myogenic somite progenitors in quail embryos and is required for the activation of MyoD, a Wnt-induced regulator of muscle specification. QSulf1 is localized on the cell surface and regulates heparan-dependent Writ signaling in C2C12 myogenic progenitor cells through a mechanism that requires its catalytic activity, providing evidence that QSulf1 regulates Writ signaling through desulfation of cell surface HSPGs.	Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Univ London Royal Vet Coll, Dept Vet Basic Sci, London NW1 0TU, England	University of Pennsylvania; University of London; University of London Royal Veterinary College	Emerson, CP (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, 1157 BRBII-III,421 Curie Blvd, Philadelphia, PA 19104 USA.							Borycki AG, 1999, DEVELOPMENT, V126, P4053; Borycki AG, 1997, DEV BIOL, V185, P185, DOI 10.1006/dbio.1997.8555; Borycki AG, 1998, DEVELOPMENT, V125, P777; Cumberledge S, 1997, TRENDS GENET, V13, P421, DOI 10.1016/S0168-9525(97)01275-4; DHOOT GK, UNPUB; Hirsinger E, 1997, DEVELOPMENT, V124, P4605; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; Kamimura K, 2001, J BIOL CHEM, V276, P17014, DOI 10.1074/jbc.M011354200; Knaust A, 1998, BIOCHEMISTRY-US, V37, P13941, DOI 10.1021/bi9810205; Lander AD, 1998, MATRIX BIOL, V17, P465, DOI 10.1016/S0945-053X(98)90093-2; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Lukatela G, 1998, BIOCHEMISTRY-US, V37, P3654, DOI 10.1021/bi9714924; Lundin L, 2000, J BIOL CHEM, V275, P24653, DOI 10.1074/jbc.M908930199; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; RAPRAEGER AC, 1994, METHOD ENZYMOL, V245, P219; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; ROBERTSON DA, 1992, BIOCHEM J, V288, P539, DOI 10.1042/bj2880539; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Safaiyan F, 1999, J BIOL CHEM, V274, P36267, DOI 10.1074/jbc.274.51.36267; Selleck SB, 2000, TRENDS GENET, V16, P206, DOI 10.1016/S0168-9525(00)01997-1; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; Wei G, 2000, J BIOL CHEM, V275, P27733	25	361	366	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1663	1666		10.1126/science.293.5535.1663	http://dx.doi.org/10.1126/science.293.5535.1663			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533491				2022-12-01	WOS:000170802900064
J	Yuan, MS; Konstantopoulos, N; Lee, JS; Hansen, L; Li, ZW; Karin, M; Shoelson, SE				Yuan, MS; Konstantopoulos, N; Lee, JS; Hansen, L; Li, ZW; Karin, M; Shoelson, SE			Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKK beta	SCIENCE			English	Article							KAPPA-B KINASE; NECROSIS-FACTOR-ALPHA; INDUCED TYROSINE PHOSPHORYLATION; SKELETAL-MUSCLE; ACTIVATION; RECEPTOR; ASPIRIN; IMPAIRS; GLUCOSE; AGENTS	We show that high doses of salicylates reverse hyperglycemia, hyperinsulinemia, and dyslipidemia in obese rodents by sensitizing insulin signaling. Activation or overexpression of the I kappaB kinase beta (IKK beta) attenuated insulin signaling in cultured cells, whereas IKK beta inhibition reversed insulin resistance. Thus, IKK beta, rather than the cyclooxygenases, appears to be the relevant molecular target. Heterozygous deletion (Ikk beta (+/-)) protected against the development of insulin resistance during high-fat feeding and in obese Lep(ob/ob) mice. These findings implicate an inflammatory process in the pathogenesis of insulin resistance in obesity and type 2 diabetes mellitus and identify the IKK beta pathway as a target for insulin sensitization.	Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; University of California System; University of California San Diego	Shoelson, SE (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA.	Steven.Shoelson@joslin.Harvard.edu	Lee, Jongsoon/AAG-1674-2020		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051729, R37DK051729, R29DK045493] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43477] Funding Source: Medline; NIDDK NIH HHS [DK45493, DK51729] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARON SH, 1982, DIABETES CARE, V5, P64, DOI 10.2337/diacare.5.1.64; CARO JF, 1989, DIABETES METAB REV, V5, P665, DOI 10.1002/dmr.5610050804; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Ebstein W, 1876, BERLINER KLIN WOCHEN, V13, P337; FEINSTEIN R, 1993, J BIOL CHEM, V268, P26055; Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42; FURST DE, 1994, ARTHRITIS RHEUM-US, V37, P1, DOI 10.1002/art.1780370102; GILGORE SG, 1960, DIABETES, V9, P392, DOI 10.2337/diab.9.5.392; GOODYEAR LJ, 1995, J CLIN INVEST, V95, P2195, DOI 10.1172/JCI117909; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Harhaj EW, 1997, J BIOL CHEM, V272, P5409, DOI 10.1074/jbc.272.9.5409; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1994, J CLIN INVEST, V94, P1543, DOI 10.1172/JCI117495; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI200111559; KONSTANTOPOULOS N, UNPUB; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; LANG CH, 1992, ENDOCRINOLOGY, V130, P43, DOI 10.1210/en.130.1.43; Lee J.-S., UNPUB; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911; Pickup JC, 1998, DIABETOLOGIA, V41, P1241, DOI 10.1007/s001250051058; REID J, 1957, BRIT MED J, V2, P1071, DOI 10.1136/bmj.2.5053.1071; ROBINSON KA, 1993, AM J PHYSIOL, V265, pE36, DOI 10.1152/ajpendo.1993.265.1.E36; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Williamson RT, 1901, BRIT MED J, V1901, P760, DOI 10.1136/bmj.1.2100.760; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	29	1451	1595	1	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2001	293	5535					1673	1677		10.1126/science.1061620	http://dx.doi.org/10.1126/science.1061620			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533494				2022-12-01	WOS:000170802900067
J	Moore, A; Herrera, G; Nyamongo, J; Lackritz, E; Granade, T; Nahlen, B; Oloo, A; Opondo, G; Muga, R; Janssen, R				Moore, A; Herrera, G; Nyamongo, J; Lackritz, E; Granade, T; Nahlen, B; Oloo, A; Opondo, G; Muga, R; Janssen, R			Estimated risk of HIV transmission by blood transfusion in Kenya	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POPULATION; CHILDREN; REGION	Background During the past decade, developing countries have received limited support for blood safety programmes. The Kenya Ministry of Health did a collaborative multicentre assessment to establish the risk of HIV transmission by transfusion in Kenya, to promote awareness of blood safety issues in this country with a mature HIV epidemic, and to identify methods to reduce the risk of HIV transmission by blood transfusion in Kenya. Methods For 12 weeks, from April to July 1994, we collected information and blood samples from all blood donors, and pretransfusion samples were collected from all recipients in six government hospitals in Kenya. Blood donations were collected and screened for HIV according to standard practice in the hospital laboratories. Test results at a reference laboratory were compared with those of the hospital laboratories and risk of transfusion-associated HIV transmission was calculated. Findings The prevalence of HIV among blood donors was 6.4% (120 of 1877) and varied by hospital (range 2-20%). HIV test results were available for 1290 donor-recipient pairs. Of these, 26 HIV-positive donations were given to HIV-negative patients. We estimate that 2.0% of transfusions transmitted HIV. Problems in the hospitals that contributed to transfusion risk included inconsistent refrigeration, data entry errors, equipment failure, and lack of a quality-assurance programme. Interpretation A high proportion of blood transfusions transmitted HIV in this high-prevalence area of Africa, primarily because of erroneous laboratory practices. On the basis of these results, the Kenya Ministry of Health introduced a number of practical and inexpensive interventions to improve national blood safety.	CDCP, Div HIV AIDS Prevent Surveillance & Epidemiol, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA; CDCP, Div AIDS STD & TB Lab Res, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; CDCP, Div Parasit Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Kenya Minist Hlth, Nairobi, Kenya; Kenya Minist Hlth, Kisumu, Kenya; Kenya Govt Med Res Ctr, Kisumu, Kenya	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute	Janssen, R (corresponding author), CDCP, Div HIV AIDS Prevent Surveillance & Epidemiol, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA.		Nahlen, Bernard/AAH-2051-2021; Oloo, James Aggrey/CAF-3948-2022	Oloo, James Aggrey/0000-0001-7495-1827; Lackritz, Eve/0000-0002-5397-7291				ADDOYOBO EOD, 1991, TROP DOCT, V21, P162, DOI 10.1177/004947559102100409; DATTA P, 1994, J INFECT DIS, V170, P1134, DOI 10.1093/infdis/170.5.1134; DORWARD JA, 1989, TROP DOCT, V19, P155, DOI 10.1177/004947558901900404; FOSTER S, 1995, LANCET, V346, P225, DOI 10.1016/S0140-6736(95)91272-X; Fransen L., 1992, SAFE BLOOD DEV COUNT, P11; GREENBERG AE, 1988, JAMA-J AM MED ASSOC, V259, P545, DOI 10.1001/jama.259.4.545; GUMODOKA B, 1993, AIDS, V7, P387, DOI 10.1097/00002030-199303000-00013; JACOBS B, 1994, E AFR MED J, V71, P720; LACKRITZ EM, 1993, AIDS, V7, P995, DOI 10.1097/00002030-199307000-00014; LACKRITZ EM, 1992, LANCET, V340, P524, DOI 10.1016/0140-6736(92)91719-O; Lackritz EM, 1995, NEW ENGL J MED, V333, P1721, DOI 10.1056/NEJM199512283332601; McFarland W, 1997, AIDS, V11, pS97; SAVARIT D, 1992, BRIT MED J, V305, P498, DOI 10.1136/bmj.305.6852.498; SCHREIBER GB, 1996, NEW ENGL J MED, V334, P1885; WATSONWILLIAMS EJ, 1994, 10 INT C AIDS AUG	15	80	85	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 25	2001	358	9282					657	660		10.1016/S0140-6736(01)05783-X	http://dx.doi.org/10.1016/S0140-6736(01)05783-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530174				2022-12-01	WOS:000170615500031
J	Elliott, P; Briggs, D; Morris, S; de Hoogh, C; Hurt, C; Jensen, TK; Maitland, I; Richardson, S; Wakefield, J; Jarup, L				Elliott, P; Briggs, D; Morris, S; de Hoogh, C; Hurt, C; Jensen, TK; Maitland, I; Richardson, S; Wakefield, J; Jarup, L			Risk of adverse birth outcomes in populations living near landfill sites	BRITISH MEDICAL JOURNAL			English	Article							HAZARDOUS-WASTE SITES; CONGENITAL-MALFORMATIONS; RETROSPECTIVE ANALYSIS; NEURAL-TUBE; HEALTH; EXPOSURE; ENGLAND; DEFECTS; MORTALITY; PROXIMITY	Objective To investigate the risk of adverse birth outcomes associated with residence near landfill sites in Great Britain. Design Geographical study of risks of adverse birth outcomes in populations living within 2 km of 9565 landfill sites operational at some time between 1982 and 1997 (from a total of 19 196 sites) compared with those living further away. Setting Great Britain. Subjects Over 8.2 million live births, 43 471 stillbirths, and 124 597 congenital anomalies (including terminations). Main outcome measures All congenital anomalies combined, sonic specific anomalies, and prevalence of low and very low birth weight (<2500 g and <1500 g). Results For all anomalies combined, relative risk of residence near landfill sites (all waste types) was 0.92 (99% confidence interval 0.907 to 0.923) unadjusted, and 1.01 (1.005 to 1.023) adjusted for confounders. Adjusted risks were 1.05 (1.01 to 1.10) for neural tube defects, 0.96 (0.93 to 0.99) for cardiovascular defects, 1.07 (1.04 to 1.10) for hypospadias and epispadias (with no excess of surgical correction), 1.08 (1.01 to 1.15) for abdominal wall defects, 1.19 (1.05 to 1.34) for surgical correction of gastroschisis and exomphalos, and 1.05 (1.047 to 1.055) and 1.04 (1.03 to 1.05) for low and very low birth weight respectively. There was no excess risk of stillbirth. Findings for special (hazardous) waste sites did not differ systematically from those for non-special sites. For some specific anomalies, higher risks were found in the period before opening compared with after opening of a landfill site, especially hospital admissions for abdominal wall defects. Conclusions We found small excess risks of congenital anomalies and low and very low birth weight in populations living near landfill sites. No causal mechanisms are available to explain these findings, and alternative explanations include data artefacts and residual confounding. Further studies are needed to help differentiate between the various possibilities.	Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, Small Area Hlth Stat Unit, London W2 1PG, England	Imperial College London	Elliott, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, Small Area Hlth Stat Unit, St Marys Campus, London W2 1PG, England.		Richardson, Sylvia T/G-4691-2015	Richardson, Sylvia T/0000-0003-1998-492X; Hurt, Chris/0000-0003-1206-8355				AFFLICK EF, 1997, AM J EPIDEMIOL, V145, P148; BALARAJAN R, 1989, Archives of Disease in Childhood, V64, P1457, DOI 10.1136/adc.64.10.1457; BRIGGS D, 2001, 20011 SAHSU; CARSTAIRS V, 1989, BRIT MED J, V299, P886, DOI 10.1136/bmj.299.6704.886; Croen LA, 1997, EPIDEMIOLOGY, V8, P347, DOI 10.1097/00001648-199707000-00001; *DEP ENV, 2001, DIG ENV STAT; Dolk H, 1998, LANCET, V352, P423, DOI 10.1016/S0140-6736(98)01352-X; ElFadel M, 1997, J ENVIRON MANAGE, V50, P1, DOI 10.1006/jema.1995.0131; ELLIOTT P, 2001, BIRTH OUTCOMES SELEC; Fielder HMP, 2000, BRIT MED J, V320, P19, DOI 10.1136/bmj.320.7226.19; GESCHWIND SA, 1992, AM J EPIDEMIOL, V135, P1197, DOI 10.1093/oxfordjournals.aje.a116226; Hamar GB, 1996, J EXPO ANAL ENV EPID, V6, P247; Johnson Barry L., 1997, Reviews on Environmental Health, V12, P235; LECK I, 1995, J EPIDEMIOL COMMUN H, V49, P171, DOI 10.1136/jech.49.2.171; LYNBERG MC, 1994, AM J EPIDEMIOL, V140, P244, DOI 10.1093/oxfordjournals.aje.a117243; Marshall EG, 1997, ARCH ENVIRON HEALTH, V52, P416, DOI 10.1080/00039899709602220; NEUTRA R, 1991, ENVIRON HEALTH PERSP, V94, P31, DOI 10.2307/3431289; *OFF POP CENS SURV, 1992, STAT REV NOT CONG MA; PARSONS L, 1990, BRIT J OBSTET GYNAEC, V97, P237, DOI 10.1111/j.1471-0528.1990.tb01788.x; ROHT LH, 1985, AM J EPIDEMIOL, V122, P418, DOI 10.1093/oxfordjournals.aje.a114123; SCHULMAN J, 1993, ARCH ENVIRON HEALTH, V48, P114, DOI 10.1080/00039896.1993.9938404; SHAW GM, 1992, ARCH ENVIRON HEALTH, V47, P147, DOI 10.1080/00039896.1992.10118769; SOLIMAN MRI, 1993, TOXICOL IND HEALTH, V9, P901, DOI 10.1177/074823379300900511; Tan KH, 1996, BRIT MED J, V313, P903; TORFS CP, 1994, TERATOLOGY, V50, P44, DOI 10.1002/tera.1420500107; *US EPA, 1999, REV RISK ASS AIR CHA, V1; VIANNA NJ, 1984, SCIENCE, V226, P1217, DOI 10.1126/science.6505690; Vrijheid M, 2000, ENVIRON HEALTH PERSP, V108, P101, DOI 10.2307/3454635; Ward RS, 1996, WASTE MANAGE RES, V14, P243; Wasserman CR, 1996, TERATOLOGY, V53, P261, DOI 10.1002/(SICI)1096-9926(199604)53:4<261::AID-TERA9>3.3.CO;2-8; *WHO, 2001, METH ASS RISK HLTH E; *WORK GROUP REG GE, 1995, 43 OPCS WORK GROUP R; [No title captured]	33	212	216	0	16	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2001	323	7309					363	368		10.1136/bmj.323.7309.363	http://dx.doi.org/10.1136/bmj.323.7309.363			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11509424	Bronze, Green Published			2022-12-01	WOS:000170581400014
J	Gersonde, R; Kyte, FT; Bleil, U; Diekmann, B; Flores, JA; Gohl, K; Grahl, G; Hagen, R; Kuhn, G; Sierro, FJ; Volker, D; Abelmann, A; Bostwick, JA				Gersonde, R; Kyte, FT; Bleil, U; Diekmann, B; Flores, JA; Gohl, K; Grahl, G; Hagen, R; Kuhn, G; Sierro, FJ; Volker, D; Abelmann, A; Bostwick, JA			Geological record and reconstruction of the late Pliocene impact of the Eltanin asteroid in the Southern Ocean	NATURE			English	Article							ANTARCTICA; HISTORY; ICE	In 1995, an expedition on board the research vessel FS Polarstern explored the impact site of the Eltanin asteroid in the Southern Ocean, the only known asteroid impact into a deep ocean basin. Analyses of the geological record of the impact region place the event in the late Pliocene (similar to 2.15 Myr) and constrain the sire of the asteroid to be >1 km, The explosive force inferred for this event places it at the threshold of impacts believed to have global consequences, and its study should therefore provide a baseline for the reconstruction and modelling of similar events, which are common on geological timescales.	UNIV CALIF LOS ANGELES,INST GEOPHYS & PLANETARY PHYS,LOS ANGELES,CA 90095; UNIV BREMEN,FACHBEREICH GEOWISSENSCH,D-28334 BREMEN,GERMANY; UNIV SALAMANCA,DEPT GEOL,S-37008 SALAMANCA,SPAIN; MACQUARIE UNIV,SCH EARTH SCI,SYDNEY,NSW 2109,AUSTRALIA; USN,RES LAB,WASHINGTON,DC 20375	University of California System; University of California Los Angeles; University of Bremen; University of Salamanca; Macquarie University; United States Department of Defense; United States Navy; Naval Research Laboratory	Gersonde, R (corresponding author), ALFRED WEGENER INST POLAR & MARINE RES,POSTBOX 120161,D-27515 BREMERHAVEN,GERMANY.		Sierro, Francisco/A-4714-2008; Flores, Jose-Abel/D-4218-2009	Sierro, Francisco/0000-0002-8647-456X; Gohl, Karsten/0000-0002-9558-2116; Kuhn, Gerhard/0000-0001-6069-7485; Flores, Jose-Abel/0000-0003-1909-293X; Diekmann, Bernhard/0000-0001-5129-3649; Abelmann, Andrea/0000-0001-9432-0002				BARRETT PJ, 1992, NATURE, V359, P816, DOI 10.1038/359816a0; BARRETT PJ, IN PRESS P TERRA ANT, V3; BERGGREN WA, 1995, SEPM SPECIAL PUBLICA, V54; Bruno LA, 1997, EARTH PLANET SC LETT, V147, P37, DOI 10.1016/S0012-821X(97)00003-4; Burckle LH, 1996, GEOLOGY, V24, P235, DOI 10.1130/0091-7613(1996)024<0235:PPDIPA>2.3.CO;2; CANDE SC, 1982, EARTH PLANET SC LETT, V57, P63, DOI 10.1016/0012-821X(82)90173-X; CHAPMAN CR, 1994, NATURE, V367, P33, DOI 10.1038/367033a0; DEMUIZON C, 1981, I FRANCAIS ETUDES AN, V6; GERSONDE R, IN PRESS MICROPALEON; GORBUNOVA ZN, 1976, INIT REP DSDP, V35, P479; Grieve RAF, 1994, HAZARDS DUE COMETS A, P417; Hall BL, 1997, J GEOL, V105, P285, DOI 10.1086/515922; HARWOOD DM, 1983, ANTARCT J US, V18, P98; HILLS JG, 1994, HAZARDS DUE COMETS A, P779; KELLOGG DE, 1984, ANTARCT J US, V19, P44; KENNETT JP, 1993, GEOGR ANN, V75, P20; KYTE FT, 1988, SCIENCE, V241, P63, DOI 10.1126/science.241.4861.63; KYTE FT, 1986, GEOLOGY, V14, P485, DOI 10.1130/0091-7613(1986)14<485:RVISCA>2.0.CO;2; KYTE FT, 1981, NATURE, V292, P417, DOI 10.1038/292417a0; KYTE FT, 1985, GEOCHIM COSMOCHIM AC, V49, P1095, DOI 10.1016/0016-7037(85)90001-8; MARGOLIS SV, 1990, SCIENCE, V251, P1594; Melosh H.L, 1989, IMPACT CRATERING GEO; OKEEFE JD, 1981, J LUNAR PLANET SCI, V12, P785; Perch-Nielsen K., 1985, PLANKTON STRATIGRAPH, V1, P427; QUILTY PG, 1992, RECENT PROGR ANTARCT, P699; RAFFI I, 1993, PALEOCEANOGRAPHY, V8, P387, DOI 10.1029/93PA00755; Shackleton N.J., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V138, P337, DOI 10.2973/odp.proc.sr.138.117.1995; Stroeven AP, 1996, GEOLOGY, V24, P727, DOI 10.1130/0091-7613(1996)024<0727:OMMTAP>2.3.CO;2; SUGDEN DE, 1995, NATURE, V376, P412, DOI 10.1038/376412a0; Toon OB, 1997, REV GEOPHYS, V35, P41, DOI 10.1029/96RG03038; WEBB PN, 1991, QUATERNARY SCI REV, V10, P215, DOI 10.1016/0277-3791(91)90020-U; WEBB PN, 1984, GEOLOGY, V12, P287, DOI 10.1130/0091-7613(1984)12<287:CMSAIV>2.0.CO;2; WEI W, 1992, PALEOCEANOGRAPHY, V8, P85; 1965, MARINE GEOLOGY USNS	34	130	134	0	23	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 27	1997	390	6658					357	363		10.1038/37044	http://dx.doi.org/10.1038/37044			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YH549	11536816	Green Submitted			2022-12-01	WOS:A1997YH54900051
J	LYONS, JR; YUNG, YL; ALLEN, M				LYONS, JR; YUNG, YL; ALLEN, M			SOLAR CONTROL OF THE UPPER-ATMOSPHERE OF TRITON	SCIENCE			English	Article							IONOSPHERE; PHOTOCHEMISTRY; CHEMISTRY; NEPTUNE; METHANE; CARBON; TITAN; MODEL	If the upper atmosphere and ionosphere of Triton are controlled by precipitation of electrons from Neptune's magnetosphere as previously proposed, Triton could have the only ionosphere in the solar system not controlled by solar radiation. However, a new model of Triton's atmosphere, in which only solar radiation is present, predicts a large column of carbon atoms. With an assumed, but reasonable, rate of charge transfer between N2+ and C, a peak C+ abundance results that is close to the peak electron densities measured by Voyager in Triton's ionosphere. These results suggest that Triton's upper atmospheric chemistry may thus be solar-controlled. Measurement of key reaction rate constants, currently unknown or highly uncertain at Triton's low temperatures, would help to clarify the chemical and physical processes occurring in Triton's atmosphere.	CALTECH,JET PROP LAB,DIV EARTH & SPACE SCI,PASADENA,CA 91109	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	LYONS, JR (corresponding author), CALTECH,DIV GEOL & PLANETARY SCI,PASADENA,CA 91125, USA.		Yung, Yuk/AAM-4850-2021	Yung, Yuk/0000-0002-4263-2562				ANICICH VG, 1986, ASTROPHYS J SUPPL S, V62, P553, DOI 10.1086/191151; BRAUN W, 1969, PROC R SOC LON SER-A, V312, P417, DOI 10.1098/rspa.1969.0168; BROADFOOT AL, 1989, SCIENCE, V246, P1459, DOI 10.1126/science.246.4936.1459; CANTU AM, 1981, PHYS REV A, V23, P1223, DOI 10.1103/PhysRevA.23.1223; CRUIKSHANK DP, 1991, B AM ASTRON SOC, V23, P1208; DELITSKY ML, 1990, GEOPHYS RES LETT, V17, P1725, DOI 10.1029/GL017i010p01725; HERBERT F, 1991, J GEOPHYS RES-PLANET, V96, P19241, DOI 10.1029/91JA01821; HUSAIN D, 1971, T FARADAY SOC, V67, P2025, DOI 10.1039/tf9716702025; IP WH, 1990, GEOPHYS RES LETT, V17, P1713, DOI 10.1029/GL017i010p01713; LINDAL GF, 1983, ICARUS, V53, P348, DOI 10.1016/0019-1035(83)90155-0; Lyons J. L., UNPUB; MAJEED T, 1990, GEOPHYS RES LETT, V17, P1721, DOI 10.1029/GL017i010p01721; Rebbert R. E., 1972, J PHOTOCHEM, V1, P171; REES MH, 1989, PHYSICS CHEM UPPER A; RICHARDSON JD, 1990, GEOPHYS RES LETT, V17, P1673, DOI 10.1029/GL017i010p01673; SCHRODER K, 1991, J PHYS B-AT MOL OPT, V24, P2487, DOI 10.1088/0953-4075/24/10/007; SMITH GR, 1982, J GEOPHYS RES-SPACE, V87, P1351, DOI 10.1029/JA087iA03p01351; SPENCER JR, 1990, GEOPHYS RES LETT, V17, P1769, DOI 10.1029/GL017i010p01769; STROBEL DF, 1990, GEOPHYS RES LETT, V17, P1729, DOI 10.1029/GL017i010p01729; STROBEL DF, 1990, GEOPHYS RES LETT, V17, P1661, DOI 10.1029/GL017i010p01661; SUMMERS ME, 1989, ASTROPHYS J, V346, P495, DOI 10.1086/168031; SUMMERS ME, 1991, GEOPHYS RES LETT, V18, P2309, DOI 10.1029/91GL01334; THOMPSON WR, 1990, SCIENCE, V250, P415, DOI 10.1126/science.11538073; TORR MR, 1985, J GEOPHYS RES-SPACE, V90, P6675, DOI 10.1029/JA090iA07p06675; TRAFTON L, 1984, ICARUS, V58, P312, DOI 10.1016/0019-1035(84)90048-4; TYLER GL, 1989, SCIENCE, V246, P1466, DOI 10.1126/science.246.4936.1466; VANDISHOECK E, IN PRESS PROTOSTARS, V3; WHYTE AR, 1983, CHEM PHYS LETT, V98, P590, DOI 10.1016/0009-2614(83)80248-6; YELLE RV, 1989, NATURE, V339, P288, DOI 10.1038/339288a0; YELLE RV, 1991, ICARUS, V89, P347, DOI 10.1016/0019-1035(91)90182-S; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963; YUNG YL, 1990, GEOPHYS RES LETT, V17, P1717, DOI 10.1029/GL017i010p01717	32	14	14	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	APR 10	1992	256	5054					204	206						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM896	11540928				2022-12-01	WOS:A1992HM89600023
J	RAU, GH; TAKAHASHI, T; MARAIS, DJD				RAU, GH; TAKAHASHI, T; MARAIS, DJD			LATITUDINAL VARIATIONS IN PLANKTON DELTA-C-13 - IMPLICATIONS FOR CO2 AND PRODUCTIVITY IN PAST OCEANS	NATURE			English	Article									NASA,AMES RES CTR,MOFFETT FIELD,CA 94035; COLUMBIA UNIV,LAMONT DOHERTY GEOL OBSERV,PALISADES,NY 10964	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Columbia University	RAU, GH (corresponding author), UNIV CALIF SANTA CRUZ,INST FIS TEORICA,SANTA CRUZ,CA 95064, USA.							ARTHUR MA, 1985, NATURE, V315, P216, DOI 10.1038/315216a0; BARRON EJ, 1985, CARBON CYCLE ATMOSPH, P504; BIGGS DC, 1987, OCEAN DRILLING PROJE, V113, P77; BRALOWER TJ, 1984, GEOLOGY, V12, P614, DOI 10.1130/0091-7613(1984)12<614:LPASDC>2.0.CO;2; CALDER JA, 1973, GEOCHIM COSMOCHIM AC, V37, P133, DOI 10.1016/0016-7037(73)90251-2; CHIPMAN DW, 1985, CARBON CHEM S ATLANT; DEAN WE, 1986, MAR GEOL, V70, P119, DOI 10.1016/0025-3227(86)90092-7; Degens E.T., 1969, ORG GEOCHEM, P304, DOI [10.1007/978-3-642-87734-6_14, DOI 10.1007/978-3-642-87734-6_14]; DEGENS ET, 1968, DEEP-SEA RES, V15, P1, DOI 10.1016/0011-7471(68)90024-7; DESCOLASGROS C, 1985, MAR BIOL, V87, P1, DOI 10.1007/BF00396999; DEUSER WG, 1970, NATURE, V225, P1069, DOI 10.1038/2251069a0; Eadie B.J., 1973, MAR CHEM, V1, P199, DOI [10.1016/0304-4203(73)90004-2, DOI 10.1016/0304-4203(73)90004-2]; ELSAYED SZ, 1984, MARINE PHYTOPLANKTON, P19; ESTEP MLF, 1984, GEOCHIM COSMOCHIM AC, V48, P591, DOI 10.1016/0016-7037(84)90287-4; FONTUGNE M, 1978, EARTH PLANET SC LETT, V41, P365, DOI 10.1016/0012-821X(78)90191-7; FONTUGNE MR, 1981, OCEANOL ACTA, V4, P85; Holm-Hansen O., 1977, ADAPTATIONS ANTARCTI, P11; KERBY NW, 1985, ADV BOT RES, V11, P71, DOI 10.1016/S0065-2296(08)60169-X; KNOLL AH, 1986, NATURE, V321, P832, DOI 10.1038/321832a0; KROOPNICK PM, 1985, DEEP-SEA RES, V32, P57, DOI 10.1016/0198-0149(85)90017-2; LASAGA AC, 1985, CARBON CYCLE ATMOSPH, P397; LEWAN MD, 1986, GEOCHIM COSMOCHIM AC, V50, P1583, DOI 10.1016/0016-7037(86)90121-3; MCCABE B, 1985, THESIS U WAIKATO; MIZUTANI H, 1982, ORIGINS LIFE EVOL B, V12, P377, DOI 10.1007/BF00927070; PARDUE JW, 1976, GEOCHIM COSMOCHIM AC, V40, P309, DOI 10.1016/0016-7037(76)90208-8; POPP BN, 1989, AM J SCI, V289, P436, DOI 10.2475/ajs.289.4.436; RAU GH, 1987, EARTH PLANET SC LETT, V82, P269, DOI 10.1016/0012-821X(87)90201-9; RAU GH, 1982, DEEP-SEA RES, V29, P1035, DOI 10.1016/0198-0149(82)90026-7; Sackett W.M., 1974, ADV ORG GEOCHEM, P661; SACKETT WM, 1986, ORG GEOCHEM, V9, P63, DOI 10.1016/0146-6380(86)90087-2; SACKETT WM, 1965, SCIENCE, V148, P235, DOI 10.1126/science.148.3667.235; Sharkey T. D., 1985, INORGANIC CARBON UPT, P389; SMITH SV, 1981, NATURE, V294, P252, DOI 10.1038/294252a0; WADA E, 1987, DEEP-SEA RES, V34, P829, DOI 10.1016/0198-0149(87)90039-2; Weiss R. F., 1974, MAR CHEM, V2, P203, DOI DOI 10.1016/0304-4203(74)90015-2; WONG WW, 1978, GEOCHIM COSMOCHIM AC, V42, P1809, DOI 10.1016/0016-7037(78)90236-3	36	448	465	2	64	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 12	1989	341	6242					516	518		10.1038/341516a0	http://dx.doi.org/10.1038/341516a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU721	11536614				2022-12-01	WOS:A1989AU72100048
J	Lammert, E; Cleaver, O; Melton, D				Lammert, E; Cleaver, O; Melton, D			Induction of pancreatic differentiation by signals from blood vessels	SCIENCE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VASCULAR ENDOTHELIUM; XENOPUS; GENE; EXPRESSION; LETHALITY; ENDODERM; FLT-1; FLK-1; PDX-1	Blood vessels supply developing organs with metabolic sustenance. Here, we demonstrate a role for blood vessels as a source of developmental signals during pancreatic organogenesis. In vitro experiments with embryonic mouse tissues demonstrate that blood vessel endothelium induces insulin expression in isolated endoderm. Removal of the dorsal aorta in Xenopus laevis embryos results in the failure of insulin expression in vivo. Furthermore, using transgenic mice, we show that ectopic vascularization in the posterior foregut leads to ectopic insulin expression and islet hyperplasia. These results indicate that vessels not only provide metabolic sustenance, but also provide inductive signals for organ development.	Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute	Melton, D (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.		Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Cleaver, Ondine/0000-0003-2454-6641				ALTABA ARI, 1993, P NATL ACAD SCI USA, V90, P8268, DOI 10.1073/pnas.90.17.8268; BANTING FG, 1990, J LAB CLIN MED, V115, P254; Brekken RA, 1998, CANCER RES, V58, P1952; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; CHRISTOFORI G, 1995, MOL ENDOCRINOL, V9, P1760, DOI 10.1210/me.9.12.1760; Cleaver O, 1998, DEVELOPMENT, V125, P3905; DUMONT DJ, 1995, DEV DYNAM, V203, P80, DOI 10.1002/aja.1002030109; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Hirsch N, 1997, J NEUROBIOL, V32, P45, DOI 10.1002/(SICI)1097-4695(199701)32:1<45::AID-NEU5>3.0.CO;2-E; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kelly OG, 2000, DEV DYNAM, V218, P615, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1027>3.0.CO;2-8; Kim SK, 1997, DEVELOPMENT, V124, P4243; Lammert E, 2000, MECH DEVELOP, V94, P199, DOI 10.1016/S0925-4773(00)00317-8; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Newman CS, 1997, MECH DEVELOP, V66, P83, DOI 10.1016/S0925-4773(97)00092-0; Offield MF, 1996, DEVELOPMENT, V122, P983; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; TEITELMAN G, 1987, DEV BIOL, V120, P425, DOI 10.1016/0012-1606(87)90246-6; Wells JM, 2000, DEVELOPMENT, V127, P1563; Wu KL, 1997, MOL CELL BIOL, V17, P6002, DOI 10.1128/MCB.17.10.6002	22	792	836	3	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					564	567		10.1126/science.1064344	http://dx.doi.org/10.1126/science.1064344			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11577200				2022-12-01	WOS:000171695600038
J	Higgins, J; Wilson, S; Bridge, P; Cooke, MW				Higgins, J; Wilson, S; Bridge, P; Cooke, MW			Communication difficulties during 999 ambulance calls: observational study	BRITISH MEDICAL JOURNAL			English	Article									Univ Birmingham, Dept Primary Care & Gen Practice, Emergency Med Res Grp, Birmingham B15 2TT, W Midlands, England; Univ Warwick, Sch Hlth & Social Studies, Ctr Primary Hlth Care Studies, Emergency Med Res Grp, Coventry CV4 7AL, W Midlands, England	University of Birmingham; University of Warwick	Wilson, S (corresponding author), Univ Birmingham, Dept Primary Care & Gen Practice, Emergency Med Res Grp, Birmingham B15 2TT, W Midlands, England.							Cooke MW, 1998, PREHOSPITAL IMMEDIAT, V2, P193; Marsden A K, 1995, Accid Emerg Nurs, V3, P177, DOI 10.1016/0965-2302(95)90002-0; MCNAUGHTON GW, 1997, PREHOSP IMMED CARE, V1, P71; *MOB PHON HLTH IND, 2000, NAT RAD PROT BOARD; NICHOLL J, 1996, PREHOSP IMMED CARE, V3, P71	5	14	14	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 6	2001	323	7316					781	782		10.1136/bmj.323.7316.781	http://dx.doi.org/10.1136/bmj.323.7316.781			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481LK	11588079	Bronze, Green Published			2022-12-01	WOS:000171520600028
J	Nicewarner-Pena, SR; Freeman, RG; Reiss, BD; He, L; Pena, DJ; Walton, ID; Cromer, R; Keating, CD; Natan, MJ				Nicewarner-Pena, SR; Freeman, RG; Reiss, BD; He, L; Pena, DJ; Walton, ID; Cromer, R; Keating, CD; Natan, MJ			Submicrometer metallic barcodes	SCIENCE			English	Article							GOLD; MONOLAYERS; ARRAYS	We synthesized multimetal microrods intrinsically encoded with submicrometer stripes. Complex striping patterns are readily prepared by sequential electrochemical deposition of metal ions into templates with uniformly sized pores. The differential reflectivity of adjacent stripes enables identification of the striping patterns by conventional tight microscopy. This readout mechanism does not interfere with the use of fluorescence for detection of analytes bound to particles by affinity capture, as demonstrated by DNA and protein bioassays.	Penn State Univ, Dept Chem, Davey Lab 152, University Pk, PA 16802 USA; SurroMed Inc, Mt View, CA 94043 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Keating, CD (corresponding author), Penn State Univ, Dept Chem, Davey Lab 152, University Pk, PA 16802 USA.			Keating, Christine/0000-0001-6039-1961	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002228] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG02228] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ALMAWLAWI D, 1994, J MATER RES, V9, P1014, DOI 10.1557/JMR.1994.1014; Battersby BJ, 2000, J AM CHEM SOC, V122, P2138, DOI 10.1021/ja993634i; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Cheung VG, 1999, NAT GENET, V21, P15, DOI 10.1038/4439; Dunbar SA, 2000, CLIN CHEM, V46, P1498; Grabar KC, 1997, ANAL CHEM, V69, P471, DOI 10.1021/ac9605962; Han MY, 2001, NAT BIOTECHNOL, V19, P631, DOI 10.1038/90228; Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z; HARRISON DJ, 1993, SCIENCE, V261, P895, DOI 10.1126/science.261.5123.895; Henry MR, 1999, ANAL BIOCHEM, V276, P204, DOI 10.1006/abio.1999.4344; Hulteen JC, 1997, J MATER CHEM, V7, P1075, DOI 10.1039/a700027h; Inoue S., 1997, VIDEO MICROSCOPY; LIDE DR, 1990, CRC HDB CHEM PHYSICS; Martin BR, 1999, ADV MATER, V11, P1021, DOI 10.1002/(SICI)1521-4095(199908)11:12<1021::AID-ADMA1021>3.0.CO;2-S; Masuda H, 2001, ADV MATER, V13, P189, DOI 10.1002/1521-4095(200102)13:3<189::AID-ADMA189>3.0.CO;2-Z; Savas TA, 1996, J VAC SCI TECHNOL B, V14, P4167, DOI 10.1116/1.588613; SKOOG DA, 1992, FUNDAMENTALS ANAL CH, P42; Thurn-Albrecht T, 2000, SCIENCE, V290, P2126, DOI 10.1126/science.290.5499.2126; Ulman A., 1991, INTRO ULTRATHIN FILM; Walt DR, 2000, SCIENCE, V287, P451, DOI 10.1126/science.287.5452.451	21	1215	1318	7	285	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2001	294	5540					137	141		10.1126/science.294.5540.137	http://dx.doi.org/10.1126/science.294.5540.137			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11588257				2022-12-01	WOS:000171448800045
J	Park, HS; Himmelbach, A; Browning, KS; Hohn, T; Ryabova, LA				Park, HS; Himmelbach, A; Browning, KS; Hohn, T; Ryabova, LA			A plant viral "reinitiation" factor interacts with the host translational machinery	CELL			English	Article							CAULIFLOWER MOSAIC-VIRUS; OPEN READING FRAME; POLYCISTRONIC MESSENGER-RNA; FACTOR 3 EIF3; RIBOSOMAL-SUBUNIT; INITIATION-FACTORS; GENE-EXPRESSION; CROSS-LINKING; PROTEIN; YEAST	The cauliflower mosaic virus transactivator, TAV, controls translation reinitiation of major open reading frames on polycistronic RNA. We show here that TAV function depends on its association with polysomes and eukaryotic initiation factor eIF3 in vitro and in vivo. TAV physically interacts with eIF3 and the 60S ribosomal subunit. Two proteins mediating these interactions were identified: eIF3g and 60S ribosomal protein L24. Transient expression of eIF3g and L24 in plant protoplasts strongly affects TAV-mediated reinitiation activity. We demonstrate that TAV/eIF3/40S and eIF3/TAV160S ternary complexes form in vitro, and propose that TAV mediates efficient recruitment of eIF3 to polysomes, allowing translation of polycistronic mRNAs by reinitiation, overcoming the normal cell barriers to this process.	Friedrich Miescher Inst, CH-4002 Basel, Switzerland; Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA	Friedrich Miescher Institute for Biomedical Research; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Hohn, T (corresponding author), Friedrich Miescher Inst, POB 2543, CH-4002 Basel, Switzerland.	hohn@fmi.ch; iryabova@fmi.ch		Himmelbach, Axel/0000-0001-7338-0946; Ryabova, Lyubov/0000-0003-1989-203X				Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bandyopadhyay A, 1999, NUCLEIC ACIDS RES, V27, P1331, DOI 10.1093/nar/27.5.1331; BARONASLOWELL DM, 1990, MOL CELL BIOL, V10, P5235, DOI 10.1128/MCB.10.10.5235; BONNEVILLE JM, 1989, CELL, V59, P1135, DOI 10.1016/0092-8674(89)90769-1; Burks EA, 2001, J BIOL CHEM, V276, P2122, DOI 10.1074/jbc.M007236200; Cerritelli SM, 1998, NUCLEIC ACIDS RES, V26, P1834, DOI 10.1093/nar/26.7.1834; DETAPIA M, 1993, EMBO J, V12, P3305, DOI 10.1002/j.1460-2075.1993.tb06000.x; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; DEZOETEN GA, 1989, VIROLOGY, V172, P213, DOI 10.1016/0042-6822(89)90123-2; Dominguez DI, 1998, J BIOL CHEM, V273, P3669, DOI 10.1074/jbc.273.6.3669; Dresios J, 2000, BIOCHEMISTRY-US, V39, P7236, DOI 10.1021/bi9925266; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; FUTTERER J, 1992, NUCLEIC ACIDS RES, V20, P3851, DOI 10.1093/nar/20.15.3851; FUTTERER J, 1991, EMBO J, V10, P3887, DOI 10.1002/j.1460-2075.1991.tb04958.x; FUTTERER J, 1990, POSTTRANSCRIPTIONAL, P347, DOI DOI 10.1007/978-3-642-75139-4_32; GIVORD L, 1984, EMBO J, V3, P1423, DOI 10.1002/j.1460-2075.1984.tb01987.x; GOWDA S, 1989, P NATL ACAD SCI USA, V86, P9203, DOI 10.1073/pnas.86.23.9203; HATAKEYAMA T, 1989, EUR J BIOCHEM, V185, P685, DOI 10.1111/j.1432-1033.1989.tb15166.x; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Herzog E, 2000, J VIROL, V74, P2073, DOI 10.1128/JVI.74.5.2073-2083.2000; HEUFLER C, 1988, BIOCHIM BIOPHYS ACTA, V951, P182, DOI 10.1016/0167-4781(88)90039-5; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; JACKSON AO, 1976, PLANT PHYSIOL, V57, P5, DOI 10.1104/pp.57.1.5; Jackson RJ, 2000, COLD SPRING HARBOR M, V39, P127; Kobayashi K, 1998, MICROBIOL IMMUNOL, V42, P377, DOI 10.1111/j.1348-0421.1998.tb02298.x; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; Kumar KU, 1999, MOL CELL BIOL, V19, P1116; Leh V, 2000, VIROLOGY, V266, P1, DOI 10.1006/viro.1999.0073; Lin L, 2001, J CELL BIOCHEM, V80, P483, DOI 10.1002/1097-4644(20010315)80:4<483::AID-JCB1002>3.0.CO;2-B; LUUKKONEN BGM, 1995, J VIROL, V69, P4086, DOI 10.1128/JVI.69.7.4086-4094.1995; MARION MJ, 1987, BIOCHEM BIOPH RES CO, V149, P1077, DOI 10.1016/0006-291X(87)90518-3; MARTINEZIZQUIERDO JA, 1987, VIROLOGY, V160, P527, DOI 10.1016/0042-6822(87)90032-8; NAKAYASHIKI H, 1993, J GEN VIROL, V74, P2469, DOI 10.1099/0022-1317-74-11-2469; PEABODY DS, 1986, MOL CELL BIOL, V6, P2695, DOI 10.1128/MCB.6.7.2695; PEABODY DS, 1986, MOL CELL BIOL, V6, P2704, DOI 10.1128/MCB.6.7.2704; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703; Phan L, 1998, MOL CELL BIOL, V18, P4935, DOI 10.1128/MCB.18.8.4935; Pooggin MM, 2000, J BIOL CHEM, V275, P17288, DOI 10.1074/jbc.M001143200; Pooggin MM, 1998, J VIROL, V72, P4157, DOI 10.1128/JVI.72.5.4157-4169.1998; RAMAIAH KVA, 1992, P NATL ACAD SCI USA, V89, P12063, DOI 10.1073/pnas.89.24.12063; ROTHNIE HM, 1994, ADV VIRUS RES, V44, P1, DOI 10.1016/S0065-3527(08)60327-9; Ryabova LA, 2000, GENE DEV, V14, P817; SchmidtPuchta W, 1997, NUCLEIC ACIDS RES, V25, P2854, DOI 10.1093/nar/25.14.2854; SCHOLTHOF HB, 1992, J VIROL, V66, P3131, DOI 10.1128/JVI.66.5.3131-3139.1992; Shepherd R J, 1976, Adv Virus Res, V20, P305, DOI 10.1016/S0065-3527(08)60508-4; SRIVASTAVA S, 1992, J MOL BIOL, V226, P301, DOI 10.1016/0022-2836(92)90946-H; Tirode F, 1997, J BIOL CHEM, V272, P22995, DOI 10.1074/jbc.272.37.22995; UCHIUMI T, 1986, J BIOL CHEM, V261, P9663; Verlhac MH, 1997, EMBO J, V16, P6812, DOI 10.1093/emboj/16.22.6812; Vornlocher HP, 1999, J BIOL CHEM, V274, P16802, DOI 10.1074/jbc.274.24.16802; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; Zhu SH, 1997, J BIOL CHEM, V272, P14434, DOI 10.1074/jbc.272.22.14434	55	123	127	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 21	2001	106	6					723	733		10.1016/S0092-8674(01)00487-1	http://dx.doi.org/10.1016/S0092-8674(01)00487-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	476EJ	11572778	Bronze			2022-12-01	WOS:000171213000009
J	Pizzarello, S; Huang, YS; Becker, L; Poreda, RJ; Nieman, RA; Cooper, G; Williams, M				Pizzarello, S; Huang, YS; Becker, L; Poreda, RJ; Nieman, RA; Cooper, G; Williams, M			The organic content of the Tagish Lake meteorite	SCIENCE			English	Article							MURCHISON METEORITE; CARBONACEOUS CHONDRITE; C-13 NMR; ACIDS; HYDROCARBONS; DERIVATIVES; MATTER	The Tagish Lake meteorite felt last year on a frozen take in Canada and may provide the most pristine material of its kind. Analyses have now shown this carbonaceous chondrite to contain a suite of soluble organic compounds (similar to 100 parts per million) that includes mono- and dicarboxylic acids, dicarboximides, pyridine carboxylic acids, a sulfonic acid, and both aliphatic and aromatic hydrocarbons. The insoluble carbon exhibits exclusive aromatic character, deuterium enrichment, and fullerenes containing "planetary" helium and argon. The findings provide insight into an outcome of early solar chemical evolution that differs from any seen so far in meteorites.	Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Univ Calif Santa Barbara, Inst Crustal Studies, Santa Barbara, CA 93106 USA; Univ Rochester, Dept Earth & Environm Sci, Rochester, NY 14627 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	Arizona State University; Arizona State University-Tempe; Brown University; University of California System; University of California Santa Barbara; University of Rochester; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Pizzarello, S (corresponding author), Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA.							ALLAMANDOLA LJ, 1987, SCIENCE, V237, P56, DOI 10.1126/science.237.4810.56; Becker L, 2000, P NATL ACAD SCI USA, V97, P2979, DOI 10.1073/pnas.050519397; Brown PG, 2000, SCIENCE, V290, P320, DOI 10.1126/science.290.5490.320; CHYBA C, 1992, NATURE, V355, P125, DOI 10.1038/355125a0; CODY GD, 1999, LUNAR PLANET SCI, V30; COOPER GW, 1995, GEOCHIM COSMOCHIM AC, V59, P1003, DOI 10.1016/0016-7037(95)00018-6; Cooper GW, 1997, SCIENCE, V277, P1072, DOI 10.1126/science.277.5329.1072; Cronin J.R., 1988, METEORITES EARLY SOL, P819; CRONIN JR, 1993, GEOCHIM COSMOCHIM AC, V57, P4745, DOI 10.1016/0016-7037(93)90197-5; CRONIN JR, 1987, GEOCHIM COSMOCHIM AC, V51, P299, DOI 10.1016/0016-7037(87)90242-0; CRONIN JR, 1993, NATO ADV SCI INST SE, V416, P209; CRONIN JR, 1990, GEOCHIM COSMOCHIM AC, V54, P2859, DOI 10.1016/0016-7037(90)90020-L; Gardinier A, 2000, EARTH PLANET SC LETT, V184, P9, DOI 10.1016/S0012-821X(00)00300-9; Gilmour I., 2001, LUNAR PLANET SCI, V32; HAN J, 1969, NATURE, V222, P364, DOI 10.1038/222364a0; KERRIDGE JF, 1987, GEOCHIM COSMOCHIM AC, V51, P2527, DOI 10.1016/0016-7037(87)90303-6; LAWLESS JG, 1979, NATURE, V282, P396, DOI 10.1038/282396a0; PELTZER ET, 1978, NATURE, V272, P443, DOI 10.1038/272443a0; Pizzarello S, 2001, METEORIT PLANET SCI, V36, P897, DOI 10.1111/j.1945-5100.2001.tb01929.x; STUDIER MH, 1972, GEOCHIM COSMOCHIM AC, V36, P189	20	197	201	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2001	293	5538					2236	2239		10.1126/science.1062614	http://dx.doi.org/10.1126/science.1062614			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11520948				2022-12-01	WOS:000171139400038
J	Klarreich, E				Klarreich, E			Top researchers plan to snub fertility conference	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					241	241		10.1038/35095185	http://dx.doi.org/10.1038/35095185			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11564998	Bronze			2022-12-01	WOS:000171040500007
J	Thewissen, JGM; Williams, EM; Roe, LJ; Hussain, ST				Thewissen, JGM; Williams, EM; Roe, LJ; Hussain, ST			Skeletons of terrestrial cetaceans and the relationship of whales to artiodactyls	NATURE			English	Article							LOCOMOTOR EVOLUTION; EARLIEST CETACEANS; MIDDLE EOCENE; ORIGIN; MAMMALIA; PAKISTAN; INDIA; MODEL; TIME	Modern members of the mammalian order Cetacea (whales, dolphins and porpoises) are obligate aquatic swimmers that are highly distinctive in morphology, lacking hair and hind limbs, and having flippers, flukes, and a streamlined body. Eocene fossils document much of cetaceans' land-to-water transition, but, until now, the most primitive representative for which a skeleton was known was clearly amphibious and lived in coastal environments. Here we report on the skeletons of two early Eocene pakicetid cetaceans, the fox-sized Ichthyolestes pinfoldi, and the wolf-sized Pakicetus attocki. Their skeletons also elucidate the relationships of cetaceans to other mammals. Morphological cladistic analyses have shown cetaceans to be most closely related to one or more mesonychians, a group of extinct, archaic ungulates, but molecular analyses have indicated that they are the sister group to hippopotamids. Our cladistic analysis indicates that cetaceans are more closely related to artiodactyls than to any mesonychian. Cetaceans are not the sister group to (any) mesonychians, nor to hippopotamids. Our analysis stops short of identifying any particular artiodactyl family as the cetacean sister group and supports monophyly of artiodactyls.	Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Anat, Rootstown, OH 44272 USA; Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA; Howard Univ, Coll Med, Dept Anat, Washington, DC 20059 USA	Northeast Ohio Medical University (NEOMED); University of Arizona; Howard University	Thewissen, JGM (corresponding author), Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Anat, Rootstown, OH 44272 USA.	thewisse@neoucom.edu		Thewissen, J. G. M./0000-0002-0973-4137				Bajpai S, 2000, CURR SCI INDIA, V79, P1478; Bajpai S, 1998, ADV VERT PALEOBIOL, P213; Bajpai S, 1998, P NATL ACAD SCI USA, V95, P15464, DOI 10.1073/pnas.95.26.15464; Gatesy J, 1998, ADV VERT PALEOBIOL, P63; Geisler JH, 1998, ADV VERT PALEOBIOL, P163; Gentry AW, 1988, PHYLOGENY CLASSIFICA, V35B, P235; GINGERICH PD, 1990, SCIENCE, V249, P154, DOI 10.1126/science.249.4965.154; GINGERICH PD, 1983, SCIENCE, V220, P403, DOI 10.1126/science.220.4595.403; GINGERICH PD, 1994, NATURE, V368, P844, DOI 10.1038/368844a0; GINGERICH PD, IN PRESS SCIENCE; Hemila S, 1999, HEARING RES, V133, P82, DOI 10.1016/S0378-5955(99)00055-6; Howell A. B., 1930, AQUATIC MAMMALS THEI; Howell AB, 1944, SPEED ANIMALS THEIR; Hulbert RC, 1998, J PALEONTOL, V72, P907, DOI 10.1017/S0022336000027232; Kellogg R, 1936, REV ARCHAEOCETI; King J. E., 1991, SEALS WORLD; LENHARDT M L, 1982, Journal of Auditory Research, V22, P153; Luckett W. Patrick, 1998, Journal of Mammalian Evolution, V5, P127, DOI 10.1023/A:1020501622015; Luo Z.-X., 1999, U MICHIGAN PAPERS PA, V31, P1; Luo ZX, 2000, NATURE, V404, P235, DOI 10.1038/35005194; Luo ZX, 1998, ADV VERT PALEOBIOL, P269; MADAR SI, IN PRESS J VERTEBR P; Milinkovitch MC, 1998, ADV VERT PALEOBIOL, P113; Milinkovitch MC, 1997, NATURE, V388, P622, DOI 10.1038/41650; Naylor GJP, 2001, SYST BIOL, V50, P444, DOI 10.1080/106351501300318030; Nikaido M, 1999, P NATL ACAD SCI USA, V96, P10261, DOI 10.1073/pnas.96.18.10261; O'Leary MA, 1999, SYST BIOL, V48, P455, DOI 10.1080/106351599260102; O'Leary MA, 1998, ADV VERT PALEOBIOL, P133; O'Leary MA, 1999, PALEOBIOLOGY, V25, P534, DOI 10.1017/S0094837300020376; RADO R, 1989, HEARING RES, V41, P23, DOI 10.1016/0378-5955(89)90175-5; SHAEFFER B, 1947, AM MUS NOVIT, P1; Shimamura M, 1997, NATURE, V388, P666, DOI 10.1038/41759; SWOFFORD DL, 1998, PAUP 40B8 PHYLOGENET; Thewissen J.G.M., 1996, Courier Forschungsinstitut Senckenberg, V191, P1; Thewissen J.G.M., 1998, Bulletin of Carnegie Museum of Natural History, V34, P220; Thewissen J. G. M., 1994, Journal of Mammalian Evolution, V2, P157, DOI 10.1007/BF01473527; Thewissen JGM, 1997, PALEOBIOLOGY, V23, P482, DOI 10.1017/S0094837300019850; THEWISSEN JGM, 1994, SCIENCE, V263, P210, DOI 10.1126/science.263.5144.210; Thewissen JGM, 2001, J VERTEBR PALEONTOL, V21, P347, DOI 10.1671/0272-4634(2001)021[0347:EMFFNI]2.0.CO;2; THEWISSEN JGM, 1993, NATURE, V361, P444, DOI 10.1038/361444a0; THEWISSEN JGM, 1990, ANAT HISTOL EMBRYOL, V19, P37, DOI 10.1111/j.1439-0264.1990.tb00876.x; Thewissen JGM, 1998, NATURE, V395, P452, DOI 10.1038/26656; Thewissen JGM, 1999, SYST BIOL, V48, P21, DOI 10.1080/106351599260418; Uhen MD, 1998, ADV VERT PALEOBIOL, P29; Uhen MD, 1999, J PALEONTOL, V73, P512, DOI 10.1017/S002233600002802X; Vaughan TA, 1986, MAMMALOGY; Weber M, 1928, SAUGETIERE; Zhou Xiaoyuan, 1992, Contributions from the Museum of Paleontology University of Michigan, V28, P289	48	208	218	5	184	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2001	413	6853					277	281		10.1038/35095005	http://dx.doi.org/10.1038/35095005			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565023				2022-12-01	WOS:000171040500030
J	Uemura, N; Okamoto, S; Yamamoto, S; Matsumura, N; Yamaguchi, S; Yamakido, M; Taniyama, K; Sasaki, N; Schlemper, RJ				Uemura, N; Okamoto, S; Yamamoto, S; Matsumura, N; Yamaguchi, S; Yamakido, M; Taniyama, K; Sasaki, N; Schlemper, RJ			Helicobacter pylori infection and the development of gastric cancer.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	101st Annual Meeting of the American-Gastroenterological-Association	MAY 21-24, 2000	SAN DIEGO, CA	Amer Gastroenterol Assoc			DUODENAL-ULCER DISEASE; CARCINOMA; STOMACH; RISK; CLASSIFICATION; INFLAMMATION; EPIDEMIOLOGY; PREVALENCE; ANTIBODY; ATROPHY	Background: Although many studies have found an association between Helicobacter pylori infection and the development of gastric cancer, many aspects of this relation remain uncertain. Methods: We prospectively studied 1526 Japanese patients who had duodenal ulcers, gastric ulcers, gastric hyperplasia, or nonulcer dyspepsia at the time of enrollment; 1246 had H. pylori infection and 280 did not. The mean follow-up was 7.8 years (range, 1.0 to 10.6). Patients underwent endoscopy with biopsy at enrollment and then between one and three years after enrollment. H. pylori infection was assessed by histologic examination, serologic testing, and rapid urease tests and was defined by a positive result on any of these tests. Results: Gastric cancers developed in 36 (2.9 percent) of the infected and none of the uninfected patients. There were 23 intestinal-type and 13 diffuse-type cancers. Among the patients with H. pylori infection, those with severe gastric atrophy, corpus-predominant gastritis, and intestinal metaplasia were at significantly higher risk for gastric cancer. We detected gastric cancers in 21 (4.7 percent) of the 445 patients with nonulcer dyspepsia, 10 (3.4 percent) of the 297 with gastric ulcers, 5 (2.2 percent) of the 229 with gastric hyperplastic polyps, and none of the 275 with duodenal ulcers. Conclusions: Gastric cancer develops in persons infected with H. pylori but not in uninfected persons. Those with histologic findings of severe gastric atrophy, corpus-predominant gastritis, or intestinal metaplasia are at increased risk. Persons with H. pylori infection and nonulcer dyspepsia, gastric ulcers, or gastric hyperplastic polyps are also at risk, but those with duodenal ulcers are not. (N Engl J Med 2001;345:784-9.) Copyright (C) 2001 Massachusetts Medical Society.	Kure Kyosai Hosp, Dept Gastroenterol, Kure, Japan; Kure Kyosai Hosp, Dept Clin Pathol, Kure, Japan; Fukuoka Univ, Sch Med, Dept Internal Med, Fukuoka 81401, Japan	Fukuoka University	Uemura, N (corresponding author), Kure Kyosai Hosp, Dept Gastroenterol, 2-3-28 Nishi Chuo, Kure, Japan.	n-uemura@mua.biglobe.ne.jp						[Anonymous], 1983, LANCET, V1, P1273; ASAKA M, 1999, GASTRIC CANC HELICOB, P116; BLASER MJ, 1992, GASTROENTEROLOGY, V102, P720, DOI 10.1016/0016-5085(92)90126-J; CORREA P, 1990, CANCER-AM CANCER SOC, V66, P2569, DOI 10.1002/1097-0142(19901215)66:12<2569::AID-CNCR2820661220>3.0.CO;2-I; CORREA P, 1992, CANCER RES, V52, P6735; Danesh J, 1999, ALIMENT PHARM THERAP, V13, P851; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Enomoto H, 1998, EUR J GASTROEN HEPAT, V10, P473, DOI 10.1097/00042737-199806000-00007; FORMAN D, 1991, BRIT MED J, V302, P1302, DOI 10.1136/bmj.302.6788.1302; GRAHAM DY, 1991, J GASTROEN HEPATOL, V6, P105, DOI 10.1111/j.1440-1746.1991.tb01448.x; Hansson LE, 1996, NEW ENGL J MED, V335, P242, DOI 10.1056/NEJM199607253350404; Huang JQ, 1998, GASTROENTEROLOGY, V114, P1169, DOI 10.1016/S0016-5085(98)70422-6; IARC, 1994, IARC MON EV CARC RIS, V61, P177; Ito S, 1996, GUT, V39, P800, DOI 10.1136/gut.39.6.800; KIKUCHI S, 1995, CANCER, V75, P2789, DOI 10.1002/1097-0142(19950615)75:12<2789::AID-CNCR2820751202>3.0.CO;2-4; Kimura K, 1969, ENDOSCOPY, V1, P1; Kokkola A, 1996, SCAND J GASTROENTERO, V31, P643, DOI 10.3109/00365529609009143; KUIPERS EJ, 1995, LANCET, V345, P1525, DOI 10.1016/S0140-6736(95)91084-0; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Meining A, 1997, VIRCHOWS ARCH, V431, P11, DOI 10.1007/s004280050063; Miwa H, 2000, DIAGN MICR INFEC DIS, V36, P95, DOI 10.1016/S0732-8893(99)00143-1; NOMURA A, 1991, NEW ENGL J MED, V325, P1132, DOI 10.1056/NEJM199110173251604; Ohara S, 1998, J GASTROENTEROL, V33, P6, DOI 10.1007/PL00009968; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; SAS Institute, 1996, SAS STAT SOFTW CHANG; Satoh K, 1996, AM J GASTROENTEROL, V91, P963; Schlemper RJ, 2000, GUT, V47, P251, DOI 10.1136/gut.47.2.251; SIPPONEN P, 1992, J CLIN PATHOL, V45, P319, DOI 10.1136/jcp.45.4.319; SIPPONEN P, 1993, SCAND J GASTROENTERO, V28, P3, DOI 10.3109/00365529309098333; Solcia E, 1996, AM J SURG PATHOL, V20, pS8; STOLTE M, 1990, Z GASTROENTEROL, V28, P229; Tabata H, 1999, DIGEST DIS SCI, V44, P2027, DOI 10.1023/A:1026622418625; Uemura N, 1997, CANCER EPIDEM BIOMAR, V6, P639	33	3228	3386	6	343	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2001	345	11					784	789		10.1056/NEJMoa001999	http://dx.doi.org/10.1056/NEJMoa001999			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	471BK	11556297				2022-12-01	WOS:000170906800002
J	Rose, NF; Marx, PA; Luckay, A; Nixon, DF; Moretto, WJ; Donahoe, SM; Montefiori, D; Roberts, A; Buonocore, L; Rose, JK				Rose, NF; Marx, PA; Luckay, A; Nixon, DF; Moretto, WJ; Donahoe, SM; Montefiori, D; Roberts, A; Buonocore, L; Rose, JK			An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants	CELL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL RESPONSES; RHESUS-MONKEYS; PRIMARY ISOLATE; NEUTRALIZING ANTIBODIES; LYMPHOCYTE DEPLETION; TYPE-1; ENVELOPE; GLYCOPROTEINS; INFECTION	We developed an AIDS vaccine based on attenuated VSV vectors expressing env and gag genes and tested it in rhesus monkeys. Boosting was accomplished using vectors with glycoproteins from different VSV serotypes. Animals were challenged with a pathogenic AIDS virus (SHIV89.6P). Control monkeys showed a severe loss of CD4(+) T cells and high viral loads, and 7/8 progressed to AIDS with an average time of 148 days. All seven vaccinees were initially infected with SHIV89.6P but have remained healthy for up to 14 months after challenge with low or undetectable viral loads. Protection from AIDS was highly significant (p=0.001). VSV vectors are promising candidates for human AIDS vaccine trials because they propagate to high titers and can be delivered without injection.	Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70043 USA; Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA; Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Yale University; Yale University; Tulane University; University of California System; University of California San Francisco; The J David Gladstone Institutes; Duke University	Rose, JK (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.	john.rose@yale.edu	Nixon, Douglas/AAU-5734-2020	Nixon, Douglas/0000-0002-2801-1786	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045510, N01AI085343, R56AI045510, R01AI040357, R37AI040357] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-45510, AI-40357, AI-85343] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Bures R, 2000, AIDS RES HUM RETROV, V16, P2019, DOI 10.1089/088922200750054756; Burton DR, 1997, P NATL ACAD SCI USA, V94, P10018, DOI 10.1073/pnas.94.19.10018; CHEN ZW, 1995, J EXP MED, V182, P21, DOI 10.1084/jem.182.1.21; Crawford JM, 1999, J VIROL, V73, P10199, DOI 10.1128/JVI.73.12.10199-10207.1999; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; Donahoe SM, 2000, VIROLOGY, V272, P347, DOI 10.1006/viro.2000.0404; FIELDS BN, 1967, NEW ENGL J MED, V277, P889, DOI 10.1056/NEJM196711092771901; Haglund K, 2000, VIROLOGY, V268, P112, DOI 10.1006/viro.1999.0120; Hinman A, 1999, ANNU REV PUBL HEALTH, V20, P211, DOI 10.1146/annurev.publhealth.20.1.211; Johnson JE, 1997, J VIROL, V71, P5060, DOI 10.1128/JVI.71.7.5060-5068.1997; JOHNSON KM, 1966, AM J TROP MED HYG, V15, P244, DOI 10.4269/ajtmh.1966.15.244; Karlsson GB, 1997, J VIROL, V71, P4218, DOI 10.1128/JVI.71.6.4218-4225.1997; Karlsson GB, 1998, J EXP MED, V188, P1159, DOI 10.1084/jem.188.6.1159; KESTLER H, 1990, SCIENCE, V248, P1109, DOI 10.1126/science.2160735; Kim SK, 1998, P NATL ACAD SCI USA, V95, P10814, DOI 10.1073/pnas.95.18.10814; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kretzschmar E, 1997, J VIROL, V71, P5982, DOI 10.1128/JVI.71.8.5982-5989.1997; Kuroda MJ, 1998, J EXP MED, V187, P1373, DOI 10.1084/jem.187.9.1373; LAWSON ND, 1995, P NATL ACAD SCI USA, V92, P4477, DOI 10.1073/pnas.92.10.4477; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Montefiori DC, 1998, J VIROL, V72, P3427, DOI 10.1128/JVI.72.4.3427-3431.1998; Moretto WJ, 2000, AIDS, V14, P2625, DOI 10.1097/00002030-200011100-00034; Musey L, 1997, NEW ENGL J MED, V337, P1267, DOI 10.1056/NEJM199710303371803; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; PACHL C, 1995, J ACQ IMMUN DEF SYND, V8, P446, DOI 10.1097/00042560-199504120-00003; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; REGIER DA, 1990, AIDS RES HUM RETROV, V6, P1221, DOI 10.1089/aid.1990.6.1221; Reimann KA, 1996, J VIROL, V70, P6922, DOI 10.1128/JVI.70.10.6922-6928.1996; Reiss CS, 1998, ANN NY ACAD SCI, V855, P751, DOI 10.1111/j.1749-6632.1998.tb10655.x; Richardson TM, 1996, J VIROL, V70, P753, DOI 10.1128/JVI.70.2.753-762.1996; Roberts A, 1998, J VIROL, V72, P4704, DOI 10.1128/JVI.72.6.4704-4711.1998; Roberts A, 1999, J VIROL, V73, P3723, DOI 10.1128/JVI.73.5.3723-3732.1999; Rose NF, 2000, J VIROL, V74, P10903, DOI 10.1128/JVI.74.23.10903-10910.2000; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Schlereth B, 2000, J VIROL, V74, P4652, DOI 10.1128/JVI.74.10.4652-4657.2000; Schnell MJ, 1996, J VIROL, V70, P2318, DOI 10.1128/JVI.70.4.2318-2323.1996; Schnell MJ, 1996, P NATL ACAD SCI USA, V93, P11359, DOI 10.1073/pnas.93.21.11359; Schnell MJ, 1998, EMBO J, V17, P1289, DOI 10.1093/emboj/17.5.1289; TESH RB, 1969, AM J EPIDEMIOL, V90, P255, DOI 10.1093/oxfordjournals.aje.a121068; *UNAIDS, 2000, AIDS EP UPD; Wagner R.R., 1996, RHABDOVIRIDAE VIRUSE, P1121; ZINKERNAGEL RM, 1978, EXP CELL BIOL, V46, P53	45	379	402	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2001	106	5					539	549		10.1016/S0092-8674(01)00482-2	http://dx.doi.org/10.1016/S0092-8674(01)00482-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551502	Bronze			2022-12-01	WOS:000170973200005
J	Sherwood, T				Sherwood, T			100 years' observation of risks from radiation for British (male) radiologists	LANCET			English	Editorial Material									Lancet, London WC1X 8RR, England		Sherwood, T (corresponding author), Lancet, London WC1X 8RR, England.							Berrington A, 2001, BRIT J RADIOL, V74, P507, DOI 10.1259/bjr.74.882.740507; COURT BROWN W M, 1958, Br Med J, V2, P181; SMITH PG, 1981, BRIT J RADIOL, V54, P187, DOI 10.1259/0007-1285-54-639-187; SOUTHWOOD TRE, 1994, CLIN RADIOL, V49, P1, DOI 10.1016/S0009-9260(05)82905-8	4	6	6	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 25	2001	358	9282					604	604		10.1016/S0140-6736(01)05818-4	http://dx.doi.org/10.1016/S0140-6736(01)05818-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530145				2022-12-01	WOS:000170615500006
J	Gotz, J; Chen, F; van Dorpe, J; Nitsch, RM				Gotz, J; Chen, F; van Dorpe, J; Nitsch, RM			Formation of neurofibrillary tangles in P301L tau transgenic mice induced by A beta 42 fibrils	SCIENCE			English	Article							PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; MICROTUBULE-BINDING; PROTEIN; PHOSPHORYLATION; NEUROTOXICITY; AMYOTROPHY; PATHOLOGY; ISOFORMS; BRAIN	beta -Amyloid plaques and neurofibrillary tangles (NFTs) are the defining neuropathological hallmarks of Alzheimer's disease, but their pathophysiological relation is unclear. Injection of beta -amyloid A beta (42) fibrils into the brains of P301L mutant tau transgenic mice caused fivefold increases in the numbers of NFTs in cell bodies within the amygdala from where neurons project to the injection sites. Gallyas silver impregnation identified NFTs that contained tau phosphorylated at serine 212/threonine 214 and serine 422. NFTs were composed of twisted filaments and occurred in 6-month-old mice as early as 18 days after A beta (42) injections. Our data support the hypothesis that A beta (42) fibrils can accelerate NFT formation in vivo.	Univ Zurich, Div Psychiat Res, CH-8008 Zurich, Switzerland; Katholieke Univ Leuven, Ctr Human Genet, Expt Genet Grp, Louvain, Belgium	University of Zurich; KU Leuven	Nitsch, RM (corresponding author), Univ Zurich, Div Psychiat Res, August Forel Str 1, CH-8008 Zurich, Switzerland.	goetz@bli.unizh.ch; nitsch@bli.unizh.ch	Götz, Jürgen/C-2448-2014	Götz, Jürgen/0000-0001-8501-7896				Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; BRAAK H, 1986, NEUROSCI LETT, V65, P351, DOI 10.1016/0304-3940(86)90288-0; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; BueeScherrer V, 1996, MOL BRAIN RES, V39, P79, DOI 10.1016/0169-328X(96)00003-4; BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; Delacourte A, 1998, ANN NEUROL, V43, P193, DOI 10.1002/ana.410430209; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; GALLYAS F, 1971, ACTA MORPHOL HUNG, V19, P1; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; Gotz J, 2001, BRAIN RES REV, V35, P266, DOI 10.1016/S0165-0173(01)00055-8; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; Gotz J, 1998, P NATL ACAD SCI USA, V95, P12370, DOI 10.1073/pnas.95.21.12370; GOTZ J, UNPUB; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; MCKEE AC, 1989, ANN NEUROL, V26, P652, DOI 10.1002/ana.410260511; Paxinos K.B.J., 1997, MOUSE BRAIN STEREOTA; PRICE DL, 1994, ANNU REV MED, V45, P435; Probst A, 2000, ACTA NEUROPATHOL, V99, P469, DOI 10.1007/s004010051148; Sergeant N, 1999, J NEUROCHEM, V72, P1243, DOI 10.1046/j.1471-4159.1999.0721243.x; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Spillantini MG, 1998, AM J PATHOL, V153, P1359, DOI 10.1016/S0002-9440(10)65721-5; Tanaka T, 1998, FEBS LETT, V426, P248, DOI 10.1016/S0014-5793(98)00346-9; Varadarajan S, 2000, J STRUCT BIOL, V130, P184, DOI 10.1006/jsbi.2000.4274; Velasco ME, 1998, BRAIN RES, V813, P329, DOI 10.1016/S0006-8993(98)01034-8	32	1177	1237	1	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1491	1495		10.1126/science.1062097	http://dx.doi.org/10.1126/science.1062097			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520988				2022-12-01	WOS:000170616000045
J	Herren, KR; Mackway-Jones, K; Richards, CR; Seneviratne, CJ; France, MW; Cotter, L				Herren, KR; Mackway-Jones, K; Richards, CR; Seneviratne, CJ; France, MW; Cotter, L			Is it possible to exclude a diagnosis of myocardial damage within six hours of admission to an emergency department? Diagnostic cohort study	BRITISH MEDICAL JOURNAL			English	Article							CARDIAC TROPONIN-T; CHEST-PAIN; INFARCTION; AUDIT; ACCIDENT; TRIAL; ROOM	Objective To assess the clinical efficacy and accuracy of an emergency department based six hour rule-out protocol for myocardial damage. Design Diagnostic cohort study. Setting Emergency department of an inner city university hospital. Participants 383 consecutive patients aged over 25 years with chest pain of less than 12 hours' duration who were at low to moderate risk of acute myocardial infarction. Intervention Serial measurements of creatine kinase MB mass and continuous ST segment monitoring for six hours with 12 leads. Main outcome measure Performance of the diagnostic test against a gold standard consisting of either a 48 hour measurement of troponin T concentration or screening for myocardial infarction according to the World Health Organization's criteria. Results Outcome of the gold standard test was available for 292 patients. On the diagnostic test for the protocol, 53 patients had positive results and 239 patients had negative results. There were 18 false positive results and one false negative result. Sensitivity was 97.2% (95% confidence interval 95.0% to 99.0%), specificity 93.0% (90.0% to 96.0%), the negative predictive value 99.6%, and the positive predictive value 66.0%. The positive likelihood ratio was 13.9 and the negative likelihood ratio 0.03. Conclusions The six hour rule-out protocol for myocardial infarction is accurate mad efficacious. It can be used in patients presenting to emergency departments with chest pain indicating a low to moderate risk of myocardial infarction.	Manchester Royal Infirm, Dept Emergency Med, Manchester M13 9WL, Lancs, England; Manchester Royal Infirm, Dept Clin Biochem, Manchester M13 9WL, Lancs, England; Manchester Royal Infirm, Manchester Heart Ctr, Manchester M13 9WL, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Mackway-Jones, K (corresponding author), Manchester Royal Infirm, Dept Emergency Med, Oxford Rd, Manchester M13 9WL, Lancs, England.							CLEMENTS FM, 1988, CRIT CARE MED, V16, P710, DOI 10.1097/00003246-198807000-00013; Collinson PO, 2000, BRIT MED J, V320, P1702, DOI 10.1136/bmj.320.7251.1702; EMERSON PA, 1989, Q J MED, V70, P213; Farkouh ME, 1998, NEW ENGL J MED, V339, P1882, DOI 10.1056/NEJM199812243392603; FOTHERGILL NJ, 1993, ARCH EMERG MED, V10, P155; Hamm CW, 1997, NEW ENGL J MED, V337, P1648, DOI 10.1056/NEJM199712043372302; HUNT D, 1992, LANCET, V339, P753; KING SB, 1994, NEW ENGL J MED, V331, P1044, DOI 10.1056/NEJM199410203311602; KRUCOFF MW, 1986, AM J CARDIOL, V57, P916, DOI 10.1016/0002-9149(86)90730-7; LEE TH, 1987, AM J CARDIOL, V60, P219, DOI 10.1016/0002-9149(87)90217-7; LEE TH, 1987, ANN INTERN MED, V106, P181, DOI 10.7326/0003-4819-106-2-181; MAIR J, 1991, CLIN CHEM, V37, P845; Ohman EM, 1996, NEW ENGL J MED, V335, P1333, DOI 10.1056/NEJM199610313351801; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P532	14	28	28	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2001	323	7309					372	374		10.1136/bmj.323.7309.372	http://dx.doi.org/10.1136/bmj.323.7309.372			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11509427	Green Published, Bronze			2022-12-01	WOS:000170581400018
J	Henneman, ML; Memmott, J				Henneman, ML; Memmott, J			Infiltration of a Hawaiian community by introduced biological control agents	SCIENCE			English	Article								To examine the community-wide effects of introduced biocontrol agents on Kauai Island, Hawaii, we constructed quantitative food webs showing interactions among plants, moths, and moth parasitoids in a native forest. Eighty-three percent of parasitoids reared from native moths were biological control agents, 14% were accidental immigrants, and 3% were native species. Although parasitism by biological control agents reached 28% in some species of moth, all biocontrol agents reared had been released before 1945. This study highlights the importance of considering the potential damage caused by an introduced control agent, in addition to that caused by the target alien species.	Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England	University of Bristol	Memmott, J (corresponding author), Univ Bristol, Sch Biol Sci, Woodland Rd, Bristol BS8 1UG, Avon, England.	Jane.Memmott@bristol.ac.uk						BEARDSLEY JOHN W., 1961, PROC HAWAIIAN ENT SOC, V17, P333; BENNETT FD, 1993, FLA ENTOMOL, V76, P54, DOI 10.2307/3496013; Boettner GH, 2000, CONSERV BIOL, V14, P1798, DOI 10.1046/j.1523-1739.2000.99193.x; CORNELL HV, 1993, AM NAT, V141, P847, DOI 10.1086/285512; COULSON J, 2001, RELEASES BENEFICIAL; Elliott N, 1996, OECOLOGIA, V105, P537, DOI 10.1007/BF00330017; FUNASAKI G Y, 1988, Proceedings of the Hawaiian Entomological Society, V28, P105; GAGNE WC, 1985, P 3 C EUR LEP CAMBR, P74; GLASSER JW, 1982, AM NAT, V119, P375, DOI 10.1086/283916; HADFIELD MG, 1993, AM ZOOL, V33, P610; HASSELL MP, 1973, J ANIM ECOL, V42, P693, DOI 10.2307/3133; HAWKINS BA, 1993, SCIENCE, V262, P1429, DOI 10.1126/science.262.5138.1429; HOWARTH FG, 1991, ANNU REV ENTOMOL, V36, P485, DOI 10.1146/annurev.en.36.010191.002413; Howarth Francis G., 2000, P369; Johnson DM, 1998, FLA ENTOMOL, V81, P12, DOI 10.2307/3495992; LAI P Y, 1986, Proceedings of the Hawaiian Entomological Society, V26, P89; LAI PY, 1983, LIST BIOL CONTROL IN; Louda SM, 1997, SCIENCE, V277, P1088, DOI 10.1126/science.277.5329.1088; MEMMOTT J, 1994, J ANIM ECOL, V63, P521, DOI 10.2307/5219; Memmott J, 2000, NONTARGET EFFECTS OF BIOLOGICAL CONTROL, P147; Messing RH, 2000, NONTARGET EFFECTS OF BIOLOGICAL CONTROL, P45; MURDOCH WW, 1985, AM NAT, V125, P344, DOI 10.1086/284347; SETTLE WH, 1990, ECOLOGY, V71, P1461, DOI 10.2307/1938283; Simberloff D, 1996, ECOLOGY, V77, P1965, DOI 10.2307/2265693; Simberloff D., 1992, Selection criteria and ecological consequences of importing natural enemies., P103; Strong DR, 2000, SCIENCE, V288, P1969, DOI 10.1126/science.288.5473.1969; Strong DR, 2001, EVALUATING INDIRECT ECOLOGICAL EFFECTS OF BIOLOGICAL CONTROL, P57, DOI 10.1079/9780851994536.0057; Thomas MB, 1998, TRENDS ECOL EVOL, V13, P325, DOI 10.1016/S0169-5347(98)01417-7; VANDRIESCHE RG, 1994, FLA ENTOMOL, V77, P20, DOI 10.2307/3495870; Williams F. X., 1931, HDB INSECTS OTHER IN; Zimmerman EC, 1978, MICROLEPIDOPTERA 2, V9, P883	31	221	233	4	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2001	293	5533					1314	1316		10.1126/science.1060788	http://dx.doi.org/10.1126/science.1060788			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509730				2022-12-01	WOS:000170492600039
J	Zabihi, N; Teichman, JMH				Zabihi, N; Teichman, JMH			Dealing with the pain of renal colic	LANCET			English	Editorial Material							URETERAL PRESSURE; INDOMETHACIN		Univ Texas, Hlth Sci Ctr, Dept Urol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Teichman, JMH (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Urol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.		Teichman, Joel/CAJ-0452-2022					Brater D. Craig, 1999, American Journal of Medicine, V107, p65S; CADNAPAPHORNCHAI P, 1978, PROSTAG OTH LIPID M, V16, P965, DOI 10.1016/0090-6980(78)90113-2; COLE RS, 1988, BRIT J UROL, V61, P19, DOI 10.1111/j.1464-410X.1988.tb09155.x; CORDELL WH, 1994, ANN EMERG MED, V23, P262, DOI 10.1016/S0196-0644(94)70038-9; ELSHERIF AE, 1995, J UROLOGY, V153, P1395, DOI 10.1016/S0022-5347(01)67411-1; HULAND H, 1981, INVEST UROL, V18, P274; KIMOTO Y, 1990, EUR J PHARMACOL, V175, P359, DOI 10.1016/0014-2999(90)90577-S; Lopes T, 2001, BJU INT, V87, P322, DOI 10.1046/j.1464-410x.2001.00068.x; MOODY TE, 1975, INVEST UROL, V13, P246; PERLMUTTER A, 1993, J UROLOGY, V149, P926, DOI 10.1016/S0022-5347(17)36261-4; SCHLONDORFF D, 1993, KIDNEY INT, V44, P643, DOI 10.1038/ki.1993.293; Segura JW, 1997, J UROLOGY, V158, P1915, DOI 10.1016/S0022-5347(01)64173-9; UDEN P, 1983, ACTA CHIR SCAND, V149, P497	13	14	14	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 11	2001	358	9280					437	438		10.1016/S0140-6736(01)05668-9	http://dx.doi.org/10.1016/S0140-6736(01)05668-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463TB	11513904				2022-12-01	WOS:000170492400006
J	Parmar, MKB; Griffiths, GO; Spiegelhalter, DJ; Souhami, RL; Altman, DG; van der Scheuren, E				Parmar, MKB; Griffiths, GO; Spiegelhalter, DJ; Souhami, RL; Altman, DG; van der Scheuren, E		CHART Steering Committee	Monitoring of large randomised clinical trials: a new approach with Bayesian methods	LANCET			English	Article							CELL LUNG-CANCER; CONVENTIONAL RADIOTHERAPY; MULTICENTER TRIAL; CHART; HEAD; NECK	Background In judging whether or not to continue enrolling patients into a randomised clinical trial, most data-monitoring and ethics committees (DMECs) rely on the p value for the difference in effect between the study groups. In the 1990s, two randomised controlled trials-one in patients with lung cancer and one in those with head and neck cancer-were instead monitored by Bayesian methods. We assessed the value of this approach in the monitoring of these clinical trials, Methods Before the trials opened, participating clinicians were asked their opinions on the expected difference between the study treatment (continuous hyperfractionated accelerated radiotherapy [CHART]) and conventional radiotherapy. These opinions were used to form an "enthusiastic" and a "sceptical" prior distribution. These prior distributions were combined with the trial data at each of the annual DMEC meetings. If, during monitoring, a result in favour of CHART was seen, the DMEC was to decide whether the results were sufficiently convincing to persuade a sceptic that CHART was worthwhile. Conversely, if there was apparently no or little difference, the DMEC was asked whether they thought the results sufficiently convincing to persuade an enthusiast that CHART was not worthwhile. Findings At each of the annual meetings, the DMEC concluded that there was insufficient evidence to convert either sceptics or enthusiasts, and that the trials should therefore remain open to recruitment. Neither trial was closed to recruitment earlier than planned. However if a conventional (p-value-based) stopping rule had been used, the lung-cancer trial would probably have been stopped. Interpretation This Bayesian approach to monitoring is simple to implement and straightforward for members of the DMEC to understand. In our opinion, it is more intuitively appealing than conventional approaches.	MRC, Clin Trials Unit, Canc Div, London NW1 2DA, England; Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England; UCL, Royal Free & Univ Coll Med Sch, London WC1E 6BT, England; Inst Hlth Sci, Ctr Stat Med, ICRF Med Stat Grp, Oxford, England; Univ Hosp Gasthuisberg, Louvain, Belgium	Medical Research Council Clinical Trials Unit; MRC Biostatistics Unit; University of Cambridge; University of London; University College London; University of Oxford; KU Leuven; University Hospital Leuven	Griffiths, GO (corresponding author), MRC, Clin Trials Unit, Canc Div, 222 Euston Rd, London NW1 2DA, England.	gg@ctu.mrc.ac.uk		Griffiths, Gareth/0000-0002-9579-8021				Armitage P, 1999, CONTROL CLIN TRIALS, V20, P207, DOI 10.1016/S0197-2456(99)00005-7; *CLIN TRIAL SERV U, 1989, ISIS3 PROT 3 INT STU; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; DeMets DL, 1999, LANCET, V354, P1983, DOI 10.1016/S0140-6736(99)03464-9; Dische S, 1997, RADIOTHER ONCOL, V44, P123, DOI 10.1016/S0167-8140(97)00094-7; Fayers PM, 1997, STAT MED, V16, P1413, DOI 10.1002/(SICI)1097-0258(19970630)16:12<1413::AID-SIM578>3.0.CO;2-U; Freidlin B, 1999, CONTROL CLIN TRIALS, V20, P395, DOI 10.1016/S0197-2456(99)00017-3; *MED RES COUNC, 1989, AXIS PROT ADJ XRAY 5; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; PARMAR MKB, 1994, STAT MED, V13, P1297, DOI 10.1002/sim.4780131304; Saunders M, 1999, RADIOTHER ONCOL, V52, P137, DOI 10.1016/S0167-8140(99)00087-0; Saunders MI, 1996, BRIT J CANCER, V73, P1455, DOI 10.1038/bjc.1996.276; SPIEGELHALTER DJ, 1994, J R STAT SOC A STAT, V157, P357, DOI 10.2307/2983527; SPIEGELHALTER DJ, 1993, STAT MED, V12, P1501, DOI 10.1002/sim.4780121516; THORNTON JG, 1996, GROWTH RESTRICTION I; Whitehead J., 1997, DESIGN ANAL SEQUENTI	16	53	53	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2001	358	9279					375	381		10.1016/S0140-6736(01)05558-1	http://dx.doi.org/10.1016/S0140-6736(01)05558-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502318				2022-12-01	WOS:000170235100013
J	Dubrulle, J; McGrew, MJ; Pourquie, O				Dubrulle, J; McGrew, MJ; Pourquie, O			FGF signaling controls somite boundary position and regulates segmentation clock control of spatiotemporal Hox gene activation	CELL			English	Article							GROWTH-FACTOR RECEPTOR; VERTEBRATE SEGMENTATION; PRESOMITIC MESODERM; AVIAN EMBRYOS; MOUSE EMBRYO; CHICK-EMBRYO; EXPRESSION; SOMITOGENESIS; GASTRULATION; CELLS	Vertebrate segmentation requires a molecular oscillator, the segmentation clock, acting in presomitic mesoderm (PSM) cells to set the pace at which segmental boundaries are laid down. However, the signals that position each boundary remain unclear. Here, we report that FGF8 which is expressed in the posterior PSM, generates a moving wavefront at which level both segment boundary position and axial identity become determined. Furthermore, by manipulating boundary position in the chick embryo, we show that Hox gene expression is maintained in the appropriately numbered somite rather than at an absolute axial position. These results implicate FGF8 in ensuring tight coordination of the segmentation process and spatiotemporal Hox gene activation.	Univ Mediterranee AP Marseille, Dev Biol Inst Marseille, Lab Genet & Physiol Dev, CNRS,INSERM, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Pourquie, O (corresponding author), Univ Mediterranee AP Marseille, Dev Biol Inst Marseille, Lab Genet & Physiol Dev, CNRS,INSERM, Campus Luminy,Case 907, F-13288 Marseille 09, France.	pourquie@ibdm.univ-mrs.fr	Pourquié, Olivier/CAJ-5443-2022	Pourquié, Olivier/0000-0001-5189-1227				AOYAMA H, 1988, DEVELOPMENT, V104, P15; Araki I, 1999, DEVELOPMENT, V126, P5127; BURGESS R, 1995, DEV BIOL, V168, P296, DOI 10.1006/dbio.1995.1081; BURKE AC, 1995, DEVELOPMENT, V121, P333; Cohn MJ, 1997, NATURE, V387, P97, DOI 10.1038/387097a0; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Dale KJ, 2000, BIOESSAYS, V22, P72, DOI 10.1002/(SICI)1521-1878(200001)22:1<72::AID-BIES12>3.0.CO;2-S; DEUCHAR EM, 1967, J EMBRYOL EXP MORPH, V17, P349; DUBAND JL, 1987, J CELL BIOL, V104, P1361, DOI 10.1083/jcb.104.5.1361; DUBOULE D, 1995, CURR OPIN GENET DEV, V5, P525, DOI 10.1016/0959-437X(95)90058-O; Gaunt SJ, 1996, DEV DYNAM, V207, P270, DOI 10.1002/(SICI)1097-0177(199611)207:3<270::AID-AJA4>3.0.CO;2-E; GOULDING M, 1994, DEVELOPMENT, V120, P957; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hirsinger E, 2000, INT REV CYTOL, V198, P1; Hirsinger E, 2001, DEVELOPMENT, V128, P107; Jiang YJ, 1998, CURR BIOL, V8, pR868, DOI 10.1016/S0960-9822(07)00547-7; Jouve C, 2000, DEVELOPMENT, V127, P1421; Kerszberg M, 2000, J THEOR BIOL, V205, P505, DOI 10.1006/jtbi.2000.2085; KEYNES RJ, 1988, DEVELOPMENT, V103, P413; KIENY M, 1972, DEV BIOL, V28, P142, DOI 10.1016/0012-1606(72)90133-9; Knezevic V, 1997, DEVELOPMENT, V124, P411; Kondo T, 1999, CELL, V97, P407, DOI 10.1016/S0092-8674(00)80749-7; McGrew MJ, 1998, CURR BIOL, V8, P979, DOI 10.1016/S0960-9822(98)70401-4; MEINHARDT H, 1986, SOMITES DEV EMBRYOS, P179; MENKES B, 1977, VERTEBRATE LIMB SOMI, V3, P405; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Nicolas JF, 1996, DEVELOPMENT, V122, P2933; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nowicki JL, 2000, DEVELOPMENT, V127, P4265; PACKARD DS, 1978, J EXP ZOOL, V203, P295, DOI 10.1002/jez.1402030212; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Palmeirim I, 1998, DEV GENET, V23, P77, DOI 10.1002/(SICI)1520-6408(1998)23:1<77::AID-DVG8>3.0.CO;2-3; Partanen J, 1998, GENE DEV, V12, P2332, DOI 10.1101/gad.12.15.2332; PATSTONE G, 1993, DEV BIOL, V155, P107, DOI 10.1006/dbio.1993.1011; Pourquie O, 2000, CURR OPIN CELL BIOL, V12, P747, DOI 10.1016/S0955-0674(00)00163-0; Pownall ME, 1996, DEVELOPMENT, V122, P3881; SCHULTEMERKER S, 1995, CURR BIOL, V5, P62, DOI 10.1016/S0960-9822(95)00017-0; Sosic D, 1997, DEV BIOL, V185, P229, DOI 10.1006/dbio.1997.8561; STERN CD, 1992, DEVELOPMENT, P151; Stern CD, 1998, CURR TOP DEV BIOL, V36, P223; STERN CD, 1988, DEVELOPMENT, V104, P231; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; Szebenyi G, 1999, INT REV CYTOL, V185, P45; Vogel A, 1996, DEVELOPMENT, V122, P1737; YAMAGUCHI TP, 1992, DEV BIOL, V152, P75, DOI 10.1016/0012-1606(92)90157-C; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032; Yamamoto Y, 1999, DEV BIOL, V214, P60, DOI 10.1006/dbio.1999.9413; Zakany J, 2001, CELL, V106, P207, DOI 10.1016/S0092-8674(01)00436-6	49	496	521	2	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2001	106	2					219	232		10.1016/S0092-8674(01)00437-8	http://dx.doi.org/10.1016/S0092-8674(01)00437-8			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511349	Bronze, Green Published			2022-12-01	WOS:000170193100011
J	Martin, W; Stoebe, B; Goremykin, V; Hansmann, S; Hasegawa, M; Kowallik, KV				Martin, W; Stoebe, B; Goremykin, V; Hansmann, S; Hasegawa, M; Kowallik, KV			Gene transfer to the nucleus and the evolution of chloroplasts	NATURE			English	Article							COMPLETE SEQUENCE; EUGLENA; PROCHLOROPHYTES; CHLOROPHYLL; ORIGINS; GENOME; ALGAE; TREES; MODEL; DNA	Photosynthetic eukaryotes, particularly unicellular forms, possess a fossil record that is either wrought with gaps or difficult to interpret, or both. Attempts to reconstruct their evolution have focused on plastid phylogeny, but were limited by the amount and type of phylogenetic information contained within single genes(1-5). Among the 210 different protein-coding genes contained in the completely sequenced chloroplast genomes from a glaucocystophyte, a rhodophyte, a diatom, a euglenophyte and five land plants, we have now identified the set of 45 common to each and to a cyanobacterial outgroup genome. Phylogenetic inference with an alignment of 11,039 amino-acid positions per genome indicates that this information is sufficient - but just barely so - to identify the rooted nine-taxon topology. We mapped the process of gene loss from chloroplast genomes across the inferred tree and found that, surprisingly, independent parallel gene losses in multiple lineages outnumber phylogenetically unique losses by more than 4:1. We identified homologues of 44 different plastid-encoded proteins as functional nuclear genes of chloroplast origin, providing evidence for endosymbiotic gene transfer to the nucleus in plants.	Tech Univ Carolo Wilhelmina Braunschweig, Inst Genet, D-38023 Braunschweig, Germany; Univ Dusseldorf, Inst Bot, D-40225 Dusseldorf, Germany; Inst Stat Math, Minato Ku, Tokyo 106, Japan	Braunschweig University of Technology; Heinrich Heine University Dusseldorf; Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan	Martin, W (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Genet, Spielmannstr 7, D-38023 Braunschweig, Germany.	w.martin@tu-bs.de	Martin, William F./O-5446-2015; Martin, William/C-5680-2008	Martin, William F./0000-0003-1478-6449; 				ACACHI J, 1996, COMPUT SCI MONOGRAPH, V28; Adachi J, 1996, J MOL EVOL, V42, P459; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; CAVALIERSMITH T, 1993, MICROBIOL REV, V57, P953, DOI 10.1128/MMBR.57.4.953-994.1993; CavalierSmith T, 1996, EUR J PHYCOL, V31, P315, DOI 10.1080/09670269600651541; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; GIBBS SP, 1978, CAN J BOT, V56, P2883, DOI 10.1139/b78-345; HALLICK RB, 1993, NUCLEIC ACIDS RES, V21, P3537, DOI 10.1093/nar/21.15.3537; Hedtke B, 1997, SCIENCE, V277, P809, DOI 10.1126/science.277.5327.809; HELMCHEN TA, 1995, J MOL EVOL, V41, P203; HENZE K, 1995, P NATL ACAD SCI USA, V92, P9122, DOI 10.1073/pnas.92.20.9122; Herrmann RG, 1997, EUKARYOTISM SYMBIOSI, P73, DOI [10.1007/978-3-642-60885-8_7, DOI 10.1007/978-3-642-60885-8_7]; Kaneko T, 1996, DNA Res, V3, P109; Kowallik KV, 1995, PLANT MOL BIOL REP, V13, P336, DOI 10.1007/BF02669188; Lockhart PJ, 1996, P NATL ACAD SCI USA, V93, P1930, DOI 10.1073/pnas.93.5.1930; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; LOFFELHARDT W, 1994, MOL BIOL CYANOBACTER, P56; Lynch M, 1996, MOL BIOL EVOL, V13, P209, DOI 10.1093/oxfordjournals.molbev.a025557; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Martin W, 1997, CURR GENET, V32, P1, DOI 10.1007/s002940050241; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; Melkonian Michael, 1996, Progress in Botany, V57, P281; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Naylor GJP, 1997, NATURE, V388, P527, DOI 10.1038/41460; PALENIK B, 1992, NATURE, V355, P265, DOI 10.1038/355265a0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; URBACH E, 1992, NATURE, V355, P267, DOI 10.1038/355267a0; VanDePeer Y, 1996, P NATL ACAD SCI USA, V93, P7732, DOI 10.1073/pnas.93.15.7732; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794	30	571	603	2	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	1998	393	6681					162	165		10.1038/30234	http://dx.doi.org/10.1038/30234			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZN200	11560168				2022-12-01	WOS:000073619900046
J	Wilkin, T; Devendra, D; Dequeker, J; Luyten, FP				Wilkin, T; Devendra, D; Dequeker, J; Luyten, FP			For and against - Bone densitometry is not a good predictor of hip fracture	BRITISH MEDICAL JOURNAL			English	Article							MINERAL DENSITY; RISK; WOMEN; OSTEOPOROSIS; TRIAL	Bone densitometry is widely used in osteoporosis clinics to identify people at increased risk of fracture. Terence Wilkin and Devasenan Devendra. believe that evidence for the efficacy of bone densitometry is weak, but Jan Dequeker and Frank P Luyten argue that their interpretation of the evidence is too narrow and that screening high risk patients is cost effective.	Derriford Hosp, Postgrad Med Sch, Dept Med, Plymouth PL6 8DH, Devon, England	Derriford Hospital; University of Plymouth	Wilkin, T (corresponding author), Derriford Hosp, Postgrad Med Sch, Dept Med, Plymouth PL6 8DH, Devon, England.		Luyten, Frank/GPS-7793-2022					Burger H, 1999, BONE, V25, P369, DOI 10.1016/S8756-3282(99)00173-8; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; DeLaet CEDH, 1997, BRIT MED J, V315, P221, DOI 10.1136/bmj.315.7102.221; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Faulkner KG, 2000, J BONE MINER RES, V15, P183, DOI 10.1359/jbmr.2000.15.2.183; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; HUI SL, 1988, J CLIN INVEST, V81, P1804, DOI 10.1172/JCI113523; Jonsson B, 1999, OSTEOPOROSIS INT, V10, P193, DOI 10.1007/s001980050215; Kanis JA, 2000, BONE, V26, P387, DOI 10.1016/S8756-3282(00)00238-6; Michaelsson K, 1998, BMJ-BRIT MED J, V316, P1858; Sackett D. L., 1995, EVIDENCE BASED MED, V1, P5; TOBIAS JH, 1994, CLIN SCI, V87, P587, DOI 10.1042/cs0870587; Wasnich RD, 2000, J CLIN ENDOCR METAB, V85, P231, DOI 10.1210/jc.85.1.231; Wilkin TJ, 1999, BRIT MED J, V318, P862, DOI 10.1136/bmj.318.7187.862; World Health Organization, 1994, WHO TECHN REP SER, V843; Xiaoge D, 2000, CALCIFIED TISSUE INT, V67, P195, DOI 10.1007/s002230001139	17	38	41	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 6	2001	323	7316					795	797		10.1136/bmj.323.7316.795	http://dx.doi.org/10.1136/bmj.323.7316.795			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481LK	11588087	Green Published			2022-12-01	WOS:000171520600034
J	Dalton, R				Dalton, R			Bilateral Vietnam study plans to assess war fallout of dioxin	NATURE			English	News Item																		2000, NATURE, V406, P818	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2001	413	6855					442	442		10.1038/35097221	http://dx.doi.org/10.1038/35097221			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586310	Bronze			2022-12-01	WOS:000171340500004
J	Haxby, JV; Gobbini, MI; Furey, ML; Ishai, A; Schouten, JL; Pietrini, P				Haxby, JV; Gobbini, MI; Furey, ML; Ishai, A; Schouten, JL; Pietrini, P			Distributed and overlapping representations of faces and objects in ventral temporal cortex	SCIENCE			English	Article							INFEROTEMPORAL CORTEX; PERCEPTION; AREA; RECOGNITION; COMPONENTS; EXPERTISE; STIMULI; SPACE	The functional architecture of the object vision pathway in the human brain was investigated using functional magnetic resonance imaging to measure patterns of response in ventral temporal cortex white subjects viewed faces, cats, five categories of man-made objects, and nonsense pictures. A distinct pattern of response was found for each stimulus category. The distinctiveness of the response to a given category was not due simply to the regions that responded maximally to that category, because the category being viewed also could be identified on the basis of the pattern of response when those regions were excluded from the analysis. Patterns of response that discriminated among A categories were found even within cortical regions that responded maximally to only one category. These results indicate that the representations of faces and objects in ventral temporal cortex are widely distributed and overlapping.	NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA; Univ Pisa, Dept Human & Environm Sci, I-56126 Pisa, Italy; Univ Pisa, Dept Expt Pathol, Lab Clin Biochem, I-56126 Pisa, Italy	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Pisa; University of Pisa	Haxby, JV (corresponding author), NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA.		Pietrini, Pietro/Z-4202-2019; Patanaik, Amiya/G-4336-2010; Furey, Maura/H-5273-2013	Pietrini, Pietro/0000-0002-6768-5556				Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Blanz V, 2000, PERCEPTION, V29, P885, DOI 10.1068/p2851; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; DEVALOIS RL, 1965, COLD SPRING HARB SYM, V30, P567, DOI 10.1101/SQB.1965.030.01.055; Edelman S, 1998, PSYCHOBIOLOGY, V26, P309; Edelman S, 1997, TRENDS COGN SCI, V1, P296, DOI 10.1016/S1364-6613(97)01090-5; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Gauthier I, 2000, TRENDS COGN SCI, V4, P1, DOI 10.1016/S1364-6613(99)01416-3; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; Hancock PJB, 1996, MEM COGNITION, V24, P26, DOI 10.3758/BF03197270; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Haxby JV, 2000, TRENDS COGN SCI, V4, P3, DOI 10.1016/S1364-6613(99)01423-0; HAXBY JV, IN PRESS MAPPING MOD; Hecaen H., 1962, ARCH NEUROL-CHICAGO, V7, P24; Hering E., 1964, OUTLINES THEORY LIGH; HURVICH LM, 1957, PSYCHOL REV, V64, P384, DOI 10.1037/h0041403; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Lanitis A, 1997, IEEE T PATTERN ANAL, V19, P743, DOI 10.1109/34.598231; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; MARTIN A, 1999, NEW COGNITIVE NEUROS, P1023; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; OTOOLE AJ, 1993, J OPT SOC AM A, V10, P405, DOI 10.1364/JOSAA.10.000405; TALAIRACH J, 1988, COPLANAR STEREOTOXIC; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; WARRINGTON EK, 1984, BRAIN, V107, P829, DOI 10.1093/brain/107.3.829	35	2476	2508	6	282	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2001	293	5539					2425	2430		10.1126/science.1063736	http://dx.doi.org/10.1126/science.1063736			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	476PD	11577229	Green Accepted			2022-12-01	WOS:000171237200038
J	Reilly, BM				Reilly, BM			Pronouncing	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Cook Cty Hosp, Dept Med, Chicago, IL 60612 USA; Rush Med Coll, Chicago, IL 60612 USA	John H Stroger Junior Hospital Cook County; Rush University	Reilly, BM (corresponding author), Cook Cty Hosp, Dept Med, Room 2129,1835 W Harrison St, Chicago, IL 60612 USA.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2001	135	6					467	470		10.7326/0003-4819-135-6-200109180-00017	http://dx.doi.org/10.7326/0003-4819-135-6-200109180-00017			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472FH	11560461				2022-12-01	WOS:000170972500009
J	Harrison, SP; Yu, G; Takahara, H; Prentice, IC				Harrison, SP; Yu, G; Takahara, H; Prentice, IC			Palaeovegetation - Diversity of temperate plants in east Asia	NATURE			English	Article									Max Planck Inst Biogeochem, D-07701 Jena, Germany; Lund Univ, S-22300 Lund, Sweden; Chinese Acad Sci, Nanjing Inst Geog & Limnol, Nanjing, Peoples R China; Kyoto Prefectural Univ, Univ Forest, Kyoto 606, Japan	Max Planck Society; Lund University; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Kyoto Prefectural University	Harrison, SP (corresponding author), Max Planck Inst Biogeochem, POB 100164, D-07701 Jena, Germany.		Takahara, Hikaru/AAZ-6642-2020	Harrison, Sandy/0000-0001-5687-1903					0	313	339	2	108	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					129	130		10.1038/35093166	http://dx.doi.org/10.1038/35093166			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557970				2022-12-01	WOS:000170918800036
J	Cederberg, A; Gronning, LM; Ahren, B; Tasken, K; Carlsson, P; Enerback, S				Cederberg, A; Gronning, LM; Ahren, B; Tasken, K; Carlsson, P; Enerback, S			FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance	CELL			English	Article							ENHANCER-BINDING-PROTEIN; PPAR-GAMMA ACTIVATORS; TARGETED DISRUPTION; ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; TRANSCRIPTION FACTOR; UNCOUPLING PROTEIN; EXPRESSION; ALPHA; MICE	Obesity, hyperlipidemia, and insulin resistance are common forerunners of type 2 diabetes mellitus. We have identified the human winged helix/forkhead transcription factor gene FOXC2 as a key regulator of adipocyte metabolism. Increased FOXC2 expression, in adipocytes, has a pleiotropic effect on gene expression, which leads to a lean and insulin sensitive phenotype. FOXC2 affects adipocyte metabolism by increasing the sensitivity of the beta -adrenergic-cAMP-protein kinase A (PIKA) signaling pathway through alteration of adipocyte PKA holoenzyme composition. Increased FOXC2 levels, induced by high fat diet, seem to counteract most of the symptoms associated with obesity, including hypertriglyceridemia and diet-induced insulin resistance-a likely consequence hereof would bo protection against type 2 diabetes.	Univ Gothenburg, Dept Med Biochem, SE-40530 Gothenburg, Sweden; Univ Oslo, Inst Med Biochem, N-0317 Oslo, Norway; Lund Univ, Malmo Univ Hosp, Dept Med, SE-20520 Malmo, Sweden	University of Gothenburg; University of Oslo; Lund University; Skane University Hospital	Enerback, S (corresponding author), Univ Gothenburg, Dept Med Biochem, Box 440, SE-40530 Gothenburg, Sweden.	sven.enerback@medgen.gu.se	Carlsson, Peter/B-5551-2008	Carlsson, Peter/0000-0001-6535-5927; Tasken, Kjetil/0000-0003-2841-4697				ABBOTT WGH, 1987, METABOLISM, V36, P576, DOI 10.1016/0026-0495(87)90170-3; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; Coe NR, 1999, J LIPID RES, V40, P967; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; DOSTMANN WRG, 1990, J BIOL CHEM, V265, P10484; ENERBACK S, 1992, MOL CELL BIOL, V12, P4622, DOI 10.1128/MCB.12.10.4622; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fajas L, 1999, MOL CELL BIOL, V19, P5495; FLIER JS, 1995, CELL, V80, P15, DOI 10.1016/0092-8674(95)90445-X; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Hamann A, 1996, ENDOCRINOLOGY, V137, P21, DOI 10.1210/en.137.1.21; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; Iida K, 1997, DEVELOPMENT, V124, P4627; KAESTNER KH, 1990, P NATL ACAD SCI USA, V87, P251, DOI 10.1073/pnas.87.1.251; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Levine JA, 1999, SCIENCE, V283, P212, DOI 10.1126/science.283.5399.212; LIN FT, 1994, P NATL ACAD SCI USA, V91, P8757, DOI 10.1073/pnas.91.19.8757; Lopez JM, 1996, P NATL ACAD SCI USA, V93, P1049, DOI 10.1073/pnas.93.3.1049; Lowell BB, 1997, ANNU REV MED, V48, P307; Martin G, 1997, J BIOL CHEM, V272, P28210, DOI 10.1074/jbc.272.45.28210; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Murray I, 1999, J BIOL CHEM, V274, P36219, DOI 10.1074/jbc.274.51.36219; ORahilly S, 1997, NAT MED, V3, P1080, DOI 10.1038/nm1097-1080; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; PARK EA, 1990, MOL CELL BIOL, V10, P6264, DOI 10.1128/MCB.10.12.6264; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; ROSS SR, 1990, P NATL ACAD SCI USA, V87, P9590, DOI 10.1073/pnas.87.24.9590; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; SUSULIC VS, 1995, J BIOL CHEM, V270, P29483, DOI 10.1074/jbc.270.49.29483; TASKEN K, 1993, J BIOL CHEM, V268, P23483; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Unger RH, 2000, INT J OBESITY, V24, pS28, DOI 10.1038/sj.ijo.0801498; Winnier GE, 1997, GENE DEV, V11, P926, DOI 10.1101/gad.11.7.926; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; YOSHIDA T, 1994, LIFE SCI, V54, P491, DOI 10.1016/0024-3205(94)00408-0; YUBERO P, 1994, BIOCHEM BIOPH RES CO, V198, P653, DOI 10.1006/bbrc.1994.1095; Zimmet PZ, 1997, LANCET, V350, pSI1	43	412	437	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2001	106	5					563	573		10.1016/S0092-8674(01)00474-3	http://dx.doi.org/10.1016/S0092-8674(01)00474-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551504	Bronze			2022-12-01	WOS:000170973200007
J	He, XL; Chow, DC; Martick, MM; Garcia, KC				He, XL; Chow, DC; Martick, MM; Garcia, KC			Allosteric activation of a spring-loaded natriuretic peptide receptor dimer by hormone	SCIENCE			English	Article							STABLE ENTEROTOXIN RECEPTOR; A GUANYLYL CYCLASE; GLYCOSYLATION SITES; BINDING DOMAIN; ATRIAL; PROTEIN; LIGAND; HEAT; IDENTIFICATION; PHARMACOLOGY	Natriuretic peptides (NPs) are vasoactive cyclic-peptide hormones important in blood pressure regulation through interaction with natriuretic cell-surface receptors. We report the hormone-binding thermodynamics and crystal structures at 2.9 and 2.0 angstroms, respectively, of the extracellular domain of the unliganded human NP receptor (NPR-C) and its complex with CNP, a 22-amino acid NP. A single CNP molecule is bound in the interface of an NPR-C dimer, resulting in asymmetric interactions between the hormone and the symmetrically related receptors. Hormone binding induces a 20 angstrom closure between the membrane-proximal domains of the dimer. In each monomer, the opening of an interdomain cleft, which is tethered together by a linker peptide acting as a molecular spring, is likely a conserved allosteric trigger for intracellular signaling by the natriuretic receptor family.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 93405 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 93405 USA	Stanford University; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Fairchild D319,299 Campus Dr, Stanford, CA 93405 USA.	kcgarcia@stanford.edu						Anand-Srivastava MB, 2000, BIOCHEMISTRY-US, V39, P6503, DOI 10.1021/bi992660q; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; BENNETT BD, 1991, J BIOL CHEM, V266, P23060; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DREWETT JG, 1994, ENDOCR REV, V15, P135, DOI 10.1210/er.15.2.135; DUDA T, 1995, BIOCHEM BIOPH RES CO, V212, P1046, DOI 10.1006/bbrc.1995.2075; ENGEL AM, 1994, J BIOL CHEM, V269, P17005; ENGEL AM, 1995, FEBS LETT, V360, P169, DOI 10.1016/0014-5793(95)00096-R; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FAIRBROTHER WJ, 1994, BIOCHEMISTRY-US, V33, P8897, DOI 10.1021/bi00196a006; Fenrick R, 1996, MOL CELL BIOCHEM, V165, P103, DOI 10.1007/BF00229471; GARBERS DL, 1994, J BIOL CHEM, V269, P30741; Hasegawa M, 1999, EUR J BIOCHEM, V263, P338, DOI 10.1046/j.1432-1327.1999.00488.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Itakura M, 1997, BIOCHEM J, V322, P585, DOI 10.1042/bj3220585; Janin J, 1997, STRUCTURE, V5, P473, DOI 10.1016/S0969-2126(97)00204-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Labrecque J, 1999, J BIOL CHEM, V274, P9752, DOI 10.1074/jbc.274.14.9752; Ladbury JE, 1996, CHEM BIOL, V3, P791, DOI 10.1016/S1074-5521(96)90063-0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LOWE DG, 1992, BIOCHEMISTRY-US, V31, P10421, DOI 10.1021/bi00158a001; LOWE DG, 1989, EMBO J, V8, P1377, DOI 10.1002/j.1460-2075.1989.tb03518.x; LOWE DG, 1992, J BIOL CHEM, V267, P21691; Lucas KA, 2000, PHARMACOL REV, V52, P375; MATSUMURA M, 1992, SCIENCE, V257, P927, DOI 10.1126/science.1323878; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McNicoll N, 1996, BIOCHEMISTRY-US, V35, P12950, DOI 10.1021/bi960818q; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Misono KS, 2000, CIRC RES, V86, P1135; Misono KS, 1999, BIOCHEMISTRY-US, V38, P516, DOI 10.1021/bi982127v; Miyagi M, 2000, EUR J BIOCHEM, V267, P5758, DOI 10.1046/j.1432-1327.2000.01647.x; Mowbray SL, 1999, J MOL BIOL, V294, P487, DOI 10.1006/jmbi.1999.3271; Pedro L, 1998, MOL CELL BIOCHEM, V178, P95, DOI 10.1023/A:1006808604321; Potter LR, 2001, J BIOL CHEM, V276, P6057, DOI 10.1074/jbc.R000033200; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; RONDEAU JJ, 1995, BIOCHEMISTRY-US, V34, P2130, DOI 10.1021/bi00007a005; RUDNER XL, 1995, P NATL ACAD SCI USA, V92, P5169, DOI 10.1073/pnas.92.11.5169; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; STULTS JT, 1994, BIOCHEMISTRY-US, V33, P11372, DOI 10.1021/bi00203a036; Takida S, 1999, HYPERTENSION, V33, P124, DOI 10.1161/01.HYP.33.1.124; Trachte GJ, 2000, J PHARMACOL EXP THER, V294, P210; TRACHTE GJ, 1995, AM J PHYSIOL-CELL PH, V268, pC978, DOI 10.1152/ajpcell.1995.268.4.C978; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van den Akker F, 2000, NATURE, V406, P101, DOI 10.1038/35017602; Wada A, 1996, INFECT IMMUN, V64, P5144, DOI 10.1128/IAI.64.12.5144-5150.1996	46	138	149	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2001	293	5535					1657	1662		10.1126/science.1062246	http://dx.doi.org/10.1126/science.1062246			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533490				2022-12-01	WOS:000170802900063
J	Passera, L; Aron, S; Vargo, EL; Keller, L				Passera, L; Aron, S; Vargo, EL; Keller, L			Queen control of sex ratio in fire ants	SCIENCE			English	Article							SOLENOPSIS-INVICTA; EUSOCIAL HYMENOPTERA; KIN SELECTION; INVESTMENT RATIOS; WORKER CONFLICT; SOCIAL INSECTS; POPULATIONS; ALLOCATION; COLONIES; FORMICIDAE	The haptodiploid sex-determination system of ants gives rise to conflict between queens and workers over colony sex ratios, and the female-biased allocation ratios seen in many species suggest that workers often prevail in this conflict. We exchanged queens between male- and female-specialist colonies of the fire ant Solenopsis invicta. These exchanges quickly reversed the sex-ratio biases of adopting colonies. The sex ratio of queen-laid eggs differed strongly between male- and female-specialist colonies. These findings suggest that queens can force workers to raise mate sexuals by limiting the number of female brood and help to explain why sex investment ratios lie between the queen and worker equilibria in this and many other ant species.	Univ Lausanne, Inst Ecol, CH-1015 Lausanne, Switzerland; Univ Toulouse 3, Lab Ethol & Anim Cognit, CNRS, FRE 2382, F-31062 Toulouse, France; Free Univ Brussels, Unit Anim Communities, B-1050 Brussels, Belgium; N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA	University of Lausanne; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of North Carolina; North Carolina State University	Keller, L (corresponding author), Univ Lausanne, Inst Ecol, CH-1015 Lausanne, Switzerland.	Laurent.keller@ie-zea.unit.ch	keller, laurent/AAI-7175-2020; Vargo, Edward/D-1097-2010	Vargo, Edward/0000-0002-8712-1248; keller, laurent/0000-0002-5046-9953				ARON S, 1995, ANIM BEHAV, V49, P749, DOI 10.1016/0003-3472(95)80207-X; ARON S, 1994, J EVOLUTION BIOL, V7, P403, DOI 10.1046/j.1420-9101.1994.7040403.x; BOOMSMA JJ, 1989, AM NAT, V133, P517, DOI 10.1086/284933; Bourke AFG, 1995, SOCIAL EVOLUTION ANT, DOI DOI 10.1186/s12862-015-0383-4; Bourke Andrew F.G., 1997, P203; BULMER MG, 1981, HEREDITY, V47, P197, DOI 10.1038/hdy.1981.76; Chapuisat M, 1997, P ROY SOC B-BIOL SCI, V264, P1255, DOI 10.1098/rspb.1997.0173; Chapuisat M, 1999, HEREDITY, V82, P473, DOI 10.1038/sj.hdy.6885340; Crozier R.H., 1996, EVOLUTION SOCIAL INS; FLETCHER DJC, 1983, SCIENCE, V219, P312, DOI 10.1126/science.219.4582.312; FLETCHER DJC, 1985, ANNU REV ENTOMOL, V30, P319, DOI 10.1146/annurev.en.30.010185.001535; Helms KR, 1999, EVOLUTION, V53, P1470, DOI 10.2307/2640893; Keller L, 1999, MG BEH ECOL, P153; Keller L, 1996, BEHAV ECOL, V7, P292, DOI 10.1093/beheco/7.3.292; Keller L, 1999, BIOSCIENCE, V49, P899, DOI 10.2307/1313649; Krieger MJB, 1997, MOL ECOL, V6, P997, DOI 10.1046/j.1365-294X.1997.00264.x; MARKIN GP, 1971, ANN ENTOMOL SOC AM, V64, P562, DOI 10.1093/aesa/64.3.562; NONACS P, 1986, Q REV BIOL, V61, P1, DOI 10.1086/414723; PAMILO P, 1982, AM NAT, V119, P638, DOI 10.1086/283940; PAMILO P, 1990, BEHAV ECOL SOCIOBIOL, V27, P31; Queller DC, 1998, BIOSCIENCE, V48, P165, DOI 10.2307/1313262; RATNIEKS FLW, 1992, J THEOR BIOL, V158, P33, DOI 10.1016/S0022-5193(05)80647-2; Reuter M, 2001, AM NAT, V158, P166, DOI 10.1086/321311; ROSS KG, 1985, BEHAV ECOL SOCIOBIOL, V17, P349, DOI 10.1007/BF00293212; ROSS KG, 1995, ANNU REV ECOL SYST, V26, P631, DOI 10.1146/annurev.es.26.110195.003215; Seger J, 1996, SCIENCE, V274, P941, DOI 10.1126/science.274.5289.941; Sundstrom L, 1996, SCIENCE, V274, P993, DOI 10.1126/science.274.5289.993; TRIVERS RL, 1976, SCIENCE, V191, P249, DOI 10.1126/science.1108197; TSCHINKEL WR, 1993, ECOL MONOGR, V63, P425, DOI 10.2307/2937154; Vargo EL, 1996, J EVOLUTION BIOL, V9, P783, DOI 10.1046/j.1420-9101.1996.9060783.x; VARGO EL, 1987, PHYSIOL ENTOMOL, V12, P109, DOI 10.1111/j.1365-3032.1987.tb00729.x	31	83	85	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2001	293	5533					1308	1310		10.1126/science.1062076	http://dx.doi.org/10.1126/science.1062076			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509728	Green Published			2022-12-01	WOS:000170492600037
J	CALDEIRA, K; KASTING, JF				CALDEIRA, K; KASTING, JF			SUSCEPTIBILITY OF THE EARLY EARTH TO IRREVERSIBLE GLACIATION CAUSED BY CARBON-DIOXIDE CLOUDS	NATURE			English	Article							CLIMATE; CO2; LUMINOSITY; FEEDBACK; MARS	SIMPLE energy-balance climate models of the Budyko/Sellers type1,2 predict that a small (2-5%) decrease in solar output could result in runaway glaciation on the Earth. But solar fluxes 25-30% lower early in the Earth's history3,4 apparently did not lead to this result. One currently favoured explanation is that high partial pressures of carbon dioxide, caused by higher volcanic outgassing rates and/or slower rates of silicate weathering, created a large enough greenhouse effect to keep the planet warm5-7. This does not resolve the problem of climate stability, however, because as we argue here, the oceans can freeze much more quickly than CO2 can accumulate in the atmosphere. Had such a transient global glaciation occurred in the distant past when solar luminosity was low, it might have been irreversible because of the formation of highly reflective CO2 clouds, similar to those encountered in climate simulations of early Mars8. Our simulations of the early Earth, incorporating the possible formation of such clouds, suggest that the Earth might not be habitable today had it not been warm during the first part of its history.	PENN STATE UNIV,DEPT GEOSCI,UNIV PK,PA 16802	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	CALDEIRA, K (corresponding author), PENN STATE UNIV,CTR EARTH SYST SCI,UNIV PK,PA 16802, USA.		Kasting, James/AAF-6851-2020; Caldeira, Ken/E-7914-2011	Caldeira, Ken/0000-0002-4591-643X				Allaart J. H., 1976, EARLY HIST EARTH, P177; BUDYKO MI, 1969, TELLUS, V21, P611, DOI 10.3402/tellusa.v21i5.10109; CAHALAN RF, 1979, J ATMOS SCI, V36, P1178, DOI 10.1175/1520-0469(1979)036<1178:ASTFEB>2.0.CO;2; GOUGH DO, 1981, SOL PHYS, V74, P21, DOI 10.1007/BF00151270; HAMBREY MJ, 1985, PALAEOGEOGR PALAEOCL, V51, P255, DOI 10.1016/0031-0182(85)90088-4; Holland H.D., 1978, CHEM ATMOSPHERE OCEA; KASTING JF, 1991, ICARUS, V94, P1, DOI 10.1016/0019-1035(91)90137-I; KASTING JF, 1986, SCIENCE, V234, P1383, DOI 10.1126/science.11539665; KASTING JF, IN PRESS ICARUS; KIEHL JT, 1987, J GEOPHYS RES-ATMOS, V92, P2991, DOI 10.1029/JD092iD03p02991; MARSHALL HG, 1988, J GEOPHYS RES-ATMOS, V93, P791, DOI 10.1029/JD093iD01p00791; MCWILLIAMS MO, 1980, J GEOL, V88, P1, DOI 10.1086/628470; NORTH GR, 1981, REV GEOPHYS, V19, P91, DOI 10.1029/RG019i001p00091; NORTH GR, 1979, J ATMOS SCI, V36, P1189, DOI 10.1175/1520-0469(1979)036<1189:DBSAMA>2.0.CO;2; OWEN T, 1979, NATURE, V277, P640, DOI 10.1038/277640a0; ROSSOW WB, 1982, SCIENCE, V217, P1245, DOI 10.1126/science.217.4566.1245; SAGAN C, 1972, SCIENCE, V177, P52, DOI 10.1126/science.177.4043.52; Sellers W.D., 1969, J APPL METEOROL, V8, P392, DOI [DOI 10.1175/1520-0450(1969)008<0392:AGCMBO>2.0.CO;2, DOI 10.1175/1520-0450(1969)008%3C0392:AGCMBO%3E2.0.CO;2]; SUNDQUIST ET, 1991, QUATERNARY SCI REV, V10, P283, DOI 10.1016/0277-3791(91)90026-Q; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; WALTER M, 1979, AM SCI, V67, P142; WARREN SG, 1986, APPL OPTICS, V25, P2650, DOI 10.1364/AO.25.002650; WORSLEY TR, 1992, GEOLOGY, V19, P1161	23	159	168	1	83	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	SEP 17	1992	359	6392					226	228		10.1038/359226a0	http://dx.doi.org/10.1038/359226a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JN944	11540934				2022-12-01	WOS:A1992JN94400057
J	Pearson, PN; Ditchfield, PW; Singano, J; Harcourt-Brown, KG; Nicholas, CJ; Olsson, RK; Shackleton, NJ; Hall, MA				Pearson, PN; Ditchfield, PW; Singano, J; Harcourt-Brown, KG; Nicholas, CJ; Olsson, RK; Shackleton, NJ; Hall, MA			Warm tropical sea surface temperatures in the Late Cretaceous and Eocene epochs	NATURE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; GLOBAL CLIMATE; MIDDLE EOCENE; OCEAN; OXYGEN; DIAGENESIS; EVOLUTION; ISOTOPES; RECORD; CO2	Climate models with increased levels of carbon dioxide predict that global warming causes heating in the tropics, but investigations of ancient climates based on palaeodata have generally indicated cool tropical temperatures during supposed greenhouse episodes. For example, in the Late Cretaceous and Eocene epochs there is abundant geological evidence for warm, mostly ice-free poles, but tropical sea surface temperatures are generally estimated to be only 15-23 degreesC, based on oxygen isotope palaeothermometry of surface-dwelling planktonic foraminifer shells. Here we question the validity of most such data on the grounds of poor preservation and diagenetic alteration. We present new data from exceptionally well preserved foraminifer shells extracted from impermeable clay-rich sediments, which indicate that for the intervals studied, tropical sea surface temperatures were at least 28-32 degreesC. These warm temperatures are more in line with our understanding of the geographical distributions of temperature-sensitive fossil organisms and the results of climate models with increased CO2 levels.	Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; Tanzania Petr Dev Corp, Dar Es Salaam, Tanzania; Univ Dublin Trinity Coll, Dept Geol, Dublin 2, Ireland; Rutgers State Univ, Dept Geol Sci, Piscataway, NJ 08855 USA; Univ Cambridge, Dept Earth Sci, Godwin Lab, Cambridge CB2 3SA, England	University of Bristol; Trinity College Dublin; Rutgers State University New Brunswick; University of Cambridge	Pearson, PN (corresponding author), Univ Bristol, Dept Earth Sci, Queens Rd, Bristol BS8 1RJ, Avon, England.	paul.pearson@bristol.ac.uk	Pearson, Paul N/B-2276-2009	Pearson, Paul N/0000-0003-4628-9818				ADAMS CG, 1990, PALAEOGEOGR PALAEOCL, V77, P289; Andreasson FP, 1998, PALEOCEANOGRAPHY, V13, P183, DOI 10.1029/98PA00120; BARRON EJ, 1995, EFFECTS PAST GLOBAL, P108; Barron EJ, 1987, PALEOCEANOGRAPHY, V2, P729, DOI 10.1029/PA002i006p00729; Bice KL, 2000, PALAEOGEOGR PALAEOCL, V161, P295, DOI 10.1016/S0031-0182(00)00072-9; Blow W.H., 1962, FUNDAMENTALS MIDTERT, P61; Blow WH, 1979, CAINOZOIC GLOBIGERIN, V1, pxv+752; Boersma A, 1987, PALEOCEANOGRAPHY, V2, P287, DOI 10.1029/PA002i003p00287; BRALOWER TJ, 1995, PALEOCEANOGRAPHY, V10, P841, DOI 10.1029/95PA01143; Bush ABG, 1997, PALEOCEANOGRAPHY, V12, P495, DOI 10.1029/97PA00721; Coxall HK, 2000, GEOLOGY, V28, P87, DOI 10.1130/0091-7613(2000)028<0087:HDAAEL>2.3.CO;2; Crowley TJ, 2001, SCIENCE, V292, P870, DOI 10.1126/science.1061664; Crowley TJ, 2000, WARM CLIMATES EARTH, P50, DOI DOI 10.1017/CBO9780511564512.004; DHONDT S, 1995, PALEOCEANOGRAPHY, V10, P123, DOI 10.1029/94PA02671; DHondt S, 1996, SCIENCE, V271, P1838, DOI 10.1126/science.271.5257.1838; EMILIANI C, 1954, AM J SCI, V252, P149, DOI 10.2475/ajs.252.3.149; EREZ J, 1983, GEOCHIM COSMOCHIM AC, V47, P1025, DOI 10.1016/0016-7037(83)90232-6; GRAHAM A, 1994, AM J BOT, V81, P301, DOI 10.2307/2445456; Hemleben Ch, 1989, MODERN PLANKTONIC FO, DOI DOI 10.1016/S0016-6995(89)80108-1; Horrell MA, 1990, PALEOCEANOGRAPHY, V5, P339, DOI 10.1029/PA005i003p00339; Huber M, 2000, PALEOCEANOGRAPHY, V15, P443, DOI 10.1029/1999PA000455; Kent PE, 1971, 6 NAT ENV RES COUNC; KILLINGLEY JS, 1983, NATURE, V301, P594, DOI 10.1038/301594a0; KOLODNY Y, 1988, PALAEOGEOGR PALAEOCL, V64, P59, DOI 10.1016/0031-0182(88)90142-3; MANABE S, 1985, J GEOPHYS RES-OCEANS, V90, P1689, DOI 10.1029/JC090iC06p11689; Markwick PJ, 1998, PALAEOGEOGR PALAEOCL, V137, P205, DOI 10.1016/S0031-0182(97)00108-9; Norris RD, 1998, GEOLOGY, V26, P823, DOI 10.1130/0091-7613(1998)026<0823:LLSSTF>2.3.CO;2; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; PEARSON PN, 1993, J FORAMIN RES, V23, P123, DOI 10.2113/gsjfr.23.2.123; RAMANATHAN V, 1991, NATURE, V351, P27, DOI 10.1038/351027a0; Retallack GJ, 2001, NATURE, V411, P287, DOI 10.1038/35077041; RIND D, 1991, J GEOPHYS RES-ATMOS, V96, P7437, DOI 10.1029/91JD00009; Rind D, 1998, J GEOPHYS RES-ATMOS, V103, P5943, DOI 10.1029/97JD03649; SAVIN SM, 1977, ANNU REV EARTH PL SC, V5, P319, DOI 10.1146/annurev.ea.05.050177.001535; SCHLUTER T, 1997, GEOLOGY E AFRICA, V239; SCHRAG DP, 1995, GEOCHIM COSMOCHIM AC, V59, P2265, DOI 10.1016/0016-7037(95)00105-9; Schrag DP, 1999, CHEM GEOL, V161, P215, DOI 10.1016/S0009-2541(99)00088-1; SHACKLETON N, 1981, J GEOL SOC LONDON, V138, P153, DOI 10.1144/gsjgs.138.2.0153; SHACKLETON NJ, 1984, FOSSILS CLIMATE, P27; Sloan LC, 1996, PALAEOGEOGR PALAEOCL, V119, P275, DOI 10.1016/0031-0182(95)00012-7; Spero HJ, 1997, NATURE, V390, P497, DOI 10.1038/37333; UREY HC, 1947, J CHEM SOC, P562, DOI 10.1039/jr9470000562; Veizer J, 2000, NATURE, V408, P698, DOI 10.1038/35047044; Wade BS, 2001, GEOL SOC SPEC PUBL, V183, P273, DOI 10.1144/GSL.SP.2001.183.01.13; Waliser DE, 1996, B AM METEOROL SOC, V77, P357; Wilson PA, 2001, NATURE, V412, P425, DOI 10.1038/35086553; Wilson PA, 1998, NATURE, V392, P889, DOI 10.1038/31865; Wilson PA, 1996, GEOLOGY, V24, P555, DOI 10.1130/0091-7613(1996)024<0555:ESSTFT>2.3.CO;2; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; ZACHOS JC, 1994, PALEOCEANOGRAPHY, V9, P353, DOI 10.1029/93PA03266	50	492	509	2	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2001	413	6855					481	487		10.1038/35097000	http://dx.doi.org/10.1038/35097000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586350				2022-12-01	WOS:000171340500037
J	Thompson, JS; Bixler, SA; Qian, F; Vora, K; Scott, ML; Cachero, TG; Hession, C; Schneider, P; Sizing, ID; Mullen, C; Strauch, K; Zafari, M; Benjamin, CD; Tschopp, J; Browning, JL; Ambrose, C				Thompson, JS; Bixler, SA; Qian, F; Vora, K; Scott, ML; Cachero, TG; Hession, C; Schneider, P; Sizing, ID; Mullen, C; Strauch, K; Zafari, M; Benjamin, CD; Tschopp, J; Browning, JL; Ambrose, C			BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF	SCIENCE			English	Article							NECROSIS-FACTOR FAMILY; CELL MATURATION ANTIGEN; A/WYSNJ MICE; MEMBER; SUPERFAMILY; APRIL; TACI; GROWTH; TALL-1; BCMA	B cell homeostasis has been shown to critically depend on BAFF, the B cell activation factor from the tumor necrosis factor (TNF) family. Although BAFF is already known to bind two receptors, BCMA and TACI, we have identified a third receptor for BAFF that we have termed BAFF-R. BAFF-R binding appears to be highly specific for BAFF, suggesting a unique role for this ligand-receptor interaction. Consistent with this, the BAFF-R locus is disrupted in A/WySnJ mice, which display a B cell phenotype qualitatively similar to that of the BAFF-deficient mice. Thus, BAFF-R appears to be the principal receptor for BAFF-mediated mature B cell survival.	Biogen Inc, Cambridge, MA 02142 USA; Univ Lausanne, Inst Biochem, CH-1066 Epalinges, Switzerland	Biogen; University of Lausanne	Ambrose, C (corresponding author), Biogen Inc, 12 Cambridge Ctr, Cambridge, MA 02142 USA.	christine_ambrose@biogen.com		Schneider, Pascal/0000-0003-0677-9409; Browning, Jeffrey/0000-0001-9168-5233				Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; Hoag KA, 2000, IMMUNOGENETICS, V51, P924, DOI 10.1007/s002510000223; HUA XX, 1995, GENOMICS, V25, P667, DOI 10.1016/0888-7543(95)80009-B; Lentz VM, 1998, J IMMUNOL, V160, P3743; Lentz VM, 1996, J IMMUNOL, V157, P598; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Madry C, 1998, INT IMMUNOL, V10, P1693, DOI 10.1093/intimm/10.11.1693; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; MILLER DJ, 1991, EUR J IMMUNOL, V21, P1123, DOI 10.1002/eji.1830210506; MILLER DJ, 1992, EUR J IMMUNOL, V22, P373, DOI 10.1002/eji.1830220213; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Mukhopadhyay A, 1999, J BIOL CHEM, V274, P15978, DOI 10.1074/jbc.274.23.15978; Naismith JH, 1998, TRENDS BIOCHEM SCI, V23, P74, DOI 10.1016/S0968-0004(97)01164-X; QIAN F, UNPUB; Rennert P, 2000, J EXP MED, V192, P1677, DOI 10.1084/jem.192.11.1677; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Shu HB, 2000, P NATL ACAD SCI USA, V97, P9156, DOI 10.1073/pnas.160213497; Shu HB, 1999, J LEUKOCYTE BIOL, V65, P680, DOI 10.1002/jlb.65.5.680; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; vonBulow GU, 1997, SCIENCE, V278, P138, DOI 10.1126/science.278.5335.138; Wu YM, 2000, J BIOL CHEM, V275, P35478, DOI 10.1074/jbc.M005224200; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137; Xu SL, 2001, MOL CELL BIOL, V21, P4067, DOI 10.1128/MCB.21.12.4067-4074.2001; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6	30	734	880	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2108	2111		10.1126/science.1061965	http://dx.doi.org/10.1126/science.1061965			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11509692				2022-12-01	WOS:000171028700079
J	Yoon, JC; Puigserver, P; Chen, GX; Donovan, J; Wu, ZD; Rhee, J; Adelmant, G; Stafford, J; Kahn, CR; Granner, DK; Newgard, CB; Spiegelman, BM				Yoon, JC; Puigserver, P; Chen, GX; Donovan, J; Wu, ZD; Rhee, J; Adelmant, G; Stafford, J; Kahn, CR; Granner, DK; Newgard, CB; Spiegelman, BM			Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1	NATURE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; GLUCOSE-6-PHOSPHATASE CATALYTIC SUBUNIT; RECEPTOR-GAMMA COACTIVATOR-1; RESPONSE UNIT; GLUCOCORTICOID RESPONSE; NUCLEAR RECEPTORS; METABOLIC IMPACT; CAMP INDUCTION; BINDING-SITES; GTP GENE	Blood glucose levels are maintained by the balance between glucose uptake by peripheral tissues and glucose secretion by the liver. Gluconeogenesis is strongly stimulated during fasting and is aberrantly activated in diabetes mellitus. Here we show that the transcriptional coactivator PGC-1 is strongly induced in liver in fasting mice and in three mouse models of insulin action deficiency: streptozotocin-induced diabetes, ob/ob genotype and liver insulin-receptor knockout. PGC-1 is induced synergistically in primary liver cultures by cyclic AMP and glucocorticoids. Adenoviral-mediated expression of PGC-1 in hepatocytes in culture or in vivo strongly activates an entire programme of key gluconeogenic enzymes, including phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase, leading to increased glucose output. Full transcriptional activation of the PEPCK promoter requires coactivation of the glucocorticoid receptor and the liver-enriched transcription factor HNF-4 alpha (hepatic nuclear factor-4 alpha) by PGC-1. These results implicate PGC-1 as a key modulator of hepatic gluconeogenesis and as a central target of the insulin-cAMP axis in liver.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ Texas, SW Med Ctr, Touchstone Ctr Diabet Res, Dept Biochem, Dallas, TX USA; Univ Texas, SW Med Ctr, Touchstone Ctr Diabet Res, Dept Internal Med, Dallas, TX USA; Vanderbilt Univ, Dept Mol Biol & Biophys, Sch Med, Nashville, TN 37232 USA; Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Vanderbilt University; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.		Kahn, Ronald/AAY-2435-2021; Rhee, James/V-9973-2019; Stafford, John/K-7763-2017	Kahn, Ronald/0000-0002-7583-9228; Stafford, John/0000-0001-6527-959X; Wu, Zhidan/0000-0001-7289-9420				Antinozzi PA, 1999, ANNU REV NUTR, V19, P511, DOI 10.1146/annurev.nutr.19.1.511; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Boss O, 1999, BIOCHEM BIOPH RES CO, V261, P870, DOI 10.1006/bbrc.1999.1145; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; DeFronzo RA, 1997, DIABETES REV, V5, P177; Glass CK, 2000, GENE DEV, V14, P121; Gomez-Ambrosi J, 2001, MOL CELL ENDOCRINOL, V176, P85, DOI 10.1016/S0303-7207(01)00451-8; HALL RK, 1995, P NATL ACAD SCI USA, V92, P412, DOI 10.1073/pnas.92.2.412; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Knutti D, 2000, MOL CELL BIOL, V20, P2411, DOI 10.1128/MCB.20.7.2411-2422.2000; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; McNeill J. H, 1999, EXPT MODELS DIABETES; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; MITCHELL J, 1994, MOL ENDOCRINOL, V8, P585, DOI 10.1210/me.8.5.585; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; O'Doherty RM, 1999, DIABETES, V48, P2022, DOI 10.2337/diabetes.48.10.2022; Park EA, 1999, J BIOL CHEM, V274, P211, DOI 10.1074/jbc.274.1.211; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; ROESLER WJ, 1994, J BIOL CHEM, V269, P14276; Scott DK, 1996, J BIOL CHEM, V271, P31909, DOI 10.1074/jbc.271.50.31909; Seoane J, 1997, J BIOL CHEM, V272, P26972, DOI 10.1074/jbc.272.43.26972; Sugiyama T, 2000, J BIOL CHEM, V275, P3446, DOI 10.1074/jbc.275.5.3446; Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200; Trinh KY, 1998, J BIOL CHEM, V273, P31615, DOI 10.1074/jbc.273.47.31615; VALERA A, 1994, P NATL ACAD SCI USA, V91, P9151, DOI 10.1073/pnas.91.19.9151; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wang JC, 1999, MOL ENDOCRINOL, V13, P604, DOI 10.1210/me.13.4.604; Wiernsperger NF, 1999, DRUGS, V58, P31, DOI 10.2165/00003495-199958001-00009; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yeagley D, 1998, J BIOL CHEM, V273, P18743, DOI 10.1074/jbc.273.30.18743	33	1439	1518	4	143	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					131	138		10.1038/35093050	http://dx.doi.org/10.1038/35093050			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557972				2022-12-01	WOS:000170918800038
J	Schwetz, BA				Schwetz, BA			Novel imaging device	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1166	1166		10.1001/jama.286.10.1166	http://dx.doi.org/10.1001/jama.286.10.1166			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471CR	11559244				2022-12-01	WOS:000170910400005
J	Tillmann, HL; Heiken, H; Knapik-Botor, A; Heringlake, S; Ockenga, J; Wilber, JC; Goergen, B; Detmer, J; McMorrow, M; Stoll, M; Schmidt, RE; Manns, MP				Tillmann, HL; Heiken, H; Knapik-Botor, A; Heringlake, S; Ockenga, J; Wilber, JC; Goergen, B; Detmer, J; McMorrow, M; Stoll, M; Schmidt, RE; Manns, MP			Infection with GB virus C and reduced mortality among HIV-infected patients.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-G VIRUS; ANTIRETROVIRAL THERAPY; CLINICAL PROGRESSION; NATURAL-HISTORY; HOMOSEXUAL MEN; LIVER-DISEASE; COINFECTION; ANTIBODIES; COHORT	Background: The flavivirus GB virus C (GBV-C, also designated hepatitis G virus) was identified in a search for hepatitis viruses, but no disease is currently known to be associated with it. We investigated the relation between coinfection with GBV-C and the long-term outcome in patients infected with the human immunodeficiency virus (HIV). Methods: A total of 197 HIV-positive patients were followed prospectively beginning in 1993 or 1994. Of these patients, 33 (16.8 percent) tested positive for GBV-C RNA, 112 (56.9 percent) had detectable antibodies against the GBV-C envelope protein E2, and 52 (26.4 percent) had no marker of GBV-C infection and were considered unexposed. We assessed the relation between GBV-C infection and the progression of HIV disease. We also tested 169 GBV-C-positive plasma samples with a quantitative branched-chain DNA (bDNA) assay in order to investigate possible correlations between GBV-C viral load and both the CD4+ cell count and the HIV load. Results: Among the patients who tested positive for GBV-C RNA, survival was significantly longer, and there was a slower progression to the acquired immunodeficiency syndrome (AIDS) (P<0.001 for both comparisons). Survival after the development of AIDS was also better among the GBV-C-positive patients. The association of GBV-C viremia with reduced mortality remained significant in analyses stratified according to age and CD4+ cell count. In an analysis restricted to the years after highly active antiretroviral therapy became available, the presence of GBV-C RNA remained predictive of longer survival (P=0.02). The HIV load was lower in the GBV-C-positive patients than in the GBV-C-negative patients. The GBV-C load correlated inversely with the HIV load (r=-0.33, P<0.001) but did not correlate with the CD4+ cell count. Conclusions: Coinfection with GBV-C is associated with a reduced mortality rate in HIV-infected patients. GBV-C is not known to cause any disease, but it is possible that its presence leads to an inhibition of HIV replication. However, GBV-C infection could also be a marker for the presence of other factors that lead to a favorable HIV response.	Hannover Med Sch, Dept Gastroenterol & Hepatol, D-30623 Hannover, Germany; Hannover Med Sch, Dept Clin Immunol, D-30623 Hannover, Germany; Bayer Diagnost, Emeryville, CA USA	Hannover Medical School; Hannover Medical School; Bayer AG	Tillmann, HL (corresponding author), Hannover Med Sch, Dept Gastroenterol & Hepatol, Neuberg Str 1, D-30623 Hannover, Germany.							Alter HJ, 1996, NEW ENGL J MED, V334, P1536, DOI 10.1056/NEJM199606063342310; BARTHOLOMEW C, 1987, LANCET, V2, P1469; Carpenter CCJ, 1998, JAMA-J AM MED ASSOC, V280, P78, DOI 10.1001/jama.280.1.78; Casoli C, 2000, BLOOD, V95, P2760, DOI 10.1182/blood.V95.9.2760.009k04_2760_2769; Dille BJ, 1997, J INFECT DIS, V175, P458, DOI 10.1093/infdis/175.2.458; EYSTER ME, 1993, J ACQ IMMUN DEF SYND, V6, P602; Fischer HP, 1996, J HEPATOL, V24, P35; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Heringlake S, 1998, J INFECT DIS, V177, P1723, DOI 10.1086/517431; Lefrere JJ, 1999, J INFECT DIS, V179, P783, DOI 10.1086/314671; Lesens O, 1999, J INFECT DIS, V179, P1254, DOI 10.1086/314720; Linnen J, 1996, SCIENCE, V271, P505, DOI 10.1126/science.271.5248.505; MARTIN P, 1989, GASTROENTEROLOGY, V97, P1559, DOI 10.1016/0016-5085(89)90405-8; MCNAIR ANB, 1992, SEMIN LIVER DIS, V12, P188, DOI 10.1055/s-2007-1007390; Ockenga J, 1997, J HEPATOL, V27, P18, DOI 10.1016/S0168-8278(97)80274-7; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pol S, 1998, J HEPATOL, V29, P12, DOI 10.1016/S0168-8278(98)80173-6; Pol S, 1998, J HEPATOL, V28, P945, DOI 10.1016/S0168-8278(98)80341-3; Rambusch EG, 1998, Z GASTROENTEROL, V36, P41; Sabin CA, 1998, J ACQ IMMUN DEF SYND, V19, P546, DOI 10.1097/00042560-199812150-00016; Sagnelli E, 2000, HEPATOLOGY, V32, P1106, DOI 10.1053/jhep.2000.19288; Sherlock S, 1999, J VIRAL HEPATITIS, V6, P1, DOI 10.1046/j.1365-2893.1999.00007.x; SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564; Soto B, 1997, J HEPATOL, V26, P1, DOI 10.1016/S0168-8278(97)80001-3; TELFER P, 1994, BRIT J HAEMATOL, V87, P555, DOI 10.1111/j.1365-2141.1994.tb08312.x; Tillmann HL, 1998, HEPATOLOGY, V28, P379, DOI 10.1002/hep.510280213; TILLMANN HL, IN PRESS ANTIVIRAL R; Toyoda H, 1998, J ACQ IMMUN DEF SYND, V17, P209, DOI 10.1097/00042560-199803010-00004; Wachtler M, 2000, INFECTION, V28, P297, DOI 10.1007/s150100070022; Watt G, 2000, LANCET, V356, P475, DOI 10.1016/S0140-6736(00)02557-5; Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364; Yeo AET, 2000, ANN INTERN MED, V132, P959, DOI 10.7326/0003-4819-132-12-200006200-00006	32	300	323	1	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2001	345	10					715	724		10.1056/NEJMoa010398	http://dx.doi.org/10.1056/NEJMoa010398			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	468RX	11547740	Bronze			2022-12-01	WOS:000170772900002
J	van den Ent, F; Amos, LA; Lowe, J				van den Ent, F; Amos, LA; Lowe, J			Prokaryotic origin of the actin cytoskeleton	NATURE			English	Article							F-ACTIN; CRYSTAL-STRUCTURE; ATPASE FRAGMENT; ATOMIC MODEL; CELL-SHAPE; PROTEINS; DOMAIN; REFINEMENT; PARAMETERS; SEQUENCE	It was thought until recently that bacteria lack the actin or tubulin filament networks that organize eukaryotic cytoplasm. However, we show here that the bacterial MreB protein assembles into filaments with a subunit repeat similar to that of F-actin-the physiological polymer of eukaryotic actin. By elucidating the MreB crystal structure we demonstrate that MreB and actin are very similar in three dimensions. Moreover, the crystals contain protofilaments, allowing visualization of actin-like strands at atomic resolution. The structure of the MreB protofilament is in remarkably good agreement with the model for F-actin, showing that the proteins assemble in identical orientations. The actin-like properties of MreB explain the finding that MreB forms large fibrous spirals under the cell membrane of rod-shaped cells, where they are involved in cell-shape determination. Thus, prokaryotes are now known to possess homologues both of tubulin, namely FtsZ, and of actin.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	van den Ent, F (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	fent@mrc-lmb.cam.ac.uk	Löwe, Jan/B-3882-2011; Löwe, Jan/X-6998-2019	Lowe, Jan/0000-0002-5218-6615; Amos, Linda/0000-0001-8305-5346				AEBI U, 1981, J CELL BIOL, V91, P340, DOI 10.1083/jcb.91.2.340; ANDERSON PK, 1978, AUST WILDLIFE RES, V5, P1; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chik JK, 1996, J MOL BIOL, V263, P607, DOI 10.1006/jmbi.1996.0602; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; DOI M, 1988, J BACTERIOL, V170, P4619, DOI 10.1128/jb.170.10.4619-4624.1988; EGELMAN EH, 1982, NATURE, V298, P131, DOI 10.1038/298131a0; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; FLAHERTY KM, 1991, P NATL ACAD SCI USA, V88, P5041, DOI 10.1073/pnas.88.11.5041; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; HURLEY JH, 1993, SCIENCE, V259, P673, DOI 10.1126/science.8430315; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; KABSCH W, 1995, FASEB J, V9, P167, DOI 10.1096/fasebj.9.2.7781919; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1991, RECENT CHANGES MOSFL; LEVIN PA, 1992, J BACTERIOL, V174, P6717, DOI 10.1128/JB.174.21.6717-6728.1992; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Page R, 1998, J MOL BIOL, V280, P463, DOI 10.1006/jmbi.1998.1879; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Steinmetz MO, 1998, J MOL BIOL, V278, P703, DOI 10.1006/jmbi.1998.1717; Straub FB, 1942, STUD I MED CHEM U SZ, V2, P3; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; TIRION MM, 1995, BIOPHYS J, V68, P5, DOI 10.1016/S0006-3495(95)80156-6; TURK D, 1992, THESIS TU MUNCHEN; van den Ent F, 1999, STRUCTURE, V7, P1181, DOI 10.1016/S0969-2126(00)80052-0; van den Ent F, 2000, EMBO J, V19, P5300, DOI 10.1093/emboj/19.20.5300; WACHI M, 1987, J BACTERIOL, V169, P4935, DOI 10.1128/jb.169.11.4935-4940.1987	39	590	605	3	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2001	413	6851					39	44		10.1038/35092500	http://dx.doi.org/10.1038/35092500			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544518				2022-12-01	WOS:000170801200031
J	Ezzati, M; Kammen, DM				Ezzati, M; Kammen, DM			Indoor air pollution from biomass combustion and acute respiratory infections in Kenya: an exposure-response study	LANCET			English	Article							DOMESTIC SMOKE POLLUTION; YOUNG GAMBIAN CHILDREN; DEVELOPING-COUNTRIES; RURAL-COMMUNITY; HILL REGION; EMISSIONS; HEALTH; WOMEN; NEPAL	Background Acute respiratory infections (ARI) are the leading cause of the global burden of disease and have been causally linked with exposure to pollutants from domestic biomass fuels in less-developed countries. We used longitudinal health data coupled with detailed monitoring of personal exposure from more than 2 years of field measurements in rural Kenya to estimate the exposure-response relation for particulates smaller than 10 mum in diameter (PM10) generated from biomass combustion. Methods 55 randomly-selected households (including 93 infants and children, 229 individuals between 5 and 49 years of age, and 23 aged 50 or older) in central Kenya were followed up for more than 2 years. Longitudinal data on ARI and acute lower respiratory infections (ALRI) were recorded at weekly clinical examinations. Exposure to PM10 was monitored by measurement of PM10 emission concentration and time-activity budgets. Findings With the best estimate of the exposure-response relation, we found that ARI and ALRI are increasing concave functions of average daily exposure to PM10, with the rate of increase declining for exposures above about 1000-2000 mug/m(3). After we had included high-intensity exposure episodes, sex was no longer a significant predictor of ARI and ALRI. Interpretation The benefits of reduced exposure to PM10 are larger for average exposure less than about 1000-2000 mug/m(3). Our findings have important consequences for international public-health policies, energy and combustion research, and technology transfer efforts that affect more than 2 billion people worldwide.	Resources Future Inc, Ctr Risk Management, Washington, DC 20036 USA; WHO, Global Programme Evidence Hlth Policy, Epidemiol & Burden Dis Unit, CH-1211 Geneva, Switzerland; Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA	Resources for the Future; World Health Organization; University of California System; University of California Berkeley	Ezzati, M (corresponding author), Resources Future Inc, Ctr Risk Management, 1616 P St NW, Washington, DC 20036 USA.							ARMSTRONG JRM, 1991, INT J EPIDEMIOL, V20, P424, DOI 10.1093/ije/20.2.424; Awasthi S, 1996, AM J TROP MED HYG, V55, P48, DOI 10.4269/ajtmh.1996.55.48; BallardTremeer G, 1996, BIOMASS BIOENERG, V11, P419, DOI 10.1016/S0961-9534(96)00040-2; Barnes D. F., 1994, WHAT MAKES PEOPLE CO; BERMAN S, 1991, REV INFECT DIS, V13, pS454; BOLEIJ JSM, 1989, ATMOS ENVIRON, V23, P1677, DOI 10.1016/0004-6981(89)90052-8; Bruce N, 1998, INT J EPIDEMIOL, V27, P454, DOI 10.1093/ije/27.3.454; Campbell H, 1997, Health Bull (Edinb), V55, P20; CERQUEIRO MC, 1990, REV INFECT DIS, V12, pS1021; CHEN B H, 1990, World Health Statistics Quarterly, V43, P127; CRUZ JR, 1990, REV INFECT DIS, V12, pS1029; DEFRANCISCO A, 1993, INT J EPIDEMIOL, V22, P1174, DOI 10.1093/ije/22.6.1174; Ellegard A, 1996, ENVIRON HEALTH PERSP, V104, P980, DOI 10.2307/3433146; Ezzati M, 2000, ENVIRON HEALTH PERSP, V108, P833, DOI 10.2307/3434990; Ezzati M, 2000, ENVIRON SCI TECHNOL, V34, P578, DOI 10.1021/es9905795; GRAHAM NMH, 1990, EPIDEMIOL REV, V12, P149, DOI 10.1093/oxfordjournals.epirev.a036050; OYEJIDE CO, 1990, REV INFECT DIS, V12, pS1042; PANDEY MR, 1984, THORAX, V39, P337, DOI 10.1136/thx.39.5.337; PANDEY MR, 1989, ENVIRON INT, V15, P337, DOI 10.1016/0160-4120(89)90046-9; SAKSENA S, 1992, ATMOS ENVIRON A-GEN, V26, P2125, DOI 10.1016/0960-1686(92)90096-4; Sharma S, 1998, ENVIRON HEALTH PERSP, V106, P291, DOI 10.2307/3434017; Smith K.R, 1988, ENVIRONMENT, V30, P16, DOI 10.1080/00139157.1988.9930921; Smith KR, 2000, THORAX, V55, P518, DOI 10.1136/thorax.55.6.518; SMITH KR, 1993, ANNU REV ENERG ENV, V18, P529, DOI 10.1146/annurev.eg.18.110193.002525; STANEK EJ, 1994, CLIN INFECT DIS, V18, P639, DOI 10.1093/clinids/18.4.639; *WHO, 1998, WORLD HLTH REP; Wilson R., 1996, PARTICLES OUR AIR CO; World Health Organization, 2000, HLTH SYSTEMS IMPROVI; World Health Organization, 1999, WORLD HLTH REPORT 19; World Health Organization, 1990, AC RESP INF CHILDR C	30	313	329	1	58	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 25	2001	358	9282					619	624		10.1016/S0140-6736(01)05777-4	http://dx.doi.org/10.1016/S0140-6736(01)05777-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530148				2022-12-01	WOS:000170615500009
J	Kourtzi, Z; Kanwisher, N				Kourtzi, Z; Kanwisher, N			Representation of perceived object shape by the human lateral occipital complex	SCIENCE			English	Article							RECOGNITION; AREAS; SELECTIVITY; ACTIVATION; CONTOURS; SURFACES	The human lateral occipital complex (LOC) has been implicated in object recognition, but it is unknown whether this region represents low-level image features or perceived object shape. We used an event-related functional magnetic resonance imaging adaptation paradigm in which the response to pairs of successively presented stimuli is tower when they are identical than when they are different. Adaptation across a change between the two stimuli in a pair provides evidence for a common neural representation invariant to that change. We found adaptation in the LOC when perceived shape was identical but contours differed, but not when contours were identical but perceived shape differed. These data indicate that the LOC represents not simple image features, but rather higher level shape information.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Nucl Magnet Resonance Ctr, Charlestown, MA 02128 USA	Max Planck Society; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital	Kourtzi, Z (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	zoe.kourtzi@tuebingen.mpg.de		Kourtzi, Zoe/0000-0001-9441-7832	NATIONAL EYE INSTITUTE [R01EY013455] Funding Source: NIH RePORTER; NEI NIH HHS [EY13455] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bakin JS, 2000, J NEUROSCI, V20, P8188; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; HE ZJ, 1992, NATURE, V359, P231, DOI 10.1038/359231a0; Kanwisher N, 1996, COGNITIVE BRAIN RES, V5, P55, DOI 10.1016/S0926-6410(96)00041-9; KELLMAN PJ, 1983, COGNITIVE PSYCHOL, V15, P483, DOI 10.1016/0010-0285(83)90017-8; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; KOURTZI Z, UNPUB; KOVACS G, 1995, J NEUROSCI, V15, P1984, DOI 10.1523/JNEUROSCI.15-03-01984.1995; Lisberger SG, 1999, J NEUROSCI, V19, P2224; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Marr D., 1982, VISION; Mattingley JB, 1997, SCIENCE, V275, P671, DOI 10.1126/science.275.5300.671; Mendola JD, 1999, J NEUROSCI, V19, P8560; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; NAKAYAMA K, 1989, PERCEPTION, V18, P55, DOI 10.1068/p180055; Nakayama K, 1995, VISUAL COGNITION INV, P1; Rosen BR, 1998, P NATL ACAD SCI USA, V95, P773, DOI 10.1073/pnas.95.3.773; SARY G, 1993, SCIENCE, V260, P995, DOI 10.1126/science.8493538; Sugita Y, 1999, NATURE, V401, P269, DOI 10.1038/45785; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Ullman S, 1998, COGNITION, V67, P21, DOI 10.1016/S0010-0277(98)00013-4; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000	30	637	643	2	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1506	1509		10.1126/science.1061133	http://dx.doi.org/10.1126/science.1061133			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520991				2022-12-01	WOS:000170616000049
J	Wand, AJ				Wand, AJ			On the dynamic origins of allosteric activation	SCIENCE			English	Editorial Material							CALMODULIN; NMR		Univ Penn, Johnson Res Fdn, Philadelphia, PA 19104 USA; Univ Penn, Dept Biochem Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Wand, AJ (corresponding author), Univ Penn, Johnson Res Fdn, Philadelphia, PA 19104 USA.	wand@mail.med.upenn.edu						AKKE M, 1993, J AM CHEM SOC, V115, P9832, DOI 10.1021/ja00074a073; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Lee AL, 2000, NAT STRUCT BIOL, V7, P72; Li ZG, 1996, PROTEIN SCI, V5, P2647, DOI 10.1002/pro.5560051228; Malmendal A, 1999, J MOL BIOL, V293, P883, DOI 10.1006/jmbi.1999.3188; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Palmer AG, 1997, CURR OPIN STRUC BIOL, V7, P732, DOI 10.1016/S0959-440X(97)80085-1; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Yang P, 1996, EUR J MINERAL, V8, P263	10	17	17	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534												1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520951				2022-12-01	WOS:000170616000001
J	VanCappellen, P; Ingall, ED				VanCappellen, P; Ingall, ED			Redox stabilization of the atmosphere and oceans by phosphorus-limited marine productivity	SCIENCE			English	Article							OXYGEN; CARBON; PRESERVATION; WATER; TIME	Data from modern and ancient marine sediments demonstrate that burial of the limiting nutrient phosphorus is less efficient when bottom waters are low in oxygen. Mass-balance calculations using a coupled model of the biogeochemical cycles of carbon, phosphorus, oxygen, and iran indicate that the redox dependence of phosphorus burial in the oceans provides a powerful forcing mechanism for balancing production and consumption of atmospheric oxygen over geologic time. The oxygen-phosphorus coupling further guards against runaway ocean anoxia. Phosphorus-mediated redox stabilization of the atmosphere and oceans may have been crucial to the radiation of higher life forms during the Phanerozoic.	UNIV TEXAS,INST MARINE SCI,PORT ARANSAS,TX 78373	University of Texas System	VanCappellen, P (corresponding author), GEORGIA INST TECHNOL,SCH EARTH & ATMOSPHER SCI,ATLANTA,GA 30332, USA.		Van Cappellen, Philippe/A-2906-2013; Ingall, Ellery/A-5447-2008	Van Cappellen, Philippe/0000-0001-5476-0820; Ingall, Ellery/0000-0003-1954-0317	NCIPC CDC HHS [OCE94-15563] Funding Source: Medline	NCIPC CDC HHS		BERKNER LV, 1965, J ATMOS SCI, V22, P225, DOI 10.1175/1520-0469(1965)022<0225:OTOARO>2.0.CO;2; BERNER RA, 1987, AM J SCI, V287, P177, DOI 10.2475/ajs.287.3.177; BERNER RA, 1989, AM J SCI, V289, P333, DOI 10.2475/ajs.289.4.333; BERNER RA, 1989, PALAEOGEOGR PALAEOCL, V75, P97, DOI DOI 10.1016/0031-0182(89)90186-7; Broecker W., 1982, TRACERS SEA; BROECKER WS, 1982, GEOCHIM COSMOCHIM AC, V46, P1689, DOI 10.1016/0016-7037(82)90110-7; CANFIELD DE, 1989, DEEP-SEA RES, V36, P121, DOI 10.1016/0198-0149(89)90022-8; FILIPPELLI GM, 1994, PALEOCEANOGRAPHY, V9, P643, DOI 10.1029/94PA01453; FOLLMI KB, 1995, GEOLOGY, V23, P859, DOI 10.1130/0091-7613(1995)023<0859:MYROMS>2.3.CO;2; HERBERT TD, 1991, GEOLOGY, V19, P702, DOI 10.1130/0091-7613(1991)019<0702:ONDAOL>2.3.CO;2; Holland H.D., 1978, CHEM ATMOSPHERE OCEA; Holland H. D., 1984, CHEM EVOLUTION ATMOS; HOLLAND HD, 1990, NATURE, V347, P17, DOI 10.1038/347017a0; INGALL E, 1994, GEOCHIM COSMOCHIM AC, V58, P2571, DOI 10.1016/0016-7037(94)90033-7; INGALL E, IN PRESS MAR GEOL; INGALL ED, 1993, GEOCHIM COSMOCHIM AC, V57, P303, DOI 10.1016/0016-7037(93)90433-W; JONES TP, 1978, PALAEOGEOGR PALAEOCL, V77, P51; JONES TP, 1991, PALAEOGEOGR PALAEOCL, V77, P39; Kump L. R, 1993, INTERACTIONS C N P S, P475; KUMP LR, 1988, NATURE, V335, P152, DOI 10.1038/335152a0; KUMP LR, 1986, AM J SCI, V286, P337, DOI 10.2475/ajs.286.5.337; LASAGA AC, 1985, CARBON CYCLE ATMOSPH, P397; REDFIELD AC, 1958, AM SCI, V46, P205; Sarmiento JL, 1988, GLOBAL BIOGEOCHEM CY, V2, P115, DOI 10.1029/GB002i002p00115; TROMP TK, 1995, GEOCHIM COSMOCHIM AC, V59, P1259, DOI 10.1016/0016-7037(95)00042-X; VANCAPPELLEN P, 1994, PALEOCEANOGRAPHY, V9, P677, DOI 10.1029/94PA01455; WATSON A, 1978, BIOSYSTEMS, V10, P293, DOI 10.1016/0303-2647(78)90012-6	27	269	272	2	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 26	1996	271	5248					493	496		10.1126/science.271.5248.493	http://dx.doi.org/10.1126/science.271.5248.493			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TR322	11541251				2022-12-01	WOS:A1996TR32200038
J	GIESEN, TF; VANORDEN, A; HWANG, HJ; FELLERS, RS; PROVENCAL, RA; SAYKALLY, RJ				GIESEN, TF; VANORDEN, A; HWANG, HJ; FELLERS, RS; PROVENCAL, RA; SAYKALLY, RJ			INFRARED-LASER SPECTROSCOPY OF THE LINEAR C-13 CARBON CLUSTER	SCIENCE			English	Article							MULTIREFERENCE CONFIGURATION-INTERACTION; ELECTRON-SPIN-RESONANCE; MOLECULAR-STRUCTURE; CHAIN MOLECULES; GAS-PHASE; ISOMERS; SPECTRA; C-6; FULLERENES; STABILITY	The infrared absorption spectrum of a linear, 13-atom carbon cluster (C-13) has been observed by the use of a supersonic cluster beam-diode laser spectrometer. Seventy-six rovibrational transitions were measured near 1809 wave numbers and assigned to an antisymmetric stretching fundamental in the (1) Sigma(g)(+) ground state of C-13. This definitive structural characterization of a carbon cluster in the intermediate size range between C-10 and C-20 is in apparent conflict with theoretical calculations, which predict that clusters of this size should exist as planar monocyclic rings.	UNIV CALIF BERKELEY,DEPT CHEM,BERKELEY,CA 94720	University of California System; University of California Berkeley			Giesen, Thomas/B-9476-2015; Van Orden, Alan K/N-4219-2015	Giesen, Thomas/0000-0002-2401-0049; SAYKALLY, RICHARD/0000-0001-8942-3656				ACHIBA Y, 1991, Z PHYS D ATOM MOL CL, V19, P427, DOI 10.1007/BF01448344; ARNOLD DW, 1991, J CHEM PHYS, V95, P8753, DOI 10.1063/1.461211; BAKOWIES D, 1991, J AM CHEM SOC, V113, P3704, DOI 10.1021/ja00010a012; BERNATH PF, 1989, SCIENCE, V244, P562, DOI 10.1126/science.244.4904.562; BERNHOLDT DE, 1988, J CHEM PHYS, V89, P3612, DOI 10.1063/1.454881; BOWERS MT, 1993, SCIENCE, V260, P1446, DOI 10.1126/science.260.5113.1446; CHELIKOWSKY JR, 1991, PHYS REV LETT, V67, P2970, DOI 10.1103/PhysRevLett.67.2970; FEYEREISEN M, 1992, J CHEM PHYS, V96, P2926, DOI 10.1063/1.461989; Guelachvili G, 1986, HDB INFRARED STANDAR; HEATH JR, 1987, J AM CHEM SOC, V109, P359, DOI 10.1021/ja00236a012; HEATH JR, 1993, CLUSTERS CLUSTERING, P7; HINKLE KW, 1988, SCIENCE, V241, P1319, DOI 10.1126/science.241.4871.1319; HOFFMANN R, 1966, TETRAHEDRON, V22, P521, DOI 10.1016/0040-4020(66)80020-0; HUTTER J, 1993, 93107 SWISS FED I TE; HWANG HJ, 1993, MOL PHYS, V79, P769, DOI 10.1080/00268979300101611; JIAO CQ, 1993, RAPID COMMUN MASS SP, V7, P404, DOI 10.1002/rcm.1290070518; KAWAGUCHI K, 1989, J CHEM PHYS, V91, P1953, DOI 10.1063/1.457054; KROTO HW, 1987, ASTROPHYS J, V314, P352, DOI 10.1086/165065; KURTZ J, 1991, ASTROPHYS J, V370, P784, DOI 10.1086/169862; LIANG CX, 1990, J CHEM PHYS, V93, P8844, DOI 10.1063/1.459223; MARTIN JML, 1991, CHEM PHYS LETT, V187, P367, DOI 10.1016/0009-2614(91)80267-2; MARTIN JML, 1991, J CHEM PHYS, V94, P3753, DOI 10.1063/1.459747; MARTIN JML, 1990, J CHEM PHYS, V93, P8850, DOI 10.1063/1.459224; MCELVANY SW, 1993, SCIENCE, V259, P1594, DOI 10.1126/science.259.5101.1594; MOAZZENAHMADI N, 1994, J CHEM PHYS, V100, P4033, DOI 10.1063/1.466340; MOAZZENAHMADI N, 1993, J CHEM PHYS, V98, P7757, DOI 10.1063/1.464583; MOAZZENAHMADI N, 1991, CHEM PHYS LETT, V186, P291, DOI 10.1016/S0009-2614(91)85144-L; NORTHRUP FJ, 1991, J MOL SPECTROSC, V145, P74, DOI 10.1016/0022-2852(91)90352-B; PARASUK V, 1991, J CHEM PHYS, V94, P8172, DOI 10.1063/1.460100; PARASUK V, 1989, J CHEM PHYS, V91, P1137, DOI 10.1063/1.457186; PITZER KS, 1959, J AM CHEM SOC, V81, P4477, DOI 10.1021/ja01526a010; RAGHAVACHARI K, 1993, CHEM PHYS LETT, V214, P357, DOI 10.1016/0009-2614(93)85650-D; RAGHAVACHARI K, 1987, J CHEM PHYS, V87, P2191, DOI 10.1063/1.453145; SLANINA Z, 1992, MOL PHYS, V76, P387, DOI 10.1080/00268979200101401; SOWA MB, 1992, J CHEM PHYS, V97, P8164, DOI 10.1063/1.463438; VANORDEN A, 1993, J CHEM PHYS, V98, P6678, DOI 10.1063/1.464785; VANZEE RJ, 1988, J CHEM PHYS, V88, P3465, DOI 10.1063/1.453895; VANZEE RJ, 1987, J CHEM PHYS, V86, P5212, DOI 10.1063/1.452643; VON HELDEN G, 1993, CHEM PHYS LETT, V212, P241, DOI 10.1016/0009-2614(93)89320-H; VON HELDEN G, 1993, CHEM PHYS LETT, V212, P247, DOI 10.1016/0009-2614(93)89321-8; VON HELDEN G, 1993, J PHYS CHEM-US, V97, P8182, DOI 10.1021/j100133a011; VON HELDEN G, 1993, CHEM PHYS LETT, V204, P15, DOI 10.1016/0009-2614(93)85599-J; VON HELDEN G, 1993, NATURE, V363, P60, DOI 10.1038/363060a0; VON HELDEN G, 1993, SCIENCE, V259, P1300, DOI 10.1126/science.259.5099.1300; WATTS JD, 1992, CHEM PHYS LETT, V190, P19, DOI 10.1016/0009-2614(92)86095-Y; WELTNER W, 1989, CHEM REV, V89, P1713, DOI 10.1021/cr00098a005; ZAJFMAN D, 1992, SCIENCE, V258, P1129, DOI 10.1126/science.258.5085.1129	47	106	106	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 5	1994	265	5173					756	759		10.1126/science.11539187	http://dx.doi.org/10.1126/science.11539187			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PA372	11539187				2022-12-01	WOS:A1994PA37200025
J	SCHOPF, JW				SCHOPF, JW			MICROFOSSILS OF THE EARLY ARCHEAN APEX CHERT - NEW EVIDENCE OF THE ANTIQUITY OF LIFE	SCIENCE			English	Article							BARBERTON MOUNTAIN LAND; WESTERN-AUSTRALIA; SOUTH-AFRICA; STROMATOLITIC MICROBIOTAS; NORTH-POLE; OLD	Eleven taxa (including eight heretofore undescribed species) of cellularly preserved filamentous microbes, among the oldest fossils known, have been discovered in a bedded chert unit of the Early Archean Apex Basalt of northwestern Western Australia. This prokaryotic assemblage establishes that trichomic cyanobacterium-like microorganisms were extant and morphologically diverse at least as early as approximately 3465 million years ago and suggests that oxygen-producing photoautotrophy may have already evolved by this early stage in biotic history.	UNIV CALIF LOS ANGELES,INST GEOPHYS & PLANETARY PHYS,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,DEPT EARTH & SPACE SCI,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	SCHOPF, JW (corresponding author), UNIV CALIF LOS ANGELES,CTR STUDY EVOLUT & ORIGIN LIFE,LOS ANGELES,CA 90024, USA.							AWRAMIK SM, 1983, PRECAMBRIAN RES, V20, P357, DOI 10.1016/0301-9268(83)90081-5; BARGHOOR.ES, 1966, SCIENCE, V152, P758, DOI 10.1126/science.152.3723.758; BARGHOORN ES, 1965, SCIENCE, V147, P563, DOI 10.1126/science.147.3658.563; BLAKE TS, 1984, U W AUST GEOL DEP U, V9, P1; Buchanan RE., 1974, BERGEYS MANUAL DETER, V8th ed., DOI 10.1007/bergeysoutline200405; BUICK R, 1981, ALCHERINGA, V5, P161, DOI 10.1080/03115518108566999; BUICK R, 1991, PALAIOS, V5, P441; BYERLY GR, 1986, NATURE, V319, P489, DOI 10.1038/319489a0; CLOUD P, 1980, GEOMICROBIOL J, V2, P161, DOI 10.1080/01490458009377759; CLOUD PE, 1965, SCIENCE, V148, P27, DOI 10.1126/science.148.3666.27; Desikachary T. V., 1959, CYANOPHYTA DESIKACHA; Hayes J. M., 1983, EARTHS EARLIEST BIOS, P93; HICKMAN AH, 1983, AUST GEOL SURV B, V127, P1; HOFMANN HJ, 1976, J PALEONTOL, V50, P1040; HOFMANN HJ, 1991, ECON GEOL BULL SOC, V86, P1023, DOI 10.2113/gsecongeo.86.5.1023; Klein C, 1992, PROTEROZOIC BIOSPHER, P603; KNOLL AH, 1977, SCIENCE, V198, P396, DOI 10.1126/science.198.4315.396; KNOLL AH, 1988, PRECAMBRIAN RES, V38, P257, DOI 10.1016/0301-9268(88)90005-8; LOWE DR, 1980, NATURE, V284, P441, DOI 10.1038/284441a0; Mendelson C.V., 1992, PROTEROZOIC BIOSPHER, P865, DOI 10.1017/CBO9780511601064.024; MENDELSON CV, 1982, J PALEONTOL, V56, P42; Muir M.D., 1976, EARLY HIST EARTH, P595; NYBERG AV, 1981, PRECAMBRIAN RES, V16, P129, DOI 10.1016/0301-9268(81)90008-5; Oehler JH, 1977, ALCHERINGA, V1, P315, DOI 10.1080/03115517708527768; Pflug H.D., 1992, EARLY ORGANIC EVOLUT, P509; PFLUG HD, 1966, U WITWATERSRAND EC G, V28, P1; Schopf J.W., 1992, P583; SCHOPF J W, 1968, Journal of Paleontology, V42, P651; Schopf J.W., 1983, P214; Schopf J.W., 1992, P1055; Schopf J. W., 1992, PROTEROZOIC BIOSPHER, P195, DOI DOI 10.1017/CBO9780511601064; Schopf J. W., 1992, PROTEROZOIC BIOSPHER, P25; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; SCHOPF JW, 1977, PRECAMBRIAN RES, V4, P269, DOI 10.1016/0301-9268(77)90017-1; SCHOPF JW, 1984, PRECAMBRIAN RES, V24, P335, DOI 10.1016/0301-9268(84)90064-0; SCHOPF JW, 1986, 5TH M INT SOC STUD O, P163; SCHOPF JW, IN PRESS EARLY LIFE; SCHOPF JW, 1992, PROTEROZOIC BIOSPHER, P179; SCHOPF JW, 1976, SCIENCE, V193, P43; Shukla M., 1986, PALAEOBOTANIST, V35, P347; Strauss H., 1992, PROTEROZOIC BIOSPHER, P709; THORPE RI, 1992, PRECAMBRIAN RES, V56, P169, DOI 10.1016/0301-9268(92)90100-3; Towe KM, 1991, PALAEOGEOGR PALAEOCL, V97, P113, DOI 10.1016/0031-0182(91)90187-V; TOWE KM, 1990, NATURE, V348, P54, DOI 10.1038/348054a0; WALSH MM, 1992, PRECAMBRIAN RES, V54, P271, DOI 10.1016/0301-9268(92)90074-X; WALSH MM, 1985, NATURE, V314, P530, DOI 10.1038/314530a0; WALTER MR, 1980, NATURE, V284, P443, DOI 10.1038/284443a0; WALTER MR, 1992, PROTEROZOIC BIOSPHER, P253; Walter MR, 1983, EARTHS EARLIEST BIOS, P187; Ward D. M., 1992, PROTEROZOIC BIOSPHER, P309	50	859	914	4	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	APR 30	1993	260	5108					640	646		10.1126/science.260.5108.640	http://dx.doi.org/10.1126/science.260.5108.640			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KZ641	11539831				2022-12-01	WOS:A1993KZ64100022
J	UGARTE, D				UGARTE, D			CURLING AND CLOSURE OF GRAPHITIC NETWORKS UNDER ELECTRON-BEAM IRRADIATION	NATURE			English	Article							CARBON; C-60; FULLERENES	THE discovery1 of buckminsterfullerene (C60) and its production in macroscopic quantities2 has stimulated a great deal of research. More recently, attention has turned towards other curved graphitic networks, such as the giant fullerenes (C(n), n > 100)3,4 and carbon nanotubes5-8. A general mechanism has been proposed9 in which the graphitic sheets bend in an attempt to eliminate the highly energetic dangling bonds present at the edge of the growing structure. Here, I report the response of carbon soot particles and tubular graphitic structures to intense electron-beam irradiation in a high-resolution electron microscope; such conditions resemble a high-temperature regime, permitting a degree of structural fluidity. With increased irradiation, there is a gradual reorganization of the initial material into quasi-spherical particles composed of concentric graphitic shells. This lends weight to the nucleation scheme proposed9 for fullerenes, and moreover, suggests that planar graphite may not be the most stable allotrope of carbon in systems of limited size.			UGARTE, D (corresponding author), ECOLE POLYTECH FED LAUSANNE,INST PHYS EXPTL,CH-1015 LAUSANNE,SWITZERLAND.		Ugarte, Daniel/C-2326-2012	Ugarte, Daniel Mario/0000-0003-3332-9139				ADAMS GB, 1992, SCIENCE, V256, P1792, DOI 10.1126/science.256.5065.1792; BUNDY FP, 1989, PHYSICA A, V156, P169, DOI 10.1016/0378-4371(89)90115-5; CHAI Y, 1991, J PHYS CHEM-US, V95, P7564, DOI 10.1021/j100173a002; Curl R. F., 1991, Scientific American (International Edition), V265, P32, DOI 10.1038/scientificamerican1091-54; EBBESEN TW, 1992, NATURE, V358, P2200; HAMADA N, 1992, PHYS REV LETT, V68, P1579, DOI 10.1103/PhysRevLett.68.1579; IIJIMA S, 1987, J PHYS CHEM-US, V91, P3466, DOI 10.1021/j100297a002; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; IIJIMA S, 1980, J CRYST GROWTH, V50, P657; KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0; KROTO HW, 1987, NATURE, V329, P529, DOI 10.1038/329529a0; KROTO HW, 1988, NATURE, V331, P328, DOI 10.1038/331328a0; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; LAMB LD, 1992, SCIENCE, V255, P1413, DOI 10.1126/science.255.5050.1413; MINTMIRE JW, 1992, PHYS REV LETT, V68, P631, DOI 10.1103/PhysRevLett.68.631; ROBERTSON DH, 1992, J PHYS CHEM-US, V96, P6133, DOI 10.1021/j100194a011; SCUSERIA GE, IN PRESS BUCKMINSTER; TANAKA K, 1992, CHEM PHYS LETT, V191, P469, DOI 10.1016/0009-2614(92)85410-C; ZHANG QL, 1986, J PHYS CHEM-US, V90, P525, DOI 10.1021/j100276a001	19	1717	1771	12	316	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 22	1992	359	6397					707	709		10.1038/359707a0	http://dx.doi.org/10.1038/359707a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JU650	11536508				2022-12-01	WOS:A1992JU65000048
J	Gabriel, JCP; Camerel, F; Lemaire, BJ; Desvaux, H; Davidson, P; Batail, P				Gabriel, JCP; Camerel, F; Lemaire, BJ; Desvaux, H; Davidson, P; Batail, P			Swollen liquid-crystalline lamellar phase based on extended solid-like sheets	NATURE			English	Article							SUSPENSIONS; MEMBRANES; DIAGRAM; SYSTEM	Ordering particles at the nanometre length scale is a challenging and active research area in materials science. Several approaches have so far been developed, ranging from the manipulation of individual particles(1,2) to the exploitation of self-assembly in colloids(3). Nanometre-scale ordering is well known to appear spontaneously when anisotropic organic moieties form liquid-crystalline phases; this behaviour is also observed for anisotropic mineral nanoparticles(4,5) resulting in the formation of nematic(4-7), smectic(8) and hexagonal(9,10) mesophases. Here we describe a lyotropic liquid-crystalline lamellar phase comprising an aqueous dispersion of planar solid-like sheets in which all the atoms involved in a layer are covalently bonded. The spacing of these phosphatoantimonate single layers can be increased 100-fold, resulting in one-dimensional structures whose periodicity can be tuned from 1.5 to 225 nanometres. These highly organized materials can be mechanically or magnetically aligned over large pH and temperature ranges, and this property can be used to measure residual dipolar couplings for the structure determination of biomolecules by liquid-state NMR. We also expect that our approach will result in the discovery of other classes of mineral lyotropic lamellar phases.	CNRS, FRE 2068, F-44322 Nantes 3, France; Univ Paris Sud, Phys Solides Lab, CNRS, UMR 8502, F-91405 Orsay, France; CEA Saclay, Serv Chim Mol, CNRS, URA 331, F-91191 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	Gabriel, JCP (corresponding author), CNRS, FRE 2068, 2 Rue Houssiniere,BP 32229, F-44322 Nantes 3, France.		Davidson, Patrick/F-7874-2017; Davidson, Patrick/Q-6691-2019; Gabriel, Jean-Christophe P/H-9959-2014	Davidson, Patrick/0000-0002-1363-6062; Davidson, Patrick/0000-0002-1363-6062; Gabriel, Jean-Christophe P/0000-0002-0194-683X; Lemaire, Bruno J./0000-0002-0227-0106				Blanco A, 2000, NATURE, V405, P437, DOI 10.1038/35013024; BOESECKE P, 1995, REV SCI INSTRUM, V66, P1636; Brown ABD, 1999, EUR PHYS J B, V11, P481, DOI 10.1007/s100510050959; DAVIDSON P, 1993, ADV MATER, V5, P665, DOI 10.1002/adma.19930050916; DERYAGUIN BV, 1941, ACTA PHYSICOCHIM USS, V14, P633; Desvaux H, 2001, ANGEW CHEM INT EDIT, V40, P373, DOI 10.1002/1521-3773(20010119)40:2<373::AID-ANIE373>3.0.CO;2-R; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Fang MM, 1999, CHEM MATER, V11, P1526, DOI 10.1021/cm981066k; Fraden S, 1995, NATO ADV SCI INST SE, V460, P113; Gabriel JCP, 1996, J PHYS CHEM-US, V100, P11139, DOI 10.1021/jp961088z; Gabriel JCP, 2000, ADV MATER, V12, P9, DOI 10.1002/(SICI)1521-4095(200001)12:1<9::AID-ADMA9>3.0.CO;2-6; Jacobson A. J., 1982, INTERCALATION CHEM; JANIAK MJ, 1976, BIOCHEMISTRY-US, V15, P4575, DOI 10.1021/bi00666a005; KAJIWARA K, 1986, MAKROMOL CHEM, V187, P2883; Kaschak DM, 1998, J AM CHEM SOC, V120, P10887, DOI 10.1021/ja9818710; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; MAEDA Y, 1983, COLLOID SURFACE, V6, P1, DOI 10.1016/0166-6622(83)80001-8; Mourchid A, 1998, LANGMUIR, V14, P4718, DOI 10.1021/la980117p; NIKOOBAKHT B, 2000, J PHYS CHEM B, V104, P1346; PIFFARD Y, 1986, REV CHIM MINER, V23, P766; Poncharal P, 1999, SCIENCE, V283, P1513, DOI 10.1126/science.283.5407.1513; Ramirez BE, 1998, J AM CHEM SOC, V120, P9106, DOI 10.1021/ja982310b; SAFINYA CR, 1993, SCIENCE, V261, P588, DOI 10.1126/science.261.5121.588; SAFINYA CR, 1986, PHYS REV LETT, V57, P2718, DOI 10.1103/PhysRevLett.57.2718; Salditt T, 1999, PHYS REV E, V60, P7285, DOI 10.1103/PhysRevE.60.7285; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; TONER J, 1990, PHYS REV LETT, V64, P1741, DOI 10.1103/PhysRevLett.64.1741; van der Kooij FM, 2000, NATURE, V406, P868, DOI 10.1038/35022535; Verwey E. J. W, 1948, THEORY STABILITY LYO	29	227	229	0	133	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2001	413	6855					504	508		10.1038/35097046	http://dx.doi.org/10.1038/35097046			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586355	Green Published			2022-12-01	WOS:000171340500042
J	Farley, KA; Mukhopadhyay, S				Farley, KA; Mukhopadhyay, S			An extraterrestrial impact at the Permian-Triassic boundary?	SCIENCE			English	Editorial Material							EXTINCTION		CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology	Farley, KA (corresponding author), CALTECH, Div Geol & Planetary Sci, MS 170-25, Pasadena, CA 91125 USA.	farley@gps.caltech.edu	Isozaki, Yukio/A-1806-2009; Farley, Kenneth/AAE-7735-2020	Isozaki, Yukio/0000-0002-3596-581X; Farley, Kenneth/0000-0002-7846-7546				ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; ANDREWS JN, 1985, CHEM GEOL, V49, P339, DOI 10.1016/0009-2541(85)90166-4; Becker L, 2001, SCIENCE, V291, P1530, DOI 10.1126/science.1057243; Bowring SA, 1998, SCIENCE, V280, P1039, DOI 10.1126/science.280.5366.1039; HEYMANN D, 1996, GEOL SOC AM SPEC PAP, V307, P453; Mukhopadhyay S, 2001, GEOCHIM COSMOCHIM AC, V65, P653, DOI 10.1016/S0016-7037(00)00555-X; ROBL TL, 1993, ORG GEOCHEM, V20, P249, DOI 10.1016/0146-6380(93)90042-A	7	75	80	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2001	293	5539					2343	+						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11577203				2022-12-01	WOS:000171237200001
J	Brott, LL; Naik, RR; Pikas, DJ; Kirkpatrick, SM; Tomlin, DW; Whitlock, PW; Clarson, SJ; Stone, MO				Brott, LL; Naik, RR; Pikas, DJ; Kirkpatrick, SM; Tomlin, DW; Whitlock, PW; Clarson, SJ; Stone, MO			Ultrafast holographic nanopatterning of biocatalytically formed silica	NATURE			English	Article								Diatoms are of interest to the materials research community because of their ability to create highly complex and intricate silica structures under physiological conditions: what these single-cell organisms accomplish so elegantly in nature requires extreme laboratory conditions to duplicate(1,2) -this is true for even the simplest of structures. Following the identification of polycationic peptides from the diatom Cylindrotheca fusiformis, simple silica nanospheres can now be synthesized in vitro from silanes at nearly neutral pH and at ambient temperatures and pressures(3,4). Here we describe a method for creating a hybrid organic/inorganic ordered nanostructure of silica spheres through the incorporation of a polycationic peptide (derived from the C. fusiformis silaffin-1 protein) into a polymer hologram created by two-photon-induced photopolymerization. When these peptide nanopatterned holographic structures are exposed to a silicic acid, an ordered array of silica nanospheres is deposited onto the clear polymer substrate. These structures exhibit a nearly fifty-fold increase in diffraction efficiency over a comparable polymer hologram without silica. This approach, combining the ease of processability of an organic polymer with the improved mechanical and optical properties of an inorganic material, could be of practical use for the fabrication of photonic devices.	USAF, Res Lab, Mat & Mfg Directorate, Wright Patterson AFB, OH 45433 USA; Univ Cincinnati, Dept Mat Sci & Engn, Cincinnati, OH 45221 USA	United States Department of Defense; United States Air Force; US Air Force Research Laboratory; University System of Ohio; University of Cincinnati	Stone, MO (corresponding author), USAF, Res Lab, Mat & Mfg Directorate, 3005 P St, Wright Patterson AFB, OH 45433 USA.							Belfield KD, 2000, J PHYS ORG CHEM, V13, P837, DOI 10.1002/1099-1395(200012)13:12<837::AID-POC315>3.0.CO;2-5; BROTT LL, 2001, POLYM PREPRINTS, V42, P675; BUNNING TJ, 1995, POLYMER, V36, P2699, DOI 10.1016/0032-3861(95)93646-4; Cha JN, 2000, NATURE, V403, P289, DOI 10.1038/35002038; Kirkpatrick SM, 1999, APPL PHYS A-MATER, V69, P461, DOI 10.1007/s003390051033; Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129; Kroger N, 2001, J BIOL CHEM, V276, P26066, DOI 10.1074/jbc.M102093200; Morse DE, 1999, TRENDS BIOTECHNOL, V17, P230, DOI 10.1016/S0167-7799(99)01309-8; Parkinson J, 1999, TRENDS BIOTECHNOL, V17, P190, DOI 10.1016/S0167-7799(99)01321-9; Wang C, 2000, CHEM MATER, V12, P3662, DOI 10.1021/cm990738j	10	209	226	2	77	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					291	293		10.1038/35095031	http://dx.doi.org/10.1038/35095031			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565027				2022-12-01	WOS:000171040500034
J	Boulay, F; Berthier, F; Schoukroun, G; Raybaut, C; Gendreike, Y; Blaive, B				Boulay, F; Berthier, F; Schoukroun, G; Raybaut, C; Gendreike, Y; Blaive, B			Seasonal variations in hospital admission for deep vein thrombosis and pulmonary embolism: analysis of discharge data	BRITISH MEDICAL JOURNAL			English	Article									Nice Teaching Hosp, Dept Resp Med, F-06003 Nice 1, France; Nice Teaching Hosp, Dept Publ Hlth & Med Informat, F-06003 Nice, France	CHU Nice; CHU Nice	Boulay, F (corresponding author), Nice Teaching Hosp, Dept Publ Hlth & Med Informat, BP 1179, F-06003 Nice 1, France.							Allan TM, 1996, BRIT MED J, V312, P1227; Bounameaux H, 1996, BMJ-BRIT MED J, V312, P284; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; ROGER JH, 1977, BIOMETRIKA, V64, P152, DOI 10.2307/2335789; WOODHOUSE PR, 1994, LANCET, V343, P435, DOI 10.1016/S0140-6736(94)92689-1	5	76	78	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 15	2001	323	7313					601	602		10.1136/bmj.323.7313.601	http://dx.doi.org/10.1136/bmj.323.7313.601			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474CT	11557707	Bronze, Green Published			2022-12-01	WOS:000171087300018
J	Cowan, CA; Henkemeyer, M				Cowan, CA; Henkemeyer, M			The SH2/SH3 adaptor Grb4 transduces B-ephrin reverse signals	NATURE			English	Article							ABL TRANSFORMING ACTIVITY; CENTRAL-NERVOUS-SYSTEM; TYROSINE KINASE; TRANSMEMBRANE LIGANDS; BINDING PROTEINS; SH3 DOMAIN; NCK; RECEPTORS; CATENIN; PATHWAY	Bidirectional signals mediated by membrane-anchored ephrins and Eph receptor tyrosine kinases have important functions in cell-cell recognition events, including those that occur during axon pathfinding(1,2) and hindbrain segmentation(3,4). The reverse signal that is transduced into B-ephrin-expressing cells is thought to involve tyrosine phosphorylation of the signal's short, conserved carboxy-terminal cytoplasmic domain(5,6). The Src-homology-2 (SH2) domain proteins that associate with activated tyrosine-phosphorylated B-subclass ephrins have not been identified, nor has a defined cellular response to reverse signals been described. Here we show that the SH2/SH3 domain adaptor protein Grb4 binds to the cytoplasmic domain of B ephrins in a phosphotyrosine-dependent manner. In response to B-ephrin reverse signalling, cells increase FAK catalytic activity, redistribute paxillin, lose focal adhesions, round up, and disassemble F-actin-containing stress fibres. These cellular responses can be blocked in a dominant-negative fashion by expression of the isolated Grb4 SH2 domain. The Grb4 SH3 domains bind a unique set of other proteins that are implicated in cytoskeletal regulation, including the Cbl-associated protein (CAP/ponsin), the Abl-interacting protein-1 (Abi-1), dynamin, PAK1, hnRNPK and axin. These data provide a biochemical pathway whereby cytoskeletal regulators are recruited to Eph-ephrin bidirectional signalling complexes.	Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Kent Waldrep Fdn Ctr Basic Res Nerve Growth & Reg, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Henkemeyer, M (corresponding author), Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA.			Henkemeyer, Mark/0000-0002-7525-1061				Asakura T, 1999, GENES CELLS, V4, P573, DOI 10.1046/j.1365-2443.1999.00283.x; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; BUSTELO XR, 1995, MOL CELL BIOL, V15, P1324; Chen M, 1998, J BIOL CHEM, V273, P25171, DOI 10.1074/jbc.273.39.25171; Chen M, 2000, MOL CELL BIOL, V20, P7867, DOI 10.1128/MCB.20.21.7867-7880.2000; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; FRADKIN LG, 1995, DEV BIOL, V168, P202, DOI 10.1006/dbio.1995.1072; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; Hamada F, 1999, SCIENCE, V283, P1739, DOI 10.1126/science.283.5408.1739; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; HOBERT O, 1994, J BIOL CHEM, V269, P20225; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Keegan K, 1996, ONCOGENE, V12, P1537; Kurakin A, 1998, J PEPT RES, V52, P331; Loureiro J, 1998, CURR BIOL, V8, P622, DOI 10.1016/S0960-9822(98)70249-0; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; Mandai K, 1999, J CELL BIOL, V144, P1001, DOI 10.1083/jcb.144.5.1001; MARGOLIS B, 1992, P NATL ACAD SCI USA, V89, P8894, DOI 10.1073/pnas.89.19.8894; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Ribon V, 1998, J BIOL CHEM, V273, P4073, DOI 10.1074/jbc.273.7.4073; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; SHI YG, 1995, GENE DEV, V9, P2583, DOI 10.1101/gad.9.21.2583; Tu YZ, 1998, MOL BIOL CELL, V9, P3367, DOI 10.1091/mbc.9.12.3367; Wunderlich L, 1999, CELL SIGNAL, V11, P25, DOI 10.1016/S0898-6568(98)00027-8; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	31	277	283	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					174	179		10.1038/35093123	http://dx.doi.org/10.1038/35093123			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557983				2022-12-01	WOS:000170918800049
J	Lapostolle, F; Surget, V; Borron, SW; Desmaizieres, M; Sordelet, D; Lapandry, C; Cupa, M; Adnet, F				Lapostolle, F; Surget, V; Borron, SW; Desmaizieres, M; Sordelet, D; Lapandry, C; Cupa, M; Adnet, F			Severe pulmonary embolism associated with air travel	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ECONOMY-CLASS SYNDROME; THROMBOEMBOLIC DISEASE; VENOUS THROMBOEMBOLISM; RISK-FACTORS; THROMBOSIS; FLIGHTS	Background Air travel is believed to be a risk factor for pulmonary embolism, but the relation between pulmonary embolism and distance flown has not been documented. The aim of this study was to investigate whether the duration of air travel is related to the risk of pulmonary embolism. Methods From November 1993 to December 2000, we systematically reviewed all cases of pulmonary embolism requiring medical care on arrival at France's busiest international airport. Data on the geographic origins of all flights and the numbers of passengers were collected in order to evaluate the incidence of pulmonary embolism per million passenger arrivals as a function of the distance traveled. Results A total of 135.29 million passengers from 145 countries or other areas arrived at Charles de Gaulle Airport during the period of the study, of whom 56 had confirmed pulmonary embolism. The incidence of pulmonary embolism was much higher among passengers traveling more than 5000 km (3100 mi) (1.5 cases per million, as compared with 0.01 case per million among those traveling less than 5000 km). The incidence of pulmonary embolism was 4.8 cases per million for those traveling more than 10,000 km (6200 mi). Conclusions A greater distance traveled is a significant contributing risk factor for pulmonary embolism associated with air travel. (N Engl J Med 2001; 345: 779-83.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Paris 13, SAMU 93, Hop Avicenne, F-93009 Bobigny, France; George Washington Univ, Sch Med, Dept Emergency Med, Washington, DC USA; George Washington Univ, Sch Med, Div Occupat & Environm Hlth, Washington, DC USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; George Washington University; George Washington University	Lapostolle, F (corresponding author), Univ Paris 13, SAMU 93, Hop Avicenne, 125 Rue Stalingrad, F-93009 Bobigny, France.	frederic.lapostolle@avc.ap-hop-paris.fr						BEIGHTON PH, 1968, BRIT HEART J, V30, P367; BENOIT R, 1992, J MAL VASCUL, V17, P84; CRUICKSHANK JM, 1988, LANCET, V2, P497, DOI 10.1016/S0140-6736(88)90134-1; DRUILHE L, 1994, J MED LEG DROIT MED, V37, P429; Eklof B, 1996, DERMATOL SURG, V22, P637, DOI 10.1111/j.1524-4725.1996.tb00610.x; Ferrari E, 1999, CHEST, V115, P440, DOI 10.1378/chest.115.2.440; Ferriman A, 2000, BRIT MED J, V321, P1310, DOI 10.1136/bmj.321.7272.1310; FINCH PJ, 1988, LANCET, V2, P1025; Geroulakos G, 2001, BRIT MED J, V322, P188, DOI 10.1136/bmj.322.7280.188; GOBIN JP, 1994, ARTERES VEINES, V13, P5; Goldhaber SZ, 1998, NEW ENGL J MED, V339, P93, DOI 10.1056/NEJM199807093390207; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; HOMANS J, 1954, NEW ENGL J MED, V250, P148, DOI 10.1056/NEJM195401282500404; KIEFFER B, 1989, MED AERONAUTIQUE SPA, V28, P300; LANDGRAF H, 1994, AVIAT SPACE ENVIR MD, V65, P930; LEDERMANN JA, 1983, POSTGRAD MED J, V59, P104, DOI 10.1136/pgmj.59.688.104; LEVY Y, 1995, ISRAEL J MED SCI, V31, P621; MARSEPOIL T, 1991, PRESSE MED, V20, P383; Mercer A, 1998, AVIAT SPACE ENVIR MD, V69, P154; MILLER GAH, 1971, BRIT MED J, V2, P681, DOI 10.1136/bmj.2.5763.681; MILLS FJ, 1983, BMJ-BRIT MED J, V286, P1131, DOI 10.1136/bmj.286.6371.1131; MOYSES C, 1987, INT J MICROCIRC, V5, P311; Nissen P, 1997, VASA-J VASCULAR DIS, V26, P239; NODDELAND H, 1988, EUR J APPL PHYSIOL O, V57, P409, DOI 10.1007/BF00417985; Paganin F, 1996, LANCET, V347, P1195, DOI 10.1016/S0140-6736(96)90659-5; Ribeiro A, 1997, AM HEART J, V134, P479, DOI 10.1016/S0002-8703(97)70085-1; Ribier G, 1997, REV MED INTERNE, V18, P601, DOI 10.1016/S0248-8663(97)82460-5; Rosendaal FR, 1999, THROMB HAEMOSTASIS, V82, P610; SARVESVARAN R, 1986, MED SCI LAW, V26, P35, DOI 10.1177/002580248602600108; Satoh A, 1998, Nihon Kokyuki Gakkai Zasshi, V36, P524; Simon R, 1999, WIEN KLIN WOCHENSCHR, V111, P596; Sinzinger H, 1999, VASA-J VASCULAR DIS, V28, P199, DOI 10.1024/0301-1526.28.3.199; SYMINGTON IS, 1977, BRIT J DIS CHEST, V71, P138, DOI 10.1016/0007-0971(77)90097-3; VOLLSET SE, 1993, STAT MED, V12, P809, DOI 10.1002/sim.4780120902; 1985, LANCET, V1, P353; 1988, LANCET, V2, P797	36	260	274	2	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2001	345	11					779	783		10.1056/NEJMoa010378	http://dx.doi.org/10.1056/NEJMoa010378			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471BK	11556296				2022-12-01	WOS:000170906800001
J	Fortnum, HM; Summerfield, AQ; Marshall, DH; Davis, AC; Bamford, JM				Fortnum, HM; Summerfield, AQ; Marshall, DH; Davis, AC; Bamford, JM			Prevalence of permanent childhood hearing impairment in the United Kingdom and implications for universal neonatal hearing screening: questionnaire based ascertainment study	BRITISH MEDICAL JOURNAL			English	Article							EARLY IDENTIFICATION; EPIDEMIOLOGY; CHILDREN; INTERVENTION	Objective To estimate the prevalence of confirmed permanent childhood hearing impairment and its profile across age and degree of impairment in the United Kingdom. Design Retrospective total ascertainment through sources in the health and education sectors by postal questionnaire. Setting Hospital based otology and audiology departments, community health clinics, education services for hearing impaired children. Participants Children born from 1980 to 1995, resident in United Kingdom in 1998, with permanent childhood hearing impairment (hearing level in the better ear >40 dB averaged over 0.5,1, 2, and 4 kHz). Main outcome measures Numbers of cases with date of birth and severity of impairment converted to prevalences for each annual birth cohort (cases/1000 live births) and adjusted for underascertainment. Results 26000 notifications ascertained 17160 individual children. Prevalence rose from 0.91 (95% confidence interval 0.85 to 0.98) for 3 year olds to 1.65 (1.62 to 1.68) for children aged 9-16 years. Adjustment for underascertainment increased estimates to 1.07 (1.03 to 1.12) and 2.05 (2.02 to 2.08). Comparison With previous studies showed that prevalence increases with age, rather than declining With year of birth. Conclusions Prevalence of confirmed permanent childhood hearing impairment increases until the age of 9 years to a level higher than previously estimated. Relative to current yields of universal neonatal hearing screening mi the United Kingdom, which are close to 1/1000 live births, 50-90% more children are diagnosed with permanent childhood hearing impairment by the age of 9 years. Paediatric audiology services must have the capacity to achieve early identification and confirmation of these additional cases.	MRC, Inst Hearing Res, Nottingham NG7 2RD, England; Univ Manchester, Human Commun & Deafness Grp, Manchester M13 9PL, Lancs, England	University of Manchester	Fortnum, HM (corresponding author), MRC, Inst Hearing Res, Univ Pk, Nottingham NG7 2RD, England.		Davis, Adrian C/E-6022-2015	Davis, Adrian C/0000-0001-7134-7528				Bloor M, 2000, J Health Serv Res Policy, V5, P89; British Society of Audiology, 1988, BRIT J AUDIOL, V22, P123, DOI DOI 10.3109/03005368809077807; Cheng AK, 2000, JAMA-J AM MED ASSOC, V284, P850, DOI 10.1001/jama.284.7.850; Conrad R., 1979, DEAF SCHOOLCHILD LAN; Cormack RM, 1999, J CLIN EPIDEMIOL, V52, P909, DOI 10.1016/S0895-4356(99)00058-X; Dalzell L, 2000, EAR HEARING, V21, P118, DOI 10.1097/00003446-200004000-00006; Davis A, 1997, HEALTH TECHNOL ASSES, V1, P1; Davis A., 1993, J AUDIOL MED, V3, P35; DAVIS A, 1997, HEALTH TECHNOL ASSES, V1, P10; *DEP HLTH, 2001, PIL INTR UN NEON HEA; Downs MP, 1999, PEDIATR CLIN N AM, V46, P79, DOI 10.1016/S0031-3955(05)70082-1; Fortnum H, 1997, BRIT J AUDIOL, V31, P409, DOI 10.3109/03005364000000037; Gregory S, 1995, DEAF CHILDREN THEIR; Kennedy CR, 1999, ACTA PAEDIATR, V88, P73, DOI 10.1080/080352599750029448; LAPORTE RE, 1992, LANCET, V339, P494, DOI 10.1016/0140-6736(92)91103-F; Maki-Torkko EM, 1998, SCAND AUDIOL, V27, P95, DOI 10.1080/010503998420333; Mohr PE, 2000, INT J TECHNOL ASSESS, V16, P1120, DOI 10.1017/S0266462300103162; *NHS EX, 2001, LAUNCH PIL PROJ PROV; *NIH, 1993, AM FAM PHYSICIAN, V48, P521; *OFF NAT STAT, 1999, POP TRENDS SUMM 1992; *OFF NAT STAT, 1999, POP TRENDS SUMM 1999; Steel KP, 2000, BRIT MED J, V320, P622, DOI 10.1136/bmj.320.7235.622; Uus K, 2000, AUDIOLOGY, V39, P192; Van Naarden K, 1999, PEDIATRICS, V103, P570, DOI 10.1542/peds.103.3.570; VANCAMP G, 2001, HEREDITARY HEARING L; Watkin PM, 1999, ARCH DIS CHILD, V81, P380, DOI 10.1136/adc.81.5.380; WOOD D, 1986, TEACHING TALKING DEA; YIP PSF, 1995, AM J EPIDEMIOL, V142, P1047	28	278	300	1	24	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 8	2001	323	7312					536	539		10.1136/bmj.323.7312.536	http://dx.doi.org/10.1136/bmj.323.7312.536			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471NC	11546698	Green Published, Bronze			2022-12-01	WOS:000170934600018
J	Gibbs, MJ; Armstrong, JS; Gibbs, AJ				Gibbs, MJ; Armstrong, JS; Gibbs, AJ			Recombination in the hemagglutinin gene of the 1918 "Spanish flu"	SCIENCE			English	Article							INFLUENZA-VIRUS; EVOLUTION; SEQUENCE; ORIGIN	When gene sequences from the influenza virus that caused the 1918 pandemic were first compared with those of related viruses, they yielded few clues about its origins and virulence. Our reanalysis indicates that the hemagglutinin gene, a key virulence determinant, originated by recombination. The "globular domain" of the 1918 hemagglutinin protein was encoded by a part of a gene derived from a swine-lineage influenza, whereas the "stalk" was encoded by parts derived from a human-lineage influenza. Phylogenetic analyses showed that this recombination, which probably changed the virulence of the virus, occurred at the start of, or immediately before, the pandemic and thus may have triggered it.	Australian Natl Univ, Fac Sci, Div Bot & Zool, Canberra, ACT 2601, Australia	Australian National University	Gibbs, AJ (corresponding author), Australian Natl Univ, Fac Sci, Div Bot & Zool, Canberra, ACT 2601, Australia.	mark.gibbs@anu.edu.au						Anderson JP, 2000, J VIROL, V74, P10752, DOI 10.1128/JVI.74.22.10752-10765.2000; Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; BEKLEMISHEV AB, 1993, MOL GEN MIKROBIOL VI, V1, P24; BERGMANN M, 1992, J VIROL, V66, P7576, DOI 10.1128/JVI.66.12.7576-7580.1992; BIKOUR MH, 1995, J GEN VIROL, V76, P2539, DOI 10.1099/0022-1317-76-10-2539; CROSBY AW, 1989, AM FORGOTTEN PLAGUE; FIELDS S, 1982, CELL, V28, P303, DOI 10.1016/0092-8674(82)90348-8; Garcia M, 1996, J GEN VIROL, V77, P1493, DOI 10.1099/0022-1317-77-7-1493; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gibbs MJ, 1999, P NATL ACAD SCI USA, V96, P8022, DOI 10.1073/pnas.96.14.8022; GORMAN OT, 1991, J VIROL, V65, P3704, DOI 10.1128/JVI.65.7.3704-3714.1991; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; KHATCHIKIAN D, 1989, NATURE, V340, P156, DOI 10.1038/340156a0; KILBOURNE ED, 1977, JAMA-J AM MED ASSOC, V237, P1225, DOI 10.1001/jama.237.12.1225; Lederberg J, 2001, P NATL ACAD SCI USA, V98, P2115, DOI 10.1073/pnas.051000798; Pita JS, 2001, J GEN VIROL, V82, P655, DOI 10.1099/0022-1317-82-3-655; Reid AH, 2000, P NATL ACAD SCI USA, V97, P6785, DOI 10.1073/pnas.100140097; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; SCHOLTISSEK C, 1993, ARCH VIROL, V131, P237, DOI 10.1007/BF01378629; Shope RE, 1936, J EXP MED, V63, P669, DOI 10.1084/jem.63.5.669; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Taubenberger JK, 2000, VIROLOGY, V274, P241, DOI 10.1006/viro.2000.0495; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Webster RG, 1999, P NATL ACAD SCI USA, V96, P1164, DOI 10.1073/pnas.96.4.1164; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; Worobey M, 1999, P NATL ACAD SCI USA, V96, P7352, DOI 10.1073/pnas.96.13.7352	31	97	116	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1842	1845		10.1126/science.1061662	http://dx.doi.org/10.1126/science.1061662			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546876				2022-12-01	WOS:000170894400051
J	Xiang, JH; Wunschmann, S; Diekema, DJ; Klinzman, D; Patrick, KD; George, SL; Stapleton, JT				Xiang, JH; Wunschmann, S; Diekema, DJ; Klinzman, D; Patrick, KD; George, SL; Stapleton, JT			Effect of coinfection with GB virus C on survival among patients with HIV infection.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPATITIS-G VIRUS; INTERFERON-ALPHA THERAPY; TYPE-1 REPLICATION; HIGH PREVALENCE; T-CELLS; PROGRESSION; DISEASE; RNA; ASSOCIATION; INHIBITION	Background: Previous studies have suggested that people with human immunodeficiency virus (HIV) infection who are coinfected with GB virus C (GBV-C, or hepatitis G virus) have delayed progression of HIV disease. GBV-C is related to hepatitis C virus but does not appear to cause liver disease. Methods: We examined the effect of coinfection with GBV-C on the survival of patients with HIV infection. We also evaluated cultures of peripheral-blood mononuclear cells infected with both viruses to determine whether GBV-C infection alters replication in vitro. Results: Of 362 HIV-infected patients, 144 (39.8 percent) had GBV-C viremia in two tests. Forty-one of the patients with GBV-C viremia (28.5 percent) died during the follow-up period, as compared with 123 of the 218 patients who tested negative for GBV-C RNA (56.4 percent; P<0.001). The mean duration of follow-up for the entire cohort was 4.1 years. In a Cox regression analysis adjusted for HIV treatment, base-line CD4+ T-cell count, age, sex, race, and mode of transmission of HIV, the mortality rate among the 218 HIV-infected patients without GBV-C coinfection was significantly higher than that among the 144 patients with GBV-C coinfection (relative risk, 3.7; 95 percent confidence interval, 2.5 to 5.4). HIV replication, as measured by the detection of p24 antigen in culture supernatants, was reproducibly inhibited in cultures of peripheral-blood mononuclear cells by GBV-C coinfection. Coinfection did not alter the surface expression of HIV cellular receptors on peripheral-blood mononuclear cells, as determined by flow cytometry. Conclusions: GBV-C infection is common in people with HIV infection and is associated with significantly improved survival.	Univ Iowa, Coll Med, Dept Internal Med, SW 54,GH UIHC, Iowa City, IA 52242 USA; Vet Affairs Med Ctr, Dept Internal Med, Iowa City, IA 52242 USA; Vet Affairs Med Ctr, Dept Res, Iowa City, IA 52242 USA; Helen C Levitt Ctr Viral Pathogenesis & Dis, Iowa City, IA USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Stapleton, JT (corresponding author), Univ Iowa, Coll Med, Dept Internal Med, SW 54,GH UIHC, 200 Hawkins Dr, Iowa City, IA 52242 USA.			Diekema, Daniel/0000-0003-1273-0724; George, Sarah/0000-0002-9699-1042; Stapleton, Jack/0000-0002-2302-9055	NIAAA NIH HHS [R01 AA12671] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012671] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Alter HJ, 1997, TRANSFUSION, V37, P569, DOI 10.1046/j.1537-2995.1997.37697335149.x; Alter HJ, 1997, NEW ENGL J MED, V336, P747, DOI 10.1056/NEJM199703133361102; Alter MJ, 1997, NEW ENGL J MED, V336, P741, DOI 10.1056/NEJM199703133361101; Asada H, 1999, J VIROL, V73, P4019, DOI 10.1128/JVI.73.5.4019-4028.1999; Cook RT, 1997, J INVEST MED, V45, P265; COX DR, 1972, J R STAT SOC B, V34, P187; Dawson GJ, 1996, J MED VIROL, V50, P97, DOI 10.1002/(SICI)1096-9071(199609)50:1&lt;97::AID-JMV16&gt;3.0.CO;2-V; Elvander M, 1998, ACTA VET SCAND, V39, P251; Fisher LD, 1993, BIOSTATISTICS METHOD; Fogeda M, 1999, J VIROL, V73, P4052, DOI 10.1128/JVI.73.5.4052-4061.1999; Haas DW, 2000, AIDS RES HUM RETROV, V16, P183, DOI 10.1089/088922200309278; Heringlake S, 1998, J INFECT DIS, V177, P1723, DOI 10.1086/517431; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lau DTY, 1999, J INFECT DIS, V180, P1334, DOI 10.1086/315031; Lefrere JJ, 1999, J INFECT DIS, V179, P783, DOI 10.1086/314671; Linnen J, 1996, SCIENCE, V271, P505, DOI 10.1126/science.271.5248.505; Nerurkar VR, 1998, J MED VIROL, V56, P123, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;123::AID-JMV4&gt;3.0.CO;2-A; Pessoa MG, 1998, HEPATOLOGY, V27, P877, DOI 10.1002/hep.510270335; Pinto LA, 2000, J VIROL, V74, P4505, DOI 10.1128/JVI.74.10.4505-4511.2000; Rey D, 2000, EUR J CLIN MICROBIOL, V19, P721, DOI 10.1007/s100960000352; RINALDO CR, 1976, INFECT IMMUN, V14, P660, DOI 10.1128/IAI.14.3.660-666.1976; Rowland-Jones S, 1999, J INFECTION, V38, P67, DOI 10.1016/S0163-4453(99)90070-1; SHIRAZI Y, 1993, VIROLOGY, V193, P303, DOI 10.1006/viro.1993.1126; SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564; Theodore D, 1997, HEPATOLOGY, V25, P1285, DOI 10.1002/hep.510250541; Thomas DL, 1998, J INFECT DIS, V177, P539, DOI 10.1086/514245; Toyoda H, 1998, J ACQ IMMUN DEF SYND, V17, P209, DOI 10.1097/00042560-199803010-00004; Wunschmann S, 2000, J CLIN MICROBIOL, V38, P3055; Wunschmann S, 2000, J VIROL, V74, P10055, DOI 10.1128/JVI.74.21.10055-10062.2000; XIANG J, 1999, J VIRAL HEPAT S1, V6, P6; Xiang JH, 1998, J VIROL, V72, P2738, DOI 10.1128/JVI.72.4.2738-2744.1998; Xiang JH, 2000, J VIROL, V74, P9125, DOI 10.1128/JVI.74.19.9125-9133.2000; Yeo AET, 2000, ANN INTERN MED, V132, P959, DOI 10.7326/0003-4819-132-12-200006200-00006; 1989, MMWR MORB MORTAL S5, V38, P1	34	289	305	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2001	345	10					707	714		10.1056/NEJMoa003364	http://dx.doi.org/10.1056/NEJMoa003364			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	468RX	11547739				2022-12-01	WOS:000170772900001
J	Smith, GCS; Pell, JP				Smith, GCS; Pell, JP			Teenage pregnancy and risk of adverse perinatal outcomes associated with first and second births: population based retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							MATERNAL AGE; INFANT-MORTALITY; PRETERM BIRTH; WEIGHT; DETERMINANTS; ADOLESCENTS; DELIVERY; SMOKING; MOTHERS; PARITY	Objective To determine whether first and second births among teenagers are associated With increased risk of adverse perinatal outcomes after confounding variables have been taken into account. Design Population based retrospective cohort study using routine discharge data for 1992-8. Setting Scotland. Main outcome measures Stillbirth, preterm. delivery, emergency caesarean section, and small for gestational age baby among non-smoking mothers aged 15-19 and 20-29. Results The 110 233 eligible deliveries Were stratified into first and second births. Among first births, the only significant difference in adverse outcomes by age group was for emergency caesarean section, which was less likely among younger mothers (odds ratio 0.5, 95% confidence interval 0.5 to 0.6). Second births in women aged 15-19 Were associated with an increased risk of moderate (1.6, 1.2 to 2.1) and extreme prematurity (2.5, 1.5 to 4.3) and stillbirth (2.6, 1.3 to 5.3) but a reduced risk of emergency caesarean section (0.7, 0.5 to 1.0). Conclusions First teenage births are not independently associated with ari increased risk of adverse pregnancy outcome and are at decreased risk of delivery by emergency caesarean section. However, second teenage births are associated with an almost threefold risk of preterm delivery and stillbirth.	Greater Glasgow Hlth Board, Dept Publ Hlth, Glasgow G3 8YU, Lanark, Scotland; Univ Glasgow, Queen Mothers Hosp, Dept Obstet & Gynaecol, Glasgow G3 8SH, Lanark, Scotland	University of Glasgow	Smith, GCS (corresponding author), Univ Cambridge, Dept Obstet & Gynaecol, Rosie Hosp, Cambridge CB2 2SW, England.		Smith, Gordon/A-8070-2008	Smith, Gordon/0000-0003-2124-0997				Astolfi P, 1999, HUM REPROD, V14, P2891, DOI 10.1093/humrep/14.11.2891; Berenson AB, 1997, J REPROD MED, V42, P559; BLANKSON ML, 1993, JAMA-J AM MED ASSOC, V269, P1401, DOI 10.1001/jama.269.11.1401; COLE SK, 1980, PERINATAL AUDIT SURV, P39; DIFRANZA JR, 1995, J FAM PRACTICE, V40, P385; ELSTER AB, 1984, AM J OBSTET GYNECOL, V149, P845, DOI 10.1016/0002-9378(84)90602-1; FRASER AM, 1995, NEW ENGL J MED, V332, P1113, DOI 10.1056/NEJM199504273321701; HELLERSTEDT WL, 1995, AM J PUBLIC HEALTH, V85, P1139, DOI 10.2105/AJPH.85.8_Pt_1.1139; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Kyrklund-Blomberg NB, 1998, AM J OBSTET GYNECOL, V179, P1051, DOI 10.1016/S0002-9378(98)70214-5; Lao TT, 1998, HUM REPROD, V13, P3228, DOI 10.1093/humrep/13.11.3228; Lao TT, 1997, HUM REPROD, V12, P2303, DOI 10.1093/humrep/12.10.2303; LEE KS, 1988, AM J OBSTET GYNECOL, V158, P84, DOI 10.1016/0002-9378(88)90783-1; LUMLEY J, 1993, BAILLIERE CLIN OB GY, V7, P477, DOI 10.1016/S0950-3552(05)80445-6; MCCORMICK MC, 1984, AM J PUBLIC HEALTH, V74, P18, DOI 10.2105/AJPH.74.1.18; MCLOONE P, 1994, BRIT MED J, V309, P1465, DOI 10.1136/bmj.309.6967.1465; Olausson PMO, 1997, OBSTET GYNECOL, V89, P451, DOI 10.1097/00006250-199703000-00027; Olausson PO, 1999, BRIT J OBSTET GYNAEC, V106, P116, DOI 10.1111/j.1471-0528.1999.tb08210.x; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3; Smith GCS, 2001, AM J OBSTET GYNECOL, V184, P489, DOI 10.1067/mob.2001.109735; STROBINO DM, 1995, AM J EPIDEMIOL, V142, P504, DOI 10.1093/oxfordjournals.aje.a117668; SWEENEY PJ, 1989, AM J OBSTET GYNECOL, V160, P1361, DOI 10.1016/0002-9378(89)90856-9; Zhu BP, 1999, NEW ENGL J MED, V340, P589, DOI 10.1056/NEJM199902253400801	24	139	142	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 1	2001	323	7311					476	479		10.1136/bmj.323.7311.476	http://dx.doi.org/10.1136/bmj.323.7311.476			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469WF	11532837	Bronze, Green Published			2022-12-01	WOS:000170838500014
J	Charrier, I; Mathevon, N; Jouventin, P				Charrier, I; Mathevon, N; Jouventin, P			Mother's voice recognition by seal pups - Newborns need to learn their mother's call before she can take off on a fishing trip.	NATURE			English	Article							ARCTOCEPHALUS-TROPICALIS; VOCAL RECOGNITION; AMSTERDAM ISLAND; FUR SEALS; GROWTH		Univ St Etienne, Lab Biol Anim, F-42023 St Etienne 2, France; CNRS, CEFE, UPR 9056, F-34213 Montpellier, France; CNRS, NAMC, UMR 8620, F-91400 Orsay, France	Universite Jean Monnet; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS)	Charrier, I (corresponding author), Univ St Etienne, Lab Biol Anim, F-42023 St Etienne 2, France.	mathevon@univ-st-etienne.fr		CHARRIER, Isabelle/0000-0003-4873-2342				Addae PC, 2000, APPL ANIM BEHAV SCI, V67, P77, DOI 10.1016/S0168-1591(99)00119-7; Gentry R.L., 1986, FUR SEALS MATERNAL S; Georges JY, 2000, ECOLOGY, V81, P295, DOI 10.2307/177427; Georges JY, 2000, J ZOOL, V251, P277, DOI 10.1111/j.1469-7998.2000.tb01078.x; Hofer M.A., 1981, P77; Insley SJ, 2000, NATURE, V406, P404, DOI 10.1038/35019064; JONES IL, 1987, ANIM BEHAV, V35, P1405, DOI 10.1016/S0003-3472(87)80013-1; KERLEY GIH, 1985, J ZOOL, V205, P315; Riedman M., 1990, PINNIPEDS SEALS SEA; Roux J.-P., 1987, NOAA Technical Report NMFS, V51, P95; STIRLING I, 1975, J AUST MAMMAL SOC, V1, P389	11	94	97	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2001	412	6850					873	873		10.1038/35091136	http://dx.doi.org/10.1038/35091136			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528465	Bronze			2022-12-01	WOS:000170689000031
J	Bibby, TS; Nield, J; Barber, J				Bibby, TS; Nield, J; Barber, J			Iron deficiency induces the formation of an antenna ring around trimeric photosystem I in cyanobacteria	NATURE			English	Article							PHOTOSYNTHETIC REACTION-CENTER; EQUATORIAL PACIFIC-OCEAN; ISIA GENE; COMPLEX; SYNECHOCYSTIS-6803; CRYSTALLOGRAPHY; LIMITATION; RESOLUTION; BACTERIA; SYSTEM	Although iron is the fourth most abundant element in the Earth's crust, its concentration in the aquatic ecosystems-particularly the open oceans-is sufficiently low to limit photosynthetic activity and phytoplankton growth(1,2). Cyanobacteria, a major class of phytoplankton, respond to iron deficiency by expressing the 'iron-stress-induced' gene, isiA(ref. 3). The protein encoded by this gene has an amino-acid sequence that shows significant homology with one of the chlorophyll a-binding proteins (CP43) of photosystem II (PSII)(4,5). The precise function of the CP43-like protein, here called CP43', has not been elucidated, although there have been many suggestions(3,6). Here we show that CP43' associates with photosystem I (PSI) to form a complex that consists of a ring of 18 CP43' molecules around a PSI trimer. This significantly increases the size of the light-harvesting system of PSI. The utilization of a PSII-like protein as an extra antenna for PSI emphasises the flexibility of cyanobacterial light-harvesting systems, and seems to be a strategy which compensates for the lowering of phycobilisome and PSI levels in response to iron deficiency.	Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Wolfson Labs, London SW7 2AY, England	Imperial College London	Barber, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Wolfson Labs, London SW7 2AY, England.	j.barber@ic.ac.uk	Bibby, Thomas/C-9159-2014; Nield, Jon/C-5892-2013	Nield, Jon/0000-0001-9983-0239; Bibby, Thomas/0000-0003-1743-473X				Behrenfeld MJ, 1996, NATURE, V383, P508, DOI 10.1038/383508a0; BOEKEMA EJ, 1994, J BIOENERG BIOMEMBR, V26, P17, DOI 10.1007/BF00763217; Bricker TM, 1998, BBA-BIOENERGETICS, V1409, P50, DOI 10.1016/S0005-2728(98)00148-0; BURNAP RL, 1993, PLANT PHYSIOL, V103, P893, DOI 10.1104/pp.103.3.893; Cogdell RJ, 1999, J BACTERIOL, V181, P3869, DOI 10.1128/JB.181.13.3869-3879.1999; FALK S, 1995, PHOTOSYNTH RES, V45, P51, DOI 10.1007/BF00032235; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hankamer B, 1999, NAT STRUCT BIOL, V6, P560, DOI 10.1038/9341; Hankamer B, 1997, EUR J BIOCHEM, V243, P422, DOI 10.1111/j.1432-1033.1997.0422a.x; Krauss N, 1996, NAT STRUCT BIOL, V3, P965, DOI 10.1038/nsb1196-965; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; Park YI, 1999, MOL MICROBIOL, V32, P123, DOI 10.1046/j.1365-2958.1999.01332.x; ROGNER M, 1990, BIOCHIM BIOPHYS ACTA, V1015, P415, DOI 10.1016/0005-2728(90)90074-E; Schubert WD, 1997, J MOL BIOL, V272, P741, DOI 10.1006/jmbi.1997.1269; Sherman MB, 1998, ULTRAMICROSCOPY, V74, P179, DOI 10.1016/S0304-3991(98)00041-2; Straus N.A., 1994, MOL BIOL CYANOBACTER, P731, DOI DOI 10.1007/978-94-011-0227-8_25; TANG XS, 1994, BIOCHEMISTRY-US, V33, P4594, DOI 10.1021/bi00181a021; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	22	288	303	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2001	412	6848					743	745		10.1038/35089098	http://dx.doi.org/10.1038/35089098			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507643				2022-12-01	WOS:000170450200047
J	Cagnin, A; Brooks, DJ; Kennedy, AM; Gunn, RN; Myers, R; Turkheimer, FE; Jones, T; Banati, RB				Cagnin, A; Brooks, DJ; Kennedy, AM; Gunn, RN; Myers, R; Turkheimer, FE; Jones, T; Banati, RB			In-vivo measurement of activated microglia in dementia	LANCET			English	Article							H-3 PK11195 BINDING; ALZHEIMERS-DISEASE; PERIPHERAL BENZODIAZEPINE; EMISSION TOMOGRAPHY; FOCAL ISCHEMIA; BRAIN; PET; LESIONS; SITES; HIPPOCAMPUS	Background Activated microglia have a key role in the brain's immune response to neuronal degeneration. The transition of microglia from the normal resting state to the activated state is associated with an increased expression of receptors known as peripheral benzodiazepine binding sites, which are abundant on cells of mononuclear phagocyte lineage. We used brain imaging to study expression of these sites in healthy individuals and patients with Alzheimer's disease. Methods We studied 15 normal individuals (age 32-80 years), eight patients with Alzheimer's disease, and one patient with minimal cognitive impairment. Quantitative in-vivo measurements of glial activation were obtained with positron emission tomography (PET) and carbon-11-labelled (R)-PK11195, a specific ligand for the peripheral benzodiazepine binding site. Findings In normal individuals, regional [C-11](R)-PK11195 binding did not significantly change with age, except in the thalamus, where an age-dependent increase was found. By contrast, patients with Alzheimer's disease showed significantly increased regional [C-11](R)-PK11195 binding in the entorhinal, temporoparietal, and cingulate cortex. Interpretation In-vivo detection of increased [C-11](R)-PK11195 binding in Alzheimer-type dementia, including mild and early forms, suggests that microglial activation is an early event in the pathogenesis of the disease.	Hammersmith Hosp, Fac Med, Imperial Coll,Div Neurosci & Psychol Med, MRC Cyclotron Unit, London W12 0NN, England; Max Planck Inst Neurobiol, Dept Neuromorphol, Martinsried, Germany; Fac Med, Imperial Coll, Dept Neuropathol, Div Neurosci & Psychol Med, London, England	Imperial College London; Max Planck Society; Imperial College London	Banati, RB (corresponding author), Hammersmith Hosp, Fac Med, Imperial Coll,Div Neurosci & Psychol Med, MRC Cyclotron Unit, London W12 0NN, England.	richard.banati@csc.mrc.ac.uk	Gunn, Roger/H-1666-2012; Turkheimer, Federico E/B-9485-2012	Gunn, Roger/0000-0003-1181-5769; Turkheimer, Federico E/0000-0002-3766-3815; Brooks, David/0000-0003-2602-2518				Alzheimer A, 1911, Z GESAMTE NEUROL PSY, V4, P356, DOI 10.1007/BF02866241; Banati RB, 1997, J NEUROCYTOL, V26, P77, DOI 10.1023/A:1018567510105; Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; Barger SW, 1997, NATURE, V388, P878, DOI 10.1038/42257; BLINZING.K, 1968, Z ZELLFORSCH MIK ANA, V85, P145, DOI 10.1007/BF00325030; Conway EL, 1998, NEUROSCIENCE, V82, P805; CUNNINGHAM VJ, 1993, J CEREBR BLOOD F MET, V13, P15, DOI 10.1038/jcbfm.1993.5; Dumont F, 1999, EUR J NUCL MED, V26, P194, DOI 10.1007/s002590050376; Esiri M. M., 1997, GREENFIELDS NEUROPAT, P153; GROOM GN, 1995, J NUCL MED, V36, P2207; Gunn RN, 1998, QUANTITATIVE FUNCTIONAL BRAIN IMAGING WITH POSITRON EMISSION TOMOGRAPHY, P401, DOI 10.1016/B978-012161340-2/50062-7; HAJNAL JV, 1995, J COMPUT ASSIST TOMO, V19, P677, DOI 10.1097/00004728-199509000-00001; Hertz L., 1993, PERIPHERAL BENZODIAZ, P27; Hu MTM, 2000, BRAIN, V123, P340, DOI 10.1093/brain/123.2.340; Hulette CM, 1998, J NEUROPATH EXP NEUR, V57, P1168, DOI 10.1097/00005072-199812000-00009; Killiany RJ, 2000, ANN NEUROL, V47, P430, DOI 10.1002/1531-8249(200004)47:4<430::AID-ANA5>3.3.CO;2-9; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; Meguro K, 1999, BRAIN, V122, P1519, DOI 10.1093/brain/122.8.1519; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; MYERS R, 1991, NEUROSCI LETT, V133, P20, DOI 10.1016/0304-3940(91)90047-W; Niemann K, 2000, PSYCHIAT RES-NEUROIM, V99, P93, DOI 10.1016/S0925-4927(00)00059-7; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; SETTE G, 1993, STROKE, V24, P2046, DOI 10.1161/01.STR.24.12.2046; SHAH F, 1994, NUCL MED BIOL, V21, P573, DOI 10.1016/0969-8051(94)90022-1; Tan J, 1999, SCIENCE, V286, P2352, DOI 10.1126/science.286.5448.2352; Veld BAI, 1998, NEUROBIOL AGING, V19, P607, DOI 10.1016/S0197-4580(98)00096-7	30	805	827	0	47	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 11	2001	358	9280					461	467		10.1016/S0140-6736(01)05625-2	http://dx.doi.org/10.1016/S0140-6736(01)05625-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463TB	11513911				2022-12-01	WOS:000170492400013
J	Gratacos, M; Nadal, M; Martin-Santos, R; Pujana, MA; Gago, J; Peral, B; Armengol, L; Ponsa, I; Miro, R; Bulbena, A; Estivill, X				Gratacos, M; Nadal, M; Martin-Santos, R; Pujana, MA; Gago, J; Peral, B; Armengol, L; Ponsa, I; Miro, R; Bulbena, A; Estivill, X			A polymorphic genomic duplication on human chromosome 15 is a susceptibility factor for panic and phobic disorders	CELL			English	Article							JOINT HYPERMOBILITY SYNDROME; ANXIETY DISORDERS; LOCUS-CERULEUS; TRK FAMILY; RECEPTOR; CELLS; NEUROTROPHIN-3; REARRANGEMENTS; ASSOCIATION; HYPOTHESIS	Anxiety disorders are complex and common psychiatric illnesses associated with considerable morbidity and social cost. We have studied the molecular basis of the cooccurrence of panic and phobic disorders with joint laxity. We have identified an interstitial duplication of human chromosome 15q24-26 (named DUP25), which is significantly associated with panic/agoraphobia/social phobia/joint laxity in families, and with panic disorder in nonfamilial cases. Mosaicism, different forms of DUP25 within the same family, and absence of segregation of 15q24-26 markers with DUP25 and the psychiatric phenotypes suggest a non-Mendelian mechanism of disease-causing mutation. We propose that DUP25, which is present in 7% control subjects, is a susceptibility factor for a clinical phenotype that includes panic and phobic disorders and joint laxity.	IRO, Ctr Genet Med & Mol, E-08907 Barcelona, Catalonia, Spain; Hosp Mare Deu Esperanca, IMAS, Dept Psiquiatria, E-08083 Barcelona, Catalonia, Spain; IMIM, Unitat Recerca Psiquiatria, E-08083 Barcelona, Catalonia, Spain; Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, E-08193 Bellaterra, Catalonia, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Autonomous University of Barcelona	Estivill, X (corresponding author), IRO, Ctr Genet Med & Mol, E-08907 Barcelona, Catalonia, Spain.	estivill@iro.es	pujana, Miguel Angel/N-3127-2014; Estivill, Xavier/A-3125-2013; Peral, Belén/F-4562-2015; Bulbena, Antonio/AAG-5411-2019; Estivill, Xavier/E-2957-2012	pujana, Miguel Angel/0000-0003-3222-4044; Estivill, Xavier/0000-0002-0723-2256; Peral, Belén/0000-0003-4984-4020; Bulbena, Antonio/0000-0003-2404-2478; Ponsa, Immaculada/0000-0003-3436-1907; Nadal, Marga/0000-0002-5739-1693; miro, rosa/0000-0003-2508-5074				*AM PSYCH ASS, 1987, DSM3R DIAGN STAT MAN; ANASTASI J, 1990, AM J PATHOL, V136, P131; BARLOW DH, 1986, J NERV MENT DIS, V174, P63, DOI 10.1097/00005053-198602000-00001; Beighton PH, 1989, HYPERMOBILITY JOINTS; BRINK RA, 1968, SCIENCE, V159, P161, DOI 10.1126/science.159.3811.161; BULBENA A, 1993, PSYCHIAT RES, V46, P59, DOI 10.1016/0165-1781(93)90008-5; BULBENA A, 1988, LANCET, V2, P694; CELI FS, 1994, GENOMICS, V21, P304, DOI 10.1006/geno.1994.1270; COHEN ME, 1951, AM J HUM GENET, V3, P126; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CROWE RR, 1983, ARCH GEN PSYCHIAT, V40, P1065; Crowe RR, 2001, AM J MED GENET, V105, P105, DOI 10.1002/1096-8628(20010108)105:1<105::AID-AJMG1072>3.0.CO;2-P; CURTIS D, 1994, ANN HUM GENET, V58, P151, DOI 10.1111/j.1469-1809.1994.tb01884.x; Deckert J, 1999, HUM MOL GENET, V8, P621, DOI 10.1093/hmg/8.4.621; Eichler EE, 1998, GENOME RES, V8, P758, DOI 10.1101/gr.8.8.758; ENG CM, 1991, GENOMICS, V9, P278, DOI 10.1016/0888-7543(91)90253-B; FOOTE SL, 1983, PHYSIOL REV, V63, P844, DOI 10.1152/physrev.1983.63.3.844; FRITZE J, 1995, J PSYCHIATR NEUROSCI, V20, P39; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Gorman JM, 2000, AM J PSYCHIAT, V157, P493, DOI 10.1176/appi.ajp.157.4.493; HOPPER JL, 1987, GENET EPIDEMIOL, V4, P33, DOI 10.1002/gepi.1370040105; Ji YG, 2000, GENOME RES, V10, P597, DOI 10.1101/gr.10.5.597; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; KENDLER KS, 1993, PSYCHOL MED, V23, P397, DOI 10.1017/S003329170002849X; Kennedy JL, 1999, MOL PSYCHIATR, V4, P284, DOI 10.1038/sj.mp.4000507; KENYON K, 1993, J BIOL CHEM, V268, P18435; Knowles JA, 1998, AM J MED GENET, V81, P139, DOI 10.1002/(SICI)1096-8628(19980328)81:2<139::AID-AJMG4>3.0.CO;2-R; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leboyer M, 1998, TRENDS NEUROSCI, V21, P102, DOI 10.1016/S0166-2236(97)01187-9; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; MAIER W, 1993, J PSYCHIAT RES, V27, P79, DOI 10.1016/0022-3956(93)90019-X; Martin-Santos R, 1998, AM J PSYCHIAT, V155, P1578, DOI 10.1176/ajp.155.11.1578; MERLIO JP, 1992, NEUROSCIENCE, V51, P513, DOI 10.1016/0306-4522(92)90292-A; Nadal M, 1997, J MED GENET, V34, P50, DOI 10.1136/jmg.34.1.50; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; OTT J, 1991, ANAL HUMAN GENETIC L, P232; PAULS DL, 1980, AM J HUM GENET, V32, P639; Perna G, 1997, PSYCHIAT RES, V66, P69, DOI 10.1016/S0165-1781(97)85177-3; Pujana MA, 2001, GENOME RES, V11, P98, DOI 10.1101/gr.155601; SAMBROOK J, 1989, MOL CLONING, V2, P9; Schinder AF, 2000, TRENDS NEUROSCI, V23, P639, DOI 10.1016/S0166-2236(00)01672-6; SMITH MA, 1995, P NATL ACAD SCI USA, V92, P8788, DOI 10.1073/pnas.92.19.8788; van Overveld PGM, 2000, HUM MOL GENET, V9, P2879; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; VIELAND VJ, 1993, PSYCHIATR GENET, V3, P63, DOI 10.1097/00041444-199322000-00001; Wang ZW, 1998, AM J MED GENET, V81, P228, DOI 10.1002/(SICI)1096-8628(19980508)81:3<228::AID-AJMG5>3.0.CO;2-S; Weiller E, 1998, BRIT J PSYCHIAT, V173, P18, DOI 10.1192/S0007125000293471; Weissman MM, 1997, ARCH GEN PSYCHIAT, V54, P305; Weissman MM, 2000, AM J MED GENET, V96, P24, DOI 10.1002/(SICI)1096-8628(20000207)96:1<24::AID-AJMG7>3.0.CO;2-E	50	155	156	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 10	2001	106	3					367	379		10.1016/S0092-8674(01)00447-0	http://dx.doi.org/10.1016/S0092-8674(01)00447-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509185	Bronze			2022-12-01	WOS:000170433300014
J	Love, SG; Ahrens, TJ				Love, SG; Ahrens, TJ			Origin of asteroid rotation rates in catastrophic impacts	NATURE			English	Article							COLLISIONAL EVOLUTION; DESPINNING ASTEROIDS	The rotation rates of asteroids, which are deduced from periodic fluctuations in their brightnesses(1), are controlled by mutual collisions(2-8). The link between asteroid spin and collision history is usually made with reference to impact experiments on centimetre-scale targets, where material strength governs the impact response(2,3,9-11). Recent work, however, indicates that for objects of the size of most observed asteroids (greater than or equal to 1 km in diameter), gravity rather than intrinsic strength controls the dynamic response to collisions(12-14). Here we explore this idea by modelling the effect of impacts on large gravitating bodies. We find that the fraction of a projectile's angular momentum that is retained by a target asteroid is both lower and more variable than expected from laboratory experiments, with spin evolution being dominated by 'catastrophic' collisions that eject similar to 50 per cent of the target's mass. The remnant of an initially non-rotating silicate asteroid that suffers such a collision rotates at a rate of similar to 2.9 per day, which is close to the observed mean asteroid rotation rate of similar to 2.5 d(-1) Moreover, our calculations suggest that the observed trend in the mean spin frequency for different classes of asteroids(4) (2.2 d(-1) for C-type asteroids, 2.5 d(-1) for S-type, and 4.0 d(-1) for M-type) is due to increasing mean density, rather than increasing material strength.			Love, SG (corresponding author), CALTECH,SEISMOL LAB 25221,PASADENA,CA 91125, USA.							[Anonymous], 1996, LPI; BELTON MJS, 1995, NATURE, V374, P785, DOI 10.1038/374785a0; Binzel R.P., 1989, ASTEROIDS, P416; BOTTKE WF, 1994, ICARUS, V107, P255, DOI 10.1006/icar.1994.1021; Bottke WF, 1996, NATURE, V381, P51, DOI 10.1038/381051a0; BURNS JA, 1973, MON NOT R ASTRON SOC, V165, P403, DOI 10.1093/mnras/165.4.403; CELLINO A, 1990, ICARUS, V87, P391, DOI 10.1016/0019-1035(90)90142-V; DAVIS DR, 1989, ASTEROIDS, V2, P805; DOBROVOLSKIS AR, 1984, ICARUS, V57, P464, DOI 10.1016/0019-1035(84)90130-1; DONES L, 1993, SCIENCE, V259, P350, DOI 10.1126/science.259.5093.350; FARINELLA P, 1992, ASTRON ASTROPHYS, V253, P604; FUJIWARA A, 1981, ICARUS, V48, P329, DOI 10.1016/0019-1035(81)90113-5; Fujiwara A., 1989, ASTEROIDS, VII, P240; HARRIS AW, 1989, ASTEROIDS, V2, P39; HARRIS AW, 1979, ICARUS, V40, P142; HOLSAPPLE KA, 1994, PLANET SPACE SCI, V42, P1067, DOI 10.1016/0032-0633(94)90007-8; Love SG, 1996, ICARUS, V124, P141, DOI 10.1006/icar.1996.0195; Melosh H.J, 1989, OXFORD MONOGRAPHS GE; MONAGHAN JJ, 1992, ANNU REV ASTRON ASTR, V30, P543, DOI 10.1146/annurev.aa.30.090192.002551; RYAN EV, 1995, EOS, V76, pF336; TILLOTSON JH, 1962, GA3216 GEN DYN CORP; YANAGISAWA M, 1991, ICARUS, V94, P272, DOI 10.1016/0019-1035(91)90227-K	22	19	19	0	5	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAR 13	1997	386	6621					154	156		10.1038/386154a0	http://dx.doi.org/10.1038/386154a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WM973	11536797				2022-12-01	WOS:A1997WM97300055
J	Schueler, MG; Higgins, AW; Rudd, MK; Gustashaw, K; Willard, HF				Schueler, MG; Higgins, AW; Rudd, MK; Gustashaw, K; Willard, HF			Genomic and genetic definition of a functional human centromere	SCIENCE			English	Article							ALPHA-SATELLITE DNA; HUMAN X-CHROMOSOME; SEQUENCE-ANALYSIS; EVOLUTION; INACTIVATION; ISOCHROMOSOMES; RECOMBINATION; ORGANIZATION; HYPOTHESIS; PRIMATES	The definition of centromeres of human chromosomes requires a complete genomic understanding of these regions. Toward this end, we report integration of physical mapping, genetic, and functional approaches, together with sequencing of selected regions, to define the centromere of the human X chromosome and to explore the evolution of sequences responsible for chromosome segregation. The transitional region between expressed sequences on the short arm of the X and the chromosome-specific alpha satellite array DXZ1 spans about 450 kilobases and is satellite-rich. At the junction between this satellite region and canonical DXZ1 repeats, diverged repeat units provide direct evidence of unequal crossover as the homogenizing force of these arrays. Results from deletion analysis of mitotically stable chromosome rearrangements and from a human artificial chromosome assay demonstrate that DXZ1 DNA is sufficient for centromere function. Evolutionary studies indicate that, white alpha satellite DNA present throughout the pericentromeric region of the X chromosome appears to be a descendant of an ancestral primate centromere, the current functional centromere based on DXZ1 sequences is the product of the much more recent concerted evolution of this satellite DNA.	Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Res Inst, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Ctr Human Genet, Cleveland, OH 44106 USA	Case Western Reserve University; University Hospitals of Cleveland; University Hospitals of Cleveland	Willard, HF (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA.	willard@uhri.org			NHGRI NIH HHS [HG00107] Funding Source: Medline; NICHD NIH HHS [HD32111, HD07518] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD032111] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alexandrov I, 2001, CHROMOSOMA, V110, P253, DOI 10.1007/s004120100146; ALEXANDROV IA, 1993, NUCLEIC ACIDS RES, V21, P2209; Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Choo KHA, 2000, TRENDS CELL BIOL, V10, P182, DOI 10.1016/S0962-8924(00)01739-6; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; Darlington CD, 1939, J GENET, V37, P341, DOI 10.1007/BF02982733; DONEHOWER L, 1979, J MOL BIOL, V134, P805, DOI 10.1016/0022-2836(79)90487-X; DURFY SJ, 1989, GENOMICS, V5, P810, DOI 10.1016/0888-7543(89)90123-7; Ebersole TA, 2000, HUM MOL GENET, V9, P1623, DOI 10.1093/hmg/9.11.1623; Goldberg IG, 1996, MOL CELL BIOL, V16, P5156; GREIG GM, 1993, HUM MOL GENET, V2, P1611; Harrington JJ, 1997, NAT GENET, V15, P345, DOI 10.1038/ng0497-345; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Higgins AW, 1999, CHROMOSOMA, V108, P256, DOI 10.1007/s004120050376; Horvath JE, 2000, HUM MOL GENET, V9, P113, DOI 10.1093/hmg/9.1.113; Horvath JE, 2000, GENOME RES, V10, P839, DOI 10.1101/gr.10.6.839; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laurent AM, 1997, GENOMICS, V46, P127, DOI 10.1006/geno.1997.4987; Laurent AM, 1999, CHROMOSOME RES, V7, P305, DOI 10.1023/A:1009283015738; Lee C, 2000, CHROMOSOMA, V109, P381, DOI 10.1007/s004120000095; Mahtani MM, 1998, GENOME RES, V8, P100, DOI 10.1101/gr.8.2.100; MILLER AP, 1995, HUM MOL GENET, V4, P731, DOI 10.1093/hmg/4.4.731; Montefalcone G, 1999, GENOME RES, V9, P1184, DOI 10.1101/gr.9.12.1184; MURPHY TD, 1995, CELL, V82, P599, DOI 10.1016/0092-8674(95)90032-2; O'Brien SJ, 1999, SCIENCE, V286, P458, DOI 10.1126/science.286.5439.458; OHNO S, 1973, NATURE, V244, P259, DOI 10.1038/244259a0; Puechberty J, 1999, GENOMICS, V56, P274, DOI 10.1006/geno.1999.5742; ROSENBERG H, 1978, SCIENCE, V200, P394, DOI 10.1126/science.205944; Schueler MG, 2000, GENOMICS, V66, P104, DOI 10.1006/geno.2000.6180; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; SMITH GP, 1976, SCIENCE, V191, P528, DOI 10.1126/science.1251186; SULLIVAN BA, 1995, HUM MOL GENET, V4, P2189, DOI 10.1093/hmg/4.12.2189; Sullivan BA, 2001, NAT REV GENET, V2, P584, DOI 10.1038/35084512; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Ventura M, 2001, GENOME RES, V11, P595, DOI 10.1101/gr.152101; Warburton P.E., 1996, HUMAN GENOME EVOLUTI, P121; Warburton PE, 2001, TRENDS GENET, V17, P243, DOI 10.1016/S0168-9525(01)02283-1; WARBURTON PE, 1991, GENOMICS, V11, P324, DOI 10.1016/0888-7543(91)90139-6; WAYE JS, 1985, NUCLEIC ACIDS RES, V13, P2731, DOI 10.1093/nar/13.8.2731; WILLARD HF, 1987, TRENDS GENET, V3, P192, DOI 10.1016/0168-9525(87)90232-0; Willard HF, 1998, CURR OPIN GENET DEV, V8, P219, DOI 10.1016/S0959-437X(98)80144-5; Wolff DJ, 1996, AM J HUM GENET, V58, P154	43	360	375	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2001	294	5540					109	115		10.1126/science.1065042	http://dx.doi.org/10.1126/science.1065042			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11588252				2022-12-01	WOS:000171448800040
J	Harvey, J				Harvey, J			The natural economy	NATURE			English	Article									NIOO NAW, Netherlands Institute of Ecology, Ctr Terr Ecol, Dept Multitroph Interact, NL-6666 ZG Heteren, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Harvey, J (corresponding author), NIOO NAW, Netherlands Institute of Ecology, Ctr Terr Ecol, Dept Multitroph Interact, POB 40, NL-6666 ZG Heteren, Netherlands.		Harvey, Jeffrey A/B-7439-2008	Harvey, Jeffrey A/0000-0002-4227-7935				BASKIN Y, 1997, WORK NATURE; Jones C. G., 1995, LINKING SPECIES ECOS; LEVIN SA, 1999, FRAGILE DOMINION COR; MAURER BA, 1999, UNTANGLING ECOLOGICA; Pimm S.L., 1991, BALANCE NATURE ECOLO	5	6	7	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2001	413	6855					463	463		10.1038/35097209	http://dx.doi.org/10.1038/35097209			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586335	Bronze			2022-12-01	WOS:000171340500024
J	Barbeau, K; Rue, EL; Bruland, KW; Butler, A				Barbeau, K; Rue, EL; Bruland, KW; Butler, A			Photochemical cycling of iron in the surface ocean mediated by microbial iron(III)-binding ligands	NATURE			English	Article							EQUATORIAL PACIFIC-OCEAN; CATHODIC STRIPPING VOLTAMMETRY; MARINE-BACTERIA; SIDEROPHORE PRODUCTION; PHYTOPLANKTON BLOOM; COMPLEXATION; CHEMISTRY; SEAWATER; FERTILIZATION; CYANOBACTERIA	Iron is a limiting nutrient for primary production in large areas of the oceans(1-4). Dissolved iron(III) in the upper oceans occurs almost entirely in the form of complexes with strong organic ligands(5-7) presumed to be of biological origin(8,9). Although the importance of organic ligands to aquatic iron cycling is becoming clear, the mechanism by which they are involved in this process remains uncertain. Here we report observations of photochemical reactions involving Fe(III) bound to siderophores-high-affinity iron(III) ligands produced by bacteria to facilitate iron acquisition(10-12). We show that photolysis of Fe(III)-siderophore complexes leads to the formation of lower-affinity Fe(III) ligands and the reduction of Fe(III), increasing the availability of siderophore-bound iron for uptake by planktonic assemblages. These photochemical reactions are mediated by the alpha -hydroxy acid moiety, a group which has generally been found to be present in the marine siderophores that have been characterized(13-15). We suggest that Fe(III)-binding ligands can enhance the photolytic production of reactive iron species in the euphotic zone and so influence iron availability in aquatic systems.	Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Cruz	Butler, A (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.		Butler, Alison/D-5094-2015	Butler, Alison/0000-0002-3525-7864; Barbeau, Katherine/0000-0002-2132-7219				Albrecht-Gary AM, 1998, MET IONS BIOL SYST, V35, P239; Archer DE, 2000, GLOBAL BIOGEOCHEM CY, V14, P269, DOI 10.1029/1999GB900053; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; DONAT JR, 1988, ANAL CHEM, V60, P240, DOI 10.1021/ac00154a011; Emmenegger L, 1998, ENVIRON SCI TECHNOL, V32, P2990, DOI 10.1021/es980207g; FAUST BC, 1993, ENVIRON SCI TECHNOL, V27, P2517, DOI 10.1021/es00048a032; GLEDHILL M, 1994, MAR CHEM, V47, P41, DOI 10.1016/0304-4203(94)90012-4; Granger J, 1999, LIMNOL OCEANOGR, V44, P541, DOI 10.4319/lo.1999.44.3.0541; HAYGOOD MG, 1993, LIMNOL OCEANOGR, V38, P1091, DOI 10.4319/lo.1993.38.5.1091; HUDSON RJM, 1989, LIMNOL OCEANOGR, V34, P1113, DOI 10.4319/lo.1989.34.6.1113; Hutchins DA, 1999, NATURE, V400, P858, DOI 10.1038/23680; Hutchins DA, 1998, NATURE, V393, P561, DOI 10.1038/31203; Johnson KS, 1997, MAR CHEM, V57, P137, DOI 10.1016/S0304-4203(97)00043-1; JOHNSON KS, 1994, MAR CHEM, V46, P319, DOI 10.1016/0304-4203(94)90029-9; LEWIS BL, 1995, MAR CHEM, V50, P179, DOI 10.1016/0304-4203(95)00034-O; MACRELLIS HM, IN PRESS MAR CHEM; MARFEY P, 1984, CARLSBERG RES COMMUN, V49, P591, DOI 10.1007/BF02908688; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; Martinez JS, 2000, SCIENCE, V287, P1245, DOI 10.1126/science.287.5456.1245; OSULLIVAN DW, 1991, LIMNOL OCEANOGR, V36, P1727, DOI 10.4319/lo.1991.36.8.1727; REID RT, 1993, NATURE, V366, P455, DOI 10.1038/366455a0; RUE EL, 1995, MAR CHEM, V50, P117, DOI 10.1016/0304-4203(95)00031-L; Rue EL, 1997, LIMNOL OCEANOGR, V42, P901, DOI 10.4319/lo.1997.42.5.0901; TRICK CG, 1989, CURR MICROBIOL, V18, P375, DOI 10.1007/BF01571131; WAITE TD, 1995, MAR CHEM, V50, P79, DOI 10.1016/0304-4203(95)00028-P; WELLS ML, 1991, NATURE, V353, P248, DOI 10.1038/353248a0; WILHELM SW, 1994, LIMNOL OCEANOGR, V39, P1979, DOI 10.4319/lo.1994.39.8.1979; WU JF, 1995, MAR CHEM, V50, P159, DOI 10.1016/0304-4203(95)00033-N; ZUO YG, 1992, ENVIRON SCI TECHNOL, V26, P1014, DOI 10.1021/es00029a022	30	388	400	5	188	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2001	413	6854					409	413		10.1038/35096545	http://dx.doi.org/10.1038/35096545			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475UY	11574885				2022-12-01	WOS:000171188700051
J	Wei, DS; Mei, YA; Bagal, A; Kao, JPY; Thompson, SM; Tang, CM				Wei, DS; Mei, YA; Bagal, A; Kao, JPY; Thompson, SM; Tang, CM			Compartmentalized and binary behavior of terminal dendrites in hippocampal pyramidal neurons	SCIENCE			English	Article							CELLS; SPINES	The dendritic arbor of pyramidal neurons is not a monolithic structure. We show here that the excitability of terminal apical, dendrites differs from that of the apical trunk. in response to fluorescence-guided focal photolysis of caged glutamate, individual terminal apical dendrites generated cadmium-sensitive all-or-none responses that were subthreshold for somatic action potentials. Calcium transients produced by all-or-none responses were not restricted to the sites of photolysis, but occurred throughout individual distal dendritic compartments, indicating that electrogenesis is mediated primarily by voltage-gated calcium channels. Compartmentalized and binary behavior of parallel-connected terminal dendrites can greatly expand the computational power of a single neuron.	Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; Univ Maryland, Inst Biotechnol, Ctr Med Biotechnol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Tang, CM (corresponding author), Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA.		Thompson, Scott M/K-8921-2015	Kao, Joseph/0000-0002-8875-2180				BANNISTER NJ, 1995, J COMP NEUROL, V360, P150, DOI 10.1002/cne.903600111; GAHWILER BH, 1991, CULTURING NERVE CELL, P379; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; HESTRIN S, 1990, COLD SH Q B, V55, P87; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; MACCAFERRI G, 1993, J NEUROPHYSIOL, V69, P2129, DOI 10.1152/jn.1993.69.6.2129; Magee J. C., 1999, DENDRITES, P139; MCALLISTER AK, 2000, BIOLISTIC TRANSFECTI; Mel B. W., 1999, DENDRITES, P271; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; RHODES PA, 1999, CEREBRAL CORTEX, V13, pCH3; Rossi FM, 1997, J BIOL CHEM, V272, P32933, DOI 10.1074/jbc.272.52.32933; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; Segev I, 1998, TRENDS NEUROSCI, V21, P453, DOI 10.1016/S0166-2236(98)01327-7; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; TANG CM, IN PRESS CURR PROTOC; TROMMALD M, 1995, J COMP NEUROL, V353, P260, DOI 10.1002/cne.903530208; YLINEN A, 1995, J NEUROSCI, V15, P30; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4	21	156	160	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2001	293	5538					2272	2275		10.1126/science.1061198	http://dx.doi.org/10.1126/science.1061198			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11567143				2022-12-01	WOS:000171139400049
J	Volpi, E; Sheffield-Moore, M; Rasmussen, BB; Wolfe, RR				Volpi, E; Sheffield-Moore, M; Rasmussen, BB; Wolfe, RR			Basal muscle amino acid kinetics and protein synthesis in healthy young and older men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESISTANCE EXERCISE; SKELETAL-MUSCLE; METABOLISM; SARCOPENIA; RATES	Context Sarcopenia is associated with loss of strength and function, eventually leading to loss of independence. Some studies suggest that basal muscle protein turnover is reduced with aging, but other studies do not confirm this finding. Objective To determine if aging per se affects basal muscle protein turnover in men. Design and Setting Cross-sectional study conducted from June 1997 to July 2000 in a general US community. Participants Twenty-six young (mean [SE] age, 28 [2] years) and 22 older (mean [SE] age, 70 [1] years) men, who were healthy and independent based on activities of daily living, physical examinations, and screening tests. Subjects were excluded if they had cardiac, pulmonary, liver, or kidney disease; any impairment in activities of daily living; or steroid use. Main Outcome Measures We measured basal muscle protein and amino acid kinetics, based on stable isotope techniques with femoral arteriovenous catheterization and muscle biopsies. Three models (arteriovenous balance, three-pool, and fractional synthesis rate) were used to estimate the metabolic parameters. Results Mean (SE) total leg volume was 9.60 (0.32) L in older men vs 10.83 (0.43) L in younger men, which suggests muscle loss in the older men. Net muscle protein balance was similar in both groups (older men, -19 [2] nmol/min per 100 mL of leg volume vs younger men, -21 [2] nmol/min per 100 ml. of leg volume; P = .51). Small differences were found in mean (SE) muscle protein synthesis in comparisons of older vs younger men: arteriovenous balance, 48 (5) nmol/min per 100 mL of leg volume vs 32 (3) nmol/min per 100 mL of leg volume; P = .004; three-pool, 58 (5) nmol/min per 100 mL of leg volume vs 43 (4) nmol/min per 100 mL of leg volume; P = .04; and fractional synthesis rate, 0.0601 (0.0046) %/h vs 0.0578 (0.0047) %/h; P = .73. Small differences were also found in mean (SE) muscle protein breakdown: arteriovenous balance, 66 (5) nmol/min per 100 mL of leg volume in older vs 53 (4) nmol/min per 100 mL of leg volume in younger men, P = .045; and three-pool, 76 (6) nmol/min per 100 mL of leg volume vs 64 (5) nmol/min per 100 mL of leg volume, P = .14. Conclusion Differences in basal muscle protein turnover between older and younger men do not appear to explain muscle loss that occurs with age.	Univ So Calif, Div Endocrinol & Diabet, Dept Med, 1333 San Pablo St,BMT-B11, Los Angeles, CA 90033 USA; Univ Texas, Med Branch, Dept Internal Med, Galveston, TX 77550 USA; Univ Texas, Med Branch, Dept Surg, Galveston, TX 77550 USA; Univ Texas, Med Branch, Dept Anesthesiol, Galveston, TX 77550 USA; Shriners Hosp Children, Galveston, TX 77550 USA; Univ So Calif, Dept Kinesiol, Los Angeles, CA 90033 USA	University of Southern California; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Southern California	Volpi, E (corresponding author), Univ So Calif, Div Endocrinol & Diabet, Dept Med, 1333 San Pablo St,BMT-B11, Los Angeles, CA 90033 USA.	volpi@usc.edu	Sheffield-Moore, Melinda/A-9794-2016; Volpi, Elena/I-4459-2012	Sheffield-Moore, Melinda/0000-0001-6579-4655; Rasmussen, Blake/0000-0001-7854-5375; Volpi, Elena/0000-0001-8776-0384	NCRR NIH HHS [M01 RR00073, M01 RR000073] Funding Source: Medline; NIA NIH HHS [P60 AG17231, R01 AG15780, R01 AG18311, R01 AG018311-01, P60 AG017231, R01 AG015780, P30 AG024832, R01 AG018311] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018311, P60AG017231, R01AG015780, P30AG024832] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Balagopal P, 1997, AM J PHYSIOL-ENDOC M, V273, pE790, DOI 10.1152/ajpendo.1997.273.4.E790; Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343; BIOLO G, 1995, AM J PHYSIOL-ENDOC M, V268, pE75, DOI 10.1152/ajpendo.1995.268.1.E75; Bonnefoy M, 2001, J AM GERIATR SOC, V49, P28, DOI 10.1046/j.1532-5415.2001.49006.x; Bross R, 1999, J CLIN ENDOCR METAB, V84, P3420, DOI 10.1210/jc.84.10.3420; CALDER AG, 1992, RAPID COMMUN MASS SP, V6, P421, DOI 10.1002/rcm.1290060704; Campbell WW, 1996, EUR J CLIN NUTR, V50, pS180; CHINKES DL, 1993, CLIN SCI, V84, P177, DOI 10.1042/cs0840177; Dionne I J, 2000, J Nutr Health Aging, V4, P156; DUTTA C, 1995, J GERONTOL A-BIOL, V50, P1, DOI 10.1093/gerona/50A.Special_Issue.1; EVANS WJ, 1995, J GERONTOL A-BIOL, V50, P147; EVANS WJ, 1995, J GERONTOL A-BIOL, V50, P5, DOI 10.1093/gerona/50A.Special_Issue.5; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; Gavin JR, 1999, DIABETES CARE, V22, pS5; Hasten DL, 2000, AM J PHYSIOL-ENDOC M, V278, pE620, DOI 10.1152/ajpendo.2000.278.4.E620; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; JORFELDT L, 1978, METABOLISM, V27, P97, DOI 10.1016/0026-0495(78)90128-2; JORFELDT L, 1971, CLIN SCI, V41, P459, DOI 10.1042/cs0410459; KATCH V, 1975, HUM BIOL, V47, P203; LEXELL J, 1995, J GERONTOL, V50; Pannemans DLE, 1998, AM J CLIN NUTR, V68, P1228, DOI 10.1093/ajcn/68.6.1228; Patterson BW, 1997, METABOLISM, V46, P943, DOI 10.1016/S0026-0495(97)90084-6; Proctor DN, 1998, J NUTR, V128, p351S, DOI 10.1093/jn/128.2.351S; ROBERTS SB, 1995, J GERONTOL A-BIOL, V50, P101; Roubenoff R, 2000, J Nutr Health Aging, V4, P140; SHETTY KR, 1995, ENDOCRIN METAB CLIN, V24, P213, DOI 10.1016/S0889-8529(18)30039-2; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; Volpi E, 2000, J CLIN ENDOCR METAB, V85, P4481, DOI 10.1210/jc.85.12.4481; Volpi E, 1999, AM J PHYSIOL-ENDOC M, V277, pE513, DOI 10.1152/ajpendo.1999.277.3.E513; WELLE S, 1993, AM J PHYSIOL, V264, pE693, DOI 10.1152/ajpendo.1993.264.5.E693; WELLE S, 1995, AM J PHYSIOL-ENDOC M, V268, pE422, DOI 10.1152/ajpendo.1995.268.3.E422; WOLFE RR, 1992, RADIOACTIVE STABLE I, P167; WOLFE RR, 1992, RADIOACTIVE STABLE I, P417; WOLFE RR, 1992, RADIOACTIVE STABLE I, P119; WOLFSON L, 1995, J GERONTOL A-BIOL, V50, P64; Yarasheski KE, 1999, AM J PHYSIOL-ENDOC M, V277, pE118, DOI 10.1152/ajpendo.1999.277.1.E118; YARASHESKI KE, 1993, AM J PHYSIOL, V265, pE210, DOI 10.1152/ajpendo.1993.265.2.E210	37	302	307	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1206	1212		10.1001/jama.286.10.1206	http://dx.doi.org/10.1001/jama.286.10.1206			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	471CR	11559266	Green Accepted, Bronze			2022-12-01	WOS:000170910400031
J	Doherty, M				Doherty, M			Risk factors for progression of knee osteoarthritis	LANCET			English	Editorial Material							ALIGNMENT		City Hosp, Acad Dept Rheumatol, Nottingham NG5 1PB, England	University of Nottingham	Doherty, M (corresponding author), City Hosp, Acad Dept Rheumatol, Clin Sci Bldg, Nottingham NG5 1PB, England.	Michael.Doherty@nottingham.ac.uk		Doherty, Michael/0000-0002-5763-8326				Brandt KD, 1998, OSTEOARTHRITIS, P70; Creamer P, 2000, RHEUMATOLOGY, V39, P490, DOI 10.1093/rheumatology/39.5.490; DOHERTY M, 1983, LANCET, V2, P8; Elahi S, 2000, ARTHRITIS RHEUM, V43, P1874, DOI 10.1002/1529-0131(200008)43:8<1874::AID-ANR25>3.0.CO;2-2; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351; HUSKISSON EC, 1995, J RHEUMATOL, V22, P1941; LEDINGHAM J, 1995, ANN RHEUM DIS, V54, P53, DOI 10.1136/ard.54.1.53; Loughlin J, 2001, CURR OPIN RHEUMATOL, V13, P111, DOI 10.1097/00002281-200103000-00004; Ogata K, 1997, INT ORTHOP, V21, P308, DOI 10.1007/s002640050174; Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91; Sharma L, 2001, JAMA-J AM MED ASSOC, V286, P188, DOI 10.1001/jama.286.2.188; Sharma L, 2000, ARTHRITIS RHEUM, V43, P568, DOI 10.1002/1529-0131(200003)43:3<568::AID-ANR13>3.0.CO;2-E	13	64	65	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 8	2001	358	9284					775	776		10.1016/S0140-6736(01)06006-8	http://dx.doi.org/10.1016/S0140-6736(01)06006-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NA	11564477				2022-12-01	WOS:000170989300003
J	Sambrano, GR; Weiss, EJ; Zheng, YW; Huang, W; Coughlin, SR				Sambrano, GR; Weiss, EJ; Zheng, YW; Huang, W; Coughlin, SR			Role of thrombin signalling in platelets in haemostasis and thrombosis	NATURE			English	Article							GLYCOPROTEIN IB-ALPHA; COLLAGEN RECEPTOR; ACTIVATION; MODEL; GENE; ANTIBODY; IIB/IIIA; FAMILY; DEATH; MICE	Platelets are critical in haemostasis and in arterial thrombosis, which causes heart attacks and other events triggered by abnormal clotting(1-5). The coagulation protease thrombin is a potent activator of platelets ex vivo(6). However, because thrombin also mediates fibrin deposition and because multiple agonists can trigger platelet activation(7), the relative importance of platelet activation by thrombin in haemostasis and thrombosis is unknown. Thrombin triggers cellular responses at least in part through protease-activated receptors (PARs)(8). Mouse platelets express PAR3 and PAR4 (ref. 9). Here we show that platelets from PAR4-deficient mice failed to change shape, mobilize calcium, secrete ATP or aggregate in response to thrombin. This result demonstrates that PAR signalling is necessary for mouse platelet activation by thrombin and supports the model that mouse PAR3 (mPAR3) does not by itself mediate transmembrane signalling but instead acts as a cofactor for thrombin cleavage and activation of mPAR4 (ref. 10). Importantly, PAR4-deficient mice had markedly prolonged bleeding times and were protected in a model of arteriolar thrombosis. Thus platelet activation by thrombin is necessary for normal haemostasis and may be an important target in the treatment of thrombosis.	Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Coughlin, SR (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, 513 Parnassus Ave, San Francisco, CA 94143 USA.							Andrews RK, 1999, THROMB HAEMOSTASIS, V82, P357, DOI 10.1055/s-0037-1615854; COLLER BS, 1986, BLOOD, V68, P783; Colman RW, 1994, HEMOSTASIS THROMBOSI, P3; COOK JJ, 1995, CIRCULATION, V91, P2961, DOI 10.1161/01.CIR.91.12.2961; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; DAVEY MG, 1967, NATURE, V216, P857, DOI 10.1038/216857a0; DAVIES MJ, 1989, EUR HEART J, V10, P203, DOI 10.1093/oxfordjournals.eurheartj.a059467; DEMARCO L, 1991, J BIOL CHEM, V266, P23776; Denis C, 1998, P NATL ACAD SCI USA, V95, P9524, DOI 10.1073/pnas.95.16.9524; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Giesen PLA, 1999, P NATL ACAD SCI USA, V96, P2311, DOI 10.1073/pnas.96.5.2311; Ishihara H, 1998, BLOOD, V91, P4152, DOI 10.1182/blood.V91.11.4152.411k22_4152_4157; Ishihara H, 1997, NATURE, V386, P502, DOI 10.1038/386502a0; Kahn ML, 1998, J BIOL CHEM, V273, P23290, DOI 10.1074/jbc.273.36.23290; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Kehrel B, 1998, BLOOD, V91, P491; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; LEWIS HD, 1983, NEW ENGL J MED, V309, P396, DOI 10.1056/NEJM198308183090703; Mann KG, 1999, THROMB HAEMOSTASIS, V82, P165; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; MORTENSEN R, 1993, CURRENT PROTOCOLS S, V23; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Offermanns S, 2000, BIOL CHEM, V381, P389, DOI 10.1515/BC.2000.051; Ramakrishnan V, 2001, P NATL ACAD SCI USA, V98, P1823, DOI 10.1073/pnas.98.4.1823; SAUER B, 1993, GUIDE TECHNIQUES MOU, P890; SCHLAEGER TM, 1995, DEVELOPMENT, V121, P1089; Schwartz MA, 2000, TRENDS BIOCHEM SCI, V25, P388, DOI 10.1016/S0968-0004(00)01605-4; Topol E, 1998, NEW ENGL J MED, V339, P436; WARE J, 1990, P NATL ACAD SCI USA, V87, P2026, DOI 10.1073/pnas.87.5.2026; Watson S, 2000, PLATELETS, V11, P252	30	407	424	1	49	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					74	78		10.1038/35092573	http://dx.doi.org/10.1038/35092573			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544528				2022-12-01	WOS:000170801200041
J	Simon, A; Cuisset, L; Vincent, MF; van der Velde-Visser, SD; Delpech, M; van der Meer, JWM; Drenth, JPH				Simon, A; Cuisset, L; Vincent, MF; van der Velde-Visser, SD; Delpech, M; van der Meer, JWM; Drenth, JPH		HIDS Study Grp	Molecular analysis of the mevalonate kinase gene in a cohort of patients with the hyper-IgD and periodic fever syndrome: Its application as a diagnostic tool	ANNALS OF INTERNAL MEDICINE			English	Article							HYPERIMMUNOGLOBULINEMIA-D; UNKNOWN ORIGIN; MUTATIONS; ATTACKS; MVK	Background: The hyper-IgD and periodic fever syndrome (HIDS) is characterized by recurrent attacks of fever, abdominal distress, and arthralgia and is caused by mevalonate kinase mutations. Objective: To ascertain the role of mevalonate kinase and the usefulness of molecular diagnosis in HIDS. Design: Cross-sectional study. Setting: The international Nijmegen HIDS registry. Patients: 54 patients from 41 families who met the clinical criteria for HIDS. Measurements: Clinical symptoms and signs, immunoglobulin concentration, leukocyte count, erythrocyte sedimentation rate, mutation analysis, and mevalonate kinase enzyme activity assay. Results: There were two groups of patients: 41 patients with mevalonate kinase mutations (classic-type HIDS) and 13 patients without mutations (variant-type HIDS). Patients with classic-type HIDS had a lower mevalonate kinase enzyme activity, a higher IgD level, and more additional symptoms with attacks. The IgD level did not correlate with disease severity, mevalonate kinase enzyme activity, or genotype. Conclusion: Genetic heterogeneity exists among patients with a clinical diagnosis of HIDS.	Radboud Univ Nijmegen Med Ctr, Div Gen Internal Med, NL-6500 HB Nijmegen, Netherlands; Genet & Physiopathol Malad Inflammatoires Heredit, Paris, France; Hop Cochin, F-75674 Paris, France; Catholic Univ Louvain, B-1200 Brussels, Belgium	Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Catholique Louvain	Simon, A (corresponding author), Radboud Univ Nijmegen Med Ctr, Div Gen Internal Med, Box 9101, NL-6500 HB Nijmegen, Netherlands.	a.simon@worldonline.nl	Drenth, J.P.H./H-8025-2014; Simon, Anna/D-3757-2009; van der Meer, Jos W.M./C-8521-2013; Drenth, Joost/V-7436-2019	Simon, Anna/0000-0002-6141-7921; van der Meer, Jos W.M./0000-0001-5120-3690; 				Aksentijevich I, 1997, CELL, V90, P797; Bernot A, 1997, NAT GENET, V17, P25; Cuisset L, 2001, EUR J HUM GENET, V9, P260, DOI 10.1038/sj.ejhg.5200614; de Kleijn EMH, 1997, MEDICINE, V76, P392, DOI 10.1097/00005792-199711000-00002; DRENTH JPH, 1994, MEDICINE, V73, P133, DOI 10.1097/00005792-199405000-00002; Drenth JPH, 1999, NAT GENET, V22, P178, DOI 10.1038/9696; Drenth JPH, 2000, BRIT MED J, V320, P1091, DOI 10.1136/bmj.320.7242.1091; DRENTH JPH, 1995, BLOOD, V85, P3586, DOI 10.1182/blood.V85.12.3586.bloodjournal85123586; DRENTH JPH, 1995, EUR J CLIN INVEST, V25, P683, DOI 10.1111/j.1365-2362.1995.tb01986.x; Eisenberg S, 1998, ANN INTERN MED, V129, P539, DOI 10.7326/0003-4819-129-7-199810010-00005; GIBSON KM, 1989, ENZYME, V41, P47, DOI 10.1159/000469050; Grose C, 1996, PEDIATR INFECT DIS J, V15, P72, DOI 10.1097/00006454-199601000-00016; HARALDSSON A, 1992, J CLIN IMMUNOL, V12, P424, DOI 10.1007/BF00918854; HOFFMANN GF, 1992, J INHERIT METAB DIS, V15, P738, DOI 10.1007/BF01800016; Houten SM, 1999, NAT GENET, V22, P175, DOI 10.1038/9691; KNOCKAERT DC, 1993, MEDICINE, V72, P184; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; Palinski W, 2000, NAT MED, V6, P1311, DOI 10.1038/82107; VANDERMEER JWM, 1984, LANCET, V1, P1087	19	63	67	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2001	135	5					338	343		10.7326/0003-4819-135-5-200109040-00010	http://dx.doi.org/10.7326/0003-4819-135-5-200109040-00010			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	468WF	11529697				2022-12-01	WOS:000170780600004
J	Ford, EB; Seager, S; Turner, EL				Ford, EB; Seager, S; Turner, EL			Characterization of extrasolar terrestrial planets from diurnal photometric variability	NATURE			English	Article							EARTH	The detection of massive planets orbiting nearby stars has become almost routine(1,2), but current techniques are as yet unable to detect terrestrial planets with masses comparable to the Earth's. Future space-based observatories to detect Earth-like planets are being planned. Terrestrial planets orbiting in the habitable zones of stars-where planetary surface conditions are compatible with the presence of liquid water-are of enormous interest because they might have global environments similar to Earth's and even harbour life. The light scattered by such a planet will vary in intensity and colour as the planet rotates; the resulting light curve will contain information about the planet's surface and atmospheric properties. Here we report a model that predicts features that should be discernible in the light curve obtained by low-precision photometry. For extrasolar planets similar to Earth, we expect daily flux variations of up to hundreds of per cent, depending sensitively on ice and cloud cover as well as seasonal variations. This suggests that the meteorological variability, composition of the surface (for example, ocean versus land fraction) and rotation period of an Earth-like planet could be derived from photometric observations. Even signatures of Earth-like plant life could be constrained or possibly, with further study, even uniquely determined.	Princeton Univ Observ, Princeton, NJ 08540 USA; Inst Adv Study, Princeton, NJ 08540 USA	Princeton University; Institute for Advanced Study - USA	Ford, EB (corresponding author), Princeton Univ Observ, Peyton Hall, Princeton, NJ 08540 USA.	eford@astro.princeton.edu	Turner, Edwin L/A-4295-2011; Ford, Eric B./AAB-5479-2019	Ford, Eric B./0000-0001-6545-639X				BEICHMAN CA, 1999, NASA JPL PUBL, V993, P1; BRICAUD A, 1995, J GEOPHYS RES-OCEANS, V100, P13321, DOI 10.1029/95JC00463; Brown TM, 2001, ASTROPHYS J, V552, P699, DOI 10.1086/320580; BUKATA RP, 1995, OPTICAL PROPERTIES R, P37; Butler RP, 1996, PUBL ASTRON SOC PAC, V108, P500, DOI 10.1086/133755; DEFRIES RS, 1994, INT J REMOTE SENS, V15, P3567, DOI 10.1080/01431169408954345; Goode PR, 2001, GEOPHYS RES LETT, V28, P1671, DOI 10.1029/2000GL012580; Hapke B., 1993, THEORY REFLECTANCE E; HOVENIER JW, 1989, ASTRON ASTROPHYS, V214, P391; JACQUEMOUD S, 1992, REMOTE SENS ENVIRON, V41, P123, DOI 10.1016/0034-4257(92)90072-R; JEROME JH, 1988, APPL OPTICS, V27, P4012, DOI 10.1364/AO.27.004012; KIRK JTO, 1991, LIMNOL OCEANOGR, V36, P455, DOI 10.4319/lo.1991.36.3.0455; Kondratyev K.Y., 1969, RAD ATMOSPHERE; Marcy G. W., 2000, Protostars and planets 4, P1285; MYNENI RB, 1995, REMOTE SENS ENVIRON, V51, P169, DOI 10.1016/0034-4257(94)00073-V; Nisenson P, 2001, ASTROPHYS J, V548, pL201, DOI 10.1086/319110; ROSSOW WB, 1991, B AM METEOROL SOC, V72, P2, DOI 10.1175/1520-0477(1991)072<0002:ICDP>2.0.CO;2; SAGAN C, 1993, NATURE, V365, P715, DOI 10.1038/365715a0; Schindler TL, 2000, ICARUS, V145, P262, DOI 10.1006/icar.2000.6340; SPERGEL DN, UNPUB APPL OPTICS; SPERGEL DN, 2001, ASTROPH0101142; VERBISCER AJ, 1990, ICARUS, V88, P418, DOI 10.1016/0019-1035(90)90092-N; VOKROUHLICKY D, 1995, ASTRON ASTROPHYS, V298, P307; WOESSNER P, 1987, REMOTE SENS ENVIRON, V21, P243, DOI 10.1016/0034-4257(87)90011-3; 2000, ESASCI200012, P1	25	157	158	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2001	412	6850					885	887		10.1038/35091009	http://dx.doi.org/10.1038/35091009			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528471	Green Submitted			2022-12-01	WOS:000170689000037
J	Pastores, GM; Thadhani, R				Pastores, GM; Thadhani, R			Enzyme-replacement therapy for Anderson-Fabry disease	LANCET			English	Editorial Material									NYU, Sch Med, Dept Neurol & Pediat, Neurogenet Program, New York, NY 10003 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Renal Unit, Boston, MA 02114 USA	New York University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Pastores, GM (corresponding author), NYU, Sch Med, Dept Neurol & Pediat, Neurogenet Program, New York, NY 10003 USA.		Pastores, Gregory M./AAE-8647-2020					Abe A, 2000, J CLIN INVEST, V105, P1563, DOI 10.1172/JCI9711; DESNIEK RJ, 2000, METABOLIC MOL BASES, V3, P3733; Eng CM, 2001, AM J HUM GENET, V68, P711, DOI 10.1086/318809; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Frustaci A, 2001, NEW ENGL J MED, V345, P25, DOI 10.1056/NEJM200107053450104; Jung SC, 2001, P NATL ACAD SCI USA, V98, P2676, DOI 10.1073/pnas.051634498; KUHN H, 1982, CIRCULATION, V66, P117; MACDERMOT KD, IN PRESS J MED GENET; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; NAKAO S, 1995, NEW ENGL J MED, V333, P288, DOI 10.1056/NEJM199508033330504; PASTORES GM, 1999, ENFERMEDAD GAUCHER E, P13; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743	12	50	55	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 25	2001	358	9282					601	603		10.1016/S0140-6736(01)05816-0	http://dx.doi.org/10.1016/S0140-6736(01)05816-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530143				2022-12-01	WOS:000170615500004
J	Jeruzalmi, D; O'Donnell, M; Kuriyan, J				Jeruzalmi, D; O'Donnell, M; Kuriyan, J			Crystal structure of the processivity clamp loader gamma (gamma) complex of E-coli DNA polymerase III	CELL			English	Article							CHROMOSOMAL REPLICATION MACHINE; ONE HOLOENZYME PARTICLE; SLIDING CLAMPS; ACCESSORY PROTEINS; DELTA-SUBUNIT; BETA-CLAMP; MECHANISM; BINDING; ASSOCIATION; HYDROLYSIS	The gamma complex, an AAA+ ATPase, is the bacterial homolog of eukaryotic replication factor C (RFC) that loads the sliding clamp (beta, homologous to PCNA) onto DNA. The 2.7/3.0 Angstrom crystal structure of gamma complex reveals a pentameric arrangement of subunits, with stoichiometry delta':gamma (3):delta. The C-terminal domains of the subunits form a circular collar that supports an asymmetric arrangement of the N-terminal ATP binding domains of the gamma motor and the structurally related domains of the delta' stator and the delta wrench. The structure suggests a mechanism by which the gamma complex switches between a closed state, in which the beta -interacting element of delta is hidden by delta', and an open form similar to the crystal structure, in which delta is free to bind to beta.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Kuriyan, J (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	kuriyan@rockefeller.edu		O'Donnell, Michael/0000-0001-9002-4214	NIGMS NIH HHS [R01 GM-38839, R01 GM-45547] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045547, R01GM038839] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; ALBERTS BM, 1982, COLD SPRING HARB SYM, V47, P655, DOI 10.1101/SQB.1983.047.01.077; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bertram JG, 2000, J BIOL CHEM, V275, P28413, DOI 10.1074/jbc.M910441199; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; CULLMANN G, 1995, MOL CELL BIOL, V15, P4661; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; FLOWER AM, 1990, P NATL ACAD SCI USA, V87, P3713, DOI 10.1073/pnas.87.10.3713; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; KELMAN Z, 1995, ANNU REV BIOCHEM, V64, P171, DOI 10.1146/annurev.bi.64.070195.001131; Kim S, 1996, J BIOL CHEM, V271, P21406, DOI 10.1074/jbc.271.35.21406; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Liu JY, 2000, MOL CELL, V6, P637, DOI 10.1016/S1097-2765(00)00062-9; May AP, 2001, J BIOL CHEM, V276, P21991, DOI 10.1074/jbc.R100013200; MCHENRY CS, 1982, J BIOL CHEM, V257, P2657; Moarefi I, 2000, J MOL BIOL, V296, P1215, DOI 10.1006/jmbi.1999.3511; Naktinis V, 1996, CELL, V84, P137, DOI 10.1016/S0092-8674(00)81000-4; NAKTINIS V, 1995, J BIOL CHEM, V270, P13358, DOI 10.1074/jbc.270.22.13358; Neuwald AF, 1999, GENOME RES, V9, P27; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; ODONNELL M, 1993, NUCLEIC ACIDS RES, V21, P1, DOI 10.1093/nar/21.1.1; ODONNELL ME, 1987, J BIOL CHEM, V262, P16558; ONRUST R, 1991, J BIOL CHEM, V266, P21681; ONRUST R, 1995, J BIOL CHEM, V270, P13366, DOI 10.1074/jbc.270.22.13366; ONRUST R, 1995, J BIOL CHEM, V270, P13348, DOI 10.1074/jbc.270.22.13348; OYAMA T, 2001, IN PRESS MOL CELL, V8; Pietroni P, 2001, J MOL BIOL, V309, P869, DOI 10.1006/jmbi.2001.4687; Pritchard AE, 2000, EMBO J, V19, P6536, DOI 10.1093/emboj/19.23.6536; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Shiomi Y, 2000, P NATL ACAD SCI USA, V97, P14127, DOI 10.1073/pnas.97.26.14127; Stewart J, 2001, J BIOL CHEM, V276, P19182, DOI 10.1074/jbc.M100592200; STILLMAN B, 1994, CELL, V78, P725, DOI 10.1016/S0092-8674(94)90362-X; STUDWELLVAUGHAN PS, 1991, J BIOL CHEM, V266, P19833; STUKENBERG PT, 1994, CELL, V78, P877, DOI 10.1016/S0092-8674(94)90662-9; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; TSUCHIHASHI Z, 1990, P NATL ACAD SCI USA, V87, P2516, DOI 10.1073/pnas.87.7.2516; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; Vetter IR, 1999, Q REV BIOPHYS, V32, P1, DOI 10.1017/S0033583599003480; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; YOUNG MC, 1992, BIOCHEMISTRY-US, V31, P8675, DOI 10.1021/bi00152a001; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843; Yuzhakov A, 1996, CELL, V86, P877, DOI 10.1016/S0092-8674(00)80163-4; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	50	244	249	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2001	106	4					429	441		10.1016/S0092-8674(01)00463-9	http://dx.doi.org/10.1016/S0092-8674(01)00463-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525729	Bronze			2022-12-01	WOS:000170665200007
J	Fairhall, AL; Lewen, GD; Bialek, W; van Steveninck, RRD				Fairhall, AL; Lewen, GD; Bialek, W; van Steveninck, RRD			Efficiency and ambiguity in an adaptive neural code	NATURE			English	Article							INFORMATION-TRANSMISSION; SPIKE TRAINS; ADAPTATION; TIME; DYNAMICS; SYSTEM	We examine the dynamics of a neural code in the context of stimuli whose statistical properties are themselves evolving dynamically. Adaptation to these statistics occurs over a wide range of timescales-from tens of milliseconds to minutes. Rapid components of adaptation serve to optimize the information that action potentials carry about rapid stimulus variations within the local statistical ensemble, while changes in the rate and statistics of action-potential firing encode information about the ensemble itself, thus resolving potential ambiguities. The speed with which information is optimized and ambiguities are resolved approaches the physical limit imposed by statistical sampling and noise.	NEC Res Inst, Princeton, NJ 08540 USA	NEC Corporation	Fairhall, AL (corresponding author), NEC Res Inst, 4 Independence Way, Princeton, NJ 08540 USA.							ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barlow H.B., 1961, SENSORY COMMUNICATIO; Berry MJ, 1997, P NATL ACAD SCI USA, V94, P5411, DOI 10.1073/pnas.94.10.5411; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; BORST A, 1987, BIOL CYBERN, V56, P209, DOI 10.1007/BF00365215; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Brown SP, 2001, NAT NEUROSCI, V4, P44, DOI 10.1038/82888; Carandini M, 1997, J NEUROSCI, V17, P8621; Clague H, 1997, J NEUROPHYSIOL, V77, P207, DOI 10.1152/jn.1997.77.1.207; DeWeese M, 1998, NEURAL COMPUT, V10, P1179, DOI 10.1162/089976698300017403; Fairhall AL, 2001, ADV NEUR IN, V13, P124; Feynman R.P., 1965, PATH INTEGRALS QUANT; Franceschini N., 1989, P360; Gerstner W, 1997, P NATL ACAD SCI USA, V94, P12740, DOI 10.1073/pnas.94.24.12740; GREEN DM, 1966, SIGNAL DETECTION THE; Hausen K., 1984, PHOTORECEPTION VISIO, P523, DOI [10.1007/978-1-4613-2743-1_15, DOI 10.1007/978-1-4613-2743-1_15]; Hopfield JJ, 1996, P NATL ACAD SCI USA, V93, P15440, DOI 10.1073/pnas.93.26.15440; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; LAND MF, 1974, J COMP PHYSIOL, V89, P331, DOI 10.1007/BF00695351; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Markram H, 1998, NEUROBIOL LEARN MEM, V70, P101, DOI 10.1006/nlme.1998.3841; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; Nelken I, 1999, NATURE, V397, P154, DOI 10.1038/16456; Perkel D, 1968, NEUROSCI RES PROG B, V6, P3; Reinagel P, 2000, J NEUROSCI, V20, P5392, DOI 10.1523/JNEUROSCI.20-14-05392.2000; Rieke F., 1997, SPIKES EXPLORING NEU; RUDERMAN DL, 1994, PHYS REV LETT, V73, P814, DOI 10.1103/PhysRevLett.73.814; Schilstra C, 1999, J EXP BIOL, V202, P1481; Schneidman E, 2001, ADV NEUR IN, V13, P159; SEGUNDO JP, 1963, J EXP BIOL, V40, P643; SHAPLEY R, 1979, VISION RES, V19, P431, DOI 10.1016/0042-6989(79)90109-3; SIMONCELLI EP, 1999, ADV NEURAL INFORMATI, V11, P166; SMIRNAKIS S, 1997, NATURE, V386, P67; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; THORSON J, 1974, SCIENCE, V183, P161, DOI 10.1126/science.183.4121.161; Toib A, 1998, J NEUROSCI, V18, P1893; VANHATEREN JH, 1992, J COMP PHYSIOL A, V171, P157, DOI 10.1007/BF00188924; VANSTEVENINCK RD, 1988, PROC R SOC SER B-BIO, V234, P379; vanSteveninck RRD, 1996, NATURE, V379, P642, DOI 10.1038/379642a0; VANSTEVENINCK RRD, 1986, BIOL CYBERN, V54, P223, DOI 10.1007/BF00318418; vanSteveninck RRD, 1996, NATURAL & ARTIFICIAL PARALLEL COMPUTATION, P21; Wainwright MJ, 1999, VISION RES, V39, P3960, DOI 10.1016/S0042-6989(99)00101-7; Wang YQ, 2000, PHYS REV E, V62, P1063, DOI 10.1103/PhysRevE.62.1063; Warland DK, 1991, READING SPIKES REAL; Wiener N., 1949, EXTRAPOLATION INTERP	45	544	552	1	41	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					787	792		10.1038/35090500	http://dx.doi.org/10.1038/35090500			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518957				2022-12-01	WOS:000170577200028
J	Brabin, L				Brabin, L			Hormonal markers of susceptibility to sexually transmitted infections: are we taking them seriously?	BRITISH MEDICAL JOURNAL			English	Article							HERPES-SIMPLEX VIRUS; CHLAMYDIA-TRACHOMATIS INFECTION; GENITAL HERPES; TYPE-2; WOMEN; RISK; TRANSMISSION		St Marys Hosp, Acad Unit Obstet & Gynaecol & Reprod Hlth Care, Manchester M13 0JH, Lancs, England	University of Manchester	Brabin, L (corresponding author), St Marys Hosp, Acad Unit Obstet & Gynaecol & Reprod Hlth Care, Manchester M13 0JH, Lancs, England.			Brabin, Loretta/0000-0003-4478-6503				Apter D, 1997, ANN NY ACAD SCI, V816, P9, DOI 10.1111/j.1749-6632.1997.tb52125.x; Brabin L, 2000, ACTA TROP, V75, P53, DOI 10.1016/S0001-706X(99)00093-5; BRABIN L, 1996, PREVENTION PELVIC IN, P160; Brown ZA, 1997, NEW ENGL J MED, V337, P509, DOI 10.1056/NEJM199708213370801; BURNSTEIN GR, 2001, SEX TRANSM INFECT, V77, P26; COTTINGHAM J, 1992, GENITOURIN MED, V68, P209; Fleming DT, 1997, NEW ENGL J MED, V337, P1105, DOI 10.1056/NEJM199710163371601; Greenblatt RM, 2000, J INFECT DIS, V181, P82, DOI 10.1086/315207; Hewitt R G, 2001, AIDS Read, V11, P29; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Langenberg AGM, 1999, NEW ENGL J MED, V341, P1432, DOI 10.1056/NEJM199911043411904; MERTZ GJ, 1992, ANN INTERN MED, V116, P197, DOI 10.7326/0003-4819-116-3-197; Moscicki AB, 1998, J PEDIATR-US, V132, P277, DOI 10.1016/S0022-3476(98)70445-7; Moscicki AB, 2001, J INFECT DIS, V183, P865, DOI 10.1086/319261; Mosure DJ, 1996, AM J EPIDEMIOL, V144, P997, DOI 10.1093/oxfordjournals.aje.a008870; O'Farrell N, 2001, SEX TRANSM DIS, V28, P84, DOI 10.1097/00007435-200102000-00005; Obasi A, 1999, J INFECT DIS, V179, P16, DOI 10.1086/314555; Robbins AS, 2001, AM J PREV MED, V20, P90, DOI 10.1016/S0749-3797(00)00280-4; SIEGEL D, 1992, JAMA-J AM MED ASSOC, V268, P1702, DOI 10.1001/jama.268.13.1702; Smith SM, 2000, J INFECT DIS, V182, P708, DOI 10.1086/315776; Sonnex C, 1998, SEX TRANSM INFECT, V74, P11, DOI 10.1136/sti.74.1.11; Stephenson J, 2000, JAMA-J AM MED ASSOC, V284, P1913, DOI 10.1001/jama.284.15.1913; *UNDP UNFPA WHO WO, 2000, REPR HLTH RES WHO NE; Wang CC, 1999, J ACQ IMMUN DEF SYND, V21, P51, DOI 10.1097/00126334-199905010-00007; WASHINGTON AE, 1985, JAMA-J AM MED ASSOC, V253, P2246, DOI 10.1001/jama.253.15.2246	25	13	13	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2001	323	7309					394	395		10.1136/bmj.323.7309.394	http://dx.doi.org/10.1136/bmj.323.7309.394			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11509437	Green Published			2022-12-01	WOS:000170581400032
J	Cunliffe, NA; Gondwe, JS; Kirkwood, CD; Graham, SM; Nhlane, NM; Thindwa, BDM; Dove, W; Broadhead, RL; Molyneux, ME; Hart, CA				Cunliffe, NA; Gondwe, JS; Kirkwood, CD; Graham, SM; Nhlane, NM; Thindwa, BDM; Dove, W; Broadhead, RL; Molyneux, ME; Hart, CA			Effect of concomitant HIV infection on presentation and outcome of rotavirus gastroenteritis in Malawian children	LANCET			English	Article							YOUNG-CHILDREN; ACUTE DIARRHEA; EPIDEMIOLOGY; SEVERITY; DISEASE; VACCINE; BLANTYRE; HEALTHY	Background Rotaviruses represent important causes of severe diarrhoea in early childhood. We examined the effect of HIV infection on the presentation and outcome of rotavirus gastroenteritis in Malawian children. Methods Children younger than 5 years who were treated for acute gastroenteritis at the Queen Elizabeth Central Hospital in Blantyre from July, 1997, to June, 1999, were enrolled. Children with rotavirus diarrhoea, with and without HIV infection, were followed up for up to 4 weeks after hospital discharge. Rotavirus disease severity (assessed with a 20-point score), duration of rotavirus shedding, and seroresponse to rotavirus were compared between HIV-infected and HIV-uninfected children. Findings 786 inpatients (median age 8 months, 271 [34%] of whom were HIV-1-infected) and 400 outpatients (median age 9 months, 65 [16%] of whom were HIV-infected) were enrolled. Rotavirus was detected less frequently among HIV-infected children (102 of 336 [30%]) than among HIV-uninfected children (348 of 850 [41%], (relative risk 0.71 [95% CI 0.53-0.87], p=0.0007). There were no differences in rotavirus disease severity for hospitalised children with and without HIV infection, but HIV-infected children were more likely to die during follow-up (11/50 [22%]) than HIV-uninfected children (0/61, p<0.0001). Of 29 HIV-infected and 45 HIV-uninfected children who completed follow-up, six (21%) HIV-infected children shed rotavirus, compared with two (4%) HIV-uninfected children (4.66 [1.01-21.51], p=0.05), but shedding was not associated with diarrhoea. Three-quarters of children exhibited a four-fold rise of serum IgG or lgA to rotavirus, which did not vary by HIV status. Interpretation. Malawian children with concomitant HIV infection resolved acute rotavirus infections. Rotavirus vaccine safety and immunogenicity in HIV-infected infants should now be determined.	Univ Liverpool, Dept Med Microbiol & Genitourinary Med, Liverpool L69 3GA, Merseyside, England; Univ Malawi, Wellcome Trust Res Labs, Coll Med, Blantyre, Malawi; Univ Liverpool, Coll Med, Blantyre, Malawi; Univ Malawi, Coll Med, Dept Paediat, Blantyre, Malawi; Royal Childrens Hosp, Dept Gastroenterol & Clin Nutr, Melbourne, Vic, Australia; Univ Liverpool, Sch Trop Med, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Malawi; University of Malawi; University of Malawi; Royal Children's Hospital Melbourne; Liverpool School of Tropical Medicine; University of Liverpool	Cunliffe, NA (corresponding author), Univ Liverpool, Dept Med Microbiol & Genitourinary Med, Duncan Bldg,Daulby St, Liverpool L69 3GA, Merseyside, England.	N.A.Cunllffe@liverpool.ac.uk		Graham, Stephen/0000-0003-3525-2294; Cunliffe, Nigel/0000-0002-5449-4988				[Anonymous], 1999, MMWR Recomm Rep, V48, P1; BERN C, 1992, J CLIN MICROBIOL, V30, P3234, DOI 10.1128/JCM.30.12.3234-3238.1992; Bresee JS, 1999, VACCINE, V17, P2207, DOI 10.1016/S0264-410X(98)00376-4; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P1007; Cunliffe NA, 1998, B WORLD HEALTH ORGAN, V76, P525; Cunliffe NA, 1999, J MED VIROL, V57, P308, DOI 10.1002/(SICI)1096-9071(199903)57:3&lt;308::AID-JMV15&gt;3.0.CO;2-B; Cunliffe NA, 2001, J CLIN MICROBIOL, V39, P836, DOI 10.1128/JCM.39.3.836-843.2001; DAGAN R, 1990, PEDIATR INFECT DIS J, V9, P314, DOI 10.1097/00006454-199005000-00003; DEZOYSA I, 1985, B WORLD HEALTH ORGAN, V63, P569; Fontana M, 1996, J PEDIATR GASTR NUTR, V23, P492, DOI 10.1097/00005176-199611000-00026; FRANCO MA, 1995, J VIROL, V69, P7800, DOI 10.1128/JVI.69.12.7800-7806.1995; GILGER MA, 1992, J PEDIATR-US, V120, P912, DOI 10.1016/S0022-3476(05)81959-6; Glass RI, 1996, J INFECT DIS, V174, pS5, DOI 10.1093/infdis/174.Supplement_1.S5; Graham SM, 2000, LANCET, V355, P369, DOI 10.1016/S0140-6736(98)11074-7; GROHMANN GS, 1993, NEW ENGL J MED, V329, P14, DOI 10.1056/NEJM199307013290103; Iturriza-Gomara M, 2000, J CLIN MICROBIOL, V38, P4394; Joensuu J, 1997, LANCET, V350, P1205, DOI 10.1016/S0140-6736(97)05118-0; Kapikian A.Z., 1996, FIELDS VIROLOGY, P1657; KOTLOFF KL, 1994, JAMA-J AM MED ASSOC, V271, P448, DOI 10.1001/jama.271.6.448; Liste MB, 2000, J CLIN MICROBIOL, V38, P2873, DOI 10.1128/JCM.38.8.2873-2877.2000; McNeal MM, 1997, J VIROL, V71, P8735, DOI 10.1128/JVI.71.11.8735-8742.1997; Miller MA, 2000, HEALTH ECON, V9, P19, DOI 10.1002/(SICI)1099-1050(200001)9:1<19::AID-HEC487>3.0.CO;2-C; MIOTTI PG, 1992, J INFECT DIS, V165, P1116, DOI 10.1093/infdis/165.6.1116; Molbak K, 2000, VACCINE, V19, P393, DOI 10.1016/S0264-410X(00)00199-7; MONROE SS, 1993, J CLIN MICROBIOL, V31, P2866, DOI 10.1128/JCM.31.11.2866-2872.1993; OSHITANI H, 1994, J INFECT DIS, V169, P897, DOI 10.1093/infdis/169.4.897; PAVIA AT, 1992, PEDIATR INFECT DIS J, V11, P996, DOI 10.1097/00006454-199211120-00002; PerezSchael I, 1997, NEW ENGL J MED, V337, P1181, DOI 10.1056/NEJM199710233371701; Richardson S, 1998, LANCET, V351, P1844, DOI 10.1016/S0140-6736(97)11257-0; RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046; SAULSBURY FT, 1980, J PEDIATR-US, V97, P61, DOI 10.1016/S0022-3476(80)80131-4; Taha T E, 2000, Pediatrics, V106, pE77, DOI 10.1542/peds.106.6.e77; THEA DM, 1993, NEW ENGL J MED, V329, P1696, DOI 10.1056/NEJM199312023292304	33	56	58	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2001	358	9281					550	555		10.1016/S0140-6736(01)05706-3	http://dx.doi.org/10.1016/S0140-6736(01)05706-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464NB	11520526				2022-12-01	WOS:000170537700013
J	Amador, V; Monte, E; Garcia-Martinez, JL; Prat, S				Amador, V; Monte, E; Garcia-Martinez, JL; Prat, S			Gibberellins signal nuclear import of PHOR1, a photoperiod-responsive protein with homology to Drosophila armadillo	CELL			English	Article							BETA-CATENIN; GENETIC-ANALYSIS; SOLANUM-TUBEROSUM; REPEAT PROTEIN; PHYTOCHROME-B; TRANSDUCTION; ARABIDOPSIS; EXPRESSION; POTATO; PLANTS	S. tuberosum ssp. andigena potato plants require short days (SD) for tuberization. We have isolated PHOR1 (photoperiod-responsive 1), which shows upregulated expression in induced leaves (SD). PHOR1 encodes an arm repeat protein with homology to the Drosophila segment polarity protein armadillo. Antisense inhibition of PHOR1 produces a semidwarf phenotype similar to that of GA-deficient plants, and the antisense lines show reduced GA responsiveness combined with a higher endogenous GA content than wild-type plants. Feedback regulation of GA biosynthetic genes is also altered in these lines. Conversely, transgenic lines overexpressing PHOR1 show an enhanced response to GA. GA application induces rapid migration of PHOR1-GFP protein to the nucleus. Thus, PHOR1 appears to be a general component of GA signaling pathways that relocalizes to the nucleus in the presence of GA.	CSIC, Inst Biol Mol Barcelona, Dept Mol Genet, ES-08034 Barcelona, Spain; Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia 46022, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institute of Molecular & Cellular Biology of Plants (IBMCP); Universitat Politecnica de Valencia	Prat, S (corresponding author), CSIC, Inst Biol Mol Barcelona, Dept Mol Genet, Jordi Girona 18-26, ES-08034 Barcelona, Spain.		Elena, Monte/I-7221-2015; Prat, Salome/L-9240-2014	Prat, Salome/0000-0003-2684-5485; Monte, Elena/0000-0002-7340-9355				AMASINO RM, 1986, ANAL BIOCHEM, V152, P304, DOI 10.1016/0003-2697(86)90413-6; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bethke PC, 1998, CURR OPIN PLANT BIOL, V1, P440, DOI 10.1016/S1369-5266(98)80270-7; Carrera E, 2000, PLANT J, V22, P247, DOI 10.1046/j.1365-313x.2000.00736.x; Cooley MB, 1999, PLANT PHYSIOL, V121, P1339, DOI 10.1104/pp.121.4.1339; Dale TC, 1998, BIOCHEM J, V329, P209; Ewing E. E., 1992, Horticultural Reviews, V14, P89; Ewing Elmer E., 1995, P698; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; FUJIOKA S, 1988, P NATL ACAD SCI USA, V85, P9031, DOI 10.1073/pnas.85.23.9031; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; Gu TS, 1998, P NATL ACAD SCI USA, V95, P382, DOI 10.1073/pnas.95.1.382; Gu XJ, 1997, PLANT CELL, V9, P157, DOI 10.1105/tpc.9.2.157; Hedden P, 2000, CURR OPIN BIOTECH, V11, P130, DOI 10.1016/S0958-1669(00)00071-9; Hedden P, 1999, PLANT PHYSIOL, V119, P365, DOI 10.1104/pp.119.2.365; HOFGEN R, 1990, PLANT SCI, V66, P221, DOI 10.1016/0168-9452(90)90207-5; HOOLEY R, 1994, PLANT MOL BIOL, V26, P1529, DOI 10.1007/BF00016489; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Jackson SD, 1996, PHYSIOL PLANTARUM, V98, P407, DOI 10.1034/j.1399-3054.1996.980224.x; Jackson SD, 1996, PLANT J, V9, P159, DOI 10.1046/j.1365-313X.1996.09020159.x; Jacobsen SE, 1996, P NATL ACAD SCI USA, V93, P9292, DOI 10.1073/pnas.93.17.9292; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kost B, 1998, PLANT J, V16, P393, DOI 10.1046/j.1365-313x.1998.00304.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lange T, 1998, PLANTA, V204, P409, DOI 10.1007/s004250050274; Lovegrove A, 2000, TRENDS PLANT SCI, V5, P102, DOI 10.1016/S1360-1385(00)01571-5; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Monte E, 1999, PLANT J, V19, P399, DOI 10.1046/j.1365-313X.1999.00537.x; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Pukatzki S, 1998, J BIOL CHEM, V273, P24131, DOI 10.1074/jbc.273.37.24131; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Reichel C, 1996, P NATL ACAD SCI USA, V93, P5888, DOI 10.1073/pnas.93.12.5888; Shi LF, 1998, PLANT MOL BIOL, V38, P1053, DOI 10.1023/A:1006007315718; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; Smith HMS, 1999, PLANT PHYSIOL, V119, P1157, DOI 10.1104/pp.119.4.1157; Sun TP, 2000, CURR OPIN PLANT BIOL, V3, P374, DOI 10.1016/S1369-5266(00)00099-6; Swain SM, 1996, PLANT PHYSIOL, V112, P11, DOI 10.1104/pp.112.1.11; TALON M, 1990, PLANTA, V182, P501, DOI 10.1007/BF02341024; Thomas SG, 1999, P NATL ACAD SCI USA, V96, P4698, DOI 10.1073/pnas.96.8.4698; Thornton TM, 1999, TRENDS PLANT SCI, V4, P424, DOI 10.1016/S1360-1385(99)01485-5; VANDENBERG JH, 1995, J PLANT PHYSIOL, V146, P467, DOI 10.1016/S0176-1617(11)82010-9; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3	44	137	161	0	31	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 10	2001	106	3					343	354		10.1016/S0092-8674(01)00445-7	http://dx.doi.org/10.1016/S0092-8674(01)00445-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509183	Bronze			2022-12-01	WOS:000170433300012
J	SHEEHAN, PM; FASTOVSKY, DE; HOFFMANN, RG; BERGHAUS, CB; GABRIEL, DL				SHEEHAN, PM; FASTOVSKY, DE; HOFFMANN, RG; BERGHAUS, CB; GABRIEL, DL			SUDDEN EXTINCTION OF THE DINOSAURS - LATEST CRETACEOUS, UPPER GREAT-PLAINS, USA	SCIENCE			English	Article							TERTIARY BOUNDARY; MASS EXTINCTIONS	Results of a three-year field study of family-level patterns of ecological diversity of dinosaurs in the Hell Creek Formation of Montana and North Dakota show no evidence (probability P < 0.05) of a gradual decline of dinosaurs at the end of the Cretaceous. Stratigraphic reliability was maintained through a tripartite division of the Hell Creek, and preservational biases were corrected for by comparison of results only from similar facies as well as through the use of large-scale, statistically rigorous survey and collection procedures. The findings are in agreement with an abrupt extinction event such as one caused by an asteroid impact.	UNIV RHODE ISL, DEPT GEOL, KINGSTON, RI 02881 USA; MED COLL WISCONSIN, DIV BIOSTAT, MILWAUKEE, WI 53226 USA	University of Rhode Island; Medical College of Wisconsin	SHEEHAN, PM (corresponding author), MILWAUKEE PUBL MUSEUM, DEPT GEOL, MILWAUKEE, WI 53233 USA.							ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; ALVAREZ LW, 1987, PHYS TODAY, V40, P24, DOI 10.1063/1.881078; ALVAREZ LW, 1983, P NATL ACAD SCI USA, V80, P627, DOI 10.1073/pnas.80.2.627; Alvarez W., 1986, EOS, V67, P649, DOI [10.1029/EO067I035P00649, DOI 10.1029/EO067I035P00649]; ARCHIBALD JD, 1982, AM SCI, V70, P377; ARCHIBALD JD, 1987, MEM SOC GEOL FR, V150, P45; Behrensmeyer A.K., 1980, P72; BOHOR BF, 1984, SCIENCE, V224, P867, DOI 10.1126/science.224.4651.867; BOHOR BF, 1987, GEOLOGY, V15, P896, DOI 10.1130/0091-7613(1987)15<896:DSATML>2.0.CO;2; CARPENTER K, 1983, NATURWISSENSCHAFTEN, V70, P611, DOI 10.1007/BF00377404; Clemens W.A., 1986, P63; CLEMENS WA, 1981, PALEOBIOLOGY, V7, P293, DOI 10.1017/S0094837300004589; CLEMENS WA, 1980, MEM SOC GEOL FR, V139, P67; CLEMENS WA, 1982, GEOL SOC AM SPEC PAP, V190, P407; Cody M. L., 1975, ECOLOGY EVOLUTION CO; FASTOVSKY D E, 1987, Palaios, V2, P282, DOI 10.2307/3514678; FASTOVSKY DE, 1986, GEOLOGY, V14, P279, DOI 10.1130/0091-7613(1986)14<279:SSAEDT>2.0.CO;2; Fastovsky DE, 1990, GEOLOGICAL SOC AM SP, V247, P541, DOI [10.1130/SPE247-p541, DOI 10.1130/SPE247-P541]; GABRIEL DL, 1980, LORE, V30, P24; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; HERBERT TD, 1990, EARTH PLANET SC LETT, V99, P263, DOI 10.1016/0012-821X(90)90115-E; Hutchinson G.E., 1978, INTRO POPULATION ECO; JOHNSON KR, 1987, GEOL SOC AM ABSTR, V19, P718; JOHNSON KR, 1990, GEOL SOC AM ABSTR, V22, pA323; Kraus M.J., 1986, PALEOSOLS THEIR RECO, P180; MacArthur R.H., 1972, pvii; May R.M., 1975, P81; MORRIS PJ, 1990, GEOL SOC AM SPEC PAP, V247, P433; OFFICER CB, 1987, NATURE, V326, P143, DOI 10.1038/326143a0; OFFICER CB, 1990, J GEOL EDUC, V38, P402; Padian K., 1985, P41; PADIAN K, 1989, AGE DINOSAURS SHORT, V2; PIELOU E C, 1969, P286; RAUP D M, 1975, Paleobiology, V1, P333; RAUP DM, 1979, SCIENCE, V206, P217, DOI 10.1126/science.206.4415.217; RETALLACK G, 1986, SCIENCE, V234, P1170, DOI 10.1126/science.234.4781.1170; RUSSELL DA, 1984, NATURE, V307, P360, DOI 10.1038/307360a0; RUSSELL DA, 1982, SCI AM, V246, P58, DOI 10.1038/scientificamerican0182-58; RUSSELL LORE S., 1965, J PALEONTOL, V39, P497; RUSSELL LS, 1973, CAN J EARTH SCI, V10, P140, DOI 10.1139/e73-016; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; SCHOPF TJM, 1982, GEOL SOC AM SPEC PAP, V190, P415; SERENO PC, 1986, NATL GEOGR RES, V2, P234; SHEEHAN PM, 1986, SCIENCE, V234, P1171, DOI 10.1126/science.234.4781.1171; Simberloff D., 1978, BIOL DATA WATER POLL, P150; SLOAN RE, 1986, SCIENCE, V232, P629, DOI 10.1126/science.232.4750.629; SLOAN RE, 1976, ATHLON ESSAYS PALAEO, P134; SLOAN RE, 1987, GEOL SOC AM ABSTR, V19, P848; SMIT J, 1984, SCIENCE, V223, P1177, DOI 10.1126/science.223.4641.1177; Smit J., 1987, MEM SOC GEOL FR, V150, P53; SMITH AB, 1988, EVOL BIOL, V23, P127; Strong D.R., 1984, ECOLOGICAL COMMUNITI; TAMM V, 1991, GEOL ASS CAN ABSTR, V16, pA122; TSCHUDY RH, 1984, SCIENCE, V225, P1030, DOI 10.1126/science.225.4666.1030; van Valen L, 1977, Evolutionary Theory, V2, P37; VANVALEN L, 1977, NATURE, V270, P193, DOI 10.1038/270193a0; WARD PD, 1990, GEOL SOC AM ABSTR, V22, pA356; Weishampel D.B., 1990, DINOSAURIA; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WOLFE JA, 1986, NATURE, V324, P148, DOI 10.1038/324148a0; ZACHOS JC, 1989, NATURE, V337, P61, DOI 10.1038/337061a0; ZALEHA MJ, 1987, SEPM ANN MIDYEAR M, V4, P94	62	93	98	0	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	1991	254	5033					835	839		10.1126/science.11536489	http://dx.doi.org/10.1126/science.11536489			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN833	11536489				2022-12-01	WOS:A1991GN83300038
J	ZAHNLE, K; GRINSPOON, D				ZAHNLE, K; GRINSPOON, D			COMET DUST AS A SOURCE OF AMINO-ACIDS AT THE CRETACEOUS TERTIARY BOUNDARY	NATURE			English	Article											ZAHNLE, K (corresponding author), NASA,AMES RES CTR,MS 245-3,MOFFETT FIELD,CA 94035, USA.							ANDERS E, 1989, NATURE, V342, P255, DOI 10.1038/342255a0; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; BROMLEY R, 1979, CRETACEOUS TERTIARY, P16; BURNS JA, 1979, ICARUS, V40, P1, DOI 10.1016/0019-1035(79)90050-2; CLUBE SVM, 1986, GALAXY SOLAR SYSTEM, P260; Cronin J R, 1983, Adv Space Res, V3, P5, DOI 10.1016/0273-1177(83)90036-4; CRONIN JR, 1989, NATURE, V339, P423, DOI 10.1038/339423a0; DONNISON JR, 1986, ASTRON ASTROPHYS, V167, P359; GILMOUR I, 1989, GEOCHIM COSMOCHIM AC, V53, P503, DOI 10.1016/0016-7037(89)90401-8; HEISLER J, 1987, ICARUS, V70, P269, DOI 10.1016/0019-1035(87)90135-7; Hills J. G., 1986, GALAXY SOLAR SYSTEM, P397; HUGHES DW, 1987, ASTRON ASTROPHYS, V187, P879; HUT P, 1987, NATURE, V329, P118, DOI 10.1038/329118a0; Jessberger E. K., 1989, ORIGIN EVOLUTION PLA, P167; KASTNER M, 1984, SCIENCE, V226, P137, DOI 10.1126/science.226.4671.137; OBERBECK V, 1988, ORIG LIFE, V19, P39; OLSSONSTEEL D, 1987, MON NOT R ASTRON SOC, V227, P501, DOI 10.1093/mnras/227.2.501; OLSSONSTEEL D, 1988, ICARUS, V75, P64, DOI 10.1016/0019-1035(88)90127-3; PREISINGER A, 1986, NATURE, V322, P794, DOI 10.1038/322794a0; SEKANINA Z, 1984, ICARUS, V58, P81, DOI 10.1016/0019-1035(84)90099-X; STOHL J, 1987, ASTRON ASTROPHYS, V187, P933; SURLYK F, 1979, CRETACEOUS TERTIARY, P164; VICKERY A, IN PRESS GLOBAL CATA; WHIPPLE F, 1976, MEM SOC R LIEGE 6, V55, P101; WHIPPLE FL, 1951, ASTROPHYS J, V113, P464, DOI 10.1086/145416; WOLBACH WS, 1985, SCIENCE, V230, P167, DOI 10.1126/science.230.4722.167; ZAHNLE K, 1989, B AM ASTRON SOC, V21, P923; ZHAO MX, 1989, NATURE, V339, P463, DOI 10.1038/339463a0	28	60	61	0	3	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 8	1990	348	6297					157	160		10.1038/348157a0	http://dx.doi.org/10.1038/348157a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG776	11536472				2022-12-01	WOS:A1990EG77600054
J	Ferguson, NM; Donnelly, CA; Anderson, RM				Ferguson, NM; Donnelly, CA; Anderson, RM			Transmission intensity and impact of control policies on the foot and mouth epidemic in Great Britain	NATURE			English	Article							DISEASE; SPREAD	The foot and mouth disease (FMD) epidemic in British livestock remains an ongoing cause for concern, with new cases still arising in previously unaffected areas. Epidemiological analyses(1-3) have been vital in delivering scientific advice to government on effective control measures. Using disease, culling and census data on all livestock farms in Great Britain, we analysed the risk factors determining the spatiotemporal evolution of the epidemic and of the impact of control policies on FMD incidence. Here we show that the species mix, animal numbers and the number of distinct land parcels in a farm are central to explaining regional variation in transmission intensity. We use the parameter estimates thus obtained in a dynamical model of disease spread to show that extended culling programmes were essential for controlling the epidemic to the extent achieved, but demonstrate that the epidemic could have been substantially reduced in scale had the most efficient control measures been rigorously applied earlier.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, London W2 1PG, England	Imperial College London	Ferguson, NM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, St Mary Campus,Norfolk Pl, London W2 1PG, England.	neil.ferguson@ic.ac.uk	Ferguson, Neil/B-8578-2008	Ferguson, Neil/0000-0002-1154-8093; Donnelly, Christl/0000-0002-0195-2463; Anderson, Roy/0000-0002-9528-3175				ANDERSON R M, 1991; [Anonymous], 2001, NATURE, V411, P977; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Donaldson AI, 2001, VET REC, V148, P602, DOI 10.1136/vr.148.19.602; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; HIGHFIELD R, 2001, TELEGRAPH       0702; HMSO (Her Majesty's Stationery Office), 1968, NORTHUMBERLAND REPOR; Kao RR, 2001, VET REC, V148, P746, DOI 10.1136/vr.148.24.746; MCCOLL KA, 1995, AUST VET J, V72, P286, DOI 10.1111/j.1751-0813.1995.tb03556.x; *UK MIN AGR FISH F, 2001, JUN 2000 AGR HORT CE; Woolhouse M, 2001, NATURE, V411, P258, DOI 10.1038/35077149; 2001, VET REC, V148, P550; 2001, GUARDIAN UNLIMI 0320	13	319	322	3	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2001	413	6855					542	548		10.1038/35097116	http://dx.doi.org/10.1038/35097116			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586365				2022-12-01	WOS:000171340500052
J	Thompson, PM; Ollason, JC				Thompson, PM; Ollason, JC			Lagged effects of ocean climate change on fulmar population dynamics	NATURE			English	Article							NORTH-ATLANTIC; CONSEQUENCES; VARIABILITY; GLACIALIS; FISHERIES; SURVIVAL; ORKNEY; TRENDS	Environmental variation reflected by the North Atlantic Oscillation affects breeding and survival in terrestrial vertebrates(1,2), and climate change is predicted to have an impact on population dynamics by influencing food quality or availability(3). The North Atlantic Oscillation also affects the abundance of marine fish and zooplankton(4,5), but it is unclear whether this filters up trophic levels to long-lived marine top predators. Here we show by analysis of data from a 50-year study of the fulmar that two different indices of ocean climate variation may have lagged effects on population dynamics in this procellariiform seabird.	Univ Aberdeen, Dept Zool, Lighthouse Field Stn, Cromarty IV11 8YJ, Ross Shire, Scotland; Univ Aberdeen, Dept Zool, Culterty Field Stn, Ellon AB41 6AA, Aberdeen, Scotland	University of Aberdeen; University of Aberdeen	Thompson, PM (corresponding author), Univ Aberdeen, Dept Zool, Lighthouse Field Stn, Cromarty IV11 8YJ, Ross Shire, Scotland.		Thompson, Paul M/B-6742-2009; Thompson, Paul Michael/AGR-6267-2022	Thompson, Paul M/0000-0001-6195-3284; Thompson, Paul Michael/0000-0001-6195-3284				Bradley JS, 2000, J ANIM ECOL, V69, P639, DOI 10.1046/j.1365-2656.2000.00422.x; Briffa KR, 1998, NATURE, V393, P450, DOI 10.1038/30943; BROWN RGB, 1970, IBIS, V112, P44, DOI 10.1111/j.1474-919X.1970.tb00074.x; COOPER CF, 1983, SCIENCE, V219, P969, DOI 10.1126/science.219.4587.969; DUNNET GM, 1991, IBIS, V133, P24, DOI 10.1111/j.1474-919X.1991.tb07665.x; DUNNET GM, 1979, IBIS, V121, P293, DOI 10.1111/j.1474-919X.1979.tb06846.x; DUNNET GM, 1961, BIRD STUDY, V8, P119; FISHER J, 1952, FULMAR; Furness RW, 1996, ECOLOGY, V77, P1181, DOI 10.2307/2265587; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Kitaysky AS, 2000, J ANIM ECOL, V69, P248, DOI 10.1046/j.1365-2656.2000.00392.x; Lloyd C, 1991, STATUS SEABIRDS BRIT; Milner JM, 1999, J ANIM ECOL, V68, P1235, DOI 10.1046/j.1365-2656.1999.00366.x; Mougin JL, 1997, IBIS, V139, P40, DOI 10.1111/j.1474-919X.1997.tb04502.x; O'Brien CM, 2000, NATURE, V404, P142, DOI 10.1038/35004654; Ollason J.C., 1988, P263; OLLASON JC, 1980, J FIELD ORNITHOL, V51, P39; Phillips RA, 1999, MAR BIOL, V135, P159, DOI 10.1007/s002270050613; Planque B, 1998, ICES J MAR SCI, V55, P644, DOI 10.1006/jmsc.1998.0390; Pomeroy PP, 2000, J ZOOL, V250, P1; Post E, 1999, NATURE, V401, P905, DOI 10.1038/44814; Post E, 1999, ECOLOGY, V80, P1322, DOI 10.1890/0012-9658(1999)080[1322:CVPPAN]2.0.CO;2; Saether BE, 2000, SCIENCE, V287, P854, DOI 10.1126/science.287.5454.854; SALOMONS.F, 1965, AUK, V82, P327, DOI 10.2307/4083117; Wilby RL, 1997, WEATHER, V52, P266, DOI [10.1002/j.1477-8696.1997.tb06323.x, DOI 10.1002/J.1477-8696.1997.TB06323.X]; Wynne-Edwards V. C., 1962, pUnpaginated	27	188	191	0	83	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2001	413	6854					417	420		10.1038/35096558	http://dx.doi.org/10.1038/35096558			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475UY	11574887				2022-12-01	WOS:000171188700053
J	Vulliamy, T; Marrone, A; Goldman, F; Dearlove, A; Bessler, M; Mason, PJ; Dokal, I				Vulliamy, T; Marrone, A; Goldman, F; Dearlove, A; Bessler, M; Mason, PJ; Dokal, I			The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita	NATURE			English	Article							MICE; CELLS	Dyskeratosis congenita is a progressive bone-marrow failure syndrome that is characterized by abnormal skin pigmentation, leukoplakia and nail dystrophy(1,2). X-linked, autosomal recessive and autosomal dominant inheritance have been found in different pedigrees. The X-linked form of the disease is due to mutations in the gene DKC1 in band 2, sub-band 8 of the long arm of the X chromosome (ref. 3). The affected protein, dyskerin, is a nucleolar protein that is found associated with the H/ACA class of small nucleolar RNAs and is involved in pseudo-uridylation of specific residues of ribosomal RNA(4). Dyskerin is also associated with telomerase RNA (hTR)(5), which contains a H/ACA consensus sequence(6,7). Here we map the gene responsible for dyskeratosis congenita in a large pedigree with autosomal dominant inheritance. Affected members of this family have an 821-base-pair deletion on chromosome 3q that removes the 3' 74 bases of hTR. Mutations in hTR were found in two other families with autosomal dominant dyskeratosis congenita.	Hammersmith Hosp, Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Haematol,Div Invest Sci, London W12 0NN, England; Univ Iowa Hosp & Clin, Dept Pediat, Iowa City, IA 52242 USA; MRC UK, HGMP Resource Ctr, Cambridge CB10 1SB, England; Washington Univ, Sch Med, Div Hematol, St Louis, MO 63110 USA	Imperial College London; University of Iowa; Washington University (WUSTL)	Mason, PJ (corresponding author), Hammersmith Hosp, Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Haematol,Div Invest Sci, Ducane Rd, London W12 0NN, England.		Mason, Philip J/B-1087-2008	Dokal, Inderjeet/0000-0003-4462-4782				Alter BP, 2000, J PEDIATR-US, V136, P275, DOI 10.1067/mpd.2000.104285; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Artandi SE, 2000, CURR OPIN GENET DEV, V10, P39, DOI 10.1016/S0959-437X(99)00047-7; Bachand F, 2001, MOL CELL BIOL, V21, P1888, DOI 10.1128/MCB.21.5.1888-1897.2001; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; BROWN WRA, 1990, CELL, V63, P119, DOI 10.1016/0092-8674(90)90293-N; Chen JL, 2000, CELL, V100, P503, DOI 10.1016/S0092-8674(00)80687-X; Collins K, 2000, CURR OPIN CELL BIOL, V12, P378, DOI 10.1016/S0955-0674(00)00103-4; Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x; DRACHTMAN RA, 1992, AM J PEDIAT HEMATOL, V14, P297; Dragon F, 2000, MOL CELL BIOL, V20, P3037, DOI 10.1128/MCB.20.9.3037-3048.2000; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Hemann MT, 2000, NUCLEIC ACIDS RES, V28, P4474, DOI 10.1093/nar/28.22.4474; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Marciniak RA, 2000, TRENDS GENET, V16, P193, DOI 10.1016/S0168-9525(00)01984-3; Martin-Rivera L, 2001, J BIOL CHEM, V276, P5856, DOI 10.1074/jbc.M008419200; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Notaro R, 1997, P NATL ACAD SCI USA, V94, P13782, DOI 10.1073/pnas.94.25.13782; Pogacic V, 2000, MOL CELL BIOL, V20, P9028, DOI 10.1128/MCB.20.23.9028-9040.2000; Prescott JC, 1999, CURR OPIN GENET DEV, V9, P368, DOI 10.1016/S0959-437X(99)80055-0; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Sambrook J., 1989, MOL CLONING LAB MANU; Tollervey D, 1997, CURR OPIN CELL BIOL, V9, P337, DOI 10.1016/S0955-0674(97)80005-1; Vulliamy TJ, 2001, BLOOD CELL MOL DIS, V27, P353, DOI 10.1006/bcmd.2001.0389; Vulliamy TJ, 1997, BLOOD, V90, P2213	29	705	734	1	31	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2001	413	6854					432	435		10.1038/35096585	http://dx.doi.org/10.1038/35096585			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475UY	11574891				2022-12-01	WOS:000171188700057
J	Peterson, EJ; Woods, ML; Dmowski, SA; Derimanov, G; Jordan, MS; Wu, JN; Myung, PS; Liu, QH; Pribila, JT; Freedman, BD; Shimizu, Y; Koretzky, GA				Peterson, EJ; Woods, ML; Dmowski, SA; Derimanov, G; Jordan, MS; Wu, JN; Myung, PS; Liu, QH; Pribila, JT; Freedman, BD; Shimizu, Y; Koretzky, GA			Coupling of the TCR to integrin activation by SLAP-130/Fyb	SCIENCE			English	Article							T-CELL RECEPTOR; ADAPTER PROTEIN SLP-76; LYMPHOCYTE MIGRATION; TYROSINE KINASES; ADHESION; MICE; LFA-1; SUBSTRATE; CLONING; ZAP-70	SLAP-130/Fyb (SLP-76-associated phosphoprotein or Fyn-binding protein; also known as Fyb/Slap) is a hematopoietic-specific adapter, which associates with and modulates function of SH2-containing leukocyte phosphoprotein of 76 kilodaltons (SLP-76). T cells from mice lacking SLAP-130/Fyb show markedly impaired proliferation following CD3 engagement. In addition, the T cell receptor (TCR) in SLAP-130/Fyb mutant cells fails to enhance integrin-dependent adhesion. Although TCR-induced actin polymerization is normal, TCR-stimulated clustering of the integrin LFA-1 is defective in SLAP-130/Fyb-deficient cells. These data indicate that SLAP-130/Fyb is important for coupling TCR-mediated actin cytoskeletal rearrangement with activation of integrin function, and for T cells to respond fully to activating signals.	Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; Univ Minnesota, Sch Med, Ctr Canc, Ctr Immunol,Dept Pathol & Lab Med, Minneapolis, MN 55455 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Minnesota System; University of Minnesota Twin Cities	Koretzky, GA (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	koretzky@mail.med.upenn.edu	Koretzky, Gary/AAU-5381-2021; Peterson, Erik/M-9365-2013	Shimizu, Yoji/0000-0001-9760-0288	NIAID NIH HHS [R01 AI060921] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060921] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Berlin-Rufenach C, 1999, J EXP MED, V189, P1467, DOI 10.1084/jem.189.9.1467; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; DaSilva AJ, 1997, P NATL ACAD SCI USA, V94, P7493, DOI 10.1073/pnas.94.14.7493; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Epler JA, 2000, J IMMUNOL, V165, P4941, DOI 10.4049/jimmunol.165.9.4941; Freedman BD, 1999, J EXP MED, V190, P943, DOI 10.1084/jem.190.7.943; GENG L, IN PRESS NATL ACAD S; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hunter AJ, 2000, J IMMUNOL, V164, P1143, DOI 10.4049/jimmunol.164.3.1143; Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Musci MA, 1997, J BIOL CHEM, V272, P11674, DOI 10.1074/jbc.272.18.11674; PETERSON ET, UNPUB; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Reichert P, 2001, J IMMUNOL, V166, P4278, DOI 10.4049/jimmunol.166.7.4278; Samelson LE, 1999, PROG BIOPHYS MOL BIO, V71, P393, DOI 10.1016/S0079-6107(98)00050-9; Scharffetter-Kochanek K, 1998, J EXP MED, V188, P119, DOI 10.1084/jem.188.1.119; Schmits R, 1996, J EXP MED, V183, P1415, DOI 10.1084/jem.183.4.1415; Stewart MP, 1996, J IMMUNOL, V156, P1810; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; VAN SG, 1990, J IMMUNOL, V144, P4579; VANKOOYK Y, 1994, J CELL BIOL, V124, P1061, DOI 10.1083/jcb.124.6.1061; VANKOOYK Y, 1989, NATURE, V342, P811, DOI 10.1038/342811a0; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; Zell T, 1999, IMMUNOL RES, V20, P127; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	28	259	273	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2001	293	5538					2263	2265		10.1126/science.1063486	http://dx.doi.org/10.1126/science.1063486			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11567141				2022-12-01	WOS:000171139400046
J	Harden, PN; Reece, SM; Fryer, AA; Smith, AG; Ramsay, HM				Harden, PN; Reece, SM; Fryer, AA; Smith, AG; Ramsay, HM			Skin cancer surveillance in renal transplant recipients: questionnaire survey of current UK practice	BRITISH MEDICAL JOURNAL			English	Article									N Staffordshire Hosp, Dept Nephrol, Stoke On Trent ST4 7LN, Staffs, England; N Staffordshire Hosp, Dept Biochem, Stoke On Trent ST4 7LN, Staffs, England; N Staffordshire Hosp, Dept Dermatol, Stoke On Trent ST4 7LN, Staffs, England	Keele University; University Hospital of North Staffordshire NHS Trust; Keele University; University Hospital of North Staffordshire NHS Trust; Keele University; University Hospital of North Staffordshire NHS Trust	Harden, PN (corresponding author), N Staffordshire Hosp, Dept Nephrol, Stoke On Trent ST4 7LN, Staffs, England.			Fryer, Anthony/0000-0001-8678-0404				Harden PN, 2001, TRANSPLANT P, V33, P1302, DOI 10.1016/S0041-1345(00)02486-6; Kasiske BL, 2000, J AM SOC NEPHROL, V11, pS1; Ramsay HM, 2000, AM J KIDNEY DIS, V36, P167, DOI 10.1053/ajkd.2000.8290; Seukeran DC, 1998, BRIT J DERMATOL, V138, P301; SLADE J, 1995, J AM ACAD DERMATOL, V32, P479, DOI 10.1016/0190-9622(95)90073-X	5	17	18	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 15	2001	323	7313					600	601		10.1136/bmj.323.7313.600	http://dx.doi.org/10.1136/bmj.323.7313.600			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474CT	11557706	Green Published, Bronze			2022-12-01	WOS:000171087300017
J	Abbott, A				Abbott, A			WHO plans study of Gulf War fallout	NATURE			English	News Item																			0	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					97	97		10.1038/35093231	http://dx.doi.org/10.1038/35093231			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557937	Bronze			2022-12-01	WOS:000170918800008
J	Diefenbach, A; Jensen, ER; Jamieson, AM; Raulet, DH				Diefenbach, A; Jensen, ER; Jamieson, AM; Raulet, DH			Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity	NATURE			English	Article							NATURAL-KILLER-CELLS; NK CELLS; T-CELLS; DEFICIENT MICE; COMMON ORIGIN; MURINE NKG2D; ACTIVATION; SURVEILLANCE; EXPRESSION; FAMILY	Natural killer (NK) cells attack many tumour cell lines, and are thought to have a critical role in anti-tumour immunity(1-7); however, the interaction between NK cells and tumour targets is poorly understood. The stimulatory lectin-like NKG2D receptor(8-13) is expressed by NK cells, activated CD8(+) T cells and by activated macrophages in mice(11). Several distinct cell-surface ligands that are related to class I major histocompatibility complex molecules have been identified(11-14), some of which are expressed at high levels by tumour cells but not by normal cells in adults(11,13,15,16). However, no direct evidence links the expression of these 'induced self' ligands with tumour cell rejection. Here we demonstrate that ectopic expression of the murine NKG2D ligands Rae1 beta or H60 in several tumour cell lines results in potent rejection of the tumour cells by syngeneic mice. Rejection is mediated by NK cells and/or CD8(+) T cells. The ligand-expressing tumour cells induce potent priming of cytotoxic T cells and sensitization of NK cells in vivo. Mice that are exposed to live or irradiated tumour cells expressing Rae1 beta or H60 are specifically immune to subsequent challenge with tumour cells that lack NKG2D ligands, suggesting application of the ligands in the design of tumour vaccines.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Raulet, DH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 485 Life Sci Addit, Berkeley, CA 94720 USA.	raulet@uclink4.berkeley.edu	Diefenbach, Andreas/T-2589-2018; Jamieson, Amanda/U-7169-2019	Diefenbach, Andreas/0000-0002-9176-9530; Jamieson, Amanda/0000-0002-5781-9231; Raulet, David/0000-0002-1257-8649	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039642] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI039642] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(09)00098-3; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Gays F, 2000, J IMMUNOL, V164, P5094, DOI 10.4049/jimmunol.164.10.5094; Glas R, 2000, J EXP MED, V191, P129, DOI 10.1084/jem.191.1.129; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Grufman P, 2000, EUR J IMMUNOL, V30, P1088, DOI 10.1002/(SICI)1521-4141(200004)30:4<1088::AID-IMMU1088>3.0.CO;2-O; HART IR, 1979, AM J PATHOL, V97, P587; Ho EL, 1998, P NATL ACAD SCI USA, V95, P6320, DOI 10.1073/pnas.95.11.6320; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Nomura M, 1996, J BIOCHEM-TOKYO, V120, P987; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; SEAMAN WE, 1987, J IMMUNOL, V138, P4539; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; van Hall T, 2000, J IMMUNOL, V165, P869, DOI 10.4049/jimmunol.165.2.869; Vance RE, 1997, EUR J IMMUNOL, V27, P3236, DOI 10.1002/eji.1830271222; vandenBroek MF, 1996, J EXP MED, V184, P1781, DOI 10.1084/jem.184.5.1781; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730	30	786	831	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2001	413	6852					165	171		10.1038/35093109	http://dx.doi.org/10.1038/35093109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557981	Green Accepted			2022-12-01	WOS:000170918800047
J	Greco, V; Hannus, M; Eaton, S				Greco, V; Hannus, M; Eaton, S			Argosomes: A potential vehicle for the spread of morphogens through epithelia	CELL			English	Article							GRADIENT FORMATION; TRANSMEMBRANE LIGAND; LYMPHOCYTES-T; CELL-SURFACE; DROSOPHILA; HEDGEHOG; PROTEIN; NOTCH; GLYCOSAMINOGLYCANS; ENDOCYTOSIS	The formation of morphogen gradients is essential for tissue patterning. Morphogens are released from producing cells and spread through adjacent tissue; paradoxically, however, many morphogens, including Wingless, associate tightly with the cell membrane. Here, we describe a novel cell biological mechanism that disperses membrane fragments over large distances through the Drosophila imaginal disc epithelium. We call these membrane exovesicles argosomes. Argosomes are derived from basolateral membranes and are produced by many different regions of the disc. They travel through adjacent tissue where they are found predominantly in endosomes. Wingless protein colocalizes with argosomes derived from Wingless-producing cells. The properties of argosomes are consistent with their being a vehicle for the spread of Wingless protein.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Eaton, S (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr-108, D-01307 Dresden, Germany.		Eaton, Suzanne/D-7698-2017	Eaton, Suzanne/0000-0002-8319-284X	NIAMS NIH HHS [R01 AR063663] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063663] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Baeg GH, 2001, DEVELOPMENT, V128, P87; BELLAICHE Y, 1998, IN PRESS NATURE; Binari RC, 1997, DEVELOPMENT, V124, P2623; BRADLEY RS, 1990, EMBO J, V9, P1569, DOI 10.1002/j.1460-2075.1990.tb08276.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; CAGAN RL, 1992, CELL, V69, P393, DOI 10.1016/0092-8674(92)90442-F; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Christian JL, 2000, CURR OPIN CELL BIOL, V12, P244, DOI 10.1016/S0955-0674(99)00082-4; Denzer K, 2000, J IMMUNOL, V165, P1259, DOI 10.4049/jimmunol.165.3.1259; Denzer K, 2000, J CELL SCI, V113, P3365; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Klueg KM, 1999, J CELL SCI, V112, P3289; Klueg KM, 1998, MOL BIOL CELL, V9, P1709, DOI 10.1091/mbc.9.7.1709; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Lin XH, 2000, MATRIX BIOL, V19, P303, DOI 10.1016/S0945-053X(00)00073-1; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Neumann C, 1997, BIOESSAYS, V19, P721, DOI 10.1002/bies.950190813; PAPKOFF J, 1990, MOL CELL BIOL, V10, P2723, DOI 10.1128/MCB.10.6.2723; Parks AL, 2000, DEVELOPMENT, V127, P1373; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; PETERS PJ, 1990, IMMUNOL TODAY, V11, P28; PETERS PJ, 1989, EUR J IMMUNOL, V19, P1469, DOI 10.1002/eji.1830190819; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; Robbins JR, 1999, J CELL BIOL, V146, P1333, DOI 10.1083/jcb.146.6.1333; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; VANDENHEUVEL M, 1989, CELL, V59, P739, DOI 10.1016/0092-8674(89)90020-2; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	34	330	340	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 7	2001	106	5					633	645		10.1016/S0092-8674(01)00484-6	http://dx.doi.org/10.1016/S0092-8674(01)00484-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551510	Bronze			2022-12-01	WOS:000170973200013
J	Middeldorp, S; Meinardi, JR; Koopman, MMW; van Pampus, ECM; Hamulyak, K; van der Meer, J; Prins, MH; Buller, HR				Middeldorp, S; Meinardi, JR; Koopman, MMW; van Pampus, ECM; Hamulyak, K; van der Meer, J; Prins, MH; Buller, HR			A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism	ANNALS OF INTERNAL MEDICINE			English	Article							ACTIVATED PROTEIN-C; DEEP-VEIN THROMBOSIS; COAGULATION-FACTOR-V; RISK-FACTORS; RESISTANCE; THROMBOPHILIA; POPULATION	Background: The factor V Leiden mutation is a common genetic defect associated with an increased risk for venous thromboembolism. The clinical implications for asymptomatic carriers of this mutation and, consequently, the usefulness of screening families in which a proband has both the mutation and venous thrombo embolism are unclear. Objective: To determine the incidence of venous thromboembolism in asymptomatic carriers of the factor V Leiden mutation. Design: Prospective cohort study. Setting: University hospitals in the Netherlands. Participants: 470 asymptomatic carriers of the factor V Leiden mutation (234 men, 236 women; mean age, 43 years [range, 15 to 88 years]), 12 of whom were homozygous. Carriers were identified by screening the first-degree relatives (>15 years of age) of 247 symptomatic probands. Measurements: Objectively diagnosed episodes of venous thromboembolism and the relationship between incidence and exposure to high-risk situations. Results: Nine venous thromboembolic events were observed in 1564 observation-years, resulting in an annual incidence of 0.58% (95% CI, 0.26% to 1.10%). The incidence of spontaneous venous thromboembolism was 0.26% (CI, 0.07% to 0.65%) per year; 3.5% (CI, 0.1% to 17.8%) per episode of surgery, trauma, or immobilization; 0.0% (CI, 0.0% to 19.5%) per pregnancy; 1.8% (CI, 0.4% to 5.2%) per year of oral contraceptive use; and 2.9% (CI, 0.8% to 15.3%) per year of use of hormone replacement therapy. Conclusions: The absolute annual incidence of spontaneous venous thromboembolism in asymptomatic carriers of the factor V Leiden mutation is low and does not justify routine screening of the families of symptomatic patients.	Acad Med Ctr, Dept Vasc Med, NL-1100 DE Amsterdam, Netherlands; Univ Groningen Hosp, Groningen, Netherlands; Univ Hosp Maastricht, Maastricht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; Maastricht University; Maastricht University Medical Centre (MUMC)	Middeldorp, S (corresponding author), Acad Med Ctr, Dept Vasc Med, F4-277,Box 22700, NL-1100 DE Amsterdam, Netherlands.		Middeldorp, Saskia/ABI-8197-2020	Middeldorp, Saskia/0000-0002-1006-6420				BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Dahlback B, 1996, LANCET, V347, P1346, DOI 10.1016/S0140-6736(96)91004-1; Desmarais S, 1996, LANCET, V347, P1374, DOI 10.1016/S0140-6736(96)91013-2; Frezzato M, 1996, AM J EPIDEMIOL, V143, P1257; GREENGARD JS, 1994, LANCET, V343, P1361, DOI 10.1016/S0140-6736(94)92497-X; HEIJBOER H, 1990, NEW ENGL J MED, V323, P1512, DOI 10.1056/NEJM199011293232202; KOSTER T, 1993, LANCET, V342, P1503, DOI 10.1016/S0140-6736(05)80081-9; Middeldorp S, 1998, ANN INTERN MED, V128, P15, DOI 10.7326/0003-4819-128-1-199801010-00003; Middeldorp S, 1998, SEMIN THROMB HEMOST, V24, P363, DOI 10.1055/s-2007-996024; NORDSTROM M, 1992, J INTERN MED, V232, P155, DOI 10.1111/j.1365-2796.1992.tb00565.x; REES DC, 1995, LANCET, V346, P1133, DOI 10.1016/S0140-6736(95)91803-5; RIDKER PM, 1995, NEW ENGL J MED, V332, P912, DOI 10.1056/NEJM199504063321403; Ridker PM, 1997, ANN INTERN MED, V126, P528, DOI 10.7326/0003-4819-126-7-199704010-00005; Rodeghiero F, 1999, ANN INTERN MED, V130, P643, DOI 10.7326/0003-4819-130-8-199904200-00004; Simioni P, 1999, ANN INTERN MED, V130, P538, DOI 10.7326/0003-4819-130-6-199903160-00012; Simioni P, 1999, THROMB HAEMOSTASIS, V81, P198, DOI 10.1055/s-0037-1614442; SVENSSON PJ, 1994, NEW ENGL J MED, V330, P517, DOI 10.1056/NEJM199402243300801; Vandenbroucke JP, 1996, BRIT MED J, V313, P1127, DOI 10.1136/bmj.313.7065.1127; VANDERMEER FJM, 1993, ARCH INTERN MED, V153, P1557, DOI 10.1001/archinte.153.13.1557; VOORBERG J, 1994, LANCET, V343, P1535, DOI 10.1016/S0140-6736(94)92939-4	20	138	140	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2001	135	5					322	327		10.7326/0003-4819-135-5-200109040-00008	http://dx.doi.org/10.7326/0003-4819-135-5-200109040-00008			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	468WF	11529695				2022-12-01	WOS:000170780600002
J	Fevre, EM; Coleman, PG; Odiit, M; Magona, JW; Welburn, SC; Woolhouse, MEJ				Fevre, EM; Coleman, PG; Odiit, M; Magona, JW; Welburn, SC; Woolhouse, MEJ			The origins of a new Trypanosoma brucei rhodesiense sleeping sickness outbreak in eastern Uganda	LANCET			English	Article								Background Sleeping sickness, caused by two trypanosome subspecies, Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense, is a parasitic disease transmitted by the tsetse fly in sub-Saharan Africa. We report on a recent outbreak of T b rhodesiense sleeping sickness outside the established south-east Ugandan focus, in Soroti District where the disease had previously been absent. Soroti District has been the subject of large-scale livestock restocking activities and, because domestic cattle are important reservoirs of T b rhodesiense, we investigated the role of cattle in the origins of the outbreak. Methods We identified the origins of cattle entering the outbreak area in the 4 years preceding the outbreak. A matched case-control study was conducted to assess whether the distance of villages from the main market involved with restocking was a risk factor for sleeping sickness. We investigated the spatial clustering of sleeping sickness cases at the start of the outbreak. Findings Over 50% (1510 of 2796) of cattle traded at the market were reported to have originated from endemic sleeping sickness areas. The case-control study revealed that distance to the cattle market was a highly significant risk factor for sleeping sickness (p<0.001) and that there was a significant clustering of cases (27 of 28) close to the market at the start of the outbreak (p<0.001). As the outbreak progressed, the average distance of cases moved away from the cattle market (0.014 km per day, 95% CI 0.008-0.020 km per day, p<0.001). Interpretations The results are consistent with the disease being introduced by cattle infected with T b rhodesiense imported to the market from the endemic sleeping sickness focus. The subsequent spread of the disease away from the market suggests that sleeping sickness is becoming established in this new focus. Public health measures directed at controlling the infection in the animal reservoir should be considered to prevent the spread of sleeping sickness.	Univ Edinburgh, Ctr Trop Vet Med, Roslin EH25 9RG, Midlothian, Scotland; Livestock Hlth Res Inst, Tororo, Uganda	University of Edinburgh	Fevre, EM (corresponding author), Univ Edinburgh, Ctr Trop Vet Med, Easter Bush, Roslin EH25 9RG, Midlothian, Scotland.			Fevre, Eric/0000-0001-8931-4986; Welburn, Susan/0000-0002-9903-7086				ABARU DE, 1985, TROP MED PARASITOL, V36, P72; Barrett MP, 1999, LANCET, V353, P1113, DOI 10.1016/S0140-6736(98)00416-4; HEISCH RB, 1958, BRIT MED J, V2, P1203, DOI 10.1136/bmj.2.5106.1203; Hide G, 1996, PARASITOL TODAY, V12, P50, DOI 10.1016/0169-4758(96)80654-5; HIDE G, 1991, EXP PARASITOL, V72, P430, DOI 10.1016/0014-4894(91)90089-F; KOERNER T, 1995, PARASITOL TODAY, V11, P303, DOI 10.1016/0169-4758(95)80046-8; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; LANCIEN J, 1991, ANN SOC BELG MED TR, V71, P35; MEHLITZ D, 1981, TROPENMED PARASITOL, V32, P129; Odiit M, 1997, E AFR MED J, V74, P792; ONYANGO RJ, 1966, T ROY SOC TROP MED H, V60, P175, DOI 10.1016/0035-9203(66)90024-1; ONYANGO RJ, 1967, HUMAN TRYPANOSOMIASI, P43; Welburn SC, 2001, TRENDS PARASITOL, V17, P19, DOI 10.1016/S1471-4922(00)01839-0	13	146	149	1	14	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 25	2001	358	9282					625	628		10.1016/S0140-6736(01)05778-6	http://dx.doi.org/10.1016/S0140-6736(01)05778-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530149				2022-12-01	WOS:000170615500010
J	Blinkhorn, S				Blinkhorn, S			Yes, but what's it for?	NATURE			English	Article									Psychometr Res & Dev Ltd, St Albans AL1 3HT, England		Blinkhorn, S (corresponding author), Psychometr Res & Dev Ltd, Brewmaster House, St Albans AL1 3HT, England.								0	2	2	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					771	771		10.1038/35090659	http://dx.doi.org/10.1038/35090659			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518944				2022-12-01	WOS:000170577200018
J	Navin, TR; Beard, CB; Huang, L; del Rio, C; Lee, S; Pieniazek, NJ; Carter, JL; Le, T; Hightower, A; Rimland, D				Navin, TR; Beard, CB; Huang, L; del Rio, C; Lee, S; Pieniazek, NJ; Carter, JL; Le, T; Hightower, A; Rimland, D			Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study	LANCET			English	Article							SULFONE PROPHYLAXIS; TRIMETHOPRIM-SULFAMETHOXAZOLE; AIDS PATIENTS; RESISTANCE; SEQUENCE	Background Investigators have reported that patients infected with Pneumocystis carinii containing mutations in the DHPS (dihydropteroate synthase) gene have a worse outcome than those infected with P carinii containing wildtype DHPS. We investigated patients with HIV-1 infection and P carinii pneumonia to determine if DHPS mutations were associated with poor outcomes in these patients. Methods We compared presence of mutations at the DHPS locus with survival and response of patients to cotrimoxazole or other drugs. Findings For patients initially given co-trimoxazole, nine (14%) of 66 with DHPS mutant died, compared with nine (25%) of 36 with wild type (risk ratio=0.55 [95% CI=0.24-1.25]; p=0.15). Ten (15%) of 66 patients with a DHPS mutant did not respond to treatment, compared with 13 (36%) of 36 patients with the wild type (0.42 [0.20-0.86]; p=0.02). For patients aged 40 years or older, four (14%) of 29 with the mutant and nine (56%) of 16 with the wild type died (0.25 [0.09-0.67]; p=0.005). Interpretation These results, by contrast with those of previous studies, suggest that patients with wild-type P carinii do not have a better outcome than patients with the mutant when given co-trimoxazole. Our results suggest that presence of a DHPS mutation should be only one of several criteria guiding the choice of initial drug treatment of P carinii pneumonia in patients with HIV-1 infection.	Ctr Dis Control & Prevent, Div Parasit Dis, Natl Ctr Infect Dis, US PHS,US Dept HHS, Atlanta, GA USA; Ctr Dis Control & Prevent, Div TB Eliminat, Natl Ctr HIV STD & TB Prevent, US PHS,US Dept HHS, Atlanta, GA USA; Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA USA; Univ Calif San Francisco, San Francisco Gen Hosp, Ctr AIDS Res, San Francisco, CA USA; Emory Univ, Sch Med, Dept Med, Atlanta, GA USA; Emory Univ, Sch Med, Ctr AIDS Res, Atlanta, GA USA; Vet Affairs Med Ctr, Atlanta, GA 30033 USA; Res Ctr AIDS & HIV Infect, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; United States Public Health Service; Centers for Disease Control & Prevention - USA; United States Public Health Service; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Emory University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Navin, TR (corresponding author), Mailstop E-10,1600 Clifton Rd, Atlanta, GA 30333 USA.		del Rio, Carlos/B-3763-2012; Huang, Laurence/AAZ-7120-2021	del Rio, Carlos/0000-0002-0153-3517; Huang, Laurence/0000-0003-3888-2195				Achari A, 1997, NAT STRUCT BIOL, V4, P490, DOI 10.1038/nsb0697-490; Beard CB, 2000, EMERG INFECT DIS, V6, P265, DOI 10.3201/eid0603.000306; BROOKS DR, 1994, EUR J BIOCHEM, V224, P397, DOI 10.1111/j.1432-1033.1994.00397.x; FERMER C, 1995, J BACTERIOL, V177, P4669, DOI 10.1128/jb.177.16.4669-4675.1995; Helweg-Larsen J, 1999, LANCET, V354, P1347, DOI 10.1016/S0140-6736(99)03320-6; Huang L, 2000, J INFECT DIS, V182, P1192, DOI 10.1086/315824; Jones J L, 1999, MMWR CDC Surveill Summ, V48, P1; Kazanjian P, 1998, AIDS, V12, P873, DOI 10.1097/00002030-199808000-00009; Kazanjian P, 2000, J INFECT DIS, V182, P551, DOI 10.1086/315719; Lane BR, 1997, J INFECT DIS, V175, P482, DOI 10.1093/infdis/175.2.482; LOPEZ P, 1987, J BACTERIOL, V169, P4320, DOI 10.1128/jb.169.9.4320-4326.1987; Ma L, 1999, J INFECT DIS, V180, P1969, DOI 10.1086/315148; Martin JN, 1999, J INFECT DIS, V180, P1809, DOI 10.1086/315132; Mei Q, 1998, LANCET, V351, P1631, DOI 10.1016/S0140-6736(05)77687-X; 1999, AIDS REPORTING UPDAT	15	92	94	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 18	2001	358	9281					545	549		10.1016/S0140-6736(01)05705-1	http://dx.doi.org/10.1016/S0140-6736(01)05705-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464NB	11520525	Green Submitted			2022-12-01	WOS:000170537700012
J	Bertrand, CA				Bertrand, CA			Color by number: Imaging large data	SCIENCE			English	Article									Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bertrand, CA (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA.							Lawler A, 2001, SCIENCE, V292, P1044, DOI 10.1126/science.292.5519.1044; Paddock S, 2001, BIOTECHNIQUES, V30, P283, DOI 10.2144/01302bt01; RUSS C, 1999, IMAGE PROCESSING HDB; Smallcombe A, 2001, BIOTECHNIQUES, V30, P1240, DOI 10.2144/01306bt01	4	4	4	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1335	1336		10.1126/science.293.5533.1335	http://dx.doi.org/10.1126/science.293.5533.1335			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509735				2022-12-01	WOS:000170492600045
J	Hauf, S; Waizenegger, IC; Peters, JM				Hauf, S; Waizenegger, IC; Peters, JM			Cohesin cleavage by separase required for anaphase and cytokinesis in human cells	SCIENCE			English	Article							SISTER-CHROMATID SEPARATION; FISSION YEAST; DEGRADATION; PROTEOLYSIS; CHROMOSOME; INHIBITOR; IDENTIFICATION; COMPLEXES; PROPHASE; MITOSIS	Cell division depends on the separation of sister chromatids in anaphase. In yeast, sister separation is initiated by cleavage of cohesin by the protease separase. In vertebrates, most cohesin is removed from chromosome arms by a cleavage-independent mechanism. Only residual amounts of cohesin are cleaved at the onset of anaphase, coinciding with its disappearance from centromeres. We have identified two separase cleavage sites in the human cohesin subunit SCC1 and have conditionally expressed noncleavable SCC1 mutants in human cells. our results indicate that cohesin cleavage by separase is essential for sister chromatid separation and for the completion of cytokinesis.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Peters, JM (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.		Hauf, Silke/H-7321-2012	Hauf, Silke/0000-0001-5938-721X				Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; HAUF S, UNPUB; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Leismann O, 2000, GENE DEV, V14, P2192, DOI 10.1101/gad.176700; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; McClintock B., 1941, COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, V9, P72; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Stratmann R, 1996, CELL, V84, P25, DOI 10.1016/S0092-8674(00)80990-3; Sumara I, 2000, J CELL BIOL, V151, P749, DOI 10.1083/jcb.151.4.749; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Vorlaufer E, 1998, MOL BIOL CELL, V9, P1817, DOI 10.1091/mbc.9.7.1817; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Yanagida M, 1998, TRENDS CELL BIOL, V8, P144, DOI 10.1016/S0962-8924(98)01236-7; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	22	368	379	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1320	1323		10.1126/science.1061376	http://dx.doi.org/10.1126/science.1061376			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509732				2022-12-01	WOS:000170492600041
J	Yusupova, GZ; Yusupov, MM; Cate, JHD; Noller, HF				Yusupova, GZ; Yusupov, MM; Cate, JHD; Noller, HF			The path of messenger RNA through the ribosome	CELL			English	Article							DIRECTED CROSS-LINKING; BINDING; SITE; INITIATION; SUBUNIT; REGION; NUCLEOTIDES; TRANSLATION; COMPLEXES; SEQUENCE	Using X-ray crystallography, we have directly observed the path of mRNA in the 70S ribosome in Fourier difference maps at 7 Angstrom resolution. About 30 nucleotides of the mRNA are wrapped in a groove that encircles the neck of the 30S subunit. The Shine-Dalgarno helix is bound in a large cleft between the head and the back of the platform. At the interface, only about eight nucleotides (-1 to +7), centered on the junction between the A and P codons, are exposed, and bond almost exclusively to 16S rRNA. The mRNA enters the ribosome around position + 13 to + 15, the location of downstream pseudoknots that stimulate -1 translational frame shifting.	Univ Calif Santa Cruz, Sinsheimer Labs, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA; Whitehead Inst, Cambridge, MA 01242 USA	University of California System; University of California Santa Cruz; Massachusetts Institute of Technology (MIT); Whitehead Institute	Noller, HF (corresponding author), Univ Calif Santa Cruz, Sinsheimer Labs, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA.	harry@nuvolari.ucsc.edu	Yusupov, Marat/I-6126-2013; Yusupova, Gulnara/E-1877-2014	Yusupov, Marat/0000-0001-5544-0597; 				Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Alam SL, 1999, P NATL ACAD SCI USA, V96, P14177, DOI 10.1073/pnas.96.25.14177; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BALAKIN A, 1990, BIOCHIM BIOPHYS ACTA, V1050, P119, DOI 10.1016/0167-4781(90)90151-Q; BELITSINA NV, 1981, FEBS LETT, V131, P289, DOI 10.1016/0014-5793(81)80387-0; BHANGU R, 1992, BIOCHEMISTRY-US, V31, P5937, DOI 10.1021/bi00140a033; BHANGU R, 1994, BIOCHEMISTRY-US, V33, P3063, DOI 10.1021/bi00176a040; BRETSCHER MS, 1968, NATURE, V220, P1088, DOI 10.1038/2201088a0; BRIERLEY I, 1989, CELL, V57, P537, DOI 10.1016/0092-8674(89)90124-4; BRIMACOMBE R, 1995, EUR J BIOCHEM, V230, P365; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; DOKUDOVSKAYA SS, 1993, BIOTECHNOL APPL BIOC, V18, P149; DONTSOVA O, 1992, EMBO J, V11, P3105, DOI 10.1002/j.1460-2075.1992.tb05383.x; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; GAVRILOVA LP, 1976, J MOL BIOL, V101, P537, DOI 10.1016/0022-2836(76)90243-6; Greuer B, 1999, RNA, V5, P1521, DOI 10.1017/S1355838299991550; GUALERZI C, 1977, BIOCHEMISTRY-US, V16, P1684, DOI 10.1021/bi00627a025; HUTTENHOFER A, 1994, EMBO J, V13, P3892, DOI 10.1002/j.1460-2075.1994.tb06700.x; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; JUZUMIENE DI, 1995, J BIOL CHEM, V270, P12794, DOI 10.1074/jbc.270.21.12794; Lata KR, 1996, J MOL BIOL, V262, P43, DOI 10.1006/jmbi.1996.0497; MOAZED D, 1990, J MOL BIOL, V211, P135, DOI 10.1016/0022-2836(90)90016-F; MOAZED D, 1986, CELL, V47, P985, DOI 10.1016/0092-8674(86)90813-5; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; OTWINOWSKI Z, 1993, DATA COLLECTION PROC, P52; PESTKA S, 1967, J BIOL CHEM, V242, P4939; RINKEAPPEL J, 1994, NUCLEIC ACIDS RES, V22, P3018, DOI 10.1093/nar/22.15.3018; RINKEAPPEL J, 1993, NUCLEIC ACIDS RES, V21, P2853, DOI 10.1093/nar/21.12.2853; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Sergiev PV, 1997, RNA, V3, P464; SHATSKY IN, 1991, BIOCHIMIE, V73, P937, DOI 10.1016/0300-9084(91)90135-N; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; STEITZ JA, 1969, NATURE, V224, P957, DOI 10.1038/224957a0; VONAHSEN U, 1995, SCIENCE, V267, P234, DOI 10.1126/science.7528943; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	39	472	534	2	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2001	106	2					233	241		10.1016/S0092-8674(01)00435-4	http://dx.doi.org/10.1016/S0092-8674(01)00435-4			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511350	Bronze			2022-12-01	WOS:000170193100012
J	Sleigh, AC; Jackson, S				Sleigh, AC; Jackson, S			Dams, development, and health: a missed opportunity	LANCET			English	Editorial Material									Univ Queensland, Sch Populat Hlth, Brisbane, Qld 4006, Australia; Univ Queensland, Sch Econ, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Sleigh, AC (corresponding author), Univ Queensland, Sch Populat Hlth, Brisbane, Qld 4006, Australia.		sleigh, adrian/J-4540-2019	sleigh, adrian/0000-0001-8443-7864				BRODY H, 2001, ADDRESSING PROJECT S; Hunter J, 1993, PARASITIC DIS WATER; Jackson S, 2000, COMMUNIS POST-COMMUN, V33, P223, DOI 10.1016/S0967-067X(00)00005-2; MUSHKIN SJ, 1962, J POLIT ECON, V70, P129, DOI 10.1086/258730; Pearson Lestor B., 1969, PARTNERS DEV REPORT; Sleigh A, 1998, LANCET, V351, P1449, DOI 10.1016/S0140-6736(05)78866-8; Strauss J, 1998, J ECON LIT, V36, P766; *WORLD COMM DAMS, 2000, DAMS DEV NEW FRAM DE	8	15	15	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2001	357	9256					570	571		10.1016/S0140-6736(00)04072-1	http://dx.doi.org/10.1016/S0140-6736(00)04072-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558476				2022-12-01	WOS:000167119100002
J	Watson, SA				Watson, SA			Oncogenic targets of beta-catenin-mediated transcription in molecular pathogenesis of intestinal polyposis	LANCET			English	Editorial Material							COLORECTAL-CANCER; COLON-CARCINOMA; ACTIVATION; PATHWAY; GASTRIN; COMPLEX; GENE		Univ Nottingham, Acad Unit Canc Studies, Nottingham NG7 2UH, England	University of Nottingham	Watson, SA (corresponding author), Univ Nottingham, Acad Unit Canc Studies, Nottingham NG7 2UH, England.	sue.watson@nottingham.ac.uk						Barker N, 2000, ADV CANCER RES, V77, P1; GOYETTE MC, 1992, MOL CELL BIOL, V12, P1387, DOI 10.1128/MCB.12.3.1387; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Koh TJ, 2000, J CLIN INVEST, V106, P533, DOI 10.1172/JCI9476; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; POLAKIS P, 1997, BIOCHIM BIOPHYS ACTA, V1332, P127; Smith AM, 2000, GUT, V47, P820, DOI 10.1136/gut.47.6.820; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Watson SA, 1998, GASTROENTEROLOGY, V114, pA701; WATSON SA, 1999, DIGESTION, V60, P600; Yamada T, 2000, CANCER RES, V60, P4761	14	17	18	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	2001	357	9256					572	573		10.1016/S0140-6736(00)04074-5	http://dx.doi.org/10.1016/S0140-6736(00)04074-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558478				2022-12-01	WOS:000167119100004
J	MARAIS, DJD; STRAUSS, H; SUMMONS, RE; HAYES, JM				MARAIS, DJD; STRAUSS, H; SUMMONS, RE; HAYES, JM			CARBON ISOTOPE EVIDENCE FOR THE STEPWISE OXIDATION OF THE PROTEROZOIC ENVIRONMENT	NATURE			English	Article							CENTRAL AUSTRALIA; AMADEUS BASIN; RECORD; OCEANS; EVAPORITE; PALEOSOL; DEPOSITS; DIOXIDE; SULFATE; OXYGEN	The oxidation of the Earth's crust and the increase in atmospheric oxygen early in Earth history have been linked to the accumulation of reduced carbon in sedimentary rocks. Trends in the carbon isotope composition of sedimentary organic carbon and carbonate show that during the Proterozoic aeon (2.5-0.54 Gyr ago) the organic carbon reservoir grew in size, relative to the carbonate reservoir. This increase, and the concomitant release of oxidizing power in the environment, occurred mostly during episodes of global rifting and orogeny.	RUHR UNIV BOCHUM, INST GEOL, W-4630 BOCHUM 1, GERMANY; BUR MINERAL RESOURCES, CANBERRA, ACT 2605, AUSTRALIA; INDIANA UNIV, DEPT GEOL SCI, BIOGEOCHEM LABS, BLOOMINGTON, IN 47405 USA; INDIANA UNIV, DEPT CHEM, BLOOMINGTON, IN 47405 USA	Ruhr University Bochum; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	MARAIS, DJD (corresponding author), NASA, AMES RES CTR, MOFFETT FIELD, CA 94035 USA.		Summons, Roger Everett/AAL-3789-2020					[Anonymous], 1992, PROTEROZOIC BIOSPHER; Badger M.R., 1987, PROGR PHOTOSYNTHESIS; BAKER AJ, 1989, NATURE, V337, P352, DOI 10.1038/337352a0; BERNER RA, 1983, AM J SCI, V283, P641, DOI 10.2475/ajs.283.7.641; BERNER RA, 1989, AM J SCI, V289, P333, DOI 10.2475/ajs.289.4.333; BETTS JN, 1991, GLOBAL PLANET CHANGE, V97, P5, DOI 10.1016/0031-0182(91)90178-T; BEUKES NJ, 1989, SEDIMENTOLOGY, V36, P383, DOI 10.1111/j.1365-3091.1989.tb00615.x; BROECKER WS, 1983, SCI AM, V249, P146, DOI 10.1038/scientificamerican0983-146; BROWN JS, 1965, GEOL SOC AM BULL, V67, P1590; BUICK R, 1992, SCIENCE, V255, P74, DOI 10.1126/science.11536492; CAMERON EM, 1982, NATURE, V296, P145, DOI 10.1038/296145a0; CANFIELD DE, IN PRESS NATO ARW IN; DEGENS ET, 1968, DEEP-SEA RES, V15, P1, DOI 10.1016/0011-7471(68)90024-7; Deines P., 1980, HDB ENV ISOTOPE GEOC, V1, P329, DOI DOI 10.1016/B978-0-444-41780-0.50015-8; DERRY LA, 1992, GEOCHIM COSMOCHIM AC, V56, P1317, DOI 10.1016/0016-7037(92)90064-P; Des Marais D.J, 1991, PALAEOGEOGRAPHY PALA, V97, P93, DOI DOI 10.1016/0031-0182(91)90185-T; EASTOE CJ, 1990, PRECAMBRIAN RES, V46, P353, DOI 10.1016/0301-9268(90)90021-H; ERIKSSON PG, 1992, PRECAMBRIAN RES, V54, P257, DOI 10.1016/0301-9268(92)90073-W; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; FROELICH PN, 1982, AM J SCI, V282, P474, DOI 10.2475/ajs.282.4.474; GARRELS RM, 1974, SEA, V5, P303; GROTZINGER JP, 1989, SOC ECON PA, V44, P79, DOI 10.2110/pec.89.44.0079; HAN TM, 1992, SCIENCE, V257, P232, DOI 10.1126/science.1631544; HARLAND WB, 1983, GEOL SOC AM MEM, V161, P279; Hayes J. M., 1983, EARTHS EARLIEST BIOS, P93; Hayes JM., 1983, EARTHS EARLIEST BIOS, P291; Holland H. D., 1978, CHEM ATMOSPHERE OCEA, P1; Holland H.D., 1984, CHEM EVOLUTION ATMOS, P1; HOLLAND HD, 1990, AM J SCI, V290A, P1; HOLLAND HD, 1989, AM J SCI, V289, P362, DOI 10.2475/ajs.289.4.362; HOLLAND HD, 1973, HYDROGEOCHEMISTRY BI, P68; Holser W. T., 1988, CHEM CYCLES EVOLUTIO, P105; JAHNKE L, 1983, J BACTERIOL, V155, P488, DOI 10.1128/JB.155.2.488-492.1983; JORDAN DB, 1983, ARCH BIOCHEM BIOPHYS, V227, P425, DOI 10.1016/0003-9861(83)90472-1; LINDSAY JF, 1987, GEOL SOC AM BULL, V99, P852, DOI 10.1130/0016-7606(1987)99<852:UPEITA>2.0.CO;2; McKirdy DM., 1974, GEOLOGY, V2, P591, DOI [591, DOI 10.1130/0091-7613(1974)2<591:MAOCIC>2.0.CO;2]; MULLER PJ, 1979, DEEP-SEA RES, V26, P1347, DOI 10.1016/0198-0149(79)90003-7; PIPER JDA, 1983, GEOL SOC AM MEM, V161, P11; PIPER JDA, 1982, EARTH PLANET SC LETT, V59, P61, DOI 10.1016/0012-821X(82)90118-2; REDDING CE, 1980, ADV ORG GEOCHEM, P711; Schidlowski, 1982, MINERAL DEPOSITS EVO, P103; SCHIDLOWSKI M, 1976, GEOCHIM COSMOCHIM AC, V40, P449, DOI 10.1016/0016-7037(76)90010-7; Schidlowski M., 1983, P149; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; Schopf J.W., 1983, P361; STEWART AJ, 1979, SEDIMENTOLOGY, V26, P33, DOI 10.1111/j.1365-3091.1979.tb00337.x; Strauss H., 1992, PROTEROZOIC BIOSPHER, P117; SUMMONS RE, 1990, AM J SCI, V290A, P212; VEIZER J, 1982, NATURWISSENSCHAFTEN, V69, P173, DOI 10.1007/BF00364890; VEIZER J, 1992, GEOCHIM COSMOCHIM AC, V56, P875, DOI 10.1016/0016-7037(92)90033-F; VEIZER J, 1988, ORIGINS LIFE EVOL B, V18, P13, DOI 10.1007/BF01808778; VEIZER J, 1976, GEOCHIM COSMOCHIM AC, V40, P905, DOI 10.1016/0016-7037(76)90139-3; WALKER JCG, 1983, EARTHS EARLIEST BIOS, P260; WALKER RN, 1977, NATURE, V265, P526, DOI 10.1038/265526a0; Windley B. F., 1984, EVOLVING CONTINENTS, P1; Worsley TR, 1986, PALEOCEANOGRAPHY, V1, P233, DOI 10.1029/PA001i003p00233; ZBINDEN EA, 1988, PRECAMBRIAN RES, V42, P141, DOI 10.1016/0301-9268(88)90014-9; [No title captured]; [No title captured]	59	318	327	10	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 15	1992	359	6396					605	609		10.1038/359605a0	http://dx.doi.org/10.1038/359605a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JT824	11536507				2022-12-01	WOS:A1992JT82400046
J	FOMENKOVA, MN; KERRIDGE, JF; MARTI, K; MCFADDEN, LA				FOMENKOVA, MN; KERRIDGE, JF; MARTI, K; MCFADDEN, LA			COMPOSITIONAL TRENDS IN ROCK-FORMING ELEMENTS OF COMET HALLEY DUST	SCIENCE			English	Article							AQUEOUS ACTIVITY; PARENT BODY; PARTICLES; SPECTRA; CHONDRITES; SURFACE; IMPACT; GRAINS	The VEGA 1 and 2 spacecraft flew by comet P/Halley in 1986 carrying, among other instruments, two mass spectrometers to measure the elemental composition of dust particles emitted from the comet. Most particles seem to be a mixture of silicates of variable magnesium-iron composition and organic matter. Comprehensive study of data and consideration of the mass of dust particles reveal cometary grains of "unusual" composition: magnesium-rich and iron-rich particles. Magnesium-rich particles are most likely magnesium carbonates, which could not have formed under conditions of equilibrium condensation but rather require formation by aqueous alteration. The composition of the iron-rich particles can also be related to secondary processes in the comet.	UNIV CALIF SAN DIEGO,CALIF SPACE INST,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,DEPT CHEM,LA JOLLA,CA 92093	University of California System; University of California San Diego; University of California System; University of California San Diego	FOMENKOVA, MN (corresponding author), ACAD SCI USSR,SPACE RES INST,MOSCOW,USSR.		McFadden, Lucy-Ann/I-4902-2013	McFadden, Lucy-Ann/0000-0002-0537-9975				ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; ARPIGNY C, 1979, ELEMENTS ISOTOPES UN, P189; BALEBANOV VM, 1984, VENUS HALLEY MISSION, P88; BREGMAN JD, 1987, ASTRON ASTROPHYS, V187, P617; BUNCH TE, 1980, GEOCHIM COSMOCHIM AC, V44, P1543, DOI 10.1016/0016-7037(80)90118-0; CLARK BC, 1987, ASTRON ASTROPHYS, V187, P779; DELSEMME AH, 1991, COMETS POSTHALLEY ER, P377; DIKOV YP, 1989, ADV SPACE RES, V9, P253; DYCHNE A, 1991, 260891 SPAC RES I TE; EVLANOV EN, 1991, CHEM SPACE, P383; FOMENKOVA M, 1991, LPSC, V22, P397; FREDRIKSSON K, 1988, METEORITICS, V23, P35, DOI 10.1111/j.1945-5100.1988.tb00894.x; HALLIDAY I, 1987, ASTRON ASTROPHYS, V187, P921; INOGAMOV NA, 1986, DOKL AKAD NAUK SSSR, V277, P1377; JESSBERGER EK, 1988, NATURE, V332, P691, DOI 10.1038/332691a0; KERRIDGE JF, 1979, SCIENCE, V205, P395, DOI 10.1126/science.205.4404.395; KERRIDGE JF, 1979, P LUNAR PLANET SCI C, V10, P989; KISSEL J, 1986, NATURE, V321, P280, DOI 10.1038/321280a0; KISSEL J, 1987, APPL PHYS A-MATER, V42, P69, DOI 10.1007/BF00618161; KORTH A, 1989, NATURE, V337, P53, DOI 10.1038/337053a0; Kracher A., 1984, J GEOPHYS RES S, V89, pB559; LANGEVIN Y, 1987, ASTRON ASTROPHYS, V187, P761; LAWLER ME, 1989, ICARUS, V80, P225, DOI 10.1016/0019-1035(89)90135-8; MUKHIN L, 1991, NATURE, V350, P480, DOI 10.1038/350480a0; MUMMA MJ, 1990, BAAS, V22, P1088; PRINN RG, 1988, ORIGIN EVOLUTION PLA, P78; RIETMEIJER FJM, 1991, EARTH PLANET SC LETT, V102, P148, DOI 10.1016/0012-821X(91)90004-2; RIETMEIJER FJM, 1989, LUNAR PLANET SCI, V20, P904; SANDFORD SA, 1985, ASTROPHYS J, V291, P838, DOI 10.1086/163120; Sears D.W.G., 1988, METEORITES EARLY SOL, P3; SHRAMM LS, 1989, METEORITICS, V24, P99; ZINNER EK, 1989, LUNAR PLANET SCI, V20, P1245; ZOLENSKY ME, 1992, P LUNAR PLANET SCI, V22, P161	33	83	83	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 9	1992	258	5080					266	269		10.1126/science.11538058	http://dx.doi.org/10.1126/science.11538058			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JR860	11538058				2022-12-01	WOS:A1992JR86000024
J	SLEEP, NH; ZAHNLE, KJ; KASTING, JF; MOROWITZ, HJ				SLEEP, NH; ZAHNLE, KJ; KASTING, JF; MOROWITZ, HJ			ANNIHILATION OF ECOSYSTEMS BY LARGE ASTEROID IMPACTS ON THE EARLY EARTH	NATURE			English	Article									NASA,AMES RES CTR,MOFFETT FIELD,CA 94035; PENN STATE UNIV,DEPT GEOSCI,UNIVERSITY PK,PA 16802; GEORGE MASON UNIV,DEPT BIOL,FAIRFAX,VA 22030	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; George Mason University	SLEEP, NH (corresponding author), STANFORD UNIV,DEPT BIOPHYS,STANFORD,CA 94305, USA.		Kasting, James/AAF-6851-2020					BALDWIN RB, 1987, ICARUS, V71, P1, DOI 10.1016/0019-1035(87)90158-8; BALDWIN RB, 1987, ICARUS, V71, P19, DOI 10.1016/0019-1035(87)90159-X; BALDWIN RB, 1981, P LUNAR PLANET SCI A, V12, P19; BRATERMAN PS, 1983, NATURE, V303, P163, DOI 10.1038/303163a0; BRATT SR, 1985, J GEOPHYS RES-SOLID, V90, P2415, DOI 10.1029/JB090iB14p12415; BRATT SR, 1985, J GEOPHYS RES-SOLID, V90, P3049, DOI 10.1029/JB090iB04p03049; CARLSON RW, 1988, EARTH PLANET SC LETT, V90, P119, DOI 10.1016/0012-821X(88)90095-7; CARLSON RW, 1979, EARTH PLANET SC LETT, V45, P123, DOI 10.1016/0012-821X(79)90114-6; CLOUD P, 1983, SCI AM, V249, P176, DOI 10.1038/scientificamerican0983-176; Connan J., 1986, ADV PETROLEUM GEOCHE, V1, P299, DOI DOI 10.1016/B978-0-12-032001-1.50011-0; DAVIS PA, 1987, J GEOPHYS RES-SOLID, V92, pE387, DOI 10.1029/JB092iB04p0E387; DONNISON JR, 1984, MON NOT R ASTRON SOC, V210, P673, DOI 10.1093/mnras/210.3.673; Hartmann W.K., 1980, LUNAR HIGHLANDS CRUS, P155; HARTMANN WK, 1987, ICARUS, V69, P33, DOI 10.1016/0019-1035(87)90005-4; HUGHES DW, 1982, MON NOT R ASTRON SOC, V199, P1149, DOI 10.1093/mnras/199.4.1149; INGERSOLL AP, 1969, J ATMOS SCI, V26, P1191, DOI 10.1175/1520-0469(1969)026<1191:TRGAHO>2.0.CO;2; JANNASCH HW, 1983, HYDROTHERMAL PROCESS, P677; KASTING JF, 1988, ICARUS, V74, P472, DOI 10.1016/0019-1035(88)90116-9; KOROTEV RL, 1987, J GEOPHYS RES-SOLID, V92, pE447, DOI 10.1029/JB092iB04p0E447; LINDSTROM MM, 1986, J GEOPHYS RES-SOLID, V91, pD263, DOI 10.1029/JB091iB04p0D263; MAHER KA, 1988, NATURE, V331, P612, DOI 10.1038/331612a0; MARVIN UB, 1989, SCIENCE, V243, P925, DOI 10.1126/science.243.4893.925; Melosh H.J., 1989, IMPACT CRATERING GEO; NEWSOM HE, 1988, NATURE, V338, P29; PIETERS CM, 1986, REV GEOPHYS, V24, P557, DOI 10.1029/RG024i003p00557; RINGWOOD AE, 1986, ORIGIN MOON, P331; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; Schopf J.W., 1983, P214; Spudis P.D., 1988, P LUN PLAN SCI C, P155; SPUDIS PD, 1986, J GEOPHYS RES-SOLID, V91, pE84, DOI 10.1029/JB091iB13p00E84; Swindle T.D., 1986, P C KON HI LUN PLAN, P331; WALKER JCG, 1985, PRECAMBRIAN RES, V28, P205, DOI 10.1016/0301-9268(85)90031-2; WALKER JCG, 1987, NATURE, V329, P710, DOI 10.1038/329710a0; WARREN PH, 1989, EARTH PLANET SC LETT, V91, P245, DOI 10.1016/0012-821X(89)90001-0; WETHERILL GW, 1988, ICARUS, V75, P552	35	325	334	1	53	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 9	1989	342	6246					139	142		10.1038/342139a0	http://dx.doi.org/10.1038/342139a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY739	11536616				2022-12-01	WOS:A1989AY73900055
J	Shenoy, SK; McDonald, PH; Kohout, TA; Lefkowitz, RJ				Shenoy, SK; McDonald, PH; Kohout, TA; Lefkowitz, RJ			Regulation of receptor fate by ubiquitination of activated beta(2)-adrenergic receptor and beta-arrestin	SCIENCE			English	Article							ADRENERGIC-RECEPTOR; CLATHRIN ADAPTER; PROTEIN LIGASE; ENDOCYTOSIS; P53; SYSTEM; MDM2; COMPLEX	Although trafficking and degradation of several membrane proteins are regulated by ubiquitination catalyzed by E3 ubiquitin ligases, there has been little evidence connecting ubiquitination with regulation of mammalian G protein (heterotrimeric guanine nucleotide-binding protein)-coupled receptor (GPCR) function. Agonist stimulation of endogenous or transfected beta (2)-adrenergic receptors (beta (2)ARs) led to rapid ubiquitination of both the receptors and the receptor regulatory protein, beta -arrestin. Moreover, proteasome inhibitors reduced receptor internalization and degradation, thus implicating a role for the ubiquitination machinery in the trafficking of the beta (2)AR. Receptor ubiquitination required beta -arrestin, which bound to the E3 ubiquitin ligase Mdm2. Abrogation of beta -arrestin ubiquitination, either by expression in Mdm2-null cells or by dominant-negative forms of Mdm2 lacking E3 ligase activity, inhibited receptor internalization with marginal effects on receptor degradation. However, a beta (2)AR mutant tacking lysine residues, which was not ubiquitinated, was internalized normally but was degraded ineffectively. These findings delineate an adapter role of beta -arrestin in mediating the ubiquitination of the beta (2)AR and indicate that ubiquitination of the receptor and of beta -arrestin have distinct and obligatory roles in the trafficking and degradation of this prototypic GPCR.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cardiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Duke University; Duke University	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Box 3821, Durham, NC 27710 USA.		Lefkowitz, Robert/AAW-2649-2021; Shenoy, Sudha/AAN-4075-2021	Shenoy, Sudha/0000-0002-2565-4663	NHLBI NIH HHS [HL16037] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037, R37HL016037] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; BOUVIER M, 1988, MOL PHARMACOL, V33, P133; Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; Chaturvedi K, 2001, J BIOL CHEM, V276, P12345, DOI 10.1074/jbc.M008054200; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; HAUSDORFF WP, 1991, P NATL ACAD SCI USA, V88, P2979, DOI 10.1073/pnas.88.8.2979; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Mori S, 1997, EUR J BIOCHEM, V247, P1190, DOI 10.1111/j.1432-1033.1997.01190.x; Nakamura K, 1999, MOL ENDOCRINOL, V13, P1295, DOI 10.1210/me.13.8.1295; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Obin MS, 1996, J BIOL CHEM, V271, P14473, DOI 10.1074/jbc.271.24.14473; Parola AL, 1997, ANAL BIOCHEM, V254, P88, DOI 10.1006/abio.1997.2361; Roth AF, 2000, J BIOL CHEM, V275, P8143, DOI 10.1074/jbc.275.11.8143; SHENOY SR, UNPUB; Tsao P, 2001, TRENDS PHARMACOL SCI, V22, P91, DOI 10.1016/S0165-6147(00)01620-5; van Kerkhof P, 2000, J BIOL CHEM, V275, P1575, DOI 10.1074/jbc.275.3.1575; van Kerkhof P, 2001, J BIOL CHEM, V276, P3778, DOI 10.1074/jbc.M007326200; Yu AX, 2001, J BIOL CHEM, V276, P381, DOI 10.1074/jbc.M007991200	25	668	688	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2001	294	5545					1307	1313		10.1126/science.1063866	http://dx.doi.org/10.1126/science.1063866			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11588219				2022-12-01	WOS:000172130200039
J	Ritz, D; Lim, J; Reynolds, CM; Poole, LB; Beckwith, J				Ritz, D; Lim, J; Reynolds, CM; Poole, LB; Beckwith, J			Conversion of a peroxiredoxin into a disulfide reductase by a triplet repeat expansion	SCIENCE			English	Article							ALKYL HYDROPEROXIDE REDUCTASE; ESCHERICHIA-COLI CYTOPLASM; OXIDATIVE STRESS; SALMONELLA-TYPHIMURIUM; FRAMESHIFT MUTATION; PEROXIDE REDUCTION; PHASE VARIATION; HYDROGEN DONOR; BOND FORMATION; THIOREDOXIN	Pathways for the reduction of protein disulfide bonds are found in all organisms and are required for the reductive recycling of certain enzymes including the essential protein ribonucleotide reductase. An Escherichia coli strain that lacks both thioredoxin reductase and glutathione reductase grows extremely poorly. Here, we show that a mutation occurring at high frequencies in the gene ahpC, encoding a peroxiredoxin, restores normal growth to this strain. This mutation is the result of a reversible expansion of a triplet nucleotide repeat sequence, leading to the addition of one amino acid that converts the AhpC protein from a peroxidase to a disulfide reductase. The ready mutational interconversion between the two activities could provide an evolutionary advantage to E. coli.	Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	Harvard University; Harvard Medical School; Wake Forest University; Wake Forest Baptist Medical Center	Beckwith, J (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, 200 Longwood Ave, Boston, MA 02115 USA.			Poole, Leslie/0000-0003-0334-7328	NIGMS NIH HHS [R01 GM050389, R001 GM55090, R01 GM50389] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055090, R01GM050389] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Aslund F, 1999, CELL, V96, P751, DOI 10.1016/S0092-8674(00)80584-X; ASLUND F, 1994, P NATL ACAD SCI USA, V91, P9813, DOI 10.1073/pnas.91.21.9813; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; Calzi ML, 1997, BIOCHEMISTRY-US, V36, P13357, DOI 10.1021/bi9713660; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Carroll PA, 1997, MOL MICROBIOL, V25, P1099, DOI 10.1046/j.1365-2958.1997.5371901.x; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P13349, DOI 10.1021/bi9713658; Hardy J, 1998, SCIENCE, V282, P1075, DOI 10.1126/science.282.5391.1075; Harvey SC, 1997, BIOCHEMISTRY-US, V36, P3047, DOI 10.1021/bi962771e; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Lillig CH, 1999, J BIOL CHEM, V274, P7695, DOI 10.1074/jbc.274.12.7695; Lowther WT, 2000, P NATL ACAD SCI USA, V97, P6463, DOI 10.1073/pnas.97.12.6463; Park SF, 2000, J BACTERIOL, V182, P207, DOI 10.1128/JB.182.1.207-210.2000; Poole LB, 2000, BIOCHEMISTRY-US, V39, P6602, DOI 10.1021/bi000405w; Poole LB, 2000, FREE RADICAL BIO MED, V28, P108, DOI 10.1016/S0891-5849(99)00218-X; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; REYNOLDS AE, 1981, NATURE, V293, P625, DOI 10.1038/293625a0; Ritz D, 2000, J BIOL CHEM, V275, P2505, DOI 10.1074/jbc.275.4.2505; RUSSEL M, 1990, J BACTERIOL, V172, P1923, DOI 10.1128/jb.172.4.1923-1929.1990; Shi J, 1999, J BIOL CHEM, V274, P36039, DOI 10.1074/jbc.274.51.36039; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; STORZ G, 1989, J BACTERIOL, V171, P2049, DOI 10.1128/jb.171.4.2049-2055.1989; Theiss P, 1997, J BACTERIOL, V179, P4013, DOI 10.1128/jb.179.12.4013-4022.1997; Warren ST, 1996, SCIENCE, V271, P1374, DOI 10.1126/science.271.5254.1374; Wood ZA, 2001, BIOCHEMISTRY-US, V40, P3900, DOI 10.1021/bi002765p	26	98	101	2	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2001	294	5540					158	160		10.1126/science.1063143	http://dx.doi.org/10.1126/science.1063143			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11588261				2022-12-01	WOS:000171448800051
J	Beaufort, L; de Garidel-Thoron, T; Mix, AC; Pisias, NG				Beaufort, L; de Garidel-Thoron, T; Mix, AC; Pisias, NG			ENSO-like forcing on oceanic primary production during the Late Pleistocene	SCIENCE			English	Article							INDIAN-OCEAN; EQUATORIAL PACIFIC; TROPICAL CLIMATE; VARIABILITY; DYNAMICS; ATLANTIC; MONSOON; AGE	Late Pleistocene changes in oceanic primary productivity along the equator in the Indian and Pacific oceans are revealed by quantitative changes in nanoplankton communities preserved in nine deep-sea cores. We show that variations in equatorial productivity are primarily caused by glacial-interglacial variability and by precession-controlled changes in the east-west thermodine slope of the Indo-Pacific. The precession-controlled variations in productivity are linked to processes similar to the Southern Oscillation phenomenon, and they precede changes in the oxygen isotopic ratio, which indicates that they are not the result of ice sheet fluctuations. The 30,000-year spectral peak in the tropical Indo-Pacific Ocean productivity records is also present in the Antarctica atmospheric CO2 record, suggesting an important rote for equatorial biological productivity in modifying atmospheric CO2.	CNRS, CEREGE, F-13545 Aix En Provence 04, France; Oregon State Univ, Coll Oceanog & Atmospher Sci, Corvallis, OR 97331 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Oregon State University	Beaufort, L (corresponding author), CNRS, CEREGE, BP 80, F-13545 Aix En Provence 04, France.		Beaufort, Luc/AAH-5305-2021; de Garidel-Thoron, Thibault/B-1204-2008; Beaufort, Luc/ABG-2289-2021	de Garidel-Thoron, Thibault/0000-0001-8983-9571; Beaufort, Luc/0000-0001-6055-9373				Bard E, 1997, NATURE, V385, P707, DOI 10.1038/385707a0; BASSINOT FC, 1994, EARTH PLANET SC LETT, V126, P91, DOI 10.1016/0012-821X(94)90244-5; Beaufort L, 1997, SCIENCE, V278, P1451, DOI 10.1126/science.278.5342.1451; Charles CD, 1997, SCIENCE, V277, P925, DOI 10.1126/science.277.5328.925; CLEMENS S, 1991, NATURE, V353, P720, DOI 10.1038/353720a0; Clement AC, 1999, PALEOCEANOGRAPHY, V14, P441, DOI 10.1029/1999PA900013; Cole JE, 2000, SCIENCE, V287, P617, DOI 10.1126/science.287.5453.617; Dollfus D, 1999, NEURAL NETWORKS, V12, P553, DOI 10.1016/S0893-6080(99)00011-8; EDWARDS RL, 1987, SCIENCE, V236, P1547, DOI 10.1126/science.236.4808.1547; Fedorov AV, 2000, SCIENCE, V288, P1997, DOI 10.1126/science.288.5473.1997; Flenley JR, 1998, CLIMATIC CHANGE, V39, P177, DOI 10.1023/A:1005367822750; GALLUP CD, 1994, SCIENCE, V263, P796, DOI 10.1126/science.263.5148.796; Harris SE, 1999, QUATERNARY RES, V51, P14, DOI 10.1006/qres.1998.2008; Henderson GM, 2000, NATURE, V404, P61, DOI 10.1038/35003541; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; LEWIS MR, 1986, SCIENCE, V234, P870, DOI 10.1126/science.234.4778.870; MEEHL GA, 1993, J CLIMATE, V6, P31, DOI 10.1175/1520-0442(1993)006<0031:ACASBM>2.0.CO;2; Mix AC, 1999, PALEOCEANOGRAPHY, V14, P350, DOI 10.1029/1999PA900012; Mix AC, 1986, PALEOCEANOGRAPHY, V1, P43, DOI 10.1029/PA001i001p00043; MOLFINO B, 1990, SCIENCE, V249, P766, DOI 10.1126/science.249.4970.766; OKADA H, 1973, DEEP-SEA RES, V20, P355, DOI 10.1016/0011-7471(73)90059-4; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI DOI 10.1029/96E000259; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pisias NG, 1997, PALEOCEANOGRAPHY, V12, P381, DOI 10.1029/97PA00583; POKRAS EM, 1987, NATURE, V326, P486, DOI 10.1038/326486a0; PRELL WL, 1984, MILANKOVITCH CLIMATE, V1, P349; Reichart GJ, 1998, PALEOCEANOGRAPHY, V13, P607, DOI 10.1029/98PA02203; Rich JJ, 1999, GLOBAL BIOGEOCHEM CY, V13, P531, DOI 10.1029/1998GB900023; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43855; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; Turk D, 2001, SCIENCE, V293, P471, DOI 10.1126/science.1056449; Villanueva J, 1998, PALEOCEANOGRAPHY, V13, P561, DOI 10.1029/98PA02318; Webster PJ, 1999, NATURE, V401, P356, DOI 10.1038/43848; [No title captured]	34	227	268	3	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2001	293	5539					2440	2444		10.1126/science.293.5539.2440	http://dx.doi.org/10.1126/science.293.5539.2440			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11577233				2022-12-01	WOS:000171237200043
J	Zhang, PC; Keleshian, AM; Sachs, F				Zhang, PC; Keleshian, AM; Sachs, F			Voltage-induced membrane movement	NATURE			English	Article							OUTER HAIR CELL; ATOMIC-FORCE MICROSCOPY; LIPID BILAYER; ION CHANNELS; SALICYLATE; MOTILITY; MODEL; ELECTROMOTILITY; CAPACITANCE; POTENTIALS	Thermodynamics predicts that transmembrane voltage modulates membrane tension(1) and that this will cause movement. The magnitude and polarity of movement is governed by cell stiffness and surface potentials. Here we confirm these predictions using the atomic force microscope to dynamically follow the movement of voltage-clamped HEK293 cells(2) in different ionic-strength solutions. In normal saline, depolarization caused an outward movement, and at low ionic strength an inward movement. The amplitude was proportional to voltage (about 1 nm per 100 mV) and increased with indentation depth. A simple physical model of the membrane and tip provided an estimate of the external and internal surface charge densities (-5 x10(-3) C m(-2) and -18x10(-3) C m(-2), respectively). Salicylate (a negative amphiphile(3)) inhibited electromotility by increasing the external charge density by -15x10(-3) C m(-2). As salicylate blocks electromotility in cochlear outer hair cells at the same concentration(4,5), the role of prestin as a motor protein(6) may need to be reassessed.	SUNY Buffalo, HHMI Ctr Single Mol Biophys, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Sachs, F (corresponding author), SUNY Buffalo, HHMI Ctr Single Mol Biophys, Buffalo, NY 14214 USA.		Zhang, Ping-Cheng/G-7862-2011					Akinlaja J, 1998, BIOPHYS J, V75, P247, DOI 10.1016/S0006-3495(98)77511-3; Bockris J. O. M., 1973, MODERN ELECTROCHEMIS, V2; CARNIE S, 1983, BIOPHYS J, V44, P325, DOI 10.1016/S0006-3495(83)84306-9; Carslaw H.S., 1959, CONDUCTION HEAT SOLI; Chou T, 1997, BIOPHYS J, V72, P2042, DOI 10.1016/S0006-3495(97)78848-9; GUTKNECHT J, 1973, SCIENCE, V182, P1258, DOI 10.1126/science.182.4118.1258; Hille B., 1992, IONIC CHANNELS EXCIT; Hwang WC, 1997, BIOPHYS J, V72, P2669, DOI 10.1016/S0006-3495(97)78910-0; IWASA K, 1980, SCIENCE, V210, P338, DOI 10.1126/science.7423196; Iwasa KH, 1997, BIOPHYS J, V73, P546, DOI 10.1016/S0006-3495(97)78092-5; Kakehata S, 1996, J NEUROSCI, V16, P4881; KRAAYENHOF R, 1993, BIOCHEMISTRY-US, V32, P10057, DOI 10.1021/bi00089a022; Lue AJC, 1999, HEARING RES, V135, P163, DOI 10.1016/S0378-5955(99)00102-1; Maingret F, 1999, J BIOL CHEM, V274, P1381, DOI 10.1074/jbc.274.3.1381; MARKIN VS, 1991, BIOPHYS J, V60, P1120, DOI 10.1016/S0006-3495(91)82147-6; MCLAUGHLIN S, 1973, NATURE, V203, P234; Mosbacher J, 1998, J GEN PHYSIOL, V111, P65, DOI 10.1085/jgp.111.1.65; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; PETROV AG, 1993, EUR BIOPHYS J BIOPHY, V22, P289, DOI 10.1007/BF00180263; Raphael RM, 2000, BIOPHYS J, V78, P2844, DOI 10.1016/S0006-3495(00)76827-5; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; SHEHATA WE, 1991, ACTA OTO-LARYNGOL, V111, P707, DOI 10.3109/00016489109138403; SHIH CW, 1992, J MATER RES, V7, P1011, DOI 10.1557/JMR.1992.1011; SINGH AK, 1992, BIOCHIM BIOPHYS ACTA, V1120, P337, DOI 10.1016/0167-4838(92)90257-E; TODOROV AT, 1994, LANGMUIR, V10, P2344, DOI 10.1021/la00019a053; WINISKI AP, 1986, BIOCHEMISTRY-US, V25, P8206, DOI 10.1021/bi00373a013; Wu HW, 1998, SCANNING, V20, P389; Wu M, 1998, J MEMBRANE BIOL, V166, P111, DOI 10.1007/s002329900453; Yamaguchi T, 1997, COLLOID SURFACE B, V9, P275, DOI 10.1016/S0927-7765(97)00033-7; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	30	172	177	3	48	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2001	413	6854					428	432		10.1038/35096578	http://dx.doi.org/10.1038/35096578			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475UY	11574890				2022-12-01	WOS:000171188700056
J	Gingerich, PD; ul Haq, M; Zalmout, IS; Khan, IH; Malkani, MS				Gingerich, PD; ul Haq, M; Zalmout, IS; Khan, IH; Malkani, MS			Origin of whales from early artiodactyls: Hands and feet of eocene Protocetidae from Pakistan	SCIENCE			English	Article							PHYLOGENETIC-RELATIONSHIPS; EARLIEST CETACEANS; MOLECULAR EVIDENCE; PRINCIPLES; DIACODEXIS; INCLUSION; RELATIVES; EVOLUTION	Partial skeletons of two new fossil whales, Artiocetus clavis and Rodhocetus balochistanensis, are among the oldest known protocetid archaeocetes. These came from early Lutetian age (47 million years ago) strata in eastern Balochistan Province, Pakistan. Both have an astragalus and cuboid in the ankle with characteristics diagnostic of artiodactyls; R. balochistanensis has virtually complete fore- and hind limbs. The new skeletons are important in augmenting the diversity of early Protocetidae, clarifying that Cetacea evolved from early Artiodactyla rather than Mesonychia and showing how early protocetids swam.	Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; Geol Survey Pakistan, Quetta, Pakistan; Univ New Hampshire, Dept Earth Sci, Durham, NH 03824 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University System Of New Hampshire; University of New Hampshire	Gingerich, PD (corresponding author), Univ Michigan, Dept Geol Sci, 1006 CC Little Bldg, Ann Arbor, MI 48109 USA.	girigeric@umich.edu	Gingerich, Philip D/A-6903-2008	Gingerich, Philip D/0000-0002-1550-2674				Arnason U, 2000, J MOL EVOL, V50, P569, DOI 10.1007/s002390010060; Bajpai S, 1998, P NATL ACAD SCI USA, V95, P15464, DOI 10.1073/pnas.95.26.15464; BERGGREN WA, 1995, SEPM SPECIAL PUBLICA, V54; BOYDEN ALAN, 1950, ZOOL [NEW YORK], V35, P145; Colbert E.H., 1935, AM MUS NOVIT, V799, P1; FORDYCE RE, 1994, ANNU REV EARTH PL SC, V22, P419, DOI 10.1146/annurev.ea.22.050194.002223; Gatesy J, 1996, MOL BIOL EVOL, V13, P954, DOI 10.1093/oxfordjournals.molbev.a025663; Gatesy J, 1999, SYST BIOL, V48, P6, DOI 10.1080/106351599260409; GINGERICH PD, 1990, SCIENCE, V249, P154, DOI 10.1126/science.249.4965.154; Gingerich PD, 1998, ADV VERT PALEOBIOL, P423; GINGERICH PD, 1983, SCIENCE, V220, P403, DOI 10.1126/science.220.4595.403; GINGERICH PD, 1994, NATURE, V368, P844, DOI 10.1038/368844a0; Gingerich Philip D., 1995, Contributions from the Museum of Paleontology University of Michigan, V29, P291; GRAUR D, 1994, MOL BIOL EVOL, V11, P357; Hardenbol J., 1998, SEPM SPEC PUBL, V60, P3, DOI DOI 10.2110/PEC.98.02.0003; Irwin David M., 1994, Journal of Mammalian Evolution, V2, P37, DOI 10.1007/BF01464349; Kleineidam RG, 1999, J MOL EVOL, V48, P360, DOI 10.1007/PL00006480; Kowalevsky W., 1873, PHILOS T ROY SOC LON, V163, P19; Liu FGR, 1999, SYST BIOL, V48, P54, DOI 10.1080/106351599260436; Luckett W. Patrick, 1998, Journal of Mammalian Evolution, V5, P127, DOI 10.1023/A:1020501622015; Lum JK, 2000, MOL BIOL EVOL, V17, P1417, DOI 10.1093/oxfordjournals.molbev.a026242; Luo Z.-X., 1999, U MICHIGAN PAPERS PA, V31, P1; MCKENNA MC, 1997, CLASSIFICATION MAMMA, P366; Montgelard C, 1997, MOL BIOL EVOL, V14, P550, DOI 10.1093/oxfordjournals.molbev.a025792; Naylor GJP, 2001, SYST BIOL, V50, P444, DOI 10.1080/106351501300318030; Nikaido M, 1999, P NATL ACAD SCI USA, V96, P10261, DOI 10.1073/pnas.96.18.10261; O'Leary MA, 1999, SYST BIOL, V48, P455, DOI 10.1080/106351599260102; ROSE KD, 1982, SCIENCE, V216, P621, DOI 10.1126/science.216.4546.621; Rose KD, 1996, P NATL ACAD SCI USA, V93, P1705, DOI 10.1073/pnas.93.4.1705; SARICH VM, 1993, MAMMAL PHYLOGENY : PLACENTALS, P103; Schaeffer Bobb, 1947, AMER MUS NOVITATES, V1356, P1; Scott W. B., 1940, Transactions of the American Philosophical Society Philadelphia, V28, P363, DOI 10.2307/1005504; SCOTT WB, 1894, J ACAD NAT SCI-PHILA, V9, P461; Shimamura M, 1997, NATURE, V388, P666, DOI 10.1038/41759; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; SZALAY FS, 1969, EVOLUTION, V23, P703, DOI 10.1111/j.1558-5646.1969.tb03552.x; Thewissen J.G.M., 1996, Courier Forschungsinstitut Senckenberg, V191, P1; Thewissen J. G. M., 1994, Journal of Mammalian Evolution, V2, P157, DOI 10.1007/BF01473527; Thewissen JGM, 1997, PALEOBIOLOGY, V23, P482, DOI 10.1017/S0094837300019850; THEWISSEN JGM, 1994, SCIENCE, V263, P210, DOI 10.1126/science.263.5144.210; THEWISSEN JGM, 1990, ANAT HISTOL EMBRYOL, V19, P37, DOI 10.1111/j.1439-0264.1990.tb00876.x; Thewissen JGM, 1998, NATURE, V395, P452, DOI 10.1038/26656; Thewissen JGM, 1999, SYST BIOL, V48, P21, DOI 10.1080/106351599260418; Ursing BM, 1998, P ROY SOC B-BIOL SCI, V265, P2251, DOI 10.1098/rspb.1998.0567; VAN VALEN LEIGH, 1966, BULL AMER MUS NATUR HIST, V132, P1; WEBB PW, 1988, AM ZOOL, V28, P709	46	229	247	4	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2001	293	5538					2239	2242		10.1126/science.1063902	http://dx.doi.org/10.1126/science.1063902			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11567134				2022-12-01	WOS:000171139400039
J	Griffiths, EK; Krawczyk, C; Kong, YY; Raab, M; Hyduk, SJ; Bouchard, D; Chan, VS; Kozieradzki, I; Oliveira-Dos-Santos, AJ; Wakeham, A; Ohashi, PS; Cybulsky, MI; Rudd, CE; Penninger, JM				Griffiths, EK; Krawczyk, C; Kong, YY; Raab, M; Hyduk, SJ; Bouchard, D; Chan, VS; Kozieradzki, I; Oliveira-Dos-Santos, AJ; Wakeham, A; Ohashi, PS; Cybulsky, MI; Rudd, CE; Penninger, JM			Positive regulation of T cell activation and integrin adhesion by the adapter Fyb/Slap	SCIENCE			English	Article							INTERLEUKIN-2 PRODUCTION; ENA/VASP PROTEINS; TYROSINE KINASES; IMMUNE-SYSTEM; DRIVING-FORCE; RECEPTOR; SLP-76; FYN; SLAP-130; CLONING	The molecular adapter Fyb/Slap regulates signaling downstream of the T cell receptor (TCR), but whether it plays a positive or negative role is controversial. We demonstrate that Fyb/Slap-deficient T cells exhibit defective proliferation and cytokine production in response to TCR stimulation. Fyb/Slap is also required in vivo for T cell-dependent immune responses. Functionally, Fyb/Slap has no apparent role in the activation of known TCR signaling pathways, F-actin polymerization, or TCR clustering. Rather, Fyb/Slap regulates TCR-induced integrin clustering and adhesion. Thus, Fyb/Slap is the first molecular adapter to be identified that couples TCR stimulation to the avidity modulation of integrins governing T cell adhesion.	Amgen Inst, Toronto, ON M5G 2C1, Canada; Univ Hlth Network, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2M9, Canada; Dana Farber Canc Inst, Div Tumor Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Univ Toronto, Toronto Gen Hosp, Res Inst, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Penninger, JM (corresponding author), Amgen Inst, 620 Univ Ave, Toronto, ON M5G 2C1, Canada.		Penninger, Josef M/I-6860-2013; Cybulsky, Myron I./AAD-6539-2019; Rudd, Christopher E/GOH-2021-2022; Chan, Vera Sau Fong/B-3419-2011; Rudd, Christopher E/ABF-7259-2021	Penninger, Josef M/0000-0002-8194-3777; Rudd, Christopher E/0000-0001-5295-9019; Cybulsky, Myron/0000-0002-1696-2867; Ohashi, Pamela S./0000-0003-2915-9317				Bachmann MF, 1999, J IMMUNOL, V163, P137; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Boerth NJ, 2000, J BIOL CHEM, V275, P5143, DOI 10.1074/jbc.275.7.5143; Chan JR, 2000, J IMMUNOL, V164, P746, DOI 10.4049/jimmunol.164.2.746; Clements JL, 1999, ANNU REV IMMUNOL, V17, P89, DOI 10.1146/annurev.immunol.17.1.89; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; DaSilva AJ, 1997, P NATL ACAD SCI USA, V94, P7493, DOI 10.1073/pnas.94.14.7493; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; GENG L, IN PRESS P NATL ACAD; Kolanus W, 1997, CURR OPIN CELL BIOL, V9, P725, DOI 10.1016/S0955-0674(97)80127-5; Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Machesky LM, 2000, CELL, V101, P685, DOI 10.1016/S0092-8674(00)80879-X; Musci MA, 1997, J BIOL CHEM, V272, P11674, DOI 10.1074/jbc.272.18.11674; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Raab M, 1999, J BIOL CHEM, V274, P21170, DOI 10.1074/jbc.274.30.21170; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; Shimizu Y, 1999, ADV IMMUNOL, V72, P325, DOI 10.1016/S0065-2776(08)60024-3; van Kooyk Y, 2000, CURR OPIN CELL BIOL, V12, P542, DOI 10.1016/S0955-0674(00)00129-0; VAN SG, 1990, J IMMUNOL, V144, P4579; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Veale M, 1999, J BIOL CHEM, V274, P28427, DOI 10.1074/jbc.274.40.28427; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413	26	240	246	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2001	293	5538					2260	2263		10.1126/science.1063397	http://dx.doi.org/10.1126/science.1063397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11567140				2022-12-01	WOS:000171139400045
J	Losick, R; Sonenshein, AL				Losick, R; Sonenshein, AL			Molecular biology - Turning gene regulation on its head	SCIENCE			English	Editorial Material							BIOSYNTHESIS		Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	Harvard University; Tufts University	Losick, R (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.							ANSTON AA, 1999, NATURE, V401, P235; GOLLNICK P, IN PRESS BACILLUS SU; GRUNDY FJ, 1994, J MOL BIOL, V235, P798, DOI 10.1006/jmbi.1994.1038; Sarsero JP, 2000, P NATL ACAD SCI USA, V97, P2656, DOI 10.1073/pnas.050578997; STEINBERG W, 1974, J BACTERIOL, V117, P1023, DOI 10.1128/JB.117.3.1023-1034.1974; Valbuzzi A, 2001, SCIENCE, V293, P2057, DOI 10.1126/science.1062187; YANOFSKY C, 1987, ESCHERICHIA COLI SAL, V2, P1453	7	3	3	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					2018	2019		10.1126/science.1064982	http://dx.doi.org/10.1126/science.1064982			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557871				2022-12-01	WOS:000171028700052
J	Lawlor, DA; Ebrahim, S; Smith, GD				Lawlor, DA; Ebrahim, S; Smith, GD			Sex matters: secular and geographical trends in sex differences in coronary heart disease mortality	BRITISH MEDICAL JOURNAL			English	Article							DIETARY-FAT; CARDIOVASCULAR-DISEASE; RISK-FACTORS; CHOLESTEROL; CONSUMPTION; WOMEN; RATES; MEN	Objective To examine secular trends and geographical variations in sex differences in mortality from coronary heart disease and investigate how these relate to distributions in risk factors. Design National and international data were used to examine secular trends and geographical variations in sex differences in mortality from coronary heart disease and risk factors. Setting England and Wales, 1921-98; Australia, France,japan, Sweden, and the United States, 1947-97; 50 countries, 1992-6. Data sources Office for National Statistics, World Health Organization, and Food and Agriculture Organization of the United Nations. Results The 20th century epidemic of coronary heart disease affected only men in most industrialised countries and had a very rapid onset in England and Wales, which has been examined in detail. If this male only epidemic had not occurred there would have been 1.2 million fewer deaths from coronary heart disease in men in England and Wales over the past 50 years. Secular trends in mean per capita fat consumption show a similar pattern to secular trends in coronary heart disease mortality in mn. Fat consumption is positively correlated with coronary heart disease mortality in men (r,=0.79; 95% confidence interval 0.70 to 0.86) and inversely associated with coronary heart disease mortality in women (-0.30; -0.49 to -0.08) over this time. Although sex ratios for mortality from coronary heart disease show a clear period effect, those for lung cancer show a cohort effect. Sex ratios for stroke mortality were constant and close to unity for the entire period. Geographical variations in the sex ratio for coronary heart disease were associated with mean per capita fat consumption (0.64; 0.44 to 0.78) but were not associated with the sex ratio for smoking. Conclusion Sex differences are largely the result of environmental factors and hence not inevitable. Understanding the factors that determine sex differences has important implications for public health, particularly for countries and parts of countries where the death rates for coronary heart disease are currently increasing.	Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of Bristol	Lawlor, DA (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.		Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; Lawlor, Debbie A/0000-0002-6793-2262				*ADV PAN DIET REL, 1974, DIET COR HEART DIS; ANDERSON TW, 1973, JAMA-J AM MED ASSOC, V224, P336; Britton A, 2000, J EPIDEMIOL COMMUN H, V54, P328, DOI 10.1136/jech.54.5.328; CHARLES N, 1997, WOMEN FOOD FAMILIES; CHARLTON J, 1997, HLTH ADULT BRITAIN 1, P17; Charlton J, 1997, HLTH ADULT BRITAIN 1; CLIFTON PM, 1992, ARTERIOSCLER THROMB, V12, P955, DOI 10.1161/01.ATV.12.8.955; COOPER S, 1986, AGE AUSTERITY 1945 5, P34; Feinleib M, 1995, AM J MED SCI, V310, pS8, DOI 10.1097/00000441-199512000-00003; Hart CL, 2000, J EPIDEMIOL COMMUN H, V54, P874, DOI 10.1136/jech.54.11.874; Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460; ISLES CG, 1992, LANCET, V339, P702, DOI 10.1016/0140-6736(92)90599-X; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; OREN L, 1974, CLIOS CONSCIOUSNESS, P226; PETERSEN S, 1999, CORONARY HEART DIS S; PLANT M, 1997, HLTH ADULT BRITAIN 1, P114; POSNER BM, 1995, J AM DIET ASSOC, V95, P171, DOI 10.1016/S0002-8223(95)00043-7; SASAKI S, 1992, AM J CLIN NUTR, V56, P716, DOI 10.1093/ajcn/56.4.716; STAMLER J, 1989, INT J EPIDEMIOL, V18, pS3; STEHBENS WE, 1987, LANCET, V1, P606; STEPHEN AM, 1994, BRIT J NUTR, V71, P775, DOI 10.1079/BJN19940183; STEPHEN AM, 1990, AM J CLIN NUTR, V52, P457, DOI 10.1093/ajcn/52.3.457; The Coronary Drug Project, 1973, JAMA-J AM MED ASSOC, V226, P652; UEMURA K, 1988, World Health Statistics Quarterly, V41, P155; Walden CE, 1997, ARTERIOSCL THROM VAS, V17, P375, DOI 10.1161/01.ATV.17.2.375; WALDRON I, 1993, SOC SCI MED, V36, P451, DOI 10.1016/0277-9536(93)90407-U; ZHANG XH, 1995, INT J EPIDEMIOL, V24, P720, DOI 10.1093/ije/24.4.720	28	141	143	0	11	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 8	2001	323	7312					541	545		10.1136/bmj.323.7312.541	http://dx.doi.org/10.1136/bmj.323.7312.541			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471NC	11546699	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000170934600020
J	Hatta, M; Gao, P; Halfmann, P; Kawaoka, Y				Hatta, M; Gao, P; Halfmann, P; Kawaoka, Y			Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses	SCIENCE			English	Article							A VIRUSES; HOST RANGE; HEMAGGLUTININ; HUMANS; GENE; PATHOGENICITY; PATHOGENESIS; ATTENUATION; MONKEYS; CELLS	In 1997, an H5N1 influenza A virus was transmitted from birds to humans in Hong Kong, killing 6 of the 18 people infected. When mice were infected with the human isolates, two virulence groups became apparent. Using reverse genetics, we showed that a mutation at position 627 in the PB2 protein influenced the outcome of infection in mice. Moreover, high cleavability of the hemagglutinin glycoprotein was an essential requirement for lethal infection.	Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan	University of Wisconsin System; University of Wisconsin Madison; University of Tokyo	Kawaoka, Y (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, 2015 Linden Dr, Madison, WI 53706 USA.	kawaokay@svm.vetmed.wisc.edu	Halfmann, Peter/W-8084-2019					ALMOND JW, 1977, NATURE, V270, P617, DOI 10.1038/270617a0; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; CLEMENTS ML, 1992, J CLIN MICROBIOL, V30, P655, DOI 10.1128/JCM.30.3.655-662.1992; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Gao P, 1999, J VIROL, V73, P3184, DOI 10.1128/JVI.73.4.3184-3189.1999; Katz JM, 2000, J VIROL, V74, P10807, DOI 10.1128/JVI.74.22.10807-10810.2000; KATZ JM, 1990, J VIROL, V64, P1808, DOI 10.1128/JVI.64.4.1808-1811.1990; KAWAOKA Y, 1988, P NATL ACAD SCI USA, V85, P324, DOI 10.1073/pnas.85.2.324; Kuechler E., 1982, NUCLEIC ACIDS RES, V10, P4803; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; MURPHY BR, 1982, SCIENCE, V218, P1330, DOI 10.1126/science.6183749; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; ROTT R, 1976, J VIROL, V19, P54, DOI 10.1128/JVI.19.1.54-60.1976; SAUTER NK, 1992, BIOCHEMISTRY-US, V31, P9609, DOI 10.1021/bi00155a013; Suarez DL, 1998, J VIROL, V72, P6678, DOI 10.1128/JVI.72.8.6678-6688.1998; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; ULMANEN I, 1981, P NATL ACAD SCI-BIOL, V78, P7355, DOI 10.1073/pnas.78.12.7355; WEBSTER RG, 1987, CELL, V50, P665, DOI 10.1016/0092-8674(87)90321-7; 1997, MORBID MORTAL WKLY R, V46, P1204	20	1064	1204	0	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1840	1842		10.1126/science.1062882	http://dx.doi.org/10.1126/science.1062882			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546875				2022-12-01	WOS:000170894400050
J	Sumbre, G; Gutfreund, Y; Fiorito, G; Flash, T; Hochner, B				Sumbre, G; Gutfreund, Y; Fiorito, G; Flash, T; Hochner, B			Control of octopus arm extension by a peripheral motor program	SCIENCE			English	Article							SYSTEM; MOVEMENTS; BEHAVIOR	For goal-directed arm movements, the nervous system generates a sequence of motor commands that bring the arm toward the target. Control of the octopus arm is especially complex because the arm can be moved in any direction, with a virtually infinite number of degrees of freedom. Here we show that arm extensions can be evoked mechanically or electrically in arms whose connection with the brain has been severed. These extensions show kinematic features that are almost identical to normal behavior, suggesting that the basic motor program for voluntary movement is embedded within the neural circuitry of the arm itself. Such peripheral motor programs represent considerable simplification in the motor control of this highly redundant appendage.	Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol & Interdisciplinary, Ctr Neuronal Computat, IL-91904 Jerusalem, Israel; Staz Zool Anton Dohrn, Neurobiol Lab, I-80121 Naples, Italy; Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; Stazione Zoologica Anton Dohrn di Napoli; Weizmann Institute of Science	Hochner, B (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol & Interdisciplinary, Ctr Neuronal Computat, IL-91904 Jerusalem, Israel.	bennyh@lobster.ls.huji.ac.il	Sumbre, German/K-7538-2017	Sumbre, German/0000-0003-4436-6840				ALTMAN JS, 1971, NATURE, V229, P204, DOI 10.1038/229204a0; Arshavsky YI, 1997, CURR OPIN NEUROBIOL, V7, P781, DOI 10.1016/S0959-4388(97)80136-5; Bizzi E, 2000, NAT REV NEUROSCI, V1, P101, DOI 10.1038/35039000; BOYCOTT BB, 1950, SYM SOC EXP BIOL, V4, P432; Chiel HJ, 1997, TRENDS NEUROSCI, V20, P553, DOI 10.1016/S0166-2236(97)01149-1; DELCOMYN F, 1980, SCIENCE, V210, P492, DOI 10.1126/science.7423199; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; FLASH T, 1991, J COGNITIVE NEUROSCI, V3, P220, DOI 10.1162/jocn.1991.3.3.220; Graziadei P., 1971, ANATOMY NERVOUS SYST, P45; Gutfreund Y, 1998, J NEUROSCI, V18, P5976; Gutfreund Y, 1996, J NEUROSCI, V16, P7297; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HOLLAND JJ, 1990, VIROLOGY, P151; KIER WM, 1985, ZOOL J LINN SOC-LOND, V83, P307, DOI 10.1111/j.1096-3642.1985.tb01178.x; Kristan WB, 2000, BIOMECHANICS AND NEURAL CONTROL OF POSTURE AND MOVEMENT, P206; Matzner H, 2000, J NEUROPHYSIOL, V83, P1315, DOI 10.1152/jn.2000.83.3.1315; Mussa-Ivaldi FA, 1999, CURR OPIN NEUROBIOL, V9, P713, DOI 10.1016/S0959-4388(99)00029-X; ROWELL CHF, 1963, J EXP BIOL, V40, P257; SHIK ML, 1976, PHYSIOL REV, V56, P465, DOI 10.1152/physrev.1976.56.3.465; WELLS MJ, 1959, J EXP BIOL, V36, P590; YOUNG JZ, 1965, PROC R SOC SER B-BIO, V162, P47, DOI 10.1098/rspb.1965.0025	21	182	184	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1845	1848		10.1126/science.1060976	http://dx.doi.org/10.1126/science.1060976			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546877				2022-12-01	WOS:000170894400052
J	Sale, JE; Calandrini, DM; Takata, M; Takeda, S; Neuberger, MS				Sale, JE; Calandrini, DM; Takata, M; Takeda, S; Neuberger, MS			Ablation of XRCC2/3 transforms immunoglobulin V gene conversion into somatic hypermutation	NATURE			English	Article							DOUBLE-STRAND BREAKS; LIGHT-CHAIN GENE; HOMOLOGOUS RECOMBINATION; CHROMOSOME STABILITY; REPAIR GENES; DNA; PROMOTES; CHICKEN; DIVERSIFICATION; MAINTENANCE	After gene rearrangement, immunoglobulin V genes are further diversified by either somatic hypermutation or gene conversion(1). Hypermutation (in man and mouse) occurs by the fixation of individual, non-templated nucleotide substitutions. Gene conversion (in chicken) is templated by a set of upstream V pseudogenes. Here we show that if the RAD51 paralogues(2) XRCC2, XRCC3 or RAD51B are ablated the pattern of diversification of the immunoglobulin V gene in the chicken DT40 B-cell lymphoma line(3) exhibits a marked shift from one of gene conversion to one of somatic hypermutation. Non-templated, single-nucleotide substitutions are incorporated at high frequency specifically into the V domain, largely at G/C and with a marked hotspot preference. These mutant DT40 cell lines provide a tractable model for the genetic dissection of immunoglobulin hypermutation and the results support the idea that gene conversion and somatic hypermutation constitute distinct pathways for processing a common lesion in the immunoglobulin V gene. The marked induction of somatic hypermutation that is achieved by ablating the RAD51 paralogues is probably a consequence of modifying the recombination-mediated repair of such initiating lesions.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Kawasaki Med Sch, Okayama 7010192, Japan; Kyoto Univ, Fac Med, CREST Res Project, Sakyo Ku, Kyoto 6068501, Japan	MRC Laboratory Molecular Biology; Kawasaki Medical School; Japan Science & Technology Agency (JST); Kyoto University	Sale, JE (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	msn@mrc-lmb.cam.ac.uk		Takata, Minoru/0000-0002-4926-3675; Sale, Julian/0000-0002-5031-3780; Takeda, Shunichi/0000-0002-7924-7991				BABA TW, 1985, VIROLOGY, V144, P139, DOI 10.1016/0042-6822(85)90312-5; Bezzubova O, 1997, CELL, V89, P185, DOI 10.1016/S0092-8674(00)80198-1; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Brenneman MA, 2000, MUTAT RES-DNA REPAIR, V459, P89, DOI 10.1016/S0921-8777(00)00002-1; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; BUERSTEDDE JM, 1990, EMBO J, V9, P921, DOI 10.1002/j.1460-2075.1990.tb08190.x; Cui X, 1999, MUTAT RES-DNA REPAIR, V434, P75, DOI 10.1016/S0921-8777(99)00010-5; Deans B, 2000, EMBO J, V19, P6675, DOI 10.1093/emboj/19.24.6675; Diaz M, 2001, PHILOS T R SOC B, V356, P67, DOI 10.1098/rstb.2000.0750; Griffin CS, 2000, NAT CELL BIOL, V2, P757, DOI 10.1038/35036399; HONJO T, 1995, IMMUNOGLOBULIN GENES; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935; KIM S, 1990, MOL CELL BIOL, V10, P3224, DOI 10.1128/MCB.10.6.3224; Liu N, 1998, MOL CELL, V1, P783, DOI 10.1016/S1097-2765(00)80078-7; MAIZELS N, 1995, CELL, V83, P9, DOI 10.1016/0092-8674(95)90227-9; MCCORMACK WT, 1993, MOL CELL BIOL, V13, P821, DOI 10.1128/MCB.13.2.821; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; REYNAUD CA, 1989, CELL, V59, P171, DOI 10.1016/0092-8674(89)90879-9; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Sayegh CE, 1999, EMBO J, V18, P6319, DOI 10.1093/emboj/18.22.6319; Takata M, 2000, MOL CELL BIOL, V20, P6476, DOI 10.1128/MCB.20.17.6476-6482.2000; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Weill JC, 1996, IMMUNOL TODAY, V17, P92, DOI 10.1016/0167-5699(96)80586-X; XU B, 1994, SCIENCE, V265, P1590, DOI 10.1126/science.8079173; Yamaguchi-Iwai Y, 1998, MOL CELL BIOL, V18, P6430, DOI 10.1128/MCB.18.11.6430	30	185	196	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2001	412	6850					921	926		10.1038/35091100	http://dx.doi.org/10.1038/35091100			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528482				2022-12-01	WOS:000170689000048
J	Lovley, DR				Lovley, DR			Bioremediation - Anaerobes to the rescue	SCIENCE			English	Editorial Material							PETROLEUM-CONTAMINATED AQUIFER; IN-SITU; BENZENE		Univ Massachusetts, Dept Microbiol, Amherst, MA 01337 USA	University of Massachusetts System; University of Massachusetts Amherst	Lovley, DR (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01337 USA.	dlovley@microbio.umass.edu						Alexander M., 1999, BIODEGRADATION BIORE; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Anderson RT, 2000, ENVIRON SCI TECHNOL, V34, P2261, DOI 10.1021/es991211a; Beja O, 2000, ENVIRON MICROBIOL, V2, P516, DOI 10.1046/j.1462-2920.2000.00133.x; CHAPELLE FH, 2001, GROUND WATER MICROBI; Cunningham JA, 2001, ENVIRON SCI TECHNOL, V35, P1663, DOI 10.1021/es001722t; Fennell DE, 2001, ENVIRON SCI TECHNOL, V35, P1830, DOI 10.1021/es0016203; Lee MD, 1998, ANNU REV MICROBIOL, V52, P423, DOI 10.1146/annurev.micro.52.1.423; Lloyd JR, 2001, CURR OPIN BIOTECH, V12, P248, DOI 10.1016/S0958-1669(00)00207-X; Lovley DR, 2000, BIODEGRADATION, V11, P107, DOI 10.1023/A:1011191220463; Nisbet EG, 2001, NATURE, V409, P1083, DOI 10.1038/35059210; Rooney-Varga JN, 1999, APPL ENVIRON MICROB, V65, P3056; Smith RL, 2001, ENVIRON SCI TECHNOL, V35, P196, DOI 10.1021/es001360p; Snoeyenbos-West OL, 2000, MICROBIAL ECOL, V39, P153, DOI 10.1007/s002480000018; Wilson MS, 1999, APPL ENVIRON MICROB, V65, P80	15	151	162	4	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1444	1446		10.1126/science.1063294	http://dx.doi.org/10.1126/science.1063294			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520973				2022-12-01	WOS:000170616000030
J	Homma, K; Yoshimura, M; Saito, J; Ikebe, R; Ikebe, M				Homma, K; Yoshimura, M; Saito, J; Ikebe, R; Ikebe, M			The core of the motor domain determines the direction of myosin movement	NATURE			English	Article							SMOOTH-MUSCLE MYOSIN; ACTIN-BASED MOTOR; UNCONVENTIONAL MYOSINS; COMPLEX; KINESIN; VI; CONFORMATION; ELEGANS; FAMILY; CHAIN	Myosins constitute a superfamily of at least 18 known classes of molecular motors that move along actin filaments(1-3). Myosins move towards the plus end of F-actin filaments; however, it was shown recently that a certain class of myosin, class VI myosin, moves towards the opposite end of F-actin, that is, in the minus direction(4). As there is a large, unique insertion in the myosin VI head domain between the motor domain and the light-chain-binding domain (the lever arm), it was thought that this insertion alters the angle of the lever-arm switch movement, thereby changing the direction of motility(4). Here we determine the direction of motility of chimaeric myosins that comprise the motor domain and the lever-arm domain (containing an insert) from myosins that have movement in the opposite direction. The results show that the motor core domain, but neither the large insert nor the converter domain, determines the direction of myosin motility.	Univ Massachusetts, Sch Med, Dept Physiol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Ikebe, M (corresponding author), Univ Massachusetts, Sch Med, Dept Physiol, 55 Lake Ave N, Worcester, MA 01655 USA.							AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Baker JP, 1997, J MOL BIOL, V272, P523, DOI 10.1006/jmbi.1997.1232; CHIEN YH, 1984, MOL CELL BIOL, V4, P507, DOI 10.1128/MCB.4.3.507; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Endow SA, 2000, NATURE, V406, P913, DOI 10.1038/35022617; Endow SA, 1998, SCIENCE, V281, P1200, DOI 10.1126/science.281.5380.1200; HASSON T, 1994, J CELL BIOL, V127, P425, DOI 10.1083/jcb.127.2.425; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Hodge T, 2000, J CELL SCI, V113, P3353; Homma K, 2000, J BIOL CHEM, V275, P34766, DOI 10.1074/jbc.M003132200; Houdusse A, 1999, CELL, V97, P459, DOI 10.1016/S0092-8674(00)80756-4; IKEBE M, 1985, J BIOL CHEM, V260, P3146; Kelleher JF, 2000, CURR BIOL, V10, P1489, DOI 10.1016/S0960-9822(00)00828-9; KELLERMAN KA, 1992, J CELL BIOL, V119, P823, DOI 10.1083/jcb.119.4.823; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; MERMALL V, 1994, NATURE, V369, P560, DOI 10.1038/369560a0; Mooseker MS, 1995, ANNU REV CELL DEV BI, V11, P633, DOI 10.1146/annurev.cellbio.11.1.633; Sablin EP, 1998, NATURE, V395, P813, DOI 10.1038/27463; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; Sata M, 1996, BIOCHEMISTRY-US, V35, P11113, DOI 10.1021/bi960435s; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Titus MA, 1997, TRENDS CELL BIOL, V7, P119, DOI 10.1016/S0962-8924(97)01019-2; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Zhu T, 1996, BIOCHEMISTRY-US, V35, P513, DOI 10.1021/bi952053c	26	60	61	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					831	834		10.1038/35090597	http://dx.doi.org/10.1038/35090597			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518969				2022-12-01	WOS:000170577200040
J	Block, BA; Dewar, H; Blackwell, SB; Williams, TD; Prince, ED; Farwell, CJ; Boustany, A; Teo, SLH; Seitz, A; Walli, A; Fudge, D				Block, BA; Dewar, H; Blackwell, SB; Williams, TD; Prince, ED; Farwell, CJ; Boustany, A; Teo, SLH; Seitz, A; Walli, A; Fudge, D			Migratory movements, depth preferences, and thermal biology of Atlantic bluefin tuna	SCIENCE			English	Article							GULF-OF-MEXICO; THUNNUS-THYNNUS; SATELLITE; FISH; TEMPERATURE; TRACKING; EAST	The deployment of electronic data storage tags that are surgically implanted or satellite-linked provides marine researchers with new ways to examine the movements, environmental preferences, and physiology of pelagic vertebrates. We report the results obtained from tagging of Atlantic bluefin tuna with implantable archival and pop-up satellite archival tags. The electronic tagging data provide insights into the seasonal movements and environmental preferences of this species. Bluefin tuna dive to depths of >1000 meters and maintain a warm body temperature. Western-tagged bluefin tuna make trans-Atlantic migrations and they frequent spawning grounds in the Gulf of Mexico and eastern Mediterranean. These data are critical for the future management and conservation of bluefin tuna in the Atlantic.	Stanford Univ, Hopkins Marine Stn, Tuna Res & Conservat Ctr, Pacific Grove, CA 93950 USA; Pfleger Inst Environm Res, Oceanside, CA 92054 USA; Monterey Bay Aquarium, Monterey, CA 93940 USA; Natl Marine Fisheries Serv, Miami, FL 33149 USA	Stanford University; Monterey Bay Aquarium Research Institute; National Oceanic Atmospheric Admin (NOAA) - USA	Block, BA (corresponding author), Stanford Univ, Hopkins Marine Stn, Tuna Res & Conservat Ctr, Pacific Grove, CA 93950 USA.	bblock@stanford.edu	Fudge, Douglas/I-6860-2016	Fudge, Douglas/0000-0001-9569-1374				Altringham JD, 1997, J EXP BIOL, V200, P2617; BAGLIN RE, 1982, FISH B-NOAA, V80, P121; BAYLIFF WH, 1991, B IATTC, V20, P1; Block BA, 1998, MAR TECHNOL SOC J, V32, P37; Block BA, 1998, P NATL ACAD SCI USA, V95, P9384, DOI 10.1073/pnas.95.16.9384; CAREY FG, 1966, P NATL ACAD SCI USA, V56, P1464, DOI 10.1073/pnas.56.5.1464; CAREY FG, 1984, J EXP BIOL, V109, P1; DELONG RL, 1992, MAR MAMMAL SCI, V8, P155, DOI 10.1111/j.1748-7692.1992.tb00375.x; Gunn J, 2001, TUNA PHYSL ECOLOGY E, V19, P167, DOI 10.1016/S1546-5098(01)19006-0; Hill Roger D., 1994, P227; Kitagawa T, 2000, MAR ECOL PROG SER, V206, P251, DOI 10.3354/meps206251; Koudil M, 2000, CR ACAD SCI III-VIE, V323, P377, DOI 10.1016/S0764-4469(00)00144-X; LEBOEUF BJ, 2000, ECOL MONOGR, V353, P70; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; MAGGIO T, 2000, MATTANZA; Magnuson J. J., 1994, ASSESSMENT ATLANTIC; Marcinek DJ, 2001, MAR BIOL, V138, P869, DOI 10.1007/s002270000492; MATHER FJ, 1995, 370 NOAA NMFSSFSC; MCGOWAN MF, 1989, FISH B-NOAA, V87, P615; Metcalfe JD, 1997, NATURE, V387, P665, DOI 10.1038/42622; Nemerson D, 2000, FISH B-NOAA, V98, P118; NISHIDA T, 1998, 107 ICCAT; RODRIGUEZRODA J, 1967, INVEST PESQ, V31, P349; Schaefer Kurt M., 2001, Fish Physiology, V19, P225; SCOTT GP, 1993, B MAR SCI, V53, P912; Sissenwine MP, 1998, T AM FISH SOC, V127, P838, DOI 10.1577/1548-8659(1998)127<0838:ACOWAB>2.0.CO;2; Welch DW, 1999, CAN J FISH AQUAT SCI, V56, P1317, DOI 10.1139/cjfas-56-7-1317	27	484	505	5	276	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2001	293	5533					1310	1314		10.1126/science.1061197	http://dx.doi.org/10.1126/science.1061197			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509729				2022-12-01	WOS:000170492600038
J	Canfield, DE; Teske, A				Canfield, DE; Teske, A			Late Proterozoic rise in atmospheric oxygen concentration inferred from phylogenetic and sulphur-isotope studies	NATURE			English	Article							SULFATE REDUCTION; MARINE-SEDIMENTS; SULFUR CYCLE; EVOLUTION; OXIDATION; IRON; BACTERIA; RATES	The evolution of non-photosynthetic sulphide-oxidizing bacteria was contemporaneous with a large shift in the isotopic composition of biogenic sedimentary sulphides between 0.64 and 1.05 billion years ago. Both events were probably driven by a vise in atmospheric oxygen concentrations to greater than 5-18% of present levels-a change that may also have triggered the evolution of animals.			Canfield, DE (corresponding author), MAX PLANCK INST MARINE MICROBIOL, CELSIUSSTR 1, D-28359 BREMEN, GERMANY.		Canfield, Don/C-1735-2012; Teske, Andreas/AAQ-9577-2021	Canfield, Don/0000-0001-7602-8366; 				BERKNER LV, 1965, J ATMOS SCI, V22, P225, DOI 10.1175/1520-0469(1965)022<0225:OTOARO>2.0.CO;2; BLAND JA, 1978, ARCH MICROBIOL, V117, P79, DOI 10.1007/BF00689355; BOWRING SA, 1993, SCIENCE, V261, P1293, DOI 10.1126/science.11539488; BRETSKY SS, 1976, PALAEONTOGR AM, V8, P217; BUMIE SW, 1972, ECON GEOL, V67, P895; CAMERON EM, 1982, NATURE, V296, P145, DOI 10.1038/296145a0; CAMPBELL KA, 1993, RES EXPLOR, V9, P326; CANFIELD DE, 1994, SCIENCE, V266, P1973, DOI 10.1126/science.11540246; CANFIELD DE, 1993, MAR GEOL, V113, P27, DOI 10.1016/0025-3227(93)90147-N; CAVANAUGH CM, 1994, AM ZOOL, V34, P79; CHAMBERS LA, 1979, GEOMICROBIOL J, V1, P249, DOI 10.1080/01490457909377735; COX DL, 1969, TREATISE INVERTEBRAT, pN225; DISTEL DL, 1994, J MOL EVOL, V38, P533, DOI 10.1007/BF00178852; FEDNKIN MA, 1992, PROTEROZOIC BIOSPHER, P389; Felsenstein J, 1993, PHYLIP PHYLOGENY INT; FOSSING H, 1995, NATURE, V374, P713, DOI 10.1038/374713a0; FOX GE, 1980, SCIENCE, V209, P457, DOI 10.1126/science.6771870; FRY B, 1991, DEEP-SEA RES, V38, pS655; GLAESSNER MF, 1971, GEOL SOC AM BULL, V82, P509, DOI 10.1130/0016-7606(1971)82[509:GDATRO]2.0.CO;2; GOEDERT JL, 1993, VELIGER, V36, P72; GOLDHABER MB, 1975, SOIL SCI, V119, P42, DOI 10.1097/00010694-197501000-00008; GUNDERSEN JK, 1990, NATURE, V345, P604, DOI 10.1038/345604a0; Hayes J.M., 1992, PROTEROZOIC BIOSPHER, P129; Holland H.D., 1978, CHEM ATMOSPHERE OCEA; HOLLAND HD, 1990, AM J SCI, V290A, P1; HOLLAND HD, 1989, AM J SCI, V289, P362, DOI 10.2475/ajs.289.4.362; JORGENSEN BB, 1991, DEEP-SEA RES, V38, pS1083; JORGENSEN BB, 1990, SCIENCE, V249, P152, DOI 10.1126/science.249.4965.152; JORGENSEN BB, 1982, PHILOS T R SOC B, V298, P543, DOI 10.1098/rstb.1982.0096; KEMP ALW, 1968, GEOCHIM COSMOCHIM AC, V32, P71, DOI 10.1016/0016-7037(68)90088-4; Knoll A. H, 1992, ORIGIN EARLY EVOLUTI, P53; KNOLL AH, 1986, NATURE, V321, P832, DOI 10.1038/321832a0; KUENEN JG, 1991, PROKARYOTES, P2638; LANE DJ, 1992, J BACTERIOL, V174, P269, DOI 10.1128/jb.174.1.269-278.1992; LINDH TB, 1983, THESIS U MIAMI; LOGAN GA, 1995, NATURE, V376, P53, DOI 10.1038/376053a0; MAIDAK BL, 1994, NUCLEIC ACIDS RES, V22, P3485, DOI 10.1093/nar/22.17.3485; MARAIS DJD, 1992, NATURE, V359, P605, DOI 10.1038/359605a0; MORAN NA, 1993, P R SOC LONDON B, V253, P157; MUYZER G, 1995, ARCH MICROBIOL, V164, P165, DOI 10.1007/BF02529967; NAKAI N, 1964, GEOCHIM COSMOCHIM AC, V28, P1893, DOI 10.1016/0016-7037(64)90136-X; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; OHMOTO H, 1993, SCIENCE, V262, P555, DOI 10.1126/science.11539502; Overmann J, 1996, LIMNOL OCEANOGR, V41, P147, DOI 10.4319/lo.1996.41.1.0147; PFENNIG N, 1975, PLANT SOIL, V43, P1, DOI 10.1007/BF01928472; Pierson B.K., 1992, PROTEROZOIC BIOSPHER, P247; Pojeta J., 1988, NEW MEXICO BUREAU MI, V44, P201; Polz MF, 1996, INT J SYST BACTERIOL, V46, P94, DOI 10.1099/00207713-46-1-94; PYZIK AJ, 1981, GEOCHIM COSMOCHIM AC, V45, P687, DOI 10.1016/0016-7037(81)90042-9; REID RGB, 1986, VELIGER, V29, P3; ROSS GM, 1995, PRECAMBRIAN RES, V73, P71, DOI 10.1016/0301-9268(94)00072-Y; RUNNEGAR B, 1986, PALAEONTOLOGY, V29, P1; Runnegar B, 1991, PALAEOGEOGR PALAEOCL, V97, P97, DOI 10.1016/0031-0182(91)90186-U; Schidlowski M, 1993, ORGANIC GEOCHEMISTRY, P639; SERGEEV VN, 1995, J PALEONTOL, V69, P1; STRAUSS H, 1993, PRECAMBRIAN RES, V63, P225, DOI 10.1016/0301-9268(93)90035-Z; Teske A, 1996, SYST APPL MICROBIOL, V18, P517; THAMDRUP B, 1993, APPL ENVIRON MICROB, V59, P101, DOI 10.1128/AEM.59.1.101-108.1993; TOWE KM, 1970, P NATL ACAD SCI USA, V65, P781, DOI 10.1073/pnas.65.4.781; TRUPER HG, 1982, PHILOS T ROY SOC B, V298, P529, DOI 10.1098/rstb.1982.0095; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987	61	619	668	6	194	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	1996	382	6587					127	132		10.1038/382127a0	http://dx.doi.org/10.1038/382127a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UW672	11536736				2022-12-01	WOS:A1996UW67200038
J	Cruzan, JD; Braly, LB; Liu, K; Brown, MG; Loeser, JG; Saykally, RJ				Cruzan, JD; Braly, LB; Liu, K; Brown, MG; Loeser, JG; Saykally, RJ			Quantifying hydrogen bond cooperativity in water: VRT spectroscopy of the water tetramer	SCIENCE			English	Article							INFRARED-LASER SPECTROMETERS; (H2O)20 CLUSTERS; MODEL (H2O)8; TRIMER; DYNAMICS; DIMER	Measurement of the far-infrared vibration-rotation tunneling spectrum of the perdeuterated water tetramer is described, Precisely determined rotational constants and relative intensity measurements indicate a cyclic quasi-planar minimum energy structure, which is in agreement with recent ab initio calculations, The O-O separation deduced from the data indicates a rapid exponential convergence to the ordered bulk value with increasing cluster size. Observed quantum tunneling splittings are interpreted in terms of hydrogen bond rearrangements connecting two degenerate structures.	UNIV CALIF BERKELEY,DEPT CHEM,BERKELEY,CA 94720	University of California System; University of California Berkeley				SAYKALLY, RICHARD/0000-0001-8942-3656				BELFORD D, 1987, J CHEM PHYS, V86, P7013, DOI 10.1063/1.452350; BLAKE GA, 1991, REV SCI INSTRUM, V62, P1701, DOI 10.1063/1.1142410; BLAKE GA, 1991, REV SCI INSTRUM, V62, P1693, DOI 10.1063/1.1142409; BRINK G, 1984, J PHYS CHEM-US, V88, P3412, DOI 10.1021/j150660a009; Bunker P.R., 2006, MOL SYMMETRY SPECTRO; DYKE TR, 1977, J CHEM PHYS, V66, P492, DOI 10.1063/1.433968; DYKE TR, 1977, J CHEM PHYS, V66, P498, DOI 10.1063/1.433969; DYKSTRA CE, 1989, J CHEM PHYS, V91, P6472, DOI 10.1063/1.457363; ELROD MJ, 1994, CHEM REV, V94, P1975, DOI 10.1021/cr00031a010; GREGORY JK, 1995, J CHEM PHYS, V102, P7817, DOI 10.1063/1.468982; Head-Gordon Martin, COMMUNICATION; KIM KS, 1986, CHEM PHYS LETT, V131, P451, DOI 10.1016/0009-2614(86)80564-4; KLOPPER W, 1995, CHEM PHYS LETT, V237, P536, DOI 10.1016/0009-2614(95)00342-2; LENTZ BR, 1973, J CHEM PHYS, V58, P5926; Liu K, 1996, SCIENCE, V271, P62, DOI 10.1126/science.271.5245.62; LIU K, 1994, FARADAY DISCUSS, V97, P35, DOI 10.1039/fd9949700035; LIU K, 1994, J AM CHEM SOC, V116, P3507, DOI 10.1021/ja00087a042; NARTEN AH, 1982, SCIENCE, V217, P1033, DOI 10.1126/science.217.4564.1033; OWICKI JC, 1975, J PHYS CHEM-US, V79, P1794, DOI 10.1021/j100584a010; PETERSON SW, 1957, ACTA CRYSTALLOGR, V10, P70, DOI 10.1107/S0365110X5700016X; PUGLIANO N, 1993, J CHEM PHYS, V98, P6600, DOI 10.1063/1.464803; PUGLIANO N, 1992, SCIENCE, V257, P1937, DOI 10.1126/science.1411509; SCHUTZ M, 1993, J CHEM PHYS, V99, P5228, DOI 10.1063/1.465991; SCHUTZ M, 1995, J CHEM PHYS, V103, P6114, DOI 10.1063/1.470439; SCHUTZ M, 1994, J CHEM PHYS, V100, P1780, DOI 10.1063/1.467292; STILLINGER FH, 1980, J CHEM PHYS, V73, P3384, DOI 10.1063/1.440534; SUZUKI S, 1994, CHEM PHYS LETT, V229, P499, DOI 10.1016/0009-2614(94)01056-0; WALES DJ, 1993, J CHEM PHYS, V98, P7257, DOI 10.1063/1.464717; WALES DJ, 1993, J AM CHEM SOC, V115, P11180, DOI 10.1021/ja00077a016; WALES DJ, 1993, J CHEM PHYS, V98, P7245, DOI 10.1063/1.464716; WALES DJ, 1993, J AM CHEM SOC, V115, P11191, DOI 10.1021/ja00077a017; WAWAK RJ, 1992, J PHYS CHEM-US, V96, P5138, DOI 10.1021/j100191a071; XANTHEAS SS, 1994, J CHEM PHYS, V100, P7523, DOI 10.1063/1.466846; XANTHEAS SS, 1993, J CHEM PHYS, V99, P8774, DOI 10.1063/1.465599; XANTHEAS SS, COMMUNICATION	35	385	392	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 5	1996	271	5245					59	62		10.1126/science.271.5245.59	http://dx.doi.org/10.1126/science.271.5245.59			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TP022	11536731				2022-12-01	WOS:A1996TP02200041
J	KOHNEN, MEL; SCHOUTEN, S; DAMSTE, JSS; DELEEUW, JW; MERRITT, DA; HAYES, JM				KOHNEN, MEL; SCHOUTEN, S; DAMSTE, JSS; DELEEUW, JW; MERRITT, DA; HAYES, JM			RECOGNITION OF PALEOBIOCHEMICALS BY A COMBINED MOLECULAR SULFUR AND ISOTOPE GEOCHEMICAL APPROACH	SCIENCE			English	Article							IMMATURE CRUDE OILS; BIOLOGICAL MARKERS; BOTRYOCOCCUS-BRAUNII; BLACK-SEA; SEDIMENTS; BACTERIA; LIPIDS; HYDROCARBONS; CARBON; IDENTIFICATION	Study of organic matter in immature sediments from a Messinian evaporitic basin shows that consideration of structures, modes of occurrence, and carbon isotopic compositions of free and sulfur-bound carbon skeletons allow identification of biochemical precursors. Detailed information concerning biotic communities present during deposition of sediments can be retrieved in this way. Moreover, unprecedented biochemicals were recognized; these extend the horizon of biomarker geochemistry.	DELFT UNIV TECHNOL,FAC CHEM TECHNOL & MAT SCI,ORGAN GEOCHEM UNIT,DE VRIES VAN HEYSTPLANTSOEN 2,2628 RZ DELFT,NETHERLANDS; INDIANA UNIV,DEPT CHEM,BIOGEOCHEM LAB,BLOOMINGTON,IN 47405; INDIANA UNIV,DEPT GEOL,BIOGEOCHEM LAB,BLOOMINGTON,IN 47405	Delft University of Technology; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington			de Leeuw, Jan W/F-6471-2011; Damste, Jaap S Sinninghe/F-6128-2011	Damste, Jaap S Sinninghe/0000-0002-8683-1854				BOON JJ, 1979, NATURE, V277, P125, DOI 10.1038/277125a0; BRASSELL SC, 1981, NATURE, V290, P693, DOI 10.1038/290693a0; BRAY EE, 1961, GEOCHIM COSMOCHIM AC, V22, P2, DOI 10.1016/0016-7037(61)90069-2; DAMSTE JSS, 1989, ORG GEOCHEM, V14, P555; DAMSTE JSS, 1990, ORG GEOCHEM, V16, P1077; DAMSTE JSS, 1988, ORG GEOCHEM, V13, P593; DAMSTE JSS, 1989, GEOCHIM COSMOCHIM AC, V53, P1343; DAMSTE JSS, 1990, NATURE, V345, P609, DOI 10.1038/345609a0; DEEVEY ES, 1964, LIMNOL OCEANOGR, V9, P1, DOI 10.4319/lo.1964.9.1.0001; Deines P., 1980, HDB ENV ISOTOPE GEOC, V1, P329, DOI DOI 10.1016/B978-0-444-41780-0.50015-8; DEROSA M, 1986, BIOCHIM BIOPHYS ACTA, V875, P487, DOI 10.1016/0005-2760(86)90068-8; DEROSA M, 1988, PROG LIPID RES, V27, P153, DOI 10.1016/0163-7827(88)90011-2; DEUSER WG, 1970, NATURE, V225, P1069, DOI 10.1038/2251069a0; Eglinton G., 1963, CHEM PLANT TAXONOMY, P87, DOI DOI 10.1016/B978-0-12-395540-1.50012-9; FREEMAN KH, 1990, NATURE, V343, P254, DOI 10.1038/343254a0; HAYES JM, 1990, ORG GEOCHEM, V16, P1115, DOI 10.1016/0146-6380(90)90147-R; HOLZER G, 1979, J CHROMATOGR, V186, P795, DOI 10.1016/S0021-9673(00)95296-8; JOHNSON JE, 1948, J AM CHEM SOC, V70, P3664, DOI 10.1021/ja01191a035; KOHNEN MEL, 1990, GEOCHIM COSMOCHIM AC, V54, P3053, DOI 10.1016/0016-7037(90)90121-Z; KOHNEN MEL, 1991, GEOCHIM COSMOCHIM AC, V55, P1375, DOI 10.1016/0016-7037(91)90315-V; KOHNEN MEL, 1990, ACS SYM SER, V429, P444; Liaaen-Jensen S., 1978, PHOTOSYNTHETIC BACTE, P233; Liaaen-Jensen S., 1978, MARINE NATURAL PRODU, V2, P1; METZGER P, 1987, TETRAHEDRON LETT, V28, P3931, DOI 10.1016/S0040-4039(00)96423-2; METZGER P, 1985, PHYTOCHEMISTRY, V24, P2305, DOI 10.1016/S0031-9422(00)83032-0; NICHOLS PD, 1988, J PHYCOL, V24, P90; OREMLAND RS, 1982, NATURE, V296, P143, DOI 10.1038/296143a0; OURISSON G, 1979, PURE APPL CHEM, V51, P709, DOI 10.1351/pac197951040709; OURISSON G, 1982, TRENDS BIOCHEM SCI, V7, P236, DOI 10.1016/0968-0004(82)90028-7; PANGANAMALA RV, 1971, CHEM PHYS LIPIDS, V7, P336, DOI 10.1016/0009-3084(71)90011-9; POPP BN, 1989, AM J SCI, V289, P436, DOI 10.2475/ajs.289.4.436; QUANDT L, 1977, FEMS MICROBIOL LETT, V1, P125, DOI 10.1016/0378-1097(77)90140-9; Risatti J.B., 1984, ORG GEOCHEM, V6, P93, DOI DOI 10.1016/0146-6380(84)90030-5; ROWLAND SJ, 1985, ORG GEOCHEM, V8, P207, DOI 10.1016/0146-6380(85)90028-2; SIREVAG R, 1977, ARCH MICROBIOL, V112, P35, DOI 10.1007/BF00446651; SUMMONS RE, 1986, NATURE, V319, P763, DOI 10.1038/319763a0; SUMMONS RE, 1987, GEOCHIM COSMOCHIM AC, V51, P557, DOI 10.1016/0016-7037(87)90069-X; TORGERSEN T, 1981, LIMNOL OCEANOGR, V26, P110, DOI 10.4319/lo.1981.26.1.0110; VAI G B, 1977, Sedimentology, V24, P211, DOI 10.1111/j.1365-3091.1977.tb00255.x; VOLKMAN JK, 1980, PHYTOCHEMISTRY, V19, P2619, DOI 10.1016/S0031-9422(00)83930-8; WAKEHAM SG, 1990, GEOCHIM COSMOCHIM AC, V54, P1325, DOI 10.1016/0016-7037(90)90157-G; [No title captured]; [No title captured]; [No title captured]; [No title captured]	45	141	144	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	APR 17	1992	256	5055					358	362		10.1126/science.256.5055.358	http://dx.doi.org/10.1126/science.256.5055.358			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP032	11540057				2022-12-01	WOS:A1992HP03200030
J	HICKS, GR; RAYLE, DL; LOMAX, TL				HICKS, GR; RAYLE, DL; LOMAX, TL			THE DIAGEOTROPICA MUTANT OF TOMATO LACKS HIGH SPECIFIC ACTIVITY AUXIN BINDING-SITES	SCIENCE			English	Article									OREGON STATE UNIV, DEPT BOT & PLANT PATHOL, CORVALLIS, OR 97331 USA; OREGON STATE UNIV, CTR GENE RES & BIOTECHNOL, CORVALLIS, OR 97331 USA; SAN DIEGO STATE UNIV, DEPT BIOL, SAN DIEGO, CA 92182 USA; SAN DIEGO STATE UNIV, INST MOLEC BIOL, SAN DIEGO, CA 92182 USA	Oregon State University; Oregon State University; California State University System; San Diego State University; California State University System; San Diego State University					NIDCD NIH HHS [DCB-8718731] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BRADFORD KJ, 1980, PLANT PHYSIOL, V65, P327, DOI 10.1104/pp.65.2.327; CROSS JW, 1985, PLANT CELL ENVIRON, V8, P351, DOI 10.1111/j.1365-3040.1985.tb01410.x; DANIEL SG, IN PRESS PLANT PHYSL; FUJINO DW, 1988, PLANT PHYSIOL, V88, P780, DOI 10.1104/pp.88.3.780; HEUKESHOVEN J, 1985, ELECTROPHORESIS, V6, P103, DOI 10.1002/elps.1150060302; HICKS GR, IN PRESS P NATL ACAD; JACKSON MB, 1979, PHYSIOL PLANTARUM, V46, P347, DOI 10.1111/j.1399-3054.1979.tb02631.x; JONES AM, 1984, PLANT PHYSIOL, V74, P295, DOI 10.1104/pp.74.2.295; JONES AM, 1984, PLANT PHYSIOL, V75, P1111, DOI 10.1104/pp.75.4.1111; KELLY MO, 1986, PLANT PHYSIOL, V82, P713, DOI 10.1104/pp.82.3.713; Libbenga K. R., 1987, Plant hormones and their role in plant growth and development., P194; MELHADO LL, 1981, PLANT PHYSIOL, V68, P469, DOI 10.1104/pp.68.2.469; RUBERY PH, 1981, ANNU REV PLANT PHYS, V32, P569, DOI 10.1146/annurev.pp.32.060181.003033; SPECTOR T, 1978, ANAL BIOCHEM, V86, P142, DOI 10.1016/0003-2697(78)90327-5; Venis M., 1985, HORMONE BINDING SITE; WIGHTMAN F, 1980, PHYSIOL PLANTARUM, V49, P304, DOI 10.1111/j.1399-3054.1980.tb02669.x; ZOBEL RW, 1972, J HERED, V63, P94, DOI 10.1093/oxfordjournals.jhered.a108241; ZOBEL RW, 1974, CAN J BOT, V52, P735, DOI 10.1139/b74-095; ZOBEL RW, 1973, PLANT PHYSIOL, V52, P385, DOI 10.1104/pp.52.4.385	19	71	71	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	1989	245	4913					52	54		10.1126/science.245.4913.52	http://dx.doi.org/10.1126/science.245.4913.52			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD786	11537490				2022-12-01	WOS:A1989AD78600029
J	Bayes-Genis, A; Conover, CA; Overgaard, MT; Bailey, KR; Christiansen, M; Holmes, DR; Virmani, R; Oxvig, C; Schwartz, RS				Bayes-Genis, A; Conover, CA; Overgaard, MT; Bailey, KR; Christiansen, M; Holmes, DR; Virmani, R; Oxvig, C; Schwartz, RS			Pregnancy-associated plasma protein a as a marker of acute coronary syndromes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MAJOR BASIC-PROTEIN; GROWTH-FACTOR-I; ACUTE MYOCARDIAL-INFARCTION; CARDIAC TROPONIN-T; EMERGENCY ROOM; CHEST PAIN; ATHEROSCLEROSIS; SERUM; RISK; EXPRESSION	Background: Circulating markers indicating the instability of atherosclerotic plaques could have diagnostic value in unstable angina or acute myocardial infarction. We evaluated pregnancy-associated plasma protein A (PAPP-A), a potentially proatherosclerotic metalloproteinase, as a marker of acute coronary syndromes. Methods: We examined the level of expression of PAPP-A in eight culprit unstable coronary plaques and four stable plaques from eight patients who had died suddenly of cardiac causes. We also measured circulating levels of PAPP-A, C-reactive protein, and insulin-like growth factor I (IGF-I) in 17 patients with acute myocardial infarction, 20 with unstable angina, 19 with stable angina, and 13 controls without atherosclerosis. Results: PAPP-A was abundantly expressed in plaque cells and extracellular matrix of ruptured and eroded unstable plaques, but not in stable plaques. Circulating PAPP-A levels were significantly higher in patients with unstable angina or acute myocardial infarction than in patients with stable angina and controls (P<0.001). A PAPP-A threshold value of 10 mIU per liter identified patients who had acute coronary syndromes with a sensitivity of 89.2 percent and a specificity of 81.3 percent. PAPP-A levels correlated with levels of C-reactive protein and free IGF-I, but not with markers of myocardial injury (troponin I and the MB isoform of creatine kinase). Conclusions: PAPP-A is present in unstable plaques, and circulating levels are elevated in acute coronary syndromes; these increased levels may reflect the instability of atherosclerotic plaques. PAPP-A is a new candidate marker of unstable angina and acute myocardial infarction. (N Engl J Med 2001;345:1022-9.) Copyright (C) 2001 Massachusetts Medical Society.	Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Endocrine Res Unit, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Stat, Rochester, MN 55905 USA; Univ Aarhus, Dept Biol Mol & Struct, Aarhus, Denmark; Statens Serum Inst, Dept Clin Biochem, DK-2300 Copenhagen, Denmark; Armed Forces Inst Pathol, Dept Cardiovasc Pathol, Washington, DC 20306 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Aarhus University; Statens Serum Institut; United States Department of Defense	Schwartz, RS (corresponding author), Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, 200 1st St SW, Rochester, MN 55905 USA.		Overgaard, Michael Toft/E-1354-2011; Bayes-Genis, Antoni/C-4002-2015; Bayes-Genis, Antonio/AAV-9422-2021; Christiansen, Michael/B-4588-2009	Overgaard, Michael Toft/0000-0002-1423-2481; Bayes-Genis, Antoni/0000-0002-3044-197X; Bayes-Genis, Antonio/0000-0002-3044-197X; Christiansen, Michael/0000-0003-4713-755X; Oxvig, Claus/0000-0002-4715-9719				Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; Bayes-Genis A, 2001, ARTERIOSCL THROM VAS, V21, P335, DOI 10.1161/01.ATV.21.3.335; Bayes-Genis A, 2000, CIRC RES, V86, P125, DOI 10.1161/01.RES.86.2.125; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; Christiansen M, 2000, CLIN CHEM, V46, P1099; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DEWINTER RJ, 1995, CIRCULATION, V92, P3401, DOI 10.1161/01.CIR.92.12.3401; DU J, 1995, CIRC RES, V76, P963, DOI 10.1161/01.RES.76.6.963; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; GALIS ZS, 1995, P NATL ACAD SCI USA, V92, P402, DOI 10.1073/pnas.92.2.402; Hamm CW, 1997, NEW ENGL J MED, V337, P1648, DOI 10.1056/NEJM199712043372302; JENKINS PJ, 1978, BMJ-BRIT MED J, V2, P388, DOI 10.1136/bmj.2.6134.388; Jones JI, 1996, P NATL ACAD SCI USA, V93, P2482, DOI 10.1073/pnas.93.6.2482; Kontos MC, 1997, J AM COLL CARDIOL, V30, P976, DOI 10.1016/S0735-1097(97)00264-7; Lawrence JB, 1999, P NATL ACAD SCI USA, V96, P3149, DOI 10.1073/pnas.96.6.3149; LIN TM, 1974, AM J OBSTET GYNECOL, V118, P223, DOI 10.1016/0002-9378(74)90553-5; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Newby LK, 2000, AM HEART J, V140, P351, DOI 10.1067/mhj.2000.108824; Nichols TC, 1999, CIRC RES, V85, P1040; NIKKARI ST, 1995, CIRCULATION, V92, P1393, DOI 10.1161/01.CIR.92.6.1393; Ohman EM, 1996, NEW ENGL J MED, V335, P1333, DOI 10.1056/NEJM199610313351801; Overgaard MT, 1999, BIOL REPROD, V61, P1083, DOI 10.1095/biolreprod61.4.1083; OXVIG C, 1995, J BIOL CHEM, V270, P13645, DOI 10.1074/jbc.270.23.13645; OXVIG C, 1994, BBA-GEN SUBJECTS, V1201, P415, DOI 10.1016/0304-4165(94)90071-X; PULEO PR, 1994, NEW ENGL J MED, V331, P561, DOI 10.1056/NEJM199409013310901; Qin QP, 1997, CLIN CHEM, V43, P2323; Renier G, 1996, ENDOCRINOLOGY, V137, P4611, DOI 10.1210/en.137.11.4611; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SABIA P, 1991, CIRCULATION, V84, pI85; Wald NJ, 1999, NEW ENGL J MED, V341, P461, DOI 10.1056/NEJM199908123410701	32	462	560	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2001	345	14					1022	1029		10.1056/NEJMoa003147	http://dx.doi.org/10.1056/NEJMoa003147			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478HF	11586954	Bronze			2022-12-01	WOS:000171340400003
J	Ramsey, JD; Butcher, MA; Murphy, MF; Lee, T; Johnston, A; Holt, DW				Ramsey, JD; Butcher, MA; Murphy, MF; Lee, T; Johnston, A; Holt, DW			A new method to monitor drugs at dance venues	BRITISH MEDICAL JOURNAL			English	Article							ECSTASY		Univ London St Georges Hosp, Sch Med, London SW17 0RE, England; Univ London Kings Coll, London SE1 8WA, England; St Bartholomews & Royal London Sch Med & Dent, London EC1M 6BQ, England	St Georges University London; University of London; King's College London; University of London; Queen Mary University London	Holt, DW (corresponding author), Univ London St Georges Hosp, Sch Med, London SW17 0RE, England.			Johnston, Atholl/0000-0001-5787-2270				MOFFAT AC, 1986, CLARKES ISOLATION ID, P139; Ramsey JD, 1999, LANCET, V354, P2166, DOI 10.1016/S0140-6736(05)77071-9; RAMSEY JD, 1999, TICTAC VERSION 4 4; Sherlock K, 1999, J ACCID EMERG MED, V16, P194	4	30	30	1	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 15	2001	323	7313					603	603		10.1136/bmj.323.7313.603	http://dx.doi.org/10.1136/bmj.323.7313.603			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474CT	11557708	Bronze, Green Published			2022-12-01	WOS:000171087300019
J	Uplekar, M; Pathania, V; Raviglione, M				Uplekar, M; Pathania, V; Raviglione, M			Private practitioners and public health: weak links in tuberculosis control	LANCET			English	Editorial Material							GENERAL-PRACTITIONERS; INDIA; CLINICS		WHO, Stop TB Dept, CH-1211 Geneva, Switzerland	World Health Organization	Uplekar, M (corresponding author), WHO, Stop TB Dept, CH-1211 Geneva, Switzerland.			RAVIGLIONE, Mario/0000-0002-9331-2067				FUJIWARA PI, 1996, TUBERCLE LUNG DIS S2, V77, P72; GRIFFIN C, 1989, 4 IFC WORLD BANK; Hong YP, 1999, INT J TUBERC LUNG D, V3, P695; Kamat V. R., 1997, PRIVATE HLTH PROVIDE, P124; LONROTH K, 2000, PUBLIC HLTH PRIVATE; LONROTH K, IN PRESS HLTH POL PL; *NAT COUNC APPL EC, 1995, 53 NCAER; Pathania V, 1997, WHOTB972231997; Reich MR, 2000, NAT MED, V6, P617, DOI 10.1038/76176; Singla N, 1998, INT J TUBERC LUNG D, V2, P384; TAYLOR E, 1999, TUBERCULOSIS AN INTE; Uplekar M, 1998, INT J TUBERC LUNG D, V2, P324; UPLEKAR M, 1996, SEARCH SOLUTIONS; UPLEKAR MW, 1991, TUBERCLE, V72, P284, DOI 10.1016/0041-3879(91)90055-W; Weil DEC, 2000, INT J TUBERC LUNG D, V4, P597; *WHO, 1995, WHOTB96202; *WHO, 2000, WHOCDSTB2000282; *WHO, 2000, WHOCDSTB2000	18	196	197	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 15	2001	358	9285					912	916		10.1016/S0140-6736(01)06076-7	http://dx.doi.org/10.1016/S0140-6736(01)06076-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474CP	11567729				2022-12-01	WOS:000171087000030
J	Mokdad, AH; Bowman, BA; Ford, ES; Vinicor, F; Marks, JS; Koplan, JP				Mokdad, AH; Bowman, BA; Ford, ES; Vinicor, F; Marks, JS; Koplan, JP			The continuing epidemics of obesity and diabetes in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPAIRED GLUCOSE-TOLERANCE; RISK FACTOR SURVEILLANCE; WEIGHT-GAIN; HEALTH; MELLITUS; US; PREVENTION; PREVALENCE; OVERWEIGHT; EXERCISE	Context Recent reports show that obesity and diabetes have increased in the United States in the past decade. Objective To estimate the prevalence of obesity, diabetes, and use of weight control strategies among US adults in 2000. Design, Setting, and Participants The Behavioral Risk Factor Surveillance System, a random-digit telephone survey conducted in all states in 2000, with 184450 adults aged 18 years or older. Main Outcome Measures Body mass index (BMI), calculated from self-reported weight and height; self-reported diabetes; prevalence of weight loss or maintenance attempts; and weight control strategies used. Results In 2000, the prevalence of obesity (BMI greater than or equal to 30 kg/m(2)) was 19.8%, the prevalence of diabetes was 7.3% and the prevalence of both combined was 2.9%. Mississippi had the highest rates of obesity (24.3%) and of diabetes (8.8%); Colorado had the lowest rate of obesity (13.8%); and Alaska had the lowest rate of diabetes (4.4%). Twenty-seven percent of US adults did not engage in any physical activity, and another 28.2% were not regularly active. Only 24.4% of US adults consumed fruits and vegetables 5 or more times daily. Among obese participants who had had a routine checkup during the past year, 42.8% had been advised by a health care professional to lose weight. Among participants trying to lose or maintain weight, 17.5% were following recommendations to eat fewer calories and increase physical activity to more than 150 min/wk. Conclusions The prevalence of obesity and diabetes continues to increase among US adults. Interventions are needed to improve physical activity and diet in communities nationwide.	Ctr Dis Control & Prevent, Data Management Div, Natl Immunizat Program, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Div Nutr & Phys Activ, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Off Director, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Mokdad, AH (corresponding author), Ctr Dis Control & Prevent, Data Management Div, Natl Immunizat Program, MS E62,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	ahm1@cdc.gov						ADAY LA, 1989, DESIGNING CONDUCTING, P79; Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; *AM DIAB ASS, 1997, DIAB FACTS FIG; CASPERSEN CJ, 1987, DHHS PUBLICATION PHS; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Colditz GA, 1999, MED SCI SPORT EXER, V31, pS663, DOI 10.1097/00005768-199911001-00026; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196; Fontaine K.R., 1998, DIS MANAGEMENT HLTH, V3, P61; Fontanarosa PB, 1999, JAMA-J AM MED ASSOC, V282, P1581, DOI 10.1001/jama.282.16.1581; Ford ES, 2001, OBES RES, V9, P21, DOI 10.1038/oby.2001.4; Ford ES, 1997, AM J EPIDEMIOL, V146, P214, DOI 10.1093/oxfordjournals.aje.a009256; Ford ES, 1998, J CLIN EPIDEMIOL, V51, P55, DOI 10.1016/S0895-4356(97)00225-4; Galuska DA, 1999, JAMA-J AM MED ASSOC, V282, P1576, DOI 10.1001/jama.282.16.1576; HANSEN RG, 1995, J IND ECON, V43, P261, DOI 10.2307/2950579; Harris MI, 1998, DIABETES CARE, V21, pC11, DOI 10.2337/diacare.21.3.C11; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; HOLBROOK TL, 1989, INT J OBESITY, V13, P723; Koplan JP, 1999, JAMA-J AM MED ASSOC, V282, P1579, DOI 10.1001/jama.282.16.1579; Li RW, 2000, AM J PUBLIC HEALTH, V90, P777, DOI 10.2105/AJPH.90.5.777; Mokdad AH, 2000, JAMA-J AM MED ASSOC, V284, P1650, DOI 10.1001/jama.284.13.1650; Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278; Mokdad AH, 2001, DIABETES CARE, V24, P412, DOI 10.2337/diacare.24.2.412; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; NELSON DE, 1998, P SECT SURV METH AM; NHLBI Obesity Education Initiative Expert Panel on the Identi-fication E and T of O in A (US), 1998, CLIN GUID ID EV TREA; PALTA M, 1982, AM J EPIDEMIOL, V115, P223, DOI 10.1093/oxfordjournals.aje.a113294; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; PISUNYER FX, 1991, AM J CLIN NUTR, V53, pS1595; PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006; Ray NF, 1998, DIABETES CARE, V21, P296; REMINGTON PL, 1988, PUBLIC HEALTH REP, V103, P366; Resnick HE, 2000, J EPIDEMIOL COMMUN H, V54, P596, DOI 10.1136/jech.54.8.596; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125, DOI 10.1093/ajcn/52.6.1125; *SAS I INC, 1998, SAS VERS 6; Serdula MK, 1999, JAMA-J AM MED ASSOC, V282, P1353, DOI 10.1001/jama.282.14.1353; SHAH BV, 1997, SUDAAN USERS MANUAL; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; World Health Organization Expert Committee on Physical Status, 1995, WHO TECHN REP SER, V854	39	1883	1941	1	138	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1195	1200		10.1001/jama.286.10.1195	http://dx.doi.org/10.1001/jama.286.10.1195			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471CR	11559264	Bronze			2022-12-01	WOS:000170910400029
J	Schwetz, BA				Schwetz, BA			Treatment for hepatitis C	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1166	1166		10.1001/jama.286.10.1166	http://dx.doi.org/10.1001/jama.286.10.1166			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471CR	11559244				2022-12-01	WOS:000170910400006
J	Ishigaki, Y; Li, XJ; Serin, G; Maquat, LE				Ishigaki, Y; Li, XJ; Serin, G; Maquat, LE			Evidence for a pioneer round of mRNA translation: mRNAs subject to nonsense-mediated decay in mammalian cells are bound by CBP80 and CBP20	CELL			English	Article							CAP-BINDING PROTEIN; GLUTATHIONE-PEROXIDASE 1; INITIATION-FACTOR 4E; POLY(A)-BINDING PROTEIN; RIBONUCLEOPROTEIN PARTICLE; UPF PROTEINS; FACTOR 4G; NUCLEAR; COMPLEX; YEAST	Nonsense-mediated decay (NMD) eliminates mRNAs that prematurely terminate translation. We used antibody to the nuclear cap binding protein CBP80 or its cytoplasmic counterpart eIF4E to immunopurify RNP containing nonsense-free or nonsense-containing transcripts. Data indicate that NMD takes place in association with CBP80. We defined other components of NMD-susceptible mRNP as CBP20, PABP2, eIF4G, and the NMD factors Upf2 and Upf3. Consistent with the dependence of NMD on translation, the NMD of CBP80-bound mRNA is blocked by cycloheximide or suppressor tRNA. These findings provide evidence that translation can take place in association with CBP80. They also indicate that CBP80-bound mRNA undergoes a "pioneer" round of translation, before CBP80-CBP20 are replaced by eIF4E, and Upf2 and Upf3 proteins dissociate from upstream of exon-exon junctions.	Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Maquat, LE (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	lynne_maquat@urmc.rochester.edu		Maquat, Lynne/0000-0002-2789-2075	NIDDK NIH HHS [DK 33938] Funding Source: Medline; NIGMS NIH HHS [GM 59614] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059614] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BELGRADER P, 1994, MOL CELL BIOL, V14, P6326, DOI 10.1128/MCB.14.9.6326; BELGRADER P, 1993, P NATL ACAD SCI USA, V90, P482, DOI 10.1073/pnas.90.2.482; BELGRADER P, 1994, MOL CELL BIOL, V14, P8219, DOI 10.1128/MCB.14.12.8219; Bhattacharya A, 2000, RNA, V6, P1226, DOI 10.1017/S1355838200000546; BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x; Carter MS, 1996, EMBO J, V15, P5965, DOI 10.1002/j.1460-2075.1996.tb00983.x; Chu E, 1999, METH MOL B, V118, P265; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; Das B, 2000, MOL CELL BIOL, V20, P2827, DOI 10.1128/MCB.20.8.2827-2838.2000; Dostie J, 2000, J CELL BIOL, V148, P239, DOI 10.1083/jcb.148.2.239; Fortes P, 2000, MOL CELL, V6, P191, DOI 10.1016/S1097-2765(00)00020-4; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; HARLOW E, 1999, USING ANTIBODIES LAB, P74; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Hentze MW, 1997, SCIENCE, V275, P500, DOI 10.1126/science.275.5299.500; Imataka H, 1998, EMBO J, V17, P7480, DOI 10.1093/emboj/17.24.7480; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; IZAURRALDE E, 1995, NATURE, V376, P709, DOI 10.1038/376709a0; Kessler SH, 1998, MOL CELL BIOL, V18, P51, DOI 10.1128/MCB.18.1.51; KRAUSE S, 1994, EXP CELL RES, V214, P75, DOI 10.1006/excr.1994.1235; KUGLER W, 1995, NUCLEIC ACIDS RES, V23, P413, DOI 10.1093/nar/23.3.413; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2000, GENE DEV, V14, P1098; LEJBKOWICZ F, 1992, P NATL ACAD SCI USA, V89, P9612, DOI 10.1073/pnas.89.20.9612; Lewis JD, 1997, EUR J BIOCHEM, V247, P461, DOI 10.1111/j.1432-1033.1997.00461.x; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Maquat LE, 2000, COLD SPRING HARBOR M, V39, P849; Maquat LE, 2001, CELL, V104, P173, DOI 10.1016/S0092-8674(01)00202-1; MAQUAT LE, 1995, RNA, V1, P453; MAQUAT LE, 2001, IN PRESS COLD SPRING; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; McKendrick L, 2001, MOL CELL BIOL, V21, P3632, DOI 10.1128/MCB.21.11.3632-3641.2001; MEHLIN H, 1992, CELL, V69, P605, DOI 10.1016/0092-8674(92)90224-Z; Mendell JT, 2000, MOL CELL BIOL, V20, P8944, DOI 10.1128/MCB.20.23.8944-8957.2000; Moriarty PM, 1998, MOL CELL BIOL, V18, P2932, DOI 10.1128/MCB.18.5.2932; Morley SJ, 1997, J BIOL CHEM, V272, P17887, DOI 10.1074/jbc.272.28.17887; NEMETH A, 1995, NUCLEIC ACIDS RES, V23, P4034, DOI 10.1093/nar/23.20.4034; Orphanides G, 2000, NATURE, V407, P471, DOI 10.1038/35035000; Pal M, 2001, RNA, V7, P5, DOI 10.1017/S1355838201000127; Ptushkina M, 1998, EMBO J, V17, P4798, DOI 10.1093/emboj/17.16.4798; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Rajavel KS, 2001, MOL CELL BIOL, V21, P5512, DOI 10.1128/MCB.21.16.5512-5519.2001; Sachs AB, 2000, NAT STRUCT BIOL, V7, P356, DOI 10.1038/75120; Serin G, 2001, MOL CELL BIOL, V21, P209, DOI 10.1128/MCB.21.1.209-223.2001; Shen EC, 2000, J BIOL CHEM, V275, P23718, DOI 10.1074/jbc.M002312200; Sun XL, 2000, EMBO J, V19, P4734, DOI 10.1093/emboj/19.17.4734; Sun XL, 1998, P NATL ACAD SCI USA, V95, P10009, DOI 10.1073/pnas.95.17.10009; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Visa N, 1996, J CELL BIOL, V133, P5, DOI 10.1083/jcb.133.1.5; WAHLE E, 1993, J BIOL CHEM, V268, P2937; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; Wang WR, 2001, EMBO J, V20, P880, DOI 10.1093/emboj/20.4.880; WIGLER M, 1979, CELL, V16, P777, DOI 10.1016/0092-8674(79)90093-X; Zhang J, 1998, MOL CELL BIOL, V18, P5272, DOI 10.1128/MCB.18.9.5272; Zhang J, 1998, RNA, V4, P801, DOI 10.1017/S1355838298971849	55	445	457	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2001	106	5					607	617		10.1016/S0092-8674(01)00475-5	http://dx.doi.org/10.1016/S0092-8674(01)00475-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551508	Bronze			2022-12-01	WOS:000170973200011
J	Kielkopf, CL; Rodionova, NA; Green, MR; Burley, SK				Kielkopf, CL; Rodionova, NA; Green, MR; Burley, SK			A novel peptide recognition mode revealed by the X-ray structure of a core U2AF-(35)/U2AF(65) heterodimer	CELL			English	Article							SPLICING FACTOR U2AF(35); PRE-MESSENGER-RNA; RIBONUCLEOPROTEIN AUXILIARY FACTOR; PROLINE-RICH LIGANDS; BINDING PROTEINS; SMALL-SUBUNIT; SH3 DOMAINS; WW DOMAIN; U2 SNRNP; SITE AG	U2 auxiliary factor (U2AF) is an essential splicing factor that recognizes the 3' splice site and recruits the U2 snRNP to the branch point. The X-ray structure of the human core U2AF heterodimer, consisting of the U2AF(35) central domain and a proline-rich region of U2AF(65), has been determined at 2.2 Angstrom resolution. The structure reveals a novel protein-protein recognition strategy, in which an atypical RNA recognition motif (RRM) of U2AF(35) and the U2AF(65) polyproline segment interact via reciprocal "tongue-in-groove" tryptophan residues. Complementary biochemical experiments demonstrate that the core U2AF heterodimer binds RNA, and that the interacting tryptophan side chains are essential for U2AF dimerization. Atypical RRMs in other splicing factors may serve as protein-protein interaction motifs elsewhere during spliceosome assembly.	Rockefeller Univ, Lab Mol Biophys, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Programs Gene Funct & Express, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Burley, SK (corresponding author), Rockefeller Univ, Lab Mol Biophys, 1230 York Ave, New York, NY 10021 USA.	burley@rockvax.rockefeller.edu		Kielkopf, Clara/0000-0002-7648-8271; Burley, Stephen/0000-0002-2487-9713				ALEXANDROPOULOS K, 1995, P NATL ACAD SCI USA, V92, P3110, DOI 10.1073/pnas.92.8.3110; Antson AA, 2000, CURR OPIN STRUC BIOL, V10, P87, DOI 10.1016/S0959-440X(99)00054-8; Bedford MT, 1997, EMBO J, V16, P2376, DOI 10.1093/emboj/16.9.2376; Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858; BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Creighton TE, 1993, PROTEINS STRUCTURES; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Fleckner J, 1997, GENE DEV, V11, P1864, DOI 10.1101/gad.11.14.1864; Gozani O, 1998, MOL CELL BIOL, V18, P4752, DOI 10.1128/MCB.18.8.4752; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Hertel KJ, 1997, CURR OPIN CELL BIOL, V9, P350, DOI 10.1016/S0955-0674(97)80007-5; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; KANAAR R, 1993, SCIENCE, V262, P569, DOI 10.1126/science.7692602; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee CH, 1998, METH MOL B, V84, P3; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Mahoney NM, 1999, NAT STRUCT BIOL, V6, P666, DOI 10.1038/10722; McKinney R, 1997, CURR GENET, V32, P323, DOI 10.1007/s002940050284; Merendino L, 1999, NATURE, V402, P838, DOI 10.1038/45602; MUSACCHIO A, 1994, NAT STRUCT BIOL, V1, P546, DOI 10.1038/nsb0894-546; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page-McCaw PS, 1999, RNA, V5, P1548, DOI 10.1017/S1355838299991938; POTASHKIN J, 1993, SCIENCE, V262, P573, DOI 10.1126/science.8211184; Price SR, 1998, NATURE, V394, P645, DOI 10.1038/29234; Reed R, 2000, CURR OPIN CELL BIOL, V12, P340, DOI 10.1016/S0955-0674(00)00097-1; Rudner DZ, 1998, MOL CELL BIOL, V18, P1765, DOI 10.1128/MCB.18.4.1765; Rudner DZ, 1996, P NATL ACAD SCI USA, V93, P10333, DOI 10.1073/pnas.93.19.10333; Rudner DZ, 1998, MOL CELL BIOL, V18, P4004, DOI 10.1128/MCB.18.7.4004; Sanchez R, 2000, METH MOL B, V143, P97; Simpson GG, 1996, PLANT MOL BIOL, V32, P1, DOI 10.1007/BF00039375; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tronchere H, 1997, NATURE, V388, P397, DOI 10.1038/41137; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Wang XQ, 2001, NAT STRUCT BIOL, V8, P141, DOI 10.1038/84131; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Wu SP, 1999, NATURE, V402, P832, DOI 10.1038/45590; Yan D, 1998, MOL CELL BIOL, V18, P5000, DOI 10.1128/MCB.18.9.5000; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0; ZAMORE PD, 1989, P NATL ACAD SCI USA, V86, P9243, DOI 10.1073/pnas.86.23.9243; ZHANG M, 1992, P NATL ACAD SCI USA, V89, P8769, DOI 10.1073/pnas.89.18.8769; Zorio DAR, 1999, NATURE, V402, P835, DOI 10.1038/45597; Zorio DAR, 1999, RNA, V5, P487, DOI 10.1017/S1355838299982225; Zuo P, 1996, GENE DEV, V10, P1356, DOI 10.1101/gad.10.11.1356	52	167	169	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2001	106	5					595	605		10.1016/S0092-8674(01)00480-9	http://dx.doi.org/10.1016/S0092-8674(01)00480-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551507	Bronze			2022-12-01	WOS:000170973200010
J	Kim, VN; Kataoka, N; Dreyfuss, G				Kim, VN; Kataoka, N; Dreyfuss, G			Role of the nonsense-mediated decay factor hUpf3 in the splicing-dependent exon-exon junction complex	SCIENCE			English	Article							PRE-MESSENGER-RNA; TRANSLATIONAL TERMINATION CODON; OPEN READING FRAME; NUCLEAR EXPORT; BINDING-PROTEINS; HNRNP PROTEINS; K-PROTEIN; SURVEILLANCE; YEAST; IDENTIFICATION	Nonsense-mediated messenger RNA (mRNA) decay, or NMD, is a critical process of selective degradation of mRNAs that contain premature stop codons. NMD depends on both pre-mRNA splicing and translation, and it requires recognition of the position of stop codons relative to exon-exon junctions. A key factor in NMD is hUpf3, a mostly nuclear protein that shuttles between the nucleus and cytoplasm and interacts specifically with spliced mRNAs. We found that hUpf3 interacts with Y14, a component of post-splicing mRNA-protein (mRNP) complexes, and that hUpf3 is enriched in Y14-containing mRNP complexes. The mRNA export factors Aly/REF and TAP are also associated with nuclear hUpf3, indicating that hUpf3 is in mRNP complexes that are poised for nuclear export. Like Y14 and Aly/REF, hUpf3 binds to spliced mRNAs specifically (similar to 20 nucleotides) upstream of exon-exon junctions. The splicing-dependent binding of hUpf3 to mRNAs before export, as part of the complex that assembles near exon-exon junctions, allows it to serve as a link between splicing and NMD in the cytoplasm.	Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania	Dreyfuss, G (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.	gdreyfuss@hhmi.upenn.edu	Dreyfuss, Gideon/D-1218-2013; Kataoka, Naoyuki/H-6298-2019	Dreyfuss, Gideon/0000-0001-8129-8774; Kataoka, Naoyuki/0000-0002-4498-7420	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037125] Funding Source: NIH RePORTER; NIGMS NIH HHS [5 R01 GM37125.14] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aoufouchi S, 1996, CELL, V85, P415, DOI 10.1016/S0092-8674(00)81119-8; Applequist SE, 1997, NUCLEIC ACIDS RES, V25, P814, DOI 10.1093/nar/25.4.814; Atkin AL, 1997, J BIOL CHEM, V272, P22163, DOI 10.1074/jbc.272.35.22163; Blencowe BJ, 1998, GENE DEV, V12, P996, DOI 10.1101/gad.12.7.996; BOCHNIG P, 1987, EUR J BIOCHEM, V168, P461, DOI 10.1111/j.1432-1033.1987.tb13439.x; Brogna S, 1999, RNA, V5, P562, DOI 10.1017/S1355838299981359; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; CHOI YD, 1984, P NATL ACAD SCI-BIOL, V81, P7471, DOI 10.1073/pnas.81.23.7471; CUI Y, 1995, GENE DEV, V9, P423, DOI 10.1101/gad.9.4.423; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; DIETZ HC, 1994, NAT GENET, V8, P183, DOI 10.1038/ng1094-183; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Gersappe A, 1999, MOL CELL BIOL, V19, P1640; He F, 1996, RNA, V2, P153; HE F, 1995, GENE DEV, V9, P437, DOI 10.1101/gad.9.4.437; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; Kim VN, 2001, EMBO J, V20, P2062, DOI 10.1093/emboj/20.8.2062; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2000, GENE DEV, V14, P1098; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; Li SL, 1998, IMMUNITY, V8, P135, DOI 10.1016/S1074-7613(00)80466-5; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; Lykke-Andersen J, 2001, CURR BIOL, V11, pR88, DOI 10.1016/S0960-9822(01)00036-7; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Maquat LE, 2001, CELL, V104, P173, DOI 10.1016/S0092-8674(01)00202-1; Matsumoto K, 1998, EMBO J, V17, P2107, DOI 10.1093/emboj/17.7.2107; MATUNIS EL, 1993, J CELL BIOL, V121, P219, DOI 10.1083/jcb.121.2.219; Mayeda A, 1999, EMBO J, V18, P4560, DOI 10.1093/emboj/18.16.4560; McGarvey T, 2000, J CELL BIOL, V150, P309, DOI 10.1083/jcb.150.2.309; Mendell JT, 2000, MOL CELL BIOL, V20, P8944, DOI 10.1128/MCB.20.23.8944-8957.2000; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; MICHAEL WM, 1995, CELL, V83, P415; Moriarty PM, 1998, MOL CELL BIOL, V18, P2932, DOI 10.1128/MCB.18.5.2932; Ohno M, 1996, GENE DEV, V10, P997, DOI 10.1101/gad.10.8.997; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Perlick HA, 1996, P NATL ACAD SCI USA, V93, P10928, DOI 10.1073/pnas.93.20.10928; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; Serin G, 2001, MOL CELL BIOL, V21, P209, DOI 10.1128/MCB.21.1.209-223.2001; Shyu AB, 2000, CELL, V102, P135, DOI 10.1016/S0092-8674(00)00018-0; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Siomi MC, 1997, J CELL BIOL, V138, P1181, DOI 10.1083/jcb.138.6.1181; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Wang WR, 2001, EMBO J, V20, P880, DOI 10.1093/emboj/20.4.880; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	46	236	249	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1832	1836		10.1126/science.1062829	http://dx.doi.org/10.1126/science.1062829			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546873				2022-12-01	WOS:000170894400048
J	McMahon, SM; Miller, KH; Drake, J				McMahon, SM; Miller, KH; Drake, J			Social science and ecology - Networking tips for social scientists and ecologists	SCIENCE			English	Editorial Material									Univ Tennessee, Dept Ecol & Evolutionary Biol, Complex Syst Grp, Knoxville, TN 37996 USA; E Carolina Univ, Coastal Resources Management Program, Greenville, NC 27858 USA; E Carolina Univ, Dept Biol, Greenville, NC 27858 USA	University of Tennessee System; University of Tennessee Knoxville; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University	McMahon, SM (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Complex Syst Grp, Knoxville, TN 37996 USA.							JOHNSON JC, 2001, J SOC STRUCT, V2; ROOT RB, 1967, ECOL MONOGR, V37, P317, DOI 10.2307/1942327; WASSERMAN S, 1994, ADV SOCIAL NETWORK A; YODZIS P, 1988, ECOLOGY, V69, P508, DOI 10.2307/1940449; NETWORK ANAL MARKS W; NETWORKING INVISIBLE	6	19	20	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1604	1605		10.1126/science.1062026	http://dx.doi.org/10.1126/science.1062026			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533467				2022-12-01	WOS:000170802900037
J	Pledger, G; Stringer, MD				Pledger, G; Stringer, MD			Childhood deaths from acute appendicitis in England and Wales 1963-97: observational population based study	BRITISH MEDICAL JOURNAL			English	Article									Oaktree Cottage Mitford, Morpeth NE61 3PN, Northd, England; Leeds Teaching Hosp NHS Trust, Dept Paediat Surg, Leeds LS9 7TF, W Yorkshire, England	University of Leeds	Pledger, G (corresponding author), Oaktree Cottage Mitford, Morpeth NE61 3PN, Northd, England.							Barker D.J.P., 1998, MOTHERS BABIES HLTH; *DEP HLTH, 1963, HOSP IN PAT ENQ HOSP; PLEDGER HG, 1969, BMJ-BRIT MED J, V4, P466, DOI 10.1136/bmj.4.5681.466; PLEDGER HG, 1987, BMJ-BRIT MED J, V295, P1233, DOI 10.1136/bmj.295.6608.1233; WILLIAMS N, 1991, ARCH DIS CHILD, V66, P1270, DOI 10.1136/adc.66.11.1270	5	13	13	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 25	2001	323	7310					430	431		10.1136/bmj.323.7310.430	http://dx.doi.org/10.1136/bmj.323.7310.430			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469BX	11520842	Green Published, Bronze			2022-12-01	WOS:000170793600023
J	Takamoto, DY; Aydil, E; Zasadzinski, JA; Ivanova, AT; Schwartz, DK; Yang, TL; Cremer, PS				Takamoto, DY; Aydil, E; Zasadzinski, JA; Ivanova, AT; Schwartz, DK; Yang, TL; Cremer, PS			Stable ordering in Langmuir-Blodgett films	SCIENCE			English	Article							X-RAY-DIFFRACTION; STEARIC-ACID; WATER; REFLECTIVITY; MONOLAYERS; GENERATION; MOLECULES; SURFACE; SALTS	Defects in the layering of Langmuir-Blodgett (LB) films can be eliminated by depositing from the appropriate monolayer phase at the air-water interface. LB films deposited from the hexagonal phase of cadmium arachidate (CdA(2)) at pH 7 spontaneously transform into the bulk soap structure, a centrosymmetric bilayer with an orthorhombic herringbone packing. A large wavelength folding mechanism accelerates the conversion between the two structures, leading to a disruption of the desired layering. At pH > 8.5, though it is more difficult to draw LB films, almost perfect layering is obtained due to the inability to convert from the as-deposited structure to the equilibrium one.	Univ Calif Santa Barbara, Dept Chem & Mat Engn, Santa Barbara, CA 93106 USA; Tulane Univ, Dept Chem, New Orleans, LA 70118 USA; Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA	University of California System; University of California Santa Barbara; Tulane University; Texas A&M University System; Texas A&M University College Station	Zasadzinski, JA (corresponding author), Univ Calif Santa Barbara, Dept Chem & Mat Engn, Santa Barbara, CA 93106 USA.		Yang, Tinglu/N-3569-2013; Schwartz, Daniel K/H-5153-2012; Aydil, Eray/M-5503-2019	Yang, Tinglu/0000-0003-0872-8218; Schwartz, Daniel K/0000-0001-5397-7200; Aydil, Eray/0000-0002-8377-9480	NHLBI NIH HHS [HL51177] Funding Source: Medline; NIGMS NIH HHS [GM47334] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047334] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashwell GJ, 1999, J MATER CHEM, V9, P1991, DOI 10.1039/a902604e; Corkery RW, 1997, LANGMUIR, V13, P3591, DOI 10.1021/la9701743; Ganguly P, 1997, LANGMUIR, V13, P6582, DOI 10.1021/la970626b; GARNAES J, 1992, NATURE, V357, P54, DOI 10.1038/357054a0; Gragson DE, 1998, J PHYS CHEM B, V102, P3847, DOI 10.1021/jp9806011; Harkins WD, 1938, J CHEM PHYS, V6, P298, DOI 10.1063/1.1750252; Kaganer VM, 1999, REV MOD PHYS, V71, P779, DOI 10.1103/RevModPhys.71.779; Kitaigorodskii A. I., 1962, ORGANIC CHEM CRYSTAL; Kuzmenko I, 1998, LANGMUIR, V14, P3882, DOI 10.1021/la970819z; LEVEILLER F, 1994, LANGMUIR, V10, P819, DOI 10.1021/la00015a037; LEVEILLER F, 1991, SCIENCE, V252, P1532, DOI 10.1126/science.252.5012.1532; Miranda PB, 1998, CHEM PHYS LETT, V286, P1, DOI 10.1016/S0009-2614(97)01476-0; PENNER TL, 1994, NATURE, V367, P49, DOI 10.1038/367049a0; ROBERTS GG, 1990, LANGMUIRBLODGETT FIL; Schwartz D. K., 1997, Surface Science Reports, V27, P241, DOI 10.1016/S0167-5729(97)00003-4; SCHWARTZ DK, 1992, J PHYS CHEM-US, V96, P10444, DOI 10.1021/j100204a059; SCHWARTZ DK, 1993, J AM CHEM SOC, V115, P7374, DOI 10.1021/ja00069a040; SCHWARTZ DK, 1993, PHYS REV E, V47, P452, DOI 10.1103/PhysRevE.47.452; SCHWARTZ DK, 1992, SCIENCE, V257, P508, DOI 10.1126/science.257.5069.508; SHEN YR, 1989, ANNU REV PHYS CHEM, V40, P327, DOI 10.1146/annurev.pc.40.100189.001551; TIPPMANNKRAYER P, 1992, THIN SOLID FILMS, V210, P577, DOI 10.1016/0040-6090(92)90346-D; WIESLER DG, 1995, THIN SOLID FILMS, V266, P69, DOI 10.1016/0040-6090(95)06603-9; YAZDANIAN M, 1992, LANGMUIR, V8, P630, DOI 10.1021/la00038a055; ZASADZINSKI JA, 1994, SCIENCE, V263, P1726, DOI 10.1126/science.8134836	24	95	98	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1292	1295		10.1126/science.1060018	http://dx.doi.org/10.1126/science.1060018			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509723				2022-12-01	WOS:000170492600032
J	Osherovich, LZ; Weissman, JS				Osherovich, LZ; Weissman, JS			Multiple GIn/Asn-rich prion domains confer susceptibility to induction of the yeast [PSI+] prion	CELL			English	Article							TRANSLATION TERMINATION EFFICIENCY; AMYLOID-LIKE FIBRILS; SACCHAROMYCES-CEREVISIAE; NEURODEGENERATIVE DISEASES; HUNTINGTONS-DISEASE; GLUTAMINE REPEATS; CELL-DEATH; POLYGLUTAMINE; PROPAGATION; INHERITANCE	The yeast prion [PSI+] results from self-propagating aggregates of Sup35p. De novo formation of [PSI+] requires an additional non-Mendelian trait, thought to result from a prion form of one or more unknown proteins. We find that the Gln/Asn-rich prion domains of two proteins, New1p and Rnq1p, can control susceptibility to [PSI+] induction as well as enhance aggregation of a human glutamine expansion disease protein. [PSI+] inducibility results from gain-of-function properties of New1p and Rnq1p aggregates rather than from inactivation of the normal proteins. These studies suggest a molecular basis for the epigenetic control of [PSI+] inducibility and may reveal a broader role for this phenomenon in the physiology of protein aggregation.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Osherovich, LZ (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, 513 Parnassus Ave, San Francisco, CA 94143 USA.	lxoshe@itsa.ucsf.edu		Weissman, Jonathan/0000-0003-2445-670X				Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Carmichael J, 2000, P NATL ACAD SCI USA, V97, P9701, DOI 10.1073/pnas.170280697; Chernoff YO, 1999, MOL CELL BIOL, V19, P8103; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Derkatch IL, 2000, EMBO J, V19, P1942, DOI 10.1093/emboj/19.9.1942; Eaglestone SS, 1999, EMBO J, V18, P1974, DOI 10.1093/emboj/18.7.1974; FESCHENKO MS, 1992, J BIOL CHEM, V267, P4097; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Kushnirov VV, 1998, CELL, V94, P13, DOI 10.1016/S0092-8674(00)81216-7; Lindquist S, 1995, COLD SPRING HARB SYM, V60, P451, DOI 10.1101/SQB.1995.060.01.050; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Newnam GP, 1999, MOL CELL BIOL, V19, P1325; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Perutz MF, 1999, TRENDS BIOCHEM SCI, V24, P58, DOI 10.1016/S0968-0004(98)01350-4; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; ROSE MD, 1987, CELL, V48, P1047, DOI 10.1016/0092-8674(87)90712-4; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Serio TR, 1999, ANNU REV CELL DEV BI, V15, P661, DOI 10.1146/annurev.cellbio.15.1.661; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Sondheimer N, 2001, EMBO J, V20, P2435, DOI 10.1093/emboj/20.10.2435; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; TUITE MF, 1981, GENETICS, V98, P691; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Wickner RB, 1999, MICROBIOL MOL BIOL R, V63, P844, DOI 10.1128/MMBR.63.4.844-861.1999; Wickner RB, 2000, CURR BIOL, V10, pR335, DOI 10.1016/S0960-9822(00)00460-7; Zhou P, 2001, MOL MICROBIOL, V39, P37, DOI 10.1046/j.1365-2958.2001.02224.x	42	257	269	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2001	106	2					183	194		10.1016/S0092-8674(01)00440-8	http://dx.doi.org/10.1016/S0092-8674(01)00440-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511346	Bronze			2022-12-01	WOS:000170193100008
J	Zakany, J; Kmita, M; Alarcon, P; de la Pompa, JL; Duboule, D				Zakany, J; Kmita, M; Alarcon, P; de la Pompa, JL; Duboule, D			Localized and transient transcription of Hox genes suggests a link between patterning and the segmentation clock	CELL			English	Article							SOMITE BOUNDARY FORMATION; LUNATIC FRINGE; DELTA-HOMOLOG; REGULATORY CONTROLS; HOMEOBOX GENE; BODY PLAN; MOUSE; EXPRESSION; COMPLEX; MURINE	During development, Hox gene transcription is activated in presomitic mesoderm with a time sequence that follows the order of the genes along the chromosome. Here, we show that Hoxd1 and other Hox genes display dynamic stripes of expression within presomitic mesoderm. The underlying transcriptional bursts may reflect the mechanism that coordinates Hox gene activation with somitogenesis. This mechanism appears to depend upon Notch signaling, as mice deficient for RBPJk, the effector of the Notch pathway, showed severely reduced Hoxd gene expression in presomitic mesoderm. These results suggest a molecular link between Hox gene activation and the segmentation clock. Such a linkage would efficiently keep in phase the production of novel segments with their morphological specification.	Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland; Hosp Duran & Reynals, Inst Recerca Oncol, Dept Mol Oncol, Barcelona, Spain; EMBL, Mouse Biol Program, Rome, Italy	University of Geneva; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; European Molecular Biology Laboratory (EMBL)	Duboule, D (corresponding author), Univ Geneva, Dept Zool & Anim Biol, Quai Ernest Ansermet 30, CH-1211 Geneva 4, Switzerland.		De La Pompa, José Luis/F-9719-2014	De La Pompa, José Luis/0000-0001-6761-7265; duboule, denis/0000-0001-9961-2960; Kmita, Marie/0000-0003-4021-0478				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Barrantes ID, 1999, CURR BIOL, V9, P470, DOI 10.1016/S0960-9822(99)80212-7; Cohen B, 1997, NAT GENET, V16, P283, DOI 10.1038/ng0797-283; CONDIE BG, 1993, DEVELOPMENT, V119, P579; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Dale KJ, 2000, BIOESSAYS, V22, P72, DOI 10.1002/(SICI)1521-1878(200001)22:1<72::AID-BIES12>3.0.CO;2-S; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; DESCHAMPS J, 1993, DEV BIOL, V156, P473, DOI 10.1006/dbio.1993.1093; DUBOULE D, 1995, CURR OPIN GENET DEV, V5, P525, DOI 10.1016/0959-437X(95)90058-O; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; DUBOULE D, 1994, DEVELOPMENT, P135; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1; FROHMAN MA, 1992, MECH DEVELOP, V38, P55, DOI 10.1016/0925-4773(92)90038-L; GAUNT SJ, 1988, DEVELOPMENT, V104, P169; Gerard M, 1997, DEV BIOL, V190, P32, DOI 10.1006/dbio.1997.8679; Gossler A, 1998, CURR TOP DEV BIOL, V38, P225; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; Herault Y, 1999, DEV BIOL, V208, P157, DOI 10.1006/dbio.1998.9179; HUNT P, 1991, NATURE, V353, P861, DOI 10.1038/353861a0; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Johnston SH, 1997, DEVELOPMENT, V124, P2245; Jouve C, 2000, DEVELOPMENT, V127, P1421; Kmita M, 2000, NAT GENET, V26, P451, DOI 10.1038/82593; Kmita M, 2000, GENE DEV, V14, P198; Kondo T, 1999, CELL, V97, P407, DOI 10.1016/S0092-8674(00)80749-7; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Kusumi K, 1998, NAT GENET, V19, P274, DOI 10.1038/961; Mann RS, 1997, BIOESSAYS, V19, P661, DOI 10.1002/bies.950190804; McGrew MJ, 1998, CURR BIOL, V8, P979, DOI 10.1016/S0960-9822(98)70401-4; Medina-Martinez O, 2000, DEV BIOL, V222, P71, DOI 10.1006/dbio.2000.9683; OKA C, 1995, DEVELOPMENT, V121, P3291; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Saga Y, 1997, GENE DEV, V11, P1827, DOI 10.1101/gad.11.14.1827; Stern CD, 2000, CURR TOP DEV BIOL, V47, P107; STUBBS L, 1990, GENOMICS, V7, P422, DOI 10.1016/0888-7543(90)90177-V; Suemori H, 2000, DEV BIOL, V220, P333, DOI 10.1006/dbio.2000.9651; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Takahashi Y, 2000, NAT GENET, V25, P390, DOI 10.1038/78062; Tam PPL, 2000, CURR TOP DEV BIOL, V47, P1; Tan DP, 1996, P NATL ACAD SCI USA, V93, P8247, DOI 10.1073/pnas.93.16.8247; vanderHoeven F, 1996, CELL, V85, P1025, DOI 10.1016/S0092-8674(00)81303-3; Zakany J, 1999, NATURE, V401, P761, DOI 10.1038/44511; Zakany J, 1997, EMBO J, V16, P4393, DOI 10.1093/emboj/16.14.4393; Zakany J, 1996, NATURE, V384, P69, DOI 10.1038/384069a0; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625	48	150	154	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2001	106	2					207	217		10.1016/S0092-8674(01)00436-6	http://dx.doi.org/10.1016/S0092-8674(01)00436-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511348	Bronze			2022-12-01	WOS:000170193100010
J	Schmitz, B; PeuckerEhrenbrink, E; Lindstrom, M; Tassinari, M				Schmitz, B; PeuckerEhrenbrink, E; Lindstrom, M; Tassinari, M			Accretion rates of meteorites and cosmic dust in the Early Ordovician	SCIENCE			English	Article							CHONDRITE PARENT BODY; ISOTOPE SYSTEMATICS; CONTINENTAL-CRUST; OSMIUM; RECORD; LIFE	Abundant fossil meteorites in marine, condensed Lower Ordovician limestones from Kinnekulle, Sweden, indicate that accretion rates of meteorites were one to two orders of magnitude higher during an interval of the Early Ordovician than at0 present, Osmium isotope and iridium analyses of whole-rock limestone indicate a coeval enhancement of one order of magnitude in the influx rate of cosmic dust. Enhanced accretion of cosmic matter may be related to the disruption of the L chondrite parent body around 500 million years ago.	WOODS HOLE OCEANOG INST,DEPT MARINE CHEM & GEOCHEM,WOODS HOLE,MA 02543; UNIV STOCKHOLM,DEPT GEOL & GEOCHEM,S-10691 STOCKHOLM,SWEDEN; PALEO GEOL CTR,S-53130 LINKOPING,SWEDEN	Woods Hole Oceanographic Institution; Stockholm University	Schmitz, B (corresponding author), GOTHENBURG UNIV,CTR EARTH SCI,DEPT MARINE GEOL,S-41381 GOTHENBURG,SWEDEN.			Peucker-Ehrenbrink, Bernhard/0000-0002-3819-992X				BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; Bland PA, 1996, GEOCHIM COSMOCHIM AC, V60, P2053, DOI 10.1016/0016-7037(96)00125-1; BOGARD DD, 1995, GEOCHIM COSMOCHIM AC, V59, P1383, DOI 10.1016/0016-7037(95)00051-Z; BURKE WH, 1982, GEOLOGY, V10, P516, DOI 10.1130/0091-7613(1982)10<516:VOSSTP>2.0.CO;2; ESSER BK, 1993, GEOCHIM COSMOCHIM AC, V57, P3093, DOI 10.1016/0016-7037(93)90296-9; ESSER BK, 1988, GEOCHIM COSMOCHIM AC, V52, P1383, DOI 10.1016/0016-7037(88)90209-8; GRIEVE RAF, 1987, ANNU REV EARTH PL SC, V15, P245, DOI 10.1146/annurev.ea.15.050187.001333; GRIEVE RAF, 1995, GSA TODAY, V5, P189; Haack H, 1996, ICARUS, V119, P182, DOI 10.1006/icar.1996.0010; HAURI EH, 1993, EARTH PLANET SC LETT, V114, P353, DOI 10.1016/0012-821X(93)90036-9; JENNISKENS P, 1994, METEORITICS, V29, P246, DOI 10.1111/j.1945-5100.1994.tb00678.x; LINDNER M, 1989, GEOCHIM COSMOCHIM AC, V53, P1597, DOI 10.1016/0016-7037(89)90241-X; LINDSTROM M, 1971, GEOL RUNDSCH, V60, P419, DOI DOI 10.1007/BF02000464; NYSTROM JO, 1988, NATURE, V336, P572, DOI 10.1038/336572a0; PEDERSEN RB, 1992, TERRA NOVA, V4, P217, DOI 10.1111/j.1365-3121.1992.tb00475.x; PeuckerEhrenbrink B, 1996, GEOCHIM COSMOCHIM AC, V60, P3187, DOI 10.1016/0016-7037(96)00161-5; PEUCKEREHRENBRINK B, 1995, EARTH PLANET SC LETT, V130, P155, DOI 10.1016/0012-821X(95)00003-U; RAVIZZA G, 1993, GEOCHIM COSMOCHIM AC, V57, P4301, DOI 10.1016/0016-7037(93)90324-P; RAVIZZA G, 1989, GEOCHIM COSMOCHIM AC, V53, P3257, DOI 10.1016/0016-7037(89)90105-1; Schmitz B, 1996, EARTH PLANET SC LETT, V145, P31, DOI 10.1016/S0012-821X(96)00205-1; SCHMITZ B, IN PRESS CHEM GEOL I; THORSLUND P, 1984, LITHOS, V17, P87, DOI 10.1016/0024-4937(84)90008-2; WEDEPOHL KH, 1995, GEOCHIM COSMOCHIM AC, V59, P1217, DOI 10.1016/0016-7037(95)00038-2	23	62	62	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 3	1997	278	5335					88	90		10.1126/science.278.5335.88	http://dx.doi.org/10.1126/science.278.5335.88			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XZ124	11536823				2022-12-01	WOS:A1997XZ12400042
J	SLOAN, LC; WALKER, JCG; MOORE, TC; REA, DK; ZACHOS, JC				SLOAN, LC; WALKER, JCG; MOORE, TC; REA, DK; ZACHOS, JC			POSSIBLE METHANE-INDUCED POLAR WARMING IN THE EARLY EOCENE	NATURE			English	Article							STRATOSPHERIC CLOUDS; CLIMATE; RATES; CH4	RECONSTRUCTIONS of early Eocene climate depict a world in which the polar environments support mammals and reptiles, deciduous forests, warm oceans and rare frost conditions 1-5. At the same time, tropical sea surface temperatures are interpreted to have been the same as or slightly cooler than present values 6. The question of how to warm polar regions of Earth without noticeably warming the tropics remains unresolved; increased amounts of greenhouse gases would be expected to warm all latitudes equally 7. Oceanic heat transport has been postulated as a mechanism for heating high latitudes 8-10, but it is difficult to explain the dynamics that would achieve this 7,11. Here we consider estimates of Eocene wetland areas and suggest that the flux of methane, an important greenhouse gas, may have been substantially greater during the Eocene than at present. Elevated methane concentrations would have enhanced early Eocene global warming, and also might specifically have prevented severe winter cooling of polar regions because of the potential of atmospheric methane to promote the formation of optically thick, polar stratospheric ice clouds 12-14.			SLOAN, LC (corresponding author), UNIV MICHIGAN,DEPT GEOL SCI,ANN ARBOR,MI 48109, USA.		Moore, Theodore/N-8848-2014; Zachos, James C/A-7674-2008	Moore, Theodore/0000-0003-4121-1325; Zachos, James C/0000-0001-8439-1886				ARTHUR MA, 1992, GEOL SOC AM PROG, V23, P178; Askin R.A., 1988, Geological Society of America Memoir, V169, P131; BARRON EJ, 1982, PALAEOGEOGR PALAEOCL, V40, P103, DOI 10.1016/0031-0182(82)90086-4; Barron EJ, 1987, PALEOCEANOGRAPHY, V2, P729, DOI 10.1029/PA002i006p00729; BERNER RA, 1991, AM J SCI, V291, P339, DOI 10.2475/ajs.291.4.339; CASE JA, 1988, GEOLOGY PALEONTOLOGY, P523; Cicerone RJ, 1988, GLOBAL BIOGEOCHEM CY, V2, P299, DOI 10.1029/GB002i004p00299; Crowley TJ, 1991, PALEOCEANOGRAPHY, V6, P387, DOI 10.1029/91PA00432; CROWLEY TJ, 1991, QUATERNARY SCI REV, V10, P275, DOI 10.1016/0277-3791(91)90025-P; ESTES R, 1980, PALAEOGEOGR PALAEOCL, V30, P325, DOI 10.1016/0031-0182(80)90064-4; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Houghton J.T., 1990, CLIMATE CHANGE IPCC; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; KINNE S, 1990, GEOPHYS RES LETT, V17, P373, DOI 10.1029/GL017i004p00373; MCCORMICK MP, 1987, J GEOPHYS RES-ATMOS, V92, P4297, DOI 10.1029/JD092iD04p04297; MCCORMICK MP, 1989, J GEOPHYS RES-ATMOS, V94, P11241, DOI 10.1029/JD094iD09p11241; Miller KG, 1987, PALEOCEANOGRAPHY, V2, P741, DOI 10.1029/PA002i006p00741; POLLACK JB, 1985, J ATMOS SCI, V42, P245, DOI 10.1175/1520-0469(1985)042<0245:TIOPSC>2.0.CO;2; RAMANATHAN V, 1989, SCIENCE, V243, P57, DOI 10.1126/science.243.4887.57; RAMANATHAN V, 1987, REV GEOPHYS, V25, P1441, DOI 10.1029/RG025i007p01441; RASMUSSEN RA, 1981, J GEOPHYS RES-OCEANS, V86, P9826, DOI 10.1029/JC086iC10p09826; RIND D, 1991, J GEOPHYS RES-ATMOS, V96, P7437, DOI 10.1029/91JD00009; RINSLAND CP, 1984, J GEOPHYS RES-ATMOS, V89, P7259, DOI 10.1029/JD089iD05p07259; Ronov A.B., 1979, INT GEOL REV, V21, P415, DOI 10.1080/00206818209467074; SCHWEITZER HJ, 1980, PALAEOGEOGR PALAEOCL, V30, P297, DOI 10.1016/0031-0182(80)90062-0; SHACKLETON N, 1981, J GEOL SOC LONDON, V138, P153, DOI 10.1144/gsjgs.138.2.0153; SHACKLETON NJ, 1984, INITIAL REP DEEP SEA, V74, P599; SHEPPARD JC, 1982, J GEOPHYS RES-OCEANS, V87, P1305, DOI 10.1029/JC087iC02p01305; SLOAN LC, 1990, THESIS PENNSYLVANIA; SLOAN LC, UNPUB GEOPHYS RES LE; WOLFE JA, 1987, PALAEOGEOGR PALAEOCL, V61, P33, DOI 10.1016/0031-0182(87)90040-X	31	106	108	1	27	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 28	1992	357	6376					320	322		10.1038/357320a0	http://dx.doi.org/10.1038/357320a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HW132	11536496	Green Published			2022-12-01	WOS:A1992HW13200044
J	YAMAGATA, Y; WATANABE, H; SAITOH, M; NAMBA, T				YAMAGATA, Y; WATANABE, H; SAITOH, M; NAMBA, T			VOLCANIC PRODUCTION OF POLYPHOSPHATES AND ITS RELEVANCE TO PREBIOTIC EVOLUTION	NATURE			English	Article							AQUEOUS-SOLUTION; PHOSPHORYLATION; PHOSPHORUS; ADENOSINE; AGENTS	PHOSPHATES would probably have been essential compounds for prebiotic evolution on the primitive Earth. In this context, there have been several studies of condensation of water-soluble phosphates to polyphosphates and phosphorylation and condensation or polymerization of biomolecules with polyphosphates 1-20. But most of the phosphorus on the early Earth would have been in the form of water-insoluble apatite, and the origin of the water-soluble polyphosphates required for prebiotic evolution has therefore been a mystery 21-24. Here we show, both from experiments that simulate magmatic conditions and from analysis of volatile condensates in volcanic gas, that volcanic activity can produce water-soluble polyphosphates through partial hydrolysis of P4O10. This mechanism seems to be the only viable route identified so far for the production of these species on the primitive Earth.			YAMAGATA, Y (corresponding author), KANAZAWA UNIV, FAC SCI, DEPT PHYS, 1-1 MARUNOUCHI, KANAZAWA, ISHIKAWA 920, JAPAN.							Best A.G, 1982, IGNEOUS METAMORPHIC; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; CHUNG NM, 1971, TETRAHEDRON, V27, P1205, DOI 10.1016/S0040-4020(01)90868-3; FERRIS JP, 1968, SCIENCE, V161, P53, DOI 10.1126/science.161.3836.53; GRIFFITH EJ, 1977, ORIGINS LIFE EVOL B, V8, P71, DOI 10.1007/BF00927976; GRIFFITH EJ, 1977, CHEM EVOLUTION EARLY, P61; GULICK A, 1957, ANN NY ACAD SCI, V69, P309, DOI 10.1111/j.1749-6632.1957.tb49666.x; HANDSCHUH GJ, 1973, J MOL EVOL, V2, P251, DOI 10.1007/BF01654094; HULSHOF J, 1976, ORIGINS LIFE EVOL B, V7, P197, DOI 10.1007/BF00926938; LOHRMANN R, 1968, SCIENCE, V161, P64, DOI 10.1126/science.161.3836.64; LOHRMANN R, 1975, J MOL EVOL, V6, P237, DOI 10.1007/BF01794633; LOHRMANN R, 1971, SCIENCE, V171, P490, DOI 10.1126/science.171.3970.490; MAMBO VS, 1991, J VOLCANOL GEOTH RES, V46, P37, DOI 10.1016/0377-0273(91)90074-A; MILLER SL, 1959, SCIENCE, V130, P245, DOI 10.1126/science.130.3370.245; MILLER SL, 1964, NATURE, V204, P1248, DOI 10.1038/2041248a0; PONNAMPE.C, 1965, SCIENCE, V148, P1221, DOI 10.1126/science.148.3674.1221; PONNAMPERUMA C, 1963, NATURE, V199, P222, DOI 10.1038/199222a0; RABINOWI.J, 1969, NATURE, V224, P795, DOI 10.1038/224795a0; RABINOWITZ J, 1970, HELV CHIM ACTA, V53, P1350, DOI 10.1002/hlca.19700530614; RABINOWITZ J, 1968, NATURE, V218, P442, DOI 10.1038/218442a0; Ross WH, 1924, IND ENG CHEM, V16, P563; SATO H, 1981, SCI REP KANAZAWA U, V26, P51; SCHOFFSTALL AM, 1976, ORIGINS LIFE EVOL B, V7, P399, DOI 10.1007/BF00927935; SCHWARTZ A, 1968, NATURE, V218, P443, DOI 10.1038/218443a0; SCHWARTZ A, 1964, BIOCHIM BIOPHYS ACTA, V87, P694, DOI 10.1016/0926-6550(64)90290-7; Schwartz A. W., 1972, MOL EVOLUTION PREBIO, P129; SCHWARTZ AW, 1967, BIOCHIM BIOPHYS ACTA, V134, P9, DOI 10.1016/0005-2787(67)90083-4; SCHWARTZ AW, 1971, CHEM EVOLUTION ORIGI, V1, P207; TATSUMI Y, 1983, J GEOPHYS RES, V88, P5815, DOI 10.1029/JB088iB07p05815; Van Wazer J.R., 1958, PHOSPHORUS ITS COMPO, V1; WAENHELDT TV, 1967, BIOCHIM BIOPHYS ACTA, V1234, P1; YAMAGATA Y, 1982, ORIGINS LIFE EVOL B, V12, P333, DOI 10.1007/BF00927064; YAMAGATA Y, 1979, NATURE, V282, P284, DOI 10.1038/282284a0; YAMANAKA J, 1988, ORIGINS LIFE EVOL B, V18, P165, DOI 10.1007/BF01804669	34	241	248	4	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	1991	352	6335					516	519		10.1038/352516a0	http://dx.doi.org/10.1038/352516a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA226	11536483				2022-12-01	WOS:A1991GA22600058
J	Reid, G; Flonta, ML				Reid, G; Flonta, ML			Physiology - Cold current in thermoreceptive neurons	NATURE			English	Article							MENTHOL; RAT		Univ Bucharest, Fac Biol, Dept Anim Physiol & Biophys, Bucharest 76201, Romania	University of Bucharest	Reid, G (corresponding author), Univ Bucharest, Fac Biol, Dept Anim Physiol & Biophys, Splaiul Independentei 91-95, Bucharest 76201, Romania.							Gee MD, 1999, NEUROSCIENCE, V90, P509, DOI 10.1016/S0306-4522(98)00454-0; HENSEL H, 1951, ACTA PHYSIOL SCAND, V24, P27, DOI 10.1111/j.1748-1716.1951.tb00824.x; HENSEL H, 1974, PFLUG ARCH EUR J PHY, V352, P87, DOI 10.1007/BF01061953; Hensel H, 1981, THERMORECEPTION TEMP; KENSHALO DR, 1977, J NEUROPHYSIOL, V40, P319, DOI 10.1152/jn.1977.40.2.319; LEEM JW, 1993, J NEUROPHYSIOL, V69, P1684, DOI 10.1152/jn.1993.69.5.1684; Okazawa M, 2000, NEUROREPORT, V11, P2151, DOI 10.1097/00001756-200007140-00018; PIERAU FK, 1974, BRAIN RES, V73, P156, DOI 10.1016/0006-8993(74)91015-4; Reid G, 2001, J NEUROSCI METH, V111, P1, DOI 10.1016/S0165-0270(01)00416-2; Reid G, 2001, NEUROSCI LETT, V297, P171, DOI 10.1016/S0304-3940(00)01694-3; SCHAFER K, 1986, J GEN PHYSIOL, V88, P757, DOI 10.1085/jgp.88.6.757; Suto K, 1999, NEUROSCIENCE, V92, P1131, DOI 10.1016/S0306-4522(99)00063-9	12	129	138	0	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2001	413	6855					480	480		10.1038/35097164	http://dx.doi.org/10.1038/35097164			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586349				2022-12-01	WOS:000171340500036
J	McDermott, MM; Greenland, P; Liu, K; Guralnik, JM; Criqui, MH; Dolan, NC; Chan, CL; Celic, L; Pearce, WH; Schneider, JR; Sharma, L; Clark, E; Gibson, D; Martin, GJ				McDermott, MM; Greenland, P; Liu, K; Guralnik, JM; Criqui, MH; Dolan, NC; Chan, CL; Celic, L; Pearce, WH; Schneider, JR; Sharma, L; Clark, E; Gibson, D; Martin, GJ			Leg symptoms in peripheral arterial disease - Associated clinical characteristics and functional impairment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOWER-EXTREMITY FUNCTION; INTERMITTENT CLAUDICATION; CARDIOVASCULAR HEALTH; PHYSICAL-DISABILITY; WOMENS HEALTH; 6-MINUTE WALK; ACCELEROMETER; PREDICTOR; MORTALITY; CRITERIA	Context Persons with lower-extremity peripheral arterial disease (PAD) are often asymptomatic or have leg symptoms other than intermittent claudication (IC). Objective To identify clinical characteristics and functional limitations associated with a broad range of leg symptoms identified among patients with PAD. Design, Setting, and Participants Cross-sectional study of 460 men and women with PAD and 130 without PAD, who were identified consecutively, conducted between October 1998 and January 2000 at 3 Chicago-area medical centers. Main Outcome Measures Ankle-brachial index score of less than 0.90; scores from 6-minute walk, accelerometer-measured physical activity over 7 days, repeated chair raises, standing balance (full tandem stand), 4-m walking velocity, San Diego claudication questionnaire, Geriatric Depression Score Short-Form, and the Walking Impairment Questionnaire. Results All groups with PAD had poorer functioning than participants without PAD. The following values are for patients without IC vs those with IC. Participants in the group with leg pain on exertion and rest (n=88) had a higher (poorer) score for neuropathy (5.6 vs 3.5; P<.001), prevalence of diabetes mellitus (48.9% vs 26.7%; P<.001), and spinal stenosis (20.8% vs 7.2%; P=.002). The atypical exertional leg pain/carry on group (exertional leg pain other than IC associated with walking through leg pain [n=41]) and the atypical exertional leg pain/stop group (exertional leg pain other than IC that causes one to stop walking [n=90]) had better functioning than the IC group. The group without exertional leg pain/inactive (no exertional leg pain in individual who walks less than or equal to6 blocks per week [n=28]) and the leg pain on exertion and rest group had poorer functioning than those with IC. Adjusting for age, sex, race, and comorbidities and compared with IC, participants with atypical exertional leg pain/carry on achieved a greater distance on the 6-minute walk (404.3 vs 328.5 m; P<.001) and were less likely to stop during the 6-minute walk (6.8% vs 36%; P=.002). The group with pain on exertion and rest had a slower time for completing 5 chair raises (13.5 vs 11.9 seconds; P=.009), completed the tandem stand less frequently (37.5% vs 60.0%; P=.004), and had a slower 4-m walking velocity (0.80 vs 0.90 m/s; P<.001). Conclusions There is a wide range of leg symptoms in persons with PAD beyond that of classic IC. Comorbid disease may contribute to these symptoms in PAD. Functional impairments are found in every PAD symptom group, and the degree of functional limitation varies depending on the type of leg symptom.	Northwestern Univ, Sch Med, Dept Med, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Dept Surg, Chicago, IL 60611 USA; Evanston Northwestern Hosp, Dept Surg, Div Vasc Surg, Evanston, IL USA; Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA; NIA, Epidemiol Demog & Biometry Program, Bethesda, MD 20892 USA; Catholic Hlth Partners, Dept Surg, Div Vasc Surg, Chicago, IL USA	Northwestern University; Northwestern University; Northwestern University; NorthShore University Health System; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	McDermott, MM (corresponding author), 675 N St Clair,Suite 18-200, Chicago, IL 60611 USA.		Greenland, Philip/ABD-5528-2021	Sharma, Leena/0000-0002-5571-1622	NCRR NIH HHS [RR-00048] Funding Source: Medline; PHS HHS [R01-58099] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALTMAN R, 1991, ARTHRITIS RHEUM, V34, P505, DOI 10.1002/art.1780340502; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; BERNSTEIN EF, 1982, SURG CLIN N AM, V62, P473; BIRKE JA, 1986, LEPROSY REV, V57, P261; Criqui M H, 1996, Vasc Med, V1, P65; ETTINGER WH, 1994, J AM GERIATR SOC, V42, P1035, DOI 10.1111/j.1532-5415.1994.tb06206.x; Feinglass J, 2000, J VASC SURG, V31, P93, DOI 10.1016/S0741-5214(00)70071-1; FRIED LP, 1994, J CLIN EPIDEMIOL, V47, P747, DOI 10.1016/0895-4356(94)90172-4; Fried LP, 1999, J CLIN EPIDEMIOL, V52, P27, DOI 10.1016/S0895-4356(98)00124-3; Gardner AW, 1998, ANGIOLOGY, V49, P327, DOI 10.1177/000331979804900501; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Guralnik JM, 1995, NIH PUBLICATION, V95-4009; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; HIATT WR, 1995, CIRCULATION, V91, P1472, DOI 10.1161/01.CIR.91.5.1472; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Lyness JM, 1997, ARCH INTERN MED, V157, P449, DOI 10.1001/archinte.157.4.449; McDermott MM, 1998, J AM GERIATR SOC, V46, P1355, DOI 10.1111/j.1532-5415.1998.tb06001.x; McDermott MM, 2000, J VASC SURG, V32, P1164, DOI 10.1067/mva.2000.108640; McDermott MM, 1999, ARCH INTERN MED, V159, P387; McDermott MM, 2000, CIRCULATION, V101, P1007, DOI 10.1161/01.CIR.101.9.1007; McDermott MM, 2001, J AM GERIATR SOC, V49, P747, DOI 10.1046/j.1532-5415.2001.49151.x; McDermott MM, 2001, J GEN INTERN MED, V16, P384, DOI 10.1046/j.1525-1497.2001.016006384.x; McDermott MM, 2000, ANGIOLOGY, V51, P91, DOI 10.1177/000331970005100201; MCKENNA M, 1991, ATHEROSCLEROSIS, V87, P119, DOI 10.1016/0021-9150(91)90014-T; MILLER DJ, 1994, MED SCI SPORT EXER, V26, P376; Montgomery PS, 1998, J AM GERIATR SOC, V46, P706, DOI 10.1111/j.1532-5415.1998.tb03804.x; NEWMAN AB, 1993, CIRCULATION, V88, P837, DOI 10.1161/01.CIR.88.3.837; OGREN M, 1995, BMJ-BRIT MED J, V310, P1294, DOI 10.1136/bmj.310.6990.1294; OLIN JW, 1998, AM J MED CONTINUING, P10; OLMOS PR, 1995, AM J MED SCI, V309, P76, DOI 10.1097/00000441-199502000-00005; Regensteiner JG., 1990, J VASC MED BIOL, V2, P142; Richardson M T, 1995, J Cardiopulm Rehabil, V15, P107, DOI 10.1097/00008483-199503000-00003; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Swan PD, 1997, BRIT J SPORT MED, V31, P235, DOI 10.1136/bjsm.31.3.235; Weitz JI, 1996, CIRCULATION, V94, P3026, DOI 10.1161/01.CIR.94.11.3026; [No title captured]	37	561	573	2	24	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2001	286	13					1599	1606						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478HH	11585483				2022-12-01	WOS:000171340600027
J	Korevaar, JC; Jansen, MAM; Dekker, FW; Jager, KJ; Boeschoten, EW; Krediet, RT; Bossuyt, PMM				Korevaar, JC; Jansen, MAM; Dekker, FW; Jager, KJ; Boeschoten, EW; Krediet, RT; Bossuyt, PMM		Netherlands Cooperative Study Adeq	When to initiate dialysis: effect of proposed US guidelines on survival	LANCET			English	Article							RESIDUAL RENAL-FUNCTION; PERITONEAL-DIALYSIS; CONTROLLED TRIALS; DISEASE; STAGE; PROGRESSION; PREDICTORS; PROTEIN; THERAPY	Background Recent guidelines from the US National Kidney Foundation Dialysis Outcomes Quality Initiative recommend an earlier start of dialysis treatment than has been common practice. Their implementation would have a substantial effect on patients' daily lives and would increase costs. The guidelines are largely opinion-based, because evidence is still lacking. Methods As part of a prospective multicentre study in the Netherlands, we included, between January, 1997, and May, 1999, all new patients with end-stage renal disease, for whom data were available on residual renal function 0-4 weeks before the start of dialysis. We recorded date of death or censoring until August, 2000. Findings 94 (37%) of 253 patients started dialysis treatment later than recommended by the US guideline. There was an increased mortality risk for these patients compared with those who started dialysis on time, although it was not significant (adjusted hazard ratio 1.66 [95% Cl 0.95-2-89]). The adjusted difference in estimated survival time after 3 years on dialysis treatment was 2.5 months (1.1-4.0) in favour of timely starters. Conversely, the average delay in dialysis initiation for late starters, the extra time free of dialysis, was at least 4.1 months. Interpretation Although we observed a gain in survival time with a timely start of dialysis, it is probably a reflection of initiating dialysis earlier in the disease. We question the benefit of putting this guideline into daily practice, given the current clinical evidence and the effects it would have on patients and dialysis resources.	Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1100 DD Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dianet Dialysis Ctr, NL-1100 DD Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Nephrol, NL-1100 DD Amsterdam, Netherlands; Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Korevaar, JC (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, POB 22660, NL-1100 DD Amsterdam, Netherlands.		Bossuyt, Patrick M/AAR-1183-2021; Krediet, Raymond/AAP-3291-2021; Jager, Kitty J/C-3887-2008; Krediet, Raymond/GLT-2390-2022; Dekker, Friedo W/B-6452-2011; Bossuyt, Patrick M./B-4557-2016	Bossuyt, Patrick M/0000-0003-4427-0128; Krediet, Raymond/0000-0002-9851-8507; Dekker, Friedo W/0000-0002-2433-2494; Bossuyt, Patrick M./0000-0003-4427-0128				Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; BERGSTROM J, 1993, KIDNEY INT, V44, P1048, DOI 10.1038/ki.1993.347; Bergstrom J, 1998, PERITON DIALYSIS INT, V18, P467; BONOMINI V, 1985, KIDNEY INT, V28, P57; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Davies SJ, 1998, NEPHROL DIAL TRANSPL, V13, P962, DOI 10.1093/ndt/13.4.962; Fink JC, 1999, AM J KIDNEY DIS, V34, P694, DOI 10.1016/S0272-6386(99)70395-1; Gokal R, 2000, PERITON DIALYSIS INT, V20, P386; HAKIM RM, 1995, J AM SOC NEPHROL, V6, P1319; Hunsicker LG, 1997, KIDNEY INT, V51, P1908, DOI 10.1038/ki.1997.260; Ifudu O, 1998, AM J NEPHROL, V18, P193, DOI 10.1159/000013336; Jacobs C, 2000, NEPHROL DIAL TRANSPL, V15, P305, DOI 10.1093/ndt/15.3.305; KHAN IH, 1993, LANCET, V341, P415, DOI 10.1016/0140-6736(93)93003-J; Moist LM, 2000, J AM SOC NEPHROL, V11, P556, DOI 10.1681/ASN.V113556; *NAT KIDN FDN, 1997, AM J KIDNEY DIS S, V30, pS1; National Kidney Foundation, 1997, AM J KIDNEY DIS, V30, pS67; Obrador GT, 1999, KIDNEY INT, V56, P2227, DOI 10.1046/j.1523-1755.1999.00779.x; Samuelsson O, 1998, J AM SOC NEPHROL, V9, P1482; TATTERSALL J, 1995, AM J NEPHROL, V15, P283, DOI 10.1159/000168850; Tonelli M., 1998, Journal of the American Society of Nephrology, V9, p80A; Van Biesen W, 1999, PERITON DIALYSIS INT, V19, pS273; WATSON PE, 1980, AM J CLIN NUTR, V33, P27, DOI 10.1093/ajcn/33.1.27	22	158	165	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 29	2001	358	9287					1046	1050		10.1016/S0140-6736(01)06180-3	http://dx.doi.org/10.1016/S0140-6736(01)06180-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479EY	11589934				2022-12-01	WOS:000171393100009
J	Richardson, JE; Pennington, RT; Pennington, TD; Hollingsworth, PM				Richardson, JE; Pennington, RT; Pennington, TD; Hollingsworth, PM			Rapid diversification of a species-rich genus of neotropical rain forest trees	SCIENCE			English	Article							RIBOSOMAL DNA; SEQUENCES; CHLOROPLAST; DIVERGENCE; PHYLOGENY; DIVERSITY; FABACEAE; REGIONS	Species richness in the tropics has been attributed to the gradual accumulation of species over a long geological period in stable equatorial climates or, conversely, to speciation in response to late Tertiary geological events and unstable Pleistocene climates. DNA sequence data are consistent with recent diversification in Inga, a species-rich neotropical tree genus. We estimate that speciation was concentrated in the past 10 million years, with many species arising as recently as 2 million years ago. This coincides with the more recent major uplifts of the Andes, the bridging of the Isthmus of Panama, and Quaternary glacial cycles. Inga may be representative of other species-rich neotropical genera with rapid growth and reproduction, which contribute substantially to species numbers in the world's most diverse flora.	Royal Bot Garden Edinburgh, Edinburgh EH3 5LR, Midlothian, Scotland; Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; Royal Bot Gardens, Richmond TW9 3AB, Surrey, England	University of California System; University of California Santa Cruz; Royal Botanic Gardens, Kew	Pennington, RT (corresponding author), Royal Bot Garden Edinburgh, 20A Inverleith Row, Edinburgh EH3 5LR, Midlothian, Scotland.	t.pennington@rbge.org.uk	Richardson, James-Edward/L-2768-2016	Richardson, James-Edward/0000-0001-9014-4865; Hollingsworth, Peter/0000-0003-0602-0654; Pennington, Toby/0000-0002-8196-288X				Baldwin BG, 1998, P NATL ACAD SCI USA, V95, P9402, DOI 10.1073/pnas.95.16.9402; Burnham RJ, 1999, ANN MO BOT GARD, V86, P546, DOI 10.2307/2666185; BUSH MB, 1994, J BIOGEOGR, V21, P5, DOI 10.2307/2845600; Coates Anthony G., 1996, P21; Comes HP, 1999, SYST ASSOC SPEC VOL, V57, P171; De Oliveira AA, 1999, BIODIVERS CONSERV, V8, P1219, DOI 10.1023/A:1008908615271; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Gentry A., 1989, TROPICAL FORESTS BOT, P113; GENTRY AH, 1982, ANN MO BOT GARD, V69, P557, DOI 10.2307/2399084; Haffer J., 1982, P6; Kass E, 1997, PLANT SYST EVOL, V208, P139, DOI 10.1007/BF00985439; KOPTUR S, 1984, EVOLUTION, V38, P1130, DOI 10.2307/2408445; LI WH, 1987, J MOL EVOL, V25, P330, DOI 10.1007/BF02603118; Mes THM, 1996, BOT ACTA, V109, P477, DOI 10.1111/j.1438-8677.1996.tb00601.x; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Pennington RT, 1996, SYST BIOL, V45, P496, DOI 10.2307/2413527; Pennington T.D., 1997, GENUS INGA BOT; PENNINGTON TD, 1998, GENUS INGA UTILIZATI, P159; Pennington TD, 1998, GENUS INGA UTILIZATI; RAMBAUT A, 2000, TREEEDIT VERSION 1 0; Richardson JE, 2001, TAXON, V50, P405, DOI 10.2307/1223889; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; SANG T, 1994, AM J BOT, V81, P1494, DOI 10.2307/2445322; SANG T, 1995, SYST BOT, V20, P55, DOI 10.2307/2419632; Stebbins G. L., 1974, EVOLUTION SPECIES LE; SUH YB, 1993, AM J BOT, V80, P1042, DOI 10.2307/2445752; Swofford D.L., 1998, PAUP 4 0B2 PHYLOGENE; Thomas WW, 1999, BIODIVERS CONSERV, V8, P1007, DOI 10.1023/A:1008857429787; VALENCIA R, 1994, BIODIVERS CONSERV, V3, P21, DOI 10.1007/BF00115330; Vargas P, 1999, AM J BOT, V86, P724, DOI 10.2307/2656582; WENDEL JF, 1995, MOL PHYLOGENET EVOL, V4, P298, DOI 10.1006/mpev.1995.1027; WHITEMORE TC, 1987, BIOGEOGRAPHY QUATERN; WHITEMORE TC, 1998, INTRO TROPICAL RAINF; Wojciechowski MF, 1999, SYST BOT, V24, P409, DOI 10.2307/2419698; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; ZURAWSKI G, 1984, GENETICS, V106, P735	36	583	605	4	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2001	293	5538					2242	2245		10.1126/science.1061421	http://dx.doi.org/10.1126/science.1061421			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11567135				2022-12-01	WOS:000171139400040
J	Linder, JA; Stafford, RS				Linder, JA; Stafford, RS			Antibiotic treatment of adults with sore throat by community primary care physicians - A national survey, 1989-1999	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	24th Annual Meeting of the Society-of-General-Internal-Medicine	MAY   04, 2001	SAN DIEGO, CALIFORNIA	Soc Gen Internal Med			RESPIRATORY-TRACT INFECTIONS; GROUP-A STREPTOCOCCI; ERYTHROMYCIN RESISTANCE; PHARYNGITIS; SUSCEPTIBILITY; MANAGEMENT; BRONCHITIS; PENICILLIN; DIAGNOSIS; PYOGENES	Context Most sore throats are due to viral upper respiratory tract infections. Group A beta -hemolytic streptococci (GABHS), the only common cause of sore throat warranting antibiotics, is cultured in 5% to 17% of adults with sore throat. The frequency of antibiotic use for pharyngitis has greatly exceeded the prevalence of GABHS, but less is known about specific classes of antibiotics used. Only penicillin and erythromycin are recommended as first-line antibiotics against GABHS. Objectives To measure trends in antibiotic use for adults with sore throat and to determine predictors of antibiotic use and nonrecommended antibiotic use. Design, Setting, and Subjects Retrospective analysis of 2244 visits to primary care physicians in off ice-based practices in the National Ambulatory Medical Care Survey, 1989-1999, by adults with a chief complaint of sore throat. Main Outcome Measures Treatment with antibiotics and treatment with nonrecommended antibiotics, extrapolated to US annual national rates. Results There were an estimated 6.7 million annual visits in the United States by adults with sore throat between 1989 and 1999. Antibiotics were used in 73% (95% confidence interval [CI] 70%-76%) of visits. Patients treated with antibiotics were given nonrecommended antibiotics in 68% (95% CI, 64%-72%) of visits. From 1989 to 1999, there was a significant decrease in use of penicillin and erythromycin and an increase in use of nonrecommended antibiotics, especially extended-spectrum macrolides and extended-spectrum fluoroquinolones (P<.001 for all trends). In multivariable modeling, increasing patient age (odds ratio [OR], 0.86 per decade; 95% CI, 0.79-0.94) and general practice specialty (OR, 1.54 compared with family practice specialty; 95% CI, 1.10-2.14) were independent predictors of antibiotic use. Among patients receiving antibiotics, nonrecommended antibiotic use became more frequent over time (OR, 1.17 per year; 95% CI, 1.11-1.24). Conclusions More than half of adults are treated with antibiotics for sore throat by community primary care physicians. Use of nonrecommended, more expensive, broader-spectrum antibiotics is frequent.	Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; Stanford Univ, Sch Med, Stanford Ctr Res Dis Prevent, Palo Alto, CA 94304 USA	Harvard University; Massachusetts General Hospital; Stanford University	Linder, JA (corresponding author), Massachusetts Gen Hosp, Div Gen Med, 50 Staniford St,9th Floor, Boston, MA 02114 USA.		Linder, Jeffrey/AAF-3424-2021; Stafford, Randall/F-3974-2017	Linder, Jeffrey/0000-0003-2217-184X; Stafford, Randall/0000-0003-1805-1271	DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA [T32PE011001] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003548] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08-HL03548] Funding Source: Medline; BHP HRSA HHS [5T32PE11001-12] Funding Source: Medline	DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); BHP HRSA HHS		Betriu C, 1999, DIAGN MICR INFEC DIS, V33, P255, DOI 10.1016/S0732-8893(98)00155-2; Bisno AL, 2001, NEW ENGL J MED, V344, P205, DOI 10.1056/NEJM200101183440308; Bisno AL, 1997, CLIN INFECT DIS, V25, P574, DOI 10.1086/513768; Boos M, 2001, ANTIMICROB AGENTS CH, V45, P938, DOI 10.1128/AAC.45.3.938-942.2001; Cooper RJ, 2001, ANN INTERN MED, V134, P509, DOI 10.7326/0003-4819-134-6-200103200-00019; DELMAR CB, 2001, COCHRANE LIB; DENNY FW, 1950, JAMA-J AM MED ASSOC, V143, P151, DOI 10.1001/jama.1950.02910370001001; *FDA, 1995, NAT DRUG COD DIR 199; Gonzales R, 1997, JAMA-J AM MED ASSOC, V278, P901, DOI 10.1001/jama.278.11.901; GWALTNEY JM, 2000, MANDELL DOUGLAS BENN, P656; HOOTON TM, 1991, AM J MED S3A, V91, P23; KAPLAN EL, 1971, J INFECT DIS, V123, P490, DOI 10.1093/infdis/123.5.490; Kaplan EL, 1999, PEDIATR INFECT DIS J, V18, P1069, DOI 10.1097/00006454-199912000-00008; KLJAKOVIC M, 1993, NEW ZEAL MED J, V106, P381; KOMAROFF AL, 1986, J GEN INTERN MED, V1, P1, DOI 10.1007/BF02596317; Macris MH, 1998, PEDIATR INFECT DIS J, V17, P377, DOI 10.1097/00006454-199805000-00006; McIsaac WJ, 2000, CAN MED ASSOC J, V163, P811; McIsaac WJ, 1998, CAN MED ASSOC J, V158, P75; *MED EC DAT, 1999, DRUG TOP RED BOOK; *NAT CTR HLTH STAT, 1999, PUBL US MICR DOC; Nyquist AC, 1998, JAMA-J AM MED ASSOC, V279, P875, DOI 10.1001/jama.279.11.875; PASKO T, 2000, PHYSICIAN CHARACTERI; PICHICHERO ME, 1991, PEDIATR INFECT DIS J, V10, P275, DOI 10.1097/00006454-199104000-00002; POSES RM, 1985, JAMA-J AM MED ASSOC, V254, P925, DOI 10.1001/jama.254.7.925; POTTHOFF RF, 1992, J AM STAT ASSOC, V87, P383, DOI 10.2307/2290269; SCHATZ RT, 1992, POLIT PSYCHOL, V13, P1, DOI 10.2307/3791421; Seppala H, 1997, NEW ENGL J MED, V337, P441, DOI 10.1056/NEJM199708143370701; Seppala H, 1995, CLIN INFECT DIS, V21, P1378, DOI 10.1093/clinids/21.6.1378; Snow V, 2001, ANN INTERN MED, V134, P506, DOI 10.7326/0003-4819-134-6-200103200-00018; WALSH BT, 1975, ARCH INTERN MED, V135, P1493, DOI 10.1001/archinte.135.11.1493; WANNAMAKER LW, 1951, AM J MED, V10, P673, DOI 10.1016/0002-9343(51)90336-1; WOODWELL DA, 2000, VITAL HLTH STAT, V315; York MK, 1999, J CLIN MICROBIOL, V37, P1727, DOI 10.1128/JCM.37.6.1727-1731.1999; Zwart S, 2000, BRIT MED J, V320, P150, DOI 10.1136/bmj.320.7228.150	34	143	157	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1181	1186		10.1001/jama.286.10.1181	http://dx.doi.org/10.1001/jama.286.10.1181			6	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471CR	11559262	Bronze			2022-12-01	WOS:000170910400027
J	Bista, MB; Banerjee, MK; Shin, SH; Tandan, JB; Kim, MH; Sohn, YM; Ohrr, HC; Tang, JL; Halstead, SB				Bista, MB; Banerjee, MK; Shin, SH; Tandan, JB; Kim, MH; Sohn, YM; Ohrr, HC; Tang, JL; Halstead, SB			Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study	LANCET			English	Article							SA14-14-2; TRIAL	Background: In China, since 1989, an estimated 120 million children have been immunised with the SA 14-14-2 live-attenuated Japanese encephalitis (JE) vaccine at ages 1, 2, and 6 years. A case-control study of licensed vaccine found two doses to be 98% effective. Subsequently, researchers found that single-dose vaccine efficacy was high; we aimed to confirm this result. Methods: During July 11-24, 1999, 160 000 doses of JE vaccine were given to children aged 1-15 years, resident in three districts of Nepal. Several cases of JE were admitted to hospital from early August. We obtained names and addresses of cases with serological evidence of a recent infection from Bheri Zonal Hospital, Nepalgunj. We did a matched case-control study and calculated the odds ratio of vaccination among JE cases and age-sex matched village controls. Findings: 20 children, aged 1-15 years, were identified whose illness conformed with the JE case definition and were resident in villages receiving the vaccine. None of 20 JE cases had received JE vaccine compared with 326 of 557 age-sex matched village controls. The efficacy of a single dose of JE vaccine was 99.3% (CI 94.9-100%). Interpretation: A single dose of JE vaccine is highly efficacious in preventing Japanese encephalitis when administered only days or weeks before exposure to infection.	Glovax Co Ltd, Kyryo Academytel, Seoul, South Korea; Minist Hlth, Epidemiol & Dis Control Div, Kathmandu, Nepal; Sch Hlth Sci, Bharatpur, Nepal; Yonsei Univ, Coll Med, Dept Pediat, Seoul, South Korea; Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; Chinese Univ Hong Kong, Dept Community & Family Med, Shatin, Hong Kong, Peoples R China; Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biostat, Bethesda, MD 20814 USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Chinese University of Hong Kong; Uniformed Services University of the Health Sciences - USA	Shin, SH (corresponding author), Glovax Co Ltd, Kyryo Academytel, 437-3 Ahyun Dong, Seoul, South Korea.	sunheang@soback.kornet2l.net	Tang, JL/G-1759-2013; Tang, Jin-Ling/AAJ-4090-2021					AO J, 1983, CHIN J MICROBIOL IMM, V3, P245; FLANDERS WD, 1986, AM J EPIDEMIOL, V124, P684, DOI 10.1093/oxfordjournals.aje.a114442; Hennessy S, 1996, LANCET, V347, P1583, DOI 10.1016/S0140-6736(96)91075-2; HIRJI KF, 1988, BIOMETRICS, V44, P803, DOI 10.2307/2531592; HOKE CH, 1988, NEW ENGL J MED, V319, P608, DOI 10.1056/NEJM198809083191004; INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418; Liu ZL, 1997, J INFECT DIS, V176, P1366, DOI 10.1086/517323; MA W X, 1993, CHINESE J BIOL, V6, P188; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; Rodrigues LC, 1999, EPIDEMIOL REV, V21, P56, DOI 10.1093/oxfordjournals.epirev.a017988; ROTHMAN KJ, 1986, MODERN EPIDEMIOLOGY, P297; Shepard D.S., 1993, DIS CONTROL PRIORITI, P303; Sohn YM, 1999, VACCINE, V17, P2259, DOI 10.1016/S0264-410X(99)00006-7; SOKHEY J, 1998, INVESTIGATION CONTRO; Takahashi H, 2000, VACCINE, V18, P2963, DOI 10.1016/S0264-410X(00)00111-0; Tsai TF, 1998, J INFECT DIS, V177, P221, DOI 10.1086/517358; TSAI TF, 1999, VACCINES, P672; UNICEF, 1994, STAT WORLDS CHILDR, P82; VAUGHN DW, 1992, EPIDEMIOL REV, V14, P197, DOI 10.1093/oxfordjournals.epirev.a036087; WERZBERGER A, 1992, NEW ENGL J MED, V327, P453, DOI 10.1056/NEJM199208133270702; YU YX, 1988, AM J TROP MED HYG, V39, P214, DOI 10.4269/ajtmh.1988.39.214; 1993, MMWR, V42, P1	22	117	128	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 8	2001	358	9284					791	795		10.1016/S0140-6736(01)05967-0	http://dx.doi.org/10.1016/S0140-6736(01)05967-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NA	11564484				2022-12-01	WOS:000170989300010
J	Cohen, J				Cohen, J			TREM-1 in sepsis	LANCET			English	Editorial Material							INNATE IMMUNITY; LIPOPOLYSACCHARIDE; ENDOTOXIN; STIMULATION; ACTIVATION; RESPONSES; MONOCYTES; SHOCK		Hammersmith Hosp, Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis & Microbiol, London W12 0NN, England	Imperial College London	Cohen, J (corresponding author), Hammersmith Hosp, Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis & Microbiol, London W12 0NN, England.							Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Blunck R, 2001, J IMMUNOL, V166, P1009, DOI 10.4049/jimmunol.166.2.1009; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Bunnell E, 2000, CRIT CARE MED, V28, P2713, DOI 10.1097/00003246-200008000-00005; Cauwels A, 1997, INFECT IMMUN, V65, P3255, DOI 10.1128/IAI.65.8.3255-3260.1997; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Daws MR, 2001, EUR J IMMUNOL, V31, P783, DOI 10.1002/1521-4141(200103)31:3<783::AID-IMMU783>3.0.CO;2-U; DINARELLO CA, 1997, CHEST S, V112, P321, DOI DOI 10.1378/CHEST.112.6_SUPPLEMENT.321S; Haworth R, 1997, J EXP MED, V186, P1431, DOI 10.1084/jem.186.9.1431; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; LYNN WA, 1993, INFECT IMMUN, V61, P4452, DOI 10.1128/IAI.61.10.4452-4461.1993; Modlin RL, 1999, NEW ENGL J MED, V340, P1834, DOI 10.1056/NEJM199906103402312; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; SRISKANDAN S, 1995, J INFECTION, V30, P201, DOI 10.1016/S0163-4453(95)90647-9; Ulevitch RJ, 1999, NAT MED, V5, P144, DOI 10.1038/5504; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Wurfel MM, 1997, J EXP MED, V186, P2051, DOI 10.1084/jem.186.12.2051	20	48	66	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 8	2001	358	9284					776	778		10.1016/S0140-6736(01)06007-X	http://dx.doi.org/10.1016/S0140-6736(01)06007-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NA	11564478				2022-12-01	WOS:000170989300004
J	Kachroo, A; Schopfer, CR; Nasrallah, ME; Nasrallah, JB				Kachroo, A; Schopfer, CR; Nasrallah, ME; Nasrallah, JB			Allele-specific receptor-ligand interactions in Brassica self-incompatibility	SCIENCE			English	Article							S-LOCUS; TRANSGENIC TOBACCO; MALE DETERMINANT; SLG ALLELES; OLERACEA; KINASE; CAMPESTRIS; GENE; GLYCOPROTEINS; HAPLOTYPES	Genetic self-incompatibility in Brassica is determined by alleles of the transmembrane serine-threonine kinase SRK, which functions in the stigma epidermis, and of the cysteine-rich peptide SCR, which functions in pollen. Using tagged versions of SRK and SCR as well as endogenous stigma and pollen proteins, we show that SCR binds the SRK ectodomain and that this binding is allele,specific. Thus, SRK and SCR function as a receptor-Ligand pair in the recognition of self pollen. Specificity in the self-incompatibility response derives from allele-specific formation of SRK-SCR complexes at the pollen-stigma interface.	Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA	Cornell University	Nasrallah, JB (corresponding author), Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA.	jnb2@cornell.edu			NIGMS NIH HHS [GM57527] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057527] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAULCOMBE DC, 1995, PLANT J, V7, P1045, DOI 10.1046/j.1365-313X.1995.07061045.x; Cabrillac D, 2001, NATURE, V410, P220, DOI 10.1038/35065626; Conner JA, 1997, PLANT J, V11, P809, DOI 10.1046/j.1365-313X.1997.11040809.x; Dixit R, 2000, PLANT PHYSIOL, V124, P297, DOI 10.1104/pp.124.1.297; DOUGHTY J, 1993, P NATL ACAD SCI USA, V90, P467, DOI 10.1073/pnas.90.2.467; Kusaba M, 1999, PLANT J, V17, P83, DOI 10.1046/j.1365-313X.1999.00355.x; Kusaba M, 1997, P NATL ACAD SCI USA, V94, P7673, DOI 10.1073/pnas.94.14.7673; Lu YB, 1996, P NATL ACAD SCI USA, V93, P12902, DOI 10.1073/pnas.93.23.12902; Nasrallah JB, 2000, CURR OPIN PLANT BIOL, V3, P368, DOI 10.1016/S1369-5266(00)00098-4; NASRALLAH JB, 1987, NATURE, V326, P617, DOI 10.1038/326617a0; Schopfer CR, 2000, PLANT PHYSIOL, V124, P935, DOI 10.1104/pp.124.3.935; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Shiba H, 2001, PLANT PHYSIOL, V125, P2095, DOI 10.1104/pp.125.4.2095; Stein JC, 1996, PLANT CELL, V8, P429, DOI 10.1105/tpc.8.3.429; STEIN JC, 1991, P NATL ACAD SCI USA, V88, P8816, DOI 10.1073/pnas.88.19.8816; Stephenson AG, 1997, PLANT J, V12, P1351, DOI 10.1046/j.1365-313x.1997.12061351.x; Takasaki T, 2000, NATURE, V403, P913, DOI 10.1038/35002628; Takayama S, 2000, P NATL ACAD SCI USA, V97, P1920, DOI 10.1073/pnas.040556397; Tantikanjana T, 1996, SEX PLANT REPROD, V9, P107; Trotochaud AE, 2000, SCIENCE, V289, P613, DOI 10.1126/science.289.5479.613; UMBACH AL, 1990, PLANT PHYSIOL, V93, P739, DOI 10.1104/pp.93.2.739; Watanabe M, 2000, FEBS LETT, V473, P139, DOI 10.1016/S0014-5793(00)01514-3	22	227	263	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1824	1826		10.1126/science.1062509	http://dx.doi.org/10.1126/science.1062509			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546871				2022-12-01	WOS:000170894400045
J	Bengel, FM; Ueberfuhr, P; Schiepel, N; Nekolla, SG; Reichart, B; Schwaiger, M				Bengel, FM; Ueberfuhr, P; Schiepel, N; Nekolla, SG; Reichart, B; Schwaiger, M			Effect of sympathetic reinnervation on cardiac performance after heart transplantation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; EXERCISE CAPACITY; SERIAL ASSESSMENT; RECIPIENTS; HUMANS; INNERVATION	Background: Late after cardiac transplantation, limited reinnervation of the transplanted heart may occur, but little is known about the effect of reinnervation on cardiac function and exercise performance. Methods: We quantified the extent of myocardial reinnervation noninvasively in 29 cardiac-transplant recipients, using positron-emission tomography and the catecholamine analogue [C-11]hydroxyephedrine. Global and regional ventricular function at rest and during standardized exercise testing was measured with the use of radionuclide angiography, and the results were compared with those in 10 healthy controls. Results: Sympathetic reinnervation, mainly in the anteroseptal wall, was present in 16 of the 29 transplant recipients. At rest, hemodynamic differences were not observed between the patients with reinnervation and those with denervation. However, the latter group had a shorter mean (+/-SD) exercise time (6.1+/-1.5 minutes, vs. 8.2+/-1.2 in the group with reinnervation; P<0.01) and a lower peak heart rate (121+/-13 vs. 143+/-15 beats per minute, P<0.01). The contractile response to exercise was significantly enhanced in transplant recipients with reinnervation and similar to that of normal controls. In a multivariate analysis, hydroxyephedrine retention was the only independent determinant of the exercise-induced increase in the ejection fraction. Conclusions: In heart-transplant recipients, the restoration of sympathetic innervation is associated with improved responses of the heart rate and contractile function to exercise. These results support the functional importance of reinnervation in transplanted hearts.	Tech Univ Munich, Nukl Med Klin & Poliklin, D-8000 Munich, Germany; Univ Munich, Herzchirurg Klin, Munich, Germany	Technical University of Munich; University of Munich	Bengel, FM (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Nukl Med Klin & Poliklin, Ismaninger Str 22, D-81675 Munich, Germany.		Bengel, Frank/AAR-7353-2020; Nekolla, Stephan G/L-1857-2013	Nekolla, Stephan G/0000-0002-8817-1482; schwaiger, markus/0000-0002-2305-7144				American Society of Nuclear Cardiology, 1996, J NUCL CARDIOL, V3, pG26; Bengel FM, 2000, EUR J NUCL MED, V27, P1650, DOI 10.1007/s002590000366; Bengel FM, 1999, CIRCULATION, V99, P1866, DOI 10.1161/01.CIR.99.14.1866; Bengel FM, 2001, CIRCULATION, V103, P1881; BURKE MN, 1995, CIRCULATION, V91, P72, DOI 10.1161/01.CIR.91.1.72; COOPER T, 1962, SCIENCE, V138, P40, DOI 10.1126/science.138.3536.40; DEMARCO T, 1995, J AM COLL CARDIOL, V25, P927, DOI 10.1016/0735-1097(94)00463-Z; DiCarli MF, 1997, NEW ENGL J MED, V336, P1208, DOI 10.1056/NEJM199704243361703; GILBERT EM, 1989, CIRCULATION, V79, P344, DOI 10.1161/01.CIR.79.2.344; Givertz MM, 1997, CIRCULATION, V96, P232; KAO AC, 1994, CIRCULATION, V89, P2605, DOI 10.1161/01.CIR.89.6.2605; KAYE DM, 1993, CIRCULATION, V88, P1110, DOI 10.1161/01.CIR.88.3.1110; LEENEN FHH, 1995, CIRCULATION, V91, P685, DOI 10.1161/01.CIR.91.3.685; Mancini D, 1997, CIRCULATION, V96, P6; MANDAK JS, 1995, J HEART LUNG TRANSPL, V14, P468; MARTI V, 1992, TRANSPLANT P, V24, P16; Nekolla SG, 1998, EUR J NUCL MED, V25, P1313, DOI 10.1007/s002590050301; Odaka K, 2001, J NUCL MED, V42, P1011; OPIE LH, 1998, HEART PHYSL CELL CIR, P193; OSTLE B, 1975, STAT RES BASIC CONCE, P321; OYER PE, 1983, TRANSPLANT P, V15, P2546; PAFFENBARGER RS, 1978, AM J EPIDEMIOL, V108, P161, DOI 10.1093/oxfordjournals.aje.a112608; PAULUS WJ, 1992, CIRCULATION, V86, P1175, DOI 10.1161/01.CIR.86.4.1175; QUIGG RJ, 1989, J AM COLL CARDIOL, V14, P338, DOI 10.1016/0735-1097(89)90183-6; ROSENSPIRE KC, 1990, J NUCL MED, V31, P1328; Schwaiblmair M, 1999, J HEART LUNG TRANSPL, V18, P838, DOI 10.1016/S1053-2498(99)00048-0; SCHWAIGER M, 1991, J CLIN INVEST, V87, P1681, DOI 10.1172/JCI115185; STARK RP, 1991, NEW ENGL J MED, V324, P1791, DOI 10.1056/NEJM199106203242507; STEVENSON LW, 1990, CIRCULATION, V81, P78, DOI 10.1161/01.CIR.81.1.78; STRANG KT, 1994, CIRC RES, V74, P542, DOI 10.1161/01.RES.74.3.542; VERANI MS, 1994, J HEART LUNG TRANSPL, V13, P181; WILSON RF, 1993, CIRCULATION, V88, P165, DOI 10.1161/01.CIR.88.1.165; WILSON RF, 1991, CIRCULATION, V83, P1210, DOI 10.1161/01.CIR.83.4.1210; Wilson RF, 2000, CIRCULATION, V101, P2727, DOI 10.1161/01.CIR.101.23.2727	34	183	188	0	8	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2001	345	10					731	738		10.1056/NEJMoa010519	http://dx.doi.org/10.1056/NEJMoa010519			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	468RX	11547742	Bronze			2022-12-01	WOS:000170772900004
J	Benson, DE; Conrad, DW; de Lorimer, RM; Trammell, SA; Hellinga, HW				Benson, DE; Conrad, DW; de Lorimer, RM; Trammell, SA; Hellinga, HW			Design of bioelectronic interfaces by exploiting hinge-bending motions in proteins	SCIENCE			English	Article							BIOSENSOR; NANOBIOTECHNOLOGY; CONSTRUCTION	We report a flexible strategy for transducing ligand-binding events into electrochemical responses for a wide variety of proteins. The method exploits ligand-mediated hinge-bending motions, intrinsic to the bacterial periplasmic binding protein superfamily, to establish allosterically controlled interactions between electrode surfaces and redox-active, Ru(II)labeled proteins. This approach allows the development of protein-based bioelectronic interfaces that respond to a diverse set of analytes. Families of these interfaces can be generated either by exploiting natural binding diversity within the superfamily or by reengineering the specificity of individual proteins. These proteins may have numerous medical, environmental, and defense applications.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; USN, Res Lab, Ctr Biomol Sci & Engn, Washington, DC 20375 USA	Duke University; United States Department of Defense; United States Navy; Naval Research Laboratory	Hellinga, HW (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Box 3711, Durham, NC 27710 USA.	hwh@biochem.duke.edu	Trammell, Scott A./ABB-7140-2020; Wood, David W/B-2992-2012	Trammell, Scott A./0000-0002-7996-590X; 				Arnold FH, 2001, NATURE, V409, P253, DOI 10.1038/35051731; Bard A. J., 1980, ELECTROCHEMICAL METH, DOI 10.1021/ed060pa25; Boon EM, 2000, NAT BIOTECHNOL, V18, P1096, DOI 10.1038/80301; BURTIS CA, 1994, CLIN CHEM; Cass AEG, 1990, BIOSENSORS PRACTICAL; Chemla YR, 2000, P NATL ACAD SCI USA, V97, P14268, DOI 10.1073/pnas.97.26.14268; Cheng Q, 1997, ADV MATER, V9, P481, DOI 10.1002/adma.19970090605; Cornell BA, 1997, NATURE, V387, P580, DOI 10.1038/42432; Creager SE, 1998, ANAL CHEM, V70, P4257, DOI 10.1021/ac980482l; Edelstein RL, 2000, BIOSENS BIOELECTRON, V14, P805, DOI 10.1016/S0956-5663(99)00054-8; Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316; GERSTEIN M, 1994, BIOCHEMISTRY-US, V33, P6739, DOI 10.1021/bi00188a001; Gu LQ, 2001, SCIENCE, V291, P636, DOI 10.1126/science.291.5504.636; Hellinga HW, 1998, TRENDS BIOTECHNOL, V16, P183, DOI 10.1016/S0167-7799(98)01174-3; Hsiao CD, 1996, J MOL BIOL, V262, P225, DOI 10.1006/jmbi.1996.0509; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Laval JM, 2000, ANALYST, V125, P29, DOI 10.1039/a907827d; Lowe CR, 2000, CURR OPIN STRUC BIOL, V10, P428, DOI 10.1016/S0959-440X(00)00110-X; Marvin JS, 1997, P NATL ACAD SCI USA, V94, P4366, DOI 10.1073/pnas.94.9.4366; Marvin JS, 1998, J AM CHEM SOC, V120, P7, DOI 10.1021/ja972993f; Marvin JS, 2001, P NATL ACAD SCI USA, V98, P4955, DOI 10.1073/pnas.091083898; Perutz M. F., 1990, MECH COOPERATIVITY A; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Schutz S, 2000, SENSOR ACTUAT B-CHEM, V65, P291, DOI 10.1016/S0925-4005(99)00325-1; SHEN Y, 1993, NATURE, V366, P48, DOI 10.1038/366048a0; Soong RK, 2000, SCIENCE, V290, P1555, DOI 10.1126/science.290.5496.1555; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Tang Y, 1998, ADV MATER, V10, P1536, DOI 10.1002/(SICI)1521-4095(199812)10:18<1536::AID-ADMA1536>3.3.CO;2-W; Thomson NH, 1999, BIOPHYS J, V76, P1024, DOI 10.1016/S0006-3495(99)77267-X; Trammell SA, 2001, BIOCONJUGATE CHEM, V12, P643, DOI 10.1021/bc010022q; VYAS NK, 1988, SCIENCE, V242, P1290, DOI 10.1126/science.3057628; Willner I, 2000, ANGEW CHEM INT EDIT, V39, P1180, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1180::AID-ANIE1180>3.0.CO;2-E	32	127	136	3	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2001	293	5535					1641	1644		10.1126/science.1062461	http://dx.doi.org/10.1126/science.1062461			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533486				2022-12-01	WOS:000170802900058
J	Hawthorne, DJ; Via, S				Hawthorne, DJ; Via, S			Genetic linkage of ecological specialization and reproductive isolation in pea aphids	NATURE			English	Article							SYMPATRIC SPECIATION; NATURAL-SELECTION; EVOLUTION; ANIMALS; RACES	The evolution of ecological specialization generates biological diversity and may lead to speciation(1-3). Genetic architecture can either speed or retard this process. If resource use and mate choice have a common genetic basis through pleiotropy or close linkage, the resulting genetic correlations can promote the joint evolution of specialization and reproductive isolation, facilitating speciation(4-6). Here we present a model of the role of genetic correlations in specialization and speciation, and test it by analysing the genetic architecture of key traits in two highly specialized host races of the pea aphid (Acyrthosiphon pisum pisum; Hemiptera : Aphididae). We found several complexes of pleiotropic or closely linked quantitative trait loci (QTL) that affect key traits in ways that would promote speciation: QTL with antagonistic effects on performance on the two hosts are linked to QTL that produce asortative mating (through habitat choice). This type of genetic architecture may be common in taxa that have speciated under divergent natural selection.	Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Via, S (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	sv47@umail.umd.edu						BASTEN CJ, 1996, QTL CARTOGRAPHER VER; BUSH GL, 1994, TRENDS ECOL EVOL, V9, P285, DOI 10.1016/0169-5347(94)90031-0; Caillaud MC, 2000, AM NAT, V156, P606, DOI 10.1086/316991; Cho YG, 1996, GENOME, V39, P373, DOI 10.1139/g96-048; CHURCHILL GA, 1994, GENETICS, V138, P963; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Filchak KE, 2000, NATURE, V407, P739, DOI 10.1038/35037578; Fry JD, 1996, AM NAT, V148, pS84, DOI 10.1086/285904; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; KONDRASHOV AS, 1986, BIOL J LINN SOC, V27, P201, DOI 10.1111/j.1095-8312.1986.tb01734.x; LANDE R, 1979, EVOLUTION, V33, P234, DOI 10.1111/j.1558-5646.1979.tb04678.x; LANDE R, 1984, GENET RES, V44, P309, DOI 10.1017/S0016672300026549; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Littel RC, 1996, SAS SYSTEM MIXED MOD; Lynch Michael, 1998; ORR HA, 1995, GENETICS, V139, P1805; Orr HA, 1998, GENETICS, V149, P2099; Rice WR, 1987, EVOL ECOL, V1, P301, DOI 10.1007/BF02071555; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; Schemske D.W., 2000, EVOLUTION, V54, P1069, DOI DOI 10.1111/J.0014-3820.2000.TB00111.X; Schluter D, 1998, ENDLESS FORMS, P114; SUN RY, 1966, CAN J ZOOLOG, V44, P649, DOI 10.1139/z66-063; Thompson J.N., 1994, COEVOLUTIONARY PROCE; Via S, 2000, EVOLUTION, V54, P1626, DOI 10.1111/j.0014-3820.2000.tb00707.x; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; Via S, 1999, EVOLUTION, V53, P1446, DOI [10.1111/j.1558-5646.1999.tb05409.x, 10.2307/2640891]; VIA S, 1991, EVOLUTION, V45, P827, DOI 10.1111/j.1558-5646.1991.tb04353.x; Whitlock MC, 1996, AM NAT, V148, pS65, DOI 10.1086/285902; [No title captured]	30	425	436	1	155	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 30	2001	412	6850					904	907		10.1038/35091062	http://dx.doi.org/10.1038/35091062			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528477				2022-12-01	WOS:000170689000043
J	Neth, O; Hann, I; Turner, MW; Klein, NJ				Neth, O; Hann, I; Turner, MW; Klein, NJ			Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study	LANCET			English	Article							SERINE-PROTEASE; GENE; ASSOCIATION; MUTATIONS; COMPLEMENT; POPULATIONS; INDUCTION; PROMOTER; LEUKEMIA; MBL	Background Infection is a major cause of morbidity and mortality in children with malignancy. Individuals with serum deficient in mannose-binding lectin (MBL)-an important component of the innate immune system-are more susceptible to infection than those with adequate concentrations. In this study, we investigated the capacity of this protein to influence infectious complications in children undergoing treatment for malignancy. Methods We enrolled 100 children receiving chemotherapy for malignancy at a children's hospital in London, UK. The frequency, duration, and causes of febrile neutropenic episodes were recorded, and MBL genotype and phenotype were determined by heteroduplex analysis and ELISAs, respectively. Serial MBL concentrations were also measured in patients during febrile episodes, and the results correlated with the MBL genotype (A/A indicating wild type, O/O indicating homozygous for MBL structural-gene mutations, and A/O indicating heterozygous for such mutations). Findings In the A/A patients, MBL concentrations almost doubled by day 7 of the febrile neutropenic episode before declining by day 14 (p=0.004). By contrast, fn patients with MBL mutations, concentrations did not alter significantly during the neutropenic episode. In the 6 months after initial diagnosis, most patients had at least one febrile neutropenic episode, but the median duration in patients with MBL mutations was twice as long as that in children with the wildtype genotype (20.5 days vs 10.0 days; p=0.014). Individuals with the lowest serum MBL concentrations at the time of diagnosis (<1000 <mu>g/L) had a higher median number of days of febrile neutropenia than did individuals with higher concentrations of MBL (p=0.012). Interpretation MBL deficiency seems to have an important influence on the duration of febrile neutropenic episodes in children with malignancy. This finding suggests that MBL infusions could represent a new therapeutic approach which would aid the management of chemotherapy-induced complications in this population of children.	Inst Child Hlth, Immunobiol Unit, London WC1N 1EH, England; Inst Child Hlth, Mol Haematol Unit, London WC1N 1EH, England	University of London; University College London; University of London; University College London	Klein, NJ (corresponding author), Inst Child Hlth, Immunobiol Unit, 30 Guilford St, London WC1N 1EH, England.		Neth, Olaf/F-1167-2015; IBIS, INMUNODEFICIEN/C-1245-2016	Neth, Olaf/0000-0001-5018-0466; Klein, Nigel/0000-0003-3925-9258				Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1; Garred P, 1999, J CLIN INVEST, V104, P431, DOI 10.1172/JCI6861; Graudal NA, 1998, J RHEUMATOL, V25, P629; Hann I, 1997, BRIT J HAEMATOL, V99, P580, DOI 10.1046/j.1365-2141.1997.4453255.x; Hargrave DR, 2001, BRIT J HAEMATOL, V112, P293, DOI 10.1046/j.1365-2141.2001.02543.x; Jack D, 1997, HUM MUTAT, V9, P41, DOI 10.1002/(SICI)1098-1004(1997)9:1<41::AID-HUMU7>3.0.CO;2-S; Koch A, 2001, JAMA-J AM MED ASSOC, V285, P1316, DOI 10.1001/jama.285.10.1316; KUHLMAN M, 1989, J EXP MED, V169, P1733, DOI 10.1084/jem.169.5.1733; Lipscombe R. J., 1992, Human Molecular Genetics, V1, P709, DOI 10.1093/hmg/1.9.709; Madsen HO, 1998, J IMMUNOL, V161, P3169; MADSEN HO, 1995, J IMMUNOL, V155, P3013; MATSUSHITA M, 1992, J EXP MED, V176, P1497, DOI 10.1084/jem.176.6.1497; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Pui CH, 1997, NEW ENGL J MED, V336, P1781, DOI 10.1056/NEJM199706193362503; Riley LC, 1999, BRIT J HAEMATOL, V106, P436, DOI 10.1046/j.1365-2141.1999.01550.x; Steffensen R, 2000, J IMMUNOL METHODS, V241, P33, DOI 10.1016/S0022-1759(00)00198-8; STILLER CA, 1997, PAEDIAT ONCOLOGY CLI, P3; Summerfield JA, 1997, BRIT MED J, V314, P1229, DOI 10.1136/bmj.314.7089.1229; SUPER M, 1989, LANCET, V2, P1236; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; THIEL S, 1992, CLIN EXP IMMUNOL, V90, P31; Turner MW, 1996, IMMUNOL TODAY, V17, P532, DOI 10.1016/0167-5699(96)10062-1; Turner MW, 2000, HUM MOL GENET, V9, P1481, DOI 10.1093/hmg/9.10.1481; Valdimarsson H, 1998, SCAND J IMMUNOL, V48, P116; vanPelt LJ, 1997, PEDIATR HEMAT ONCOL, V14, P539, DOI 10.3109/08880019709030910	25	238	251	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 25	2001	358	9282					614	618		10.1016/S0140-6736(01)05776-2	http://dx.doi.org/10.1016/S0140-6736(01)05776-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530147				2022-12-01	WOS:000170615500008
J	SCHUTTE, WA; ALLAMANDOLA, LJ; SANDFORD, SA				SCHUTTE, WA; ALLAMANDOLA, LJ; SANDFORD, SA			FORMALDEHYDE AND ORGANIC-MOLECULE PRODUCTION IN ASTROPHYSICAL ICES AT CRYOGENIC TEMPERATURES	SCIENCE			English	Article							MU-M; COMET; EMISSION	Thermally promoted formaldehyde (H2CO) reactions in cryogenic ices have been studied to test their importance as a source of organic molecules in comets and interstellar ices. Ices containing H2CO, H2O, CH3OH, CO, and NH3 were investigated by using infrared spectroscopy. Small traces of NH3 (NH3/H2CO greater-than-or-equal-to 0.005) are sufficient to convert significant fractions (greater-than-or-equal-to 40%) of the H2CO into more complex organics. However, H2CO reactions do not proceed without NH3. Spectral evidence for reaction onset appeared between 40 and 80 kelvin, depending on the ice. Five distinct products were formed. These principally consist of polyoxymethylene and related derivatives. Polyoxymethylene itself was not made in significant amounts in cometary analogs. These products differ from those produced by ultraviolet and particle irradiation. The nature and relative amounts of the products depend on the initial composition, making these materials excellent tracers of a comet's history. About 3% of the organics in p-Halley's coma could have been produced by thermal H2CO reactions.			SCHUTTE, WA (corresponding author), NASA,AMES RES CTR,MS 245-6,MOFFETT FIELD,CA 94035, USA.							AGARWAL VK, 1985, ORIGINS LIFE EVOL B, V16, P21, DOI 10.1007/BF01808047; ALLAMANDOLA LJ, 1988, ICARUS, V76, P225, DOI 10.1016/0019-1035(88)90070-X; ALLAMANDOLA LJ, 1992, ASTROCHEMISTRY COSMI, P65; BROOKE TY, 1991, ASTRON J, V101, P268, DOI 10.1086/115686; DANKS AC, 1987, ASTRON ASTROPHYS, V184, P329; MUMMA MJ, 1989, ASTROPHYS J, V344, P940, DOI 10.1086/167862; SANDFORD SA, IN PRESS ASTRONOMICA; SCHUTTE W, UNPUB; SCHUTTE WA, 1988, THESIS U LEIDEN LEID; SNYDER LE, 1989, ASTRON J, V97, P246, DOI 10.1086/114976; TADOKORO H, 1963, J CHEM PHYS, V38, P703, DOI 10.1063/1.1733727; TIELENS AGGM, 1982, ASTRON ASTROPHYS, V114, P245; Walker J. F., 1964, FORMALDEHYDE; WALSMLEY C, 1989, INTERSTELLAR DUST, P263; ZHAO NS, 1990, THESIS U LEIDEN LEID	15	75	75	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 19	1993	259	5098					1143	1145		10.1126/science.11540093	http://dx.doi.org/10.1126/science.11540093			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KM917	11540093				2022-12-01	WOS:A1993KM91700033
J	KNOLL, AH; WALTER, MR				KNOLL, AH; WALTER, MR			LATEST PROTEROZOIC STRATIGRAPHY AND EARTH HISTORY	NATURE			English	Review							SEQUENCE STRATIGRAPHY; CENTRAL AUSTRALIA; EAST GREENLAND; TRACE FOSSILS; CARBONATES; BIOSTRATIGRAPHY; SUCCESSIONS; SVALBARD; METAZOA; AMADEUS	The end of the Proterozoic Eon was a time of pronounced biological, biogeochemical, climatic and tectonic change. New bio- and chemostratigraphic data provide an improved framework for stratigraphic correlation, making possible a deeper understanding of latest Proterozoic Earth history and providing tools for a chronostratigraphic division of late Proterozoic time.	MACQUARIE UNIV,SCH EARTH SCI,MACQUARIE,NSW 2109,AUSTRALIA	Macquarie University	KNOLL, AH (corresponding author), HARVARD UNIV,BOT MUSEUM,CAMBRIDGE,MA 02138, USA.							AHARON P, 1987, NATURE, V327, P699, DOI 10.1038/327699a0; [Anonymous], 1978, BUREAU MINERAL RESOU; ASMEROM Y, 1991, GEOCHIM COSMOCHIM AC, V55, P2883, DOI 10.1016/0016-7037(91)90453-C; BEANUS MA, 1985, GEOL SOC AM BULL, V96, P737; BERTRANDSARFATI J, 1981, PRECAMBRIAN RES, V15, P353, DOI 10.1016/0301-9268(81)90057-7; CHRISTIEBLICK N, 1991, MAR GEOL, V97, P35, DOI 10.1016/0025-3227(91)90018-Y; CHRISTIEBLICK N, 1990, AM J SCI, V290A, P295; CHRISTIEBLICK N, 1988, GEOLOGY, V16, P100, DOI 10.1130/0091-7613(1988)016<0100:SSIPS>2.3.CO;2; CLAYPOOL GE, 1980, CHEM GEOL, V28, P199, DOI 10.1016/0009-2541(80)90047-9; CLOUD P, 1982, SCIENCE, V217, P783, DOI 10.1126/science.217.4562.783; COMPSTON W, 1990, RES SCH EARTH SCI AU, P26; COWIE JW, 1989, PRECAMBRIAN CAMBRIAN, P186; CRIMES TP, 1987, GEOL MAG, V124, P97; Darwin C.R., 1877, DIFFERENT FORMS FLOW; DERRY LA, 1989, GEOCHIM COSMOCHIM AC, V53, P2331, DOI 10.1016/0016-7037(89)90355-4; DERRY LA, IN PRESS GEOCHIM COS; DONNELLY TH, 1990, GEOLOGICAL SOC SPECI, V52, P273; FAIRCHILD IJ, 1987, SEDIMENTOLOGY, V34, P973, DOI 10.1111/j.1365-3091.1987.tb00587.x; FAIRCHILD IJ, 1990, AM J SCI, V290A, P46; FEDONKIN MA, 1990, VENDIAN SYSTEM, V1, P112; GERMS GJB, 1972, AM J SCI, V272, P752, DOI 10.2475/ajs.272.8.752; Glaessner M.F., 1984, DAWN ANIMAL LIFE; Gnilovskaya M.B., 1988, VENDOTAENIDS E EUROP; GRANT SWF, 1990, AM J SCI, V290A, P261; HAMBREY MJ, 1981, EARTHS PREPLEISTOCEN; Harland W.B., 1990, GEOLOGIC TIME SCALE; Harland W.B., 1964, INT J EARTH SCI, V54, P45, DOI [10.1007/BF01821169, DOI 10.1007/BF01821169]; HARLAND WB, 1975, ICE AGES ANCIENT MOD, P189; HOFMANN HJ, 1990, GEOLOGY, V18, P1199, DOI 10.1130/0091-7613(1990)018<1199:ERFIBI>2.3.CO;2; HOFMANN HJ, 1987, GEOSCI CAN, V14, P135; Holser W.T., 1984, PATTERNS CHANGE EART, P123, DOI DOI 10.1007/978-3-642-69317-5_8; JENKINS RJF, 1984, GEOL MAG, V121, P635, DOI 10.1017/S0016756800030788; JENKINS RJF, 1984, T R SOC S AUST, V105, P179; KAUFMAN AJ, 1991, PRECAMBRIAN RES, V49, P301, DOI 10.1016/0301-9268(91)90039-D; KAUFMAN AJ, IN PRESS EARTH PLANE; KHOMENTOVSKY AA, 1990, VENDIAN SYSTEM, V2, P102; Kirschvink J.L., 1991, GSA TODAY, V1, P69; KNOLL AH, 1986, NATURE, V321, P832, DOI 10.1038/321832a0; KNOLL AH, 1989, NATURE, V337, P602, DOI 10.1038/337602a0; KNOLL AH, IN PRESS PALAEONTOLO; KNOLL AH, 1991, SCI AM, V265, P65; KROGH TE, 1988, CAN J EARTH SCI, V25, P442, DOI 10.1139/e88-045; LAMBERT IB, 1987, NATURE, V325, P140, DOI 10.1038/325140a0; Lindsay J. F., 1989, BASIN RES, V2, P3; LINDSAY JF, 1987, AAPG BULL, V71, P1387; Moczydlowska M., 1991, FOSSILS STRATA, V29, P1; MORRIS SC, 1990, AM J SCI, V290A, P245; MORRIS SC, 1989, PRECAMBRIAN CAMBRIAN, P7; NARBONNE GM, 1988, B NEW YORK STATE MUS, V463, P72; PLUMB KA, 1991, EPISODES, V14, P139, DOI 10.18814/epiiugs/1991/v14i2/005; ROSS GM, 1988, GEOLOGY, V16, P139, DOI 10.1130/0091-7613(1988)016<0139:TSAARC>2.3.CO;2; ROSS GM, 1991, GEOLOGICAL ASS CANAD, V16, P108; Schopf JW, 1983, EARTHS EARLIEST BIOS; Sokolov B. S., 1952, IZV AN SSSR GEOL, V5, P21; SOKOLOV BS, 1990, VENDIAN SYSTEM, V1; VEIZER J, 1983, GEOCHIM COSMOCHIM AC, V47, P295, DOI 10.1016/0016-7037(83)90142-4; VIDAL G, 1990, PALAEONTOLOGY, V33, P287; VONDERBORCH CC, 1988, AUST J EARTH SCI, V35, P59, DOI 10.1080/08120098808729439; Walter M.R., 1976, STROMATOLITES; WALTER MR, 1985, PRECAMBRIAN RES, V29, P149, DOI 10.1016/0301-9268(85)90066-X; WALTER MR, 1989, ALCHERINGA, V13, P209, DOI 10.1080/03115518908527821; WHITTAKER A, 1991, J GEOL SOC LONDON, V148, P813, DOI 10.1144/gsjgs.148.5.0813; Willis BJ, 1907, RES CHINA; Yin L., 1985, PALAEONTOLOGIA CATHA, V2, P229; ZANG W, 1989, NATURE, V337, P632	65	238	260	0	25	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 23	1992	356	6371					673	678		10.1038/356673a0	http://dx.doi.org/10.1038/356673a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ146	11537861				2022-12-01	WOS:A1992HQ14600048
J	MCKAY, CP; POLLACK, JB; COURTIN, R				MCKAY, CP; POLLACK, JB; COURTIN, R			THE GREENHOUSE AND ANTIGREENHOUSE EFFECTS ON TITAN	SCIENCE			English	Article							ATMOSPHERE; OCEAN	There are many parallels between the atmospheric thermal structure of the Saturnian satellite Titan and the terrestrial greenhouse effect; these parallels provide a comparison for theories of the heat balance of Earth. Titan's atmosphere has a greenhouse effect caused primarily by pressure-induced opacity of N2, CH4, and H-2. H-2 is a key absorber because it is primarily responsible for the absorption in the wave number 400 to 600 cm-1 "window" region of Titan's infrared spectrum. The concentration of CH4, also an important absorber, is set by the saturation vapor pressure and hence is dependent on temperature. In this respect there is a similarity between the role of H-2 and CH4 on Titan and that of CO2 and H2O on Earth. Titan also has an antigreenhouse effect that results from the presence of a high-altitude haze layer that is absorbing at solar wavelengths but transparent in the thermal infrared. The antigreenhouse effect on Titan reduces the surface temperature by 9 K whereas the greenhouse effect increases it by 21 K. The net effect is that the surface temperature (94 K) is 12 K warmer than the effective temperature (82 K). If the haze layer were removed, the antigreenhouse effect would be greatly reduced, the greenhouse effect would become even stronger, and the surface temperature would rise by over 20 K.	OBSERV PARIS,RECH SPATIALE LAB,F-92195 MEUDON,FRANCE	UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris	MCKAY, CP (corresponding author), NASA,AMES RES CTR,DIV SPACE SCI,MOFFETT FIELD,CA 94035, USA.							DANIELSON RE, 1973, ICARUS, V20, P437, DOI 10.1016/0019-1035(73)90016-X; Hunten D.M, 1984, SATURN, P671; KHARE BN, 1984, ICARUS, V60, P127, DOI 10.1016/0019-1035(84)90142-8; LELLOUCH E, 1989, ICARUS, V79, P328, DOI 10.1016/0019-1035(89)90081-X; LUNINE JI, 1983, SCIENCE, V222, P1229, DOI 10.1126/science.222.4629.1229; MCKAY CP, 1989, ICARUS, V80, P23, DOI 10.1016/0019-1035(89)90160-7; MUHLEMAN DO, 1990, SCIENCE, V248, P975, DOI 10.1126/science.248.4958.975; POLLACK JB, 1991, ICARUS, V91, P173, DOI 10.1016/0019-1035(91)90017-N; POLLACK JB, 1983, SCIENCE, V219, P287, DOI 10.1126/science.219.4582.287; RAGES K, 1983, ICARUS, V55, P50, DOI 10.1016/0019-1035(83)90049-0; RAGES K, 1979, ICARUS, V41, P119; SAGAN C, 1984, ICARUS, V59, P133, DOI 10.1016/0019-1035(84)90018-6; SAMUELSON RE, 1981, NATURE, V292, P688, DOI 10.1038/292688a0; SAMUELSON RE, 1983, ICARUS, V53, P364, DOI 10.1016/0019-1035(83)90156-2; TOON OB, 1988, ICARUS, V75, P255, DOI 10.1016/0019-1035(88)90005-X; TOON OB, 1982, P C LARGE BODY IMPAC, P187; TURCO RP, 1983, SCIENCE, V222, P1283, DOI 10.1126/science.222.4630.1283; WEST RA, 1983, J GEOPHYS RES-SPACE, V88, P8699, DOI 10.1029/JA088iA11p08699	18	157	160	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 6	1991	253	5024					1118	1121		10.1126/science.11538492	http://dx.doi.org/10.1126/science.11538492			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD808	11538492				2022-12-01	WOS:A1991GD80800025
J	SCHWARTZ, AW; BAKKER, CG				SCHWARTZ, AW; BAKKER, CG			WAS ADENINE THE 1ST PURINE	SCIENCE			English	Article											SCHWARTZ, AW (corresponding author), CATHOLIC UNIV NIJMEGEN,FAC SCI,EXOBIOL LAB,6525 ED NIJMEGEN,NETHERLANDS.							Cronin J.R., 1988, METEORITES EARLY SOL, P819; FERRIS JP, 1978, J MOL EVOL, V11, P293, DOI 10.1007/BF01733839; JOYCE GF, 1987, P NATL ACAD SCI USA, V84, P4398, DOI 10.1073/pnas.84.13.4398; Miller S. L., 1974, ORIGINS LIFE EARTH; ORO J, 1960, BIOCHEM BIOPH RES CO, V2, P407, DOI 10.1016/0006-291X(60)90138-8; SANCHEZ RA, 1967, J MOL BIOL, V30, P223; SCHWARTZ AW, 1983, NATURWISSENSCHAFTEN, V70, P373, DOI 10.1007/BF01047172; SCHWARTZ AW, 1984, ORIGINS LIFE EVOL B, V14, P91, DOI 10.1007/BF00933644; SCHWARTZ AW, 1982, J MOL EVOL, V18, P351, DOI 10.1007/BF01733902; SCHWARTZ AW, 1985, SCIENCE, V228, P585, DOI 10.1126/science.228.4699.585; SMITH CVZ, 1973, CHEM SOC PERKIN T 1, P1855; STRIBLING R, 1987, ORIGINS LIFE EVOL B, V17, P261, DOI 10.1007/BF02386466; VISSCHER J, 1989, SCIENCE, V244, P329, DOI 10.1126/science.2540527; VISSCHER J, 1988, J MOL EVOL, V28, P3, DOI 10.1007/BF02143492; VOET AB, 1983, BIOORG CHEM, V12, P8, DOI 10.1016/0045-2068(83)90003-2	15	31	33	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 8	1989	245	4922					1102	1104		10.1126/science.11538344	http://dx.doi.org/10.1126/science.11538344			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN702	11538344				2022-12-01	WOS:A1989AN70200034
J	Parkhill, J; Wren, BW; Thomson, NR; Titball, RW; Holden, MTG; Prentice, MB; Sebaihia, M; James, KD; Churcher, C; Mungall, KL; Baker, S; Basham, D; Bentley, SD; Brooks, K; Cerdeno-Tarraga, AM; Chillingworth, T; Cronin, A; Davies, RM; Davis, P; Dougan, G; Feltwell, T; Hamlin, N; Holroyd, S; Jagels, K; Karlyshev, AV; Leather, S; Moule, S; Oyston, PCF; Quail, M; Rutherford, K; Simmonds, M; Skelton, J; Stevens, K; Whitehead, S; Barrell, BG				Parkhill, J; Wren, BW; Thomson, NR; Titball, RW; Holden, MTG; Prentice, MB; Sebaihia, M; James, KD; Churcher, C; Mungall, KL; Baker, S; Basham, D; Bentley, SD; Brooks, K; Cerdeno-Tarraga, AM; Chillingworth, T; Cronin, A; Davies, RM; Davis, P; Dougan, G; Feltwell, T; Hamlin, N; Holroyd, S; Jagels, K; Karlyshev, AV; Leather, S; Moule, S; Oyston, PCF; Quail, M; Rutherford, K; Simmonds, M; Skelton, J; Stevens, K; Whitehead, S; Barrell, BG			Genome sequence of Yersinia pestis, the causative agent of plague	NATURE			English	Article							DNA-SEQUENCE; PSEUDOTUBERCULOSIS; ENTEROCOLITICA; VIRULENCE; IDENTIFICATION; INVASION; PLASMID; LOCUS; CELLS; SHOWS	The Gram-negative bacterium Yersinia pestis is the causative agent of the systemic invasive infectious disease classically referred to as plague(1), and has been responsible for three human pandemics: the Justinian plague (sixth to eighth centuries), the Black Death (fourteenth to nineteenth centuries) and modern plague (nineteenth century to the present day). The recent identification of strains resistant to multiple drugs(2) and the potential use of Y. pestis as an agent of biological warfare mean that plague still poses a threat to human health. Here we report the complete genome sequence of Y. pestis strain CO92, consisting of a 4.65-megabase (Mb) chromosome and three plasmids of 96.2 kilobases (kb), 70.3 kb and 9.6 kb. The genome is unusually rich in insertion sequences and displays anomalies in GC base-composition bias, indicating frequent intragenomic recombination. Many genes seem to have been acquired from other bacteria and viruses (including adhesins, secretion systems and insecticidal toxins). The genome contains around 150 pseudogenes, many of which are remnants of a redundant enteropathogenic lifestyle. The evidence of ongoing genome fluidity, expansion and decay suggests Y. pestis is a pathogen that has undergone large-scale genetic flux and provides a unique insight into the ways in which new and highly virulent pathogens evolve.	Sanger Ctr, Cambridge CB10 1SA, England; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Chem & Biol Sci, Salisbury SP4 0JQ, Wilts, England; St Bartholomews & Royal London Sch Med & Dent, Dept Med Microbiol, London EC1A 7BE, England; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Ctr Mol Microbiol & Infect, London SW7 2AZ, England	Wellcome Trust Sanger Institute; University of London; London School of Hygiene & Tropical Medicine; University of London; Queen Mary University London; Imperial College London	Parkhill, J (corresponding author), Sanger Ctr, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.		Sebaihia, Mohammed/AAF-6589-2019; Rutherford, Kim/Y-7995-2018; Holden, Matthew TG/K-6449-2014; Prentice, Michael/AAE-7246-2019; Quail, michael/ABE-6131-2020; Parkhill, Julian/G-4703-2011; Karlyshev, Andrey/D-2797-2011; Thomson, Nicholas/P-5988-2014	Sebaihia, Mohammed/0000-0002-3324-3346; Rutherford, Kim/0000-0001-6277-726X; Holden, Matthew TG/0000-0002-4958-2166; Prentice, Michael/0000-0003-1117-2388; Parkhill, Julian/0000-0002-7069-5958; Karlyshev, Andrey/0000-0003-3124-019X; Cerdeno-Tarraga, Ana M./0000-0001-6635-3237; Davies, Robert/0000-0002-9983-1378; Thomson, Nicholas/0000-0002-4432-8505; Davis, Paul/0000-0001-5545-0824; Baker, Stephen/0000-0003-1308-5755				Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Buchrieser C, 1999, INFECT IMMUN, V67, P4851, DOI 10.1128/IAI.67.9.4851-4861.1999; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Cowan C, 2000, INFECT IMMUN, V68, P4523, DOI 10.1128/IAI.68.8.4523-4530.2000; Darwin AJ, 1999, MOL MICROBIOL, V32, P51, DOI 10.1046/j.1365-2958.1999.01324.x; DOLL JM, 1994, AM J TROP MED HYG, V51, P109, DOI 10.4269/ajtmh.1994.51.109; Galimand M, 1997, NEW ENGL J MED, V337, P677, DOI 10.1056/NEJM199709043371004; Guiyoule A, 1997, J CLIN MICROBIOL, V35, P2826, DOI 10.1128/JCM.35.11.2826-2833.1997; Haller JC, 2000, MOL MICROBIOL, V36, P1436, DOI 10.1046/j.1365-2958.2000.01964.x; Henderson IR, 1999, MOL MICROBIOL, V33, P919, DOI 10.1046/j.1365-2958.1999.01555.x; Hinnebusch J, 2000, INT J MED MICROBIOL, V290, P483, DOI 10.1016/S1438-4221(00)80070-3; Lerm M, 2000, FEMS MICROBIOL LETT, V188, P1; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; McDonough KA, 1997, J BACTERIOL, V179, P2081, DOI 10.1128/jb.179.6.2081-2085.1997; Mecsas J, 2001, INFECT IMMUN, V69, P2779, DOI 10.1128/IAI.67.5.2779-2787.2001; Nesper J, 2001, INFECT IMMUN, V69, P435, DOI 10.1128/IAI.69.1.435-445.2001; Odaert M, 1996, J CLIN MICROBIOL, V34, P2231, DOI 10.1128/JCM.34.9.2231-2235.1996; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; PIERSON DE, 1994, J BACTERIOL, V176, P4043, DOI 10.1128/JB.176.13.4043-4051.1994; Prentice MB, 2001, J BACTERIOL, V183, P2586, DOI 10.1128/JB.183.8.2586-2594.2001; Sebbane F, 2001, INFECT IMMUN, V69, P170, DOI 10.1128/IAI.69.1.170-176.2001; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Skurnik M, 2000, MOL MICROBIOL, V37, P316, DOI 10.1046/j.1365-2958.2000.01993.x; TOROSIAN SD, 1996, 96 GEN M AM SOC MICR, P191; Townsend SM, 2001, INFECT IMMUN, V69, P2894, DOI 10.1128/IAI.69.5.2894-2901.2001; WACHTEL MR, 1995, INFECT IMMUN, V63, P2541, DOI 10.1128/IAI.63.7.2541-2548.1995; Wang P, 1997, P NATL ACAD SCI USA, V94, P6977, DOI 10.1073/pnas.94.13.6977; Waterfield NR, 2001, TRENDS MICROBIOL, V9, P185, DOI 10.1016/S0966-842X(01)01978-3; Young GM, 2000, INFECT IMMUN, V68, P4323, DOI 10.1128/IAI.68.7.4323-4326.2000	30	934	2060	4	145	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2001	413	6855					523	527		10.1038/35097083	http://dx.doi.org/10.1038/35097083			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586360	Green Accepted, hybrid			2022-12-01	WOS:000171340500047
J	Schwetz, BA				Schwetz, BA			Hypercalcemia of malignancy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	4	4	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2001	286	13					1569	1569		10.1001/jama.286.13.1569-b	http://dx.doi.org/10.1001/jama.286.13.1569-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478HH	11585463				2022-12-01	WOS:000171340600005
J	Deshpande, G; Swanhart, L; Chiang, P; Schedl, P				Deshpande, G; Swanhart, L; Chiang, P; Schedl, P			Hedgehog signaling in germ cell migration	CELL			English	Article							GONADAL MESODERM; CUBITUS-INTERRUPTUS; GENE-EXPRESSION; FAT-BODY; DROSOPHILA-MELANOGASTER; TRANSDUCING HEDGEHOG; MEMBRANE-PROTEIN; RECEPTOR COMPLEX; EMBRYONIC GONAD; NANOS	The primitive gonad of the Drosophila embryo is formed from two cell types, the somatic gonad precursor cells (SGPs) and the germ cells, which originate at distant sites. To reach the SGPs the germ cells must undergo a complex series of cell movements. While there is evidence that attractive and repulsive signals guide germ cell migration through the embryo, the molecular identity of these instructive molecules has remained elusive. Here, we present evidence suggesting that hedgehog (hh) may serve as such an attractive guidance cue. Misexpression of hh in the soma induces germ cells to migrate to inappropriate locations. Conversely, cell-autonomous components of the hh pathway appear to be required in the germline for proper germ cell migration.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Deshpande, G (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.							Alcedo J, 1997, BIOL CHEM, V378, P583; Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Azpiazu N, 1996, GENE DEV, V10, P3183, DOI 10.1101/gad.10.24.3183; Boyle M, 1997, DEVELOPMENT, V124, P971; BOYLE M, 1995, DEVELOPMENT, V121, P1815; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broihier HT, 1998, DEVELOPMENT, V125, P655; BROOKMAN JJ, 1992, DEVELOPMENT, V116, P1185; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chen Y, 1998, DEVELOPMENT, V125, P4943; CHOU TB, 1992, GENETICS, V131, P643; Chuang PT, 2000, CURR OPIN GENET DEV, V10, P515, DOI 10.1016/S0959-437X(00)00121-0; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; DESHPANDE G, 1995, MOL CELL BIOL, V15, P4430; Deshpande G, 1999, CELL, V99, P271, DOI 10.1016/S0092-8674(00)81658-X; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; Forbes A, 1998, DEVELOPMENT, V125, P679; FRASCH M, 1995, NATURE, V374, P464, DOI 10.1038/374464a0; HEEMSKERK J, 1994, CELL, V76, P449, DOI 10.1016/0092-8674(94)90110-4; HOOPER JE, 1989, CELL, V59, P751, DOI 10.1016/0092-8674(89)90021-4; Howard K, 1998, NATURE, V396, P406, DOI 10.1038/24714; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; JAGLARZ MK, 1995, DEVELOPMENT, V121, P3495; Johnson RL, 1998, CURR OPIN GENET DEV, V8, P450, DOI 10.1016/S0959-437X(98)80117-2; Kalderon D, 2000, CELL, V103, P371, DOI 10.1016/S0092-8674(00)00129-X; Kobayashi S, 1996, NATURE, V380, P708, DOI 10.1038/380708a0; Kuwabara PE, 2000, GENE DEV, V14, P1933; LANE ME, 1995, MECH DEVELOP, V49, P191, DOI 10.1016/0925-4773(94)00317-G; Luer K, 1997, DEVELOPMENT, V124, P2681; Methot N, 2001, DEVELOPMENT, V128, P733; Moore LA, 1998, DEVELOPMENT, V125, P837; Moore LA, 1998, DEVELOPMENT, V125, P667; NAKANO Y, 1989, NATURE, V341, P508, DOI 10.1038/341508a0; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; PREAT T, 1990, NATURE, V347, P87, DOI 10.1038/347087a0; Ramirez-Weber FA, 2000, MOL CELL, V6, P479, DOI 10.1016/S1097-2765(00)00046-0; Riechmann V, 1998, DEVELOPMENT, V125, P713; Sam S, 1996, MECH DEVELOP, V60, P197, DOI 10.1016/S0925-4773(96)00615-6; Seydoux G, 1999, DEVELOPMENT, V126, P3275; SMITH JL, 1992, CELL, V70, P849, DOI 10.1016/0092-8674(92)90318-7; St Johnston Daniel, 1993, P325; STAEHLINGHAMPTON K, 1994, NATURE, V372, P783; Strigini M, 1997, DEVELOPMENT, V124, P4697; Struhl G, 1997, DEVELOPMENT, V124, P2155; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Van Doren M, 1998, NATURE, V396, P466, DOI 10.1038/24871; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; Wang QT, 2000, DEVELOPMENT, V127, P3131; WARRIOR R, 1994, DEV BIOL, V166, P180, DOI 10.1006/dbio.1994.1306; Williamson A, 1996, ANNU REV CELL DEV BI, V12, P365, DOI 10.1146/annurev.cellbio.12.1.365; ZALOKAR M, 1976, J MICROSC BIOL CELL, V25, P97; Zhang N, 1997, NATURE, V385, P64, DOI 10.1038/385064a0; Zhang N, 1996, GENETICS, V143, P1231	58	67	70	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 21	2001	106	6					759	769		10.1016/S0092-8674(01)00488-3	http://dx.doi.org/10.1016/S0092-8674(01)00488-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	476EJ	11572781	Bronze			2022-12-01	WOS:000171213000012
J	Hiroi, T; Zolensky, ME; Pieters, CM				Hiroi, T; Zolensky, ME; Pieters, CM			The Tagish Lake meteorite: A possible sample from a D-type asteroid	SCIENCE			English	Article							MAIN-BELT; BODIES; VESTA	A new type of carbonaceous chondrite, the Tagish Lake meteorite, exhibits a reflectance spectrum similar to spectra observed from the D-type asteroids, which are relatively abundant in the outer solar system beyond the main asteroid belt and have been inferred to be more primitive than any known meteorite. Until the Tagish Lake fait, these asteroids had no analog in the meteorite collections. The Tagish Lake meteorite is a carbon-rich (4 to 5 weight %), aqueously altered carbonaceous chondrite and contains high concentrations of presolar grains and carbonate minerals, which is consistent with the expectation that the D-type asteroids were originally made of primitive materials and did not experience any extensive heating.	Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; NASA, Earth Sci & Solar Syst Explorat Div, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA	Brown University; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Hiroi, T (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.			Zolensky, Michael/0000-0002-3181-1303				Bell J.F., 1989, ASTEROIDS, P921; BELL JF, 1988, LUNAR PLANET SCI, V19, P57; BINZEL RP, 1993, SCIENCE, V260, P186, DOI 10.1126/science.260.5105.186; Brown PG, 2000, SCIENCE, V290, P320, DOI 10.1126/science.290.5490.320; CASSIDY W, 1975, ICARUS, V25, P371, DOI 10.1016/0019-1035(75)90002-0; GAFFEY MJ, 1993, METEORITICS, V28, P161, DOI 10.1111/j.1945-5100.1993.tb00755.x; GOUNELLE M, 2001, LUNAR PLANET SCI, V32; LEBOFSKY LA, 1990, ICARUS, V83, P16, DOI 10.1016/0019-1035(90)90003-R; MCCORD TB, 1970, SCIENCE, V168, P1445, DOI 10.1126/science.168.3938.1445; MILANI A, 1994, ICARUS, V107, P219, DOI 10.1006/icar.1994.1020; NOBILI AM, 1989, ASTEROIDS, V2, P862; Opik E.J., 1951, P R IRISH ACAD A, V54, P165; TEDESCO EF, 1989, ASTEROIDS, V2, P1090; Tholen D., 1984, THESIS U ARIZONA TUS; VILAS F, 1985, ICARUS, V64, P503, DOI 10.1016/0019-1035(85)90071-5; Vokrouhlicky D, 2000, NATURE, V407, P606, DOI 10.1038/35036528; XU S, 1995, ICARUS, V115, P1, DOI 10.1006/icar.1995.1075; Yamada M, 1999, EARTH PLANETS SPACE, V51, P1255, DOI 10.1186/BF03351599; ZELLNER B, 1985, ICARUS, V61, P335	19	172	172	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2001	293	5538					2234	2236		10.1126/science.1063734	http://dx.doi.org/10.1126/science.1063734			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11520950				2022-12-01	WOS:000171139400037
J	Johnson, ES; Gupta, AA				Johnson, ES; Gupta, AA			An E3-like factor that promotes SUMO conjugation to the yeast septins	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; UBIQUITIN; PROTEIN; COMPLEX; ENZYME; HOMOLOG; GENE; ACTIVATION; COMPONENT; PATHWAY	Covalent attachment of the ubiquitin-related protein SUMO to other proteins participates in many processes including signal transduction, transcriptional regulation, and growth control. We report the characterization of Siz1 as an E3-like factor in the SUMO pathway. Siz1 is required for SUMO attachment to the S. cerevisiae septins in vivo and strongly stimulates septin sumoylation in vitro. Siz1 and the related protein Siz2 promote SUMO conjugation to different substrates at different stages of the cell cycle and, together, are required for most SUMO conjugation in yeast. Siz1, Siz2, and the PIAS (protein inhibitor of activated STAT) proteins form a conserved family defined by an unusual RING-related motif. Our results suggest that this family functions by promoting SUMO conjugation to specific substrates.	Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Jefferson University	Johnson, ES (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062268] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62268] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Betting J, 1996, J BIOL CHEM, V271, P25790, DOI 10.1074/jbc.271.42.25790; BUSCHMANN T, 2001, IN PRESS J BIOL CHEM; CHEN ZJ, 1991, J BIOL CHEM, V266, P15698; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Desterro JMP, 1999, J BIOL CHEM, V274, P10618, DOI 10.1074/jbc.274.15.10618; DOHMEN RJ, 1995, J BIOL CHEM, V270, P18099, DOI 10.1074/jbc.270.30.18099; Field CM, 1996, J CELL BIOL, V133, P605, DOI 10.1083/jcb.133.3.605; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; Frazier JA, 1998, J CELL BIOL, V143, P737, DOI 10.1083/jcb.143.3.737; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Johnson EW, 1997, J BACK MUSCULOSKELET, V9, P3, DOI 10.3233/BMR-1997-9102; Kwon YT, 1998, P NATL ACAD SCI USA, V95, P7898, DOI 10.1073/pnas.95.14.7898; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; MELUH PB, 1995, MOL BIOL CELL, V6, P793, DOI 10.1091/mbc.6.7.793; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Moilanen AM, 1999, J BIOL CHEM, V274, P3700, DOI 10.1074/jbc.274.6.3700; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Okuma T, 1999, BIOCHEM BIOPH RES CO, V254, P693, DOI 10.1006/bbrc.1998.9995; Page AM, 1999, ANNU REV BIOCHEM, V68, P583, DOI 10.1146/annurev.biochem.68.1.583; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; PRINGLE J R, 1991, P565; Rosenblum JS, 1998, J CELL BIOL, V143, P887, DOI 10.1083/jcb.143.4.887; SAMPSON DA, 2001, J BIOL CHEM, V19, P19; Schwienhorst I, 2000, MOL GEN GENET, V263, P771, DOI 10.1007/s004380000254; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Sherman F., 1986, METHODS YEAST GENETI; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; Smith J.A., 2000, CURRENT PROTOCOLS MO; Strunnikov AV, 2001, GENETICS, V158, P95; Takahashi Y, 1999, BIOCHEM BIOPH RES CO, V259, P582, DOI 10.1006/bbrc.1999.0821; Tanaka K, 1999, MOL CELL BIOL, V19, P8660; TATHAM MH, 2001, IN PRESS J BIOL CHEM; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; WHITE HD, 1993, BIOCHEMISTRY-US, V32, P9859, DOI 10.1021/bi00088a042; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819	46	515	538	1	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 21	2001	106	6					735	744		10.1016/S0092-8674(01)00491-3	http://dx.doi.org/10.1016/S0092-8674(01)00491-3			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	476EJ	11572779	Bronze			2022-12-01	WOS:000171213000010
J	Noonan, FP; Recio, JA; Takayama, H; Duray, P; Anver, MR; Rush, WL; De Fabo, EC; Merlino, G				Noonan, FP; Recio, JA; Takayama, H; Duray, P; Anver, MR; Rush, WL; De Fabo, EC; Merlino, G			Neonatal sunburn and melanoma in mice - Severe sunburn in newborn, but not adult, mice is linked with melanoma in later life.	NATURE			English	Article							FACTOR SCATTER FACTOR; MALIGNANT-MELANOMA		George Washington Univ, Sch Med, Dept Dermatol, Lab Photobiol & Photoimmunol, Washington, DC 20037 USA; George Washington Univ, Sch Med, Dept Immunol, Lab Photobiol & Photoimmunol, Washington, DC 20037 USA; NCI, Mol Biol Lab, Bethesda, MD 20892 USA; NCI, Pathol Lab, Bethesda, MD 20892 USA; NCI, Pathol Histotechnol Lab, Sci Applicat Int Corp, Frederick, MD 21702 USA; Armed Forces Inst Pathol, Dept Dermatopathol, Washington, DC 20306 USA	George Washington University; George Washington University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); United States Department of Defense	Noonan, FP (corresponding author), George Washington Univ, Sch Med, Dept Dermatol, Lab Photobiol & Photoimmunol, Washington, DC 20037 USA.			Noonan, Frances/0000-0002-3302-7280; Recio, Juan Angel/0000-0002-7320-3832	NATIONAL CANCER INSTITUTE [Z01BC008756] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chin L, 1998, GENE DEV, V12, P3467, DOI 10.1101/gad.12.22.3467; DEFABO EC, 1990, PHOTOCHEM PHOTOBIOL, V52, P811; HIROBE T, 1988, DEVELOPMENT, V102, P567; HOLMAN CDJ, 1983, JNCI-J NATL CANCER I, V71, P651; International Agency for Research on Cancer IARC Monographs, 1992, IARC MON, V55; Jeffers M, 1996, J MOL MED-JMM, V74, P505, DOI 10.1007/BF00204976; NATALI PG, 1993, BRIT J CANCER, V68, P746, DOI 10.1038/bjc.1993.422; Noonan FP, 2000, CANCER RES, V60, P3738; NOONAN FP, 1990, PHOTOCHEM PHOTOBIOL, V52, P801, DOI 10.1111/j.1751-1097.1990.tb08685.x; Otsuka T, 1998, CANCER RES, V58, P5157; Takayama H, 1997, P NATL ACAD SCI USA, V94, P701, DOI 10.1073/pnas.94.2.701; Tietze MK, 2000, MOL MED TODAY, V6, P408, DOI 10.1016/S1357-4310(00)01781-0; Whiteman DC, 2001, CANCER CAUSE CONTROL, V12, P69, DOI 10.1023/A:1008980919928	13	284	288	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					271	272		10.1038/35095108	http://dx.doi.org/10.1038/35095108			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565020				2022-12-01	WOS:000171040500027
J	Lipton, AJ; Johnson, MA; Macdonald, T; Lieberman, MW; Gozal, D; Gaston, B				Lipton, AJ; Johnson, MA; Macdonald, T; Lieberman, MW; Gozal, D; Gaston, B			S-nitrosothiols signal the ventilatory response to hypoxia	NATURE			English	Article							NUCLEUS-TRACTUS-SOLITARII; NITRIC-OXIDE SYNTHASE; RAT; NITROSOGLUTATHIONE	Increased ventilation in response to hypoxia has been appreciated for over a century(1), but the biochemistry underlying this response remains poorly understood. Here we define a pathway in which increased minute ventilation ((V)over dot(E)) is signalled by deoxyhaemoglobin-derived S-nitrosothiols (SNOs). Specifically, we demonstrate that S-nitrosocysteinyl glycine (CGSNO) and S-nitroso-L-cysteine (L-CSNO)-but not S-nitroso-D-cysteine (D-CSNO)-reproduce the ventilatory effects of hypoxia at the level of the nucleus tractus solitarius (NTS). We show that plasma from deoxygenated, but not from oxygenated, blood produces the ventilatory effect of both SNOs and hypoxia. Further, this activity is mediated by S-nitrosoglutathione (GSNO), and GSNO activation by gamma -glutamyl transpeptidase (gamma -GT) is required. The normal response to hypoxia is impaired in a knockout mouse lacking gamma GT. These observations suggest that S-nitrosothiol biochemistry is of central importance to the regulation of breathing.	Univ Virginia, Sch Med, Dept Pediat, Div Resp Med, Charlottesville, VA 22908 USA; Univ Louisville, Kosair Childrens Hosp Res Inst, Dept Pediat, Louisville, KY 40202 USA; Univ Louisville, Kosair Childrens Hosp Res Inst, Dept Pharmacol & Toxicol, Louisville, KY 40202 USA; Univ Virginia, Dept Chem, Charlottesville, VA 22906 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Univ Virginia, Sch Med, Dept Pediat, Div Resp Med, Charlottesville, VA 22908 USA	University of Virginia; University of Louisville; University of Louisville; University of Virginia; Baylor College of Medicine; Baylor College of Medicine; University of Virginia	Gaston, B (corresponding author), Univ Virginia, Sch Med, Dept Pediat, Div Resp Med, Charlottesville, VA 22908 USA.		Gozal, David/ABH-3805-2020; Gozal, David/M-9492-2017	Johnson, Michael/0000-0001-5078-9896				ANWAR M, 1990, CIRC RES, V67, P1365, DOI 10.1161/01.RES.67.6.1365; ASKEW SC, 1995, BIOORGAN MED CHEM, V3, P1, DOI 10.1016/0968-0896(94)00139-T; BISGARD GE, 1995, REGULATION BREATHING; Chiueh CC, 1999, FREE RADICAL RES, V31, P641, DOI 10.1080/10715769900301211; Choi YB, 2000, NAT NEUROSCI, V3, P15, DOI 10.1038/71090; Davisson RL, 1997, AM J PHYSIOL-HEART C, V272, pH2361, DOI 10.1152/ajpheart.1997.272.5.H2361; Fang KZ, 1998, BIOCHEM BIOPH RES CO, V252, P535, DOI 10.1006/bbrc.1998.9688; Gaston B, 1998, BIOCHEM BIOPH RES CO, V253, P899, DOI 10.1006/bbrc.1998.9865; Gozal D, 1996, J APPL PHYSIOL, V81, P2068, DOI 10.1152/jappl.1996.81.5.2068; Gozal D, 1997, AM J RESP CRIT CARE, V155, P1755, DOI 10.1164/ajrccm.155.5.9154888; Haldane J, 1892, J PATHOL BACTERIOL, V1, P168; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Kline DD, 2000, J APPL PHYSIOL, V88, P1496, DOI 10.1152/jappl.2000.88.4.1496; Kluge I, 1997, J NEUROCHEM, V69, P2599; Lieberman MW, 1996, P NATL ACAD SCI USA, V93, P7923, DOI 10.1073/pnas.93.15.7923; Lin LH, 2000, NEUROSCIENCE, V96, P341, DOI 10.1016/S0306-4522(99)00560-6; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Menendez AA, 1999, J APPL PHYSIOL, V86, P1478, DOI 10.1152/jappl.1999.86.5.1478; Ohta H, 1997, BRAIN RES, V746, P98, DOI 10.1016/S0006-8993(96)01188-2; Palmer LA, 2000, MOL PHARMACOL, V58, P1197, DOI 10.1124/mol.58.6.1197; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd ed; Schmidt HHHW, 1996, P NATL ACAD SCI USA, V93, P14492, DOI 10.1073/pnas.93.25.14492; SMITH TK, 1995, P NATL ACAD SCI USA, V92, P2360, DOI 10.1073/pnas.92.6.2360; STAMLER JS, 1996, METHODS NITRIC OXIDE, P521; Torres JE, 1997, NEUROSCI LETT, V232, P175, DOI 10.1016/S0304-3940(97)00598-3	26	265	279	2	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					171	174		10.1038/35093117	http://dx.doi.org/10.1038/35093117			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557982				2022-12-01	WOS:000170918800048
J	Knight, J				Knight, J			Celera and Motorola brought in to aid hunt for disease genes	NATURE			English	News Item																		2001, NATURE, V412, P105	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					9	9		10.1038/35092692	http://dx.doi.org/10.1038/35092692			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544494	Bronze			2022-12-01	WOS:000170801200011
J	Sharpless, NE; Bardeesy, N; Lee, KH; Carrasco, D; Castrillon, DH; Aguirre, AJ; Wu, EA; Horner, JW; DePinho, RA				Sharpless, NE; Bardeesy, N; Lee, KH; Carrasco, D; Castrillon, DH; Aguirre, AJ; Wu, EA; Horner, JW; DePinho, RA			Loss of p16(Ink4a) with retention of p19(Arf) predisposes mice to tumorigenesis	NATURE			English	Article							PLASMACYTOMA SUSCEPTIBILITY; TUMOR SUPPRESSION; G(1) CONTROL; INK4A LOCUS; MOUSE SKIN; IN-VIVO; IMMORTALIZATION; CELLS; GENE; FIBROBLASTS	The cyclin-dependent kinase inhibitor p16(INK4a) can induce senescence of human cells, and its loss by deletion, mutation or epigenetic silencing is among the most frequently observed molecular lesions in human cancer(1,2). Overlapping reading frames in the INK4A/ARF gene encode p16(INK4a) and a distinct tumour-suppressor protein, p19(ARF) (ref. 3). Here we describe the generation and characterization of a p16(Ink4a)-specific knockout mouse that retains normal p19(Arf) function. Mice lacking p16(Ink4a) were born with the expected mendelian distribution and exhibited normal development except for thymic hyperplasia. T cells deficient in p16(Ink4a) exhibited enhanced mitogenic responsiveness, consistent with the established role of p16(Ink4a) in constraining cellular proliferation. In contrast to mouse embryo fibroblasts (MEFs) deficient in p19(Arf) (ref. 4), p16(Ink4a)-null MEFs possessed normal growth characteristics and remained susceptible to Ras-induced senescence. Compared with wild-type MEFs, p16(Ink4a) null MEFs exhibited an increased rate of immortalization, although this rate was less than that observed previously for cells null for Ink4a/Arf, p19(Arf) or p53 (refs 4, 5). Furthermore, p16(Ink4a) deficiency was associated with an increased incidence of spontaneous and carcinogen-induced cancers. These data establish that p16(Ink4a), along with p19(Arf), functions as a tumour suppressor in mice.	Harvard Univ, Sch Med, Dept Adult Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	DePinho, RA (corresponding author), Harvard Univ, Sch Med, Dept Adult Oncol, Boston, MA 02115 USA.			Sharpless, Norman/0000-0001-7078-9455; DePinho, Ronald/0000-0002-5625-577X				Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; BUCHMANN A, 1991, CANCER RES, V51, P4097; Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020; Carrasco D, 1998, J EXP MED, V187, P973, DOI 10.1084/jem.187.7.973; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Groth A, 2000, J BIOL CHEM, V275, P27473; HERMAN JG, 1995, CANCER RES, V55, P4525; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Herzog CR, 1999, MOL CARCINOGEN, V25, P92, DOI 10.1002/(SICI)1098-2744(199906)25:2<92::AID-MC3>3.0.CO;2-2; Kamijo T, 1999, CANCER RES, V59, P2217; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; LINARDOPOULOS S, 1995, CANCER RES, V55, P5168; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Patel AC, 2000, CARCINOGENESIS, V21, P1691, DOI 10.1093/carcin/21.9.1691; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; QUELLE DE, 1995, CELL, V83, P993; Reznikoff CA, 1996, CANCER RES, V56, P2886; ROGAN EM, 1995, MOL CELL BIOL, V15, P4745; Ruas M, 1998, BIOCHIM BIOPHYS ACTA, V1378, P115, DOI 10.1016/s0304-419x(98)00017-1; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; Swafford DS, 1997, MOL CELL BIOL, V17, P1366, DOI 10.1128/MCB.17.3.1366; Zhang SL, 1998, P NATL ACAD SCI USA, V95, P2429, DOI 10.1073/pnas.95.5.2429; Zhang SL, 2001, MOL CELL BIOL, V21, P310, DOI 10.1128/MCB.21.1.310-318.2001; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	30	601	615	0	22	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					86	91		10.1038/35092592	http://dx.doi.org/10.1038/35092592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544531				2022-12-01	WOS:000170801200044
J	Bar-Nahum, G; Nudler, E				Bar-Nahum, G; Nudler, E			Isolation and characterization of sigma(70)-retaining transcription elongation complexes from Escherichia coli	CELL			English	Article							CORE RNA-POLYMERASE; SIGMA-SUBUNIT; PROMOTER STRENGTH; TERNARY COMPLEXES; PROTEIN; INITIATION; TERMINATION; RELEASE; INVITRO; ENZYME	sigma (70) subunit is thought to be released from the core RNA polymerase (RNAP) upon the transition from initiation to elongation or shortly afterward. Here, we identify a population of RNAP from E. coli that retains sigma (70) throughout elongation. The relative amount of this population appears to depend on cellular growth and reaches its maximum during the stationary phase. The proportion of sigma (70)-retaining elongation complexes (EC-sigma (70)) is invariant with various promoters or distances from the transcription start site. EC-sigma (70) responds to pauses, intrinsic terminators, and the elongation factor NusA similarly to EC without sigma (70). However, EC-sigma (70) has a substantially higher ability to support multiple rounds of transcription at certain promoters, suggesting its profound role in gene expression and regulation in bacteria.	NYU, Med Ctr, Dept Biochem, New York, NY 10016 USA	New York University	Nudler, E (corresponding author), NYU, Med Ctr, Dept Biochem, New York, NY 10016 USA.			Nudler, Evgeny/0000-0002-8811-3071	NIGMS NIH HHS [GM58750] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058750] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRUNNER M, 1987, EMBO J, V6, P3139, DOI 10.1002/j.1460-2075.1987.tb02624.x; BURGESS RR, 1971, ANNU REV BIOCHEM, V40, P711, DOI 10.1146/annurev.bi.40.070171.003431; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; GILL SC, 1991, J MOL BIOL, V220, P307, DOI 10.1016/0022-2836(91)90015-X; GNATT AL, 2001, STRUCTURAL BASIS TRA, P3; Gourse RL, 1998, COLD SPRING HARB SYM, V63, P131, DOI 10.1101/sqb.1998.63.131; GREENBLATT J, 1981, CELL, V24, P421, DOI 10.1016/0092-8674(81)90332-9; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; GROSS CA, 1992, TRANSCRIPTIONAL REGU, P129; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; HANSEN UM, 1980, J BIOL CHEM, V255, P9564; HELMANN JD, 1988, ANNU REV BIOCHEM, V57, P839, DOI 10.1146/annurev.bi.57.070188.004203; Hengge-Aronis R, 1999, CURR OPIN MICROBIOL, V2, P148, DOI 10.1016/S1369-5274(99)80026-5; Jishage M, 1998, P NATL ACAD SCI USA, V95, P4953, DOI 10.1073/pnas.95.9.4953; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; KRUMMEL B, 1989, BIOCHEMISTRY-US, V28, P7829, DOI 10.1021/bi00445a045; Kusano S, 1997, GENES CELLS, V2, P433, DOI 10.1046/j.1365-2443.1997.13203301320330.x; LEIRMO S, 1987, BIOCHEMISTRY-US, V26, P2095, DOI 10.1021/bi00382a006; Liu KB, 1996, EMBO J, V15, P150, DOI 10.1002/j.1460-2075.1996.tb00343.x; LIU KB, 1995, P NATL ACAD SCI USA, V92, P5012, DOI 10.1073/pnas.92.11.5012; Maeda H, 2000, NUCLEIC ACIDS RES, V28, P3497, DOI 10.1093/nar/28.18.3497; Mukhopadhyay J, 2001, CELL, V106, P453, DOI 10.1016/S0092-8674(01)00464-0; NUDLER E, 1995, CELL, V81, P351, DOI 10.1016/0092-8674(95)90388-7; Nudler E, 1998, SCIENCE, V281, P424, DOI 10.1126/science.281.5375.424; Nudler E, 1999, J MOL BIOL, V288, P1, DOI 10.1006/jmbi.1999.2641; Nudler E, 1996, SCIENCE, V273, P211, DOI 10.1126/science.273.5272.211; OSUMIDAVIS PA, 1987, BIOCHIM BIOPHYS ACTA, V910, P130, DOI 10.1016/0167-4781(87)90065-0; PAVCO PA, 1990, J BIOL CHEM, V265, P9960; RAO L, 1994, J MOL BIOL, V235, P1421, DOI 10.1006/jmbi.1994.1098; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; SCHMIDT MC, 1984, BIOCHEMISTRY-US, V23, P197, DOI 10.1021/bi00297a004; SHIMAMOTO N, 1986, J BIOL CHEM, V261, P1859; STACKHOUSE TM, 1989, BIOCHEMISTRY-US, V28, P7781, DOI 10.1021/bi00445a038; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; WU FYH, 1976, BIOCHEMISTRY-US, V15, P3254, DOI 10.1021/bi00660a014	35	96	99	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 24	2001	106	4					443	451		10.1016/S0092-8674(01)00461-5	http://dx.doi.org/10.1016/S0092-8674(01)00461-5			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525730	Bronze			2022-12-01	WOS:000170665200008
J	Zhang, Z; Carmichael, GG				Zhang, Z; Carmichael, GG			The fate of dsRNA in the nucleus: A p54(nrb)-containing complex retention of promiscuously mediates the nuclear A-to-I edited RNAs	CELL			English	Article							DOUBLE-STRANDED-RNA; SPLICING FACTOR PSF; CONSTITUTIVE TRANSPORT ELEMENT; DNA-BINDING PROTEIN; UNWINDING ACTIVITY; SCAFFOLD PROTEINS; TOPOISOMERASE-I; ANTISENSE RNA; ADENOSINE; EXPORT	How do cells discriminate between selectively edited mRNAs that encode new protein isoforms, and dsRNA-induced, promiscuously edited RNAs that encode nonfunctional, mutant proteins? We have developed a Xenopus oocyte model system which shows that a variety of hyperedited, inosine-containing RNAs are specifically retained in the nucleus. To uncover the mechanism of inosine-induced retention, HeLa cell nuclear extracts were used to isolate a multiprotein complex that binds specifically and cooperatively to inosine-containing RNAs. This complex contains the inosine-specific RNA binding protein p54(nrb), the splicing factor PSF, and the inner nuclear matrix structural protein matrin 3. We provide evidence that one function of the complex identified here is to anchor hyperedited RNAs to the nuclear matrix, while allowing selectively edited mRNAs to be exported.	Univ Connecticut, Ctr Hlth, Dept Microbiol, Farmington, CT 06030 USA	University of Connecticut	Carmichael, GG (corresponding author), Univ Connecticut, Ctr Hlth, Dept Microbiol, Farmington, CT 06030 USA.	carmichael@nso2.uchc.edu			NATIONAL CANCER INSTITUTE [R01CA045382] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA045382, CA32325] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akhmedov AT, 2000, NUCLEIC ACIDS RES, V28, P3022, DOI 10.1093/nar/28.16.3022; Ausubel F.M., 1989, SHORT PROTOCOLS MOL; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Bass BL, 2000, CELL, V101, P235, DOI 10.1016/S0092-8674(02)71133-1; BASS BL, 1987, CELL, V48, P607, DOI 10.1016/0092-8674(87)90239-X; Bass BL, 1997, TRENDS BIOCHEM SCI, V22, P157, DOI 10.1016/S0968-0004(97)01035-9; Basu A, 1997, MOL CELL BIOL, V17, P677, DOI 10.1128/MCB.17.2.677; BELGRADER P, 1991, J BIOL CHEM, V266, P9893; BRAUN IC, 2001, J BIOL CHEM, V19, P19; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Carmichael GG, 2000, BLOOD CELL MOL DIS, V26, P57; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DONG BH, 1993, NUCLEIC ACIDS RES, V21, P4085, DOI 10.1093/nar/21.17.4085; EGEBJERG J, 1994, P NATL ACAD SCI USA, V91, P10270, DOI 10.1073/pnas.91.22.10270; Fischer U, 1999, NUCLEIC ACIDS RES, V27, P4128, DOI 10.1093/nar/27.21.4128; GOZANI O, 1994, EMBO J, V13, P3356, DOI 10.1002/j.1460-2075.1994.tb06638.x; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; HAMM J, 1990, CELL, V63, P109, DOI 10.1016/0092-8674(90)90292-M; Herb A, 1996, P NATL ACAD SCI USA, V93, P1875, DOI 10.1073/pnas.93.5.1875; Herold A, 2000, MOL CELL BIOL, V20, P8996, DOI 10.1128/MCB.20.23.8996-9008.2000; HIBINO Y, 1993, BIOCHIM BIOPHYS ACTA, V1174, P162, DOI 10.1016/0167-4781(93)90110-Y; HIBINO Y, 1993, BIOCHEM BIOPH RES CO, V197, P336, DOI 10.1006/bbrc.1993.2480; Hibino Y, 2000, BIOCHEM BIOPH RES CO, V279, P282, DOI 10.1006/bbrc.2000.3938; Hibino Y, 1998, BBA-GENE STRUCT EXPR, V1396, P88, DOI 10.1016/S0167-4781(97)00176-0; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; JONES KR, 1990, NEURON, V4, P711, DOI 10.1016/0896-6273(90)90197-N; Karhumaa P, 2000, J BIOL CHEM, V275, P16044, DOI 10.1074/jbc.275.21.16044; Kumar M, 1997, P NATL ACAD SCI USA, V94, P3542, DOI 10.1073/pnas.94.8.3542; Kumar M, 1998, MICROBIOL MOL BIOL R, V62, P1415, DOI 10.1128/MMBR.62.4.1415-1434.1998; LINDSEY LA, 1995, J BIOL CHEM, V270, P13415, DOI 10.1074/jbc.270.22.13415; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Lutz CS, 1998, RNA, V4, P1493, DOI 10.1017/S1355838298981183; Maquat LE, 2001, CELL, V104, P173, DOI 10.1016/S0092-8674(01)00202-1; Mathur M, 2001, MOL CELL BIOL, V21, P2298, DOI 10.1128/MCB.21.7.2298-2311.2001; Meissner M, 2000, J CELL BIOCHEM, V76, P559, DOI 10.1002/(SICI)1097-4644(20000315)76:4<559::AID-JCB4>3.0.CO;2-U; Miralles F, 2000, J CELL BIOL, V148, P271, DOI 10.1083/jcb.148.2.271; NISHIKURA K, 1992, ANN NY ACAD SCI, V660, P240, DOI 10.1111/j.1749-6632.1992.tb21076.x; Niswender CM, 1998, ANN NY ACAD SCI, V861, P38, DOI 10.1111/j.1749-6632.1998.tb10171.x; Otto H, 2001, EUR J BIOCHEM, V268, P420, DOI 10.1046/j.1432-1033.2001.01901.x; Pasquinelli AE, 1997, EMBO J, V16, P7500, DOI 10.1093/emboj/16.24.7500; PATTON JG, 1993, GENE DEV, V7, P393, DOI 10.1101/gad.7.3.393; POLSON AG, 1994, EMBO J, V13, P5701, DOI 10.1002/j.1460-2075.1994.tb06908.x; POLSON AG, 1991, BIOCHEMISTRY-US, V30, P11507, DOI 10.1021/bi00113a004; Reim I, 1999, CHROMOSOMA, V108, P162, DOI 10.1007/s004120050365; Reim I, 1999, EXP CELL RES, V253, P573, DOI 10.1006/excr.1999.4647; Saavedra C, 1997, CURR BIOL, V7, P619, DOI 10.1016/S0960-9822(06)00288-0; SACCOMANNO L, 1994, MOL CELL BIOL, V14, P5425, DOI 10.1128/MCB.14.8.5425; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Straub T, 1998, J BIOL CHEM, V273, P26261, DOI 10.1074/jbc.273.41.26261; Straub T, 2000, BIOCHEMISTRY-US, V39, P7552, DOI 10.1021/bi992898e; Tiscornia G, 2000, MOL CELL, V5, P959, DOI 10.1016/S1097-2765(00)80261-0; Traish AM, 1997, DIAGN MOL PATHOL, V6, P209, DOI 10.1097/00019606-199708000-00005; Urban RJ, 2000, MOL ENDOCRINOL, V14, P774, DOI 10.1210/me.14.6.774; WAGNER RW, 1989, P NATL ACAD SCI USA, V86, P2647, DOI 10.1073/pnas.86.8.2647; Yang YS, 1997, NUCLEIC ACIDS RES, V25, P2284, DOI 10.1093/nar/25.12.2284; YANG YS, 1993, MOL CELL BIOL, V13, P5593, DOI 10.1128/MCB.13.9.5593; ZHANG WW, 1993, BIOCHEM J, V290, P267, DOI 10.1042/bj2900267; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	61	373	393	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2001	106	4					465	475		10.1016/S0092-8674(01)00466-4	http://dx.doi.org/10.1016/S0092-8674(01)00466-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525732	Bronze			2022-12-01	WOS:000170665200010
J	Kessler, RC; Davis, RB; Foster, DF; Van Rompay, MI; Walters, EE; Wilkey, SA; Kaptchuk, TJ; Eisenberg, DM				Kessler, RC; Davis, RB; Foster, DF; Van Rompay, MI; Walters, EE; Wilkey, SA; Kaptchuk, TJ; Eisenberg, DM			Long-term trends in the use of complementary and alternative medical therapies in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							SERVICES; CARE	Background: Although recent research has shown that many people in the United States use complementary and alternative medical (CAM) therapies, little is known about time trends in use. Objective: To present data on time trends in CAM therapy use in the United States over the past half-century. Design: Nationally representative telephone survey of 2055 respondents that obtained information on current use, lifetime use, and age at first use for 20 CAM therapies. Setting: The 48 contiguous U.S. states. Participants: Household residents 18 years of age and older. Measurement: Retrospective self-reports of age at first use for each of 20 CAM therapies. Results: Previously reported analyses of these data showed that more than one third of the U.S. population was currently using CAM therapy in the year of the interview (1997). Subsequent analyses of lifetime use and age at onset showed that 67.6% of respondents had used at least one CAM therapy in their lifetime. Lifetime use steadily increased with age across three age cohorts: Approximately 3 of every 10 respondents in the pre-baby boom cohort, 5 of 10 in the baby boom cohort, and 7 of 10 in the post-baby boom cohort reported using some type of CAM therapy by age 33 years. Of respondents who ever used a CAM therapy, nearly half continued to use many years later. A wide range of individual CAM therapies increased in use over time, and the growth was similar across all major sociodemographic sectors of the study sample. Conclusions: Use of CAM therapies by a large proportion of the study sample is the result of a secular trend that began at least a half century ago. This trend suggests a continuing demand for CAM therapies that will affect health care delivery for the foreseeable future.	Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Ctr Alternat Med Res & Educ, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Kessler, RC (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	kessler@hcp.med.harvard.edu	Van Rompay, Maria/G-9452-2012		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U24AR043441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K05MH000507] Funding Source: NIH RePORTER; NIAMS NIH HHS [U24 AR43441] Funding Source: Medline; NIMH NIH HHS [K05 MH00507] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; BERLINER HS, 1980, INT J HEALTH SERV, V10, P133, DOI 10.2190/XWR6-5QPX-GEGE-5GWR; CLAYTON D, 1993, STAT MODELS EPIDEMIO, P31; Delbanco T, 1998, JAMA-J AM MED ASSOC, V280, P1560, DOI 10.1001/jama.280.18.1560; Druss BG, 1999, JAMA-J AM MED ASSOC, V282, P651, DOI 10.1001/jama.282.7.651; EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Goldstein M. S., 1992, HLTH MOVEMENT PROMOT; HOLT D, 1979, J ROY STAT SOC A STA, V142, P33, DOI 10.2307/2344652; LEE ES, 1989, ANAL COMPLEXX SURVEY; Paramore LC, 1997, J PAIN SYMPTOM MANAG, V13, P83, DOI 10.1016/S0885-3924(96)00299-0; Pelletier KR, 1997, AM J HEALTH PROMOT, V12, P112, DOI 10.4278/0890-1171-12.2.112; ROTHSTEIN WG, 1985, AM PHYSICIANS 19 CEN; SAS, 1996, SAS US GUID REL 6 12; Shekelle PG, 1996, MED CARE, V34, P863, DOI 10.1097/00005650-199609000-00001; SHYROCK HS, 1971, METHODS MAT DEMOGRAP, V1; *US BUR CENS, 2001, US POP EST AG SEX RA; Wetzel MS, 1998, JAMA-J AM MED ASSOC, V280, P784, DOI 10.1001/jama.280.9.784; Whorton J C, 1986, Pharm Hist, V28, P14; WILLETT JB, 1993, J CONSULT CLIN PSYCH, V61, P952, DOI 10.1037/0022-006X.61.6.952; [No title captured]	21	487	495	0	41	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2001	135	4					262	268		10.7326/0003-4819-135-4-200108210-00011	http://dx.doi.org/10.7326/0003-4819-135-4-200108210-00011			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	465KE	11511141				2022-12-01	WOS:000170587500005
J	Smaglik, P				Smaglik, P			Biologists officially welcome plan	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2001	412	6848					665	665		10.1038/35089190	http://dx.doi.org/10.1038/35089190			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507594	Bronze			2022-12-01	WOS:000170450200003
J	Schatz, IJ; Masaki, K; Yano, K; Chen, R; Rodriguez, BL; Curb, JD				Schatz, IJ; Masaki, K; Yano, K; Chen, R; Rodriguez, BL; Curb, JD			Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study	LANCET			English	Article							LOW SERUM-CHOLESTEROL; PHYSICAL-ACTIVITY; MEN; DISEASE; CANCER; RISK; DEATH	Background A generally held belief is that cholesterol concentrations should be kept low to lessen the risk of cardiovascular disease. However, studies of the relation between serum cholesterol and all-cause mortality in elderly people have shown contrasting results. To investigate these discrepancies, we did a longitudinal assessment of changes in both lipid and serum cholesterol concentrations over 20 years, and compared them with mortality. Methods Lipid and serum cholesterol concentrations were measured in 3572 Japanese/American men (aged 71-93 years) as part of the Honolulu Heart Program. We compared changes in these concentrations over 20 years with all-case mortality using three different Cox proportional hazards models. Findings Mean cholesterol fell significantly with increasing age. Age-adjusted mortality rates were 68.3, 48.9, 41.1, and 43.3 for the first to fourth quartiles of cholesterol concentrations, respectively. Relative risks for mortality were 0.72 (95% CI 0.60-0.87), 0.60 (0.49-0.74), and 0.65 (0.53-0.80), in the second, third, and fourth quartiles, respectively, with quartile 1 as reference. A Cox proportional hazard model assessed changes in cholesterol concentrations between examinations three and four. Only the group with low cholesterol concentration at both examinations had a significant association with mortality (risk ratio 1.64, 95% CI 1.13-2.36). Interpretation We have been unable to explain our results. These data cast doubt on the scientific justification for lowering cholesterol to very low concentrations (<4.65 mmol/L) in elderly people.	Univ Hawaii Manoa, John A Burns Sch Med, Dept Med, Clin Epidemiol & Geriatr Div, Honolulu, HI 96813 USA; Kuakini Med Ctr, Honolulu, HI USA	University of Hawaii System; University of Hawaii Manoa	Schatz, IJ (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Med, Clin Epidemiol & Geriatr Div, 1356 Lusitana St,7th Floor, Honolulu, HI 96813 USA.	schatzi@hawaii.edu			NIA NIH HHS [N0I-AG-4-2149] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [N01AG042149] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abbott RD, 1997, ANN EPIDEMIOL, V7, P417, DOI 10.1016/S1047-2797(97)00043-4; Burchfiel CM, 1996, ANN EPIDEMIOL, V6, P490, DOI 10.1016/S1047-2797(96)00103-2; BURCHFIEL CM, 1995, AM J EPIDEMIOL, V141, P360, DOI 10.1093/aje/141.4.360; Corti MC, 1997, ANN INTERN MED, V126, P753, DOI 10.7326/0003-4819-126-10-199705150-00001; EPSTEIN FH, 1992, ATHEROSCLEROSIS, V94, P1, DOI 10.1016/0021-9150(92)90182-G; ETTINGER WH, 1995, J GERONTOL A-BIOL, V50, pM137, DOI 10.1093/gerona/50A.3.M137; Grundy S, 1996, CIRCULATION, V93, P1067; IRIBARREN C, 1995, CIRCULATION, V92, P2396, DOI 10.1161/01.CIR.92.9.2396; JACOBS DR, 1993, ANNU REV PUBL HEALTH, V14, P95; KANNEL WB, 1979, ARCH INTERN MED, V139, P857, DOI 10.1001/archinte.139.8.857; KRITCHEVSKY SB, 1992, ANNU REV NUTR, V12, P391, DOI 10.1146/annurev.nu.12.070192.002135; LAW MR, 1992, BRIT J CANCER, V65, P307, DOI 10.1038/bjc.1992.63; Manolio T A, 1992, Ann Epidemiol, V2, P161, DOI 10.1016/1047-2797(92)90051-Q; PEDERSEN TR, 1994, LANCET, V344, P1383; Rantanen T, 1999, JAMA-J AM MED ASSOC, V281, P558, DOI 10.1001/jama.281.6.558; Sharp DS, 1996, AM J RESP CRIT CARE, V153, P805, DOI 10.1164/ajrccm.153.2.8564136; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Song YM, 2000, AM J EPIDEMIOL, V151, P739, DOI 10.1093/oxfordjournals.aje.a010272; WORTH RM, 1970, J CHRON DIS, V23, P389, DOI 10.1016/0021-9681(70)90022-6; YANO K, 1984, AM J EPIDEMIOL, V119, P653, DOI 10.1093/oxfordjournals.aje.a113787; YOUNG DR, 1995, J AM GERIATR SOC, V43, P845, DOI 10.1111/j.1532-5415.1995.tb05525.x	21	307	316	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2001	358	9279					351	355		10.1016/S0140-6736(01)05553-2	http://dx.doi.org/10.1016/S0140-6736(01)05553-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	459DE	11502313				2022-12-01	WOS:000170235100008
J	PRICE, LC; SCHOELL, M				PRICE, LC; SCHOELL, M			CONSTRAINTS ON THE ORIGINS OF HYDROCARBON-GAS FROM COMPOSITIONS OF GASES AT THEIR SITE OF ORIGIN	NATURE			English	Article							NATURAL GASES; KEROGEN	It is widely accepted that natural gas is formed from thermal decomposition of both oil in reservoirs and, to a lesser extent, the organic matter in shales from which the oil was derived(1-6). But laboratory pyrolysis experiments on shales do not reproduce the methane-rich composition typical of most gas reservoirs(7), leading to suggestions(7) that other mechanisms, such as transition-metal catalysis, may be important. The discrepancy might, however, instead arise because gas (and oil) deposits have migrated from their source rocks, so that the reservoir composition might not be representative of the composition in the source rocks where the hydrocarbons were generated. To address this question, we have analysed gas samples coproduced with oils directly from a source rock (the Bakken shales, North Dakota, USA) where the local geology has prevented significant hydrocarbon migration. The methane contents of these Bakken-shale gases are much lower than that of conventional gas reservoirs, but are consistent with that from pyrolysis experiments(8,9) on these shales. Thus, because these Bakken gases form with (rather than from) oils, we argue that compositional differences between gases from source rocks and conventional gas deposits result from fractionation processes occurring after hydrocarbon expulsion from the source rock.	CHEVRON PETR TECHNOL CO,LA HABRA,CA 90633	Chevron	PRICE, LC (corresponding author), US GEOL SURVEY,DENVER FED CTR,MS-940,DENVER,CO 80225, USA.							CHUNG HM, 1988, CHEM GEOL, V71, P97, DOI 10.1016/0009-2541(88)90108-8; CLAYTON C, 1991, MAR PETROL GEOL, V8, P232, DOI 10.1016/0264-8172(91)90010-X; FUEX AN, 1977, J GEOCHEM EXPLOR, V7, P155, DOI 10.1016/0375-6742(77)90080-2; GALIMOV EM, 1988, CHEM GEOL, V71, P77, DOI 10.1016/0009-2541(88)90107-6; GUSSOW WC, 1954, AAPG BULL, V38, P816; JAMES AT, 1983, AAPG BULL, V67, P1176; JENDEN PD, 1988, CHEM GEOL, V71, P117, DOI 10.1016/0009-2541(88)90110-6; MANGO FD, 1994, NATURE, V368, P536, DOI 10.1038/368536a0; MCNEIL RI, IN PRESS ENERGY FUEL; NAMAK JE, 1991, 9301 US DEP INT BUR; PRICE LC, 1994, B CAN PETROL GEOL, V42, P187; PRICE LC, 1985, J PETROL GEOL, V8, P59, DOI 10.1111/j.1747-5457.1985.tb00191.x; PRICE LC, 1992, GEOLOGICAL STUDIES R, P199; PRICE LC, SOURCES NATURAL GAS; RICE DD, 1988, 88391 US GEOL SURV O; SALISBURY GP, 1968, MEM AM ASS PETROL 9, V2, P1433; SCHOELL M, 1983, AAPG BULL, V67, P2225; SCHOELL M, 1988, CHEM GEOL, V71, P1, DOI 10.1016/0009-2541(88)90101-5; Tissot B.P., 1984, PETROLEUM FORMATION, DOI DOI 10.1007/978-3-642-96446-6; WENGER LM, 1991, ORGANIC GEOCHEMISTRY, P335	20	79	91	1	45	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 23	1995	378	6555					368	371		10.1038/378368a0	http://dx.doi.org/10.1038/378368a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF893	11536709				2022-12-01	WOS:A1995TF89300052
J	RAUP, DM; JABLONSKI, D				RAUP, DM; JABLONSKI, D			GEOGRAPHY OF END-CRETACEOUS MARINE BIVALVE EXTINCTIONS	SCIENCE			English	Article							MASS EXTINCTIONS; BOUNDARY	Analysis of the end-Cretaceous mass extinction, based on 3514 occurrences of 340 genera of marine bivalves (Mollusca), suggests that extinction intensities were uniformly global; no latitudinal gradients or other geographic patterns are detected. Elevated extinction intensities in some tropical areas are entirely a result of the distribution of one extinct group of highly specialized bivalves, the rudists. When rudists are omitted, intensities at those localities are statistically indistinguishable from those of both the rudist-free tropics and extratropical localities.			RAUP, DM (corresponding author), UNIV CHICAGO,DEPT GEOPHYS SCI,5734 ELLIS AVE,CHICAGO,IL 60637, USA.							ERWIN D H, 1989, Palaios, V4, P424, DOI 10.2307/3514587; JABLONSKI D, 1986, SCIENCE, V231, P129, DOI 10.1126/science.231.4734.129; Jablonski D., 1986, P183; JABLONSKI D, 1991, SCIENCE, V253, P754, DOI 10.1126/science.253.5021.754; JABLONSKI D, 1989, PHILOS T ROY SOC B, V325, P357, DOI 10.1098/rstb.1989.0093; JOHNSON CC, 1990, EXTINCTION EVENTS EA, P305; KAUFFMAN E G, 1988, Palaios, V3, P194, DOI 10.2307/3514530; KAUFFMAN EG, 1986, GLOBAL BIOEVENTS, P279; KELLER G, 1989, GEOL SOC AM BULL, V101, P1408, DOI 10.1130/0016-7606(1989)101<1408:EPOEAT>2.3.CO;2; Lipps J.H., 1986, P87; MACLEOD KG, 1990, GEOLOGICAL SOC AM SP, V247, P509; MARINCOVICH L, 1985, GEOLOGY, V13, P770, DOI 10.1130/0091-7613(1985)13<770:ETMFFN>2.0.CO;2; Masse J.-P., 1986, Bulletin du Centre de Recherches Exploration-Production Elf-Aquitaine, V10, P437; Myers N, 1990, Environmentalist, V10, P243, DOI 10.1007/BF02239720; PERCHNIELSEN K, 1982, GEOL SOC AM SPEC PAP, V190, P353; Rosen B.R., 1989, Memoir of the Association of Australasian Palaeontologists, V8, P355; SEPKOSKI JJ, 1989, J GEOL SOC LONDON, V146, P7, DOI 10.1144/gsjgs.146.1.0007; SHARPTON VL, 1992, NATURE, V359, P819, DOI 10.1038/359819a0; SOHL NF, 1987, J PALEONTOL, V61, P1085, DOI 10.1017/S0022336000029486; Stanley S.M., 1984, P69; STANLEY SM, 1988, AM J SCI, V288, P334, DOI 10.2475/ajs.288.4.334; WALLER TR, 1992, J PALEONTOL, V66, P215, DOI 10.1017/S0022336000033746; WESTROP SR, 1989, PALEOBIOLOGY, V15, P46, DOI 10.1017/S0094837300009179; Zachos JC, 1986, PALEOCEANOGRAPHY, V1, P5, DOI 10.1029/PA001i001p00005; ZINSMEISTER WJ, 1989, J PALEONTOL, V63, P731, DOI 10.1017/S0022336000036453; [No title captured]; [No title captured]	27	87	90	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 14	1993	260	5110					971	973		10.1126/science.11537491	http://dx.doi.org/10.1126/science.11537491			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LB791	11537491				2022-12-01	WOS:A1993LB79100039
J	SALAMA, F; ALLAMANDOLA, LJ				SALAMA, F; ALLAMANDOLA, LJ			IS A PYRENE-LIKE MOLECULAR ION THE CAUSE OF THE 4,430-ANGSTROM DIFFUSE INTERSTELLAR ABSORPTION-BAND	NATURE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; EMISSION; SPECTRA; NAPHTHALENE; FEATURES; RADICALS	THE diffuse interstellar bands (DIBs), ubiquitous absorption features in astronomical spectra, have been known since early this century 1 and now number more than a hundred. Ranging from 4,400 angstrom to the near infrared 2, they differ markedly in depth, width and shape, making the concept of a single carrier unlikely. Whether they are due to gas or grains is not settled, but recent results 3 suggest that the DIB carriers are quite separate from the grains that cause visual extinction. Among molecular candidates the polycyclic aromatic hydrocarbons (PAHs) have been proposed as the possible carriers of some of the DIBs 4-7, and we present here laboratory measurements of the optical spectrum of the pyrene cation C16H10+ in neon and argon. matrices. The strongest absorption feature falls at 4,435 +/- 5 angstrom in the argon matrix and 4,395 +/- 5 angstrom in the neon matrix, both close to the strong 4,430-angstrom DIB. If this or a related pyrene-like species is responsible for this particular band, it must account for 0.2% of all cosmic carbon. The ion also shows an intense but puzzling broad continuum, extending from the ultraviolet to the visible, similar to what is seen in the naphthalene cation 8 and perhaps therefore a common feature of all PAH cations. This may provide an explanation of how PAHs convert a large fraction of interstellar radiation from ultraviolet and visible wavelengths down to the infrared.			SALAMA, F (corresponding author), NASA,AMES RES CTR,DIV SPACE SCI,MS 245-6,MOFFETT FIELD,CA 94035, USA.		Salama, Farid/A-8787-2009	Salama, Farid/0000-0002-6064-4401				AITKEN DK, 1983, MON NOT R ASTRON SOC, V202, P1233, DOI 10.1093/mnras/202.4.1233; ALLAMANDOLA LJ, 1985, ASTROPHYS J, V290, pL25, DOI 10.1086/184435; ANDREWS L, 1982, J PHYS CHEM-US, V86, P2916, DOI 10.1021/j100212a023; Bondybey V. E., 1983, Molecular ions: Spectroscopy, structure and chemistry, P125; CLAR E, 1976, TETRAHEDRON, V32, P2563, DOI 10.1016/0040-4020(76)88027-1; CRAWFORD MK, 1985, ASTROPHYS J, V293, pL45, DOI 10.1086/184488; Hayes D. S., 1973, International Astronomical Union Symposium No.52, Interstellar Dust and Related Topics, P83; HERBIG GH, 1991, ASTROPHYS J, V382, P193, DOI 10.1086/170708; HERBIG GH, 1975, ASTROPHYS J, V196, P129, DOI 10.1086/153400; KARCHER W, 1983, SPECTRAL ATLAS POLYC, P92; KIRA A, 1976, J PHYS CHEM-US, V80, P1445, DOI 10.1021/j100554a011; KRELOWSKI J, 1989, INTERSTELLAR DUST, P67; LEGER A, 1985, ASTRON ASTROPHYS, V146, P81; LEGER A, 1984, ASTRON ASTROPHYS, V137, pL5; PANKASEM S, 1991, J PHYS CHEM-US, V95, P7385, DOI 10.1021/j100172a051; SALAMA F, 1991, J CHEM PHYS, V94, P6964, DOI 10.1063/1.460230; SALAMA F, 1991, J CHEM PHYS, V95, P6190, DOI 10.1063/1.461827; SALAMA F, IN PRESS ASTROPHYS J; SELLGREN K, 1990, ASTROPHYS J, V359, P384, DOI 10.1086/169072; SELLGREN K, 1984, ASTROPHYS J, V277, P623, DOI 10.1086/161733; SHIDA T, 1973, J AM CHEM SOC, V95, P3473, DOI 10.1021/ja00792a005; SNOW TP, 1991, ASTROPHYS J, V382, P189, DOI 10.1086/170707; VANBREDA IG, 1981, MON NOT R ASTRON SOC, V195, P79, DOI 10.1093/mnras/195.1.79; VANDERZWET GP, 1985, ASTRON ASTROPHYS, V146, P76	24	94	94	0	14	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUL 2	1992	358	6381					42	43		10.1038/358042a0	http://dx.doi.org/10.1038/358042a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB341	11536498				2022-12-01	WOS:A1992JB34100045
J	JASPER, JP; HAYES, JM				JASPER, JP; HAYES, JM			A CARBON ISOTOPE RECORD OF CO2 LEVELS DURING THE LATE QUATERNARY	NATURE			English	Article									INDIANA UNIV,DEPT CHEM,BLOOMINGTON,IN 47405	Indiana University System; Indiana University Bloomington	JASPER, JP (corresponding author), INDIANA UNIV,DEPT GEOL SCI,BIOGEOCHEM LABS,BLOOMINGTON,IN 47405, USA.							BARNOLA JM, 1987, NATURE, V329, P408, DOI 10.1038/329408a0; BERGER WH, 1978, OCEANOL ACTA, V1, P203; BOUMA AH, 1983, AM ASS PET GEOL MEM, V34, P567; BOUMA AH, 1986, INITIAL REPORTS DSDP, V96, P777; BOYLE EA, 1988, J GEOPHYS RES-OCEANS, V93, P15701, DOI 10.1029/JC093iC12p15701; BROECKER WS, 1982, PROG OCEANOGR, V11, P151, DOI 10.1016/0079-6611(82)90007-6; BROECKER WS, 1970, REV GEOPHYS SPACE GE, V8, P169, DOI 10.1029/RG008i001p00169; BROECKER WS, 1982, GEOCHIM COSMOCHIM AC, V46, P1689, DOI 10.1016/0016-7037(82)90110-7; CONSTANS RE, 1986, INITIAL REP DEEP SEA, V96, P601; de Leeuw J.W., 1980, PHYS CHEM EARTH, V12, P211, DOI [10.1016/0079-1946(79)90105-8, DOI 10.1016/0079-1946(79)90105-8]; EWING M., 1958, HABITAT OIL, P995; FAIRBANKS RG, 1982, NATURE, V298, P841, DOI 10.1038/298841a0; FARRIMOND P, 1985, ADV ORG GEOCHEM, P897; FREEMAN KH, 1990, NATURE, V343, P254, DOI 10.1038/343254a0; HAYES JM, 1989, GEOCHIM COSMOCHIM AC, V53, P2961, DOI 10.1016/0016-7037(89)90172-5; Jasper JP, 1989, PALEOCEANOGRAPHY, V4, P603, DOI 10.1029/PA004i006p00603; JASPER JP, 1989, NATURE, V342, P60, DOI 10.1038/342060a0; JASPER JP, 1990, GEOCHIM COSMOCHIM AC, V54, P1117, DOI 10.1016/0016-7037(90)90443-O; KOHL B, 1986, INITIAL REP DEEP SEA, V96, P657; LEDBETTER MT, 1986, INITIAL REP DEEP SEA, V96, P685; LORIUS C, 1985, NATURE, V316, P591, DOI 10.1038/316591a0; MARLOWE IT, 1984, BRIT PHYCOL J, V19, P203, DOI 10.1080/00071618400650221; MCCABE B, 1985, THESIS U WAIKATO; NEWMAN JW, 1973, GEOCHIM COSMOCHIM AC, V37, P225, DOI 10.1016/0016-7037(73)90130-0; OKADA H, 1977, Micropaleontology (New York), V23, P1, DOI 10.2307/1485309; POPP BN, 1989, AM J SCI, V289, P436, DOI 10.2475/ajs.289.4.436; RAU GH, 1989, NATURE, V341, P516, DOI 10.1038/341516a0; RECHKA JA, 1988, TETRAHEDRON LETT, V29, P2599, DOI 10.1016/S0040-4039(00)86122-5; SHACKLETON NJ, 1983, NATURE, V306, P319, DOI 10.1038/306319a0; Steeman Nielsen E., 1975, MARINE PHOTOSYNTHESI; TANS PP, 1990, SCIENCE, V247, P1431, DOI 10.1126/science.247.4949.1431; WILLIAMS DF, 1986, INITIAL REP DEEP SEA, V96, P671	32	248	266	3	44	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 4	1990	347	6292					462	464		10.1038/347462a0	http://dx.doi.org/10.1038/347462a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB446	11536468				2022-12-01	WOS:A1990EB44600066
J	SANDER, SP; FRIEDL, RR; YUNG, YL				SANDER, SP; FRIEDL, RR; YUNG, YL			RATE OF FORMATION OF THE CLO DIMER IN THE POLAR STRATOSPHERE - IMPLICATIONS FOR OZONE LOSS	SCIENCE			English	Article									CALTECH,DIV GEOL & PLANETARY SCI,PASADENA,CA 91125	California Institute of Technology	SANDER, SP (corresponding author), CALTECH,JET PROP LAB,PASADENA,CA 91109, USA.		Yung, Yuk/AAM-4850-2021	Yung, Yuk/0000-0002-4263-2562				ALLEN M, 1981, J GEOPHYS RES-SPACE, V86, P3617, DOI 10.1029/JA086iA05p03617; ANDERSON JG, 1988, MAY NAT AER SPAC ADM; BARRETT JW, 1988, NATURE, V336, P455, DOI 10.1038/336455a0; Benson S., 1976, THERMOCHEMICAL KINET; BURKHOLDER JV, IN PRESS J PHYS CHEM; CRUTZEN PJ, 1986, NATURE, V324, P651, DOI 10.1038/324651a0; DEMORE WB, 1987, JPL PUBL, V8741; DEZAFRA RL, 1987, NATURE, V328, P408, DOI 10.1038/328408a0; FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; FARMER CB, 1987, NATURE, V329, P126, DOI 10.1038/329126a0; FRIEDL RR, 1989, J PHYS CHEM-US, V93, P4756, DOI 10.1021/j100349a016; FROIDEVAUX L, 1985, J GEOPHYS RES-ATMOS, V90, P2999, DOI 10.1029/JD090iD07p12999; HARTMANN DL, IN PRESS J GEOPHYS R; HAYMAN GD, 1989, CHEM PHYS LETT, V155, P1, DOI 10.1016/S0009-2614(89)87350-6; HAYMAN GD, 1986, GEOPHYS RES LETT, V13, P1347, DOI 10.1029/GL013i012p01347; HILLS AJ, 1987, NATURE, V328, P405, DOI 10.1038/328405a0; HOFMANN DJ, 1988, NASA10014 C PUBL; LUTHER K, 1979, S INT COMBUST P, V17, P535; MCELROY MB, 1986, NATURE, V321, P759, DOI 10.1038/321759a0; MCELROY MB, 1989, SCIENCE, V243, P763, DOI 10.1126/science.243.4892.763; MCELROY MB, 1988, PLANET SPACE SCI, V36, P73, DOI 10.1016/0032-0633(88)90148-1; MOLINA LT, 1987, J PHYS CHEM-US, V91, P433, DOI 10.1021/j100286a035; PATRICK R, 1983, INT J CHEM KINET, V15, P1189, DOI 10.1002/kin.550151107; PERMIEN T, 1988, SEP COOP SCI TECHN 6; RODRIGUEZ JM, 1986, GEOPHYS RES LETT, V13, P1292, DOI 10.1029/GL013i012p01292; SALAWITCH RJ, 1988, PLANET SPACE SCI, V36, P213, DOI 10.1016/0032-0633(88)90058-X; SANDER S, UNPUB; SANDER SP, 1988, GEOPHYS RES LETT, V15, P887, DOI 10.1029/GL015i008p00887; SANDER SP, 1989, J PHYS CHEM-US, V93, P4764, DOI 10.1021/j100349a017; SIMON FG, IN PRESS J PHYS CHEM; SOLOMON S, 1986, NATURE, V321, P755, DOI 10.1038/321755a0; SOLOMON S, 1987, J GEOPHYS RES-ATMOS, V92, P8329, DOI 10.1029/JD092iD07p08329; SOLOMON SC, IN PRESS J GEOPHYS R; STOLARSKI RS, 1986, NATURE, V322, P808, DOI 10.1038/322808a0; Toon GC, COMMUNICATION; TROE J, 1979, J PHYS CHEM-US, V83, P114, DOI 10.1021/j100464a019; WATSON RT, 1979, J PHYS CHEM-US, V83, P2936, DOI 10.1021/j100486a002; YUNG YL, IN PRESS	38	150	150	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 8	1989	245	4922					1095	1098		10.1126/science.245.4922.1095	http://dx.doi.org/10.1126/science.245.4922.1095			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN702	11538343				2022-12-01	WOS:A1989AN70200031
J	Raghuraman, MK; Winzeler, EA; Collingwood, D; Hunt, S; Wodicka, L; Conway, A; Lockhart, DJ; Davis, RW; Brewer, BJ; Fangman, WL				Raghuraman, MK; Winzeler, EA; Collingwood, D; Hunt, S; Wodicka, L; Conway, A; Lockhart, DJ; Davis, RW; Brewer, BJ; Fangman, WL			Replication dynamics of the yeast genome	SCIENCE			English	Article							CEREVISIAE CHROMOSOME-VI; S-PHASE; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; ORIGIN ACTIVATION; MAMMALIAN-CELLS; ARS ELEMENTS; TIME; INITIATION; TELOMERES	Oligonucleotide microarrays were used to map the detailed topography of chromosome replication in the budding yeast Saccharomyces cerevisiae. The times of replication of thousands of sites across the genome were determined by hybridizing replicated and unreplicated DNAs, isolated at different times in S phase, to the microarrays. Origin activations take place continuously throughout S phase but with most firings near mid-S phase. Rates of replication fork movement vary greatly from region to region in the genome. The two ends of each of the 16 chromosomes are highly correlated in their times of replication. This microarray approach is readily applicable to other organisms, including humans.	Univ Washington, Dept Genet, Seattle, WA 98195 USA; Univ Washington, Dept Math, Seattle, WA 98195 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Affymetrix, Santa Clara, CA USA; Silicon Genet, San Carlos, CA 94070 USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Novartis; Affymetrix; Stanford University	Raghuraman, MK (corresponding author), Univ Washington, Dept Genet, Seattle, WA 98195 USA.		Winzeler, Elizabeth/AAP-6752-2020	Winzeler, Elizabeth/0000-0002-4049-2113				APARICIO O, COMMUNICATION; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Donaldson AD, 1998, MOL CELL, V2, P173, DOI 10.1016/S1097-2765(00)80127-6; Donaldson AD, 1998, GENE DEV, V12, P491, DOI 10.1101/gad.12.4.491; Donaldson AD, 1999, CURR OPIN GENET DEV, V9, P62, DOI 10.1016/S0959-437X(99)80009-4; DROUIN R, 1990, CHROMOSOMA, V99, P273, DOI 10.1007/BF01731703; FERGUSON BM, 1991, CELL, V65, P507, DOI 10.1016/0092-8674(91)90468-E; FERGUSON BM, 1992, CELL, V68, P333, DOI 10.1016/0092-8674(92)90474-Q; Friedman KL, 1996, GENE DEV, V10, P1595, DOI 10.1101/gad.10.13.1595; Friedman KL, 1997, GENES CELLS, V2, P667, DOI 10.1046/j.1365-2443.1997.1520350.x; HAND R, 1975, J CELL BIOL, V64, P89, DOI 10.1083/jcb.64.1.89; HATTON KS, 1988, MOL CELL BIOL, V8, P2149, DOI 10.1128/MCB.8.5.2149; KEARSEY S, 1984, CELL, V37, P299, DOI 10.1016/0092-8674(84)90326-X; Khodursky AB, 2000, P NATL ACAD SCI USA, V97, P9419, DOI 10.1073/pnas.97.17.9419; KOLOR K, UNPUB; Lengronne A, 2001, NUCLEIC ACIDS RES, V29, P1433, DOI 10.1093/nar/29.7.1433; MCCARROLL RM, 1988, CELL, V54, P505, DOI 10.1016/0092-8674(88)90072-4; NATALE DA, 1992, P NATL ACAD SCI USA, V89, P2654, DOI 10.1073/pnas.89.7.2654; NEWLON CS, 1993, CURR OPIN GENET DEV, V3, P752, DOI 10.1016/S0959-437X(05)80094-2; NEWLON CS, 1980, ICN UCLA S MOL CELL, V19, P399; Pasero P, 2000, CURR OPIN GENET DEV, V10, P178, DOI 10.1016/S0959-437X(00)00067-8; REYNOLDS AE, 1989, MOL CELL BIOL, V9, P4488, DOI 10.1128/MCB.9.10.4488; RIVIN CJ, 1980, J CELL BIOL, V85, P108, DOI 10.1083/jcb.85.1.108; Seoighe C, 1999, GENE, V238, P253, DOI 10.1016/S0378-1119(99)00319-4; SHARP PM, 1993, NUCLEIC ACIDS RES, V21, P179, DOI 10.1093/nar/21.2.179; Stevenson JB, 1999, GENE DEV, V13, P146, DOI 10.1101/gad.13.2.146; Toone WM, 1997, ANNU REV MICROBIOL, V51, P125, DOI 10.1146/annurev.micro.51.1.125; VANHOUTEN JV, 1990, MOL CELL BIOL, V10, P3917, DOI 10.1128/MCB.10.8.3917; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; WOLFFE AP, 1994, DEV GENET, V15, P463, DOI 10.1002/dvg.1020150604; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Yamashita M, 1997, GENES CELLS, V2, P655, DOI 10.1046/j.1365-2443.1997.1530351.x	35	596	607	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2001	294	5540					115	121		10.1126/science.294.5540.115	http://dx.doi.org/10.1126/science.294.5540.115			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11588253				2022-12-01	WOS:000171448800041
J	Miyamoto, K; Miyake, S; Yamamura, T				Miyamoto, K; Miyake, S; Yamamura, T			A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing T(H)2 bias of natural killer T cells	NATURE			English	Article							ALTERED PEPTIDE LIGAND; ALPHA-GALACTOSYLCERAMIDE; SELECTIVE REDUCTION; MULTIPLE-SCLEROSIS; NKT CELLS; TCR; RECOGNITION; ACTIVATION; ANTIGENS; DISEASE	Experimental autoimmune encephalomyelitis (EAE) is a prototype autoimmune disease mediated by type 1 helper T (T(H)1) cells and under the control of regulatory cells(1-3). Here we report that a synthetic glycolipid ligand for CD1d-restricted natural killer T (NKT) cells expressing the semi-invariant T-cell receptor (V alpha 14(+)) is preventive against EAE. The ligand is an analogue of alpha -galactosylceramide (alpha -GC), a prototype NKT cell ligand, with a truncated sphingosine chain. alpha -GC causes NKT cells to produce both interferon (IFN)-gamma and interleukin (IL)-4 (refs 4, 5). However, this new ligand can induce a predominant production of IL-4 by the NKT cells. A single injection of this glycolipid, but not of alpha -GC, consistently induced T(H)2 bias of autoimmune T cells by causing NKT cells to produce IL-4, leading to suppression of EAE. The lack of polymorphism of CD1d and cross-reactive response of mouse and human NKT cells to the same ligand(6) indicates that targeting NKT cells with this ligand may be an attractive means for intervening in human autoimmune diseases such as multiple sclerosis.	NCNP, Natl Inst Neurosci, Dept Immunol, Tokyo 1878502, Japan	National Center for Neurology & Psychiatry - Japan	Yamamura, T (corresponding author), NCNP, Natl Inst Neurosci, Dept Immunol, 4-1-1 Ogawahigashi, Tokyo 1878502, Japan.							Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; BIX M, 1995, J IMMUNOL, V155, P1020; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Illes Z, 2000, J IMMUNOL, V164, P4375, DOI 10.4049/jimmunol.164.8.4375; Kappos L, 2000, NAT MED, V6, P1176, DOI 10.1038/80525; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; KIRSTEN JL, 1998, J EXP MED, V187, P1047; Kumar V, 1997, J EXP MED, V185, P1725, DOI 10.1084/jem.185.10.1725; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Mieza MA, 1996, J IMMUNOL, V156, P4035; Moody DB, 1999, IMMUNOL REV, V172, P285, DOI 10.1111/j.1600-065X.1999.tb01373.x; MORITA M, 1995, BIOORG MED CHEM LETT, V5, P699, DOI 10.1016/0960-894X(95)00097-D; Nicholson LB, 1996, CURR OPIN IMMUNOL, V8, P837, DOI 10.1016/S0952-7915(96)80013-6; Pal E, 2001, J IMMUNOL, V166, P662, DOI 10.4049/jimmunol.166.1.662; Pedotti R, 2001, NAT IMMUNOL, V2, P216, DOI 10.1038/85266; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; Spada FM, 1998, J EXP MED, V188, P1529, DOI 10.1084/jem.188.8.1529; SUMIDA T, 1995, J EXP MED, V182, P1163, DOI 10.1084/jem.182.4.1163; Wilson SB, 1998, NATURE, V391, P177, DOI 10.1038/34419; Zhang BN, 1997, J EXP MED, V186, P1677, DOI 10.1084/jem.186.10.1677	21	720	785	1	20	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2001	413	6855					531	534		10.1038/35097097	http://dx.doi.org/10.1038/35097097			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586362				2022-12-01	WOS:000171340500049
J	McCracken, KG; Wilson, RE; McCracken, PJ; Johnson, KP				McCracken, KG; Wilson, RE; McCracken, PJ; Johnson, KP			Sexual selection - Are ducks impressed by Drakes' display?	NATURE			English	Article									Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA; Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK 99775 USA; Univ Alaska Museum, Fairbanks, AK 99775 USA; Illinois Nat Hist Survey, Champaign, IL 61820 USA	University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; Illinois Natural History Survey	McCracken, KG (corresponding author), Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA.							Birkhead TR., 1992, SPERM COMPETITION BI; Briskie JV, 1997, J AVIAN BIOL, V28, P73, DOI 10.2307/3677097; JOHNSGARD PA, 1996, RUDDY DUCKS OTHER ST; McCracken KG, 2000, AUK, V117, P820, DOI 10.1642/0004-8038(2000)117[0820:TCSPOT]2.0.CO;2; Mead C, 2000, NATURE, V407, P461, DOI 10.1038/35035183	5	10	11	1	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					128	128		10.1038/35093160	http://dx.doi.org/10.1038/35093160			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557968	Bronze			2022-12-01	WOS:000170918800034
J	MacPherson, H; Thomas, K; Walters, S; Fitter, M				MacPherson, H; Thomas, K; Walters, S; Fitter, M			The York acupuncture safety study: prospective survey of 34 000 treatments by traditional acupuncturists	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Fdn Tradit Chinese Med, York YO24 4EY, N Yorkshire, England; Univ Sheffield, Med Care Res Unit, Sheffield S1 4DA, S Yorkshire, England; Univ Sheffield, Sheffield Hlth Econ Grp, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England	University of Sheffield; University of Sheffield	MacPherson, H (corresponding author), Fdn Tradit Chinese Med, York YO24 4EY, N Yorkshire, England.	hugh@ftcm.org.uk		Walters, Stephen/0000-0001-9000-8126; MacPherson, Hugh/0000-0003-4255-4768				*BRIT MED ASS BOAR, 2000, AC EFF SAF PRACT; EYPASCH E, 1995, BRIT MED J, V311, P619, DOI 10.1136/bmj.311.7005.619; *HOUS LORDS, 2000, COMPL ALT MED; MacPherson H, 1999, J ALTERN COMPLEM MED, V5, P223, DOI 10.1089/acm.1999.5.223; Tramer MR, 2000, PAIN, V85, P169, DOI 10.1016/S0304-3959(99)00267-5	5	245	254	3	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2001	323	7311					486	487		10.1136/bmj.323.7311.486	http://dx.doi.org/10.1136/bmj.323.7311.486			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469WF	11532841	Bronze, Green Published			2022-12-01	WOS:000170838500018
J	Richardson, DK; Heffner, LJ				Richardson, DK; Heffner, LJ			Fetal-lung maturity: tests mature, interpretation not	LANCET			English	Editorial Material							AMNIOTIC-FLUID; PRETERM LABOR; INDEXES		Beth Israel Deaconess Med Ctr, Dept Neonatol, Boston, MA 02215 USA; Brigham & Womens Hosp, Dept Obstet & Gynecol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital	Richardson, DK (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neonatol, Boston, MA 02215 USA.			Heffner, Linda/0000-0001-9623-7210				ACOG educational bulletin, 1997, INT J GYNECOL OBSTET, V56, P191; ASHWOOD ER, 1993, OBSTET GYNECOL, V81, P619; DUBIN SB, 1990, CLIN CHEM, V36, P1867; FAGAN TJ, 1975, NEW ENGL J MED, V293, P257; Field NT, 1997, CLIN OBSTET GYNECOL, V40, P366, DOI 10.1097/00003081-199706000-00012; Ghidini A, 1997, AM J PERINAT, V14, P75, DOI 10.1055/s-2007-994101; GILSTRAP LC, 1995, JAMA-J AM MED ASSOC, V273, P413, DOI 10.1001/jama.1995.03520290065031; GLUCK L, 1971, AM J OBSTET GYNECOL, V109, P440, DOI 10.1016/0002-9378(71)90342-5; HALLMAN M, 1976, AM J OBSTET GYNECOL, V125, P613, DOI 10.1016/0002-9378(76)90782-1; HUNINK MGM, 1990, MED DECIS MAKING, V10, P201, DOI 10.1177/0272989X9001000307; Lauria MR, 1996, J REPROD MED, V41, P685; Macones GA, 1998, BRIT J OBSTET GYNAEC, V105, P541, DOI 10.1111/j.1471-0528.1998.tb10156.x; Myers ER, 1997, OBSTET GYNECOL, V90, P824, DOI 10.1016/S0029-7844(97)00412-2; Wijnberger LDE, 2001, BRIT J OBSTET GYNAEC, V108, P583, DOI 10.1111/j.1471-0528.2001.00142.x	14	9	9	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 1	2001	358	9283					684	686		10.1016/S0140-6736(01)05848-2	http://dx.doi.org/10.1016/S0140-6736(01)05848-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467XR	11551571				2022-12-01	WOS:000170729500004
J	Huang, Y; Street-Perrott, FA; Metcalfe, SE; Brenner, M; Moreland, M; Freeman, KH				Huang, Y; Street-Perrott, FA; Metcalfe, SE; Brenner, M; Moreland, M; Freeman, KH			Climate change as the dominant control on glacial-interglacial variations in C-3 and C-4 plant abundance	SCIENCE			English	Article							ATMOSPHERIC CO2; CARBON-DIOXIDE; LATE MIOCENE; EXPANSION; BOUNDARY; GRASSES; NEOGENE; RECORD; KENYA	Although C-4 plant expansions have been recognized in the late Miocene, identification of the underlying causes is complicated by the uncertainties associated with estimates of ancient precipitation, temperature, and partial pressure of atmospheric carbon dioxide (PCO2). Here we report the carbon isotopic compositions of leaf wax n-alkanes in take sediment cores from two sites in Mesoamerica that have experienced contrasting moisture variations since the last glacial maximum. Opposite isotopic trends obtained from these two sites indicate that regional climate exerts a strong control on the relative abundance of C-3 and C-4 plants and that in the absence of favorable moisture and temperature conditions, low PCO2 atone is insufficient to drive an expansion of C-4 plants.	Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Univ Coll Swansea, Dept Geog, Swansea SA2 8PP, W Glam, Wales; Univ Edinburgh, Dept Geog, Edinburgh EH8 9XP, Midlothian, Scotland; Univ Florida, Dept Geol Sci, Gainesville, FL 32611 USA; Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	Brown University; Swansea University; University of Edinburgh; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Huang, Y (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.		Metcalfe, Sarah/H-9484-2013; Freeman, Katherine H/H-5140-2011	Freeman, Katherine H/0000-0002-3350-7671				Bernor R.L., 1996, P449; BOUTTON TW, 1994, NATURE, V372, P625, DOI 10.1038/372625a0; Bradbury JP, 1997, QUATERN INT, V43-4, P97, DOI 10.1016/S1040-6182(97)00025-6; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Connin SL, 1998, QUATERNARY RES, V50, P179, DOI 10.1006/qres.1998.1986; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; Fischer H.G., COMMUNICATION; HODELL DA, 1995, NATURE, V375, P391, DOI 10.1038/375391a0; HUANG CT, 1971, INSECT BIOCHEM, V1, P27; Huang YS, 1999, GEOCHIM COSMOCHIM AC, V63, P1383, DOI 10.1016/S0016-7037(99)00074-5; KUTZBACH JE, 1988, SCIENCE, V241, P1043, DOI 10.1126/science.241.4869.1043; Kuypers MMM, 1999, NATURE, V399, P342, DOI 10.1038/20659; Latorre C, 1997, EARTH PLANET SC LETT, V146, P83, DOI 10.1016/S0012-821X(96)00231-2; LEYDEN BW, 1994, PALAEOGEOGR PALAEOCL, V109, P193, DOI 10.1016/0031-0182(94)90176-7; Metcalfe SE, 1997, J PALEOLIMNOL, V17, P155, DOI 10.1023/A:1007905824147; MORGAN ME, 1994, NATURE, V367, P162, DOI 10.1038/367162a0; Muhs DR, 1999, GEOL SOC AM BULL, V111, P1861, DOI 10.1130/0016-7606(1999)111<1861:LQLINC>2.3.CO;2; Pagani M, 1999, SCIENCE, V285, P876, DOI 10.1126/science.285.5429.876; RAMIREZ JO, 1995, GEOFISICA INT, V34, P107; Rea DK, 1998, PALEOCEANOGRAPHY, V13, P215, DOI 10.1029/98PA00123; Retallack GJ, 1997, PALAIOS, V12, P380, DOI 10.2307/3515337; RIELEY G, 1993, RAPID COMMUN MASS SP, V7, P488, DOI 10.1002/rcm.1290070617; Sage R.F., 1999, C4 PLANT BIOL, P3; Schulze ED, 1996, OECOLOGIA, V106, P352, DOI 10.1007/BF00334563; StreetPerrott FA, 1997, SCIENCE, V278, P1422, DOI 10.1126/science.278.5342.1422; SUKUMAR R, 1993, NATURE, V364, P703, DOI 10.1038/364703a0; TALBOT MR, 1992, EARTH PLANET SC LETT, V110, P23, DOI 10.1016/0012-821X(92)90036-U; Williams DG, 1996, OECOLOGIA, V106, P455, DOI 10.1007/BF00329701	28	290	351	6	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1647	1651		10.1126/science.1060143	http://dx.doi.org/10.1126/science.1060143			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533488				2022-12-01	WOS:000170802900060
J	O'Boyle, CP; Cole, RP				O'Boyle, CP; Cole, RP			Rationing in the NHS: audit of outcome and acceptance of restriction criteria for minor operations	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Salisbury Dist Hosp, Odstock Ctr Burns Plast & Maxillofacial Surg, Salisbury SP2 8BJ, Wilts, England	Salisbury District Hospital	O'Boyle, CP (corresponding author), Salisbury Dist Hosp, Odstock Ctr Burns Plast & Maxillofacial Surg, Salisbury SP2 8BJ, Wilts, England.	ciaranoboyle@saintly.com	O'Boyle, Ciaran P/J-5853-2019	O'Boyle, Ciaran/0000-0001-9650-2133				Asch DA, 1997, NEW ENGL J MED, V336, P1668, DOI 10.1056/NEJM199706053362309; Charatan FB, 1996, BRIT MED J, V313, P1506, DOI 10.1136/bmj.313.7071.1506a; Latham SR, 1999, CLIN PLAST SURG, V26, P115; MCWILLIAM LJ, 1991, BRIT MED J, V303, P1177, DOI 10.1136/bmj.303.6811.1177; Timmons MJ, 2000, ANN ROY COLL SURG, V82, P332	5	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 25	2001	323	7310					428	429		10.1136/bmj.323.7310.428	http://dx.doi.org/10.1136/bmj.323.7310.428			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469BX	11520840	Green Published, Bronze			2022-12-01	WOS:000170793600021
J	Casares, F; Mann, RS				Casares, F; Mann, RS			The ground state of the ventral appendage in Drosophila	SCIENCE			English	Article							DISTAL-LESS; HOX GENE; PROXIMODISTAL AXIS; ANTENNAL IDENTITY; LEG DEVELOPMENT; NOTCH; EVOLUTION; SEGMENTATION; HOMOTHORAX; DOMAINS	In Drosophila melanogaster, the antennae, legs, genitalia, and analia make up a serially homologous set of ventral appendages that depend on different selector genes for their unique identities. The diversity among these structures implies that there is a common ground state that selector genes modify to generate these different appendage morphologies. Here we show that the ventral appendage that forms in the absence of selector gene activity is leglike but consists of only two segments along its proximo-distal axis: a proximal segment and a distal tarsus. These results raise the possibility that, during evolution, leglike appendages could have developed without selector gene activity.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University	Mann, RS (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 701 W 168 St, New York, NY 10032 USA.	rsm10@columbia.edu	Casares, Fernando/M-5451-2019	Casares, Fernando/0000-0002-2181-3858	NIGMS NIH HHS [R01 GM058575] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058575] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abu-Shaar M, 1998, DEVELOPMENT, V125, P3821; BEEMAN RW, 1989, DEV BIOL, V133, P196, DOI 10.1016/0012-1606(89)90311-4; Bishop SA, 1999, DEVELOPMENT, V126, P2993; BOUDREAUX BH, 1987, ARTHROPOD PHYLOGENY; Brown S, 2000, P NATL ACAD SCI USA, V97, P4510, DOI 10.1073/pnas.97.9.4510; Casares F, 1998, NATURE, V392, P723, DOI 10.1038/33706; de Celis JF, 1998, DEVELOPMENT, V125, P4617; Dong PDS, 2000, DEVELOPMENT, V127, P209; Duncan DM, 1998, GENE DEV, V12, P1290, DOI 10.1101/gad.12.9.1290; Estrada B, 2001, DEVELOPMENT, V128, P331; Gehring W., 1966, ARCH JULIUS KALAUSST, V41, P44; Gellon G, 1998, BIOESSAYS, V20, P116, DOI 10.1002/(SICI)1521-1878(199802)20:2<116::AID-BIES4>3.3.CO;2-N; Gorfinkiel N, 1997, GENE DEV, V11, P2259, DOI 10.1101/gad.11.17.2259; Grenier JK, 1997, CURR BIOL, V7, P547, DOI 10.1016/S0960-9822(06)00253-3; HANNAH-ALAVA ALOHA, 1958, J MORPH, V103, P281, DOI 10.1002/jmor.1051030205; Hughes CL, 2000, DEVELOPMENT, V127, P3683; Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Moreno E, 1999, NATURE, V400, P873, DOI 10.1038/23709; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Rauskolb C, 1999, DEV BIOL, V210, P339, DOI 10.1006/dbio.1999.9273; Snodgrass R, 1935, PRINCIPLES INSECT MO, P83; STRUHL G, 1981, NATURE, V292, P635, DOI 10.1038/292635a0; STRUHL G, 1982, P NATL ACAD SCI-BIOL, V79, P7380, DOI 10.1073/pnas.79.23.7380; VILLANO JL, 1995, DEVELOPMENT, V121, P2767; Weatherbee SD, 1999, CELL, V97, P283, DOI 10.1016/S0092-8674(00)80737-0; Wu J, 1999, DEVELOPMENT, V126, P109	27	76	79	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1477	1480		10.1126/science.1062542	http://dx.doi.org/10.1126/science.1062542			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520984				2022-12-01	WOS:000170616000041
J	Drazner, MH; Rame, JE; Stevenson, LW; Dries, DL				Drazner, MH; Rame, JE; Stevenson, LW; Dries, DL			Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DILATED CARDIOMYOPATHY; CRITICALLY ILL; HEMODYNAMIC CORRELATIONS; INTEROBSERVER AGREEMENT; CARDIAC TRANSPLANTATION; MYOCARDIAL-INFARCTION; PHYSICAL-EXAMINATION; DOPPLER EVALUATION; CATHETERIZATION; SURVIVAL	Background: The independent prognostic value of elevated jugular venous pressure or a third heart sound in patients with heart failure is not well established. Methods: We performed a retrospective analysis of the Studies of Left Ventricular Dysfunction treatment trial, in which 2569 patients with symptomatic heart failure or a history of it were randomly assigned to receive enalapril or placebo. The mean (+/-SD) follow-up was 32+/-15 months. The presence of elevated jugular venous pressure or a third heart sound was ascertained by physical examination on entry into the trial. The risks of hospitalization for heart failure and progression of heart failure as defined by death from pump failure and the composite end point of death or hospitalization for heart failure were compared in patients with these findings on physical examination and patients without these findings. Results: In multivariate analyses that were adjusted for other markers of the severity of heart failure, elevated jugular venous pressure was associated with an increased risk of hospitalization for heart failure (relative risk, 1.32; 95 percent confidence interval, 1.08 to 1.62; P<0.01), death or hospitalization for heart failure (relative risk, 1.30; 95 percent confidence interval, 1.11 to 1.53; P<0.005), and death from pump failure (relative risk, 1.37; 95 percent confidence interval, 1.07 to 1.75; P<0.05). The presence of a third heart sound was associated with similarly increased risks of these outcomes. Conclusions: In patients with heart failure, elevated jugular venous pressure and a third heart sound are each independently associated with adverse outcomes, including progression of heart failure. Assessment for these findings is clinically meaningful.	Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Heart Failure Res Unit, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Brigham & Women's Hospital	Drazner, MH (corresponding author), Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Heart Failure Res Unit, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Rame, J. Eduardo/ABF-2208-2021	Rame, J. Eduardo/0000-0002-2936-1702				Aaronson KD, 1997, CIRCULATION, V95, P2660, DOI 10.1161/01.CIR.95.12.2660; Adolph RJ, 1998, CHEST, V114, P1235, DOI 10.1378/chest.114.5.1235; Azevedo ER, 2000, CIRCULATION, V101, P2053, DOI 10.1161/01.CIR.101.17.2053; Badgett RG, 1997, JAMA-J AM MED ASSOC, V277, P1712, DOI 10.1001/jama.277.21.1712; BRAUNWALD E, 1997, HEART DIS TXB CARDIO, V1, P445; BUTMAN SM, 1993, J AM COLL CARDIOL, V22, P968, DOI 10.1016/0735-1097(93)90405-P; CAMPANA C, 1993, J HEART LUNG TRANSPL, V12, P756; CHAKKO S, 1991, AM J MED, V90, P353, DOI 10.1016/0002-9343(91)90576-J; CONNORS AF, 1983, NEW ENGL J MED, V308, P263, DOI 10.1056/NEJM198302033080508; COOK DJ, 1990, AM J MED SCI, V299, P175, DOI 10.1097/00000441-199003000-00006; CRAIGE E, 1988, NEW ENGL J MED, V318, P1611, DOI 10.1056/NEJM198806163182409; CURRIE PJ, 1985, J AM COLL CARDIOL, V6, P750, DOI 10.1016/S0735-1097(85)80477-0; DAVISON R, 1974, AM HEART J, V87, P279, DOI 10.1016/0002-8703(74)90064-7; Drazner MH, 1999, J HEART LUNG TRANSPL, V18, P1126, DOI 10.1016/S1053-2498(99)00070-4; Dries DL, 1999, NEW ENGL J MED, V340, P609, DOI 10.1056/NEJM199902253400804; Dries DL, 1998, J AM COLL CARDIOL, V32, P695, DOI 10.1016/S0735-1097(98)00297-6; Dries DL, 1999, NEW ENGL J MED, V341, P298; EISENBERG PR, 1984, CRIT CARE MED, V12, P549, DOI 10.1097/00003246-198407000-00001; FLETCHER RH, 1992, ANN INTERN MED, V117, P786, DOI 10.7326/0003-4819-117-9-786; FOLLAND ED, 1992, NEW ENGL J MED, V327, P458, DOI 10.1056/NEJM199208133270703; GADSBOLL N, 1989, EUR HEART J, V10, P1017, DOI 10.1093/oxfordjournals.eurheartj.a059414; GLOVER DR, 1987, BRIT HEART J, V57, P125; HARLAN WR, 1977, ANN INTERN MED, V86, P133, DOI 10.7326/0003-4819-86-2-133; ISHIMITSU T, 1985, J AM COLL CARDIOL, V5, P268, DOI 10.1016/S0735-1097(85)80046-2; ISHMAIL AA, 1987, CHEST, V91, P870, DOI 10.1378/chest.91.6.870; Joshi N, 1999, SOUTH MED J, V92, P756, DOI 10.1097/00007611-199908000-00002; KAYE DM, 1994, J AM COLL CARDIOL, V23, P570, DOI 10.1016/0735-1097(94)90738-2; KEOGH AM, 1990, AM J CARDIOL, V65, P903, DOI 10.1016/0002-9149(90)91434-8; Leri A, 1998, J CLIN INVEST, V101, P1326, DOI 10.1172/JCI316; Levin A, 1998, ANN INTERN MED, V128, P334, DOI 10.7326/0003-4819-128-4-199802150-00057; LIKOFF MJ, 1987, AM J CARDIOL, V59, P634; Lok CE, 1998, CHEST, V114, P1283, DOI 10.1378/chest.114.5.1283; Lucas C, 2000, AM HEART J, V140, P840, DOI 10.1067/mhj.2000.110933; Mangione S, 1998, JAMA-J AM MED ASSOC, V279, P1444; McGee SR, 1998, AM HEART J, V136, P10, DOI 10.1016/S0002-8703(98)70175-9; MORLEY D, 1994, AM J CARDIOL, V73, P379, DOI 10.1016/0002-9149(94)90012-4; PATEL R, 1993, WESTERN J MED, V158, P606; PINAMONTI B, 1993, J AM COLL CARDIOL, V22, P808, DOI 10.1016/0735-1097(93)90195-7; Pozzoli M, 1997, CIRCULATION, V95, P1222; POZZOLI M, 1990, EUR HEART J, V11, P500, DOI 10.1093/oxfordjournals.eurheartj.a059742; RIHAL CS, 1994, CIRCULATION, V90, P2772, DOI 10.1161/01.CIR.90.6.2772; SHAH PM, 1969, AM HEART J, V78, P823, DOI 10.1016/0002-8703(69)90450-5; STCLAIR EW, 1992, ANN INTERN MED, V117, P751, DOI 10.7326/0003-4819-117-9-751; Stein JH, 1997, AM J CARDIOL, V80, P1615, DOI 10.1016/S0002-9149(97)00776-5; STEVENSON LW, 1990, AM J CARDIOL, V66, P1348, DOI 10.1016/0002-9149(90)91166-4; STEVENSON LW, 1989, JAMA-J AM MED ASSOC, V261, P884, DOI 10.1001/jama.261.6.884; *STUD LEFT VENTR D, 1990, AM J CARDIOL, V66, P1026; UNVERFERTH DV, 1984, AM J CARDIOL, V54, P147, DOI 10.1016/0002-9149(84)90320-5; VANDEWERF F, 1984, CIRCULATION, V69, P1070, DOI 10.1161/01.CIR.69.6.1070; Weitz HH, 2000, AM J MED, V108, P669, DOI 10.1016/S0002-9343(00)00385-5; WESTMAN EC, 1995, J GEN INTERN MED, V10, P455, DOI 10.1007/BF02599919; XIE GY, 1994, J AM COLL CARDIOL, V24, P132, DOI 10.1016/0735-1097(94)90553-3; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; YUSUF S, 1990, AM J CARDIOL, V66, P315	54	414	435	0	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2001	345	8					574	581		10.1056/NEJMoa010641	http://dx.doi.org/10.1056/NEJMoa010641			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464ZH	11529211				2022-12-01	WOS:000170562900004
J	Snell, B				Snell, B			Inappropriate drug donations: the need for reforms	LANCET			English	Editorial Material									Macfarlane Burnet Ctr Med Res, Int Hlth Unit, Fairfield, Vic 3078, Australia		Snell, B (corresponding author), Macfarlane Burnet Ctr Med Res, Int Hlth Unit, POB 254, Fairfield, Vic 3078, Australia.							Forte GB, 1998, NEW ENGL J MED, V338, P1473; WHO, 1999, GUID SAF DISP UNW PH; World Health Organization, 1999, GUID DRUG DON	3	7	8	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 18	2001	358	9281					578	580		10.1016/S0140-6736(01)05712-9	http://dx.doi.org/10.1016/S0140-6736(01)05712-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464NB	11520548				2022-12-01	WOS:000170537700036
J	Cifuentes, L; Borja-Aburto, VH; Gouveia, N; Thurston, G; Davis, DL				Cifuentes, L; Borja-Aburto, VH; Gouveia, N; Thurston, G; Davis, DL			Climate change: Hidden health benefits of greenhouse gas mitigation	SCIENCE			English	Editorial Material							AIR-POLLUTION; INFANT-MORTALITY		Carnegie Mellon Univ, H John Heinz III Sch Publ Policy & Management, Pittsburgh, PA 15213 USA; NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY 10987 USA; Univ Sao Paulo, Fac Med, Dept Prevent Med, Sao Paulo, Brazil; Direcc Gen Salud Ambiental, Mexico City, DF, Mexico; Pontificia Univ Catolica Chile, Santiago, Chile	Carnegie Mellon University; New York University; Universidade de Sao Paulo; Pontificia Universidad Catolica de Chile	Davis, DL (corresponding author), Carnegie Mellon Univ, H John Heinz III Sch Publ Policy & Management, Pittsburgh, PA 15213 USA.	ddavis@andrew.cmu.edu	Cifuentes, Luis Abdon/C-7081-2009; Gouveia, Nelson C/C-4580-2013	Cifuentes, Luis Abdon/0000-0001-7416-5607; Gouveia, Nelson C/0000-0003-0625-0265	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES00260] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		*ABT ASS INC, 2000, PART REL HLTH BEN RE; Bernard SM, 2001, ENVIRON HEALTH PERSP, V109, P199, DOI 10.2307/3435010; Bobak M, 1999, EPIDEMIOLOGY, V10, P666, DOI 10.1097/00001648-199911000-00004; Cifuentes L, 2001, ENVIRON HEALTH PERSP, V109, P419, DOI 10.2307/3434790; Davis DL, 1997, LANCET, V350, P1341, DOI 10.1016/S0140-6736(97)10209-4; *EPA NCEA, 1996, EPA600P93004AC NCEA; Farrow RS, 2001, IMPROVING REGULATION: CASES IN ENVIRONMENT HEALTH AND SAFETY, P429; Friedman MS, 2001, JAMA-J AM MED ASSOC, V285, P897, DOI 10.1001/jama.285.7.897; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 SCI; Krewski D, 2000, REANALYSIS HARVARD 1; Kunzli N, 2000, LANCET, V356, P795, DOI 10.1016/S0140-6736(00)02653-2; LEVY J, 2001, RISK PERSPECT, V9, P2; Loomis D, 1999, EPIDEMIOLOGY, V10, P118, DOI 10.1097/00001648-199903000-00006; Maisonet M, 2001, ENVIRON HEALTH PERSP, V109, P351, DOI 10.2307/3434782; Murray CJL., 1996, GLOBAL BURDEN DIS CO; National Research Council, 2001, CLIM CHANG SCI AN SO; *ONT MED ASS, 2000, ILLN COSTS AIR POLL; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; U.S. Environmental Protection Agency (EPA), 1996, EPA600P95001CF NCEA; [WHO] World Health Organization, 1997, HLTH ENV SUST DEV 5	20	109	111	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2001	293	5533					1257	1259		10.1126/science.1063357	http://dx.doi.org/10.1126/science.1063357			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509711				2022-12-01	WOS:000170492600018
J	Fuchs, M; Gerber, J; Drapkin, R; Sif, S; Ikura, T; Ogryzko, V; Lane, WS; Nakatani, Y; Livingston, DM				Fuchs, M; Gerber, J; Drapkin, R; Sif, S; Ikura, T; Ogryzko, V; Lane, WS; Nakatani, Y; Livingston, DM			The p400 complex is an essential E1A transformation target	CELL			English	Article							CHROMATIN REMODELING COMPLEX; HISTONE ACETYLASE COMPLEX; ESSENTIAL COFACTOR; C-MYC; ACETYLTRANSFERASE COMPLEX; SWI/SNF COMPLEX; PROTEIN; TRANSCRIPTION; BINDING; ONCOPROTEINS	Here, we report the identification of a new E1A binding protein complex that is essential for E1A-mediated transformation. Its core component is a SWI2/SNF2-related, 400 kDa protein (p400). Other components include the myc- and p/CAF-associated cofactor, TRRAP/PAF400, the DNA helicases TAP54 alpha/beta, actin-like proteins, and the human homolog of the Drosophila Enhancer of Polycomb protein. An E1A mutant, defective in p400 binding, is also defective in transformation. Certain p400 fragments partially rescued this phenotype, underscoring the role of E1A-p400 complex formation in the E1A transforming process. Furthermore, E1A and c-myc each alter the subunit composition of p400 complexes, implying that physiological p400 complex formation contributes to transformation suppression.	Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Ohio State Univ, Sch Med, Columbus, OH 43210 USA; Harvard Univ, Microchem & Proteom Anal Facil, Cambridge, MA 02138 USA; Inst Andre Lwoff, Villejuif, France	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University System of Ohio; Ohio State University; Harvard University	Livingston, DM (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.		Sif, Said/AAE-5554-2019; Drapkin, Ronny/E-9944-2016; Ogryzko, Vasily/M-6665-2015	Drapkin, Ronny/0000-0002-6912-6977; Ogryzko, Vasily/0000-0002-8548-1389; Sif, Said/0000-0001-6268-1145	NHLBI NIH HHS [T32-HL07627-16] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; BARBEAU D, 1994, ONCOGENE, V9, P359; BAYLEY ST, 1994, INT J ONCOL, V5, P425; Cairns BR, 1998, MOL CELL, V2, P639, DOI 10.1016/S1097-2765(00)80162-8; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Drapkin R, 1996, P NATL ACAD SCI USA, V93, P6488, DOI 10.1073/pnas.93.13.6488; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Galarneau L, 2000, MOL CELL, V5, P927, DOI 10.1016/S1097-2765(00)80258-0; Goodman RH, 2000, GENE DEV, V14, P1553; Grand F, 1999, CANCER RES, V59, P3870; HOWE JA, 1992, VIROLOGY, V186, P15, DOI 10.1016/0042-6822(92)90057-V; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; JELSMA TN, 1989, VIROLOGY, V171, P120, DOI 10.1016/0042-6822(89)90518-7; Johnston H, 1999, J BIOL CHEM, V274, P16370, DOI 10.1074/jbc.274.23.16370; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; LAND H, 1995, METHOD ENZYMOL, V254, P37; Margolis RL, 1997, HUM GENET, V100, P114, DOI 10.1007/s004390050476; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; NEVINS JR, 1992, SCIENCE, V258, P424; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Peterson CL, 1998, J BIOL CHEM, V273, P23641, DOI 10.1074/jbc.273.37.23641; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Saleh A, 1998, J BIOL CHEM, V273, P26559, DOI 10.1074/jbc.273.41.26559; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; SHIMONO Y, 1939, J BIOL CHEM, P275; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Sinclair DAR, 1998, GENETICS, V148, P211; Vassilev A, 1998, MOL CELL, V2, P869, DOI 10.1016/S1097-2765(00)80301-9; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; WHYTE P, 1988, J VIROL, V62, P257, DOI 10.1128/JVI.62.1.257-265.1988; Wood MA, 2000, MOL CELL, V5, P321, DOI 10.1016/S1097-2765(00)80427-X; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	36	243	249	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 10	2001	106	3					297	307		10.1016/S0092-8674(01)00450-0	http://dx.doi.org/10.1016/S0092-8674(01)00450-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509179	Bronze			2022-12-01	WOS:000170433300008
J	Foster, JE; Holmes, SF; Erie, DA				Foster, JE; Holmes, SF; Erie, DA			Allosteric binding of nucleoside triphosphates to RNA polymerase regulates transcription elongation	CELL			English	Article							RIBONUCLEIC-ACID POLYMERASE; TERMINATION; ENZYME; DNA; MECHANISM; SITES; CONFORMATIONS; FIDELITY; MODEL	The regulation of transcription elongation and termination appears to be governed by the ability of RNA polymerase elongation complexes to adopt multiple conformational states; however, the factors controlling the distribution between these states remain elusive. We used transient-state kinetics to investigate the incorporation of single nucleotides. We demonstrate that E. coli RNA polymerase contains an allosteric binding site in addition to the catalytic site. Binding of the templated nucleoside triphosphate (NTP), but not nontemplated NTPs, to this site increases the rate of nucleotide incorporation. The data suggest that RNA polymerase can exist in a state that catalyzes synthesis slowly (unactivated) and one that catalyzes synthesis rapidly (activated), with the transition from the slow to the fast state being induced by binding of the templated NTP to the allosteric site.	Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Erie, DA (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.				NIGMS NIH HHS [GM-54316] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON KS, 1988, BIOCHEMISTRY-US, V27, P7395, DOI 10.1021/bi00419a034; ARMSTRONG VW, 1979, BIOCHEMISTRY-US, V18, P4120, DOI 10.1021/bi00586a010; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; Buc H, 2000, SCIENCE, V287, P2437, DOI 10.1126/science.287.5462.2437; BURGESS RR, 1975, BIOCHEMISTRY-US, V14, P4634, DOI 10.1021/bi00692a011; Conaway JW, 1999, ANNU REV BIOCHEM, V68, P301, DOI 10.1146/annurev.biochem.68.1.301; Coulombre B, 1999, MICROBIOL MOL BIOL R, V63, P457, DOI 10.1128/MMBR.63.2.457-478.1999; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; DEMERCOYROL L, 1990, BIOCHEM J, V269, P651, DOI 10.1042/bj2690651; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; ERIE DA, 1992, ANNU REV BIOPH BIOM, V21, P379, DOI 10.1146/annurev.bb.21.060192.002115; Gelles J, 1998, CELL, V93, P13, DOI 10.1016/S0092-8674(00)81140-X; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Guthold M, 2001, CHEMBIOCHEM, V2, P167; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Landick R, 1999, SCIENCE, V284, P598, DOI 10.1126/science.284.5414.598; LEVIN JR, 1987, J MOL BIOL, V196, P61, DOI 10.1016/0022-2836(87)90511-0; MATSUZAKI H, 1994, J MOL BIOL, V235, P1173, DOI 10.1006/jmbi.1994.1072; Mooney RA, 1999, CELL, V98, P687, DOI 10.1016/S0092-8674(00)81483-X; MOORE DS, 1995, BASIC PRACTICE STAT, P630; NEFF NF, 1980, BIOCHEMISTRY-US, V19, P3005, DOI 10.1021/bi00554a027; NIERMAN WC, 1980, J BIOL CHEM, V255, P4495; POLYAKOV A, 1995, CELL, V83, P365, DOI 10.1016/0092-8674(95)90114-0; SCHULZ AR, 1994, ENZYME KINETICS DIST, P133; Segel IH., 1975, ENZYME KINETICS, P227; SHOEMAKER DP, 1981, EXPT PHYSICAL CHEM, P727; TELESNITSKY APW, 1989, J MOL BIOL, V205, P315, DOI 10.1016/0022-2836(89)90343-4; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Uptain SM, 1997, P NATL ACAD SCI USA, V94, P13548, DOI 10.1073/pnas.94.25.13548; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; von Hippel PH, 1998, SCIENCE, V281, P660, DOI 10.1126/science.281.5377.660; YANG XJ, 1989, P NATL ACAD SCI USA, V86, P5301, DOI 10.1073/pnas.86.14.5301; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; Yin H, 1999, P NATL ACAD SCI USA, V96, P13124, DOI 10.1073/pnas.96.23.13124; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; ZIMMERLE CT, 1989, BIOCHEM J, V258, P381, DOI 10.1042/bj2580381	39	93	95	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2001	106	2					243	252		10.1016/S0092-8674(01)00420-2	http://dx.doi.org/10.1016/S0092-8674(01)00420-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511351	Bronze, Green Published			2022-12-01	WOS:000170193100013
J	Smith, HJ; Fischer, H; Wahlen, M; Mastroianni, D; Deck, B				Smith, HJ; Fischer, H; Wahlen, M; Mastroianni, D; Deck, B			Dual modes of the carbon cycle since the Last Glacial Maximum	NATURE			English	Article							ICE-CORE; ATMOSPHERIC CO2; GREENLAND ICE; RECORD	The most conspicuous feature of the record of past climate contained in polar ice is the rapid warming which occurs after long intervals of gradual cooling. During the last four transitions from glacial to interglacial conditions, over which such abrupt warmings occur, ice records indicate that the CO2 concentration of the atmosphere increased by roughly 80 to 100 parts per million by volume (refs 1-4). But the causes of the atmospheric CO2 concentration increases are unclear. Here we present the stable-carbon-isotope composition (delta(13)CO(2)) Of CO2 extracted from air trapped in ice at Taylor Dome, Antarctica, rom the Last Glacial Maximum to the onset of Holocene times. The global carbon cycle is shown to have operated in two distinct primary modes on the timescale of thousands of years, one when climate was changing relatively slowly and another when warming was rapid, each with a characteristic average stable-carbon-isotope composition of the net CO2 exchanged by the atmosphere with the land and oceans. delta(13)CO(2) increased betiveen 16.5 and 9 thousand years ago by slightly more than would be estimated to be caused by the physical effects of a 5 degrees C rise in global average sea surface temperature driving a CO2 efflux from the ocean, but our data do not allow specific causes to be constrained.	Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Smith, HJ (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	hjsmith@aaas.org	Fischer, Hubertus/A-1211-2014	Fischer, Hubertus/0000-0002-2787-4221				ANKLIN M, 1995, TELLUS B, V47, P461, DOI 10.1034/j.1600-0889.47.issue4.6.x; BARNOLA JM, 1995, TELLUS B, V47, P264, DOI 10.1034/j.1600-0889.47.issue1.22.x; BARNOLA JM, 1987, NATURE, V329, P408, DOI 10.1038/329408a0; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; *CLIMAP PROJ MEMB, 1981, MAP CHART SER; CRAIG H, 1957, GEOCHIM COSMOCHIM AC, V12, P133, DOI 10.1016/0016-7037(57)90024-8; CRAIG H, 1988, SCIENCE, V242, P1675, DOI 10.1126/science.242.4886.1675; DELMAS RJ, 1993, TELLUS B, V45, P391, DOI 10.1034/j.1600-0889.1993.t01-3-00006.x; Duplessy JC, 1988, PALEOCEANOGRAPHY, V3, P343, DOI 10.1029/PA003i003p00343; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Fairbanks RG, 1990, PALEOCEANOGRAPHY, V5, P937, DOI 10.1029/PA005i006p00937; Fischer H, 1999, SCIENCE, V283, P1712, DOI 10.1126/science.283.5408.1712; FRIEDLI H, 1986, NATURE, V324, P237, DOI 10.1038/324237a0; GUILDERSON TP, 1994, SCIENCE, V263, P663, DOI 10.1126/science.263.5147.663; Indermuhle A, 1999, NATURE, V398, P121, DOI 10.1038/18158; LEUENBERGER M, 1992, NATURE, V360, P449, DOI 10.1038/360449a0; LEUENBERGER M, 1992, NATURE, V357, P488, DOI 10.1038/357488a0; MARINO BD, 1992, NATURE, V357, P461, DOI 10.1038/357461a0; MOOK WG, 1974, EARTH PLANET SC LETT, V22, P169, DOI 10.1016/0012-821X(74)90078-8; NEFTEL A, 1988, NATURE, V331, P609, DOI 10.1038/331609a0; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; SCHWANDER J, 1989, PHYS CH EAR, V8, P53; Smith HJ, 1997, GEOPHYS RES LETT, V24, P1, DOI 10.1029/96GL03700; SOWERS T, 1989, J GEOPHYS RES, V94, P3137; Steig EJ, 1998, SCIENCE, V282, P92, DOI 10.1126/science.282.5386.92; SUCHER C, 1997, TRAPPED GASES TAYLOR; TAKAHASHI T, 1993, GLOBAL BIOGEOCHEM CY, V7, P843, DOI 10.1029/93GB02263; TANS PP, 1993, GLOBAL BIOGEOCHEM CY, V7, P353, DOI 10.1029/93GB00053; WAHLEN M, 1991, GEOPHYS RES LETT, V18, P1457, DOI 10.1029/91GL01724; Weiss R. F., 1974, MAR CHEM, V2, P203, DOI DOI 10.1016/0304-4203(74)90015-2	30	147	153	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	1999	400	6741					248	250		10.1038/22291	http://dx.doi.org/10.1038/22291			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217MP	11536907	Green Published			2022-12-01	WOS:000081503800039
J	Sagan, C; Chyba, C				Sagan, C; Chyba, C			The early faint sun paradox: Organic shielding of ultraviolet-labile greenhouse gases	SCIENCE			English	Review							EARTHS EARLY ATMOSPHERE; CHARGED-PARTICLE IRRADIATION; OUTER SOLAR-SYSTEM; OPTICAL-PROPERTIES; AMORPHOUS-CARBON; EARLY MARS; VERTICAL-DISTRIBUTION; NORTHERN PLAINS; EARLY EVOLUTION; ENERGY YIELDS	Atmospheric mixing ratios of similar to 10(-5 +/- 1) for ammonia on the early Earth would have been sufficient, through the resulting greenhouse warming, to counteract the temperature effects of the faint early sun. One argument against such model atmospheres has been the short time scale for ammonia photodissociation by solar ultraviolet light. Here it is shown that ultraviotet absorption by steady-state amounts of high-attitude organic solids produced from methane photolysis may have shielded ammonia sufficiently that ammonia resupply rates were able to maintain surface temperatures above freezing.	CORNELL UNIV,PLANETARY STUDIES LAB,ITHACA,NY 14853; UNIV ARIZONA,DEPT PLANETARY SCI,TUCSON,AZ 85721	Cornell University; University of Arizona								ABELSON PH, 1966, P NATL ACAD SCI USA, V55, P1365, DOI 10.1073/pnas.55.6.1365; ACKERMAN M, 1971, MESOSPHERIC MODELS R, P00149; ANDERSON DA, 1977, PHILOS MAG, V35, P17, DOI 10.1080/14786437708235968; ANDERSON DL, 1993, SCIENCE, V261, P170, DOI 10.1126/science.261.5118.170; ARAKAWA ET, 1985, PHYS REV B, V31, P8097, DOI 10.1103/PhysRevB.31.8097; ARCULUS RJ, 1985, ANNU REV EARTH PL SC, V13, P75, DOI 10.1146/annurev.ea.13.050185.000451; BADA JL, 1968, SCIENCE, V159, P423, DOI 10.1126/science.159.3813.423; BAKER VR, 1991, NATURE, V352, P589, DOI 10.1038/352589a0; BAULCH DL, 1982, J PHYS CHEM REF DATA, V11, P327, DOI 10.1063/1.555664; BOOTHROYD AI, 1991, ASTROPHYS J, V377, P318, DOI 10.1086/170361; Burns R.C., 2012, MOL BIOL BIOCH BIOPH, DOI DOI 10.1007/978-3-642-80926-2; BUSSOLETTI E, 1987, ASTRON ASTROPHYS SUP, V70, P257; Carr M.H, 1996, WATER MARS; CHLEWICKI G, 1990, ASTROPHYS J, V365, P230, DOI 10.1086/169474; CHYBA C, 1992, NATURE, V355, P125, DOI 10.1038/355125a0; Chyba C.F., 1994, HAZARDS DUE COMETS A, P9; DAWSON GA, 1977, J GEOPHYS RES-OC ATM, V82, P3125, DOI 10.1029/JC082i021p03125; DULEY WW, 1984, ASTROPHYS J, V287, P694, DOI 10.1086/162727; Eiler JM, 1997, NATURE, V386, P665, DOI 10.1038/386665a0; ERIKSSON KA, 1982, TECTONOPHYSICS, V81, P179, DOI 10.1016/0040-1951(82)90128-7; FARQUHAR GD, 1980, PLANT PHYSIOL, V66, P710, DOI 10.1104/pp.66.4.710; GOGARTENBOEKELS M, 1995, ORIGINS LIFE EVOL B, V25, P251, DOI 10.1007/BF01581588; GOLDSPIEL JM, 1991, ICARUS, V89, P392, DOI 10.1016/0019-1035(91)90186-W; GOLDSPIEL JM, 1994, THESIS CORNELL U; GOUGH DO, 1981, SOL PHYS, V74, P21, DOI 10.1007/BF00151270; GRAEDEL TE, 1991, GEOPHYS RES LETT, V18, P1881, DOI 10.1029/91GL02314; GREENBERG JM, 1990, ASTROPHYS J, V361, P260, DOI 10.1086/169191; GUZIK JA, 1987, ASTROPHYS J, V319, P957, DOI 10.1086/165512; HAGEMANN HJ, 1975, J OPT SOC AM, V65, P742, DOI 10.1364/JOSA.65.000742; HENDERSON-SELLERS A, 1980, NATURE, V287, P526, DOI 10.1038/287526a0; HENDERSONSELLER.A, 1973, NATURE, V279, P786; Holland H. D., 1984, CHEM EVOLUTION ATMOS; HOLMAN MJ, 1993, ASTRON J, V105, P1987, DOI 10.1086/116574; HONG KY, 1974, SCIENCE, V184, P984, DOI 10.1126/science.184.4140.984; HUNTEN DM, 1976, ANNU REV EARTH PL SC, V4, P265, DOI 10.1146/annurev.ea.04.050176.001405; JENKINS GS, 1993, J GEOPHYS RES-ATMOS, V98, P8785, DOI 10.1029/93JD00033; JENNISKENS P, 1993, ASTRON ASTROPHYS, V272, P465; KARHU J, 1986, GEOCHIM COSMOCHIM AC, V50, P1745, DOI 10.1016/0016-7037(86)90136-5; Kasting J.F., 1991, SUN TIME, P447; KASTING JF, 1991, ICARUS, V94, P1, DOI 10.1016/0019-1035(91)90137-I; KASTING JF, 1993, J GEOL, V101, P245, DOI 10.1086/648219; KASTING JF, 1986, SCIENCE, V234, P1383, DOI 10.1126/science.11539665; KASTING JF, 1982, J GEOPHYS RES-OCEANS, V87, P3091, DOI 10.1029/JC087iC04p03091; KASTING JF, 1989, ORIGINS LIFE EVOL B, V19, P95, DOI 10.1007/BF01808144; KASTING JF, 1992, PROTEROZOIC BIOSPHER, P165; KASTING JF, 1989, PALAEOGEOGR PALAEOCL, V75, P83; KHARE BN, 1978, SCIENCE, V199, P1199, DOI 10.1126/science.199.4334.1199; KHARE BN, 1981, ICARUS, V48, P290, DOI 10.1016/0019-1035(81)90110-X; KHARE BN, 1984, ICARUS, V60, P127, DOI 10.1016/0019-1035(84)90142-8; KHARE BN, 1993, ICARUS, V103, P290, DOI 10.1006/icar.1993.1071; KHARE BN, 1989, ICARUS, V79, P350, DOI 10.1016/0019-1035(89)90082-1; KNAUTH LP, 1976, GEOCHIM COSMOCHIM AC, V40, P1095, DOI 10.1016/0016-7037(76)90051-X; KUHN WR, 1979, ICARUS, V37, P207, DOI 10.1016/0019-1035(79)90126-X; KUHN WR, 1983, NATURE, V301, P53, DOI 10.1038/301053a0; LANGFORD AO, 1992, SCIENCE, V255, P581, DOI 10.1126/science.255.5044.581; LASAGA AC, 1971, SCIENCE, V174, P53, DOI 10.1126/science.174.4004.53; LEE SC, 1981, 18TH S INT COMB PITT, P1159; LEVINE JS, 1985, ORIGINS LIFE EVOL B, V15, P299, DOI 10.1007/BF01808175; LEVINE JS, 1980, GEOPHYS RES LETT, V7, P317, DOI 10.1029/GL007i005p00317; LOVELOCK J, 1988, AGES GAIA, pCH4; MCDONALD GD, 1994, ICARUS, V107, P137; MCGOVERN WE, 1969, J ATMOS SCI, V26, P623, DOI 10.1175/1520-0469(1969)26<623:TPETMO>2.0.CO;2; Miller S. L., 1981, ORIGINS LIFE, P135; MILLER SL, 1959, SCIENCE, V130, P245, DOI 10.1126/science.130.3370.245; MILLER SL, 1984, ORIGINS LIFE EVOL B, V14, P83, DOI 10.1007/BF00933643; Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0; MUMMA MJ, 1993, PROTOSTARS PLANETS, V3, P1177; NEWMAN MJ, 1977, SCIENCE, V198, P1035, DOI 10.1126/science.198.4321.1035; NORTH GR, 1975, J ATMOS SCI, V32, P2033, DOI 10.1175/1520-0469(1975)032<2033:TOEBCM>2.0.CO;2; Noyes W.A., 1941, AM CHEM SOC, V19, P809, DOI [10.1021/cen-v019n014.p809, DOI 10.1021/CEN-V019N014.P809]; NUTMAN AP, 1984, PRECAMBRIAN RES, V25, P365, DOI 10.1016/0301-9268(84)90010-X; OBERBECK VR, 1989, ORIGINS LIFE EVOL B, V19, P39, DOI 10.1007/BF01808286; OBERBECK VR, 1993, J GEOL, V101, P1, DOI 10.1086/648193; OHMOTO H, 1987, NATURE, V328, P244, DOI 10.1038/328244a0; OWEN T, 1979, NATURE, V277, P640, DOI 10.1038/277640a0; PARKER TJ, 1993, J GEOPHYS RES-PLANET, V98, P11061, DOI 10.1029/93JE00618; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; POLLACK JB, 1979, ICARUS, V37, P479, DOI 10.1016/0019-1035(79)90012-5; POLLACK JB, 1993, NEAR EARTH RESOURCES; QUINN PK, 1988, NATURE, V335, P336, DOI 10.1038/335336a0; RAGES K, 1980, ICARUS, V41, P119, DOI 10.1016/0019-1035(80)90164-5; RAVEN JA, 1992, NEW PHYTOL, V121, P5, DOI 10.1111/j.1469-8137.1992.tb01087.x; ROBINSON E, 1970, Journal of the Air Pollution Control Association, V20, P303; ROSSOW WB, 1982, SCIENCE, V217, P1245, DOI 10.1126/science.217.4566.1245; ROULEAU F, 1991, ASTROPHYS J, V377, P526, DOI 10.1086/170382; RYE R, 1995, NATURE, V378, P603, DOI 10.1038/378603a0; SAGAN C, 1984, ICARUS, V59, P133, DOI 10.1016/0019-1035(84)90018-6; SAGAN C, 1977, NATURE, V269, P224, DOI 10.1038/269224a0; SAGAN C, 1972, SCIENCE, V177, P52, DOI 10.1126/science.177.4043.52; SAGAN C, 1973, J THEOR BIOL, V39, P195, DOI 10.1016/0022-5193(73)90216-6; SAGAN C, 1973, J GEOPHYS RES, V78, P1250; SAGAN C, 1984, SATURN, P788; SCHAEFER MW, 1990, J GEOPHYS RES-SOLID, V95, P14291, DOI 10.1029/JB095iB09p14291; SQUYRES SW, 1994, SCIENCE, V265, P744, DOI 10.1126/science.265.5173.744; STEVENSON DJ, 1981, SCIENCE, V214, P611, DOI 10.1126/science.214.4521.611; STRIBLING R, 1987, ORIGINS LIFE EVOL B, V17, P261, DOI 10.1007/BF02386466; SUMMERS DP, 1993, NATURE, V365, P630, DOI 10.1038/365630a0; THOMAS PJ, 1997, COMETS ORIGIN EVOLUT, P147; THOMPSON WR, 1994, ICARUS, V112, P376, DOI 10.1006/icar.1994.1191; THOMPSON WR, 1987, J GEOPHYS RES, V92, P14933, DOI 10.1029/JA092iA13p14933; TJEPKEMA JD, 1981, NATURE, V294, P445, DOI 10.1038/294445a0; TOUPANCE G, 1977, ORIGINS LIFE EVOL B, V8, P259, DOI 10.1007/BF00930687; Walker J. C. G., 1977, EVOLUTION ATMOSPHERE; WALKER JCG, 1983, NATURE, V302, P518, DOI 10.1038/302518a0; WALKER JCG, 1985, ORIGINS LIFE EVOL B, V16, P117, DOI 10.1007/BF01809466; WANG WC, 1980, J ATMOS SCI, V37, P545, DOI 10.1175/1520-0469(1980)037<0545:EOIAFO>2.0.CO;2; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; WOFSY SC, 1973, J GEOPHYS RES, V78, P2619, DOI 10.1029/JC078i015p02619; YUNG YL, 1978, NATURE, V273, P730, DOI 10.1038/273730a0; ZAHNLE KJ, 1986, J GEOPHYS RES-ATMOS, V91, P2819, DOI 10.1029/JD091iD02p02819; ZAHNLE KJ, 1982, REV GEOPHYS, V20, P280, DOI 10.1029/RG020i002p00280; [No title captured]	112	256	259	4	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 23	1997	276	5316					1217	1221		10.1126/science.276.5316.1217	http://dx.doi.org/10.1126/science.276.5316.1217			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XA497	11536805				2022-12-01	WOS:A1997XA49700032
J	BOWRING, SA; GROTZINGER, JP; ISACHSEN, CE; KNOLL, AH; PELECHATY, SM; KOLOSOV, P				BOWRING, SA; GROTZINGER, JP; ISACHSEN, CE; KNOLL, AH; PELECHATY, SM; KOLOSOV, P			CALIBRATING RATES OF EARLY CAMBRIAN EVOLUTION	SCIENCE			English	Article							PHANEROZOIC TAXONOMIC DIVERSITY; SOUTHERN BRITAIN; IGNEOUS ROCKS; KINETIC-MODEL; TIME-SCALE; AGES; SURVIVORSHIP; ORDOVICIAN; BOUNDARY	An explosive episode of biological diversification occurred near the beginning of the Cambrian period. Evolutionary rates in the Cambrian have been difficult to quantify accurately because of a lack of high-precision ages. Currently, uranium-lead zircon geochronology is the most powerful method for dating rocks of Cambrian age. Uranium-lead zircon data from lower Cambrian rocks located in northeast Siberia indicate that the Cambrian period began at approximately 544 million years ago and that its oldest (Manykaian) stage lasted no less than 10 million years. Other data indicate that the Tommotian and Atdabanian stages together lasted only 5 to 10 million years. The resulting compression of Early Cambrian time accentuates the rapidity of both the faunal diversification and subsequent Cambrian turnover.	YAKUTIAN GEOSCI INST, YAKUTSK, RUSSIA; HARVARD UNIV, BOT MUSEUM, CAMBRIDGE, MA 02138 USA	Diamond & Precious Metal Geology Institute Siberian Branch of Russian Academy of Sciences; Harvard University	BOWRING, SA (corresponding author), MIT, DEPT EARTH ATMOSPHER & PLANETARY SCI, CAMBRIDGE, MA 02139 USA.		Kolosov, Petr/J-9338-2018; Koroleva, Olga/C-1306-2012					Benus AP., 1988, GEOLOGICAL SURVEY B, P8; BOWRING SA, 1992, AM J SCI, V292, P1, DOI 10.2475/ajs.292.1.1; COMPSTON W, 1992, J GEOL SOC LONDON, V149, P171, DOI 10.1144/gsjgs.149.2.0171; Compston W., 1984, Journal of Geophysical Research, V89, P525, DOI 10.1029/JB089iS02p0B525; COOPER JA, 1992, J GEOL SOC LONDON, V149, P185, DOI 10.1144/gsjgs.149.2.0185; COWIE JW, 1989, PRECAMBRIAN CAMBRIAN, P186; Crimes T.P., 1989, Oxford Monographs on Geology and Geophysics, V12, P166; DROSER ML, 1988, GEOLOGY, V16, P233, DOI 10.1130/0091-7613(1988)016<0233:TIDAEO>2.3.CO;2; FOOTE M, 1988, PALEOBIOLOGY, V14, P258, DOI 10.1017/S0094837300011994; Gould S. J, 1990, WONDERFUL LIFE; Harland W. B., 1989, GEOLOGIC TIME SCALE; ISACHSEN CE, UNPUB; KARLOVA GA, 1987, 1ST FINDINGS SKELETA, V292, P204; KHOMENTOVSKY VV, 1986, GEOL MAG, V123, P333, DOI 10.1017/S0016756800033422; KHOMENTOVSKY VV, 1966, GEOL MAG, V154; KNOLL AG, UNPUB; KOMAR VA, 1966, UPPER PRECAMBRIAN ST, V154; KRASILSHCHIKOV AA, 1970, GEOLOGIYA SSSR 1, V18, P91; KROGH TE, 1973, GEOCHIM COSMOCHIM AC, V37, P485, DOI 10.1016/0016-7037(73)90213-5; KROGH TE, 1982, GEOCHIM COSMOCHIM AC, V46, P637, DOI 10.1016/0016-7037(82)90165-X; Landing E., 1992, ORIGIN EARLY EVOLUTI, P283; LUDWIG KR, 1988, 88557 US GEOL SURV O; Meshkova N.P., 1973, PROBLEMY PALEONTOLOG; MISSARZHEVSKY VV, 1989, PROBLEMS UPPER PROTE, P59; MISSARZHEVSKY VV, 1989, OLDEST SKELETAL FOSS; MOCZYDLOWSKA M, 1991, ACRITARCH BIOSTRATIG, V29; ODIN GS, 1983, NATURE, V301, P21, DOI 10.1038/301021a0; OGURTSOVA RN, 1975, INT GEOL REV, V18, P921; PATCHETT PJ, 1980, J GEOL SOC LONDON, V137, P649, DOI 10.1144/gsjgs.137.5.0649; RAUP DM, 1978, PALEOBIOLOGY, V4, P1; Repina L. N., 1974, LOWER CAMBRIAN BIOST; Rozanov A.Yu., 1992, ORIGIN EARLY EVOLUTI, P205; SAMSON SD, 1992, GEOL SOC AM ABSTR, V24, P117; Sepkoski J.J. Jr, 1992, P553; SEPKOSKI JJ, 1978, PALEOBIOLOGY, V4, P223, DOI 10.1017/S0094837300005972; SEPKOSKI JJ, 1979, PALEOBIOLOGY, V5, P222, DOI 10.1017/S0094837300006539; SEPKOSKI JJ, 1988, PALEOBIOLOGY, V14, P221, DOI 10.1017/S0094837300011969; SHPUNT BR, 1982, GEOLOGY USSR W PART; STACEY JS, 1975, EARTH PLANET SC LETT, V26, P207, DOI 10.1016/0012-821X(75)90088-6; TUCKER RD, 1990, EARTH PLANET SC LETT, V100, P51, DOI 10.1016/0012-821X(90)90175-W; TUCKER RD, 1991, J GEOL SOC LONDON, V148, P435, DOI 10.1144/gsjgs.148.3.0435; VALENTINE JW, 1991, EVOLUTIONARY BIOL, V25, P279; WRIGHT AE, 1993, GEOL MAG, V130, P257, DOI 10.1017/S0016756800009900; [No title captured]	44	433	458	3	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	1993	261	5126					1293	1298		10.1126/science.11539488	http://dx.doi.org/10.1126/science.11539488			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LV656	11539488				2022-12-01	WOS:A1993LV65600019
J	THOMPSON, WR; SAGAN, C				THOMPSON, WR; SAGAN, C			COLOR AND CHEMISTRY ON TRITON	SCIENCE			English	Article											THOMPSON, WR (corresponding author), CORNELL UNIV,PLANETARY STUDIES LAB,ITHACA,NY 14853, USA.							Billmeyer F.W., 1981, PRINCIPLES COLOR TEC; BROADFOOT AL, 1989, SCIENCE, V246, P1459, DOI 10.1126/science.246.4936.1459; Brown G. N.  Jr., 1980, Advances in Cryogenic Engineering. Vol.25. Proceedings of the 1979 Cryogenic Engineering Conference, P662; CONRATH B, 1989, SCIENCE, V246, P1454, DOI 10.1126/science.246.4936.1454; CRUIKSHANK DP, 1984, ICARUS, V58, P306, DOI 10.1016/0019-1035(84)90047-2; CRUIKSHANK DP, 1988, ICARUS, V74, P413, DOI 10.1016/0019-1035(88)90112-1; CRUIKSHANK DP, 1984, ICARUS, V58, P293, DOI 10.1016/0019-1035(84)90046-0; DELITSKY ML, 1987, ICARUS, V70, P354, DOI 10.1016/0019-1035(87)90141-2; LARK NL, 1989, ICARUS, V79, P15, DOI 10.1016/0019-1035(89)90104-8; MCEWEN AS, GEOPHYS RES LETT, V17, P1733; MCKAY CP, 1989, GEOPHYS RES LETT, V16, P973, DOI 10.1029/GL016i008p00973; PISCITELLI JR, 1988, ICARUS, V76, P118, DOI 10.1016/0019-1035(88)90144-3; SAGAN C, 1990, NATURE, V346, P546, DOI 10.1038/346546a0; SAGAN C, 1984, ICARUS, V59, P133, DOI 10.1016/0019-1035(84)90018-6; SMITH BA, 1989, SCIENCE, V246, P1422, DOI 10.1126/science.246.4936.1422; SODERBLOM LA, 1990, SCIENCE, V250, P410, DOI 10.1126/science.250.4979.410; SPENCER JR, 1990, GEOPHYS RES LETT, V17, P1769, DOI 10.1029/GL017i010p01769; SPENCER JR, IN PRESS ICARUS; STANSBERRY JA, 1990, GEOPHYS RES LETT, V17, P1773, DOI 10.1029/GL017i010p01773; STROBEL DF, 1990, GEOPHYS RES LETT, V17, P1729, DOI 10.1029/GL017i010p01729; THOMPSON WR, 1989, GEOPHYS RES LETT, V16, P969, DOI 10.1029/GL016i008p00969; THOMPSON WR, 1987, J GEOPHYS RES, V92, P14933, DOI 10.1029/JA092iA13p14933; THOMPSON WR, 1989, GEOPHYS RES LETT, V16, P981, DOI 10.1029/GL016i008p00981; THOMPSON WR, 1990, INT J SUPERCOMPUT AP, V4, P48, DOI 10.1177/109434209000400205; THOMPSON WR, IN PRESS ICARUS; TYLER GL, 1989, SCIENCE, V246, P1466, DOI 10.1126/science.246.4936.1466	26	24	24	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 19	1990	250	4979					415	418		10.1126/science.11538073	http://dx.doi.org/10.1126/science.11538073			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED616	11538073				2022-12-01	WOS:A1990ED61600032
J	CHYBA, CF; THOMAS, PJ; BROOKSHAW, L; SAGAN, C				CHYBA, CF; THOMAS, PJ; BROOKSHAW, L; SAGAN, C			COMETARY DELIVERY OF ORGANIC-MOLECULES TO THE EARLY EARTH	SCIENCE			English	Article									YALE UNIV,APPL PHYS SECT,NEW HAVEN,CT 06520	Yale University	CHYBA, CF (corresponding author), CORNELL UNIV,PLANETARY STUDIES LAB,ITHACA,NY 14853, USA.							Abelson P.H., 1959, RES GEOCHEMISTRY, P79; ALLEN HJ, 1963, NASA TR R185 TECHN R; ALLEN M, 1987, ASTRON ASTROPHYS, V187, P502; ANDERS E, 1977, SCIENCE, V198, P453, DOI 10.1126/science.198.4316.453; ANDERS E, 1989, NATURE, V342, P255, DOI 10.1038/342255a0; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; ARAKAWA ET, 1989, BAAS, V21, P940; ARNOSTI C, 1987, ORG GEOCHEM, V11, P505, DOI 10.1016/0146-6380(87)90006-4; ATKINS PW, 1986, PHYSICAL CHEM; BALDWIN B, 1971, J GEOPHYS RES, V76, P4653, DOI 10.1029/JA076i019p04653; BARAK I, 1975, ORIGINS LIFE EVOL B, V6, P483, DOI 10.1007/BF00928897; BARNUN A, 1970, SCIENCE, V168, P470, DOI 10.1126/science.168.3930.470; BENSON SW, 1970, NSRDSDNBS21 PUBL; BENZ W, 1989, ICARUS, V81, P113, DOI 10.1016/0019-1035(89)90129-2; BENZ W, 1987, ICARUS, V71, P30, DOI 10.1016/0019-1035(87)90160-6; BENZ W, 1988, ICARUS, V74, P516, DOI 10.1016/0019-1035(88)90118-2; BRONSHTEN VA, 1983, PHYSICS METEORIC PHE; BROWN WT, 1981, AIP C, V78, P529; BURNHAM AK, 1987, ENERG FUEL, V1, P452, DOI 10.1021/ef00006a001; CEPLECHA Z, 1977, COMETS ASTEROIDS MET, pCH5; Chamberlin T C, 1908, Science, V28, P897, DOI 10.1126/science.28.730.897; CHANG S, 1978, NASA C PUBLICATION, V2089, P59; Chang S., 1983, EARTHS EARLIEST BIOS, P53; CHYBA C, 1988, NATURE, V332, P592, DOI 10.1038/332592a0; CHYBA C, 1989, NASA CONF P, V3036, P433; CHYBA C, 1987, NATURE, V330, P350, DOI 10.1038/330350a0; CHYBA C, 1987, NATURE, V329, P208, DOI 10.1038/329208a0; CHYBA CF, 1987, NATURE, V330, P632, DOI 10.1038/330632a0; CHYBA CF, 1990, NATURE, V343, P129, DOI 10.1038/343129a0; CLARK BC, 1988, ORIGINS LIFE EVOL B, V18, P209, DOI 10.1007/BF01804671; Cronin J.R., 1988, METEORITES EARLY SOL, P819; CRUIKSHANK DP, 1983, ICARUS, V53, P90, DOI 10.1016/0019-1035(83)90023-4; DELSEMME AH, 1988, PHILOS T R SOC A, V325, P509, DOI 10.1098/rsta.1988.0064; DELSEMME AH, 1989, ADV SPACE RES, V9, P25; DURHAM R, 1989, ICARUS, V77, P59, DOI 10.1016/0019-1035(89)90006-7; EPSTEIN S, 1987, NATURE, V326, P477, DOI 10.1038/326477a0; FEGLEY B, 1986, NATURE, V319, P305, DOI 10.1038/319305a0; FERNANDEZ JA, 1983, ICARUS, V54, P377, DOI 10.1016/0019-1035(83)90235-X; Folinsbee R.E., 1967, GEOCHIM COSMOCHIM AC, V31, P1625; GOBEL JH, 1980, ASTROPHYS J, V235, P104; GRADIE J, 1980, NATURE, V283, P840, DOI 10.1038/283840a0; Greenberg J., 1982, COMETS, P131; GREENBERG JM, 1986, GALAXY SOLAR SYSTEM, P103; Hayes J. M., 1983, EARTHS EARLIEST BIOS, P93; HOYLE F, 1988, NATURE, V331, P123, DOI 10.1038/331123c0; HOYLE F, 1987, NATURE, V328, P117, DOI 10.1038/328117a0; HOYLE F, 1988, NATURE, V331, P666, DOI 10.1038/331666c0; HUGHES DW, 1988, ICARUS, V73, P149, DOI 10.1016/0019-1035(88)90089-9; HUGHES DW, 1987, S DIVERSITY SIMILAAR, P43; JESSBERGER EK, 1988, NATURE, V332, P691, DOI 10.1038/332691a0; KASTING J F, 1989, Origins of Life and Evolution of the Biosphere, V19, P225, DOI 10.1007/BF02388821; KASTING JF, 1988, SCI AM, V258, P90, DOI 10.1038/scientificamerican0288-90; KASTING JF, UNPUB; Kasting JF, 1989, ORIGIN EVOLUTION PLA, P423; KASTING JF, 1989, PALAEOGEOGR PALAEOCL, V75, P83; Khandelwal S., 1981, SHOCK WAVES CHEM, P1; KHARE BN, 1989, ICARUS, V79, P350, DOI 10.1016/0019-1035(89)90082-1; KRUEGER FR, 1987, NATURWISSENSCHAFTEN, V74, P312, DOI 10.1007/BF00367925; KSTING JF, 1986, SCIENCE, V234, P1383; KUHN WR, 1979, ICARUS, V37, P207, DOI 10.1016/0019-1035(79)90126-X; LARSON HP, 1989, ASTROPHYS J, V338, P1106, DOI 10.1086/167260; LEVIN BY, 1986, METEORITICS, V21, P199, DOI 10.1111/j.1945-5100.1986.tb01242.x; LEVINE JS, 1985, ORIGINS LIFE EVOL B, V15, P299, DOI 10.1007/BF01808175; LEWIS JS, 1984, SATUM, P788; LIU VC, 1978, GEOPHYS RES LETT, V5, P309, DOI 10.1029/GL005i004p00309; MCKAY CP, 1989, LUNAR PLANET SCI C, V20, P671; Melosh H.L, 1989, IMPACT CRATERING GEO; MONAGHAN JJ, 1985, COMPUT PHYS REP, V3, P71, DOI 10.1016/0167-7977(85)90010-3; MONAHAN JJ, 1988, COMMUNICATION; MUKHIN LM, 1989, NATURE, V340, P46, DOI 10.1038/340046a0; MUMMA MJ, 1989, ASTROPHYS J, V344, P940, DOI 10.1086/167862; MUMMA MJ, 1989, ICARUS, V79, P362; NOH WF, 1987, J COMPUT PHYS, V72, P78, DOI 10.1016/0021-9991(87)90074-X; OBERBECK VR, 1989, ORIGINS LIFE EVOL B, V19, P39, DOI 10.1007/BF01808286; OKEEFE JD, 1982, SPECIAL PAPER GEOLOG, V190, P103, DOI DOI 10.1130/SPE190-P103; OPIK EJ, 1958, PHYSICS METEOR FLIGH; ORO J, 1961, NATURE, V190, P389, DOI 10.1038/190389a0; PASSEY QR, 1980, ICARUS, V42, P211, DOI 10.1016/0019-1035(80)90072-X; PINTO JP, 1980, SCIENCE, V210, P183, DOI 10.1126/science.210.4466.183; PONGRACIC H, 1988, THESIS MONASH U CLAY; PONNAMPERUMA C, 1981, COMETS ORIGIN LIFE; RATCLIFF MA, 1974, J ORG CHEM, V39, P1481, DOI 10.1021/jo00924a007; REUTER DC, 1989, B AM ASTRON SOC, V21, P937; ROTH P, 1976, BER BUNSEN PHYS CHEM, V80, P171, DOI 10.1002/bbpc.19760800216; SAGAN C, 1979, NATURE, V277, P102, DOI 10.1038/277102a0; SAGDEEV RZ, 1988, NATURE, V331, P240, DOI 10.1038/331240a0; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; SCHLESINGER G, 1983, J MOL EVOL, V19, P383, DOI 10.1007/BF02101643; SCHLESINGER G, 1983, J MOL EVOL, V19, P376, DOI 10.1007/BF02101642; Sekanina Z., 1982, COMETS, P251; Shoemaker E. M., 1979, ASTEROIDS, P253; SHOEMAKER EM, 1983, ANNU REV EARTH PL SC, V11, P461, DOI 10.1146/annurev.ea.11.050183.002333; SHOEMAKER EM, 1984, LUNAR PLANET SCI, V15, P780; SHURSHALOV IV, 1967, IZV AKAD NAUK SSSR M, V2, P184; SHURSHALOV IV, 1967, FLUID DYN, V2, P133; SLEEP NH, 1989, NATURE, V342, P139, DOI 10.1038/342139a0; SMITH GG, 1964, J PHYS CHEM-US, V68, P1231, DOI 10.1021/j100787a506; SNYDER LE, 1983, ASTROPHYS J, V268, P123, DOI 10.1086/160937; STEVENSON DJ, 1983, EARTHS EARLIEST BIOS, P32; STRIBLING R, 1987, ORIGINS LIFE EVOL B, V17, P261, DOI 10.1007/BF02386466; SZEKELY A, 1984, J PHYS CHEM-US, V88, P666, DOI 10.1021/j150648a009; THOMAS P, UNPUB; THOMAS PJ, 1989, LUNAR PLANET SCI C, V20, P117; THOMPSON WR, 1987, J GEOPHYS RES, V92, P14933, DOI 10.1029/JA092iA13p14933; TILLOTSON JH, 1962, GA3216 GEN AT CORP R; TSANG W, 1978, INT J CHEM KINET, V10, P41; TURCOTTE DL, 1986, J GEOPHYS RES-SOLID, V91, P1921, DOI 10.1029/JB091iB02p01921; VALLENTYNE JR, 1964, GEOCHIM COSMOCHIM AC, V28, P157, DOI 10.1016/0016-7037(64)90147-4; Walker J. C. G., 1977, EVOLUTION ATMOSPHERE; WALKER JCG, 1986, ORIGINS LIFE, V16, P117; Warnatz J., 1984, COMBUSTION CHEM; WEISSMAN PR, 1985, NATURE, V314, P517, DOI 10.1038/314517a0; WILKENING LL, 1978, NATURWISSENSCHAFTEN, V65, P73, DOI 10.1007/BF00440544; WOLFE RF, 1986, GALAXY SOLAR SYSTEM, P338; ZAHNLE K, UNPUB; ZAHNLE KJ, 1986, J GEOPHYS RES-ATMOS, V91, P2819, DOI 10.1029/JD091iD02p02819; ZHAO MX, 1989, NATURE, V339, P463, DOI 10.1038/339463a0; 1983, LALP834 LOS AL NAT L	118	436	438	6	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 27	1990	249	4967					366	373		10.1126/science.11538074	http://dx.doi.org/10.1126/science.11538074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ702	11538074				2022-12-01	WOS:A1990DQ70200030
J	REPETA, DJ; SIMPSON, DJ; JORGENSEN, BB; JANNASCH, HW				REPETA, DJ; SIMPSON, DJ; JORGENSEN, BB; JANNASCH, HW			EVIDENCE FOR ANOXYGENIC PHOTOSYNTHESIS FROM THE DISTRIBUTION OF BACTERIOCHLOROPHYLLS IN THE BLACK-SEA	NATURE			English	Article									WOODS HOLE OCEANOG INST,DEPT BIOL,WOODS HOLE,MA 02543; AARHUS UNIV,DEPT ECOL & GENET,DK-8000 AARHUS C,DENMARK	Woods Hole Oceanographic Institution; Aarhus University	REPETA, DJ (corresponding author), WOODS HOLE OCEANOG INST,DEPT CHEM,WOODS HOLE,MA 02543, USA.		Jorgensen, Bo B/C-2214-2013	Jorgensen, Bo B/0000-0001-9398-8027				BERGSTEIN T, 1979, CAN J MICROBIOL, V25, P999, DOI 10.1139/m79-154; BROCKMANN H, 1976, PHILOS T ROY SOC B, V273, P277, DOI 10.1098/rstb.1976.0013; CAPLE MB, 1978, J BIOL CHEM, V253, P6730; DEUSER WG, 1971, DEEP-SEA RES, V18, P995, DOI 10.1016/0011-7471(71)90004-0; DICKMAN M, 1978, NATURE, V275, P191, DOI 10.1038/275191a0; HASHWA FA, 1978, HELGOLAND WISS MEER, V31, P249, DOI 10.1007/BF02297000; JANNASCH HW, 1974, AAPG BULL, V20, P419; KARL DM, 1988, EOS, V69, P1241; KRISS AE, 1953, DOKL AKAD NAUK SSSR+, V93, P1107; LIAAENJENSEN S, 1985, PURE APPL CHEM, V57, P649, DOI 10.1351/pac198557050649; LIAAENJENSEN S, 1978, MARINE NATURAL PRODU, V2, P2; LIAAENJENSEN S, 1965, ACTA CHEM SCAND, V19, P1025; MURRAY JW, 1989, NATURE, V338, P411, DOI 10.1038/338411a0; Pfenning N., 1978, PHOTOSYNTHETIC BACTE, P3; SIMPSON DJ, 1988, J AM CHEM SOC, V110, P1753, DOI 10.1021/ja00214a016; SMITH KM, 1983, J CHROMATOGR, V281, P209, DOI 10.1016/S0021-9673(01)87879-1; Sorokin Y. I., 1964, J CONS PERM INT EXPL, V29, P41, DOI [10.1093/icesjms/29.1.41, DOI 10.1093/ICESJMS/29.1.41]; TRUPER HG, 1968, LIMNOL OCEANOGR, V13, P225, DOI 10.4319/lo.1968.13.2.0225; WIRSEN CO, 1988, EOS, V69, P1241; WRIGHT SW, 1987, MAR ECOL PROG SER, V38, P259, DOI 10.3354/meps038259	20	179	185	2	19	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 2	1989	342	6245					69	72		10.1038/342069a0	http://dx.doi.org/10.1038/342069a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX868	11536615				2022-12-01	WOS:A1989AX86800056
J	MCCLURE, BA; GUILFOYLE, T				MCCLURE, BA; GUILFOYLE, T			RAPID REDISTRIBUTION OF AUXIN-REGULATED RNAS DURING GRAVITROPISM	SCIENCE			English	Article									UNIV MISSOURI,DEPT BIOCHEM,COLUMBIA,MO 65211	University of Missouri System; University of Missouri Columbia					NIDCD NIH HHS [DCB 8517676] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BRIGGS WR, 1963, ANN REV PLANT PHYSL, V38, P311; CASSAB GI, 1987, J CELL BIOL, V105, P2581, DOI 10.1083/jcb.105.6.2581; HAGEN G, 1984, PLANTA, V162, P147, DOI 10.1007/BF00410211; MCCLURE BA, 1987, PLANT MOL BIOL, V9, P611, DOI 10.1007/BF00020537; MCCLURE BA, UNPUB; THEOLOGIS A, 1985, J MOL BIOL, V183, P53, DOI 10.1016/0022-2836(85)90280-3; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TREWAVAS A, 1981, PLANT CELL ENVIRON, V4, P203, DOI 10.1111/j.1365-3040.1981.tb01048.x; VANDERHOEF LN, 1975, P NATL ACAD SCI USA, V72, P1822, DOI 10.1073/pnas.72.5.1822; WALKER JC, 1982, P NATL ACAD SCI-BIOL, V79, P7185, DOI 10.1073/pnas.79.23.7185	10	150	155	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 6	1989	243	4887					91	93		10.1126/science.11540631	http://dx.doi.org/10.1126/science.11540631			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	R6469	11540631				2022-12-01	WOS:A1989R646900039
J	MCKAY, CP; SCATTERGOOD, TW; POLLACK, JB; BORUCKI, WJ; VANGHYSEGHEM, HT				MCKAY, CP; SCATTERGOOD, TW; POLLACK, JB; BORUCKI, WJ; VANGHYSEGHEM, HT			HIGH-TEMPERATURE SHOCK FORMATION OF N-2 AND ORGANICS ON PRIMORDIAL TITAN	NATURE			English	Article									SUNY STONY BROOK,STONY BROOK,NY 11794	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	MCKAY, CP (corresponding author), NASA,AMES RES CTR,SOLAR SYST EXPLORAT BRANCH,MOFFETT FIELD,CA 94035, USA.							ATREYA SK, 1978, SCIENCE, V201, P611, DOI 10.1126/science.201.4356.611; BORUCKI WJ, 1987, APPL OPTICS, V26, P4319, DOI 10.1364/AO.26.004319; BORUCKI WJ, 1984, REV GEOPHYS, V22, P363, DOI 10.1029/RG022i004p00363; BORUCKI WJ, 1985, ICARUS, V64, P221, DOI 10.1016/0019-1035(85)90087-9; BORUCKI WJ, 1987, NATURE, V328, P509, DOI 10.1038/328509a0; BORUCKI WJ, 1984, ICARUS, V60, P260, DOI 10.1016/0019-1035(84)90188-X; BORUCKI WJ, IN PRESS ICARUS; CHAMEIDES WL, 1981, ORIGINS LIFE EVOL B, V11, P291, DOI 10.1007/BF00931483; CHAMEIDES WL, 1979, NATURE, V277, P123, DOI 10.1038/277123a0; FEGLEY B, 1986, NATURE, V319, P305, DOI 10.1038/319305a0; JONES TD, 1987, ICARUS, V72, P381, DOI 10.1016/0019-1035(87)90181-3; LEWIS JS, 1982, SP190 GEOL SOC AM, P215; LUNINE JI, IN PRESS ORIGIN EVOL; PARK C, 1978, J GEOPHYS RES-OCEANS, V83, P4029, DOI 10.1029/JC083iC08p04029; POLLACK JB, 1986, ICARUS, V67, P409, DOI 10.1016/0019-1035(86)90123-5; POLLACK JB, IN PRESS ORIGIN EVOL; PRINN RG, 1981, ASTROPHYS J, V249, P308, DOI 10.1086/159289; PRINN RG, 1987, EARTH PLANET SC LETT, V83, P1, DOI 10.1016/0012-821X(87)90046-X; Stevenson DJ, 1986, SATELLITES, P687	19	67	67	1	7	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 7	1988	332	6164					520	522		10.1038/332520a0	http://dx.doi.org/10.1038/332520a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	M8230	11536599				2022-12-01	WOS:A1988M823000051
J	LaRiviere, FJ; Wolfson, AD; Uhlenbeck, OC				LaRiviere, FJ; Wolfson, AD; Uhlenbeck, OC			Uniform binding of aminoacyl-tRNAs to elongation factor Tu by thermodynamic compensation	SCIENCE			English	Article							TRANSFER RNA-SYNTHETASES; INDIRECT READOUT; TERNARY COMPLEX; EF-TU; GTP; ASSOCIATION; DISCRIMINATION; AFFINITIES; PROTEINS; ACIDS	Elongation factor Tu (EF-Tu) binds all elongator aminoacyl-transfer RNAs (aa-tRNAs) for delivery to the ribosome during protein synthesis. Here, we show that EF-Tu binds misacylated tRNAs over a much wider range of affinities than it binds the corresponding correctly acylated tRNAs, suggesting that the protein exhibits considerable specificity for both the amino acid side chain and the tRNA body. The thermodynamic contributions of the amino acid and the tRNA body to the overall binding affinity are independent of each other and compensate for one another when the tRNAs are correctly acylated. Because certain misacylated tRNAs bind EF-Tu significantly more strongly or weakly than cognate aa-tRNAs, EF-Tu may contribute to translational accuracy.	Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Uhlenbeck, OC (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.				NIGMS NIH HHS [GM-37552] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037552] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bareket-Samish A, 1998, J MOL BIOL, V277, P1071, DOI 10.1006/jmbi.1998.1638; Becker HD, 1998, P NATL ACAD SCI USA, V95, P12832, DOI 10.1073/pnas.95.22.12832; BRUCE AG, 1982, BIOCHEMISTRY-US, V21, P855, DOI 10.1021/bi00534a007; CHAPEVILLE F, 1962, P NATL ACAD SCI USA, V48, P1086, DOI 10.1073/pnas.48.6.1086; CRICK F H, 1958, Symp Soc Exp Biol, V12, P138; Doring V, 2001, SCIENCE, V292, P501, DOI 10.1126/science.1057718; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P2627, DOI 10.1021/bi00579a030; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JAKUBOWSKI H, 1988, J THEOR BIOL, V133, P363, DOI 10.1016/S0022-5193(88)80327-8; JANIAK F, 1990, BIOCHEMISTRY-US, V29, P4268, DOI 10.1021/bi00470a002; KNOWLTON RG, 1980, J MOL BIOL, V139, P721, DOI 10.1016/0022-2836(80)90057-1; Leonard DA, 1998, NAT STRUCT BIOL, V5, P877, DOI 10.1038/2316; Liu JCH, 1998, RNA, V4, P639, DOI 10.1017/S1355838298980013; LOUIE A, 1985, BIOCHEMISTRY-US, V24, P6433, DOI 10.1021/bi00344a019; LOUIE A, 1984, J BIOL CHEM, V259, P5010; Martin AM, 1999, NAT STRUCT BIOL, V6, P269; MCCLAIN WH, 1988, SCIENCE, V242, P1681, DOI 10.1126/science.2462282; NAZARENKO IA, 1994, EMBO J, V13, P2464, DOI 10.1002/j.1460-2075.1994.tb06531.x; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nissen P, 1999, STRUCTURE, V7, P143, DOI 10.1016/S0969-2126(99)80021-5; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; NORMANLY J, 1990, J MOL BIOL, V213, P719, DOI 10.1016/S0022-2836(05)80258-X; NORMANLY J, 1986, NATURE, V321, P2163; OTT G, 1990, BIOCHIM BIOPHYS ACTA, V1050, P222, DOI 10.1016/0167-4781(90)90170-7; Pleiss JA, 2001, J MOL BIOL, V308, P895, DOI 10.1006/jmbi.2001.4612; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; SHERMAN JM, 1992, NUCLEIC ACIDS RES, V20, P2847, DOI 10.1093/nar/20.11.2847; STANZEL M, 1994, EUR J BIOCHEM, V219, P435, DOI 10.1111/j.1432-1033.1994.tb19956.x; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; YARUS M, 1972, NATURE-NEW BIOL, V239, P106, DOI 10.1038/newbio239106a0	31	260	267	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2001	294	5540					165	168		10.1126/science.1064242	http://dx.doi.org/10.1126/science.1064242			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11588263				2022-12-01	WOS:000171448800053
J	Marcil, I; Stern, RS				Marcil, I; Stern, RS			Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study	LANCET			English	Article							SEVERE PSORIASIS; TRANSPLANT RECIPIENTS; RISK; CYCLOSPORINE; CARCINOMA; PHOTOCHEMOTHERAPY; THERAPY	Background Immunosuppressive treatments have been associated with an increased risk of skin cancer, especially in patients who have had organ transplants. We aimed to assess the risk of skin cancer in patients taking the ciclosporin who had been exposed to psoralen and ultraviolet-A light (PUVA) and other treatments for severe psoriasis. Methods We did a nested cohort crossover study of 28 participants in the PUVA follow-up study who were on ciclosporin to compare the frequency of squamous-cell carcinoma before and after first use of ciclosporin. We also analysed the entire PUVA study cohort (1380) to assess the relation between use of this drug and frequency of squamous-cell carcinoma. Findings In the 5 years before first use, six of 28 (21%) ciclosporin users developed a total of 20 squamous cell cancers. After ciclosporin use (average follow-up 6 years), 13 (46%) developed a total of 169 squamous-cell carcinomas. In the nested cohort, after adjustment for amount of exposure to PUVA and methotrexate, incidence of tumours was seven times higher after first ciclosporin use than in the previous 5 years (incidence rate ratio 6.9 [95% CI 4.3-11]). Multivariate, analysis of the entire cohort showed that risk of squamous-cell carcinoma after any use of ciclosporin is close to that recorded for at least 200 PUVA treatments (3.1 [2.6-3.7] and 2.8 [2.6-3.2], respectively). Interpretation The risk of squamous cell cancer of the skin is increased by ciclosporin in patients with psoriasis who have been exposed to PUVA. Such risks should be balanced against the effectiveness of the drug and possible newer immunosuppressive agents.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Dermatol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Stern, RS (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Dermatol, 330 Brookline Ave, Boston, MA 02215 USA.	rstern@caregroup.harvard.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [N01AR042214, N01AR002246] Funding Source: NIH RePORTER; NIAMS NIH HHS [N01-AR-4-2214, N01-AR-0-2246] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abrams JR, 2000, J EXP MED, V192, P681, DOI 10.1084/jem.192.5.681; Bavinck JNB, 1996, TRANSPLANTATION, V61, P715, DOI 10.1097/00007890-199603150-00008; BIRKELAND SA, 1995, INT J CANCER, V60, P183, DOI 10.1002/ijc.2910600209; Cribier B, 1999, DERMATOLOGY, V199, P208, DOI 10.1159/000018276; Grundmann-Kollmann M, 2000, J AM ACAD DERMATOL, V42, P835, DOI 10.1067/mjd.2000.104890; HENSELER T, 1987, J AM ACAD DERMATOL, V16, P108, DOI 10.1016/S0190-9622(87)70010-3; Ho VC, 1999, BRIT J DERMATOL, V141, P283; Hojo M, 1999, NATURE, V397, P530, DOI 10.1038/17401; Jensen P, 1999, J AM ACAD DERMATOL, V40, P177, DOI 10.1016/S0190-9622(99)70185-4; Koo J, 1998, BRIT J DERMATOL, V139, P88; LINDELOF B, 1991, LANCET, V338, P91, DOI 10.1016/0140-6736(91)90083-2; Lindelof B, 2000, BRIT J DERMATOL, V143, P513, DOI 10.1046/j.1365-2133.2000.03703.x; LONDON NJ, 1995, LANCET, V346, P403, DOI 10.1016/S0140-6736(95)92780-8; Nabel GJ, 1999, NATURE, V397, P471, DOI 10.1038/17207; Owen CM, 2000, CLIN EXP DERMATOL, V25, P195, DOI 10.1046/j.1365-2230.2000.00612.x; Ramsay HM, 2000, AM J KIDNEY DIS, V36, P167, DOI 10.1053/ajkd.2000.8290; SCOTTO J, 1983, PUBLICATION NIH; STERN RS, 1984, NEW ENGL J MED, V310, P1156, DOI 10.1056/NEJM198405033101805; Stern RS, 1998, JNCI-J NATL CANCER I, V90, P1278, DOI 10.1093/jnci/90.17.1278; STERN RS, 1994, CANCER-AM CANCER SOC, V73, P2759, DOI 10.1002/1097-0142(19940601)73:11<2759::AID-CNCR2820731118>3.0.CO;2-C; STERN RS, 1979, NEW ENGL J MED, V300, P809, DOI 10.1056/NEJM197904123001501; VandeKerkhof PCM, 1997, BRIT J DERMATOL, V136, P275, DOI 10.1046/j.1365-2133.1997.d01-1187.x	22	163	168	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	2001	358	9287					1042	1045		10.1016/S0140-6736(01)06179-7	http://dx.doi.org/10.1016/S0140-6736(01)06179-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479EY	11589933				2022-12-01	WOS:000171393100008
J	Klein, G; Klein, E				Klein, G; Klein, E			Bridge or ravine?	NATURE			English	Article									Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden	Karolinska Institutet	Klein, G (corresponding author), Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden.								0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2001	413	6854					365	365						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475UY	11574864				2022-12-01	WOS:000171188700032
J	Zhu, RX; Hoffman, KA; Potts, R; Deng, CL; Pan, YX; Guo, B; Shi, CD; Guo, ZT; Yuan, BY; Hou, YM; Huang, WW				Zhu, RX; Hoffman, KA; Potts, R; Deng, CL; Pan, YX; Guo, B; Shi, CD; Guo, ZT; Yuan, BY; Hou, YM; Huang, WW			Earliest presence of humans in northeast Asia	NATURE			English	Article							MAGNETIC-SUSCEPTIBILITY; BASIN; CHINA; HOMO	The timing of the earliest habitation and oldest stone technologies in different regions of the world remains a contentious topic in the study of human evolution(1-4). Here we contribute to this debate with detailed magnetostratigraphic results on two exposed parallel sections of lacustrine sediments at Xiaochangliang in the Nihewan Basin, north China; these results place stringent controls on the age of Palaeolithic stone artifacts that were originally reported over two decades ago(5). Our palaeomagnetic findings indicate that the artifact layer resides in a reverse polarity magnetozone bounded by the Olduvai and Jaramillo subchrons. Coupled with an estimated rate of sedimentation, these findings constrain the layer's age to roughly 1.36 million years ago. This result represents the age of the oldest known stone assemblage comprising recognizable types of Palaeolithic tool in east Asia, and the earliest definite occupation in this region as far north as 40 degrees N.	Chinese Acad Sci, Inst Geol & Geophys, Beijing 100101, Peoples R China; Calif Polytech State Univ San Luis Obispo, Dept Phys, San Luis Obispo, CA 93410 USA; Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20560 USA; Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China	Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; California State University System; California Polytechnic State University San Luis Obispo; Smithsonian Institution; Smithsonian National Museum of Natural History; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Zhu, RX (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, Beijing 100101, Peoples R China.		Pan, Yongxin/B-4302-2008; Huang, WW/GXH-0977-2022; Zhu, Rixiang/F-2126-2018; huang, wen/GXW-0661-2022; Deng, Chenglong/B-8871-2009; Deng, Chenglong/B-8881-2009; Guo, Zhengtang/B-6854-2008	Pan, Yongxin/0000-0002-4227-3061; Zhu, Rixiang/0000-0002-4985-925X; Deng, Chenglong/0000-0003-1848-3170; Guo, Zhengtang/0000-0003-2259-9715				Ambrose SH, 2001, SCIENCE, V291, P1748, DOI 10.1126/science.1059487; AN ZH, 1989, QUATERNARY RES, V32, P213, DOI 10.1016/0033-5894(89)90077-X; Barbour G.B., 1925, B GEOLOGICAL SOC CHI, V4, P53; BERGGREN WA, 1995, SEPM SPECIAL PUBLICA, V54; CHEN C, IN PRESS ACTA ANTHR; Chen IM, 1999, INT J ROBOT RES, V18, P225; DAY R, 1977, PHYS EARTH PLANET IN, V13, P260, DOI 10.1016/0031-9201(77)90108-X; Gabunia L, 2000, SCIENCE, V288, P1019, DOI 10.1126/science.288.5468.1019; Hou YM, 2000, SCIENCE, V287, P1622, DOI 10.1126/science.287.5458.1622; Huang Weiwen, 1985, Acta Anthropologica Sinica, V4, P301; HUANG WP, 1995, NATURE, V378, P275; HUANG WP, 1991, WUSHAN HOMINID SITE, P105; JELINEK V, 1978, STUD GEOPHYS GEOD, V22, P50, DOI 10.1007/BF01613632; JIA LP, 1980, QUAT SINICA, V5, P12; Keates SG, 2000, BAR INT SERIES, V863, P107; Li YX, 1999, ACTA ANTHR SINICA, V18, P241; LIU TS, 1999, QUAT SCI, V4, P289; Morwood MJ, 1998, NATURE, V392, P173, DOI 10.1038/32401; PEI WZ, 1980, QUAT SINICA, V5, P11; Qiu Z.X., 2000, QUATERNARY SCI, V20, P142; ROCHETTE P, 1992, REV GEOPHYS, V30, P209, DOI 10.1029/92RG00733; Rutherford S, 2000, NATURE, V408, P72, DOI 10.1038/35040533; SCHICK K, 1991, J HUM EVOL, V21, P13, DOI 10.1016/0047-2484(91)90033-R; Tang Yingjun, 1995, Vertebrata Palasiatica, V33, P74; Teilhard de Chardin P., 1930, ANN PALEONTOL, V19, P1; Wei Q., 1997, EVIDENCE EVOLUTION E, P193; Wei Qi, 1985, Acta Anthropologica Sinica, V4, P223; You Y.Z., 1980, QUATERNARIA SINICA, V5, P1	28	164	261	2	54	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2001	413	6854					413	417		10.1038/35096551	http://dx.doi.org/10.1038/35096551			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475UY	11574886				2022-12-01	WOS:000171188700052
J	Bruneau, BG; Nemer, G; Schmitt, JP; Charron, F; Robitaille, L; Caron, S; Conner, DA; Gessler, M; Nemer, M; Seidman, CE; Seidman, JG				Bruneau, BG; Nemer, G; Schmitt, JP; Charron, F; Robitaille, L; Caron, S; Conner, DA; Gessler, M; Nemer, M; Seidman, CE; Seidman, JG			A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease	CELL			English	Article							ULNAR-MAMMARY SYNDROME; CARDIAC CONDUCTION; MICE LACKING; CONNEXIN40-DEFICIENT MICE; GENE FAMILY; HEART; EXPRESSION; MUTATIONS; MOUSE; NKX2-5	Heterozygous Tbx5(del/+) mice were generated to study the mechanisms by which TBX5 haploinsufficiency causes cardiac and forelimb abnormalities seen in Holt-Oram syndrome. Tbx5 deficiency in homozygous mice (Tbx5(del/del)) decreased expression of multiple genes and caused severe hypoplasia of posterior domains in the developing heart. Surprisingly, Tbx5 haploinsufficiency also markedly decreased atrial natriuretic factor (ANF) and connexin 40 (cx40) transcription, implicating these as Tbx5 target genes and providing a mechanism by which 50% reduction of T-box transcription factors cause disease. Direct and cooperative transactivation of the ANF and cx40 promoters by Tbx5 and the homeodomain transcription factor Nkx2-5 was also demonstrated. These studies provide one potential explanation for Holt-Oram syndrome conduction system defects, suggest mechanisms for intrafamilial phenotypic variability, and account for related cardiac malformations caused by other transcription factor mutations.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Inst Rech Clin Montreal, Lab Dev & Differenciat Cardiaques, Montreal, PQ H2W 1R7, Canada; Univ Wurzburg, Biozentrum, D-97074 Wurzburg, Germany; Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Wurzburg; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital	Nemer, M (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.		Schmitt, Joachim/GQP-7068-2022; Nemer, Georges/H-7801-2014; Charron, Frederic/O-8017-2019; Nemer, Georges/ABB-5117-2020	Charron, Frederic/0000-0003-3483-8672; Nemer, Georges/0000-0003-2157-5279; Bruneau, Benoit/0000-0002-0804-7597; Gessler, Manfred/0000-0002-7915-6045	NCRR NIH HHS [S10 RR14792] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR014792] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ARGENTIN S, 1994, MOL CELL BIOL, V14, P777, DOI 10.1128/MCB.14.1.777; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; BASSON CT, 1994, NEW ENGL J MED, V330, P885, DOI 10.1056/NEJM199403313301302; Basson CT, 1999, P NATL ACAD SCI USA, V96, P2919, DOI 10.1073/pnas.96.6.2919; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; Bevilacqua LM, 2000, J INTERV CARD ELECTR, V4, P459, DOI 10.1023/A:1009800328836; Bruneau BG, 1999, DEV BIOL, V211, P100, DOI 10.1006/dbio.1999.9298; Bruneau BG, 2000, DEV BIOL, V217, P266, DOI 10.1006/dbio.1999.9548; Bruneau BG, 2001, MOL CELL BIOL, V21, P1730, DOI 10.1128/MCB.21.5.1730-1736.2001; Carreira S, 1998, MOL CELL BIOL, V18, P5099, DOI 10.1128/MCB.18.9.5099; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Erives A, 2000, DEV BIOL, V225, P169, DOI 10.1006/dbio.2000.9815; GREPIN C, 1995, MOL CELL BIOL, V15, P4095; Gutstein DE, 2001, CIRC RES, V88, P333, DOI 10.1161/01.RES.88.3.333; HAEFLIGER JA, 1992, J BIOL CHEM, V267, P2057; Hagendorff A, 1999, CIRCULATION, V99, P1508, DOI 10.1161/01.CIR.99.11.1508; He ML, 1999, P NATL ACAD SCI USA, V96, P10212, DOI 10.1073/pnas.96.18.10212; HENDRICKSON BA, 1995, J EXP MED, V182, P1905, DOI 10.1084/jem.182.6.1905; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Horb ME, 1999, DEVELOPMENT, V126, P1739; Kirchhoff S, 2000, CIRC RES, V87, P399; Kirchhoff S, 1998, CURR BIOL, V8, P299, DOI 10.1016/S0960-9822(98)70114-9; KISPERT A, 1993, EMBO J, V12, P4898, DOI 10.1002/j.1460-2075.1993.tb06179.x; KNOWLTON KU, 1995, J CLIN INVEST, V96, P1311, DOI 10.1172/JCI118166; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Li QY, 1997, NAT GENET, V15, P21; LYONS GE, 1990, J CELL BIOL, V111, P2427, DOI 10.1083/jcb.111.6.2427; MARRIOTT HJL, 1983, PRACTICAL ELECTROCAR; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Muller CW, 1997, NATURE, V389, P884, DOI 10.1038/39929; NewburyEcob RA, 1996, J MED GENET, V33, P300, DOI 10.1136/jmg.33.4.300; Papaioannou VE, 1998, BIOESSAYS, V20, P9, DOI 10.1002/(SICI)1521-1878(199801)20:1<9::AID-BIES4>3.0.CO;2-Q; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Seul KH, 1997, GENOMICS, V46, P120, DOI 10.1006/geno.1997.5025; Simon AM, 1998, CURR BIOL, V8, P295, DOI 10.1016/S0960-9822(98)70113-7; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Tada M, 2001, DEV GROWTH DIFFER, V43, P1	45	758	786	1	42	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 21	2001	106	6					709	721		10.1016/S0092-8674(01)00493-7	http://dx.doi.org/10.1016/S0092-8674(01)00493-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	476EJ	11572777	Bronze			2022-12-01	WOS:000171213000008
J	Hylek, EM; Regan, S; Go, AS; Hughes, RA; Singer, DE; Skates, SJ				Hylek, EM; Regan, S; Go, AS; Hughes, RA; Singer, DE; Skates, SJ			Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin	ANNALS OF INTERNAL MEDICINE			English	Article							RISK-FACTORS; BLEEDING COMPLICATIONS; DRUG-METABOLISM; PROTEIN-BINDING; AGING LIVER; AGE; DISCONTINUATION; OUTPATIENTS; CLEARANCE	Background: An elevated international normalized ratio (INR) increases the risk for major hemorrhage during warfarin therapy. Optimal management of patients with asymptomatic elevations in INR is hampered by the lack of understanding of the time course of INR decay after cessation of warfarin therapy. Objective: To identify predictors of the rate of INR normalization after excessive anticoagulation. Design: Retrospective cohort study. Setting: Outpatient anticoagulant therapy unit. Patients: Outpatients with an INR greater than 6.0 were identified from August 1993 to September 1998. Patients in whom two doses of warfarin were withheld and a follow-up INR was obtained on the second calendar day were enrolled. No patient received vitamin K-tau. Measurements: The INR was measured 2 days after an INR greater than 6.0 was recorded. Results: Of 633 study patients with an initial INR greater than 6.0, 232 (37%) still had an INR of 4.0 or greater after two doses of warfarin were withheld. Patients who required larger weekly maintenance doses of warfarin were less likely to have an INR of 4.0 or greater on day 2 (adjusted odds ratio per 10 mg of warfarin, 0.87 [95% Cl, 0.79 to 0.97]). Other risk factors for having an INR of 4.0 or greater on day 2 included age (odds ratio per decade of life, 1.18 [Cl, 1.01 to 1.38]), index INR (odds ratio per unit, 1.25 [Cl, 1.14 to 1.37]), decompensated congestive heart failure (odds ratio, 2.79 [Cl, 1.30 to 5.98]), and active cancer (odds ratio, 2.48 [Cl, 1.11 to 5.57]). Conclusions: Steady-state warfarin dose, advanced age, and extreme elevation in INR are risk factors for prolonged delay in return of the INR to within the therapeutic range. Decompensated congestive heart failure and active cancer greatly increase this risk.	Massachusetts Gen Hosp, Clin Epidemiol Unit, Div Gen Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Kaiser Permanente Med Care Program, Oakland, CA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Kaiser Permanente; University of California System; University of California San Francisco	Hylek, EM (corresponding author), Massachusetts Gen Hosp, Clin Epidemiol Unit, Div Gen Med, 50 Staniford St,9th Floor, Boston, MA 02114 USA.		Go, Alan S./AAE-7745-2019	Hylek, Elaine/0000-0001-8263-8304	NATIONAL INSTITUTE ON AGING [R01AG015478] Funding Source: NIH RePORTER; NIA NIH HHS [AG15478] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 1998, Br J Haematol, V101, P374; Ansell J, 2001, CHEST, V119, p22S, DOI 10.1378/chest.119.1_suppl.22S; Bonow RO, 1998, CIRCULATION, V98, P1949, DOI 10.1161/01.CIR.98.18.1949; BRADBURY H, 1994, BRIT J PHARMACOL, V37, P563; CHAN E, 1994, BRIT J CLIN PHARMACO, V37, P563, DOI 10.1111/j.1365-2125.1994.tb04305.x; Chesebro JH, 1996, ARCH INTERN MED, V156, P409; Crowther MA, 1998, THROMB HAEMOSTASIS, V79, P1116; DURNAS C, 1990, CLIN PHARMACOKINET, V19, P359, DOI 10.2165/00003088-199019050-00002; FIHN SD, 1993, ANN INTERN MED, V118, P511, DOI 10.7326/0003-4819-118-7-199304010-00005; Grandison MK, 2000, CLIN PHARMACOKINET, V38, P271, DOI 10.2165/00003088-200038030-00005; Hammerlein A, 1998, CLIN PHARMACOKINET, V35, P49; Hirsh J, 1998, CHEST, V114, p445S, DOI 10.1378/chest.114.5_Supplement.445S; HIRSH J, 1995, CHEST, V108, pS231, DOI 10.1378/chest.108.4_Supplement.231S; Hosmer DW, 1989, APPL LOGISTIC REGRES, P140; Hylek E. M., 1999, JGIM, V14, P42; HYLEK EM, 1994, ANN INTERN MED, V120, P897, DOI 10.7326/0003-4819-120-11-199406010-00001; Hylek EM, 1998, JAMA-J AM MED ASSOC, V279, P657, DOI 10.1001/jama.279.9.657; JAMES OFW, 1985, J HEPATOL, V1, P431, DOI 10.1016/S0168-8278(85)80780-7; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES PR, P299; LANDEFELD CS, 1989, AM J MED, V87, P144; Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003; Levine MN, 2001, CHEST, V119, p108S, DOI 10.1378/chest.119.1_suppl.108S; Lousberg TR, 1998, ARCH INTERN MED, V158, P528, DOI 10.1001/archinte.158.5.528; NOTARI RE, 1987, BIOPHARMACEUTICS CLI, P7; Palareti G, 2000, ARCH INTERN MED, V160, P470, DOI 10.1001/archinte.160.4.470; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; PENGO V, 1993, BLOOD COAGUL FIBRIN, V4, P739, DOI 10.1097/00001721-199304050-00010; ROUTLEDGE PA, 1979, BRIT J CLIN PHARMACO, V8, P243, DOI 10.1111/j.1365-2125.1979.tb01009.x; SCHOFIELD KP, 1987, CLIN LAB HAEMATOL, V9, P255, DOI 10.1111/j.1365-2257.1987.tb00089.x; SHEPHERD AM, 1979, DRUGS ELDERLY PERSPE; SHEPHERD AMM, 1977, BRIT J CLIN PHARMACO, V4, P315, DOI 10.1111/j.1365-2125.1977.tb00719.x; VANDERMEER FJM, 1993, ARCH INTERN MED, V153, P1557, DOI 10.1001/archinte.153.13.1557; VESTAL RE, 1989, HEPATOLOGY, V9, P331, DOI 10.1002/hep.1840090228; WALLACE SM, 1987, CLIN PHARMACOKINET, V12, P41, DOI 10.2165/00003088-198712010-00004; Weibert RT, 1997, ANN INTERN MED, V126, P959, DOI 10.7326/0003-4819-126-12-199706150-00005; WELLS PS, 1994, ANN INTERN MED, V121, P676, DOI 10.7326/0003-4819-121-9-199411010-00009; WHITE RH, 1995, ANN INTERN MED, V122, P40, DOI 10.7326/0003-4819-122-1-199501010-00006; WOODHOUSE KW, 1984, AGE AGEING, V13, P328, DOI 10.1093/ageing/13.6.328; WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222	39	138	142	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2001	135	6					393	400		10.7326/0003-4819-135-6-200109180-00008	http://dx.doi.org/10.7326/0003-4819-135-6-200109180-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472FH	11560452				2022-12-01	WOS:000170972500001
J	Giribet, G; Edgecombe, GD; Wheeler, WC				Giribet, G; Edgecombe, GD; Wheeler, WC			Arthropod phylogeny based on eight molecular loci and morphology	NATURE			English	Article							SEQUENCE ALIGNMENT; DNA-SEQUENCES; HISTONE H3; CRUSTACEANS; INSECTS; ORIGIN; HYPOTHESIS; PATTERN	The interrelationships of major clades within the Arthropoda remain one of the most contentious issues in systematics, which has traditionally been the domain of morphologists(1,2). A growing body of DNA sequences and other types of molecular data has revitalized study of arthropod phylogeny(3-7) and has inspired new considerations of character evolution(8,9). Novel hypotheses such as a crustacean-hexapod affinity(4,10-12) were based on analyses of single or few genes and limited taxon sampling, but have received recent support from mitochondrial gene order(13), and eye and brain ultrastructure and neurogenesis(14,15). Here we assess relationships within Arthropoda based on a synthesis of all well sampled molecular loci together with a comprehensive data set of morphological, developmental, ultrastructural and gene-order characters. The molecular data include sequences of three nuclear ribosomal genes, three nuclear protein-coding genes, and two mitochondrial genes (one protein coding, one ribosomal). We devised new optimization procedures(16,17) and constructed a parallel computer cluster with 256 central processing units(18) to analyse molecular data on a scale not previously possible. The optimal 'total evidence' cladogram supports the crustacean-hexapod clade, recognizes pycnogonids as sister to other euarthropods, and indicates monophyly of Myriapoda and Mandibulata.	Harvard Univ, Dept Organism & Evolut Biol, Cambridge, MA 02138 USA; Australian Museum, Sydney, NSW 2010, Australia; Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA	Harvard University; Australian Museum; American Museum of Natural History (AMNH)	Giribet, G (corresponding author), Harvard Univ, Dept Organism & Evolut Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	ggiribet@oeb.harvard.edu	Giribet, Gonzalo/P-1086-2015	Giribet, Gonzalo/0000-0002-5467-8429; Edgecombe, Gregory/0000-0002-9591-8011				Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; BREMER K, 1988, EVOLUTION, V42, P795, DOI [10.2307/2408870, 10.1111/j.1558-5646.1988.tb02497.x]; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Dohle W, 2001, ANN SOC ENTOMOL FR, V37, P85; Edgecombe GD, 2000, CLADISTICS, V16, P155, DOI 10.1111/j.1096-0031.2000.tb00352.x; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; FRIEDRICH M, 1995, NATURE, V376, P165, DOI 10.1038/376165a0; Gee H, 2000, NATURE, V404, P214, DOI 10.1038/35005235; Giribet G, 2000, CLADISTICS, V16, P204, DOI 10.1111/j.1096-0031.2000.tb00353.x; Giribet G, 1996, MOL BIOL EVOL, V13, P76, DOI 10.1093/oxfordjournals.molbev.a025573; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; GOLOBOFF PA, 1998, NONA V 2 0; KLUGE AG, 1989, SYST ZOOL, V38, P7, DOI 10.2307/2992432; Popadic A, 1998, DEV GENES EVOL, V208, P142, DOI 10.1007/s004270050165; Regier JC, 1998, AM ZOOL, V38, P918; Regier JC, 1997, MOL BIOL EVOL, V14, P902, DOI 10.1093/oxfordjournals.molbev.a025833; Scholtz G, 1998, INT J DEV BIOL, V42, P801; Shultz JW, 2000, P ROY SOC B-BIOL SCI, V267, P1011, DOI 10.1098/rspb.2000.1104; SNODGRASS R. E., 1938, SMITHSONIAN MISC COLL, V97, P1; Spears T., 1998, Systematics Association Special Volume Series, V55, P169; Strausfeld NJ, 1998, BRAIN BEHAV EVOLUT, V52, P186, DOI 10.1159/000006563; Wahlberg N, 2000, CLADISTICS, V16, P347, DOI 10.1111/j.1096-0031.2000.tb00355.x; Wheeler W, 1996, CLADISTICS, V12, P1, DOI 10.1111/j.1096-0031.1996.tb00189.x; Wheeler W, 1998, ARTHROPOD FOSSILS AND PHYLOGENY, P9; WHEELER WC, 1993, CLADISTICS, V9, P1, DOI 10.1111/j.1096-0031.1993.tb00207.x; WHEELER WC, 1995, SYST BIOL, V44, P321, DOI 10.2307/2413595; Wills MA, 1998, ARTHROPOD FOSSILS AND PHYLOGENY, P33; Zrzavy J., 1998, Arthropod relationships., P97; Zrzavy J, 1997, J EVOLUTION BIOL, V10, P353, DOI 10.1007/s000360050029	29	437	469	4	129	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 13	2001	413	6852					157	161		10.1038/35093097	http://dx.doi.org/10.1038/35093097			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557979				2022-12-01	WOS:000170918800045
J	Walsh, EC; Stainier, DYR				Walsh, EC; Stainier, DYR			UDP-glucose dehydrogenase required for cardiac valve formation in zebrafish	SCIENCE			English	Article							ENDOCARDIAL CUSHION FORMATION; TGF-BETA RECEPTOR; CELL-TRANSFORMATION; NEUREGULIN RECEPTOR; HEART; GENE; BIOSYNTHESIS; DROSOPHILA; MORPHOGENESIS; PROTEOGLYCANS	Cardiac valve formation is a complex process that involves cell signaling events between the myocardial and endocardial layers of the heart across an elaborate extracellular matrix. These signals lead to marked morphogenetic movements and transdifferentiation of the endocardial cells at chamber boundaries. Here we identify the genetic defect in zebrafish jekyll mutants, which are deficient in the initiation of heart valve formation. The jekyll mutation disrupts a homolog of Drosophila Sugarless, a uridine 5'-diphosphate (UDP)-glucose dehydrogenase required for heparan sulfate, chondroitin sulfate, and hyaluronic acid production, The atrioventricular border cells do not differentiate from their neighbors in jekyll mutants, suggesting that Jekyll is required in a cell signaling event that establishes a boundary between the atrium and ventricle.	Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Genet Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Program Human Genet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stainier, DYR (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, San Francisco, CA 94143 USA.			Stainier, Didier/0000-0002-0382-0026	NHLBI NIH HHS [HL54737] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054737] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Binari RC, 1997, DEVELOPMENT, V124, P2623; Boyer AS, 1999, DEV BIOL, V208, P530, DOI 10.1006/dbio.1999.9211; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; Brown CB, 1996, DEV BIOL, V174, P248, DOI 10.1006/dbio.1996.0070; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P7012, DOI 10.1021/bi000181h; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Hacker U, 1997, DEVELOPMENT, V124, P3565; Haerry TE, 1997, DEVELOPMENT, V124, P3055; Kim C., UNPUB; Lander AD, 2000, J CELL BIOL, V148, P227, DOI 10.1083/jcb.148.2.227; Laufer E, 1997, NATURE, V386, P366, DOI 10.1038/386366a0; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Lin XH, 1999, DEVELOPMENT, V126, P3715; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Nakajima Y, 2000, ANAT RECORD, V258, P119, DOI 10.1002/(SICI)1097-0185(20000201)258:2<119::AID-AR1>3.0.CO;2-U; Neff MM, 1998, PLANT J, V14, P387, DOI 10.1046/j.1365-313X.1998.00124.x; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Postlethwait JH, 1997, TRENDS GENET, V13, P183, DOI 10.1016/S0168-9525(97)01129-3; RodriguezEsteban C, 1997, NATURE, V386, P360, DOI 10.1038/386360a0; SAQI MAS, 1994, COMPUT APPL BIOSCI, V10, P545; STAINIER DYR, 1995, DEVELOPMENT, V121, P3141; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Thisse C, 1999, DEVELOPMENT, V126, P229; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; WALSH EC, UNPUB; Westin J, 1997, DEV GENES EVOL, V207, P51, DOI 10.1007/s004270050091; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406	34	230	233	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1670	1673		10.1126/science.293.5535.1670	http://dx.doi.org/10.1126/science.293.5535.1670			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533493				2022-12-01	WOS:000170802900066
J	Ballard, C; Fosssey, J; Chithramohan, R; Howard, R; Burns, A; Thompson, P; Tadros, G; Fairbairn, A				Ballard, C; Fosssey, J; Chithramohan, R; Howard, R; Burns, A; Thompson, P; Tadros, G; Fairbairn, A			Quality of care in private sector and NHS facilities for people with dementia: cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article									Royal Coll Psychiatrists, London SW1X 8PG, England		Fairbairn, A (corresponding author), Royal Coll Psychiatrists, London SW1X 8PG, England.		Howard, Robert/E-4890-2010	Burns, Alistair/0000-0002-9837-0645; Ballard, Clive/0000-0003-0022-5632; Howard, Robert/0000-0002-3071-2338				Brooker D., 1995, J MENTAL HLTH, V4, P145, DOI DOI 10.1080/09638239550037686; COPELAND JRM, 1976, PSYCHOL MED, V6, P439, DOI 10.1017/S0033291700015889; *DEP HLTH, 1999, FIT FUT NAT REQ STAN; Kitwood T., 1997, EVALUATING DEMENTIA; LEAPER R, 1998, TRAINING QUALIFICATI	5	74	75	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 25	2001	323	7310					426	427		10.1136/bmj.323.7310.426	http://dx.doi.org/10.1136/bmj.323.7310.426			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469BX	11520838	Bronze, Green Published			2022-12-01	WOS:000170793600019
J	Lewis, J; Dickson, DW; Lin, WL; Chisholm, L; Corral, A; Jones, G; Yen, SH; Sahara, N; Skipper, L; Yager, D; Eckman, C; Hardy, J; Hutton, M; McGowan, E				Lewis, J; Dickson, DW; Lin, WL; Chisholm, L; Corral, A; Jones, G; Yen, SH; Sahara, N; Skipper, L; Yager, D; Eckman, C; Hardy, J; Hutton, M; McGowan, E			Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP	SCIENCE			English	Article							FAMILIAL ALZHEIMERS-DISEASE; AMYLOID PRECURSOR PROTEIN; PAIRED HELICAL FILAMENTS; BETA-PROTEIN; IN-VIVO; A-BETA; PRESENILIN-1; GENE; MUTATIONS; A-BETA-42(43)	JNPL3 transgenic mice expressing a mutant tau protein, which develop neurofibrillary tangles and progressive motor disturbance, were crossed with Tg2576 transgenic mice expressing mutant beta -amyloid precursor protein (APP), thus modulating the APP-A beta (beta -amyloid peptide) environment. The resulting double mutant (tau/APP) progeny and the Tg2576 parental strain developed A beta deposits at the same age; however, relative to JNPL3 mice, the double mutants exhibited neurofibrillary tangle pathology that was substantially enhanced in the limbic system and olfactory cortex. These results indicate that either APP or A beta influences the formation of neurofibrillary tangles. The interaction between A beta and tau pathologies in these mice supports the hypothesis that a similar interaction occurs in Alzheimer's disease.	Mayo Clin Jacksonville, Jacksonville, FL 32224 USA	Mayo Clinic	Hutton, M (corresponding author), Mayo Clin Jacksonville, Birdsall Bldg,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	hutton.michael@mayo.edu	Hardy, John/C-2451-2009	Hardy, John/0000-0002-3122-0423; Skipper, Lisa/0000-0002-1524-9787; Dickson, Dennis W/0000-0001-7189-7917	NATIONAL INSTITUTE ON AGING [ZIAAG000951, Z01AG000951] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; DeTure M, 2001, ALZHEIMER'S DISEASE, P651, DOI 10.1002/0470846453.ch60; DICKSON DW, 1993, ACTA NEUROPATHOL, V85, P463; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P131; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; Hardy J, 1998, NAT NEUROSCI, V1, P355, DOI 10.1038/1565; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Haugabook SJ, 2001, FASEB J, V15, P16; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jicha GA, 1999, J NEUROSCI, V19, P7486, DOI 10.1523/JNEUROSCI.19-17-07486.1999; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; JORM AF, 1987, ACTA PSYCHIAT SCAND, V76, P465, DOI 10.1111/j.1600-0447.1987.tb02906.x; Kawas C, 1999, ALZHEIMER DIS, P95; LANNFELT L, 1994, NEUROSCI LETT, V168, P254, DOI 10.1016/0304-3940(94)90463-4; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; LEWIS J, 2000, NEUROSCI NEWS, V3, P63; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; Mehta ND, 1998, ANN NEUROL, V43, P256, DOI 10.1002/ana.410430217; MIKOL J, 1980, ACTA NEUROPATHOL, V49, P57, DOI 10.1007/BF00692220; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; ROCCA WA, 1991, ANN NEUROL, V30, P381, DOI 10.1002/ana.410300310; ROSES AD, 1994, J NEUROPATH EXP NEUR, V53, P429, DOI 10.1097/00005072-199409000-00002; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SELKOE DJ, 1994, J NEUROPATH EXP NEUR, V53, P438, DOI 10.1097/00005072-199409000-00003; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Vincent I, 1998, NEUROBIOL AGING, V19, P287, DOI 10.1016/S0197-4580(98)00071-2; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506	37	1147	1222	0	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1487	1491		10.1126/science.1058189	http://dx.doi.org/10.1126/science.1058189			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520987				2022-12-01	WOS:000170616000044
J	Michaud, DS; Giovannucci, E; Willett, WC; Colditz, GA; Stampfer, MJ; Fuchs, CS				Michaud, DS; Giovannucci, E; Willett, WC; Colditz, GA; Stampfer, MJ; Fuchs, CS			Physical activity, obesity, height, and the risk of pancreatic cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-FAT DISTRIBUTION; NATIONAL DEATH INDEX; GROWTH-FACTOR-I; DIABETES-MELLITUS; ACTIVITY QUESTIONNAIRE; NUTRITIONAL FACTORS; INSULIN; MORTALITY; MEN; GLUCOSE	Context Diabetes mellitus and elevated postload plasma glucose levels have been associated with an increased risk of pancreatic cancer in previous studies. By virtue of their influence on insulin resistance, obesity and physical inactivity may increase risk of pancreatic cancer. Objective To examine obesity, height, and physical activity in relation to pancreatic cancer risk. Design and Setting Two US cohort studies conducted by mailed questionnaire, the Health Professionals Follow-Up Study (initiated in 1986) and the Nurses' Health Study (initiated in 1976), with 10 to 20 years of follow-up. Participants A total of 46648 men aged 40 to 75 years and 117041 women aged 30 to 55 years who were free of prior cancer at baseline and had complete data on height and weight. Main Outcome Measures Relative risk of pancreatic cancer, analyzed by self-reported body mass index (BMI), height, and level of physical activity. Results During follow-up, we documented 350 incident pancreatic cancer cases. Individuals with a BMI of at least 30 kg/m(2) had an elevated risk of pancreatic cancer compared with those with a BMI of less than 23 kg/m(2) (multivariable relative risk [RR], 1.72; 95% confidence interval [CI], 1.19-2.48), Height was associated with an increased pancreatic cancer risk (multivariable RR, 1.81; 95% CI, 1.31-2.52 for the highest vs lowest categories). An inverse relation was observed for moderate activity (multivariable RR, 0.45; 95% CI, 0.29-0.70 for the highest vs lowest categories; P for trend <.001). Total physical activity was not associated with risk among individuals with a BMI of less than 25 kg/m(2) but was inversely associated with risk among individuals with a BMI of at least 25 kg/m(2) (pooled multivariable RR, 0.59; 95% CI, 0.37-0.94 for the top vs bottom tertiles of total physical activity; P for trend=.04). Conclusion In 2 prospective cohort studies, obesity significantly increased the risk of pancreatic cancer. Physical activity appears to decrease the risk of pancreatic cancer, especially among those who are overweight.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Michaud, DS (corresponding author), NCI, 6120 Execut Blvd,EPS Room 7026, Rockville, MD 20852 USA.	michaudd@mail.nih.gov	Colditz, Graham/A-3963-2009; Michaud, Dominique S/I-5231-2014	Colditz, Graham/0000-0002-7307-0291; 	NCI NIH HHS [CA 55075, CA 86102, CA 87969] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA087969, R01CA086102] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahlgren JD, 1996, SEMIN ONCOL, V23, P241; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; ALBANES D, 1988, CANCER RES, V48, P1658; *AM CANC SOC INC, 2000, CANC FACTS FIG 2000; Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; BERGMANN U, 1995, CANCER RES, V55, P2007; BOYLE P, 1989, INT J PANCREATOL, V5, P327, DOI 10.1007/BF02924298; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; CHAPMAN DG, 1968, BIOMETRICS, V24, P315, DOI 10.2307/2528037; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Chow WH, 1999, BRIT J CANCER, V79, P640, DOI 10.1038/sj.bjc.6690101; Coughlin SS, 2000, CANCER CAUSE CONTROL, V11, P915, DOI 10.1023/A:1026580131793; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; DEMESQUITA HBB, 1992, INT J CANCER, V52, P24, DOI 10.1002/ijc.2910520106; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DESPRES JP, 1990, ARTERIOSCLEROSIS, V10, P497, DOI 10.1161/01.ATV.10.4.497; DiPietro L, 1998, J AM GERIATR SOC, V46, P875, DOI 10.1111/j.1532-5415.1998.tb02722.x; EVERHART J, 1995, JAMA-J AM MED ASSOC, V273, P1605, DOI 10.1001/jama.273.20.1605; Fisher WE, 1996, J SURG RES, V63, P310, DOI 10.1006/jsre.1996.0266; FRIEDMAN GD, 1993, INT J EPIDEMIOL, V22, P30, DOI 10.1093/ije/22.1.30; Fuchs CS, 1996, ARCH INTERN MED, V156, P2255, DOI 10.1001/archinte.156.19.2255; Gapstur SM, 2000, JAMA-J AM MED ASSOC, V283, P2552, DOI 10.1001/jama.283.19.2552; GHADIRIAN P, 1991, INT J CANCER, V47, P1, DOI 10.1002/ijc.2910470102; GIOVANNUCCI E, 1995, ANN INTERN MED, V122, P327, DOI 10.7326/0003-4819-122-5-199503010-00002; HENDERSON JR, 1981, GUT, V22, P158, DOI 10.1136/gut.22.2.158; HOWE GR, 1992, INT J CANCER, V51, P365, DOI 10.1002/ijc.2910510306; Ji BT, 1996, INT J CANCER, V66, P432; KALAPOTHAKI V, 1993, CANCER CAUSE CONTROL, V4, P375, DOI 10.1007/BF00051341; Kelley DE, 1999, MED SCI SPORT EXER, V31, pS619, DOI 10.1097/00005768-199911001-00021; KISSEBAH AH, 1982, J CLIN ENDOCR METAB, V54, P254, DOI 10.1210/jcem-54-2-254; KROTKIEWSKI M, 1983, J CLIN INVEST, V72, P1150, DOI 10.1172/JCI111040; LEVINE W, 1990, AM J EPIDEMIOL, V131, P254, DOI 10.1093/oxfordjournals.aje.a115495; LYON JL, 1993, CANCER EPIDEM BIOMAR, V2, P513; MANSON JE, 1987, JAMA-J AM MED ASSOC, V257, P353, DOI 10.1001/jama.257.3.353; Michaud DS, 2001, CANCER EPIDEM BIOMAR, V10, P429; MOLLER H, 1994, EUR J CANCER, V30A, P344, DOI 10.1016/0959-8049(94)90254-2; OHMURA E, 1990, CANCER RES, V50, P103; OSHIDA Y, 1989, J APPL PHYSIOL, V66, P2206, DOI 10.1152/jappl.1989.66.5.2206; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; SHIBATA A, 1994, INT J CANCER, V58, P46, DOI 10.1002/ijc.2910580109; Silverman DT, 1998, JNCI-J NATL CANCER I, V90, P1710, DOI 10.1093/jnci/90.22.1710; Silverman DT, 1999, BRIT J CANCER, V80, P1830, DOI 10.1038/sj.bjc.6690607; Silverman DT, 2001, TERATOGEN CARCIN MUT, V21, P7, DOI 10.1002/1520-6866(2001)21:1<7::AID-TCM3>3.0.CO;2-A; Smith GD, 1998, BMJ-BRIT MED J, V317, P1351, DOI 10.1136/bmj.317.7169.1351; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; TAKEDA Y, 1991, J CANCER RES CLIN, V117, P416, DOI 10.1007/BF01612760; Wang MY, 1998, CANCER RES, V58, P38; Wareham NJ, 2000, AM J EPIDEMIOL, V152, P132, DOI 10.1093/aje/152.2.132; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	50	433	444	1	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2001	286	8					921	929		10.1001/jama.286.8.921	http://dx.doi.org/10.1001/jama.286.8.921			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465EU	11509056	Bronze			2022-12-01	WOS:000170577300026
J	SAGAN, C; THOMPSON, WR; CARLSON, R; GURNETT, D; HORD, C				SAGAN, C; THOMPSON, WR; CARLSON, R; GURNETT, D; HORD, C			A SEARCH FOR LIFE ON EARTH FROM THE GALILEO SPACECRAFT	NATURE			English	Article							SPECTROMETER EXPERIMENT	In its December 1990 fly-by of Earth, the Galileo spacecraft found evidence of abundant gaseous oxygen, a widely distributed surface pigment with a sharp absorption edge in the red part of the visible spectrum, and atmospheric methane in extreme thermodynamic disequilibrium; together, these are strongly suggestive of life on Earth. Moreover, the presence of narrow-band, pulsed, amplitude-modulated radio transmission seems uniquely attributable to intelligence. These observations constitute a control experiment for the search for extraterrestrial life by modern interplanetary spacecraft.	JET PROP LAB,ATMOSPHER & COMETARY SCI SECT,PASADENA,CA 91109; UNIV IOWA,DEPT PHYS & ASTRON,IOWA CITY,IA 52242; UNIV COLORADO,ATMOSPHER & SPACE PHYS LAB,BOULDER,CO 80309	National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Iowa; University of Colorado System; University of Colorado Boulder	SAGAN, C (corresponding author), CORNELL UNIV,PLANETARY STUDIES LAB,ITHACA,NY 14853, USA.							BELTON MJS, 1992, SPACE SCI REV, V60, P413, DOI 10.1007/BF00216864; BOWKER DE, 1985, REF PUBL NASA, V1139; CARLSON RW, 1992, SPACE SCI REV, V60, P457, DOI 10.1007/BF00216865; CARLSON RW, IN PRESS ANTARCT J U; CHAMEIDES WL, 1992, CHEM ENG NEWS, V60, P38; Chapman S, 1931, P PHYS SOC, V43, P483, DOI 10.1088/0959-5309/43/5/302; DROSSART PJ, UNPUB PLANET SPACE S; FAINBERG J, 1974, SPACE SCI REV, V16, P145, DOI 10.1007/BF00240885; GOLD T, 1992, P NATL ACAD SCI USA, V89, P6045, DOI 10.1073/pnas.89.13.6045; GURNETT DA, 1992, SPACE SCI REV, V60, P341, DOI 10.1007/BF00216861; GURNETT DA, 1974, J GEOPHYS RES, V79, P4227, DOI 10.1029/JA079i028p04227; Henderson L.J., 1913, FITNESS ENV INQUIRY; HINES CO, 1965, PHYSICS EARTHS UPPER; HOGAN KB, 1991, NATURE, V354, P181, DOI 10.1038/354181a0; HORD CW, 1992, SPACE SCI REV, V60, P503, DOI 10.1007/BF00216866; KELLER A, 1990, THESIS U IOWA; KILSTON SD, 1966, ICARUS, V5, P79, DOI 10.1016/0019-1035(66)90010-8; LABELLE J, 1989, RADIO SCI, V24, P725, DOI 10.1029/RS024i006p00725; LEDERBERG J, 1965, NATURE, V207, P9, DOI 10.1038/207009a0; LEDERBERG J, 1962, P NATL ACAD SCI USA, V48, P1473, DOI 10.1073/pnas.48.9.1473; LEGER A, IN PRESS ASTR ASTROP; Lewis JS., 1984, PLANETS THEIR ATMOSP; LIPPINCOTT ER, 1967, ASTROPHYS J, V147, P753, DOI 10.1086/149051; LOVELOCK JE, 1975, PROC R SOC SER B-BIO, V189, P167, DOI 10.1098/rspb.1975.0051; LOVELOCK JE, 1965, NATURE, V207, P568, DOI 10.1038/207568a0; Owen T, 1980, STRATEGIES SEARCH LI, P177, DOI DOI 10.1007/978-94-009-9115-6_17; SAGAN C, 1975, PROC R SOC SER B-BIO, V189, P143, DOI 10.1098/rspb.1975.0048; SAGAN C, 1971, ICARUS, V15, P515, DOI 10.1016/0019-1035(71)90132-1; SAGAN C, 1966, BIOL EXPLORATION MAR, pCH9; Shklovskii IS, 1966, INTELLIGENT LIFE UNI, V399, P639; SULLIVAN WT, 1978, SCIENCE, V199, P377, DOI 10.1126/science.199.4327.377; VONZAHN U, 1983, VENUS, pCH13; Walker J. C. G., 1977, EVOLUTION ATMOSPHERE; [No title captured]	34	246	246	1	56	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 21	1993	365	6448					715	721		10.1038/365715a0	http://dx.doi.org/10.1038/365715a0			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC812	11536539				2022-12-01	WOS:A1993MC81200051
J	BUTTERFIELD, NJ; KNOLL, AH; SWETT, K				BUTTERFIELD, NJ; KNOLL, AH; SWETT, K			A BANGIOPHYTE RED ALGA FROM THE PROTEROZOIC OF ARCTIC CANADA	SCIENCE			English	Article									UNIV IOWA,DEPT GEOL,IOWA CITY,IA 52242	University of Iowa	BUTTERFIELD, NJ (corresponding author), HARVARD UNIV,BOT MUSEUM,CAMBRIDGE,MA 02138, USA.		Butterfield, Nicholas/AAV-8215-2021	Butterfield, Nicholas/0000-0002-3046-7520				[Anonymous], 1985, PALEOALGOLOGY; BEEUNAS MA, 1985, GEOL SOC AM BULL, V96, P737, DOI 10.1130/0016-7606(1985)96<737:PSISOS>2.0.CO;2; BHATTACHARYA D, 1987, J PHYCOL, V26, P181; BOLD HC, 1986, INTRO ALGAE; Buss L. W., 1987, EVOLUTION INDIVIDUAL; BUTTERFIELD NJ, 1988, NATURE, V334, P424, DOI 10.1038/334424a0; BUTTERFIELD NJ, 1989, GEOL SOC AM ABSTR, V21, pA146; BUTTERFIELD NJ, UNPUB; CAMPBELL SE, 1980, PHYCOLOGIA, V19, P25, DOI 10.2216/i0031-8884-19-1-25.1; COLE K, 1975, Phycologia, V14, P239, DOI 10.2216/i0031-8884-14-4-239.1; COLE KM, 1985, J PHYCOL, V21, P585; DU RL, 1986, ACTA GEOL SINICA, P115; FRITSCH FE, 1965, STRUCTURE REPRODUCTI; FRY WL, 1983, REV PALAEOBOT PALYNO, V39, P313, DOI 10.1016/0034-6667(83)90018-0; GARBARY DJ, 1980, SYESIS, V13, P137; GERMAN TN, 1981, PALEONTOLOG J, P100; Gnilovskaya M.B., 1988, VENDOTAENIDS E EUROP; GOLUBIC S, COMMUNICATION; GRANT SWF, 1987, GEOL SOC AM ABSTR, V19, P681; GREY K, 1990, PRECAMBRIAN RES, V46, P307, DOI 10.1016/0301-9268(90)90018-L; Heaman L.M., 1990, GEOLOGICAL ASS CANAD, V15, pA55; KNOLL AH, 1986, NATURE, V321, P832, DOI 10.1038/321832a0; LECHEMINANT AN, 1989, EARTH PLANET SC LETT, V96, P38, DOI 10.1016/0012-821X(89)90122-2; MARTIN TC, 1974, J PHYCOL, V10, P57, DOI 10.1111/j.0022-3646.1974.00057.x; PERASSO R, 1989, NATURE, V339, P142, DOI 10.1038/339142a0; SHEATH RG, 1985, J PHYCOL, V21, P297; SHEATH RG, 1980, J PHYCOL, V16, P412; SHEATH RG, 1984, PHYCOLOGIA, V23, P383, DOI 10.2216/i0031-8884-23-3-383.1; STEWART WD, 1987, 8326 GEOL SURV CAN P; TAPPAN H, 1976, GEOL SOC AM BULL, V87, P633, DOI 10.1130/0016-7606(1976)87<633:PEABAE>2.0.CO;2; VIDAL G, 1989, LETHAIA, V22, P375, DOI 10.1111/j.1502-3931.1989.tb01437.x; Walcott C.D., 1919, SMITHSONIAN MISCELLA, V67, P217; WALTER MR, 1976, J PALEONTOL, V50, P872; WHELAN JF, 1990, AM J SCI, V290, P396, DOI 10.2475/ajs.290.4.396; Zhang Y., 1989, LETHAIA, V22, P113	35	135	147	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 5	1990	250	4977					104	107		10.1126/science.11538072	http://dx.doi.org/10.1126/science.11538072			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB467	11538072				2022-12-01	WOS:A1990EB46700030
J	ROTHSCHILD, LJ; MANCINELLI, RL				ROTHSCHILD, LJ; MANCINELLI, RL			MODEL OF CARBON FIXATION IN MICROBIAL MATS FROM 3,500 MYR AGO TO THE PRESENT	NATURE			English	Article											ROTHSCHILD, LJ (corresponding author), NASA,AMES RES CTR,SOLAR SYST EXPLORAT BRANCH,MAIL STOP 239-12,MOFFETT FIELD,CA 94035, USA.		Mancinelli, Rocco/L-8971-2016					AWRAMIK SM, 1971, SCIENCE, V174, P825, DOI 10.1126/science.174.4011.825; Awramik SM, 1984, MICROBIAL MATS STROM, P1; BADGER MR, 1982, PLANT PHYSIOL, V70, P517, DOI 10.1104/pp.70.2.517; Brasier M. D., 1980, MICROFOSSILS; DAMELIO ED, 1987, ARCH MICROBIOL, V147, P528; Des Marais D.J., 1989, MICROBIAL MATPHYSL, P191; GARRETT P, 1970, SCIENCE, V169, P171, DOI 10.1126/science.169.3941.171; Glaessner M.F., 1984, DAWN ANIMAL LIFE; JAVOR BJ, 1981, GEOMICROBIOL J, V2, P237, DOI 10.1080/01490458109377766; KASTING JF, 1987, PRECAMBRIAN RES, V34, P205, DOI 10.1016/0301-9268(87)90001-5; OWEN T, 1979, NATURE, V277, P640, DOI 10.1038/277640a0; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; WALKER JCG, 1985, ORIGINS LIFE EVOL B, V16, P117, DOI 10.1007/BF01809466; Walter MR, 1983, EARTHS EARLIEST BIOS, P187	16	26	26	0	6	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 21	1990	345	6277					710	712		10.1038/345710a0	http://dx.doi.org/10.1038/345710a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK399	11536465				2022-12-01	WOS:A1990DK39900063
J	SHOCK, EL; SCHULTE, MD				SHOCK, EL; SCHULTE, MD			AMINO-ACID SYNTHESIS IN CARBONACEOUS METEORITES BY AQUEOUS ALTERATION OF POLYCYCLIC AROMATIC-HYDROCARBONS	NATURE			English	Article											SHOCK, EL (corresponding author), WASHINGTON UNIV,DEPT EARTH & PLANETARY SCI,ST LOUIS,MO 63130, USA.			Shock, Everett/0000-0002-4283-0163; Schulte, Mitchell/0000-0001-8141-2020				ALLAMANDOLA LJ, 1987, SCIENCE, V237, P56, DOI 10.1126/science.237.4810.56; Basile B. P., 1984, ORG GEOCHEM, V5, P211, DOI 10.1016/0146-6380(84)90008-1; BECKER RH, 1982, GEOCHIM COSMOCHIM AC, V46, P97, DOI 10.1016/0016-7037(82)90294-0; BERNATOWICZ T, 1987, NATURE, V330, P728, DOI 10.1038/330728a0; Bradley J. P., 1988, METEORITES EARLY SOL, P861; BUNCH TE, 1980, GEOCHIM COSMOCHIM AC, V44, P1543, DOI 10.1016/0016-7037(80)90118-0; CHANG S, 1986, P116; CHANG S, 1978, LUNAR PLANET SCI, V9, P157; CLAYTON RN, 1963, SCIENCE, V140, P192, DOI 10.1126/science.140.3563.192; CLAYTON RN, 1984, EARTH PLANET SC LETT, V67, P151, DOI 10.1016/0012-821X(84)90110-9; Cronin J.R., 1988, METEORITES EARLY SOL, P819; DAYHOFF MO, 1967, NASA SP3040; DUFRESNE ER, 1962, GEOCHIM COSMOCHIM AC, V26, P1085, DOI 10.1016/0016-7037(62)90047-9; EPSTEIN S, 1987, NATURE, V326, P477, DOI 10.1038/326477a0; FRENKLACH M, 1989, NATURE, V339, P196, DOI 10.1038/339196a0; GRIMM RE, 1989, ICARUS, V82, P244, DOI 10.1016/0019-1035(89)90038-9; HAYATSU R, 1981, TOP CURR CHEM, V99, P1; HERBERT F, 1989, ICARUS, V78, P402, DOI 10.1016/0019-1035(89)90187-5; HERBST E, 1985, ORIGINS LIFE EVOL B, V16, P3, DOI 10.1007/BF01808046; HUSS GR, 1987, EARTH MOON PLANETS, V40, P165; Kerridge J.F., 1979, ASTEROIDS, P745; KERRIDGE JF, 1987, GEOCHIM COSMOCHIM AC, V51, P2527, DOI 10.1016/0016-7037(87)90303-6; LANGE MA, 1985, GEOCHIM COSMOCHIM AC, V49, P1715, DOI 10.1016/0016-7037(85)90142-5; LARIMER JW, 1967, GEOCHIM COSMOCHIM AC, V31, P1239, DOI 10.1016/S0016-7037(67)80014-0; MCSWEEN HY, 1987, GEOCHIM COSMOCHIM AC, V51, P2469, DOI 10.1016/0016-7037(87)90298-5; MCSWEEN HY, 1979, GEOCHIM COSMOCHIM AC, V43, P1761, DOI 10.1016/0016-7037(79)90024-3; Peltzer E T, 1984, Adv Space Res, V4, P69, DOI 10.1016/0273-1177(84)90546-5; PRINN RG, 1987, ANNU REV EARTH PL SC, V15, P171; SHOCK E L, 1989, Origins of Life and Evolution of the Biosphere, V19, P538, DOI 10.1007/BF02388991; SHOCK EL, 1988, GEOLOGY, V16, P886, DOI 10.1130/0091-7613(1988)016<0886:OAMISB>2.3.CO;2; SHOCK EL, 1989, GEOLOGY, V17, P572, DOI 10.1130/0091-7613(1989)017<0572:CTOAMI>2.3.CO;2; SHOCK EL, IN PRES GEOCHIM COSM; Stull D.R., 1969, CHEM THERMODYN; TOMEOKA K, 1985, GEOCHIM COSMOCHIM AC, V49, P2149, DOI 10.1016/0016-7037(85)90073-0; WONG WK, 1971, J CHEM THERMODYN, V3, P105, DOI 10.1016/S0021-9614(71)80071-X; YUEN G, 1984, NATURE, V307, P252, DOI 10.1038/307252a0; ZENOBI R, 1989, SCIENCE, V1246, P1026; Zinner E., 1988, METEORITES EARLY SOL; Zolensky M., 1988, METEORITES EARLY SOL, P114; ZOLENSKY ME, 1989, ICARUS, V78, P411, DOI 10.1016/0019-1035(89)90188-7	40	74	74	0	25	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	FEB 22	1990	343	6260					728	731		10.1038/343728a0	http://dx.doi.org/10.1038/343728a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP807	11536464				2022-12-01	WOS:A1990CP80700051
J	Eggert, US; Ruiz, N; Falcone, BV; Branstrom, AA; Goldman, RC; Silhavy, TJ; Kahne, D				Eggert, US; Ruiz, N; Falcone, BV; Branstrom, AA; Goldman, RC; Silhavy, TJ; Kahne, D			Genetic basis for activity differences between vancomycin and glycolipid derivatives of vancomycin	SCIENCE			English	Article							ESCHERICHIA-COLI; GLYCOPEPTIDE ANTIBIOTICS; LYTIC TRANSGLYCOSYLASE; MEMBRANE LOCALIZATION; RESISTANCE; IDENTIFICATION; CHROMOSOME; STRAINS; SYSTEM; GROWTH	Small molecules that affect specific protein functions can be valuable tools for dissecting complex cellular processes. Peptidoglycan synthesis and degradation is a process in bacteria that involves multiple enzymes under strict temporal and spatial regulation. We used a set of small molecules that inhibit the transglycosylation step of peptidoglycan synthesis to discover genes that help to regulate this process. We identified a gene responsible for the susceptibility of Escherichia coli cells to killing by glycolipid derivatives of vancomycin, thus establishing a genetic basis for activity differences between these compounds and vancomycin.	Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Adv Med Inc, San Francisco, CA 94080 USA	Princeton University; Princeton University	Kahne, D (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	dkahne@princeton.edu		Falcone, Brian/0000-0001-8506-0915; Silhavy, Thomas/0000-0001-7672-5153; Ruiz, Natividad/0000-0002-6369-2206; Eggert, Ulrike/0000-0003-0932-5525				Alaimo PJ, 2001, CURR OPIN CHEM BIOL, V5, P360, DOI 10.1016/S1367-5931(00)00215-5; BARNA JCJ, 1984, ANNU REV MICROBIOL, V38, P339, DOI 10.1146/annurev.mi.38.100184.002011; Bernhardt TG, 2001, SCIENCE, V292, P2326, DOI 10.1126/science.1058289; Branstrom AA, 2000, FEMS MICROBIOL LETT, V191, P187, DOI 10.1111/j.1574-6968.2000.tb09338.x; BUGG TDH, 1991, BIOCHEMISTRY-US, V30, P2017, DOI 10.1021/bi00222a002; Ge M, 1999, SCIENCE, V284, P507, DOI 10.1126/science.284.5413.507; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Kerns R, 2000, J AM CHEM SOC, V122, P12608, DOI 10.1021/ja0027665; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Lommatzsch J, 1997, J BACTERIOL, V179, P5465, DOI 10.1128/jb.179.17.5465-5470.1997; NAGARAJAN R, 1989, J ANTIBIOT, V42, P63, DOI 10.7164/antibiotics.42.63; Novak R, 1999, NATURE, V399, P590, DOI 10.1038/21202; SAMPSON BA, 1989, GENETICS, V122, P491; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; Silhavy T.J., 1984, EXPT GENE FUSIONS; SINGER M, 1989, MICROBIOL REV, V53, P1; TOMASZ A, 1970, NATURE, V227, P138, DOI 10.1038/227138a0; TUOMANEN E, 1986, J GEN MICROBIOL, V132, P1297; UMEDA M, 1991, GENE, V98, P1, DOI 10.1016/0378-1119(91)90096-T; VANHEIJENOORT Y, 1987, J GEN MICROBIOL, V133, P667; Vollmer W, 1999, J BIOL CHEM, V274, P6726, DOI 10.1074/jbc.274.10.6726; Williams DH, 1999, ANGEW CHEM INT EDIT, V38, P1173, DOI 10.1002/(SICI)1521-3773(19990503)38:9<1172::AID-ANIE1172>3.0.CO;2-C; YAMAGUCHI K, 1988, CELL, V53, P423, DOI 10.1016/0092-8674(88)90162-6; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zelenitsky SA, 1997, ANTIMICROB AGENTS CH, V41, P1407, DOI 10.1128/AAC.41.6.1407	25	111	115	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2001	294	5541					361	364		10.1126/science.1063611	http://dx.doi.org/10.1126/science.1063611			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482WZ	11520949				2022-12-01	WOS:000171601400040
J	Lendon, C; Craddock, N				Lendon, C; Craddock, N			Is LBP-1c/CP2/LSF a disease-modifying gene for Alzheimer's disease?	LANCET			English	Editorial Material							CHROMOSOME-12; LOCUS; HETEROGENEITY		Univ Birmingham, Queen Elizabeth Psychiat Hosp, Dept Psychiat, Div Neurosci, Birmingham B15 2QZ, W Midlands, England	University of Birmingham	Lendon, C (corresponding author), Univ Birmingham, Queen Elizabeth Psychiat Hosp, Dept Psychiat, Div Neurosci, Birmingham B15 2QZ, W Midlands, England.							Blacker D, 1998, NAT GENET, V19, P357, DOI 10.1038/1243; Craddock N, 1998, LANCET, V352, P1720, DOI 10.1016/S0140-6736(98)00075-0; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; Lambert JC, 2000, HUM MOL GENET, V9, P2275, DOI 10.1093/oxfordjournals.hmg.a018918; Lendon CL, 1997, NEUROSCI LETT, V222, P187, DOI 10.1016/S0304-3940(97)13381-X; Martin ES, 1998, JAMA-J AM MED ASSOC, V279, P433, DOI 10.1001/jama.279.6.433; PericakVance MA, 1997, JAMA-J AM MED ASSOC, V278, P1237, DOI 10.1001/jama.278.15.1237; Rogaeva E, 1998, JAMA-J AM MED ASSOC, V280, P614, DOI 10.1001/jama.280.7.614; Schellenberg G D, 2000, Curr Psychiatry Rep, V2, P158, DOI 10.1007/s11920-000-0061-z; Scott WK, 2000, AM J HUM GENET, V66, P922, DOI 10.1086/302828; Taylor AE, 2001, J MED GENET, V38, P232, DOI 10.1136/jmg.38.4.232; Wu WS, 1998, JAMA-J AM MED ASSOC, V280, P619, DOI 10.1001/jama.280.7.619	12	10	10	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 29	2001	358	9287					1029	1030		10.1016/S0140-6736(01)06228-6	http://dx.doi.org/10.1016/S0140-6736(01)06228-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479EY	11589929				2022-12-01	WOS:000171393100004
J	Chiappe, LM; Salgado, L; Coria, RA				Chiappe, LM; Salgado, L; Coria, RA			Embryonic skulls of titanosaur sauropod dinosaurs	SCIENCE			English	Article								Little is known about the cranial anatomy of the taxonomically diverse and geographically widespread titanosaurs, a paucity that has hindered inferences about the genealogical history and evolutionary development of the latest sauropod dinosaurs. Newly discovered fossil eggs containing embryonic remains from the Late Cretaceous of Argentina provide the first articulated skulls of titanosaur dinosaurs. The nearly complete fetal skulls shed light on the evolution of some of the most notable cranial features of sauropod dinosaurs, including the retraction of the external nares, the forward rotation of the braincase, and the abbreviation of the infraorbital region.	Nat Hist Museum Los Angeles, Dept Vertebrate Paleontol, Los Angeles, CA 90007 USA; Univ Nacl Comahue, Museo Geol & Paleontol, RA-8300 Neuquen, Argentina; Museo Carmen Funes, RA-8318 Plaza Huincul, Neuquen, Argentina	Universidad Nacional del Comahue	Chiappe, LM (corresponding author), Nat Hist Museum Los Angeles, Dept Vertebrate Paleontol, 900 Exposit Blvd, Los Angeles, CA 90007 USA.	lchiappe@nhm.org		Chiappe, Luis/0000-0001-9661-0601				Calvo Jorge O., 1994, Gaia, V10, P183; Chiappe L. M., 2001, WALKING EGGS; Chiappe L.M., 2000, 1 INT S DIN EGGS BAB, P23; Chiappe LM, 1998, NATURE, V396, P258, DOI 10.1038/24370; Coria RA, 1999, AMEGHINIANA, V36, P98; Dingus Lowell, 2000, American Museum Novitates, V3290, P1, DOI 10.1206/0003-0082(2000)290<0001:SAMFCF>2.0.CO;2; JACOBS LL, 1993, PALAEONTOLOGY, V36, P523; McIntosh J.S., 1990, P345; MCINTOSH JS, 1997, ENCY DINOSAURS, P664; Powell JE, 1986, THESIS U NACL TUCUMA; Rogers KC, 2001, NATURE, V412, P530, DOI 10.1038/35087566; Salgado Leonardo, 1997, Ameghiniana, V34, P33; Shubin Neil H., 1994, P249; Upchurch P, 1999, J VERTEBR PALEONTOL, V19, P106, DOI 10.1080/02724634.1999.10011127; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115	15	103	111	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2001	293	5539					2444	2446		10.1126/science.1063723	http://dx.doi.org/10.1126/science.1063723			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11577234				2022-12-01	WOS:000171237200044
J	Isozaki, Y				Isozaki, Y			An extraterrestrial impact at the Permian-Triassic boundary?	SCIENCE			English	Editorial Material									Univ Tokyo, Dept Earth Sci & Astron, Tokyo 1538902, Japan	University of Tokyo	Isozaki, Y (corresponding author), Univ Tokyo, Dept Earth Sci & Astron, Tokyo 1538902, Japan.		Isozaki, Yukio/A-1806-2009	Isozaki, Yukio/0000-0002-3596-581X				Becker L, 2001, SCIENCE, V291, P1530, DOI 10.1126/science.1057243; Isozaki Y, 1997, SCIENCE, V276, P235, DOI 10.1126/science.276.5310.235; Kakuwa Y, 1996, PALAEOGEOGR PALAEOCL, V121, P35, DOI 10.1016/0031-0182(95)00070-4; Kuwahara K., 1991, Journal of the Geological Society of Japan, V97, P1005	4	35	35	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2001	293	5539					2343	2343						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11579934				2022-12-01	WOS:000171237200002
J	Macfarlane, GJ; McBeth, J; Silman, AJ				Macfarlane, GJ; McBeth, J; Silman, AJ			Widespread body pain and mortality: prospective population based study	BRITISH MEDICAL JOURNAL			English	Article							LOW-BACK-PAIN; GENERAL-POPULATION; FIBROMYALGIA SYNDROME; PREVALENCE; CANCER	Objective To determine whether there is excess mortality in groups of people who report widespread body pain, and if so to establish the nature and extent of any excess. Design Prospective follow up study over eight years. Mortality rate ratios were adjusted for age group, sex, and study location. Setting North west England. Participants 6569 people who took part in two pain surveys during 1991-2. Main outcome measures Pain status at baseline and subsequent mortality. Results 1005 (15%) participants had widespread pain, 3176 (48%) had regional pain, and 2388 (36%) had no pain. During follow up mortality was higher in people with regional pain (mortality rate ratio 1.21, 95% confidence interval 1.01 to 1.44) and widespread pain (1.31, 1.05 to 1.65) than in those who reported no pain. The excess mortality among people with regional and widespread pain was almost entirely related to deaths from cancer (1.55 (1.09 to 2.19) for regional pain and 2.07 (1.37 to 3.13) for widespread pain). The excess cancer mortality remained after exclusion of people in whom cancer had been diagnosed before the original survey and after adjustment for potential confounding factors. There were also more deaths from causes other than disease (for example, accidents, suicide, violence) among people with widespread pain (5.21, 0.94 to 28.78). Conclusion There is an intriguing association between the report of widespread pain and subsequent death from cancer in the medium and long term. This may have implications for the long term follow up of patients with "unexplained widespread pain symptoms, such as those with fibromyalgia.	Univ Manchester, Sch Med, Unit Chron Dis Epidemiol, Manchester M13 9PT, Lancs, England; Univ Manchester, Sch Med, Arthrit Res Campaign Epidemiol Unit, Manchester M13 9PT, Lancs, England	University of Manchester; University of Manchester	Macfarlane, GJ (corresponding author), Univ Manchester, Sch Med, Unit Chron Dis Epidemiol, Manchester M13 9PT, Lancs, England.		McBeth, John/AAG-1954-2019; Macfarlane, Gary J/I-9521-2014	Macfarlane, Gary J/0000-0003-2322-3314; McBeth, John/0000-0001-7047-2183				Andersson HI, 1996, SCAND J RHEUMATOL, V25, P146, DOI 10.3109/03009749609080005; BOISSETPIORO MH, 1995, ARTHRITIS RHEUM, V38, P235, DOI 10.1002/art.1780380212; COX T, 1982, SOC SCI MED, V16, P381, DOI 10.1016/0277-9536(82)90048-X; CROFT P, 1993, J RHEUMATOL, V20, P710; Goldberg D., 1988, USERS GUIDE GEN HLTH; HAWLEY DJ, 1988, J RHEUMATOL, V15, P1551; Hunt IM, 1999, RHEUMATOLOGY, V38, P275, DOI 10.1093/rheumatology/38.3.275; International Association for the Study of Pain, 1986, PAIN S, V3, P1; McBeth J, 2001, RHEUMATOLOGY, V40, P95, DOI 10.1093/rheumatology/40.1.95; McBeth J, 2001, ARTHRITIS RHEUM, V44, P940, DOI 10.1002/1529-0131(200104)44:4<940::AID-ANR151>3.0.CO;2-S; MCBETH J, IN PRESS J RHEUMATOL; *OFF NAT STAT, 1998, SER DH1, V31; PAPAGEORGIOU AC, 1995, SPINE, V20, P1889, DOI 10.1097/00007632-199509000-00009; PAPAGEORGIOUS AC, 1997, SPINE, V22, P137; SHEKELLE RB, 1981, PSYCHOSOM MED, V43, P117, DOI 10.1097/00006842-198104000-00003; Spiegel D, 1998, ANN NY ACAD SCI, V840, P674, DOI 10.1111/j.1749-6632.1998.tb09606.x; Spiegel D, 1996, BRIT J PSYCHIAT, V168, P109, DOI 10.1192/S0007125000298486; WALSH K, 1992, J EPIDEMIOL COMMUN H, V46, P227, DOI 10.1136/jech.46.3.227; White KP, 1999, J RHEUMATOL, V26, P1570; WOLFE F, 1995, ARTHRITIS RHEUM-US, V38, P19, DOI 10.1002/art.1780380104; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203	21	149	150	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 22	2001	323	7314					662	664B		10.1136/bmj.323.7314.662	http://dx.doi.org/10.1136/bmj.323.7314.662			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	476LP	11566829	Bronze, Green Published			2022-12-01	WOS:000171228800016
J	Williams, JA; Su, HS; Bernards, A; Field, J; Sehgal, A				Williams, JA; Su, HS; Bernards, A; Field, J; Sehgal, A			A circadian output in Drosophila mediated by neurofibromatosis-1 and Ras/MAPK	SCIENCE			English	Article							ACTIVATED PROTEIN-KINASE; PATHWAY; CLOCK; RAS; SEVENLESS; RHYTHMS; SON; PHOSPHORYLATION; MELANOGASTER; GENES	Output from the circadian clock controls rhythmic behavior through poorly understood mechanisms. In Drosophila, null mutations of the neurofibromatosis-1 (Nf1) gene produce abnormalities of circadian rhythms in locomotor activity. Mutant flies show normal oscillations of the clock genes period (per) and timeless (tim) and of their corresponding proteins, but altered oscillations and levels of a clock-controlled reporter. Mitogen-activated protein kinase (MAPK) activity is increased in Nf1 mutants, and the circadian phenotype is rescued by loss-of-function mutations in the Ras/MAPK pathway. Thus, Nf1 signals through Ras/MAPK in Drosophila. Immunohistochemical staining revealed a circadian oscillation of phospho-MAPK in the vicinity of nerve terminals containing pigment-dispersing factor (PDF), a secreted output from clock cells, suggesting a coupling of PDF to Ras/MAPK signaling.	Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Sleep & Resp Neurobiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Harvard University; Massachusetts General Hospital	Sehgal, A (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.							Akashi M, 2000, GENE DEV, V14, P645; Belvin MP, 1999, NEURON, V22, P777, DOI 10.1016/S0896-6273(00)80736-9; BONFINI L, 1992, SCIENCE, V255, P603, DOI 10.1126/science.1736363; CHERNIACK AD, 1994, J BIOL CHEM, V269, P4717; CorbalanGarcia S, 1996, MOL CELL BIOL, V16, P5674; Guo HF, 2000, NATURE, V403, P895, DOI 10.1038/35002593; Harada Y, 2000, J BIOL CHEM, V275, P37078, DOI 10.1074/jbc.M004706200; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; HICKMAN L, UNPUB; Howe AK, 2000, NAT CELL BIOL, V2, P593, DOI 10.1038/35023536; Huang AM, 2000, GENETICS, V156, P1219; Ko GYP, 2001, NEURON, V29, P255, DOI 10.1016/S0896-6273(01)00195-7; Krishnan B, 2001, NATURE, V411, P313, DOI 10.1038/35077094; LEVINE JD, 1994, NEURON, V13, P967, DOI 10.1016/0896-6273(94)90262-3; MAJORCAK J, 1997, MOL CELL BIOL, V17, P5915; MCCORMICK F, 1995, CURR OPIN GENET DEV, V5, P51, DOI 10.1016/S0959-437X(95)90053-5; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; ROGGE RD, 1991, CELL, V64, P39, DOI 10.1016/0092-8674(91)90207-F; Sanada K, 2000, J NEUROSCI, V20, P986, DOI 10.1523/JNEUROSCI.20-03-00986.2000; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; The I, 1997, SCIENCE, V276, P791, DOI 10.1126/science.276.5313.791; VISCKOCHIL D, 1993, ANNU REV NEUROSCI, V16, P183; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959	26	168	174	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2001	293	5538					2251	2256		10.1126/science.1063097	http://dx.doi.org/10.1126/science.1063097			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11567138				2022-12-01	WOS:000171139400043
J	Kim, SK; Lund, J; Kiraly, M; Duke, K; Jiang, M; Stuart, JM; Eizinger, A; Wylie, BN; Davidson, GS				Kim, SK; Lund, J; Kiraly, M; Duke, K; Jiang, M; Stuart, JM; Eizinger, A; Wylie, BN; Davidson, GS			A gene expression map for Caenorhabditis elegans	SCIENCE			English	Article							FUNCTIONAL GENOMIC ANALYSIS; PROTEIN; ORGANIZATION; MICROARRAY; MUTATIONS; DISCOVERY; PATTERNS; RNAI	We have assembled data from Caenorhabditis elegans DNA microarray experiments involving many growth conditions, developmental stages, and varieties of mutants. Co-regulated genes were grouped together and visualized in a three-dimensional expression map that displays correlations of gene expression profiles as distances in two dimensions and gene density in the third dimension. The gene expression map can be used as a gene discovery toot to identify genes that are co-regulated with known sets of genes (such as heat shock, growth control genes, germ line genes, and so forth) or to uncover previously unknown genetic functions (such as genomic instability in mates and sperm caused by specific transposons).	Stanford Univ, Sch Med, Dept Dev Biol & Genet, Stanford, CA 94305 USA; Stanford Med Informat, Stanford, CA 94305 USA; Sandia Natl Labs, Computat Comp & Math Ctr, Albuquerque, NM 87185 USA	Stanford University; Stanford University; United States Department of Energy (DOE); Sandia National Laboratories	Kim, SK (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol & Genet, Stanford, CA 94305 USA.	kim@cmgm.stanford.edu		Lund, Jim/0000-0002-1437-8448; Stuart, Joshua/0000-0002-2171-565X				Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chen SH, 1999, J BIOL CHEM, V274, P288, DOI 10.1074/jbc.274.1.288; Costanzo MC, 2000, NUCLEIC ACIDS RES, V28, P73, DOI 10.1093/nar/28.1.73; Davidson GS, 1998, J INTELL INF SYST, V11, P259, DOI 10.1023/A:1008690008856; DAVIDSON GS, IN PRESS IEEE S INF; DeRisi J, 1996, NAT GENET, V14, P457; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; EDGAR LG, 1986, DEV BIOL, V114, P109, DOI 10.1016/0012-1606(86)90387-8; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FERGUSON EL, 1989, GENETICS, V123, P109; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; FREEDMAN JH, 1993, J BIOL CHEM, V268, P2554; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Kim S.O., UNPUB; Kim SK, 1997, CURR OPIN CELL BIOL, V9, P853, DOI 10.1016/S0955-0674(97)80088-9; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; LHernault SW, 1995, METHOD CELL BIOL, V48, P273; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Lyon CJ, 2000, GENE, V252, P147, DOI 10.1016/S0378-1119(00)00213-4; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Piano F, 2000, CURR BIOL, V10, P1619, DOI 10.1016/S0960-9822(00)00869-1; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; ROGALSKI TM, 1993, GENE DEV, V7, P1471, DOI 10.1101/gad.7.8.1471; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shalon D, 1996, GENOME RES, V6, P639, DOI 10.1101/gr.6.7.639; VILLENEUVE AM, COMMUNICATION; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116	31	510	526	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2087	2092		10.1126/science.1061603	http://dx.doi.org/10.1126/science.1061603			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557892				2022-12-01	WOS:000171028700074
J	Hu, FB; Manson, JE; Stampfer, MJ; Colditz, G; Liu, S; Solomon, CG; Willett, WC				Hu, FB; Manson, JE; Stampfer, MJ; Colditz, G; Liu, S; Solomon, CG; Willett, WC			Diet, lifestyle, and the risk of type 2 diabetes mellitus in women.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; PHYSICAL-ACTIVITY; CIGARETTE-SMOKING; GLYCEMIC LOAD; FAT INTAKE; WEIGHT; PREVENTION; FIBER; HEALTH; NIDDM	Background: Previous studies have examined individual dietary and lifestyle factors in relation to type 2 diabetes, but the combined effects of these factors are largely unknown. Methods: We followed 84,941 female nurses from 1980 to 1996; these women were free of diagnosed cardiovascular disease, diabetes, and cancer at base line. Information about their diet and lifestyle was updated periodically. A low-risk group was defined according to a combination of five variables: a body-mass index (the weight in kilograms divided by the square of the height in meters) of less than 25; a diet high in cereal fiber and polyunsaturated fat and low in trans fat and glycemic load (which reflects the effect of diet on the blood glucose level); engagement in moderate-to-vigorous physical activity for at least half an hour per day; no current smoking; and the consumption of an average of at least half a drink of an alcoholic beverage per day. Results: During 16 years of follow-up, we documented 3300 new cases of type 2 diabetes. Overweight or obesity was the single most important predictor of diabetes. Lack of exercise, a poor diet, current smoking, and abstinence from alcohol use were all associated with a significantly increased risk of diabetes, even after adjustment for the body-mass index. As compared with the rest of the cohort, women in the low-risk group (3.4 percent of the women) had a relative risk of diabetes of 0.09 (95 percent confidence interval, 0.05 to 0.17). A total of 91 percent of the cases of diabetes in this cohort (95 percent confidence interval, 83 to 95 percent) could be attributed to habits and forms of behavior that did not conform to the low-risk pattern. Conclusions: Our findings support the hypothesis that the majority of cases of type 2 diabetes could be prevented by the adoption of a healthier lifestyle. (N Engl J Med 2001;345:790-7.) Copyright (C) 2001 Massachusetts Medical Society.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA USA; Brigham & Womens Hosp, Dept Med, Div Gen Med, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	frank.hu@channing.harvard.edu	Hu, Frank/C-1919-2013; Colditz, Graham/A-3963-2009; Liu, Simin/GSN-4159-2022; Liu, Simin/I-3689-2014; Robles-Sardin, Alma E/M-7714-2015	Colditz, Graham/0000-0002-7307-0291; Liu, Simin/0000-0003-2098-3844; Robles-Sardin, Alma E/0000-0003-2044-7793	NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036798] Funding Source: NIH RePORTER; NCI NIH HHS [CA87969] Funding Source: Medline; NIDDK NIH HHS [DK36798] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ajani UA, 2000, ARCH INTERN MED, V160, P1025, DOI 10.1001/archinte.160.7.1025; [Anonymous], 1996, JAMA, V276, P241; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; COLDITZ GA, 1990, AM J EPIDEMIOL, V132, P501, DOI 10.1093/oxfordjournals.aje.a115686; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Gavin JR, 1997, DIABETES CARE, V20, P1183; HARRIS M, 1979, DIABETES, V28, P1039; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547; Jeffery RW, 2000, HEALTH PSYCHOL, V19, P5, DOI 10.1037/0278-6133.19.Suppl1.5; Liu SM, 2001, AM J CLIN NUTR, V73, P560; Liu SM, 2000, AM J PUBLIC HEALTH, V90, P1409, DOI 10.2105/AJPH.90.9.1409; Lynch J, 1996, ARCH INTERN MED, V156, P1307, DOI 10.1001/archinte.156.12.1307; MANNING A, 2001, US TODAY        0108, pD7; Manson JE, 2000, AM J MED, V109, P538, DOI 10.1016/S0002-9343(00)00568-4; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; Meyer KA, 2000, AM J CLIN NUTR, V71, P921; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; RIMM EB, 1995, BRIT MED J, V310, P555, DOI 10.1136/bmj.310.6979.555; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; Salmeron J, 1997, DIABETES CARE, V20, P545, DOI 10.2337/diacare.20.4.545; Salmeron J, 2001, AM J CLIN NUTR, V73, P1019; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vessby B, 2000, BRIT J NUTR, V83, pS91; WACHOLDER S, 1994, AM J EPIDEMIOL, V140, P668; Wei M, 2000, DIABETES CARE, V23, P18, DOI 10.2337/diacare.23.1.18; WHO, 1998, OB PREV MAN GLOB EP; Willet W., 1998, NUTR EPIDEMIOLOGY, P74, DOI DOI 10.1093/ACPROF:OSO/9780195122978.001.0001; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086	39	1868	1933	6	341	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2001	345	11					790	797		10.1056/NEJMoa010492	http://dx.doi.org/10.1056/NEJMoa010492			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471BK	11556298				2022-12-01	WOS:000170906800003
J	Schwetz, BA				Schwetz, BA			New FDA Web sites	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1166	1166		10.1001/jama.286.10.1166	http://dx.doi.org/10.1001/jama.286.10.1166			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471CR	11559244				2022-12-01	WOS:000170910400007
J	Wentworth, P; Jones, LH; Wentworth, AD; Zhu, XY; Larsen, NA; Wilson, IA; Xu, X; Goddard, WA; Janda, KD; Eschenmoser, A; Lerner, RA				Wentworth, P; Jones, LH; Wentworth, AD; Zhu, XY; Larsen, NA; Wilson, IA; Xu, X; Goddard, WA; Janda, KD; Eschenmoser, A; Lerner, RA			Antibody catalysis of the oxidation of water	SCIENCE			English	Article							HYDROGEN TRIOXIDE HOOOH; LOW-TEMPERATURE OZONATION; MOLECULAR-OXYGEN; SINGLET OXYGEN; PEROXIDE; PHOTOOXIDATION; DECOMPOSITION; TRYPTOPHAN; MECHANISM; SEQUENCE	Recently we reported that antibodies can generate hydrogen peroxide (H2O2) from singlet molecular oxygen (O-1(2)*), We now show that this process is catalytic, and we identify the electron source for a quasi-unlimited generation of H2O2. Antibodies produce up to 500 mote equivalents of H2O2 from O-1(2)*, without a reduction in rate, and we have excluded metals or Cl- as the electron source. On the basis of isotope incorporation experiments and kinetic data, we propose that antibodies use H2O as an electron source, facilitating its addition to O-1(2)* to form H2O3 as the first intermediate in a reaction cascade that eventually leads to H2O2. X-ray crystallographic studies with xenon point to putative conserved oxygen binding sites within the antibody fold where this chemistry could be initiated. Our findings suggest a protective function of immunoglobulins against O-1(2)* and raise the question of whether the need to detoxify O-1(2)* has played a decisive role in the evolution of the immunoglobulin fold.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; CALTECH, Div Chem & Chem Engn, Mat & Proc Simulat Ctr, Pasadena, CA 91125 USA; ETH Zurich, Organ Chem Lab, CH-8092 Zurich, Switzerland	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; California Institute of Technology; Swiss Federal Institutes of Technology Domain; ETH Zurich	Wentworth, P (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Zhu, Xueyong/ABE-3068-2021	Xu, Xin/0000-0002-5247-2937; Jones, Lyn/0000-0002-8388-5865	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD036385] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA027489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM043858, R01GM043858] Funding Source: NIH RePORTER; NCI NIH HHS [CA27489] Funding Source: Medline; NICHD NIH HHS [HD 36385] Funding Source: Medline; NIGMS NIH HHS [GM43858] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cacace F, 1999, SCIENCE, V285, P81, DOI 10.1126/science.285.5424.81; Cannac-Caffrey V, 1998, BIOCHIMIE, V80, P1003, DOI 10.1016/S0300-9084(99)80005-4; CERKOVNIK J, 1993, J AM CHEM SOC, V115, P12169, DOI 10.1021/ja00078a067; COREY EJ, 1986, J AM CHEM SOC, V108, P2472, DOI 10.1021/ja00269a070; Datta D., UNPUB; DEBY C, 1991, RECHERCHE, V228, P378; DETTY MR, 1990, J AM CHEM SOC, V112, P4086, DOI 10.1021/ja00166a083; FOOTE CS, 1968, ACCOUNTS CHEM RES, V1, P104, DOI 10.1021/ar50004a002; FOWLER AV, 1978, J BIOL CHEM, V253, P5521; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Han J, 1996, ANAL BIOCHEM, V234, P107, DOI 10.1006/abio.1996.0059; KANOFSKY JR, 1989, CHEM-BIOL INTERACT, V70, P1, DOI 10.1016/0009-2797(89)90059-8; Koller J, 1996, J AM CHEM SOC, V118, P2470, DOI 10.1021/ja9503387; LI TY, 1995, J AM CHEM SOC, V117, P3308, DOI 10.1021/ja00116a050; LIDE DR, 1992, HDB CHEM PHYSICS, P73; MCCORMICK JP, 1978, J AM CHEM SOC, V100, P312, DOI 10.1021/ja00469a068; Plesnicar B, 2000, CHEM-EUR J, V6, P809; Prange T, 1998, PROTEINS, V30, P61, DOI 10.1002/(SICI)1097-0134(19980101)30:1<61::AID-PROT6>3.0.CO;2-N; Sawyer D. T., 1991, OXYGEN CHEM; SCHARF HD, 1979, CATAL CHEM BIOCH THE, V12, P355; SCHOENBORN BP, 1965, NATURE, V207, P28, DOI 10.1038/207028a0; Scott EE, 1997, BIOCHEMISTRY-US, V36, P11909, DOI 10.1021/bi970719s; TILSON RF, 1988, J MOL BIOL, V199, P195; VINCENT MA, 1995, J PHYS CHEM-US, V99, P3109, DOI 10.1021/j100010a021; WALRANT P, 1974, PHOTOCHEM PHOTOBIOL, V19, P411, DOI 10.1111/j.1751-1097.1974.tb06533.x; WELINDER KG, 1991, MOL IMMUNOL, V28, P177, DOI 10.1016/0161-5890(91)90102-P; Wentworth AD, 2000, P NATL ACAD SCI USA, V97, P10930, DOI 10.1073/pnas.97.20.10930; WILKINSON F, 1993, J PHYS CHEM REF DATA, V22, P113, DOI 10.1063/1.555934; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	29	241	258	8	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1806	1811		10.1126/science.1062722	http://dx.doi.org/10.1126/science.1062722			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546867				2022-12-01	WOS:000170894400040
J	Reynolds, JNJ; Hyland, BI; Wickens, JR				Reynolds, JNJ; Hyland, BI; Wickens, JR			A cellular mechanism of reward-related learning	NATURE			English	Article							MEMBRANE-POTENTIAL FLUCTUATIONS; NIGROSTRIATAL DOPAMINE SYSTEM; VENTRAL TEGMENTAL AREA; SELF-STIMULATION; SPINY NEURONS; IN-VIVO; BRAIN-STIMULATION; RAT NEOSTRIATUM; NEURAL-NETWORK; BASAL GANGLIA	Positive reinforcement helps to control the acquisition of learned behaviours. Here we report a cellular mechanism in the brain that may underlie the behavioural effects of positive reinforcement. We used intracranial self-stimulation (ICSS) as a model of reinforcement learning(1), in which each rat learns to press a lever that applies reinforcing electrical stimulation to its own substantia nigra(2,3). The outputs from neurons of the substantia nigra terminate on neurons in the striatum in close proximity to inputs from the cerebral cortex on the same striatal neurons(4). We measured the effect of substantia nigra stimulation on these inputs from the cortex to striatal neurons and also on how quickly the rats learned to press the lever. We found that stimulation of the substantia nigra (with the optimal parameters for lever-pressing behaviour) induced potentiation of synapses between the cortex and the striatum, which required activation of dopamine receptors. The degree of potentiation within ten minutes of the ICSS trains was correlated with the time taken by the rats to learn ICSS behaviour.	Univ Otago, Sch Med Sci, Neurosci Res Ctr, Dunedin, New Zealand; Univ Otago, Sch Med Sci, Dept Anat & Struct Biol, Dunedin, New Zealand; Univ Otago, Sch Med Sci, Dept Physiol, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago	Wickens, JR (corresponding author), Univ Otago, Sch Med Sci, Neurosci Res Ctr, Dunedin, New Zealand.		Reynolds, John/C-5636-2009; Hyland, Brian I/F-7840-2012; Wickens, Jeffery R/N-6055-2014	Hyland, Brian I/0000-0001-7593-4885; Wickens, Jeffery R/0000-0002-8795-1209				ALEXANDER GE, 1990, J NEUROPHYSIOL, V64, P133, DOI 10.1152/jn.1990.64.1.133; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; [Anonymous], [No title captured]; AOSAKI T, 1994, SCIENCE, V265, P412, DOI 10.1126/science.8023166; BENINGER RJ, 1977, SCIENCE, V196, P547, DOI 10.1126/science.850798; BIELAJEW C, 1986, J NEUROSCI, V6, P919; Charpier S, 1997, P NATL ACAD SCI USA, V94, P7036, DOI 10.1073/pnas.94.13.7036; CORBETT D, 1980, BRAIN RES, V185, P1, DOI 10.1016/0006-8993(80)90666-6; FIBIGER HC, 1987, J NEUROSCI, V7, P3888; HODOS W, 1962, J COMP PHYSIOL PSYCH, V55, P80, DOI 10.1037/h0047681; HUNT GE, 1994, PHARMACOL BIOCHEM BE, V48, P853, DOI 10.1016/0091-3057(94)90192-9; KIMURA M, 1990, J NEUROPHYSIOL, V63, P1277, DOI 10.1152/jn.1990.63.6.1277; MAJOR R, 1978, PHYSIOL BEHAV, V20, P723, DOI 10.1016/0031-9384(78)90298-6; Matsumoto N, 1999, J NEUROPHYSIOL, V82, P978, DOI 10.1152/jn.1999.82.2.978; MILLER RM, 1981, MEANING PURPOSE INTA, P62; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Reynolds JNJ, 2000, NEUROSCIENCE, V99, P199, DOI 10.1016/S0306-4522(00)00273-6; REYNOLDS RW, 1958, J COMP PHYSIOL PSYCH, V51, P193, DOI 10.1037/h0048362; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; SMITH AD, 1990, TRENDS NEUROSCI, V13, P259; Stern EA, 1998, NATURE, V394, P475, DOI 10.1038/28848; Suri RE, 1999, NEUROSCIENCE, V91, P871, DOI 10.1016/S0306-4522(98)00697-6; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; WILSON CJ, 1981, BRAIN RES, V220, P67, DOI 10.1016/0006-8993(81)90211-0; WILSON CJ, 1986, BRAIN RES, V367, P201, DOI 10.1016/0006-8993(86)91593-3; Wilson CJ, 1996, J NEUROSCI, V16, P2397; Wise RA, 1996, ANNU REV NEUROSCI, V19, P319, DOI 10.1146/annurev.ne.19.030196.001535	30	559	572	0	38	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					67	70		10.1038/35092560	http://dx.doi.org/10.1038/35092560			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544526				2022-12-01	WOS:000170801200039
J	Benhamou, Y; Bochet, M; Thibault, V; Calvez, V; Fievet, MH; Vig, P; Gibbs, CS; Brosgart, C; Fry, J; Namini, H; Katiama, C; Poynard, T				Benhamou, Y; Bochet, M; Thibault, V; Calvez, V; Fievet, MH; Vig, P; Gibbs, CS; Brosgart, C; Fry, J; Namini, H; Katiama, C; Poynard, T			Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study	LANCET			English	Article							MUTATIONS; IDENTIFICATION; REINFECTION; FAMCICLOVIR; THERAPY; TRIAL	Background Lamivudine-resistant hepatitis B virus (HBV) is found in about 15-32% of infected patients with or without co-infection with HIV-1 after 1 year of lamivudine therapy. Adefovir dipivoxil is active in vivo and in vitro against wild-type and lamivudine-resistant HBV. We assessed the safety and efficacy of a once daily dose of adefovir dipivoxil in an open-label trial for the treatment of lamivudine-resistant HBV infection in HIV-1-infected patients. Methods 35 HIV-1/HBV co-infected patients receiving lamivudine therapy (150 mg twice daily) as part of their current HIV-1 antiretroviral regimen were enrolled. Patients received a 10 mg once-daily dose of adefovir dipivoxil for 48 weeks while maintaining their existing anti-HIV-1 therapy, including lamivudine. Patients were assessed every 4 weeks for safety and efficacy. Findings Four patients withdrew from the study (two because of adverse events), leaving 31 patients who received adefovir dipivoxil for a median of 48 weeks (range 44-48). Mean decreases in serum HBV DNA concentrations from baseline (log 8.64 copies/mL [SE log 0.08]) were -log 3.40 copies/mL [log 0.12] at week 24 (n=31) and -log 4.01 copies/mL [log 0.17] at week 48 (n=29; p<0.0001). Two patients underwent hepatitis B e antigen seroconversion-one at week 32 and one at week 36. Adefovir dipivoxil was generally well tolerated, but was associated with a transient increase in serum alanine aminotransferase concentrations in 15 patients. We found no significant changes in either HIV-1 RNA or CD4 cell count. Interpretation These results indicate that 48 weeks of 10 mg daily adefovir dipivoxil is well tolerated and active against lamivudine-resistant HBV in HIV-1/HBV co-infected patients.	Grp Hosp Pitie Salpetriere, Serv Hepatogastroenterol, F-75651 Paris 13, France; Grp Hosp Pitie Salpetriere, Serv Malad Infect, F-75651 Paris 13, France; Grp Hosp Pitie Salpetriere, Virol Lab, F-75651 Paris 13, France; Grp Hosp Pitie Salpetriere, Serv Pharm, F-75651 Paris 13, France; Univ Paris 06, CNRS, UPRESA 8087, Paris, France; Gilead Sci Inc, Foster City, CA 94404 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Gilead Sciences	Benhamou, Y (corresponding author), Grp Hosp Pitie Salpetriere, Serv Hepatogastroenterol, 27 Blvd Hop, F-75651 Paris 13, France.	ybenhamou@teaser.fr	THIBAULT, Vincent/AAB-5241-2020; Poynard, Thierry/C-1355-2010; THIBAULT, Vincent/J-7193-2015	THIBAULT, Vincent/0000-0001-6517-2901; Poynard, Thierry/0000-0002-3726-7230; THIBAULT, Vincent/0000-0001-6517-2901; Poynard, Thierry/0000-0002-2050-640X				Allen MI, 1998, HEPATOLOGY, V27, P1670, DOI 10.1002/hep.510270628; Atkins M, 1998, HEPATOLOGY, V28, p319A; Bartholomew MM, 1997, LANCET, V349, P20, DOI 10.1016/S0140-6736(96)02266-0; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Benhamou Y, 1996, ANN INTERN MED, V125, P705, DOI 10.7326/0003-4819-125-9-199611010-00001; Benhamou Y, 1999, HEPATOLOGY, V30, P1302, DOI 10.1002/hep.510300525; CHANG TT, 2000, ANTIVIR THER S, V5, P44; Colin JF, 1999, HEPATOLOGY, V29, P1306, DOI 10.1002/hep.510290447; DIENSTAG JL, 1995, NEW ENGL J MED, V333, P1657, DOI 10.1056/NEJM199512213332501; Gilson RJC, 1999, J VIRAL HEPATITIS, V6, P387, DOI 10.1046/j.1365-2893.1999.00182.x; Hardy H, 2001, ANN PHARMACOTHER, V35, P343, DOI 10.1345/aph.10044; Heathcote EJ, 1998, HEPATOLOGY, V28, p317A; Kahn J, 1999, JAMA-J AM MED ASSOC, V282, P2305, DOI 10.1001/jama.282.24.2305; KANE MA, 1993, GUT, V34, pS10, DOI 10.1136/gut.34.2_Suppl.S10; Lai CL, 1998, NEW ENGL J MED, V339, P61, DOI 10.1056/NEJM199807093390201; Leung N.W.Y., 1999, Journal of Hepatology, V30, P59; Liaw YF, 1998, GASTROENTEROLOGY, V114, pA1289, DOI 10.1016/S0016-5085(98)85233-5; Nicoll AJ, 1998, ANTIMICROB AGENTS CH, V42, P3130, DOI 10.1128/AAC.42.12.3130; Niesters HGM, 1998, J INFECT DIS, V177, P1382, DOI 10.1086/517819; Perrillo R, 2000, HEPATOLOGY, V32, P129, DOI 10.1053/jhep.2000.8626; Pillay D., 1998, International Antiviral News, V6, P167; RUSTGI VK, 1984, ANN INTERN MED, V101, P795, DOI 10.7326/0003-4819-101-6-795; SCHINAZI R, 2000, ANTIVIRAL NEWS, P8; Schuhbauer H, 1999, WIRTSCHAFTSINF, V41, P58, DOI 10.1007/BF03250636; Thibault V, 1999, J CLIN MICROBIOL, V37, P3013, DOI 10.1128/JCM.37.9.3013-3016.1999; Tillmann HL, 1999, HEPATOLOGY, V30, P244, DOI 10.1002/hep.510300141; Xiong XF, 1998, HEPATOLOGY, V28, P1669, DOI 10.1002/hep.510280629; Xiong XF, 2000, HEPATOLOGY, V31, P219, DOI 10.1002/hep.510310132; Xiong XF, 1997, ANTIVIR RES, V36, P131, DOI 10.1016/S0166-3542(97)00050-8; Yoshida EM, 1998, CAN J GASTROENTEROL, V12, P125, DOI 10.1155/1998/617039	30	241	261	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 1	2001	358	9283					718	723		10.1016/S0140-6736(01)05840-8	http://dx.doi.org/10.1016/S0140-6736(01)05840-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467XR	11551579				2022-12-01	WOS:000170729500012
J	Norell, MA; Makovicky, PJ; Currie, PJ				Norell, MA; Makovicky, PJ; Currie, PJ			Palaeontology - The beaks of ostrich dinosaurs	NATURE			English	Article									Amer Museum Nat Hist, New York, NY 10024 USA; Field Museum Nat Hist, Chicago, IL 60605 USA; Royal Tyrell Museum Palaeontol, Drumheller, AB T0J 0Y0, Canada	American Museum of Natural History (AMNH); Field Museum of Natural History (Chicago)	Norell, MA (corresponding author), Amer Museum Nat Hist, Cent Pk W & 79th St, New York, NY 10024 USA.	norell@amnh.org	Currie, Philip J/A-2628-2014	Currie, Philip J/0000-0001-6857-3161				CURRIE PJ, 1993, CRETACEOUS RES, V14, P127, DOI 10.1006/cres.1993.1011; Eberth D.A., 1997, ENCY DINOSAURS, P379; GOODMAN DC, 1962, FUNCTIONAL ANATOMY F, P1; JERZYKIEWICZ T, 1991, CRETACEOUS RES, V12, P345, DOI 10.1016/0195-6671(91)90015-5; Kobayashi Y, 1999, NATURE, V402, P480, DOI 10.1038/44999; Makovicky Peter J., 1998, American Museum Novitates, V3247, P1; Osborn HF, 1916, B AM MUS NAT HIST, V35, P733; Osmolska H., 1972, Palaeontologia Polonica, VNo. 27, P103; Padian K., 1997, ENCY DINOSAURS, P499; STERNBERG C. M., 1933, CANADIAN FIELD NATURALIST, V47, P79; Zweers G.A, 1977, Contributions vert. Evol., V3, P1	11	59	60	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2001	412	6850					873	874		10.1038/35091139	http://dx.doi.org/10.1038/35091139			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528466				2022-12-01	WOS:000170689000032
J	Cui, Y; Wei, QQ; Park, HK; Lieber, CM				Cui, Y; Wei, QQ; Park, HK; Lieber, CM			Nanowire nanosensors for highly sensitive and selective detection of biological and chemical species	SCIENCE			English	Article								Boron-doped silicon nanowires (SiNWs) were used to create highly sensitive, real-time electrically based sensors for biological and chemical species. Amine- and oxide-functionalized SiNWs exhibit pH-dependent conductance that was linear over a large dynamic range and could be understood in terms of the change in surface charge during protonation and deprotonation. Biotin-modified SiNWs were used to detect streptavidin down to at least a picomolar concentration range. In addition, antigen-functionalized SiNWs show reversible antibody binding and concentration-dependent detection in real time. Lastly, detection of the reversible binding of the metabolic indicator Ca2+ was demonstrated, The small size and capability of these semiconductor nanowires for sensitive, label-free, real-time detection of a wide range of chemical and biological species could be exploited in array-based screening and in vivo diagnostics.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Lieber, CM (corresponding author), Harvard Univ, Dept Chem & Biol Chem, 12 Oxford St, Cambridge, MA 02138 USA.	cmt@cmliris.harvard.edu	Park, Hongkun/R-9842-2019; Dee, Chang Fu/G-4842-2010; Chu, Yung-Ming/C-6318-2009; Cui, Yi/L-5804-2013	Park, Hongkun/0000-0001-9576-8829; Dee, Chang Fu/0000-0003-1015-9181; Cui, Yi/0000-0002-6103-6352				BAGCI H, 1993, FEBS LETT, V322, P47, DOI 10.1016/0014-5793(93)81108-C; BARTLETT PN, 1996, HDB CHEM BIOL SENSOR, P139; BAYER EA, 1990, METHOD ENZYMOL, V184, P49; BERGVELD P, 1972, IEEE T BIO-MED ENG, VBM19, P342, DOI 10.1109/TBME.1972.324137; Blackburn G.F., 1987, BIOSENSORS FUNDAMENT, P481; Blake RC, 1999, ANAL BIOCHEM, V272, P123, DOI 10.1006/abio.1999.4176; BOLT GH, 1957, J PHYS CHEM-US, V61, P1166, DOI 10.1021/j150555a007; Collins PC, 2001, SCIENCE, V292, P706, DOI 10.1126/science.1058782; Cui Y, 2001, SCIENCE, V291, P851, DOI 10.1126/science.291.5505.851; Cui Y, 2001, APPL PHYS LETT, V78, P2214, DOI 10.1063/1.1363692; Cui Y, 2000, J PHYS CHEM B, V104, P5213, DOI 10.1021/jp0009305; Duan XF, 2001, NATURE, V409, P66, DOI 10.1038/35051047; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; HAFEMAN DG, 1988, SCIENCE, V240, P1182, DOI 10.1126/science.3375810; Huang Y, 2001, SCIENCE, V291, P630, DOI 10.1126/science.291.5504.630; Iler R., 1979, CHEM SILICA; KLEE CB, 1982, ADV PROTEIN CHEM, V35, P213, DOI 10.1016/S0065-3233(08)60470-2; Kong J, 2000, SCIENCE, V287, P622, DOI 10.1126/science.287.5453.622; Movileanu L, 2000, NAT BIOTECHNOL, V18, P1091, DOI 10.1038/80295; Seker F, 2000, CHEM REV, V100, P2505, DOI 10.1021/cr980093r; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Vezenov DV, 1997, J AM CHEM SOC, V119, P2006, DOI 10.1021/ja963375m	22	5143	5445	56	2427	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2001	293	5533					1289	1292		10.1126/science.1062711	http://dx.doi.org/10.1126/science.1062711			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509722				2022-12-01	WOS:000170492600031
J	Karcher, RL; Roland, JT; Zappacosta, F; Huddleston, MJ; Annan, RS; Carr, SA; Gelfand, V				Karcher, RL; Roland, JT; Zappacosta, F; Huddleston, MJ; Annan, RS; Carr, SA; Gelfand, V			Cell cycle regulation of myosin-V by calcium/calmodulin-dependent protein kinase II	SCIENCE			English	Article							MASS-SPECTROMETRY; ORGANELLE TRANSPORT; SELECTIVE DETECTION; MOTOR PROTEIN; MELANOPHORES; PHOSPHOPEPTIDES; PHOSPHORYLATION; MUTAGENESIS; DEGRADATION; ASSOCIATION	Organelle transport by myosin-V is down-regulated during mitosis, presumably by myosin-V phosphorylation. We used mass spectrometry phosphopeptide mapping to show that the tall of myosin-V was phosphorylated in mitotic Xenopus egg extract on a single serine residue localized in the carboxyl-terminal organelle-binding domain. Phosphorylation resulted in the release of the motor from the organelle. The phosphorylation site matched the consensus sequence of calcium/calmodulin-dependent protein kinase II (CaMKII), and inhibitors of CaMKII prevented myosin-V release. The modulation of cargo binding by phosphorylation is likely to represent a general mechanism regulating organelle transport by myosin-V.	Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA; GlaxoSmithKline, Dept Phys & Struct Chem, King Of Prussia, PA 19406 USA	University of Illinois System; University of Illinois Urbana-Champaign; GlaxoSmithKline	Gelfand, V (corresponding author), Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA.		Gelfand, Vladimir/M-1974-2019; Roland, Joseph/C-9592-2013; Carr, Steven A./AAH-8366-2019; Gelfand, Vladimir I/D-2545-2013	Gelfand, Vladimir/0000-0002-6361-2798; Gelfand, Vladimir I/0000-0002-6361-2798; Roland, Jr., J. Thomas/0000-0003-1181-4651	NIGMS NIH HHS [GM-52111] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052111, R55GM052111] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLAN VJ, 1991, J CELL BIOL, V113, P347, DOI 10.1083/jcb.113.2.347; Annan RS, 1996, ANAL CHEM, V68, P3413, DOI 10.1021/ac960221g; Annan RS, 2001, ANAL CHEM, V73, P393, DOI 10.1021/ac001130t; BENFENATI F, 1992, NATURE, V359, P417, DOI 10.1038/359417a0; BIEMANN K, 1990, METHOD ENZYMOL, V193, P886, DOI 10.1016/0076-6879(90)93460-3; Carr SA, 1996, ANAL BIOCHEM, V239, P180, DOI 10.1006/abio.1996.0313; Catlett NL, 1998, P NATL ACAD SCI USA, V95, P14799, DOI 10.1073/pnas.95.25.14799; Costa MCR, 1999, J BIOL CHEM, V274, P15811, DOI 10.1074/jbc.274.22.15811; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HUDDLESTON MJ, 1993, J AM SOC MASS SPECTR, V4, P710, DOI 10.1016/1044-0305(93)80049-5; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; Joyal JL, 1997, J BIOL CHEM, V272, P15419, DOI 10.1074/jbc.272.24.15419; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; LINDSAY HD, 1995, J CELL SCI, V108, P3557; Niclas J, 1996, J CELL BIOL, V133, P585, DOI 10.1083/jcb.133.3.585; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; Nilsson H, 1997, CELL MOTIL CYTOSKEL, V38, P397, DOI 10.1002/(SICI)1097-0169(1997)38:4<397::AID-CM9>3.3.CO;2-5; Ohi R, 1999, CURR OPIN CELL BIOL, V11, P267, DOI 10.1016/S0955-0674(99)80036-2; Patel R, 1999, J BIOL CHEM, V274, P7958, DOI 10.1074/jbc.274.12.7958; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; Rogers SL, 1999, J CELL BIOL, V146, P1265, DOI 10.1083/jcb.146.6.1265; Rogers SL, 1997, P NATL ACAD SCI USA, V94, P3720, DOI 10.1073/pnas.94.8.3720; Rogers SL, 1998, CURR BIOL, V8, P161, DOI 10.1016/S0960-9822(98)70063-6; STARODUBOV S M, 1988, Ontogenez, V19, P279; Tuma MC, 1998, J CELL BIOL, V143, P1547, DOI 10.1083/jcb.143.6.1547; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Warren G, 1996, CELL, V84, P395, DOI 10.1016/S0092-8674(00)81284-2; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899	30	118	120	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1317	1320		10.1126/science.1061086	http://dx.doi.org/10.1126/science.1061086			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509731				2022-12-01	WOS:000170492600040
J	Drake, MJ; Mills, IW; Gillespie, JI				Drake, MJ; Mills, IW; Gillespie, JI			Model of peripheral autonomous modules and a myovesical plexus in normal and overactive bladder function	LANCET			English	Article							HUMAN URINARY-BLADDER; OBSTRUCTION; TISSUE; CELLS; PIG	Normal bladder function is controlled by the central nervous system (CNS) and any peripheral contribution to bladder control is believed to be small. Nevertheless, anatomically and functionally, such a contribution might exist. Taking account of this evidence, we propose that the detrusor muscle is arranged into modules, which are circumscribed areas of muscle active during the filling phase of the micturition cycle. These modules might be controlled by a peripheral myovesical plexus, consisting of intramural ganglia and interstitial cells. Detrusor overactivity is the occurrence of abnormal increases in pressure during bladder filling, which the patient cannot inhibit. This disorder is thought to be a consequence of abnormal expression of the micturition reflex or changes in the properties of the smooth muscle. We propose that detrusor overactivity results from exaggerated symptomatic expression of peripheral autonomous activity, resulting from a shift in the balance of excitation and inhibition in smooth muscle modules. These structures responsible for origin and spread of peripheral autonomous activity could be targeted to help develop new therapeutic strategies.	Univ Newcastle Upon Tyne, Sch Med, Tyne Micturit Res Grp, Sch Surg Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; St Marys Hosp, Dept Urol, London, England	Newcastle University - UK; Imperial College London	Drake, MJ (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Tyne Micturit Res Grp, Sch Surg Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.		Drake, Marcus/C-4542-2014	Drake, Marcus/0000-0002-6230-2552				BRADING AF, 1994, BRIT J UROL, V73, P3, DOI 10.1111/j.1464-410X.1994.tb07447.x; Brading AF, 1997, UROLOGY, V50, P57, DOI 10.1016/S0090-4295(97)00591-8; Bristow SE, 1996, BRIT J UROL, V77, P333, DOI 10.1046/j.1464-410X.1996.08981.x; Charlton RG, 1999, BJU INT, V84, P953; COOLSAET BLRA, 1993, NEUROUROL URODYNAM, V12, P463, DOI 10.1002/nau.1930120504; DEGROAT WC, 1997, UROLOGY S6A, V50, pS36; Furness JB., 1987, ENTERIC NERVOUS SYST; Greenland JE, 2000, BJU INT, V85, P1109, DOI 10.1046/j.1464-410x.2000.00611.x; LENNON GM, 1993, BRIT J UROL, V72, P702, DOI 10.1111/j.1464-410X.1993.tb16251.x; Mills I. W., 1998, Neurourology and Urodynamics, V17, P352; Sanders KM, 1996, GASTROENTEROLOGY, V111, P492, DOI 10.1053/gast.1996.v111.pm8690216; Sergeant GP, 2000, J PHYSIOL-LONDON, V526, P359, DOI 10.1111/j.1469-7793.2000.t01-2-00359.x; SETHIA KK, 1990, J UROLOGY, V143, P1243, DOI 10.1016/S0022-5347(17)40246-1; SKEHAN AM, 1993, J UROLOGY, V149, P1156, DOI 10.1016/S0022-5347(17)36339-5; Smet PJ, 1996, NEUROSCIENCE, V71, P337, DOI 10.1016/0306-4522(95)00453-X; Smet PJ, 1996, J NEUROCYTOL, V25, P112, DOI 10.1007/BF02284790	16	114	124	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2001	358	9279					401	403		10.1016/S0140-6736(01)05549-0	http://dx.doi.org/10.1016/S0140-6736(01)05549-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502339				2022-12-01	WOS:000170235100034
J	BECKER, L; BADA, JL; WINANS, RE; HUNT, JE; BUNCH, TE; FRENCH, BM				BECKER, L; BADA, JL; WINANS, RE; HUNT, JE; BUNCH, TE; FRENCH, BM			FULLERENES IN THE 1.85-BILLION-YEAR-OLD SUDBURY IMPACT STRUCTURE	SCIENCE			English	Article							EARTHS EARLY ATMOSPHERE; MASS-SPECTROMETRY; ALLENDE METEORITE; ION FORMATION; C-60; CARBON; C60	Fullerenes (C-60 and C-70) have been identified by laser desorption, laser desorption postionization, and high-resolution electron-impact mass spectrometry in shock-produced breccias (Onaping Formation) of the Sudbury impact structure in Ontario, Canada, The C-60 isotope is present at a level of a few parts per million. The fullerenes were likely synthesized within the impact plume from the carbon contained in the bolide. The oxidation of the fullerenes during the 1.85 billion years of exposure was apparently prevented by the presence of sulfur in the form of sulfide-silicate complexes associated with the fullerenes.	ARGONNE NATL LAB,DIV CHEM,ARGONNE,IL 60439; NASA,AMES RES CTR,DIV SPACE SCI,MOFFETT FIELD,CA 94035; NASA HEADQUARTERS,WASHINGTON,DC 20546	United States Department of Energy (DOE); Argonne National Laboratory; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA)	BECKER, L (corresponding author), UNIV CALIF SAN DIEGO,SCRIPPS INST OCEANOG,LA JOLLA,CA 92093, USA.			Winans, Randall/0000-0002-7080-7673				AVERMANN M, 1992, TECTONOPHYSICS, V216, P227, DOI 10.1016/0040-1951(92)90169-7; BECKER L, 1993, NATURE, V361, P595, DOI 10.1038/361595a0; BECKER L, UNPUB; BECKER L, 1993, THESIS U CALIFORNIA; BRINKMALM G, 1992, CHEM PHYS LETT, V191, P345, DOI 10.1016/0009-2614(92)85312-X; BURROWS AG, 1929, ONT DEP MINES B, V38, P1; BUSECK PR, 1992, SCIENCE, V257, P215, DOI 10.1126/science.257.5067.215; CHANG TM, 1992, J AM CHEM SOC, V114, P7603, DOI 10.1021/ja00045a066; CHIBANTE LPF, 1993, GEOCHIM COSMOCHIM AC, V57, P1879, DOI 10.1016/0016-7037(93)90119-H; CREASY WR, 1988, CHEM PHYS, V126, P453, DOI 10.1016/0301-0104(88)85053-5; CURL RF, 1988, SCIENCE, V242, P1017, DOI 10.1126/science.242.4881.1017; DALY TK, 1993, SCIENCE, V259, P1599, DOI 10.1126/science.259.5101.1599; DEVRIES MS, 1993, GEOCHIM COSMOCHIM AC, V57, P933, DOI 10.1016/0016-7037(93)90179-Z; DIBIOZALO FR, 1994, NATURE, V369, P37; Dietz R.S., 1968, SHOCK METAMORPHISM N, P267; DIETZ RS, 1964, J GEOL, V72, P412, DOI 10.1086/626999; FAGGART BE, 1985, SCIENCE, V230, P436, DOI 10.1126/science.230.4724.436; French B.M., 1968, SHOCK METAMORPHISM N, P383; FRENCH BM, 1972, GEOL ASSOC CAN SPEC, V10, P19; GREENWOOD PF, 1990, ORG MASS SPECTROM, V25, P353, DOI 10.1002/oms.1210250703; GRIEVE RAF, 1991, J GEOPHYS RES-PLANET, V96, P22753, DOI 10.1029/91JE02513; HAHN JH, 1988, SCIENCE, V239, P1523, DOI 10.1126/science.239.4847.1523; HEYMANN D, 1992, LUNAR PLANET SCI, V23, P1053; HEYMANN D, 1991, LUNAR PLANET SCI, V22, P569; HEYMANN D, 1993, LUNAR PLANET, V24, P437; HEYMANN D, 1994, LUNAR PLANET SCI, V25, P545; HOWARD JB, 1990, NATURE, V352, P141; HUNT JE, 1991, NATO ASI SER, P309; KASTING JF, 1990, ORIGINS LIFE EVOL B, V20, P199, DOI 10.1007/BF01808105; KASTING JF, 1993, SCIENCE, V259, P920, DOI 10.1126/science.11536547; KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0; KROTO H, 1988, SCIENCE, V242, P1139, DOI 10.1126/science.242.4882.1139; KROTO HW, 1990, NASA CONF P, V3061, P275; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; KROUGH TE, 1984, ONT GEOL SURV SPEC, V1, P431; MCELVANY SW, 1993, SCIENCE, V259, P1594, DOI 10.1126/science.259.5101.1594; MCKINNON JT, 1992, COMBUST FLAME, V88, P102, DOI 10.1016/0010-2180(92)90010-M; MUIR TL, 1984, ONT GEOL SURV REP, V1, P103; OBERBECK VR, 1989, LUNAR PLANET SCI, V20, P671; OTT U, 1981, GEOCHIM COSMOCHIM AC, V45, P1751, DOI 10.1016/0016-7037(81)90009-0; PILLINGER CT, 1993, PHILOS T R SOC A, V343, P73, DOI 10.1098/rsta.1993.0042; ROHLING EA, 1984, J CHEM PHYS, V81, P3332; SHARPTON VL, 1992, NATURE, V359, P819, DOI 10.1038/359819a0; TAYLOR R, 1993, NATURE, V366, P728, DOI 10.1038/366728a0; TAYLOR R, 1991, NATURE, V351, P277, DOI 10.1038/351277a0; UGARTE D, 1992, NATURE, V359, P707, DOI 10.1038/359707a0; WEBSTER A, 1991, NATURE, V352, P412, DOI 10.1038/352412a0; WEBSTER A, 1993, MONTHLY NOT R ASTRON, V255, P41; WURZ P, 1992, VACUUM, V43, P381, DOI 10.1016/0042-207X(92)90041-T; WURZ P, 1992, J PHYS CHEM-US, V96, P10129, DOI 10.1021/j100204a011; ZENOBI R, 1989, SCIENCE, V246, P1026, DOI 10.1126/science.246.4933.1026	51	115	119	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 29	1994	265	5172					642	645		10.1126/science.11536660	http://dx.doi.org/10.1126/science.11536660			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NZ538	11536660				2022-12-01	WOS:A1994NZ53800027
J	TOWE, KM				TOWE, KM			AEROBIC RESPIRATION IN THE ARCHEAN	NATURE			English	Article											TOWE, KM (corresponding author), SMITHSONIAN INST,DEPT PALEOBIOL,WASHINGTON,DC 20560, USA.							BERNER RA, 1989, AM J SCI, V289, P333, DOI 10.2475/ajs.289.4.333; BRALOWER TJ, 1984, GEOLOGY, V12, P614, DOI 10.1130/0091-7613(1984)12<614:LPASDC>2.0.CO;2; Chapman D.J., 1983, P302; CLOUD P, 1973, ECON GEOL, V68, P1135, DOI 10.2113/gsecongeo.68.7.1135; DREVER JI, 1974, GEOL SOC AM BULL, V85, P1099, DOI 10.1130/0016-7606(1974)85<1099:GMFTOO>2.0.CO;2; DYMEK RF, 1988, PRECAMBRIAN RES, V39, P247, DOI 10.1016/0301-9268(88)90022-8; GARRELS RM, 1974, SEA, V5, P303; Hayes JM., 1983, EARTHS EARLIEST BIOS, P291; HENRICHS SM, 1987, GEOMICROBIOL J, V5, P191, DOI 10.1080/01490458709385971; Hitchon B., 1974, NATURAL GASES MARINE, V3, P195, DOI [10.1007/978-1-4684-2757-8_12, DOI 10.1007/978-1-4684-2757-8_8]; Holland H. D., 1984, CHEM EVOLUTION ATMOS; KASTING JF, 1987, PRECAMBRIAN RES, V34, P205, DOI 10.1016/0301-9268(87)90001-5; KASTING JF, 1981, J GEOPHYS RES-OCEANS, V86, P1147, DOI 10.1029/JC086iC02p01147; KASTING JF, 1983, PRECAMBRIAN RES, V20, P121, DOI 10.1016/0301-9268(83)90069-4; KNOLL AH, 1979, ORIGINS LIFE EVOL B, V9, P313, DOI 10.1007/BF00926824; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; MOFETT JW, 1990, NATURE, V345, P421; MULLER PJ, 1979, DEEP-SEA RES, V26, P1347, DOI 10.1016/0198-0149(79)90003-7; REIMER TO, 1979, PRECAMBRIAN RES, V9, P93, DOI 10.1016/0301-9268(79)90053-6; ROSENFELD WD, 1959, SCIENCE, V130, P1658, DOI 10.1126/science.130.3389.1658-a; Schidlowski M., 1983, P149; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; SCHOPF JW, 1988, MOL EVOLUTION FOSSIL, P89; SCHWARTZ RM, 1978, SCIENCE, V199, P395, DOI 10.1126/science.202030; TOWE KM, 1985, ORIGINS LIFE EVOL B, V15, P235, DOI 10.1007/BF01808171; Towe KM, 1988, MOL EVOLUTION FOSSIL, P114; VEIZER J, 1985, J GEOL, V93, P625, DOI 10.1086/628992; WALKER JCG, 1985, PRECAMBRIAN RES, V28, P205, DOI 10.1016/0301-9268(85)90031-2; WALKER JCG, 1980, HDB ENV CHEM A, V1, P87; WALKER JCG, 1983, EARTHS EARLIEST BIOS, P260; WINFREY MR, 1983, APPL ENVIRON MICROB, V45, P193, DOI 10.1128/AEM.45.1.193-199.1983; WOLIN MJ, 1987, GEOMICROBIOL J, V5, P239, DOI 10.1080/01490458709385972	32	56	58	2	16	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 1	1990	348	6296					54	56		10.1038/348054a0	http://dx.doi.org/10.1038/348054a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF994	11536471				2022-12-01	WOS:A1990EF99400059
J	Nott, J; Hayne, M				Nott, J; Hayne, M			High frequency of 'super-cyclones' along the Great Barrier Reef over the past 5,000 years	NATURE			English	Article							CORAL-REEFS; RECRUITMENT; DISTURBANCE; COMMUNITY; DIVERSITY; ATOLL; BEBE	Understanding long-term variability in the occurrence of tropical cyclones that are of extreme intensity is important for determining their role in ecological disturbances(1-5), for predicting present and future community vulnerability and economic loss(6) and for assessing whether changes in the variability of such cyclones are induced by climate change(7). Our ability to accurately make these assessments has been limited by the short (less than 100 years) instrumented record of cyclone intensity. Here we determine the intensity of prehistoric tropical cyclones over the past 5,000 years from ridges of detrital coral and shell deposited above highest tide and terraces that have been eroded into coarse-grained alluvial fan deposits. These features occur along 1,500 km of the Great Barrier Reef and also the Gulf of Carpentaria, Australia. We infer that the deposits were formed by storms with recurrence intervals of two to three centuries(8-11), and we show that the cyclones responsible must have been of extreme intensity (central pressures less than 920 hPa). Our estimate of the frequency of such 'super-cyclones' is an order of magnitude higher than that previously estimated (which was once every several millennia(12-14)), and is sufficiently high to suggest that the character of rainforests and coral reef communities were probably shaped by these events.	James Cook Univ N Queensland, Sch Trop Environm Studies & Geog, Cairns, Qld 4870, Australia; Australial Geol Survey Org, Canberra, ACT 2601, Australia	James Cook University	Nott, J (corresponding author), James Cook Univ N Queensland, Sch Trop Environm Studies & Geog, POB 6811, Cairns, Qld 4870, Australia.	Jonathan.Nott@jcu.edu.au	Nott, Jonathan/H-5156-2011	Nott, Jonathan/0000-0001-7258-017X				BLUMENSTOCK DI, 1958, NATURE, V182, P1267, DOI 10.1038/1821267a0; Bryant E. A., 1991, NATURAL HAZARDS; CHAPPELL J, 1983, BMR J AUST GEOL GEOP, V8, P223; CHAPPELL J, 1984, COASTAL GEOMORPHOLOG, P197; CHIVAS A, 1986, MAR GEOL, V69, P273, DOI 10.1016/0025-3227(86)90043-5; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Everham EM, 1996, BOT REV, V62, P113, DOI 10.1007/BF02857920; Fitchett K, 1987, AUST GEOGR, V18, P1, DOI 10.1080/00049188708702920; HARPER B, 1998, 10 QUEENSL DEP ENV H; Hayne M, 2001, PALAEOGEOGR PALAEOCL, V168, P207, DOI 10.1016/S0031-0182(00)00217-0; HAYNE M, IN PRESS PALAEOGEOGR; Henderson-Sellers A, 1998, B AM METEOROL SOC, V79, P19, DOI 10.1175/1520-0477(1998)079<0019:TCAGCC>2.0.CO;2; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Hubbert GD, 1999, J COASTAL RES, V15, P168; HUGHES TP, 1989, ECOLOGY, V70, P275, DOI 10.2307/1938434; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; LIRMAN D, 1997, P 8 INT COR REEF S P, V1, P561; LOURENSZ H, 1981, TROPICAL CYCLONES AU; MARAGOS JE, 1973, SCIENCE, V181, P1161, DOI 10.1126/science.181.4105.1161; MCINNES K, 2000, CYCLONES IMPACTS TOU; OLIVER J, 1989, NATURAL HAZARDS REIN; POTTS DC, 1985, MAR ECOL PROG SER, V23, P79, DOI 10.3354/meps023079; SANDERSON B, 1995, 9528 MON U DEP MATH; SCOFFIN TP, 1993, CORAL REEFS, V12, P203, DOI 10.1007/BF00334480; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Tanner JE, 1996, ECOLOGY, V77, P108, DOI 10.2307/2265660; *USA CORPS ENG, 1986, SHOR PROT MAN; Walsh K., 2001, CLIMATE CHANGE QUEEN	29	155	162	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2001	413	6855					508	512		10.1038/35097055	http://dx.doi.org/10.1038/35097055			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586356				2022-12-01	WOS:000171340500043
J	Hollander, E; Evers, M				Hollander, E; Evers, M			New developments in impulsivity	LANCET			English	Editorial Material							VENTROMEDIAL PREFRONTAL CORTEX; DECISION-MAKING; DEFICIT; BLIND		Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Hollander, E (corresponding author), Mt Sinai Sch Med, Dept Psychiat, Box 1230, New York, NY 10029 USA.	eric.hollander@mssm.edu						Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bechara A, 1999, J NEUROSCI, V19, P5473; Brunner D, 1997, ANN NY ACAD SCI, V836, P81, DOI 10.1111/j.1749-6632.1997.tb52356.x; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Ernst M, 1998, J NEUROSCI, V18, P5901; Hollander E, 1998, AM J PSYCHIAT, V155, P1781, DOI 10.1176/ajp.155.12.1781; Hollander E, 1998, BRIT J PSYCHIAT, V173, P7, DOI 10.1192/S0007125000297845; Hollander E, 2001, J CLIN PSYCHIAT, V62, P199, DOI 10.4088/JCP.v62n0311; Hollander E, 2000, PSYCHIAT CLIN N AM, V23, P629, DOI 10.1016/S0193-953X(05)70185-4; HOLLANDER E, IN PRESS AM PSYCHIAT; Luria A. R., 2012, HIGHER CORTICAL FUNC; New AS, 1998, AM J MED GENET, V81, P13, DOI 10.1002/(SICI)1096-8628(19980207)81:1<13::AID-AJMG3>3.0.CO;2-O; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; Siever LJ, 1999, NEUROPSYCHOPHARMACOL, V20, P413, DOI 10.1016/S0893-133X(98)00111-0	15	41	44	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	2001	358	9286					949	950		10.1016/S0140-6736(01)06114-1	http://dx.doi.org/10.1016/S0140-6736(01)06114-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474YR	11583745				2022-12-01	WOS:000171135300012
J	Hale, ML; Lurz, PWW; Shirley, MDF; Rushton, S; Fuller, RM; Wolff, K				Hale, ML; Lurz, PWW; Shirley, MDF; Rushton, S; Fuller, RM; Wolff, K			Impact of landscape management on the genetic structure of red squirrel populations	SCIENCE			English	Article							MICROSATELLITE DATA; DISPERSAL; DISTANCE; FOREST; MAP	Landscape management practices that alter the degree of habitat fragmentation can significantly affect the genetic structure of animal populations. British red squirrels use "stepping stone" patches of habitat to move considerable distances through a fragmented habitat. Over the past few decades, the planting of a large conifer forest has connected groups of forest fragments in the north of England with those in southern Scotland. This "defragmentation" of the landscape has resulted in substantial genetic mixing of Scottish and Cumbrian genes in squirrel populations up to 100 kilometers from the site of the new forest. These results have implications for the conservation management of animal and plant species in fragmented landscapes such as those found in Britain.	Univ Newcastle Upon Tyne, Dept Agr & Environm Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Newcastle Upon Tyne, Ctr Life Sci Modelling, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Ctr Ecol & Hydrol, Huntingdon PE28 2LS, England	Newcastle University - UK; Newcastle University - UK; UK Centre for Ecology & Hydrology (UKCEH)	Hale, ML (corresponding author), Univ Newcastle Upon Tyne, Dept Agr & Environm Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.		Wolff, Kirsten/E-7961-2012; Lurz, Peter/O-5108-2019	Wolff, Kirsten/0000-0002-6050-8493; Shirley, Mark/0000-0002-6220-2578				[Anonymous], 1997, ECOL SOC, DOI DOI 10.5751/ES-00015-010104; Beier P, 1998, CONSERV BIOL, V12, P1241, DOI 10.1046/j.1523-1739.1998.98036.x; Bevers M, 1999, THEOR POPUL BIOL, V55, P61, DOI 10.1006/tpbi.1998.1392; CARO TM, 1994, SCIENCE, V263, P485, DOI 10.1126/science.8290956; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; FULLER RM, 1994, PHOTOGRAMM ENG REM S, V60, P553; Gaggiotti OE, 1999, MOL ECOL, V8, P1513, DOI 10.1046/j.1365-294x.1999.00730.x; Gurnell J, 1997, CONSERVATION RED SQU; Haddad N, 2000, CONSERV BIOL, V14, P738, DOI 10.1046/j.1523-1739.2000.99041.x; Hale ML, 2001, MOL ECOL NOTES, V1, P47, DOI 10.1046/j.1471-8278 .2000.00020.x; Lande R, 1996, EVOLUTION, V50, P434, DOI [10.2307/2410812, 10.1111/j.1558-5646.1996.tb04504.x]; Lurz, 1997, CONSERVATION RED SQU, P5; Lurz P.W.W., 1995, THESIS U NEWCASTLE N; Lurz PWW, 1995, FOREST ECOL MANAG, V79, P79, DOI 10.1016/0378-1127(95)03617-2; Matthews J. D., 1955, Report on forest research by the Forestry Commission for the year ending March, 1954., P64; McIntosh R, 1995, FOREST ECOL MANAG, V79, P1, DOI 10.1016/0378-1127(95)03628-8; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Paetkau D, 1997, GENETICS, V147, P1943; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; REYNOLDS JC, 1985, J ANIM ECOL, V54, P149, DOI 10.2307/4627; Schneider S., 2000, ARLEQUIN VERSION 200; Shorten M, 1954, SQUIRRELS; TONKIN JM, 1983, THESIS U BRADFORD BR; Waser PM, 1998, TRENDS ECOL EVOL, V13, P43, DOI 10.1016/S0169-5347(97)01255-X; WAUTERS L, 1994, OIKOS, V69, P140, DOI 10.2307/3545294	26	98	110	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2001	293	5538					2246	2248		10.1126/science.1062574	http://dx.doi.org/10.1126/science.1062574			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11567136				2022-12-01	WOS:000171139400041
J	Ji, YD; Zhang, B; Van Horn, SF; Warren, P; Woodnutt, G; Burnham, MKR; Rosenberg, M				Ji, YD; Zhang, B; Van Horn, SF; Warren, P; Woodnutt, G; Burnham, MKR; Rosenberg, M			Identification of critical staphylococcal genes using conditional phenotypes generated by antisense RNA	SCIENCE			English	Article							IN-VITRO; REGULATED EXPRESSION; BACILLUS-SUBTILIS; AUREUS; VIRULENCE; OLIGONUCLEOTIDES; INACTIVATION; MUTAGENESIS; PLASMIDS; SYSTEM	Comprehensive genomic analysis of the important human pathogen Staphylococcus aureus was achieved by a strategy involving antisense technology in a regulatable gene expression system. In addition to known essential genes, many genes of unknown or poorly defined biological function were identified. This methodology allowed gene function to be characterized in a comprehensive, defined set of conditionally growth-defective/lethal isogenic strains. Quantitative titration of the conditional growth effect was performed either in bacterial culture or in an animal model of infection. This genomic strategy offers an approach to the identification of staphylococcal gene products that could serve as targets for antibiotic discovery.	GlaxoSmithKline Pharmaceut Res & Dev, Dept Microbiol, Collegeville, PA 19426 USA; GlaxoSmithKline Pharmaceut Res & Dev, Genet Res, Collegeville, PA 19426 USA	GlaxoSmithKline; GlaxoSmithKline	Ji, YD (corresponding author), 1250 S Collegeville Rd,UP1345, Collegeville, PA 19426 USA.							Agrawal S, 1997, P NATL ACAD SCI USA, V94, P2620, DOI 10.1073/pnas.94.6.2620; Akerley BJ, 1998, P NATL ACAD SCI USA, V95, P8927, DOI 10.1073/pnas.95.15.8927; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arigoni F, 1998, NAT BIOTECHNOL, V16, P851, DOI 10.1038/nbt0998-851; Brantl S, 2000, MOL MICROBIOL, V35, P1469, DOI 10.1046/j.1365-2958.2000.01813.x; CHEUNG AL, 1995, J BACTERIOL, V177, P3220, DOI 10.1128/jb.177.11.3220-3226.1995; De Backer MD, 2001, NAT BIOTECHNOL, V19, P235, DOI 10.1038/85677; DEBEAUREGARD MAC, 1995, EMBO J, V14, P409, DOI 10.1002/j.1460-2075.1995.tb07017.x; DELORENZO V, 1993, GENE, V123, P17, DOI 10.1016/0378-1119(93)90533-9; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GEISSENDORFER M, 1990, APPL MICROBIOL BIOT, V33, P657, DOI 10.1007/BF00604933; Good L, 1998, NAT BIOTECHNOL, V16, P355, DOI 10.1038/nbt0498-355; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Ji YD, 1999, J BACTERIOL, V181, P6585, DOI 10.1128/JB.181.21.6585-6590.1999; Martin PK, 1999, J BACTERIOL, V181, P3666, DOI 10.1128/JB.181.12.3666-3673.1999; Mizuta T, 1999, NAT BIOTECHNOL, V17, P583, DOI 10.1038/9893; Parish T, 1997, FEMS MICROBIOL LETT, V154, P151, DOI 10.1016/S0378-1097(97)00317-0; Rappleye CA, 1997, J BACTERIOL, V179, P5827, DOI 10.1128/jb.179.18.5827-5834.1997; SCHMID MB, 1989, GENETICS, V123, P625; Stieger M, 1999, GENE, V226, P243, DOI 10.1016/S0378-1119(98)00561-7; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; WAGNER EGH, 1994, ANNU REV MICROBIOL, V48, P717; Zhang L, 2000, GENE, V255, P297, DOI 10.1016/S0378-1119(00)00325-5	24	328	2946	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2001	293	5538					2266	2269		10.1126/science.1063566	http://dx.doi.org/10.1126/science.1063566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11567142				2022-12-01	WOS:000171139400047
J	Hodge, A; Campbell, CD; Fitter, AH				Hodge, A; Campbell, CD; Fitter, AH			An arbuscular mycorrhizal fungus accelerates decomposition and acquires nitrogen directly from organic material	NATURE			English	Article							ROOT PROLIFERATION; SOIL; BIODIVERSITY; ACQUISITION; ASSOCIATION; DIVERSITY; HYPHAE; INFLOW	Arbuscular mycorrhizal fungi (order Glomales), which form mycorrhizal symbioses with two out of three of all plant species(1), are believed to be obligate biotrophs that are wholly dependent on the plant partner for their carbon supply(2). It is thought that they possess no degradative capability and that they are unable to decompose complex organic molecules, the form in which most soil nutrients occur. Earlier suggestions that they could exist saprotrophically were based on observation of hyphal proliferation on organic materials(3,4). In contrast, other mycorrhizal types have been shown to acquire nitrogen directly from organic sources(5-7). Here we show that the arbuscular mycorrhizal symbiosis can both enhance decomposition of and increase nitrogen capture from complex organic material (grass leaves) in soil. Hyphal growth of the fungal partner was increased in the presence of the organic material, independently of the host plant.	Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; Macaulay Land Use Res Inst, Aberdeen AB15 8QH, Scotland	University of York - UK; James Hutton Institute	Hodge, A (corresponding author), Univ York, Dept Biol, POB 373, York YO10 5YW, N Yorkshire, England.		Campbell, Colin D/B-3944-2010	Campbell, Colin D/0000-0002-5163-7656	Biotechnology and Biological Sciences Research Council [JF13140] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ABUZINADAH RA, 1989, NEW PHYTOL, V112, P55, DOI 10.1111/j.1469-8137.1989.tb00308.x; [Anonymous], 1982, METHODS PRINCIPLES M; Bever JD, 1999, ECOL LETT, V2, P52, DOI 10.1046/j.1461-0248.1999.21050.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CHAPIN FS, 1993, NATURE, V361, P150, DOI 10.1038/361150a0; Fransen B, 1998, OECOLOGIA, V115, P351, DOI 10.1007/s004420050527; Frostegard A, 1996, SOIL BIOL BIOCHEM, V28, P55, DOI 10.1016/0038-0717(95)00100-X; Hodge A, 1998, NEW PHYTOL, V139, P479, DOI 10.1046/j.1469-8137.1998.00216.x; HODGE A, 1995, MYCOL RES, V99, P935, DOI 10.1016/S0953-7562(09)80752-1; JONES DL, 1992, PLANT SOIL, V143, P259, DOI 10.1007/BF00007881; KOIDE RT, 1989, NEW PHYTOL, V111, P35, DOI 10.1111/j.1469-8137.1989.tb04215.x; LEAKE JR, 1990, NEW PHYTOL, V116, P123, DOI 10.1111/j.1469-8137.1990.tb00517.x; Mader P, 2000, NEW PHYTOL, V146, P155, DOI 10.1046/j.1469-8137.2000.00615.x; MOSSE BARBARA, 1959, TRANS BRIT MYOL SOC, V42, P439; NEWSHAM KK, 1995, TRENDS ECOL EVOL, V10, P407, DOI 10.1016/S0169-5347(00)89157-0; READ DJ, 1991, EXPERIENTIA, V47, P376, DOI 10.1007/BF01972080; SANDERS FE, 1971, NATURE, V233, P278, DOI 10.1038/233278c0; Smith SE., 1996, MYCORRHIZAL SYMBIOSI; Staddon PL, 1999, GLOBAL CHANGE BIOL, V5, P347, DOI 10.1046/j.1365-2486.1999.00230.x; Stark JM, 1994, EXPLOITATION ENV HET, P255; STJOHN TV, 1983, ECOLOGY, V64, P957, DOI 10.2307/1937216; Tinker PBH., 2000, SOLUTE TRANSPORT RHI; TOBAR RM, 1994, MYCORRHIZA, V4, P105, DOI 10.1007/BF00203769; Trappe JM, 1987, ECOPHYSIOLOGY VA MYC, P525; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; vanVuuren MMI, 1996, PLANT SOIL, V178, P185, DOI 10.1007/BF00011582; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87	27	671	771	27	542	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					297	299		10.1038/35095041	http://dx.doi.org/10.1038/35095041			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565029	Green Accepted			2022-12-01	WOS:000171040500036
J	Giles, J				Giles, J			Relaxed restrictions blamed for rise in foot and mouth	NATURE			English	News Item																		Woolhouse M, 2001, NATURE, V411, P258, DOI 10.1038/35077149	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					98	98		10.1038/35093234	http://dx.doi.org/10.1038/35093234			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557938	Bronze			2022-12-01	WOS:000170918800009
J	Chalder, T; Hotopf, M; Unwin, C; Hull, L; Ismail, K; David, A; Wessely, S				Chalder, T; Hotopf, M; Unwin, C; Hull, L; Ismail, K; David, A; Wessely, S			Prevalence of Gulf war veterans who believe they have Gulf war syndrome: questionnaire study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH	Objectives To determine how many veterans in a random sample of British veterans who served in the Gulf war believe they have "Gulf war syndrome," to examine factors associated with the presence of this belief, and to compare the health status of those who believe they have Gulf war syndrome with those who do not. Design Questionnaire study asking British Gulf war veterans whether they believe they have Gulf war syndrome and about symptoms, fatigue, psychological distress, post-traumatic stress, physical functioning, and their perception of health, Participants 2961 respondents to questionnaires sent out to a random sample of 4250 Gulf war veterans (69.7%). Main outcome measure The proportion of veterans who believe they have Gulf war syndrome. Results Overall, 17.3% (95% confidence interval 15.9 to 18.7) of the respondents believed they had Gulf war syndrome. The belief was associated with the veteran having poor health, not serving in the army when responding to the questionnaire, and having received a high number of vaccinations before deployment to the Gulf. The strongest association was knowing another person who also thought they had Gulf war syndrome. Conclusions Substantial numbers of British Gulf war veterans believe they have Gulf war syndrome, which is associated with psychological distress, a high number of symptoms, and some reduction in activity levels. A combination of biological, psychological, and sociological factors are associated with the belief, and these factors should be addressed in clinical practice.	Kings Coll London, Guys Kings Coll, Gulf War Res Unit, London SE5 8AZ, England; Kings Coll London, St Thomass Sch Med, London SE5 8AZ, England	University of London; King's College London; University of London; King's College London	Chalder, T (corresponding author), Kings Coll London, Guys Kings Coll, Gulf War Res Unit, London SE5 8AZ, England.	sphatrc@iop.kcl.ac.uk	Wessely, Simon C/A-8713-2008; David, Anthony S/C-1315-2011; Hotopf, Matthew/E-4971-2010; David, Anthony/O-1750-2019; Chalder, Trudie/A-5717-2011	David, Anthony S/0000-0003-0967-774X; David, Anthony/0000-0003-0967-774X; Wessely, Simon Charles/0000-0002-6743-9929; Ismail, Khalida/0000-0001-6084-449X; Chalder, Trudie/0000-0003-0775-1045; Hotopf, Matthew/0000-0002-3980-4466				CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Cherry N, 2001, OCCUP ENVIRON MED, V58, P291, DOI 10.1136/oem.58.5.291; Coker WJ, 1999, BMJ-BRIT MED J, V318, P290, DOI 10.1136/bmj.318.7179.290; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Goldberg D., 1988, USERS GUIDE GEN HLTH; Haley RW, 1997, JAMA-J AM MED ASSOC, V277, P215, DOI 10.1001/jama.277.3.215; Hotopf M, 2000, BRIT MED J, V320, P1363, DOI 10.1136/bmj.320.7246.1363; Ismail K, 1999, LANCET, V353, P179, DOI 10.1016/S0140-6736(98)11339-9; O'Brien LS, 1998, TRAUMATIC EVENTS MEN; Schwartz DA, 1997, JAMA-J AM MED ASSOC, V277, P238, DOI 10.1001/jama.277.3.238; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7	13	29	29	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2001	323	7311					473	476		10.1136/bmj.323.7311.473	http://dx.doi.org/10.1136/bmj.323.7311.473			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469WF	11532836	Bronze, Green Published			2022-12-01	WOS:000170838500013
J	Davies, MK; Hobbs, FDR; Davis, RC; Kenkre, JE; Roalfe, AK; Hare, R; Wosornu, D; Lancashire, RJ				Davies, MK; Hobbs, FDR; Davis, RC; Kenkre, JE; Roalfe, AK; Hare, R; Wosornu, D; Lancashire, RJ			Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study	LANCET			English	Article							DIAGNOSIS; MORBIDITY; CAPTOPRIL; MORTALITY; TIME	Background Accurate data for prevalence rates for heart failure due to various causes, and for left-ventricular systolic dysfunction in all adults are unavailable. Our aim was to assess prevalence of left-ventricular systolic dysfunction and heart failure in a large representative adult population in England. Methods Of 6286 randomly selected patients aged 45 years and older, 3960 (63%) participated in the study. They came from 16 randomly selected general practices. We assessed patients by history and examination, electrocardiography, and echocardiography. Prevalence of left-ventricular systolic dysfunction (defined as ejection fraction <40%) and heart failure was calculated for the overall population on the basis of strict criteria and, when necessary, adjudication by a panel. Findings Left-ventricular systolic dysfunction was diagnosed in 72 (1.8% [95% CI 1.4-2.3]) participants, half of whom had no symptoms. Borderline left-ventricular function (ejection fraction 40-50%) was seen in 139 patients (3.5% [3.0-4.1]). Definite heart failure was seen in 92 (2.3%, [1.9-2.8]) and was associated with an ejection fraction of less than 40% in 38 (41%) patients, atrial fibrillation in 30 (33%), and valve disease in 24 (26%). Probable heart failure was seen in a further 32 (0.8% [0.6-1.1]) patients. In total, 124 (3.1% [2.6-3.7]) patients aged 45 years or older had definite or probable heart failure. Interpretation Heart failure is often misdiagnosed or underdiagnosed in primary care. Our results suggest that assessment of left-ventricular function in patients with suspected heart failure could lead to more effective diagnosis and treatment of this disorder.	Univ Birmingham, Sch Med, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Sch Med, Dept Publ Hlth & Epidemiol, Birmingham B15 2TT, W Midlands, England; Selly Oak Hosp, Dept Cardiol, Selly Oak, W Midlands, England	University of Birmingham; University of Birmingham	Hobbs, FDR (corresponding author), Univ Birmingham, Sch Med, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England.	f.d.r.hobbs@bham.ac.uk		hobbs, richard/0000-0001-7976-7172				Caruana L, 2000, BRIT MED J, V321, P215, DOI 10.1136/bmj.321.7255.215; CLELAND JG, 1995, EUR HEART J, V16, P741; Davie AP, 1997, EUR HEART J, V18, P981; *DEP HLTH, 2000, NAT SERV FRAM COR HE; ERIKSSON H, 1995, J INTERN MED, V237, P135, DOI 10.1111/j.1365-2796.1995.tb01153.x; FOLLAND ED, 1979, CIRCULATION, V60, P760, DOI 10.1161/01.CIR.60.4.760; GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450; GILLUM RF, 1993, AM HEART J, V126, P1042, DOI 10.1016/0002-8703(93)90738-U; Hjalmarson A, 1999, LANCET, V353, P2001; Hobbs FDR, 2000, EUR HEART J, V21, P1877, DOI 10.1053/euhj.2000.2170; Lechat P, 1999, LANCET, V353, P9; MARANTZ PR, 1988, CIRCULATION, V77, P607, DOI 10.1161/01.CIR.77.3.607; McDonagh TA, 1997, LANCET, V350, P829, DOI 10.1016/S0140-6736(97)03033-X; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Morgan S, 1999, BRIT MED J, V318, P368, DOI 10.1136/bmj.318.7180.368; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; NORRIS RM, 1984, AM J CARDIOL, V53, P408, DOI 10.1016/0002-9149(84)90003-1; PARAMESHWAR J, 1992, BRIT J GEN PRACT, V42, P287; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pitt B, 1997, LANCET, V349, P747, DOI 10.1016/S0140-6736(97)01187-2; REMES J, 1992, EUR HEART J, V13, P588, DOI 10.1093/oxfordjournals.eurheartj.a060220; REMES J, 1991, EUR HEART J, V12, P315, DOI 10.1093/oxfordjournals.eurheartj.a059896; Remme WJ, 1997, EUR HEART J, V18, P736; Schunkert H, 1998, LANCET, V351, P372, DOI 10.1016/S0140-6736(05)78298-2; SUTTON GC, 1990, AM HEART J, V120, P1538, DOI 10.1016/0002-8703(90)90055-3; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Townsend P, 1988, HLTH DEPRIVATION INE; Vasan RS, 2001, NEW ENGL J MED, V344, P56, DOI 10.1056/NEJM200101043440111; WHEELDON NM, 1993, Q J MED, V86, P17	30	365	373	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 11	2001	358	9280					439	444		10.1016/S0140-6736(01)05620-3	http://dx.doi.org/10.1016/S0140-6736(01)05620-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463TB	11513906				2022-12-01	WOS:000170492400008
J	Reddy, A; Caler, EV; Andrews, NW				Reddy, A; Caler, EV; Andrews, NW			Plasma membrane repair is mediated by Ca2+-regulated exocytosis of lysosomes	CELL			English	Article							REGULATES CA2+-DEPENDENT EXOCYTOSIS; EPITHELIAL-CELLS; PC12 CELLS; FIBROBLASTS; SYNAPTOTAGMINS; RELEASE; MACROMOLECULES; CONTRACTION; DISRUPTIONS; MECHANISM	Plasma membrane wounds are repaired by a mechanism involving Ca2+-regulated exocytosis. Elevation in intracellular [Ca2+] triggers fusion of lysosomes with the plasma membrane, a process regulated by the lysosomal synaptotagmin isoform Syt VII. Here, we show that Ca2+-regulated exocytosis of lysosomes is required for the repair of plasma membrane disruptions. Lysosomal exocytosis and membrane resealing are inhibited by the recombinant Syt VII C(2)A domain or anti-Syt VII C(2)A antibodies, or by antibodies against the cytosolic domain of Lamp-1, which specifically aggregate lysosomes. We further demonstrate that lysosomal exocytosis mediates the resealing of primary skin fibroblasts wounded during the contraction of collagen matrices. These findings reveal a fundamental, novel role for lysosomes: as Ca2+-regulated exocytic compartments responsible for plasma membrane repair.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06520 USA	Yale University	Andrews, NW (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06520 USA.			Andrews, Norma/0000-0002-0611-2412	NIAID NIH HHS [AI34867] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034867, R37AI034867] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andrews NW, 2000, TRENDS CELL BIOL, V10, P316, DOI 10.1016/S0962-8924(00)01794-3; Bakker AC, 1997, J CELL SCI, V110, P2227; Bi GQ, 1995, J CELL BIOL, V131, P1747, DOI 10.1083/jcb.131.6.1747; BODEMANN H, 1972, J MEMBRANE BIOL, V8, P1, DOI 10.1007/BF01868092; BUSSONMABILLOT S, 1984, BIOL CELL, V51, P53, DOI 10.1111/j.1768-322X.1984.tb00283.x; Butcher BA, 2000, MOL BIOCHEM PARASIT, V107, P207, DOI 10.1016/S0166-6851(00)00189-4; Caler EV, 2001, J EXP MED, V193, P1097, DOI 10.1084/jem.193.9.1097; CHANG DC, 1990, BIOPHYS J, V58, P1, DOI 10.1016/S0006-3495(90)82348-1; Chavez RA, 1996, J CELL BIOL, V133, P1177, DOI 10.1083/jcb.133.6.1177; CHEN WT, 1981, J CELL SCI, V49, P1; Coorssen JR, 1996, EMBO J, V15, P3787, DOI 10.1002/j.1460-2075.1996.tb00752.x; Dai J, 1995, COLD SPRING HARB SYM, V60, P567, DOI 10.1101/SQB.1995.060.01.060; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; Detrait ER, 2000, J NEUROSCI RES, V62, P566, DOI 10.1002/1097-4547(20001115)62:4<566::AID-JNR11>3.3.CO;2-W; Eddleman CS, 1997, P NATL ACAD SCI USA, V94, P4745, DOI 10.1073/pnas.94.9.4745; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; Grinnell F, 2000, TRENDS CELL BIOL, V10, P362, DOI 10.1016/S0962-8924(00)01802-X; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; HART NH, 1987, J EXP ZOOL, V244, P17, DOI 10.1002/jez.1402440104; HARTER C, 1992, J CELL BIOL, V117, P311, DOI 10.1083/jcb.117.2.311; Kasai H, 1999, P NATL ACAD SCI USA, V96, P945, DOI 10.1073/pnas.96.3.945; LEE B, 1985, BIOCHIM BIOPHYS ACTA, V815, P128, DOI 10.1016/0005-2736(85)90482-1; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; LIEBER MR, 1982, J BIOL CHEM, V257, P1660; Lin YC, 1997, MOL BIOL CELL, V8, P59, DOI 10.1091/mbc.8.1.59; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; MCNEIL PL, 1987, J CELL SCI, V88, P669; McNeil PL, 2000, J CELL SCI, V113, P1891; MCNEIL PL, 1989, GASTROENTEROLOGY, V96, P1238, DOI 10.1016/S0016-5085(89)80010-1; MCNEIL PL, 1992, AM J PATHOL, V140, P1097; McNeil PL, 1997, J CELL BIOL, V137, P1, DOI 10.1083/jcb.137.1.1; MCNEIL PL, 1984, J CELL BIOL, V98, P1556, DOI 10.1083/jcb.98.4.1556; MIKOSHIBA K, 1995, P NATL ACAD SCI USA, V92, P10703, DOI 10.1073/pnas.92.23.10703; Miyake K, 1995, J CELL BIOL, V131, P1737, DOI 10.1083/jcb.131.6.1737; MOCHITATE K, 1991, EXP CELL RES, V193, P198, DOI 10.1016/0014-4827(91)90556-A; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Ninomiya Y, 1996, J BIOL CHEM, V271, P17751, DOI 10.1074/jbc.271.30.17751; Rodriguez A, 1996, J CELL BIOL, V134, P349, DOI 10.1083/jcb.134.2.349; Rodriguez A, 1999, J BIOL CHEM, V274, P16754, DOI 10.1074/jbc.274.24.16754; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Schiavo G, 1998, BIOCHEM BIOPH RES CO, V248, P1, DOI 10.1006/bbrc.1998.8527; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; Sugita S, 2000, BIOCHEMISTRY-US, V39, P2940, DOI 10.1021/bi9920984; SWANSON JA, 1987, SCIENCE, V238, P548, DOI 10.1126/science.2443981; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; Togo T, 1999, J CELL SCI, V112, P719; Togo T, 2000, MOL BIOL CELL, V11, P4339, DOI 10.1091/mbc.11.12.4339; TOMASEK JJ, 1992, ANAT REC, V232, P359, DOI 10.1002/ar.1092320305; ULLRICH B, 1995, NEUROPHARMACOLOGY, V34, P1371, DOI 10.1016/0028-3908(95)00132-P; WALL DA, 1985, J CELL BIOL, V101, P1651, DOI 10.1083/jcb.101.5.1651	52	722	738	3	31	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2001	106	2					157	169		10.1016/S0092-8674(01)00421-4	http://dx.doi.org/10.1016/S0092-8674(01)00421-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511344	Bronze			2022-12-01	WOS:000170193100006
J	YUNG, YL; ALLEN, M; CRISP, D; ZUREK, RW; SANDER, SP				YUNG, YL; ALLEN, M; CRISP, D; ZUREK, RW; SANDER, SP			SPATIAL VARIATION OF OZONE DEPLETION RATES IN THE SPRINGTIME ANTARCTIC POLAR VORTEX	SCIENCE			English	Article									CALTECH,JET PROP LAB,PASADENA,CA 91109	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	YUNG, YL (corresponding author), CALTECH,DIV GEOL & PLANETARY SCI,PASADENA,CA 91125, USA.		Crisp, David/F-6642-2017; Yung, Yuk/AAM-4850-2021	Crisp, David/0000-0002-4573-9998; Yung, Yuk/0000-0002-4263-2562				ANDERSON JG, 1989, J GEOPHYS RES-ATMOS, V94, P11465, DOI 10.1029/JD094iD09p11465; ANDERSON JG, 1989, J GEOPHYS RES-ATMOS, V94, P11480, DOI 10.1029/JD094iD09p11480; BARRETT JW, 1988, NATURE, V336, P455, DOI 10.1038/336455a0; BRUNE WH, 1989, EOS, V70, P1040; BUTCHART N, 1986, J ATMOS SCI, V43, P1319, DOI 10.1175/1520-0469(1986)043<1319:TAOTSP>2.0.CO;2; DEZAFRA RL, 1989, J GEOPHYS RES-ATMOS, V94, P11423, DOI 10.1029/JD094iD09p11423; FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; FARMER CB, 1987, NATURE, V329, P126, DOI 10.1038/329126a0; KRUEGER A, 1988, NASA REF PUBL, V1201; MAHLMAN JD, 1986, GEOPHYS RES LETT, V13, P1316, DOI 10.1029/GL013i012p01316; MCELROY MB, 1986, NATURE, V321, P759, DOI 10.1038/321759a0; MCINTYRE ME, 1984, J ATMOS TERR PHYS, V46, P825, DOI 10.1016/0021-9169(84)90063-1; MOLINA LT, 1987, J PHYS CHEM-US, V91, P433, DOI 10.1021/j100286a035; SANDER SP, 1989, SCIENCE, V245, P1095, DOI 10.1126/science.245.4922.1095; SANDERS RW, 1989, J GEOPHYS RES-ATMOS, V94, P11381, DOI 10.1029/JD094iD09p11381; SCHOEBERL MR, 1986, GEOPHYS RES LETT, V13, P1217, DOI 10.1029/GL013i012p01217; SOLOMON S, 1986, NATURE, V321, P755, DOI 10.1038/321755a0; SOLOMON S, 1989, J GEOPHYS RES-ATMOS, V94, P11393, DOI 10.1029/JD094iD09p11393; STOLARSKI RS, 1986, GEOPHYS RES LETT, V13, P1210, DOI 10.1029/GL013i012p01210; STOLARSKI RS, 1986, NATURE, V322, P808, DOI 10.1038/322808a0; TUNG KK, 1986, NATURE, V333, P811; WATSON B, 1989, J GEOPHYS RES-ATMOS, V94, P11179, DOI 10.1029/JD094iD09p11179; WATSON R, 1989, J GEOPHYS RES, V94, P16437	23	7	7	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 11	1990	248	4956					721	724		10.1126/science.11538181	http://dx.doi.org/10.1126/science.11538181			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC926	11538181				2022-12-01	WOS:A1990DC92600030
J	BLAKE, DF; FREUND, F; KRISHNAN, KFM; ECHER, CJ; SHIPP, R; BUNCH, TE; TIELENS, AG; LIPARI, RJ; HETHERINGTON, CJD; CHANG, S				BLAKE, DF; FREUND, F; KRISHNAN, KFM; ECHER, CJ; SHIPP, R; BUNCH, TE; TIELENS, AG; LIPARI, RJ; HETHERINGTON, CJD; CHANG, S			THE NATURE AND ORIGIN OF INTERSTELLAR DIAMOND	NATURE			English	Article									UNIV CALIF BERKELEY LAWRENCE BERKELEY LAB,NATL CTR ELECTRON MICROSCOPY,BERKELEY,CA 94720; SURFACE SCI LABS,MT VIEW,CA 94043	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	BLAKE, DF (corresponding author), NASA,AMES RES CTR,MOFFETT FIELD,CA 94035, USA.							ASH RD, IN PRESS METEORITICS, V22; CAREY W, IN PRESS METEORITICS, V22; DECARLI PS, 1961, SCIENCE, V133, P1821, DOI 10.1126/science.133.3467.1821; HECHT JH, 1987, NATURE, V328, P765, DOI 10.1038/328765a0; KERRIDGE JF, 1987, GEOCHIM COSMOCHIM AC, V51, P2527, DOI 10.1016/0016-7037(87)90303-6; LEWIS RS, 1987, NATURE, V326, P160, DOI 10.1038/326160a0; LEWIS RS, 1983, NATURE, V305, P767, DOI 10.1038/305767a0; LEWIS RS, 1983, SCI AM, V249, P66, DOI 10.1038/scientificamerican0883-66; MORAR JF, 1986, PHYS REV B, V33, P1346, DOI 10.1103/PhysRevB.33.1346; NUTH JA, 1987, NATURE, V329, P589, DOI 10.1038/329589b0; OTT U, 1981, GEOCHIM COSMOCHIM AC, V45, P1751, DOI 10.1016/0016-7037(81)90009-0; ROY R, 1987, NATURE, V325, P17, DOI 10.1038/325017a0; SWART PK, 1983, SCIENCE, V220, P406, DOI 10.1126/science.220.4595.406; TIELENS AGG, 1987, APJ, V319, pL103; VANDERBILT D, 1984, PHYS REV B, V30, P6118, DOI 10.1103/PhysRevB.30.6118	15	61	60	0	16	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 14	1988	332	6165					611	613		10.1038/332611a0	http://dx.doi.org/10.1038/332611a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	M9218	11536600				2022-12-01	WOS:A1988M921800051
J	Hippisley-Cox, J; Pringle, M; Hammersley, V; Crown, N; Wynn, A; Meal, A; Coupland, C				Hippisley-Cox, J; Pringle, M; Hammersley, V; Crown, N; Wynn, A; Meal, A; Coupland, C			Antidepressants as risk factor for ischaemic heart disease: case-control study in primary care	BRITISH MEDICAL JOURNAL			English	Article							MYOCARDIAL-INFARCTION; TRICYCLIC ANTIDEPRESSANTS; PSYCHOTROPIC-DRUGS; DEPRESSION	Objectives To determine whether antidepressants are a risk factor for ischaemic heart disease and tp compare the risk for different subgroups of antidepressants and individual antidepressants. Design Case-control study. Setting Nine general practices recruited from the Trent Focus Collaborative Research Network, Participants 933 men and women with ischaemic heart disease matched by age, sex, and practice to 5516 controls. Main outcome measure Adjusted odds ratio for ischaemic heart disease calculated by logistic regression. Results Odds ratios for ischaemic heart disease were significantly raised for patients who had ever received a prescription for tricyclic antidepressants even after diabetes, hypertension, smoking, body mass index, and use of selective serotonin reuptake inhibitors had been adjusted for (1.56; 95% confidence interval 1.18 to 2.05). Patients who had ever taken dosulepin (dothiepin) had a significantly raised odds ratio for ischaemic heart disease after adjustment for confounding factors and use of other antidepressants (1.67, 1.17 to 2.36), There was no significant increase in the odds ratios for amitriptyline, lofepramine, and selective serotonin reuptake inhibitors in multivariate analysis. Increasing maximum doses of dosulepin were associated with increasing odds ratios for ischaemic heart disease. Similarly, there was a significant positive trend associated with increasing numbers of prescriptions of dosulepin (adjusted odds ratio 1.52 for 1 prescription, 1.39 for 2-3, and 1.96 for greater than or equal to4,P<0.002). Conclusion There is good evidence for an association between dosulepin and subsequent ischaemic heart disease and for a dose-response relation.	Univ Nottingham, Div Gen Practice, Nottingham NG7 2RD, England; Collingham Med Ctr, Collingham NG23 7LB, Notts, England; Queens Med Ctr, Sch Med, Sch Nursing, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham	Hippisley-Cox, J (corresponding author), Univ Nottingham, Div Gen Practice, Nottingham NG7 2RD, England.		Hippisley-Cox, Julia/AAY-2788-2020; Meal, Andy/B-9083-2008	Hippisley-Cox, Julia/0000-0002-2479-7283; Coupland, Carol/0000-0002-2327-3306				*AG HLTH CAR POL R, 1999, TREATM DEPR NEW PHAR; Breslow NE, 1987, STAT METHODS CANC RE; BUCKLEY NA, 1994, LANCET, V343, P159, DOI 10.1016/S0140-6736(94)90940-7; Campbell NC, 1998, BMJ-BRIT MED J, V316, P1430, DOI 10.1136/bmj.316.7142.1430; CARNEY RM, 1988, PSYCHOSOM MED, V50, P627, DOI 10.1097/00006842-198811000-00009; Cohen HW, 2000, AM J MED, V108, P2, DOI 10.1016/S0002-9343(99)00301-0; FRASURESMITH N, 1995, CIRCULATION, V91, P999, DOI 10.1161/01.CIR.91.4.999; GLASSMAN AH, 1994, GERONTOLOGY, V40, P15, DOI 10.1159/000213616; Glassman AH, 1998, J CLIN PSYCHIAT, V59, P13; HAMMERSLEY V, 1998, J INF PRIMARY CARE, V1, P3; HARRIS M, 1992, CLASSIFICATION DIABE; Hippisley-Cox J, 1998, BMJ-BRIT MED J, V316, P1714, DOI 10.1136/bmj.316.7146.1714; LADWIG KH, 1994, LANCET, V343, P20, DOI 10.1016/S0140-6736(94)90877-X; LAPANE KL, 1995, EPIDEMIOLOGY, V6, P376, DOI 10.1097/00001648-199507000-00008; Penttinen J, 1996, INT J EPIDEMIOL, V25, P760, DOI 10.1093/ije/25.4.760; PRATT L, 1996, CIRCULATION, V94, P123; ROOSE SP, 1994, J CLIN PSYCHIAT, V55, P83; Royal College of General Practitioners Office of Population Consensus & Survey. Department of Health, 1995, MORB STAT GEN PRACT; SCHLEIFER SJ, 1989, ARCH INTERN MED, V149, P1785, DOI 10.1001/archinte.149.8.1785; Sheline YI, 1997, AM J MED, V102, P54, DOI 10.1016/S0002-9343(96)00374-9	20	76	76	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 22	2001	323	7314					666	669		10.1136/bmj.323.7314.666	http://dx.doi.org/10.1136/bmj.323.7314.666			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	476LP	11566831	Green Published, Bronze			2022-12-01	WOS:000171228800019
J	Lomvardas, S; Thanos, D				Lomvardas, S; Thanos, D			Nucleosome sliding via TBP DNA binding in vivo	CELL			English	Article							REMODELING COMPLEX; TRANSCRIPTION FACTORS; CHROMATIN STRUCTURE; HISTONE OCTAMER; ARCHITECTURAL SPECIFICITY; POSITIONED NUCLEOSOMES; ORDERED RECRUITMENT; CRYSTAL-STRUCTURE; GENE-EXPRESSION; HMG I(Y)	Here, we show that a nucleosome obstructing transcription from the IFN-beta promoter slides in vivo in response to virus infection, thus exposing the previously masked TATA box and the initiation site, a requirement for transcriptional activation. Our experiments also revealed that this mode of chromatin remodeling is a two-step reaction. First, the enhanceosome recruits the SWI/SNF chromatin-remodeling complex that modifies the nucleosome to allow binding of TBP. Second, DNA bending is induced by TBP binding, and the nucleosome slides to a new position. Experiments with other DNA binding proteins demonstrated a strong correlation between the ability to bend DNA and nucleosome sliding, suggesting that the sliding is induced by the bend.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University	Thanos, D (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.		Thanos, Dimitris/AAE-5720-2019	Lomvardas, Stavros/0000-0002-7668-3026	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054605] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-54605] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aalfs JD, 2000, TRENDS BIOCHEM SCI, V25, P548, DOI 10.1016/S0968-0004(00)01689-3; Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; ARCHER TK, 1991, MOL CELL BIOL, V11, P688, DOI 10.1128/MCB.11.2.688; Biggar SR, 1999, EMBO J, V18, P2254, DOI 10.1093/emboj/18.8.2254; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Dilworth FJ, 2000, MOL CELL, V6, P1049, DOI 10.1016/S1097-2765(00)00103-9; Falvo JV, 1995, CELL, V83, P1101, DOI 10.1016/0092-8674(95)90137-X; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Gavin I, 2001, MOL CELL, V7, P97, DOI 10.1016/S1097-2765(01)00158-7; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; Goldmark JP, 2000, CELL, V103, P423, DOI 10.1016/S0092-8674(00)00134-3; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Havas K, 2000, CELL, V103, P1133, DOI 10.1016/S0092-8674(00)00215-4; HONG L, 1993, J BIOL CHEM, V268, P305; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Jaskelioff M, 2000, MOL CELL BIOL, V20, P3058, DOI 10.1128/MCB.20.9.3058-3068.2000; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; Kim JS, 1996, NUCLEIC ACIDS RES, V24, P4341, DOI 10.1093/nar/24.21.4341; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Li GF, 1998, P NATL ACAD SCI USA, V95, P4772, DOI 10.1073/pnas.95.8.4772; Lohr D, 1997, J BIOL CHEM, V272, P26795, DOI 10.1074/jbc.272.43.26795; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; Lorch Y, 2001, MOL CELL, V7, P89, DOI 10.1016/S1097-2765(01)00157-5; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; MARMORSTEIN R, 1992, NATURE, V356, P408, DOI 10.1038/356408a0; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; Moreira JMA, 1999, EMBO J, V18, P2836, DOI 10.1093/emboj/18.10.2836; Munshi N, 1999, COLD SPRING HARB SYM, V64, P149, DOI 10.1101/sqb.1999.64.149; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Munshi N, 2001, SCIENCE, V293, P1133, DOI 10.1126/science.293.5532.1133; Mutskov V, 1998, MOL CELL BIOL, V18, P6293, DOI 10.1128/MCB.18.11.6293; Peterson CL, 2000, FEBS LETT, V476, P68, DOI 10.1016/S0014-5793(00)01673-2; Reeves R, 2000, MOL CELL BIOL, V20, P4666, DOI 10.1128/MCB.20.13.4666-4679.2000; Reinke H, 2001, MOL CELL, V7, P529, DOI 10.1016/S1097-2765(01)00200-3; Roychoudhury M, 2000, P NATL ACAD SCI USA, V97, P13608, DOI 10.1073/pnas.250476297; Rubbi L, 1997, BIOCHEM J, V328, P401, DOI 10.1042/bj3280401; Schnitzler G, 1998, CELL, V94, P17, DOI 10.1016/S0092-8674(00)81217-9; Senger K, 2000, MOL CELL, V6, P931, DOI 10.1016/S1097-2765(05)00081-X; Sewack GF, 1997, J BIOL CHEM, V272, P31118, DOI 10.1074/jbc.272.49.31118; Shen CH, 2001, MOL CELL BIOL, V21, P534, DOI 10.1128/MCB.21.2.534-547.2001; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sudarsanam P, 1999, EMBO J, V18, P3101, DOI 10.1093/emboj/18.11.3101; Syntichaki P, 2000, NATURE, V404, P414, DOI 10.1038/35006136; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; Verdone L, 1996, MOL CELL BIOL, V16, P1978; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Weinmann AS, 1999, IMMUNITY, V11, P665, DOI 10.1016/S1074-7613(00)80141-7; Weinmann AS, 2001, NAT IMMUNOL, V2, P51, DOI 10.1038/83168; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; Wolffe A., 1995, CHROMATIN STRUCTURE; XIAO H, 2001, IN PRESS MOL CELL	61	161	164	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 21	2001	106	6					685	696		10.1016/S0092-8674(01)00490-1	http://dx.doi.org/10.1016/S0092-8674(01)00490-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	476EJ	11572775	Bronze			2022-12-01	WOS:000171213000006
J	Simon, I; Barnett, J; Hannett, N; Harbison, CT; Rinaldi, NJ; Volkert, TL; Wyrick, JJ; Zeitlinger, J; Gifford, DK; Jaakkola, TS; Young, RA				Simon, I; Barnett, J; Hannett, N; Harbison, CT; Rinaldi, NJ; Volkert, TL; Wyrick, JJ; Zeitlinger, J; Gifford, DK; Jaakkola, TS; Young, RA			Serial regulation of transcriptional regulators in the yeast cell cycle	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; S-PHASE; SWI5 TRANSCRIPTION; GENE-EXPRESSION; DNA-REPLICATION; FORKHEAD GENES; G1 CYCLINS; PROTEIN; IDENTIFICATION	Genome-wide location analysis was used to determine how the yeast cell cycle gene expression program is regulated by each of the nine known cell cycle transcriptional activators. We found that cell cycle transcriptional activators that function during one stage of the cell cycle regulate transcriptional activators that function during the next stage. This serial regulation of transcriptional activators forms a connected regulatory network that is itself a cycle. Our results also reveal how the nine transcriptional regulators coordinately regulate global gene expression and diverse stage-specific functions to produce a continuous cycle of cellular events. This information forms the foundation for a complete map of the transcriptional regulatory network that controls the cell cycle.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Artificial Intelligence Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Young, Richard A/F-6495-2012; Rinaldi, Nicola J/J-5858-2017	Young, Richard A/0000-0001-8855-8647; Rinaldi, Nicola J/0000-0002-0358-0747; Simon, Itamar/0000-0002-8517-1903				ALTHOEFER H, 1995, MOL CELL BIOL, V15, P5917; AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Breeden LL, 2000, CURR BIOL, V10, pR586, DOI 10.1016/S0960-9822(00)00634-5; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; DIRICK L, 1992, NATURE, V357, P508, DOI 10.1038/357508a0; DIRICK L, 1995, EMBO J, V14, P4803, DOI 10.1002/j.1460-2075.1995.tb00162.x; GORDON CB, 1991, P NATL ACAD SCI USA, V88, P6058, DOI 10.1073/pnas.88.14.6058; Grether ME, 1999, MOL BIOL CELL, V10, P3689, DOI 10.1091/mbc.10.11.3689; Hollenhorst PC, 2000, GENETICS, V154, P1533; Igual JC, 1996, EMBO J, V15, P5001, DOI 10.1002/j.1460-2075.1996.tb00880.x; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; Knapp D, 1996, MOL CELL BIOL, V16, P5701; KOCH C, 1994, CURR OPIN CELL BIOL, V6, P451, DOI 10.1016/0955-0674(94)90039-6; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Koch C, 1996, GENE DEV, V10, P129, DOI 10.1101/gad.10.2.129; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Kumar R, 2000, CURR BIOL, V10, P896, DOI 10.1016/S0960-9822(00)00618-7; KUO MH, 1994, MOL CELL BIOL, V14, P348, DOI 10.1128/MCB.14.1.348; LOWNDES NF, 1991, NATURE, V350, P247, DOI 10.1038/350247a0; Loy CJ, 1999, MOL CELL BIOL, V19, P3312; LYDALL D, 1991, GENE DEV, V5, P2405, DOI 10.1101/gad.5.12b.2405; MacKay VL, 2001, MOL CELL BIOL, V21, P4140, DOI 10.1128/MCB.21.13.4140-4148.2001; McBride HJ, 1999, J BIOL CHEM, V274, P21029, DOI 10.1074/jbc.274.30.21029; McInerny CJ, 1997, GENE DEV, V11, P1277, DOI 10.1101/gad.11.10.1277; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; NASMYTH K, 1990, CELL, V62, P631, DOI 10.1016/0092-8674(90)90110-Z; NASMYTH K, 1991, CELL, V66, P995, DOI 10.1016/0092-8674(91)90444-4; Nurse P, 2000, CELL, V100, P71, DOI 10.1016/S0092-8674(00)81684-0; Oehlen LJWM, 1996, MOL CELL BIOL, V16, P2830; OGAS J, 1991, CELL, V66, P1015, DOI 10.1016/0092-8674(91)90445-5; Partridge JF, 1997, J BIOL CHEM, V272, P9071; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; Pic A, 2000, EMBO J, V19, P3750, DOI 10.1093/emboj/19.14.3750; PIZZAGALLI A, 1988, P NATL ACAD SCI USA, V85, P3772, DOI 10.1073/pnas.85.11.3772; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; SCHWOB E, 1993, GENE DEV, V7, P1160, DOI 10.1101/gad.7.7a.1160; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; SURANA U, 1991, CELL, V65, P145, DOI 10.1016/0092-8674(91)90416-V; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; TOONE WM, 1995, EMBO J, V14, P5824, DOI 10.1002/j.1460-2075.1995.tb00270.x; Toyn JH, 1997, GENETICS, V145, P85; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; VERMA R, 1991, P NATL ACAD SCI USA, V88, P7155, DOI 10.1073/pnas.88.16.7155; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581	53	481	497	0	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 21	2001	106	6					697	708		10.1016/S0092-8674(01)00494-9	http://dx.doi.org/10.1016/S0092-8674(01)00494-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	476EJ	11572776	Bronze			2022-12-01	WOS:000171213000007
J	Gerrish, P				Gerrish, P			The rhythm of microbial adaptation	NATURE			English	Article							DIMINISHING RETURNS; EVOLUTION; POPULATION; LIMITS; INTERFERENCE; MUTATIONS; LINKAGE	The evolutionary biologist "studies the steps by which the miraculous adaptations so characteristic of every aspect of the organic world have evolved''(1). But the general nature of such adaptive steps is still unclear. Evolution is often thought to be random and dependent on unpredictable events(2). In this light, one might expect the steps taken by adaptation to be completely random, both biologically and temporally. Here I present a mathematical derivation to show that, on the contrary, adaptive steps can have fairly strong rhythm. I find that the strength of the adaptive rhythm, that is its relative temporal regularity, is equal to a constant that is the same for all microbial populations. As a consequence, numbers of accumulated adaptations are predicted to have a universal variance/mean ratio. The theory derived here is potentially applicable to the study of molecular evolution.	Los Alamos Natl Lab, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Gerrish, P (corresponding author), Los Alamos Natl Lab, T-10,Mailstop K710, Los Alamos, NM 87545 USA.	gerrish@lanl.gov	Gerrish, Philip/AAE-7346-2019	Gerrish, Philip/0000-0001-6393-0553				BARTON NH, 1995, GENETICS, V140, P821; BARTON NH, 1994, GENET RES, V64, P199, DOI 10.1017/S0016672300032857; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Feisenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FELLER W, 1968, INTRO PROBABILITY TH, V2, P346; FELSENSTEIN J, 1974, GENETICS, V78, P737; Fisher R., 1930, GENETICAL THEORY NAT, P102; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; GILLESPIE JH, 1998, POPULATION GENETICS, P77; Gould S.J., 1989, WONDERFUL LIFE BURGE; HAIGH J, 1978, THEOR POPUL BIOL, V14, P251, DOI 10.1016/0040-5809(78)90027-8; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; HOGG RV, 1995, INTRO MATH STAT, P59; KORBER BT, 1998, SNAP SYNONYMOUS NONS; MAYR E, 1988, NEW PHILOS BIOL, P26; McVean GAT, 2000, GENETICS, V155, P929; Miralles R, 1999, SCIENCE, V285, P1745, DOI 10.1126/science.285.5434.1745; Miralles R, 2000, J VIROL, V74, P3566, DOI 10.1128/JVI.74.8.3566-3571.2000; Morgan T.H., 1913, HEREDITY SEX; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; Orr HA, 2000, GENETICS, V155, P961; Orr HA, 1998, EVOLUTION, V52, P935, DOI 10.1111/j.1558-5646.1998.tb01823.x; OSMANOV S, 1994, AIDS RES HUM RETROV, V10, P1327, DOI 10.1089/aid.1994.10.1327; Ota T, 1971, J Mol Evol, V1, P18, DOI 10.1007/BF01659391; Otto SP, 1997, GENETICS, V147, P879; ROBERTSON A, 1970, MATH TOPICS POPULATI, P246; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wahl LM, 2000, GENETICS, V156, P1437	29	57	58	1	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 20	2001	413	6853					299	302		10.1038/35095046	http://dx.doi.org/10.1038/35095046			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565030				2022-12-01	WOS:000171040500037
J	Karp, PD				Karp, PD			Pathway databases: A case study in computational symbolic theories	SCIENCE			English	Editorial Material							GENOME SEQUENCE	A pathway database (DB) is a DB that describes biochemical pathways, reactions, and enzymes. The EcoCyc pathway DB (see http://ecocyc.org) describes the metabolic, transport, and genetic-regulatory networks of Escherichia coli. EcoCyc is an example of a computational symbolic theory, which is a DB that structures a scientific theory within a formal ontology so that it is available for computational analysis. it is argued that by encoding scientific theories in symbolic form, we open new realms of analysis and understanding for theories that would otherwise be too large and complex for scientists to reason with effectively.	SRI Int, Bioinformat Res Grp, Menlo Pk, CA 94025 USA	SRI International	Karp, PD (corresponding author), SRI Int, Bioinformat Res Grp, EK223,333 Ravenswood Ave, Menlo Pk, CA 94025 USA.	pkarp@ai.sri.com	Karp, Peter/C-3514-2012	Karp, Peter/0000-0002-5876-6418	NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR007861] Funding Source: NIH RePORTER; NCRR NIH HHS [1-R01-RR07861-01] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Ellis LBM, 2000, NUCLEIC ACIDS RES, V28, P377, DOI 10.1093/nar/28.1.377; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KARP P, 1996, P 4 INT C INT SYST M; KARP P, 1999, NUCL ACID PROTEIN DA, P269; Karp PD, 2000, BIOINFORMATICS, V16, P269, DOI 10.1093/bioinformatics/16.3.269; Karp PD, 1998, TRENDS BIOCHEM SCI, V23, P114, DOI 10.1016/S0968-0004(98)01184-0; Karp PD, 2000, NUCLEIC ACIDS RES, V28, P56, DOI 10.1093/nar/28.1.56; Karp PP, 1999, TRENDS BIOTECHNOL, V17, P275, DOI 10.1016/S0167-7799(99)01316-5; Ouzounis CA, 2000, GENOME RES, V10, P568, DOI 10.1101/gr.10.4.568; Overbeek R, 2000, NUCLEIC ACIDS RES, V28, P123, DOI 10.1093/nar/28.1.123; Romero P R, 2001, Pac Symp Biocomput, P471; SCHILLING C, 1988, P NATL ACAD SCI USA, V95, P4193; Stewart G., 1975, TOPICS NUMERICAL ANA, VII, P185, DOI [DOI 10.1016/B978-0-12-108550-6.50012-4, 10.1016/B978-0-12-496952-0.50023-4, DOI 10.1016/B978-0-12-496952-0.50023-4]	16	148	158	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2040	2044		10.1126/science.1064621	http://dx.doi.org/10.1126/science.1064621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557880				2022-12-01	WOS:000171028700061
J	Luo, Y; Pfuetzner, RA; Mosimann, S; Paetzel, M; Frey, EA; Cherney, M; Kim, B; Little, JW; Strynadka, NCJ				Luo, Y; Pfuetzner, RA; Mosimann, S; Paetzel, M; Frey, EA; Cherney, M; Kim, B; Little, JW; Strynadka, NCJ			Crystal structure of LexA: A conformational switch for regulation of self-cleavage	CELL			English	Article							ESCHERICHIA-COLI; UMUD PROTEIN; INTERMOLECULAR CLEAVAGE; REPRESSOR; AUTODIGESTION; DNA; IDENTIFICATION; MECHANISM; PURIFICATION; PROGRAM	LexA repressor undergoes a self-cleavage reaction. In vivo, this reaction requires an activated form of RecA, but it occurs spontaneously in vitro at high pH. Accordingly, LexA must both allow self-cleavage and yet prevent this reaction in the absence of a stimulus. We have solved the crystal structures of several mutant forms of LexA. Strikingly, two distinct conformations are observed, one compatible with cleavage, and the other in which the cleavage site is similar to 20 Angstrom from the catalytic center. Our analysis provides insight into the structural and energetic features that modulate the interconversion between these two forms and hence the rate of the self-cleavage reaction. We suggest RecA activates the self-cleavage of LexA and related proteins through selective stabilization of the cleavable conformation.	Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA; Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	University of British Columbia; University of Alberta; University of Arizona; University of Arizona	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2146 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	natalie@byron.biochem.ubc.ca		Paetzel, Mark/0000-0002-7408-5487	NIGMS NIH HHS [GM24178] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024178] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Bell CE, 2000, CELL, V101, P801, DOI 10.1016/S0092-8674(00)80891-0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURCKHARDT SE, 1988, P NATL ACAD SCI USA, V85, P1811, DOI 10.1073/pnas.85.6.1811; CHAN AWE, 1993, PROTEIN SCI, V2, P1574, DOI 10.1002/pro.5560021004; DAOPIN S, 1991, BIOCHEMISTRY-US, V30, P11521, DOI 10.1021/bi00113a006; DEANDA J, 1983, J BIOL CHEM, V258, P536; Ferentz AE, 1997, NAT STRUCT BIOL, V4, P979, DOI 10.1038/nsb1297-979; FOGH RH, 1994, EMBO J, V13, P3936, DOI 10.1002/j.1460-2075.1994.tb06709.x; Friedberg EC, 1995, DNA REPAIR MUTAGENES; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; GIMBLE FS, 1986, J MOL BIOL, V192, P39, DOI 10.1016/0022-2836(86)90462-6; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; HURSTEL S, 1986, EMBO J, V5, P793, DOI 10.1002/j.1460-2075.1986.tb04283.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIM B, 1993, CELL, V73, P1165, DOI 10.1016/0092-8674(93)90645-7; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; Laskowski M, 2000, BBA-PROTEIN STRUCT M, V1477, P324, DOI 10.1016/S0167-4838(99)00284-8; Lejal N, 2000, J GEN VIROL, V81, P983, DOI 10.1099/0022-1317-81-4-983; Liao DI, 2000, NAT STRUCT BIOL, V7, P749, DOI 10.1038/78973; LIN LL, 1988, J BACTERIOL, V170, P2163, DOI 10.1128/jb.170.5.2163-2173.1988; LIN LL, 1989, J MOL BIOL, V210, P439, DOI 10.1016/0022-2836(89)90121-6; LITTLE JW, 1984, P NATL ACAD SCI-BIOL, V81, P1375, DOI 10.1073/pnas.81.5.1375; LITTLE JW, 1991, BIOCHIMIE, V73, P411, DOI 10.1016/0300-9084(91)90108-D; LITTLE JW, 1994, METHOD ENZYMOL, V244, P266; LITTLE JW, 1980, P NATL ACAD SCI-BIOL, V77, P3225, DOI 10.1073/pnas.77.6.3225; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; LITTLE JW, 1993, J BACTERIOL, V175, P4943, DOI 10.1128/JB.175.16.4943-4950.1993; McDonald JP, 1998, P NATL ACAD SCI USA, V95, P1478, DOI 10.1073/pnas.95.4.1478; McDonald JP, 1999, J MOL BIOL, V285, P2199, DOI 10.1006/jmbi.1998.2433; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Opperman T, 1999, P NATL ACAD SCI USA, V96, P9218, DOI 10.1073/pnas.96.16.9218; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; Patricelli MP, 1999, BIOCHEMISTRY-US, V38, P9804, DOI 10.1021/bi990637z; Peat TS, 1996, STRUCTURE, V4, P1401, DOI 10.1016/S0969-2126(96)00148-7; Peat TS, 1996, NATURE, V380, P727, DOI 10.1038/380727a0; Ptashne M, 1992, GENETIC SWITCH PHAGE; ROBERTS JW, 1978, P NATL ACAD SCI USA, V75, P4714, DOI 10.1073/pnas.75.10.4714; ROLAND KL, 1990, J BIOL CHEM, V265, P12828; ROLAND KL, 1992, J MOL BIOL, V228, P395, DOI 10.1016/0022-2836(92)90829-9; SCHNARR M, 1985, BIOCHEMISTRY-US, V24, P2812, DOI 10.1021/bi00332a032; Shepley DP, 1996, P NATL ACAD SCI USA, V93, P11528, DOI 10.1073/pnas.93.21.11528; SLILATY SN, 1987, P NATL ACAD SCI USA, V84, P3987, DOI 10.1073/pnas.84.12.3987; SLILATY SN, 1991, PROTEIN ENG, V4, P919, DOI 10.1093/protein/4.8.919; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429	51	170	174	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2001	106	5					585	594		10.1016/S0092-8674(01)00479-2	http://dx.doi.org/10.1016/S0092-8674(01)00479-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551506	Bronze			2022-12-01	WOS:000170973200009
J	Brown, GD; Gordon, S				Brown, GD; Gordon, S			Immune recognition - A new receptor for beta-glucans	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; PHAGOCYTOSIS; BINDING		Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Brown, GD (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	gbrown@molbiol.ox.ac.uk	brown, gordon/B-4249-2012	brown, gordon/0000-0002-0287-5383				Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; BARTNICK.S, 1968, ANNU REV MICROBIOL, V22, P87, DOI 10.1146/annurev.mi.22.100168.000511; CZOP JK, 1986, PATHOL IMMUNOPATH R, V5, P286, DOI 10.1159/000157022; DICARLO FJ, 1958, SCIENCE, V127, P756, DOI 10.1126/science.127.3301.756-a; GIAIMIS J, 1993, J LEUKOCYTE BIOL, V54, P564, DOI 10.1002/jlb.54.6.564; JANUSZ MJ, 1988, IMMUNOLOGY, V65, P181; Mueller A, 2000, GLYCOBIOLOGY, V10, P339, DOI 10.1093/glycob/10.4.339; Muller A, 1996, J IMMUNOL, V156, P3418; ROSS GD, 1985, J IMMUNOL, V134, P3307; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; WILLIAMS DL, 1991, CARBOHYD RES, V219, P203, DOI 10.1016/0008-6215(91)89052-H	11	1164	1232	3	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2001	413	6851					36	37		10.1038/35092620	http://dx.doi.org/10.1038/35092620			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544516				2022-12-01	WOS:000170801200029
J	Pavlov, P; Svendsen, JI; Indrelid, S				Pavlov, P; Svendsen, JI; Indrelid, S			Human presence in the European Arctic nearly 40,000 years ago	NATURE			English	Article							ICE SHEETS; BARENTS; KARA; COLONIZATION; RUSSIA; EXTENT	The transition from the Middle to the Upper Palaeolithic, approximately 40,000-35,000 radiocarbon years ago, marks a turning point in the history of human evolution in Europe. Many changes in the archaeological and fossil record at this time have been associated with the appearance of anatomically modern humans(1,2). Before this transition, the Neanderthals roamed the continent, but their remains have not been found in the northernmost part of Eurasia. It is generally believed that this vast region was not colonized by humans until the final stage of the last Ice Age some 13,000-14,000 years ago(3,4). Here we report the discovery of traces of human occupation nearly 40,000 years old at Mamontovaya Kurya, a Palaeolithic site situated in the European part of the Russian Arctic. At this site we have uncovered stone artefacts, animal bones and a mammoth tusk with human-made marks from strata covered by thick Quaternary deposits. This is the oldest documented evidence for human presence at this high latitude; it implies that either the Neanderthals expanded much further north than previously thought or that modern humans were present in the Arctic only a few thousand years after their first appearance in Europe.	Univ Bergen, Ctr Studies Environm & Resources, N-5020 Bergen, Norway; Russian Acad Sci, Inst Language Literature & Hist, Komi Sci Ctr, Ural Div, Syktyvkar 167000, Russia; Univ Bergen, Bergen Museum, N-5020 Bergen, Norway	University of Bergen; Russian Academy of Sciences; Institute of Language, Literature & History, Komi Scientific Centre of the RAS; Komi Science Centre of the Ural Branch of the Russian Academy of Sciences; University of Bergen	Svendsen, JI (corresponding author), Univ Bergen, Ctr Studies Environm & Resources, N-5020 Bergen, Norway.	john.svendsen@smr.uib.no	Pavlov, Pavel Yu/S-3823-2016	Pavlov, Pavel Yu/0000-0001-8827-5719				ALLSWORTHJONES P, 1986, SZELETIAN, P83; ANIKOVICH MV, 1991, EARLY UPPER PALAEOLI; Astakhov VI, 1999, BOREAS, V28, P23, DOI 10.1111/j.1502-3885.1999.tb00205.x; Bader O.N., 1978, SUNGIR UPPER PALAEOL; Bar-Yosef O, 1998, NEANDERTALS AND MODERN HUMANS IN WESTERN ASIA, P39; Bocquet-Appel JP, 2000, ANTIQUITY, V74, P544, DOI 10.1017/S0003598X00059901; DERICCO F, 1998, CURR ANTHROPOL S, V39, P1; GAMBLE C, 1999, PALAEOLITHIC SOC EUR, P268; Halvorsen L. S., 2000, THESIS U BERGEN; HOFFECKER JF, 1993, SCIENCE, V259, P46, DOI 10.1126/science.259.5091.46; Kanivets V.I., 1976, PALEOLITHIC EXTREME; Kolosov YG, 1983, MOUSTERIAN SITES BEL; Mangerud J, 1999, BOREAS, V28, P46, DOI 10.1111/j.1502-3885.1999.tb00206.x; MOCHANOV YA, 1977, INITIAL SETTLING TER; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; PAVLOV PY, 1999, B I BIOL SYKTYVKAR, V2, P24; PAVLOV PY, 1986, PAMIATNIKI MAT KULTY, P7; PAVLOV PY, 1996, PALAEOLITHIC ARCHAEO, P44; Powers WR, 1996, INTERD CONT, P229; PRASLOV ND, 1982, PALEOLIT KOSTENKOVSK, P16; SINITSYN AA, 1997, RADIOUGLERODNAYA KHR, P21; Smith NP, 1999, COMPUT SCI ENG, V1, P96; Straus LG, 2000, ANTIQUITY, V74, P553; STRAUS LG, 1989, NATURE, V342, P476; STRINGER CB, 1996, AFRICAN EXODUS ORIGI, P84; Svendsen JI, 1999, BOREAS, V28, P234, DOI 10.1111/j.1502-3885.1999.tb00217.x; VanAndel TH, 1996, QUATERNARY SCI REV, V15, P481, DOI 10.1016/0277-3791(96)00028-5	27	104	109	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					64	67		10.1038/35092552	http://dx.doi.org/10.1038/35092552			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544525				2022-12-01	WOS:000170801200038
J	White, A; Hayhoe, S; Hart, A; Ernst, E				White, A; Hayhoe, S; Hart, A; Ernst, E			Adverse events following acupuncture: prospective survey of 32 000 consultations with doctors and physiotherapists	BRITISH MEDICAL JOURNAL			English	Article									Univ Exeter, Sch Postgrad Med & Hlth Sci, Dept Complementary Med, Exeter EX2 4NT, Devon, England; Colchester Dist Gen Hosp, Pain Clin, Colchester CO4 5JL, Essex, England; Univ Cent Lancashire, Fac Sci, Preston PR1 2HE, Lancs, England	University of Exeter; University of Central Lancashire	White, A (corresponding author), Univ Exeter, Sch Postgrad Med & Hlth Sci, Dept Complementary Med, Exeter EX2 4NT, Devon, England.							*BRIT MED ASS ETH, 1993, MED ETH TOD ITS PRAC; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Ernst E, 1997, PAIN, V71, P123, DOI 10.1016/S0304-3959(97)03368-X; EYPASCH E, 1995, BRIT MED J, V311, P619, DOI 10.1136/bmj.311.7005.619; White A, 1997, ACUPUNCT MED, V15, P67	5	235	243	3	13	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 1	2001	323	7311					485	486		10.1136/bmj.323.7311.485	http://dx.doi.org/10.1136/bmj.323.7311.485			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469WF	11532840	Bronze, Green Published			2022-12-01	WOS:000170838500017
J	Higashiyama, T; Yabe, S; Sasaki, N; Nishimura, Y; Miyagishima, S; Kuroiwa, H; Kuroiwa, T				Higashiyama, T; Yabe, S; Sasaki, N; Nishimura, Y; Miyagishima, S; Kuroiwa, H; Kuroiwa, T			Pollen tube attraction by the synergid cell	SCIENCE			English	Article							NAKED EMBRYO SAC; TORENIA-FOURNIERI; DOUBLE FERTILIZATION; FEMALE GAMETOPHYTE; NICOTIANA-ALATA; AXON GUIDANCE; IN-VITRO; GROWTH; ARABIDOPSIS; ORGANIZATION	In flowering plants, guidance of the pollen tube to the embryo sac (the haploid female gametophyte) is critical for successful fertilization. The target embryo sac may attract the pollen tube as the final step of guidance in the pistil. We show by laser Ceti ablation that two synergid cells adjacent to the egg cell attract the pollen tube. A single synergid cell was sufficient to generate an attraction signal, and two cells enhanced it. After fertilization, the embryo sac no longer attracts the pollen tube, despite the persistence of one synergid cell. This cessation of attraction might be involved in blocking polyspermy.	Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; Ochanomizu Univ, Dept Biol, Tokyo 1128610, Japan	University of Tokyo; Ochanomizu University	Higashiyama, T (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan.	higashi@biol.s.u-tokyo.ac.jp	Higashiyama, Tetsuya/C-2882-2012	Higashiyama, Tetsuya/0000-0002-7346-360X; Miyagishima, Shin-ya/0000-0002-9111-0832; Nishimura, Yoshiki/0000-0001-8686-9206				CASS DD, 1974, PROTOPLASMA, V81, P49, DOI 10.1007/BF02055773; CHEUNG AY, 1995, CELL, V82, P383, DOI 10.1016/0092-8674(95)90427-1; Drews GN, 1998, PLANT CELL, V10, P5, DOI 10.1105/tpc.10.1.5; DUMAS C, 1984, INT REV CYTOL, V90, P239, DOI 10.1016/S0074-7696(08)61491-6; Goodhill GJ, 1997, EUR J NEUROSCI, V9, P1414, DOI 10.1111/j.1460-9568.1997.tb01496.x; GUILFORD VIVIAN B., 1952, BULL TORREY BOT CLUB, V79, P6, DOI 10.2307/2482102; Higashiyama T, 1997, PLANTA, V203, P101, DOI 10.1007/s004250050170; Higashiyama T, 1998, PLANT CELL, V10, P2019, DOI 10.1105/tpc.10.12.2019; Higashiyama T, 2000, PLANT PHYSIOL, V122, P11, DOI 10.1104/pp.122.1.11; HIGASHIYAMA T, UNPUB; HUANG BQ, 1992, INT REV CYTOL, V140, P233, DOI 10.1016/S0074-7696(08)61099-2; HULSKAMP M, 1995, PLANT CELL, V7, P57, DOI 10.1105/tpc.7.1.57; Lord E, 2000, TRENDS PLANT SCI, V5, P368, DOI 10.1016/S1360-1385(00)01744-1; Lush WM, 1999, TRENDS PLANT SCI, V4, P413, DOI 10.1016/S1360-1385(99)01473-9; Lush WM, 1998, PLANT PHYSIOL, V118, P733, DOI 10.1104/pp.118.3.733; Maheshwari P., 1950, INTRO EMBRYOLOGY ANG; MOL R, 1986, PLANT CELL REP, V3, P202; Palanivelu R, 2000, TRENDS CELL BIOL, V10, P517, DOI 10.1016/S0962-8924(00)01849-3; Pruitt RE, 1999, CURR OPIN PLANT BIOL, V2, P419, DOI 10.1016/S1369-5266(99)00015-1; Ray S, 1997, DEVELOPMENT, V124, P2489; Russell SD, 1996, SEX PLANT REPROD, V9, P337, DOI 10.1007/BF02441952; RUSSELL SD, 1992, INT REV CYTOL, V140, P357, DOI 10.1016/S0074-7696(08)61102-X; Shimizu KK, 2000, DEVELOPMENT, V127, P4511; Wilhelmi LK, 1996, SCIENCE, V274, P1535, DOI 10.1126/science.274.5292.1535; Wilhelmi LK, 1997, PLANT PHYSIOL, V113, P307, DOI 10.1104/pp.113.2.307; Wolters-Arts M, 1998, NATURE, V392, P818, DOI 10.1038/33929; Wu HM, 2000, PLANT J, V22, P165, DOI 10.1046/j.1365-313x.2000.00731.x; WU HM, 1995, CELL, V82, P395, DOI 10.1016/0092-8674(95)90428-X	28	303	338	6	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1480	1483		10.1126/science.1062429	http://dx.doi.org/10.1126/science.1062429			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520985				2022-12-01	WOS:000170616000042
J	Stene, LC; Magnus, P; Lie, RT; Sovik, O; Joner, G				Stene, LC; Magnus, P; Lie, RT; Sovik, O; Joner, G		Norwegian Childhood Diabet Study	Maternal and paternal age at delivery, birth order, and risk of childhood onset type 1 diabetes: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							ENVIRONMENTAL-FACTORS; MELLITUS; DETERMINANTS; YORKSHIRE; UK	Objective To estimate the associations of maternal and paternal age at delivery and of birth order with the risk of childhood onset type I diabetes. Design Cohort study by record linkage of the medical birth registry and the national childhood diabetes registry in Norway. Setting Norway. Subjects All live births in Norway between 1974 and 1998 (1.4 million people) were followed for a maximum of 15 years, contributing 8.2 million person years of observation during 1989-98. 1824 cases of type I diabetes diagnosed between 1989 and 1998 were identified. Main outcome measures Incidence of type I diabetes. Results There was no association between maternal age at delivery and type 1 diabetes among firstborn children, but among fourthborn children there was a 43.2% increase in incidence of diabetes for each five year increase in maternal age (95% confidence interval 6.4% to 92.6%). Each increase in birth order was associated with a 17.9% reduction in incidence (3.2% to 30.4%) when maternal age was 20-24 years, but the association was weaker when maternal age was 30 years or more. Paternal age was not associated with type 1 diabetes after maternal age was adjusted for. Conclusions Intrauterine factors and early life environment may influence the risk of type I diabetes. The relation of maternal age and birth order to risk of type I diabetes is complex.	Aker Hosp, Ctr Diabet Res, N-0407 Oslo, Norway; Univ Oslo, Ulleval Hosp, Ctr Diabet Res, Dept Paediat, N-0407 Oslo, Norway; Natl Publ Hlth Inst, Dept Populat Hlth Sci, Epidemiol Sect, N-0403 Oslo, Norway; Haukeland Hosp, Med Birth Registry Norway, N-5021 Bergen, Norway; Haukeland Hosp, Dept Paediat, N-5021 Bergen, Norway	University of Oslo; University of Oslo; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Stene, LC (corresponding author), Aker Hosp, Ctr Diabet Res, N-0407 Oslo, Norway.							Akerblom HK, 1998, DIABETES METAB REV, V14, P31, DOI 10.1002/(SICI)1099-0895(199803)14:1&lt;31::AID-; Bache I, 1999, DIABETES CARE, V22, P1063, DOI 10.2337/diacare.22.7.1063; BERENDES HW, 1991, REPROD PERINATAL EPI, P28; Bingley PJ, 2000, BMJ-BRIT MED J, V321, P420, DOI 10.1136/bmj.321.7258.420; BYRNES G, 2000, FLAWED ANAL INVALIDA; DAHLQUIST G, 1992, DIABETOLOGIA, V35, P671, DOI 10.1007/BF00400261; DAHLQUIST G, 1991, DIABETOLOGIA, V34, P757, DOI 10.1007/BF00401524; Dahlquist GG, 1999, DIABETES CARE, V22, P1698, DOI 10.2337/diacare.22.10.1698; FLOOD TM, 1982, DIABETES CARE, V5, P571, DOI 10.2337/diacare.5.6.571; Green A, 2000, LANCET, V355, P873; Jones ME, 1998, INT J EPIDEMIOL, V27, P444, DOI 10.1093/ije/27.3.444; McKinney PA, 2000, DIABETIC MED, V17, P236, DOI 10.1046/j.1464-5491.2000.00220.x; McKinney PA, 1999, DIABETES CARE, V22, P928, DOI 10.2337/diacare.22.6.928; MORINPAPUNEN L, 1984, MED BIOL, V62, P323; PATTERSON CC, 1994, DIABETES CARE, V17, P376, DOI 10.2337/diacare.17.5.376; Preston DL, 1993, EPICURE USERS GUIDE; SKJAERVEN R, 1988, AM J EPIDEMIOL, V128, P1352, DOI 10.1093/oxfordjournals.aje.a115088; SOLTESZ G, 1994, ACTA PAEDIATR, V83, P730, DOI 10.1111/j.1651-2227.1994.tb13128.x; Stene LC, 2001, BMJ-BRIT MED J, V322, P889, DOI 10.1136/bmj.322.7291.889; Tai TY, 1998, DIABETES RES CLIN PR, V42, P197, DOI 10.1016/S0168-8227(98)00105-3; Wadsworth EJK, 1997, DIABETIC MED, V14, P390, DOI 10.1002/(SICI)1096-9136(199705)14:5<390::AID-DIA364>3.0.CO;2-E; WAGENER DK, 1983, DIABETOLOGIA, V25, P82	22	69	71	0	10	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2001	323	7309					369	371		10.1136/bmj.323.7309.369	http://dx.doi.org/10.1136/bmj.323.7309.369			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11509426	Bronze, Green Published			2022-12-01	WOS:000170581400015
J	Dhar, SK; Yoshida, K; Machida, Y; Khaira, P; Chaudhuri, B; Wohlschlegel, JA; Leffak, M; Yates, J; Dutta, A				Dhar, SK; Yoshida, K; Machida, Y; Khaira, P; Chaudhuri, B; Wohlschlegel, JA; Leffak, M; Yates, J; Dutta, A			Replication from oriP of Epstein-Barr virus requires human ORC and is inhibited by geminin	CELL			English	Article							ORIGIN RECOGNITION COMPLEX; DNA-REPLICATION; DROSOPHILA HOMOLOG; CELL-CYCLE; INITIATION; PROTEINS; XENOPUS; YEAST; ASSOCIATION; SEPARATION	A hypomorphic mutation made in the ORC2 gene of a human cancer cell line through homologous recombination decreased Orc2 protein levels by 90%. The G1 phase of the cell cycle was prolonged, but there was no effect on the utilization of either the c-Myc or beta -globin cellular origins of replication. Cells carrying this mutation failed to support the replication of a plasmid bearing the oriP replicator of Epstein Barr virus (EBV), and this defect was rescued by reintroduction of Orc2. Orc2 specifically associates with oriP in cells, most likely through its interaction with EBNA1. Geminin, an inhibitor of the mammalian replication initiation complex, inhibits replication from oriP. Therefore, ORC and the human replication initiation apparatus is required for replication from a viral origin of replication.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University System of Ohio; Wright State University Dayton; Roswell Park Cancer Institute	Dutta, A (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	adutta@rics.bwh.harvard.edu	Dutta, Anindya/P-3203-2016; Machida, Yuichi/AAO-3533-2021	Machida, Yuichi/0000-0003-1414-0568; Dutta, Anindya/0000-0002-4319-0073	NATIONAL CANCER INSTITUTE [R01CA060499, R01CA043122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053819] Funding Source: NIH RePORTER; NCI NIH HHS [CA43122, CA60499] Funding Source: Medline; NIGMS NIH HHS [GM53819] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aladjem MI, 1998, SCIENCE, V281, P1005, DOI 10.1126/science.281.5379.1005; Austin RJ, 1999, GENE DEV, V13, P2639, DOI 10.1101/gad.13.20.2639; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Carpenter PB, 1996, NATURE, V379, P357, DOI 10.1038/379357a0; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; CHEN CL, 1993, J VIROL, V67, P6303, DOI 10.1128/JVI.67.10.6303-6308.1993; Chesnokov I, 1999, GENE DEV, V13, P1289, DOI 10.1101/gad.13.10.1289; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; DERSHOWITZ A, 1993, MOL CELL BIOL, V13, P391, DOI 10.1128/MCB.13.1.391; Diffley JFX, 1995, J CELL SCI, P67; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; EHRENHOFERMURRAY AE, 1995, SCIENCE, V270, P1671, DOI 10.1126/science.270.5242.1671; FOSS M, 1993, SCIENCE, V262, P1838, DOI 10.1126/science.8266071; FRAPPIER L, 1991, J BIOL CHEM, V266, P7819; GAHN TA, 1989, CELL, V58, P527, DOI 10.1016/0092-8674(89)90433-9; GAVIN KA, 1995, SCIENCE, V270, P1667, DOI 10.1126/science.270.5242.1667; GILBERT DM, 1995, J BIOL CHEM, V270, P9597, DOI 10.1074/jbc.270.16.9597; GOSSEN M, 1995, SCIENCE, V270, P1674, DOI 10.1126/science.270.5242.1674; HARRISON S, 1994, J VIROL, V68, P1913, DOI 10.1128/JVI.68.3.1913-1925.1994; IP YT, 1988, J BIOL CHEM, V263, P14044; Kamath S, 2001, NUCLEIC ACIDS RES, V29, P809, DOI 10.1093/nar/29.3.809; Landis G, 1997, P NATL ACAD SCI USA, V94, P3888, DOI 10.1073/pnas.94.8.3888; LASKEY R, 1996, DNA REPLICATION EUKA, P119; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Malott M, 1999, MOL CELL BIOL, V19, P5685; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; MIDDLETON T, 1992, J VIROL, V66, P489, DOI 10.1128/JVI.66.1.489-495.1992; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Pinto S, 1999, NEURON, V23, P45, DOI 10.1016/S0896-6273(00)80752-7; Quintana DG, 1997, J BIOL CHEM, V272, P28247, DOI 10.1074/jbc.272.45.28247; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tao L, 2000, J CELL BIOCHEM, V78, P442, DOI 10.1002/1097-4644(20000901)78:3<442::AID-JCB9>3.0.CO;2-1; Tatsumi Y, 2000, J BIOL CHEM, V275, P5904, DOI 10.1074/jbc.275.8.5904; Thome KC, 2000, J BIOL CHEM, V275, P35233, DOI 10.1074/jbc.M005765200; Tugal T, 1998, J BIOL CHEM, V273, P32421, DOI 10.1074/jbc.273.49.32421; WALDMAN T, 1995, CANCER RES, V55, P5187; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; Yates JL, 2000, J VIROL, V74, P4512, DOI 10.1128/JVI.74.10.4512-4522.2000; YATES JL, 1991, J VIROL, V65, P483, DOI 10.1128/JVI.65.1.483-488.1991; YATES JL, 1988, CANC CELLS, P197	44	232	239	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2001	106	3					287	296		10.1016/S0092-8674(01)00458-5	http://dx.doi.org/10.1016/S0092-8674(01)00458-5			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509178	Bronze			2022-12-01	WOS:000170433300007
J	Menz, RI; Walker, JE; Leslie, AGW				Menz, RI; Walker, JE; Leslie, AGW			Structure of bovine mitochondrial Fl-ATPase with nucleotide bound to all three catalytic sites: Implications for the mechanism of rotary catalysis	CELL			English	Article							F-1-ATPASE; SYNTHASE; HYDROLYSIS; ROTATION; COMPLEXES; BINDING; CONFORMATION; F(1)-ATPASE; REFINEMENT; TRYPTOPHAN	The crystal structure of a novel aluminium fluoride inhibited form of bovine mitochondrial F-1-ATPase has been determined at 2 Angstrom resolution. In contrast to all previously determined structures of the bovine enzyme, all three catalytic sites are occupied by nucleotide. The subunit that did not bind nucleotide in previous structures binds ADP and sulfate (mimicking phosphate), and adopts a "half-closed" conformation. This structure probably represents the posthydrolysis, pre-product release step on the catalytic pathway. A catalytic scheme for hydrolysis (and synthesis) at physiological rates and a mechanism for the ATP-driven rotation of the gamma subunit are proposed based on the crystal structures of the bovine enzyme.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England	MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Leslie, AGW (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	jew@mrc-dunn.cam.ac.uk; andrew@mrc-imb.cam.ac.uk		Walker, John/0000-0001-7929-2162				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Amano T, 1996, J BIOL CHEM, V271, P18128, DOI 10.1074/jbc.271.30.18128; AMANO T, 1994, FEBS LETT, V348, P93, DOI 10.1016/0014-5793(94)00588-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boyer PD, 2000, BBA-BIOENERGETICS, V1458, P252, DOI 10.1016/S0005-2728(00)00077-3; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; Braig K, 2000, STRUCTURE, V8, P567, DOI 10.1016/S0969-2126(00)00145-3; CROSS RL, 1982, J BIOL CHEM, V257, P2101; DeckersHebestreit G, 1996, ANNU REV MICROBIOL, V50, P791, DOI 10.1146/annurev.micro.50.1.791; Dou C, 1997, BIOCHEMISTRY-US, V36, P3719, DOI 10.1021/bi962353+; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; ELSHAWI MK, 1990, J BIOL CHEM, V265, P4402; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FELDMAN RI, 1983, J BIOL CHEM, V258, P2178; Fersht A., 1999, STRUCTURE MECH PROTE; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; ISSARTEL JP, 1991, BIOCHEMISTRY-US, V30, P4726, DOI 10.1021/bi00233a013; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le NP, 2000, BIOCHEMISTRY-US, V39, P2778, DOI 10.1021/bi992530h; Leslie A., 1992, JOINT CCP4 EACMB NEW; Lobau S, 1997, J BIOL CHEM, V272, P3648, DOI 10.1074/jbc.272.6.3648; LUTTER R, 1993, J MOL BIOL, V229, P787, DOI 10.1006/jmbi.1993.1081; Masaike T, 2000, J EXP BIOL, V203, P1; McCarty RE, 2000, ANNU REV PLANT PHYS, V51, P83, DOI 10.1146/annurev.arplant.51.1.83; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nadanaciva S, 2000, BIOCHEMISTRY-US, V39, P9583, DOI 10.1021/bi000941o; Nadanaciva S, 1999, BIOCHEMISTRY-US, V38, P15493, DOI 10.1021/bi9917683; Nadanaciva S, 1999, BIOCHEMISTRY-US, V38, P7670, DOI 10.1021/bi990663x; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Ren HM, 2000, BBA-BIOENERGETICS, V1458, P221, DOI 10.1016/S0005-2728(00)00075-X; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; ROSING J, 1977, J BIOL CHEM, V252, P2478; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stryer L, 1995, BIOCHEMISTRY; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; Tsunoda SP, 1999, J BIOL CHEM, V274, P5701, DOI 10.1074/jbc.274.9.5701; Walker JE, 1998, ANGEW CHEM INT EDIT, V37, P2309, DOI 10.1002/(SICI)1521-3773(19980918)37:17<2308::AID-ANIE2308>3.0.CO;2-W; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; Weber J, 2000, BBA-BIOENERGETICS, V1458, P300, DOI 10.1016/S0005-2728(00)00082-7; WEBER J, 1993, J BIOL CHEM, V268, P20126; Weber J, 1996, J BIOL CHEM, V271, P18711, DOI 10.1074/jbc.271.31.18711; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513	46	386	392	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2001	106	3					331	341		10.1016/S0092-8674(01)00452-4	http://dx.doi.org/10.1016/S0092-8674(01)00452-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509182	Bronze			2022-12-01	WOS:000170433300011
J	CRISP, D; ALLEN, DA; GRINSPOON, DH; POLLACK, JB				CRISP, D; ALLEN, DA; GRINSPOON, DH; POLLACK, JB			THE DARK SIDE OF VENUS - NEAR-INFRARED IMAGES AND SPECTRA FROM THE ANGLO-AUSTRALIAN-OBSERVATORY	SCIENCE			English	Article							HEATING RATES; NIGHT-SIDE; RADIATIVE-TRANSFER; LINE PARAMETERS; ENERGY-LEVELS; SOLAR FLUXES; ATMOSPHERE; INTENSITIES; GREENHOUSE; MESOSPHERE	Near-infrared images and spectra of the night side of Venus taken at the Anglo-Australian Telescope during February 1990 reveal four new thermal emission windows at 1.10, 1.18, 1.27, and 1.31 micrometers (mu-m), in addition to the previously discovered windows at 1.74 and 2.3-mu-m. Images of the Venus night side show similar bright and dark markings in all windows, but their contrast is much lower at short wavelengths. The 1.27-mu-m window includes a bright, high-altitude O2 airglow feature in addition to a thermal contribution from the deep atmosphere. Simulations of the 1.27- and 2.3-mu-m spectra indicate water vapor mixing ratios near 40 +/- 20 parts per million by volume between the surface and the cloud base. No large horizontal gradients in the water vapor mixing ratios were detected at these altitudes.	ANGLO AUSTRALIAN OBSERV,EPPING,NSW 2121,AUSTRALIA; NASA,AMES RES CTR,MOFFETT FIELD,CA 94035	National Aeronautics & Space Administration (NASA); NASA Ames Research Center	CRISP, D (corresponding author), CALTECH,JET PROP LAB,MS 169-237,4800 OAK GROVE DR,PASADENA,CA 91109, USA.		Crisp, David/F-6642-2017	Crisp, David/0000-0002-4573-9998				ALLEN D, 1990, 4962 INT ASTR UN CIR; ALLEN DA, 1984, NATURE, V307, P222, DOI 10.1038/307222a0; ALLEN DA, 1986, ICARUS, V69, P221; BAILEY J, 1988, PUBL ASTRON SOC PAC, V100, P1178, DOI 10.1086/132286; BELL JF, 1991, SCIENCE, V252, P1293, DOI 10.1126/science.252.5010.1293; BELL JF, 1990, B AM ASTRON SOC, V22, P1052; BEZARD B, 1990, NATURE, V345, P508, DOI 10.1038/345508a0; BROWN LR, 1987, APPL OPTICS, V26, P5154, DOI 10.1364/AO.26.005154; CLOUGH SA, 1981, P SOC PHOTO-OPT INST, V277, P152; CONNES P, 1979, ASTROPHYS J, V233, pL29, DOI 10.1086/183070; CRISP D, 1986, ICARUS, V67, P484, DOI 10.1016/0019-1035(86)90126-0; CRISP D, 1989, SCIENCE, V246, P506, DOI 10.1126/science.246.4929.506; CRISP D, 1990, J GEOPHYS RES-SOLID, V95, P14577, DOI 10.1029/JB095iB09p14577; DEBERGH C, 1991, SCIENCE, V21, P547; GRINSPOON DH, 1987, SCIENCE, V238, P1702, DOI 10.1126/science.238.4834.1702; Hoffman JH, 1980, J GEOPHYS RES-SPACE, V85, P7882, DOI 10.1029/JA085iA13p07882; HUSSON N, 1986, ANN GEOPHYS A-UPPER, V4, P185; INGERSOLL AP, 1969, J ATMOS SCI, V26, P1191, DOI 10.1175/1520-0469(1969)026<1191:TRGAHO>2.0.CO;2; KAMP LW, 1988, NATURE, V336, P360, DOI 10.1038/336360a0; KAMP LW, 1990, ICARUS, V86, P510, DOI 10.1016/0019-1035(90)90231-W; KASTING JF, 1988, ICARUS, V74, P472, DOI 10.1016/0019-1035(88)90116-9; Knollenberg RG, 1980, J GEOPHYS RES-SPACE, V85, P8039, DOI 10.1029/JA085iA13p08039; Moore JF, 1971, X6307248 NASA GODD S; Moroz V. I., 1983, Venus, P45; Oyama VI, 1980, J GEOPHYS RES-SPACE, V85, P7891, DOI 10.1029/JA085iA13p07891; PALMER KF, 1975, APPL OPTICS, V14, P208, DOI 10.1364/AO.14.000208; PARISOT JP, 1980, ICARUS, V42, P46, DOI 10.1016/0019-1035(80)90241-9; Pollack JB, 1980, J GEOPHYS RES-SPACE, V85, P8141, DOI 10.1029/JA085iA13p08141; Pollack JB, 1980, J GEOPHYS RES-SPACE, V85, P8223, DOI 10.1029/JA085iA13p08223; POLLACK JB, 1971, ICARUS, V14, P295, DOI 10.1016/0019-1035(71)90001-7; ROTHMAN LS, 1986, APPL OPTICS, V25, P1795, DOI 10.1364/AO.25.001795; ROTHMAN LS, 1987, APPL OPTICS, V26, P4085; Seiff A., 1983, Venus, P215; TOON OB, 1977, ICARUS, V30, P663, DOI 10.1016/0019-1035(77)90088-4; TOON OB, 1989, J GEOPHYS RES-ATMOS, V94, P16287, DOI 10.1029/JD094iD13p16287; WATTSON RB, 1986, J MOL SPECTROSC, V119, P83, DOI 10.1016/0022-2852(86)90203-1; YUNG YL, 1982, ICARUS, V51, P199, DOI 10.1016/0019-1035(82)90080-X	37	70	71	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 13	1991	253	5025					1263	1266		10.1126/science.11538493	http://dx.doi.org/10.1126/science.11538493			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE689	11538493				2022-12-01	WOS:A1991GE68900035
J	ZHANG, YX; STOLPER, EM				ZHANG, YX; STOLPER, EM			WATER DIFFUSION IN A BASALTIC MELT	NATURE			English	Article							ION MICRO-PROBE; ELEVATED-TEMPERATURES; SUBMARINE BASALTS; SILICATE MELTS; GLASSES; CARBON; H2O; CO2; PRESSURES; ABUNDANCE	WATER is the most abundant volatile component in terrestrial basalts and is a significant constituent of the gases that escape from basaltic magmas. Knowledge of the diffusivity of water (and other volatiles) in basaltic melts is important for understanding the degassing of basaltic magma and for assessing the fractionation of volatiles during degassing. We report here measurements of water diffusivity in a basaltic liquid. The water concentration profiles through the samples, determined by Fourier-transform infrared spectroscopy, cannot be modelled adequately on the basis of a constant water diffusivity 1-7, but instead can be fitted by assuming that only molecular H2O is diffusing and that there is a local equilibrium between H2O molecules and OH groups 7-13. The concentration-dependent total water diffusivities in the basaltic melt at 1,300-1,500-degrees-C are 30-50 times as large as those in rhyolitic melts 4-7, and are greater than the total CO2 diffusivity in basaltic melts, contrary to previous expectations 14. These results suggest that diffusive fractionation would increase the ratio of water to carbon dioxide in growing bubbles relative to equilibrium partitioning, and decrease the ratio in interface melts near an advancing anhydrous phenocryst.			ZHANG, YX (corresponding author), CALTECH,DEPT GEOL & PLANETARY SCI,17025,PASADENA,CA 91125, USA.		Zhang, Youxue/D-2922-2011					BURN I, 1970, PHYS CHEM GLASSES, V11, P106; CABLE M, 1987, J MATER SCI, V22, P919, DOI 10.1007/BF01103530; CARROLL MR, 1990, EOS, V71, P1664; CHEKHMIR AS, 1988, GEOKHIMIYA+, V10, P303; Crank J., 1979, MATH DIFFUSION; DELANEY JR, 1978, GEOCHIM COSMOCHIM AC, V42, P581, DOI 10.1016/0016-7037(78)90003-0; DELANEY JR, 1981, EARTH PLANET SC LETT, V52, P191, DOI 10.1016/0012-821X(81)90220-X; DIXON JE, 1988, EARTH PLANET SC LETT, V90, P87, DOI 10.1016/0012-821X(88)90114-8; Doremus R. H., 1969, REACT SOLID, P667; DUNN T, 1983, GEOCHIM COSMOCHIM AC, V47, P1923, DOI 10.1016/0016-7037(83)90209-0; ERNSBERGER FM, 1980, PHYS CHEM GLASSES, V21, P146; HARRIS DM, 1981, J GEOL, V89, P689, DOI 10.1086/628636; HARRIS DM, 1983, GEOCHIM COSMOCHIM AC, V47, P1139, DOI 10.1016/0016-7037(83)90244-2; JAMBON A, 1987, CHEM GEOL, V62, P177, DOI 10.1016/0009-2541(87)90084-2; KARSTEN JL, 1982, EARTH PLANET SC LETT, V59, P420, DOI 10.1016/0012-821X(82)90143-1; KYSER TK, 1984, GEOCHIM COSMOCHIM AC, V48, P2123, DOI 10.1016/0016-7037(84)90392-2; LAPHAM KE, 1984, J NON-CRYST SOLIDS, V67, P179, DOI 10.1016/0022-3093(84)90148-0; LUX G, 1987, GEOCHIM COSMOCHIM AC, V51, P1549, DOI 10.1016/0016-7037(87)90336-X; MOORE JG, 1977, J VOLCANOL GEOTH RES, V2, P309, DOI 10.1016/0377-0273(77)90018-X; MUENOW DW, 1979, EARTH PLANET SC LETT, V42, P71, DOI 10.1016/0012-821X(79)90191-2; PINEAU F, 1983, EARTH PLANET SC LETT, V62, P239, DOI 10.1016/0012-821X(83)90087-0; Roberts GJ, 1964, PHYS CHEM GLASSES-B, V5, P26; SMETS BM, 1983, PHYS CHEM GLASSES, V24, P635; STANTON TR, 1985, EOS, V66, P1131; STOLPER E, 1988, EARTH PLANET SC LETT, V87, P397, DOI 10.1016/0012-821X(88)90004-0; STOLPER E, 1982, CONTRIB MINERAL PETR, V81, P1, DOI 10.1007/BF00371154; WAKABAYASHI H, 1989, J AM CERAM SOC, V72, P1850, DOI 10.1111/j.1151-2916.1989.tb05990.x; WASSERBERG GJ, 1988, J GEOL, V65, P15; WATSON EB, 1982, EARTH PLANET SC LETT, V61, P346, DOI 10.1016/0012-821X(82)90065-6; ZHANG Y, 1990, GEOCHEM SOC GOLDSCHM, P94; ZHANG Y, IN PRESS EARTH PLANE; ZHANG YX, 1991, GEOCHIM COSMOCHIM AC, V55, P441, DOI 10.1016/0016-7037(91)90003-N; ZHANG YX, 1989, CONTRIB MINERAL PETR, V102, P492, DOI 10.1007/BF00371090	33	151	156	0	30	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAY 23	1991	351	6324					306	309		10.1038/351306a0	http://dx.doi.org/10.1038/351306a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM976	11538704				2022-12-01	WOS:A1991FM97600056
J	MILLER, SL; BADA, JL				MILLER, SL; BADA, JL			SUBMARINE HOT SPRINGS AND THE ORIGIN OF LIFE	NATURE			English	Article									UNIV CALIF SAN DIEGO,SCRIPPS INST OCEANOG,AMINO ACID DATING LAB A-012B,LA JOLLA,CA 92093	University of California System; University of California San Diego; Scripps Institution of Oceanography	MILLER, SL (corresponding author), UNIV CALIF SAN DIEGO,DEPT CHEM B-017,LA JOLLA,CA 92093, USA.							BADA JL, 1987, BIOSYSTEMS, V20, P21, DOI 10.1016/0303-2647(87)90016-5; BADA JL, 1978, EARTH PLANET SC LETT, V41, P67, DOI 10.1016/0012-821X(78)90042-0; BAROSS JA, 1983, NATURE, V303, P423, DOI 10.1038/303423a0; BAROSS JA, 1985, ORIGINS LIFE EVOL B, V15, P327, DOI 10.1007/BF01808177; BERNHARDT G, 1984, NATURWISSENSCHAFTEN, V71, P583, DOI 10.1007/BF01189186; CECH TR, 1986, P NATL ACAD SCI USA, V83, P4360, DOI 10.1073/pnas.83.12.4360; CECH TR, 1986, ANNU REV BIOCHEM, V55, P599, DOI 10.1146/annurev.biochem.55.1.599; Corliss J. B., 1981, Oceanologica Acta, V4, P59; EDMOND JM, 1982, NATURE, V297, P187, DOI 10.1038/297187a0; Feather M.S., 1973, ADV CARBOHYDR CHEM B, V28, P161, DOI 10.1016/S0065-2318(08)60383-2; Fox SW, 1972, MOL EVOLUTION ORIGIN; FULLER WD, 1972, J MOL EVOL, V1, P249, DOI 10.1007/BF01660244; GINOZA W, 1964, NATURE, V203, P606, DOI 10.1038/203606a0; HARADA K, 1964, NATURE, V201, P335, DOI 10.1038/201335a0; HAYATSU R, 1981, TOP CURR CHEM, V99, P1; JOYCE GF, 1987, P NATL ACAD SCI USA, V84, P4398, DOI 10.1073/pnas.84.13.4398; KNOLL AH, 1988, SCIENCE, V239, P199, DOI 10.1126/science.239.4836.199; LAWLESS JG, 1973, NATURE, V243, P405, DOI 10.1038/243405a0; MACDONALD KC, 1980, EARTH PLANET SC LETT, V48, P1, DOI 10.1016/0012-821X(80)90163-6; MAHER KA, 1988, NATURE, V331, P612, DOI 10.1038/331612a0; MEGGY AB, 1956, J CHEM SOC, P1444, DOI 10.1039/jr9560001444; MILLER SL, 1976, J MOL EVOL, V9, P59, DOI 10.1007/BF01796123; MILLER SL, 1974, ORIGINS LIFE EARTH, P118; MOPPER K, 1980, MAR CHEM, V10, P55, DOI 10.1016/0304-4203(80)90058-4; NISBET EG, 1987, YOUNG EARTH; SIMONEIT BRT, 1985, CAN J EARTH SCI, V22, P1919, DOI 10.1139/e85-208; SLEEP NH, 1986, ORIGINS LIFE EVOL B, V16, P179, DOI 10.1007/BF02421968; Storch HH, 1951, FISCHER TROPSCH RELA; STRIBLING R, 1988, ORIGINS LIFE, V17, P261; TRENT JD, 1984, NATURE, V307, P737, DOI 10.1038/307737a0; TUREKIAN KK, 1986, P NATL ACAD SCI USA, V83, P6241, DOI 10.1073/pnas.83.17.6241; VALLENTYNE JR, 1968, GEOCHIM COSMOCHIM AC, V32, P1853; WESTHEIMER FH, 1986, NATURE, V319, P534, DOI 10.1038/319534a0; WHITE RH, 1984, NATURE, V310, P430, DOI 10.1038/310430a0; YAYANOS AA, 1983, APPL ENVIRON MICROB, V46, P1357, DOI 10.1128/AEM.46.6.1357-1363.1983	35	253	257	2	104	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	AUG 18	1988	334	6183					609	611		10.1038/334609a0	http://dx.doi.org/10.1038/334609a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P7090	11536607				2022-12-01	WOS:A1988P709000061
J	Avise, JC				Avise, JC			Evolving genomic metaphors: A new look at the language of DNA	SCIENCE			English	Editorial Material								Recent genome-sequencing efforts have confirmed that traditional "good-citizen" genes (those that encode functional RNA and protein molecules of obvious benefit to the organism) constitute only a small fraction of the genomic populace in humans and other multicellular creatures. The rest of the DNA sequence includes an astonishing collection of noncoding regions, regulatory modules, deadbeat pseudogenes, legions of repetitive elements, and hosts of oft-shifty, self-interested nomads, renegades, and immigrants. To help visualize functional operations in such intracellular genomic societies and to better encapsulate the evolutionary origins of complex genomes, new and evocative metaphors may be both entertaining and research-stimulating.	Univ Georgia, Dept Genet, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Avise, JC (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	avise@arches.uga.edu						AVISE J, 1998, GENETIC GODS EVOLUTI; CONDIT CM, 1999, MEANING GENE; Dawkins R., 1976, SELFISH GENE; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	6	52	53	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2001	294	5540					86	87		10.1126/science.294.5540.86	http://dx.doi.org/10.1126/science.294.5540.86			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11588247	Green Submitted			2022-12-01	WOS:000171448800035
J	Johnson, ME; Viggiano, L; Bailey, JA; Abdul-Rauf, M; Goodwin, G; Rocchi, M; Eichler, EE				Johnson, ME; Viggiano, L; Bailey, JA; Abdul-Rauf, M; Goodwin, G; Rocchi, M; Eichler, EE			Positive selection of a gene family during the emergence of humans and African apes	NATURE			English	Article							DARWINIAN SELECTION; RAPID EVOLUTION; HUMAN-GENOME; DNA; DUPLICATIONS	Gene duplication followed by adaptive evolution is one of the primary forces for the emergence of new gene function(1). Here we describe the recent proliferation, transposition and selection of a 20-kilobase (kb) duplicated segment throughout 15 Mb of the short arm of human chromosome 16. The dispersal of this segment was accompanied by considerable variation in chromosomal-map location and copy number among hominoid species. In humans, we identified a gene family (morpheus) within the duplicated segment. Comparison of putative protein-encoding exons revealed the most extreme case of positive selection among hominoids. The major episode of enhanced amino-acid replacement occurred after the separation of human and great-ape lineages from the orangutan. Positive selection continued to alter amino-acid composition after the divergence of human and chimpanzee lineages. The rapidity and bias for amino-acid-altering nucleotide changes suggest adaptive evolution of the morpheus gene family during the emergence of humans and African apes. Moreover, some genes emerge and evolve very rapidly, generating copies that bear little similarity to their ancestral precursors. Consequently, a small fraction of human genes may not possess discernible orthologues within the genomes of model organisms.	Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ctr Human Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; DAPEG, Sez Genet, I-70126 Bari, Italy; Inst Canc Res, Sect Mol Carcinogenesis, Haddow Labs, Surrey MS2 5NG, England	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; University of London; Institute of Cancer Research - UK	Eichler, EE (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA.	eee@po.cwru.edu	Rocchi, Mariano/B-8451-2011	Viggiano, Luigi/0000-0002-2067-5166	Telethon [C.50] Funding Source: Medline	Telethon(Fondazione Telethon)		Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; Duda TF, 1999, P NATL ACAD SCI USA, V96, P6820, DOI 10.1073/pnas.96.12.6820; Goodman M, 1999, AM J HUM GENET, V64, P31, DOI 10.1086/302218; Horvath JE, 2000, GENOME RES, V10, P839, DOI 10.1101/gr.10.6.839; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; JUKES T H, 1969, P21; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li W.H., 1997, MOL EVOLUTION; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; Loftus BJ, 1999, GENOMICS, V60, P295, DOI 10.1006/geno.1999.5927; Messler W, 1997, NATURE, V385, P151, DOI 10.1038/385151a0; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M., 2000, MOL EVOLUTION PHYLOG; Nurminsky DI, 1998, NATURE, V396, P572, DOI 10.1038/25126; Ohno S., 1970, EVOLUTION GENE DUPLI, DOI [DOI 10.1007/978-3-642-86659-3, 10.1007/978-3-642-86659-3_11]; STALLINGS RL, 1993, CYTOGENET CELL GENET, V63, P97, DOI 10.1159/000133509; TAJIMA F, 1993, GENETICS, V135, P599; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; Vacquier VD, 1997, J MOL EVOL, V44, pS15, DOI 10.1007/PL00000049; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708	22	233	241	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2001	413	6855					514	519		10.1038/35097067	http://dx.doi.org/10.1038/35097067			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586358				2022-12-01	WOS:000171340500045
J	Jones, JK; Fife, D; Curkendall, S; Goehring, E; Guo, JJF; Shannon, M				Jones, JK; Fife, D; Curkendall, S; Goehring, E; Guo, JJF; Shannon, M			Coprescribing and codispensing of cisapride and contraindicated drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPACT	Context Cisapride, an oral prokinetic drug indicated for the symptomatic treatment of nocturnal heartburn due to gastroesophageal reflux disease, was approved by the US Food and Drug Administration in July 1993. After reports of serious cardiac arrhythmias and deaths during administration of cisapride, most involving concomitant exposure to another drug, a series of label changes and warnings were issued in February 1995, October 1995, June 1998, and June 1999. Cisapride was removed from general distribution in July 2000. Objective To determine the frequency of contraindicted coprescribing and codispensings, in which cisapride and a contraindicated drug were prescribed or dispensed to the same patient for overlapping periods, and the proportion of contraindicated coprescribing by the same physicians and codispensing by the same pharmacies. Design and Setting Retrospective study of prescription claims from a managed care organization database for all patients with cisapride prescriptions between July 1993 and December 1998. Participants A total of 38757 adult and pediatric patients who had a cisapride prescription immediately preceded by at least 60 days of insurance eligibility. Main Outcome Measure Proportion of cisapride prescriptions or dispensing occurring during the same treatment period as a drug contraindicated at that time prescribed by the same physicians or dispensed by the same pharmacies. Results Of 131485 cisapride prescriptions dispensed after the warnings began, 4414 (3.4%) overlapped with at least 1 drug contraindicated in the labeling at the time of the prescription. Of all overlapping prescription pairs, 2190 (50%) were by the same physicians, 3908 (89%) were by the same pharmacies, and 765 (17%) were dispensed on the same day. Conclusion Prescriptions dispensed by the same pharmacies accounted for afar higher proportion of contraindicated medication pairs than prescriptions from the same physicians. The pharmacy may be an important and underutilized intervention point to prevent contraindicated drugs from being used together.	Degge Grp Ltd, Res, Arlington, VA 22209 USA; Janssen Res Inst, Dept Epidemiol Drug Safety & Surveillance, Titusville, NJ USA; Univ Cincinnati, Med Ctr, Coll Pharm, Cincinnati, OH 45267 USA; Jorie Kent Associates Inc, Milton, DE USA	Johnson & Johnson; Johnson & Johnson USA; University System of Ohio; University of Cincinnati	Curkendall, S (corresponding author), Degge Grp Ltd, Res, 1616 N Ft Myer Dr,1430, Arlington, VA 22209 USA.							Cavuto NJ, 1996, JAMA-J AM MED ASSOC, V275, P1086, DOI 10.1001/jama.275.14.1086; McMullin ST, 1999, ARCH INTERN MED, V159, P2077, DOI 10.1001/archinte.159.17.2077; *MED EC CO, 2000, PHYS DESK REF, P1451; Piquette RK, 1999, ANN PHARMACOTHER, V33, P22, DOI 10.1345/aph.18107; Smalley W, 2000, JAMA-J AM MED ASSOC, V284, P3036, DOI 10.1001/jama.284.23.3036; SOUMERAI SB, 1989, MILBANK Q, V67, P268, DOI 10.2307/3350142; SOUMERAI SB, 1987, AM J PUBLIC HEALTH, V77, P1518, DOI 10.2105/AJPH.77.12.1518; Thompson D, 1996, JAMA-J AM MED ASSOC, V275, P1339, DOI 10.1001/jama.275.17.1339; *US FOOD DRUG ADM, 2000, JAMA-J AM MED ASSOC, V283, P2228; Wysowski DK, 1996, NEW ENGL J MED, V335, P290, DOI 10.1056/NEJM199607253350416	10	42	43	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2001	286	13					1607	1609		10.1001/jama.286.13.1607	http://dx.doi.org/10.1001/jama.286.13.1607			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478HH	11585484	Bronze			2022-12-01	WOS:000171340600028
J	Jutel, M; Watanabe, T; Klunker, S; Akdis, M; Thomet, OAR; Malolepszy, J; Zak-Nejmark, T; Koga, R; Kobayashi, T; Blaser, K; Akdis, CA				Jutel, M; Watanabe, T; Klunker, S; Akdis, M; Thomet, OAR; Malolepszy, J; Zak-Nejmark, T; Koga, R; Kobayashi, T; Blaser, K; Akdis, CA			Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors	NATURE			English	Article							BEE VENOM IMMUNOTHERAPY; MOLECULAR-BASIS; LYMPHOCYTES; MICE; INDUCTION; IMMUNITY	Many pathological processes, including those causing allergies and autoimmune diseases, are associated with the presence of specialized subsets of T helper cells (T(H)1 and T(H)2) at the site of inflammation(1-4). The diversity of T(H)1 and T(H)2 function is not predetermined but depends on signals that drive the cells towards either subset(1-4). Histamine, released from effector cells (mast cells and basophils) during inflammatory reactions can influence immune response(5-8). Here we report that histamine enhances T(H)1-type responses by triggering the histamine receptor type 1 (H1R), whereas both T(H)1- and T(H)2-type responses are negatively regulated by H2R through the activation of different biochemical intracellular signals. In mice, deletion of H1R results in suppression of interferon (IFN)-gamma and dominant secretion of T(H)2 cytokines (interleukin (IL)-4 and IL-13). Mutant mice lacking H2R showed upregulation of both T(H)1 and T(H)2 cytokines. Relevant to T-cell cytokine profiles, mice lacking H1R displayed increased specific antibody response with increased immunoglobulin-e (IgE) and IgG1, IgG2b and IgG3 compared with mice lacking H2R. These findings account for an important regulatory mechanism in the control of inflammatory functions through effector-cell-derived histamine.	Swiss Inst Allergy & Asthma Res, CH-7270 Davos, Switzerland; Kyushu Univ, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan; Wroclaw Med Univ, Dept Internal Med & Allergol, PL-50417 Wroclaw, Poland	Swiss Institute of Allergy & Asthma Research; Kyushu University; Wroclaw Medical University	Jutel, M (corresponding author), Swiss Inst Allergy & Asthma Res, Obere Str 22, CH-7270 Davos, Switzerland.		Akdis, Cezmi/AAV-4844-2020	Akdis, Cezmi/0000-0001-8020-019X				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Akdis CA, 1998, J CLIN INVEST, V102, P98, DOI 10.1172/JCI2250; Akdis CA, 2000, FASEB J, V14, P1666; Akdis CA, 1999, FASEB J, V13, P603, DOI 10.1096/fasebj.13.6.603; Banu Y, 1999, J EXP MED, V189, P673, DOI 10.1084/jem.189.4.673; BEER DJ, 1987, CRC CR REV IMMUNOL, V7, P55; Bodor J, 1996, P NATL ACAD SCI USA, V93, P3536, DOI 10.1073/pnas.93.8.3536; Boss V, 1996, J BIOL CHEM, V271, P10429, DOI 10.1074/jbc.271.18.10429; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; Corry DB, 1999, NATURE, V402, pB18; DELPRETE GF, 1991, J CLIN INVEST, V88, P344; Faith A, 1997, J IMMUNOL, V159, P53; GANTZ I, 1992, J BIOL CHEM, V267, P20840; Inoue I, 1996, P NATL ACAD SCI USA, V93, P13316, DOI 10.1073/pnas.93.23.13316; Jutel M, 1996, CLIN EXP ALLERGY, V26, P1112, DOI 10.1111/j.1365-2222.1996.tb00496.x; JUTEL M, 1995, J IMMUNOL, V154, P4187; Kobayashi T, 2000, J CLIN INVEST, V105, P1741, DOI 10.1172/JCI9441; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; LEURS R, 1995, PHARMACOL THERAPEUT, V66, P413, DOI 10.1016/0163-7258(95)00006-3; Mobarakeh JI, 2000, EUR J PHARMACOL, V391, P81, DOI 10.1016/S0014-2999(00)00060-1; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; NOVAK TJ, 1990, P NATL ACAD SCI USA, V87, P9353, DOI 10.1073/pnas.87.23.9353; PLAUT M, 1983, J IMMUNOL, V131, P2945; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; ROSZKOWSKI W, 1977, SCIENCE, V195, P683, DOI 10.1126/science.190677; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; VANNIER E, 1993, J CLIN INVEST, V92, P281, DOI 10.1172/JCI116562; WATANABE N, 1988, P NATL ACAD SCI USA, V85, P4460, DOI 10.1073/pnas.85.12.4460; YAMASHITA M, 1991, P NATL ACAD SCI USA, V88, P11515, DOI 10.1073/pnas.88.24.11515	29	437	463	1	32	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2001	413	6854					420	425		10.1038/35096564	http://dx.doi.org/10.1038/35096564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475UY	11574888				2022-12-01	WOS:000171188700054
J	Malik, I; Danesh, J; Whincup, P; Bhatia, V; Papacosta, O; Walker, M; Lennon, L; Thomson, A; Haskard, D				Malik, I; Danesh, J; Whincup, P; Bhatia, V; Papacosta, O; Walker, M; Lennon, L; Thomson, A; Haskard, D			Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis	LANCET			English	Article							C-REACTIVE PROTEIN; MIDDLE-AGED MEN; CARDIOVASCULAR RISK-FACTORS; APPARENTLY HEALTHY-MEN; UNSTABLE ANGINA; E-SELECTIN; MYOCARDIAL-INFARCTION; P-SELECTIN; PLASMA-CONCENTRATION; HELICOBACTER-PYLORI	Background Previous studies have suggested that circulating concentrations of soluble adhesion molecules are useful predictors of risk of coronary heart disease (CHD). Larger studies are needed, however, to test this hypothesis. Methods We measured serum concentrations of four soluble cell adhesion molecules (intercellular adhesion molecule-1 [ICAM-1], vascular cell adhesion molecule-1 [VCAM-1], E-selectin, and P-selectin) in the stored baseline serum samples of 643 men with coronary heart disease and 1278 controls nested in a prospective study of 5661 men who were monitored for 16 years. We also did a meta-analysis of previous relevant studies to place our findings in context. Results Concentrations of soluble adhesion molecules were significantly associated with one another, with other markers of inflammation, and with some classic coronary risk factors. For ICAM-1, the odds ratio for CHD was 1.68 (95% Cl 1.32-2.14) in a comparison of men in the top third with those in the bottom third of baseline measurements after adjustments for age and town. This decreased to 1.11 (0.75-1.64) after adjustment for some classic coronary risk factors and indicators of socioeconomic status. For the three other cell adhesion molecules, the odds ratios for CHD, first adjusted for age and town only, and then additionally adjusted for other risk factors, were: VCAM-1:1.26 (0.99-1.61) and 0.96 (0.66-1.40); E-selectin: 1.27 (1.00-1.61) and 1.13 (0.78-1.62); and P-selectin: 1.23 (0.96-1.56) and 1.20 (0.81-.1.76). Interpretation The measurement of these adhesion molecules is unlikely to add much predictive information to that provided by more established risk factors.	Hammersmith Hosp, Imperial Coll Sch Med, BHF Cardiovasc Med Unit, Natl Heart & Lung Inst, London W12 0NN, England; Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 1TN, England; Univ London St Georges Hosp, Sch Med, Dept Publ Hlth Sci, London SW17 0RE, England; UCL Royal Free & UCL Med Sch, Dept Primary Care & Populat Sci, London, England	Imperial College London; University of Cambridge; St Georges University London; University of London; University College London	Haskard, D (corresponding author), Hammersmith Hosp, Imperial Coll Sch Med, BHF Cardiovasc Med Unit, Natl Heart & Lung Inst, London W12 0NN, England.	d.haskard@ic.ac.uk	Lennon, Lucy/ABB-9433-2020; Lennon, Lucy/AFT-1973-2022	Lennon, Lucy/0000-0002-1738-1351; Whincup, Peter/0000-0002-5589-4107; Papacosta, Olia/0000-0001-8781-6747				Blann AD, 1997, ATHEROSCLEROSIS, V132, P151, DOI 10.1016/S0021-9150(97)00081-6; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Collins RG, 2000, J EXP MED, V191, P189, DOI 10.1084/jem.191.1.189; Danesh J, 2000, BRIT MED J, V321, P208, DOI 10.1136/bmj.321.7255.208; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; DAVIES MJ, 1993, J PATHOL, V171, P223, DOI 10.1002/path.1711710311; de Lemos JA, 2000, J AM COLL CARDIOL, V36, P423, DOI 10.1016/S0735-1097(00)00742-7; Dong ZM, 1998, J CLIN INVEST, V102, P145, DOI 10.1172/JCI3001; GEARING AJH, 1993, IMMUNOL TODAY, V14, P506, DOI 10.1016/0167-5699(93)90267-O; Ghaisas NK, 1997, AM J CARDIOL, V80, P617, DOI 10.1016/S0002-9149(97)00432-3; Haverkate F, 1997, LANCET, V349, P462, DOI 10.1016/S0140-6736(96)07591-5; Hwang SJ, 1997, CIRCULATION, V96, P4219; Johnson RC, 1997, J CLIN INVEST, V99, P1037, DOI 10.1172/JCI119231; Kaikita K, 1997, JPN CIRC J, V61, P741, DOI 10.1253/jcj.61.741; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; Nageh MF, 1997, ARTERIOSCL THROM VAS, V17, P1517, DOI 10.1161/01.ATV.17.8.1517; POSTON RN, 1992, AM J PATHOL, V140, P665; Rebuzzi AG, 1998, AM J CARDIOL, V82, P715, DOI 10.1016/S0002-9149(98)00458-5; Ridker PM, 1998, LANCET, V351, P88, DOI 10.1016/S0140-6736(97)09032-6; Ridker PM, 2001, CIRCULATION, V103, P491, DOI 10.1161/01.CIR.103.4.491; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rohde LEP, 1999, ARTERIOSCL THROM VAS, V19, P1595, DOI 10.1161/01.ATV.19.7.1595; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SHAPER AG, 1981, BRIT MED J, V283, P179, DOI 10.1136/bmj.283.6285.179; Shyu KG, 1996, CHEST, V109, P1627, DOI 10.1378/chest.109.6.1627; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; TEDDER TF, 1995, FASEB J, V9, P866, DOI 10.1096/fasebj.9.10.7542213; Walker M, 2000, J PUBLIC HEALTH MED, V22, P479, DOI 10.1093/pubmed/22.4.479; Wallen NH, 1999, EUR HEART J, V20, P1039; Whincup P, 2000, CIRCULATION, V101, P1647; Whincup PH, 1996, HEART, V75, P568, DOI 10.1136/hrt.75.6.568	32	311	328	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 22	2001	358	9286					971	975		10.1016/S0140-6736(01)06104-9	http://dx.doi.org/10.1016/S0140-6736(01)06104-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474YR	11583751				2022-12-01	WOS:000171135300018
J	Mjolsness, E; DeCoste, D				Mjolsness, E; DeCoste, D			Machine learning for science: State of the art and future prospects	SCIENCE			English	Editorial Material							PREDICTION	Recent advances in machine learning methods, along with successful applications across a wide variety of fields such as planetary science and bioinformatics, promise powerful new tools for practicing scientists. This viewpoint highlights some useful characteristics of modern machine learning methods and their relevance to scientific applications. We conclude with some speculations on near-term progress and promising directions.	CALTECH, Jet Prop Lab, Machine Learning Syst Grp, Pasadena, CA 91109 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Mjolsness, E (corresponding author), CALTECH, Jet Prop Lab, Machine Learning Syst Grp, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	mjolsness@jpl.nasa.gov						BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BROWN M, 2000, P NATL ACAD SCI USA, V97, P1; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burl MC, 1998, MACH LEARN, V30, P165, DOI 10.1023/A:1007400206189; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Jung TP, 2001, P IEEE, V89, P1107, DOI 10.1109/5.939827; Mitchell T. M., 1997, MACH LEARN, pXVII; Mjolsness E, 2000, ADV NEUR IN, V12, P928; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Scholkopf B, 1999, ADVANCES IN KERNEL METHODS, P327; Shiozawa M, 1999, NUCL INSTRUM METH A, V433, P240, DOI 10.1016/S0168-9002(99)00359-9; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Zien A, 2000, BIOINFORMATICS, V16, P799, DOI 10.1093/bioinformatics/16.9.799	15	202	223	12	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2051	+		10.1126/science.293.5537.2051	http://dx.doi.org/10.1126/science.293.5537.2051			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557883	Green Submitted			2022-12-01	WOS:000171028700064
J	Gill, TM; Desai, MM; Gahbauer, EA; Holford, TR; Williams, CS				Gill, TM; Desai, MM; Gahbauer, EA; Holford, TR; Williams, CS			Restricted activity among community-living older persons: Incidence, precipitants, and health care utilization	ANNALS OF INTERNAL MEDICINE			English	Article							BASE-LINE VULNERABILITY; RANDOMIZED-TRIAL; PREVENTING DISABILITY; FUNCTIONAL DEPENDENCE; ADULTS; SYMPTOMS; PEOPLE; DISEASE; EVENTS; FALLS	Background: Restricted activity is a potentially important indicator of health and functional status. Yet, relatively little is known about the incidence, precipitants, or health care utilization associated with restricted activity among older persons. Objective: To more accurately estimate the rate of restricted activity among community-living older persons, to identify the health-related and non-health-related problems that lead to restricted activity, and to determine whether restricted activity is associated with increased health care utilization. Design: Prospective cohort study. Setting: New Haven, Connecticut. Participants: 754 nondisabled members of a large health plan, 70 years of age or older, who were categorized according to their risk for disability (low, intermediate, or high). Measurements: Occurrence of restricted activity (defined as having stayed in bed for at least half a day or having cut down on one's usual activities because of an illness, injury, or another problem), problems leading to restricted activity, and health care utilization were ascertained during monthly telephone interviews for up to 2 years. Results: In median follow-up of 15 months, 76.6% of participants reported restricted activity during at least 1 month and 39.3% reported restricted activity during 2 consecutive months. The rates of restricted activity per 100 person-months were 19.0 episodes for all participants and 16.9, 27.3, and 22.7 episodes for participants at low, intermediate, and high risk for disability, respectively. Of the 24 prespecified health-related and non-health-related problems, the rates per 100 person-months of restricted activity ranged from 0.1 episode for "problem with alcohol" to 65.5 episodes for "been fatigued." On average, participants identified 4.5 different problems as a cause for their restricted activity, Health care utilization was substantially greater during months with restricted activity than months without restricted activity. The corresponding rates per 100 person-months were 63.8 and 45.1 for physician office visits, 12.5 and 1.0 for emergency department visits, 14.1 and 0.3 for hospital admissions, and 67.6 and 45.1 for any health care utilization (P<0.001 for each pairwise comparison). Conclusions: Restricted activity is common among community-living older persons, regardless of risk for disability, and it is usually attributable to several concurrent health-related problems. Although restricted activity is associated with a. substantial increase in health care utilization, older persons with restricted activity often do not seek medical attention.	Yale Univ, Sch Med, Dorothy Adler Geriat Assessment Ctr, New Haven, CT 06504 USA; Dept Vet Affairs, Connecticut Healthcare Syst, West Haven, CT USA	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Gill, TM (corresponding author), Yale Univ, Sch Med, Dorothy Adler Geriat Assessment Ctr, 20 York St, New Haven, CT 06504 USA.		Fazli, Ghazal/AAE-8320-2022; Gill, Thomas M./H-7043-2019	Gill, Thomas M./0000-0002-6450-0368; Desai, Mayur/0000-0001-6616-0945	NATIONAL INSTITUTE ON AGING [R01AG017560, K23AG000759] Funding Source: NIH RePORTER; NIA NIH HHS [K23AG00759, 1RO1AG17560-01A1] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baker DW, 1998, SOC SCI MED, V47, P1601, DOI 10.1016/S0277-9536(98)00215-9; BRODY EM, 1983, GERONTOLOGIST, V23, P75, DOI 10.1093/geront/23.1.75; BRODY EM, 1983, J AM GERIATR SOC, V31, P489, DOI 10.1111/j.1532-5415.1983.tb05124.x; Feinstein AR., 1987, CLINIMETRICS; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fried LP, 1997, J AM GERIATR SOC, V45, P92, DOI 10.1111/j.1532-5415.1997.tb00986.x; Gill TM, 1999, J GERONTOL A-BIOL, V54, pM377, DOI 10.1093/gerona/54.7.M377; Glynn RJ, 1996, BMJ-BRIT MED J, V312, P364; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Haas J, 1998, NEW ENGL J MED, V338, P1694, DOI 10.1056/NEJM199806043382312; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Inouye SK, 1996, JAMA-J AM MED ASSOC, V275, P852, DOI 10.1001/jama.275.11.852; Institute of Medicine, 1996, HLTH OUTC OLD PEOPL; Jones R, 2000, BMJ-BRIT MED J, V320, P596, DOI 10.1136/bmj.320.7235.596; KOSOROK MR, 1992, AM J PUBLIC HEALTH, V82, P1263, DOI 10.2105/AJPH.82.9.1263; Leveille SG, 1998, J AM GERIATR SOC, V46, P1191, DOI 10.1111/j.1532-5415.1998.tb04533.x; Leveille SG, 2000, J GERONTOL B-PSYCHOL, V55, pS41; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; *NAT CTR HLTH STAT, 1986, DHHS PUBL; Nevitt MC, 2000, ARCH INTERN MED, V160, P77, DOI 10.1001/archinte.160.1.77; RAKOWSKI W, 1988, MED CARE, V26, P278, DOI 10.1097/00005650-198803000-00005; Reuben DB, 1999, J AM GERIATR SOC, V47, P269, DOI 10.1111/j.1532-5415.1999.tb02988.x; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3; *SAS I, 1996, SAS SOFTW SYST VERS; SCHOLES D, 1991, AM J PUBLIC HEALTH, V81, P485, DOI 10.2105/AJPH.81.4.485; STUKEL TA, 1994, STAT MED, V13, P1781, DOI 10.1002/sim.4780131709; Szklo M, 1998, EPIDEMIOL REV, V20, P81, DOI 10.1093/oxfordjournals.epirev.a017974; TINETTI ME, 1995, JAMA-J AM MED ASSOC, V273, P1348, DOI 10.1001/jama.273.17.1348; TINETTI ME, 1994, J GERONTOL, V49, pM140, DOI 10.1093/geronj/49.3.M140; *US DHEW, 1979, DHEW PUBL; VERBRUGGE LM, 1985, SOC SCI MED, V20, P855, DOI 10.1016/0277-9536(85)90343-0; VERBRUGGE LM, 1987, MED CARE, V25, P539, DOI 10.1097/00005650-198706000-00008; WAGNER EH, 1994, AM J PUBLIC HEALTH, V84, P1800, DOI 10.2105/AJPH.84.11.1800; WAGNER EH, 1993, J AM GERIATR SOC, V41, P241, DOI 10.1111/j.1532-5415.1993.tb06700.x	34	247	248	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2001	135	5					313	321		10.7326/0003-4819-135-5-200109040-00007	http://dx.doi.org/10.7326/0003-4819-135-5-200109040-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	468WF	11529694				2022-12-01	WOS:000170780600001
J	Isshiki, T; Pearson, B; Holbrook, S; Doe, CQ				Isshiki, T; Pearson, B; Holbrook, S; Doe, CQ			Drosophila neuroblasts sequentially express transcription factors which specify the temporal identity of their neuronal progeny	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; IKAROS GENE FAMILY; EMBRYONIC NEUROBLASTS; SEGMENTATION GENE; DOMAIN GENE; GLIAL-CELLS; CNS; HUNCHBACK; SPECIFICATION; KRUPPEL	Neural precursors often generate distinct cell types in a specific order, but the intrinsic or extrinsic cues regulating the timing of cell fate specification are poorly understood. Here we show that Drosophila neural precursors (neuroblasts) sequentially express the transcription factors Hunchback --> Kruppel --> Pdm --> Castor, with differentiated progeny maintaining the transcription factor profile present at their birth. Hunchback is necessary and sufficient for first-born cell fates, whereas Kruppel is necessary and sufficient for second-born cell fates; this is observed in multiple lineages and is independent of the cell type involved. We propose that Hunchback and Kruppel control early-born temporal identity in neuroblast cell lineages.	Univ Oregon 1254, Howard Hughes Med Inst, Inst Neurosci, Inst Mol Biol, Eugene, OR 97403 USA	Howard Hughes Medical Institute; University of Oregon	Doe, CQ (corresponding author), Univ Oregon 1254, Howard Hughes Med Inst, Inst Neurosci, Inst Mol Biol, Eugene, OR 97403 USA.		Isshiki, Takako/L-5255-2013	Pearson, Bret/0000-0002-3473-901X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027056] Funding Source: NIH RePORTER; NICHD NIH HHS [HD27056] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; BROADUS J, 1995, MECH DEVELOP, V53, P393, DOI 10.1016/0925-4773(95)00454-8; Brody T, 2000, DEV BIOL, V226, P34, DOI 10.1006/dbio.2000.9829; Cepko CL, 1999, CURR OPIN NEUROBIOL, V9, P37, DOI 10.1016/S0959-4388(99)80005-1; Cortes M, 1999, CURR OPIN IMMUNOL, V11, P167, DOI 10.1016/S0952-7915(99)80028-4; CUI X, 1995, DEVELOPMENT, V121, P3233; CUI X, 1992, DEVELOPMENT, V116, P943; DOE CQ, 1985, DEV BIOL, V111, P206, DOI 10.1016/0012-1606(85)90446-4; Durand B, 2000, BIOESSAYS, V22, P64; Farkas G, 2000, GENE, V253, P117, DOI 10.1016/S0378-1119(00)00240-7; Fay DS, 1999, DEV BIOL, V205, P240, DOI 10.1006/dbio.1998.9096; FRANTZ GD, 1994, J NEUROSCI, V14, P472; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; FURST A, 1985, DEV BIOL, V109, P184, DOI 10.1016/0012-1606(85)90359-8; GAUL U, 1987, CELL, V50, P639, DOI 10.1016/0092-8674(87)90037-7; Graba Y, 1997, BIOESSAYS, V19, P379, DOI 10.1002/bies.950190505; Harris WA, 1997, CURR OPIN GENET DEV, V7, P651, DOI 10.1016/S0959-437X(97)80013-5; Hoch M, 1998, EMBO J, V17, P5766, DOI 10.1093/emboj/17.19.5766; Honma Y, 1999, FEBS LETT, V447, P76, DOI 10.1016/S0014-5793(99)00265-3; HULSKAMP M, 1994, GENETICS, V138, P125; Iwasa JH, 2000, DEV GENES EVOL, V210, P277, DOI 10.1007/s004270050315; Kambadur R, 1998, GENE DEV, V12, P246, DOI 10.1101/gad.12.2.246; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; Lundell MJ, 1998, DEVELOPMENT, V125, P463; MARGOLIS JS, 1995, DEVELOPMENT, V121, P3067; MCCONNELL SK, 1995, J NEUROSCI, V15, P6987; MELLERICK DM, 1992, NEURON, V9, P789, DOI 10.1016/0896-6273(92)90234-5; Muller C, 2001, CURR OPIN GENET DEV, V11, P167, DOI 10.1016/S0959-437X(00)00175-1; Ohnuma S, 1999, CELL, V99, P499, DOI 10.1016/S0092-8674(00)81538-X; Perron M, 1998, DEV BIOL, V199, P185, DOI 10.1006/dbio.1998.8939; PROKOP A, 1994, DEVELOPMENT, V120, P2567; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Romani S, 1996, MECH DEVELOP, V60, P95, DOI 10.1016/S0925-4773(96)00603-X; Schmid A, 1999, DEVELOPMENT, V126, P4653; Skeath JB, 1998, DEVELOPMENT, V125, P1857; SOMMER RJ, 1992, P NATL ACAD SCI USA, V89, P10782, DOI 10.1073/pnas.89.22.10782; WEIGMANN K, 1995, DEVELOPMENT, V121, P3713; Wimmer EA, 2000, SCIENCE, V287, P2476, DOI 10.1126/science.287.5462.2476; YANG XH, 1993, GENE DEV, V7, P504, DOI 10.1101/gad.7.3.504	39	463	466	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 24	2001	106	4					511	521		10.1016/S0092-8674(01)00465-2	http://dx.doi.org/10.1016/S0092-8674(01)00465-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525736	Bronze			2022-12-01	WOS:000170665200014
J	Mohle-Boetani, JC; Farrar, JA; Werner, SB; Minassian, D; Bryant, R; Abbott, S; Slutsker, L; Vugia, DJ				Mohle-Boetani, JC; Farrar, JA; Werner, SB; Minassian, D; Bryant, R; Abbott, S; Slutsker, L; Vugia, DJ		Investigation Team	Escherichia coli O157 and Salmonella infections associated with sprouts in California, 1996-1998	ANNALS OF INTERNAL MEDICINE			English	Article							OUTBREAK	Background: In California, from 1996 through 1998, more than 50% of multicounty outbreaks with confirmed food vehicles were related to alfalfa or clover sprouts. Objective: To summarize investigations of sprout-associated outbreaks. Design: Matched case-control studies. Setting: California. Patients: Outbreak-associated patients and matched population controls. Measurements: Matched odds ratios and 95% Cis; traceback and environmental investigations of sprout and seed growers; and pulsed-field gel electrophoresis of isolates from patients, sprouts, and seeds. Results: Five sprout-associated outbreaks of salmonellosis and one outbreak of infection with nonmotile Shiga toxin-producing Escherichia coli O157 occurred. Six hundred patients had culture-confirmed disease, and two died. It is estimated that these outbreaks caused 22 800 cases of gastrointestinal illness or urinary tract infection. In the case-control studies, odds ratios for the association between illness and alfalfa sprout consumption ranged from 5.0 to proportional to (all were statistically significant). Three sprout growers were implicated, and each was associated with two outbreaks. Outbreak strains of Salmonella were isolated from sprouts supplied by two sprout growers and from seeds used by the third sprout grower. Conclusions: As currently produced, sprouts can be a hazardous food. Seeds can be contaminated before sprouting, and no method can eliminate all pathogens from seeds. Seed and sprout growers should implement measures to decrease contamination. The general public should recognize the risks of eating sprouts, and populations at high risk for complications from salmonellosis or E coli O157 infection should avoid sprout consumption.	Calif Dept Hlth Serv, Berkeley, CA 94704 USA; Los Angeles Cty Dept Hlth Serv, Los Angeles, CA USA; Ctr Dis Control & Prevent, Atlanta, GA USA	California Department of Health Care Services; Centers for Disease Control & Prevention - USA	Mohle-Boetani, JC (corresponding author), Dis Invest & Surveillance Branch, Div Communicable Dis Control, 2151 Berkeley Way,Room 708, Berkeley, CA 94704 USA.	jmohlebo@dhs.ca.gov	Mohle-Boetani, Janet/AAH-4221-2019					Abbott SL, 1999, J CLIN MICROBIOL, V37, P4177, DOI 10.1128/JCM.37.12.4177-4178.1999; Andre AD, 1995, INT J AVIAT PSYCHOL, V5, P1, DOI 10.1207/s15327108ijap0501_1; Backer HD, 2000, PUBLIC HEALTH REP, V115, P339, DOI 10.1093/phr/115.4.339; Buck P., 1998, 47 ANN EP INT SERV C; *CDCP, 1999, FOODB DIS ACT SURV N, P6; *CDCP, 1995, EPI INFO VERS 6 04B; GLYNN MK, 1998, 36 ANN M INF DIS SOC; Inami GB, 1999, J FOOD PROTECT, V62, P662, DOI 10.4315/0362-028X-62.6.662; Kurtzweil P, 1999, FDA Consum, V33, P18; Mahon BE, 1997, J INFECT DIS, V175, P876, DOI 10.1086/513985; MARTIN D, 1991, EPIDEMIOLOGY, V2, P359, DOI 10.1097/00001648-199109000-00008; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Michino H, 1999, AM J EPIDEMIOL, V150, P787, DOI 10.1093/oxfordjournals.aje.a010082; OMAHONEY M, 1990, J PUBLIC HEALTH MED, V12, P91; PONKA A, 1995, LANCET, V345, P462, DOI 10.1016/S0140-6736(95)90451-4; Puohiniemi R, 1997, J CLIN MICROBIOL, V35, P2487, DOI 10.1128/JCM.35.10.2487-2491.1997; SWAMINATHAN B, 1993, DIAGNOSTIC MOL MICRO; Taormina PJ, 1999, EMERG INFECT DIS, V5, P626, DOI 10.3201/eid0505.990503; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Van Beneden CA, 1999, JAMA-J AM MED ASSOC, V281, P158, DOI 10.1001/jama.281.2.158; 1997, MMWR MORB MORTAL WKL, V46, P741	21	88	90	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2001	135	4					239	247		10.7326/0003-4819-135-4-200108210-00008	http://dx.doi.org/10.7326/0003-4819-135-4-200108210-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465KE	11511138				2022-12-01	WOS:000170587500002
J	Hall, NF; Gale, CR; Syddall, H; Phillips, DIW; Martyn, CN				Hall, NF; Gale, CR; Syddall, H; Phillips, DIW; Martyn, CN			Risk of macular degeneration in users of statins: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article									Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England	University of Southampton	Martyn, CN (corresponding author), Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England.		Gale, Catharine R/B-1653-2012	Gale, Catharine/0000-0002-3361-8638	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bressler NM, 2000, BRIT MED J, V321, P1425, DOI 10.1136/bmj.321.7274.1425; Dithmar S, 2000, INVEST OPHTH VIS SCI, V41, P2035; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; Pignone M, 2000, BRIT MED J, V321, P983, DOI 10.1136/bmj.321.7267.983	5	98	101	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2001	323	7309					375	376		10.1136/bmj.323.7309.375	http://dx.doi.org/10.1136/bmj.323.7309.375			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11509429	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000170581400020
J	Sano, Y; Inamura, K; Miyake, A; Mochizuki, S; Yokoi, H; Matsushime, H; Furuichi, K				Sano, Y; Inamura, K; Miyake, A; Mochizuki, S; Yokoi, H; Matsushime, H; Furuichi, K			Immunocyte Ca2+ influx system mediated by LTRPC2	SCIENCE			English	Article							TRP; DROSOPHILA; CHANNELS; PROTEIN; GENE; FAMILY; CD38	We characterized an activation mechanism of the human LTRPC2 protein, a member of the transient receptor potential family of ion channels, and demonstrated that LTRPC2 mediates Call influx into immunocytes. Intracellular pyrimidine nucleotides, adenosine 5'-diphosphoribose (ADPR), and nicotinamide adenine dinucleotide (NAD), directly activated LTRPC2, which functioned as a Ca2+-permeable nonselective cation channel and enabled Ca2+ influx into cells. This activation was suppressed by intracellular adenosine triphosphate. These results reveal that ADPR and NAD act as intracellular messengers and may have an important role in Ca2+ influx by activating LTRPC2 in immunocytes.	Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Mol Med Labs, Tsukuba, Ibaraki 3058585, Japan	Astellas Pharmaceuticals	Sano, Y (corresponding author), Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Mol Med Labs, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.	sano.yorikata@yamanouchi.co.jp						Agam K, 2000, J NEUROSCI, V20, P5748, DOI 10.1523/JNEUROSCI.20-15-05748.2000; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Duncan LM, 1998, CANCER RES, V58, P1515; FINKEL TH, 1991, IMMUNOL TODAY, V12, P79, DOI 10.1016/0167-5699(91)90162-M; Guse AH, 2000, J MOL MED, V78, P26, DOI 10.1007/s001090000076; Guse AH, 1998, CRIT REV IMMUNOL, V18, P419, DOI 10.1615/CritRevImmunol.v18.i5.20; Han MK, 2000, J BIOL CHEM, V275, P20799, DOI 10.1074/jbc.M001189200; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hofmann T, 2000, J MOL MED, V78, P14, DOI 10.1007/s001090050378; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; KATO I, 1995, J BIOL CHEM, V270, P30045, DOI 10.1074/jbc.270.50.30045; LEWIS CA, 1979, J PHYSIOL-LONDON, V286, P417, DOI 10.1113/jphysiol.1979.sp012629; Mehta K, 1996, FASEB J, V10, P1408, DOI 10.1096/fasebj.10.12.8903511; Missiaen L, 2000, CELL CALCIUM, V28, P1, DOI 10.1054/ceca.2000.0131; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Nagamine K, 1998, GENOMICS, V54, P124, DOI 10.1006/geno.1998.5551; Prawitt D, 2000, HUM MOL GENET, V9, P203, DOI 10.1093/hmg/9.2.203; Putney JW, 1999, BIOESSAYS, V21, P38; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; SANO Y, UNPUB; Sestini S, 2000, ARCH BIOCHEM BIOPHYS, V379, P277, DOI 10.1006/abbi.2000.1888; WEISS A, 1991, ANNU REV GENET, V25, P487, DOI 10.1146/annurev.ge.25.120191.002415; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wilding M, 1998, AM J PHYSIOL-CELL PH, V275, pC1277, DOI 10.1152/ajpcell.1998.275.5.C1277	25	358	379	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2001	293	5533					1327	1330		10.1126/science.1062473	http://dx.doi.org/10.1126/science.1062473			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509734				2022-12-01	WOS:000170492600043
J	Donaldson, M				Donaldson, M			What is the role of growth-hormone therapy in short children who were small for gestational age?	LANCET			English	Editorial Material							SHORT STATURE; FINAL HEIGHT; RETARDATION; BIRTH; TERM		Royal Hosp Sick Children, Dept Child Hlth, Glasgow GS3 8SJ, Lanark, Scotland	University of Glasgow	Donaldson, M (corresponding author), Royal Hosp Sick Children, Dept Child Hlth, Glasgow GS3 8SJ, Lanark, Scotland.							Coutant R, 1998, J CLIN ENDOCR METAB, V83, P1070, DOI 10.1210/jc.83.4.1070; de Zegher F, 2000, J CLIN ENDOCR METAB, V85, P2816, DOI 10.1210/jc.85.8.2816; DEWAAL WJ, 1994, CLIN ENDOCRINOL, V41, P621; DEZEGHER F, 1990, BIOL NEONATE, V58, P188; KARLBERG J, 1995, PEDIATR RES, V38, P733, DOI 10.1203/00006450-199511000-00017; Zucchini S, 2001, ARCH DIS CHILD, V84, P340, DOI 10.1136/adc.84.4.340	6	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2001	358	9279					347	348		10.1016/S0140-6736(01)05585-4	http://dx.doi.org/10.1016/S0140-6736(01)05585-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502309				2022-12-01	WOS:000170235100004
J	He, XW; Rines, DR; Espelin, CW; Sorger, PK				He, XW; Rines, DR; Espelin, CW; Sorger, PK			Molecular analysis of kinetochore-microtubule attachment in budding yeast	CELL			English	Article							SPINDLE POLE BODY; CELL-CYCLE ARREST; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SEGREGATION; MITOTIC SPINDLE; PRECOCIOUS SEPARATION; CENTROMERE PROTEIN; FISSION YEAST; XENOPUS EGGS; PLUS-END	The complex series of movements that mediates chromosome segregation during mitosis is dependent on the attachment of microtubules to kinetochores, DNA-protein complexes that assemble on centromeric DNA. We describe the use of live-cell imaging and chromatin immunoprecipitation in S. cerevisiae to identify ten kinetochore subunits, among which are yeast homologs of microtubule binding proteins in animal cells. By analyzing conditional mutations in several of these proteins, we show that they are required for the imposition of tension on paired sister kinetochores and for correct chromosome movement. The proteins include both molecular motors and microtubule associated proteins (MAPs), implying that motors and MAPs function together in binding chromosomes to spindle microtubules.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Sorger, PK (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.			Rines, Daniel/0000-0002-1830-2926; Sorger, Peter/0000-0002-3364-1838	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051464] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM19483, GM51464] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERLIN V, 1990, J CELL BIOL, V111, P2573, DOI 10.1083/jcb.111.6.2573; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Bloom K, 2000, NAT CELL BIOL, V2, pE96, DOI 10.1038/35014089; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Cheeseman IM, 2001, J CELL BIOL, V152, P197, DOI 10.1083/jcb.152.1.197; Diamantopoulos GS, 1999, J CELL BIOL, V144, P99, DOI 10.1083/jcb.144.1.99; DOHENY KF, 1993, CELL, V73, P761, DOI 10.1016/0092-8674(93)90255-O; Donaldson AD, 1996, J CELL BIOL, V132, P887, DOI 10.1083/jcb.132.5.887; Dujardin D, 1998, J CELL BIOL, V141, P849, DOI 10.1083/jcb.141.4.849; Freeman L, 2000, J CELL BIOL, V149, P811, DOI 10.1083/jcb.149.4.811; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; Gardner RD, 2001, GENETICS, V157, P1493; Gheber L, 1999, J BIOL CHEM, V274, P9564, DOI 10.1074/jbc.274.14.9564; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; Hildebrandt ER, 2000, BBA-MOL CELL RES, V1496, P99, DOI 10.1016/S0167-4889(00)00012-4; Hofmann C, 1998, J CELL BIOL, V143, P1029, DOI 10.1083/jcb.143.4.1029; HOYT MA, 1992, J CELL BIOL, V118, P109, DOI 10.1083/jcb.118.1.109; Hunter AW, 2000, J CELL SCI, V113, P4379; Hyland KM, 1999, J CELL BIOL, V145, P15, DOI 10.1083/jcb.145.1.15; Hyman AA, 1995, ANNU REV CELL DEV BI, V11, P471, DOI 10.1146/annurev.cellbio.11.1.471; Janke C, 2001, EMBO J, V20, P777, DOI 10.1093/emboj/20.4.777; Jones MH, 1999, MOL BIOL CELL, V10, P2377, DOI 10.1091/mbc.10.7.2377; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Kim JH, 1999, J CELL BIOL, V145, P1381, DOI 10.1083/jcb.145.7.1381; Korinek WS, 2000, SCIENCE, V287, P2257, DOI 10.1126/science.287.5461.2257; Megee PC, 1999, MOL CELL, V4, P445, DOI 10.1016/S1097-2765(00)80347-0; Meluh PB, 1999, METHOD ENZYMOL, V304, P414; Meluh PB, 1997, GENE DEV, V11, P3401, DOI 10.1101/gad.11.24.3401; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Miller RK, 2000, MOL BIOL CELL, V11, P2949, DOI 10.1091/mbc.11.9.2949; Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; Ortiz J, 1999, GENE DEV, V13, P1140, DOI 10.1101/gad.13.9.1140; OSBORNE MA, 1994, J CELL BIOL, V125, P853, DOI 10.1083/jcb.125.4.853; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; ROOF DM, 1992, J CELL BIOL, V118, P95, DOI 10.1083/jcb.118.1.95; Sassoon I, 1999, GENE DEV, V13, P545, DOI 10.1101/gad.13.5.545; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Spittle C, 2000, J BIOL CHEM, V275, P20748, DOI 10.1074/jbc.M002597200; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; STRUNNIKOV AV, 1995, J CELL BIOL, V128, P749, DOI 10.1083/jcb.128.5.749; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Tanaka TU, 1999, CELL, V98, P847, DOI 10.1016/S0092-8674(00)81518-4; Tavormina PA, 1998, GENETICS, V148, P1701; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; VASQUEZ RJ, 1994, J CELL BIOL, V127, P985, DOI 10.1083/jcb.127.4.985; Wang PJJ, 1997, J CELL BIOL, V139, P1271, DOI 10.1083/jcb.139.5.1271; Wigge PA, 2001, J CELL BIOL, V152, P349, DOI 10.1083/jcb.152.2.349; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; Zeng XM, 1999, J CELL BIOL, V146, P415, DOI 10.1083/jcb.146.2.415; Zheng L, 1999, MOL CELL BIOL, V19, P5417; Zheng L, 2000, MOL CELL BIOL, V20, P3529, DOI 10.1128/MCB.20.10.3529-3537.2000	54	212	215	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2001	106	2					195	206		10.1016/S0092-8674(01)00438-X	http://dx.doi.org/10.1016/S0092-8674(01)00438-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511347	Bronze			2022-12-01	WOS:000170193100009
J	RYE, R; KUO, PH; HOLLAND, HD				RYE, R; KUO, PH; HOLLAND, HD			ATMOSPHERIC CARBON-DIOXIDE CONCENTRATIONS BEFORE 2.2-BILLION YEARS AGO	NATURE			English	Article							SURFACE TEMPERATURES; EARLY EARTH; DISSOLUTION; EVOLUTION; SEDIMENT; FEEDBACK	THE composition of the Earth's early atmosphere is a subject of continuing debate(1-4). In particular, it has been suggested that elevated concentrations of atmospheric carbon dioxide would have been necessary to maintain normal surface temperatures in the face of lower solar luminosity in early Earth history(5,6). Fossil weathering profiles, known as palaeosols, have provided semiquantitative constraints on atmospheric oxygen partial pressure (pO(2)) before 2.2 Gyr ago(36,37). Here we use the same well studied palaeosols to constrain atmospheric p(CO2) between 2.75 and 2.2 Gyr ago, The observation that iron lost from the tops of these profiles was reprecipitated lower down as iron silicate minerals(7-9), rather than as iron carbonate, indicates that atmospheric p(CO2) must have been less than 10(-1.4) atm-about 100 times today's level of 360 p.p.m., and at least five times lower than that required in one-dimensional climate models to compensate for lower solar luminosity at 2.75 Gyr. Our results suggest that either the Earth's early climate was much more sensitive to increases in p(CO2) than has been thought, or that one or more greenhouse gases other than CO2 contributed significantly to the atmosphere's radiative balance during the late Archaean and early Proterozoic eons.			RYE, R (corresponding author), HARVARD UNIV,DEPT EARTH & SPACE SCI,20 OXFORD ST,CAMBRIDGE,MA 02138, USA.							ARNDT NT, 1991, AUST J EARTH SCI, V38, P261, DOI 10.1080/08120099108727971; BAKER JA, 1955, USGS1257 WAT SUPPL P; BRUNO J, 1992, GEOCHIM COSMOCHIM AC, V56, P1149, DOI 10.1016/0016-7037(92)90052-K; BUICK R, 1995, NATURE, V375, P674; BUTTON A, 1981, EC GEOLOGY ANNIVERSA, V0075, P00686; BUTTON A, 1979, 133 U WITW EC GEOL R; CESS RD, 1990, J GEOPHYS RES-ATMOS, V95, P16601, DOI 10.1029/JD095iD10p16601; COTTER RD, 1965, USGS1759BE WAT PAP; EUGSTER HP, 1973, ECON GEOL, V68, P1144, DOI 10.2113/gsecongeo.68.7.1144; GOUGH DO, 1981, SOL PHYS, V74, P21, DOI 10.1007/BF00151270; GREENBERG J, 1992, APPL GEOCHEM, V7, P185, DOI 10.1016/0883-2927(92)90036-3; Hayes JM, 1994, NOBEL S, P220; HOFFMAN PF, 1995, NATURE, V375, P537, DOI 10.1038/375537a0; HOLLAND HD, 1990, AM J SCI, V290A, P1; HOLLAND HD, 1994, CHEM EVOLUTION ATMOS; Kasting J.F., 1991, SUN TIME, P447; KASTING JF, 1987, PRECAMBRIAN RES, V34, P205, DOI 10.1016/0301-9268(87)90001-5; KASTING JF, 1993, SCIENCE, V259, P920, DOI 10.1126/science.11536547; KIEHL JT, 1987, J GEOPHYS RES-ATMOS, V92, P2991, DOI 10.1029/JD092iD03p02991; KLEIN C, 1983, IRON FORMATION FACTS, V6, P417; MACFARLANE AW, 1994, PRECAMBRIAN RES, V65, P297, DOI 10.1016/0301-9268(94)90110-4; MAY F, 1994, MINERAL MAG A, V58, P577; OHMOTO H, 1987, NATURE, V328, P244, DOI 10.1038/328244a0; Pinto J.P., 1988, GEOL SOC AM SPEC PAP, P21, DOI DOI 10.1130/SPE216-P21; POSTMA D, 1981, CHEM GEOL, V31, P225; POSTMA D, 1977, J SEDIMENT PETROL, V47, P1089; POTH CW, 1963, B PENNS GEOL SURVEY, V16; POTH CW, 1973, B WATER RESOURCES RE, V36; POWELL JD, 1985, USGS2274 WAT SUPP PA; PRASAD N, 1991, 91IC GEOL SURV CAN P, P43; ROSSOW WB, 1982, SCIENCE, V217, P1245, DOI 10.1126/science.217.4566.1245; SAGAN C, 1972, SCIENCE, V177, P52, DOI 10.1126/science.177.4043.52; SAGAN C, 1994, 1ST INT C CIRC HAB Z, P2; SUTTON SJ, 1993, CAN J EARTH SCI, V30, P60, DOI 10.1139/e93-006; TOWE KM, 1994, NOBEL S, V84, P36; WALKER JCG, 1990, GLOBAL PLANET CHANGE, V82, P261; WILLIAMS DR, 1991, USGS90384 OP FIL REP; WUNSCH DR, 1993, THESIS 5	38	266	271	1	49	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	DEC 7	1995	378	6557					603	605		10.1038/378603a0	http://dx.doi.org/10.1038/378603a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TJ221	11536713				2022-12-01	WOS:A1995TJ22100072
J	JABLONSKI, D; RAUP, DM				JABLONSKI, D; RAUP, DM			SELECTIVITY OF END-CRETACEOUS MARINE BIVALVE EXTINCTIONS	SCIENCE			English	Article							TERTIARY BOUNDARY; DEEP-SEA; MASS EXTINCTIONS; OCEAN; EVOLUTION; PATTERNS; SIZE	Analyses of the end-Cretaceous or Cretaceous-Tertiary mass extinction show no selectivity of marine bivalve genera by life position (burrowing versus exposed), body size, bathymetric position on the continental shelf, or relative breadth of bathymetric range. Deposit-feeders as a group have significantly lower extinction intensities than suspension-feeders, but this pattern is due entirely to low extinction in two groups (Nuculoida and Lucinoidea), which suggests that survivorship was not simply linked to feeding mode. Geographically widespread genera have significantly lower extinction intensities than narrowly distributed genera. These results corroborate earlier work suggesting that some biotic factors that enhance survivorship during times of lesser extinction intensities are ineffectual during mass extinctions.			JABLONSKI, D (corresponding author), UNIV CHICAGO, DEPT GEOPHYS SCI, 5734 S ELLIS AVE, CHICAGO, IL 60637 USA.							BOTTJER D J, 1988, Palaios, V3, P540, DOI 10.2307/3514444; BROWN JH, 1993, AM NAT, V142, P573, DOI 10.1086/285558; Calder W. A, 1984, SIZE FUNCTION LIFE H; CAMPOSCREASEY LS, 1994, DEEP-SEA RES PT I, V41, P369, DOI 10.1016/0967-0637(94)90009-4; DANDO PR, 1994, MAR ECOL PROG SER, V107, P169, DOI 10.3354/meps107169; ERWIN D H, 1989, Palaios, V4, P424, DOI 10.2307/3514587; ERWIN DH, 1994, NATURE, V367, P231, DOI 10.1038/367231a0; GOODAY AJ, 1990, PHILOS T R SOC A, V331, P119, DOI 10.1098/rsta.1990.0060; HICKMAN CS, 1994, VELIGER, V37, P43; HUBER BT, 1994, MAR MICROPALEONTOL, V24, P91, DOI 10.1016/0377-8398(94)90017-5; JABLONSKI D, 1986, SCIENCE, V231, P129, DOI 10.1126/science.231.4734.129; JABLONSKI D, 1986, B MAR SCI, V39, P565; Jablonski D., 1986, P183; JABLONSKI D, 1991, SCIENCE, V253, P754, DOI 10.1126/science.253.5021.754; JABLONSKI D, 1994, PHILOS T R SOC B, V344, P11, DOI 10.1098/rstb.1994.0045; JABLONSKI D, IN PRESS GEOL SOC AM; Jablonski David, 1995, P25; JOHNSON CC, 1990, EXTINCTION EVENTS EA, P305; JUMARS PA, 1990, PHILOS T R SOC A, V331, P85, DOI 10.1098/rsta.1990.0058; KAMERMANS P, 1994, MAR ECOL PROG SER, V104, P63, DOI 10.3354/meps104063; Kauffman E.G., 1973, P353; KAUFFMAN EG, 1978, PHILOS T ROY SOC B, V284, P277, DOI 10.1098/rstb.1978.0068; KAUFFMAN EG, 1986, GLOBAL BIOEVENTS, P279; KELLER G, 1993, MAR MICROPALEONTOL, V21, P1, DOI 10.1016/0377-8398(93)90010-U; KELLER G, 1993, GEOL SOC AM BULL, V105, P979, DOI 10.1130/0016-7606(1993)105<0979:GMESSA>2.3.CO;2; LAMBSHEAD PJD, 1990, DEEP-SEA RES, V37, P1263, DOI 10.1016/0198-0149(90)90042-T; LEVINTON JS, 1991, MAR BIOL, V110, P375, DOI 10.1007/BF01344356; LIN JD, 1994, OIKOS, V69, P28, DOI 10.2307/3545280; MACLEOD KG, 1994, GEOLOGY, V22, P139, DOI 10.1130/0091-7613(1994)022<0139:BIEAMM>2.3.CO;2; MACLEOD KG, 1994, J PALEONTOL, V68, P1048, DOI 10.1017/S0022336000026652; MACLEOD KG, 1990, GEOLOGICAL SOC AM SP, V247, P509; MARINCOVICH L, 1993, J PALEONTOL, V67, P1; Martin R.A., 1992, Historical Biology, V6, P73; McGhee G.R. Jr, 1989, P133; McKinney M.L., 1990, P75; NAKAOKA M, 1992, MAR ECOL PROG SER, V88, P215, DOI 10.3354/meps088215; PAUL CRC, 1994, GEOLOGY, V22, P679, DOI 10.1130/0091-7613(1994)022<0679:IFACFI>2.3.CO;2; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; POHLO R, 1969, Proceedings of the Malacological Society of London, V38, P361; RAUP D., 1991, ANAL PALEOBIOLOGY, V4, P207; RAUP DM, 1993, SCIENCE, V260, P971, DOI 10.1126/science.11537491; REID RGB, 1986, VELIGER, V29, P3; REX MA, 1993, NATURE, V365, P636, DOI 10.1038/365636a0; RHODES MC, 1991, GEOLOGY, V19, P877, DOI 10.1130/0091-7613(1991)019<0877:MEESAP>2.3.CO;2; ROY K, 1994, PALEOBIOLOGY, V20, P274, DOI 10.1017/S0094837300012781; SEPKOSKI JJ, 1987, SCIENCE, V235, P64, DOI 10.1126/science.11539724; SHEEHAN PM, 1992, GEOLOGY, V20, P556, DOI 10.1130/0091-7613(1992)020<0556:MEOLDV>2.3.CO;2; SHEEHAN PM, 1986, GEOLOGY, V14, P868, DOI 10.1130/0091-7613(1986)14<868:DFAABT>2.0.CO;2; SORAUF JE, 1986, CAN J EARTH SCI, V23, P1265, DOI 10.1139/e86-123; STANLEY SM, 1986, PALEOBIOLOGY, V12, P89, DOI 10.1017/S0094837300003006; STANLEY SM, 1988, MOLLUSCA, V11, P105; TYLER PA, 1988, OCEANOGR MAR BIOL, V26, P227; VANVALEN LM, 1994, MASS-EXTINCTION DEBATES: HOW SCIENCE WORKS IN A CRISIS, P200; WARD PD, 1991, GEOLOGY, V19, P1181, DOI 10.1130/0091-7613(1991)019<1181:AAIBEP>2.3.CO;2; WESTROP SR, 1989, PALEOBIOLOGY, V15, P46, DOI 10.1017/S0094837300009179; WINGARD GL, 1990, US GEOL SURV B, V1881, pD1; WINGARD GL, 1994, US GEOL SURV PROF PA, V1535, P1	58	161	164	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	1995	268	5209					389	391		10.1126/science.11536722	http://dx.doi.org/10.1126/science.11536722			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QU572	11536722				2022-12-01	WOS:A1995QU57200030
J	BUICK, R				BUICK, R			THE ANTIQUITY OF OXYGENIC PHOTOSYNTHESIS - EVIDENCE FROM STROMATOLITES IN SULFATE-DEFICIENT ARCHEAN LAKES	SCIENCE			English	Article							WESTERN-AUSTRALIA; LACUSTRINE STROMATOLITES; WARRAWOONA GROUP; NORTH-POLE; BIOSTRATIGRAPHY; MICROFOSSILS; ROCKS	The Tumbiana Formation, about 2700 million years old, was largely deposited in ephemeral saline lakes, as judged by the unusual evaporite paragenesis of carbonate and halite with no sulfate. Stromatolites of diverse morphology occur in the lacustrine sediments, some with palimpsest fabrics after erect filaments. These stromatolites were probably accreted by phototropic microbes that, from their habitat in shallow isolated basins with negligible sulfate concentrations, almost certainly metabolized by oxygenic photosynthesis.	HARVARD UNIV,MUSEUM BOT,CAMBRIDGE,MA 02138	Harvard University				Buick, Roger/0000-0003-0139-1659				ABELL PI, 1982, SEDIMENT GEOL, V32, P1, DOI 10.1016/0037-0738(82)90011-2; BERTRANDSARFATI J, 1981, PRECAMBRIAN RES, V15, P353, DOI 10.1016/0301-9268(81)90057-7; BLAKE TS, 1987, GEOLOGY, V15, P229, DOI 10.1130/0091-7613(1987)15<229:CRATAT>2.0.CO;2; BLAKE TS, 1984, NATURE, V307, P721, DOI 10.1038/307721a0; BUICK R, 1990, SEDIMENTOLOGY, V37, P247, DOI 10.1111/j.1365-3091.1990.tb00958.x; BUICK R, 1981, ALCHERINGA, V5, P161, DOI 10.1080/03115518108566999; GREY K, 1982, PRECAMBRIAN RES, V18, P347, DOI 10.1016/0301-9268(82)90008-0; Grotzinger J.P., 1989, SOC EC PALEONTOLOGIS, V44, P79, DOI DOI 10.2110/PEC; Hayes J. M., 1983, EARTHS EARLIEST BIOS, P93; Hayes JM., 1983, EARTHS EARLIEST BIOS, P291; Hofmann HJ, 1983, EARTHS EARLIEST BIOS, P321; HOLLAND HD, 1990, AM J SCI, V290A, P1; KRYLOV IN, 1982, SEDIMENT GEOL, V32, P27, DOI 10.1016/0037-0738(82)90012-4; KUMAR S, 1984, PRECAMBRIAN RES, V14, P96; LIANG YZ, 1985, PRECAMBRIAN RES, V29, P15, DOI 10.1016/0301-9268(85)90056-7; Schidlowski M., 1983, P149; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; Schopf J.W., 1983, P361; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; SMITH RE, 1982, J PETROL, V23, P75, DOI 10.1093/petrology/23.1.75; SOUTHGATE PN, 1986, GEOLOGY, V14, P683, DOI 10.1130/0091-7613(1986)14<683:DEAMOP>2.0.CO;2; Thorne A.M., 1990, U W AUST PUBL, P14; TOWE KM, 1990, NATURE, V348, P54, DOI 10.1038/348054a0; TRENDALL AF, 1990, 3RD INT ARCH S PERTH, P81; VEIZER J, 1990, GEOCHIM COSMOCHIM AC, V54, P2717, DOI 10.1016/0016-7037(90)90007-8; Walter MR, 1983, EARTHS EARLIEST BIOS, P187; [No title captured]	27	264	275	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 3	1992	255	5040					74	77		10.1126/science.11536492	http://dx.doi.org/10.1126/science.11536492			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX791	11536492				2022-12-01	WOS:A1992GX79100039
J	Van Dover, CL; Humphris, SE; Fornari, D; Cavanaugh, CM; Collier, R; Goffredi, SK; Hashimoto, J; Lilley, MD; Reysenbach, AL; Shank, TM; Von Damm, KL; Banta, A; Gallant, RM; Gotz, D; Green, D; Hall, J; Harmer, TL; Hurtado, LA; Johnson, P; McKiness, ZP; Meredith, C; Olson, E; Pan, IL; Turnipseed, M; Won, Y; Young, CR; Vrijenhoek, RC				Van Dover, CL; Humphris, SE; Fornari, D; Cavanaugh, CM; Collier, R; Goffredi, SK; Hashimoto, J; Lilley, MD; Reysenbach, AL; Shank, TM; Von Damm, KL; Banta, A; Gallant, RM; Gotz, D; Green, D; Hall, J; Harmer, TL; Hurtado, LA; Johnson, P; McKiness, ZP; Meredith, C; Olson, E; Pan, IL; Turnipseed, M; Won, Y; Young, CR; Vrijenhoek, RC			Biogeography and ecological setting of Indian Ocean hydrothermal vents	SCIENCE			English	Article							MID-ATLANTIC RIDGE; SHRIMP; FLUIDS; BRESILIIDAE; DISPERSAL; PRIMERS; FAUNA	Within the endemic invertebrate faunas of hydrothermal vents, five biogeographic provinces are recognized. Invertebrates at two Indian Ocean vent fields (Kairei and Edmond) belong to a sixth province, despite ecological settings and invertebrate-bacterial symbioses similar to those of both western Pacific and Atlantic vents. Most organisms found at these Indian Ocean vent fields have evolutionary affinities with western Pacific vent faunas, but a shrimp that ecologically dominates Indian Ocean vents closely resembles its Mid-Atlantic counterpart. These findings contribute to a global assessment of the biogeography of chemosynthetic faunas and indicate that the Indian Ocean vent community follows asymmetric assembly rules biased toward Pacific evolutionary alliances.	Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA; Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; Harvard Univ, Cambridge, MA 02138 USA; Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Japan Marine Sci & Technol Ctr, Kanagawa 2370061, Japan; Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; Portland State Univ, Dept Biol, Portland, OR 97201 USA; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA; Univ Southampton, Southampton Oceanog Ctr, Southampton, Hants, England; Louisiana State Univ, Baton Rouge, LA 70803 USA; Univ Hawaii Manoa, Honolulu, HI 96822 USA	William & Mary; Woods Hole Oceanographic Institution; Harvard University; Oregon State University; Monterey Bay Aquarium Research Institute; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Washington; University of Washington Seattle; Portland State University; Woods Hole Oceanographic Institution; University System Of New Hampshire; University of New Hampshire; NERC National Oceanography Centre; University of Southampton; Louisiana State University System; Louisiana State University; University of Hawaii System; University of Hawaii Manoa	Van Dover, CL (corresponding author), Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA.	cindy_vandover@wm.edu	Harmer Luke, Tara/R-6816-2018; Hurtado, Luis A/B-5953-2008; Luke, Tara Harmer/S-5923-2019	Harmer Luke, Tara/0000-0003-2529-1708; Hurtado, Luis A/0000-0002-9773-4996; Luke, Tara Harmer/0000-0003-2529-1708; Van Dover, Cindy/0000-0001-9845-8391; Banta, Amy/0000-0002-1843-5059				AREVALO E, 1994, SYST BIOL, V43, P387, DOI 10.2307/2413675; Bielawski JP, 1996, MOL BIOL EVOL, V13, P889, DOI 10.1093/oxfordjournals.molbev.a025649; BRIAIS A, 1995, MAR GEOPHYS RES, V17, P431, DOI 10.1007/BF01371787; CAVANAUGH CM, 1983, NATURE, V302, P58, DOI 10.1038/302058a0; Chevaldonne P, 1998, CAH BIOL MAR, V39, P347; Craig H., 1980, EOS, V61, P992; DEMETS C, 1988, J GEOPHYS RES-SOLID, V93, P11877, DOI 10.1029/JB093iB10p11877; Donval J.P., 1997, EOS T AM GEOPHYS UNI, V78, pF832; EVANS WC, 1988, J GEOPHYS RES-SOLID, V93, P15305, DOI 10.1029/JB093iB12p15305; Fisher C.R., 1995, SEAFLOOR HYDROTHERMA, V91, P297; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FOUQUET Y, 1993, ECON GEOL BULL SOC, V88, P2018, DOI 10.2113/gsecongeo.88.8.2018; GRASSLE JF, 1985, SCIENCE, V229, P713, DOI 10.1126/science.229.4715.713; Hashimoto J, 2001, ZOOL SCI, V18, P717, DOI 10.2108/zsj.18.717; Herring PJ, 1998, DEEP-SEA RES PT I, V45, P2105, DOI 10.1016/S0967-0637(98)00050-8; HERZIG PM, 1988, CAN MINERAL, V26, P721; HESSLER RR, 1991, DEEP-SEA RES, V38, P185, DOI 10.1016/0198-0149(91)90079-U; HUBER R, 1992, SYST APPL MICROBIOL, V15, P340, DOI 10.1016/S0723-2020(11)80206-7; Kleinrock MC, 1996, NATURE, V382, P149, DOI 10.1038/382149a0; LILLEY M, UNPUB; LUTZ RA, 1979, AM ZOOL, V19, P927; Maas PAY, 1999, BIOL BULL, V196, P265, DOI 10.2307/1542951; Merritt TJS, 1998, MOL MAR BIOL BIOTECH, V7, P7; Mironov AN, 1998, CAH BIOL MAR, V39, P367; Palumbi Stephen R., 1996, P205; PLUGER WL, 1990, MAR MINING, V9, P73; Polz MF, 1998, LIMNOL OCEANOGR, V43, P1631, DOI 10.4319/lo.1998.43.7.1631; Pond DW, 2000, MAR ECOL PROG SER, V198, P171, DOI 10.3354/meps198171; Reysenbach AL, 2000, NATURE, V404, P835, DOI 10.1038/35009029; Reysenbach AL, 2000, APPL ENVIRON MICROB, V66, P3798, DOI 10.1128/AEM.66.9.3798-3806.2000; Robinson JL, 1995, LIMNOL OCEANOGR, V40, P1496, DOI 10.4319/lo.1995.40.8.1496; Shank TM, 1998, MOL MAR BIOL BIOTECH, V7, P88; Shank TM, 1999, MOL PHYLOGENET EVOL, V13, P244, DOI 10.1006/mpev.1999.0642; TUNNICLIFFE V, 1988, PROC R SOC SER B-BIO, V233, P347, DOI 10.1098/rspb.1988.0025; Tunnicliffe V, 1996, NATURE, V379, P531, DOI 10.1038/379531a0; TUNNICLIFFE V, 1998, GEOLOGICAL SOC SPEC, V118, P225; Van Dover C., 2000, ECOLOGY DEEP SEA HYD; Van Dover Cindy Lee, 1995, Geological Society Special Publication, V87, P257; Van Dover CL, 2000, MAR ECOL PROG SER, V195, P169, DOI 10.3354/meps195169; VANDOVER CL, 1989, MAR BIOL, V102, P257, DOI 10.1007/BF00428287; VANDOVER CL, 1994, LIMNOL OCEANOGR, V39, P51, DOI 10.4319/lo.1994.39.1.0051; VANDOVER CL, 1990, GORDA RIDGE, P253; VANDOVER CL, IN PRESS MAR ECOL PR; Von Damm KL, 1998, EARTH PLANET SC LETT, V160, P521, DOI 10.1016/S0012-821X(98)00108-3; Von Damm KL, 2000, J GEOPHYS RES-SOL EA, V105, P11203, DOI 10.1029/1999JB900414; Vrijenhoek RC, 1997, J HERED, V88, P285, DOI 10.1093/oxfordjournals.jhered.a023106; VRIJENHOEK RC, 1997, JAMSTEC DEEP SEA RES, V111; White SN, 1998, MAR GEOPHYS RES, V20, P41, DOI 10.1023/A:1004376229719; AF393376 GENB; AF393378 GENB; AF393377 GENB; AF393379 GENB	52	261	262	0	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2001	294	5543					818	823		10.1126/science.1064574	http://dx.doi.org/10.1126/science.1064574			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11557843				2022-12-01	WOS:000171851800037
J	Derry, WB; Putzke, AP; Rothman, JH				Derry, WB; Putzke, AP; Rothman, JH			Caenorhabditis elegans p53: Role in apoptosis, meiosis, and stress resistance	SCIENCE			English	Article							PROGRAMMED CELL-DEATH; TRANSCRIPTIONAL ACTIVATION; GENETIC-CONTROL; DROSOPHILA P53; TUMOR-ANTIGEN; C-ELEGANS; PROTEIN; EMBRYOGENESIS; ACCUMULATION; CHECKPOINT	We have identified a homolog of the mammalian p53 tumor suppressor protein in the nematode Caenorhabditis elegans that is expressed ubiquitously in embryos. The gene encoding this protein, cep-1, promotes DNA damage-induced apoptosis and is required for normal meiotic chromosome segregation in the germ line. Moreover, although somatic apoptosis is unaffected, cep-1 mutants show hypersensitivity to hypoxia-induced lethality and decreased longevity in response to starvation-induced stress. Overexpression of cep-1 promotes widespread caspase-independent cell death, demonstrating the critical importance of regulating p53 function at appropriate levels. These findings show that C. elegans p53 mediates multiple stress responses in the soma, and mediates apoptosis and meiotic chromosome segregation in the germ line.	Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Derry, WB (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	derry@lifesci.ucsb.edu	Derry, Brent/CAF-4503-2022	Derry, Brent/0000-0002-1977-8475	NIA NIH HHS [AG13736] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG013736] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Alarcon R, 1999, CANCER RES, V59, P6046; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BIENZ B, 1984, EMBO J, V3, P2179, DOI 10.1002/j.1460-2075.1984.tb02110.x; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; DERRY WB, UNPUB; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; GRAEBER TG, 1994, MOL CELL BIOL, V14, P6264, DOI 10.1128/MCB.14.9.6264; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; HENIKOFF S, 1995, GENE, V163, P17; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; Jin SK, 2000, P NATL ACAD SCI USA, V97, P7301, DOI 10.1073/pnas.97.13.7301; Kitanaka C, 1999, CELL DEATH DIFFER, V6, P508, DOI 10.1038/sj.cdd.4400526; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; LAMB P, 1986, MOL CELL BIOL, V6, P1379, DOI 10.1128/MCB.6.5.1379; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Riddle D. L, 1997, C ELEGANS, P47; ROGEL A, 1985, MOL CELL BIOL, V5, P2851, DOI 10.1128/MCB.5.10.2851; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHMID P, 1991, DEVELOPMENT, V113, P857; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; THUT CJ, 1995, SCIENCE, V267, P100, DOI 10.1126/science.7809597; Wallingford JB, 1997, CURR BIOL, V7, P747, DOI 10.1016/S0960-9822(06)00333-2	32	370	397	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					591	595		10.1126/science.1065486	http://dx.doi.org/10.1126/science.1065486			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11557844				2022-12-01	WOS:000171695600046
J	Xiong, JP; Stehle, T; Diefenbach, B; Zhang, RG; Dunker, R; Scott, DL; Joachimiak, A; Goodman, SL; Arnaout, MA				Xiong, JP; Stehle, T; Diefenbach, B; Zhang, RG; Dunker, R; Scott, DL; Joachimiak, A; Goodman, SL; Arnaout, MA			Crystal structure of the extracellular segment of integrin alpha V beta 3	SCIENCE			English	Article							IIB-IIIA COMPLEX; LIGAND-BINDING; A-DOMAIN; CELL-ADHESION; CONFORMATIONAL-CHANGES; PROTEIN; AFFINITY; SITES; FIBRINOGEN; INSIGHTS	Integrins are alpha beta heterodimeric receptors that mediate divalent cation-dependent cell-cell and cell-matrix adhesion through tightly regulated interactions with ligands. We have solved the crystal structure of the extracellular portion of integrin alphaV beta3 at 3.1 Angstrom resolution. Its 12 domains assemble into an ovoid "head" and two "tails." In the crystal, alphaV beta3 is severely bent at a defined region in its tails, reflecting an unusual flexibility that may be linked to integrin regulation. The main intersubunit interface ties within the head, between a seven-bladed beta -propeller from alphaV and an A domain from beta3, and bears a striking resemblance to the G alpha /G beta interface in G proteins. A metal ion-dependent adhesion site (MIDAS) in the betaA domain is positioned to participate in a ligand-binding interface formed of loops from the propeller and betaA domains. MIDAS ties adjacent to a calcium-binding site with a potential regulatory function.	Massachusetts Gen Hosp, Struct Biol Program, Leukocyte Biol & Inflammat Program, Renal Unit, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Lab Dev Immunol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Merck KGaA, Dept Biotechnol, D-64271 Darmstadt, Germany; Merck KGaA, Dept Biomed Res Immunol Oncol, D-64271 Darmstadt, Germany; Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Merck KGaA; Merck KGaA; United States Department of Energy (DOE); Argonne National Laboratory	Arnaout, MA (corresponding author), Massachusetts Gen Hosp, Struct Biol Program, Leukocyte Biol & Inflammat Program, Renal Unit, 149 13th St, Charlestown, MA 02129 USA.	arnaout@receptor.mgh.harvard.edu		Goodman, Simon L./0000-0002-3480-1346	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048549, P01DK050305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM062414] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bork P, 1999, TRENDS BIOCHEM SCI, V24, P261, DOI 10.1016/S0968-0004(99)01416-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calvete JJ, 1999, P SOC EXP BIOL MED, V222, P29, DOI 10.1111/j.1525-1373.1999.09993.x; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Chothia C, 1997, ANNU REV BIOCHEM, V66, P823, DOI 10.1146/annurev.biochem.66.1.823; DANA N, 1991, P NATL ACAD SCI USA, V88, P3106, DOI 10.1073/pnas.88.8.3106; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; DU XP, 1993, J BIOL CHEM, V268, P23087; Eliceiri BP, 1999, J CLIN INVEST, V103, P1227, DOI 10.1172/JCI6869; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Erb EM, 1997, BIOCHEMISTRY-US, V36, P7395, DOI 10.1021/bi9702187; FITZGERALD LA, 1985, J BIOL CHEM, V260, P1366; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Hantgan RR, 1999, BIOCHEMISTRY-US, V38, P14461, DOI 10.1021/bi9907680; Hemler ME, 1998, CURR OPIN CELL BIOL, V10, P578, DOI 10.1016/S0955-0674(98)80032-X; Hogg N, 2000, MATRIX BIOL, V19, P211, DOI 10.1016/S0945-053X(00)00066-4; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu DD, 1996, J BIOL CHEM, V271, P21745, DOI 10.1074/jbc.271.36.21745; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Li R, 1998, J CELL BIOL, V143, P1523, DOI 10.1083/jcb.143.6.1523; Mehta RJ, 1998, BIOCHEM J, V330, P861; MICHISHITA M, 1993, CELL, V72, P857, DOI 10.1016/0092-8674(93)90575-B; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Mould AP, 1998, BIOCHEM J, V331, P821, DOI 10.1042/bj3310821; NERMUT MV, 1988, EMBO J, V7, P4093, DOI 10.1002/j.1460-2075.1988.tb03303.x; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARISE LV, 1985, J BIOL CHEM, V260, P1750; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Pujades C, 1997, MOL BIOL CELL, V8, P2647, DOI 10.1091/mbc.8.12.2647; SIMS PJ, 1991, J BIOL CHEM, V266, P7345; van Kooyk Y, 1999, J BIOL CHEM, V274, P26869, DOI 10.1074/jbc.274.38.26869; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; WEISEL JW, 1992, J BIOL CHEM, V267, P16637; Xiong JP, 2000, J BIOL CHEM, V275, P38762, DOI 10.1074/jbc.C000563200; Yamada KM, 1997, CURR OPIN CELL BIOL, V9, P76, DOI 10.1016/S0955-0674(97)80155-X; [No title captured]	45	1041	1095	2	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2001	294	5541					339	345		10.1126/science.1064535	http://dx.doi.org/10.1126/science.1064535			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482WZ	11546839	Green Accepted			2022-12-01	WOS:000171601400034
J	Thompson, WT; Cupples, ME; Sibbett, CH; Skan, DI; Bradley, T				Thompson, WT; Cupples, ME; Sibbett, CH; Skan, DI; Bradley, T			Challenge of culture, conscience, and contract to general practitioners' care of their own health: qualitative study	BRITISH MEDICAL JOURNAL			English	Article							DOCTORS; ILLNESS; SICKNESS; STRESS; JOB	Objective To explore general practitioners' perceptions of the effects of their profession and training on their attitudes to illness in themselves and colleagues. Design Qualitative study using focus groups and indepth interviews. Setting Primary care in Northern Ireland. Participants 27 general practitioners, including six recently appointed principals and six who also practised occupational medicine part time. Main outcome measures Participants' views about their own and colleagues' health. Results Participants were concerned about the current level of illness within the profession. They described their need to portray a healthy image to both patients and colleagues. This hindered acknowledgement of personal illness and engaging in health screening. Embarrassment in adopting the role of a patient and concerns about confidentiality also influenced their reactions to personal illness. Doctors' attitudes can impede their access to appropriate health care for themselves, their families, and their colleagues. A sense of conscience towards patients and colleagues and the working arrangements of the practice were cited as reasons for working through illness and expecting colleagues to do likewise. Conclusions General practitioners perceive that their professional position and training adversely influence their attitudes to illness in themselves and their colleagues. Organisational changes within general practice, including revalidation, must take account of barriers experienced by general practitioners in accessing health care. Medical education and culture should strive to promote appropriate self care among doctors.	Queens Univ Belfast, Sch Med, Dept Gen Practice, Belfast BT9 7HR, Antrim, North Ireland; Queens Univ Belfast, Grad Sch Educ, Belfast BT7 1HL, Antrim, North Ireland; Hlth & Safety Execut No Ireland, Employment Med Advisory Serv, Belfast BT6 9FR, Antrim, North Ireland; No Ireland Council Postgrad Med & Dent Educ, Belfast BT7 3JH, Antrim, North Ireland	Queens University Belfast; Queens University Belfast	Cupples, ME (corresponding author), Queens Univ Belfast, Sch Med, Dept Gen Practice, Belfast BT9 7HR, Antrim, North Ireland.			Cupples, Margaret/0000-0002-4248-9700				Appleton K, 1998, BRIT J GEN PRACT, V48, P1059; *BMA BOARD SCI ED, 1993, MORB MORT MED PROF; BRANDON S, 1997, BRIT MED J, V314, P2; Chambers R, 1996, BRIT MED J, V312, P722; CHAMBERS R, 1992, BRIT J GEN PRACT, V42, P153; Clarke J, 1998, IRISH MED J, V91, P175; Forsythe M, 1999, BRIT MED J, V319, P605, DOI 10.1136/bmj.319.7210.605; *GEN MED COUNC, 1998, GOOD MED PRACT; *GEN MED COUNC, 2000, REV DOCT ENS STAND; Gilliland AEV, 1998, BRIT J GEN PRACT, V48, P1663; Glaser B. G., 1978, THEORETICAL SENSITIV; *HLTH POL EC RES U, 2000, WORK REL STRESS SEN; KING MB, 1992, J ROY SOC MED, V85, P605; McKevitt C, 1997, J PUBLIC HEALTH MED, V19, P295, DOI 10.1093/oxfordjournals.pubmed.a024633; McKevitt C, 1997, SOCIOL HEALTH ILL, V19, P644, DOI 10.1111/1467-9566.ep10935530; McKevitt C, 1996, DOCTORS HLTH NEEDS S; MILLAR RL, 2000, RES LIFE STORIES FAM; MORTONWILLIAMS J, 1988, APPL QUALITATIVE RES, P27; PILOWSKI L, 1989, BRIT MED J, V298, P269, DOI 10.1136/bmj.298.6669.269; Schneck SA, 1998, JAMA-J AM MED ASSOC, V280, P2039, DOI 10.1001/jama.280.23.2039; Waldron HA, 1996, ANN OCCUP HYG, V40, P391, DOI 10.1093/annhyg/40.4.391; Wall TD, 1997, BRIT J PSYCHIAT, V171, P519, DOI 10.1192/bjp.171.6.519; Williams S, 1998, IMPROVING HLTH NHS W; 1994, LANCET, V344, P1583	24	107	109	0	18	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 29	2001	323	7315					728	731		10.1136/bmj.323.7315.728	http://dx.doi.org/10.1136/bmj.323.7315.728			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	478HJ	11576981	Green Published			2022-12-01	WOS:000171340700021
J	Nash, MS; Young, KW; Challiss, RAJ; Nahorski, SR				Nash, MS; Young, KW; Challiss, RAJ; Nahorski, SR			Intracellular signalling - Receptor-specific messenger oscillations	NATURE			English	Article							CALCIUM OSCILLATIONS; FEEDBACK		Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	University of Leicester	Nash, MS (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Med Sci Bldg,Univ Rd, Leicester LE1 9HN, Leics, England.		Challiss, R.A. John/A-9412-2008	Challiss, John/0000-0001-5506-2848				Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BIRD GSJ, 1993, J BIOL CHEM, V268, P8425; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; HAROOTUNIAN AT, 1991, SCIENCE, V251, P75, DOI 10.1126/science.1986413; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Kawabata S, 1996, NATURE, V383, P89, DOI 10.1038/383089a0; Nash MS, 2001, BIOCHEM J, V356, P137, DOI 10.1042/0264-6021:3560137; Petersen OH, 1999, TRENDS NEUROSCI, V22, P488, DOI 10.1016/S0166-2236(99)01456-3; Taylor CW, 2001, CURR BIOL, V11, pR352, DOI 10.1016/S0960-9822(01)00192-0; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200	12	114	115	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2001	413	6854					381	382		10.1038/35096643	http://dx.doi.org/10.1038/35096643			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475UY	11574876				2022-12-01	WOS:000171188700042
J	Strohmaier, H; Spruck, CH; Kaiser, P; Won, KA; Sangfelt, O; Reed, SI				Strohmaier, H; Spruck, CH; Kaiser, P; Won, KA; Sangfelt, O; Reed, SI			Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line	NATURE			English	Article								Cyclin E, one of the activators of the cyclin-dependent kinase Cdk2, is expressed near the G(1)-S phase transition and is thought to be critical for the initiation of DNA replication and other S-phase functions(1-3). Accumulation of cyclin E at the G(1)-S boundary is achieved by periodic transcription coupled with regulated proteolysis linked to autophosphorylation of cyclin E-4. The proper timing and amplitude of cyclin E expression seem to be important, because elevated levels of cyclin E have been associated with a variety of malignancies(5,6) and constitutive expression of cyclin E leads to genomic instability(7). Here we show that turnover of phosphorylated cyclin E depends on an SCF-type protein-ubiquitin ligase that contains the human homologue of yeast Cdc4, which is an F-box protein containing repeated sequences of WD40 (a unit containing about 40 residues with tryptophan (W) and aspartic acid (D) at defined positions). The gene encoding hCdc4 was found to be mutated in a cell line derived from breast cancer that expressed extremely high levels of cyclin E.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Karolinska Hosp, Dept Oncol Pathol, S-17176 Stockholm, Sweden	Scripps Research Institute; Karolinska Institutet; Karolinska University Hospital	Reed, SI (corresponding author), Scripps Res Inst, Dept Mol Biol, MB-7,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	sreed@scripps.edu						BETT AJ, 1994, P NATL ACAD SCI USA, V91, P8802, DOI 10.1073/pnas.91.19.8802; Bortner DM, 1997, MOL CELL BIOL, V17, P453, DOI 10.1128/MCB.17.1.453; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Dealy MJ, 1999, NAT GENET, V23, P245, DOI 10.1038/13886; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Donnellan R, 1999, FASEB J, V13, P773, DOI 10.1096/fasebj.13.8.773; Ekholm SV, 2000, CURR OPIN CELL BIOL, V12, P676, DOI 10.1016/S0955-0674(00)00151-4; KEYOMARSI K, 1993, P NATL ACAD SCI USA, V90, P1112, DOI 10.1073/pnas.90.3.1112; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; MUHLRAD D, 1992, YEAST, V8, P79, DOI 10.1002/yea.320080202; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; REED SI, 1985, P NATL ACAD SCI USA, V82, P4055, DOI 10.1073/pnas.82.12.4055; Reed SI, 1996, BBA-REV CANCER, V1287, P151, DOI 10.1016/0304-419X(96)00006-6; Reed SI, 1997, CANCER SURV, V29, P7; Sambrook J., 1989, MOL CLONING LAB MANU, V3; Sandhu C, 2000, CANCER DETECT PREV, V24, P107; Sauer K, 1995, Prog Cell Cycle Res, V1, P125; Spruck C, 2001, MOL CELL, V7, P639, DOI 10.1016/S1097-2765(01)00210-6; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Tyers M, 2000, CURR OPIN GENET DEV, V10, P54, DOI 10.1016/S0959-437X(99)00049-0; WALEN KH, 1989, CANCER GENET CYTOGEN, V37, P249, DOI 10.1016/0165-4608(89)90056-3; Wang YS, 1999, CURR BIOL, V9, P1191, DOI 10.1016/S0960-9822(00)80024-X; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Yeh KH, 2001, BIOCHEM BIOPH RES CO, V281, P884, DOI 10.1006/bbrc.2001.4442	26	498	512	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2001	413	6853					316	322		10.1038/35095076	http://dx.doi.org/10.1038/35095076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565034				2022-12-01	WOS:000171040500041
J	Greene, JD; Sommerville, RB; Nystrom, LE; Darley, JM; Cohen, JD				Greene, JD; Sommerville, RB; Nystrom, LE; Darley, JM; Cohen, JD			An fMRI investigation of emotional engagement in moral judgment	SCIENCE			English	Article							WORKING-MEMORY; BRAIN	The long-standing rationalist tradition in moral psychology emphasizes the rote of reason in moral judgment. A more recent trend places increased emphasis on emotion. Although both reason and emotion are likely to play important roles in moral judgment, relatively tittle is known about their neural correlates, the nature of their interaction, and the factors that modulate their respective behavioral influences in the context of moral judgment. In two functional magnetic resonance imaging (fMRI) studies using moral dilemmas as probes, we apply the methods of cognitive neuroscience to the study of moral judgment. We argue that moral dilemmas vary systematically in the extent to which they engage emotional processing and that these variations in emotional engagement influence moral judgment. These results may shed light on some puzzling patterns in moral judgment observed by contemporary philosophers.	Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA; Princeton Univ, Dept Philosophy, Princeton, NJ 08544 USA; Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA	Princeton University; Princeton University; Princeton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Greene, JD (corresponding author), Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA.							Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; DAMASIO AR, 1994, DESCARTES ERROR; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Drevets WC, 1998, COGNITION EMOTION, V12, P353, DOI 10.1080/026999398379646; HAIDT JD, IN PRESS PSYCH REV; Isenberg N, 1999, P NATL ACAD SCI USA, V96, P10456, DOI 10.1073/pnas.96.18.10456; Kosslyn SM, 1996, NEUROREPORT, V7, P1569, DOI 10.1097/00001756-199607080-00007; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; Reiman EM, 1997, J CLIN PSYCHIAT, V58, P4; Reiman EM, 1997, AM J PSYCHIAT, V154, P918; Smith EE, 1997, COGNITIVE PSYCHOL, V33, P5, DOI 10.1006/cogp.1997.0658; STROOP JR, 1935, J EXP PSYCHOL, V72, P219; Talairach J., 1988, COPLANAR STEREOTAXIC, P5; Thomson J.J., 1986, RIGHTS RESTITUTION R, P94	15	2511	2581	41	661	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					2105	2108		10.1126/science.1062872	http://dx.doi.org/10.1126/science.1062872			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	473FB	11557895				2022-12-01	WOS:000171028700078
J	Hwang, UW; Friedrich, M; Tautz, D; Park, CJ; Kim, W				Hwang, UW; Friedrich, M; Tautz, D; Park, CJ; Kim, W			Mitochondrial protein phylogeny joins myriapods with chelicerates	NATURE			English	Article							ARTHROPOD PHYLOGENY; HOX GENES; SEQUENCE; EXPRESSION; EVOLUTION; POSITION; INSECTS; PATTERN; MODEL	The animal phylum Arthropoda is very useful for the study of body plan evolution given its abundance of morphologically diverse species and our profound understanding of Drosophila development(1). However, there is a lack of consistently resolved phylogenetic relationships between the four extant arthropod subphyla, Hexapoda, Myriapoda, Chelicerata and Crustacea. Recent molecular studies(2-4) have strongly supported a sister group relationship between Hexapoda and Crustacea, but have not resolved the phylogenetic position of Chelicerata and Myriapoda. Here we sequence the mitochondrial genome of the centipede species Lithobius forficatus and investigate its phylogenetic information content. Molecular phylogenetic analysis of conserved regions from the arthropod mitochondrial proteome yields highly resolved and congruent trees. We also rnd that a sister group relationship between Myriapoda and Chelicerata is strongly supported. We propose a model to explain the apparently parallel evolution of similar head morphologies in insects and myriapods.	Kyungpook Natl Univ, Dept Biol, Teachers Coll, Taegu 702701, South Korea; Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; Univ Cologne, Abt Evolut Genet, Inst Genet, D-50931 Cologne, Germany	Kyungpook National University; Seoul National University (SNU); Wayne State University; University of Cologne	Friedrich, M (corresponding author), Kyungpook Natl Univ, Dept Biol, Teachers Coll, Taegu 702701, South Korea.	mf@biology.biosci.wayne.edu	Tautz, Diethard/D-4304-2011; Tautz, Diethard/H-8436-2014	Tautz, Diethard/0000-0002-0460-5344				Adachi J, 1996, J MOL EVOL, V42, P459; Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Akam M, 2000, P NATL ACAD SCI USA, V97, P4438, DOI 10.1073/pnas.97.9.4438; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; BOORE JL, 1995, NATURE, V376, P163, DOI 10.1038/376163a0; Casares F, 1998, NATURE, V392, P723, DOI 10.1038/33706; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CISNE JL, 1974, SCIENCE, V186, P13, DOI 10.1126/science.186.4158.13; Cook CE, 2001, CURR BIOL, V11, P759, DOI 10.1016/S0960-9822(01)00222-6; Curole JP, 1999, TRENDS ECOL EVOL, V14, P394, DOI 10.1016/S0169-5347(99)01660-2; Damen WGM, 1998, P NATL ACAD SCI USA, V95, P10665, DOI 10.1073/pnas.95.18.10665; delle Cave L., 1991, P189; FELSENSTEIN J, 1995, PHYLIP PHYLOGENY INF; Foster PG, 1999, J MOL EVOL, V48, P284, DOI 10.1007/PL00006471; FRIEDRICH M, 1995, NATURE, V376, P165, DOI 10.1038/376165a0; Garcia-Machado E, 1999, J MOL EVOL, V49, P142, DOI 10.1007/PL00006527; Giribet G, 2000, CLADISTICS, V16, P204, DOI 10.1111/j.1096-0031.2000.tb00353.x; Hausdorf B, 2000, SYST BIOL, V49, P130, DOI 10.1080/10635150050207438; Kusche K, 2001, MOL BIOL EVOL, V18, P1566, DOI 10.1093/oxfordjournals.molbev.a003943; MUSE SV, 2000, HY PHY 0 7 BETA; Peterson KJ, 2001, EVOL DEV, V3, P170, DOI 10.1046/j.1525-142x.2001.003003170.x; Shultz JW, 2000, P ROY SOC B-BIOL SCI, V267, P1011, DOI 10.1098/rspb.2000.1104; SIDOW A, 1994, CURR BIOL, V4, P596, DOI 10.1016/S0960-9822(00)00131-7; SNODGRASS RE, 1938, SMITHSON MISC COLLEC, V138, P1; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Telford MJ, 1998, P NATL ACAD SCI USA, V95, P10671, DOI 10.1073/pnas.95.18.10671; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wilson K, 2000, MOL BIOL EVOL, V17, P863, DOI 10.1093/oxfordjournals.molbev.a026366	30	212	220	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2001	413	6852					154	157		10.1038/35093090	http://dx.doi.org/10.1038/35093090			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557978				2022-12-01	WOS:000170918800044
J	Hugouvieux, V; Kwak, JM; Schroeder, JI				Hugouvieux, V; Kwak, JM; Schroeder, JI			An mRNA cap binding protein, ABH1, modulates early abscisic acid signal transduction in Arabidopsis	CELL			English	Article							CYTOPLASMIC CALCIUM; ANION CHANNELS; CYTOSOLIC CA-2+; GENE-EXPRESSION; ION CHANNELS; ETHYLENE; COMPLEX; MUTANT; ABA; GROWTH	The plant hormone abscisic acid (ABA) regulates important stress and developmental responses. We have isolated a recessive ABA hypersensitive mutant, abh1, that shows hormone specificity to ABA. ABH1 encodes the Arabidopsis homolog of a nuclear mRNA cap binding protein and functions in a heterodimeric complex to bind the mRNA cap structure. DNA chip analyses show that only a few transcripts are downregulated in abh1, several of which are implicated in ABA signaling. Consistent with these results, abh1 plants show ABA-hypersensitive stomatal closing and reduced wilting during drought. Interestingly, ABA-hypersensitive cytosolic calcium increases in abh1 guard cells demonstrate amplification of early ABA signaling. Thus, ABH1 represents a modulator of ABA signaling proposed to function by transcript alteration of early ABA signaling elements.	Univ Calif San Diego, Div Biol, Cell & Dev Biol Sect, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Schroeder, JI (corresponding author), Univ Calif San Diego, Div Biol, Cell & Dev Biol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.	julian@biomail.ucsd.edu	Kwak, June M/G-8332-2011	Kwak, June M/0000-0001-6948-5155; Schroeder, Julian/0000-0002-3283-5972	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060396] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM60396-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLAN AC, 1994, PLANT CELL, V6, P1319; Allen GJ, 1999, PLANT CELL, V11, P1785, DOI 10.1105/tpc.11.9.1785; Allen GJ, 1999, PLANT J, V19, P735, DOI 10.1046/j.1365-313x.1999.00574.x; Allen GJ, 2000, SCIENCE, V289, P2338, DOI 10.1126/science.289.5488.2338; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; ARMSTRONG F, 1995, P NATL ACAD SCI USA, V92, P9520, DOI 10.1073/pnas.92.21.9520; Beaudoin N, 2000, PLANT CELL, V12, P1103, DOI 10.1105/tpc.12.7.1103; Bethke PC, 1998, CURR OPIN PLANT BIOL, V1, P440, DOI 10.1016/S1369-5266(98)80270-7; Bonetta D, 2000, PLANTA, V211, P182, DOI 10.1007/s004250000283; Bueno P, 1998, PLANT SCI, V138, P27, DOI 10.1016/S0168-9452(98)00154-X; CARY AJ, 1995, PLANT PHYSIOL, V107, P1075, DOI 10.1104/pp.107.4.1075; Cutler S, 1996, SCIENCE, V273, P1239, DOI 10.1126/science.273.5279.1239; Ephritikhine G, 1999, PLANT J, V18, P303, DOI 10.1046/j.1365-313X.1999.00454.x; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Flaherty SM, 1997, P NATL ACAD SCI USA, V94, P11893, DOI 10.1073/pnas.94.22.11893; Fortes P, 2000, MOL CELL, V6, P191, DOI 10.1016/S1097-2765(00)00020-4; Fortes P, 1999, MOL CELL BIOL, V19, P6543; Foster R, 1999, PLANT J, V17, P363, DOI 10.1046/j.1365-313X.1999.00384.x; FURUICHI Y, 1977, NATURE, V266, P235, DOI 10.1038/266235a0; Ghassemian M, 2000, PLANT CELL, V12, P1117, DOI 10.1105/tpc.12.7.1117; GILMOUR SJ, 1992, PLANT MOL BIOL, V18, P13, DOI 10.1007/BF00018452; GILROY S, 1990, NATURE, V346, P769, DOI 10.1038/346769a0; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Grabov A, 1998, P NATL ACAD SCI USA, V95, P4778, DOI 10.1073/pnas.95.8.4778; Guan LQM, 2000, PLANT J, V22, P87, DOI 10.1046/j.1365-313x.2000.00723.x; Gutierrez RA, 1999, TRENDS PLANT SCI, V4, P429, DOI 10.1016/S1360-1385(99)01484-3; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; IZAURRALDE E, 1995, NATURE, V376, P709, DOI 10.1038/376709a0; KARSSEN CM, 1989, ANN BOT-LONDON, V63, P71, DOI 10.1093/oxfordjournals.aob.a087730; KATAOKA N, 1995, NUCLEIC ACIDS RES, V23, P3638, DOI 10.1093/nar/23.18.3638; KOOMNEEF M, 1998, PLANT PHYSIOL BIOCH, V36, P83, DOI DOI 10.1016/S0981-9428(98)80093-4; KOOMNEEF M, 1994, PHYSIOL PLANTARUM, P313; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Lewis JD, 1997, EUR J BIOCHEM, V247, P461, DOI 10.1111/j.1432-1033.1997.00461.x; Li JX, 2000, SCIENCE, V287, P300, DOI 10.1126/science.287.5451.300; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; MacIntosh GC, 2001, P NATL ACAD SCI USA, V98, P1018, DOI 10.1073/pnas.98.3.1018; MacRobbie EAC, 1998, PHILOS T ROY SOC B, V353, P1475, DOI 10.1098/rstb.1998.0303; MARCOTTE WR, 1992, BIOCHEM SOC T, V20, P93, DOI 10.1042/bst0200093; MCAINSH MR, 1990, NATURE, V343, P186, DOI 10.1038/343186a0; NAMBARA E, 1992, PLANT J, V2, P435, DOI 10.1111/j.1365-313X.1992.00435.x; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; Pei ZM, 1998, SCIENCE, V282, P287, DOI 10.1126/science.282.5387.287; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; SCHROEDER JI, 1990, P NATL ACAD SCI USA, V87, P9305, DOI 10.1073/pnas.87.23.9305; SCHROEDER JI, 1989, NATURE, V338, P427, DOI 10.1038/338427a0; Schwartz SH, 1997, PLANT PHYSIOL, V114, P161, DOI 10.1104/pp.114.1.161; Seki M, 2001, PLANT CELL, V13, P61, DOI 10.1105/tpc.13.1.61; SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8; Sheen J, 1998, P NATL ACAD SCI USA, V95, P975, DOI 10.1073/pnas.95.3.975; SHIMOTOHNO K, 1977, P NATL ACAD SCI USA, V74, P2734, DOI 10.1073/pnas.74.7.2734; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; STASWICK PE, 1992, P NATL ACAD SCI USA, V89, P6837, DOI 10.1073/pnas.89.15.6837; Staxen I, 1999, P NATL ACAD SCI USA, V96, P1779, DOI 10.1073/pnas.96.4.1779; Steber CM, 1998, GENETICS, V149, P509; Takahashi S, 2000, PLANT CELL PHYSIOL, V41, P898, DOI 10.1093/pcp/pcd010; UEMURA H, 1992, J BACTERIOL, V174, P5526, DOI 10.1128/JB.174.17.5526-5532.1992; Vranova E, 2000, J EXP BOT, V51, P1763, DOI 10.1093/jexbot/51.351.1763; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; WILHELM KS, 1993, PLANT MOL BIOL, V23, P1073, DOI 10.1007/BF00021822; Wilson KF, 1999, J BIOL CHEM, V274, P4166, DOI 10.1074/jbc.274.7.4166; Yalovsky S, 2000, PLANT CELL, V12, P1257, DOI 10.1105/tpc.12.8.1257; Ziegelhoffer EC, 2000, P NATL ACAD SCI USA, V97, P7633, DOI 10.1073/pnas.130189397	67	321	332	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2001	106	4					477	487		10.1016/S0092-8674(01)00460-3	http://dx.doi.org/10.1016/S0092-8674(01)00460-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525733	Bronze			2022-12-01	WOS:000170665200011
J	Vocadlo, DJ; Davies, GJ; Laine, R; Withers, SG				Vocadlo, DJ; Davies, GJ; Laine, R; Withers, SG			Catalysis by hen egg-white lysozyme proceeds via a covalent intermediate	NATURE			English	Article							CRYSTALLOGRAPHIC EVIDENCE; BETA-GLUCOSIDASE; HYDROLYSIS; DISTORTION; MECHANISM; INSIGHTS; ACID	Hen egg-white lysozyme (HEWL) was the first enzyme to have its three-dimensional structure determined by X-ray diffraction techniques(1). A catalytic mechanism, featuring a long-lived oxo-carbenium-ion intermediate, was proposed on the basis of model-building studies(2). The `Phillips' mechanism is widely held as the paradigm for the catalytic mechanism of beta -glycosidases that cleave glycosidic linkages with net retention of configuration of the anomeric centre. Studies with other retaining beta -glycosidases, however, provide strong evidence pointing to a common mechanism for these enzymes that involves a covalent glycosyl-enzyme intermediate, as previously postulated(3). Here we show, in three different cases using electrospray ionization mass spectrometry, a catalytically competent covalent glycosyl-enzyme intermediate during the catalytic cycle of HEWL. We also show the three-dimensional structure of this intermediate as determined by Xray diffraction. We formulate a general catalytic mechanism for all retaining beta -glycosidases that includes substrate distortion, formation of a covalent intermediate, and the electrophilic migration of C1 along the reaction coordinate.	Univ British Columbia, Prot Engn Network Ctr Excellence, Vancouver, BC V6T 1Z1, Canada; Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; Univ York, Dept Chem, Struct Biol Lab, York YO10 5DD, N Yorkshire, England; Louisiana State Univ, Dept Biol, Baton Rouge, LA 70808 USA; Louisiana State Univ, Dept Chem, Baton Rouge, LA 70808 USA	University of British Columbia; University of British Columbia; University of York - UK; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Withers, SG (corresponding author), Univ British Columbia, Prot Engn Network Ctr Excellence, Vancouver, BC V6T 1Z1, Canada.	withers@chem.ubc.ca	Laine, Roger/ABE-2473-2020; Withers, Stephen G/I-7229-2019; Laine, Roger A/B-9434-2014; Davies, Gideon J/A-9042-2011; Vocadlo, David J/E-5508-2014	Withers, Stephen G/0000-0002-6722-5701; Laine, Roger A/0000-0001-5984-4409; Davies, Gideon J/0000-0002-7343-776X; Vocadlo, David J/0000-0001-6897-5558				AMYES TL, 1989, J AM CHEM SOC, V111, P7888, DOI 10.1021/ja00202a033; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BALLARDIE FW, 1977, BIOORG CHEM, V6, P483, DOI 10.1016/0045-2068(77)90047-5; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burmeister WP, 1997, STRUCTURE, V5, P663, DOI 10.1016/S0969-2126(97)00221-9; CHIPMAN DM, 1968, J BIOL CHEM, V243, P487; DAHLQUIS.FW, 1969, BIOCHEMISTRY-US, V8, P4214, DOI 10.1021/bi00838a045; Davies G. J., 1998, INCOMPREHENSIVE BIOL, P119; Davies GJ, 1998, BIOCHEMISTRY-US, V37, P11707, DOI 10.1021/bi981315i; Fedorov A, 2001, BIOCHEMISTRY-US, V40, P853, DOI 10.1021/bi002499f; FINK AL, 1980, BIOCHEMISTRY-US, V19, P811, DOI 10.1021/bi00545a030; HOLLER E, 1975, BIOCHEMISTRY-US, V14, P2377, DOI 10.1021/bi00682a017; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Kuroki R, 1999, P NATL ACAD SCI USA, V96, P8949, DOI 10.1073/pnas.96.16.8949; MALCOLM BA, 1989, P NATL ACAD SCI USA, V86, P133, DOI 10.1073/pnas.86.1.133; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Matsumura I, 1996, BIOCHEMISTRY-US, V35, P1881, DOI 10.1021/bi951671q; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Notenboom V, 1998, NAT STRUCT BIOL, V5, P812, DOI 10.1038/1852; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PHILLIPS DC, 1967, P NATL ACAD SCI USA, V57, P484; RANDMEIR T, 1969, BIOCHEMISTRY-US, V8, P4206, DOI 10.1021/bi00838a044; ROSENBERG S, 1981, BIOCHEMISTRY-US, V20, P3196, DOI 10.1021/bi00514a032; SINNOTT ML, 1973, BIOCHEM J, V133, P89, DOI 10.1042/bj1330089; STRYNADKA NCJ, 1991, J MOL BIOL, V220, P401, DOI 10.1016/0022-2836(91)90021-W; Sulzenbacher G, 1996, BIOCHEMISTRY-US, V35, P15280, DOI 10.1021/bi961946h; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; WANG Q, 1995, BIOCHEMISTRY-US, V34, P14554, DOI 10.1021/bi00044a034	29	509	524	2	193	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 23	2001	412	6849					835	838		10.1038/35090602	http://dx.doi.org/10.1038/35090602			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518970	Green Accepted			2022-12-01	WOS:000170577200041
J	des Etangs, AL; Vidal-Madjar, A; Roberge, A; Feldman, PD; Deleuil, M; Andre, M; Blair, WP; Bouret, JC; Desert, JM; Ferlet, R; Friedman, S; Hebrard, G; Lemoine, M; Moos, HW				des Etangs, AL; Vidal-Madjar, A; Roberge, A; Feldman, PD; Deleuil, M; Andre, M; Blair, WP; Bouret, JC; Desert, JM; Ferlet, R; Friedman, S; Hebrard, G; Lemoine, M; Moos, HW			Deficiency of molecular hydrogen in the disk of beta Pictoris	NATURE			English	Article							HST-GHRS OBSERVATIONS; CIRCUMSTELLAR DISK; CO; GAS; BODIES; SPACE; CI	Molecular hydrogen (H-2) is by far the most abundant material from which stars, protoplanetary disks and giant planets form, but it is difficult to detect directly. Infrared emission lines from H-2 have recently been reported(1) towards beta Pictoris, a star harbouring a young planetary system(2). This star is surrounded by a dusty 'debris disk' that is continuously replenished either by collisions between asteroidal objects(3) or by evaporation of ices on Chiron-like objects(4). A gaseous disk has also been inferred from absorption lines in the stellar spectrum(5-8). Here we present the far-ultraviolet spectrum of beta Pictoris, in which H-2 absorption lines are not seen. This allows us to set a very low upper limit on the column density of H-2 : N(H-2) less than or equal to 10(18) cm(-2). This non-detection is puzzling when compared to the quantity of H-2 inferred from the infrared observations, but it does show that H-2 is not in the disk on the direct line of sight. Carbon monoxide (CO) has been seen in absorption against the star(8-10), yielding a ratio of CO/H-2 >6 x 10(-4). As CO would be destroyed under ambient conditions in about 200 years (refs 9, 11), our result demonstrates that the CO in the disk arises from evaporation of planetesimals.	CNRS, Inst Astrophys Paris, F-75014 Paris, France; Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; Lab Astrophys Marseille, F-13376 Marseille 2, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Johns Hopkins University; UDICE-French Research Universities; Aix-Marseille Universite	des Etangs, AL (corresponding author), CNRS, Inst Astrophys Paris, 98 Bis Bld Arago, F-75014 Paris, France.	lecaveli@iap.fr	Roberge, Aki/D-2782-2012; Lecavelier des Etangs, Alain/GLU-6503-2022; Lemoine, Martin/AAE-6416-2019	Roberge, Aki/0000-0002-2989-3725; Lecavelier des Etangs, Alain/0000-0002-5637-5253; Lemoine, Martin/0000-0002-2395-7812; Deleuil, Magali/0000-0001-6036-0225				Backman D. E., 1993, PROTOSTARS PLANETS, P1253; BEUST H, 1990, ASTRON ASTROPHYS, V236, P202; CARRUTHERS GR, 1970, ASTROPHYS J, V161, pL81, DOI 10.1086/180575; DELEUIL M, IN PRESS ASTROPHYS J; desEtangs AL, 1996, ASTRON ASTROPHYS, V307, P542; DESETANGS AL, 1999, PLANETS OUTSIDE SOLA, P95; FERLET R, 1987, ASTRON ASTROPHYS, V185, P267; HOBBS LM, 1985, ASTROPHYS J, V293, pL29, DOI 10.1086/184485; Jolly A, 1998, ASTRON ASTROPHYS, V329, P1028; Kamp I, 2000, ASTRON ASTROPHYS, V353, P276; Lagrange AM, 1998, ASTRON ASTROPHYS, V330, P1091; Liseau R, 1998, ASTRON ASTROPHYS, V334, P935; Magnani L, 1998, ASTROPHYS J, V504, P290, DOI 10.1086/306062; Moos HW, 2000, ASTROPHYS J, V538, pL1, DOI 10.1086/312795; Navascues DBY, 1999, ASTROPHYS J, V520, pL123, DOI 10.1086/312162; Roberge A, 2000, ASTROPHYS J, V538, P904, DOI 10.1086/309157; ROBERGE A, 1908, ASTROPHYS J, V551, pL97; SHULL JM, 1982, ANNU REV ASTRON ASTR, V20, P163, DOI 10.1146/annurev.aa.20.090182.001115; SPITZER L, 1973, ASTROPHYS J, V181, pL116, DOI 10.1086/181197; Thi WF, 2001, NATURE, V409, P60, DOI 10.1038/35051033; VANDISHOECK EF, 1988, ASTROPHYS J, V334, P771, DOI 10.1086/166877; Vidal-Madjar A, 1998, PLANET SPACE SCI, V46, P629, DOI 10.1016/S0032-0633(97)00192-X; VIDALMADJAR A, 1994, ASTRON ASTROPHYS, V290, P245; VIDALMADJAR A, 1986, ASTRON ASTROPHYS, V167, P325	24	94	95	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2001	412	6848					706	708		10.1038/35089006	http://dx.doi.org/10.1038/35089006			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507632				2022-12-01	WOS:000170450200036
J	Feltbower, RG; Moorman, AV; Dovey, G; Kinsey, S; McKinney, PA				Feltbower, RG; Moorman, AV; Dovey, G; Kinsey, S; McKinney, PA			Incidence of childhood acute lymphoblastic leukaemia in Yorkshire, UK	LANCET			English	Article							LEUKEMIA	Between 1980 and 1998, in the north-west of England, a significant rise in childhood acute lymphoblastic leukaemia was caused by an Increase in the precursor B-cell form of this disease. We analysed data on children who were diagnosed with leukaemia in Yorkshire, UK, between 1974 and 1997. The incidence of acute lymphoblastic leukaemia remained stable, although a non-significant yearly increase of 2.4% was noted for the precursor B-cell form of this disease from 1980 onwards. The precursor B-cell form accounted for 80% of all acute lymphoblastic leukaemia. Our data are not consistent with increasing Incidence for precursor B-cell acute lymphoblastic leukaemia, although numbers of children with acute myeloid leukaemia are rising.	Paediat Epidemiol Grp, Leeds LS2 9LN, W Yorkshire, England; Leukaemia Res Fund Ctr Clin Epidemiol, Leeds LS2 9LN, W Yorkshire, England; Unit Epidemiol & Hlth Serv Res, Leeds LS2 9LN, W Yorkshire, England; St James Univ Hosp, Childrens Day Hosp, Leeds LS9 7TF, W Yorkshire, England	University of Leeds; University of Leeds; University of Leeds; Saint James's University Hospital	McKinney, PA (corresponding author), Paediat Epidemiol Grp, 30 Hyde Terrace, Leeds LS2 9LN, W Yorkshire, England.	p.a.mckinney@leeds.ac.uk	Moorman, Anthony/F-5518-2010; Moorman, Anthony/G-1468-2014	Moorman, Anthony/0000-0002-9781-6107				BLAIR V, 1994, EUR J CANCER, V30A, P1490, DOI 10.1016/0959-8049(94)00274-9; COEBERGH JWW, 1989, BRIT J CANCER, V59, P100, DOI 10.1038/bjc.1989.20; DRAPER GJ, 1994, CANCER SURV, V20, P493; McKinney PA, 1998, BRIT J CANCER, V78, P974, DOI 10.1038/bjc.1998.612; McNally RJQ, 2000, LANCET, V356, P485, DOI 10.1016/S0140-6736(00)02562-9	5	22	22	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2001	358	9279					385	387		10.1016/S0140-6736(01)05581-7	http://dx.doi.org/10.1016/S0140-6736(01)05581-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502322				2022-12-01	WOS:000170235100017
J	Derkatch, IL; Bradley, ME; Hong, JY; Liebman, SW				Derkatch, IL; Bradley, ME; Hong, JY; Liebman, SW			Prions affect the appearance of other prions: The story of [PIN+]	CELL			English	Article							DE-NOVO APPEARANCE; YEAST SACCHAROMYCES-CEREVISIAE; RELEASE FACTOR; PSI+ PRION; IN-VITRO; PROTEIN HSP104; FORMING DOMAIN; SUP35 PROTEIN; PROPAGATION; PSI(+)	Prions are self-propagating protein conformations. Recent research brought insight into prion propagation, but how they first appear is unknown. We previously established that the yeast non-Mendelian trait [PIN+] is required for the de novo appearance of the [PSI+] prion. Here, we show that the presence of prions formed by Rnq1 or Ure2 is sufficient to make cells [PIN+]. Thus, [PIN+] can be caused by more than one prion. Furthermore, an unbiased functional screen for [PIN+] prions uncovered the known prion gene, URE2, the proposed prion gene, NEW1, and nine novel candidate prion genes all carrying prion domains. Importantly, the de novo appearance of Rnq1::GFP prion aggregates also requires the presence of other prions, suggesting the existence of a general mechanism by which the appearance of prions is enhanced by heterologous prion aggregates.	Univ Illinois, Dept Biol Sci, Mol Biol Lab, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Liebman, SW (corresponding author), Univ Illinois, Dept Biol Sci, Mol Biol Lab, 900 S Ashland Ave, Chicago, IL 60607 USA.	suel@uic.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056350] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM056350, GM 56350] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1996, METHOD ENZYMOL, V266, P460; Bailleul PA, 1999, GENETICS, V153, P81; Caughey B, 2000, NAT MED, V6, P751, DOI 10.1038/77476; Caughey B, 1995, CHEM BIOL, V2, P807, DOI 10.1016/1074-5521(95)90087-X; Chernoff YO, 1999, MOL CELL BIOL, V19, P8103; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CHERNOFF YO, 1993, CURR GENET, V24, P268, DOI 10.1007/BF00351802; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; COX B, 1994, CURR BIOL, V4, P744, DOI 10.1016/S0960-9822(00)00167-6; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 1998, P NATL ACAD SCI USA, V95, P2400, DOI 10.1073/pnas.95.5.2400; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2000, EMBO J, V19, P1942, DOI 10.1093/emboj/19.9.1942; Fernandez-Bellot E, 2000, EMBO J, V19, P3215, DOI 10.1093/emboj/19.13.3215; Friesen MJ, 2000, J BIOL CHEM, V275, P26370, DOI 10.1074/jbc.M003299200; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; INGEVECHTOMOV SG, 1988, GENETIKA+, V24, P2110; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; Johan K, 1998, P NATL ACAD SCI USA, V95, P2558, DOI 10.1073/pnas.95.5.2558; King CY, 1997, P NATL ACAD SCI USA, V94, P6618, DOI 10.1073/pnas.94.13.6618; Kisilevsky R, 1999, AMYLOID, V6, P98, DOI 10.3109/13506129909007309; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liebman SW, 1999, J BIOL CHEM, V274, P1181, DOI 10.1074/jbc.274.3.1181; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Masison DC, 1997, P NATL ACAD SCI USA, V94, P12503, DOI 10.1073/pnas.94.23.12503; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Moriyama H, 2000, MOL CELL BIOL, V20, P8916, DOI 10.1128/MCB.20.23.8916-8922.2000; NEHLIN JO, 1989, GENE, V85, P313, DOI 10.1016/0378-1119(89)90423-X; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1997, SCIENCE, V277, P381, DOI 10.1126/science.277.5324.381; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Pellizzoni L, 1999, P NATL ACAD SCI USA, V96, P11167, DOI 10.1073/pnas.96.20.11167; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; ROSE MD, 1990, METHODS YEAST GENETI; Sambrook J., 1989, MOL CLONING LAB MANU, V3; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Schlumpberger M, 2000, PROTEIN SCI, V9, P440; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Sherman F., 1986, METHODS YEAST GENETI; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; TERAVANESYAN MD, 1994, GENETICS, V137, P671; Thual C, 1999, J BIOL CHEM, V274, P13666, DOI 10.1074/jbc.274.19.13666; Tuite MF, 2000, CELL, V100, P289, DOI 10.1016/S0092-8674(00)80663-7; TUITE MF, 1981, GENETICS, V98, P691; Wickner RB, 1999, MICROBIOL MOL BIOL R, V63, P844, DOI 10.1128/MMBR.63.4.844-861.1999; Wickner RB, 2000, J STRUCT BIOL, V130, P310, DOI 10.1006/jsbi.2000.4250; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 1995, YEAST, V11, P1671, DOI 10.1002/yea.320111609; Zhou P, 1999, EMBO J, V18, P1182, DOI 10.1093/emboj/18.5.1182; Zhou P, 2001, MOL MICROBIOL, V39, P37, DOI 10.1046/j.1365-2958.2001.02224.x	57	469	487	6	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2001	106	2					171	182		10.1016/S0092-8674(01)00427-5	http://dx.doi.org/10.1016/S0092-8674(01)00427-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511345	Bronze			2022-12-01	WOS:000170193100007
J	CANFIELD, DE; THAMDRUP, B				CANFIELD, DE; THAMDRUP, B			THE PRODUCTION OF S-34-DEPLETED SULFIDE DURING BACTERIAL DISPROPORTIONATION OF ELEMENTAL SULFUR	SCIENCE			English	Article							SULFATE REDUCTION RATES; MARINE-SEDIMENTS; BLACK-SEA; MANGANESE REDUCTION; COASTAL SEDIMENTS; ORGANIC-MATTER; IRON; ISOTOPE; OXIDATION; KINETICS	Bacteria that disproportionate elemental sulfur fractionate sulfur isotopes such that sulfate is enriched in sulfur-34 by 12.6 to 15.3 per mil and sulfide is depleted in sulfur-34 by 7.3 to 8.6 per mil. Through a repeated cycle of sulfide oxidation to S-0 and subsequent disproportionation, these bacteria can deplete sedimentary sulfides in sulfur-34. A prediction, borne out by observation, is that more extensive sulfide oxidation will lead to sulfides that are more depleted in sulfur-34. Thus, the oxidative part of the sulfur cycle creates circumstances by which sulfides become more depleted in sulfur-34 than would be possible with sulfate-reducing bacteria alone.	GEORGIA INST TECHNOL,SCH EARTH & ATMOSPHER SCI,ATLANTA,GA 30332	University System of Georgia; Georgia Institute of Technology	CANFIELD, DE (corresponding author), MAX PLANCK INST MARINE MICROBIOL,FAHRENHEITSTR 1,D-28359 BREMEN,GERMANY.		Canfield, Don/C-1735-2012; Thamdrup, Bo/F-3889-2016	Canfield, Don/0000-0001-7602-8366; Thamdrup, Bo/0000-0002-1221-7077				BEMER RA, 1964, MAR GEOL, V1, P117; BEMER RA, 1985, AM J SCI, V285, P193; BURDIGE DJ, 1986, GEOMICROBIOL J, V4, P361, DOI 10.1080/01490458609385944; CANFIELD DE, 1993, GEOCHIM COSMOCHIM AC, V57, P3867, DOI 10.1016/0016-7037(93)90340-3; CANFIELD DE, 1992, AM J SCI, V292, P659, DOI 10.2475/ajs.292.9.659; CANFIELD DE, UNPUB; CHAMBERS LA, 1975, CAN J MICROBIOL, V21, P1602, DOI 10.1139/m75-234; CHAMBERS LA, 1982, GEOCHIM COSMOCHIM AC, V46, P721, DOI 10.1016/0016-7037(82)90023-0; CHANTON JP, 1985, THESIS U N CAROLINA; CHEN KY, 1972, ENVIRON SCI TECHNOL, V6, P529, DOI 10.1021/es60065a008; CRILL PM, 1987, GEOCHIM COSMOCHIM AC, V51, P1175, DOI 10.1016/0016-7037(87)90210-9; FRY B, 1991, DEEP-SEA RES, V38, pS1003, DOI 10.1016/S0198-0149(10)80021-4; GOLDHABER MB, 1975, SOIL SCI, V119, P42, DOI 10.1097/00010694-197501000-00008; GOLDHABER MB, 1974, SEA, P569; HARRISON A, 1958, T FARADAY SOC, V53, P84; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; JORGENSEN BB, 1991, DEEP-SEA RES, V38, pS1083; JORGENSEN BB, 1990, SCIENCE, V249, P152, DOI 10.1126/science.249.4965.152; JORGENSEN BB, 1979, GEOCHIM COSMOCHIM AC, V43, P363, DOI 10.1016/0016-7037(79)90201-1; KAPLAN IR, 1964, J GEN MICROBIOL, V34, P195, DOI 10.1099/00221287-34-2-195; KEMP ALW, 1968, GEOCHIM COSMOCHIM AC, V32, P71, DOI 10.1016/0016-7037(68)90088-4; LUTHER GW, 1991, DEEP-SEA RES, V38, pS1121, DOI 10.1016/S0198-0149(10)80027-5; MURAMOTO JA, 1991, DEEP-SEA RES, V38, pS1151, DOI 10.1016/S0198-0149(10)80029-9; Ohmoto H., 1990, STABLE ISOTOPES FLUI, V23, P70; PYZIK AJ, 1981, GEOCHIM COSMOCHIM AC, V45, P687, DOI 10.1016/0016-7037(81)90042-9; THAMDRUP B, 1993, APPL ENVIRON MICROB, V59, P101, DOI 10.1128/AEM.59.1.101-108.1993; THODEANDERSEN S, 1989, LIMNOL OCEANOGR, V34, P793, DOI 10.4319/lo.1989.34.5.0793; TROELSEN H, 1982, ESTUAR COAST SHELF S, V15, P255, DOI 10.1016/0272-7714(82)90062-2; UYAMA F, 1985, GEOCHEM J, V19, P301, DOI 10.2343/geochemj.19.301; WESTRICH J, UNPUB; Westrich J.T., 1983, THESIS YALE U, pYale	31	461	487	3	101	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 23	1994	266	5193					1973	1975		10.1126/science.11540246	http://dx.doi.org/10.1126/science.11540246			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ267	11540246				2022-12-01	WOS:A1994PZ26700024
J	HARTGERS, WA; DAMSTE, JSS; REQUEJO, AG; ALLAN, J; HAYES, JM; DELEEUW, JW				HARTGERS, WA; DAMSTE, JSS; REQUEJO, AG; ALLAN, J; HAYES, JM; DELEEUW, JW			EVIDENCE FOR ONLY MINOR CONTRIBUTIONS FROM BACTERIA SEDIMENTARY ORGANIC-CARBON	NATURE			English	Article							BASIN; PHOTOSYNTHESIS; DISTRIBUTIONS; HYDROCARBONS; ORIGINS; SULFUR; SHALE	BECAUSE their molecular signatures are often prominent in extracts of sediments, bacteria are thought to be important contributors to petroleum source beds(1). It has been shown recently(2,3), however, that abundances of biomarkers do not always reflect relative contributions to sedimentary organic carbon (C-org). The contribution of photosynthetic green sulphur bacteria to sediments can be assessed effectively because the diagenetic products of distinctive carotenoids from these organisms occur widely(4-11) and their biomass is isotopically labelled, being enriched in C-13 (refs 11, 13). We show here that, although sediments and oils from the Western Canada and Williston basins contain prominent biomarkers of photosynthetic bacteria, the absence of C-13 enrichment in the total C-org requires that the bacterial contribution is in fact minimal. Although the importance of bacterial reworking of sedimentary debris cannot be doubted(14), we argue that our findings, when considered in conjunction with those from other settings, suggest that bacterial biomass may commonly represent only a minor component of total C-org in carbonaceous rocks.	TEXAS A&M UNIV,GEOCHEM & ENVIRONV RES GRP,COLLEGE STN,TX 77845; ESSO RESOURCES CANADA LTD,CALGARY T2P 0H6,AB,CANADA; INDIANA UNIV,DEPT CHEM,BIOGEOCHEM LABS,BLOOMINGTON,IN 47405; INDIANA UNIV,DEPT GEOL SCI,BIOGEOCHEM LABS,BLOOMINGTON,IN 47405	Texas A&M University System; Texas A&M University College Station; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	HARTGERS, WA (corresponding author), NETHERLANDS INST SEA RES,DIV MARINE BIOGEOCHEM,POB 59,1790 AB DEN BURG,NETHERLANDS.		de Leeuw, Jan W/F-6471-2011; Damste, Jaap S Sinninghe/F-6128-2011	Damste, Jaap S Sinninghe/0000-0002-8683-1854				ALLAN J, 1991, B CAN PETROL GEOL, V39, P107; COLLISTER JW, 1992, ORG GEOCHEM, V19, P265, DOI 10.1016/0146-6380(92)90042-V; DAMSTE JSS, 1993, NATURE, V362, P827, DOI 10.1038/362827a0; DAMSTE JSS, 1993, GEOCHIM COSMOCHIM AC, V57, P389; DERENNE S, 1991, ORGANIC GEOCHEMISTRY, P408; DOUGLAS AG, 1991, GEOCHIM COSMOCHIM AC, V55, P275, DOI 10.1016/0016-7037(91)90417-4; EDLINGTON TI, IN PRESS ORG GEOCHEM; EGLINTON TI, 1991, ORGANIC GEOCHEMISTRY, P411; FREEMAN KH, 1990, NATURE, V343, P254, DOI 10.1038/343254a0; GOTH K, 1988, NATURE, V336, P759, DOI 10.1038/336759a0; HARTGERS WA, 1991, ORGANIC GEOCHEMISTRY, P420; HARTGERS WA, 1993, J CHEM SOC CHEM COMM, V23, P1715; HAYES JM, 1987, NATURE, V329, P48, DOI 10.1038/329048a0; KOHNEN MEL, 1992, SCIENCE, V256, P358, DOI 10.1126/science.256.5055.358; KOHNEN MEL, 1991, NATURE, V349, P775, DOI 10.1038/349775a0; Liaaen-Jensen S., 1978, PHOTOSYNTHETIC BACTE, P233; Ostroukhov S. B., 1982, PETROL CHEM-USSR+, V22, P723; OURLSSON G, 1984, SCI AM, V251, P34; PARKES RJ, 1993, MAR GEOL, V113, P55, DOI 10.1016/0025-3227(93)90149-P; QUANDT L, 1977, FEMS MICROBIOL LETT, V1, P125, DOI 10.1016/0378-1097(77)90140-9; REPETA DJ, 1989, NATURE, V342, P69, DOI 10.1038/342069a0; REPETA DJ, 1993, GEOCHIM COSMOCHIM AC, V57, P4337, DOI 10.1016/0016-7037(93)90334-S; REQUEJO AG, 1992, ORG GEOCHEM, V19, P245, DOI 10.1016/0146-6380(92)90041-U; Schaefle J., 1977, TETRAHEDRON LETT, V18, P3673, DOI [DOI 10.1016/S0040-4039(01)83324-4, 10.1016/S0040-4039(01)83324-4]; SCHOELL M, 1994, SCIENCE, V263, P1122, DOI 10.1126/science.263.5150.1122; SCHWARK L, 1990, ORG GEOCHEM, V16, P749, DOI 10.1016/0146-6380(90)90114-F; SIREVAG R, 1977, ARCH MICROBIOL, V112, P35, DOI 10.1007/BF00446651; SUMMONS RE, 1986, NATURE, V319, P763, DOI 10.1038/319763a0; XINKE Y, 1990, ORG GEOCHEM, V15, P433, DOI 10.1016/0146-6380(90)90170-5; [No title captured]	30	70	75	0	7	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 19	1994	369	6477					224	227		10.1038/369224a0	http://dx.doi.org/10.1038/369224a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NM067	11539490				2022-12-01	WOS:A1994NM06700053
J	CANFIELD, DE; DESMARAIS, DJ				CANFIELD, DE; DESMARAIS, DJ			AEROBIC SULFATE REDUCTION IN MICROBIAL MATS	SCIENCE			English	Article							COASTAL MARINE-SEDIMENTS; CYANOBACTERIAL MATS; OXYGEN MICROPROFILE; REDUCING BACTERIA; ORGANIC-MATTER; SULFUR; PHOTOSYNTHESIS; SULFIDE	Measurements of bacterial sulfate reduction and dissolved oxygen (O2) in hypersaline bacterial mats from Baja California, Mexico, revealed that sulfate reduction occurred consistently within the well-oxygenated photosynthetic zone of the mats. This evidence that dissimilatory sulfate reduction can occur in the presence of O2 challenges the conventional view that sulfate reduction is a strictly anaerobic process. At constant temperature, the rates of sulfate reduction in oxygenated mats during daytime were similar to rates in anoxic mats at night: thus, during a 24-hour cycle, variations in light and O2 have little effect on rates of sulfate reduction in these mats.			CANFIELD, DE (corresponding author), NASA,AMES RES CTR,DIV SPACE SCI,MAIL STOP 239-4,MOFFETT FIELD,CA 94035, USA.		Canfield, Don/C-1735-2012	Canfield, Don/0000-0001-7602-8366				BERNER RA, 1980, EARLY DIAGENESIS; CANFIELD DE, 1989, DEEP-SEA RES, V36, P121, DOI 10.1016/0198-0149(89)90022-8; CANFIELD DE, 1986, CHEM GEOL, V54, P149, DOI 10.1016/0009-2541(86)90078-1; CANFIELD DE, UNPUB; Cohen Y., 1984, EOS, V65, P905; CRILL PM, 1987, GEOCHIM COSMOCHIM AC, V51, P1175, DOI 10.1016/0016-7037(87)90210-9; CYPIONKA H, 1985, FEMS MICROBIOL ECOL, V31, P39, DOI 10.1016/0378-1097(85)90045-X; Dijk C. v., 1983, FEBS LETT, V156, P340; DILLING W, 1990, FEMS MICROBIOL LETT, V71, P123; FROELICH PN, 1979, GEOCHIM COSMOCHIM AC, V43, P1075, DOI 10.1016/0016-7037(79)90095-4; HARDY JA, 1981, CURR MICROBIOL, V6, P259, DOI 10.1007/BF01566873; HARGRAVE B, COMMUNICATION; HASTINGS D, 1988, LIMNOL OCEANOGR, V33, P391, DOI 10.4319/lo.1988.33.3.0391; JORGENSEN BB, 1977, MAR BIOL, V41, P7, DOI 10.1007/BF00390576; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; JORGENSEN BB, 1987, APPL ENVIRON MICROB, V53, P879, DOI 10.1128/AEM.53.4.879-886.1987; JORGENSEN BB, 1986, FEMS MICROBIOL ECOL, V38, P179, DOI 10.1016/0378-1097(86)90049-2; JORGENSEN BB, 1978, GEOMICROBIOL J, V1, P11; JORGENSEN BB, 1989, OPHELIA, V31, P29, DOI 10.1080/00785326.1989.10430849; JORGENSEN BB, 1977, LIMNOL OCEANOGR, V22, P814; JORGENSEN BB, 1988, LIMNOL OCEANOGR, V33, P99, DOI 10.4319/lo.1988.33.1.0099; KAPLAN IR, 1964, J GEN MICROBIOL, V34, P195, DOI 10.1099/00221287-34-2-195; Lovely D.R., 1987, APPL ENVIRON MICROB, V53, P2636; MARAIS DJD, 1990, TRENDS ECOL EVOL, V5, P140, DOI 10.1016/0169-5347(90)90219-4; MARAIS DJD, 1989, MICROBIAL MATS PHYSL, pCH17; OREMLAND RS, 1988, ADV MICROB ECOL, V10, P285; Peck H. D. Jr., 1988, The Nitrogen and Sulphur Cycles. Proceedings of the 42nd Symposium of the Society for General Microbiology. Southampton, UK, January 1988., P99; Postgate J.R, 1979, SULPHATE REDUCING BA; REVSBECH NP, 1981, LIMNOL OCEANOGR, V26, P717, DOI 10.4319/lo.1981.26.4.0717; REVSBECH NP, 1983, LIMNOL OCEANOGR, V28, P749, DOI 10.4319/lo.1983.28.4.0749; REVSBECH NP, 1983, LIMNOL OCEANOGR, V28, P1062, DOI 10.4319/lo.1983.28.6.1062; REVSBECH NP, 1980, LIMNOL OCEANOGR, V25, P403, DOI 10.4319/lo.1980.25.3.0403; REVSBECH NP, 1989, MICROBIAL MATS PHYSL, pCH13; SKYRING GW, 1983, AUST J MAR FRESH RES, V34, P359; THODEANDERSEN S, 1989, LIMNOL OCEANOGR, V34, P793, DOI 10.4319/lo.1989.34.5.0793; Zhabina N.N., 1978, ENV BIOGEOCHEMISTRY, P735	36	310	315	5	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 22	1991	251	5000					1471	1473		10.1126/science.11538266	http://dx.doi.org/10.1126/science.11538266			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC853	11538266				2022-12-01	WOS:A1991FC85300043
J	MELOSH, HJ; VICKERY, AM				MELOSH, HJ; VICKERY, AM			IMPACT EROSION OF THE PRIMORDIAL ATMOSPHERE OF MARS	NATURE			English	Article											MELOSH, HJ (corresponding author), UNIV ARIZONA,LUNAR & PLANETARY LAB,TUCSON,AZ 85721, USA.							Ahrens T.J., 1987, INT J IMPACT ENG, V5, P13; BAKER VR, 1986, J GEOPHYS RES-SOLID, V91, P3561, DOI 10.1029/JB091iB03p03561; CAMERON AGW, 1983, ICARUS, V56, P195, DOI 10.1016/0019-1035(83)90032-5; CESS RD, 1980, ICARUS, V41, P159, DOI 10.1016/0019-1035(80)90169-4; CHAPMAN CR, 1977, ANNU REV EARTH PL SC, V5, P515, DOI 10.1146/annurev.ea.05.050177.002503; HARTMANN WK, 1977, ICARUS, V31, P260, DOI 10.1016/0019-1035(77)90037-9; Melosh H.L, 1989, IMPACT CRATERING GEO; MELOSH HJ, 1988, EOS, V69, P388; NEUKUM G, 1976, SCIENCE, V194, P1381, DOI 10.1126/science.194.4272.1381; Schmidt R. M., 1987, INT J IMPACT ENG, V5, P543, DOI [10.1016/0734-743X(87)90069-8, DOI 10.1016/0734-743X(87)90069-8]; STROM RG, 1984, NASA SP469; WALKER JGC, 1987, ICARUS, V68, P87; WATKINS GH, 1983, THESIS MIT; 1981, BASALTIC VOLCANISM T	14	311	311	0	30	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 6	1989	338	6215					487	489		10.1038/338487a0	http://dx.doi.org/10.1038/338487a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	U0084	11536608				2022-12-01	WOS:A1989U008400048
J	BUTTERFIELD, NJ; KNOLL, AH; SWETT, K				BUTTERFIELD, NJ; KNOLL, AH; SWETT, K			EXCEPTIONAL PRESERVATION OF FOSSILS IN AN UPPER PROTEROZOIC SHALE	NATURE			English	Article									UNIV IOWA,DEPT GEOL,IOWA CITY,IA 52242	University of Iowa	BUTTERFIELD, NJ (corresponding author), HARVARD UNIV,BOT MUSEUM,CAMBRIDGE,MA 02138, USA.			Butterfield, Nicholas/0000-0002-3046-7520				AWRAMIK SM, NATURE, V315, P655; CHRISTIEBLICK N, 1988, GEOLOGY, V16, P100, DOI 10.1130/0091-7613(1988)016<0100:SSIPS>2.3.CO;2; HORODYSKI RJ, 1978, SCIENCE, V199, P682, DOI 10.1126/science.199.4329.682; Jankauskas T.V, 1982, STRATOTYPE RIPHEAN P, P84; KIRSCHVINK JL, 1978, GEOL MAG, V115, P139, DOI 10.1017/S0016756800041200; KNOLL AH, 1985, PHILOS T R SOC B, V311, P111, DOI 10.1098/rstb.1985.0143; KNOLL AH, 1986, NATURE, V321, P832, DOI 10.1038/321832a0; LANIER WP, 1988, J SEDIMENT PETROL, V58, P89; MAGARITZ M, 1986, NATURE, V320, P258, DOI 10.1038/320258a0; RAABEN ME, 1972, T GEOL I AKAD NAUK S, V217, P1; Round F.E., 1981, ECOLOGY ALGAE; SOUTHGATE PN, 1986, GEOLOGY, V14, P683, DOI 10.1130/0091-7613(1986)14<683:DEAMOP>2.0.CO;2; VEIZER J, 1983, GEOCHIM COSMOCHIM AC, V47, P295, DOI 10.1016/0016-7037(83)90142-4; VIDAL G, 1983, GEOL SOC AM MEM, V161, P265; WILSON CB, 1961, GEOL MAG, V98, P89; YIN L, 1984, PALAEONT CATHAYANA, V2, P229	16	71	72	0	18	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	AUG 4	1988	334	6181					424	427		10.1038/334424a0	http://dx.doi.org/10.1038/334424a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P5292	11542151				2022-12-01	WOS:A1988P529200055
J	Larkin, M				Larkin, M			New York physicians respond to the terror, tragedy, and trauma	LANCET			English	Article																			0	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 22	2001	358	9286					940	940		10.1016/S0140-6736(01)06117-7	http://dx.doi.org/10.1016/S0140-6736(01)06117-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474YR	11584817				2022-12-01	WOS:000171135300003
J	Kang, HJ; Sun, LD; Atkins, CM; Soderling, TR; Wilson, MA; Tonegawa, S				Kang, HJ; Sun, LD; Atkins, CM; Soderling, TR; Wilson, MA; Tonegawa, S			An important role of neural activity-dependent CaMKIV signaling in the consolidation of long-term memory	CELL			English	Article							ELEMENT-BINDING PROTEIN; LATE-PHASE; CREB PHOSPHORYLATION; RETROGRADE-AMNESIA; ADENYLYL-CYCLASE; CONTEXTUAL FEAR; DORSAL STRIATUM; KINASE-IV; CALCIUM; TRANSCRIPTION	Calcium/calmodulin-dependent protein kinase IV (CaMKIV) has been implicated in the regulation of CRE-dependent transcription. To investigate the role of this kinase in neuronal plasticity and memory, we generated transgenic mice in which the expression of a dominant-negative form of CaMKIV (dnCaMKIV) is restricted to the postnatal forebrain. In these transgenic mice, activity-induced CREB phosphorylation and c-Fos expression were significantly attenuated. Hippocampal late LTP (L-LTP) was also impaired, whereas basic synaptic function and early LTP (E-LTP) were unaffected. These deficits correlated with impairments in long-term memory, specifically in its consolidation/retention phase but not in the acquisition phase. These results indicate that neural activity-dependent CaMKIV signaling in the neuronal nucleus plays an important role in the consolidation/retention of hippocampus-dependent long-term memory.	MIT, RIKEN MIT Neurosci Res Ctr, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, Ctr Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; Massachusetts Institute of Technology (MIT); Oregon Health & Science University	Tonegawa, S (corresponding author), MIT, RIKEN MIT Neurosci Res Ctr, Dept Biol, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tonegawa@mit.edu		Atkins, Coleen/0000-0003-4718-7493	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027037, R01NS032925] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS27037, R01-NS32925] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Blendy JA, 1996, EMBO J, V15, P1098, DOI 10.1002/j.1460-2075.1996.tb00447.x; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Churchill L, 1998, J NEUROSCI, V18, P8074; CRUZ APM, 1994, PHARMACOL BIOCHEM BE, V49, P171, DOI 10.1016/0091-3057(94)90472-3; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Devan BD, 1999, J NEUROSCI, V19, P2789; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Grewal SS, 2000, J BIOL CHEM, V275, P34433, DOI 10.1074/jbc.M004728200; Gringhuis SI, 1997, J BIOL CHEM, V272, P31809, DOI 10.1074/jbc.272.50.31809; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; JENSEN KF, 1991, P NATL ACAD SCI USA, V88, P2850, DOI 10.1073/pnas.88.7.2850; Kim JJ, 2001, J NEUROSCI, V21, P5222, DOI 10.1523/JNEUROSCI.21-14-05222.2001; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kogan JH, 1997, CURR BIOL, V7, P1, DOI 10.1016/S0960-9822(06)00022-4; MCDONALD RJ, 1994, BEHAV NEURAL BIOL, V61, P260, DOI 10.1016/S0163-1047(05)80009-3; MIYAKAWA T, 2001, IN PRESS J NEUROSCI; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; NAKAMURA Y, 1995, NEUROSCIENCE, V68, P181, DOI 10.1016/0306-4522(95)00092-W; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; PICCIOTTO MR, 1995, SYNAPSE, V20, P75, DOI 10.1002/syn.890200111; Ribar TJ, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-22-j0004.2000; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Sun PQ, 1996, J BIOL CHEM, V271, P3066, DOI 10.1074/jbc.271.6.3066; Tokumitsu H, 1996, J BIOL CHEM, V271, P5617, DOI 10.1074/jbc.271.10.5617; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Wayman GA, 1996, MOL CELL BIOL, V16, P6075; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Wu JY, 2000, NAT GENET, V25, P448, DOI 10.1038/78153; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	52	226	236	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 21	2001	106	6					771	783		10.1016/S0092-8674(01)00497-4	http://dx.doi.org/10.1016/S0092-8674(01)00497-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	476EJ	11572782	Bronze			2022-12-01	WOS:000171213000013
J	Pimm, SL; Ayres, M; Balmford, A; Branch, G; Brandon, K; Brooks, T; Bustamante, R; Costanza, R; Cowling, R; Curran, LM; Dobson, A; Farber, S; da Fonseca, GAB; Gascon, C; Kitching, R; McNeely, J; Lovejoy, T; Mittermeier, RA; Myers, N; Patz, JA; Raffle, B; Rapport, D; Raven, P; Roberts, C; Rodriguez, JP; Rylands, AB; Tucker, C; Safina, C; Samper, C; Stiassny, MLJ; Supriatna, J; Hall, DH; Wilcove, D				Pimm, SL; Ayres, M; Balmford, A; Branch, G; Brandon, K; Brooks, T; Bustamante, R; Costanza, R; Cowling, R; Curran, LM; Dobson, A; Farber, S; da Fonseca, GAB; Gascon, C; Kitching, R; McNeely, J; Lovejoy, T; Mittermeier, RA; Myers, N; Patz, JA; Raffle, B; Rapport, D; Raven, P; Roberts, C; Rodriguez, JP; Rylands, AB; Tucker, C; Safina, C; Samper, C; Stiassny, MLJ; Supriatna, J; Hall, DH; Wilcove, D			Environment - Can we defy nature's end?	SCIENCE			English	Editorial Material							CONSERVATION		Columbia Univ, Ctr Environm Res & Conservat, New York, NY 10027 USA	Columbia University	Pimm, SL (corresponding author), Columbia Univ, Ctr Environm Res & Conservat, MC 5556, New York, NY 10027 USA.	StuartPimm@aol.com	Costanza, Robert/A-4912-2008; Costanza, Robert/AAJ-3546-2021; Rodriguez, Jon P/G-7224-2012; Ayres, Matthew/AAI-6873-2020; Kitching, Roger/C-5102-2009; Rodriguez, Jon P/A-1491-2009; Wall, Diana H/F-5491-2011	Costanza, Robert/0000-0001-6348-8734; Ayres, Matthew/0000-0001-6120-9068; Rodriguez, Jon P/0000-0001-5019-2870; Wilcove, David S./0000-0002-1354-0503; Balmford, Andrew/0000-0002-0144-3589; Brooks, Thomas/0000-0001-8159-3116				Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; DYNESIUS M, 1994, SCIENCE, V266, P753, DOI 10.1126/science.266.5186.753; GRAINGER A, 1988, International Tree Crops Journal, V5, P31; HARDNER JJ, 2000, MITIG ADAPT STRAT GL, V5, P61, DOI DOI 10.1023/A:1009685323704; James A, 2000, NATURE, V404, P120, DOI 10.1038/35004750; Kremen C, 2000, SCIENCE, V288, P1828, DOI 10.1126/science.288.5472.1828; Kress WJ, 2001, SCIENCE, V291, P828; LUDWIG D, 1993, SCIENCE, V260, P17, DOI 10.1126/science.260.5104.17; MICKLIN PP, 1988, SCIENCE, V241, P1170, DOI 10.1126/science.241.4870.1170; Milazzo M, 1998, WTP406; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N, 1998, NATURE, V392, P327, DOI 10.1038/32761; Myers N, 2001, PERVERSE SUBSIDIES T; MYERS N, 1992, PRIMARY SOURCE TROPI; National Research Council, 1980, RES PRIOR TROP BIOL; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; Patz JA, 2000, ANNU REV PUBL HEALTH, V21, P271, DOI 10.1146/annurev.publhealth.21.1.271; Pimm S. L., 2001, WORLD ACCORDING PIMM; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pimm SL, 1998, SCIENCE, V279, P2068, DOI 10.1126/science.279.5359.2068; Rapport DJ, 1998, TRENDS ECOL EVOL, V13, P397, DOI 10.1016/S0169-5347(98)01449-9; Resiner Marc., 1993, CADILLAC DESERT AM W; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; SIZER N, 2001, INCREASED INVESTMENT; Smith AT, 2000, SCIENCE, V290, P2073; Stein B.A., 2000, PRECIOUS HERITAGE ST, DOI 10.1046/j.1526-100x.2001.94017.x; Sugden A, 2000, SCIENCE, V289, P2305; *UN ENV PROGR, 2000, STAT DES IMPL UN PLA; *UN FAO, 2000, STAT WORLD FISH AQ 2; Wilson EO, 2000, SCIENCE, V289, P2279	31	177	186	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2001	293	5538					2207	2208		10.1126/science.1061626	http://dx.doi.org/10.1126/science.1061626			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11567124				2022-12-01	WOS:000171139400024
J	Giles, J				Giles, J			Mad cow disease comes to Japan	NATURE			English	News Item																			0	9	10	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					240	240		10.1038/35095180	http://dx.doi.org/10.1038/35095180			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11564996	Bronze			2022-12-01	WOS:000171040500005
J	Scott, SH; Gribble, PL; Graham, KM; Cabel, DW				Scott, SH; Gribble, PL; Graham, KM; Cabel, DW			Dissociation between hand motion and population vectors from neural activity in motor cortex	NATURE			English	Article							ARM MOVEMENTS; REACHING MOVEMENTS; CORTICAL CONTROL; DIRECTION; REPRESENTATION; SHOULDER; MUSCLE; PATHS; SPACE	The population vector hypothesis was introduced almost twenty years ago to illustrate that a population vector constructed from neural activity in primary motor cortex (MI) of non-human primates could predict the direction of hand movement during reaching(1-6). Alternative explanations for this population signal have been suggested(7,8) but could not be tested experimentally owing to movement complexity in the standard reaching model. We re-examined this issue by recording the activity of neurons in contralateral MI of monkeys while they made reaching movements with their right arms oriented in the horizontal plane-where the mechanics of limb motion are measurable and anisotropic. Here we found systematic biases between the population vector and the direction of hand movement. These errors were attributed to a non-uniform distribution of preferred directions of neurons and the non-uniformity covaried with peak joint power at the shoulder and elbow. These observations contradict the population vector hypothesis and show that non-human primates are capable of generating reaching movements to spatial targets even though population vectors based on MI activity do not point in the direction of hand motion.	Queens Univ, CIHR Grp Sensory Motor Syst, Ctr Neurosci Studies, Dept Anat & Cell Biol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Scott, SH (corresponding author), Queens Univ, CIHR Grp Sensory Motor Syst, Ctr Neurosci Studies, Dept Anat & Cell Biol, Kingston, ON K7L 3N6, Canada.	steve@biomed.queensu.ca		Gribble, Paul/0000-0002-1368-032X				BATSCHELET E, 1981, MATH BIOL CIRCULAR S; CAMINITI R, 1990, J NEUROSCI, V10, P2039; Cheng EJ, 2000, J MORPHOL, V245, P206, DOI 10.1002/1097-4687(200009)245:3<206::AID-JMOR3>3.3.CO;2-L; GABEL DW, IN PRESS J NEUROPHYS; GEORGOPOULOS AP, 1988, J NEUROSCI, V8, P2928; GEORGOPOULOS AP, 1995, TRENDS NEUROSCI, V18, P506, DOI 10.1016/0166-2236(95)92775-L; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GEORGOPOULOS AP, 1983, EXP BRAIN RES, V49, P327; Gomi H, 1996, SCIENCE, V272, P117, DOI 10.1126/science.272.5258.117; GORDON J, 1994, EXP BRAIN RES, V99, P112, DOI 10.1007/BF00241416; HOLLERBACH JM, 1982, BIOL CYBERN, V44, P67, DOI 10.1007/BF00353957; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; KALASKA JF, 1989, J NEUROSCI, V9, P2080; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; KARST GM, 1991, J NEUROPHYSIOL, V66, P1594, DOI 10.1152/jn.1991.66.5.1594; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; MUSSAIVALDI FA, 1988, NEUROSCI LETT, V91, P106, DOI 10.1016/0304-3940(88)90257-1; MUSSAIVALDI FA, 1985, J NEUROSCI, V5, P2732; Sainburg RL, 1999, J NEUROPHYSIOL, V81, P1045, DOI 10.1152/jn.1999.81.3.1045; SANGER TD, 1994, NEURAL COMPUT, V6, P29, DOI 10.1162/neco.1994.6.1.29; Sanger TD, 1996, J NEUROPHYSIOL, V76, P2790, DOI 10.1152/jn.1996.76.4.2790; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; Scott SH, 1996, J MUSCLE RES CELL M, V17, P207, DOI 10.1007/BF00124243; Scott SH, 1997, J NEUROPHYSIOL, V77, P826, DOI 10.1152/jn.1997.77.2.826; SCOTT SH, 1995, J NEUROPHYSIOL, V73, P2563, DOI 10.1152/jn.1995.73.6.2563; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shen LM, 1997, J NEUROPHYSIOL, V77, P1195, DOI 10.1152/jn.1997.77.3.1195; Todorov E, 2000, NAT NEUROSCI, V3, P391, DOI 10.1038/73964; WINTER DA, 1984, CRIT REV BIOMED ENG, V9, P287; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017	30	121	122	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2001	413	6852					161	165		10.1038/35093102	http://dx.doi.org/10.1038/35093102			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557980				2022-12-01	WOS:000170918800046
J	Lykke-Andersen, J; Shu, MD; Steitz, JA				Lykke-Andersen, J; Shu, MD; Steitz, JA			Communication of the position of exon-exon junctions to the mRNA surveillance machinery by the protein RNPS1	SCIENCE			English	Article							NONSENSE-MEDIATED DECAY; CAENORHABDITIS-ELEGANS; UPF PROTEINS; TRANSLATION; TERMINATION; INTERACTS; NUCLEUS; MESSAGE; COMPLEX; EXPORT	In mammalian cells, splice junctions play a dual rote in mRNA quality control: They mediate selective nuclear export of mature mRNA and they serve as a mark for mRNA surveillance, which subjects aberrant mRNAs with premature termination codons to nonsense-mediated decay (NMD). Here, we demonstrate that the protein RNPS1, a component of the postsplicing complex that is deposited 5' to exon-exon junctions, interacts with the evolutionarily conserved human Upf complex, a central component of NMD. Significantly, RNPS1 triggers NMD when tethered to the 3' untranslated region of beta -globin mRNA, demonstrating its role as a subunit of the postsplicing complex directly involved in mRNA surveillance.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06536 USA	Howard Hughes Medical Institute; Yale University	Steitz, JA (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 295 Congress Ave, New Haven, CT 06536 USA.	joan.steitz@yale.edu		Lykke-Andersen, Jens/0000-0003-1821-0754	NATIONAL CANCER INSTITUTE [P01CA016038] Funding Source: NIH RePORTER; NCI NIH HHS [CA 16038] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Blencowe BJ, 1998, GENE DEV, V12, P996, DOI 10.1101/gad.12.7.996; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; Czaplinski K, 1999, BIOESSAYS, V21, P685, DOI 10.1002/(SICI)1521-1878(199908)21:8<685::AID-BIES8>3.0.CO;2-4; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Gonzalez CI, 2000, MOL CELL, V5, P489, DOI 10.1016/S1097-2765(00)80443-8; He F, 1997, MOL CELL BIOL, V17, P1580, DOI 10.1128/MCB.17.3.1580; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Hilleren P, 1999, ANNU REV GENET, V33, P229, DOI 10.1146/annurev.genet.33.1.229; Jacobson A, 2000, COLD SPRING HARBOR M, V39, P827; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; Kim VN, 2001, EMBO J, V20, P2062, DOI 10.1093/emboj/20.8.2062; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Li SL, 1998, IMMUNITY, V8, P135, DOI 10.1016/S1074-7613(00)80466-5; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; Lykke-Andersen J, 2001, CURR BIOL, V11, pR88, DOI 10.1016/S0960-9822(01)00036-7; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; LYKKEANDERSEN J, UNPUB; Maquat LE, 2000, COLD SPRING HARBOR M, V39, P849; Mayeda A, 1999, EMBO J, V18, P4560, DOI 10.1093/emboj/18.16.4560; McGarvey T, 2000, J CELL BIOL, V150, P309, DOI 10.1083/jcb.150.2.309; Mendell JT, 2000, MOL CELL BIOL, V20, P8944, DOI 10.1128/MCB.20.23.8944-8957.2000; Page MF, 1999, MOL CELL BIOL, V19, P5943; Pal M, 2001, RNA, V7, P5, DOI 10.1017/S1355838201000127; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; Serin G, 2001, MOL CELL BIOL, V21, P209, DOI 10.1128/MCB.21.1.209-223.2001; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Sun XL, 1998, P NATL ACAD SCI USA, V95, P10009, DOI 10.1073/pnas.95.17.10009; Wang WR, 2001, EMBO J, V20, P880, DOI 10.1093/emboj/20.4.880; Zhang J, 1998, RNA, V4, P801, DOI 10.1017/S1355838298971849; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	32	301	314	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1836	1839		10.1126/science.1062786	http://dx.doi.org/10.1126/science.1062786			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546874				2022-12-01	WOS:000170894400049
J	Shimojo, S; Kamitani, Y; Nishida, S				Shimojo, S; Kamitani, Y; Nishida, S			Afterimage of perceptually filled-in surface	SCIENCE			English	Article							SUBJECTIVE CONTOURS; FILLING-IN; ILLUSION; DEPTH	An afterimage induced by prior adaptation to a visual stimulus is believed to be due to bleaching of photochemical pigments or neural adaptation in the retina. We report a type of afterimage that appears to require cortical adaptation. Fixating a neon-color spreading configuration led not only to negative afterimages corresponding to the inducers (local afterimages), but also to one corresponding to the perceptually fitted-in surface during adaptation (global afterimage). These afterimages were mutually exclusive, undergoing monocular rivalry. The strength of the global afterimage correlated to a greater extent with perceptual filling-in during adaptation than with the strength of the local afterimages. Thus, global afterimages are not merely by-products of local afterimages, but involve adaptation at a cortical representation of surface.	CALTECH, Div Biol Computat & Neural Syst, Pasadena, CA 91125 USA; NTT Corp, NTT Commun Sci Labs, Human & Informat Sci Lab, Kanagawa 2430198, Japan	California Institute of Technology; Nippon Telegraph & Telephone Corporation	Shimojo, S (corresponding author), CALTECH, Div Biol Computat & Neural Syst, Pasadena, CA 91125 USA.							ANSTIS S, 1978, VISION RES, V18, P899, DOI 10.1016/0042-6989(78)90016-0; ATKINSON J, 1972, J EXP PSYCHOL, V98, P55; ATKINSON J, 1973, PERCEPT PSYCHOPHYS, V12, P257; BRINDLEY GS, 1962, J PHYSIOL-LONDON, V164, P168, DOI 10.1113/jphysiol.1962.sp007011; Craik KJW, 1940, NATURE, V145, P512, DOI 10.1038/145512a0; CRASSINI B, 1982, VISION RES, V22, P203, DOI 10.1016/0042-6989(82)90184-5; DAVIES P, 1973, BRIT J PSYCHOL, V64, P325, DOI 10.1111/j.2044-8295.1973.tb01358.x; De Weerd P, 1998, VISION RES, V38, P2721, DOI 10.1016/S0042-6989(97)00432-X; Gilbert CD, 1996, P NATL ACAD SCI USA, V93, P615, DOI 10.1073/pnas.93.2.615; HAYHOE MM, 1984, PERCEPTION, V13, P455, DOI 10.1068/p130455; KELLY DH, 1993, J OPT SOC AM A, V10, P29, DOI 10.1364/JOSAA.10.000029; LAMME VAF, 1995, J NEUROSCI, V15, P1605; LOOMIS JM, 1978, J OPT SOC AM, V68, P411, DOI 10.1364/JOSA.68.000411; LOOMIS JM, 1972, VISION RES, V12, P1587, DOI 10.1016/0042-6989(72)90031-4; MEYER GE, 1987, J EXP PSYCHOL HUMAN, V13, P353; MOTHER G, 1998, MOTION AFTEREFFECT; NAKAYAMA K, 1992, SCIENCE, V257, P1357, DOI 10.1126/science.1529336; NAKAYAMA K, 1990, PERCEPTION, V19, P497, DOI 10.1068/p190497; NAKAYAMA K, 1998, VIS COGN, V2, P1; Pessoa L, 1998, BEHAV BRAIN SCI, V21, P723; Pessoa L, 1998, TRENDS COGN SCI, V2, P422, DOI 10.1016/S1364-6613(98)01237-6; RAMACHANDRAN VS, 1991, NATURE, V350, P699, DOI 10.1038/350699a0; REDIES C, 1981, PERCEPTION, V10, P667, DOI 10.1068/p100667; REDIES C, 1984, VISION RES, V24, P1301, DOI 10.1016/0042-6989(84)90185-8; SHIRNOJO S, 1999, NEUR ABSTR, P1053; SHIVELY F, 1973, PERCEPT PSYCHOPHYS, V13, P525, DOI 10.3758/BF03205814; SINDERMANN F, 1972, VISION RES, V12, P763, DOI 10.1016/0042-6989(72)90002-8; TAKEICHI H, 1992, PERCEPTION, V21, P313, DOI 10.1068/p210313; VANTUIJL HFJM, 1975, ACTA PSYCHOL, V39, P441, DOI 10.1016/0001-6918(75)90042-6; Varin D., 1971, RIV PSICOL, V65, P101; VIRSU V, 1977, VISION RES, V17, P853, DOI 10.1016/0042-6989(77)90129-8; VIRSU V, 1962, MED BIOL, V56, P84; WARE C, 1980, PERCEPTION, V9, P103, DOI 10.1068/p090103	33	93	94	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1677	1680		10.1126/science.1060161	http://dx.doi.org/10.1126/science.1060161			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	469FA	11533495				2022-12-01	WOS:000170802900068
J	Jeruzalmi, D; Yurieva, O; Zhao, YX; Young, M; Stewart, J; Hingorani, M; O'Donnell, M; Kuriyan, J				Jeruzalmi, D; Yurieva, O; Zhao, YX; Young, M; Stewart, J; Hingorani, M; O'Donnell, M; Kuriyan, J			Mechanism of processivity clamp opening by the delta subunit wrench of the clamp loader complex of E-coli DNA polymerase III	CELL			English	Article							CELL NUCLEAR ANTIGEN; C-TERMINAL REGION; CRYSTAL-STRUCTURE; SLIDING CLAMP; ACCESSORY PROTEINS; BETA-CLAMP; HOLOENZYME; PEPTIDE; BINDING; DOMAIN	The dimeric ring-shaped sliding clamp of E. coli DNA polymerase III (beta subunit, homolog of eukaryotic PCNA) is loaded onto DNA by the clamp loader gamma complex (homolog of eukaryotic Replication Factor C, RFC). The delta subunit of the gamma complex binds to the beta ring and opens it. The crystal structure of a beta:delta complex shows that delta, which is structurally related to the delta' and gamma subunits of the gamma complex, is a molecular wrench that induces or traps a conformational change in beta such that one of its dimer interfaces is destabilized. Structural comparisons and molecular dynamics simulations suggest a spring-loaded mechanism in which the beta ring opens spontaneously once a dimer interface is perturbed by the delta wrench.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Kuriyan, J (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	kuriyan@rockefeller.edu	Young, Matthew/D-2033-2011; Young, Matthew/AAE-2632-2020	Young, Matthew/0000-0003-2921-3432; Young, Matthew/0000-0003-2921-3432; O'Donnell, Michael/0000-0001-9002-4214; Zhao, Yanxiang/0000-0002-9408-9979	NIGMS NIH HHS [R01 GM-45547, R01 GM-38839] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038839, R01GM045547] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alley SC, 2000, BIOCHEMISTRY-US, V39, P3076, DOI 10.1021/bi992377r; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; CULLMANN G, 1995, MOL CELL BIOL, V15, P4661; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DONG ZM, 1993, J BIOL CHEM, V268, P11758; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FLORESROZAS H, 1994, P NATL ACAD SCI USA, V91, P8655, DOI 10.1073/pnas.91.18.8655; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Hingorani MM, 2000, CURR BIOL, V10, pR25, DOI 10.1016/S0960-9822(99)00252-3; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; HUANG CC, 1981, J BIOL CHEM, V256, P4087; JORGENSEN WL, 1981, J AM CHEM SOC, V103, P335, DOI 10.1021/ja00392a016; Kelman Z, 2000, J BIOL CHEM, V275, P7327, DOI 10.1074/jbc.275.10.7327; KELMAN Z, 1995, ANNU REV BIOCHEM, V64, P171, DOI 10.1146/annurev.bi.64.070195.001131; Kleywegt GJ, 1997, STRUCTURE, V5, P1557, DOI 10.1016/S0969-2126(97)00305-5; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Kornberg A., 1991, DNA REPLICATION; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Leu FP, 2000, J BIOL CHEM, V275, P34609, DOI 10.1074/jbc.M005495200; Matsumiya S, 2001, PROTEIN SCI, V10, P17, DOI 10.1110/ps.36401; May AP, 2001, J BIOL CHEM, V276, P21991, DOI 10.1074/jbc.R100013200; MIRANKER A, 1991, NATURE, V349, P633, DOI 10.1038/349633a0; Moarefi I, 2000, J MOL BIOL, V296, P1215, DOI 10.1006/jmbi.1999.3511; NAKANISHI M, 1995, J BIOL CHEM, V270, P17060, DOI 10.1074/jbc.270.29.17060; NAKTINIS V, 1995, J BIOL CHEM, V270, P13358, DOI 10.1074/jbc.270.22.13358; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Neuwald AF, 1999, GENOME RES, V9, P27; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; ODONNELL M, 1993, NUCLEIC ACIDS RES, V21, P1, DOI 10.1093/nar/21.1.1; ONRUST R, 1991, J BIOL CHEM, V266, P21681; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEARLMAN DA, 1995, AMBER 4 1; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Stewart J, 2001, J BIOL CHEM, V276, P19182, DOI 10.1074/jbc.M100592200; STILLMAN B, 1994, CELL, V78, P725, DOI 10.1016/S0092-8674(94)90362-X; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; WARBRICK E, 1995, CURR BIOL, V5, P275, DOI 10.1016/S0960-9822(95)00058-3; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x; YOUNG MC, 1992, BIOCHEMISTRY-US, V31, P8675, DOI 10.1021/bi00152a001; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843	49	203	211	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2001	106	4					417	428		10.1016/S0092-8674(01)00462-7	http://dx.doi.org/10.1016/S0092-8674(01)00462-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525728	Bronze			2022-12-01	WOS:000170665200006
J	SUMMERS, DP; CHANG, S				SUMMERS, DP; CHANG, S			PREBIOTIC AMMONIA FROM REDUCTION OF NITRITE BY IRON(II) ON THE EARLY EARTH	NATURE			English	Article							AQUEOUS-SOLUTION; CARBON-DIOXIDE; ATMOSPHERE; EVOLUTION; NITROGEN; FIXATION; SEAWATER; IMPACTS; OXYGEN; SULFUR	THEORIES for the origin of life require the availability of reduced (or 'fixed') nitrogen-containing compounds, in particular ammonia. In reducing atmospheres, such compounds are readily formed by electrical discharges1-2, but geochemical evidence suggests that the early Earth had a non-reducing atmosphere1,3-6, in which discharges would have instead produced NO (refs 7-10). This would have been converted into nitric and nitrous acids and delivered to the early oceans as acid rain11. It is known12-15, however, that Fe(II) was present in the early oceans at much higher concentrations than are found today, and thus the oxidation of Fe(II) to Fe(III) provides a possible means for reducing nitrites and nitrates to ammonia. Here we explore this possibility in a series of experiments which mimic a broad range of prebiotic seawater conditions (the actual conditions on the early Earth remain poorly constrained). We find that the reduction by Fe(II) of nitrites and nitrates to ammonia could have been a significant source of reduced nitrogen on the early Earth, provided that the ocean pH exceeded 7.3 and is favoured for temperatures greater than about 25-degrees-C.			SUMMERS, DP (corresponding author), NASA,AMES RES CTR,MOFFETT FIELD,CA 94035, USA.							BADA JL, 1968, SCIENCE, V159, P423, DOI 10.1126/science.159.3813.423; Broecker W.S., 1982, TRACERS SEA, P243; BURESH RJ, 1976, J ENVIRON QUAL, V5, P320, DOI 10.2134/jeq1976.00472425000500030021x; Butler J.N., 1982, CARBON DIOXIDE EQUIL, P87, DOI [10.1016/0146-6380(83)90006-2, DOI 10.1016/0146-6380(83)90006-2]; CHAMEIDES WL, 1981, ORIGINS LIFE EVOL B, V11, P291, DOI 10.1007/BF00931483; CHYBA C, 1991, ORIGINS LIFE EVOL B, V21, P3, DOI 10.1007/BF01809509; DERRY LA, 1990, GEOCHIM COSMOCHIM AC, V54, P2965, DOI 10.1016/0016-7037(90)90114-Z; DOYLE MP, 1984, J AM CHEM SOC, V106, P3678, DOI 10.1021/ja00324a049; FEGLEY B, 1986, NATURE, V319, P305, DOI 10.1038/319305a0; Freier R.K., 1976, AQUEOUS SOLUTIONS; GRATZEL M, 1970, BERICH BUNSEN GESELL, V74, P1003; GREGOR CB, 1988, CHEM CYCLES EVOLUTIO, P42; HOLLAND HD, 1973, ECON GEOL, V68, P1169, DOI 10.2113/gsecongeo.68.7.1169; HOLLAND HD, CHEM EVOLUTION ATMOS, P205; HOLLAND HD, 1989, CHEM EVOLUTION ATMOS, pCH4; KASTING JF, 1990, ORIGINS LIFE EVOL B, V20, P199, DOI 10.1007/BF01808105; KASTING JF, 1987, PRECAMBRIAN RES, V34, P205, DOI 10.1016/0301-9268(87)90001-5; KASTING JF, 1982, J GEOPHYS RES-OCEANS, V87, P3091, DOI 10.1029/JC087iC04p03091; KASTING JF, 1989, ORIGINS LIFE EVOL B, V19, P95, DOI 10.1007/BF01808144; KUHN WR, 1983, NATURE, V301, P53, DOI 10.1038/301053a0; MANCINELLI RL, 1988, ORIGINS LIFE EVOL B, V18, P311, DOI 10.1007/BF01808213; MATTIOLI GS, 1986, NATURE, V322, P626, DOI 10.1038/322626a0; SCHOPF JW, 1983, EARTHS EARLIEST BIOS, P53; STRIBLING R, 1987, ORIGINS LIFE EVOL B, V17, P261, DOI 10.1007/BF02386466; TURCOTTE DL, 1980, EARTH PLANET SC LETT, V48, P50; WALKER JCG, 1985, PRECAMBRIAN RES, V28, P205, DOI 10.1016/0301-9268(85)90031-2; WALKER JCG, 1985, ORIGINS LIFE EVOL B, V16, P117, DOI 10.1007/BF01809466; WALKER JCG, 1983, EARTHS EARLIEST BIOS, P260; YUNG YL, 1979, SCIENCE, V203, P1002, DOI 10.1126/science.203.4384.1002; ZAFIRIOU OC, 1979, MAR CHEM, V8, P9, DOI 10.1016/0304-4203(79)90029-X; [No title captured]	31	128	130	1	62	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 14	1993	365	6447					630	632		10.1038/365630a0	http://dx.doi.org/10.1038/365630a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB846	11540245				2022-12-01	WOS:A1993MB84600053
J	SCHMUTTENMAER, CA; COHEN, RC; PUGLIANO, N; HEATH, JR; COOKSY, AL; BUSAROW, KL; SAYKALLY, RJ				SCHMUTTENMAER, CA; COHEN, RC; PUGLIANO, N; HEATH, JR; COOKSY, AL; BUSAROW, KL; SAYKALLY, RJ			TUNABLE FAR-IR LASER SPECTROSCOPY OF JET-COOLED CARBON CLUSTERS - THE NU-2 BENDING VIBRATION OF C-3	SCIENCE			English	Article									UNIV CALIF BERKELEY,DIV CHEM SCI,BERKELEY,CA 94720; UNIV CALIF BERKELEY LAWRENCE BERKELEY LAB,BERKELEY,CA 94720	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	SCHMUTTENMAER, CA (corresponding author), UNIV CALIF BERKELEY,DEPT CHEM,BERKELEY,CA 94720, USA.		Cohen, Ronald C/A-8842-2011	Cohen, Ronald C/0000-0001-6617-7691; Cooksy, Andrew/0000-0002-2794-4269; SAYKALLY, RICHARD/0000-0001-8942-3656				BERNATH PF, 1989, SCIENCE, V244, P562, DOI 10.1126/science.244.4904.562; COHEN RC, 1989, CHEM PHYS LETT, V164, P321, DOI 10.1016/0009-2614(89)85212-1; CURL RF, 1988, SCIENCE, V242, P1017, DOI 10.1126/science.242.4881.1017; GAUSSET L, 1965, ASTROPHYS J, V142, P45, DOI 10.1086/148262; Herzberg G, 1942, ASTROPHYS J, V96, P314, DOI 10.1086/144464; KAUR D, 1990, APPL OPTICS, V29, P119, DOI 10.1364/AO.29.000119; KAWAGUCHI K, 1989, J CHEM PHYS, V91, P1953, DOI 10.1063/1.457054; KROTO H, 1988, SCIENCE, V242, P1139, DOI 10.1126/science.242.4882.1139; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; MATSUMURA K, 1988, J CHEM PHYS, V89, P3491, DOI 10.1063/1.454919; RAGHAVACHARI K, 1987, J CHEM PHYS, V87, P2191, DOI 10.1063/1.453145; RHEATH JR, 1989, SCIENCE, V244, P564; ROHLFING EA, 1988, J CHEM PHYS, V89, P6103, DOI 10.1063/1.455426; WELTNER W, 1989, CHEM REV, V89, P1713, DOI 10.1021/cr00098a005; ZMUIDZINAS J, 1988, ASTROPHYS J, V335, P774, DOI 10.1086/166966	15	102	102	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 24	1990	249	4971					897	900		10.1126/science.11538082	http://dx.doi.org/10.1126/science.11538082			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV751	11538082				2022-12-01	WOS:A1990DV75100038
J	Girardi, M; Oppenheim, DE; Steele, CR; Lewis, JM; Glusac, E; Filler, R; Hobby, P; Sutton, B; Tigelaar, RE; Hayday, AC				Girardi, M; Oppenheim, DE; Steele, CR; Lewis, JM; Glusac, E; Filler, R; Hobby, P; Sutton, B; Tigelaar, RE; Hayday, AC			Regulation of cutaneous malignancy by gamma delta T cells	SCIENCE			English	Article							EPIDERMAL-CELLS; NATURAL-KILLER; EXPRESSION; RECEPTOR; ANTIGEN; LIGAND; FAMILY; GENES; NKG2D; MICE	The localization of gamma delta T cells within epithelia suggests that these cells may contribute to the down-regulation of epithelial malignancies. We report that mice lacking gamma delta cells are highly susceptible to multiple regimens of cutaneous carcinogenesis. After exposure to carcinogens, skin cells expressed Rae-1 and H60, major histocompatibility complex-related molecules structurally resembling human MICA. Each of these is a ligand for NKG2d, a receptor expressed by cytolytic T cells and natural killer(NK) cells. In vitro, skin-associated NKG2d(+) gamma delta cells killed skin carcinoma cells by a mechanism that was sensitive to blocking NKG2d engagement. Thus, local T cells may use evolutionarily conserved proteins to negatively regulate malignancy.	Guys Kings St Thomas Med Sch, Peter Gorer Dept Immunobiol, London SE1 9RT, England; Guys Kings St Thomas Med Sch, Dept Dermatol, London SE1 9RT, England; Guys Kings St Thomas Med Sch, Yale Skin Dis Res Core Ctr, London SE1 9RT, England; Kings Coll London, Guys Hosp, Randall Ctr Mol Med, London SE1 9RT, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Hayday, AC (corresponding author), Guys Kings St Thomas Med Sch, Peter Gorer Dept Immunobiol, London SE1 9RT, England.	adrian.hayday@kcl.ac.uk		Girardi, Michael/0000-0003-1887-9343; HAYDAY, ADRIAN/0000-0002-9495-5793	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027855] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 27855] Funding Source: Medline; PHS HHS [KO8] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ASARNOW DM, 1988, CELL, V55, P837, DOI 10.1016/0092-8674(88)90139-0; Brown MH, 1998, J EXP MED, V188, P2083, DOI 10.1084/jem.188.11.2083; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Coligan JKA, 1991, CURRENT PROTOCOLS IM; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(09)00098-3; Coussens LM, 2001, J EXP MED, V193, pF23, DOI 10.1084/jem.193.6.F23; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; FUSENIG NE, 1978, B CANCER, V65, P271; Girardi M., UNPUB; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Ho EL, 1998, P NATL ACAD SCI USA, V95, P6320, DOI 10.1073/pnas.95.11.6320; Holtmeier V, 2001, J INVEST DERMATOL, V116, P275, DOI 10.1046/j.1523-1747.2001.01250.x; JANEWAY CA, 1988, IMMUNOL TODAY, V9, P73, DOI 10.1016/0167-5699(88)91267-4; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Lewis J M, UNPUB; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; Malarkannan S, 1998, J IMMUNOL, V161, P3501; MARSHALL V, 1974, TRANSPLANTATION, V17, P272, DOI 10.1097/00007890-197403000-00006; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; MOMBAERTS P, 1993, NATURE, V365, P53, DOI 10.1038/365053a0; Nomura M, 1996, J BIOCHEM-TOKYO, V120, P987; Owens DM, 1999, CARCINOGENESIS, V20, P1837, DOI 10.1093/carcin/20.9.1837; Sanchez LM, 1999, SCIENCE, V283, P1914, DOI 10.1126/science.283.5409.1914; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Wolan DW, 2001, NAT IMMUNOL, V2, P248, DOI 10.1038/85311	27	746	774	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					605	609		10.1126/science.1063916	http://dx.doi.org/10.1126/science.1063916			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11567106				2022-12-01	WOS:000171695600050
J	Heppner, FL; Musahl, C; Arrighi, I; Klein, MA; Rulicke, T; Oesch, B; Zinkernagel, RM; Kalinke, U; Aguzzi, A				Heppner, FL; Musahl, C; Arrighi, I; Klein, MA; Rulicke, T; Oesch, B; Zinkernagel, RM; Kalinke, U; Aguzzi, A			Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies	SCIENCE			English	Article							FOLLICULAR DENDRITIC CELLS; PRP KNOCKOUT MICE; B-CELLS; VARIANT CJD; PURIFICATION; LYMPHOCYTES; REPLICATION; RESISTANT; LACKING; AGENT	Variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy are initiated by extracerebral exposure to prions. Although prion transmission from extracerebral sites to the brain represents a potential target for prophylaxis, attempts at vaccination have been limited by the poor immunogenicity of prion proteins. To circumvent this, we expressed an anti-prion protein (anti-PrP) mu chain in Prnp(o/o) mice. Transgenic mice developed sustained anti-PrP titers, which were not suppressed by introduction of Prnp(+) alleles. Transgene expression prevented pathogenesis of prions introduced by intraperitoneal injection in the spleen and brain. Expression of endogenous PrP (PrPC) in the spleen and brain was unaffected, suggesting that immunity was responsible for protection. This indicates the feasibility of immunological inhibition of prion disease in vivo.	Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Inst Lab Anim Sci, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland; Prion AG, CH-8057 Zurich, Switzerland; European Mol Biol Lab, Mouse Biol Programme, I-00016 Monterotondo, Rome, Italy	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; European Molecular Biology Laboratory (EMBL)	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.		Aguzzi, Adriano/A-3351-2008; Heppner, Frank/ABH-8393-2020	Heppner, Frank/0000-0001-9816-8917; Kalinke, Ulrich/0000-0003-0503-9564; Aguzzi, Adriano/0000-0002-0344-6708				ADELSTEIN S, 1991, SCIENCE, V251, P1223, DOI 10.1126/science.1900950; Aguzzi A, 2001, NAT REV MOL CELL BIO, V2, P118, DOI 10.1038/35052063; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Forster I, 1989, Int Immunol, V1, P321, DOI 10.1093/intimm/1.4.321; GABIZON R, 1988, P NATL ACAD SCI USA, V85, P6617, DOI 10.1073/pnas.85.18.6617; HEPPNER FL, UNPUB; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; Hornemann S, 1997, FEBS LETT, V413, P277, DOI 10.1016/S0014-5793(97)00921-6; KITAMOTO T, 1991, J VIROL, V65, P6292, DOI 10.1128/JVI.65.11.6292-6295.1991; Klein MA, 2001, NAT MED, V7, P488, DOI 10.1038/86567; Klein MA, 1998, NAT MED, V4, P1429, DOI 10.1038/4022; Klein MA, 1997, NATURE, V390, P687, DOI 10.1038/37789; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; KOSCO MH, 1992, J IMMUNOL, V148, P2331; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; Raeber AJ, 1999, P NATL ACAD SCI USA, V96, P3987, DOI 10.1073/pnas.96.7.3987; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; SAILER A, 1994, CELL, V77, P967, DOI 10.1016/0092-8674(94)90436-7; TARABOULOS A, 1992, P NATL ACAD SCI USA, V89, P7620, DOI 10.1073/pnas.89.16.7620; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; ZINKERNAGEL RM, 1990, NATURE, V345, P68, DOI 10.1038/345068a0	28	274	298	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2001	294	5540					178	182		10.1126/science.1063093	http://dx.doi.org/10.1126/science.1063093			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11546838				2022-12-01	WOS:000171448800056
J	Hammarstrom, P; Schneider, F; Kelly, JW				Hammarstrom, P; Schneider, F; Kelly, JW			Trans-suppression of misfolding in an amyloid disease	SCIENCE			English	Article							POLYNEUROPATHY; STABILITY; HOMOZYGOSITY; TRANSTHYRETIN-MET30-GENE; PROTEIN	The transthyretin (TTR) amyloid diseases, representative of numerous misfolding disorders, are of considerable interest because there are mutations that cause or suppress disease. The Val(30) --> Met(30) (V30M) TTR mutation is the most prevalent cause of familial amyloid polyneuropathy in heterozygotes, whereas a Thr(119) ---> Met(119) (T119M) mutation on the second TTR allele protects V30M carriers from disease. Here, we show that the incorporation of one or more T119M TTR subunits into a predominantly V30M tetramer strongly stabilized the! mixed tetramer against dissociation. Dissociation is required for amyloid formation, so these findings provide a molecular explanation for intragenic trans-suppression of amyloidosis. The data also suggest a potential therapeutic strategy, provide insight into tissue-specific deposition and amyloid composition, and support the validity of the amyloid hypothesis in human disease.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Kelly, JW (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd BCC265, La Jolla, CA 92037 USA.	jkelly@scripps.edu		Hammarstrom, Per/0000-0001-5827-3587	NIDDK NIH HHS [DK46335-09] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK046335, R01DK046335, R29DK046335] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alves IL, 1997, EUR J BIOCHEM, V249, P662, DOI 10.1111/j.1432-1033.1997.00662.x; Ando Y, 1999, AMYLOID, V6, P119, DOI 10.3109/13506129909007312; Coehlo T., 1996, NEUROMUSCUL DISORD, V6, P27; Coelho Teresa, 1993, Journal of Rheumatology, V20, P179; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; DWULET FE, 1984, P NATL ACAD SCI-BIOL, V81, P694, DOI 10.1073/pnas.81.3.694; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Hammarstrom P, 2001, BIOCHEMISTRY-US, V40, P11453, DOI 10.1021/bi010673+; HOLMGREN G, 1992, CLIN GENET, V41, P39; HOLMGREN G, 1988, CLIN GENET, V34, P333; IKEDA S, 1992, EUR NEUROL, V32, P308, DOI 10.1159/000116850; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; MCCUTCHEN SL, 1995, BIOCHEMISTRY-US, V34, P13527, DOI 10.1021/bi00041a032; Nikolova PV, 2000, EMBO J, V19, P370, DOI 10.1093/emboj/19.3.370; SANDGREN O, 1990, ARCH OPHTHALMOL-CHIC, V108, P1584, DOI 10.1001/archopht.1990.01070130086036; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SARAIVA MJM, 1984, J CLIN INVEST, V74, P104, DOI 10.1172/JCI111390; Schneider F, 2001, PROTEIN SCI, V10, P1606, DOI 10.1110/ps.8901; Schuler B, 1998, J MOL BIOL, V281, P227, DOI 10.1006/jmbi.1998.1944; Sebastiao MP, 2001, J MOL BIOL, V306, P733, DOI 10.1006/jmbi.2000.4415; SUHR OB, 1995, TRANSPLANTATION, V60, P933, DOI 10.1097/00007890-199511150-00009; Yazaki M, 2000, BIOCHEM BIOPH RES CO, V274, P702, DOI 10.1006/bbrc.2000.3203	22	231	238	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2001	293	5539					2459	2462		10.1126/science.1062245	http://dx.doi.org/10.1126/science.1062245			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11577236				2022-12-01	WOS:000171237200049
J	Hwang, I; Sheen, J				Hwang, I; Sheen, J			Two-component circuitry in Arabidopsis cytokinin signal transduction	NATURE			English	Article							2-COMPONENT RESPONSE REGULATOR; MAP KINASE CASCADE; HISTIDINE KINASE; ASP PHOSPHORELAY; LEAF SENESCENCE; PROTEIN-KINASES; PLANTS; THALIANA; YEAST; TRANSFORMATION	Cytokinins are essential plant hormones that are involved in shoot meristem and leaf formation, cell division, chloroplast biogenesis and senescence. Although hybrid histidine protein kinases have been implicated in cytokinin perception in Arabidopsis, the action of histidine protein kinase receptors and the downstream signalling pathway has not been elucidated to date. Here we identify a eukaryotic two-component signalling circuit that initiates cytokinin signalling through distinct hybrid histidine protein kinase activities at the plasma membrane. Histidine phosphotransmitters act as signalling shuttles between the cytoplasm and nucleus in a cytokinin-dependent manner. The short signalling circuit reaches the nuclear target genes by enabling nuclear response regulators ARR1, ARR2 and ARR10 as transcription activators. The cytokinin-inducible ARR4, ARR5, ARR6 and ARR7 genes encode transcription repressors that mediate a negative feedback loop in cytokinin signalling. Ectopic expression in transgenic Arabidopsis of ARR2, the rate-limiting factor in the response to cytokinin, is sufficient to mimic cytokinin in promoting shoot meristem proliferation and leaf differentiation, and in delaying leaf senescence.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Sheen, J (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.		Ding, Cheng-Qiang/B-6287-2011					[Anonymous], 1995, PLANT HORMONES PHYSL, DOI DOI 10.1007/978-94-011-0473-9; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; CLARKE FH, 1995, J DYNAMICAL CONTROL, V0001, P00001, DOI DOI 10.1007/BF02254655; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; D'Agostino IB, 2000, PLANT PHYSIOL, V124, P1706, DOI 10.1104/pp.124.4.1706; D'Agostino IB, 1999, TRENDS BIOCHEM SCI, V24, P452, DOI 10.1016/S0968-0004(99)01465-6; ELBEIN AD, 1984, CRC CR REV BIOCH MOL, V16, P21, DOI 10.3109/10409238409102805; Frank M, 2000, PLANT PHYSIOL, V122, P721, DOI 10.1104/pp.122.3.721; Gamble RL, 1998, P NATL ACAD SCI USA, V95, P7825, DOI 10.1073/pnas.95.13.7825; GAN SS, 1995, SCIENCE, V270, P1986, DOI 10.1126/science.270.5244.1986; Haseloff J, 1997, P NATL ACAD SCI USA, V94, P2122, DOI 10.1073/pnas.94.6.2122; Imamura A, 1999, PLANT CELL PHYSIOL, V40, P733, DOI 10.1093/oxfordjournals.pcp.a029600; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Kakimoto T, 1996, SCIENCE, V274, P982, DOI 10.1126/science.274.5289.982; Kiba T, 1999, PLANT CELL PHYSIOL, V40, P767, DOI 10.1093/oxfordjournals.pcp.a029604; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Lohrmann J, 2001, MOL GENET GENOMICS, V265, P2, DOI 10.1007/s004380000400; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; Meijer M, 2001, CURR OPIN PLANT BIOL, V4, P44, DOI 10.1016/S1369-5266(00)00134-5; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; Nakamura A, 1999, BIOSCI BIOTECH BIOCH, V63, P1627, DOI 10.1271/bbb.63.1627; Ori N, 1999, PLANT CELL, V11, P1073, DOI 10.1105/tpc.11.6.1073; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Posas F, 1998, EMBO J, V17, P1385, DOI 10.1093/emboj/17.5.1385; Quirino BF, 2000, TRENDS PLANT SCI, V5, P278, DOI 10.1016/S1360-1385(00)01655-1; Riou-Khamlichi C, 1999, SCIENCE, V283, P1541, DOI 10.1126/science.283.5407.1541; Sakai H, 1998, PLANT CELL PHYSIOL, V39, P1232, DOI 10.1093/oxfordjournals.pcp.a029325; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Sakakibara H, 2000, PLANT MOL BIOL, V42, P273, DOI 10.1023/A:1006334926388; Sheen J, 1996, SCIENCE, V274, P1900, DOI 10.1126/science.274.5294.1900; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sussman MR, 2000, PLANT PHYSIOL, V124, P1465, DOI 10.1104/pp.124.4.1465; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P107, DOI 10.1093/pcp/pce037; Suzuki T, 1998, PLANT CELL PHYSIOL, V39, P1258, DOI 10.1093/oxfordjournals.pcp.a029329; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P37, DOI 10.1093/pcp/pce011; Suzuki T, 2000, BIOSCI BIOTECH BIOCH, V64, P2486, DOI 10.1271/bbb.64.2486; Thomason P, 2000, J CELL SCI, V113, P3141; Tsiantis M, 2001, PLANT CELL, V13, P733, DOI 10.1105/tpc.13.4.733; Ueguchi C, 2001, PLANT CELL PHYSIOL, V42, P231, DOI 10.1093/pcp/pce015; Urao T, 2000, TRENDS PLANT SCI, V5, P67, DOI 10.1016/S1360-1385(99)01542-3; Urao T, 2000, FEBS LETT, V478, P227, DOI 10.1016/S0014-5793(00)01860-3; Urao T, 1998, FEBS LETT, V427, P175, DOI 10.1016/S0014-5793(98)00418-9; Urao T, 1999, PLANT CELL, V11, P1743, DOI 10.1105/tpc.11.9.1743; WurglerMurphy SM, 1997, TRENDS BIOCHEM SCI, V22, P172, DOI 10.1016/S0968-0004(97)01036-0; Xiang CB, 1999, PLANT MOL BIOL, V40, P711, DOI 10.1023/A:1006201910593; Yanagisawa S, 1998, PLANT CELL, V10, P75, DOI 10.1105/tpc.10.1.75; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976	48	680	747	5	110	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2001	413	6854					383	389		10.1038/35096500	http://dx.doi.org/10.1038/35096500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475UY	11574878				2022-12-01	WOS:000171188700044
J	Moberg, KH; Bell, DW; Wahrer, DCR; Haber, DA; Hariharan, IK				Moberg, KH; Bell, DW; Wahrer, DCR; Haber, DA; Hariharan, IK			Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines	NATURE			English	Article							EYE IMAGINAL DISC; CONTROLS S-PHASE; F-BOX; PROLIFERATION; EXPRESSION; PROTEINS; ELEGANS; BREAST; ARREST; FAMILY	During Drosophila development and mammalian embryogenesis, exit from the cell cycle is contingent on tightly controlled downregulation of the activity of Cyclin E-Cdk2 complexes that normally promote the transition from G1 to S phase(1,2). Although protein degradation has a crucial role in downregulating levels of Cyclin E, many of the proteins that function in degradation of Cyclin E have not been identified. In a screen for Drosophila mutants that display increased cell proliferation, we identified archipelago, a gene encoding a protein with an F-box and seven tandem WD (tryptophan-aspartic acid) repeats. Here we show that archipelago mutant cells have persistently elevated levels of Cyclin E protein without increased levels of cyclin E RNA. They are under-represented in G1 fractions and continue to proliferate when their wild-type neighbours become quiescent. The Archipelago protein binds directly to Cyclin E and probably targets it for ubiquitin-mediated degradation. A highly conserved human homologue is present and is mutated in four cancer cell lines including three of ten derived from ovarian carcinomas. These findings implicate archipelago in developmentally regulated degradation of Cyclin E and potentially in the pathogenesis of human cancers.	Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Hariharan, IK (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Bldg 149,13th St, Charlestown, MA 02129 USA.		Moberg, Ken/J-4849-2017	Moberg, Ken/0000-0002-9820-5543				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Courjal F, 1996, INT J CANCER, V69, P247; Dealy MJ, 1999, NAT GENET, V23, P245, DOI 10.1038/13886; FitzGerald MG, 1997, NAT GENET, V15, P307, DOI 10.1038/ng0397-307; HAY BA, 1994, DEVELOPMENT, V120, P2121; Horsfield J, 1998, DEVELOPMENT, V125, P5069; Hubbard EJA, 1997, GENE DEV, V11, P3182, DOI 10.1101/gad.11.23.3182; Keyomarsi K, 1997, Prog Cell Cycle Res, V3, P171; Kipreos ET, 2000, DEVELOPMENT, V127, P5071; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; Kiyokawa H, 1998, CURR TOP MICROBIOL, V227, P105; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; PERRY MM, 1968, J MORPHOL, V124, P249, DOI 10.1002/jmor.1051240209; RICHARDSON H, 1995, DEVELOPMENT, V121, P3371; Secombe J, 1998, GENETICS, V149, P1867; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Wang YS, 1999, CURR BIOL, V9, P1191, DOI 10.1016/S0960-9822(00)80024-X	22	375	390	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					311	316		10.1038/35095068	http://dx.doi.org/10.1038/35095068			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565033				2022-12-01	WOS:000171040500040
J	Rioual, P; Andrieu-Ponel, V; Rietti-Shati, M; Battarbee, RW; de Beaulieu, JL; Cheddadi, R; Reille, M; Svobodova, H; Shemesh, A				Rioual, P; Andrieu-Ponel, V; Rietti-Shati, M; Battarbee, RW; de Beaulieu, JL; Cheddadi, R; Reille, M; Svobodova, H; Shemesh, A			High-resolution record of climate stability in France during the last interglacial period	NATURE			English	Article							EUROPEAN POLLEN RECORDS; LAKE DEVELOPMENT; OXYGEN ISOTOPES; BIOGENIC SILICA; NORTH-ATLANTIC; OCEAN; RECONSTRUCTION; VARIABILITY; TEMPERATURE; REGION	The last interglacial period (127-110 kyr ago) has been considered to be an analogue to the present interglacial period, the Holocene, which may help us to understand present climate evolution. But whereas Holocene climate has been essentially stable in Europe, variability in climate during the last interglacial period has remained unresolved, because climate reconstructions from ice cores(1,2), continental records(3,4) and marine sediment cores(5,6) give conflicting results for this period(7). Here we present a high-resolution multi-proxy lacustrine record of climate change during the last interglacial period, based on oxygen isotopes in diatom silica, diatom assemblages and pollen-climate transfer functions from the Ribains maar in France. Contrary to a previous study(8), our data do not show a cold event interrupting the warm interglacial climate. Instead, we rnd an early temperature maximum with a transition to a colder climate about halfway through the sequence. The end of the interglacial period is clearly marked by an abrupt change in all proxy records. Our study confirms that in southwestern Europe the last interglacial period was a time of climatic stability and is therefore still likely to represent a useful analogue for the present climate.	UCL, Environm Change Res Ctr, London WC1H 0AP, England; Fac Sci & Tech St Jerome, UDESAM, Inst Mediterraneen Ecol & Paleoecol, CNRS,UMR 6116, F-13397 Marseille 20, France; Weizmann Inst Sci, Dept Environm Sci & Energy Res, IL-76100 Rehovot, Israel; Inst Bot, CZ-25243 Prague, Czech Republic	University of London; University College London; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Weizmann Institute of Science; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Rioual, P (corresponding author), UCL, Environm Change Res Ctr, 26 Bedford Way, London WC1H 0AP, England.	prioual@geog.ucl.ac.uk	ANDRIEU-PONEL, Valerie/J-2818-2014; Svitavska, Helena Svobodova/D-4161-2013; Rioual, Patrick/H-5140-2018	ANDRIEU-PONEL, Valerie/0000-0001-7044-967X; Rioual, Patrick/0000-0001-9491-9197; Svitavska Svobodova, Helena/0000-0001-6092-4588				Aalbersberg G, 1998, J QUATERNARY SCI, V13, P367, DOI 10.1002/(SICI)1099-1417(1998090)13:5<367::AID-JQS400>3.0.CO;2-I; ANKLIN M, 1993, NATURE, V364, P203, DOI 10.1038/364203a0; BATTARBEE RW, 1982, LIMNOL OCEANOGR, V27, P184, DOI 10.4319/lo.1982.27.1.0184; Beyerle U, 1998, SCIENCE, V282, P731, DOI 10.1126/science.282.5389.731; Bjorck S, 2000, QUATERNARY SCI REV, V19, P509, DOI 10.1016/S0277-3791(99)00025-6; Cheddadi R, 1998, PALAEOGEOGR PALAEOCL, V143, P73, DOI 10.1016/S0031-0182(98)00067-4; Cortijo E, 2000, QUATERNARY SCI REV, V19, P227, DOI 10.1016/S0277-3791(99)00063-3; de Beaulieu J.L., 1992, VEG HIST ARCHAEOBOT, V1, P233, DOI DOI 10.1007/BF00189500; Frogley MR, 1999, SCIENCE, V285, P1886, DOI 10.1126/science.285.5435.1886; Fronval T, 1996, NATURE, V383, P806, DOI 10.1038/383806a0; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; GUIOT J, 1989, NATURE, V338, P309, DOI 10.1038/338309a0; JUILLETLECLERC A, 1987, EARTH PLANET SCI NEW, V84, P69, DOI DOI 10.1016/0012-821X(87)90177-4; Kukla G, 1997, QUATERNARY SCI REV, V16, P605, DOI 10.1016/S0277-3791(96)00114-X; Kukla GJ, 2000, SCIENCE, V287, P987, DOI 10.1126/science.287.5455.987; Litt T, 1996, VEG HIST ARCHAEOBOT, V5, P247, DOI 10.1007/BF00217502; MABERLY SC, 1994, FRESHWATER BIOL, V31, P19, DOI 10.1111/j.1365-2427.1994.tb00835.x; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Reille M, 2000, J QUATERNARY SCI, V15, P665, DOI 10.1002/1099-1417(200010)15:7<665::AID-JQS560>3.0.CO;2-G; Rosqvist GC, 1999, GEOLOGY, V27, P967, DOI 10.1130/0091-7613(1999)027<0967:LGTMHC>2.3.CO;2; Rozanski K., 1993, CLIMATE CHANGE CONTI, V78, P1, DOI DOI 10.1029/GM078P0001; SHEMESH A, 1992, SCIENCE, V256, P1434, DOI 10.1126/science.256.5062.1434; Shemesh A, 2001, GEOPHYS RES LETT, V28, P2305, DOI 10.1029/2000GL012720; SMOL JP, 1985, HYDROBIOLOGIA, V123, P199, DOI 10.1007/BF00034378; Stockhausen H, 1999, EARTH PLANET SC LETT, V173, P299, DOI 10.1016/S0012-821X(99)00237-X; Stoermer Eugene F., 1993, Journal of Paleolimnology, V8, P71; THOUVENY N, 1994, NATURE, V371, P503, DOI 10.1038/371503a0; Weckstrom J, 1997, ARCTIC ALPINE RES, V29, P75, DOI 10.2307/1551838; WOILLARD G, 1979, NATURE, V281, P558, DOI 10.1038/281558a0; Wolin JA, 1996, J PALEOLIMNOL, V15, P19; Zagwijn WH, 1996, QUATERNARY SCI REV, V15, P451, DOI 10.1016/0277-3791(96)00011-X	31	92	97	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					293	296		10.1038/35095037	http://dx.doi.org/10.1038/35095037			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565028				2022-12-01	WOS:000171040500035
J	Levinsky, NG; Yu, W; Ash, A; Moskowitz, M; Gazelle, G; Saynina, O; Emanuel, EJ				Levinsky, NG; Yu, W; Ash, A; Moskowitz, M; Gazelle, G; Saynina, O; Emanuel, EJ			Influence of age on medicare expenditures and medical care in the last year of life	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ILL HOSPITALIZED ADULTS; SERIOUSLY ILL; DEATH; MORBIDITY; DECISIONS	Context Expenditures for Medicare beneficiaries in the last year of life decrease with increasing age. The cause of this phenomenon is uncertain. Objectives To examine this pattern in detail and evaluate whether decreases in aggressiveness of medical care explain the phenomenon. Design, Setting, and Patients Analysis of sample Medicare data for beneficiaries aged 65 years or older from Massachusetts (n=34131) and California (n=19064) who died in 1996. Main Outcome Measure Medical expenditures during the last year of life, analyzed by age group, sex, race, place and cause of death, comorbidity, and use of hospital services. Results For Massachusetts and California, respectively, Medicare expenditures per beneficiary were $35300 and $27800 among those aged 65 through 74 years vs $22000 and $21600 for those aged 85 years or older. The pattern of decreasing Medicare expenditures with age is pervasive, persisting throughout the last year of life in both states for both sexes, for black and white beneficiaries, for persons with varying levels of comorbidity, and for those receiving hospice vs conventional care, regardless of cause and site of death. The aggressiveness of medical care in both Massachusetts and California also decreased with age, as judged by less frequent hospital and intensive care unit admissions and by markedly decreasing use of cardiac catheterization, dialysis, ventilators, and pulmonary artery monitors, regardless of cause of death. Decrease in the cost of hospital services accounts for approximately 80% of the decrease in Medicare expenditures with age in both states. Conclusions Medicare expenditures in the last year of life decrease with age, especially for those aged 85 years or older. This is in large part because the aggressiveness of medical care in the last year of life decreases with increasing age.	Boston Univ, Med Ctr, Sch Med, Dept Med,Sect Gen Internal Med,Hlth Care Res Unit, Boston, MA 02118 USA; US Dept Vet Affairs, Hlth Econ Resource Ctr Hlth Sci, Res Serv, Menlo Pk, CA USA; US Dept Vet Affairs, Hlth Econ Resource Ctr Hlth Sci, Dev Serv, Menlo Pk, CA USA; US Dept Vet Affairs, Ctr Cooperat Studies Hlth Serv, Menlo Pk, CA USA; Harvard Vanguard Med Associates, Palliat & Support Med Program, Boston, MA USA; Natl Bur Econ Res, Palo Alto, CA USA; NIH, Dept Clin Bioeth, Bethesda, MD 20892 USA	Boston University; US Department of Veterans Affairs; US Department of Veterans Affairs; US Department of Veterans Affairs; Harvard Vanguard Medical Associates; National Bureau of Economic Research; National Institutes of Health (NIH) - USA	Levinsky, NG (corresponding author), Boston Univ, Med Ctr, Sch Med, Dept Med,Sect Gen Internal Med,Hlth Care Res Unit, 715 Albany St, Boston, MA 02118 USA.		Ash, Arlene/AAG-2914-2019	Ash, Arlene/0000-0002-8448-0253	CLINICAL CENTER [Z01CL010508] Funding Source: NIH RePORTER	CLINICAL CENTER		Callahan D, 2000, NEW ENGL J MED, V342, P654, DOI 10.1056/NEJM200003023420910; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Hamel MB, 1999, ANN INTERN MED, V131, P721, DOI 10.7326/0003-4819-131-10-199911160-00002; Hamel MB, 2000, J AM GERIATR SOC, V48, pS176, DOI 10.1111/j.1532-5415.2000.tb03129.x; Hamel MB, 1996, J AM GERIATR SOC, V44, P1043, DOI 10.1111/j.1532-5415.1996.tb02935.x; Hamel MB, 1999, ANN INTERN MED, V130, P116, DOI 10.7326/0003-4819-130-2-199901190-00005; Johnson MF, 2000, J CLIN ETHIC, V11, P323; Levinsky NG, 1999, J AM GERIATR SOC, V47, P553, DOI 10.1111/j.1532-5415.1999.tb02569.x; Lubitz J, 1984, Health Care Financ Rev, V5, P117; LUBITZ JD, 1993, NEW ENGL J MED, V328, P1092, DOI 10.1056/NEJM199304153281506; PICKLE LW, 1996, ATLAS US MORTALITY, P4; RILEY G, 1987, INQUIRY-J HEALTH CAR, V24, P233; Yu W, 2000, J GEN INTERN MED, V15, P97, DOI 10.1046/j.1525-1497.2000.02349.x	14	148	148	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2001	286	11					1349	1355		10.1001/jama.286.11.1349	http://dx.doi.org/10.1001/jama.286.11.1349			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	473DJ	11560540	Green Published, Bronze			2022-12-01	WOS:000171024500028
J	Valbuzzi, A; Yanofsky, C				Valbuzzi, A; Yanofsky, C			Inhibition of the B-subtilis regulatory protein TRAP by the TRAP-inhibitory protein, AT	SCIENCE			English	Article							BINDING ATTENUATION PROTEIN; BACILLUS-SUBTILIS; LEADER RNA; EXPRESSION; OPERON; GENES; BIOSYNTHESIS; TRANSCRIPTS; REPEATS; DOMAIN	An anti-TRAP (AT) protein, a factor of previously unknown function, conveys the metabolic signal that the cellular transfer RNA for tryptophan (tRNA(Trp)) is predominantly uncharged. Expression of the operon encoding AT is induced by uncharged tRNA(Trp). AT associates with TRAP, the trp operon attenuation protein, and inhibits its binding to its target RNA sequences. This relieves TRAP-mediated transcription termination and translation inhibition, increasing the rate of tryptophan biosynthesis. AT binds to TRAP primarily when it is in the tryptophan-activated state. The 53-residue AT polypeptide is homologous to the zinc-binding domain of DnaJ. The mechanisms regulating tryptophan biosynthesis in Bacillus subtilis differ from those used by Escherichia coli.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Yanofsky, C (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.							Antson AA, 1999, NATURE, V401, P235, DOI 10.1038/45730; ANTSON AA, 1995, NATURE, V374, P693, DOI 10.1038/374693a0; BABITZKE P, 1995, P NATL ACAD SCI USA, V92, P7916, DOI 10.1073/pnas.92.17.7916; BABITZKE P, 1993, P NATL ACAD SCI USA, V90, P133, DOI 10.1073/pnas.90.1.133; BABITZKE P, 1994, J BIOL CHEM, V269, P16597; Du HS, 1997, J BACTERIOL, V179, P2582, DOI 10.1128/jb.179.8.2582-2586.1997; GOLLNICK P, IN PRESS BACILLUS SU; GRUNDY FJ, 1994, J MOL BIOL, V235, P798, DOI 10.1006/jmbi.1994.1038; HALL CV, 1982, J BACTERIOL, V151, P918, DOI 10.1128/JB.151.2.918-923.1982; Henner Dennis, 1993, P269; Martinez-Yamout M, 2000, J MOL BIOL, V300, P805, DOI 10.1006/jmbi.2000.3923; MERINO E, 1995, J BACTERIOL, V177, P6362, DOI 10.1128/jb.177.22.6362-6370.1995; Miller, 1972, EXPT MOL GENETICS; OTRIDGE J, 1993, P NATL ACAD SCI USA, V90, P128, DOI 10.1073/pnas.90.1.128; Sarsero JP, 2000, P NATL ACAD SCI USA, V97, P2656, DOI 10.1073/pnas.050578997; SHIMOTSU H, 1986, J BACTERIOL, V166, P461, DOI 10.1128/jb.166.2.461-471.1986; STEINBERG W, 1974, J BACTERIOL, V117, P1023, DOI 10.1128/JB.117.3.1023-1034.1974; STRAGIER P, 1988, CELL, V52, P697, DOI 10.1016/0092-8674(88)90407-2; Szabo A, 1996, EMBO J, V15, P408, DOI 10.1002/j.1460-2075.1996.tb00371.x; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; VALBUZZI A, UNPUB; YANOFSKY C, 1999, ENCY MOL BIOL, V4, P2676	22	61	64	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					2057	2059		10.1126/science.1062187	http://dx.doi.org/10.1126/science.1062187			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557884				2022-12-01	WOS:000171028700065
J	Ghavidel, A; Schultz, MC				Ghavidel, A; Schultz, MC			TATA binding protein-associated CK2 transduces DNA damage, signals to the RNA polymerase III transcriptional machinery	CELL			English	Article							CASEIN KINASE-II; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; BETA-SUBUNIT; GENE; YEAST; CHECKPOINT; PROMOTERS; CKII; TBP	Here we report that RNA polymerase (pol) III transcription is repressed in response to DNA damage by downregulation of TFIIIB, the core component of the pol III transcriptional machinery. Protein kinase CK2 transduces this stress signal to TFIIIB. CK2 associates with and normally activates the TATA binding protein (TBP) subunit of TFIIIB. The beta regulatory subunit of CK2 binds to TBP and is required for high TBP-associated CK2 activity and pol III transcription in unstressed cells. Transcriptional repression induced by DNA damage requires CK2 and coincides with downregulation of TBP-associated CK2 and dissociation of catalytic subunits from TBP-CK2 complexes. Therefore, CK2 is the terminal effector in a signaling pathway that represses pol III transcription when genome integrity is compromised.	Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	University of Alberta	Schultz, MC (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.							Aboussekhra A, 1998, GENE DEV, V12, P411, DOI 10.1101/gad.12.3.411; Aboussekhra A, 1996, EMBO J, V15, P3912, DOI 10.1002/j.1460-2075.1996.tb00765.x; ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; Ausubel F.M., 1995, CURRENT PROTOCOLS MO; BIDWAI AP, 1995, J BIOL CHEM, V270, P10395, DOI 10.1074/jbc.270.18.10395; BRAUN BR, 1989, P NATL ACAD SCI USA, V86, P2530, DOI 10.1073/pnas.86.8.2530; Chantalat L, 1999, EMBO J, V18, P2930, DOI 10.1093/emboj/18.11.2930; Cho H, 1999, GENE DEV, V13, P1540, DOI 10.1101/gad.13.12.1540; CORMACK BP, 1993, SCIENCE, V262, P244, DOI 10.1126/science.8211143; Dobrowolska G, 1999, MOL CELL BIOCHEM, V191, P3, DOI 10.1023/A:1006882910351; Fan HY, 1996, GENETICS, V142, P749; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Fritz G, 1999, ONCOGENE, V18, P1033, DOI 10.1038/sj.onc.1202394; Ghavidel A, 1999, MOL CELL BIOCHEM, V191, P143, DOI 10.1023/A:1006885522221; Ghavidel A, 1997, GENE DEV, V11, P2780, DOI 10.1101/gad.11.21.2780; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; Guerra B, 1999, ELECTROPHORESIS, V20, P391, DOI 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N; HANNA DE, 1995, J BIOL CHEM, V270, P25905, DOI 10.1074/jbc.270.43.25905; Heriche JK, 1997, SCIENCE, V276, P952, DOI 10.1126/science.276.5314.952; Hockman DJ, 1996, MOL CELL BIOL, V16, P892; *IARC, 1999, IARC MON EV CARC R 3, V71, P1059; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; KASSAVETIS GA, 1989, MOL CELL BIOL, V9, P2551, DOI 10.1128/MCB.9.6.2551; Kelliher MA, 1996, EMBO J, V15, P5160, DOI 10.1002/j.1460-2075.1996.tb00900.x; KOCH H, 1976, BIOCHIM BIOPHYS ACTA, V454, P436, DOI 10.1016/0005-2787(76)90270-7; Landesman-Bollag E, 1998, ONCOGENE, V16, P2965, DOI 10.1038/sj.onc.1201854; Lee TI, 1998, GENE DEV, V12, P1398, DOI 10.1101/gad.12.10.1398; Maldonado E, 1999, FEBS LETT, V443, P256, DOI 10.1016/S0014-5793(98)01734-7; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; McCulloch V, 2000, EMBO J, V19, P4134, DOI 10.1093/emboj/19.15.4134; MIYATA Y, 1992, J BIOL CHEM, V267, P7042; Neufeld TP, 1998, CURR OPIN CELL BIOL, V10, P784, DOI 10.1016/S0955-0674(98)80122-1; NIKOLOV DB, 1994, NAT STRUCT BIOL, V1, P621, DOI 10.1038/nsb0994-621; Orlandini M, 1998, J BIOL CHEM, V273, P21291, DOI 10.1074/jbc.273.33.21291; PEPPERKOK R, 1994, J BIOL CHEM, V269, P6986; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; Polymenis M, 1999, CURR OPIN GENET DEV, V9, P76, DOI 10.1016/S0959-437X(99)80011-2; Raman C, 1998, J IMMUNOL, V161, P5817; Sayed M, 2000, J BIOL CHEM, V275, P16569, DOI 10.1074/jbc.M000312200; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schramm L, 2000, GENE DEV, V14, P2650, DOI 10.1101/gad.836400; SCHULTZ MC, 1992, CELL, V69, P697, DOI 10.1016/0092-8674(92)90233-3; SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532; SETHY I, 1995, J BIOL CHEM, V270, P28463; SIEDE W, 1993, P NATL ACAD SCI USA, V90, P7985, DOI 10.1073/pnas.90.17.7985; SMITH GJ, 1983, MUTAT RES, V111, P405, DOI 10.1016/0027-5107(83)90036-2; TEITZ T, 1990, MUTAT RES, V236, P85, DOI 10.1016/0921-8777(90)90036-5; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WHITE RJ, 1998, RNA POLYM 3 TRANSCRI; ZANDOMENI R, 1986, J BIOL CHEM, V261, P3414; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	52	112	118	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 7	2001	106	5					575	584		10.1016/S0092-8674(01)00473-1	http://dx.doi.org/10.1016/S0092-8674(01)00473-1			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551505	Bronze			2022-12-01	WOS:000170973200008
J	Berlin, S; Ellegren, H				Berlin, S; Ellegren, H			Evolutionary genetics - Clonal inheritance of avian mitochondrial DNA	NATURE			English	Article							MODERN HUMANS; ORIGIN		Uppsala Univ, Dept Evolutionary Biol, Evolutionary Biol Ctr, SE-75236 Uppsala, Sweden	Uppsala University	Berlin, S (corresponding author), Uppsala Univ, Dept Evolutionary Biol, Evolutionary Biol Ctr, Norbyvagen 18D, SE-75236 Uppsala, Sweden.	hans.ellegren@ebc.uu.se						Awadalla P, 1999, SCIENCE, V286, P2524, DOI 10.1126/science.286.5449.2524; Cramp S, 1980, HDB BIRDS EUROPE MID, V2; Ellegren H, 2000, TRENDS ECOL EVOL, V15, P188, DOI 10.1016/S0169-5347(00)01821-8; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; Elson JL, 2001, AM J HUM GENET, V68, P145, DOI 10.1086/316938; Eyre-Walker A, 1999, P ROY SOC B-BIOL SCI, V266, P477, DOI 10.1098/rspb.1999.0662; Fridolfsson AK, 2000, GENETICS, V155, P1903; Garcia-Moreno J, 2000, MOL BIOL EVOL, V17, P1826, DOI 10.1093/oxfordjournals.molbev.a026283; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Klicka J, 1997, SCIENCE, V277, P1666, DOI 10.1126/science.277.5332.1666; MONTELL H, IN PRESS MOL BIOL EV; Nesje M, 2000, HEREDITAS, V132, P261, DOI 10.1111/j.1601-5223.2000.00261.x; Sharma A, 2000, SCIENCE, V288, P977	14	35	37	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2001	413	6851					37	38		10.1038/35092623	http://dx.doi.org/10.1038/35092623			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544517				2022-12-01	WOS:000170801200030
J	Mumby, PJ; Chisholm, JRM; Clark, CD; Hedley, JD; Jaubert, J				Mumby, PJ; Chisholm, JRM; Clark, CD; Hedley, JD; Jaubert, J			Spectrographic imaging - A bird's-eye view of the health of coral reefs	NATURE			English	Article							SPECTRAL DISCRIMINATION		Univ Newcastle Upon Tyne, Dept Marine Sci & Coastal Management, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Observ Oceanol Europeen, Ctr Sci Monaco, MC-98000 Monaco, Monaco; Univ Sheffield, Dept Geog, Sheffield S10 2TN, S Yorkshire, England; Univ Sheffield, Ctr Earth Observat Sci, Sheffield S10 2TN, S Yorkshire, England; Khaled Bin Sultan Living Oceans Fdn, E Lansing, MI 48823 USA	Newcastle University - UK; University of Sheffield; University of Sheffield	Mumby, PJ (corresponding author), Univ Newcastle Upon Tyne, Dept Marine Sci & Coastal Management, Ridley Bldg, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.		Mumby, Peter/F-9914-2010; Clark, Chris/C-3830-2009	Mumby, Peter/0000-0002-6297-9053; Clark, Chris/0000-0002-1021-6679				CARLETON JH, 1995, CORAL REEFS, V14, P35, DOI 10.1007/BF00304070; Clark CD, 2000, INT J REMOTE SENS, V21, P2321, DOI 10.1080/01431160050029602; English S., 1997, SURVEY MANUAL TROPIC, V2nd Edition; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hochberg EJ, 2000, CORAL REEFS, V19, P164, DOI 10.1007/s003380000087; Holden H, 1998, REMOTE SENS ENVIRON, V65, P217, DOI 10.1016/S0034-4257(98)00029-7; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Lubin D, 2001, REMOTE SENS ENVIRON, V75, P127, DOI 10.1016/S0034-4257(00)00161-9; Mumby PJ, 2001, MAR BIOL, V139, P183; Myers MR, 1999, CORAL REEFS, V18, P179, DOI 10.1007/s003380050177; Pittock AB, 1999, AM ZOOL, V39, P10; Tsai F, 1998, REMOTE SENS ENVIRON, V66, P41, DOI 10.1016/S0034-4257(98)00032-7	13	51	53	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					36	36		10.1038/35092617	http://dx.doi.org/10.1038/35092617			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544515				2022-12-01	WOS:000170801200028
J	Chen, LF; Fischle, W; Verdin, E; Greene, WC				Chen, LF; Fischle, W; Verdin, E; Greene, WC			Duration of nuclear NF-kappa B action regulated by reversible acetylation	SCIENCE			English	Article							HISTONE DEACETYLASES; ALPHA; EXPRESSION; PHOSPHORYLATION; INHIBITOR; PROTEINS; BINDING	The nuclear expression and action of the nuclear factor kappa B (NF-kappaB) transcription factor requires signal-coupled phosphorylation and degradation of the I kappaB inhibitors, which normally bind and sequester this pleiotropically active factor in the cytoplasm. The subsequent molecular events that regulate the termination of nuclear NF-kappaB action remain poorly defined, although the activation of de novo I kappaB alpha gene expression by NF-kappaB likely plays a key rote. Our studies now demonstrate that the RelA subunit of NF-kappaB is subject to inducible acetylation and that acetylated forms of RelA interact weakly, if at all, with I kappaB alpha. Acetytated RelA is subsequently deacetylated through a specific interaction with histone deacetylase 3 (HDAC3). This deacetylation reaction promotes effective binding to I kappaB alpha and leads in turn to I kappaB alpha -dependent nuclear export of the complex through a chromosomal region maintenance-1 (CRM-1)-dependent pathway. Deacetylation of RelA by HDAC3 thus acts as an intranuclear molecular switch that both controls the duration of the NF-kappaB transcriptional response and contributes to the replenishment of the depleted cytoplasmic pool of latent NF-kappaB-I kappaB alpha complexes.	Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94141 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Greene, WC (corresponding author), Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA.	wgreene@gladstone.ucsf.edu	Verdin, Eric/AAB-7999-2019	Verdin, Eric/0000-0003-3703-3183	NIMH NIH HHS [P30MH59037] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH059037] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; BOGERD H, 1993, J VIROL, V67, P2496, DOI 10.1128/JVI.67.5.2496-2502.1993; BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; Denoyelle S., SYNTHESIS SAR STUDY; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hottiger MO, 1998, EMBO J, V17, P3124, DOI 10.1093/emboj/17.11.3124; Imhof A, 1998, CURR BIOL, V8, pR422, DOI 10.1016/S0960-9822(98)70268-4; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Klement JF, 1996, MOL CELL BIOL, V16, P2341; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; Spilianakis C, 2000, MOL CELL BIOL, V20, P8489, DOI 10.1128/MCB.20.22.8489-8498.2000; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Yoshida M, 1999, ANN NY ACAD SCI, V886, P23, DOI 10.1111/j.1749-6632.1999.tb09397.x; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	24	994	1029	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2001	293	5535					1653	1657		10.1126/science.1062374	http://dx.doi.org/10.1126/science.1062374			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533489	Green Submitted			2022-12-01	WOS:000170802900062
J	Griffin, CT; Srinivasan, Y; Zheng, YW; Huang, W; Coughlin, SR				Griffin, CT; Srinivasan, Y; Zheng, YW; Huang, W; Coughlin, SR			A role of thrombin receptor signaling in endothelial cells during embryonic development	SCIENCE			English	Article							TISSUE FACTOR; TRANSGENIC MICE; GROWTH-FACTOR; PROTHROMBIN DEFICIENCY; BLEEDING EVENTS; GENE-EXPRESSION; LETHALITY; COAGULATION; HEMORRHAGE	The coagulation protease thrombin triggers fibrin formation, platelet activation, and other cellular responses at sites of tissue injury. We report a rote for PAR1, a protease-activated G protein-coupled receptor for thrombin, in em,. bryonic development. Approximately half of Par1(-/-) mouse embryos died at midgestation with bleeding from multiple sites. PAR1 is expressed in endothelial cells, and a PAR1 transgene driven by an endothetial-specific promoter prevented death of Par1(-/-) embryos. our results suggest that the coagulation cascade and PAR1 modulate endothelial cell function in developing blood vessels and that thrombin's actions on endothelial cells-rather than on platelets, mesenchymal cells, or fibrinogen-contribute to vascular development and hemostasis in the mouse embryo.	Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Coughlin, SR (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.				NHLBI NIH HHS [HL44907, HL65590] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065590, R01HL044907] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bugge TH, 1996, P NATL ACAD SCI USA, V93, P6258, DOI 10.1073/pnas.93.13.6258; Carmeliet P, 1996, NATURE, V383, P73, DOI 10.1038/383073a0; COLMAN RW, 1994, HEMOSTASIS THROMBOSI, P3; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Cui JS, 1996, NATURE, V384, P66, DOI 10.1038/384066a0; DANIEL TO, 1986, J BIOL CHEM, V261, P9579; Darrow AL, 1996, THROMB HAEMOSTASIS, V76, P860; Erlich JH, 2000, AM J PATHOL, V157, P1849, DOI 10.1016/S0002-9440(10)64824-9; Esmon CT, 2000, BLOOD, V95, P1113, DOI 10.1182/blood.V95.4.1113.004k54_1113_1116; GOSPODAROWICZ D, 1978, J CELL BIOL, V77, P774, DOI 10.1083/jcb.77.3.774; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Papadimitriou E, 1997, AM J PHYSIOL-CELL PH, V272, pC1112, DOI 10.1152/ajpcell.1997.272.4.C1112; Rabiet MJP, 1996, ARTERIOSCL THROM VAS, V16, P488, DOI 10.1161/01.ATV.16.3.488; Rugh R, 1990, MOUSE ITS REPROD DEV; SAMBRANO GR, IN PRESS NATURE; SCHLAEGER TM, 1995, DEVELOPMENT, V121, P1089; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; SHIVDASANI RA, 1995, CELL, V81, P695, DOI 10.1016/0092-8674(95)90531-6; SOIFER SJ, 1994, AM J PATHOL, V144, P60; Srinivasan Y, 1998, J CLIN INVEST, V101, P625, DOI 10.1172/JCI1360; SUH TT, 1995, GENE DEV, V9, P2020, DOI 10.1101/gad.9.16.2020; Sun WY, 1998, P NATL ACAD SCI USA, V95, P7597, DOI 10.1073/pnas.95.13.7597; Toomey JR, 1996, BLOOD, V88, P1583; Tsopanoglou NE, 1999, J BIOL CHEM, V274, P23969, DOI 10.1074/jbc.274.34.23969; Vouret-Craviari V, 1998, MOL BIOL CELL, V9, P2639, DOI 10.1091/mbc.9.9.2639; Xue JC, 1998, P NATL ACAD SCI USA, V95, P7603, DOI 10.1073/pnas.95.13.7603	27	221	236	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1666	1670		10.1126/science.1061259	http://dx.doi.org/10.1126/science.1061259			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533492				2022-12-01	WOS:000170802900065
J	Harries, AD; Nyangulu, DS; Hargreaves, NJ; Kaluwa, O; Salaniponi, FM				Harries, AD; Nyangulu, DS; Hargreaves, NJ; Kaluwa, O; Salaniponi, FM			Preventing antiretroviral anarchy in sub-Saharan Africa	LANCET			English	Editorial Material							TUBERCULOSIS; AIDS	Combination antiretroviral therapy has dramatically improved the survival of patients living with HIV and AIDS In Industrialised countries of the world. Despite this enormous benefit, there are some major problems and obstacles to be overcome.(1) Treatment of HIV-infection is likely to be lifelong.(2) Unfortunately, many HIV-Infected individuals cannot tolerate the toxic effects of the drugs, or have difficulty complying with treatment which involves large numbers of pills and complicated dosing schedules. Poor adherence to treatment leads to the emergence of drug-resistant viral strains that need new combinations of drugs or new drugs altogether.	Natl TB Control Programme, Community Hlth Sci Unit, Lilongwe, Malawi; Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; Natl AIDS Control Programme, Lilongwe, Malawi	Liverpool School of Tropical Medicine	Harries, AD (corresponding author), British High Commiss, POB 30042, Lilongwe 3, Malawi.	adharries@malawi.net	Franzeck, Fabian C/B-5055-2011					Attaran A, 2001, LANCET, V357, P57, DOI 10.1016/S0140-6736(00)03576-5; Bosman MCJ, 2000, INT J TUBERC LUNG D, V4, P606; Carr A, 2000, LANCET, V356, P1423, DOI 10.1016/S0140-6736(00)02854-3; Fauci AS, 1999, NEW ENGL J MED, V341, P1046, DOI 10.1056/NEJM199909303411406; HARRIES AD, 1996, WHOTB96200; Harrington M, 2000, LANCET, V355, P2147, DOI 10.1016/S0140-6736(00)02388-6; Horton R, 2000, LANCET, V356, P1541, DOI 10.1016/S0140-6736(00)03122-6; Kumar S, 2001, LANCET, V357, P616, DOI 10.1016/S0140-6736(05)71411-2; MAHER D, 1997, WHOTB97220; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Pozniak AL, 1999, AIDS, V13, P435, DOI 10.1097/00002030-199903110-00001; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Raviglione MC, 1997, LANCET, V350, P624, DOI 10.1016/S0140-6736(97)04146-9; *UNAIDS, 2000, AIDS EP UPD; Volmink J, 2000, LANCET, V355, P1345, DOI 10.1016/S0140-6736(00)02124-3; *WHO, 2000, GLOB TUB CONTR WHO R; *WHO, 2001, WHOHIS200004; Wood E, 2000, LANCET, V355, P2095, DOI 10.1016/S0140-6736(00)02375-8; World Health Organization, 1994, WHOTB94179	19	180	186	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2001	358	9279					410	414		10.1016/S0140-6736(01)05551-9	http://dx.doi.org/10.1016/S0140-6736(01)05551-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502341				2022-12-01	WOS:000170235100036
J	Lam, RW				Lam, RW			Patients' preferences and counselling for depression in primary care	LANCET			English	Editorial Material							CONTROLLED TRIALS; MAJOR DEPRESSION		Univ British Columbia, Dept Psychiat, UBC Hosp, Vancouver, BC V6T 2A1, Canada	University of British Columbia	Lam, RW (corresponding author), Univ British Columbia, Dept Psychiat, UBC Hosp, 2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada.		Lam, Raymond W/D-2529-2013	Lam, Raymond W/0000-0001-7142-4669				Bedi N, 2000, BRIT J PSYCHIAT, V175, P217; Bower P, 2000, BMJ-BRIT MED J, V321, P1389, DOI 10.1136/bmj.321.7273.1389; Churchill R, 1999, BRIT J GEN PRACT, V49, P738; Hotopf M, 1999, BRIT J PSYCHIAT, V175, P217, DOI 10.1192/bjp.175.3.217; Katon W, 1999, ARCH GEN PSYCHIAT, V56, P1109, DOI 10.1001/archpsyc.56.12.1109; Mynors-Wallis LM, 2000, BMJ-BRIT MED J, V320, P26, DOI 10.1136/bmj.320.7226.26; Priest RG, 1996, BRIT MED J, V313, P858; Schulberg HC, 1997, ARCH FAM MED, V6, P334, DOI 10.1001/archfami.6.4.334; Scott C, 1997, BRIT J PSYCHIAT, V171, P131, DOI 10.1192/bjp.171.2.131; SIBBALD B, 1993, BMJ-BRIT MED J, V306, P29, DOI 10.1136/bmj.306.6869.29; Silverman WA, 1996, LANCET, V347, P171, DOI 10.1016/S0140-6736(96)90347-5; Simon GE, 2000, BRIT MED J, V320, P550, DOI 10.1136/bmj.320.7234.550; Torgerson DJ, 1998, BRIT MED J, V316, P360, DOI 10.1136/bmj.316.7128.360; Ward E, 2000, BRIT MED J, V321, P1383, DOI 10.1136/bmj.321.7273.1383	14	4	4	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2001	357	9256					575	576		10.1016/S0140-6736(00)04076-9	http://dx.doi.org/10.1016/S0140-6736(00)04076-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558480				2022-12-01	WOS:000167119100006
J	Holland, HD				Holland, HD			Geochemistry - Evidence for life on Earth more than 3850 million years ago	SCIENCE			English	Editorial Material											Holland, HD (corresponding author), HARVARD UNIV,DEPT EARTH & PLANETARY SCI,20 OXFORD ST,CAMBRIDGE,MA 02138, USA.							Chang S., 1983, EARTHS EARLIEST BIOS, P53; Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0; SCHIDLOWSKI M, 1979, GEOCHIM COSMOCHIM AC, V43, P189, DOI 10.1016/0016-7037(79)90238-2; SCHOPF JW, 1993, SCIENCE, V260, P640, DOI 10.1126/science.260.5108.640	4	39	41	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 3	1997	275	5296					38	39		10.1126/science.275.5296.38	http://dx.doi.org/10.1126/science.275.5296.38			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WA903	11536783				2022-12-01	WOS:A1997WA90300035
J	HEATH, JR; COOKSY, AL; GRUEBELE, MHW; SCHMUTTENMAER, CA; SAYKALLY, RJ				HEATH, JR; COOKSY, AL; GRUEBELE, MHW; SCHMUTTENMAER, CA; SAYKALLY, RJ			DIODE-LASER ABSORPTION-SPECTROSCOPY OF SUPERSONIC CARBON CLUSTER BEAMS - THE V3 SPECTRUM OF C-5	SCIENCE			English	Article											HEATH, JR (corresponding author), UNIV CALIF BERKELEY,DEPT CHEM,BERKELEY,CA 94720, USA.			Cooksy, Andrew/0000-0002-2794-4269; SAYKALLY, RICHARD/0000-0001-8942-3656				BERNATH PF, 1989, SCIENCE, V244, P562, DOI 10.1126/science.244.4904.562; DOUGLAS AE, 1951, ASTROPHYS J, V114, P466, DOI 10.1086/145486; DROWART J, 1959, J CHEM PHYS, V31, P1131, DOI 10.1063/1.1730519; EWING DW, 1987, CHEM PHYS LETT, V134, P413, DOI 10.1016/0009-2614(87)87164-6; FUSINA L, 1980, J MOL SPECTROSC, V79, P101, DOI 10.1016/0022-2852(80)90296-9; GERHARDT P, 1987, CHEM PHYS LETT, V137, P306, DOI 10.1016/0009-2614(87)80889-8; HEATH JR, 1987, J AM CHEM SOC, V109, P359, DOI 10.1021/ja00236a012; HEATH JR, UNPUB; HEATH JR, 1987, ASTROPHYS J, V314, P352; Herzberg G, 1942, ASTROPHYS J, V96, P314, DOI 10.1086/144464; HINKLE KW, 1988, SCIENCE, V241, P1319, DOI 10.1126/science.241.4871.1319; HOFFMANN R, 1966, TETRAHEDRON, V22, P521, DOI 10.1016/0040-4020(66)80020-0; Huggins W., 1882, P R SOC LONDON, V33, P1; KRISHNAN R, 1986, J CHEM PHYS, V85, P6623; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; MAGERS DH, 1986, J CHEM PHYS, V84, P3284, DOI 10.1063/1.450259; MATSUMURA K, 1988, J CHEM PHYS, V89, P3491, DOI 10.1063/1.454919; MCKELLAR ARW, IN PRESS CHEM PHYS L; PITZER KS, 1959, J AM CHEM SOC, V81, P4477, DOI 10.1021/ja01526a010; RAGHAVACHARI K, 1987, J CHEM PHYS, V87, P2191, DOI 10.1063/1.453145; RITCHIE JP, 1986, J CHEM PHYS, V85, P5175, DOI 10.1063/1.451711; ROHLFING EA, 1984, J CHEM PHYS, V81, P3322, DOI 10.1063/1.447994; VALA M, 1989, J CHEM PHYS, V90, P595, DOI 10.1063/1.456458; VANZEE RJ, 1988, J CHEM PHYS, V88, P3465, DOI 10.1063/1.453895; WHITESIDE RA, 1981, CHEM PHYS LETT, V78, P538, DOI 10.1016/0009-2614(81)85253-0	25	89	89	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 5	1989	244	4904					564	566						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	U4450	11539817				2022-12-01	WOS:A1989U445000023
J	Wang, HY; Ma, LG; Li, JM; Zhao, HY; Deng, XW				Wang, HY; Ma, LG; Li, JM; Zhao, HY; Deng, XW			Direct interaction of Arabidopsis cryptochromes with COP1 in light control development	SCIENCE			English	Article							BZIP PROTEIN; GENE; ENCODES; HY5	Arabidopsis seedling photomorphogenesis involves two antagonistically acting components, COP1 and HY5. COP1 specifically targets HY5 for degradation via the 26S proteasome in the dark through their direct physical interaction. Little is known regarding how light signals perceived by photoreceptors are transduced to regulate COP1. Arabidopsis has two related cryptochromes (cry1 and cry2) mediating various blue/ultraviolet-A light responses. Here we show that both photoactivated cryptochromes repress COP1 activity through a direct protein-protein contact and that this direct regulation is primarily responsible for the cryptochrome-mediated blue light regulation of seedling photomorphogenic development and genome expression profile.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Beijing Univ, Coll Life Sci, Peking Yale Joint Ctr Plant Mol Genet & Agrobiote, Beijing 100871, Peoples R China; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA	Yale University; Peking University; Yale University	Deng, XW (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	xingwang.deng@yale.edu	Deng, Xing Wang/ABF-4107-2020		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047850, R37GM047850, R01GM059507, R29GM047850] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-47850, GM59507] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; ANG LH, 1994, PLANT CELL, V6, P613, DOI 10.1105/tpc.6.5.613; Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Chattopadhyay S, 1998, PLANT CELL, V10, P673, DOI 10.1105/tpc.10.5.673; Cosgrove DJ, 2001, PLANT PHYSIOL, V125, P131, DOI 10.1104/pp.125.1.131; DENG XW, 1992, CELL, V71, P791, DOI 10.1016/0092-8674(92)90555-Q; Deng XW, 1999, SEMIN CELL DEV BIOL, V10, P121, DOI 10.1006/scdb.1999.0287; Guo HW, 1999, PLANT J, V19, P279, DOI 10.1046/j.1365-313X.1999.00525.x; Holm M, 1999, PLANT MOL BIOL, V41, P151, DOI 10.1023/A:1006324115086; Lin CT, 1998, P NATL ACAD SCI USA, V95, P2686, DOI 10.1073/pnas.95.5.2686; Lin CT, 1996, PLANT J, V10, P893, DOI 10.1046/j.1365-313X.1996.10050893.x; MA L, IN PRESS PLANT CELL; Maurel C, 2001, PLANT PHYSIOL, V125, P135, DOI 10.1104/pp.125.1.135; MCNELLIS TW, 1994, PLANT CELL, V6, P1391, DOI 10.1105/tpc.6.10.1391; Mockler TC, 1999, DEVELOPMENT, V126, P2073; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Osterlund MT, 1999, TRENDS CELL BIOL, V9, P113, DOI 10.1016/S0962-8924(99)01499-3; Oyama T, 1997, GENE DEV, V11, P2983, DOI 10.1101/gad.11.22.2983; Serino G, 1999, PLANT CELL, V11, P1967, DOI 10.1105/tpc.11.10.1967; Wei N, 1996, PLANT PHYSIOL, V112, P871, DOI 10.1104/pp.112.3.871; Wei N, 1999, TRENDS GENET, V15, P98, DOI 10.1016/S0168-9525(98)01670-9; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7	23	370	409	3	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2001	294	5540					154	158		10.1126/science.1063630	http://dx.doi.org/10.1126/science.1063630			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11509693				2022-12-01	WOS:000171448800050
J	Lai, CSL; Fisher, SE; Hurst, JA; Vargha-Khadem, F; Monaco, AP				Lai, CSL; Fisher, SE; Hurst, JA; Vargha-Khadem, F; Monaco, AP			A forkhead-domain gene is mutated in a severe speech and language disorder	NATURE			English	Article							TRANSCRIPTION FACTORS; CLEFT-PALATE; HEAD; FAMILY; LOCALIZATION; MUTATIONS; GLAUCOMA; MODEL; FOXC1; FKHL7	Individuals affected with developmental disorders of speech and language have substantial difficulty acquiring expressive and/or receptive language in the absence of any profound sensory or neurological impairment and despite adequate intelligence and opportunity(1). Although studies of twins consistently indicate that a significant genetic component is involved(1-3), most families segregating speech and language deficits show complex patterns of inheritance, and a gene that predisposes individuals to such disorders has not been identified. We have studied a unique three-generation pedigree, KE, in which a severe speech and language disorder is transmitted as an autosomal-dominant monogenic trait(4). Our previous work mapped the locus responsible, SPCH1, to a 5.6-cM interval of region 7q31 on chromosome 7 (ref. 5). We also identified an unrelated individual, CS, in whom speech and language impairment is associated with a chromosomal translocation involving the SPCH1 interval(6). Here we show that the gene FOXP2, which encodes a putative transcription factor containing a polyglutamine tract and a forkhead DNA-binding domain, is directly disrupted by the translocation breakpoint in CS. In addition, we identify a point mutation in affected members of the KE family that alters an invariant amino-acid residue in the forkhead domain. Our findings suggest that FOXP2 is involved in the developmental process that culminates in speech and language.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Oxford Radcliffe Hosp, Dept Clin Genet, Oxford OX3 7LJ, England; Inst Child Hlth, Dev Cognit Neurosci Unit, London WC1N 2AP, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of London; University College London	Monaco, AP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.		Vargha-Khadem, Faraneh/C-2558-2008; Monaco, Anthony P/A-4495-2010; Fisher, Simon E./E-9130-2012	Monaco, Anthony P/0000-0001-7480-3197; Fisher, Simon E./0000-0002-3132-1996; vargha-khadem, faraneh/0000-0003-4890-8379				Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; BISHOP DVM, 1995, DEV MED CHILD NEUROL, V37, P56; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Clifton-Bligh RJ, 1998, NAT GENET, V19, P399, DOI 10.1038/1294; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Cummings CJ, 2000, HUM MOL GENET, V9, P909, DOI 10.1093/hmg/9.6.909; Dale PS, 1998, NAT NEUROSCI, V1, P324, DOI 10.1038/1142; De Felice M, 1998, NAT GENET, V19, P395, DOI 10.1038/1289; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; Fisher SE, 1998, NAT GENET, V18, P168, DOI 10.1038/ng0298-168; GOPNIK M, 1991, COGNITION, V39, P1, DOI 10.1016/0010-0277(91)90058-C; Kaestner KH, 2000, GENE DEV, V14, P142; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; Lai CSL, 2000, AM J HUM GENET, V67, P357, DOI 10.1086/303011; LAI E, 1993, P NATL ACAD SCI USA, V90, P10421, DOI 10.1073/pnas.90.22.10421; Lehmann OJ, 2000, AM J HUM GENET, V67, P1129; LI C, 1993, P NATL ACAD SCI USA, V90, P11583, DOI 10.1073/pnas.90.24.11583; Margolis RL, 1997, HUM GENET, V100, P114, DOI 10.1007/s004390050476; Mears AJ, 1998, AM J HUM GENET, V63, P1316, DOI 10.1086/302109; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Nishimura DY, 2001, AM J HUM GENET, V68, P364, DOI 10.1086/318183; Semina EV, 2001, HUM MOL GENET, V10, P231, DOI 10.1093/hmg/10.3.231; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; Smith RS, 2000, HUM MOL GENET, V9, P1021, DOI 10.1093/hmg/9.7.1021; Tomblin JB, 1998, J SPEECH LANG HEAR R, V41, P188, DOI 10.1044/jslhr.4101.188; Vargha-Khadem F, 1998, P NATL ACAD SCI USA, V95, P12695, DOI 10.1073/pnas.95.21.12695; VARGHAKHADEM F, 1995, P NATL ACAD SCI USA, V92, P930, DOI 10.1073/pnas.92.3.930; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; [No title captured]	30	1292	1338	3	221	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2001	413	6855					519	523		10.1038/35097076	http://dx.doi.org/10.1038/35097076			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586359	Green Published			2022-12-01	WOS:000171340500046
J	Falkenburger, BH; Barstow, KL; Mintz, IM				Falkenburger, BH; Barstow, KL; Mintz, IM			Dendrodendritic inhibition through reversal of dopamine transport	SCIENCE			English	Article							RAT SUBSTANTIA NIGRA; VENTRAL TEGMENTAL AREA; DENDRITIC RELEASE; PARS RETICULATA; IN-VITRO; NEURONS; SLICES; ELECTROPHYSIOLOGY; STIMULATION; CHANNELS	Synapses in the central nervous system are usually defined by presynaptic exocytotic release sites and postsynaptic differentiations. We report here a demonstration of dendrodendritic inhibition that does not engage a conventional synapse. Using amperometric and patch-clamp recordings in rat brain slices of the substantia nigra, we found that blockade of the dopamine transporter abolished the dendritic release of dopamine and the resulting self-inhibition. These findings demonstrate that dendrodendritic autoinhibition entails the carrier-mediated release of dopamine rather than conventional exocytosis. This suggests that some widely used antidepressants that inhibit the dopamine transporter may benefit patients in the early stages of Parkinson's disease.	Boston Univ, Med Ctr, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA	Boston University	Mintz, IM (corresponding author), Boston Univ, Med Ctr, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA.	imintz@bu.edu		Falkenburger, Bjoern/0000-0002-2387-526X	PHS HHS [R01-3445] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ARANEDA R, 1989, J NEUROCHEM, V52, P962, DOI 10.1111/j.1471-4159.1989.tb02548.x; BARSTOW KL, 2001, THESIS BOSTON U SCH; Bjorklund A, 1984, HDB CHEM NEUROANAT 1, V2, P55; BUDA M, 1981, EUR J PHARMACOL, V73, P61, DOI 10.1016/0014-2999(81)90145-X; CHERAMY A, 1981, NATURE, V16, P415; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; COLLINGRIDGE GL, 1979, J PHYSIOL-LONDON, V290, pP44; DRAY A, 1976, BRAIN RES, V113, P45, DOI 10.1016/0006-8993(76)90005-6; Elverfors A, 1997, SYNAPSE, V26, P359, DOI 10.1002/(SICI)1098-2396(199708)26:4<359::AID-SYN4>3.0.CO;2-5; ESHLEMAN AJ, 1994, MOL PHARMACOL, V45, P312; GEFFEN LB, 1976, NATURE, V260, P258, DOI 10.1038/260258a0; GIROS B, 1993, TRENDS PHARMACOL SCI, V14, P43, DOI 10.1016/0165-6147(93)90029-J; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; GROVES PM, 1975, SCIENCE, V190, P522, DOI 10.1126/science.242074; HAUSSER M, 1995, NEURON, V15, P637, DOI 10.1016/0896-6273(95)90152-3; Hoffman AF, 1998, J PHARMACOL EXP THER, V287, P487; Hoffman AF, 1999, J PHARMACOL EXP THER, V289, P455; Iribe Y, 1999, J NEUROPHYSIOL, V82, P925, DOI 10.1152/jn.1999.82.2.925; Jaffe EH, 1998, J NEUROSCI, V18, P3548; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; Lai CT, 1997, BIOCHEM PHARMACOL, V53, P363, DOI 10.1016/S0006-2952(96)00731-9; LLINAS R, 1984, BRAIN RES, V294, P127, DOI 10.1016/0006-8993(84)91316-7; Lozano AM, 1998, CURR OPIN NEUROBIOL, V8, P783, DOI 10.1016/S0959-4388(98)80122-0; MINTZ I, 1986, BRAIN RES, V376, P406, DOI 10.1016/0006-8993(86)90209-X; Nirenberg MJ, 1996, J NEUROSCI, V16, P436; PUCAK ML, 1995, CRIT REV NEUROBIOL, V9, P67; Rice ME, 1997, J NEUROPHYSIOL, V77, P853, DOI 10.1152/jn.1997.77.2.853; ROSALES MG, 1994, BRAIN RES, V645, P335, DOI 10.1016/0006-8993(94)91669-1; ROTHMAN RB, 1993, SYNAPSE, V14, P34, DOI 10.1002/syn.890140106; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SHARIF NA, 1992, NEUROCHEM INT, V21, P69, DOI 10.1016/0197-0186(92)90068-3; Sonders MS, 1996, CURR OPIN NEUROBIOL, V6, P294, DOI 10.1016/S0959-4388(96)80111-5; WASSEF M, 1981, NEUROSCIENCE, V6, P2125, DOI 10.1016/0306-4522(81)90003-8; YUNG WH, 1991, J PHYSIOL-LONDON, V436, P643, DOI 10.1113/jphysiol.1991.sp018571	34	163	165	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2001	293	5539					2465	2470		10.1126/science.1060645	http://dx.doi.org/10.1126/science.1060645			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11577238				2022-12-01	WOS:000171237200051
J	Garcia-Pichel, F; Pringault, O				Garcia-Pichel, F; Pringault, O			Microbiology - Cyanobacteria track water in desert soils	NATURE			English	Article							CHEMOTAXIS; MIGRATIONS		Arizona State Univ, Dept Microbiol, Tempe, AZ 85287 USA; Univ Bordeaux 1, Lab Oceanog Biol, CNRS, UMR EPOC 5805, F-33120 Arcachon, France	Arizona State University; Arizona State University-Tempe; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux	Garcia-Pichel, F (corresponding author), Arizona State Univ, Dept Microbiol, Tempe, AZ 85287 USA.	ferran@asu.edu	Pringault, Olivier/A-7399-2008; Pringault, Olivier/P-2495-2019	Pringault, Olivier/0000-0003-2363-8376; Pringault, Olivier/0000-0003-2363-8376				Armitage JP, 1999, ADV MICROB PHYSIOL, V41, P229, DOI 10.1016/S0065-2911(08)60168-X; BEBOUT BM, 1995, APPL ENVIRON MICROB, V61, P4215, DOI 10.1128/AEM.61.12.4215-4222.1995; BELNAP J, 1993, GREAT BASIN NAT, V53, P40; Garcia-Pichel F, 2001, APPL ENVIRON MICROB, V67, P1902, DOI 10.1128/AEM.67.4.1902-1910.2001; GarciaPichel F, 1996, J PHYCOL, V32, P774, DOI 10.1111/j.0022-3646.1996.00774.x; GARCIAPICHEL F, 1994, APPL ENVIRON MICROB, V60, P1500, DOI 10.1128/AEM.60.5.1500-1511.1994; LI CY, 1988, P NATL ACAD SCI USA, V85, P9451, DOI 10.1073/pnas.85.24.9451; MALIN G, 1985, J GEN MICROBIOL, V131, P2643; MARTINAC B, 1990, NATURE, V348, P261, DOI 10.1038/348261a0; Wilkinson PC, 1997, AUTOIMMUNITY, V26, P55, DOI 10.3109/08916939709009550	10	146	154	4	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2001	413	6854					380	381		10.1038/35096640	http://dx.doi.org/10.1038/35096640			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475UY	11574875				2022-12-01	WOS:000171188700041
J	Milan, M; Weihe, U; Perez, L; Cohen, SM				Milan, M; Weihe, U; Perez, L; Cohen, SM			The LRR proteins Capricious and Tartan mediate cell interactions during DV boundary formation in the Drosophila wing	CELL			English	Article							LIM-HOMEODOMAIN ACTIVITY; APICAL ECTODERMAL RIDGE; VENTRAL CELLS; EPH RECEPTORS; DORSOVENTRAL COMPARTMENTALIZATION; LINEAGE RESTRICTION; GRADIENT FORMATION; ADHESION MOLECULE; GENE-EXPRESSION; RADICAL FRINGE	Mechanisms to segregate cell populations play important roles in tissue patterning during animal development. Rhombomeres and compartments in the ectoderm and imaginal discs of Drosophila are examples in which initially homogenous populations of cells come to be separated by boundaries of lineage restriction. Boundary formation depends in part on signaling between the distinctly specified cell populations that comprise compartments and in part on formation of affinity boundaries that prevent intermingling of these cell populations. Here, we present evidence that two transmembrane proteins with leucine-rich repeats, known as Capricious and Tartan, contribute to formation of the affinity boundary between dorsal and ventral compartments during Drosophila wing development.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Cohen, SM (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	cohen@embl-heidelberg.de	Milan, Marco/H-1450-2015; Cohen, Stephen M/G-9930-2011; Perez, Lidia/F-7695-2016	Milan, Marco/0000-0002-7111-6444; Cohen, Stephen M/0000-0003-2858-9163; Perez, Lidia/0000-0002-8821-1202				BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; BLAIR SS, 1994, DEVELOPMENT, V120, P1805; Blair SS, 1997, DEVELOPMENT, V124, P4053; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Bruckner K, 1998, CURR OPIN NEUROBIOL, V8, P375, DOI 10.1016/S0959-4388(98)80064-0; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; CHANG Z, 1993, DEV BIOL, V160, P315, DOI 10.1006/dbio.1993.1310; Cho KO, 2000, CELL, V103, P331, DOI 10.1016/S0092-8674(00)00124-0; COHEN B, 1992, GENE DEV, V6, P715, DOI 10.1101/gad.6.5.715; Dahmann C, 1999, TRENDS GENET, V15, P320, DOI 10.1016/S0168-9525(99)01774-6; Dahmann C, 2000, CELL, V100, P411, DOI 10.1016/S0092-8674(00)80677-7; deCelis JF, 1996, DEVELOPMENT, V122, P359; DiazBenjumea FJ, 1995, DEVELOPMENT, V121, P4215; DIAZBENJUMEA FJ, 1993, CELL, V75, P741, DOI 10.1016/0092-8674(93)90494-B; Doherty D, 1996, GENE DEV, V10, P421, DOI 10.1101/gad.10.4.421; Dominguez M, 1996, SCIENCE, V272, P1621, DOI 10.1126/science.272.5268.1621; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Fernandez-Funez P, 1998, EMBO J, V17, P6846, DOI 10.1093/emboj/17.23.6846; Fleming RJ, 1997, DEVELOPMENT, V124, P2973; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; GARCIABELLIDO A, 1972, GENETICS, V72, P87; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hynes RO, 1999, TRENDS CELL BIOL, V9, pM33, DOI 10.1016/S0962-8924(99)01667-0; IRVINE KD, 1994, CELL, V79, P595, DOI 10.1016/0092-8674(94)90545-2; Laufer E, 1997, NATURE, V386, P366, DOI 10.1038/386366a0; Martin-Blanco E, 2000, P NATL ACAD SCI USA, V97, P7888, DOI 10.1073/pnas.97.14.7888; MEADOWS LA, 1994, J CELL SCI, V107, P321; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Micchelli CA, 1999, NATURE, V401, P473, DOI 10.1038/46779; Milan M, 1999, MOL CELL, V4, P267, DOI 10.1016/S1097-2765(00)80374-3; Milan M, 1998, GENE DEV, V12, P2912, DOI 10.1101/gad.12.18.2912; Milan M, 1999, MOL CELL, V4, P1073, DOI 10.1016/S1097-2765(00)80235-X; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; Morcillo P, 1997, GENE DEV, V11, P2729, DOI 10.1101/gad.11.20.2729; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Raghavan S, 1997, NEURON, V18, P873, DOI 10.1016/S0896-6273(00)80327-X; Raich WB, 1999, CURR BIOL, V9, P1139, DOI 10.1016/S0960-9822(00)80015-9; Ramirez-Weber FA, 2000, MOL CELL, V6, P479, DOI 10.1016/S1097-2765(00)00046-0; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Rauskolb C, 1999, NATURE, V401, P476, DOI 10.1038/46786; Rodriguez I, 1997, NATURE, V389, P614, DOI 10.1038/39343; RodriguezEsteban C, 1997, NATURE, V386, P360, DOI 10.1038/386360a0; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; Salzberg A, 1997, GENETICS, V147, P1723; Shishido E, 1998, SCIENCE, V280, P2118, DOI 10.1126/science.280.5372.2118; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; TABATA T, 1995, DEVELOPMENT, V121, P3359; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; van Meyel DJ, 1999, MOL CELL, V4, P259, DOI 10.1016/S1097-2765(00)80373-1; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vasioukhin V, 2001, CURR OPIN CELL BIOL, V13, P76, DOI 10.1016/S0955-0674(00)00177-0; Vleminckx K, 1999, BIOESSAYS, V21, P211, DOI 10.1002/(SICI)1521-1878(199903)21:3<211::AID-BIES5>3.3.CO;2-G; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; ZECCA M, 1995, DEVELOPMENT, V121, P2265	58	106	107	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 21	2001	106	6					785	794		10.1016/S0092-8674(01)00489-5	http://dx.doi.org/10.1016/S0092-8674(01)00489-5			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	476EJ	11572783	Bronze			2022-12-01	WOS:000171213000014
J	Fox, JE; Starcevic, M; Kow, KY; Burow, ME; McLachlan, JA				Fox, JE; Starcevic, M; Kow, KY; Burow, ME; McLachlan, JA			Nitrogen fixation - Endocrine disrupters and flavonoid signalling	NATURE			English	Article							MELILOTI NODULATION GENES; RHIZOBIUM-MELILOTI; EXPRESSION; INDUCTION; PROTEIN; NODD		Tulane Univ, Environm Endocrinol Lab, Ctr Bioenvironm Res, Sch Med, New Orleans, LA 70112 USA; Xavier Univ, Environm Endocrinol Lab, Ctr Bioenvironm Res, Cincinnati, OH 45207 USA; Tulane Univ, Mol & Cellular Biol Program, Sch Med, New Orleans, LA 70112 USA; Tulane Univ, Dept Pharmacol, Sch Med, New Orleans, LA 70112 USA	Tulane University; Xavier University; Tulane University; Tulane University	McLachlan, JA (corresponding author), Tulane Univ, Environm Endocrinol Lab, Ctr Bioenvironm Res, Sch Med, New Orleans, LA 70112 USA.		Burow, Matthew/D-6351-2013	Burow, Matthew/0000-0002-0642-6630				Baker ME, 1998, ADV EXP MED BIOL, V439, P249; Collins-Burow BM, 2000, NUTR CANCER, V38, P229, DOI 10.1207/S15327914NC382_13; DJORDJEVIC MA, 1987, EMBO J, V6, P1173, DOI 10.1002/j.1460-2075.1987.tb02351.x; FIRMIN JL, 1986, NATURE, V324, P90, DOI 10.1038/324090a0; Gage DJ, 1996, J BACTERIOL, V178, P7159, DOI 10.1128/jb.178.24.7159-7166.1996; GYORGYPAL Z, 1991, MOL GEN GENET, V226, P337, DOI 10.1007/BF00273624; McLachlan JA, 2001, ENDOCR REV, V22, P319, DOI 10.1210/er.22.3.319; MULLIGAN JT, 1985, P NATL ACAD SCI USA, V82, P6609, DOI 10.1073/pnas.82.19.6609; PETERS NK, 1986, SCIENCE, V233, P977, DOI 10.1126/science.3738520; PETERS NK, 1988, PLANT PHYSIOL, V88, P396, DOI 10.1104/pp.88.2.396; REDMOND JW, 1986, NATURE, V323, P632, DOI 10.1038/323632a0; Schultze M, 1998, ANNU REV GENET, V32, P33, DOI 10.1146/annurev.genet.32.1.33; Tham DM, 1998, J CLIN ENDOCR METAB, V83, P2223, DOI 10.1210/jc.83.7.2223	13	49	51	3	38	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					128	129		10.1038/35093163	http://dx.doi.org/10.1038/35093163			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557969				2022-12-01	WOS:000170918800035
J	Gum, PA; Thamilarasan, M; Watanabe, J; Blackstone, EH; Lauer, MS				Gum, PA; Thamilarasan, M; Watanabe, J; Blackstone, EH; Lauer, MS			Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease - A propensity analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC STABLE ANGINA; HEART-RATE RECOVERY; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; PRIMARY PREVENTION; RANDOMIZED-TRIALS; UNSTABLE ANGINA; EXERCISE; ASSOCIATION; PREDICTOR	Context Although aspirin has been shown to reduce cardiovascular morbidity and short-term mortality following acute myocardial infarction, the association between its use and long-term all-cause mortality has not been well defined. Objectives To determine whether aspirin is associated with a mortality benefit in stable patients with known or suspected coronary disease and to identify patient characteristics that predict the maximum absolute mortality benefit from aspirin. Design and Setting Prospective, nonrandomized, observational cohort study conducted between 1990 and 1998 at an academic medical institution, with a median follow-up of 3.1 years. Patients Of 6174 consecutive adults undergoing stress echocardiography for evaluation of known or suspected coronary disease, 2310 (37%) were taking aspirin. Patients with significant valvular disease or documented contraindication to aspirin use, including peptic ulcer disease, renal insufficiency, and use of nonsteroidal antiinflammatory drugs, were excluded. Main Outcome Measure All-cause mortality according to aspirin use. Results During 3.1 years of follow-up, 276 patients (4.5%) died. In a simple univariable analysis, there was no association between aspirin use and mortality(4.5% vs 4.5%). However, after adjustment for age, sex, standard cardiovascular risk factors, use of other medications, coronary disease history, ejection fraction, exercise capacity, heart rate recovery, and echocardiographic ischemia, aspirin use was associated with reduced mortality (hazard ratio [HR], 0.67; 95% confidence interval [CI], 0.51-0.87; P = .002). In further analysis using matching by propensity score, 1351 patients who were taking aspirin were at lower risk for death than 1351 patients not using aspirin (4% vs 8%, respectively; HR, 0.53; 95% Cl, 0.38-0.74; P = .002). After adjusting for the propensity for using aspirin, as well as other possible confounders and interactions, aspirin use remained associated with a lower risk for death (adjusted HR, 0.56; 95% Cl, 0.40-0.78; P<.001). The patient characteristics associated with the most aspirin-related reductions in mortality were older age, known coronary artery disease, and impaired exercise capacity. Conclusion Aspirin use among patients undergoing stress echocardiography was independently associated with reduced long-term all-cause mortality, particularly among older patients, those with known coronary artery disease, and those with impaired exercise capacity.	Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Thorac & Cardiovasc Surg, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Biostat & Epidemiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Lauer, MS (corresponding author), Cleveland Clin Fdn, Dept Cardiol, Desk F25,9500 Euclid Ave, Cleveland, OH 44195 USA.	lauerm@ccf.org	Lauer, Michael S/L-9656-2013	Lauer, Michael S/0000-0002-9217-8177	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066004] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 66004-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; [Anonymous], 1988, LANCET, V2, P349; BASTYR EJ, 1990, AM J MED, V88, P601, DOI 10.1016/0002-9343(90)90525-I; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; BLACKSTONE EH, 1986, J AM STAT ASSOC, V81, P615, DOI 10.2307/2288989; BOYLE CA, 1990, AM J EPIDEMIOL, V131, P160, DOI 10.1093/oxfordjournals.aje.a115470; Buffon A, 1999, J AM COLL CARDIOL, V34, P1512, DOI 10.1016/S0735-1097(99)00348-4; CAIRNS JA, 1985, NEW ENGL J MED, V313, P1369, DOI 10.1056/NEJM198511283132201; CAIRNS P, 1987, ARCH PATHOL LAB MED, V111, P80; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Cook NR, 2000, ARCH INTERN MED, V160, P921, DOI 10.1001/archinte.160.7.921; COX DR, 1972, J R STAT SOC B, V34, P187; Gibbons RJ, 1997, J AM COLL CARDIOL, V30, P260; Harpaz D, 1998, AM J MED, V105, P494, DOI 10.1016/S0002-9343(98)00328-3; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; HUBBARD BL, 1992, ARCH INTERN MED, V152, P309, DOI 10.1001/archinte.152.2.309; Ikonomidis I, 1999, CIRCULATION, V100, P793, DOI 10.1161/01.CIR.100.8.793; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Joint National Committee on Detection Evaluation and Treatment of High Blood Pressure, 1993, ARCH INTERN MED, V153, P154, DOI DOI 10.1001/archinte.1993.00410020010002; JUULMOLLER S, 1992, LANCET, V340, P1421, DOI 10.1016/0140-6736(92)92619-Q; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KESTIN AS, 1993, CIRCULATION, V88, P1502, DOI 10.1161/01.CIR.88.4.1502; Krumholz HM, 2001, ARCH INTERN MED, V161, P577, DOI 10.1001/archinte.161.4.577; Lauer MS, 1999, J AM COLL CARDIOL, V34, P618, DOI 10.1016/S0735-1097(99)00250-8; Lauer MS, 1999, JAMA-J AM MED ASSOC, V281, P524, DOI 10.1001/jama.281.6.524; Lauer MS, 2000, JAMA-J AM MED ASSOC, V283, P2988, DOI 10.1001/jama.283.22.2988; Lauer MS, 1998, J AM COLL CARDIOL, V32, P1280, DOI 10.1016/S0735-1097(98)00377-5; Leor J, 1999, J AM COLL CARDIOL, V33, P1920, DOI 10.1016/S0735-1097(99)00129-1; LEWIS HD, 1983, NEW ENGL J MED, V309, P396, DOI 10.1056/NEJM198308183090703; Lytle BW, 1999, J THORAC CARDIOV SUR, V117, P855, DOI 10.1016/S0022-5223(99)70365-X; MANSON JE, 1991, JAMA-J AM MED ASSOC, V266, P521, DOI 10.1001/jama.266.4.521; Meade TW, 1998, LANCET, V351, P233; MOSES LE, 1995, MED CARE, V33, pAS8; Newman TB, 1997, J AM MED INFORM ASSN, V4, P233, DOI 10.1136/jamia.1997.0040233; Nishime EO, 2000, JAMA-J AM MED ASSOC, V284, P1392, DOI 10.1001/jama.284.11.1392; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Pocock SJ, 2000, NEW ENGL J MED, V342, P1907, DOI 10.1056/NEJM200006223422511; RIDKER PM, 1991, ANN INTERN MED, V114, P835, DOI 10.7326/0003-4819-114-10-835; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Snader CE, 1997, J AM COLL CARDIOL, V30, P641, DOI 10.1016/S0735-1097(97)00217-9; THEROUX P, 1988, NEW ENGL J MED, V319, P1105, DOI 10.1056/NEJM198810273191701; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; TOHGI H, 1992, STROKE, V23, P1400, DOI 10.1161/01.STR.23.10.1400; TRIP MD, 1990, NEW ENGL J MED, V322, P1549, DOI 10.1056/NEJM199005313222201; TSCHOEPE D, 1993, CIRCULATION, V88, P37, DOI 10.1161/01.CIR.88.1.37; WALLENTIN L, 1990, LANCET, V336, P827	49	183	190	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1187	1194		10.1001/jama.286.10.1187	http://dx.doi.org/10.1001/jama.286.10.1187			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471CR	11559263				2022-12-01	WOS:000170910400028
J	Nardi, M; Tomlinson, S; Greco, MA; Karpatkin, S				Nardi, M; Tomlinson, S; Greco, MA; Karpatkin, S			Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia	CELL			English	Article							HEPARIN-INDUCED THROMBOCYTOPENIA; CHRONIC GRANULOMATOUS-DISEASE; MICROPARTICLE FORMATION; PLASMA-MEMBRANE; PROCOAGULANT ACTIVITY; ANTIPLATETLET GPIIIA; ACTIVATED PLATELETS; HIV-1 INFECTION; HOMOSEXUAL MEN; PURPURA	Immunologic thrombocytopenia is seen commonly in HIV-1 infection. The pathogenesis of this problem has been unclear, but it is associated with circulating immune complexes that contain platelet membrane, components and anti-platelet membrane GPIIIa49-66 IgG antibodies. These antibodies cause acute thrombocytopenia when injected into mice. We now show, that purified anti-GPIIIa49-66 causes platelet fragmentation, in vitro in the absence of complement, and in vivo in wild-type and C3-deficient mice. The mechanism of complement-independent platelet lysis; is shown to be caused by the antibody-induced generation of H2O2, as indicated by in vitro experiments with inhibitors of reactive oxygen species, and in vivo studies carried out with p47phox-deficient mice. Thus, a novel mechanism of immunologic platelet clearance is described in which an anti-platelet IgG causes platelet fragmentation via the induction of reactive oxygen species.	NYU, Sch Med, Dept Med, New York, NY 10016 USA; NYU, Sch Med, Dept Pediat, New York, NY 10016 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	New York University; New York University; New York University	Karpatkin, S (corresponding author), NYU, Sch Med, Dept Med, 550 1st Ave, New York, NY 10016 USA.			Nardi, Michael/0000-0002-3276-3198	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL013336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004315] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-13336] Funding Source: Medline; NIDA NIH HHS [DA-04315] Funding Source: Medline; PHS HHS [A134451] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ABRAMS CS, 1990, BLOOD, V75, P128; ARMSTRONG MJ, 1988, BIOCHIM BIOPHYS ACTA, V946, P106, DOI 10.1016/0005-2736(88)90462-2; Aupeix K, 1997, J CLIN INVEST, V99, P1546, DOI 10.1172/JCI119317; Barry OP, 1998, J CLIN INVEST, V102, P136, DOI 10.1172/JCI2592; BASS DA, 1983, J IMMUNOL, V130, P1910; BEAUDOIN AR, 1991, BIOCHIM BIOPHYS ACTA, V1071, P203, DOI 10.1016/0304-4157(91)90014-N; Circolo A, 1999, IMMUNOPHARMACOLOGY, V42, P135, DOI 10.1016/S0162-3109(99)00021-1; FADOK VA, 1992, J IMMUNOL, V149, P4029; FOX JEB, 1991, J BIOL CHEM, V266, P13289; GEMMELL CH, 1993, J BIOL CHEM, V268, P14586; GEORGE JN, 1986, J CLIN INVEST, V78, P340, DOI 10.1172/JCI112582; HOLME PA, 1994, THROMB HAEMOSTASIS, V72, P666; Holme PA, 1998, FASEB J, V12, P79, DOI 10.1096/fasebj.12.1.79; Holme PA, 1998, THROMB HAEMOSTASIS, V79, P389; Holme PA, 1997, ARTERIOSCL THROM VAS, V17, P646, DOI 10.1161/01.ATV.17.4.646; Hughes M, 2000, BLOOD, V96, P188, DOI 10.1182/blood.V96.1.188.013k12_188_194; Inngjerdingen M, 1999, THROMB RES, V95, P215, DOI 10.1016/S0049-3848(99)00035-3; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; JOST J, 1988, SCHWEIZ MED WSCHR, V118, P206; JY W, 1992, J LAB CLIN MED, V119, P119; KARPATKI.S, 1969, J CLIN INVEST, V48, P1073, DOI 10.1172/JCI106063; Karpatkin S, 1997, LANCET, V349, P1531, DOI 10.1016/S0140-6736(96)12118-8; KARPATKIN S, 1988, P NATL ACAD SCI USA, V85, P9763, DOI 10.1073/pnas.85.24.9763; KARPATKIN S, 1995, P NATL ACAD SCI USA, V92, P2263, DOI 10.1073/pnas.92.6.2263; KARPATKIN S, 1992, P NATL ACAD SCI USA, V89, P1487, DOI 10.1073/pnas.89.4.1487; KARPATKIN S, 1992, BLOOD, V80, P3164; Kelton JG, 1996, BRIT J HAEMATOL, V93, P421, DOI 10.1046/j.1365-2141.1996.4891031.x; KHAN I, 1975, BRIT J HAEMATOL, V31, P449, DOI 10.1111/j.1365-2141.1975.tb00880.x; LEAF AN, 1988, ANN INTERN MED, V109, P194, DOI 10.7326/0003-4819-109-3-194; LEE YJ, 1993, THROMB RES, V72, P295, DOI 10.1016/0049-3848(93)90138-E; LIU LX, 1995, BRIT J HAEMATOL, V91, P976; Mallat Z, 1999, CIRCULATION, V99, P348, DOI 10.1161/01.CIR.99.3.348; Miyamoto S, 1998, THROMB HAEMOSTASIS, V80, P225, DOI 10.1055/s-0037-1615177; MORRIS L, 1982, ANN INTERN MED, V96, P714, DOI 10.7326/0003-4819-96-6-714; MURPHY MF, 1987, BRIT J HAEMATOL, V66, P337, DOI 10.1111/j.1365-2141.1987.tb06920.x; NAJEAN Y, 1994, J LAB CLIN MED, V123, P415; Nardi M, 2000, J EXP MED, V191, P2093, DOI 10.1084/jem.191.12.2093; Nardi MA, 1997, P NATL ACAD SCI USA, V94, P7589, DOI 10.1073/pnas.94.14.7589; Nieuwland R, 2000, BLOOD, V95, P930, DOI 10.1182/blood.V95.3.930.003k46_930_935; Nieuwland R, 1997, CIRCULATION, V96, P3534; NOMURA S, 1995, ATHEROSCLEROSIS, V116, P235, DOI 10.1016/0021-9150(95)05551-7; OWENS MR, 1992, THROMB RES, V66, P247, DOI 10.1016/0049-3848(92)90195-G; RATNOFF OD, 1983, NEW ENGL J MED, V308, P439, DOI 10.1056/NEJM198302243080808; SAVONA S, 1985, ANN INTERN MED, V102, P737, DOI 10.7326/0003-4819-102-6-737; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; Segundo C, 1999, BLOOD, V94, P1012, DOI 10.1182/blood.V94.3.1012.415k05_1012_1020; Shcherbina A, 1999, BLOOD, V93, P4222, DOI 10.1182/blood.V93.12.4222.412k34_4222_4231; SIMS PJ, 1989, J BIOL CHEM, V264, P17049; SIMS PJ, 1988, J BIOL CHEM, V263, P18205; Tait JF, 1999, J BIOL CHEM, V274, P3048, DOI 10.1074/jbc.274.5.3048; VARON D, 1983, P NATL ACAD SCI-BIOL, V80, P6992, DOI 10.1073/pnas.80.22.6992; WALSH CM, 1984, NEW ENGL J MED, V311, P635, DOI 10.1056/NEJM198409063111004; WARKENTIN TE, 1994, BLOOD, V84, P3691, DOI 10.1182/blood.V84.11.3691.bloodjournal84113691; WEIDMER T, 1990, BIOCHEMISTRY-US, V29, P623; Wentworth AD, 2000, P NATL ACAD SCI USA, V97, P10930, DOI 10.1073/pnas.97.20.10930; Wolf BB, 1999, BLOOD, V94, P1683, DOI 10.1182/blood.V94.5.1683.417k37_1683_1692; YANO Y, 1993, THROMB RES, V71, P385, DOI 10.1016/0049-3848(93)90163-I; YU JR, 1986, J CLIN INVEST, V77, P1756, DOI 10.1172/JCI112498; ZUCKERFRANKLIN D, 1977, NEW ENGL J MED, V297, P517, DOI 10.1056/NEJM197709082971001	59	110	110	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 7	2001	106	5					551	561		10.1016/S0092-8674(01)00477-9	http://dx.doi.org/10.1016/S0092-8674(01)00477-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551503	Bronze			2022-12-01	WOS:000170973200006
J	Fitzgerald, KA; Palsson-McDermott, EM; Bowie, AG; Jefferies, CA; Mansell, AS; Brady, G; Brint, E; Dunne, A; Gray, P; Harte, MT; McMurray, D; Smith, DE; Sims, JE; Bird, TA; O'Neill, LAJ				Fitzgerald, KA; Palsson-McDermott, EM; Bowie, AG; Jefferies, CA; Mansell, AS; Brady, G; Brint, E; Dunne, A; Gray, P; Harte, MT; McMurray, D; Smith, DE; Sims, JE; Bird, TA; O'Neill, LAJ			Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction	NATURE			English	Article							DROSOPHILA TOLL; MYD88; ACTIVATION; FAMILY; IL-1; LIPOPROTEINS; RECOGNITION; PATHOGENS; ADAPTER; MEMBER	The recognition of microbial pathogens by the innate immune system involves Toll-like receptors (TLRs), which recognize pathogen-associated molecular patterns (1-9). Different TLRs recognize different pathogen-associated molecular patterns, with TLR-4 mediating the response to lipopolysaccharide from Gram-negative bacteria(5-7). All TLRs have a Toll/IL-1 receptor (TIR) domain, which is responsible for signal transduction(1,2). MyD88 is one such protein that contains a TIR domain(10,11). It acts as an adapter, being involved in TLR-2, TLR-4 and TLR-9 signalling(12-15); however, our understanding of how TLR-4 signals is incomplete(15,16). Here we describe a protein, Mal (MyD88-adapter-like), which joins MyD88 as a cytoplasmic TIR-domain-containing protein in the human genome. Mal activates NF-kappaB, Jun amino-terminal kinase and extracellular signal-regulated kinase-1 and -2. Mal can form homodimers and can also form heterodimers with MyD88. Activation of NF-kappaB by Mal requires IRAK-2, but not IRAK, whereas MyD88 requires both IRAKs. Mal associates with IRAK-2 by means of its TIR domain. A dominant negative form of Mal inhibits NF-kappaB, which is activated by TLR-4 or lipopolysaccharide, but it does not inhibit NF-kappaB activation by IL-1RI or IL-18R. Mal associates with TLR-4. Mal is therefore an adapter in TLR-4 signal transduction.	Univ Dublin Trinity Coll, Dept Biochem, Dublin 2, Ireland; Immunex Res & Dev Corp, Seattle, WA 98101 USA	Trinity College Dublin	O'Neill, LAJ (corresponding author), Univ Dublin Trinity Coll, Dept Biochem, Dublin 2, Ireland.		Jefferies, Caroline/AAI-1543-2021; Mansell, Ashley/B-9553-2008; Fitzgerald, Katherine/ABE-6317-2020	Jefferies, Caroline/0000-0002-8879-6722; Mansell, Ashley/0000-0002-6540-1281; Sims, John/0000-0002-5667-9185; O'Neill, Luke/0000-0002-4333-2748; dunne, aisling/0000-0002-2342-9518; Brint, Elizabeth/0000-0001-9214-149X; Fitzgerald, Kate/0000-0003-3175-609X; Brady, Gareth/0000-0001-5376-0060; Bowie, Andrew/0000-0001-5316-4373				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; COSMAN D, 1984, NATURE, V312, P768, DOI 10.1038/312768a0; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Jefferies C, 2001, MOL CELL BIOL, V21, P4544, DOI 10.1128/MCB.21.14.4544-4552.2001; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Schnare M, 2000, CURR BIOL, V10, P1139, DOI 10.1016/S0960-9822(00)00700-4; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008	23	944	1003	0	73	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					78	83		10.1038/35092578	http://dx.doi.org/10.1038/35092578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544529				2022-12-01	WOS:000170801200042
J	Johnson, JP; Zagotta, WN				Johnson, JP; Zagotta, WN			Rotational movement during cyclic nucleotide-gated channel opening	NATURE			English	Article							LIGAND-BINDING DOMAIN; ACTIVATED CHANNELS; GATING MACHINERY; REARRANGEMENTS; STOICHIOMETRY; TRANSITION; MECHANISM; RESIDUE; NICKEL; CELLS	Cyclic nucleotide-gated (CNG) channels are crucial components of visual, olfactory and gustatory signalling pathways. They open in response to direct binding of intracellular cyclic nucleotides and thus contribute to cellular control of both the membrane potential and intracellular Ca2+ levels(1). Cytosolic Ni2+ potentiates the rod channel (CNG1) response to cyclic nucleotides(2-4) and inhibits the olfactory channel (CNG2) response(5). Modulation is due to coordination of Ni2+ by channel-specific histidines in the Clinker, between the S6 transmembrane segment and the cyclic nucleotide-binding domain. Here we report, using a histidine scan of the initial C-linker of the CNG1 channel, stripes of sites producing Ni2+ potentiation or Ni2+ inhibition, separated by 50 degrees on an a-helix. These results suggest a model for channel gating where rotation of the post-S6 region around the channel's central axis realigns the Ni2+-coordinating residues of multiple subunits. This rotation probably initiates movement of the S6 and pore opening.	Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Sch Med, Howard Hughes Med Inst, Box 357290, Seattle, WA 98195 USA.			Johnson Jr., J.P./0000-0002-5762-5138	NEI NIH HHS [R01 EY010329, R01 EY010329-08] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010329] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Broillet MC, 2000, J BIOL CHEM, V275, P15135, DOI 10.1074/jbc.275.20.15135; Brown RL, 1998, BIOPHYS J, V75, P825, DOI 10.1016/S0006-3495(98)77571-X; Cortes DM, 2001, J GEN PHYSIOL, V117, P165, DOI 10.1085/jgp.117.2.165; Cowan J.A., 1997, INORGANIC BIOCH INTR; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Ermler U, 1998, CURR OPIN STRUC BIOL, V8, P749, DOI 10.1016/S0959-440X(98)80095-X; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; GORDON SE, 1995, P NATL ACAD SCI USA, V92, P10222, DOI 10.1073/pnas.92.22.10222; Gordon SE, 1996, BIOCHEMISTRY-US, V35, P3994, DOI 10.1021/bi952607b; GORDON SE, 1995, NEURON, V14, P857, DOI 10.1016/0896-6273(95)90229-5; GORDON SE, 1995, NEURON, V14, P177; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; ILDEFONSE M, 1992, J MEMBRANE BIOL, V130, P91; KARPEN JW, 1993, J GEN PHYSIOL, V101, P1, DOI 10.1085/jgp.101.1.1; KNELLER DG, 1990, J MOL BIOL, V214, P171, DOI 10.1016/0022-2836(90)90154-E; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Maroney MJ, 1999, CURR OPIN CHEM BIOL, V3, P188, DOI 10.1016/S1367-5931(99)80032-5; Matulef K, 1999, NEURON, V24, P443, DOI 10.1016/S0896-6273(00)80857-0; Paoletti P, 1999, J GEN PHYSIOL, V113, P17, DOI 10.1085/jgp.113.1.17; Perozo E, 1998, NAT STRUCT BIOL, V5, P459, DOI 10.1038/nsb0698-459; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Shammat IM, 1999, NEURON, V23, P809, DOI 10.1016/S0896-6273(01)80038-6; Sunderman ER, 1999, J GEN PHYSIOL, V113, P601, DOI 10.1085/jgp.113.5.601; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.neuro.12.1.289; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243; Zong XG, 1998, EMBO J, V17, P353, DOI 10.1093/emboj/17.2.353	26	88	90	1	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2001	412	6850					917	921		10.1038/35091089	http://dx.doi.org/10.1038/35091089			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528481				2022-12-01	WOS:000170689000047
J	Raj, K; Ogston, P; Beard, P				Raj, K; Ogston, P; Beard, P			Virus-mediated killing of cells that lack p53 activity	NATURE			English	Article							ADENOASSOCIATED VIRUS; DNA-DAMAGE; E2 PROTEIN; PHOSPHORYLATION; REQUIREMENT; INHIBITION; MITOSIS; KINASE; CDC25C; PHASE	A major goal of molecular oncology is to identify means to kill cells lacking p53 function. Most current cancer therapy is based on damaging cellular DNA by irradiation or chemicals. Recent reports(1,2) support the notion that, in the event of DNA damage, the p53 tumour-suppressor protein is able to prevent cell death by sustaining an arrest of the cell cycle at the G2 phase. We report here that adeno-associated virus (AAV) selectively induces apoptosis in cells that lack active p53. Cells with intact p53 activity are not killed but undergo arrest in the G2 phase of the cell cycle. This arrest is characterized by an increase in p53 activity and p21 levels and by the targeted destruction of CDC25C. Neither cell killing nor arrest depends upon AAV-encoded proteins. Rather, AAV DNA, which is single-stranded with hairpin structures at both ends(3,4), elicits in cells a DNA damage response that, in the absence of active p53, leads to cell death. AAV inhibits tumour growth in mice. Thus viruses can be used to deliver DNA of unusual structure into cells to trigger a DNA damage response without damaging cellular DNA and to selectively eliminate those cells lacking p53 activity.	Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland	Swiss Institute Experimental Cancer Research	Beard, P (corresponding author), Swiss Inst Expt Canc Res, 155 Ch Boveresses, CH-1066 Epalinges, Switzerland.							BEAMISH H, 1994, INT J RADIAT BIOL, V65, P175, DOI 10.1080/09553009414550211; BERNS KI, 1995, BIOESSAYS, V17, P237, DOI 10.1002/bies.950170310; Blasina A, 1999, CURR BIOL, V9, P1135, DOI 10.1016/S0960-9822(99)80486-2; Bowman T, 1996, GENE DEV, V10, P826, DOI 10.1101/gad.10.7.826; Brown JM, 1999, CANCER RES, V59, P1391; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; DELAMAZA LM, 1981, JNCI-J NATL CANCER I, V67, P1323; Finkel E, 1999, SCIENCE, V286, P2256, DOI 10.1126/science.286.5448.2256; Fournier N, 1999, ONCOGENE, V18, P4015, DOI 10.1038/sj.onc.1202775; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Ogston P, 2000, J VIROL, V74, P3494, DOI 10.1128/JVI.74.8.3494-3504.2000; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rotman G, 1999, ONCOGENE, V18, P6135, DOI 10.1038/sj.onc.1203124; RUFFING M, 1992, J VIROL, V66, P6922, DOI 10.1128/JVI.66.12.6922-6930.1992; Saudan P, 2000, EMBO J, V19, P4351, DOI 10.1093/emboj/19.16.4351; SRIVASTAVA A, 1983, J VIROL, V45, P555, DOI 10.1128/JVI.45.2.555-564.1983; STRAUSFELD U, 1994, J BIOL CHEM, V269, P5989; WOZNIAK AJ, 1983, CANCER RES, V43, P120; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; YANG DZ, 1995, NAT STRUCT BIOL, V2, P577, DOI 10.1038/nsb0795-577	22	161	173	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2001	412	6850					914	917		10.1038/35091082	http://dx.doi.org/10.1038/35091082			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528480				2022-12-01	WOS:000170689000046
J	Aizenberg, J; Tkachenko, A; Weiner, S; Addadi, L; Hendler, G				Aizenberg, J; Tkachenko, A; Weiner, S; Addadi, L; Hendler, G			Calcitic microlenses as part of the photoreceptor system in brittlestars	NATURE			English	Article							OPHIUROIDEA; ECHINODERMATA; BIOMINERALIZATION; LOCALIZATION	Photosensitivity in most echinoderms has been attributed to 'diffuse' dermal receptors(1-3). Here we report that certain single calcite crystals used by brittlestars for skeletal construction(4,5) are also a component of specialized photosensory organs, conceivably with the function of a compound eye. The analysis of arm ossicles in Ophiocoma(6) showed that in light-sensitive species, the periphery of the labyrinthic calcitic skeleton extends into a regular array of spherical microstructures that have a characteristic double-lens design. These structures are absent in light-indifferent species. Photolithographic experiments in which a photoresist film was illuminated through the lens array showed selective exposure of the photoresist under the lens centres. These results provide experimental evidence that the microlenses are optical elements that guide and focus the light inside the tissue. The estimated focal distance (4-7 mum below the lenses) coincides with the location of nerve bundles-the presumed primary photoreceptors. The lens array is designed to minimize spherical aberration and birefringence and to detect light from a particular direction. The optical performance is further optimized by phototropic chromatophores that regulate the dose of illumination reaching the receptors. These structures represent an example of a multifunctional biomaterial that fulfills both mechanical and optical functions.	Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA; Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; Natl Hist Museum Los Angeles Cty, Los Angeles, CA 90007 USA	Alcatel-Lucent; Lucent Technologies; AT&T; Weizmann Institute of Science	Aizenberg, J (corresponding author), Bell Labs, Lucent Technol, 600 Mt Ave, Murray Hill, NJ 07974 USA.		Tkachenko, Alexei V/I-9040-2012	Tkachenko, Alexei V/0000-0003-1291-243X				Aizenberg J, 1997, APPL PHYS LETT, V71, P3773, DOI 10.1063/1.120502; Ameye L, 1999, J HISTOCHEM CYTOCHEM, V47, P1189, DOI 10.1177/002215549904700911; Belcher AM, 1998, ACTA MATER, V46, P733, DOI 10.1016/S1359-6454(97)00253-X; CLARKSON ENK, 1975, NATURE, V254, P663, DOI 10.1038/254663a0; COBB JLS, 1990, COMP BIOCHEM PHYS A, V97, P329, DOI 10.1016/0300-9629(90)90619-4; COBB JLS, 1986, J NEUROCYTOL, V15, P97, DOI 10.1007/BF02057908; Cowles RP, 1910, J EXP ZOOL, V9, P387, DOI 10.1002/jez.1400090209; Doderlein L, 1898, DENKSCHR MED NAT GES, V8, P491; DONNAY G, 1969, SCIENCE, V166, P1147, DOI 10.1126/science.166.3909.1147; FLINT HT, 1936, GEOMETRICAL OPTICS; Gal J, 2000, VISION RES, V40, P843, DOI 10.1016/S0042-6989(99)00216-3; HENDLER G, 1984, PSZNI MAR ECOL, V5, P379, DOI 10.1111/j.1439-0485.1984.tb00131.x; HENDLER G, 1987, ZOOMORPHOLOGY, V107, P261, DOI 10.1007/BF00312172; Hyman L.H., 1955, INVERTEBRATES, V4; Johnsen S, 1997, BIOL BULL, V193, P97, DOI 10.2307/1542739; Land M. F., 1981, COMP PHYSL EVOLUTI B, P471; Lowenstam H. A., 1989, BIOMINERALISATION, P123; Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0; MILLOTT N, 1975, ADV MAR BIOL, V13, P1, DOI 10.1016/S0065-2881(08)60279-5; Smith AB., 1980, SPEC PAP PALAEONTOL, V25, P1; Stubbs T.R., 1982, Echinoderms, P403; TOWE KM, 1973, SCIENCE, V179, P1007, DOI 10.1126/science.179.4077.1007; Wainwright SA., 1976, MECH DESIGN ORGANISM; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Yoshida M., 1984, PHOTORECEPTION ECHIN, P743	25	466	492	10	230	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					819	822		10.1038/35090573	http://dx.doi.org/10.1038/35090573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518966				2022-12-01	WOS:000170577200037
J	Lewis, S; Sherratt, TN; Hamer, KC; Wanless, S				Lewis, S; Sherratt, TN; Hamer, KC; Wanless, S			Evidence of intra-specific competition for food in a pelagic seabird	NATURE			English	Article							COLONY DISTRIBUTIONS; BRITISH-ISLES; POPULATION; SIZE; SEA	The factors affecting the population dynamics of seabirds have long intrigued biologists(1-5). Current data suggest that density-dependent depletion of prey during the breeding season may regulate population size(6-9). However, much of the evidence for this has been circumstantial, and the underlying mechanisms are unclear(5,10). Here, we show that the per capita population growth rates of northern gannet Morus bassanus at colonies in Britain and Ireland have declined with increasing population size. Furthermore, direct observations reveal that the mean foraging trip duration of breeding gannets is positively correlated with colony size, both among colonies of different sizes in the same year, and within colonies as they change in size. To understand this phenomenon, we have developed a model which demonstrates that disturbance of fish alone can readily generate conditions under which gannets at larger colonies have to travel further to obtain food.	Univ Durham, Dept Biol Sci, Durham DH1 3LE, England; Ctr Ecol & Hydrol, Banchory Res Stn, Hill Of Brathens AB31 4BW, Aberdeen, Scotland	Durham University; UK Centre for Ecology & Hydrology (UKCEH)	Sherratt, TN (corresponding author), Univ Durham, Dept Biol Sci, South Rd, Durham DH1 3LE, England.		Wanless, Sarah/K-2338-2012; Lewis, Sue/D-3380-2012	Wanless, Sarah/0000-0002-2788-4606; 				ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Birkhead T.R., 1985, P145; BIRT VL, 1987, MAR ECOL PROG SER, V40, P205, DOI 10.3354/meps040205; CAIRNS DK, 1989, AM NAT, V134, P141, DOI 10.1086/284970; COULSON JC, 1983, BIRD STUDY, V30, P9, DOI 10.1080/00063658309476769; CRAMP S, 1974, SEABIRDS BRITAIN IRE, P238; Croxall JP., 1987, SEABIRDS FEEDING ECO; CROXALL JP, 1991, BIRD POPULATION STUD, P272; Fisher J, 1943, J ANIM ECOL, V12, P173, DOI 10.2307/1376; Forbes LS, 2000, ECOGRAPHY, V23, P575, DOI 10.1034/j.1600-0587.2000.230508.x; Furness R. W., 1997, P INT S ROL FOR FISH, P147; FURNESS RW, 1984, NATURE, V311, P655, DOI 10.1038/311655a0; FURNESS RW, 1992, ARDEA, V80, P105; Garthe S, 1999, MAR ECOL PROG SER, V185, P93, DOI 10.3354/meps185093; GASTON AJ, 1983, CAN J ZOOL, V61, P2465, DOI 10.1139/z83-327; Hamer KC, 2000, MAR ECOL PROG SER, V200, P257, DOI 10.3354/meps200257; HAMER KC, IN PRESS MAR ECOL PR; HUNT GL, 1986, AUK, V103, P306, DOI 10.1093/auk/103.2.306; LACK D, 1966, POPULATION STUDIES B, P252; LLOYD C, 1991, STATUS SEABIRDS BRIT, P13; LOGERWELL EA, 1997, P INT S ROL FOR FISH, P191; MONAGHAN P, 1989, J FISH BIOL, V35, P339; Murray S., 1997, Scottish Birds, V19, P10; MURRAY S, 1986, Scottish Birds, V14, P74; Nelson J. B., 1978, SULIDAE GANNETS BOOB; NUR N, 2000, BIRD STUDY, V46, P575; POLLARD E, 1987, ECOLOGY, V68, P2046, DOI 10.2307/1939895; POTTS GR, 1980, J ANIM ECOL, V49, P465, DOI 10.2307/4258; UPTON AJ, 2000, 24 JNCC UK NAT CONS; WOOLLER RD, 1992, TRENDS ECOL EVOL, V7, P111, DOI 10.1016/0169-5347(92)90143-Y	30	314	325	2	102	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					816	819		10.1038/35090566	http://dx.doi.org/10.1038/35090566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518965				2022-12-01	WOS:000170577200036
J	Sawka, AM; Young, WF; Thompson, GB; Grant, CS; Farley, DR; Leibson, C; van Heerden, JA				Sawka, AM; Young, WF; Thompson, GB; Grant, CS; Farley, DR; Leibson, C; van Heerden, JA			Primary aldosteronism: Factors associated with normalization of blood pressure after surgery	ANNALS OF INTERNAL MEDICINE			English	Article							PRIMARY HYPERALDOSTERONISM; UNILATERAL ADRENALECTOMY; PERSISTENT HYPERTENSION; DIAGNOSIS; PREVALENCE; ADENOMA	Background: Hypertension often persists after adrenalectomy for primary aldosteronism. Objective: To determine factors associated with resolution of hypertension after adrenalectomy for primary aldosteronism. Design: Retrospective cohort study. Setting: Tertiary care referral center in Rochester, Minnesota. Patients: All patients who underwent adrenalectomy for primary aldosteronism between I January 1993 and 31 December 1999. Measurements: Preoperative plasma renin activity, plasma and urinary aldosterone concentrations, and adrenal imaging. Followup blood pressure, measured at a clinic visit or at home, was reviewed. Results: 97 adrenalectomies were performed, and follow-up was available in 93 patients. Hypertension was resolved at follow-up (blood pressure < 140/90 mm Hg) without use of antihypertensive agents in 31 of 93 patients (33%). According to a stepwise multivariable logistic regression analysis adjusted for duration of follow-up, resolution of hypertension was independently associated with family history of hypertension in no more than 1 first-degree relative (odds ratio [OR], 10.9; P < 0.001) and preoperative use of two or fewer antihypertensive agents (OR, 4.7; P = 0.005). Additional factors associated with resolution of hypertension based on univariate analysis included younger age, shorter duration of hypertension, higher preoperative ratio of plasma aldosterone concentration to plasma renin activity, and higher urine aldosterone level (P < 0.05). Conclusions: Resolution of hypertension after adrenalectomy for primary aldosteronism is independently associated with a lack of family history of hypertension and preoperative use of two or fewer anti hypertensive agents.	Mayo Clin & Mayo Fdn, Div Metab Endocrinol & Nutr, Rochester, MN 55905 USA	Mayo Clinic	Young, WF (corresponding author), Mayo Clin & Mayo Fdn, Div Metab Endocrinol & Nutr, 200 1st St SW, Rochester, MN 55905 USA.		Sawka, Anna/AAA-4336-2020					BLUMENFELD JD, 1994, ANN INTERN MED, V121, P877, DOI 10.7326/0003-4819-121-11-199412010-00010; Celen O, 1996, ARCH SURG-CHICAGO, V131, P646; CONN JW, 1990, J LAB CLIN MED, V116, P253; FAVIA G, 1992, WORLD J SURG, V16, P680, DOI 10.1007/BF02067355; GORDON RD, 1994, CLIN EXP PHARMACOL P, V21, P315, DOI 10.1111/j.1440-1681.1994.tb02519.x; IRONY I, 1990, AM J HYPERTENS, V3, P576, DOI 10.1093/ajh/3.7.576; Lim PO, 1999, LANCET, V353, P40, DOI 10.1016/S0140-6736(05)74868-6; Lo CY, 1996, ANN SURG, V224, P125, DOI 10.1097/00000658-199608000-00003; Loh KC, 2000, J CLIN ENDOCR METAB, V85, P2854, DOI 10.1210/jc.85.8.2854; LUND JO, 1981, ACTA MED SCAND, P54; *NAT HIGH BLOOD PR, 1997, REP JOINT NAT COMM P; OBARA T, 1992, SURGERY, V112, P987; Proye CAG, 1998, SURGERY, V124, P1128, DOI 10.1067/msy.1998.93108; Shen WT, 1999, ARCH SURG-CHICAGO, V134, P628, DOI 10.1001/archsurg.134.6.628; STOWASSER M, 1994, CLIN EXP PHARMACOL P, V21, P319, DOI 10.1111/j.1440-1681.1994.tb02520.x; STREETEN DHP, 1979, AM J MED, V67, P403, DOI 10.1016/0002-9343(79)90786-1; Torpy DJ, 1999, VITAM HORM, V57, P177; Young W F Jr, 1999, Cardiol Rev, V7, P207, DOI 10.1097/00045415-199907000-00012; Young WF, 1997, ENDOCRINOLOGIST, V7, P213, DOI 10.1097/00019616-199707040-00003	19	232	242	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2001	135	4					258	261		10.7326/0003-4819-135-4-200108210-00010	http://dx.doi.org/10.7326/0003-4819-135-4-200108210-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465KE	11511140				2022-12-01	WOS:000170587500004
J	Ylikorkala, A; Rossi, DJ; Korsisaari, N; Luukko, K; Alitalo, K; Henkemeyer, M; Makela, TP				Ylikorkala, A; Rossi, DJ; Korsisaari, N; Luukko, K; Alitalo, K; Henkemeyer, M; Makela, TP			Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice	SCIENCE			English	Article							ENDOTHELIAL GROWTH-FACTOR; EMBRYONIC LETHALITY; FACTOR EXPRESSION; GENE; KINASE; ACTIVATION; CARCINOMA; HYPOXIA; PROTEIN; FLK-1	The LKB1 tumor suppressor gene, mutated in Peutz-Jeghers syndrome, encodes a serine/threonine kinase of unknown function. Here we show that mice with a targeted disruption of Lkb1 die at midgestation, with the embryos showing neural tube defects, mesenchymal cell death, and vascular abnormalities. Extraembryonic development was also severely affected; the mutant placentas exhibited defective labyrinth layer development and the fetal vessels failed to invade the placenta. These phenotypes were associated,with tissue-specific deregulation of vascular endothelial growth factor (VEGF) expression, including a marked increase in the amount of VEGF messenger RNA. Moreover, VEGF production in cultured Lkb1(-/-) fibroblasts was elevated in both normoxic and hypoxic conditions. These findings place Lkb1 in the VEGF signaling pathway and suggest that the vascular defects accompanying Lkb1 loss are mediated at least in part by VEGF.	Univ Helsinki, Haartman Inst, Mol & Canc Biol Program, FIN-00014 Helsinki, Finland; Univ Helsinki, Biomedicum Helsinki, FIN-00014 Helsinki, Finland; Univ Bergen, Dept Anat & Cell Biol, N-5009 Bergen, Norway; Univ Helsinki, Cent Hosp, Diagnost Lab, Helsinki 00029, Finland; Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75235 USA	University of Helsinki; University of Helsinki; University of Bergen; University of Helsinki; Helsinki University Central Hospital; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Makela, TP (corresponding author), Univ Helsinki, Haartman Inst, Mol & Canc Biol Program, POB 63, FIN-00014 Helsinki, Finland.		makela, tomi/B-3734-2009; Alitalo, Kari K/J-5013-2014	makela, tomi/0000-0002-4869-8044; Alitalo, Kari K/0000-0002-7331-0902; Henkemeyer, Mark/0000-0002-7525-1061				Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; DUMONT DJ, 1995, DEV DYNAM, V203, P80, DOI 10.1002/aja.1002030109; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Giardiello FM, 2000, GASTROENTEROLOGY, V119, P1447, DOI 10.1053/gast.2000.20228; Gleadle JM, 1997, BLOOD, V89, P503, DOI 10.1182/blood.V89.2.503; Gnarra JR, 1997, P NATL ACAD SCI USA, V94, P9102, DOI 10.1073/pnas.94.17.9102; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; JOYNER AL, 1987, GENE DEV, V1, P29, DOI 10.1101/gad.1.1.29; KAIPAINEN A, 1993, J EXP MED, V178, P2077, DOI 10.1084/jem.178.6.2077; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Luukko K, 1999, MECH DEVELOP, V83, P187, DOI 10.1016/S0925-4773(99)00050-7; Pal S, 1997, J BIOL CHEM, V272, P27509, DOI 10.1074/jbc.272.44.27509; Siemeister G, 1996, CANCER RES, V56, P2299; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; YLIKORKALA A, UNPUB	17	237	256	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1323	1326		10.1126/science.1062074	http://dx.doi.org/10.1126/science.1062074			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509733				2022-12-01	WOS:000170492600042
J	Hammes, A; Guo, JK; Lutsch, G; Leheste, JR; Landrock, D; Ziegler, U; Gubler, MC; Schedl, A				Hammes, A; Guo, JK; Lutsch, G; Leheste, JR; Landrock, D; Ziegler, U; Gubler, MC; Schedl, A			Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation	CELL			English	Article							TUMOR-SUPPRESSOR GENE; SRY-RELATED GENE; FRASIER-SYNDROME; SUBNUCLEAR LOCALIZATION; CAMPOMELIC DYSPLASIA; GLOMERULAR PROTEIN; WT1; EXPRESSION; MOUSE; MUTATIONS	Alternative splicing of Wt1 results in the insertion or omission of the three amino acids KTS between zinc fingers 3 and 4. In vitro experiments suggest distinct molecular functions for + and -KTS isoforms. We have generated mouse strains in which specific isoforms have been removed. Heterozygous mice with a reduction of +KTS levels develop glomerulosclerosis and represent a model for Frasier syndrome. Homozygous mutants of both strains die after birth due to kidney defects. Strikingly, mice lacking +KTS isoforms show a complete XY sex reversal due to a dramatic reduction of Sry expression levels. Our data demonstrate distinct functions for the two splice variants and place the +KTS variants as important regulators for Sty in the sex determination pathway.	MDC Mol Med, D-13092 Berlin, Germany; Hop Necker Enfants Malad, Dept Pediat Nephrol, F-75743 Paris 15, France	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Schedl, A (corresponding author), Newcastle Univ, Sch Biochem & Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	andreas.schedl@ncl.ac.uk	Schedl, Andreas/F-8823-2015; Schedl, Andreas/GOP-3427-2022	Schedl, Andreas/0000-0001-9380-7396; Hammes-Lewin, Annette/0000-0003-1663-8378; Gubler, Marie-Claire/0000-0002-3526-5661				Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; ARMSTRONG JF, 1993, MECH DEVELOP, V40, P85, DOI 10.1016/0925-4773(93)90090-K; Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; BRADLEY A, 1987, TERATOCARCINOMAS EMB, P113; Caricasole A, 1996, P NATL ACAD SCI USA, V93, P7562, DOI 10.1073/pnas.93.15.7562; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; Davies RC, 1998, GENE DEV, V12, P3217, DOI 10.1101/gad.12.20.3217; Davies RC, 2000, HUM MOL GENET, V9, P1177, DOI 10.1093/hmg/9.8.1177; De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653; Englert C, 1995, P NATL ACAD SCI USA, V92, P11960, DOI 10.1073/pnas.92.26.11960; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Gubler M C, 1999, Adv Nephrol Necker Hosp, V29, P299; HACKER A, 1995, DEVELOPMENT, V121, P1603; Herzer U, 1999, CURR BIOL, V9, P837, DOI 10.1016/S0960-9822(99)80369-8; Hogan B., 2014, MANIPULATING MOUSE E; Hossain A, 2001, J BIOL CHEM, V276, P16817, DOI 10.1074/jbc.M009056200; Ito S, 1999, PEDIATR NEPHROL, V13, P790, DOI 10.1007/s004670050702; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kennedy D, 1996, NAT GENET, V12, P329, DOI 10.1038/ng0396-329; KENT J, 1995, ONCOGENE, V11, P1781; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kikuchi H, 1998, J MED GENET, V35, P45, DOI 10.1136/jmg.35.1.45; Kim J, 1999, MOL CELL BIOL, V19, P2289; Klamt B, 1998, HUM MOL GENET, V7, P709, DOI 10.1093/hmg/7.4.709; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Ladomery MR, 1999, J BIOL CHEM, V274, P36520, DOI 10.1074/jbc.274.51.36520; Laity JH, 2000, P NATL ACAD SCI USA, V97, P11932, DOI 10.1073/pnas.97.22.11932; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; Lee SB, 1999, CELL, V98, P663, DOI 10.1016/S0092-8674(00)80053-7; Menke AL, 1998, INT REV CYTOL, V181, P151, DOI 10.1016/S0074-7696(08)60418-0; Miles C, 1998, P NATL ACAD SCI USA, V95, P13068, DOI 10.1073/pnas.95.22.13068; Moore AW, 1999, DEVELOPMENT, V126, P1845; Nachtigal MW, 1998, CELL, V93, P445, DOI 10.1016/S0092-8674(00)81172-1; Nagamine CM, 1999, DEV BIOL, V216, P182, DOI 10.1006/dbio.1999.9436; Patek CE, 1999, P NATL ACAD SCI USA, V96, P2931, DOI 10.1073/pnas.96.6.2931; Putaala H, 2000, J AM SOC NEPHROL, V11, P991, DOI 10.1681/ASN.V116991; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Shimamura R, 1997, CLIN CANCER RES, V3, P2571; Swain A, 1996, NAT GENET, V12, P404, DOI 10.1038/ng0496-404; Swain A, 1998, NATURE, V391, P761, DOI 10.1038/35799; Toyooka Y, 1998, INT J DEV BIOL, V42, P1143; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75; WILLNOW TE, 1994, METHOD CELL BIOL, V43, P305	45	382	396	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2001	106	3					319	329		10.1016/S0092-8674(01)00453-6	http://dx.doi.org/10.1016/S0092-8674(01)00453-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509181	Bronze			2022-12-01	WOS:000170433300010
J	Coker, R				Coker, R			Detention and mandatory treatment for tuberculosis patients in Russia	LANCET			English	Editorial Material									Univ London London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Coker, R (corresponding author), Univ London London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, Keppel St, London WC1E 7HT, England.							Coker R. J., 2000, CHAOS COERCION DETEN; COKER RJ, 1994, IN PRESS THORAX; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; FARMER P, 1999, GLOBAL IMPACT DRUG R; Gasner MR, 1999, NEW ENGL J MED, V340, P359, DOI 10.1056/NEJM199902043400506; GOSTIN LO, 1993, JAMA-J AM MED ASSOC, V269, P255, DOI 10.1001/jama.269.2.255; KRAUT AM, 1994, SILENT TRAVELLERS GE; MACLEOD RM, 1967, PUBLIC LAW, V107, P189; RISSE GB, 1988, AIDS BURDENS HIST, P33; RISSE GB, 1988, AIDS BURDENS HIST; SHILOVA MV, 2000, TUBERCULOSIS RUSSIA; Stern V., 1999, SENTENCED DIE PROBLE; *U CAL FJ CURR NAT, 1996, P C OCT 24 26 1996; Wares DF, 1997, LANCET, V350, P957, DOI 10.1016/S0140-6736(05)63295-3	14	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2001	358	9279					349	350		10.1016/S0140-6736(01)05587-8	http://dx.doi.org/10.1016/S0140-6736(01)05587-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502311				2022-12-01	WOS:000170235100006
J	ALVAREZ, W; ASARO, F; MONTANARI, A				ALVAREZ, W; ASARO, F; MONTANARI, A			IRIDIUM PROFILE FOR 10-MILLION YEARS ACROSS THE CRETACEOUS-TERTIARY BOUNDARY AT GUBBIO (ITALY)	SCIENCE			English	Article									UNIV CALIF BERKELEY LAWRENCE BERKELEY LAB, BERKELEY, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	ALVAREZ, W (corresponding author), UNIV CALIF BERKELEY, DEPT GEOL & GEOPHYS, BERKELEY, CA 94720 USA.				NIDCR NIH HHS [DE-AC03-76SF00098] Funding Source: Medline	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; ALVAREZ LW, 1988, 196TH AM CHEM SOC NA; ALVAREZ W, 1985, J SEDIMENT PETROL, V55, P720; ALVAREZ W, 1977, GEOL SOC AM BULL, V88, P383, DOI 10.1130/0016-7606(1977)88<383:UCMSAG>2.0.CO;2; ALVAREZ W, 1990, SCI AM, V263, P78, DOI 10.1038/scientificamerican1090-78; Alvarez W., 1986, EOS, V67, P649, DOI [10.1029/EO067I035P00649, DOI 10.1029/EO067I035P00649]; ALVAREZ W, 1979, EOS, V60, P734; [Anonymous], [No title captured]; ARTHUR MA, 1977, GEOL SOC AM BULL, V88, P367, DOI 10.1130/0016-7606(1977)88<367:UCMSAG>2.0.CO;2; BERGGREN WA, 1985, GEOL SOC AM BULL, V96, P1407, DOI 10.1130/0016-7606(1985)96<1407:CG>2.0.CO;2; CROCKET JH, 1988, GEOLOGY, V16, P77, DOI 10.1130/0091-7613(1988)016<0077:DONMAT>2.3.CO;2; FISCHER AG, 1986, SOC GEOL ITAL MEM, V31, P45; HERBERT TD, 1990, EARTH PLANET SC LETT, V99, P263, DOI 10.1016/0012-821X(90)90115-E; HERBERT TD, 1986, NATURE, V321, P739, DOI 10.1038/321739a0; Herbert TD, 1986, PALEOCEANOGRAPHY, V1, P495, DOI 10.1029/PA001i004p00495; JOHNSSON MJ, 1986, J SEDIMENT PETROL, V56, P501; KENT DV, 1985, GEOL SOC AM BULL, V96, P1419, DOI 10.1130/0016-7606(1985)96<1419:ACAJG>2.0.CO;2; KOTAKE N, 1989, LETHAIA, V22, P327, DOI 10.1111/j.1502-3931.1989.tb01349.x; KYTE FT, 1986, SCIENCE, V232, P1225, DOI 10.1126/science.232.4755.1225; LOWRIE W, 1990, EARTH PLANET SC LETT, V98, P303, DOI 10.1016/0012-821X(90)90032-S; LOWRIE W, 1981, GEOLOGY, V9, P392, DOI 10.1130/0091-7613(1981)9<392:OHMYOG>2.0.CO;2; LUTERBACHER H. P., 1962, RIV ITAL PALEONTOL E STRATIGR, V68, P253; MICHEL HV, 1985, INITIAL REP DEEP SEA, V86, P533; MICHEL HV, 1990, P OC DRILL PROGR SCI, V0113; ORTH CJ, 1984, SCIENCE, V223, P163, DOI 10.1126/science.223.4632.163; ROCCHIA R, 1990, EARTH PLANET SC LETT, V99, P206, DOI 10.1016/0012-821X(90)90111-A; Schwarzacher W, 1987, PALEOCEANOGRAPHY, V2, P79, DOI 10.1029/PA002i001p00079; SCHWARZACHER W, 1982, CYCLIC EVENT STRATIF, P72; SHARPTON VL, IN PRESS GEOL SOC AM, V247; SMIT J, COMMUNICATION; SMIT J, 1989, TERR ABS, V1, P421; TORNAGHI M E, 1989, Rivista Italiana di Paleontologia e Stratigrafia, V95, P223; VANNUCCI R, 1982, RENDICONTI SOC ITALI, V38, P413; WEZEL FC, 1981, CR ACAD SCI II, V293, P837	34	50	52	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	1990	250	4988					1700	1702		10.1126/science.11538083	http://dx.doi.org/10.1126/science.11538083			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN920	11538083				2022-12-01	WOS:A1990EN92000037
J	MELOSH, HJ				MELOSH, HJ			THE ROCKY ROAD TO PANSPERMIA	NATURE			English	Letter											MELOSH, HJ (corresponding author), UNIV ARIZONA,LUNAR & PLANETARY LAB,TUCSON,AZ 85721, USA.							Curran D. R., 1977, IMPACT EXPLOSION CRA, P1057; GRIEVE RAF, 1987, ANNU REV EARTH PL SC, V15, P245, DOI 10.1146/annurev.ea.15.050187.001333; MCSWEEN HY, 1985, REV GEOPHYS, V23, P391, DOI 10.1029/RG023i004p00391; Melosh H.J., 1981, P 17 LUN PLAN SCI, V12A, P29; MELOSH HJ, 1984, ICARUS, V59, P234, DOI 10.1016/0019-1035(84)90026-5; MELOSH HJ, 1985, GEOLOGY, V13, P144, DOI 10.1130/0091-7613(1985)13<144:EORFFP>2.0.CO;2; Mitchell F.J., 1972, ANAL SURVEYOR 3 MAT, P239; PASSEY QR, 1980, ICARUS, V42, P211, DOI 10.1016/0019-1035(80)90072-X; RODDY DJ, 1987, INT J IMPACT ENG, V5, P525; Schmidt R. M., 1987, INT J IMPACT ENG, V5, P543, DOI [10.1016/0734-743X(87)90069-8, DOI 10.1016/0734-743X(87)90069-8]; VICKERY AM, 1987, SCIENCE, V237, P738, DOI 10.1126/science.237.4816.738; WETHERILL GW, 1984, METEORITICS, V19, P1	12	147	149	3	80	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 21	1988	332	6166					687	688		10.1038/332687a0	http://dx.doi.org/10.1038/332687a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	N0293	11536601				2022-12-01	WOS:A1988N029300038
